PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sountoulidis, A; Stavropoulos, A; Giaglis, S; Apostolou, E; Monteiro, R; Lopes, SMCD; Chen, HY; Stripp, BR; Mummery, C; Andreakos, E; Sideras, P				Sountoulidis, Alexandros; Stavropoulos, Athanasios; Giaglis, Stavros; Apostolou, Eirini; Monteiro, Rui; Lopes, Susana M. Chuva de Sousa; Chen, Huaiyong; Stripp, Barry R.; Mummery, Christine; Andreakos, Evangelos; Sideras, Paschalis			Activation of the Canonical Bone Morphogenetic Protein (BMP) Pathway during Lung Morphogenesis and Adult Lung Tissue Repair	PLOS ONE			English	Article							EMBRYONIC MOUSE LUNG; STEM-CELLS; BRANCHING MORPHOGENESIS; STEM/PROGENITOR CELLS; SIGNAL-TRANSDUCTION; PULMONARY-FIBROSIS; EPITHELIAL-CELLS; SELF-RENEWAL; EXPRESSION; GROWTH	Signaling by Bone Morphogenetic Proteins (BMP) has been implicated in early lung development, adult lung homeostasis and tissue-injury repair. However, the precise mechanism of action and the spatio-temporal pattern of BMP-signaling during these processes remains inadequately described. To address this, we have utilized a transgenic line harboring a BMP-responsive eGFP-reporter allele (BRE-eGFP) to construct the first detailed spatiotemporal map of canonical BMP-pathway activation during lung development, homeostasis and adult-lung injury repair. We demonstrate that during the pseudoglandular stage, when branching morphogenesis progresses in the developing lung, canonical BMP-pathway is active mainly in the vascular network and the sub-epithelial smooth muscle layer of the proximal airways. Activation of the BMP-pathway becomes evident in epithelial compartments only after embryonic day (E) 14.5 primarily in cells negative for epithelial-lineage markers, located in the proximal portion of the airway-tree, clusters adjacent to neuro-epithelial-bodies (NEBs) and in a substantial portion of alveolar epithelial cells. The pathway becomes activated in isolated E12.5 mesenchyme-free distal epithelial buds cultured in Matrigel suggesting that absence of reporter activity in these regions stems from a dynamic cross-talk between endoderm and mesenchyme. Epithelial cells with activated BMP-pathway are enriched in progenitors capable of forming colonies in three-dimensional Matrigel cultures. As lung morphogenesis approaches completion, eGFP-expression declines and in adult lung its expression is barely detectable. However, upon tissue-injury, either with naphthalene or bleomycin, the canonical BMP-pathways is re-activated, in bronchial or alveolar epithelial cells respectively, in a manner reminiscent to early lung development and in tissue areas where reparatory progenitor cells reside. Our studies illustrate the dynamic activation of canonical BMP-pathway during lung development and adult lung tissue-repair and highlight its involvement in two important processes, namely, the early development of the pulmonary vasculature and the management of epithelial progenitor pools both during lung development and repair of adult lung tissue-injury.	[Sountoulidis, Alexandros; Stavropoulos, Athanasios; Giaglis, Stavros; Apostolou, Eirini; Andreakos, Evangelos; Sideras, Paschalis] Acad Athens, Biomed Res Fdn, Ctr Immunol & Transplantat, Athens, Greece; [Monteiro, Rui; Lopes, Susana M. Chuva de Sousa; Mummery, Christine] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Chen, Huaiyong; Stripp, Barry R.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care, Durham, NC USA	Academy of Athens; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Duke University	Sountoulidis, A (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Immunol & Transplantat, Athens, Greece.	sideras@bioacademy.gr	Stripp, Barry/AAI-1467-2021; Monteiro, Rui/AAL-4904-2020; Giaglis, Stavros/GSO-0043-2022; Chen, Huaiyong/G-3822-2014	Monteiro, Rui/0000-0002-4223-8506; Giaglis, Stavros/0000-0003-2216-9539; Stavropoulos, Athanasios/0000-0002-5101-1899; Mummery, Christine/0000-0002-4549-6535; Sideras, Paschalis/0000-0003-0701-1258; Stripp, Barry/0000-0003-4348-2137	Hellenic Ministries of Health and Education; Hellenic Ministry of Development [03ED245, 09SYN-12-1075]; Hellenic Ministry of Finances; European Economic Area-EEA [EL0084]; Interuniversity Attraction Poles (PAI) [P6/20]; General Secretariat of Research and Technology	Hellenic Ministries of Health and Education; Hellenic Ministry of Development; Hellenic Ministry of Finances; European Economic Area-EEA; Interuniversity Attraction Poles (PAI); General Secretariat of Research and Technology(Greek Ministry of Development-GSRT)	This work was supported by core funding from the Hellenic Ministries of Health and Education and by grant awards from the Hellenic Ministry of Development, General Secretariat of Research and Technology (PENED "03ED245" and SYNERGASIA "09SYN-12-1075"), the Hellenic Ministry of Finances and the European Economic Area-EEA (EL0084). SMCSL and CM were supported by the Interuniversity Attraction Poles (PAI) (P6/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Alcazar MA, 2007, DEV DYNAM, V236, P2825, DOI 10.1002/dvdy.21293; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Blank U, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-86; Blewett CJ, 1996, J PEDIATR SURG, V31, P869, DOI 10.1016/S0022-3468(96)90400-5; Bragg AD, 2001, MECH DEVELOP, V109, P13, DOI 10.1016/S0925-4773(01)00508-1; BUCKPITT A, 1995, MOL PHARMACOL, V47, P74; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Farkas L, 2010, AM J RESP CELL  0603; Fulcoli FG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006049; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Hogan B, 1994, MANIPULATING MOUSE E; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; JONES AW, 1978, J PATHOL, V124, P227, DOI 10.1002/path.1711240407; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim Namjin, 2006, Birth Defects Research, V78, P80, DOI 10.1002/bdrc.20062; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Leeuwis JW, 2011, J PATHOL, V224, P121, DOI 10.1002/path.2844; Li Y, 2008, DEV BIOL, V322, P145, DOI 10.1016/j.ydbio.2008.07.021; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Millino C, 2000, DEV DYNAM, V218, P414, DOI 10.1002/1097-0177(200007)218:3<414::AID-DVDY1002>3.0.CO;2-H; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Monteiro RM, 2008, GENESIS, V46, P335, DOI 10.1002/dvg.20402; Myllarniemi M, 2008, J PATHOL, V214, P456, DOI 10.1002/path.2300; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Sun JP, 2008, AM J PATHOL, V172, P571, DOI 10.2353/ajpath.2008.070286; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Teisanu RM, 2011, AM J RESP CELL MOL, V44, P794, DOI 10.1165/rcmb.2010-0098OC; Warburton D, 2004, CURR TOP DEV BIOL, V64, P1, DOI 10.1016/S0070-2153(04)64001-4; Warburton D, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-5; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9; Weaver M, 2000, DEVELOPMENT, V127, P2695; Weaver M, 1999, DEVELOPMENT, V126, P4005; Wiley DM, 2011, SEMIN CELL DEV BIOL, V22, P1012, DOI 10.1016/j.semcdb.2011.10.005; Xu B, 2011, DEVELOPMENT, V138, P925, DOI 10.1242/dev.062687; Xu JS, 2006, J BIOL CHEM, V281, P38894, DOI 10.1074/jbc.M609339200; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	68	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41460	10.1371/journal.pone.0041460	http://dx.doi.org/10.1371/journal.pone.0041460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916109	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800012
J	Corbiere, V; Pottier, G; Bonkain, F; Schepers, K; Verscheure, V; Lecher, S; Doherty, TM; Locht, C; Mascart, F				Corbiere, Veronique; Pottier, Gaelle; Bonkain, Florence; Schepers, Kinda; Verscheure, Virginie; Lecher, Sophie; Doherty, T. Mark; Locht, Camille; Mascart, Francoise			Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays	PLOS ONE			English	Article							HEPARIN-BINDING-HEMAGGLUTININ; TBNET CONSENSUS STATEMENT; ACTIVE TUBERCULOSIS; T-CELL; IMMUNE-RESPONSES; DIALYSIS PATIENTS; PREDICTIVE-VALUE; INFECTION; ANTIGEN; INTERVENTION	Background: Most individuals infected with Mycobacterium tuberculosis develop latent tuberculosis infection (LTBI). Some may progress to active disease and would benefit from preventive treatment yet no means currently exists to predict who will reactivate. Here, we provide an approach to stratify LTBI based on IFN-gamma responses to two antigens, the recombinant Early-Secreted Antigen Target-6 (rESAT-6) and the latency antigen Heparin-Binding Haemagglutinin (HBHA). Methods: We retrospectively analyzed results from in-house IFN-gamma-release assays with HBHA (HBHA-IGRA) and rESAT-6 (rESAT-6-IGRA) performed during a 12-year period on serial blood samples (3 to 9) collected from 23 LTBI subjects in a low-TB incidence country. Both the kinetics of the absolute IFN-gamma concentrations secreted in response to each antigen and the dynamics of HBHA/rESAT-6-induced IFN-gamma concentrations ratios were examined. Results: This analysis allowed the identification among the LTBI subjects of three major groups. Group A featured stable HBHA and rESAT-6-IGRA profiles with an HBHA/rESAT-6 ratio persistently higher than 1, and with high HBHA-and usually negative rESAT-6-IGRA responses throughout the study. Group B had changing HBHA/rESAT-6 ratios fluctuating from 0.0001 to 10,000, with both HBHA and rESAT-6 responses varying over time at least once during the follow-up. Group C was characterized by a progressive disappearance of all responses. Conclusions: By combining the measures of IFN-gamma concentrations secreted in response to an early and a latency antigens, LTBI subjects can be stratified into different risk groups. We propose that disappearing responses indicate cure, that persistent responses to HBHA with HBHA/rESAT-6 ratios >= 1 represent stable LTBI subjects, whereas subjects with ratios varying from >= 1 to <1 should be closely monitored as they may represent the highest-risk group, as illustrated by a case report, and should therefore be prioritized for preventive treatment.	[Corbiere, Veronique; Pottier, Gaelle; Verscheure, Virginie; Mascart, Francoise] Univ Libre Bruxelles ULB Brussels, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Bonkain, Florence] Univ Libre Bruxelles ULB Brussels, Hop Erasme, Dept Nephrol, Brussels, Belgium; [Schepers, Kinda] Univ Libre Bruxelles ULB Brussels, Hop Erasme, Immunodeficiency Unit, Brussels, Belgium; [Lecher, Sophie; Locht, Camille] INSERM, U1019, F-59045 Lille, France; [Lecher, Sophie; Locht, Camille] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Lecher, Sophie; Locht, Camille] Univ Lille Nord France, Inst Pasteur Lille, Lille, France; [Lecher, Sophie; Locht, Camille] Ctr Infect & Immun Lille, Lille, France; [Doherty, T. Mark] Statens Serum Inst, Dept TB Immunol, DK-2300 Copenhagen, Denmark; [Mascart, Francoise] Univ Libre Bruxelles ULB Brussels, Hop Erasme, Immunobiol Clin, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Statens Serum Institut; Universite Libre de Bruxelles	Corbiere, V (corresponding author), Univ Libre Bruxelles ULB Brussels, Lab Vaccinol & Mucosal Immun, Brussels, Belgium.	fmascart@ulb.ac.be		Bonkain, Florence/0000-0002-6643-1300; Locht, Camille/0000-0001-7295-7336	E.C. FP6 program TB-VAC (An integrated project for the design and testing of vaccine candidates against tuberculosis: identification, development, and clinical studies) [LSHP-CT-2003-503367]; FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines) [HEALTH-2009-2.3.2-2]; Region de Bruxelles Capitale	E.C. FP6 program TB-VAC (An integrated project for the design and testing of vaccine candidates against tuberculosis: identification, development, and clinical studies); FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines); Region de Bruxelles Capitale	This work is supported by the E.C. FP6 program TB-VAC (An integrated project for the design and testing of vaccine candidates against tuberculosis: identification, development, and clinical studies)(LSHP-CT-2003-503367), FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines)(HEALTH-2009-2.3.2-2), and the "Region de Bruxelles Capitale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cengiz K, 1996, NEPHRON, V73, P421; Chou KJ, 2001, NEPHRON, V88, P138, DOI 10.1159/000045974; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Lawn SD, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/980594; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Lin May Young, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P15, DOI 10.2174/187153008783928398; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 2006, MICROBES INFECT, V8, P1, DOI 10.1016/j.micinf.2005.03.023; Moore DAJ, 2002, EMERG INFECT DIS, V8, P77, DOI 10.3201/eid0801.010017; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Parra M, 2004, INFECT IMMUN, V72, P6799, DOI 10.1128/IAI.72.12.6799-6805.2004; Place S, 2010, AM J RESP CRIT CARE, V182, P848, DOI 10.1164/rccm.201001-0083OC; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Rouanet Carine, 2010, Expert Rev Respir Med, V4, P339, DOI 10.1586/ers.10.25; Rouanet C, 2009, MICROBES INFECT, V11, P995, DOI 10.1016/j.micinf.2009.07.005; Segall L, 2010, CLIN J AM SOC NEPHRO, V5, P1114, DOI 10.2215/CJN.09231209; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Temmerman ST, 2005, J INFECT DIS, V192, P226, DOI 10.1086/430930; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; WILKINSON D, 2000, COCHRANE DB SYST REV, V4; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	34	49	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43285	10.1371/journal.pone.0043285	http://dx.doi.org/10.1371/journal.pone.0043285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912846	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700075
J	El Hamidieh, A; Grammatikakis, N; Patsavoudi, E				El Hamidieh, Avraam; Grammatikakis, Nicholas; Patsavoudi, Evangelia			Cell Surface Cdc37 Participates in Extracellular HSP90 Mediated Cancer Cell Invasion	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY 4C5; DEVELOPING NERVOUS-SYSTEM; KINASE-TARGETING SUBUNIT; MOLECULAR CHAPERONE; P50(CDC37); HSP90-ALPHA; METASTASIS; ONCOGENE; PATHWAYS; MOTILITY	Cdc37 is a 50 kDa molecular chaperone which targets intrinsically unstable protein kinases to the molecular chaperone HSP90. It is also an over-expressed oncoprotein that mediates carcinogenesis and maintenance of the malignant phenotype by stabilizing the compromised structures of mutant and/or over-expressed oncogenic kinases. Here we report that Cdc37 is not restricted intracellularly but instead it is also present on the surface of MDA-MB-453 and MDA-MB-231 human breast cancer cells, where it is shown to participate in cancer cell motility processes. Furthermore, we demonstrate using an anti-Cdc37 cell impermeable antibody, that similarly to its intracellular counterpart, this surface pool of Cdc37 specifically interacts with HSP90 as well as the kinase receptors HER2 and EGFR on the cell surface, probably acting as a co-factor in HSP90's extracellular chaperoning activities. Finally, we show that functional inhibition of surface HSP90 using mAb 4C5, a cell impermeable monoclonal antibody against this protein, leads not only to disruption of the Cdc37/HSP90 complex but also to inhibition of the Cdc37/ErbB receptors complexes. These results support an essential role for surface Cdc37 in concert with HSP90 on the cell surface during cancer cell invasion processes and strengthen the therapeutic potential of mAb 4C5 for the treatment of cancer.	[El Hamidieh, Avraam; Patsavoudi, Evangelia] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece; [Grammatikakis, Nicholas] Natl Ctr Sci Res Demokritos, Inst Biol, Athens, Greece; [Patsavoudi, Evangelia] Technol Educ Inst Athens, Dept Biomed Instrumentat Technol, Athens, Greece	National Centre of Scientific Research "Demokritos"; University of West Attica	El Hamidieh, A (corresponding author), Hellenic Pasteur Inst, Dept Biochem, Athens, Greece.	epatsavoudi@pasteur.gr			Hellenic Pasteur Institute	Hellenic Pasteur Institute	AEH received a fellowship from the Hellenic Pasteur Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2004, MOL CANCER THER, V3, P1021; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Casas S, 2003, CANCER GENET CYTOGEN, V146, P89, DOI 10.1016/S0165-4608(03)00102-X; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Eustace BK, 2004, CELL CYCLE, V3, P1098; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Feo F, 2006, BBA-REV CANCER, V1765, P126, DOI 10.1016/j.bbcan.2005.08.007; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Katayama Y, 2004, INT J ONCOL, V25, P579; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Matei D, 2007, J BIOL CHEM, V282, P445, DOI 10.1074/jbc.M607012200; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; PATSAVOUDI E, 1991, J NEUROCHEM, V56, P782, DOI 10.1111/j.1471-4159.1991.tb01992.x; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Smith JR, 2009, CELL CYCLE, V8, P362, DOI 10.4161/cc.8.3.7531; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 1997, METHOD ENZYMOL, V283, P220; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000; THOMAIDOU D, 1993, NEUROSCIENCE, V53, P813, DOI 10.1016/0306-4522(93)90626-Q; Thompson MA, 2005, HUM PATHOL, V36, P494, DOI 10.1016/j.humpath.2005.03.004; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	38	29	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42722	10.1371/journal.pone.0042722	http://dx.doi.org/10.1371/journal.pone.0042722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912728	gold, Green Submitted, Green Published			2022-12-27	WOS:000308063700019
J	Gutknecht, L; Araragi, N; Merker, S; Waider, J; Sommerlandt, FMJ; Mlinar, B; Baccini, G; Mayer, U; Proft, F; Hamon, M; Schmitt, AG; Corradetti, R; Lanfumey, L; Lesch, KP				Gutknecht, Lise; Araragi, Naozumi; Merker, Soeren; Waider, Jonas; Sommerlandt, Frank M. J.; Mlinar, Boris; Baccini, Gilda; Mayer, Ute; Proft, Florian; Hamon, Michel; Schmitt, Angelika G.; Corradetti, Renato; Lanfumey, Laurence; Lesch, Klaus-Peter			Impacts of Brain Serotonin Deficiency following Tph2 Inactivation on Development and Raphe Neuron Serotonergic Specification	PLOS ONE			English	Article							KNOCK-OUT MICE; ENERGY-EXPENDITURE; LOCOMOTOR-ACTIVITY; 5-HT TRANSPORTER; ANXIETY-LIKE; RECEPTORS; BEHAVIOR; TRYPTOPHAN; NUCLEUS; LACKING	Brain serotonin (5-HT) is implicated in a wide range of functions from basic physiological mechanisms to complex behaviors, including neuropsychiatric conditions, as well as in developmental processes. Increasing evidence links 5-HT signaling alterations during development to emotional dysregulation and psychopathology in adult age. To further analyze the importance of brain 5-HT in somatic and brain development and function, and more specifically differentiation and specification of the serotonergic system itself, we generated a mouse model with brain-specific 5-HT deficiency resulting from a genetically driven constitutive inactivation of neuronal tryptophan hydroxylase-2 (Tph2). Tph2 inactivation (Tph2-/-) resulted in brain 5-HT deficiency leading to growth retardation and persistent leanness, whereas a sex- and age-dependent increase in body weight was observed in Tph2+/- mice. The conserved expression pattern of the 5-HT neuron-specific markers (except Tph2 and 5-HT) demonstrates that brain 5-HT synthesis is not a prerequisite for the proliferation, differentiation and survival of raphe neurons subjected to the developmental program of serotonergic specification. Furthermore, although these neurons are unable to synthesize 5-HT from the precursor tryptophan, they still display electrophysiological properties characteristic of 5-HT neurons. Moreover, 5-HT deficiency induces an up-regulation of 5-HT1A and 5-HT1B receptors across brain regions as well as a reduction of norepinephrine concentrations accompanied by a reduced number of noradrenergic neurons. Together, our results characterize developmental, neurochemical, neurobiological and electrophysiological consequences of brain-specific 5-HT deficiency, reveal a dual dose-dependent role of 5-HT in body weight regulation and show that differentiation of serotonergic neuron phenotype is independent from endogenous 5-HT synthesis.	[Gutknecht, Lise; Araragi, Naozumi; Merker, Soeren; Waider, Jonas; Sommerlandt, Frank M. J.; Mayer, Ute; Schmitt, Angelika G.; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, Wurzburg, Germany; [Mlinar, Boris; Baccini, Gilda; Corradetti, Renato] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Hamon, Michel; Lanfumey, Laurence] Natl Inst Hlth & Med Res, INSERM U894, Med Fac Pierre & Marie Curie, Ctr Psychiat & Neurosci, Paris, France	University of Wurzburg; University of Florence; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Gutknecht, L (corresponding author), Univ Montpellier I, Inst Funct Genom, Natl Ctr Sci Res CNRS UMR 5203, INSERM U661,Dept Neurobiol, Montpellier, France.	Gutknecht.Lise@yahoo.fr; kplesch@mail.uni-wuerzburg.de	Corradetti, Renato/A-1604-2008; Lesch, Klaus-Peter/J-4906-2013; Lanfumey, Laurence/F-7695-2013; Lanfumey, Laurence/P-3037-2017; Mlinar, Boris/A-7034-2008	Corradetti, Renato/0000-0002-2588-0484; Lesch, Klaus-Peter/0000-0001-8348-153X; Mlinar, Boris/0000-0001-9082-0827	German research foundation (DFG) [SFB 581, SFB TRR 58, KFO 125]; IZKF [N-162]; European Community [NEWMOOD LSHM-CT-2003-503474]	German research foundation (DFG)(German Research Foundation (DFG)); IZKF; European Community(European Commission)	This study was supported by the German research foundation (DFG) (SFB 581, SFB TRR 58, KFO 125), IZKF (N-162) and the European Community (NEWMOOD LSHM-CT-2003-503474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; BRADY LS, 1992, BRAIN RES, V572, P117, DOI 10.1016/0006-8993(92)90459-M; BROSS R, 1995, AM J CLIN NUTR, V61, P1020, DOI 10.1093/ajcn/61.5.1020; Compan V, 1998, BRAIN RES, V795, P264, DOI 10.1016/S0006-8993(98)00316-3; Conductier G, 2005, NEUROPSYCHOPHARMACOL, V30, P1056, DOI 10.1038/sj.npp.1300662; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; CURZON G, 1990, ANN NY ACAD SCI, V600, P521; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Erritzoe D, 2010, NEUROIMAGE, V52, P284, DOI 10.1016/j.neuroimage.2010.03.086; Evrard A, 2002, EUR J NEUROSCI, V15, P841, DOI 10.1046/j.1460-9568.2002.01917.x; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; GALLAGER DW, 1976, NEUROPHARMACOLOGY, V15, P149, DOI 10.1016/0028-3908(76)90023-X; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Jacobsen JP, 2011, MOL PSYCHIAT; Jean A, 2007, P NATL ACAD SCI USA, V104, P16335, DOI 10.1073/pnas.0701471104; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Lanoir J, 2006, J COMP NEUROL, V495, P607, DOI 10.1002/cne.20916; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lesch KP, 2004, INT J NEUROPSYCHOPH, V7, P381, DOI 10.1017/S1461145704004845; Li Q, 2000, J NEUROSCI, V20, P7888; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Mlinar B, 2005, NEUROREPORT, V16, P1351, DOI 10.1097/01.wnr.0000175249.25535.bf; Mongeau R, 1997, BRAIN RES REV, V23, P145, DOI 10.1016/S0165-0173(96)00017-3; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Pudovkina OL, 2002, EUR J PHARMACOL, V445, P37, DOI 10.1016/S0014-2999(02)01663-1; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Sziray N, 2010, BEHAV BRAIN RES, V209, P93, DOI 10.1016/j.bbr.2010.01.019; Uceyler N, 2010, INT J OBESITY, V34, P701, DOI 10.1038/ijo.2009.289; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	46	77	80	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43157	10.1371/journal.pone.0043157	http://dx.doi.org/10.1371/journal.pone.0043157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912815	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700051
J	Kozuka-Hata, H; Nasu-Nishimura, Y; Koyama-Nasu, R; Ao-Kondo, H; Tsumoto, K; Akiyama, T; Oyama, M				Kozuka-Hata, Hiroko; Nasu-Nishimura, Yukiko; Koyama-Nasu, Ryo; Ao-Kondo, Hiroko; Tsumoto, Kouhei; Akiyama, Tetsu; Oyama, Masaaki			Phosphoproteome of Human Glioblastoma Initiating Cells Reveals Novel Signaling Regulators Encoded by the Transcriptome	PLOS ONE			English	Article							CANCER STEM-CELLS; PHOSPHORYLATION DYNAMICS; C-TRAP; PROTEOMICS; BRAIN; DIFFERENTIATION; IDENTIFICATION; NETWORKS; KINASES; CULTURE	Background: Glioblastoma is one of the most aggressive tumors with poor prognosis. Although various studies have been performed so far, there are not effective treatments for patients with glioblastoma. Methodology/Principal Findings: In order to systematically elucidate the aberrant signaling machinery activated in this malignant brain tumor, we investigated phosphoproteome dynamics of glioblastoma initiating cells using high-resolution nanoflow LC-MS/MS system in combination with SILAC technology. Through phosphopeptide enrichment by titanium dioxide beads, a total of 6,073 phosphopeptides from 2,282 phosphorylated proteins were identified based on the two peptide fragmentation methodologies of collision induced dissociation and higher-energy C-trap dissociation. The SILAC-based quantification described 516 up-regulated and 275 down-regulated phosphorylation sites upon epidermal growth factor stimulation, including the comprehensive status of the phosphorylation sites on stem cell markers such as nestin. Very intriguingly, our in-depth phosphoproteome analysis led to identification of novel phosphorylated molecules encoded by the undefined sequence regions of the human transcripts, one of which was regulated upon external stimulation in human glioblastoma initiating cells. Conclusions/Significance: Our result unveils an expanded diversity of the regulatory phosphoproteome defined by the human transcriptome.	[Kozuka-Hata, Hiroko; Ao-Kondo, Hiroko; Tsumoto, Kouhei; Oyama, Masaaki] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Nasu-Nishimura, Yukiko; Koyama-Nasu, Ryo; Akiyama, Tetsu] Univ Tokyo, Lab Mol & Genet Informat, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Kozuka-Hata, H (corresponding author), Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan.	moyama@ims.u-tokyo.ac.jp		Oyama, Masaaki/0000-0001-6478-3735; Kozuka-Hata, Hiroko/0000-0002-9286-6594	Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology of Japan	Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Dai L, 2010, J PROTEOME RES, V9, P3394, DOI 10.1021/pr100231m; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Liu G., 2006, MOL CANC; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zou JA, 2011, WORLD J GASTROENTERO, V17, P1276, DOI 10.3748/wjg.v17.i10.1276	40	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43398	10.1371/journal.pone.0043398	http://dx.doi.org/10.1371/journal.pone.0043398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912867	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700095
J	Hino, H; Takahashi, H; Suzuki, Y; Tanaka, J; Ishii, E; Fukuda, M				Hino, Hitomi; Takahashi, Hisaaki; Suzuki, Yuka; Tanaka, Junya; Ishii, Eiichi; Fukuda, Mitsumasa			Anticonvulsive Effect of Paeoniflorin on Experimental Febrile Seizures in Immature Rats: Possible Application for Febrile Seizures in Children	PLOS ONE			English	Article							HYPERTHERMIA-INDUCED SEIZURES; POWER SPECTRUM CHANGES; PEONY ROOT EXTRACT; GLUTAMATE RECEPTORS; VALPROIC ACID; EPILEPSY; MODEL; MICE; HIPPOCAMPUS; MECHANISMS	Febrile seizures (FS) is the most common convulsive disorder in children, but there have been no clinical and experimental studies of the possible treatment of FS with herbal medicines, which are widely used in Asian countries. Paeoniflorin (PF) is a major bioactive component of Radix Paeoniae alba, and PF-containing herbal medicines have been used for neuromuscular, neuropsychiatric, and neurodegenerative disorders. In this study, we analyzed the anticonvulsive effect of PF and Keishikashakuyaku-to (KS; a PF-containing herbal medicine) for hyperthermia-induced seizures in immature rats as a model of human FS. When immature (P5) male rats were administered PF or KS for 10 days, hyperthermia-induced seizures were significantly suppressed compared to control rats. In cultured hippocampal neurons, PF suppressed glutamate-induced elevation of intracellular Ca2+ ([Ca2+](i)), glutamate receptor-mediated membrane depolarization, and glutamate-induced neuronal death. In addition, PF partially suppressed the elevation in [Ca2+](i) induced by activation of the metabotropic glutamate receptor 5 (mGluR5), but not that mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid (AMPA) or N-methyl-D-aspartate (NMDA) receptors. However, PF did not affect production or release of gamma-aminobutyric acid (GABA) in hippocampal neurons. These results suggest that PF or PF-containing herbal medicines exert anticonvulsive effects at least in part by preventing mGluR5-dependent [Ca2+](i) elevations. Thus, it could be a possible candidate for the treatment of FS in children.	[Hino, Hitomi; Suzuki, Yuka; Ishii, Eiichi; Fukuda, Mitsumasa] Ehime Univ, Dept Pediat, Grad Sch Med, Toon, Ehime, Japan; [Takahashi, Hisaaki; Tanaka, Junya] Ehime Univ, Dept Mol & Cellular Physiol, Grad Sch Med, Toon, Ehime, Japan; [Takahashi, Hisaaki; Tanaka, Junya; Fukuda, Mitsumasa] Ehime Univ, Ehime Proteomed Res Ctr, Dept Basic & Clin Neurosci, Toon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Hino, H (corresponding author), Ehime Univ, Dept Pediat, Grad Sch Med, Toon, Ehime, Japan.	fukumits@m.ehime-u.ac.jp	Tanaka, Junya/Y-1033-2019	Tanaka, Junya/0000-0003-1056-5948	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Epilepsy Research Foundation; Ehime University; Grants-in-Aid for Scientific Research [23659688] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Epilepsy Research Foundation; Ehime University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (C) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Research Grant of the Japan Epilepsy Research Foundation, and a Research Promotion Award of Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafez AA, 1999, BIOL PHARM BULL, V22, P491, DOI 10.1248/bpb.22.491; Anderson GD, 2002, EPILEPSIA, V43, P53, DOI 10.1046/j.1528-1157.43.s.3.5.x; Audenaert D, 2006, NEUROLOGY, V67, P687, DOI 10.1212/01.wnl.0000230145.73496.a2; BARAM TZ, 1991, DEV BRAIN RES, V61, P97, DOI 10.1016/0165-3806(91)90118-3; Bender RA, 2003, HIPPOCAMPUS, V13, P399, DOI 10.1002/hipo.10089; Camfield C, 2005, EPILEPTIC SYNDROMES; Castro-Gago M, 2011, J CHILD NEUROL, V26, P1522, DOI 10.1177/0883073811409227; Cendes F, 2005, EPILEPTIC SYNDROMES, P555; DEZAKI K, 1995, JPN J PHARMACOL, V69, P281, DOI 10.1254/jjp.69.281; DOBBING J, 1973, LANCET, V1, P48; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; FRANDSEN A, 1993, J NEUROCHEM, V60, P1202, DOI 10.1111/j.1471-4159.1993.tb03278.x; Freeman A.R., 1976, Progress Neurobiol, V6, P137, DOI 10.1016/0301-0082(76)90012-5; Fukuda M, 1997, DEV BRAIN RES, V104, P197, DOI 10.1016/S0165-3806(97)00157-0; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Hiratsuka T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013280; HJERESEN DL, 1988, DEV PSYCHOBIOL, V21, P261, DOI 10.1002/dev.420210307; KNIGHT M, 1985, ARCH NEUROL-CHICAGO, V42, P474, DOI 10.1001/archneur.1985.04060050076011; Lu YM, 1997, J NEUROSCI, V17, P5196; Lux AL, 2010, BRAIN DEV-JPN, V32, P42, DOI 10.1016/j.braindev.2009.09.016; Mao QQ, 2010, CELL MOL NEUROBIOL, V30, P1059, DOI 10.1007/s10571-010-9537-5; MORIMOTO T, 1995, DEV BRAIN RES, V84, P204, DOI 10.1016/0165-3806(94)00173-W; NAGAKUBO S, 1993, JPN J PSYCHIAT NEUR, V47, P609; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; Neville B, 2010, DEV MED CHILD NEUROL, V52, P1151, DOI 10.1111/j.1469-8749.2010.03745.x; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Pal S, 2001, CELL CALCIUM, V30, P285, DOI 10.1054/ceca.2001.0236; Qu LT, 2008, J NEUROCHEM, V106, P2158, DOI 10.1111/j.1471-4159.2008.05576.x; RATING D, 1983, J NEUROL, V230, P217, DOI 10.1007/BF00313697; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shitak R, 2007, METHOD FIND EXP CLIN, V29, P11, DOI 10.1358/mf.2007.29.1.1063489; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; SUGAYA A, 1991, J ETHNOPHARMACOL, V33, P159, DOI 10.1016/0378-8741(91)90174-C; SUGAYA E, 1988, EPILEPSY RES, V2, P337, DOI 10.1016/0920-1211(88)90043-5; SUGAYA E, 1988, EPILEPSY RES, V2, P27, DOI 10.1016/0920-1211(88)90006-X; Suzuki Y, 2009, BRAIN RES, V1268, P17, DOI 10.1016/j.brainres.2009.02.074; Tanabe T, 2011, EPILEPSIA, V52, P837, DOI 10.1111/j.1528-1167.2010.02958.x; Tang NY, 2010, AM J CHINESE MED, V38, P51, DOI 10.1142/S0192415X10007786; Tsuda T, 1997, EXP NEUROL, V146, P518, DOI 10.1006/exnr.1997.6570; Verrotti A, 2011, OBES REV, V12, pe32, DOI 10.1111/j.1467-789X.2010.00800.x; Watanabe H, 1997, BEHAV BRAIN RES, V83, P135, DOI 10.1016/S0166-4328(97)86057-3; Zarate CA, 1999, J CLIN PSYCHIAT, V60, P232, DOI 10.4088/JCP.v60n0405; Zhang LL, 2011, EPILEPTIC DISORD, V13, P349, DOI 10.1684/epd.2011.0444	44	26	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42920	10.1371/journal.pone.0042920	http://dx.doi.org/10.1371/journal.pone.0042920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916181	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300021
J	Larsson, EC; Thorson, AE; Pariyo, G; Waiswa, P; Kadobera, D; Marrone, G; Ekstrom, AM				Larsson, Elin C.; Thorson, Anna Ekeus; Pariyo, George; Waiswa, Peter; Kadobera, Daniel; Marrone, Gaetano; Ekstrom, Anna Mia			Missed Opportunities: Barriers to HIV Testing during Pregnancy from a Population Based Cohort Study in Rural Uganda	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; EASTERN UGANDA; ANTENATAL CARE; OPT-OUT; PREVENTION; SERVICES; BOTSWANA; ZIMBABWE; NEWBORN; WOMEN	The aim was to assess population-level HIV-testing uptake among pregnant women, key for access to prevention-of mother to child transmission (PMTCT) services, and to identify risk factors for not being HIV tested, The study was conducted May 2008-May 2010 in the Iganga/Mayuge Health and Demographic Surveillance Site (HDSS), Eastern Uganda, during regular surveillance of 68,000 individuals. All women identified to be pregnant May-July 2008 (n = 881) were interviewed about pregnancy-related issues and linked to the HDSS database for socio-demographic data. Women were followed-up via antenatal care (ANC) register reviews at the health facilities to collect data related to ANC services received, including HIV testing. Adjusted relative risk (aRR), and 95% confidence intervals (CI) for not being HIV tested were calculated using multivariable binomial regression among the 544 women who remained after record review. Despite high ANC attendance (96%), the coverage of HIV testing was 64%. Only 6% of pregnant women who sought ANC at a facility without HIV testing services were referred for testing and only 20% received counseling regarding HIV. At ANC facilities with HIV testing services, 85% were tested. Only 4% of the women tested had been couple tested for HIV. Living more than three kilometers away from a health facility with HIV testing services was associated with not being tested both among the poorest (aRR, CI; 1.44,1.02-2.04) and the least poor women (aRR, CI; 1.72,1.12-2.63). The lack of onsite HIV testing services and distant ANC facilities lead to missed opportunities for PMTCT, especially for the poorest women. Referral systems for HIV testing need to be improved and testing should be expanded to lower level health facilities. This is in order to ensure that the policy of HIV testing during pregnancy is implemented more effectively and that testing is accessible for all.	[Larsson, Elin C.; Thorson, Anna Ekeus; Marrone, Gaetano; Ekstrom, Anna Mia] Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden; [Pariyo, George; Waiswa, Peter] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Pariyo, George; Waiswa, Peter; Kadobera, Daniel] Iganga Mayuge Hlth & Demog Surveillance Site, Iganga, Uganda	Karolinska Institutet; Makerere University	Larsson, EC (corresponding author), Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden.	elinlarsson7@yahoo.se	Larsson, Elin/AAQ-5596-2020; Pariyo, George W/K-2335-2017; Ekström, Anna Mia/H-6901-2013	Pariyo, George W/0000-0002-4411-2309; Marrone, Gaetano/0000-0002-2991-1663; Larsson, Elin C./0000-0002-5189-808X; Thorson, Anna/0000-0002-8703-6561	European Union, through the European Community; Swedish International Development Cooperation Agency (Sida); Karolinska Institutet	European Union, through the European Community; Swedish International Development Cooperation Agency (Sida); Karolinska Institutet(Karolinska Institutet)	This study was funded by grants from The European Union, through the European Community's FP6, the Swedish International Development Cooperation Agency (Sida), and Karolinska Institutet's funds for PhD students (KID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio P, 2009, AIDS CARE, V21, P1537, DOI 10.1080/09540120902903719; [Anonymous], 2007, MANUAL ESTIMATING NA; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Byamugisha R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-290; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chicago IL, 2007, STAT SOFTW; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ettarh R, 2010, HLTH PLACE; Falnes EF, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-36; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hirsch JS, 2009, GOING PUBLIC MODERN; Homsy J, 2007, JAIDS-J ACQ IMM DEF, V44, P366, DOI 10.1097/QAI.0b013e31802f1303; Homsy J, 2006, JAIDS-J ACQ IMM DEF, V42, P149, DOI 10.1097/01.qai.0000225032.52766.c2; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Kilewo C, 2008, J ACQUIR IMMUNE DEFI; Larsson EC, 2011, HLTH POLICY PLAN; Larsson EC, 2012, HEALTH POLICY PLANN, V27, P69, DOI 10.1093/heapol/czr009; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Larsson EC, 2009, AIDS, V23, P1924, DOI 10.1097/QAD.0b013e32832eff81; Mbonye AK, 2009, SEX TRANSM INFECT, V85, P534, DOI 10.1136/sti.2009.037986; *MIN HLTH UG, 2006, POL GUID PREV MOTH T; Ministry of Health Uganda, 2000, HLTH SECT STRAT PLAN; Namukwaya Z, 2010, J ACQUIR IMMUNE DEFI; Perez F, 2006, JAIDS-J ACQ IMM DEF, V41, P514, DOI 10.1097/01.qai.0000191285.70331.a0; Sanjana P, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-44; StataCorp L, 2007, STAT DAT AN STAT SOF; Steen TW, 2007, JAIDS-J ACQ IMM DEF, V44, P484, DOI 10.1097/QAI.0b013e318030ffa9; Thorsen VC, 2008, DEV WORLD BIOETH, V8, P43, DOI 10.1111/j.1471-8847.2008.00227.x; Uganda Bureau of Statistics & Macro International, 2007, UG DEM HLTH SURV; Uganda Ministry of Health and ORC Macro, 2006, UG HIV AIDS SER SURV; UNAIDS, 2011, GLOB PLAN EL NEW HIV; UNAIDS, 2010, GLOB REP UNAIDS REP; Waiswa P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-9; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO, 2006, ANT DRUGS TREAT PREG; *WHO, 2009, RAP ADV US ANT DRUGS; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; [No title captured]	42	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e37590	10.1371/journal.pone.0037590	http://dx.doi.org/10.1371/journal.pone.0037590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AN	22916089	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300001
J	Rodriguez-Sanchez, AJ; Tsotsos, JK				Rodriguez-Sanchez, Antonio J.; Tsotsos, John K.			The Roles of Endstopped and Curvature Tuned Computations in a Hierarchical Representation of 2D Shape	PLOS ONE			English	Article							CAT STRIATE CORTEX; VISUAL-CORTEX; OBJECT RECOGNITION; RECEPTIVE-FIELDS; AREA V4; FUNCTIONAL ARCHITECTURE; INFEROTEMPORAL CORTEX; NEURAL MECHANISMS; MODEL; SELECTIVITY	That shape is important for perception has been known for almost a thousand years (thanks to Alhazen in 1083) and has been a subject of study ever since by scientists and phylosophers (such as Descartes, Helmholtz or the Gestalt psychologists). Shapes are important object descriptors. If there was any remote doubt regarding the importance of shape, recent experiments have shown that intermediate areas of primate visual cortex such as V2, V4 and TEO are involved in analyzing shape features such as corners and curvatures. The primate brain appears to perform a wide variety of complex tasks by means of simple operations. These operations are applied across several layers of neurons, representing increasingly complex, abstract intermediate processing stages. Recently, new models have attempted to emulate the human visual system. However, the role of intermediate representations in the visual cortex and their importance have not been adequately studied in computational modeling. This paper proposes a model of shape-selective neurons whose shape-selectivity is achieved through intermediate layers of visual representation not previously fully explored. We hypothesize that hypercomplex - also known as endstopped - neurons play a critical role to achieve shape selectivity and show how shape-selective neurons may be modeled by integrating endstopping and curvature computations. This model - a representational and computational system for the detection of 2-dimensional object silhouettes that we term 2DSIL - provides a highly accurate fit with neural data and replicates responses from neurons in area V4 with an average of 83% accuracy. We successfully test a biologically plausible hypothesis on how to connect early representations based on Gabor or Difference of Gaussian filters and later representations closer to object categories without the need of a learning phase as in most recent models.	[Rodriguez-Sanchez, Antonio J.] Univ Innsbruck, A-6020 Innsbruck, Austria; [Tsotsos, John K.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Tsotsos, John K.] York Univ, Dept Comp Sci & Engn, Toronto, ON M3J 2R7, Canada	University of Innsbruck; York University - Canada; York University - Canada	Rodriguez-Sanchez, AJ (corresponding author), Univ Innsbruck, A-6020 Innsbruck, Austria.	Antonio.Rodriguez-Sanchez@uibk.ac.at	Tsotsos, John/N-1131-2019	Tsotsos, John/0000-0002-8621-9147	Natural Sciences and Engineering Research Council of Canada [4557-2009]; Teledyne Scientific Company, Durham, North Carolina [BOU546385]; Canada Research Chair in Computational Vision; York University from Teledyne; Teledyne Scientific Company, Durham, North Carolina	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Teledyne Scientific Company, Durham, North Carolina; Canada Research Chair in Computational Vision; York University from Teledyne; Teledyne Scientific Company, Durham, North Carolina	The authors are grateful for research support from the Natural Sciences and Engineering Research Council of Canada through a grant to JKT (4557-2009) and the Teledyne Scientific Company, Durham, North Carolina, through a contract to JKT (BOU546385). JKT holds the Canada Research Chair in Computational Vision which also supported this work. JKT is not an employee of Teledyne - he was PI on a contract to York University from Teledyne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest to declare. This study was partly funded by the Teledyne Scientific Company, Durham, North Carolina. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Amit Y, 2003, VISION RES, V43, P2073, DOI 10.1016/S0042-6989(03)00306-7; Amit Y, 2000, NEURAL COMPUT, V12, P1141, DOI 10.1162/089976600300015538; BISHOP PO, 1980, J NEUROPHYSIOL, V43, P1266, DOI 10.1152/jn.1980.43.5.1266; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Cajal S. R., 1888, REV TRIM HISTOL NORM, V1, P33; Cajal S.R.y., 1894, P R SOC LOND, V55, P444; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DOBBINS A, 1989, VISION RES, V29, P1371, DOI 10.1016/0042-6989(89)90193-4; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Dobbins A, 1992, THESIS MCGILL U; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Fukushima K, 1983, IEEE T SYSTEMS MAN C, P13; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Geman S, 2006, J PHYSIOL-PARIS, V100, P212, DOI 10.1016/j.jphysparis.2007.01.001; GROSSBERG S, 1971, P NATL ACAD SCI USA, V68, P828, DOI 10.1073/pnas.68.4.828; Grossberg S, 1975, Int Rev Neurobiol, V18, P263, DOI 10.1016/S0074-7742(08)60037-9; GROSSBERG S, 1970, J THEOR BIOL, V27, P291, DOI 10.1016/0022-5193(70)90143-8; GROSSBERG S, 1968, P NATL ACAD SCI USA, V59, P368, DOI 10.1073/pnas.59.2.368; HAWKEN MJ, 1987, PROC R SOC SER B-BIO, V231, P251, DOI 10.1098/rspb.1987.0044; Hegde J, 2000, J NEUROSCI, V20, part. no.; Heitger F., 1993, [1993] Proceedings Fourth International Conference on Computer Vision, P32, DOI 10.1109/ICCV.1993.378238; Heitger F, 1998, IMAGE VISION COMPUT, V16, P407, DOI 10.1016/S0262-8856(97)00083-8; HEITGER F, 1992, VISION RES, V32, P963, DOI 10.1016/0042-6989(92)90039-L; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jones EG, 2007, BRAIN RES REV, V55, P248, DOI 10.1016/j.brainresrev.2007.06.001; KATO H, 1978, J NEUROPHYSIOL, V41, P1071, DOI 10.1152/jn.1978.41.5.1071; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Marr D., 1982, VISION COMPUTATIONAL; Martinez-Trujillo JC, 2005, NEUROREPORT, V16, P435, DOI 10.1097/00001756-200504040-00004; Meese TS, 2002, VISION RES, V42, P1073, DOI 10.1016/S0042-6989(02)00058-5; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P818, DOI 10.1152/jn.1979.42.3.818; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P833, DOI 10.1152/jn.1979.42.3.833; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Ramon y Cajal S., 1904, TRAB LAB INVEST BIOL, V3, P9; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rao RPN, 1997, NEURAL COMPUT, V9, P721, DOI 10.1162/neco.1997.9.4.721; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Rodriguez-Sanchez A. J., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P4321, DOI 10.1109/CVPR.2011.5995671; Rodriguez-Sanchez AJ, 2007, INT J NEURAL SYST, V17, P275, DOI 10.1142/S0129065707001135; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Serre T, 2005, PROC CVPR IEEE, P994; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; SPITZER H, 1985, J NEUROPHYSIOL, V53, P1266, DOI 10.1152/jn.1985.53.5.1266; Suzuki N, 2004, BIOSYSTEMS, V76, P33, DOI 10.1016/j.biosystems.2004.05.004; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Treue S, 1996, VISUAL NEUROSCI, V13, P797, DOI 10.1017/S095252380000866X; Tsotsos J. K., 2011, COMPUTATIONAL PERSPE, DOI DOI 10.7551/MITPRESS/9780262015417.001.0001; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Tsotsos JK, 2005, COMPUT VIS IMAGE UND, V100, P3, DOI 10.1016/j.cviu.2004.10.011; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Willmore BDB, 2010, J NEUROSCI, V30, P2102, DOI 10.1523/JNEUROSCI.4099-09.2010; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zucker S., 1981, P 7 INT C ART INT AU, P1102	67	40	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42058	10.1371/journal.pone.0042058	http://dx.doi.org/10.1371/journal.pone.0042058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912683	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500010
J	Fyhrquist, N; Wolff, H; Lauerma, A; Alenius, H				Fyhrquist, Nanna; Wolff, Henrik; Lauerma, Antti; Alenius, Harri			CD8+T Cell Migration to the Skin Requires CD4+Help in a Murine Model of Contact Hypersensitivity	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; CD8(+) T-CELLS; DERMATITIS; EFFECTOR; INFLAMMATION; SENSITIVITY; CD4(+)	The relative roles of CD4+ and CD8+ T cells in contact hypersensitivity responses have not been fully solved, and remain an important question. Using an adoptive transfer model, we investigated the role of the respective T cell subset. Magnetic bead separated CD4+ and CD8+ T cells from oxazolone sensitized C57BL/6 mice were transferred into RAG(-/-) mice, followed by hapten challenge and analysis of inflammatory parameters at 24 hours post exposure. The CD4+ T cell recipient mice developed partial contact hypersensitivity responses to oxazolone. CD8+ T cells caused significant amplification of the response in recipients of both CD4+ and CD8+ T cells including ear swelling, type 1 inflammatory mediators, and cell killing. Unexpectedly, CD8+ T cells were not sufficient to mediate contact hypersensitivity, although abundantly present in the lymph nodes in the CD8+ T cell reconstituted mice. There were no signs of inflammation at the site of hapten exposure, indicating impaired recruitment of CD8+ T cells in the absence of CD4+ T cells. These data show that CD4+ T cells mediate contact hypersensitivity to oxazolone, but CD8+ T cells contribute with the most potent effector mechanisms. Moreover, our results suggest that CD4+ T cell function is required for the mobilization of CD8+ effector T cells to the site of hapten exposure. The results shed new light on the relative importance of CD4+ and CD8+ T cells during the effector phase of contact hypersensitivity.	[Fyhrquist, Nanna; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland; [Wolff, Henrik] Finnish Inst Occupat Hlth, Team Biol Mechanisms & Prevent Work Related Dis, Helsinki, Finland; [Wolff, Henrik] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Lauerma, Antti] Univ Helsinki, Dept Dermatol Venereol & Allergol, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Fyhrquist, N (corresponding author), Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland.	nanna.fyhrquist@ttl.fi	Lauerma, Antti/J-8180-2016	Alenius, Harri/0000-0003-0106-8923; Fyhrquist, Nanna Theresia/0000-0002-5408-0005	Academy of Finland [213072, 214479]	Academy of Finland(Academy of Finland)	This work was partly supported by grants from the Academy of Finland (Contracts No 213072 and 214479). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bangert C, 2003, J INVEST DERMATOL, V121, P1409, DOI 10.1111/j.1523-1747.2003.12623.x; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Cavani A, 2001, TRENDS IMMUNOL, V22, P118, DOI 10.1016/S1471-4906(00)01815-9; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Coenraads P-J, 2007, Eur J Dermatol, V17, P564; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dearman RJ, 1996, IMMUNOLOGY, V89, P502, DOI 10.1046/j.1365-2567.1996.d01-778.x; deLuca LS, 2012, NAT REV IMMUNOL, V12, P339, DOI 10.1038/nri3193; GOCINSKI BL, 1990, J IMMUNOL, V144, P4121; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Martin S, 2000, J INVEST DERMATOL, V115, P260, DOI 10.1046/j.1523-1747.2000.00038.x; Meller S, 2007, J ALLERGY CLIN IMMUN, V119, P1470, DOI 10.1016/j.jaci.2006.12.654; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x	17	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41038	10.1371/journal.pone.0041038	http://dx.doi.org/10.1371/journal.pone.0041038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916101	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800007
J	Hall, SA; Howlin, BJ; Hamerton, I; Baidak, A; Billaud, C; Ward, S				Hall, Stephen A.; Howlin, Brendan J.; Hamerton, Ian; Baidak, Alex; Billaud, Claude; Ward, Steven			Solving the Problem of Building Models of Crosslinked Polymers: An Example Focussing on Validation of the Properties of Crosslinked Epoxy Resins	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; GLASS-TRANSITION TEMPERATURES; MECHANICAL-PROPERTIES; FORCE-FIELD; DIFFUSION; POLYSILOXANES; PREDICTION; BLENDS	The construction of molecular models of crosslinked polymers is an area of some difficulty and considerable interest. We report here a new method of constructing these models and validate the method by modelling three epoxy systems based on the epoxy monomers bisphenol F diglycidyl ether (BFDGE) and triglycidyl-p-amino phenol (TGAP) with the curing agent diamino diphenyl sulphone (DDS). The main emphasis of the work concerns the improvement of the techniques for the molecular simulation of these epoxies and specific attention is paid towards model construction techniques, including automated model building and prediction of glass transition temperatures (T-g). Typical models comprise some 4200-4600 atoms (ca. 120-130 monomers). In a parallel empirical study, these systems have been cast, cured and analysed by dynamic mechanical thermal analysis (DMTA) to measure Tg. Results for the three epoxy systems yield good agreement with experimental T-g ranges of 200-220 degrees C, 270-285 degrees C and 285-290 degrees C with corresponding simulated ranges of 210-230 degrees C, 250-300 degrees C, and 250-300 degrees C respectively.	[Hall, Stephen A.; Howlin, Brendan J.; Hamerton, Ian] Univ Surrey, Div Chem Sci, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Billaud, Claude; Ward, Steven] Cytec Engn Mat, Wilton Ctr R422, Cleveland, OH USA	University of Surrey	Hall, SA (corresponding author), Univ Surrey, Div Chem Sci, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Howlin, Brendan J/F-3343-2011; Hamerton, Ian/AAV-8918-2021	Howlin, Brendan J/0000-0002-9398-7152; Hamerton, Ian/0000-0003-3113-0345	Engineering and Physical Sciences Research Council, Departmental Training Allowance	Engineering and Physical Sciences Research Council, Departmental Training Allowance(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the Engineering and Physical Sciences Research Council for funding from the Departmental Training Allowance. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MACR MAK EP RES; [Anonymous], 2008, BTCL SCRIPT MAT STUD; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Box G. E., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.2307/1266454, 10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; Cantwell W.J., 1993, CHEM TECHNOLOGY EPOX; Fan HB, 2007, POLYMER, V48, P2174, DOI 10.1016/j.polymer.2007.02.007; Fried JR, 2001, COMPUT THEOR POLYM S, V11, P273, DOI 10.1016/S1089-3156(00)00021-0; GOODMAN JM, 1998, CHEM APPL MOL MODELL; Gou JH, 2004, COMP MATER SCI, V31, P225, DOI 10.1016/j.commatsci.2004.03.002; Grujicic M, 2007, APPL SURF SCI, V253, P3009, DOI 10.1016/j.apsusc.2006.06.050; Gumen VR, 2001, POLYMER, V42, P5717, DOI 10.1016/S0032-3861(00)00930-7; Haines PJ, 2002, ROY S CH P, P1; Hamerton I, 2006, POLYMER, V47, P690, DOI 10.1016/j.polymer.2005.11.082; Hamerton I, 2006, REACT FUNCT POLYM, V66, P21, DOI 10.1016/j.reactfunctpolym.2005.07.018; Hamerton I., 2005, ENCY CHEM PROCESSING, P911; Hofmann D, 2000, COMPUT THEOR POLYM S, V10, P419, DOI 10.1016/S1089-3156(00)00007-6; Lin YC, 2005, CHEM PHYS LETT, V412, P322, DOI 10.1016/j.cplett.2005.07.022; Liu HP, 2004, POLYMER, V45, P2051, DOI 10.1016/j.polymer.2004.01.008; Martyna GJ, 1992, CHEM PHYS, V97, P4; Neyertz S, 2006, J MEMBRANE SCI, V280, P517, DOI 10.1016/j.memsci.2006.02.011; Pan R, 2007, COMP MATER SCI, V39, P887, DOI 10.1016/j.commatsci.2006.10.019; Pavel D, 2005, POLYMER, V46, P6135, DOI 10.1016/j.polymer.2005.05.085; Potter WG, 1975, USES OF EPOXY RESINS; Ren H, 2007, POLYMER, V48, P887, DOI 10.1016/j.polymer.2006.12.016; Rigby D, 1997, POLYM INT, V44, P311, DOI 10.1002/(SICI)1097-0126(199711)44:3<311::AID-PI880>3.0.CO;2-H; SCHMIEGEL WW, 1979, ANGEW MAKROMOL CHEM, V76-7, P39, DOI 10.1002/apmc.1979.050760103; Sun H, 1997, SPECTROCHIM ACTA A, V53, P1301, DOI 10.1016/S1386-1425(97)00013-9; Tack JL, 2008, J MOL GRAPH MODEL, V26, P1269, DOI 10.1016/j.jmgm.2007.12.001; Wu CF, 2007, POLYMER, V48, P5802, DOI 10.1016/j.polymer.2007.07.019; Wu CF, 2006, POLYMER, V47, P6004, DOI 10.1016/j.polymer.2006.06.025	30	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42928	10.1371/journal.pone.0042928	http://dx.doi.org/10.1371/journal.pone.0042928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916182	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800036
J	McEvoy, J; Ulyanov, A; Brennan, R; Wu, G; Pounds, S; Zhang, JH; Dyer, MA				McEvoy, Justina; Ulyanov, Anatoly; Brennan, Rachel; Wu, Gang; Pounds, Stanley; Zhang, Jinghui; Dyer, Michael A.			Analysis of MDM2 and MDM4 Single Nucleotide Polymorphisms, mRNA Splicing and Protein Expression in Retinoblastoma	PLOS ONE			English	Article							TUMOR-FORMATION; P53; CELLS; GENE; IDENTIFICATION; PROGRESSION; VARIANTS; THERAPY; PATHWAY; DISEASE	Retinoblastoma is a childhood cancer of the developing retina that begins in utero and is diagnosed in the first years of life. Biallelic RB1 gene inactivation is the initiating genetic lesion in retinoblastoma. The p53 gene is intact in human retinoblastoma but the pathway is believed to be suppressed by increased expression of MDM4 (MDMX) and MDM2. Here we quantify the expression of MDM4 and MDM2 mRNA and protein in human fetal retinae, primary retinoblastomas, retinoblastoma cell lines and several independent orthotopic retinoblastoma xenografts. We found that MDM4 is the major p53 antagonist expressed in retinoblastoma and in the developing human retina. We also discovered that MDM4 protein steady state levels are much higher in retinoblastoma than in human fetal retinae. This increase would not have been predicted based on the mRNA levels. We explored several possible post-transcriptional mechanisms that may contribute to the elevated levels of MDM4 protein. A proportion of MDM4 transcripts are alternatively spliced to produce protein products that are reported to be more stable and oncogenic. We also discovered that a microRNA predicted to target MDM4 (miR191) was downregulated in retinoblastoma relative to human fetal retinae and a subset of samples had somatic mutations that eliminated the miR-191 binding site in the MDM4 mRNA. Taken together, these data suggest that post-transcriptional mechanisms may contribute to stabilization of the MDM4 protein in retinoblastoma.	[McEvoy, Justina; Brennan, Rachel; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Ulyanov, Anatoly; Wu, Gang; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Pounds, Stanley] St Jude Childrens Res Hosp, Dept Stat, Memphis, TN 38105 USA; [Dyer, Michael A.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute	McEvoy, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Pounds, Stanley B/N-2480-2018; Zhang, Jing/GWZ-7332-2022; Dyer, Michael/N-8134-2018; Wu, Gang/M-8012-2014	Pounds, Stanley B/0000-0002-9167-2114; Wu, Gang/0000-0002-1678-5864; McEvoy, Justina/0000-0003-0382-1288	Cancer Center [CA21765]; National Institutes of Health [EY014867, EY018599]; American Cancer Society; Research to Prevent Blindness Foundation; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018599, R01EY014867] Funding Source: NIH RePORTER	Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Cancer Center Support NCI (CA21765); National Institutes of Health (EY014867 and EY018599); American Cancer Society; Research to Prevent Blindness Foundation; American Lebanese Syrian Associated Charities (ALSAC). MD is a Howard Hughes Medical Institute Early Career Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Castera L, 2010, J NATL CANCER I, V102, P1805, DOI 10.1093/jnci/djq416; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dyer MA, 2005, PLOS MED, V2, P971, DOI 10.1371/journal.pmed.0020332; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; Harbour JW, 2002, ARCH OPHTHALMOL-CHIC, V120, P1341, DOI 10.1001/archopht.120.10.1341; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Kulkarni DA, 2009, CARCINOGENESIS, V30, P1910, DOI 10.1093/carcin/bgp224; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2004, CELL CYCLE, V3, P900; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; McKenzie PP, 1999, CLIN CANCER RES, V5, P4199; Rallapalli R, 2003, J CELL BIOCHEM, V89, P563, DOI 10.1002/jcb.10535; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Thompson J, 1997, CLIN CANCER RES, V3, P423; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	26	57	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42739	10.1371/journal.pone.0042739	http://dx.doi.org/10.1371/journal.pone.0042739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916154	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800027
J	Carroll, ME; Zlebnik, NE; Anker, JJ; Kosten, TR; Orson, FM; Shen, XY; Kinsey, B; Parks, RJ; Gao, Y; Brimijoin, S				Carroll, Marilyn E.; Zlebnik, Natalie E.; Anker, Justin J.; Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma; Parks, Robin J.; Gao, Yang; Brimijoin, Stephen			Combined Cocaine Hydrolase Gene Transfer and Anti-Cocaine Vaccine Synergistically Block Cocaine-Induced Locomotion	PLOS ONE			English	Article							HUMAN SERUM BUTYRYLCHOLINESTERASE; DEPENDENT ADENOVIRAL VECTORS; CARDIOVASCULAR-RESPONSES; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSE; ACUTE TOXICITY; DRUG-ABUSE; IN-VIVO; RATS; MICE	Mice and rats were tested for reduced sensitivity to cocaine-induced hyper-locomotion after pretreatment with anti-cocaine antibody or cocaine hydrolase (CocH) derived from human butyrylcholinesterase (BChE). In Balb/c mice, direct i.p. injection of CocH protein (1 mg/kg) had no effect on spontaneous locomotion, but it suppressed responses to i.p. cocaine up to 80 mg/kg. When CocH was injected i.p. along with a murine cocaine antiserum that also did not affect spontaneous locomotion, there was no response to any cocaine dose. This suppression of locomotor activity required active enzyme, as it was lost after pretreatment with iso-OMPA, a selective BChE inhibitor. Comparable results were obtained in rats that developed high levels of CocH by gene transfer with helper-dependent adenoviral vector, and/or high levels of anti-cocaine antibody by vaccination with norcocaine hapten conjugated to keyhole limpet hemocyanin (KLH). After these treatments, rats were subjected to a locomotor sensitization paradigm involving a "training phase" with an initial i.p. saline injection on day 1 followed by 8 days of repeated cocaine injections (10 mg/kg, i.p.). A 15-day rest period then ensued, followed by a final "challenge" cocaine injection. As in mice, the individual treatment interventions reduced cocaine-stimulated hyperactivity to a modest extent, while combined treatment produced a greater reduction during all phases of testing compared to control rats (with only saline pretreatment). Overall, the present results strongly support the view that anti-cocaine vaccine and cocaine hydrolase vector treatments together provide enhanced protection against the stimulatory actions of cocaine in rodents. A similar combination therapy in human cocaine users might provide a robust therapy to help maintain abstinence.	[Carroll, Marilyn E.; Zlebnik, Natalie E.; Anker, Justin J.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma] Baylor Coll Med, Dept Psychiat & Neurosci, Houston, TX 77030 USA; [Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma] Vet Adm Med Ctr, Houston, TX 77211 USA; [Parks, Robin J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Gao, Yang; Brimijoin, Stephen] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Ottawa; Ottawa Hospital Research Institute; Mayo Clinic	Carroll, ME (corresponding author), Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA.	Brimijoin@mayo.edu	Kosten, Thomas/AAI-5998-2021; Anker, Justin J/H-4748-2019	Anker, Justin J/0000-0002-2115-5170	National Institute on Drug Abuse [DP1 DA031340, R01 DA023979, R01 DA023979 S1, K05 DA015267, R01 DA030338]; Department of Veterans Affairs; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023979, R01DA030338, DP1DA031340, K05DA015267] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse [DP1 DA031340, R01 DA023979, R01 DA023979 S1 (SB, MEC subcontractor) and K05 DA015267 (MEC), R01 DA030338 (FO)] and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker JJ, 2011, BIOL PSYCHIAT; Brimijoin S, 2002, ANAL BIOCHEM, V309, P200, DOI 10.1016/S0003-2697(02)00238-5; Brimijoin S, 2008, NEUROPSYCHOPHARMACOL, V33, P2715, DOI 10.1038/sj.npp.1301666; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; CARRERA MRA, 1995, NATURE, V378, P727, DOI 10.1038/378727a0; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Collins GT, 2012, NEUROPSYCHOPHARMACOL, V37, P1092, DOI 10.1038/npp.2011.226; Collins GT, 2009, J PHARMACOL EXP THER, V331, P445, DOI 10.1124/jpet.108.150029; Cooper ZD, 2006, MOL PHARMACOL, V70, P1885, DOI 10.1124/mol.106.025999; Ferrario CR, 2010, NEUROPSYCHOPHARMACOL, V35, P818, DOI 10.1038/npp.2009.190; Gao Y, 2005, MOL PHARMACOL, V67, P204, DOI 10.1124/mol.104.006924; Gao Y, 2004, J PHARMACOL EXP THER, V310, P1046, DOI 10.1124/jpet.104.068122; Gao Y, 2008, CHEM-BIOL INTERACT, V175, P83, DOI 10.1016/j.cbi.2008.04.024; Gao Y, 2010, CHEM-BIOL INTERACT, V187, P421, DOI 10.1016/j.cbi.2010.02.036; Gao Y, 2009, J PHARMACOL EXP THER, V330, P449, DOI 10.1124/jpet.109.152231; Gorelick DA, 1997, DRUG ALCOHOL DEPEN, V48, P159, DOI 10.1016/S0376-8716(97)00119-1; HICKS MJ, 2011, MOL THER; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; Kantak KM, 2003, EXPERT OPIN PHARMACO, V4, P213; Kantak KM, 2001, PSYCHOPHARMACOLOGY, V153, P334, DOI 10.1007/s002130000555; Kantak KN, 2000, PSYCHOPHARMACOLOGY, V148, P251, DOI 10.1007/s002130050049; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Kinsey BM, 2010, DRUG FUTURE, V35, P301, DOI 10.1358/dof.2010.035.04.1474292; Koetzner L, 2002, DRUG METAB DISPOS, V30, P716, DOI 10.1124/dmd.30.6.716; Kosten T, 2005, PHARMACOL THERAPEUT, V108, P76, DOI 10.1016/j.pharmthera.2005.06.009; Kosten TR, 2002, VACCINE, V20, P1196, DOI 10.1016/S0264-410X(01)00425-X; LeSage MG, 2006, AAPS J, V8, pE65, DOI 10.1208/aapsj080108; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Mane VP, 2006, GENE THER, V13, P1272, DOI 10.1038/sj.gt.3302792; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Martell BA, 2005, BIOL PSYCHIAT, V58, P158, DOI 10.1016/j.biopsych.2005.04.032; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; National Research Council, 2011, GUID CAR US LAB AN, P8; Norman AB, 2009, J PHARMACOL EXP THER, V328, P873, DOI 10.1124/jpet.108.146407; Norman AB, 2007, J PHARMACOL EXP THER, V320, P145, DOI 10.1124/jpet.106.111781; Orson FM, 2009, HUM VACCIN, V5; Orson FM, 2008, ANN NY ACAD SCI, V1141, P257, DOI 10.1196/annals.1441.027; Orson Frank M, 2007, Curr Psychiatry Rep, V9, P381, DOI 10.1007/s11920-007-0049-z; Orson FM, 2009, HUM VACCINES, V5, P194, DOI 10.4161/hv.5.4.7457; Pan YM, 2005, P NATL ACAD SCI USA, V102, P16656, DOI 10.1073/pnas.0507332102; Pan YM, 2008, J AM CHEM SOC, V130, P5140, DOI 10.1021/ja077972s; Pan YM, 2007, J AM CHEM SOC, V129, P13537, DOI 10.1021/ja073724k; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Riday TT, 2012, NEUROPHARMACOLOGY, V62, P1858, DOI 10.1016/j.neuropharm.2011.12.011; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Saxena A, 2005, CHEM-BIOL INTERACT, V157, P199, DOI 10.1016/j.cbi.2005.10.028; Saxena A, 2011, BIOCHEM PHARMACOL, V81, P164, DOI 10.1016/j.bcp.2010.09.007; Sun H, 2002, MOL PHARMACOL, V62, P220, DOI 10.1124/mol.62.2.220; Sun H, 2001, J BIOL CHEM, V276, P9330, DOI 10.1074/jbc.M006676200; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Weber A, 2011, VOX SANG, V100, P285, DOI 10.1111/j.1423-0410.2010.01415.x; Wee S, 2012, NEUROPSYCHOPHARMACOL, V37, P1083, DOI 10.1038/npp.2011.200; Xue L, 2011, MOL PHARMACOL, V79, P290, DOI 10.1124/mol.110.068494; Yang WC, 2010, CHEM-BIOL INTERACT, V187, P148, DOI 10.1016/j.cbi.2010.01.004; Zhou S.J., 2011, PSYCHOPHARMACOLOGY B	58	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43536	10.1371/journal.pone.0043536	http://dx.doi.org/10.1371/journal.pone.0043536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912888	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700116
J	Herrera, VLM; Pasion, KA; Moran, AM; Ruiz-Opazo, N				Herrera, Victoria L. M.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson			Differential Genetic Basis for Pre-Menopausal and Post-Menopausal Salt-Sensitive Hypertension	PLOS ONE			English	Article							DIASTOLIC BLOOD-PRESSURE; QUANTITATIVE TRAIT LOCUS; RATS; SEX; QTLS; MAP; MENOPAUSE; BEHAVIOR; MODEL; MICE	Essential hypertension affects 75% of post-menopausal women in the United States causing greater cardiovascular complications compared with age-matched men and pre-menopausal women. Hormone replacement and current antihypertensive therapies do not correct this post-menopausal increased risk suggesting a distinct pathogenic framework. We investigated the hypothesis that distinct genetic determinants might underlie susceptibility to salt sensitive hypertension in pre-menopausal and post-menopausal states. To determine whether distinct genetic loci contribute to post-menopausal salt-sensitive hypertension, we performed a genome-wide scan for quantitative trait loci (QTLs) affecting blood pressure (BP) in 16-month old post-menopausal F2 (Dahl SxR)-intercross female rats characterized for blood pressure by radiotelemetry. Given identical environments and high salt challenge, post-menopausal BP levels were significantly higher than observed in pre-menopausal (post-menopausal versus pre-menopausal SBP, P < 0.0001) and ovariectomized (post-menopausal versus ovariectomized SBP, P < 0.001) F2-intercross female rats. We detected four significant to highly significant BP-QTLs (BP-pm1 on chromosome 13, LOD 3.78; BP-pm2 on chromosome 11, LOD 2.76; BP-pm3 on chromosome 2, LOD 2.61; BP-pm4 on chromosome 4, LOD 2.50) and two suggestive BP-QTLs (BP-pm5 on chromosome 15, LOD 2.37; BP-f1 on chromosome 5, LOD 1.65), four of which (BP-pm2, BP-pm3, BP-pm4, BP-pm5) were unique to this post-menopausal cohort. These data demonstrate distinct polygenic susceptibility underlying post-menopausal salt-sensitive hypertension providing a pathway towards the identification of mechanism-based therapy for post-menopausal hypertension and ensuing target-organ complications.	[Herrera, Victoria L. M.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA	Boston University	Herrera, VLM (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.	nruizo@bu.edu		Herrera, Victoria/0000-0001-8991-2134; Ruiz-Opazo, Nelson/0000-0001-8234-1332	National Heart, Lung and Blood Institute [HL086532]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086532] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Heart, Lung and Blood Institute HL086532 (to NRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adarichev VA, 2003, ARTHRITIS RHEUM-US, V48, P1708, DOI 10.1002/art.11016; Anunciado RVP, 2003, EXP ANIM TOKYO, V52, P37, DOI 10.1538/expanim.52.37; Brown MJ, 2000, J CARDIOVASC PHARM, V35, pS41, DOI 10.1097/00005344-200000002-00010; Coylewright M, 2008, HYPERTENSION, V51, P952, DOI 10.1161/HYPERTENSIONAHA.107.105742; Deng AY, 1997, HYPERTENSION, V30, P199, DOI 10.1161/01.HYP.30.2.199; Fortepiani LA, 2003, HYPERTENSION, V41, P640, DOI 10.1161/01.HYP.0000046924.94886.EF; Gabory A, 2011, AM J CLIN NUTR, V94, p1943S, DOI 10.3945/ajcn.110.000927; Gill K, 1998, MAMM GENOME, V9, P929, DOI 10.1007/s003359900902; GUIMARAES CL, 1992, HYPERTENSION, V19, P79; Herrera VL, 2012, J HYPERTENS, V30, P1572, DOI 10.1097/HJH.0b013e3283550eb8; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; Koledova Vera V, 2007, Expert Rev Cardiovasc Ther, V5, P777; LEFEVRE J, 1988, BIOL REPROD, V38, P780, DOI 10.1095/biolreprod38.4.780; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Moreno C, 2007, PHYSIOL GENOMICS, V31, P228, DOI 10.1152/physiolgenomics.00280.2006; MYERS J, 1983, CLIN EXP HYPERTENS A, V5, P99, DOI 10.3109/10641968309048813; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Pechere-Bertschi A, 2004, AM J HYPERTENS, V17, P994, DOI 10.1016/j.amjhyper.2004.08.009; Qiao XY, 2008, GENDER MED, V5, pS46, DOI 10.1016/j.genm.2008.03.006; Ramos A, 1999, MOL PSYCHIATR, V4, P453, DOI 10.1038/sj.mp.4000546; Reckelhoff JF, 2004, HYPERTENSION, V43, P918, DOI 10.1161/01.HYP.0000124670.03674.15; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Schulman IH, 2006, HYPERTENSION, V47, P1168, DOI 10.1161/01.HYP.0000218857.67880.75; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43160	10.1371/journal.pone.0043160	http://dx.doi.org/10.1371/journal.pone.0043160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912817	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700053
J	Hoffmann, J; Rabezanahary, H; Randriamarotia, M; Ratsimbasoa, A; Najjar, J; Vernet, G; Contamin, B; Paranhos-Baccala, G				Hoffmann, Jonathan; Rabezanahary, Henintsoa; Randriamarotia, Martin; Ratsimbasoa, Arsene; Najjar, Josette; Vernet, Guy; Contamin, Benedicte; Paranhos-Baccala, Glaucia			Viral and Atypical Bacterial Etiology of Acute Respiratory Infections in Children under 5 Years Old Living in a Rural Tropical Area of Madagascar	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RHINOVIRUS GENOTYPE; PATHOGENS; VIRUSES; PCR	Background: In Madagascar, very little is known about the etiology and prevalence of acute respiratory infections (ARIs) in a rural tropical area. Recent data are needed to determine the viral and atypical bacterial etiologies in children with defined clinical manifestations of ARIs. Methods: During one year, we conducted a prospective study on ARIs in children between 2 to 59 months in the community hospital of Ampasimanjeva, located in the south-east of Madagascar. Respiratory samples were analyzed by multiplex real-time RT-PCR, including 18 viruses and 2 atypical bacteria. The various episodes of ARI were grouped into four clinical manifestations with well-documented diagnosis: "Community Acquired Pneumonia"(CAP, group I), "Other acute lower respiratory infections (Other ALRIs, group II)", "Upper respiratory tract infections with cough (URTIs with cough, group III)" and "Upper respiratory tract infections without cough (URTIs without cough, group IV)". Results: 295 children were included in the study between February 2010 and February 2011. Viruses and/or atypical bacteria respiratory pathogens were detected in 74.6% of samples, the rate of co-infection was 27.3%. Human rhinovirus (HRV; 20.5%), metapneumovirus (HMPV A/B, 13.8%), coronaviruses (HCoV, 12.5%), parainfluenza virus (HPIV, 11.8%) and respiratory syncytial virus A and B (RSV A/B, 11.8%) were the most detected. HRV was predominantly single detected (23.8%) in all the clinical groups while HMPV A/B (23.9%) was mainly related to CAP (group I), HPIV (17.3%) to the "Other ALRIs" (group II), RSV A/B (19.5%) predominated in the group "URTIs with cough" (group III) and Adenovirus (HAdV, 17.8%) was mainly detected in the "without cough" (group IV). Interpretation: This study describes for the first time the etiology of respiratory infections in febrile children under 5 years in a malaria rural area of Madagascar and highlights the role of respiratory viruses in a well clinically defined population of ARIs.	[Hoffmann, Jonathan; Rabezanahary, Henintsoa; Contamin, Benedicte] CICM, Fac Med, Antananarivo, Madagascar; [Hoffmann, Jonathan; Ratsimbasoa, Arsene; Contamin, Benedicte] Fdn Merieux, Antananarivo, Madagascar; [Randriamarotia, Martin] FMA, Ampasimanjeva, Madagascar; [Ratsimbasoa, Arsene] Minist Sante Publ, Antanananarivo, Madagascar; [Najjar, Josette; Vernet, Guy; Paranhos-Baccala, Glaucia] SFR BioSci Gerland Lyon Sud, UMS3444, US8, Emerging Pathogens Lab,Fdn Merieux, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Hoffmann, J (corresponding author), CICM, Fac Med, Antananarivo, Madagascar.	glaucia.baccala@fondation-merieux.org	Ratsimbasoa, Arsene/AAE-9306-2020	HOFFMANN, JONATHAN/0000-0002-2400-8862	Fondation Merieux; NGO Reggio Terzo Mundo through European Union; Government of Monaco's cooperation	Fondation Merieux; NGO Reggio Terzo Mundo through European Union; Government of Monaco's cooperation	This project was jointly funded by Fondation Merieux, the NGO Reggio Terzo Mundo (through funding from the European Union) and Government of Monaco's cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Blic J, 2009, FLAMMARION MED SCI, P69; Broberg E, 2011, J CLIN VIROL, V51, P79, DOI 10.1016/j.jcv.2011.01.018; Brownlee JW, 2008, CURR OPIN PEDIATR, V20, P67, DOI 10.1097/MOP.0b013e3282f41cb6; Caliendo AM, 2011, CLIN INFECT DIS, V52, pS326, DOI 10.1093/cid/cir047; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; Garcia Ramos E, 1991, Rev Latinoam Microbiol, V33, P109; Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x; Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; McCracken GH, 2000, PEDIATR INFECT DIS J, V19, P924, DOI 10.1097/00006454-200009000-00036; Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070; Nascimento-Carvalho CM, 2011, INFLUENZA OTHER RESP, V5, P285, DOI 10.1111/j.1750-2659.2011.00206.x; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; ONUAIDS, 2010, UNAIDS REP GLOB AIDS; PALMA S. CAMILO, 2005, Rev. chil. infectol., V22, P247; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; SAIKKU P, 1993, AM J TROP MED HYG, V49, P88, DOI 10.4269/ajtmh.1993.49.88; Tapparel C, 2009, J CLIN VIROL, V45, P157, DOI 10.1016/j.jcv.2009.03.014; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2010, J CLIN VIROL, V48, P104, DOI 10.1016/j.jcv.2010.02.023; *WHO, 2008, GLOB ACT PLAN PREV C; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; World Health Organization, 2012, AC RESP INF CHILDR	37	36	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43666	10.1371/journal.pone.0043666	http://dx.doi.org/10.1371/journal.pone.0043666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912897	Green Published, gold			2022-12-27	WOS:000308063700125
J	Murray, LB; Lau, YKI; Yu, Q				Murray, Lucas B.; Lau, Ying-Ka Ingar; Yu, Qin			Merlin Is a Negative Regulator of Human Melanoma Growth	PLOS ONE			English	Article							TUMOR-SUPPRESSOR MERLIN; CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; HIPPO PATHWAY; METASTATIC MELANOMA; YAP ONCOPROTEIN; PROTEIN YAP; CANCER; GENE; PROLIFERATION	Merlin is encoded by the neurofibromatosis type 2 (NF2) gene and is a member of the Band 4.1 protein family. This protein acts as a linker that connects cell surface proteins to the actin cytoskeleton. Defects caused by mutations of the NF2 gene give rise to NF2 disease, which is generally characterized by the formation of bilateral vestibular schwannomas and, to a lesser extent, meningiomas and ependymomas. In addition to these tumor types, NF2 is mutated and/or merlin expression is reduced or lost in numerous non-NF2 associated tumors, including melanoma. However, the role of merlin in human melanoma growth and the mechanism underlying its effect are currently unknown. In the present study, we show that merlin knockdown enhances melanoma cell proliferation, migration, and invasion in vitro and that decreased merlin expression promotes subcutaneous melanoma growth in immunocompromised mice. Concordantly, we find that increased expression of merlin in a metastatic melanoma cell line reduced their in vitro migration and proliferation, and diminished their ability to grow in an anchorage independent manner. Increased merlin expression also inhibits in vivo growth of these melanoma cells. Lastly, we demonstrate that higher merlin levels in human melanoma cells promote the H2O2-induced activation of MST1/2 Ser/Thr kinases, which are known tumor suppressors in the Hippo signaling pathway. Taken together, these results provide for the first time evidence that merlin negatively regulates human melanoma growth, and that loss of merlin, or impaired merlin function, results in an opposite effect. In addition, we show that increased merlin expression leads to enhanced activation of the MTS1/2 kinases, implying the potential roles of MST1/2 in mediating the anti-melanoma effects of merlin.	[Murray, Lucas B.; Lau, Ying-Ka Ingar; Yu, Qin] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Murray, LB (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA.	qin.yu@mssm.edu			 [R01CA135158]; NATIONAL CANCER INSTITUTE [R01CA150355, R01CA135158] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01CA135158. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Bai Y, 2007, ONCOGENE, V26, P836, DOI 10.1038/sj.onc.1209849; BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; Brose MS, 2002, CANCER RES, V62, P6997; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; EVANS DGR, 1992, Q J MED, V84, P603; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fraenzer JT, 2003, INT J ONCOL, V23, P1493; Galcheva-Gargova Z, 2008, INT J ONCOL, V32, P1237; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Gutmann DH, 1997, NEUROLOGY, V49, P267, DOI 10.1212/WNL.49.1.267; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Horiguchi A, 2008, PROSTATE, V68, P975, DOI 10.1002/pros.20760; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; Hu SS, 2009, ARCH DERMATOL, V145, P1369, DOI 10.1001/archdermatol.2009.302; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; LUIKART SD, 1984, J CLIN ONCOL, V2, P164, DOI 10.1200/JCO.1984.2.3.164; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; McCartney BM, 2000, DEVELOPMENT, V127, P1315; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrow KA, 2011, J BIOL CHEM, V286, P40376, DOI 10.1074/jbc.M111.250035; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Thurneysen C, 2009, LUNG CANCER, V64, P140, DOI 10.1016/j.lungcan.2008.08.014; Trofatter J A, 1993, Cell, V75, P826; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Weatherhead SC, 2007, BRIT J DERMATOL, V156, P72, DOI 10.1111/j.1365-2133.2006.07570.x; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Xu ZP, 2011, HEPATO-GASTROENTEROL, V58, P1611, DOI 10.5754/hge10669; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	51	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43295	10.1371/journal.pone.0043295	http://dx.doi.org/10.1371/journal.pone.0043295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912849	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700077
J	Sun, J; Sun, QH; Brown, MF; Dudgeon, C; Chandler, J; Xu, X; Shu, YQ; Zhang, L; Yu, J				Sun, Jing; Sun, Quanhong; Brown, Matthew F.; Dudgeon, Crissy; Chandler, Julie; Xu, Xiang; Shu, Yongqian; Zhang, Lin; Yu, Jian			The Multi-Targeted Kinase Inhibitor Sunitinib Induces Apoptosis in Colon Cancer Cells via PUMA	PLOS ONE			English	Article							COLORECTAL-CANCER; BH3-ONLY PROTEINS; TUMOR-CELLS; P53; GROWTH; MECHANISMS; INDUCTION; RESPONSES; PATHWAYS; STAT3	Constitutive activation of pro-survival kinases has become a promising target of small molecules with an increasing interest in developing multi-targeted agents. The mechanisms underlying the responsiveness to most agents targeting cancer specific survival pathways are still poorly understood but critical for their clinical application. In this study, we found that sunitinib, a small molecule inhibitor of multiple tyrosine kinases including VEGFRs and PDGFRs induces apoptosis and inhibits cell growth in colon cancer cells in cell culture and xenograft models via the BH3-only protein PUMA. Sunitinib treatment induced PUMA transcription via the AKT/FoxO3a axis. PUMA, BH3 mimetics, or 5-Flurourical sensitized colon cancer cells to sunitinib-induced apoptosis. Furthermore, PUMA was induced by sunitinib treatment in xenograft tumors, and deficiency in PUMA significantly suppressed the anti-tumor effects of sunitinib. Our study suggests that PUMA-mediated apoptosis is important for the therapeutic responses to sunitinib, and activation of the mitochondrial pathway by BH3 mimetics or PUMA manipulation may be useful for improving the antitumor activity of sunitinib. Modulation of PUMA and selective Bcl-2 family members might be potential biomarkers for predicting sunitinib responses.	[Sun, Jing; Sun, Quanhong; Brown, Matthew F.; Dudgeon, Crissy; Chandler, Julie; Zhang, Lin; Yu, Jian] Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA; [Sun, Jing; Sun, Quanhong; Brown, Matthew F.; Dudgeon, Crissy; Chandler, Julie; Zhang, Lin; Yu, Jian] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Sun, Jing; Sun, Quanhong; Brown, Matthew F.; Dudgeon, Crissy; Chandler, Julie; Zhang, Lin; Yu, Jian] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Sun, Jing; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Xu, Xiang] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Xu, Xiang] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University; Army Medical University; Army Medical University	Sun, J (corresponding author), Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA.	yuj2@upmc.edu	Zhang, Lin/A-7389-2009; Shu, Yongqian/ABD-5698-2021; xu, xiang/L-2579-2014; Yu, Jian/A-8301-2009	Zhang, Lin/0000-0003-0018-3903; Yu, Jian/0000-0002-4021-1000; Dudgeon, Crissy/0000-0001-9010-2569; xu, xiang/0000-0002-1026-2210	National Institutes of Health (NIH) [CA129829, CA106348, CA121105]; American Cancer Society [RGS-10-124-01-CCE, RSG-07-156-01-CNE]; FAMRI; National Natural Science Foundation of China [30772549];  [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA129829, R01CA106348, R01CA172136, R01CA121105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); FAMRI; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health (NIH) grant CA129829, American Cancer Society grant RGS-10-124-01-CCE and FAMRI (J. Yu), and by NIH grants CA106348, CA121105 and American Cancer Society grant RSG-07-156-01-CNE (L. Zhang). This project used the UPCI shared facilities that were supported in part by award P30CA047904. J. Sun and Y. Shu are supported in part by National Natural Science Foundation of China Grants 30772549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Arena S, 2008, CELL CYCLE, V7, P1560, DOI 10.4161/cc.7.11.6031; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burkitt K, 2009, MOL CANCER THER, V8, P1148, DOI 10.1158/1535-7163.MCT-08-0944; Mena AC, 2010, ANTI-CANCER DRUG, V21, pS3, DOI 10.1097/01.cad.0000361534.44052.c5; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Dudgeon C, 2010, MOL CANCER THER, V9, P2893, DOI 10.1158/1535-7163.MCT-10-0635; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson KD, 2002, METHODS, V26, P27, DOI 10.1016/S1046-2023(02)00005-1; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Leibowitz BJ, 2011, MOL CANCER RES, V9, P616, DOI 10.1158/1541-7786.MCR-11-0052; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Naik E, 2011, J EXP MED, V208, P1351, DOI 10.1084/jem.20100951; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Qiu W, 2009, CANCER RES, V69, P4999, DOI 10.1158/0008-5472.CAN-09-0262; Rolff J, 2009, J ONCOL, V2009, DOI 10.1155/2009/814140; Saltz LB, 2007, J CLIN ONCOL, V25, P4793, DOI 10.1200/JCO.2007.12.8637; Sun Q, 2009, ONCOGENE, V28, P2348, DOI 10.1038/onc.2009.108; Sun Q, 2011, CLIN CANC RES; Sun Q, 2007, MOL CANCER THER, V6, P3180, DOI 10.1158/1535-7163.MCT-07-0265; Takezawa K, 2011, CLIN CANCER RES, V17, P2140, DOI 10.1158/1078-0432.CCR-10-2798; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yang F, 2010, MOL CANCER RES, V8, P35, DOI 10.1158/1541-7786.MCR-09-0220; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Yu J, 2006, CLIN CANCER RES, V12, P2928, DOI 10.1158/1078-0432.CCR-05-2429; Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang L, 2007, DRUG RESIST UPDATE, V10, P207, DOI 10.1016/j.drup.2007.08.002	48	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43158	10.1371/journal.pone.0043158	http://dx.doi.org/10.1371/journal.pone.0043158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912816	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308063700052
J	Ueta, M; Tokunaga, K; Sotozono, C; Sawai, H; Tamiya, G; Inatomi, T; Kinoshita, S				Ueta, Mayumi; Tokunaga, Katsushi; Sotozono, Chie; Sawai, Hiromi; Tamiya, Gen; Inatomi, Tsutomu; Kinoshita, Shigeru			HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications	PLOS ONE			English	Article							TOXIC EPIDERMAL NECROLYSIS; ERYTHEMA MULTIFORME; GENE POLYMORPHISMS; JAPANESE PATIENTS; ASSOCIATION; MANIFESTATIONS; CHILDREN; RISK	Background: Stevens-Johnson syndrome (SJS) is an acute inflammatory vesiculobullous reaction of the skin and mucosa, often including the ocular surface, and toxic epidermal necrolysis (TEN) occurs with its progression. Although SJS/TEN is thought to be initiated by certain types of medication coupled with possible infection. In the present study we examined the multiplicative interaction(s) between HLA-A*0206 and 7 Toll-like receptor 3 (TLR3) Single-nucleotide polymorphisms (SNPs) in patients with SJS/TEN. Principal Findings: We analyzed the genotypes for HLA-A and 7 TLR3 SNPs in 110 Japanese SJS/TEN patients with severe ocular complications and 206 healthy volunteers to examine the interactions between the two loci. We found that HLA-A*0206 exhibited a high odds ratio for SJS/TEN (carrier frequency: OR = 5.1; gene frequency: OR = 4.0) and that there was a strong association with TLR3 rs.5743312T/T SNP (OR = 7.4), TLR3 rs.3775296T/T SNP (OR = 5.8), TLR3 rs.6822014G/G SNP (OR = 4.8), TLR3 rs.3775290A/A SNP (OR = 2.9), TLR3 rs.7668666A/A SNP (OR = 2.7), TLR3 rs.4861699G/G SNP (OR = 2.3), and TLR3 rs.11732384G/G SNP (OR = 1.9). There was strong linkage disequilibrium (LD) between rs.3775296 and rs.5743312 and between rs.7668666 and rs.3775290. The results of interaction analysis showed that the pair, HLA-A*0206 and TLR3 SNP rs3775296T/T, which exhibited strong LD with TLR3 rs.5743312, exerted more than additive effects (OR = 47.7). The other pairs, HLA-A*0206 and TLR3 rs.3775290A/A SNP (OR = 11.4) which was in strong LD with TLR3 rs7668666A/A SNP, and TLR3 rs4861699G/G SNP (OR = 7.6) revealed additive effects. Moreover, the combination HLA-A*0206 and TLR3 rs3775296T/T was stronger than the TLR3 rs6822014G/G and TLR3 rs3775290A/A pair, which reflected the interactions within the TLR3 gene alone. Significance: By interaction analysis, HLA-A*0206 and TLR3 SNP rs3775296T/T, which were in strong LD with TLR3 SNP rs5743312T/T, manifested more than additive effects that were stronger than the interactions within the TLR3 gene alone. Therefore, multiplicative interactions of HLA-A and TLR3 gene might be required for the onset of SJS/TEN with ocular complications.	[Ueta, Mayumi; Sotozono, Chie; Inatomi, Tsutomu; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Ueta, Mayumi] Doshisha Univ, Fac Life & Med Sci, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan; [Tokunaga, Katsushi; Sawai, Hiromi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Tamiya, Gen] Yamagata Univ, Adv Mol Epidemiol Res Inst, Fac Medcine, Yamagata 990, Japan	Kyoto Prefectural University of Medicine; Doshisha University; University of Tokyo; Yamagata University	Ueta, M (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.	mueta@koto.kpu-m.ac.jp		Tamiya, Gen/0000-0002-0597-415X	Japanese Ministry of Health, Labour and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology; Kyoto Foundation for the Promotion of Medical Science; Intramural Research Fund of Kyoto Prefectural University of Medicine; Grants-in-Aid for Scientific Research [22133008] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto Foundation for the Promotion of Medical Science(Kyoto Foundation for the Promotion of Medical Science); Intramural Research Fund of Kyoto Prefectural University of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japanese Ministry of Health, Labour and Welfare, the Japanese Ministry of Education, Culture, Sports, Science and Technology, a research grant from the Kyoto Foundation for the Promotion of Medical Science, and the Intramural Research Fund of Kyoto Prefectural University of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auquier-Dunant A, 2002, ARCH DERMATOL, V138, P1019, DOI 10.1001/archderm.138.8.1019; Di Pascuale MA, 2005, OPHTHALMOLOGY, V112, P904, DOI 10.1016/j.ophtha.2004.11.035; Forman R, 2002, DRUG SAFETY, V25, P965, DOI 10.2165/00002018-200225130-00006; Kaniwa N, 2010, EPILEPSIA, V51, P2461, DOI 10.1111/j.1528-1167.2010.02766.x; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Leaute-Labreze C, 2000, ARCH DIS CHILD, V83, P347, DOI 10.1136/adc.83.4.347; MONDINO BJ, 1982, ARCH OPHTHALMOL-CHIC, V100, P1453; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Sotozono C, 2007, OPHTHALMOLOGY, V114, P1294, DOI 10.1016/j.ophtha.2006.10.029; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; Stevens AM, 1922, AM J DIS CHILD, V24, P526, DOI 10.1001/archpedi.1922.04120120077005; Ueta M, 2008, BRIT J OPHTHALMOL, V92, P989, DOI 10.1136/bjo.2007.136796; Ueta M, J ALLERGY C IN PRESS; Ueta M, 2008, MOL VIS, V14, P550; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P1809, DOI 10.1167/iovs.07-1401; Ueta M, 2007, J ALLERGY CLIN IMMUN, V120, P1457, DOI 10.1016/j.jaci.2007.07.048; Ueta M, 2007, BRIT J OPHTHALMOL, V91, P962, DOI 10.1136/bjo.2006.113449; Ueta M, 2007, AM J OPHTHALMOL, V143, P367, DOI 10.1016/j.ajo.2006.09.029; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Ueta M, 2010, BRAIN RES BULL, V81, P219, DOI 10.1016/j.brainresbull.2009.10.001; Wolf R, 2005, CLIN DERMATOL, V23, P171, DOI 10.1016/j.clindermatol.2004.06.012; YETIV JZ, 1980, SOUTH MED J, V73, P599, DOI 10.1097/00007611-198005000-00015	23	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43650	10.1371/journal.pone.0043650	http://dx.doi.org/10.1371/journal.pone.0043650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912896	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700124
J	Crisan, A; Goya, R; Ha, G; Ding, JR; Prentice, LM; Oloumi, A; Senz, J; Zeng, T; Tse, K; Delaney, A; Marra, MA; Huntsman, DG; Hirst, M; Aparicio, S; Shah, S				Crisan, Anamaria; Goya, Rodrigo; Ha, Gavin; Ding, Jiarui; Prentice, Leah M.; Oloumi, Arusha; Senz, Janine; Zeng, Thomas; Tse, Kane; Delaney, Allen; Marra, Marco A.; Huntsman, David G.; Hirst, Martin; Aparicio, Sam; Shah, Sohrab			Mutation Discovery in Regions of Segmental Cancer Genome Amplifications with CoNAn-SNV: A Mixture Model for Next Generation Sequencing of Tumors	PLOS ONE			English	Article							MYELOID-LEUKEMIA GENOME; HIDDEN-MARKOV MODEL; NONRANDOM DUPLICATION; SOMATIC MUTATIONS; GENOTYPING DATA; RESOLUTION; ALLELE; GENES	Next generation sequencing has now enabled a cost-effective enumeration of the full mutational complement of a tumor genome-in particular single nucleotide variants (SNVs). Most current computational and statistical models for analyzing next generation sequencing data, however, do not account for cancer-specific biological properties, including somatic segmental copy number alterations (CNAs)-which require special treatment of the data. Here we present CoNAn-SNV (Copy Number Annotated SNV): a novel algorithm for the inference of single nucleotide variants (SNVs) that overlap copy number alterations. The method is based on modelling the notion that genomic regions of segmental duplication and amplification induce an extended genotype space where a subset of genotypes will exhibit heavily skewed allelic distributions in SNVs (and therefore render them undetectable by methods that assume diploidy). We introduce the concept of modelling allelic counts from sequencing data using a panel of Binomial mixture models where the number of mixtures for a given locus in the genome is informed by a discrete copy number state given as input. We applied CoNAn-SNV to a previously published whole genome shotgun data set obtained from a lobular breast cancer and show that it is able to discover 21 experimentally revalidated somatic non-synonymous mutations in a lobular breast cancer genome that were not detected using copy number insensitive SNV detection algorithms. Importantly, ROC analysis shows that the increased sensitivity of CoNAn-SNV does not result in disproportionate loss of specificity. This was also supported by analysis of a recently published lymphoma genome with a relatively quiescent karyotype, where CoNAn-SNV showed similar results to other callers except in regions of copy number gain where increased sensitivity was conferred. Our results indicate that in genomically unstable tumors, copy number annotation for SNV detection will be critical to fully characterize the mutational landscape of cancer genomes.	[Crisan, Anamaria; Goya, Rodrigo; Ha, Gavin; Ding, Jiarui; Prentice, Leah M.; Oloumi, Arusha; Aparicio, Sam; Shah, Sohrab] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada; [Ding, Jiarui; Senz, Janine; Zeng, Thomas] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1W5, Canada; [Goya, Rodrigo; Tse, Kane; Delaney, Allen; Marra, Marco A.; Hirst, Martin] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Shah, Sohrab] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia	Crisan, A (corresponding author), BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada.	sshah@bccrc.ca	Marra, Marco A/B-5987-2008; Huntsman, David/ABE-6082-2020; Ha, Gavin/N-1984-2019; Hirst, Martin/B-7684-2016	Marra, Marco A/0000-0001-7146-7175; Ha, Gavin/0000-0001-7578-7272; Aparicio, Samuel/0000-0002-0487-9599	Canadian Breast Cancer Foundation; Canadian Institutes of Health Research University of British Columbia/Simon Fraser University Bioinformatics training program	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research University of British Columbia/Simon Fraser University Bioinformatics training program(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Breast Cancer Foundation (fellowship to SPS), and the Canadian Institutes of Health Research University of British Columbia/Simon Fraser University Bioinformatics training program (scholarship to AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCHI AB, 1990, P NATL ACAD SCI USA, V87, P6902, DOI 10.1073/pnas.87.17.6902; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gelman A., 2003, BAYESIAN DATA ANAL; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Herrick J, 2005, CANCER RES, V65, P1174, DOI 10.1158/0008-5472.CAN-04-2802; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LaFramboise T, 2005, PLOS COMPUTATIONAL B, V1, P11; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Scharpf RB, 2008, ANN APPL STAT, V2, P687, DOI 10.1214/07-AOAS155; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang WY, 2008, J COMPUT BIOL, V15, P857, DOI 10.1089/cmb.2007.0148; Zhuang ZP, 1998, NAT GENET, V20, P66, DOI 10.1038/1727	26	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e41551	10.1371/journal.pone.0041551	http://dx.doi.org/10.1371/journal.pone.0041551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916110	gold, Green Published, Green Submitted			2022-12-27	WOS:000307824300006
J	Fowler, TW; McKelvey, KD; Akel, NS; Schilden, JV; Bacon, AW; Bracey, JW; Sowder, T; Skinner, RA; Swain, FL; Hogue, WR; Leblanc, DB; Gaddy, D; Wenger, GR; Suva, LJ				Fowler, Tristan W.; McKelvey, Kent D.; Akel, Nisreen S.; Schilden, Jaclyn Vander; Bacon, Anthony W.; Bracey, John W.; Sowder, Timothy; Skinner, Robert A.; Swain, Frances L.; Hogue, William R.; Leblanc, Donna B.; Gaddy, Dana; Wenger, Galen R.; Suva, Larry J.			Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED OSTEOPOROSIS; MINERAL DENSITY; MOUSE MODEL; POSTMENOPAUSAL WOMEN; ANIMAL-MODEL; YOUNG MEN; MASS; TERIPARATIDE; STRENGTH; ADULTS	Trisomy 21 affects virtually every organ system and results in the complex clinical presentation of Down syndrome (DS). Patterns of differences are now being recognized as patients' age and these patterns bring about new opportunities for disease prevention and treatment. Low bone mineral density (BMD) has been reported in many studies of males and females with DS yet the specific effects of trisomy 21 on the skeleton remain poorly defined. Therefore we determined the bone phenotype and measured bone turnover markers in the murine DS model Ts65Dn. Male Ts65Dn DS mice are infertile and display a profound low bone mass phenotype that deteriorates with age. The low bone mass was correlated with significantly decreased osteoblast and osteoclast development, decreased bone biochemical markers, a diminished bone formation rate and reduced mechanical strength. The low bone mass observed in 3 month old Ts65Dn mice was significantly increased after 4 weeks of intermittent PTH treatment. These studies provide novel insight into the cause of the profound bone fragility in DS and identify PTH as a potential anabolic agent in the adult low bone mass DS population.	[Fowler, Tristan W.; Akel, Nisreen S.; Gaddy, Dana; Suva, Larry J.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Fowler, Tristan W.; Akel, Nisreen S.; Schilden, Jaclyn Vander; Bacon, Anthony W.; Bracey, John W.; Sowder, Timothy; Skinner, Robert A.; Swain, Frances L.; Hogue, William R.; Gaddy, Dana; Suva, Larry J.] Univ Arkansas Med Sci, Ctr Orthopaed Res, Dept Orthopaed Surg, Little Rock, AR 72205 USA; [McKelvey, Kent D.; Leblanc, Donna B.] Univ Arkansas Med Sci, Dept Genet, Little Rock, AR 72205 USA; [Wenger, Galen R.] Univ Arkansas Med Sci, Dept Pharmacol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Fowler, TW (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	suvalarryj@uams.edu		Suva, Larry/0000-0002-2892-9757	NIH [R01-DK54044, R21-74024, R01 HD047656]; UAMS Translational Research Institute (TRI) [UL1RR029884]; Winthrop P Rockefeller Chair in Clinical Genetics; Carl L. Nelson Endowed Chair in Orthopaedic Creativity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS Translational Research Institute (TRI); Winthrop P Rockefeller Chair in Clinical Genetics; Carl L. Nelson Endowed Chair in Orthopaedic Creativity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01-DK54044 and R21-74024 (DG), NIH R01 HD047656 (GRW), UAMS Translational Research Institute (TRI) clinical award (KGM), UAMS TRI UL1RR029884, the Winthrop P Rockefeller Chair in Clinical Genetics (KDM) and the Carl L. Nelson Endowed Chair in Orthopaedic Creativity (LJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford KA, 2010, BLOOD, V115, P2928, DOI 10.1182/blood-2009-06-227629; Angelopoulou N, 1999, EUR RADIOL, V9, P648, DOI 10.1007/s003300050726; Angelopoulou N, 2000, CALCIFIED TISSUE INT, V66, P176, DOI 10.1007/s002230010035; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Baptista F, 2005, OSTEOPOROSIS INT, V16, P380, DOI 10.1007/s00198-004-1687-1; Bittles AH, 2004, DEV MED CHILD NEUROL, V46, P282, DOI 10.1017/S0012162204000441; Blazek JD, 2011, BONE, V48, P275, DOI 10.1016/j.bone.2010.09.028; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; CAMPBELL WA, 1982, J MED GENET, V19, P98, DOI 10.1136/jmg.19.2.98; Down JL, 1866, CLIN LECT REPORTS LO, V3, P259; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Gonzalez-Aguero A, 2011, OSTEOPOROSIS INT, V22, P2151, DOI 10.1007/s00198-010-1443-7; Granholm ACE, 2002, PHYSIOL BEHAV, V77, P371, DOI 10.1016/S0031-9384(02)00884-3; Grimwood JS, 2000, HISTOPATHOLOGY, V36, P279; Guijarro M, 2008, J INTELL DISABIL RES, V52, P182, DOI 10.1111/j.1365-2788.2007.00992.x; Hawli Y, 2009, NAT REV ENDOCRINOL, V5, P327, DOI 10.1038/nrendo.2009.80; Hui S L, 1990, Osteoporos Int, V1, P30, DOI 10.1007/BF01880413; JOHANNISSON R, 1983, HUM GENET, V63, P132, DOI 10.1007/BF00291532; KAO CH, 1992, NUCL MED COMMUN, V13, P773, DOI 10.1097/00006231-199213100-00012; Kirsammer G, 2008, BLOOD, V111, P767, DOI 10.1182/blood-2007-04-085670; Leffler A, 1999, ANN ANAT, V181, P247, DOI 10.1016/S0940-9602(99)80039-9; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; Ma YFL, 2006, J BONE MINER RES, V21, P855, DOI 10.1359/JBMR.060314; da Silva VZM, 2010, RES DEV DISABIL, V31, P1585, DOI 10.1016/j.ridd.2010.05.003; McKelvey KD, 2012, OSTEOPOROS IN PRESS; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Olson LE, 2011, AM J MED GENET A, V155A, P2436, DOI 10.1002/ajmg.a.34203; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parsons T, 2007, ANAT REC, V290, P414, DOI 10.1002/ar.20494; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Roy A, 2009, BRIT J HAEMATOL, V147, P3, DOI 10.1111/j.1365-2141.2009.07789.x; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Sakadamis A, 2002, EUR J OBSTET GYN R B, V100, P208, DOI 10.1016/S0301-2115(01)00478-X; SEEMAN E, 1994, OSTEOPOROSIS INT, V4, P15; SEPULVEDA D, 1995, AM J MENT RETARD, V100, P109; Stefanidis K, 2011, ANDROLOGIA, V43, P353, DOI 10.1111/j.1439-0272.2010.01043.x; Suva LJ, 2008, AM J PATHOL, V172, P430, DOI 10.2353/ajpath.2008.070417; SUVA LJ, 1993, J BONE MINER RES, V8, P379; Van Allen MI, 1999, AM J MED GENET, V89, P100, DOI 10.1002/(SICI)1096-8628(19990625)89:2<100::AID-AJMG8>3.3.CO;2-E	46	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42967	10.1371/journal.pone.0042967	http://dx.doi.org/10.1371/journal.pone.0042967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916188	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800034
J	Gomez-Marin, A; Partoune, N; Stephens, GJ; Louis, M				Gomez-Marin, Alex; Partoune, Nicolas; Stephens, Greg J.; Louis, Matthieu			Automated Tracking of Animal Posture and Movement during Exploration and Sensory Orientation Behaviors	PLOS ONE			English	Article							DROSOPHILA LARVA; DECISION-MAKING; LIGHT-AVOIDANCE; HIGH-RESOLUTION; MACHINE VISION; CHEMOTAXIS; MECHANISMS; ELEGANS; SYSTEM; STRATEGIES	Background: The nervous functions of an organism are primarily reflected in the behavior it is capable of. Measuring behavior quantitatively, at high-resolution and in an automated fashion provides valuable information about the underlying neural circuit computation. Accordingly, computer-vision applications for animal tracking are becoming a key complementary toolkit to genetic, molecular and electrophysiological characterization in systems neuroscience. Methodology/Principal Findings: We present Sensory Orientation Software ( SOS) to measure behavior and infer sensory experience correlates. SOS is a simple and versatile system to track body posture and motion of single animals in two-dimensional environments. In the presence of a sensory landscape, tracking the trajectory of the animal's sensors and its postural evolution provides a quantitative framework to study sensorimotor integration. To illustrate the utility of SOS, we examine the orientation behavior of fruit fly larvae in response to odor, temperature and light gradients. We show that SOS is suitable to carry out high-resolution behavioral tracking for a wide range of organisms including flatworms, fishes and mice. Conclusions/Significance: Our work contributes to the growing repertoire of behavioral analysis tools for collecting rich and fine-grained data to draw and test hypothesis about the functioning of the nervous system. By providing open-access to our code and documenting the software design, we aim to encourage the adaptation of SOS by a wide community of non-specialists to their particular model organism and questions of interest.	[Gomez-Marin, Alex; Partoune, Nicolas; Louis, Matthieu] Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona, Spain; [Gomez-Marin, Alex; Partoune, Nicolas; Louis, Matthieu] Univ Pompeu Fabra, Barcelona, Spain; [Partoune, Nicolas] Univ Liege, Dept Elect Engn & Comp Sci, B-4000 Sart Tilman Par Liege, Belgium; [Stephens, Greg J.] Princeton Univ, Joseph Henry Labs, Phys & Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; University of Liege; Princeton University	Gomez-Marin, A (corresponding author), Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona, Spain.	agomezmarin@gmail.com; matthieu.louis@crg.eu	Louis, Matthieu/J-5566-2015; Gomez Marin, Alejandro/M-6408-2015	Louis, Matthieu/0000-0002-2267-0262; Stephens, Greg/0000-0003-3135-3514; Gomez Marin, Alejandro/0000-0003-2764-2583	Juan de la Cierva program from the Spanish Ministry of Science and Innovation; ERASMUS scholarship; University of Liege; National Science Foundation [PHY-0650617, IIS-0613435]; National Institutes of Health [P50 GM071508]; Swartz Foundation; Spanish Ministry of Science and Innovation [BFU2008-00362, BFU2009-07757-E/BMC]; European Molecular Biology Laboratory/Center for Genomic Regulation Systems Biology Program; Marie Curie Reintegration Grant [PIRG02-GA-2007-224791]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Juan de la Cierva program from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); ERASMUS scholarship; University of Liege(University of Liege); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Molecular Biology Laboratory/Center for Genomic Regulation Systems Biology Program; Marie Curie Reintegration Grant(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AGM is supported by the Juan de la Cierva program from the Spanish Ministry of Science and Innovation. NP was funded through an ERASMUS scholarship granted by the University of Liege. GJS is supported in part by grants PHY-0650617 and IIS-0613435 from the National Science Foundation, by grant P50 GM071508 from the National Institutes of Health, and by the Swartz Foundation. ML acknowledges funding from the Spanish Ministry of Science and Innovation (BFU2008-00362 and BFU2009-07757-E/BMC), the European Molecular Biology Laboratory/Center for Genomic Regulation Systems Biology Program and a Marie Curie Reintegration Grant (PIRG02-GA-2007-224791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Busto M, 1999, J NEUROSCI, V19, P3337; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; Crespo JE, 2011, J INSECT PHYSIOL, V57, P191, DOI 10.1016/j.jinsphys.2010.11.010; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Faumont S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024666; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fraenkel GS, 1961, ORIENTATION ANIMALS; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gershow M, 2012, NAT METHODS, V9, P290, DOI [10.1038/NMETH.1853, 10.1038/nmeth.1853]; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Gomez-Marin A, 2012, CURR OPIN NEUROBIOL, V22, P208, DOI 10.1016/j.conb.2011.11.008; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gomez-Marin A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00006; Hassan J, 2000, BEHAV GENET, V30, P59, DOI 10.1023/A:1002090627601; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Kane E, SENSORIMOTOR B UNPUB; Keene AC, 2011, J NEUROSCI, V31, P6527, DOI 10.1523/JNEUROSCI.6165-10.2011; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015259; Kohlhoff KJ, 2011, INTEGR BIOL-UK, V3, P755, DOI 10.1039/c0ib00149j; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Leshner A, 2011, P NATL ACAD SCI USA, V108, P15537, DOI 10.1073/pnas.1010653108; Lockery SR, 2011, CURR OPIN NEUROBIOL; Lott GK, 2010, GVISION SCI VIDEO IM; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Min TL, 2009, NAT METHODS, V6, P831, DOI [10.1038/NMETH.1380, 10.1038/nmeth.1380]; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Orgogozo V, 2006, GENETICS, V173, P197, DOI 10.1534/genetics.105.054098; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; SAWIN FP, 1994, J INSECT BEHAV, V7, P553, DOI 10.1007/BF02025449; Scantlebury N, 2007, BEHAV GENET, V37, P513, DOI 10.1007/s10519-007-9146-3; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stephens GJ, 2011, P NATL ACAD SCI USA, V108, P15565, DOI 10.1073/pnas.1010868108; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Webster DR, 2009, ANNU REV FLUID MECH, V41, P73, DOI 10.1146/annurev.fluid.010908.165240; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576	49	64	65	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41642	10.1371/journal.pone.0041642	http://dx.doi.org/10.1371/journal.pone.0041642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912674	gold, Green Published, Green Submitted			2022-12-27	WOS:000307378500007
J	Foersch, S; Heimann, A; Ayyad, A; Spoden, GA; Florin, L; Mpoukouvalas, K; Kiesslich, R; Kempski, O; Goetz, M; Charalampaki, P				Foersch, Sebastian; Heimann, Axel; Ayyad, Ali; Spoden, Gilles A.; Florin, Luise; Mpoukouvalas, Konstantin; Kiesslich, Ralf; Kempski, Oliver; Goetz, Martin; Charalampaki, Patra			Confocal Laser Endomicroscopy for Diagnosis and Histomorphologic Imaging of Brain Tumors In Vivo	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; COLORECTAL-CANCER; MALIGNANT GLIOMA; MICROSCOPY; RESECTION; NEUROSURGERY; LAPAROSCOPY; SURVIVAL; SURGERY	Early detection and evaluation of brain tumors during surgery is crucial for accurate resection. Currently cryosections during surgery are regularly performed. Confocal laser endomicroscopy (CLE) is a novel technique permitting in vivo histologic imaging with miniaturized endoscopic probes at excellent resolution. Aim of the current study was to evaluate CLE for in vivo diagnosis in different types and models of intracranial neoplasia. In vivo histomorphology of healthy brains and two different C6 glioma cell line allografts was evaluated in rats. One cell line expressed EYFP, the other cell line was used for staining with fluorescent dyes (fluorescein, acriflavine, FITC-dextran and Indocyanine green). To evaluate future application in patients, fresh surgical resection specimen of human intracranial tumors (n = 15) were examined (glioblastoma multiforme, meningioma, craniopharyngioma, acoustic neurinoma, brain metastasis, medulloblastoma, epidermoid tumor). Healthy brain tissue adjacent to the samples served as control. CLE yielded high-quality histomorphology of normal brain tissue and tumors. Different fluorescent agents revealed distinct aspects of tissue and cell structure (nuclear pattern, axonal pathways, hemorrhages). CLE discrimination of neoplastic from healthy brain tissue was easy to perform based on tissue and cellular architecture and resemblance with histopathology was excellent. Confocal laser endomicroscopy allows immediate in vivo imaging of normal and neoplastic brain tissue at high resolution. The technology might be transferred to scientific and clinical application in neurosurgery and neuropathology. It may become helpful to screen for tumor free margins and to improve the surgical resection of malignant brain tumors, and opens the door to in vivo molecular imaging of tumors and other neurologic disorders.	[Foersch, Sebastian; Kiesslich, Ralf; Goetz, Martin] Univ Med Ctr, Med Clin 1, Mainz, Germany; [Heimann, Axel; Kempski, Oliver; Charalampaki, Patra] Univ Med Ctr, Inst Neurosurg Pathophysiol, Mainz, Germany; [Ayyad, Ali] Univ Med Ctr, Dept Neurosurg, Mainz, Germany; [Charalampaki, Patra] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Spoden, Gilles A.; Florin, Luise] Univ Med Ctr, Dept Med Microbiol & Hyg, Mainz, Germany; [Mpoukouvalas, Konstantin] Inst Microtechnol Mainz, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Medical University of Graz; Johannes Gutenberg University of Mainz	Foersch, S (corresponding author), Univ Med Ctr, Med Clin 1, Mainz, Germany.	kempski@nc-patho.klinik.uni-mainz.de	Ralf Kiesslich, Dr./AAK-9313-2021	Heimann, Axel/0000-0003-2510-3228	German Federal Ministry of Education and Research [16SV5069]; Boehringer-Ingelheim-Foundation; Professional Association of German Internists; Olympus Europe Foundation	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Boehringer-Ingelheim-Foundation(Boehringer Ingelheim); Professional Association of German Internists; Olympus Europe Foundation	This work was supported by a governmental grant from the German Federal Ministry of Education and Research (No. 16SV5069) to OK. SF received scholarships from the Boehringer-Ingelheim-Foundation, the Professional Association of German Internists and a grant from the Olympus Europe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker V, 2007, GASTROINTEST ENDOSC, V66, P1001, DOI 10.1016/j.gie.2007.04.015; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Callovini GM, 2008, MINIM INVAS NEUROSUR, V51, P109, DOI 10.1055/s-2008-1058096; Deinert K, 2007, ENDOSCOPY, V39, P366, DOI 10.1055/s-2007-966217; Dunbar KB, 2009, GASTROINTEST ENDOSC, V70, P645, DOI 10.1016/j.gie.2009.02.009; Eschbacher J, 2012, J NEUROSURG, V116, P854, DOI 10.3171/2011.12.JNS11696; Field P, 2001, J NEUROSURG, V94, P545, DOI 10.3171/jns.2001.94.4.0545; Foersch S, 2010, GUT, V59, P1046, DOI 10.1136/gut.2009.202986; Goetz M, 2008, EUR SURG RES, V41, P290, DOI 10.1159/000148242; Goetz M, 2007, ENDOSCOPY, V39, P350, DOI 10.1055/s-2007-966262; Goetz M, 2008, J HEPATOL, V48, P91, DOI 10.1016/j.jhep.2007.07.029; Goetz M, 2010, J HEPATOL, V53, P84, DOI 10.1016/j.jhep.2010.01.039; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; Goetz M, 2009, GASTROINTEST ENDOSC, V70, P959, DOI 10.1016/j.gie.2009.04.016; Gunther U, 2008, GUT, V57, P1331; Hale SL, 2011, TOXICOL PATHOL, V39, P52, DOI 10.1177/0192623310394213; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Kiesslich R, 2007, GASTROENTEROLOGY, V133, P742, DOI 10.1053/j.gastro.2007.07.037; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Krizova A, 2011, AM J SURG PATHOL, V35, P115, DOI 10.1097/PAS.0b013e31820273dc; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Martirosyan NL, 2011, J NEUROSURG, V115, P1131, DOI 10.3171/2011.8.JNS11559; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sankar T, 2010, NEUROSURGERY, V66, P410, DOI 10.1227/01.NEU.0000365772.66324.6F; Schlosser HG, 2010, CENT EUR NEUROSURG, V71, P13, DOI 10.1055/s-0029-1237735; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 1998, J PHOTOCH PHOTOBIO B, V45, P160, DOI 10.1016/S1011-1344(98)00176-6; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Stummer W, 2011, ACTA NEUROCHIR, V153, P1211, DOI 10.1007/s00701-011-1001-x; Suh JH, 2010, NEW ENGL J MED, V362, P1119, DOI 10.1056/NEJMct0806951; Tanaka Y, 2009, J NEUROSURG, V110, P163, DOI 10.3171/2008.4.17569; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wiesner C, 2011, BJU INT, V107, P399, DOI 10.1111/j.1464-410X.2010.09540.x	36	56	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41760	10.1371/journal.pone.0041760	http://dx.doi.org/10.1371/journal.pone.0041760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911853	Green Published, gold			2022-12-27	WOS:000306751300071
J	Wang, CY; Zhu, Z; Xu, Q; Xu, AQ; Fang, XQ; Song, LZ; Li, WX; Xiong, P; Xu, WB				Wang, Changyin; Zhu, Zhen; Xu, Qing; Xu, Aiqiang; Fang, Xueqiang; Song, Lizhi; Li, Weixiu; Xiong, Ping; Xu, Wenbo			Rubella Epidemics and Genotypic Distribution of the Rubella Virus in Shandong Province, China, in 1999-2010	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PREVENTION	Background: The rubella vaccine was introduced into the immunization program in 1995 in the Shandong province, China. A series of different rubella vaccination strategies were implemented at different stages of measles control in Shandong province. Methodology/Principal Findings: The average reported incidence rate of rubella cases remained at a low level in Shandong province after 1999. However, rubella epidemics occurred repeatedly in 2001/2002, 2006, and 2008/2009. The age of the onset of rubella cases gradually increased during 1999-2010, which showed that most cases were found among the 10 years old in 1999 and among the 17 years old in 2010. Phylogenetic analysis was performed and a phylogenetic tree was constructed based on the World Health Organization standard sequence window for rubella virus isolates. All rubella viruses isolated in Shandong province were divided into 4 genotypes: 1E, 1F, 2A, and 2B. Genotype 1E viruses accounted for the majority (79%) of all these viruses. The similarity of nucleotide and amino acid sequences among genotype 1E viruses was 98.2-100% and 99.1-100%, respectively. All Shandong genotype 1E strains, differed from international genotype 1E strains, belonged to cluster 1 and interdigitated with the viruses from other provinces in mainland China. The effective number of infections indicated by a Bayesian skyline plot remained constant from 2001 to 2009. Conclusions/Significance: The gradual shift of disease burden to an older age group occurred after a rubella-containing vaccine was introduced into the childhood immunization schedule in 1995 in Shandong province. Four genotypes, including 1E, 1F, 2A, and 2B, were found in Shandong province during 2000-2009. Genotype 1E, rather than genotype 1F, became the predominant genotype circulating in Shandong province from 2001. All Shandong genotype 1E viruses belong to the genotype 1E/cluster 1; they have constantly circulated, and co-evolved and co-circulated, with those from other provinces.	[Wang, Changyin; Xu, Qing; Xu, Aiqiang; Fang, Xueqiang; Song, Lizhi; Li, Weixiu; Xiong, Ping] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Peoples R China; [Zhu, Zhen; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, CY (corresponding author), Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jingshi Rd, Jinan, Peoples R China.	aqxuepi@163.com; wenbo_xu1@yahoo.com.cn		ll, li/0000-0001-9925-3021	Key Research Plan on Medicine from the Health Department of Shandong province in China [2009HD014]; National Natural Science Foundation of China [81101244]; National Infectious Diseases Surveillance Program [2012ZX10004201, 2008ZX10004-008, 2009ZX10004-201, 2009ZX10004-202]; WHO Measles Regional Reference Laboratory funding [WPCHN1002802]	Key Research Plan on Medicine from the Health Department of Shandong province in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Infectious Diseases Surveillance Program; WHO Measles Regional Reference Laboratory funding	This work was supported by the Key Research Plan on Medicine from the Health Department of Shandong province in China (2009HD014), the National Natural Science Foundation of China (project no. 81101244), the National Infectious Diseases Surveillance Program (2012ZX10004201, 2008ZX10004-008, 2009ZX10004-201, and 2009ZX10004-202), and WHO Measles Regional Reference Laboratory funding (WPCHN1002802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; Adam O, 2010, CLIN MICROBIOL INFEC, V16, P678, DOI 10.1111/j.1469-0691.2009.02966.x; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P216; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P126; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P290; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P474; Castillo-Solorzano C, 2003, J INFECT DIS, V187, pS146, DOI 10.1086/368034; Chen MH, 2007, PERSP MED V, V15, P1, DOI 10.1016/S0168-7069(06)15001-6; COOPER LZ, 1985, REV INFECT DIS, V7, pS2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; HAN YR, 1985, REV INFECT DIS, V7, pS79; Hubschen JM, 2007, J GEN VIROL, V88, P1960, DOI 10.1099/vir.0.82580-0; Jin L, 2007, J MED VIROL, V79, P1017, DOI 10.1002/jmv.20847; Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000; Reef SE, 2011, J INFECT DIS, V204, pS24, DOI 10.1093/infdis/jir155; Song XQ, 2007, PREVENTIVE MED TRIBU, V7, P577; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vauloup-Fellous C, 2010, J CLIN MICROBIOL, V48, P2530, DOI 10.1128/JCM.00181-10; Vynnycky E, 2003, VACCINE, V21, P2708, DOI 10.1016/S0264-410X(03)00229-9; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P141; World Health Organization, 2000, Weekly Epidemiological Record, V75, P161; Xu Aiqiang, 2003, Journal of Infectious Diseases, V187, pS258, DOI 10.1086/368044; Zheng DP, 2003, EMERG INFECT DIS, V9, P1523; Zheng DP, 2003, J INFECT DIS, V187, P1587, DOI 10.1086/374972; Zhu Z, 2007, J CLIN MICROBIOL, V45, P2847, DOI 10.1128/JCM.00289-07; Zhu Z, 2012, J CLIN MICROBIOL, V50, P353, DOI 10.1128/JCM.01264-11; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	29	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e42013	10.1371/journal.pone.0042013	http://dx.doi.org/10.1371/journal.pone.0042013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911874	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300090
J	Lee, TH; Wu, TS; Tseng, CP; Qiu, JT				Lee, Ta-Hsien; Wu, Tzong-Shoon; Tseng, Ching-Ping; Qiu, Jiantai Timothy			High-Resolution Melting Molecular Signatures for Rapid Identification of Human Papillomavirus Genotypes	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CERVICAL-CANCER; CONSENSUS PCR; HPV GENOTYPES; DNA; RISK; INFECTIONS; ASSAY; HYBRIDIZATION; PERSISTENCE	Background: Genotyping of human papillomarvirus (HPV) is crucial for patient management in a clinical setting. This study accesses the combined use of broad-range real-time PCR and high-resolution melting (HRM) analysis for rapid identification of HPV genotypes. Methods: Genomic DNA sequences of 8 high-risk genotypes (HPV16/18/39/45/52/56/58/68) were subject to bioinformatic analysis to select for appropriate PCR amplicon. Asymmetric broad-range real-time PCR in the presence of HRM dye and two unlabeled probes specific to HPV16 and 18 was employed to generate HRM molecular signatures for HPV genotyping. The method was validated via assessment of 119 clinical HPV isolates. Results: A DNA fragment within the L1 region was selected as the PCR amplicon ranging from 215-221 bp for different HPV genotypes. Each genotype displayed a distinct HRM molecular signature with minimal inter-assay variability. According to the HRM molecular signatures, HPV genotypes can be determined with one PCR within 3 h from the time of viral DNA isolation. In the validation assay, a 91% accuracy rate was achieved when the genotypes were in the database. Concomitantly, the HRM molecular signatures for additional 6 low-risk genotypes were established. Conclusions: This assay provides a novel approach for HPV genotyping in a rapid and cost-effective manner.	[Lee, Ta-Hsien; Wu, Tzong-Shoon; Tseng, Ching-Ping; Qiu, Jiantai Timothy] Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Tzong-Shoon; Qiu, Jiantai Timothy] Coll Med, Dept Biomed Sci, Tao Yuan, Taiwan; [Tseng, Ching-Ping] Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Qiu, Jiantai Timothy] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Lee, TH (corresponding author), Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	ctseng@mail.cgu.edu.tw; jtqiu@cgmh.org.tw	Timothy, Qiu J./AAV-3086-2020	Qiu, JT/0000-0001-7090-6906; TSENG, CHING-PING/0000-0002-2587-210X	National Science Council [NMRPD180311]; Department of Health [DOH99-TD-C-111-006]; Chang Gung Molecular Medicine Research Center [EMRPD1B0151]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Chang Gung Molecular Medicine Research Center	This work was supported by the National Science Council [NMRPD180311 to J.T.Q.], Department of Health [DOH99-TD-C-111-006 to J.T.Q.] and Chang Gung Molecular Medicine Research Center [EMRPD1B0151 to C.-P.T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baay MFD, 1996, J CLIN MICROBIOL, V34, P745, DOI 10.1128/JCM.34.3.745-747.1996; Chang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020303; Chao A, 2004, AM J OBSTET GYNECOL, V190, P1046, DOI 10.1016/j.ajog.2003.09.054; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Chua KL, 1996, CANCER, V77, P121, DOI 10.1002/(SICI)1097-0142(19960101)77:1<121::AID-CNCR20>3.0.CO;2-6; Cope JU, 1997, J CLIN MICROBIOL, V35, P2262, DOI 10.1128/JCM.35.9.2262-2265.1997; Coutlee F, 2011, J MED VIROL, V83, P1034, DOI 10.1002/jmv.22081; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Dames S, 2007, CLIN CHEM, V53, P1847, DOI 10.1373/clinchem.2007.090761; Dames S, 2007, J MOL DIAGN, V9, P290, DOI 10.2353/jmoldx.2007.060139; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Franco EL, 2006, LANCET ONCOL, V7, P527, DOI 10.1016/S1470-2045(06)70735-5; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; Huang HJ, 2004, INT J GYNECOL CANCER, V14, P639, DOI 10.1111/j.1048-891X.2004.14418.x; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; HUSMAN AMD, 1995, BRIT J CANCER, V72, P412, DOI 10.1038/bjc.1995.347; Iftner T, 2009, J CLIN MICROBIOL, V47, P2106, DOI 10.1128/JCM.01907-08; Jacobs MV, 1999, J CLIN PATHOL, V52, P498, DOI 10.1136/jcp.52.7.498; Kulasingam SL, 2007, VACCINE, V25, P8110, DOI 10.1016/j.vaccine.2007.09.035; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Lai CH, 2007, INT J CANCER, V120, P1999, DOI 10.1002/ijc.22538; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; Lin P, 2001, CANCER EPIDEM BIOMAR, V10, P1037; LOW SH, 1990, JPN J CANCER RES, V81, P1118, DOI 10.1111/j.1349-7006.1990.tb02522.x; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; Mori S, 2011, CANCER SCI, V102, P1223, DOI 10.1111/j.1349-7006.2011.01922.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Raj GV, 1998, CANCER-AM CANCER SOC, V82, P1419, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1419::AID-CNCR1>3.0.CO;2-4; Sandri MT, 2006, J CLIN MICROBIOL, V44, P2141, DOI 10.1128/JCM.00049-06; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; Seipp MT, 2007, J MOL DIAGN, V9, P284, DOI 10.2353/jmoldx.2007.060136; Sjoeborg KD, 2010, GYNECOL ONCOL, V118, P29, DOI 10.1016/j.ygyno.2010.03.007; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Tucker RA, 2001, MOL DIAGN, V6, P39, DOI 10.2165/00066982-200106010-00005; van Ham MAPC, 2005, J CLIN MICROBIOL, V43, P2662, DOI 10.1128/JCM.43.6.2662-2667.2005; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Won H, 2010, J CLIN MICROBIOL, V48, P3410, DOI 10.1128/JCM.00718-10; Yang S, 2009, J CLIN MICROBIOL, V47, P2252, DOI 10.1128/JCM.00033-09; Zhou LM, 2004, CLIN CHEM, V50, P1328, DOI 10.1373/clinchem.2004.034322; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	49	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42051	10.1371/journal.pone.0042051	http://dx.doi.org/10.1371/journal.pone.0042051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916117	gold, Green Submitted, Green Published			2022-12-27	WOS:000307733800015
J	Muentener, P; Friel, D; Schulz, L				Muentener, Paul; Friel, Daniel; Schulz, Laura			Giving the Giggles: Prediction, Intervention, and Young Children's Representation of Psychological Events	PLOS ONE			English	Article							PRESCHOOLERS CAUSAL INFERENCES; INFANT PERCEPTION; DETERMINISM; IMITATION; BLICKETS; DOMAINS	Adults recognize that if event A predicts event B, intervening on A might generate B. Research suggests that young children have difficulty making this inference unless the events are initiated by goal-directed actions [1]. The current study tested the domain-generality and development of this phenomenon. Replicating previous work, when the events involved a physical outcome, toddlers (mean: 24 months) failed to generalize the outcome of spontaneously occurring predictive events to their own interventions; toddlers did generalize from prediction to intervention when the events involved a psychological outcome. We discuss these findings as they bear on the development of causal concepts.	[Muentener, Paul; Friel, Daniel; Schulz, Laura] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Muentener, P (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	pmuenten@mit.edu			John Templeton Foundation [12667]; James S. McDonnell Foundation; National Science Foundation Career Award [0744213]	John Templeton Foundation; James S. McDonnell Foundation; National Science Foundation Career Award(National Science Foundation (NSF))	This research was supported by grants from the John Templeton Foundation (# 12667) and the James S. McDonnell Foundation Causal Learning Collaborative to LS, as well as a National Science Foundation Career Award (# 0744213) to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball W. A., 1973, M SOC RES CHILD DEV; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Bonawitz EB, 2010, COGNITION, V115, P104, DOI 10.1016/j.cognition.2009.12.001; Bullock M., 1982, DEV PSYCHOL TIME; Carey S., 1985, CONCEPTUAL CHANGE CH; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Goodman N, PSYCHOL REV IN PRESS; Gopnik A, 2000, CHILD DEV, V71, P1205, DOI 10.1111/1467-8624.00224; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A., 1997, WORDS THOUGHTS THEOR; Kotovsky L, 2000, DEVELOPMENTAL SCI, V3, P344, DOI 10.1111/1467-7687.00129; Kushnir T, 2007, DEV PSYCHOL, V43, P186, DOI 10.1037/0012-1649.43.1.186; LESLIE AM, 1984, BRIT J DEV PSYCHOL, V2, P19, DOI 10.1111/j.2044-835X.1984.tb00531.x; LESLIE AM, 1987, COGNITION, V25, P265, DOI 10.1016/S0010-0277(87)80006-9; Luo YY, 2009, COGNITIVE PSYCHOL, V58, P441, DOI 10.1016/j.cogpsych.2008.11.001; Meltzoff A. N., DEV PSYCHOL IN PRESS; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Michotte A, 1947, PERCEPTION CAUSALITY; Muentener P, 2010, COGNITIVE PSYCHOL, V61, P63, DOI 10.1016/j.cogpsych.2010.02.001; Nichols S, 2007, NOUS, V41, P663, DOI 10.1111/j.1468-0068.2007.00666.x; OAKES LM, 1990, COGNITIVE DEV, V5, P193, DOI 10.1016/0885-2014(90)90026-P; Rochat P, 2004, PERCEPTION, V33, P355, DOI 10.1068/p3389; Rovee-Collier C. K, 1987, HDB INFANT DEV, P98; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Saxe R, 2007, DEV PSYCHOL, V43, P149, DOI 10.1037/0012-1649.43.1.149; Saxe R, 2006, ACTA PSYCHOL, V123, P144, DOI 10.1016/j.actpsy.2006.05.005; Schlottmann A, 1999, PERCEPTION, V28, P1105, DOI 10.1068/p2767; Schlottmann A, 2000, TRENDS COGN SCI, V4, P441, DOI 10.1016/S1364-6613(00)01555-2; Schlottmann A, J EXP CHILD IN PRESS; Schlottmann A, 2009, J EXP CHILD PSYCHOL, V103, P87, DOI 10.1016/j.jecp.2008.09.003; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schulz LE, 2007, DEV PSYCHOL, V43, P1124, DOI 10.1037/0012-1649.43.5.1124; Schulz LE, 2008, COGNITION, V109, P211, DOI 10.1016/j.cognition.2008.07.017; Schulz LE, 2006, CHILD DEV, V77, P427, DOI 10.1111/j.1467-8624.2006.00880.x; Schulz LE, 2004, DEV PSYCHOL, V40, P162, DOI 10.1037/0012-1649.40.2.162; SHULTZ TR, 1982, MONOGR SOC RES CHILD, V47, P1, DOI 10.2307/1165893; Slobin Dan Isaac, 1985, CROSSLINGUISTIC STUD; SLOBIN DI, 1981, COGNITION, V10, P275, DOI 10.1016/0010-0277(81)90057-3; Sobel DM, 2006, DEV PSYCHOL, V42, P1103, DOI 10.1037/0012-1649.42.6.1103; Thompson D, 2004, SIGHT SOUND, V14, P40; Tomasello M, 1997, PRIMATE COGNITION; Watson John S., 1987, COGNITIVE DEV INFANC; WELLMAN HM, 1992, ANNU REV PSYCHOL, V43, P337, DOI 10.1146/annurev.ps.43.020192.002005; Williamson RA, 2008, DEV PSYCHOL, V44, P275, DOI 10.1037/0012-1649.44.1.275; Woodward J., 2007, CAUSAL LEARNING PSYC, P19, DOI DOI 10.1093/ACPROF:OSO/9780195176803.003.0002; Woodward J., 2011, PERCEPTION CAUSATION	47	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42495	10.1371/journal.pone.0042495	http://dx.doi.org/10.1371/journal.pone.0042495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916130	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800019
J	Shivaraj, MC; Marcy, G; Low, GL; Ryu, JR; Zhao, XF; Rosales, FJ; Goh, ELK				Shivaraj, Mattu Chetana; Marcy, Guillaume; Low, Guoliang; Ryu, Jae Ryun; Zhao, Xianfeng; Rosales, Francisco J.; Goh, Eyleen L. K.			Taurine Induces Proliferation of Neural Stem Cells and Synapse Development in the Developing Mouse Brain	PLOS ONE			English	Article							DENTATE GYRUS; HIPPOCAMPAL-NEURONS; PRECURSOR CELLS; GRANULE CELLS; IN-VITRO; FETAL; PROGENITOR; MICE; RAT; DIFFERENTIATION	Taurine is a sulfur-containing amino acid present in high concentrations in mammalian tissues. It has been implicated in several processes involving brain development and neurotransmission. However, the role of taurine in hippocampal neurogenesis during brain development is still unknown. Here we show that taurine regulates neural progenitor cell (NPC) proliferation in the dentate gyrus of the developing brain as well as in cultured early postnatal (P5) hippocampal progenitor cells and hippocampal slices derived from P5 mice brains. Taurine increased cell proliferation without having a significant effect on neural differentiation both in cultured P5 NPCs as well as cultured hippocampal slices and in vivo. Expression level analysis of synaptic proteins revealed that taurine increases the expression of Synapsin 1 and PSD 95. We also found that taurine stimulates the phosphorylation of ERK1/2 indicating a possible role of the ERK pathway in mediating the changes that we observed, especially in proliferation. Taken together, our results demonstrate a role for taurine in neural stem/progenitor cell proliferation in developing brain and suggest the involvement of the ERK1/2 pathways in mediating these actions. Our study also shows that taurine influences the levels of proteins associated with synapse development. This is the first evidence showing the effect of taurine on early postnatal neuronal development using a combination of in vitro, ex-vivo and in vivo systems.	[Shivaraj, Mattu Chetana; Marcy, Guillaume; Low, Guoliang; Ryu, Jae Ryun; Goh, Eyleen L. K.] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorder, Singapore, Singapore; [Zhao, Xianfeng; Rosales, Francisco J.] Asia Pacific Ctr, Cognit Ctr Excellence Abbott Nutr Res & Dev, Singapore, Singapore; [Goh, Eyleen L. K.] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Goh, Eyleen L. K.] A STAR Duke NUS Neurosci Res Partnership, Singapore, Singapore	National University of Singapore; National University of Singapore	Shivaraj, MC (corresponding author), Duke NUS Grad Med Sch, Program Neurosci & Behav Disorder, Singapore, Singapore.	eyleen.goh@duke-nus.edu.sg	Goh, Eyleen/A-8006-2013; Marcy, Geoff/AAC-6050-2019; Marcy, Guillaume/M-8063-2014	Goh, Eyleen/0000-0002-8244-6959; Marcy, Guillaume/0000-0002-3469-8131	Duke-NUS Graduate Medical School, Singapore [169857]; Abbott Nutrition Research & Development, Singapore [138668]	Duke-NUS Graduate Medical School, Singapore; Abbott Nutrition Research & Development, Singapore	The present research is supported by: A Startup fund from Duke-NUS Graduate Medical School, Singapore 169857 and Abbott Nutrition Research & Development, Singapore 138668. The funders had no role in study design, data collection, decision to publish and analysis or preparation of the manuscript.	AGRAWAL HC, 1968, J NEUROCHEM, V15, P917, DOI 10.1111/j.1471-4159.1968.tb11633.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Boyer P, 2007, BRAIN RES REV, V54, P92, DOI 10.1016/j.brainresrev.2006.12.008; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Chen XC, 1998, ADV EXP MED BIOL, V442, P397; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Coecke S, 2007, ENVIRON HEALTH PERSP, V115, P924, DOI 10.1289/ehp.9427; Davidson S, 2010, BRAIN RES, V1307, P43, DOI 10.1016/j.brainres.2009.10.024; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; El-Hussein AE, 2000, SCIENCE, V290, P1364; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Goh ELK, 2003, J HEMATOTH STEM CELL, V12, P671, DOI 10.1089/15258160360732696; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Hernandez-Benitez R, 2010, J NEUROSCI RES, V88, P1673, DOI 10.1002/jnr.22328; Hu SX, 2006, J PHARMACOL EXP THER, V318, P1280, DOI 10.1124/jpet.106.103853; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Jeon SH, 2007, FEBS LETT, V581, P5929, DOI 10.1016/j.febslet.2007.11.035; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kelly CM, 2005, BRAIN RES BULL, V68, P83, DOI 10.1016/j.brainresbull.2005.08.020; Kuriyama K, 1983, Prog Clin Biol Res, V125, P127; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Militante JD, 2002, NUTR NEUROSCI, V5, P75, DOI 10.1080/10284150290018991; Militante JD, 1999, BRAIN RES, V818, P368, DOI 10.1016/S0006-8993(98)01318-3; Miller TJ, 2000, COMP BIOCHEM PHYS A, V125, P45, DOI 10.1016/S1095-6433(99)00160-9; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; NEURINGER M, 1990, PROG CLIN BIOL RES, V351, P415; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Park HR, 2011, ANN NY ACAD SCI, V1229, P23, DOI 10.1111/j.1749-6632.2011.06089.x; Peltier J., 2010, ISOLATION ADULT HIPP, P57; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rao A, 1998, J NEUROSCI, V18, P1217; Rosales FJ, 2008, NUTR NEUROSCI, V11, P135, DOI 10.1179/147683008X301522; SCHULLERLEVIS G, 1990, J LEUKOCYTE BIOL, V47, P321, DOI 10.1002/jlb.47.4.321; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; STURMAN JA, 1975, J NEUROCHEM, V25, P831, DOI 10.1111/j.1471-4159.1975.tb04414.x; STURMAN JA, 1985, J NEUROSCI RES, V13, P405, DOI 10.1002/jnr.490130307; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; TAPPAZ M, 1992, NEUROCHEM RES, V17, P849, DOI 10.1007/BF00993260; Taupin P, 2009, EXPERT OPIN THER PAT, V19, P523, DOI 10.1517/13543770902721279; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Wharton BA, 2004, ARCH DIS CHILD-FETAL, V89, pF497, DOI 10.1136/adc.2003.048389; Whittle N, 2007, PEDIATRICS, V120, pE1465, DOI 10.1542/peds.2006-3448	48	62	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42935	10.1371/journal.pone.0042935	http://dx.doi.org/10.1371/journal.pone.0042935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916184	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800037
J	Barchi, L; Lanteri, S; Portis, E; Vale, G; Volante, A; Pulcini, L; Ciriaci, T; Acciarri, N; Barbierato, V; Toppino, L; Rotino, GL				Barchi, Lorenzo; Lanteri, Sergio; Portis, Ezio; Vale, Giampiero; Volante, Andrea; Pulcini, Laura; Ciriaci, Tommaso; Acciarri, Nazareno; Barbierato, Valeria; Toppino, Laura; Rotino, Giuseppe Leonardo			A RAD Tag Derived Marker Based Eggplant Linkage Map and the Location of QTLs Determining Anthocyanin Pigmentation	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SOLANUM-MELONGENA L.; MOLECULAR ANALYSIS; HIGH-RESOLUTION; FRUIT-SHAPE; TUBEROSUM L; COLOR LOCI; A-LOCUS; TOMATO; RESISTANCE	Both inter-and intra-specific maps have been developed in eggplant (Solanum melongena L.). The former benefit from an enhanced frequency of marker polymorphism, but their relevance to marker-assisted crop breeding is limited. Combining the restriction-site associated DNA strategy with high throughput sequencing has facilitated the discovery of a large number of functional single nucleotide polymorphism (SNP) markers discriminating between the two eggplant mapping population parental lines '305E40' and '67/3'. A set of 347 de novo SNPs, together with 84 anchoring markers, were applied to the F-2 mapping population bred from the cross '305E40' x '67/3' to construct a linkage map. In all, 415 of the 431 markers were assembled into twelve major and one minor linkage group, spanning 1,390 cM, and the inclusion of established markers allowed each linkage group to be assigned to one of the 12 eggplant chromosomes. The map was then used to discover the genetic basis of seven traits associated with anthocyanin content. Each of the traits proved to be controlled by between one and six quantitative trait loci (QTL), of which at least one was a major QTL. Exploitation of syntenic relationships between the eggplant and tomato genomes facilitated the identification of potential candidate genes for the eggplant QTLs related to anthocyanin accumulation. The intra-specific linkage map should have utility for elucidating the genetic basis of other phenotypic traits in eggplant.	[Barchi, Lorenzo; Lanteri, Sergio; Portis, Ezio] Univ Turin, DIVAPRA Plant Genet & Breeding, Turin, Italy; [Vale, Giampiero; Volante, Andrea] CRA GPG Genom Res Ctr, Fiorenzuola Darda, Piacenza, Italy; [Vale, Giampiero] CRA RIS, Rice Res Unit, Vercelli, Italy; [Pulcini, Laura; Ciriaci, Tommaso; Acciarri, Nazareno] CRA ORA Res Unit Vegetable Crops, Monsampolo Del Tronto, Ascoli Piceno, Italy; [Barbierato, Valeria; Toppino, Laura; Rotino, Giuseppe Leonardo] CRA ORL Res Unit Vegetable Crops, Lodi, Italy	University of Turin	Barchi, L (corresponding author), Univ Turin, DIVAPRA Plant Genet & Breeding, Turin, Italy.	ezio.portis@unito.it	BARCHI, Lorenzo/ABC-4206-2020; Volante, Andrea/ADB-8436-2022; Valè, Giampiero/ABF-1492-2020; Lanteri, Sergio/P-4902-2015	BARCHI, Lorenzo/0000-0001-6414-4239; Valè, Giampiero/0000-0003-2158-9726; Lanteri, Sergio/0000-0003-3012-8710; volante, andrea/0000-0002-0463-5375; PORTIS, Ezio/0000-0002-1548-6096; PULCINI, LAURA/0000-0002-8335-4108; Toppino, Laura/0000-0002-8664-1233; Acciarri, Nazzareno/0000-0002-0892-5994	Italian Ministry of Agricultural Alimentary and Forest Politics	Italian Ministry of Agricultural Alimentary and Forest Politics	This research was partially supported by the Italian Ministry of Agricultural Alimentary and Forest Politics in the framework of "PROM", "ESPLORA" and "AGRONANOTECH" projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sane KO, 2011, PLANT BIOSYST, V145, P436, DOI 10.1080/11263504.2010.548914; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Barbierato V, 2011, P JOINT M AGI SIBV S; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Barchi L, 2010, GENOME, V53, P805, DOI [10.1139/g10-073, 10.1139/G10-073]; BERNATZKY R, 1986, GENETICS, V112, P887; Borovsky Y, 2004, THEOR APPL GENET, V109, P23, DOI 10.1007/s00122-004-1625-9; Bovy A, 2007, METABOLOMICS, V3, P399, DOI 10.1007/s11306-007-0074-2; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chaim AB, 2003, THEOR APPL GENET, V106, P889, DOI 10.1007/s00122-002-1132-9; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; CHURCHILL GA, 1994, GENETICS, V138, P963; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; De Jong WS, 2004, THEOR APPL GENET, V108, P423, DOI 10.1007/s00122-003-1455-1; DEVICENTE MC, 1993, GENETICS, V134, P585; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Doganlar S, 2002, GENETICS, V161, P1697; Doganlar S, 2002, GENETICS, V161, P1713; Frary A, 2005, THEOR APPL GENET, V111, P291, DOI 10.1007/s00122-005-2023-7; Fukuoka H, 2012, THEOR APPL GENET, V125, P47, DOI 10.1007/s00122-012-1815-9; Gonzali S, 2009, TRENDS PLANT SCI, V14, P237, DOI 10.1016/j.tplants.2009.02.001; Gould K. S., 2006, Flavonoids: chemistry, biochemistry and applications, P397; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; JANSEN RC, 1994, GENETICS, V138, P871; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER ES, 1989, GENETICS, V121, P185; Li Z, 2001, THEOR APPL GENET, V103, P1167, DOI 10.1007/s001220100672; Lindhout P, 2002, EUPHYTICA, V124, P217, DOI 10.1023/A:1015686601404; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Miyatake K, 2012, THEOR APPL GENET, V124, P1403, DOI 10.1007/s00122-012-1796-8; Nunome T, 2003, PLANT BREEDING, V122, P256, DOI 10.1046/j.1439-0523.2003.00816.x; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Pilet-Nayel ML, 2002, THEOR APPL GENET, V106, P28, DOI 10.1007/s00122-002-0985-2; Polignano G, 2010, GENET RESOUR CROP EV, V57, P171, DOI 10.1007/s10722-009-9459-6; Prohens J, 2012, EUPHYTICA, V186, P517, DOI 10.1007/s10681-012-0652-x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Rizza F, 2002, PLANT CELL REP, V20, P1022, DOI 10.1007/s00299-001-0429-5; Stagel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-357; TANKSLEY SD, 1992, GENETICS, V132, P1141; TATEBE T., 1939, Idengahu Zasshi = Japanese Journal of Genetics, V15, P261, DOI 10.1266/jjg.15.261; Team RDC, 2009, R LANG ENV STAT COMP; TIGCHELAAR EC, 1968, GENETICS, V60, P475; Toppino L, 2010, ADV GENETICS BREEDIN, P241; Toppino L, 2008, MOL BREEDING, V22, P237, DOI 10.1007/s11032-008-9170-x; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; VANECK HJ, 1994, HEREDITY, V73, P410, DOI 10.1038/hdy.1994.189; VANECK HJ, 1993, THEOR APPL GENET, V86, P295, DOI 10.1007/BF00222091; VANECK HJ, 1994, GENETICS, V137, P303; Vilanova S, 2012, MOL BREEDING, V30, P647, DOI 10.1007/s11032-011-9650-2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Wu FN, 2009, THEOR APPL GENET, V118, P1279, DOI 10.1007/s00122-009-0980-y; Wu FN, 2009, THEOR APPL GENET, V118, P927, DOI 10.1007/s00122-008-0950-9	60	92	101	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43740	10.1371/journal.pone.0043740	http://dx.doi.org/10.1371/journal.pone.0043740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912903	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700131
J	Esposito, E; Impellizzeri, D; Mazzon, E; Paterniti, I; Cuzzocrea, S				Esposito, Emanuela; Impellizzeri, Daniela; Mazzon, Emanuela; Paterniti, Irene; Cuzzocrea, Salvatore			Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; SPINAL-CORD-INJURY; ACUTE-INFLAMMATION; NITRIC-OXIDE; PPAR-ALPHA; MPTP MODEL; IN-VITRO; NEURONS; MINOCYCLINE; THERAPY	The biochemical and cellular changes that occur following treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine (MPTP) are remarkably similar to that seen in idiopathic Parkinson's disease (PD). PD is characterized by the degeneration of dopaminergic nigrostriatal neurons, which results in disabling motor disturbances. Activation of glial cells and the consequent neuroinflammatory response is increasingly recognized as a prominent neuropathological feature of PD. There is currently no effective disease-modifying therapy. Targeting the signaling pathways in glial cells responsible for neuroinflammation represents a promising new therapeutic approach designed to preserve remaining neurons in PD. Chronic treatment with palmitoylethanolamide (PEA, 10 mg/kg, i.p.), initiated 24 hr after MPTP injection (20 mg/kg), protected against MPTP-induced loss of tyrosine hydroxylase positive neurons in the substantia nigra pars compacta. Treatment with PEA reduced MPTP-induced microglial activation, the number of GFAP-positive astrocytes and S100 beta overexpression, and protected against the alterations of microtubule-associated protein 2a,b-, dopamine transporter-, nNOS-positive cells in the substantia nigra. Furthermore, chronic PEA reversed MPTP-associated motor deficits, as revealed by the analysis of forepaw step width and percentage of faults. Genetic ablation of peroxisome proliferator activated receptor (PPAR)-alpha in PPAR-alpha KO mice exacerbated MPTP systemic toxicity, while PEA-induced neuroprotection seemed be partially PPAR alpha-dependent. The effects of PEA on molecules typically involved in apoptotic pathways were also analyzed. Our results indicate that PEA protects against MPTP-induced neurotoxicity and the ensuing functional deficits even when administered once the insult has been initiated.	[Esposito, Emanuela; Impellizzeri, Daniela; Mazzon, Emanuela; Paterniti, Irene; Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Mazzon, Emanuela] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	University of Messina; IRCCS Bonino Pulejo	Esposito, E (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy.	salvator@unime.it	Mazzon, Emanuela/AAL-4334-2020	Impellizzeri, Daniela/0000-0001-9492-3161; mazzon, emanuela/0000-0002-5073-717X; Cuzzocrea, Salvatore/0000-0001-6131-3690; Esposito, Emanuela/0000-0002-2663-6387	Programma Operativo Nazionale "Ricerca e Competitivita" (PON RC) [01_02512]	Programma Operativo Nazionale "Ricerca e Competitivita" (PON RC)	This study was supported by Programma Operativo Nazionale "Ricerca e Competitivita 2007-2013" (PON R&C) 01_02512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzoulatos E, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/138471; Araki T, 2001, BRAIN RES, V918, P176, DOI 10.1016/S0006-8993(01)02944-4; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; Barcia C, 2004, GLIA, V46, P402, DOI 10.1002/glia.20015; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Costa B, 2002, BRIT J PHARMACOL, V137, P413, DOI 10.1038/sj.bjp.0704900; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Filippis D, 2008, J NEUROENDOCRINOL, V20, P20, DOI 10.1111/j.1365-2826.2008.01674.x; Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Esposito E, 2005, ENDOCRINOLOGY, V146, P3301, DOI 10.1210/en.2005-0375; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Esposito E, 2010, PPAR RES, V2010, DOI 10.1155/2010/917312; Fleming SM, 2011, MOL CELL NEUROSCI, V46, P597, DOI 10.1016/j.mcn.2010.12.011; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Galan-Rodriguez B, 2009, NEUROPHARMACOLOGY, V56, P653, DOI 10.1016/j.neuropharm.2008.11.006; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Imamura N, 2003, NEUROSCI RES, V46, P289, DOI 10.1016/S0168-0102(03)00065-8; Inoue Ikuo, 2003, J Atheroscler Thromb, V10, P99; KAINU T, 1994, NEUROREPORT, V5, P2481, DOI 10.1097/00001756-199412000-00019; Kidd P M, 2000, Altern Med Rev, V5, P502; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kreisler A, 2007, BRAIN RES, V1135, P77, DOI 10.1016/j.brainres.2006.12.011; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; MCGEER PL, 2002, SCI AGING KNOWLEDGE, pRE3; Melis M, 2008, J NEUROSCI, V28, P13985, DOI 10.1523/JNEUROSCI.3221-08.2008; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; Obata T, 2006, J NEURAL TRANSM, V113, P1131, DOI 10.1007/s00702-005-0415-0; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Raso GM, 2011, J NEUROENDOCRINOL, V23, P591, DOI 10.1111/j.1365-2826.2011.02152.x; Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Sasso O, 2011, PAIN; Schulz JB, 2004, CELL TISSUE RES, V318, P135, DOI 10.1007/s00441-004-0954-y; Scuderi C, 2011, J CELL MOL MED, DOI 10.111141582-4934.2011.01267.x; SHEA TB, 1994, BIOTECHNIQUES, V16, P1126; Takahashi H, 2005, PARKINSONISM RELAT D, V11, pS31, DOI 10.1016/j.parkreldis.2005.02.011; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; WHITE NJ, 1982, LANCET, V2, P99; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	53	114	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41880	10.1371/journal.pone.0041880	http://dx.doi.org/10.1371/journal.pone.0041880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912680	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700008
J	Han, XJ; Lu, MZ; Chen, YC; Zhan, ZY; Cui, QQ; Wang, YD				Han, Xiaojiao; Lu, Mengzhu; Chen, Yicun; Zhan, Zhiyong; Cui, Qinqin; Wang, Yangdong			Selection of Reliable Reference Genes for Gene Expression Studies Using Real-Time PCR in Tung Tree during Seed Development	PLOS ONE			English	Article							NORMALIZING RNA EXPRESSION; CANDIDATE REFERENCE GENES; QUANTITATIVE RT-PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; VALIDATION; QUANTIFICATION; EVOLUTION	Quantitative real-time PCR (RT-qPCR) has become an accurate and widely used technique to analyze expression levels of selected genes. It is very necessary to select appropriate reference genes for gene expression normalization. In the present study, we assessed the expression stability of 11 reference genes including eight traditional housekeeping genes and three novel genes in different tissues/organs and developing seeds from four cultivars of tung tree. All 11 reference genes showed a wide range of Ct values in all samples, indicating that they differently expressed. Three softwares - geNorm, NormFinder and BestKeeper - were used to determine the stability of these references except for ALB (2S albumin), which presented a little divergence. The results from the three softwares showed that ACT7 (Actin7a), UBQ (Ubiquitin), GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and EF1 alpha (elongation factor 1-alpha) were the most stable reference genes across all of the tested tung samples and tung developing seeds, while ALB (2S albumin) was unsuitable as internal controls. ACT7, EF1 beta (elongation factor1-beta), GAPDH and TEF1 (transcription elongation factor 1) were the top four choices for different tissues/organs whereas LCR69 did not favor normalization of RT-qPCR in these tissues/organs. Meanwhile, the expression profiles of FAD2 and FADX were realized using stable reference genes. The relative quantification of the FAD2 and FADX genes varied according to the internal controls and the number of internal controls. The results further proved the importance of the choice of reference genes in the tung tree. These stable reference genes will be employed in normalization and quantification of transcript levels in future expression studies of tung genes.	[Han, Xiaojiao; Lu, Mengzhu; Chen, Yicun; Wang, Yangdong] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Han, Xiaojiao; Chen, Yicun; Zhan, Zhiyong; Cui, Qinqin; Wang, Yangdong] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Peoples R China; [Lu, Mengzhu] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Chinese Academy of Forestry; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Han, XJ (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	wyd11111@126.com	Lu, Meng-Zhu/AAN-9710-2020	Han, Xiaojiao/0000-0001-6082-7569	State Forestry Administration Foundation of China [2009-4-23]	State Forestry Administration Foundation of China	The work presented here was supported by the State Forestry Administration Foundation of China (2009-4-23).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Banda M, 2008, MUTAT RES-GEN TOX EN, V649, P126, DOI 10.1016/j.mrgentox.2007.08.005; Basa B, 2009, FUNCT PLANT BIOL, V36, P1079, DOI 10.1071/FP09073; Brown K., 2005, WILDL WEEDS, V9, P4; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Chen YC, 2010, IND CROP PROD, V32, P684, DOI 10.1016/j.indcrop.2010.06.009; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Ketelaere A, 2006, J DAIRY SCI, V89, P4066, DOI 10.3168/jds.S0022-0302(06)72450-X; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2008, PHYSIOL PLANTARUM, V132, P11, DOI 10.1111/j.1399-3054.2007.01021.x; Fang JX, 1998, TUNG OIL TREES CHINA, P104; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Kumar V, 2011, AUST J CROP SCI, V5, P1455; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luo HL, 2010, ANAL BIOCHEM, V404, P100, DOI 10.1016/j.ab.2010.05.002; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Martin RC, 2008, CROP SCI, V48, P1881, DOI 10.2135/cropsci2007.10.0597; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pastor S, 2011, 1337 U NEW ORL; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Phillips MA, 2009, PLANT MOL BIOL REP, V27, P407, DOI 10.1007/s11105-008-0072-1; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Shang Q, 2010, BIORESOURCE TECHNOL, V101, P826, DOI 10.1016/j.biortech.2009.08.047; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sonntag N.O.V., 1979, BAILEYS IND OIL FAT, V1, P289; Thanamongkollit N, 2008, MODIFICATION TUNG OI; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008	45	84	96	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43084	10.1371/journal.pone.0043084	http://dx.doi.org/10.1371/journal.pone.0043084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912794	gold, Green Submitted, Green Published			2022-12-27	WOS:000308063700039
J	Kwak, KJ; Jung, HJ; Lee, KH; Kim, YS; Kim, WY; Ahn, SJ; Kang, H				Kwak, Kyung Jin; Jung, Hyun Ju; Lee, Kwang Ho; Kim, Young Soon; Kim, Won Yong; Ahn, Sung Ju; Kang, Hunseung			The Minor Spliceosomal Protein U11/U12-31K Is an RNA Chaperone Crucial for U12 Intron Splicing and the Development of Dicot and Monocot Plants	PLOS ONE			English	Article							ESCHERICHIA-COLI; U12-TYPE INTRONS; U12-DEPENDENT INTRONS; ARABIDOPSIS-THALIANA; U11-59K PROTEIN; U4ATAC SNRNA; CSPA-FAMILY; DOMAIN; COMPONENT; DISORDER	U12 intron-specific spliceosomes contain U11 and U12 small nuclear ribonucleoproteins and mediate the removal of U12 introns from precursor-mRNAs. Among the several proteins unique to the U12-type spliceosomes, an Arabidopsis thaliana AtU11/U12-31K protein has been shown to be indispensible for proper U12 intron splicing and for normal growth and development of Arabidopsis plants. Here, we assessed the functional roles of the rice (Oryza sativa) OsU11/U12-31K protein in U12 intron splicing and development of plants. The U11/U12-31K transcripts were abundantly expressed in the shoot apical meristems (SAMs) of Arabidopsis and rice. Ectopic expression of OsU11/U12-31K in AtU11/U12-31K-defecient Arabidopsis mutant complemented the incorrect U12 intron splicing and abnormal development phenotypes of the Arabidopsis mutant plants. Impaired cell division activity in the SAMs and inflorescence stems observed in the AtU11/U12-31K-deficient mutant was completely recovered to normal by the expression of OsU11/U12-31K. Similar to Arabidopsis AtU11/U12-31K, rice OsU11/U12-31K was determined to harbor RNA chaperone activity. Collectively, the present findings provide evidence for the emerging idea that the U11/U12-31K protein is an indispensible RNA chaperone that functions in U12 intron splicing and is necessary for normal development of monocotyledonous plants as well as dicotyledonous plants.	[Kwak, Kyung Jin; Jung, Hyun Ju; Kim, Won Yong; Kang, Hunseung] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Plant Biotechnol, Kwangju, South Korea; [Kwak, Kyung Jin; Jung, Hyun Ju; Kim, Won Yong; Kang, Hunseung] Chonnam Natl Univ, Coll Agr & Life Sci, Kumho Life Sci Lab, Kwangju, South Korea; [Lee, Kwang Ho] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Wood Sci & Landscape Architecture, Kwangju, South Korea; [Kim, Young Soon; Ahn, Sung Ju] Chonnam Natl Univ, Coll Agr & Life Sci, Bioenergy Res Ctr, Kwangju, South Korea; [Ahn, Sung Ju] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Bioenergy Sci & Technol, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Kwak, KJ (corresponding author), Chonnam Natl Univ, Coll Agr & Life Sci, Dept Plant Biotechnol, Kwangju, South Korea.	hskang@jnu.ac.kr	Kang, Hunseung/AAE-9912-2020	Kim, Wonyong/0000-0002-9094-8908	Mid-career Researcher Program through the National Research Foundation (NRF) of Korea [2011-0017357]; Ministry of Education, Science and Technology (MEST); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ00803701]; Priority Research Centers Program through the NRF of Korea [2011-0018393]; MEST	Mid-career Researcher Program through the National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea; Priority Research Centers Program through the NRF of Korea(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the Mid-career Researcher Program (2011-0017357) through the National Research Foundation (NRF) of Korea grant funded by the Ministry of Education, Science and Technology (MEST), by a grant from the Next-Generation BioGreen 21 Program (SSAC, PJ00803701), Rural Development Administration, Republic of Korea, and by Priority Research Centers Program (2011-0018393) through the NRF of Korea funded by the MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Bechtold N, 1998, METH MOL B, V82, P259; Benecke H, 2005, EMBO J, V24, P3057, DOI 10.1038/sj.emboj.7600765; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Chang WC, 2007, NUCLEIC ACIDS RES, V35, P1833, DOI 10.1093/nar/gkm026; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Frilander MJ, 1999, GENE DEV, V13, P851, DOI 10.1101/gad.13.7.851; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Hirose T, 2004, P NATL ACAD SCI USA, V101, P17976, DOI 10.1073/pnas.0408435102; Jiang WN, 1997, J BIOL CHEM, V272, P196; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kim WY, 2010, PLANT CELL, V22, P3951, DOI 10.1105/tpc.110.079103; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Lahmy S, 2007, PLANT J, V50, P615, DOI 10.1111/j.1365-313X.2007.03072.x; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Lin CF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-47; Lopez MD, 2008, NUCLEIC ACIDS RES, V36, P3001, DOI 10.1093/nar/gkn142; Lorkovic ZJ, 2005, RNA, V11, P1095, DOI 10.1261/rna.2440305; Lorkovic ZJ, 2004, J BIOL CHEM, V279, P33890, DOI 10.1074/jbc.M400270200; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Phadtare S, 2002, J BIOL CHEM, V277, P7239, DOI 10.1074/jbc.M111496200; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Milla MA, 2006, PLANT MOL BIOL, V61, P13, DOI 10.1007/s11103-005-5798-7; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Sikand K, 2011, NUCLEIC ACIDS RES, V39, P8531, DOI 10.1093/nar/gkr530; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Tsukagoshi H, 2007, P NATL ACAD SCI USA, V104, P2543, DOI 10.1073/pnas.0607940104; Turunen JJ, 2008, MOL CELL BIOL, V28, P3548, DOI 10.1128/MCB.01928-07; WASSARMAN KM, 1992, MOL CELL BIOL, V12, P1276, DOI 10.1128/MCB.12.3.1276; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Zhu W, 2003, NUCLEIC ACIDS RES, V31, P4561, DOI 10.1093/nar/gkg492	36	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43707	10.1371/journal.pone.0043707	http://dx.doi.org/10.1371/journal.pone.0043707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912901	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700129
J	Sugiyama, T; Sugioka-Sugiyama, R; Hada, K; Niwa, R				Sugiyama, Tomoyasu; Sugioka-Sugiyama, Rie; Hada, Kazumasa; Niwa, Ryusuke			Rhn1, a Nuclear Protein, Is Required for Suppression of Meiotic mRNAs in Mitotically Dividing Fission Yeast	PLOS ONE			English	Article							PROMOTES TRANSCRIPTION TERMINATION; SCHIZOSACCHAROMYCES-POMBE; POLYMERASE-II; C-ELEGANS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; SELECTIVE ELIMINATION; DHP1(+) GENE; MEIOSIS; INTERFERENCE	In the fission yeast Schizosaccharomyces pombe, many meiotic mRNAs are transcribed during mitosis and meiosis and selectively eliminated in mitotic cells. However, this pathway for mRNA decay, called the determinant of selective removal (DSR)-Mmi1 system, targets only some of the numerous meiotic mRNAs that are transcribed in mitotic cells. Here we describe Rhn1, a nuclear protein involved in meiotic mRNA suppression in vegetative fission yeast. Rhn1 is homologous to budding yeast Rtt103 and localizes to one or a few discrete nuclear dots in growing vegetative cells. Rhn1 colocalizes with a pre-mRNA 3'-end processing factor, Pcf11, and with the 5'-3' exoribonuclease, Dhp1; moreover, Rhn1 coimmunoprecipitates with Pcf11. Loss of rhn1 results in elevated sensitivity to high temperature, to thiabendazole (TBZ), and to UV. Interestingly, meiotic mRNAs-including moa1(+), mcp5(+), and mug96(+)-accumulate in mitotic rhn1 Delta cells. Accumulation of meiotic mRNAs also occurs in strains lacking Lsk1, a kinase that phosphorylates serine 2 (Ser-2) in the C-terminal domain (CTD) of RNA polymerase II (Pol II), and in strains lacking Sen1, an ATP-dependent 5'-3' RNA/DNA helicase: notably, both Lsk1 and Sen1 have been implicated in termination of Pol II-dependent transcription. Furthermore, RNAi knockdown of cids-2, a Caenorhabditis elegans ortholog of rhn1(+), leads to elevated expression of a germline-specific gene, pgl-1, in somatic cells. These results indicate that Rhn1 contributes to the suppression of meiotic mRNAs in vegetative fission yeast and that the mechanism by which Rhn1 downregulates germline-specific transcripts may be conserved in unicellular and multicellular organisms.	[Sugiyama, Tomoyasu; Sugioka-Sugiyama, Rie; Hada, Kazumasa; Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Sugiyama, Tomoyasu; Sugioka-Sugiyama, Rie; Hada, Kazumasa; Niwa, Ryusuke] Univ Tsukuba, Initiat Promot Young Scientists Independent Res, Tsukuba, Ibaraki, Japan; [Sugiyama, Tomoyasu] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Sugiyama, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	sugiyamt@biol.tsukuba.ac.jp		Sugiyama, Tomoyasu/0000-0001-5704-6606	Japanese Government; Japan Society for the Promotion of Science [22687013]; Nakajima Foundation	Japanese Government; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nakajima Foundation	This work was supported by the Japanese Government's Special Coordination Funds for Promoting Science and Technology (to T.S. and R.N.), by a Grant-in-Aid for Young Scientists (A) (22687013) from the Japan Society for the Promotion of Science (to T.S.), and a research grant from the Nakajima Foundation (to T.S.). T.S. was a JST PRESTO researcher. The funders had no role in study design, data collection, data analysis, preparation of the manuscript, or the decision to publish.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; BRENNER S, 1974, GENETICS, V77, P71; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chen HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029917; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Coudreuse D, 2010, CURR BIOL, V20, P1053, DOI 10.1016/j.cub.2010.04.054; Cui MX, 2008, P NATL ACAD SCI USA, V105, P16665, DOI 10.1073/pnas.0807104105; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ogawa H, 2004, BIOCHEM BIOPH RES CO, V320, P218, DOI 10.1016/j.bbrc.2004.05.161; Saberianfar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024694; Scholes DT, 2001, GENETICS, V159, P1449; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; Spector DL, 2001, J CELL SCI, V114, P2891; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; SUGANO S, 1994, MOL GEN GENET, V243, P1, DOI 10.1007/BF00283869; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Sukegawa Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002387; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Updike DL, 2009, GENETICS, V183, P1397, DOI 10.1534/genetics.109.110171; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yamamoto M, 2010, P JPN ACAD B-PHYS, V86, P788, DOI 10.2183/pjab.86.788; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007	47	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42962	10.1371/journal.pone.0042962	http://dx.doi.org/10.1371/journal.pone.0042962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912768	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700031
J	Biber, A; Abuelaish, I; Rahav, G; Raz, M; Cohen, L; Valinsky, L; Taran, D; Goral, A; Elhamdany, A; Regev-Yochay, G				Biber, Asaf; Abuelaish, Izeldeen; Rahav, Galia; Raz, Meir; Cohen, Liran; Valinsky, Lea; Taran, Dianna; Goral, Aviva; Elhamdany, Abedalla; Regev-Yochay, Gili		PICR Study Grp	A Typical Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clone Is Widespread in the Community in the Gaza Strip	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; EPIDEMIC MRSA; INFECTIONS; PREVALENCE; MULTIPLEX; EMERGENCE; OUTBREAK; GERMANY; STRAIN; GENE	Epidemiological data on community acquired methicillin-resistant-Staphylococcus aureus (CA-MRSA) carriage and infection in the Middle-East region is scarce with only few reports in the Israeli and Palestinian populations. As part of a Palestinian-Israeli collaborative research, we have conducted a cross-sectional survey of nasal S. aureus carriage in healthy children and their parents throughout the Gaza strip. Isolates were characterized for antibiotic susceptibility, mec gene presence, PFGE, spa type, SCCmec-type, presence of PVL genes and multi-locus-sequence-type (MLST). S. aureus was carried by 28.4% of the 379 screened children-parents pairs. MRSA was detected in 45% of S. aureus isolates, that is, in 12% of the study population. A single ST22-MRSA-IVa, spa t223, PVL-gene negative strain was detected in 64% of MRSA isolates. This strain is typically susceptible to all non-beta-lactam antibiotics tested. The only predictor for MRSA carriage in children was having an MRSA carrier-parent (OR = 25.5, P = 0.0004). Carriage of the Gaza strain was not associated with prior hospitalization. The Gaza strain was closely related genetically to a local MSSA spa t223 strain and less so to EMRSA15, one of the pandemic hospital-acquired-MRSA clones, scarcely reported in the community. The rapid spread in the community may be due to population determinants or due to yet unknown advantageous features of this particular strain.	[Biber, Asaf; Rahav, Galia; Cohen, Liran; Goral, Aviva; Regev-Yochay, Gili] Tel Aviv Univ, Infect Dis Unit, Sackler Sch Med, Sheba Med Ctr, Ramat Gan, Israel; [Biber, Asaf; Cohen, Liran; Goral, Aviva; Regev-Yochay, Gili] Gertner Inst Epidemiol & Hlth Policy Res, Infect Dis Epidemiol Sect, Ramat Gan, Israel; [Abuelaish, Izeldeen] Univ Toronto, Global Hlth Div, Dala Lana Sch Publ Hlth, Toronto, ON, Canada; [Raz, Meir] Maccabi Healthcare Serv, Jerusalem Hashfela Dist, Modiin, Israel; [Valinsky, Lea] Minist Hlth, Govt Cent Labs, Jerusalem, Israel; [Taran, Dianna] Maccabi Healthcare Serv, Cent Lab, Rehovot, Israel; [Elhamdany, Abedalla] Keystone Consulting Serv, Gaza City, The Gaza Strip, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Toronto	Biber, A (corresponding author), Tel Aviv Univ, Infect Dis Unit, Sackler Sch Med, Sheba Med Ctr, Ramat Gan, Israel.	asafbib@gmail.com; gregev@hsph.harvard.edu	Goral, Aviva/K-8254-2016; Biber, Asaf/AAX-2966-2021	Goral, Aviva/0000-0002-0784-0569; Biber, Asaf/0000-0001-6007-0383; Regev-Yochay, Gili/0000-0001-7163-4607	Gertner Institute for Epidemiology Research and Health Policy; Maccabi Healthcare Services Research Institute [RC-24010]	Gertner Institute for Epidemiology Research and Health Policy; Maccabi Healthcare Services Research Institute	This study was funded by the Gertner Institute for Epidemiology Research and Health Policy 2009 and by Maccabi Healthcare Services Research Institute RC-24010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Campbell KM, 2004, J CLIN MICROBIOL, V42, P4050, DOI 10.1128/JCM.42.9.4050-4053.2004; Carmichael IC, 1999, J ANTIMICROB CHEMOTH, V44, P293, DOI 10.1093/jac/44.2.293; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; Cuny C, 2009, INT J MED MICROBIOL, V300, P109; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fontanilla JM, 2010, J CLIN MICROBIOL, V48, P609, DOI 10.1128/JCM.02297-09; Ghebremedhin B, 2007, J MED MICROBIOL, V56, P365, DOI 10.1099/jmm.0.46883-0; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Huijsdens XW, 2006, J CLIN MICROBIOL, V44, P2994, DOI 10.1128/JCM.00846-06; Kaibni MH, 2009, J MED MICROBIOL, V58, P644, DOI 10.1099/jmm.0.007617-0; Kajita E, 2007, NAT REV MICROBIOL, V5, P700, DOI 10.1038/nrmicro1660; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Mollaghan AM, 2010, EPIDEMIOL INFECT, V138, P673, DOI 10.1017/S0950268810000191; O'Neill GL, 2001, J CLIN MICROBIOL, V39, P1540, DOI 10.1128/JCM.39.4.1540-1548.2001; Regev-Yochay G, 2006, EUR J CLIN MICROBIOL, V25, P719, DOI 10.1007/s10096-006-0210-3; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Simoes RR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017630, 10.1371/journal.pone.0029279]; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Witte W, 2001, INT J MED MICROBIOL, V290, P677, DOI 10.1016/S1438-4221(01)80006-0; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	27	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42864	10.1371/journal.pone.0042864	http://dx.doi.org/10.1371/journal.pone.0042864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916171	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300020
J	Grooman, B; Fujiwara, I; Otey, C; Upadhyaya, A				Grooman, Brian; Fujiwara, Ikuko; Otey, Carol; Upadhyaya, Arpita			Morphology and Viscoelasticity of Actin Networks Formed with the Mutually Interacting Crosslinkers: Palladin and Alpha-actinin	PLOS ONE			English	Article							CYTOSKELETAL POLYMER NETWORKS; F-ACTIN; MECHANICAL-PROPERTIES; FILAMENT NETWORKS; BINDING PROTEINS; CELL MECHANICS; GELS; DETERMINES; ELASTICITY; STIFFNESS	Actin filaments and associated actin binding proteins play an essential role in governing the mechanical properties of eukaryotic cells. Even though cells have multiple actin binding proteins (ABPs) that exist simultaneously to maintain the structural and mechanical integrity of the cellular cytoskeleton, how these proteins work together to determine the properties of actin networks is not clearly understood. The ABP, palladin, is essential for the maintenance of cell morphology and the regulation of cell movement. Palladin coexists with alpha-actinin in stress fibers and focal adhesions and binds to both actin and alpha-actinin. To obtain insight into how mutually interacting actin crosslinking proteins modulate the properties of actin networks, we characterized the micro-structure and mechanics of actin networks crosslinked with palladin and alpha-actinin. We first showed that palladin crosslinks actin filaments into bundled networks which are viscoelastic in nature. Our studies also showed that composite networks of alpha-actinin/palladin/actin behave very similar to pure palladin or pure alpha-actinin networks. However, we found evidence that palladin and alpha-actinin synergistically modify network viscoelasticity. To our knowledge, this is the first quantitative characterization of the physical properties of actin networks crosslinked with two mutually interacting crosslinkers.	[Grooman, Brian] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Fujiwara, Ikuko] NHLBI, NIH, Bethesda, MD 20892 USA; [Otey, Carol] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Upadhyaya, Arpita] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Upadhyaya, Arpita] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Grooman, B (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	arpitau@umd.edu	Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X	Alfred P. Sloan Foundation; National Science Foundation [112170]; Direct For Biological Sciences [1121710] Funding Source: National Science Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work has been supported by the Alfred P. Sloan Foundation and the National Science Foundation (Grant 112170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrego-Diaz E, 2006, J STRUCT BIOL, V155, P230, DOI 10.1016/j.jsb.2006.01.013; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Esue O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004411; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Gardel ML, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088102; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Kas J, 1996, BIOPHYS J, V70, P609, DOI 10.1016/S0006-3495(96)79630-3; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Lieleg O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.158105; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; Lieleg O, 2009, BIOPHYS J, V96, P4725, DOI 10.1016/j.bpj.2009.03.038; Lindstrom SB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051905; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; SATO M, 1987, NATURE, V325, P828, DOI 10.1038/325828a0; Schmoller KM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118102; Schmoller KM, 2009, BIOPHYS J, V97, P83, DOI 10.1016/j.bpj.2009.04.040; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Strehle D, 2011, EUR BIOPHYS J BIOPHY, V40, P93, DOI 10.1007/s00249-010-0621-z; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Ward SMV, 2008, BIOPHYS J, V95, P4915, DOI 10.1529/biophysj.108.131722	44	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42773	10.1371/journal.pone.0042773	http://dx.doi.org/10.1371/journal.pone.0042773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916157	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300015
J	Swanson, JM; Wood, GC; Xu, LJ; Tang, LE; Meibohm, B; Homayouni, R; Croce, MA; Fabian, TC				Swanson, Joseph M.; Wood, G. Christopher; Xu, Lijing; Tang, Lisa E.; Meibohm, Bernd; Homayouni, Ramin; Croce, Martin A.; Fabian, Timothy C.			Developing a Gene Expression Model for Predicting Ventilator-Associated Pneumonia in Trauma Patients: A Pilot Study	PLOS ONE			English	Article							POSTTRAUMATIC PNEUMONIA; NEUTROPHIL RECRUITMENT; SEVERE SEPSIS; L-SELECTIN; POLYMORPHISMS; ACTIVATION; RIBOLEUKOGRAM; INHIBITION; CYTOKINES; UTILITY	Background: Ventilator-associated pneumonia (VAP) carries significant mortality and morbidity. Predicting which patients will become infected could lead to measures to reduce the incidence of VAP. Methodology/Principal Findings: The goal was to begin constructing a model for VAP prediction in critically-injured trauma patients, and to identify differentially expressed genes in patients who go on to develop VAP compared to similar patients who do not. Gene expression profiles of lipopolysaccharide stimulated blood cells in critically injured trauma patients that went on to develop ventilator-associated pneumonia (n = 10) was compared to those that never developed the infection (n = 10). Eight hundred and ten genes were differentially expressed between the two groups (ANOVA, P<0.05) and further analyzed by hierarchical clustering and principal component analysis. Functional analysis using Gene Ontology and KEGG classifications revealed enrichment in multiple categories including regulation of protein translation, regulation of protease activity, and response to bacterial infection. A logistic regression model was developed that accurately predicted critically-injured trauma patients that went on to develop VAP (VAP+) and those that did not (VAP-). Five genes (PIK3R3, ATP2A1, PI3, ADAM8, and HCN4) were common to all top 20 significant genes that were identified from all independent training sets in the cross validation. Hierarchical clustering using these five genes accurately categorized 95% of patients and PCA visualization demonstrated two discernable groups (VAP+ and VAP-). Conclusions/Significance: A logistic regression model using cross-validation accurately predicted patients that developed ventilator-associated pneumonia and should now be tested on a larger cohort of trauma patients.	[Swanson, Joseph M.; Wood, G. Christopher] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA; [Tang, Lisa E.; Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Croce, Martin A.; Fabian, Timothy C.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Homayouni, Ramin] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Xu, Lijing; Homayouni, Ramin] Univ Memphis, Bioinformat Program, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis	Swanson, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA.	jswanson@uthsc.edu	Homayouni, Ramin/U-2837-2019; Homayouni, Ramin/B-3547-2009	Homayouni, Ramin/0000-0003-0186-5076; Homayouni, Ramin/0000-0003-0186-5076; Meibohm, Bernd/0000-0003-3923-3648	Society of Infectious Diseases Pharmacists/Cubist Research Award	Society of Infectious Diseases Pharmacists/Cubist Research Award	This study was funded by the Society of Infectious Diseases Pharmacists/Cubist Research Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Baruscotti M, 2010, PFLUG ARCH EUR J PHY, V460, P405, DOI 10.1007/s00424-010-0810-8; Bryant PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019556; Cobb JP, 2009, ANN SURG, V250, P531, DOI [10.1097/SLA.0b013e3181b8fbd5, 10.1097/SLA.0b013e3181b81bd5]; Croce MA, 2001, AM SURGEON, V67, P105; Croce MA, 1998, ANN SURG, V227, P743, DOI 10.1097/00000658-199805000-00015; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Ferrandi C, 2007, J PHARMACOL EXP THER, V322, P923, DOI 10.1124/jpet.107.123026; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Heagy Wyrta, 2003, Surg Infect (Larchmt), V4, P171, DOI 10.1089/109629603766956960; Hedrick TL, 2008, J TRAUMA, V64, P714, DOI 10.1097/TA.0b013e31811ec18e; Heesen M, 2002, INTENS CARE MED, V28, P1161, DOI 10.1007/s00134-002-1389-0; Heitner SB, 2009, CRIT CARE, V13, DOI 10.1186/cc7752; Hovnanian A., 2007, V45, P337; Lowe PR, 2003, CRIT CARE MED, V31, P34, DOI 10.1097/00003246-200301000-00005; Ma PG, 2002, CRIT CARE MED, V30, P1046, DOI 10.1097/00003246-200205000-00015; McDunn JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001564; Namath A, 2009, CRIT CARE CLIN, V25, P835, DOI 10.1016/j.ccc.2009.06.004; O'Dwyer MJ, 2006, SHOCK, V26, P544, DOI 10.1097/01.shk.0000235091.38174.8d; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; Sasaki T, 2002, J BIOCHEM, V131, P495, DOI 10.1093/oxfordjournals.jbchem.a003126; Simon R, 2002, GENET EPIDEMIOL, V23, P21, DOI 10.1002/gepi.202; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Stassen NA, 2002, SURGERY, V132, P289, DOI 10.1067/msy.2002.127167; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swanson JM, 2008, J TRAUMA, V65, P1271, DOI 10.1097/TA.0b013e3181574d6a; Textoris J, 2011, ANESTHESIOLOGY, V115, P344, DOI 10.1097/ALN.0b013e318225ba26; Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746; Wood GC, 2002, PHARMACOTHERAPY, V22, P972, DOI 10.1592/phco.22.12.972.33596; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	31	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42065	10.1371/journal.pone.0042065	http://dx.doi.org/10.1371/journal.pone.0042065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916119	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600008
J	Wu, XC; Liu, HY; Guo, DL; Anenkhonov, OA; Badmaeva, NK; Sandanov, DV				Wu, Xiuchen; Liu, Hongyan; Guo, Dali; Anenkhonov, Oleg A.; Badmaeva, Natalya K.; Sandanov, Denis V.			Growth Decline Linked to Warming-Induced Water Limitation in Hemi-Boreal Forests	PLOS ONE			English	Article							CLIMATE-CHANGE; SOIL-MOISTURE; TEMPORAL VARIABILITY; LARIX-SIBIRICA; RADIAL GROWTH; WOODY BIOMASS; WHITE SPRUCE; PLANT-GROWTH; TREE-GROWTH; DROUGHT	Hemi-boreal forests, which make up the transition from temperate deciduous forests to boreal forests in southern Siberia, have experienced significant warming without any accompanying increase in precipitation during the last 80 years. This climatic change could have a profound impact on tree growth and on the stability of forest ecosystems in this region, but at present evidence for these impacts is lacking. In this study, we report a recent dramatic decline in the growth of hemi-boreal forests, based on ring width measurements from three dominant tree-species (Pinus sylvestris, Larix sibirica and Larix gmelinii), sampled from eight sites in the region. We found that regional tree growth has become increasingly limited by low soil water content in the pre- and early-growing season (from October of the previous year to July of the current year) over the past 80 years. A warming-induced reduction in soil water content has also increased the climate sensitivity of these three tree species. Beginning in the mid-1980s, a clear decline in growth is evident for both the pine forests and the larch forests, although there are increasing trends in the proxy of soil water use efficiencies. Our findings are consistent with those from other parts of the world and provide valuable insights into the regional carbon cycle and vegetation dynamics, and should be useful for devising adaptive forest management strategies.	[Wu, Xiuchen; Liu, Hongyan; Guo, Dali] Peking Univ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Anenkhonov, Oleg A.; Badmaeva, Natalya K.; Sandanov, Denis V.] Russian Acad Sci, Inst Gen & Expt Biol, Siberian Branch, Ulan Ude, Russia	Peking University; Russian Academy of Sciences	Wu, XC (corresponding author), Max Planck Inst Biogeochem, Jena, Germany.	xcwu@bgc-jena.mpg.de; lhy@urban.pku.edu.cn	Anenkhonov, Oleg/J-8690-2016; Badmaeva, Natalia/AAC-2817-2022; Guo, Dali/G-2158-2014; Guo, Dali/C-3498-2012; Sandanov, Denis V/J-6472-2018	Anenkhonov, Oleg/0000-0001-8633-7154; Sandanov, Denis V/0000-0002-8504-3485	National Natural Science Foundation [40711120173]; Russian Foundation for Basic Research [06-04-39012]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by the National Natural Science Foundation (40711120173) and Russian Foundation for Basic Research (06-04-39012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JC, 2009, HYDROL PROCESS, V23, P962, DOI 10.1002/hyp.7201; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andreu L, 2007, GLOBAL CHANGE BIOL, V13, P804, DOI 10.1111/j.1365-2486.2007.01322.x; Anisimov O, 2006, AMBIO, V35, P169, DOI 10.1579/0044-7447(2006)35[169:PACCTR]2.0.CO;2; [Anonymous], 1985, TIME SERIES ANAL APP; Badmaev NB, 2006, DIVERSITY SOILS PERM; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Biondi F, 1999, ECOL APPL, V9, P216, DOI 10.1890/1051-0761(1999)009[0216:CTRCAR]2.0.CO;2; Bogaert J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001075; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bunn AG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023646; Bunn AG, 2006, EARTH INTERACT, V10; Cook E., 1990, METHODS DENDROCHRONO, P104, DOI 10.1007/978-94-015-7879-0; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Dong JR, 2003, REMOTE SENS ENVIRON, V84, P393, DOI 10.1016/S0034-4257(02)00130-X; Dulamsuren C, 2010, GLOBAL CHANGE BIOL, V16, P3024, DOI 10.1111/j.1365-2486.2009.02147.x; Dulamsuren C, 2010, OECOLOGIA, V163, P1091, DOI 10.1007/s00442-010-1689-y; Dulamsuren C, 2009, CAN J FOREST RES, V39, P2520, DOI 10.1139/X09-156; Dulamsuren C, 2009, TREE PHYSIOL, V29, P99, DOI 10.1093/treephys/tpn008; Fang JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024231; Fritts H., 1976, TREE RINGS CLIMATE; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Hogg EH, 2005, CAN J FOREST RES, V35, P610, DOI 10.1139/X04-211; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Holmes RL, 1992, DENDROCHRONOLOGY PRO; Johnson EA, 1998, J VEG SCI, V9, P603, DOI 10.2307/3237276; Kagawa A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003019; Kasyanova LN, 2004, ECOLOGY PLANTS BAIKA; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kendall M. G., 1962, RANK CORRELATION MET; Klos RJ, 2009, ECOL APPL, V19, P699, DOI 10.1890/08-0330.1; Laurent M, 2003, FOREST ECOL MANAG, V183, P47, DOI 10.1016/S0378-1127(03)00098-7; Lawrence DM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL025080; Leithead MD, 2010, OECOLOGIA, V164, P1095, DOI 10.1007/s00442-010-1769-z; Leshchikov FN, 1993, DIVISION DISTRICTS A; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li SG, 2007, TREES-STRUCT FUNCT, V21, P479, DOI 10.1007/s00468-007-0142-2; Liang EY, 2005, INT J REMOTE SENS, V26, P2901, DOI 10.1080/01431160500056931; Lloyd AH, 2002, CLIMATIC CHANGE, V52, P481, DOI 10.1023/A:1014278819094; Lopatin E, 2006, BOREAL ENVIRON RES, V11, P341; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Nealis VG, 2004, CAN J FOREST RES, V34, P1870, DOI 10.1139/X04-061; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; PHIPPS RL, 1988, CAN J FOREST RES, V18, P24, DOI 10.1139/x88-005; Piovesan G, 2008, GLOBAL CHANGE BIOL, V14, P1265, DOI 10.1111/j.1365-2486.2008.01570.x; Poutou E, 2004, CLIM DYNAM, V23, P621, DOI 10.1007/s00382-004-0459-0; ROBOCK A, 1995, J CLIMATE, V8, P15, DOI 10.1175/1520-0442(1995)008<0015:UOMSMA>2.0.CO;2; Rouault G, 2006, ANN FOREST SCI, V63, P613, DOI 10.1051/forest:2006044; Sidorova OV, 2009, OECOLOGIA, V161, P825, DOI 10.1007/s00442-009-1411-0; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sugimoto A, 2002, ECOL RES, V17, P493, DOI 10.1046/j.1440-1703.2002.00506.x; Tchebakova NM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045013; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Velisevich SN, 2006, RUSS J ECOL+, V37, P241, DOI 10.1134/S1067413606040047; Vinnikov KY, 1996, J GEOPHYS RES-ATMOS, V101, P7163, DOI 10.1029/95JD02753; Wang WZ, 2012, FOREST ECOL MANAG, V275, P14, DOI 10.1016/j.foreco.2012.02.027; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Ye HC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016873	70	28	33	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42619	10.1371/journal.pone.0042619	http://dx.doi.org/10.1371/journal.pone.0042619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916142	Green Published, gold			2022-12-27	WOS:000307823600019
J	Proust, R; Bertoglio, J; Gesbert, F				Proust, Richard; Bertoglio, Jacques; Gesbert, Franck			The Adaptor Protein SAP Directly Associates with CD3 zeta Chain and Regulates T Cell Receptor Signaling	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; SYNDROME GENE-PRODUCT; ZETA-CHAIN; SH2 DOMAIN; TYROSINE KINASE; ENCODING GENE; XLP SYNDROME; ACTIVATION; SLAM; TRANSDUCTION	Mutations altering the gene encoding the SLAM associated protein (SAP) are responsible for the X-linked lymphoproliferative disease or XLP1. Its absence is correlated with a defective NKT cells development, a decrease in B cell functions and a reduced T cells and NK cells cytotoxic activities, thus leading to an immunodeficiency syndrome. SAP is a small 128 amino-acid long protein that is almost exclusively composed of an SH2 domain. It has been shown to interact with the CD150/SLAM family of receptors, and in a non-canonical manner with SH3 containing proteins such as Fyn, beta PIX, PKC theta and Nck1. It would thus play the role of a minimal adaptor protein. It has been shown that SAP plays an important function in the activation of T cells through its interaction with the SLAM family of receptors. Therefore SAP defective T cells display a reduced activation of signaling events downstream of the TCR-CD3 complex triggering. In the present work, we evidence that SAP is a direct interactor of the CD3 zeta chain. This direct interaction occurs through the first ITAM of CD3 zeta, proximal to the membrane. Additionally, we show that, in the context of the TCR-CD3 signaling, an Sh-RNA mediated silencing of SAP is responsible for a decrease of several canonical T cell signaling pathways including Erk, Akt and PLC gamma 1 and to a reduced induction of IL-2 and IL-4 mRNA. Altogether, we show that SAP plays a central function in the T cell activation processes through a direct association with the CD3 complex.	[Proust, Richard; Gesbert, Franck] Univ Paris 11, Hop Paul Brousse, INSERM, UMR S1004, Villejuif, France; [Bertoglio, Jacques] Inst Gustave Roussy, INSERM, UMR S749, F-94805 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Proust, R (corresponding author), Univ Paris 11, Hop Paul Brousse, INSERM, UMR S1004, Villejuif, France.	franck.gesbert@u-psud.fr		Gesbert, Franck/0000-0002-5800-8385	INSERM; La Ligue Nationale contre le Cancer; association Nouvelles Recherches Biomedicales (NRB)-Vaincre le cancer; universite Paris-Sud; Ministere de l'Enseignement Superieur et de la Recherche; Association pour la Recherche contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); association Nouvelles Recherches Biomedicales (NRB)-Vaincre le cancer; universite Paris-Sud; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by INSERM, La Ligue Nationale contre le Cancer (equipe labellisee to JB), association Nouvelles Recherches Biomedicales (NRB)-Vaincre le cancer and universite Paris-Sud (FG and RP). RP received a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. RP is funded by the Association pour la Recherche contre le Cancer (aide individuelle) and received the prize Challenge Nathalie from the NRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Al-Alem U, 2005, BLOOD, V106, P2069, DOI 10.1182/blood-2004-07-2731; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ardouin L, 1999, IMMUNITY, V10, P409, DOI 10.1016/S1074-7613(00)80041-2; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Baldanzi G, 2011, J IMMUNOL, V187, P5941, DOI 10.4049/jimmunol.1002476; Bida AT, 2011, MOL IMMUNOL, V48, P1149, DOI 10.1016/j.molimm.2011.02.008; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Gesbert F, 1998, J BIOL CHEM, V273, P18273, DOI 10.1074/jbc.273.29.18273; Gu CP, 2006, P NATL ACAD SCI USA, V103, P14447, DOI 10.1073/pnas.0606624103; Haughn L, 1998, J EXP MED, V188, P1575, DOI 10.1084/jem.188.9.1575; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Hwang PM, 2002, EMBO J, V21, P314, DOI 10.1093/emboj/21.3.314; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Li CJ, 2008, CELL SIGNAL, V20, P1960, DOI 10.1016/j.cellsig.2008.07.004; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Li-Weber M, 2002, EUR J IMMUNOL, V32, P3587, DOI 10.1002/1521-4141(200212)32:12<3587::AID-IMMU3587>3.0.CO;2-E; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nakamura H, 2001, J IMMUNOL, V167, P2657, DOI 10.4049/jimmunol.167.5.2657; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Ostrakhovitch EA, 2009, CELL SIGNAL, V21, P540, DOI 10.1016/j.cellsig.2008.12.006; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; PURTILO D T, 1975, Lancet, V1, P935; REIF K, 1993, J BIOL CHEM, V268, P10780; Romero X, 2004, TISSUE ANTIGENS, V64, P132, DOI 10.1111/j.1399-0039.2004.00247.x; Sanzone S, 2003, J BIOL CHEM, V278, P29593, DOI 10.1074/jbc.M300565200; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Snow AL, 2009, J CLIN INVEST, V119, P2976, DOI 10.1172/JCI39518; Veillette A, 2009, IMMUNOL REV, V232, P229, DOI 10.1111/j.1600-065X.2009.00824.x; Waterman PM, 2010, FEBS LETT, V584, P4878, DOI 10.1016/j.febslet.2010.09.029; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; Weiss A, 1991, Semin Immunol, V3, P313; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	51	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43200	10.1371/journal.pone.0043200	http://dx.doi.org/10.1371/journal.pone.0043200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912825	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100070
J	Sysa-Shah, P; Xu, Y; Guo, X; Belmonte, F; Kang, B; Bedja, D; Pin, S; Tsuchiya, N; Gabrielson, K				Sysa-Shah, Polina; Xu, Yi; Guo, Xin; Belmonte, Frances; Kang, Byunghak; Bedja, Djahida; Pin, Scott; Tsuchiya, Noriko; Gabrielson, Kathleen			Cardiac-Specific Over-Expression of Epidermal Growth Factor Receptor 2 (ErbB2) Induces Pro-Survival Pathways and Hypertrophic Cardiomyopathy in Mice	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; UP-REGULATION; MOUSE MODEL; HEART; KINASE; ACTIVATION; NEUREGULIN; MUTATION; STIMULATION; DYSFUNCTION	Background: Emerging evidence shows that ErbB2 signaling has a critical role in cardiomyocyte physiology, based mainly on findings that blocking ErbB2 for cancer therapy is toxic to cardiac cells. However, consequences of high levels of ErbB2 activity in the heart have not been previously explored. Methodology/Principal Findings: We investigated consequences of cardiac-restricted over-expression of ErbB2 in two novel lines of transgenic mice. Both lines develop striking concentric cardiac hypertrophy, without heart failure or decreased life span. ErbB2 transgenic mice display electrocardiographic characteristics similar to those found in patients with Hypertrophic Cardiomyopathy, with susceptibility to adrenergic-induced arrhythmias. The hypertrophic hearts, which are 2-3 times larger than those of control littermates, express increased atrial natriuretic peptide and b-myosin heavy chain mRNA, consistent with a hypertrophic phenotype. Cardiomyocytes in these hearts are significantly larger than wild type cardiomyocytes, with enlarged nuclei and distinctive myocardial disarray. Interestingly, the over-expression of ErbB2 induces a concurrent up-regulation of multiple proteins associated with this signaling pathway, including EGFR, ErbB3, ErbB4, PI3K subunits p110 and p85, bcl-2 and multiple protective heat shock proteins. Additionally, ErbB2 up-regulation leads to an anti-apoptotic shift in the ratio of bcl-xS/xL in the heart. Finally, ErbB2 over-expression results in increased activation of the translation machinery involving S6, 4E-BP1 and eIF4E. The dependence of this hypertrophic phenotype on ErbB family signaling is confirmed by reduction in heart mass and cardiomyocyte size, and inactivation of pro-hypertrophic signaling in transgenic animals treated with the ErbB1/2 inhibitor, lapatinib. Conclusions/Significance: These studies are the first to demonstrate that increased ErbB2 over-expression in the heart can activate protective signaling pathways and induce a phenotype consistent with Hypertrophic Cardiomyopathy. Furthermore, our work suggests that in the situation where ErbB2 signaling contributes to cardiac hypertrophy, inhibition of this pathway may reverse this process.	[Sysa-Shah, Polina; Xu, Yi; Guo, Xin; Belmonte, Frances; Kang, Byunghak; Bedja, Djahida; Pin, Scott; Tsuchiya, Noriko; Gabrielson, Kathleen] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Tsuchiya, Noriko] Shionogi & Co Ltd, Drug Dev Res Labs, Osaka, Japan	Johns Hopkins University; Shionogi & Company Limited	Sysa-Shah, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	kgabriel@jhmi.edu			NIH [RO1 HL088649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant RO1 HL088649. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Baselga J, 2001, EUR J CANCER, V37, pS18, DOI 10.1016/S0959-8049(00)00404-4; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Behr TM, 2001, NEW ENGL J MED, V345, P995; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Boluyt MO, 2004, CARDIOVASC DRUG THER, V18, P257, DOI 10.1023/B:CARD.0000041245.61136.56; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Ciampi Q, 2002, J AM COLL CARDIOL, V40, P278, DOI 10.1016/S0735-1097(02)01950-2; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Daugherty A., 2009, JOVE, P2, DOI [10.3791/1291, DOI 10.3791/1291]; de Bakker JMT, 2006, J CARDIOVASC ELECTR, V17, P567, DOI 10.1111/j.1540-8167.2006.00367.x; Di Mauro S, 2007, Acta Myol, V26, P79; Doggen K, 2009, J MOL CELL CARDIOL, V46, P33, DOI 10.1016/j.yjmcc.2008.10.010; EFTHIMIOU J, 1986, POSTGRAD MED J, V62, P285, DOI 10.1136/pgmj.62.726.285; Emanuel SL, 2008, MOL PHARMACOL, V73, P338, DOI 10.1124/mol.107.041236; Esparis-Ogando A, 1999, BIOCHEM J, V344, P339, DOI 10.1042/0264-6021:3440339; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fineschi V, 2005, INT J CARDIOL, V99, P277, DOI 10.1016/j.ijcard.2004.01.022; Forsha D, 2011, GENET MED, V13, P625, DOI 10.1097/GIM.0b013e3182142966; Gabrielson K, 2007, CANCER RES, V67, P1436, DOI 10.1158/0008-5472.CAN-06-3721; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Gorlick R, 2009, PEDIATR BLOOD CANCER, V53, P594, DOI 10.1002/pbc.21989; Grazette LP, 2004, J AM COLL CARDIOL, V44, P2231, DOI 10.1016/j.jacc.2004.08.066; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Ho Carolyn Y, 2010, Heart Fail Clin, V6, P141, DOI 10.1016/j.hfc.2009.12.001; Horie T, 2010, CARDIOVASC RES, V87, P656, DOI 10.1093/cvr/cvq148; Jimenez J, 2011, AM J PHYSIOL-HEART C, V300, pH627, DOI 10.1152/ajpheart.00247.2010; Knollmann BC, 2001, J BIOL CHEM, V276, P10039, DOI 10.1074/jbc.M006745200; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Martens UM, 2009, SMALL MOL ONCOLOGY; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McConnell BK, 2001, CIRC RES, V88, P383; McKeage K, 2002, DRUGS, V62, P209, DOI 10.2165/00003495-200262010-00008; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Muthuchamy M, 1999, CIRC RES, V85, P47; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Okin PM, 2002, J AM COLL CARDIOL, V40, P1395, DOI 10.1016/S0735-1097(02)02171-X; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Oliveira SMJ, 2003, J MOL CELL CARDIOL, V35, P1251, DOI 10.1016/S0022-2828(03)00237-2; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Perik PJ, 2007, EUR J HEART FAIL, V9, P173, DOI 10.1016/j.ejheart.2006.05.010; Prabhakar R, 2003, MOL CELL BIOCHEM, V251, P33, DOI 10.1023/A:1025409227350; Prasad SVN, 2009, J BIOL CHEM, V284, P27487, DOI 10.1074/jbc.M109.036541; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Ripplinger CM, 2007, CIRC RES, V101, P1049, DOI 10.1161/CIRCRESAHA.107.161240; Rohrbach S, 1999, CIRCULATION, V100, P407, DOI 10.1161/01.CIR.100.4.407; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Rohrbach S, 2005, J MOL CELL CARDIOL, V38, P485, DOI 10.1016/j.yjmcc.2004.12.013; ROMHILT DW, 1968, AM HEART J, V75, P752, DOI 10.1016/0002-8703(68)90035-5; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sakamoto M, 2006, CIRC RES, V99, P1411, DOI 10.1161/01.RES.0000252345.80198.97; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sweeney C, 2000, ONCOGENE, V19, P5568, DOI 10.1038/sj.onc.1203913; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Taniyama Yoshiaki, 2005, J Mol Cell Cardiol, V38, P375, DOI 10.1016/j.yjmcc.2004.12.002; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Uray I. P., 2001, Journal of Heart and Lung Transplantation, V20, P210, DOI 10.1016/S1053-2498(00)00454-X; Uzzaman M, 2000, CIRC RES, V86, P871, DOI 10.1161/01.RES.86.8.871; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wolf CM, 2005, P NATL ACAD SCI USA, V102, P18123, DOI 10.1073/pnas.0509145102; Yang Z, 2010, CIRC-CARDIOVASC GENE, V3, P129, DOI 10.1161/CIRCGENETICS.109.901785; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YOKOYAMA A, 1987, BRIT HEART J, V57, P296; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	74	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42805	10.1371/journal.pone.0042805	http://dx.doi.org/10.1371/journal.pone.0042805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912742	Green Published, gold			2022-12-27	WOS:000307378500027
J	Hernandez, DG; Nalls, MA; Ylikotila, P; Keller, M; Hardy, JA; Majamaa, K; Singleton, AB				Hernandez, Dena G.; Nalls, Michael A.; Ylikotila, Pauli; Keller, Margaux; Hardy, John A.; Majamaa, Kari; Singleton, Andrew B.			Genome Wide Assessment of Young Onset Parkinson's Disease from Finland	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; FAMILIAL AGGREGATION; ASSOCIATION; VARIANTS; C9ORF72; LOCI	In the current study we undertook a series of experiments to test the hypothesis that a monogenic cause of disease may be detectable within a cohort of Finnish young onset Parkinson's disease patients. In the first instance we performed standard genome wide association analyses, and subsequent risk profile analysis. In addition we performed a series of analyses that involved testing measures of global relatedness within the cases compared to controls, searching for excess homozygosity in the cases, and examining the cases for signs of excess local genomic relatedness using a sliding window approach. This work suggested that the previously identified common, low risk alleles, and the risk models associated with these alleles, were generalizable to the Finnish Parkinson's disease population. However, we found no evidence that would suggest a single common high penetrance mutation exists in this cohort of young onset patients.	[Hernandez, Dena G.; Nalls, Michael A.; Keller, Margaux; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Ylikotila, Pauli] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland; [Hardy, John A.] UCL Inst Neurol, Reta Lilla Weston Labs, London, England; [Hardy, John A.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Majamaa, Kari] Univ Oulu, Inst Clin Med, Dept Neurol, Oulu, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Turku; University of London; University College London; University of London; University College London; University of Oulu	Hernandez, DG (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	singleta@mail.nih.gov	Hardy, John/C-2451-2009; Majamaa, Kari/A-1344-2012; Singleton, Andrew B/C-3010-2009	Hardy, John/0000-0002-3122-0423; Majamaa, Kari/0000-0002-9070-3791	Michael J. Fox Foundation for Parkinson's Disease Research through the Rapid Response Innovation Award program; Intramural Research Program of the National Institute on Aging; National Institutes of Health; Department of Health and Human Services [Z01 AG000949-06]; Academy of Finland [127764]; Finnish Parkinson Foundation; MRC [G0701075] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Medical Research Council [G0701075] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [ZIAAG000949, Z01AG000949] Funding Source: NIH RePORTER	Michael J. Fox Foundation for Parkinson's Disease Research through the Rapid Response Innovation Award program; Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Academy of Finland(Academy of Finland); Finnish Parkinson Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Michael J. Fox Foundation for Parkinson's Disease Research through the 2009 Rapid Response Innovation Award program. This work was also supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services; project Z01 AG000949-06. This work was supported by grants from the Academy of Finland (project number 127764) and The Finnish Parkinson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autere JM, 2000, J NEUROL NEUROSUR PS, V69, P107, DOI 10.1136/jnnp.69.1.107; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Moilanen JS, 2001, HUM GENET, V108, P184; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nalls MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000415; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Payami H, 2002, ARCH NEUROL-CHICAGO, V59, P848, DOI 10.1001/archneur.59.5.848; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton A, 2011, HUM MOL GENET, V20, pR158, DOI 10.1093/hmg/ddr358; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706	20	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41859	10.1371/journal.pone.0041859	http://dx.doi.org/10.1371/journal.pone.0041859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911860	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300078
J	Vinogradov, AE				Vinogradov, Alexander E.			Human More Complex than Mouse at Cellular Level	PLOS ONE			English	Article							GENE-EXPRESSION	The family of transcription factors with the C2H2 zinc finger domain is expanding in the evolution of vertebrates, reaching its highest numbers in the mammals. The question arises: whether an increased amount of these transcription factors is related to embryogenesis, nervous system, pathology or more of them are expressed in individual cells? Among mammals, the primates have a more complex anatomical structure than the rodents (e. g., brain). In this work, I show that a greater number of C2H2-ZFgenes are expressed in the human cells than in the mouse cells. The effect is especially pronounced for C2H2-ZF genes accompanied with the KRAB domain. The relative difference between the numbers of C2H2-ZF(-KRAB) genes in the human and mouse cellular transcriptomes even exceeds their difference in the genomes (i.e. a greater subset of existing in the genome genes is expressed in the human cellular transcriptomes compared to the mouse transcriptomes). The evolutionary turnover of C2H2-ZF(-KRAB) genes acts in the direction of the revealed phenomenon, i.e. gene duplication and loss enhances the difference in the relative number of C2H2-ZF(-KRAB) genes between human and mouse cellular transcriptomes. A higher amount of these genes is expressed in the brain and embryonic cells (compared with other tissues), whereas a lower amount - in the cancer cells. It is specifically the C2H2-ZF transcription factors whose repertoire is poorer in the cancer and richer in the brain (other transcription factors taken together do not show this trend). These facts suggest that increase of anatomical complexity is accompanied by a more complex intracellular regulation involving these transcription factors. Malignization is associated with simplification of this regulation. These results agree with the known fact that human cells are more resistant to oncogenic transformation than mouse cells. The list of C2H2-ZF genes whose suppression might be involved in malignization is provided.	Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Vinogradov, AE (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	aevin@mail.cytspb.rssi.ru	Vinogradov, Alexander E/GZA-4008-2022; Vinogradov, Alexander E/R-3923-2016	Vinogradov, Alexander E/0000-0001-5540-8896; 	Russian Foundation for Basic Research (RFBR)	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research (RFBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; Demetrius Lloyd, 2005, EMBO Rep, V6 Spec No, pS39; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Lorenz P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-206; Meylan S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-378; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; Pearson William, 2004, Curr Protoc Bioinformatics, VChapter 3, DOI 10.1002/0471250953.bi0309s04; Pontius JU, 2003, NCBI HDB, V1, P1; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vinogradov AE, 2007, NUCLEIC ACIDS RES, V35, P6350, DOI 10.1093/nar/gkm723; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865	21	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41753	10.1371/journal.pone.0041753	http://dx.doi.org/10.1371/journal.pone.0041753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911852	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300070
J	Wang, DS; Wang, ZQ; Zhang, L; Qiu, MZ; Luo, HY; Ren, C; Zhang, DS; Wang, FH; Li, YH; Xu, RH				Wang, De-shen; Wang, Zhi-qiang; Zhang, Le; Qiu, Miao-zhen; Luo, Hui-yan; Ren, Chao; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua			Are Risk Factors Associated with Outcomes in Pancreatic Cancer?	PLOS ONE			English	Article							ABO BLOOD-GROUP; HEPATITIS-B-VIRUS; BODY-MASS INDEX; METABOLIC SYNDROME; GROUP ALLELES; COHORT; INFECTION; INFLAMMATION; MALIGNANCY; SURVIVAL	Background: The development of pancreatic cancer is a process in which genes interact with environmental factors. We performed this study to determine the effects of the ABO blood group, obesity, diabetes mellitus, metabolic syndrome (MetS), smoking, alcohol consumption and hepatitis B viral (HBV) infection on patient survival. Methods: A total of 488 patients with pancreatic cancer were evaluated. Result: Patients who presented as chronic carriers of HBV infection were younger at disease onset (p = 0.001) and more predominantly male (p = 0.020) than those never exposed to HBV. Patients with MetS had later disease staging (p = 0.000) and a lower degree of pathological differentiation (p = 0.008) than those without MetS. In a univariate analysis, the ABO blood group, smoking and alcohol consumption were not associated with overall survival. HBsAg-positivity and elevated fasting plasma glucose were significantly associated with unfavorable survival though not in the multivariate analysis. The presence of MetS (HR: 1.541, 95% CI: 1.095-2.169, p = 0.013), age >= 65, an elevated CA19-9 baseline level, TNM staging, the type of surgery, the degree of differentiation and chemotherapy were independently associated with overall survival. Conclusion: We report, for the first time, that patients with chronic HBV infection may represent a special subtype of pancreatic cancer, who have a younger age of disease onset and male dominancy. Patients with MetS had later disease staging and a poorer histological grade. Patients with MetS demonstrated significantly poorer survival.	[Wang, De-shen; Wang, Zhi-qiang; Zhang, Le; Qiu, Miao-zhen; Luo, Hui-yan; Ren, Chao; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, DS (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	xurh@sysucc.org.cn	Xu, Rui-Hua/AAW-4766-2021; 骆, 卉妍/GWR-3383-2022; xu, rui/GRX-5734-2022; Li, yu/HHZ-5236-2022; li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022	Xu, Rui-Hua/0000-0001-9771-8534; 骆, 卉妍/0000-0001-6312-9299; 	National Natural Science Foundation of China [30672408]; Guangzhou Bureau of Science and Technology [2006Z3-E0041]; Sun Yat-sen University 985 Program Initiation Fund (China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Bureau of Science and Technology; Sun Yat-sen University 985 Program Initiation Fund (China)	This work was supported by the National Natural Science Foundation of China grant 30672408(http://www.nsfc.gov.cn/), Guangzhou Bureau of Science and Technology grant 2006Z3-E0041 (http://gdsf.gdstc.gov.cn/) and Sun Yat-sen University 985 Program Initiation Fund (China)(http://www.sysu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Bao B, 2012, CANC PREV RES PHILA; Ben QW, 2011, INT J CANCER, V128, P1179, DOI 10.1002/ijc.25426; Chae YK, 2011, CANCER INVEST, V29, P585, DOI 10.3109/07357907.2011.616252; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dandona M, 2010, JNCI-J NATL CANCER I, V102, P135, DOI 10.1093/jnci/djp447; Devaraj S, 2004, ENDOCRIN METAB CLIN, V33, P431, DOI 10.1016/j.ecl.2004.03.008; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Felini M, 2011, ANN EPIDEMIOL, V21, P755, DOI 10.1016/j.annepidem.2011.07.001; Feng Y, 2008, J CLIN ONCOL, V26; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Gapstur SM, 2011, ARCH INTERN MED, V171, P444, DOI 10.1001/archinternmed.2010.536; Geraci JM, 2006, J CLIN ONCOL, V24, p333S; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hassan MM, 2008, J CLIN ONCOL, V26, P4557, DOI 10.1200/JCO.2008.17.3526; Healy L, 2011, COLORECTAL DIS; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Iloeje UH, 2010, LIVER INT, V30, P423, DOI 10.1111/j.1478-3231.2009.02147.x; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johansen D, 2010, CANCER EPIDEM BIOMAR, V19, P2307, DOI 10.1158/1055-9965.EPI-10-0234; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Li DH, 2011, CANCER-AM CANCER SOC, V117, P2863, DOI 10.1002/cncr.25858; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Magruder JT, 2011, PANCREAS, V40, P339, DOI 10.1097/MPA.0b013e318209e05d; McWilliams RR, 2010, CANCER, V116, P203, DOI [10.1002/cncr.24697, 10.1002/cncr.25465]; McWilliams RR, 2005, CANCER, V104, P388, DOI 10.1002/cncr.21166; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Nakamura K, 2011, JPN J CLIN ONCOL, V41, P225, DOI 10.1093/jjco/hyq185; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olowokure OO, 2010, J CLIN ONCOL, V28, P4114; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Rosato V, 2011, METABOLISM, V60, P1372, DOI 10.1016/j.metabol.2011.03.005; Russo A, 2008, EUR J CANCER, V44, P293, DOI 10.1016/j.ejca.2007.11.005; Shama MA, 2010, J CLIN ONCOL, V28, P4117, DOI DOI 10.1200/JCO.2010.28.15_SUPPL.4117; Shan T, 2011, EUR J PHARMACOL, V665, P1, DOI 10.1016/j.ejphar.2011.04.055; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Suganuma M, 1999, CANCER RES, V59, P4516; Tang HW, 2011, CANCER EPIDEM BIOMAR, V20, P779, DOI 10.1158/1055-9965.EPI-10-0845; Trikudanathan G, 2011, J PANCREAS, V12, P26; Wang DS, 2012, INT J CANCER, V131, P461, DOI 10.1002/ijc.26376; Wang W, 2011, PANCREATOLOGY, V11, P16, DOI 10.1159/000322982; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Wolpin BM, 2010, CANCER EPIDEM BIOMAR, V19, P3140, DOI 10.1158/1055-9965.EPI-10-0751; Wolpin BM, 2010, CANCER RES, V70, P1015, DOI 10.1158/0008-5472.CAN-09-2993; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020	50	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41984	10.1371/journal.pone.0041984	http://dx.doi.org/10.1371/journal.pone.0041984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911869	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300086
J	Hefferan, MP; Galik, J; Kakinohana, O; Sekerkova, G; Santucci, C; Marsala, S; Navarro, R; Hruska-Plochan, M; Johe, K; Feldman, E; Cleveland, DW; Marsala, M				Hefferan, Michael P.; Galik, Jan; Kakinohana, Osamu; Sekerkova, Gabriela; Santucci, Camila; Marsala, Silvia; Navarro, Roman; Hruska-Plochan, Marian; Johe, Karl; Feldman, Eva; Cleveland, Don W.; Marsala, Martin			Human Neural Stem Cell Replacement Therapy for Amyotrophic Lateral Sclerosis by Spinal Transplantation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SOD1 TRANSGENIC RATS; MOTOR-NEURONS; SUPEROXIDE-DISMUTASE; PROGENITOR CELLS; ALS MICE; CORTICOSPINAL TRACT; FAMILIAL ALS; DORSAL-HORN; CORD-INJURY	Background: Mutation in the ubiquitously expressed cytoplasmic superoxide dismutase (SOD1) causes an inherited form of Amyotrophic Lateral Sclerosis (ALS). Mutant synthesis in motor neurons drives disease onset and early disease progression. Previous experimental studies have shown that spinal grafting of human fetal spinal neural stem cells (hNSCs) into the lumbar spinal cord of SOD1(G93A) rats leads to a moderate therapeutical effect as evidenced by local alpha-motoneuron sparing and extension of lifespan. The aim of the present study was to analyze the degree of therapeutical effect of hNSCs once grafted into the lumbar spinal ventral horn in presymptomatic immunosuppressed SOD1(G93A) rats and to assess the presence and functional integrity of the descending motor system in symptomatic SOD1(G93A) animals. Methods/Principal Findings: Presymptomatic SOD1(G93A) rats (60-65 days old) received spinal lumbar injections of hNSCs. After cell grafting, disease onset, disease progression and lifespan were analyzed. In separate symptomatic SOD1(G93A) rats, the presence and functional conductivity of descending motor tracts (corticospinal and rubrospinal) was analyzed by spinal surface recording electrodes after electrical stimulation of the motor cortex. Silver impregnation of lumbar spinal cord sections and descending motor axon counting in plastic spinal cord sections were used to validate morphologically the integrity of descending motor tracts. Grafting of hNSCs into the lumbar spinal cord of SOD1(G93A) rats protected alpha-motoneurons in the vicinity of grafted cells, provided transient functional improvement, but offered no protection to alpha-motoneuron pools distant from grafted lumbar segments. Analysis of motor-evoked potentials recorded from the thoracic spinal cord of symptomatic SOD1(G93A) rats showed a near complete loss of descending motor tract conduction, corresponding to a significant (50-65%) loss of large caliber descending motor axons. Conclusions/Significance: These data demonstrate that in order to achieve a more clinically-adequate treatment, cell-replacement/gene therapy strategies will likely require both spinal and supraspinal targets.	[Hefferan, Michael P.; Kakinohana, Osamu; Santucci, Camila; Marsala, Silvia; Navarro, Roman; Hruska-Plochan, Marian; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA; [Galik, Jan; Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia; [Galik, Jan] Pavol Jozef Safarik Univ, Fac Sci, Inst Biol & Ecol, Kosice, Slovakia; [Sekerkova, Gabriela] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Johe, Karl] Neuralstem Inc, Rockville, MD USA; [Feldman, Eva] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Cleveland, Don W.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cleveland, Don W.] Univ Calif San Diego, Sch Med, Ludwig Inst, La Jolla, CA 92093 USA; [Hruska-Plochan, Marian] Acad Sci Czech Republic, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Hruska-Plochan, Marian] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic	University of California System; University of California San Diego; Slovak Academy of Sciences; University of Pavol Jozef Safarik Kosice; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague	Hefferan, MP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA.	mmarsala@ucsd.edu	Hruska-Plochan, Marian/I-3982-2014; Galik, Jan/I-2324-2016; Cleveland, Don/AAN-9783-2021	Galik, Jan/0000-0001-9581-9585; Feldman, Eva/0000-0002-9162-2694; Cleveland, Don/0000-0002-1934-3682; Hruska-Plochan, Marian/0000-0002-9253-4362	California Institute for Regenerative Medicine [RC1-00131-1-M.M.]; Taubman Foundation	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Taubman Foundation	This work was supported by the California Institute for Regenerative Medicine (RC1-00131-1-M.M.) and by Taubman Foundation (M.M., E.F., M.H.).; Funding provided by Taubmann Foundation (EF, MM, MH) and California Institute of Regenerative Medicine (MM-RC1-00131-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BRAAK H, 1988, STAIN TECHNOL, V63, P197, DOI 10.3109/10520298809107184; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CASTRO AJ, 1972, BRAIN RES, V44, P313, DOI 10.1016/0006-8993(72)90305-8; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; da Rocha AJ, 2004, AM J NEURORADIOL, V25, P1509; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Davison C, 1941, ARCH NEURO PSYCHIATR, V46, P1039, DOI 10.1001/archneurpsyc.1941.02280240094006; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; FEHLINGS MG, 1987, NEUROSURGERY, V20, P125; FEHLINGS MG, 1988, ELECTROEN CLIN NEURO, V69, P65, DOI 10.1016/0013-4694(88)90036-3; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Horner PJ, 2000, J NEUROSCI, V20, P2218; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kakinohana O, 2006, NEUROSCIENCE, V141, P1569, DOI 10.1016/j.neuroscience.2006.04.083; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; Kakinohana O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030561; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Mackie M, 2003, NEUROSCIENCE, V119, P461, DOI 10.1016/S0306-4522(03)00174-X; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Ozdinler PH, 2011, J NEUROSCI, V31, P4166, DOI 10.1523/JNEUROSCI.4184-10.2011; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; SCHWARZ M, 1994, NEUROREPORT, V5, P1981, DOI 10.1097/00001756-199410000-00036; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176; ZAPPULLA RA, 1988, NEUROSURGERY, V22, P846, DOI 10.1227/00006123-198805000-00005	55	64	68	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42614	10.1371/journal.pone.0042614	http://dx.doi.org/10.1371/journal.pone.0042614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916141	gold, Green Published			2022-12-27	WOS:000307733800022
J	Maehata, Y; Miyagawa, S; Sawa, Y				Maehata, Yoshito; Miyagawa, Shigeru; Sawa, Yoshiki			Activated Protein C Has a Protective Effect against Myocardial I/R Injury by Improvement of Endothelial Function and Activation of AKT1	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; ISCHEMIA/REPERFUSION INJURY; INDUCED APOPTOSIS; RAT HEARTS; IN-VIVO; INHIBITION; RECEPTOR-1; INSULIN; INFLAMMATION; PATHWAY	Objectives: Activated protein C (APC) has a protective efficacy against ischemia-reperfusion (I/R) injury in several organs. The objective of this study was to investigate effect of APC in myocardium with possible mechanism. Methods: We used regional and global myocardial I/R injury models of rats. They consisted of I/R injuries (1) by ligation of left coronary artery, or (2) using Langendorff apparatus. Langendorff was used to focus the mechanism of APC excluding coagulation cascade in a working heart. Each experiment had an APC group (n = 10) and a control group with normal saline (n = 10). Injections of these solutions into rats were performed 30 minutes before the planned-I/R injury. Cardiac performance after the procedure was evaluated by echocardiography or indices with Langendorff apparatus. Coronary flow (CF) was measured in the global I/R injury model. Western blotting was performed to detect the change of AKT1 signal in myocardium after global I/R injury. Results: LV function improved significantly in the APC group: %EF at 2 weeks after procedure, 70.8%+/- 4.5% vs. 56.5%+/- 0.7%; APC vs. control; p<0.01. Percent LV development pressure (LVDP) also improved in the APC group significantly, 88.8%+/- 45.3% vs. 28.1%+/- 15.4%; APC vs. control; p<0.01. In APC group, %CF improved significantly, 88.5%+/- 15.8% vs. 65.0%+/- 13.4%; APC vs. control; p<0.01. It was enhanced significantly when acetylcholine was administered; % CF: 103.5%+/- 9.9% vs. 87.0%+/- 12.1%; APC vs. control; p<0.05. Western blotting revealed that APC significantly induced activation of phosphorylated AKT1 in myocardium (p<0.05). Conclusions: APC has a novel effect to protect myocardium and cardiac performance against I/R injury through improvement of endothelial function and activation of AKT1.	[Maehata, Yoshito; Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Osaka, Japan	Osaka University	Maehata, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Osaka, Japan.	yoppymae@yahoo.co.jp		Miyagawa, Shigeru/0000-0003-0015-6569				Abraham Edward, 2005, Proc Am Thorac Soc, V2, P243, DOI 10.1513/pats.200501-004AC; Aikawa R, 2000, CIRCULATION, V102, P2873; Chang WL, 2004, NITRIC OXIDE-BIOL CH, V11, P307, DOI 10.1016/j.niox.2004.10.004; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Dossumbekova A, 2008, AM J PHYSIOL-HEART C, V295, pH2417, DOI 10.1152/ajpheart.00501.2008; Favory R, 2006, INTENS CARE MED, V32, P899, DOI 10.1007/s00134-006-0166-x; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fernandez JA, 2006, CARDIOVASC DRUG THER, V20, P113, DOI 10.1007/s10557-006-7448-y; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; Fukui S, 2008, ANN THORAC SURG, V85, P562, DOI 10.1016/j.athoracsur.2007.06.002; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Gaudreault N, 2008, ARTERIOSCL THROM VAS, V28, P1527, DOI 10.1161/ATVBAHA.108.166975; Griffin JH, 2004, CRIT CARE MED, V32, pS247, DOI 10.1097/01.CCM.0000126127.87484.2B; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Isobe H, 2001, CIRCULATION, V104, P1171, DOI 10.1161/hc3501.093799; Jackson CJ, 2005, WOUND REPAIR REGEN, V13, P284, DOI 10.1111/j.1067-1927.2005.00130311.x; Joyce DE, 2002, CRIT CARE MED, V30, pS288, DOI 10.1097/00003246-200205001-00019; Liakopoulos OJ, 2006, EUR J CARDIO-THORAC, V30, P263, DOI 10.1016/j.ejcts.2006.04.019; Loubele STBG, 2009, ARTERIOSCL THROM VAS, V29, P1087, DOI 10.1161/ATVBAHA.109.188656; Matsui T, 2001, CIRCULATION, V104, P330; Mizutani A, 2000, BLOOD, V95, P3781; Morissette MR, 2005, CURR OPIN PHARMACOL, V5, P165, DOI 10.1016/j.coph.2005.01.004; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Nick JA, 2004, BLOOD, V104, P3878, DOI 10.1182/blood-2004-06-2140; Ono M, 2005, EUR J CARDIO-THORAC, V27, P117, DOI 10.1016/j.ejcts.2004.09.025; Pirat B, 2007, CORONARY ARTERY DIS, V18, P61, DOI 10.1097/MCA.0b013e328010a44a; RUBANYI GM, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199304000-00002; Swaidi JA, 2000, NY TIMES        1026, V101, P948; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Yamauchi T, 2006, STROKE, V37, P1081, DOI 10.1161/01.STR.0000206280.30972.21; Yamenel L, 2005, CRIT CARE, V9, pR184, DOI 10.1186/cc3485	33	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e38738	10.1371/journal.pone.0038738	http://dx.doi.org/10.1371/journal.pone.0038738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916090	gold, Green Submitted, Green Published			2022-12-27	WOS:000307733800002
J	Bakker, D; Smits, WK; Kuijper, EJ; Corver, J				Bakker, Dennis; Smits, Wiep Klaas; Kuijper, Ed J.; Corver, Jeroen			TcdC Does Not Significantly Repress Toxin Expression in Clostridium difficile 630 Delta Erm	PLOS ONE			English	Article							ESCHERICHIA-COLI; NORTH-AMERICA; SIGMA-FACTOR; RT-PCR; DISEASE; STRAIN; GENE; INFECTION; GENOME; PATHOGENICITY	In the past decade, Clostridium difficile has emerged as an important gut pathogen. Symptoms of C. difficile infection range from mild diarrhea to pseudomembranous colitis, sometimes resulting in colectomy or death. The main virulence factors of C. difficile are toxin A and toxin B. Besides the genes encoding these toxins (tcdA and tcdB), the pathogenicity locus (PaLoc) also contains genes encoding a sigma factor (tcdR) and a putative anti-sigma factor (tcdC). The important role of TcdR as a sigma factor for toxin expression is undisputed, whereas the role of TcdC as an anti-sigma factor, inhibiting toxin expression, is currently the subject of debate. To clarify the role of TcdC in toxin expression, we generated an isogenic ClosTron-based mutant of tcdC in Clostridium difficile strain 630 Delta Erm (CT::tcdC) and determined the transcription levels of the PaLoc genes and the expression levels of the toxins in the wild type strain and the tcdC mutant strain. We found only minor differences in transcription levels of the PaLoc genes between the wild type and CT:: tcdC strains and total toxin levels did not significantly differ either. These results suggest that in C. difficile 630 Delta erm TcdC is not a major regulator of toxin expression under the conditions tested.	[Bakker, Dennis; Smits, Wiep Klaas; Kuijper, Ed J.; Corver, Jeroen] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Med Microbiol, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bakker, D (corresponding author), Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Med Microbiol, NL-2300 RA Leiden, Netherlands.	j.corver@lumc.nl	Smits, Wiep Klaas/A-8366-2008; Kuijper, ed/AAB-7853-2022	Smits, Wiep Klaas/0000-0002-7409-2847; Kuijper, ed/0000-0001-5726-2405; Corver, Jeroen/0000-0002-9262-5475	Netherlands Organization for Health, Research and Development (NWO-ZOnMW) [016.116.043]; Gisela Thier fellowship (LUMC); European Union [Health-F3-2008-223585]	Netherlands Organization for Health, Research and Development (NWO-ZOnMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Gisela Thier fellowship (LUMC); European Union(European Commission)	W.K. Smits was supported by Veni grant 016.116.043 from The Netherlands Organization for Health, Research and Development (NWO-ZOnMW) and a Gisela Thier fellowship (LUMC). This study was supported by the European Union (HYPERDIFF-The Physiological Basis of Hypervirulence in Clostridium difficile: a Prerequisite for Effective Infection Control; Health-F3-2008-223585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Carter GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002317; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; Dawson LF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-86; DECKERSHEBESTREIT G, 1986, EUR J BIOCHEM, V161, P225, DOI 10.1111/j.1432-1033.1986.tb10146.x; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; GARNIER T, 1986, J BACTERIOL, V168, P1189, DOI 10.1128/jb.168.3.1189-1196.1986; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Govind R, 2006, J BACTERIOL, V188, P3716, DOI 10.1128/JB.188.10.3716-3720.2006; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Ho TD, 2011, INFECT IMMUN, V79, P3229, DOI 10.1128/IAI.00019-11; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Karlsson S, 2000, INFECT IMMUN, V68, P5881, DOI 10.1128/IAI.68.10.5881-5888.2000; Knetsch CW, 2012, INFECT GENET EVOL, V12, P1577, DOI 10.1016/j.meegid.2012.06.003; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kuijper E.J., 2008, EURO SURVEILL, V13; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; LYERLY DM, 1983, J CLIN MICROBIOL, V17, P72, DOI 10.1128/JCM.17.1.72-78.1983; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mani N, 2002, J BACTERIOL, V184, P5971, DOI 10.1128/JB.184.21.5971-5978.2002; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Metcalf D, 2010, ANAEROBE, V16, P439, DOI 10.1016/j.anaerobe.2010.06.007; Murray R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-103; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Paltansing S, 2007, CLIN MICROBIOL INFEC, V13, P1058, DOI 10.1111/j.1469-0691.2007.01793.x; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Tan KS, 2001, J MED MICROBIOL, V50, P613, DOI 10.1099/0022-1317-50-7-613; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilcox MH, 2009, CLOSTRIDIUM DIFFICLE; WREN BW, 1987, J CLIN MICROBIOL, V25, P2402, DOI 10.1128/JCM.25.12.2402-2404.1987	45	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43247	10.1371/journal.pone.0043247	http://dx.doi.org/10.1371/journal.pone.0043247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912837	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700067
J	Feng, B; Dong, TT; Wang, LL; Zhou, HM; Zhao, HC; Dong, F; Zheng, MH				Feng, Bo; Dong, Tao Tao; Wang, Lin Lin; Zhou, Hou Min; Zhao, Hong Chao; Dong, Feng; Zheng, Min Hua			Colorectal Cancer Migration and Invasion Initiated by microRNA-106a	PLOS ONE			English	Article							TGF-BETA; TUMOR-METASTASIS; CELL-GROWTH; EXPRESSION; RECEPTOR; GENE; CARCINOMA; TARGET; ADENOCARCINOMA; INHIBITION	MicroRNAs have been implicated in the regulation of several cellular signaling pathways of colorectal cancer (CRC) cells. Although emerging evidence proves that microRNA (miR)-106a is expressed highly in primary tumor and stool samples of CRC patients; whether or not miR-106a mediates cancer metastasis is unknown. We show here that miR-106a is highly expressed in metastatic CRC cells, and regulates cancer cell migration and invasion positively in vitro and in vivo. These phenotypes do not involve confounding influences on cancer cell proliferation. MiR-106a inhibits the expression of transforming growth factor-beta receptor 2 (TGFBR2), leading to increased CRC cell migration and invasion. Importantly, miR-106a expression levels in primary CRCs are correlated with clinical cancer progression. These observations indicate that miR-106a inhibits the anti-metastatic target directly and results in CRC cell migration and invasion.	[Feng, Bo; Zhou, Hou Min; Zhao, Hong Chao; Dong, Feng; Zheng, Min Hua] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Feng, Bo; Zhou, Hou Min; Zhao, Hong Chao; Zheng, Min Hua] Shanghai Inst Digest Surg, Shanghai, Peoples R China; [Feng, Bo; Zhou, Hou Min; Zhao, Hong Chao; Zheng, Min Hua] Shanghai Minimally Invas Surg Ctr, Shanghai, Peoples R China; [Dong, Tao Tao] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Wang, Lin Lin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Hosp, Shanghai Inst Med Genet, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shandong University; Shanghai Jiao Tong University	Feng, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	dfsnake@yahoo.cn; fengbo2022@163.com	wang, lin/HHM-2225-2022					Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Borczuk AC, 2011, CANCER RES, V71, P6665, DOI 10.1158/0008-5472.CAN-11-1590; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Dong TT, 2011, ANN SURG ONCOL, V18, P1797, DOI 10.1245/s10434-011-1561-2; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirai Y, 2004, AM J OBSTET GYNECOL, V191, P1173, DOI 10.1016/j.ajog.2004.04.015; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MacKay SLD, 1998, ANN SURG, V227, P781, DOI 10.1097/00000658-199806000-00001; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sathyanarayana UG, 2004, CANCER RES, V64, P1425, DOI 10.1158/0008-5472.CAN-03-0701; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	37	72	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43452	10.1371/journal.pone.0043452	http://dx.doi.org/10.1371/journal.pone.0043452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912877	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700105
J	Jensen, SMR; Schmitz, A; Pedersen, FS; Kjems, J; Bramsen, JB				Jensen, Stig Molgaard Rask; Schmitz, Alexander; Pedersen, Finn Skou; Kjems, Jorgen; Bramsen, Jesper Bertram			Functional Selection of shRNA Loops from Randomized Retroviral Libraries	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NUCLEAR EXPORT; INTERFERING RNAS; GENE; SEQUENCE; BINDING; HAIRPIN; MOTIFS; SYSTEM; PACT	Gene silencing by RNA interference (RNAi) can be achieved by the ectopic expression of tailored short hairpin RNAs (shRNAs) which after export to the cytoplasm are processed by Dicer and incorporated into the RNA induced silencing complex (RISC). Design rules for shRNAs have been the focus of several studies, but only a few reports have turned the attention to the sequence of the loop-region. In this work we selected high-functional and low-functional shRNA loops from retroviral hairpin-loop-libraries in an RNAi reporter assay. The procedure revealed a very significant and stem sequence-dependent effect of the loop on shRNA function and although neither strong consensus loop sequence nor structural motifs could be identified, a preferred loop sequence (5'-UGUGCUU-3') was found to support robust knock down with little stem sequence dependency. These findings will serve as a guide for designing shRNAs with improved knock down capacity.	[Jensen, Stig Molgaard Rask; Schmitz, Alexander; Pedersen, Finn Skou; Kjems, Jorgen; Bramsen, Jesper Bertram] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Kjems, Jorgen; Bramsen, Jesper Bertram] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark	Aarhus University; Aarhus University	Jensen, SMR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	jk@mb.au.dk	Kjems, Jorgen/I-3490-2016; Jensen, Stig/H-2126-2019	Kjems, Jorgen/0000-0003-4128-9317; Jensen, Stig/0000-0002-4256-3202	RIGHT EU consortium [LSHB-CT-2004-005276]; SIROCCO EU consortium [LSHG-CT-2006-037900]; Danish Technical Research Council; Danish Strategic Research Council; Lundbeck Foundation through the LUNA Nanomedicine Center, Denmark	RIGHT EU consortium; SIROCCO EU consortium; Danish Technical Research Council; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation through the LUNA Nanomedicine Center, Denmark	This work was supported by the RIGHT EU consortium (no. LSHB-CT-2004-005276), the SIROCCO EU consortium (LSHG-CT-2006-037900), the Danish Technical Research Council, the Danish Strategic Research Council and the Lundbeck Foundation through the LUNA Nanomedicine Center, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frilander MJ, 2001, MOL CELL, V7, P217, DOI 10.1016/S1097-2765(01)00169-1; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schopman NC, ANTIVIRAL RES, V86, P204; Schopman NCT, 2010, ANTIVIR RES, V86, P204, DOI 10.1016/j.antiviral.2010.02.320; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Vlassov AV, 2007, OLIGONUCLEOTIDES, V17, P223, DOI 10.1089/oli.2006.0069; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Wu HH, 2001, EMBO J, V20, P7240, DOI 10.1093/emboj/20.24.7240; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43095	10.1371/journal.pone.0043095	http://dx.doi.org/10.1371/journal.pone.0043095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912797	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700040
J	Loitfelder, M; Filippi, M; Rocca, M; Valsasina, P; Ropele, S; Jehna, M; Fuchs, S; Schmidt, R; Neuper, C; Fazekas, F; Enzinger, C				Loitfelder, Marisa; Filippi, Massimo; Rocca, Mara; Valsasina, Paola; Ropele, Stefan; Jehna, Margit; Fuchs, Siegrid; Schmidt, Reinhold; Neuper, Christa; Fazekas, Franz; Enzinger, Christian			Abnormalities of Resting State Functional Connectivity Are Related to Sustained Attention Deficits in MS	PLOS ONE			English	Article							COMPENSATORY CORTICAL ACTIVATION; MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; DEFAULT-MODE; FMRI DATA; BRAIN; FREQUENCY; FLUCTUATIONS; DYSFUNCTION; MEMORY	Objectives: Resting state (RS) functional MRI recently identified default network abnormalities related to cognitive impairment in MS. fMRI can also be used to map functional connectivity (FC) while the brain is at rest and not adhered to a specific task. Given the importance of the anterior cingulate cortex (ACC) for higher executive functioning in MS, we here used the ACC as seed-point to test for differences and similarities in RS-FC related to sustained attention between MS patients and controls. Design: Block-design rest phases of 3 Tesla fMRI data were analyzed to assess RS-FC in 31 patients (10 clinically isolated syndromes, 16 relapsing-remitting, 5 secondary progressive MS) and 31 age-and gender matched healthy controls (HC). Participants underwent extensive cognitive testing. Observations: In both groups, signal changes in several brain areas demonstrated significant correlation with RS-activity in the ACC. These comprised the posterior cingulate cortex (PCC), insular cortices, the right caudate, right middle temporal gyrus, angular gyri, the right hippocampus, and the cerebellum. Compared to HC, patients showed increased FC between the ACC and the left angular gyrus, left PCC, and right postcentral gyrus. Better cognitive performance in the patients was associated with increased FC to the cerebellum, middle temporal gyrus, occipital pole, and the angular gyrus. Conclusion: We provide evidence for adaptive changes in RS-FC in MS patients compared to HC in a sustained attention network. These results extend and partly mirror findings of task-related fMRI, suggesting FC may increase our understanding of cognitive dysfunction in MS.	[Loitfelder, Marisa; Ropele, Stefan; Jehna, Margit; Fuchs, Siegrid; Schmidt, Reinhold; Fazekas, Franz; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Filippi, Massimo; Rocca, Mara; Valsasina, Paola] Inst Sci, Neuroimaging Res Unit, Inst Expt Neurol, Milan, Italy; [Filippi, Massimo; Rocca, Mara; Valsasina, Paola] Univ Vita Salute San Raffaele, Osped San Raffaele, Milan, Italy; [Loitfelder, Marisa; Jehna, Margit; Neuper, Christa] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Enzinger, Christian] Med Univ Graz, Dept Radiol, Neuroradiol Sect, Graz, Austria	Medical University of Graz; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Graz; Medical University of Graz	Loitfelder, M (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	chris.enzinger@medunigraz.at	Filippi, Massimo/K-1755-2018; Rocca, Maria Assunta/K-1619-2018; Valsasina, Paola/K-5820-2016; Jehna, Margit/M-9873-2017; Schmidt, Reinhold/E-1137-2014	Filippi, Massimo/0000-0002-5485-0479; Rocca, Maria Assunta/0000-0003-2358-4320; Valsasina, Paola/0000-0001-5390-2655; Jehna, Margit/0000-0003-3376-7753	Sanofi Aventis; Bayer Schering Pharma; Biogen-Dompe; Genmab A/S; Merck Serono; Teva Pharmaceutical Industries Ltd.; Fondazione Italiana Sclerosi Multipla; Biogen-Idec; Teva-Aventis; Merck-Serono; Bayer-Schering	Sanofi Aventis(Sanofi-Aventis); Bayer Schering Pharma(Bayer AG); Biogen-Dompe(Biogen); Genmab A/S(Genmab); Merck Serono(Merck & Company); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Biogen-Idec(Biogen); Teva-Aventis(Teva Pharmaceutical Industries); Merck-Serono(Merck & Company); Bayer-Schering(Bayer AG)	Marisa Loitfelder received unrestricted research funds from Sanofi Aventis. Massimo Filippi serves on scientific advisory boards for Teva Pharmaceutical Industries Ltd. and Genmab A/S and has received funding for travel from Bayer Schering Pharma, Biogen-Dompe, Genmab A/S, Merck Serono, and Teva Pharmaceutical Industries Ltd. Massimo Filippi also serves as a consultant to Bayer Schering Pharma, Biogen-Dompe, Genmab A/S, Merck Serono, Pepgen Corporation, and Teva Pharmaceutical Industries Ltd. and serves on speakers' bureaus for Bayer Schering Pharma, Biogen-Dompe, Genmab A/S, Merck Serono, and Teva Pharmaceutical Industries Ltd. He also receives research support from Bayer Schering Pharma, Biogen-Dompe, Genmab A/S, Merck Serono, Teva Pharmaceutical Industries Ltd., and Fondazione Italiana Sclerosi Multipla, and serves on editorial boards of the American Journal of Neuroradiology, BMC Musculoskeletal Disorders, Clinical Neurology and Neurosurgery, Erciyes Medical Journal, Journal of Neuroimaging, Journal of Neurovirology, Magnetic Resonance Imaging, Multiple Sclerosis, Neurological Sciences, and Lancet Neurology. Maria Rocca has served as consultant to Bayer Schering Pharma and received speakers' bureaus for Biogen-Dompe. Paola Valsasina reports no disclosures. Stefan Ropele reports no disclosures. Margit Jehna reports no disclosures. Siegrid Fuchs serves on scientific advisory boards for Bayer Schering, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical Industries Ltd./Sanofi Aventis and has received speaker honoraria from Biogen Idec, Merck Serono, and Sanofi-Aventis. Reinhold Schmidt has received consulting fees or honoraria from Pfizer, Novartis, Janssen, Lundbeck and Merz. Christa Neuper reports no disclosures. Franz Fazekas serves on scientific advisory boards for Bayer Schering, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical Industries Ltd./Sanofi Aventis and serves on the editorial boards of Cerebrovascular Diseases, Multiple Sclerosis, the Polish Journal of Neurology and Neurosurgery, Stroke, Therapeutic Advances in Neurological Disorders, and the Swiss Archives of Neurology and Psychiatry. Franz Fazekas has received speaker honoraria from Biogen Idec, Merck Serono, Novartis and Sanofi-Aventis. Christian Enzinger has received travel grants and speaking honoraria from Biogen-Idec, Teva-Aventis, Merck-Serono, Bayer-Schering and unrestricted research grants from Teva-Aventis and Merck-Serono. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Audoin B, 2005, MAGN RESON MATER PHY, V18, P96, DOI 10.1007/s10334-004-0098-9; Audoin B, 2003, HUM BRAIN MAPP, V20, P51, DOI 10.1002/hbm.10128; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chang CH, 2003, MULT SCLER J, V9, P160, DOI 10.1191/1352458503ms885oa; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Duong MVA, 2005, J CEREBR BLOOD F MET, V25, P1245, DOI 10.1038/sj.jcbfm.9600122; Eryilmaz H, 2011, NEUROIMAGE, V54, P2481, DOI 10.1016/j.neuroimage.2010.10.021; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Hayter AL, 2007, NEUROIMAGE, V36, P943, DOI 10.1016/j.neuroimage.2007.03.011; Kalkers NF, 2000, NEUROLOGY, V54, P1233, DOI 10.1212/WNL.54.6.1233; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Lesage E, 2010, BEHAV NEUROL, V23, P39, DOI [10.1155/2010/482139, 10.3233/BEN-2010-0267]; Loitfelder M, 2011, NEUROLOGY, V76, P526, DOI 10.1212/WNL.0b013e31820b75cf; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Lowe MJ, 1995, MAGNETIC RESONANCE M, V29, P537; Lowe MJ, 1995, MAGNETIC RESONANCE M, V29, P818; Lowe MJ, 1995, MAGNETIC RESONANCE M, V29, P541; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Morrow SA, 2010, MULT SCLER J, V16, P1385, DOI 10.1177/1352458510378021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patti F, 2010, NEUROL SCI, V31, P265, DOI 10.1007/s10072-010-0438-7; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1986, J CLIN EXP NEUROPSYC, V8, P503, DOI 10.1080/01688638608405173; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Staffen W, 2002, BRAIN, V125, P1275, DOI 10.1093/brain/awf125; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Valentino P, 2009, MULT SCLER J, V15, P854, DOI 10.1177/1352458509104589; Valsasina P, 2011, EUR J NEUROSCI, V33, P1256, DOI 10.1111/j.1460-9568.2011.07623.x; Zhao JZ, 2011, NEUROSCI LETT, V487, P27, DOI 10.1016/j.neulet.2010.09.067	42	44	45	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42862	10.1371/journal.pone.0042862	http://dx.doi.org/10.1371/journal.pone.0042862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912754	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700026
J	Wei, K; Sun, ZH; Zhu, SF; Guo, WL; Sheng, PC; Wang, ZM; Zhao, CL; Zhao, QY; Zhu, RL				Wei, Kai; Sun, Zhenhong; Zhu, Shufen; Guo, Wenlong; Sheng, Pengcheng; Wang, Zunmin; Zhao, Changliang; Zhao, Qingyou; Zhu, Ruiliang			Probable Congenital Transmission of Reticuloendotheliosis Virus Caused by Vaccination with Contaminated Vaccines	PLOS ONE			English	Article							AVIAN-LEUKOSIS-VIRUS; VERTICAL TRANSMISSION; SUBGROUP J; CHICKENS; INFECTION; GENOME; STRAIN	Contaminated vaccine is one unexpected and potential origin of virus infection. In order to investigate the most likely cause of disease in a broiler breeder company of Shandong Province, all 17 batches of live-virus vaccines used in the affected flocks and 478 tissue samples were tested by dot-blot hybridization, nested PCR, and IFA. The results suggested the outbreak of disease was most probably due to the vaccination of REV-contaminated MD-CVI988/Rispens vaccines and ND-LaSota+IB-H120 vaccines. Furthermore, the REV was probably transmitted to the commercial chickens through congenital transmission.	[Wei, Kai; Sun, Zhenhong; Zhu, Shufen; Guo, Wenlong; Sheng, Pengcheng; Wang, Zunmin; Zhao, Changliang; Zhao, Qingyou; Zhu, Ruiliang] Shandong Agr Univ, Coll Anim Sci & Technol, Key Lab Biol Prod, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wei, K (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Key Lab Biol Prod, Tai An, Shandong, Peoples R China.	zhurl@sdau.edu.cn			National Natural Science Foundation of China [30972183, 30740077]; Special Fund Research of Public Welfare Industries of Ministry of Agriculture [200803019]; Science and Technology Development Plan of Shandong Province [2012GNC11020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund Research of Public Welfare Industries of Ministry of Agriculture; Science and Technology Development Plan of Shandong Province	This work was supported by National Natural Science Foundation of China (30972183, 30740077), Special Fund Research of Public Welfare Industries of Ministry of Agriculture (200803019), and Science and Technology Development Plan of Shandong Province (2012GNC11020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad AM, 2010, POULTRY SCI, V89, P2389, DOI 10.3382/ps.2010-00899; Barbosa T, 2007, VIRUS RES, V124, P68, DOI 10.1016/j.virusres.2006.10.002; Biswas SK, 2011, VET ITAL, V47, P147; Bohls RL, 2006, VIRUS RES, V119, P187, DOI 10.1016/j.virusres.2006.01.011; Cheng Z, 2011, ISR J VET MED, V66, P34; Cui ZZ, 2010, VIRUS GENES, V40, P236, DOI 10.1007/s11262-009-0437-z; Cui ZZ, 2009, AVIAN PATHOL, V38, P443, DOI 10.1080/03079450903349188; Davidson I, 2008, J GEN VIROL, V89, P2456, DOI 10.1099/vir.0.2008/001313-0; Davidson T, 2005, J MED ENTOMOL, V42, P128, DOI 10.1603/0022-2585(2005)042[0128:ICTHTO]2.0.CO;2; Diao XiuGuo, 2008, Agricultural Sciences in China, V7, P1387, DOI 10.1016/S1671-2927(08)60189-3; Fadly AM, 1997, AVIAN DIS, V41, P695, DOI 10.2307/1592163; Hatai H, 2009, J VET DIAGN INVEST, V21, P519, DOI 10.1177/104063870902100415; Hauck R, 2009, AVIAN DIS, V53, P211, DOI 10.1637/8452-081908-Reg.1; JACKSON CAW, 1977, AUST VET J, V53, P457, DOI 10.1111/j.1751-0813.1977.tb05509.x; KAWAMURA H, 1976, NATL I ANIM HEALTH Q, V16, P135; Mays JK, 2010, AVIAN PATHOL, V39, P383, DOI 10.1080/03079457.2010.510828; MOTHA MXJ, 1987, AVIAN PATHOL, V16, P141, DOI 10.1080/03079458708436359; Ni Nan, 2008, Weishengwu Xuebao, V48, P514; Pastoret PP, 2010, BIOLOGICALS, V38, P332, DOI 10.1016/j.biologicals.2010.02.015; Sun SH, 2009, AVIAN PATHOL, V38, P31, DOI 10.1080/03079450802607504; WITTER RL, 1989, AVIAN DIS, V33, P226, DOI 10.2307/1590836; YUASA N, 1976, NATL I ANIM HEALTH Q, V16, P141; Yue H., 2010, CHINA POULTRY, V32, P27; Zheng YS, 2007, J VET MED SCI, V69, P213, DOI 10.1292/jvms.69.213	24	35	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43422	10.1371/journal.pone.0043422	http://dx.doi.org/10.1371/journal.pone.0043422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912872	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700100
J	Costa, TL; Barboni, MTS; Moura, ALD; Bonci, DMO; Gualtieri, M; Silveira, LCD; Ventura, DF				Costa, Thiago Leiros; Salgueiro Barboni, Mirella Telles; de Araujo Moura, Ana Laura; Oliveira Bonci, Daniela Maria; Gualtieri, Mirella; de Lima Silveira, Luiz Carlos; Ventura, Dora Fix			Long-Term Occupational Exposure to Organic Solvents Affects Color Vision, Contrast Sensitivity and Visual Fields	PLOS ONE			English	Article							ABUSED SOLVENT; MERCURY-VAPOR; IMPAIRMENT; TOLUENE; WORKERS; PERFORMANCE; POTENTIALS; RECEPTORS; INDICATOR; MIXTURES	The purpose of this study was to evaluate the visual outcome of chronic occupational exposure to a mixture of organic solvents by measuring color discrimination, achromatic contrast sensitivity and visual fields in a group of gas station workers. We tested 25 workers (20 males) and 25 controls with no history of chronic exposure to solvents (10 males). All participants had normal ophthalmologic exams. Subjects had worked in gas stations on an average of 9.6 +/- 6.2 years. Color vision was evaluated with the Lanthony D15d and Cambridge Colour Test (CCT). Visual field assessment consisted of white-on-white 24-2 automatic perimetry (Humphrey II-750i). Contrast sensitivity was measured for sinusoidal gratings of 0.2, 0.5, 1.0, 2.0, 5.0, 10.0 and 20.0 cycles per degree (cpd). Results from both groups were compared using the Mann-Whitney U test. The number of errors in the D15d was higher for workers relative to controls (p<0.01). Their CCT color discrimination thresholds were elevated compared to the control group along the protan, deutan and tritan confusion axes (p<0.01), and their ellipse area and ellipticity were higher (p<0.01). Genetic analysis of subjects with very elevated color discrimination thresholds excluded congenital causes for the visual losses. Automated perimetry thresholds showed elevation in the 9 degrees, 15 degrees and 21 degrees of eccentricity (p<0.01) and in MD and PSD indexes (p<0.01). Contrast sensitivity losses were found for all spatial frequencies measured (p<0.01) except for 0.5 cpd. Significant correlation was found between previous working years and deutan axis thresholds (rho = 0.59; p<0.05), indexes of the Lanthony D15d (rho = 0.52; p<0.05), perimetry results in the fovea (rho = -0.51; p<0.05) and at 3, 9 and 15 degrees of eccentricity (rho = -0.46; p<0.05). Extensive and diffuse visual changes were found, suggesting that specific occupational limits should be created.	[Costa, Thiago Leiros; Salgueiro Barboni, Mirella Telles; de Araujo Moura, Ana Laura; Oliveira Bonci, Daniela Maria; Gualtieri, Mirella; Ventura, Dora Fix] Univ Sao Paulo, Inst Psicol, Sao Paulo, Brazil; [Costa, Thiago Leiros; Salgueiro Barboni, Mirella Telles; de Araujo Moura, Ana Laura; Oliveira Bonci, Daniela Maria; Gualtieri, Mirella; Ventura, Dora Fix] Univ Sao Paulo, Nucleo Neurociencias & Comportamento, Sao Paulo, Brazil; [de Lima Silveira, Luiz Carlos] Fed Univ Para, Dept Fisiol, BR-66059 Belem, Para, Brazil; [de Lima Silveira, Luiz Carlos] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Para; Universidade Federal do Para	Costa, TL (corresponding author), Univ Sao Paulo, Inst Psicol, Sao Paulo, Brazil.	e.thiagocosta@gmail.com	Silveira, Luiz Carlos L/H-9647-2014; Ventura, Dora F/B-9071-2012; Barboni, Mirella T. S./C-9874-2014; Gualtieri, Mirella/L-2781-2016	Silveira, Luiz Carlos L/0000-0001-9414-1573; Ventura, Dora F/0000-0002-7616-4031; Gualtieri, Mirella/0000-0002-1091-1321	FAPESP Projeto Tematico [08/58731-2, 02/12733-8]; FAPESP Master's Degree scholarship [2009/07089-1]; FAPESP [07/55125-1, 08/52427-0]	FAPESP Projeto Tematico(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP Master's Degree scholarship; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants from FAPESP Projeto Tematico #08/58731-2 and #02/12733-8. TLC had FAPESP Master's Degree scholarship #2009/07089-1. MTSB and ALM had doctoral scholarships (FAPESP 07/55125-1 and 08/52427-0). LCLS is a CNPq research fellow. DFV is a CNPq 1A research fellow. FAPESP = Fundacao de Amparo a Pesquisa do Estado de Sao Paulo http://www.fapesp.br/. CNPq = Conselho Nacional de Desenvolvimento Cientifico e Tecnologico http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANP Anuario, 2010, EST BRAS PETR GAS NA; Bale AS, 2002, BRIT J PHARMACOL, V137, P375, DOI 10.1038/sj.bjp.0704874; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P368; Boeckelmann I, 2003, J OCCUP ENVIRON MED, V45, P25, DOI 10.1097/00043764-200301000-00009; Castillo L, 2001, AM J IND MED, V39, P351, DOI 10.1002/ajim.1025; Correa SM, 2006, 36 ENC NAC ENG PROD; Costa MF, 2007, AM J HUM GENET, V80, P1064, DOI 10.1086/518127; Costa MF, 2006, VISUAL NEUROSCI, V23, P461, DOI 10.1017/S095252380623311X; Cruz SL, 1998, J PHARMACOL EXP THER, V286, P334; Lacerda EMDB, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/784390; Edling C, 1997, INT ARCH OCC ENV HEA, V70, P180, DOI 10.1007/s004200050204; Eisenberg D.P., 2003, EINSTEIN QJ BIOL MED, V19, P150; Feitosa-Santana C, 2007, BRAZ J MED BIOL RES, V40, P409, DOI 10.1590/S0100-879X2006005000063; Feitosa-Santana C, 2010, OPHTHAL PHYSL OPT, V30, P717, DOI 10.1111/j.1475-1313.2010.00776.x; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Geller AM, 2001, NEUROTOXICOL TERATOL, V23, P265, DOI 10.1016/S0892-0362(01)00139-8; Gobba F, 2003, NEUROTOXICOLOGY, V24, P675, DOI 10.1016/S0161-813X(03)00038-X; Gobba F, 2003, NEUROTOXICOLOGY, V24, P693, DOI 10.1016/S0161-813X(03)00037-8; Gobba F, 2000, NEUROTOXICOLOGY, V21, P857; Gobba F, 2000, NEUROTOXICOLOGY, V21, P777; Gong YY, 2003, NEUROTOXICOLOGY, V24, P703, DOI 10.1016/S0161-813X(03)00034-2; Greenberg MM, 1997, ENVIRON RES, V72, P1, DOI 10.1006/enrs.1996.3686; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; Hinrichsen SL, 2004, REV BRAS MED, V61, P529; Kiyokawa M, 1999, JPN J OPHTHALMOL, V43, P438, DOI 10.1016/S0021-5155(99)00102-1; Laurentino L, 2007, 11 ENC SBQ, P124; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; MERGLER D, 1988, TOXICOLOGY, V49, P341, DOI 10.1016/0300-483X(88)90017-0; MERGLER D, 1987, INT ARCH OCC ENV HEA, V59, P313, DOI 10.1007/BF00405275; Meyer-Baron M, 2008, NEUROTOXICOLOGY, V29, P349, DOI 10.1016/j.neuro.2008.02.005; MORATA TC, 1995, ARCH TOXICOL, V69, P431, DOI 10.1007/s002040050196; Moura ALA, 2008, VISUAL NEUROSCI, V25, P1; Muttray A, 1997, INT ARCH OCC ENV HEA, V70, P407, DOI 10.1007/s004200050237; Nasanen R, 2005, ENVIRON TOXICOL PHAR, V19, P497, DOI 10.1016/j.etap.2004.12.013; NEITZ M, 1995, SCIENCE, V267, P1013, DOI 10.1126/science.7863325; Neitz M, 2004, VISUAL NEUROSCI, V21, P205, DOI 10.1017/S0952523804213293; Paallysaho J, 2007, HUM EXP TOXICOL, V26, P375, DOI 10.1177/0960327107076820; Pacheco-Cutillas M, 1999, BRIT J OPHTHALMOL, V83, P1396, DOI 10.1136/bjo.83.12.1396; Paramei GV, 2004, NEUROTOXICOLOGY, V25, P803, DOI 10.1016/j.neuro.2004.01.006; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; Barboni MTS, 2009, J OCCUP ENVIRON MED, V51, P1403, DOI 10.1097/JOM.0b013e3181bca9ea; Schaper M, 2004, TOXICOL LETT, V151, P193, DOI 10.1016/j.toxlet.2004.01.020; Sekhar GC, 2000, OPHTHALMOLOGY, V107, P1303, DOI 10.1016/S0161-6420(00)00140-8; Semple S, 2000, OCCUP ENVIRON MED, V57, P582, DOI 10.1136/oem.57.9.582; SHAPLEY R, 1990, ANNU REV PSYCHOL, V41, P635, DOI 10.1146/annurev.psych.41.1.635; Soderkvist P, 1996, SCAND J WORK ENV HEA, V22, P360; URBAN P, 1990, BRIT J IND MED, V47, P819; Ventura DF, 2005, ENVIRON TOXICOL PHAR, V19, P523, DOI 10.1016/j.etap.2004.12.016; Ventura DF, 2004, VISUAL NEUROSCI, V21, P421, DOI 10.1017/S0952523804213372; Ventura DSF, 2003, NORMAL DEFECTIVE COL; Visser I, 2008, ANN NEUROL, V63, P572, DOI 10.1002/ana.21364; Wani JS, 2005, JK PRACTITIONER, V12, P219; Zavalic M, 1998, INT ARCH OCC ENV HEA, V71, P194, DOI 10.1007/s004200050270	54	18	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42961	10.1371/journal.pone.0042961	http://dx.doi.org/10.1371/journal.pone.0042961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916187	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600035
J	Ligresti, G; Aplin, AC; Dunn, BE; Morishita, A; Nicosia, RF				Ligresti, Giovanni; Aplin, Alfred C.; Dunn, Bruce E.; Morishita, Ann; Nicosia, Roberto F.			The Acute Phase Reactant Orosomucoid-1 Is a Bimodal Regulator of Angiogenesis with Time- and Context-Dependent Inhibitory and Stimulatory Properties	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIAL GROWTH-FACTOR; AORTIC RING MODEL; IN-VIVO MODEL; ALPHA(1)-ACID GLYCOPROTEIN; ALPHA-1-ACID GLYCOPROTEIN; RAT AORTA; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; INFLAMMATORY CYTOKINES	Background: Tissues respond to injury by releasing acute phase reaction (APR) proteins which regulate inflammation and angiogenesis. Among the genes upregulated in wounded tissues are tumor necrosis factor-alpha (TNF alpha) and the acute phase reactant orosomucoid-1 (ORM1). ORM1 has been shown to modulate the response of immune cells to TNF alpha, but its role on injury- and TNF alpha-induced angiogenesis has not been investigated. This study was designed to characterize the role of ORM1 in the angiogenic response to injury and TNF alpha. Methods and Results: Angiogenesis was studied with in vitro, ex vivo, and in vivo angiogenesis assays. Injured rat aortic rings cultured in collagen gels produced an angiogenic response driven by macrophage-derived TNF alpha. Microarray analysis and qRT-PCR showed that TNF alpha and ORM1 were upregulated prior to angiogenic sprouting. Exogenous ORM1 delayed the angiogenic response to injury and inhibited the proangiogenic effect of TNF alpha in cultures of aortic rings or isolated endothelial cells, but stimulated aortic angiogenesis over time while promoting VEGF production and activity. ORM1 inhibited injury- and TNF alpha-induced phosphorylation of MEK1/2 and p38 MAPK in aortic rings, but not of NF kappa B. This effect was injury/TNF alpha-specific since ORM1 did not inhibit VEGF-induced signaling, and cell-specific since ORM1 inhibited TNF alpha-induced phosphorylation of MEK1/2 and p38 MAPK in macrophages and endothelial cells, but not mural cells. Experiments with specific inhibitors demonstrated that the MEK/ERK pathway was required for angiogenesis. ORM1 inhibited angiogenesis in a subcutaneous in vivo assay of aortic ring-induced angiogenesis, but stimulated developmental angiogenesis in the chorioallantoic membrane (CAM) assay. Conclusion: ORM1 regulates injury-induced angiogenesis in a time- and context-dependent manner by sequentially dampening the initial TNF alpha-induced angiogenic response and promoting the downstream stimulation of the angiogenic process by VEGF. The context-dependent nature of ORM1 angioregulatory function is further demonstrated in the CAM assay where ORM1 stimulates developmental angiogenesis without exerting any inhibitory activity.	[Ligresti, Giovanni; Aplin, Alfred C.; Morishita, Ann; Nicosia, Roberto F.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Nicosia, Roberto F.] Vet Adm Puget Sound Hlth Care Syst, Pathol & Lab Med Serv, Seattle, WA USA; [Dunn, Bruce E.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Dunn, Bruce E.] Dept Vet Affairs Med Ctr, Pathol & Lab Med Serv, Milwaukee, WI USA	University of Washington; University of Washington Seattle; Medical College of Wisconsin	Ligresti, G (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	roberto.nicosia@va.gov	Ligresti, Giovanni/AAB-9881-2019	Aplin, Alfred/0000-0002-3346-9484	National Heart, Lung, and Blood Institute [HL52585]; United States Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052585] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work presented in the paper was supported by National Heart, Lung, and Blood Institute Grant HL52585 and a Merit Review Grant from United States Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagappan VKT, 2005, CELL BIOCHEM BIOPHYS, V43, P119, DOI 10.1385/CBB:43:1:119; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Aplin AC, 2006, PHYSIOL GENOMICS, V27, P20, DOI 10.1152/physiolgenomics.00048.2006; Atemezem A, 2001, BIOCHEM J, V356, P121, DOI 10.1042/0264-6021:3560121; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Benelli R, 2006, CURR PHARM DESIGN, V12, P3101, DOI 10.2174/138161206777947461; Ceciliani F, 2007, CURR PROTEIN PEPT SC, V8, P91, DOI 10.2174/138920307779941497; Chu SC, 2004, J ENDODONT, V30, P704, DOI 10.1097/01.DON.0000129962.65752.C6; COSTELLO MJ, 1984, CLIN EXP IMMUNOL, V55, P465; Cray C, 2009, COMPARATIVE MED, V59, P517; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; DUNN BE, 1981, ANAT REC, V199, P33, DOI 10.1002/ar.1091990105; Elg SA, 1997, CANCER, V80, P1448, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1448::AID-CNCR12>3.3.CO;2-D; FAJARDO LF, 1992, AM J PATHOL, V140, P539; Fogel Eric, 2007, Angiogenesis, V10, P287, DOI 10.1007/s10456-007-9082-0; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gao BC, 2002, AM J PHYSIOL-CELL PH, V283, pC1196, DOI 10.1152/ajpcell.00064.2002; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gelati M, 2008, J IMMUNOL, V181, P5711, DOI 10.4049/jimmunol.181.8.5711; Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com; Hlushchuk R, 2007, MICROCIRCULATION, V14, P813, DOI 10.1080/10739680701370021; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Irmak S, 2009, EXP CELL RES, V315, P3201, DOI 10.1016/j.yexcr.2009.07.024; Jupp OJ, 2001, BIOCHEM J, V359, P525, DOI 10.1042/0264-6021:3590525; Kim I, 2000, BIOCHEM BIOPH RES CO, V269, P361, DOI 10.1006/bbrc.2000.2296; LAINE E, 1990, INFLAMMATION, V14, P1, DOI 10.1007/BF00914025; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; LIBERT C, 1994, J EXP MED, V180, P1571, DOI 10.1084/jem.180.4.1571; Ligresti G, 2011, ARTERIOSCL THROM VAS, V31, P1151, DOI 10.1161/ATVBAHA.111.223917; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Matsumoto K, 2010, DRUG METAB PHARMACOK, V25, P101, DOI 10.2133/dmpk.25.101; Montrucchio G, 1997, AM J PATHOL, V151, P557; Muchitsch EM, 1996, ARCH INT PHARMACOD T, V331, P313; Muchitsch EM, 1998, FUNDAM CLIN PHARM, V12, P173, DOI 10.1111/j.1472-8206.1998.tb00938.x; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; NICOSIA RF, 1990, LAB INVEST, V63, P115; NICOSIA RF, 1994, IN VITRO CELL DEV-AN, V30A, P394, DOI 10.1007/BF02634360; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; Niida Hirohito, 1995, Neurologia Medico-Chirurgica, V35, P209, DOI 10.2176/nmc.35.209; Otani N, 2003, ACT NEUR S, V86, P287; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; ROESEL JF, 1995, J SURG RES, V58, P449, DOI 10.1006/jsre.1995.1071; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; SATO N, 1987, J NATL CANCER I, V79, P1383; SCHWEIGERER L, 1987, BIOCHEM BIOPH RES CO, V143, P997, DOI 10.1016/0006-291X(87)90350-0; Scott BB, 2005, BIOCHEM BIOPH RES CO, V328, P409, DOI 10.1016/j.bbrc.2004.12.180; SNYDER S, 1976, ARCH INTERN MED, V136, P778, DOI 10.1001/archinte.136.7.778; Sorensson J, 2000, AM J PHYSIOL-HEART C, V278, pH1725, DOI 10.1152/ajpheart.2000.278.5.H1725; TILG H, 1993, J EXP MED, V178, P1629, DOI 10.1084/jem.178.5.1629; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; van Hinsbergh V W, 1997, EXS, V79, P391; Vanderslice P, 1998, Angiogenesis, V2, P265, DOI 10.1023/A:1009296700991; VanMolle W, 1997, J IMMUNOL, V159, P3555; VILLASCHI S, 1994, IN VITRO CELL DEV-AN, V30A, P589; Yang H, 2004, J SURG RES, V122, P249, DOI 10.1016/j.jss.2004.05.007; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284; Zhu WH, 2002, AM J PATHOL, V161, P823, DOI 10.1016/S0002-9440(10)64242-3; Zorzi P, 2010, J LEUKOCYTE BIOL, V88, P1051, DOI 10.1189/jlb.0310178	64	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e41387	10.1371/journal.pone.0041387	http://dx.doi.org/10.1371/journal.pone.0041387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916107	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800005
J	Rodriguez, GP; Song, JB; Crouse, GF				Rodriguez, Gina P.; Song, Joseph B.; Crouse, Gray F.			Transformation with Oligonucleotides Creating Clustered Changes in the Yeast Genome	PLOS ONE			English	Article							SINGLE-STRANDED OLIGONUCLEOTIDES; MISMATCH REPAIR PROTEIN; SACCHAROMYCES-CEREVISIAE; DNA OLIGONUCLEOTIDES; SYNTHETIC OLIGONUCLEOTIDES; ESCHERICHIA-COLI; REPLICATION FORK; GENE DISRUPTION; IN-VIVO; POLYMERASES	We have studied single-strand oligonucleotide (oligo) transformation of yeast by using 40-nt long oligos that create multiple base changes to the yeast genome spread throughout the length of the oligos, making it possible to measure the portions of an oligo that are incorporated during transformation. Although the transformation process is greatly inhibited by DNA mismatch repair (MMR), the pattern of incorporation is essentially the same in the presence or absence of MMR, whether the oligo anneals to the leading or lagging strand of DNA replication, or whether phosphorothioate linkages are used at either end. A central core of approximately 15 nt is incorporated with a frequency of >90%; the ends are incorporated with a lower frequency, and loss of the two ends appears to be by different mechanisms. Bases that are 5-10 nt from the 5' end are generally lost with a frequency of >95%, likely through a process involving flap excision. On the 3' end, bases 5-10 nt from the 3' end are lost about 1/3 of the time. These results indicate that oligos can be used to create multiple simultaneous changes to the yeast genome, even in the presence of MMR.	[Rodriguez, Gina P.; Song, Joseph B.; Crouse, Gray F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Crouse, Gray F.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Rodriguez, GP (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	gcrouse@biology.emory.edu			National Institutes of Health [R01 GM80754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R01 GM80754 to GFC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2011, GENE THER, V18, P213, DOI 10.1038/gt.2010.161; Aarts M, 2010, NUCLEIC ACIDS RES, V38, P6956, DOI 10.1093/nar/gkq589; Agarwal S, 2003, BIOMOL ENG, V20, P7, DOI 10.1016/S1389-0344(02)00088-6; Balakrishnan L, 2011, J BIOL CHEM, V286, P6865, DOI 10.1074/jbc.R110.209502; Bonner M, 2009, MUTAT RES-FUND MOL M, V669, P85, DOI 10.1016/j.mrfmmm.2009.05.004; Brachman EE, 2003, GENETICS, V163, P527; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Dekker M, 2006, GENE THER, V13, P686, DOI 10.1038/sj.gt.3302689; Dekker M, 2011, MUTAT RES-FUND MOL M, V715, P52, DOI 10.1016/j.mrfmmm.2011.07.008; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guga P, 2011, CHEM BIODIVERS, V8, P1642, DOI 10.1002/cbdv.201100130; Hegele H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-14; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kow YW, 2007, P NATL ACAD SCI USA, V104, P11352, DOI 10.1073/pnas.0704695104; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li XT, 2003, NUCLEIC ACIDS RES, V31, P6674, DOI 10.1093/nar/gkg844; Maguire KK, 2007, GENE, V386, P107, DOI 10.1016/j.gene.2006.08.014; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; MOERSCHELL RP, 1988, P NATL ACAD SCI USA, V85, P524, DOI 10.1073/pnas.85.2.524; Olsen PA, 2009, DNA REPAIR, V8, P298, DOI 10.1016/j.dnarep.2008.11.011; Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Rios X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036697; Rodriguez GP, 2012, P NATL ACAD SCI USA, V109, P6153, DOI 10.1073/pnas.1115361109; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SKERRA A, 1992, NUCLEIC ACIDS RES, V20, P3551, DOI 10.1093/nar/20.14.3551; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Wang TCV, 2005, BIOESSAYS, V27, P633, DOI 10.1002/bies.20233; Williams TM, 2005, GENETICS, V170, P1423, DOI 10.1534/genetics.105.042697; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YAMAMOTO T, 1992, GENETICS, V131, P811; YAMAMOTO T, 1992, YEAST, V8, P935, DOI 10.1002/yea.320081104; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	39	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42905	10.1371/journal.pone.0042905	http://dx.doi.org/10.1371/journal.pone.0042905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916177	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800029
J	Chan, VBS; Li, CY; Lane, AC; Wang, YC; Lu, XW; Shih, KM; Zhang, T; Thiyagarajan, V				Chan, Vera Bin San; Li, Chaoyi; Lane, Ackley Charles; Wang, Yanchun; Lu, Xingwen; Shih, Kaimin; Zhang, Tong; Thiyagarajan, Vengatesen			CO2-Driven Ocean Acidification Alters and Weakens Integrity of the Calcareous Tubes Produced by the Serpulid Tubeworm, Hydroides elegans	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; LARVAL DEVELOPMENT; SHELL DISSOLUTION; COASTAL ZONE; CALCIFICATION; SALINITY; SEAWATER; MECHANISMS; OYSTERS; DIOXIDE	As a consequence of anthropogenic CO2-driven ocean acidification (OA), coastal waters are becoming increasingly challenging for calcifiers due to reductions in saturation states of calcium carbonate (CaCO3) minerals. The response of calcification rate is one of the most frequently investigated symptoms of OA. However, OA may also result in poor quality calcareous products through impaired calcification processes despite there being no observed change in calcification rate. The mineralogy and ultrastructure of the calcareous products under OA conditions may be altered, resulting in changes to the mechanical properties of calcified structures. Here, the warm water biofouling tubeworm, Hydroides elegans, was reared from larva to early juvenile stage at the aragonite saturation state (Omega(A)) for the current pCO(2) level (ambient) and those predicted for the years 2050, 2100 and 2300. Composition, ultrastructure and mechanical strength of the calcareous tubes produced by those early juvenile tubeworms were examined using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and nanoindentation. Juvenile tubes were composed primarily of the highly soluble CaCO3 mineral form, aragonite. Tubes produced in seawater with aragonite saturation states near or below one had significantly higher proportions of the crystalline precursor, amorphous calcium carbonate (ACC) and the calcite/aragonite ratio dramatically increased. These alterations in tube mineralogy resulted in a holistic deterioration of the tube hardness and elasticity. Thus, in conditions where Omega(A) is near or below one, the aragonite-producing juvenile tubeworms may no longer be able to maintain the integrity of their calcification products, and may result in reduced survivorship due to the weakened tube protection.	[Chan, Vera Bin San; Li, Chaoyi; Lane, Ackley Charles; Thiyagarajan, Vengatesen] Univ Hong Kong, Swire Inst Marine Sci, Pokfulam, Hong Kong, Peoples R China; [Chan, Vera Bin San; Li, Chaoyi; Lane, Ackley Charles; Thiyagarajan, Vengatesen] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Wang, Yanchun; Lu, Xingwen; Shih, Kaimin; Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, VBS (corresponding author), Univ Hong Kong, Swire Inst Marine Sci, Pokfulam, Hong Kong, Peoples R China.	rajan@hku.hk	Zhang, Tong/HGC-1090-2022; Shih, Kaimin/N-8512-2017; 張彤, Tong Zhang/C-6786-2008	Shih, Kaimin/0000-0002-6461-3207; Zhang, Tong/0000-0003-1148-4322; Thiyagarajan, Vengatesen/0000-0002-2062-4799; Chan, Bin San/0000-0003-3935-2700	Research Grants Council, Hong Kong [778309M]	Research Grants Council, Hong Kong(Hong Kong Research Grants Council)	This study was supported by a research grant from the Research Grants Council, Hong Kong (no. 778309M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Albright R, 2011, POPULATION, V12, P15; Allemand D, 2011, COROL CALCIFICATION; Allison N, 2011, CHEM GEOL, V289, P171, DOI 10.1016/j.chemgeo.2011.08.001; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Auzoux-Bordenave S, 2010, J STRUCT BIOL, V171, P277, DOI 10.1016/j.jsb.2010.05.012; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Bentov S, 2010, J STRUCT BIOL, V171, P207, DOI 10.1016/j.jsb.2010.04.007; Bish DL, 1989, REV MINERAL, V73, P20; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; BRADSHAW AL, 1988, MAR CHEM, V23, P69, DOI 10.1016/0304-4203(88)90023-0; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; Cleroux C, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001505; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Dai MH, 2008, CONT SHELF RES, V28, P1416, DOI 10.1016/j.csr.2007.04.018; Dekens PS, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001931; Dickinson GH, 2012, J EXP BIOL, V215, P29, DOI 10.1242/jeb.061481; DODD J. ROBERT, 1967, J PALEONTOL, V41, P1313; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Duenas-Bohorquez A, 2009, MAR MICROPALEONTOL, V73, P178, DOI 10.1016/j.marmicro.2009.09.002; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Feely RA, 2009, GEOPHYS MONOGR SER, V183, P175, DOI 10.1029/2005GM000337; Feng QL, 2000, MAT SCI ENG C-BIO S, V11, P19, DOI 10.1016/S0928-4931(00)00138-7; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Green MA, 2004, LIMNOL OCEANOGR, V49, P727, DOI 10.4319/lo.2004.49.3.0727; Hadfield MG, 2001, AM ZOOL, V41, P1123, DOI 10.1668/0003-1569(2001)041[1123:MCAMAC]2.0.CO;2; HE MY, 1991, J AM CERAM SOC, V74, P767, DOI 10.1111/j.1151-2916.1991.tb06922.x; Heinemann A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003790; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Jacob DE, 2008, GEOCHIM COSMOCHIM AC, V72, P5401, DOI 10.1016/j.gca.2008.08.019; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lane A, MAR BIOL IN PRESS; Larson AC., 1994, J APPL CRYSTALLOGR, V34, P210, DOI DOI 10.1107/S0021889801002242; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; MacDonald J, 2010, MAR BIOL, V157, P2087, DOI 10.1007/s00227-010-1476-7; Marshall DJ, 2008, MAR ENVIRON RES, V66, P422, DOI 10.1016/j.marenvres.2008.07.003; McClintock JB, 2011, J GEOL, V119, P457, DOI 10.1086/660890; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; Medakovic D, 1997, MAR BIOL, V129, P615, DOI 10.1007/s002270050204; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Merkel C, 2009, J STRUCT BIOL, V168, P396, DOI 10.1016/j.jsb.2009.08.014; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Nedved BT, 2009, SPRINGER SER BIOFILM, V4, P203, DOI 10.1007/7142_2008_15; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Parmigiani JP, 2006, J MECH PHYS SOLIDS, V54, P266, DOI 10.1016/j.jmps.2005.09.002; Pechenik JA, 2007, BIOL BULL-US, V212, P151, DOI 10.2307/25066592; Perez-Huerta A, 2008, MINERAL MAG, V72, P563, DOI 10.1180/minmag.2008.072.2.563; Pierrot D., 2006, ORNLCDIAC105A US DEP, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Qiu JW, 1997, MAR ECOL PROG SER, V152, P79, DOI 10.3354/meps152079; Raz S, 2003, ADV FUNCT MATER, V13, P480, DOI 10.1002/adfm.200304285; Riebesell U., 2011, GUIDE BEST PRACTICES, DOI DOI 10.2777/58454; Ries JB, 2004, GEOLOGY, V32, P981, DOI 10.1130/G20851.1; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; SIKES CS, 1986, BIOL BULL, V170, P494, DOI 10.2307/1541857; Simkiss K, 1989, BIOMINERALIZATION CE; Snyder R, 1989, REV MINERAL, V101, P20; STENZEL HB, 1964, SCIENCE, V145, P155, DOI 10.1126/science.145.3628.155; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Sumitomo T, 2011, J STRUCT BIOL, V174, P31, DOI 10.1016/j.jsb.2011.01.001; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Tanur AE, 2010, J STRUCT BIOL, V169, P145, DOI 10.1016/j.jsb.2009.09.008; Taylor PD, 2010, J STRUCT BIOL, V171, P402, DOI 10.1016/j.jsb.2010.05.010; Twitchett R.J., 2009, BIOGEOSCIENCES DISCU, V6, P2267, DOI [DOI 10.5194/BGD-6-2267-2009, 10.5194/bgd-6-2267-2009]; Vinn O, 2008, PALAEONTOLOGY, V51, P295, DOI 10.1111/j.1475-4983.2008.00763.x; Vinn O, 2011, CARNETS GEOL, P137, DOI 10.4267/2042/43896; Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Welladsen HM, 2010, MOLLUSCAN RES, V30, P125; WHEELER AP, 1984, AM ZOOL, V24, P933; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Yang W, 2011, J MATER SCI TECHNOL, V27, P139, DOI 10.1016/S1005-0302(11)60039-X; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124; Zhu ZH, 2006, MICRON, V37, P35, DOI 10.1016/j.micron.2005.07.001	94	53	56	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42718	10.1371/journal.pone.0042718	http://dx.doi.org/10.1371/journal.pone.0042718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912726	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100024
J	Chen, N; Hong, FL; Wang, HH; Yuan, QH; Ma, WY; Gao, XN; Shi, R; Zhang, RJ; Sun, CS; Wang, SB				Chen, Nan; Hong, Fu-Lin; Wang, Hai-Hong; Yuan, Qi-Hang; Ma, Wan-Yan; Gao, Xu-Na; Shi, Rui; Zhang, Rui-Juan; Sun, Chang-Sheng; Wang, Sheng-Bin			Modified Recombinant Proteins Can Be Exported via the Sec Pathway in Escherichia coli	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; ACYL CARRIER PROTEIN; BACTERIAL CYTOPLASMIC MEMBRANE; POSTTRANSLATIONAL MODIFICATION; DOMAIN; EXPRESSION; BIOTINYLATION; TRANSLOCATION; BIOSYNTHESIS; PURIFICATION	The correct folding of a protein is a pre-requirement for its proper posttranslational modification. The Escherichia coli Sec pathway, in which preproteins, in an unfolded, translocation-competent state, are rapidly secreted across the cytoplasmic membrane, is commonly assumed to be unfavorable for their modification in the cytosol. Whether posttranslationally modified recombinant preproteins can be efficiently transported via the Sec pathway, however, remains unclear. ACP and BCCP domain (BCCP87) are carrier proteins that can be converted into active phosphopantetheinylated ACP (holo-ACP) and biotinylated-BCCP (holo-BCCP) by AcpS and BirA, respectively. In the present study, we show that, when ACP or BCCP87 is fused to the C-terminus of secretory protein YebF or MBP, the resulting fusion protein preYebF-ACP, preYebF-BCCP87, preMBP-ACP or preMBP-BCCP87 can be modified and then secreted. Our data demonstrate that posttranslational modification of preYebF-ACP, preYebF-BCCP87 preMBP-ACP and preMBP-BCCP87 can take place in the cytosol prior to translocation, and the Sec machinery accommodates these previously modified fusion proteins. High levels of active holo-ACP and holo-BCCP87 are achieved when AcpS or BirA is co-expressed, especially when sodium azide is used to retard their translocation across the inner membrane. Our results also provide an alternative to achieve a high level of modified recombinant proteins expressed extracellularly.	[Chen, Nan; Hong, Fu-Lin; Wang, Hai-Hong; Yuan, Qi-Hang; Ma, Wan-Yan; Gao, Xu-Na; Shi, Rui; Zhang, Rui-Juan; Sun, Chang-Sheng; Wang, Sheng-Bin] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Chen, N (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	swwl@scau.edu.cn			Chinese National Nature Science Foundation [30470994, 30671424]	Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese National Nature Science Foundation (30470994 and 30671424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgese N, 2009, EMBO REP, V10, P337, DOI 10.1038/embor.2009.48; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; ChapmanSmith A, 1997, J BIOL CHEM, V272, P26017, DOI 10.1074/jbc.272.41.26017; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; Cronan JE, 2001, J BIOL CHEM, V276, P37355, DOI 10.1074/jbc.M106353200; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Filenko NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016299; Fisher AC, 2008, MICROB BIOTECHNOL, V1, P403, DOI 10.1111/j.1751-7915.2008.00041.x; Flugel RS, 2000, J BIOL CHEM, V275, P959, DOI 10.1074/jbc.275.2.959; Garcia-Estrada C, 2008, BIOCHEM J, V415, P317, DOI 10.1042/BJ20080369; Gravel RA, 2005, J NUTR BIOCHEM, V16, P428, DOI 10.1016/j.jnutbio.2005.03.020; Hansen EH, 2009, APPL ENVIRON MICROB, V75, P2765, DOI 10.1128/AEM.02681-08; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ingaranno M, 2011, J BIOL CHEM, V286, P13071, DOI 10.1074/jbc.M110.183624; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Kay Brian K., 2009, V498, P185, DOI 10.1007/978-1-59745-196-3_13; Keating DH, 1996, J BACTERIOL, V178, P2662, DOI 10.1128/jb.178.9.2662-2667.1996; Keating DH, 1996, J BIOL CHEM, V271, P15905, DOI 10.1074/jbc.271.27.15905; Kotzsch A, 2011, PROTEIN SCI, V20, P597, DOI 10.1002/pro.593; Li SY, 2006, J BIOTECHNOL, V122, P412, DOI 10.1016/j.jbiotec.2005.09.011; Maeda Y, 2010, APPL ENVIRON MICROB, V76, P5785, DOI 10.1128/AEM.00916-10; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Ni Y, 2009, BIOTECHNOL LETT, V31, P1661, DOI 10.1007/s10529-009-0077-3; Nomen N, 2007, J MOL BIOL, V372, P422, DOI 10.1016/j.jmb.2007.07.003; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Qian ZG, 2008, BIOTECHNOL BIOENG, V101, P587, DOI 10.1002/bit.21898; REED KE, 1991, J BIOL CHEM, V266, P11425; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Saitoh Hisato, 2009, V497, P211, DOI 10.1007/978-1-59745-566-4_14; SAMOLS D, 1988, J BIOL CHEM, V263, P6461; Shields JA, 2010, CHEMBIOCHEM, V11, P248, DOI 10.1002/cbic.200900565; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Sugase K, 2008, PROTEIN EXPRES PURIF, V57, P108, DOI 10.1016/j.pep.2007.10.018; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Terai T, 2011, CHEM BIOL, V18, P1261, DOI 10.1016/j.chembiol.2011.09.007; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Yoon Sung Ho, 2010, Recent Pat Biotechnol, V4, P23, DOI 10.2174/187220810790069550; Zhang GJ, 2006, NAT BIOTECHNOL, V24, P100, DOI 10.1038/nbt1174	43	5	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42519	10.1371/journal.pone.0042519	http://dx.doi.org/10.1371/journal.pone.0042519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912705	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100014
J	Chen, YH; Li, SH; Chiu, YC; Lu, HI; Huang, CH; Rau, KM; Liu, CT				Chen, Yen-Hao; Li, Shau-Hsuan; Chiu, Yi-Chun; Lu, Hung-I; Huang, Cheng-Hua; Rau, Kun-Ming; Liu, Chien-Ting			Comparative Study of Esophageal Stent and Feeding Gastrostomy/Jejunostomy for Tracheoesophageal Fistula Caused by Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							EXPANDING METAL STENTS; MALIGNANT ESOPHAGORESPIRATORY FISTULA; 20-YEAR PERIOD; MANAGEMENT; CANCER; PROSTHESES; THERAPY; AIRWAY	Background: A malignant tracheoesophageal/bronchoesophageal fistula (TEF) is a life-threatening complication of esophageal squamous cell carcinoma. A feeding gastrostomy/jejunostomy had been the most common treatment method for patients with TEF before the era of stenting. The aim of this retrospective study is to compare the prognosis of esophageal squamous cell carcinoma patients with TEF treated with an esophageal metallic stent to those treated with a feeding gastrostomy/jejunostomy. Methods: We retrospectively reviewed a total of 1011 patients with esophageal squamous cell carcinoma between 1996 and 2011 at Kaohsiung Chang Gung Memorial Hospital, and 86 patients with TEF (8.5%) were identified. The overall survival and other clinical data were compared between 30 patients treated with an esophageal metallic stent and 35 patients treated with a feeding gastrostomy/jejunostomy. Results: Among the 65 patients receiving either an esophageal metallic stent or a feeding gastrostomy/jejunostomy, univariate analysis showed that treatment modality with an esophageal metallic stent (P = 0.007) and radiotherapy treatment after fistula diagnosis (P = 0.04) were predictive of superior overall survival. In the multivariate comparison, treatment modality with an esophageal metallic stent (P = 0.026, odds ratio: 1.859) represented the independent predictive factor of superior overall survival. There were no significant differences between groups in mean decrease in serum albumin or mean body weight loss. Compared to the feeding gastrostomy/jejunostomy group, a significantly higher proportion of patients in the stenting group (53% versus 14%, P = 0.001) were able to receive chemotherapy within 30 days after fistula diagnosis, indicating better infection control in the stenting group. Conclusions: Compared with a feeding gastrostomy/jejunostomy, an esophageal metallic stent significantly improves overall survival in patients with malignant TEF in our retrospective analysis. Esophageal metallic stent placement may be considered the first-line of treatment for patients with malignant TEF.	[Chen, Yen-Hao; Li, Shau-Hsuan; Huang, Cheng-Hua; Rau, Kun-Ming; Liu, Chien-Ting] Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan; [Chen, Yen-Hao; Li, Shau-Hsuan; Chiu, Yi-Chun; Lu, Hung-I; Huang, Cheng-Hua; Rau, Kun-Ming; Liu, Chien-Ting] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chiu, Yi-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Hepatogastroenterol, Kaohsiung, Taiwan; [Lu, Hung-I] Kaohsiung Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan.	lee.a0928@msa.hinet.net			National Science Council, Taiwan [NSC 100-2314-B-182A-044-MY3]; Chang Gung Memorial Hospital [CMRPG8B0431]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by grants from the National Science Council, Taiwan (NSC 100-2314-B-182A-044-MY3) and Chang Gung Memorial Hospital (CMRPG8B0431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Balazs A, 2008, EUR J CARDIO-THORAC, V34, P1103, DOI 10.1016/j.ejcts.2008.06.025; Balazs A, 2009, WORLD J SURG, V33, P994, DOI 10.1007/s00268-009-9988-3; BURT M, 1991, ANN THORAC SURG, V52, P1222, DOI 10.1016/0003-4975(91)90005-B; Choi MK, 2010, MED ONCOL, V27, P1234, DOI 10.1007/s12032-009-9364-z; Freitag L, 1996, CHEST, V110, P1155, DOI 10.1378/chest.110.5.1155; GUDOVSKY LM, 1993, ANN THORAC SURG, V55, P868, DOI 10.1016/0003-4975(93)90108-T; Hu Y, 2009, DIS ESOPHAGUS, V22, P526, DOI 10.1111/j.1442-2050.2009.00950.x; Lazaraki G, 2011, SURG ENDOSC, V25, P628, DOI 10.1007/s00464-010-1236-2; LOLLEY DM, 1978, ANN THORAC SURG, V25, P516, DOI 10.1016/S0003-4975(10)63600-4; Low DE, 2003, SURG ENDOSC, V17, P990, DOI 10.1007/s00464-002-8528-0; Low DE, 1998, ANN THORAC SURG, V65, P919, DOI 10.1016/S0003-4975(98)00081-2; Margolis M, 2003, ANN THORAC SURG, V76, P1694, DOI 10.1016/S0003-4975(02)04890-7; MARTINI N, 1970, J THORAC CARDIOV SUR, V59, P319, DOI 10.1016/S0022-5223(19)42464-1; May A, 1996, J CLIN GASTROENTEROL, V22, P261, DOI 10.1097/00004836-199606000-00004; Morgan RA, 1997, RADIOLOGY, V204, P527, DOI 10.1148/radiology.204.2.9240548; Nomori H, 2000, ANN THORAC SURG, V70, P1803, DOI 10.1016/S0003-4975(00)02042-7; Paganin F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003101; Shin JH, 2004, RADIOLOGY, V232, P252, DOI 10.1148/radiol.2321030733; Siddiqui AA, 2009, DIS ESOPHAGUS, V22, P216, DOI 10.1111/j.1442-2050.2008.00905.x; Siersema PD, 1998, GASTROINTEST ENDOSC, V47, P113, DOI 10.1016/S0016-5107(98)70342-6; Siewert JR, 2007, SEMIN RADIAT ONCOL, V17, P38, DOI 10.1016/j.semradonc.2006.09.007; Spivak H, 1996, J SURG ONCOL, V63, P65, DOI 10.1002/(SICI)1096-9098(199609)63:1<65::AID-JSO13>3.0.CO;2-O; Talreja JP, 2011, SURG ENDOSC     1216; Tomaselli F, 2001, EUR J CARDIO-THORAC, V20, P734, DOI 10.1016/S1010-7940(01)00867-3; WEIGERT N, 1995, GASTROINTEST ENDOSC, V41, P490, DOI 10.1016/S0016-5107(05)80009-4	25	38	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42766	10.1371/journal.pone.0042766	http://dx.doi.org/10.1371/journal.pone.0042766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912737	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500100030
J	Esapa, CT; Head, RA; Jeyabalan, J; Evans, H; Hough, TA; Cheeseman, MT; McNally, EG; Carr, AJ; Thomas, GP; Brown, MA; Croucher, PI; Brown, SDM; Cox, RD; Thakker, RV				Esapa, Christopher T.; Head, Rosie A.; Jeyabalan, Jeshmi; Evans, Holly; Hough, Tertius A.; Cheeseman, Michael T.; McNally, Eugene G.; Carr, Andrew J.; Thomas, Gethin P.; Brown, Matthew A.; Croucher, Peter I.; Brown, Steve D. M.; Cox, Roger D.; Thakker, Rajesh V.			A Mouse with an N-Ethyl-N-Nitrosourea (ENU) Induced Trp589Arg Galnt3 Mutation Represents a Model for Hyperphosphataemic Familial Tumoural Calcinosis	PLOS ONE			English	Article							HOMOZYGOUS MISSENSE MUTATION; ALPHA-D-GALACTOSAMINE; INTACT FIBROBLAST-GROWTH-FACTOR-23; TARGETED INACTIVATION; GENE LEADS; PHOSPHATE; FGF23; HYPERCALCIURIA; GLYCOSYLATION; METABOLISM	Mutations of UDP-N-acetyl-alpha-D-galactosamine polypeptide N-acetyl galactosaminyl transferase 3 (GALNT3) result in familial tumoural calcinosis (FTC) and the hyperostosis-hyperphosphataemia syndrome (HHS), which are autosomal recessive disorders characterised by soft-tissue calcification and hyperphosphataemia. To facilitate in vivo studies of these heritable disorders of phosphate homeostasis, we embarked on establishing a mouse model by assessing progeny of mice treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU), and identified a mutant mouse, TCAL, with autosomal recessive inheritance of ectopic calcification, which involved multiple tissues, and hyperphosphataemia; the phenotype was designated TCAL and the locus, Tcal. TCAL males were infertile with loss of Sertoli cells and spermatozoa, and increased testicular apoptosis. Genetic mapping localized Tcal to chromosome 2 (62.64-71.11 Mb) which contained the Galnt3. DNA sequence analysis identified a Galnt3 missense mutation (Trp589Arg) in TCAL mice. Transient transfection of wild-type and mutant Galnt3-enhanced green fluorescent protein (EGFP) constructs in COS-7 cells revealed endoplasmic reticulum retention of the Trp589Arg mutant and Western blot analysis of kidney homogenates demonstrated defective glycosylation of Galnt3 in Tcal/Tcal mice. Tcal/Tcal mice had normal plasma calcium and parathyroid hormone concentrations; decreased alkaline phosphatase activity and intact Fgf23 concentrations; and elevation of circulating 1,25-dihydroxyvitamin D. Quantitative reverse transcriptase-PCR (qRT-PCR) revealed that Tcal/Tcal mice had increased expression of Galnt3 and Fgf23 in bone, but that renal expression of Klotho, 25-hydroxyvitamin D-1 alpha-hydroxylase (Cyp27b1), and the sodium-phosphate co-transporters type-IIa and -IIc was similar to that in wild-type mice. Thus, TCAL mice have the phenotypic features of FTC and HHS, and provide a model for these disorders of phosphate metabolism.	[Esapa, Christopher T.; Head, Rosie A.; Jeyabalan, Jeshmi; Thakker, Rajesh V.] Univ Oxford, Nuffield Dept Clin Med, Acad Endocrine Unit, Oxford Ctr Diabet Endocrinol & Metab,Churchill Ho, Oxford, England; [Evans, Holly; Croucher, Peter I.] Univ Sheffield, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [McNally, Eugene G.] Univ Oxford, Dept Radiol, Nuffield Orthopaed Ctr, Oxford OX1 2JD, England; [Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, NIHR Biomed Res Unit, Oxford OX1 2JD, England; [Thomas, Gethin P.; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4072, Australia; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Oxford; University of Sheffield; Nuffield Orthopaedic Centre; University of Oxford; University of Oxford; University of Queensland; Garvan Institute of Medical Research	Esapa, CT (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Acad Endocrine Unit, Oxford Ctr Diabet Endocrinol & Metab,Churchill Ho, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Thomas, Gethin P/A-3624-2011; Brown, Matthew A/E-5749-2010	Brown, Matthew A/0000-0003-0538-8211; Thomas, Gethin/0000-0001-9081-3686; Cox, Roger/0000-0001-7170-5014; Croucher, Peter/0000-0002-7102-2413; Thakker, Rajesh/0000-0002-1438-3220	Medical Research Council UK [G0600702/1, G9825289, G1000467]; European Union [FP7-200800]; Ernest Heine Family Foundation; Lions Senior Medical Research Fellowship; BBSRC [BBS/E/D/20251969] Funding Source: UKRI; MRC [MC_U142684172, MC_U142684175, MC_U142661184, MC_UP_1502/1, G9825289, G0600702, G1000467, MC_U142670371] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969] Funding Source: researchfish; Medical Research Council [G1000467, MC_U142684172, MC_UP_1502/1, G0600702, MC_U142684175, MC_U142670371, MC_U142661184, G9825289] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Ernest Heine Family Foundation; Lions Senior Medical Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council UK [grant numbers G0600702/1, G9825289 and G1000467]; and European Union Framework 7 [grant number FP7-200800, TREAT-OA]. PIC is supported by the Ernest Heine Family Foundation and Mrs Janice Gibson. GPT was supported by a Lions Senior Medical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Araya K, 2005, J CLIN ENDOCR METAB, V90, P5523, DOI 10.1210/jc.2005-0301; Barbieri AM, 2007, J HUM GENET, V52, P464, DOI 10.1007/s10038-007-0126-5; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Campagnoli MF, 2006, J CLIN PATHOL, V59, P440, DOI 10.1136/jcp.2005.026369; Carmichael KD, 2009, J BONE JOINT SURG AM, V91A, P664, DOI 10.2106/JBJS.G.01512; Chefetz I, 2005, HUM GENET, V118, P261, DOI 10.1007/s00439-005-0026-8; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P847, DOI 10.1016/j.bbadis.2008.10.008; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P61, DOI 10.1016/j.bbadis.2008.09.016; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Dumitrescu CE, 2009, OSTEOPOROSIS INT, V20, P1273, DOI 10.1007/s00198-008-0775-z; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Esapa CT, 2007, HUM MOL GENET, V16, P327, DOI 10.1093/hmg/ddl472; Esapa CT, 2012, J BONE MINER RES, V27, P413, DOI 10.1002/jbmr.547; Frishberg Y, 2005, J MOL MED, V83, P33, DOI 10.1007/s00109-004-0610-8; Frishberg Y, 2007, J BONE MINER RES, V22, P235, DOI 10.1359/JBMR.061105; Fukumoto S, 2008, INTERNAL MED, V47, P337, DOI 10.2169/internalmedicine.47.0730; Garringer HJ, 2007, AM J MED GENET A, V143A, P2390, DOI 10.1002/ajmg.a.31947; Garringer HJ, 2006, J CLIN ENDOCR METAB, V91, P4037, DOI 10.1210/jc.2006-0305; Gok F, 2009, ACTA ORTHOP, V80, P131, DOI 10.1080/17453670902807482; Hannan FM, 2008, EUR J ENDOCRINOL, V158, P265, DOI 10.1530/EJE-07-0485; Hannan FM, 2008, NAT CLIN PRACT ENDOC, V4, P53, DOI 10.1038/ncpendmet0718; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Ichikawa S, 2005, J CLIN ENDOCR METAB, V90, P2420, DOI 10.1210/jc.2004-2302; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Ichikawa S, 2007, J CLIN ENDOCR METAB, V92, P1943, DOI 10.1210/jc.2006-1825; Ichikawa S, 2006, J CLIN ENDOCR METAB, V91, P4472, DOI 10.1210/jc.2006-1247; Ichikawa S, 2011, ENDOCRINOLOGY, V152, P4504, DOI 10.1210/en.2011-1137; Ichikawa S, 2010, AM J MED GENET A, V152A, P896, DOI 10.1002/ajmg.a.33337; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Joseph L, 2010, SKELETAL RADIOL, V39, P63, DOI 10.1007/s00256-009-0808-5; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Laleye A, 2008, GENET COUNSEL, V19, P183; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Olauson H, 2008, EUR J ENDOCRINOL, V158, P929, DOI 10.1530/EJE-08-0011; Olsen KM, 2006, RADIOGRAPHICS, V26, P871, DOI 10.1148/rg.263055099; Pakasa NM, 1997, HISTOPATHOLOGY, V31, P18, DOI 10.1046/j.1365-2559.1997.6050831.x; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Shaw N, 2008, TUMORAL CALCINOSIS D; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Specktor P, 2006, J HUM GENET, V51, P487, DOI 10.1007/s10038-006-0377-6; Stechman MJ, 2010, LAB ANIM-UK, V44, P218, DOI 10.1258/la.2010.009128; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang PF, 2008, MOL CELL BIOL, V28, P2930, DOI 10.1128/MCB.00654-07; Williams SE, 2009, HUM MOL GENET; Yancovitch A, 2011, J BONE MINER METAB	60	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43205	10.1371/journal.pone.0043205	http://dx.doi.org/10.1371/journal.pone.0043205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912827	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000307500100071
J	Ghandi, M; Beer, MA				Ghandi, Mahmoud; Beer, Michael A.			Group Normalization for Genomic Data	PLOS ONE			English	Article							CHIP-CHIP EXPERIMENTS; SACCHAROMYCES-CEREVISIAE; EXPRESSION; MODEL; MICROARRAYS; SEQ	Data normalization is a crucial preliminary step in analyzing genomic datasets. The goal of normalization is to remove global variation to make readings across different experiments comparable. In addition, most genomic loci have non-uniform sensitivity to any given assay because of variation in local sequence properties. In microarray experiments, this non-uniform sensitivity is due to different DNA hybridization and cross-hybridization efficiencies, known as the probe effect. In this paper we introduce a new scheme, called Group Normalization (GN), to remove both global and local biases in one integrated step, whereby we determine the normalized probe signal by finding a set of reference probes with similar responses. Compared to conventional normalization methods such as Quantile normalization and physically motivated probe effect models, our proposed method is general in the sense that it does not require the assumption that the underlying signal distribution be identical for the treatment and control, and is flexible enough to correct for nonlinear and higher order probe effects. The Group Normalization algorithm is computationally efficient and easy to implement. We also describe a variant of the Group Normalization algorithm, called Cross Normalization, which efficiently amplifies biologically relevant differences between any two genomic datasets.	[Ghandi, Mahmoud] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Ghandi, M (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	mbeer@jhu.edu	Beer, Michael/AFV-4282-2022	Beer, Michael A/0000-0001-9955-3809; Ghandi, Mahmoud/0000-0003-1897-2265	Searle Scholars program	Searle Scholars program	This work was supported by the Searle Scholars program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Boes T, 2005, METHOD INFORM MED, V44, P414; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Droit A, 2010, BIOINFORMATICS, V26, P678, DOI 10.1093/bioinformatics/btq023; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; He QY, 2008, EUKARYOT CELL, V7, P1649, DOI 10.1128/EC.00233-08; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Judy JT, 2009, BIOINFORMATICS, V25, P2369, DOI 10.1093/bioinformatics/btp425; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sun W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-173; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Zawadzki KA, 2009, MOL BIOL CELL, V20, P3503, DOI 10.1091/mbc.E09-02-0111; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836	21	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e38695	10.1371/journal.pone.0038695	http://dx.doi.org/10.1371/journal.pone.0038695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912661	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100001
J	Morenos, L; Saffery, R; Mechinaud, F; Ashley, D; Elwood, N; Craig, JM; Wong, NC				Morenos, Leah; Saffery, Richard; Mechinaud, Francoise; Ashley, David; Elwood, Ngaire; Craig, Jeffrey M.; Wong, Nicholas C.			Evaluation of MicroRNA Expression in Patient Bone Marrow Aspirate Slides	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL-LINE; MESSENGER-RNA; RT-PCR; PATHOLOGY ARCHIVES; QUANTITATIVE PCR; ESTABLISHMENT; DNA; EXTRACTION; CANCER	Like formalin fixed paraffin embedded (FFPE) tissues, archived bone marrow aspirate slides are an abundant and untapped resource of biospecimens that could enable retrospective molecular studies of disease. Historically, RNA obtained from slides is limited in utility because of their low quality and highly fragmented nature. MicroRNAs are small (approximate to 22 nt) non-coding RNA that regulate gene expression, and are speculated to preserve well in FFPE tissue. Here we investigate the use of archived bone marrow aspirate slides for miRNA expression analysis in paediatric leukaemia. After determining the optimal method of miRNA extraction, we used TaqMan qRT-PCR to identify reference miRNA for normalisation of other miRNA species. We found hsa-miR-16 and hsa-miR-26b to be the most stably expressed between lymphoblastoid cell lines, primary bone marrow aspirates and archived samples. We found the average fold change in expression of hsa-miR-26b and two miRNA reportedly dysregulated in leukaemia (hsa-miR-128a, hsa-miR-223) was <0.5 between matching archived slide and bone marrow aspirates. Differential expression of hsa-miR-128a and hsa-miR-223 was observed between leukaemic and non-leukaemic bone marrow from archived slides or flash frozen bone marrow. The demonstration that archived bone marrow aspirate slides can be utilized for miRNA expression studies offers tremendous potential for future investigations into the role miRNA play in the development and long term outcome of hematologic, as well as non-hematologic, diseases.	[Morenos, Leah; Elwood, Ngaire] Murdoch Childrens Res Inst, BMDI Cord Blood Bank, Melbourne, Vic, Australia; [Morenos, Leah; Saffery, Richard; Craig, Jeffrey M.; Wong, Nicholas C.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Mechinaud, Francoise] Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia; [Ashley, David] Deakin Univ, Andrew Love Canc Ctr, Geelong, Vic 3217, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; Deakin University	Morenos, L (corresponding author), Murdoch Childrens Res Inst, BMDI Cord Blood Bank, Melbourne, Vic, Australia.	leah.morenos@gmail.com	Craig, Jeffrey M/B-3484-2012; Morenos, Leah/H-2733-2017; Saffery, Richard/GLS-1976-2022; Wong, Nick Wong/AAF-8627-2021	Craig, Jeffrey M/0000-0003-3979-7849; Saffery, Richard/0000-0002-9510-4181; Wong, Nick Wong/0000-0003-4393-7541; Elwood, Ngaire/0000-0002-4740-2416	Victorian Cancer Agency Grant; National Health & Medical Research Council, Australia [607306]; Victorian Government's Operational Infrastructure Support Program; National Health & Medical Research Council Dora Lush Postgraduate Scholarship; Leukaemia Foundation of Australia Phillip Desbrow Postdoctoral Fellowship	Victorian Cancer Agency Grant; National Health & Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; National Health & Medical Research Council Dora Lush Postgraduate Scholarship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Foundation of Australia Phillip Desbrow Postdoctoral Fellowship	This work was supported by the Victorian Cancer Agency Grant; the National Health & Medical Research Council, Australia [Project Grant number 607306]; the Victorian Government's Operational Infrastructure Support Program; the National Health & Medical Research Council Dora Lush Postgraduate Scholarship to LM; and the Leukaemia Foundation of Australia Phillip Desbrow Postdoctoral Fellowship and Project Grant in Aid to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ASOU H, 1991, BLOOD, V77, P2031; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Borze I, 2011, LEUKEMIA RES, V35, P188, DOI 10.1016/j.leukres.2010.08.005; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Egyhazi S, 2004, CLIN CHEM, V50, P975, DOI 10.1373/clinchem.2003.027102; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Fulci V, 2009, GENE CHROMOSOME CANC, V48, P1069, DOI 10.1002/gcc.20709; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Glenn ST, 2010, J BIOMOL SCREEN, V15, P80, DOI 10.1177/1087057109355059; Goswami RS, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-47; GRUNEWALD K, 1991, ANN HEMATOL, V62, P108, DOI 10.1007/BF01702923; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hoefig KP, 2008, ANTICANCER RES, V28, P119; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; KAPLAN J, 1974, CANCER RES, V34, P521; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; LANGE B, 1987, BLOOD, V70, P192; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Pabst T, 1996, BRIT J HAEMATOL, V95, P135, DOI 10.1046/j.1365-2141.1996.7622385.x; PATTILLO RA, 1968, CANCER RES, V28, P1231; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schoch R, 1996, BRIT J HAEMATOL, V92, P140, DOI 10.1046/j.1365-2141.1996.302841.x; Seelenfreund E, 2011, BIOPRESERV BIOBANK, V9, P29, DOI 10.1089/bio.2010.0026; Siebolts U, 2009, J CLIN PATHOL, V62, P84, DOI 10.1136/jcp.2008.058339; Szafranska AE, 2008, J MOL DIAGN, V10, P415, DOI 10.2353/jmoldx.2008.080018; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Tsai LM, 2010, CLIN EXP PHARMACOL P, V37, P102, DOI 10.1111/j.1440-1681.2009.05269.x; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wong L., 2007, ENDOGENOUS CONTROLS; Wong NC, 2008, BIOTECHNIQUES, V45, P423, DOI 10.2144/000112945; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; YOKOTA M, 1995, J CLIN LAB ANAL, V9, P387, DOI 10.1002/jcla.1860090609; Zanssen S, 2004, J CLIN LAB ANAL, V18, P176, DOI 10.1002/jcla.20019; Zhao GW, 2010, CURR OPIN HEMATOL, V17, P155, DOI 10.1097/MOH.0b013e328337ba6c	59	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42951	10.1371/journal.pone.0042951	http://dx.doi.org/10.1371/journal.pone.0042951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912766	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100045
J	Vinkers, CH; van Oorschot, R; Nielsen, EO; Cook, JM; Hansen, HH; Groenink, L; Olivier, B; Mirza, NR				Vinkers, Christiaan H.; van Oorschot, Ruud; Nielsen, Elsebet O.; Cook, James M.; Hansen, Henrik H.; Groenink, Lucianne; Olivier, Berend; Mirza, Naheed R.			GABA(A) Receptor alpha Subunits Differentially Contribute to Diazepam Tolerance after Chronic Treatment	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; STRESS-INDUCED HYPERTHERMIA; MESSENGER-RNA LEVELS; ELEVATED PLUS-MAZE; IN-SITU; SELECTIVE AGONIST; EXPRESSION; MOUSE; ANXIETY; BENZODIAZEPINES	Background: Within the GABA(A)-receptor field, two important questions are what molecular mechanisms underlie benzodiazepine tolerance, and whether tolerance can be ascribed to certain GABA(A)-receptor subtypes. Methods: We investigated tolerance to acute anxiolytic, hypothermic and sedative effects of diazepam in mice exposed for 28-days to non-selective/selective GABA(A)-receptor positive allosteric modulators: diazepam (non-selective), bretazenil (partial non-selective), zolpidem (alpha(1) selective) and TPA023 (alpha(2/3) selective). In-vivo binding studies with [H-3]flumazenil confirmed compounds occupied CNS GABA(A) receptors. Results: Chronic diazepam treatment resulted in tolerance to diazepam's acute anxiolytic, hypothermic and sedative effects. In mice treated chronically with bretazenil, tolerance to diazepam's anxiolytic and hypothermic, but not sedative, effects was seen. Chronic zolpidem treatment resulted in tolerance to diazepam's hypothermic effect, but partial anxiolytic tolerance and no sedative tolerance. Chronic TPA023 treatment did not result in tolerance to diazepam's hypothermic, anxiolytic or sedative effects. Conclusions: Our data indicate that: (i) GABA(A)-alpha(2)/alpha(3) subtype selective drugs might not induce tolerance; (ii) in rodents quantitative and temporal variations in tolerance development occur dependent on the endpoint assessed, consistent with clinical experience with benzodiazepines (e. g., differential tolerance to antiepileptic and anxiolytic actions); (iii) tolerance to diazepam's sedative actions needs concomitant activation of GABA(A)-alpha(1)/GABA(A)-alpha(5) receptors. Regarding mechanism, in-situ hybridization studies indicated no gross changes in expression levels of GABA(A) alpha(1), alpha(2) or alpha(5) subunit mRNA in hippocampus or cortex. Since selective chronic activation of either GABA(A) alpha(2), or alpha(3) receptors does not engender tolerance development, subtype-selective GABA(A) drugs might constitute a promising class of novel drugs.	[Vinkers, Christiaan H.; van Oorschot, Ruud; Groenink, Lucianne; Olivier, Berend] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Vinkers, Christiaan H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Nielsen, Elsebet O.; Hansen, Henrik H.; Mirza, Naheed R.] NeuroSearch AS, NsDiscovery, Ballerup, Denmark; [Cook, James M.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA; [Hansen, Henrik H.] Gubra ApS, Horsholm, Denmark; [Olivier, Berend] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Mirza, Naheed R.] Aniona ApS, Ballerup, Denmark	Utrecht University; Utrecht University; Utrecht University Medical Center; University of Wisconsin System; University of Wisconsin Milwaukee; Yale University	Vinkers, CH (corresponding author), Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	c.h.vinkers@uu.nl	Groenink, Lucianne/O-6588-2016; Vinkers, Christiaan/AAV-1720-2020	Groenink, Lucianne/0000-0002-4971-7796; Vinkers, Christiaan/0000-0003-3698-0744	National Institute for Mental Health [MH-046851]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076517] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by MH-046851 (National Institute for Mental Health) (JMC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NJ, 2001, J NEUROCHEM, V79, P1100, DOI 10.1046/j.1471-4159.2001.00664.x; Allison C, 2006, NEUROPSYCHOPHARMACOL, V31, P602, DOI 10.1038/sj.npp.1300800; Arnot MI, 2001, J NEUROSCI RES, V64, P617, DOI 10.1002/jnr.1115.abs; Atack JR, 2009, ADV PHARMACOL, V57, P137, DOI 10.1016/S1054-3589(08)57004-9; Atack JR, 2006, J PHARMACOL EXP THER, V316, P410, DOI 10.1124/jpet.105.089920; Atack JR, 1999, NEUROPSYCHOPHARMACOL, V20, P255, DOI 10.1016/S0893-133X(98)00052-9; Ator NA, 2010, J PHARMACOL EXP THER, V332, P4, DOI 10.1124/jpet.109.158303; Auta J, 2008, NEUROPHARMACOLOGY, V55, P148, DOI 10.1016/j.neuropharm.2008.05.002; Bateson AN, 2002, CURR PHARM DESIGN, V8, P5, DOI 10.2174/1381612023396681; Bosman LWJ, 2002, J PHYSIOL-LONDON, V545, P169, DOI 10.1113/jphysiol.2002.026534; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Bouwknecht JA, 2004, EUR J PHARMACOL, V494, P35, DOI 10.1016/j.ejphar.2004.04.036; Carling RW, 2005, J MED CHEM, V48, P7089, DOI 10.1021/jm058034a; de Hass SL, 2007, J PSYCHOPHARMACOL, V21, P374, DOI 10.1177/0269881106072343; Di Lio A, 2011, NEUROPHARMACOLOGY, V60, P626, DOI 10.1016/j.neuropharm.2010.11.026; Fahey JM, 2006, BRAIN RES, V1118, P13, DOI 10.1016/j.brainres.2006.08.017; Fahey JM, 1999, J PSYCHOPHARMACOL, V13, P211, DOI 10.1177/026988119901300301; Gill KM, 2011, NEUROPSYCHOPHARMACOL, V36, P1903, DOI 10.1038/npp.2011.76; Groenink L, 2009, CURRENT PROTOCOLS PH, VS45, P51611; HAEFELY W, 1990, TRENDS PHARMACOL SCI, V11, P452, DOI 10.1016/0165-6147(90)90126-S; Heldt SA, 2007, NEUROSCIENCE, V150, P370, DOI 10.1016/j.neuroscience.2007.09.008; HENINGER C, 1990, J MOL NEUROSCI, V2, P101, DOI 10.1007/BF02876917; Holmes A, 2003, EUR J PHARMACOL, V459, P221, DOI 10.1016/S0014-2999(02)02874-1; Holt RA, 1997, EUR J PHARMACOL, V329, P129, DOI 10.1016/S0014-2999(97)00168-4; Huopaniemi L, 2004, J NEUROCHEM, V88, P1059, DOI 10.1046/j.1471-4159.2003.02216.x; Hutchinson MA, 1996, PROG NEUROBIOL, V49, P73, DOI 10.1016/S0301-0082(96)00011-1; Impagnatiello F, 1996, MOL PHARMACOL, V49, P822; KANG I, 1991, BRIT J PHARMACOL, V103, P1285, DOI 10.1111/j.1476-5381.1991.tb09781.x; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; LARSEN PJ, 1993, J NEUROSCI, V13, P1138; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mirza NR, 2010, DRUG NEWS PERSPECT, V23, P351, DOI 10.1358/dnp.2010.23.6.1489909; Mirza NR, 2006, J PHARMACOL EXP THER, V316, P1378, DOI 10.1124/jpet.105.094474; Mirza NR, 2006, J PHARMACOL EXP THER, V316, P1291, DOI 10.1124/jpet.105.094003; Paxinos G, 2004, MOUSE BRAIN STEREOTA; PERSOHN E, 1992, J COMP NEUROL, V326, P193, DOI 10.1002/cne.903260204; Pesold C, 1997, NEUROSCIENCE, V79, P477, DOI 10.1016/S0306-4522(96)00609-4; Primus RJ, 1996, J PHARMACOL EXP THER, V276, P882; PUIA G, 1992, P NATL ACAD SCI USA, V89, P3620, DOI 10.1073/pnas.89.8.3620; RamseyWilliams VA, 1996, MOL BRAIN RES, V43, P132, DOI 10.1016/S0169-328X(96)00166-0; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; Rowlett JK, 2005, P NATL ACAD SCI USA, V102, P915, DOI 10.1073/pnas.0405621102; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sanger DJ, 1999, PHARMACOL BIOCHEM BE, V64, P269, DOI 10.1016/S0091-3057(99)00081-7; Savic MM, 2008, NEUROPSYCHOPHARMACOL, V33, P332, DOI 10.1038/sj.npp.1301403; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Tietz EI, 1999, NEUROSCIENCE, V91, P327, DOI 10.1016/S0306-4522(98)00516-8; TIETZ EI, 1993, J MOL NEUROSCI, V4, P277, DOI 10.1007/BF02821559; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; van Rijnsoever C, 2004, J NEUROSCI, V24, P6785, DOI 10.1523/JNEUROSCI.1067-04.2004; VanderHeyden JAM, 1997, PHYSIOL BEHAV, V62, P463, DOI 10.1016/S0031-9384(97)00157-1; Vinkers CH, 2010, OPEN PHARM J, V4, P1; Vinkers CH, 2008, EUR J PHARMACOL, V585, P407, DOI 10.1016/j.ejphar.2008.02.097; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; Vinkers CH, 2010, PSYCHOPHARMACOLOGY, V211, P123, DOI 10.1007/s00213-010-1895-7; Vinkers CH, 2009, PSYCHOPHARMACOLOGY, V204, P299, DOI 10.1007/s00213-009-1460-4; Wafford KA, 2005, CURR OPIN PHARMACOL, V5, P47, DOI 10.1016/j.coph.2004.08.006; WU YX, 1994, J MOL NEUROSCI, V5, P105, DOI 10.1007/BF02736752; ZHAO TJ, 1994, MOL PHARMACOL, V45, P657	63	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43054	10.1371/journal.pone.0043054	http://dx.doi.org/10.1371/journal.pone.0043054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912786	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100058
J	Wang, SH; Yuan, Y; Xia, WQ; Li, FF; Huang, Y; Zhou, Y; Guo, YJ				Wang, Shaohua; Yuan, Yang; Xia, Wenqing; Li, Fengfei; Huang, Yan; Zhou, Yi; Guo, Yijing			Neuronal Apoptosis and Synaptic Density in the Dentate Gyrus of Ischemic Rats' Response to Chronic Mild Stress and the Effects of Notch Signaling	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; GRANULE CELLS; EXPRESSION; PROTEOLYSIS; DEPRESSION; PLASTICITY; BRAIN; MODEL	Our previous research highlighted an inconsistency with Notch1 signaling-related compensatory neurogenesis after chronic mild stress (CMS) in rodents suffering from cerebral ischemia, which continue to display post-stroke depressive symptoms. Here, we hypothesize that CMS aggrandized ischemia-related apoptosis injury and worsened synaptic integrity via gamma secretase-meditated Notch1 signaling. Adult rats were exposed to a CMS paradigm after left middle cerebral artery occlusion (MCAO). Open-field and sucrose consumption testing were employed to assess depression-like behavior. Gene expression of pro-apoptotic Bax, anti-apoptotic Bcl-2, and synaptic density-related synaptophysin were measured by western blotting and real-time PCR on Day 28 after MCAO surgery. CMS induced depressive behaviors in ischemic rats, which was accompanied by an elevation in Bax/bcl-2 ratio, TUNEL staining in neurons and reduced synaptophysin expression in the dentate gyrus. These collective effects were reversed by the gamma-secretase inhibitor DAPT (N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenyl-glycine t-butyl ester). We found that post-stroke stressors made neurons in the dentate gyrus vulnerable to apoptosis, which supports a putative role for Notch signaling in neural integrity, potentially in newborn cells' synaptic deficit with regard to preexisting cells. These findings suggest that post-stroke depression therapeutically benefits from blocking gamma secretase mediated Notch signaling, and whether this signaling pathway could be a therapeutic target needs to be further investigated.	[Wang, Shaohua; Yuan, Yang; Xia, Wenqing; Li, Fengfei; Huang, Yan; Zhou, Yi] Southeast Univ, Affiliated ZhongDa Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Guo, Yijing] Southeast Univ, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Guo, YJ (corresponding author), Southeast Univ, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	janegyj@yahoo.com.cn			National Nature Science Foundation of China [30870870, 81070638, 81070916]; Nature Science Foundation of JiangSu Province [BK2011601]; Social Development Project of JiangSu Province [SBE201170735]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of JiangSu Province(Natural Science Foundation of Jiangsu Province); Social Development Project of JiangSu Province	This work was partially supported by the National Nature Science Foundation of China (No. 30870870, Wang SH), (No. 81070638, Wang SH) and (No. 81070916, Guo YJ). We would like to express our heartfelt gratitude to the staff of the Department of Neurology, Medical School of Southeast University, for their valuable assistance.; This work was partially supported by the foundations shown as follows: the National Nature Science Foundation of China (No. 30870870, SH Wang), (No. 81070638, SH Wang) and (No. 81070916, YJ Guo), Nature Science Foundation of JiangSu Province (No. BK2011601, Y Yuan), Social Development Project of JiangSu Province (No. SBE201170735, SH Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Barinaga M, 1998, SCIENCE, V281, P1302, DOI 10.1126/science.281.5381.1302; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Costa RM, 2005, TRENDS NEUROSCI, V28, P429, DOI 10.1016/j.tins.2005.05.003; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Gainotti G, 2003, BRAIN, V126, P792, DOI 10.1093/brain/awg092; Gainotti G, 1999, BRIT J PSYCHIAT, V175, P163, DOI 10.1192/bjp.175.2.163; Guo YJ, 2009, PROG NEURO-PSYCHOPH, V33, P688, DOI 10.1016/j.pnpbp.2009.03.022; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; House A, 1996, J NEUROPSYCH CLIN N, V8, P453; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Liu JL, 1998, J NEUROSCI, V18, P7768; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacManus JP, 1997, J CEREBR BLOOD F MET, V17, P815, DOI 10.1038/aj.jcbfm.9590266; Markakis EA, 1999, J COMP NEUROL, V406, P449; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; SLOVITER RS, 1993, J COMP NEUROL, V330, P324, DOI 10.1002/cne.903300304; STANFIELD BB, 1988, EXP BRAIN RES, V72, P399; Stroemer RP, 1998, J CEREBR BLOOD F MET, V18, P833, DOI 10.1097/00004647-199808000-00003; Villa PG, 1998, J CELL SCI, V111, P713; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wang SH, 2009, J PSYCHOPHARMACOL, V23, P295, DOI 10.1177/0269881108089814; Wang SH, 2008, BEHAV BRAIN RES, V189, P9, DOI 10.1016/j.bbr.2007.11.028; WOOLLEY CS, 1991, BRAIN RES, V554, P312, DOI 10.1016/0006-8993(91)90207-C; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhu DY, 2003, J NEUROSCI, V23, P223	39	30	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42828	10.1371/journal.pone.0042828	http://dx.doi.org/10.1371/journal.pone.0042828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912748	gold, Green Published, Green Submitted			2022-12-27	WOS:000307378500029
J	Feine, I; Pinkas, I; Salomon, Y; Scherz, A				Feine, Ilan; Pinkas, Iddo; Salomon, Yoram; Scherz, Avigdor			Local Oxidative Stress Expansion through Endothelial Cells - A Key Role for Gap Junction Intercellular Communication	PLOS ONE			English	Article							REACTIVE OXYGEN; NITRIC-OXIDE; CONNEXIN43 EXPRESSION; PHOTODYNAMIC THERAPY; HYDROGEN-PEROXIDE; DEATH; PROPAGATION; APOPTOSIS; RESPONSES; PEROXYNITRITE	Background: Major circulation pathologies are initiated by oxidative insult expansion from a few injured endothelial cells to distal sites; this possibly involves mechanisms that are important to understanding circulation physiology and designing therapeutic management of myocardial pathologies. We tested the hypothesis that a localized oxidative insult of endothelial cells (ECs) propagates through gap junction inter-cellular communication (GJIC). Methodology/Principal Findings: Cultures comprising the bEnd.3 cell line, that have been established and recognized as suitable for examining communication among ECs, were used to study the propagation of a localized oxidative insult to remote cells. Spatially confined near infrared illumination of parental or genetically modified bEnd.3 cultures, pretreated with the photosensitizer WST11, generated O-2 center dot(-) and center dot OH radicals in the illuminated cells. Time-lapse fluorescence microscopy, utilizing various markers, and other methods, were used to monitor the response of non-illuminated bystander and remote cells. Functional GJIC among ECs was shown to be mandatory for oxidative insult propagation, comprising denovo generation of reactive oxygen and nitrogen species (ROS and RNS, respectively), activation and nuclear translocation of c-Jun N-terminal kinase, followed by massive apoptosis in all bystander cells adjacent to the primarily injured ECs. The oxidative insult propagated through GJIC for many hours, over hundreds of microns from the primary photogeneration site. This wave is shown to be limited by intracellular ROS scavenging, chemical GJIC inhibition or genetic manipulation of connexin 43 (a key component of GJIC). Conclusion/Significance: Localized oxidative insults propagate through GJIC between ECs, while stimulating de-novo generation of ROS and RNS in bystander cells, thereby driving the insult's expansion.	[Feine, Ilan; Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Feine, Ilan; Salomon, Yoram] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Pinkas, Iddo] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Feine, I (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	Avigdor.Scherz@weizmann.ac.il	Pinkas, Iddo/I-7970-2019	Pinkas, Iddo/0000-0001-7434-9844	The Susan Komen Foundation for the Cure [BCTR0707388]; Women's Health Research Center", Weizmann Institute of Science	The Susan Komen Foundation for the Cure; Women's Health Research Center", Weizmann Institute of Science	This research is funded by grant # BCTR0707388 from 'The Susan Komen Foundation for the Cure', a non-profit organization and the "Women's Health Research Center", Weizmann Institute of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Ashur I, 2009, J PHYS CHEM A, V113, P8027, DOI 10.1021/jp900580e; Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Bagher P, 2011, ACTA PHYSIOL, V202, P271, DOI 10.1111/j.1748-1716.2010.02244.x; Banaz-Yasar F, 2005, CELL COMMUN ADHES, V12, P249, DOI 10.1080/15419060500514101; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cai H, 2005, CIRC RES, V96, P818, DOI 10.1161/01.RES.0000163631.07205.fb; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chakraborty A, 2009, RADIAT RES, V172, P74, DOI 10.1667/RR1669.1; De Maio A, 2002, J CELL PHYSIOL, V191, P269, DOI 10.1002/jcp.10108; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Forman LJ, 1998, NEUROCHEM RES, V23, P141, DOI 10.1023/A:1022468522564; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Garcia-Dorado D, 2004, CARDIOVASC RES, V61, P386, DOI 10.1016/j.cardiores.2003.11.039; Garcia-Dorado D, 2000, NEWS PHYSIOL SCI, V15, P326; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gatti R, 1998, J HISTOCHEM CYTOCHEM, V46, P895, DOI 10.1177/002215549804600804; Goldberg GS, 1998, EXP CELL RES, V239, P82, DOI 10.1006/excr.1997.3872; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Gross S, 2003, NAT MED, V9, P1327, DOI 10.1038/nm940; Hammond S, 2011, EUR J PHARMACOL, V668, P225, DOI 10.1016/j.ejphar.2011.06.050; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kavdia M, 2006, ANTIOXID REDOX SIGN, V8, P1103, DOI 10.1089/ars.2006.8.1103; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Kwak BR, 2005, CELL COMMUN ADHES, V12, P261, DOI 10.1080/15419060500514119; Kwak BR, 2001, MOL BIOL CELL, V12, P831, DOI 10.1091/mbc.12.4.831; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lyon AR, 2010, J MOL CELL CARDIOL, V49, P565, DOI 10.1016/j.yjmcc.2010.07.002; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Mao XL, 2004, ONCOGENE, V23, P5632, DOI 10.1038/sj.onc.1207756; Matsumura T, 1997, J IMMUNOL, V158, P3408; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; McLaughlin R, 2001, IRISH J MED SCI, V170, P132, DOI 10.1007/BF03168827; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Mesnil M, 2000, CANCER RES, V60, P3989; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Morre DM, 2000, J EXP BIOL, V203, P1513; Mulders ACM, 2006, ARTERIOSCL THROM VAS, V26, P2043, DOI 10.1161/01.ATV.0000237569.95046.b9; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Parola M, 1998, J CLIN INVEST, V102, P1942, DOI 10.1172/JCI1413; Pepper MS, 1997, TUMOUR ANGIOGENESIS, P309; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Posen Y, 2005, J CELL SCI, V118, P1957, DOI 10.1242/jcs.02323; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rozental R, 2001, METH MOL B, V154, P447; Rubio N, 2009, PHOTOCH PHOTOBIO SCI, V8, P457, DOI 10.1039/b815343d; Ruiz-Gines JA, 2000, J CARDIOVASC PHARM, V35, P109, DOI 10.1097/00005344-200001000-00014; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shaul Yoav D, 2004, Methods Mol Biol, V250, P113; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Trosko JE, 2000, METHODS, V20, P245, DOI 10.1006/meth.1999.0941; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; Wong HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290pe60; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	75	33	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41633	10.1371/journal.pone.0041633	http://dx.doi.org/10.1371/journal.pone.0041633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911831	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700130
J	Chen, JM; Uplekar, S; Gordon, SV; Cole, ST				Chen, Jeffrey M.; Uplekar, Swapna; Gordon, Stephen V.; Cole, Stewart T.			A Point Mutation in cycA Partially Contributes to the D-cycloserine Resistance Trait of Mycobacterium bovis BCG Vaccine Strains	PLOS ONE			English	Article							D-ALANINE RACEMASE; TUBERCULOSIS; SMEGMATIS; MUTANTS; TRANSFORMATION; POLYMORPHISMS; EFFICACY; SEQUENCE; IMPACT; GROWTH	In mycobacteria, CycA a D-serine, L-and D-alanine, and glycine transporter also functions in the uptake of D-cycloserine, an important second-line anti-tubercular drug. A single nucleotide polymorphism identified in the cycA gene of BCG was hypothesized to contribute to the increased resistance of Mycobacterium bovis bacillus Calmette-Guerin (BCG) to D-cycloserine compared to wild-type Mycobacterium tuberculosis or Mycobacterium bovis. Working along these lines, a merodiploid strain of BCG expressing Mycobacterium tuberculosis CycA was generated and found to exhibit increased susceptibility to D-cycloserine albeit not to the same extent as wild-type Mycobacterium tuberculosis or Mycobacterium bovis. In addition, recombinant Mycobacterium smegmatis strains expressing either Mycobacterium tuberculosis or Mycobacterium bovis CycA but not BCG CycA were rendered more susceptible to D-cycloserine. These findings support the notion that CycA-mediated uptake in BCG is impaired as a result of a single nucleotide polymorphism; however, the partial contribution of this impairment to D-cycloserine resistance suggests the involvement of additional genetic lesions in this phenotype.	[Chen, Jeffrey M.; Uplekar, Swapna; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Med, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Med Sci, Dublin 2, Ireland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University College Dublin; University College Dublin; University College Dublin; University College Dublin; University College Dublin	Chen, JM (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland.	jeffrey.chen@epfl.ch		Chen, Jeffrey/0000-0001-8431-3802; Gordon, Stephen/0000-0002-4833-5542	Canadian Thoracic Society/Canadian Lung Association; Canadian Institutes of Health Research; SystemsX.ch	Canadian Thoracic Society/Canadian Lung Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); SystemsX.ch	JMC is a recipient of fellowships from the Canadian Thoracic Society/Canadian Lung Association and the Canadian Institutes of Health Research. This work was supported by SystemsX.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, TUBERCULOSIS EDINB, V88, P100; Bange F.-C., 1999, Tubercle and Lung Disease, V79, P171, DOI 10.1054/tuld.1998.0201; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Belanger AE, 2000, J BACTERIOL, V182, P6854, DOI 10.1128/JB.182.23.6854-6856.2000; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Bruning JB, 2011, ANTIMICROB AGENTS CH, V55, P291, DOI 10.1128/AAC.00558-10; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Caceres NE, 1997, J BACTERIOL, V179, P5046, DOI 10.1128/jb.179.16.5046-5055.1997; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chacon O, 2002, ANTIMICROB AGENTS CH, V46, P47, DOI 10.1128/AAC.46.2.47-54.2002; Chen JM, 2007, VACCINE, V25, P8114, DOI 10.1016/j.vaccine.2007.09.041; Chen JM, 2003, INFECT IMMUN, V71, P708, DOI 10.1128/IAI.71.2.708-716.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; DAVID HL, 1971, APPL MICROBIOL, V21, P888, DOI 10.1128/AEM.21.5.888-892.1971; DONNELLYWU MK, 1993, MOL MICROBIOL, V7, P407, DOI 10.1111/j.1365-2958.1993.tb01132.x; Durek C, 2000, EUR UROL, V37, P21, DOI 10.1159/000052378; Feher T, 2006, MUTAT RES-FUND MOL M, V595, P184, DOI 10.1016/j.mrfmmm.2005.11.004; Feng ZY, 2003, ANTIMICROB AGENTS CH, V47, P283, DOI 10.1128/AAC.47.1.283-291.2003; GOH KS, 1991, RES MICROBIOL, V142, P659, DOI 10.1016/0923-2508(91)90079-P; GRIFFITH ME, 1992, ANTIMICROB AGENTS CH, V36, P2398, DOI 10.1128/AAC.36.11.2398; Halouska S, 2007, J PROTEOME RES, V6, P4608, DOI 10.1021/pr0704332; Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Mostowy S, 2003, VACCINE, V21, P4270, DOI 10.1016/S0264-410X(03)00484-5; Pelayo MCG, 2009, INFECT IMMUN, V77, P2230, DOI 10.1128/IAI.01099-08; Peteroy M, 2000, ANTIMICROB AGENTS CH, V44, P1701, DOI 10.1128/AAC.44.6.1701-1704.2000; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Wards BJ, 1996, FEMS MICROBIOL LETT, V145, P101, DOI 10.1016/0378-1097(96)00394-1	36	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43467	10.1371/journal.pone.0043467	http://dx.doi.org/10.1371/journal.pone.0043467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912881	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700109
J	Huang, T; Jiang, M; Kong, XY; Cai, YD				Huang, Tao; Jiang, Min; Kong, Xiangyin; Cai, Yu-Dong			Dysfunctions Associated with Methylation, MicroRNA Expression and Gene Expression in Lung Cancer	PLOS ONE			English	Article							SOMATIC MUTATIONS; SYSTEMS BIOLOGY; NONSMALL; PROFILES; TARGETS; CELLS; ADENOCARCINOMA; EGFR; ACTIVATION; PREDICTION	Integrating high-throughput data obtained from different molecular levels is essential for understanding the mechanisms of complex diseases such as cancer. In this study, we integrated the methylation, microRNA and mRNA data from lung cancer tissues and normal lung tissues using functional gene sets. For each Gene Ontology (GO) term, three sets were defined: the methylation set, the microRNA set and the mRNA set. The discriminating ability of each gene set was represented by the Matthews correlation coefficient (MCC), as evaluated by leave-one-out cross-validation (LOOCV). Next, the MCCs in the methylation sets, the microRNA sets and the mRNA sets were ranked. By comparing the MCC ranks of methylation, microRNA and mRNA for each GO term, we classified the GO sets into six groups and identified the dysfunctional methylation, microRNA and mRNA gene sets in lung cancer. Our results provide a systematic view of the functional alterations during tumorigenesis that may help to elucidate the mechanisms of lung cancer and lead to improved treatments for patients.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Jiang, Min; Kong, Xiangyin] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Jiang, Min; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Jiang, Min; Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Huang, T (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101, 2011CB910200, 2010CB912702]; National Natural Science Foundation of China [90913009]; Research Program of the Chinese Academy of Sciences [KSCX2-EW-R-04]; Innovation Program of the Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Program of the Chinese Academy of Sciences; Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by grants from the National Basic Research Program of China (2011CB510102, 2011CB510101, 2011CB910200 and 2010CB912702), the National Natural Science Foundation of China (90913009), Research Program of the Chinese Academy of Sciences (KSCX2-EW-R-04) and the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babbar N, 2006, J BIOL CHEM, V281, P24182, DOI 10.1074/jbc.M601871200; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bastide K, 2009, LUNG CANCER, V63, P348, DOI 10.1016/j.lungcan.2008.06.007; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Cai Y., 2011, AMINO ACIDS; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chari R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-67; Chari R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-422; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Chou RH, 2011, BIOCHEM BIOPH RES CO, V409, P442, DOI 10.1016/j.bbrc.2011.05.022; Christensen BC, 2009, CANCER RES, V69, P6315, DOI 10.1158/0008-5472.CAN-09-1073; Dacic S, 2010, MODERN PATHOL, V23, P1577, DOI 10.1038/modpathol.2010.152; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; De Jong WK, 2009, ANTICANCER RES, V29, P363; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fruh M, 2011, LUNG CANCER, V72, P265, DOI 10.1016/j.lungcan.2011.02.020; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gregorc V, 2003, LUNG CANCER, V42, P275, DOI 10.1016/j.lungcan.2003.07.003; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Huang T, 2011, CROSSTISSUE COEXPRES; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034460; Huang T, 2012, BIOCHIMIE, V94, P1017, DOI 10.1016/j.biochi.2011.12.024; Huang T, 2012, PROTEIN CELL, V3, P38, DOI 10.1007/s13238-011-1130-2; Huang T, 2011, NEUROCOMPUTING, V74, P3677, DOI 10.1016/j.neucom.2011.07.019; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, OMICS, V15, P665, DOI 10.1089/omi.2011.0034; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jiang Lili, 2009, Zhongguo Fei Ai Za Zhi, V12, P1069, DOI 10.3779/j.issn.1009-3419.2009.10.03; Jiang Lili, 2009, Zhongguo Fei Ai Za Zhi, V12, P951, DOI 10.3779/j.issn.1009-3419.2009.09.002; Jo UH, 2008, BMC CANCER, V9, DOI 10.1186/1471-2407-8-359; Katsuda K, 2002, ONCOGENE, V21, P2108, DOI 10.1038/sj.onc.1205272; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021300; Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Peng J, 2010, ANN APPL STAT, V4, P53, DOI 10.1214/09-AOAS271; Ponomareva A A, 2011, Mol Biol (Mosk), V45, P203; Reinmuth N, 2008, LUNG CANCER, V62, P193, DOI 10.1016/j.lungcan.2008.03.011; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sanchez-Palencia A, 2010, INT J CANC; Sasaki H, 2009, J CANCER RES CLIN, V135, P313, DOI 10.1007/s00432-008-0464-5; Selamat SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021443; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Tan X, 2011, CLIN CANC RES; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Toyooka S, 2011, GEN THORAC CARDIOVAS, V59, P527, DOI 10.1007/s11748-010-0743-3; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zimmer S, 2009, J CANCER RES CLIN, V135, P723, DOI 10.1007/s00432-008-0509-9	76	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43441	10.1371/journal.pone.0043441	http://dx.doi.org/10.1371/journal.pone.0043441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912875	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700103
J	Kooshiar, H; Yahaya, N; Hamid, TA; Abu Samah, A; Jou, VS				Kooshiar, Hadi; Yahaya, Nurizan; Hamid, Tengku Aizan; Abu Samah, Asnarulkhadi; Jou, Vajiheh Sedaghat			Living Arrangement and Life Satisfaction in Older Malaysians: The Mediating Role of Social Support Function	PLOS ONE			English	Article							HONG-KONG; ADULTS; PEOPLE; HEALTH; AGE; CHINA; NETWORKS; FAMILY	Background: This cross-sectional and correlational survey examines the association between different types of living arrangements and life satisfaction in older Malaysians, while taking into account the mediating effects of social support function. Methodology and Findings: A total of 1880 of older adults were selected by multistage stratified sampling. Life satisfaction and social support were measured with the Philadelphia Geriatric Center Morale Scale and Medical Outcomes Study Social Support Survey. The result shows living with children as the commonest type of living arrangement for older adults in peninsular Malaysia. Compared to living alone, living only with a spouse especially and then co-residency with children were both associated with better life satisfaction (p < .01) and social support function (p < .01). The mediating effect of social support function enhanced the relation between living arrangements and life satisfaction. Conclusion: This study revealed that types of living arrangement directly, and indirectly through social support function, play an important role in predicting life satisfaction for older adults in Malaysia. This study makes remarkable contributions to the Convoy model in older Malaysians.	[Kooshiar, Hadi] Mashhad Univ Med Sci, Dept Med Surg, Sch Nursing & Midwifery, Mashhad, Iran; [Yahaya, Nurizan] Univ Putra Malaysia, Dept Resource Management & Consumer Studies, Serdang, Malaysia; [Hamid, Tengku Aizan] Univ Putra Malaysia, Inst Gerontol, Serdang, Malaysia; [Abu Samah, Asnarulkhadi] Univ Putra Malaysia, Dept Social & Dev Sci, Serdang, Malaysia; [Jou, Vajiheh Sedaghat] Simon Fraser Univ, Dept Math Educ, Vancouver, BC, Canada	Mashhad University Medical Science; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Simon Fraser University	Kooshiar, H (corresponding author), Mashhad Univ Med Sci, Dept Med Surg, Sch Nursing & Midwifery, Mashhad, Iran.	h_kooshiar@yahoo.com	Sedaghatjou, Mina/ABD-5602-2020; Kooshiar, Hadi/A-7740-2017	Sedaghatjou, Mina/0000-0003-4043-3604; Kooshiar, Hadi/0000-0002-2316-0344	Ministry of Science, Technology, and Innovation, Malaysia [06-01-04-SF0479]	Ministry of Science, Technology, and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The study is funded by the eScienceFund (grant number 06-01-04-SF0479), Ministry of Science, Technology, and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2012, ASIAN POPUL STUD, V8, P87, DOI 10.1080/17441730.2012.646842; Antonucci T.C., 2009, HDB THEORIES AGING, V2nd ed., P247; Antonucci T.C., 2007, ENCY GERONTOLOGY, VSecond Edn, P531, DOI [10.1016/B0-12-370870-2/00175-X, DOI 10.1016/B0-12-370870-2/00175-X]; Antonucci T. C., 2001, HDB MIDLIFE DEV, P571; ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beard V. A., 2001, INT J POPULATION GEO, V7, P17, DOI [10.1002/ijpg.202, DOI 10.1002/IJPG.202]; Bongguk Jin, 2001, THESIS INDIANA U; Borg C, 2006, J CLIN NURS, V15, P607, DOI 10.1111/j.1365-2702.2006.01375.x; BOWLING A, 1991, J GERONTOL, V46, pS20, DOI 10.1093/geronj/46.1.S20; Bowung A, 1991, INT J GERIATR PSYCH, V6, P549; Brajkovic L, 2011, COLLEGIUM ANTROPOL, V35, P665; Chai ST, 2009, RELIABILITY VALIDITY; Chan A, 2005, J CROSS-CULT GERONTO, V20, P269, DOI 10.1007/s10823-006-9006-2; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Chen X, 2000, RES AGING, V22, P43, DOI 10.1177/0164027500221003; Chou KL, 2006, AGING MENT HEALTH, V10, P583, DOI 10.1080/13607860600641150; Cong Z, 2004, GERONTOLOGIST, V44, P377; Deva MP, 2004, INT REV PSYCHIATR, V16, P167, DOI 10.1080/09540260310001635203; Gerstorf D, 2008, DEV PSYCHOL, V44, P1148, DOI 10.1037/0012-1649.44.4.1148; Gow A.J., 2007, J INDIVID DIFFER, V28, P103, DOI [10.1027/1614-0001.28.3.103, DOI 10.1027/1614-0001.28.3.103]; Gray B, 2007, THESIS CALIFORNIA ST; Hsu HC, 2012, ARCH GERONTOL GERIAT, V55, P210, DOI 10.1016/j.archger.2011.08.011; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUGHES M, 1981, AM J SOCIOL, V87, P48, DOI 10.1086/227419; Hughes ME, 2002, J HEALTH SOC BEHAV, V43, P1, DOI 10.2307/3090242; Jose Jr Sanchez, 2006, THESIS C ALBIZU U FL; Kafetsios K, 2006, J HEALTH PSYCHOL, V11, P863, DOI 10.1177/1359105306069084; Kahn RL., 1980, LIFE SPAN DEV BEHAV, P253, DOI DOI 10.1038/NATURE12518; Kim I K, 2001, J Cross Cult Gerontol, V16, P237, DOI 10.1023/A:1011957222884; Kristen Peek Mary, 1996, THESIS DUKE U N CARO; Kudo H, 2007, GERIATR GERONTOL INT, V7, P15, DOI 10.1111/j.1447-0594.2007.00362.x; Lawton M. P., 2003, LAWTONS PGC MORALE S; LEVITT MJ, 1993, PSYCHOL AGING, V8, P323, DOI 10.1037/0882-7974.8.3.323; Loke SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016490; Lou VWQ, 2010, SOC INDIC RES, V95, P377, DOI 10.1007/s11205-009-9526-6; Lowenstein A, 2005, AGEING SOC, V25, P749, DOI 10.1017/S0144686X04002892; MANCINI JA, 1980, HUM RELAT, V33, P543, DOI 10.1177/001872678003300802; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Ng ACY, 2002, J AGING STUD, V16, P135, DOI 10.1016/S0890-4065(02)00040-3; Ng KM, 2004, AUSTRALAS J AGEING, V23, P167, DOI 10.1111/j.1741-6612.2004.00044.x; Onishi J., 2005, GERIATR GERONTOL INT, V5, P71; Park J, 2011, GERONTOLOGIST; Phillips DR, 2008, J CROSS-CULT GERONTO, V23, P39, DOI 10.1007/s10823-007-9056-0; Rausa B.A., 2008, ENCY AGING PUBLIC HL, P751; Russell D, 2007, THESIS FLORIDA STATE; SEEMAN TE, 1988, SOC SCI MED, V26, P737, DOI 10.1016/0277-9536(88)90065-2; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sherina M S, 2004, Asia Pac J Public Health, V16, P109, DOI 10.1177/101053950401600206; Shin SH, 2012, INT NURS REV, V59, P252, DOI 10.1111/j.1466-7657.2011.00946.x; Shyu YIL, 2006, NURS RES, V55, P411, DOI 10.1097/00006199-200611000-00005; Sugisawa H, 1993, Nihon Koshu Eisei Zasshi, V40, P171; UN, 2005, LIVING ARRANGEMENTS; Velkoff VA, 2001, UN POPULATION B; Waite LJ, 1999, J GERONTOL B-PSYCHOL, V54, pS136, DOI 10.1093/geronb/54B.3.S136; Yeh SCJ, 2004, SOC BEHAV PERSONAL, V32, P129, DOI 10.2224/sbp.2004.32.2.129; Zhang WG, 2007, J CROSS-CULT GERONTO, V22, P185, DOI 10.1007/s10823-007-9037-3	58	42	42	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43125	10.1371/journal.pone.0043125	http://dx.doi.org/10.1371/journal.pone.0043125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912806	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700046
J	Pope, MD; Asthagiri, AR				Pope, Melissa D.; Asthagiri, Anand R.			Short-Lived, Transitory Cell-Cell Interactions Foster Migration-Dependent Aggregation	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELL; EPIDERMAL-GROWTH-FACTOR; ADHESION; EXPRESSION; MOTILITY; CADHERIN; MORPHOGENESIS; ORGANIZATION; MORPHOLOGY; MECHANISM	During embryonic development, motile cells aggregate into cohesive groups, which give rise to tissues and organs. The role of cell migration in regulating aggregation is unclear. The current paradigm for aggregation is based on an equilibrium model of differential cell adhesivity to neighboring cells versus the underlying substratum. In many biological contexts, however, dynamics is critical. Here, we provide evidence that multicellular aggregation dynamics involves both local adhesive interactions and transport by cell migration. Using time-lapse video microscopy, we quantified the duration of cell-cell contacts among migrating cells that collided and adhered to another cell. This lifetime of cell-cell interactions exhibited a monotonic decreasing dependence on substratum adhesivity. Parallel quantitative measurements of cell migration speed revealed that across the tested range of adhesive substrata, the mean time needed for cells to migrate and encounter another cell was greater than the mean adhesion lifetime, suggesting that aggregation dynamics may depend on cell motility instead of the local differential adhesivity of cells. Consistent with this hypothesis, aggregate size exhibited a biphasic dependence on substratum adhesivity, matching the trend we observed for cell migration speed. Our findings suggest a new role for cell motility, alongside differential adhesion, in regulating developmental aggregation events and motivate new design principles for tuning aggregation dynamics in tissue engineering applications.	[Pope, Melissa D.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Asthagiri, Anand R.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA	University of Colorado System; University of Colorado Boulder; Northeastern University	Pope, MD (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	anand@cell-engineering.org			National Institutes of Health (NIH) [R01-CA138899]; Jacobs Institute for Molecular Engineering for Medicine; National Science Foundation; NIH [NIH/NRSA5T32GM07616Z]; NATIONAL CANCER INSTITUTE [R01CA138899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jacobs Institute for Molecular Engineering for Medicine; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grant R01-CA138899 and the Jacobs Institute for Molecular Engineering for Medicine. MP was supported by a National Science Foundation Graduate Research Fellowship and an NIH Molecular Cell Biology Training Grant (NIH/NRSA5T32GM07616Z). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758, DOI 10.1152/ajprenal.2000.278.5.F758; CLARK RAF, 1990, J INVEST DERMATOL, V94, pS128, DOI 10.1111/1523-1747.ep12876104; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; LI Y, 1994, IN VITRO CELL DEV-AN, V30A, P105; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Luther MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE502, DOI 10.1152/ajpendo.00424.2004; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; Mori H, 2009, P NATL ACAD SCI USA, V106, P14890, DOI 10.1073/pnas.0901269106; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pandis S. N., 2006, ATMOSPHERIC CHEM PHY; Pope MD, 2008, CELL ADHES MIGR, V2, P110, DOI 10.4161/cam.2.2.6218; Powers MJ, 1997, BIOTECHNOL BIOENG, V53, P415, DOI 10.1002/(SICI)1097-0290(19970220)53:4<415::AID-BIT10>3.3.CO;2-3; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Runyan RB, 2005, MOL B INT U, P40; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Stefanelli A., 1961, ACTA EMBRYOL MORPHOL, V4, P47; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Steinberg MS, 1997, J CELL PHYSIOL, V173, P135, DOI 10.1002/(SICI)1097-4652(199711)173:2<135::AID-JCP10>3.3.CO;2-Y; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1769, DOI 10.1073/pnas.48.10.1769; SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Umeda T, 2004, J THEOR BIOL, V226, P215, DOI 10.1016/j.jtbi.2003.08.016; Walmod PS, 2001, METH MOL B, V161, P59; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673	34	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43237	10.1371/journal.pone.0043237	http://dx.doi.org/10.1371/journal.pone.0043237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912835	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700065
J	Xia, L; Yin, SK; Wang, J				Xia, Li; Yin, Shankai; Wang, Jian			Inner Ear Gene Transfection in Neonatal Mice Using Adeno-Associated Viral Vector: A Comparison of Two Approaches	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; HEARING IMPAIRMENT; MOUSE MODELS; VIRUS; DELIVERY; COCHLEA; THERAPY; INFANTICIDE; CONNEXIN26; TRANSGENE	Local gene transfection is a promising technique for the prevention and/or correction of inner ear diseases, particularly those resulting from genetic defects. Adeno-associated virus (AAV) is an ideal viral vector for inner ear gene transfection because of its safety, stability, long-lasting expression, and its high tropism for many different cell types. Recently, a new generation of AAV vectors with a tyrosine mutation (mut-AAV) has demonstrated significant improvement in transfection efficiency. A method for inner ear gene transfection via the intact round window membrane (RWM) has been developed in our laboratory. This method has not been tested in neonatal mice, an important species for the study of inherited hearing loss. Following a preliminary study to optimize the experimental protocol in order to reduce mortality, the present study investigated inner ear gene transfection in mice at postnatal day 7. We compared transfection efficiency, the safety of the scala tympani injection via RWM puncture, and the trans-RWM diffusion following partial digestion with an enzyme technique. The results revealed that approximately 47% of inner hair cells (IHCs) and 17% of outer hair cells (OHCs) were transfected via the trans-RWM approach. Transfection efficiency via RWM puncture (58% and 19% for IHCs and OHCs, respectively) was slightly higher, but the difference was not significant.	[Xia, Li; Yin, Shankai; Wang, Jian] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Otolaryngol Inst, Dept Otolaryngol, Shanghai 200030, Peoples R China; [Wang, Jian] Dalhousie Univ, Sch Human Commun Disorder, Halifax, NS, Canada	Shanghai Jiao Tong University; Dalhousie University	Xia, L (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Otolaryngol Inst, Dept Otolaryngol, Shanghai 200030, Peoples R China.	yinshankai@china.com; Jian.Wang@dal.ca	wang, JP/AGG-5573-2022	Wang, Jian/0000-0003-3633-6799	Canadian Institute of Health Research [MOP79452]; State Key Development Program for Basic Research of China [2011CB504503]; China National Funds for Distinguished Young Scientists [30925035]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC))	Funding for this research was provided by the Canadian Institute of Health Research (MOP79452), the State Key Development Program for Basic Research of China (Grant No. 2011CB504503) and China National Funds for Distinguished Young Scientists (Grant No. 30925035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrup C, 2007, J NEUROL NEUROSUR PS, V78, P114, DOI 10.1136/jnnp.2006.092064; Ahmad S, 2007, P NATL ACAD SCI USA, V104, P1337, DOI 10.1073/pnas.0606855104; Anderson DR, 2002, TOXICOL MECH METHOD, V12, P59, DOI 10.1080/15376510209167936; Carnicero E, 2002, NEUROSCI LETT, V321, P149, DOI 10.1016/S0304-3940(01)02501-0; Chang EH, 2003, EAR HEARING, V24, P314, DOI 10.1097/01.AUD.0000079801.55588.13; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Cooper LB, 2006, OTOL NEUROTOL, V27, P484, DOI 10.1097/00129492-200606000-00009; Coutelle C, 2005, GENE THER, V12, P1601, DOI 10.1038/sj.gt.3302632; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Fritzsch B, 1997, J NEUROSCI, V17, P6213; GRATTON MA, 1990, HEARING RES, V50, P211, DOI 10.1016/0378-5955(90)90046-R; Iizuka T, 2008, HUM GENE THER, V19, P384, DOI 10.1089/hum.2007.167; Imamura S, 2003, JARO-J ASSOC RES OTO, V4, P176, DOI 10.1007/s10162-002-2036-8; Jero J, 2001, HUM GENE THER, V12, P539, DOI 10.1089/104303401300042465; Keenan J F, 1990, America (NY), V163, P262; Kilpatrick LA, 2011, GENE THER, V18, P569, DOI 10.1038/gt.2010.175; KIMURA RS, 1975, INT REV CYTOL, V42, P173, DOI 10.1016/S0074-7696(08)60981-X; Konishi M, 2008, J GENE MED, V10, P610, DOI 10.1002/jgm.1189; Lalwani AK, 1996, GENE THER, V3, P588; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Lv P, 2010, J BIOL CHEM, V285, P34699, DOI 10.1074/jbc.M110.136192; MANN MA, 1983, PHYSIOL BEHAV, V30, P697, DOI 10.1016/0031-9384(83)90165-8; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; NADOL JB, 1978, ANN OTO RHINOL LARYN, V87, P70, DOI 10.1177/000348947808700113; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Newton V E, 1985, J Laryngol Otol Suppl, V10, P1; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Pietola L, 2008, ACTA OTO-LARYNGOL, V128, P613, DOI 10.1080/00016480701663409; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Salt AN, 2003, HEARING RES, V182, P24, DOI 10.1016/S0378-5955(03)00137-0; SVARE B, 1984, PHYSIOL BEHAV, V33, P137, DOI 10.1016/0031-9384(84)90024-6; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Thorne M, 1999, LARYNGOSCOPE, V109, P1661, DOI 10.1097/00005537-199910000-00021; Wang H, 2011, GENE THER; Wenzel GI, 2007, OTOL NEUROTOL, V28, P1100, DOI 10.1097/MAO.0b013e318158973f; Zhong L, 2008, VIROLOGY, V381, P194, DOI 10.1016/j.virol.2008.08.027; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	39	29	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43218	10.1371/journal.pone.0043218	http://dx.doi.org/10.1371/journal.pone.0043218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912830	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700062
J	Li, X; Wang, W; Gao, Q; Wu, LJ; Luo, YX; Tang, Z; Guo, XH				Li, Xia; Wang, Wei; Gao, Qi; Wu, Lijuan; Luo, Yanxia; Tang, Zhe; Guo, Xiuhua			The Trajectories and Correlation between Physical Limitation and Depression in Elderly Residents of Beijing, 1992-2009	PLOS ONE			English	Article							FUNCTIONAL DISABILITY; LATE-LIFE; DEVELOPMENTAL TRAJECTORIES; MENTAL-DISORDERS; SAS PROCEDURE; OLDER-PEOPLE; HEALTH-CARE; SYMPTOMS; PREVALENCE; CHINESE	Background: Physical limitation and psychological distress have been reported to be related, but studies describing the change of instrumental activities of daily living (IADLs) and depression syndrome over time or exploring the link pattern for their development are limited. The study was to assess distinctive patterns for the development of physical limitation and depression and to explore their correlation to form a proper prevention strategy. Methods: Dual trajectory analysis was conducted using data from the Beijing Longitudinal Study of Aging (BLSA) 1992-2009 hosted by Xuanwu hospital for subjects with full information on depression and physical limitation for all available visits. Physical limitation was measured by the Instrumental Activities of Daily Living (IADL) scale and depression by the Center for Epidemiological Studies Depression scale (CES-D). The covariates were gender, age at baseline and number of chronic conditions. Results: Three heterogeneous trajectories for physical limitation and two distinct groups for an increase in depression were detected. Among them, 10.13% of subjects experienced an increase in physical limitation, while 13.22% demonstrated a high, stable level of depressive mood. In all, 80.4% of the subjects enjoyed a relatively low, stable level of IADL and CES-D scores. People in the late increase group for IADL score were more likely to have depressive mood when adjusted for gender, age and number of chronic conditions (OR = 3.900, 95%CI = 1.347-11.290). Conclusions: The development of physical limitation among the elderly may significantly increase the risk for depressive symptoms.	[Li, Xia; Wang, Wei; Gao, Qi; Wu, Lijuan; Luo, Yanxia; Guo, Xiuhua] Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Li, Xia; Wang, Wei; Gao, Qi; Wu, Lijuan; Luo, Yanxia; Guo, Xiuhua] Beijing Key Lab Clin Epidemiol, Beijing, Peoples R China; [Tang, Zhe] Capital Med Univ, Xuanwu Hosp, Dept Epidemiol & Social Med, Beijing, Peoples R China; [Tang, Zhe] Beijing Geriatr Clin & Res Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Li, X (corresponding author), Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth & Family Med, Beijing, Peoples R China.	tangzhe@medmail.com.cn; guoxiuh@ccmu.edu.cn	liu, li/HGC-0900-2022; Gao, Qi/N-8721-2019	wang, wei/0000-0002-1430-1360	Funding Project for Beijing Municipal Natural Science Foundation [7122016]; Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR201007112]; National S&T Major Special Project on Major New Drug Innovation [2010ZX09401]; Basic and Clinical Scientific Research Cooperation Foundation [11JL19]	Funding Project for Beijing Municipal Natural Science Foundation; Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality; National S&T Major Special Project on Major New Drug Innovation; Basic and Clinical Scientific Research Cooperation Foundation	The research was supported by the Funding Project for Beijing Municipal Natural Science Foundation (7122016); Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201007112); National S&T Major Special Project on Major New Drug Innovation (2010ZX09401) and the Basic and Clinical Scientific Research Cooperation Foundation (11JL19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT SM, 2004, PUBLIC HLTH AGING IN; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Braam AW, 2005, BRIT J PSYCHIAT, V187, P35, DOI 10.1192/bjp.187.1.35; Chemerinski E, 2001, STROKE, V32, P113, DOI 10.1161/01.STR.32.1.113; Chiu HC, 2005, INT J GERIATR PSYCH, V20, P635, DOI 10.1002/gps.1292; Chou KL, 2005, INT J GERIATR PSYCH, V20, P570, DOI 10.1002/gps.1328; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Gao SJ, 2009, INT J GERIATR PSYCH, V24, P1358, DOI 10.1002/gps.2271; Gayman MD, 2008, J GERONTOL B-PSYCHOL, V63, pS219, DOI 10.1093/geronb/63.4.S219; HAYS RD, 1995, ARCH GEN PSYCHIAT, V52, P11; Himes CL, 2000, DEMOGRAPHY, V37, P73, DOI 10.2307/2648097; Huang JF, 2011, J AFFECT DISORDERS, V133, P499, DOI 10.1016/j.jad.2011.04.048; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; Jiang Jingmei, 2002, Environ Health Prev Med, V7, P199, DOI 10.1007/BF02898005; Jiang JM, 2004, QUAL LIFE RES, V13, P1337, DOI 10.1023/B:QURE.0000037500.26166.0c; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Kessler RC, 2001, HEALTH SERV RES, V36, P987; Lenze EJ, 2005, J AM GERIATR SOC, V53, P569, DOI 10.1111/j.1532-5415.2005.53202.x; Liang J, 2001, J CLIN EPIDEMIOL, V54, P1126, DOI 10.1016/S0895-4356(01)00390-0; Mayo NE, 2009, STROKE, V40, P3299, DOI 10.1161/STROKEAHA.109.554410; Mayou RA, 2000, PSYCHOSOM MED, V62, P212, DOI 10.1097/00006842-200003000-00011; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Narrow WE, 2002, ARCH GEN PSYCHIAT, V59, P115, DOI 10.1001/archpsyc.59.2.115; Ormel J, 2002, J GERONTOL B-PSYCHOL, V57, pP338, DOI 10.1093/geronb/57.4.P338; Peters R, 2010, AGE AGEING, V39, P439, DOI 10.1093/ageing/afq042; Peytremann-Bridevaux I, 2008, J AFFECT DISORDERS, V105, P247, DOI 10.1016/j.jad.2007.04.011; Smalbrugge M, 2006, INT J GERIATR PSYCH, V21, P325, DOI 10.1002/gps.1466; Tang Z, 1999, ARCH GERONTOL GERIAT, V29, P115, DOI 10.1016/S0167-4943(99)00026-6; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WOO J, 1994, ACTA PSYCHIAT SCAND, V89, P8, DOI 10.1111/j.1600-0447.1994.tb01478.x; Wu X., 2009, POPUL RES, V33, P54; Yang Y, 2005, J AGING HEALTH, V17, P263, DOI 10.1177/0898264305276295; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; Zimmer Z, 2004, J AGING HEALTH, V16, P44, DOI 10.1177/0898264303260440; Zimmer Z, 2002, POP STUD-J DEMOG, V56, P265, DOI 10.1080/00324720215931	41	13	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42999	10.1371/journal.pone.0042999	http://dx.doi.org/10.1371/journal.pone.0042999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22916193	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600038
J	Lei, XY; Ou, T; Zhang, QY				Lei, Xiao-Ying; Ou, Tong; Zhang, Qi-Ya			Rana grylio Virus (RGV) 50L Is Associated with Viral Matrix and Exhibited Two Distribution Patterns	PLOS ONE			English	Article							MAJOR CAPSID PROTEIN; FISH CELL-LINE; FAMILY IRIDOVIRIDAE; SEQUENCE-ANALYSIS; GENE; EXPRESSION; DNA; MORPHOGENESIS; REPLICATION; TRANSPORT	Background: The complete genome of Rana grylio virus (RGV) was sequenced and analyzed recently, which revealed that RGV 50L had homologues in many iridoviruses with different identities; however, the characteristics and functions of 50L have not been studied yet. Methodology/Principal Findings: We cloned and characterized RGV50L, and revealed 50L functions in virus assembly and gene regulation. 50L encoded a 499-amino acid structural protein of about 85 kDa in molecular weight and contained a nuclear localization signal (NLS) and a helix-extension-helix motif. Drug inhibition assay demonstrated that 50L was an immediate-early (IE) gene. Immuno-fluorescence assay revealed that 50L appeared early and persisted in RGV-infected cells following two distribution patterns. One pattern was that 50L exhibited a cytoplasm-nucleus-viromatrix distribution pattern, and mutagenesis of the NLS motif revealed that localization of 50L in the nucleus was NLS-dependent; the other was that 50L co-localized with viral matrix which plays important roles in virus assembly and the life circle of viruses. Conclusion/Significance: RGV 50L is a novel iridovirus IE gene encoded structural protein which plays important roles in virus assembly.	[Lei, Xiao-Ying; Ou, Tong; Zhang, Qi-Ya] Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Lei, XY (corresponding author), Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	zhangqy@ihb.ac.cn			National Major Basic Research Program [2010CB126303, 2009CB118704]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-3]; National Key Technologies R & D Program of China [2012BAD25B00]; National Natural Science Foundation of China [31072239]; FEBL [Y15B121F01]	National Major Basic Research Program(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Key Technologies R & D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FEBL	This work was funded by National Major Basic Research Program (2010CB126303, 2009CB118704), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-3), National Key Technologies R & D Program of China (2012BAD25B00), National Natural Science Foundation of China (31072239), and the FEBL research grant (Y15B121F01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2003, J BIOL CHEM, V278, P29121, DOI 10.1074/jbc.M302314200; Andres G, 2002, J VIROL, V76, P2654, DOI 10.1128/JVI.76.6.2654-2666.2002; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Capul AA, 2007, J VIROL, V81, P9451, DOI 10.1128/JVI.00499-07; Castillo JP, 2002, GENE, V290, P19, DOI 10.1016/S0378-1119(02)00566-8; Chen ZY, 2008, VET IMMUNOL IMMUNOP, V123, P266, DOI 10.1016/j.vetimm.2008.02.011; Chen ZY, 2012, VET MICROBIOL, V157, P264, DOI 10.1016/j.vetmic.2011.12.025; Chinchar VG, 2009, CURR TOP MICROBIOL, V328, P123; Chinchar VG, 2011, VIRUSES-BASEL, V3, P1959, DOI 10.3390/v3101959; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DEVAUCHELLE G, 1985, CURR TOP MICROBIOL, V116, P1; Du CS, 2004, VIRUS RES, V101, P119, DOI 10.1016/j.virusres.2003.12.034; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; He LB, 2012, VIRUS RES, V163, P66, DOI 10.1016/j.virusres.2011.08.012; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huang XH, 2006, J VIROL METHODS, V133, P117, DOI 10.1016/j.jviromet.2005.10.029; Huang YH, 2007, APOPTOSIS, V12, P1569, DOI 10.1007/s10495-007-0089-1; Jancovich J.K., 2011, VIRUS TAXONOMY 9 REP, P193; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Ke F, 2009, MOL BIOL REP, V36, P1651, DOI 10.1007/s11033-008-9365-6; Kim YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010308; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lei XY, 2012, FISH PHYSIOL BIOCHEM, V38, P1175, DOI 10.1007/s10695-012-9603-7; Lei XY, 2012, ARCH VIROL IN PRESS; Liu YL, 2012, VIRUS RES; Lua DT, 2005, J VIROL, V79, P15151, DOI 10.1128/JVI.79.24.15151-15164.2005; Mao J, 1996, VIROLOGY, V216, P431, DOI 10.1006/viro.1996.0080; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; Moroianu J, 1999, J CELL BIOCHEM, P76; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Robinson AR, 2011, J VIROL, V85, P8940, DOI 10.1128/JVI.00569-11; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sample R, 2007, VIROLOGY, V358, P311, DOI 10.1016/j.virol.2006.07.009; Song WJ, 2006, MOL CELL PROTEOMICS, V5, P256, DOI 10.1074/mcp.M500149-MCP200; Su D, 2012, EPIGENETICS-US, V7, P146, DOI 10.4161/epi.7.2.18907; Sun W, 2006, BIOCHEM BIOPH RES CO, V351, P44, DOI 10.1016/j.bbrc.2006.09.169; Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Whitley DS, 2011, DEV COMP IMMUNOL, V35, P937, DOI 10.1016/j.dci.2010.12.002; Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3; Xia LQ, 2010, VIRUS RES, V147, P30, DOI 10.1016/j.virusres.2009.09.015; Xia LQ, 2009, ARCH VIROL, V154, P1409, DOI 10.1007/s00705-009-0457-y; Yan XD, 2009, J MOL BIOL, V385, P1287, DOI 10.1016/j.jmb.2008.11.002; Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91; Zhang QiYa, 1996, Acta Hydrobiologica Sinica, V20, P390; Zhang QY, 1999, AQUACULTURE, V175, P185, DOI 10.1016/S0044-8486(99)00041-1; Zhang QY, 2006, AQUACULTURE, V251, P1, DOI 10.1016/j.aquaculture.2005.05.012; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027; Zhao Z, 2008, J GEN VIROL, V89, P1866, DOI 10.1099/vir.0.2008/000810-0; Zhao Z, 2007, VIRUS RES, V123, P128, DOI 10.1016/j.virusres.2006.08.007; Zhao Z, 2009, VIRUS GENES, V38, P345, DOI 10.1007/s11262-008-0318-x	54	15	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43033	10.1371/journal.pone.0043033	http://dx.doi.org/10.1371/journal.pone.0043033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912781	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500100055
J	Sedykh, SE; Buneva, VN; Nevinsky, GA				Sedykh, Sergey E.; Buneva, Valentina N.; Nevinsky, Georgy A.			Human Milk IgGs Contain Various Combinations of Different Antigen-Binding Sites Resulting in Multiple Variants of their Bispecificity	PLOS ONE			English	Article							NUCLEOTIDE-HYDROLYZING ANTIBODIES; KINASE-ACTIVITY	In the classic paradigm, immunoglobulins represent products of clonal B cell populations, each producing antibodies (Abs) recognizing a single antigen. There is a common belief that IgGs in mammalian biological fluids are monovalent molecules having stable structures and two identical antigen-binding sites. However, human milk IgGs to different antigens undergo extensive half-molecule exchange. In the IgGs pool, only 33 +/- 5% and 13 +/- 5% of Abs contained light chains exclusively of kappa-or lambda-type, respectively, while 54 +/- 10% of the IgGs contained both kappa-and lambda-light chains. All Ab preparations contained different amounts of IgGs of all four subclasses. Interestingly, lambda-IgGs contained an increased amount of IgG2 (87%) and only 3-6% of each of IgG1, IgG3, and IgG4, while kappa-IgGs consisted of comparable (17-32%) amounts of all IgG subtypes. Chimeric kappa-lambda-IgGs consisted of similar to 74% IgG1, similar to 16% IgG2, similar to 5% IgG3 and similar to 5% IgG4. As the result of the exchange, all IgG fractions eluted from several specific affinity sorbents under the conditions destroying strong immunocomplexes demonstrated high catalytic activities in hydrolysis of ATP, DNA, oligosaccharides, phosphorylation of proteins, lipids, and oligosaccharides. In vitro, an addition of reduced glutathione and milk plasma to two IgG fractions with different affinity for DNA-cellulose led to a transition of 25-60% of Ab of one fraction to the other fraction. Our data are indicative of the possibility of half-molecule exchange between milk IgGs of various subclasses, raised against different antigens (including abzymes), which explains the polyspecificity and cross-reactivity of these IgGs.	[Sedykh, Sergey E.; Buneva, Valentina N.; Nevinsky, Georgy A.] Russian Acad Sci, Siberian Div, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Sedykh, SE (corresponding author), Russian Acad Sci, Siberian Div, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.	nevinsky@niboch.nsc.ru	Nevinsky, Georgy/E-6053-2012; Buneva, Valentina Nikolaevna/I-6329-2012; Sedykh, Sergey/C-9881-2013	Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Sedykh, Sergey/0000-0003-0882-8171; Menzorova, Natalia/0000-0002-2616-7023	Presidium of the Russian Academy of Sciences [6.7, 10-04-00281]; Siberian Division of the Russian Academy of Sciences	Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Siberian Division of the Russian Academy of Sciences(Russian Academy of Sciences)	This research was made possible in part by grants from the Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, No, 6.7, Russian Foundation for Basic Research (10-04-00281), and funds from the Siberian Division of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; AMINO N, 1982, NEW ENGL J MED, V306, P849, DOI 10.1056/NEJM198204083061405; Andryushkova AA, 2009, INT IMMUNOL, V21, P935, DOI 10.1093/intimm/dxp060; Buneva VN, 1998, APPL BIOCHEM BIOTECH, V75, P63, DOI 10.1007/BF02787709; Fersht AR., 1977, ENZYME STRUCTURE MEC; Gagnon P, 2011, J CHROMATOGR A, V1218, P2402, DOI 10.1016/j.chroma.2010.12.008; Gorbunov DV, 2005, BBA-MOL CELL BIOL L, V1735, P153, DOI 10.1016/j.bbalip.2005.06.007; IZADYAR L, 1993, P NATL ACAD SCI USA, V90, P8876, DOI 10.1073/pnas.90.19.8876; KALAGA R, 1995, J IMMUNOL, V155, P2695; Kanyshkova TG, 1997, FEBS LETT, V416, P23, DOI 10.1016/S0014-5793(97)01163-0; Karataeva NA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1207, DOI 10.1134/S000629790611006X; Karataeva NA, 2006, IMMUNOL LETT, V103, P58, DOI 10.1016/j.imlet.2005.10.009; Keinan E, 2021, ASIACHEM, V2, P96; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Nevinsky G.A., 2010, AUTOIMMUNE DIS SYMPT, P1; Nevinsky G.A., 2005, CATALYTIC ANTIBODIES, P503; Nevinsky G.A., 2003, PROTEIN STRUCTURES K, P133; Nevinsky GA, 1998, APPL BIOCHEM BIOTECH, V75, P77, DOI 10.1007/BF02787710; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Odintsova ES, 2011, J MOL RECOGNIT, V24, P45, DOI 10.1002/jmr.1022; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Rispens T, 2010, MOL IMMUNOL, V47, P1592, DOI 10.1016/j.molimm.2010.02.021; Savel'ev AN, 2001, CLIN CHIM ACTA, V314, P141, DOI 10.1016/S0009-8981(01)00691-X; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Semenov DV, 2004, MED SCI MONITOR, V10, pBR23; Tanaka A, 2000, LIVER TRANSPLANT, V6, P138, DOI 10.1002/lt.500060225; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015	28	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42942	10.1371/journal.pone.0042942	http://dx.doi.org/10.1371/journal.pone.0042942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912765	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100044
J	Viginier, B; Dolmazon, C; Lantier, I; Lantier, F; Archer, F; Leroux, C; Terzian, C				Viginier, Barbara; Dolmazon, Christine; Lantier, Isabelle; Lantier, Frederic; Archer, Fabienne; Leroux, Caroline; Terzian, Christophe			Copy Number Variation and Differential Expression of a Protective Endogenous Retrovirus in Sheep	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; JAAGSIEKTE SHEEP; IN-VITRO; LUNG-CANCER; JSRV; GAG; RESTRICTION; GENE	The Jaagsiekte sheep retrovirus exJSRV and its endogenous counterpart enJSRV co-exist in sheep. exJSRV, a betaretrovirus, is the etiological agent of ovine pulmonary adenocarcinoma, and it has been demonstrated in vitro that an enJSRV Gag variant bearing the R-to-W amino acid change at position 21 was able to block exJSRV budding from the cells, providing a potential protective role for the host. In this work, we developed a fast mutation detection assay based on the oligo ligation assay (OLA) that permits the quantification of the relative proportions of the R21 and W21 Gag variants present in individual genomes and in cDNA obtained from normal and exJSRV-induced lung tumors. We have shown that the W21/R21 ratio is variable within and between breeds. We also describe for the first time that putative protecting enJSRV variants were expressed in alveolar type II cells (AECII), the major target of exJSRV.	[Viginier, Barbara; Dolmazon, Christine; Archer, Fabienne; Leroux, Caroline; Terzian, Christophe] Univ Lyon 1, Retrovirus & Pathol Comparee INRA UMR754, F-69365 Lyon, France; [Viginier, Barbara; Terzian, Christophe] Ecole Prat Hautes Etud, Paris, France; [Lantier, Isabelle; Lantier, Frederic] INRA Ctr Tours, Nouzilly, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); INRAE	Viginier, B (corresponding author), Univ Lyon 1, Retrovirus & Pathol Comparee INRA UMR754, F-69365 Lyon, France.	christophe.terzian@univ-lyon1.fr	Archer, Fabienne/E-9371-2010	Archer, Fabienne/0000-0002-8175-866X; leroux, caroline/0000-0002-7923-3127; Lantier, Frederic/0000-0001-5896-330X	Institut National de la Recherche Agronomique; Ecole Pratique des Hautes Etudes; Agence National Recherche "Genomobile''; Fondation Innovation en Infectiologie	Institut National de la Recherche Agronomique; Ecole Pratique des Hautes Etudes; Agence National Recherche "Genomobile''(French National Research Agency (ANR)); Fondation Innovation en Infectiologie	This work was supported by Institut National de la Recherche Agronomique, Ecole Pratique des Hautes Etudes, Agence National Recherche "Genomobile'' and Fondation Innovation en Infectiologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer F, 2007, AM J RESP CELL MOL, V36, P534, DOI 10.1165/rcmb.2006-0285OC; Armezzani A, 2011, J VIROL, V85, P7118, DOI 10.1128/JVI.00407-11; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Black LR, 2010, J VIROL, V84, P6564, DOI 10.1128/JVI.00210-10; Carlson J, 2003, J VIROL, V77, P9662, DOI 10.1128/JVI.77.17.9662-9668.2003; Hallwirth C, 2005, VIRUS GENES, V30, P59, DOI 10.1007/s11262-004-4582-0; IKEDA H, 1989, J VIROL, V63, P5405, DOI 10.1128/JVI.63.12.5405-5412.1989; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Leroux C, 2007, VET RES, V38, P211, DOI 10.1051/vetres:2006060; Murcia PR, 2007, J VIROL, V81, P1762, DOI 10.1128/JVI.01859-06; Palmarini M, 2000, J VIROL, V74, P8065, DOI 10.1128/JVI.74.17.8065-8076.2000; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; PRYCIAK PM, 1992, J VIROL, V66, P5959, DOI 10.1128/JVI.66.10.5959-5966.1992; Wang Y, 2010, TRANSGENIC RES, V19, P775, DOI 10.1007/s11248-009-9355-z	15	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41965	10.1371/journal.pone.0041965	http://dx.doi.org/10.1371/journal.pone.0041965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911867	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300084
J	English, AK; Chauvenet, ALM; Safi, K; Pettorelli, N				English, Annie K.; Chauvenet, Alienor L. M.; Safi, Kamran; Pettorelli, Nathalie			Reassessing the Determinants of Breeding Synchrony in Ungulates	PLOS ONE			English	Article							ROE DEER FAWNS; CLIMATE-CHANGE; BIRTH SYNCHRONY; REPRODUCTIVE SYNCHRONY; ECOLOGICAL RESPONSES; PRIMARY PRODUCTIVITY; GESTATION LENGTH; RED DEER; PATTERNS; POPULATION	Predicting the consequences of climate change is a major challenge in ecology and wildlife management. While the impact of changes in climatic conditions on distribution ranges has been documented for many organisms, the consequences of changes in resource dynamics for species' overall performance have seldom been investigated. This study addresses this gap by identifying the factors shaping the reproductive synchrony of ungulates. In temporally-variable environments, reproductive phenology of individuals is a key determinant of fitness, with the timing of reproduction affecting their reproductive output and future performance. We used a satellite-based index of resource availability to explore how the level of seasonality and inter-annual variability in resource dynamics affect birth season length of ungulate populations. Contrary to what was previously thought, we found that both the degree of seasonal fluctuation in resource dynamics and inter-annual changes in resource availability influence the degree of birth synchrony within wild ungulate populations. Our results highlight how conclusions from previous interspecific analyses, which did not consider the existence of shared life-history among species, should be treated with caution. They also support the existence of a multi-faceted link between temporal variation in resource availability and breeding synchrony in terrestrial mammals, and increase our understanding of the mechanisms shaping reproductive synchrony in large herbivores, thus enhancing our ability to predict the potential impacts of climate change on biodiversity.	[English, Annie K.; Chauvenet, Alienor L. M.] Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; [English, Annie K.; Chauvenet, Alienor L. M.; Pettorelli, Nathalie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Safi, Kamran] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany	Imperial College London; Zoological Society of London; Max Planck Society	Pettorelli, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	Nathalie.Pettorelli@ioz.ac.uk	Chauvenet, Alienor/A-7952-2011; Chauvenet, Alienor/L-9135-2015; Pettorelli, Nathalie/AAW-8438-2021; Safi, Kamran/B-2079-2008	Chauvenet, Alienor/0000-0002-3743-7375; Chauvenet, Alienor/0000-0002-3743-7375; Safi, Kamran/0000-0002-8418-6759				Asher GW, 2011, ANIM REPROD SCI, V124, P170, DOI 10.1016/j.anireprosci.2010.08.026; Asher G W, 2007, Soc Reprod Fertil Suppl, V64, P255; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; BERGER J, 1992, ECOLOGY, V73, P323, DOI 10.2307/1938743; Berteaux D, 2006, CLIM RES, V32, P151, DOI 10.3354/cr032151; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birgersson B, 1997, BEHAV ECOL, V8, P493, DOI 10.1093/beheco/8.5.493; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Bivand R., 2020, SPDEP SPATIAL DEPEND; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; BOYCE MS, 1979, AM NAT, V114, P569, DOI 10.1086/283503; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burthe S, 2011, J ANIM ECOL, V1865, P1365; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Darling F.F., 1938, BIRD FLOCKS BREEDING; Di Bitetti MS, 2000, AM J PRIMATOL, V50, P109, DOI 10.1002/(SICI)1098-2345(200002)50:2<109::AID-AJP2>3.3.CO;2-N; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Ejsmond MJ, 2010, AM NAT, V175, P551, DOI 10.1086/651589; ESRI, 2009, ARCGIS VERS 9 3 1; ESTES R D, 1976, East African Wildlife Journal, V14, P135; FAIRBANKS WS, 1993, J MAMMAL, V74, P129, DOI 10.2307/1381911; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foden W., 2008, 2008 REV IUCN RED LI, P77, DOI DOI 10.1128/AEM.01630-08; Freckleton RP, 2000, FUNCT ECOL, V14, P129, DOI 10.1046/j.1365-2435.2000.00400.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garel M, 2009, AM NAT, V173, P89, DOI 10.1086/593359; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Garonna I, 2009, ENVIRON CONSERV, V36, P253, DOI 10.1017/S0376892909990208; Gordon IJ, 2003, FOREST ECOL MANAG, V181, P13, DOI 10.1016/S0378-1127(03)00124-5; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hodge SJ, 2011, BIOL LETTERS, V7, P54, DOI 10.1098/rsbl.2010.0555; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Huffman B, 2011, UNGULATES WORLD; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; IMS RA, 1990, AM NAT, V136, P485, DOI 10.1086/285109; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Jarnemo A, 2004, CAN J ZOOL, V82, P416, DOI 10.1139/z04-011; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kingdon J., 1997, KINGDOM FIELD GUIDE; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; MacDonald D, 2009, ENCY MAMMALS; Markon Carl J., 1995, Polar Record, V31, P179; Markon CJ, 2002, INT J REMOTE SENS, V23, P4571, DOI 10.1080/01431160110113926; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mysterud A, 2003, N ATLANTIC OSCILLATI, P235; Oftedal O.T., 1985, P215; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Panzacchi M, 2008, CAN J ZOOL, V86, P116, DOI 10.1139/Z07-120; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Post E, 1999, J WILDLIFE MANAGE, V63, P335, DOI 10.2307/3802517; RACHLOW JL, 1991, J MAMMAL, V72, P487, DOI 10.2307/1382131; Reznick D, 2002, ECOLOGY, V83, P1509, DOI 10.2307/3071970; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Rowell JE, 2009, THERIOGENOLOGY, V72, P190, DOI 10.1016/j.theriogenology.2009.01.022; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; RUTBERG AT, 1984, J MAMMAL, V65, P418, DOI 10.2307/1381088; Ryan SJ, 2007, BEHAV ECOL, V18, P635, DOI 10.1093/beheco/arm028; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Sato T, 2008, ZOOL SCI, V25, P766, DOI 10.2108/zsj.25.766; Scott IC, 2008, ANIM REPROD SCI, V109, P206, DOI 10.1016/j.anireprosci.2007.11.025; SEKULIC R, 1978, E AFR WILDL J, V16, P177; Sheehy DP, 1996, J RANGE MANAGE, V49, P16, DOI 10.2307/4002719; Sigouin D, 1997, ALCES N AM, V33, P85; Sinclair ARE, 2000, ECOLOGY, V81, P2100, DOI 10.1890/0012-9658(2000)081[2100:WDPASO]2.0.CO;2; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Testa JW, 2002, J MAMMAL, V83, P699, DOI 10.1644/1545-1542(2002)083<0699:DPONIS>2.0.CO;2; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walker EP, 1975, MAMMALS WORLD; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson DE, 2011, HOOFED MAMMALS, V2	88	512	518	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41444	10.1371/journal.pone.0041444	http://dx.doi.org/10.1371/journal.pone.0041444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911793	Green Submitted, Green Published, gold			2022-12-27	WOS:000306644600078
J	Qi, RF; Xu, Q; Zhang, LJH; Zhong, J; Zheng, G; Wu, SY; Zhang, ZQ; Liao, W; Zhong, Y; Ni, L; Jiao, Q; Zhang, ZJ; Liu, YJ; Lu, GM				Qi, Rongfeng; Xu, Qiang; Zhang, Long Jiang; Zhong, Jianhui; Zheng, Gang; Wu, Shengyong; Zhang, Zhiqiang; Liao, Wei; Zhong, Yuan; Ni, Ling; Jiao, Qing; Zhang, Zongjun; Liu, Yijun; Lu, Guangming			Structural and Functional Abnormalities of Default Mode Network in Minimal Hepatic Encephalopathy: A Study Combining DTI and fMRI	PLOS ONE			English	Article							RESTING-STATE NETWORKS; BRAIN NETWORKS; CEREBRAL EDEMA; CONNECTIVITY; CIRRHOSIS; ARCHITECTURE; COMPONENTS; DIAGNOSIS; DISEASE; NUMBER	Background and Purpose: Live failure can cause brain edema and aberrant brain function in cirrhotic patients. In particular, decreased functional connectivity within the brain default-mode network (DMN) has been recently reported in overt hepatic encephalopathy (HE) patients. However, so far, little is known about the connectivity among the DMN in the minimal HE (MHE), the mildest form of HE. Here, we combined diffusion tensor imaging (DTI) and resting-state functional MRI (rs-fMRI) to test our hypothesis that both structural and functional connectivity within the DMN were disturbed in MHE. Materials and Methods: Twenty MHE patients and 20 healthy controls participated in the study. We explored the changes of structural (path length, tracts count, fractional anisotropy [FA] and mean diffusivity [MD] derived from DTI tractography) and functional (temporal correlation coefficient derived from rs-fMRI) connectivity of the DMN in MHE patients. Pearson correlation analysis was performed between the structural/functional indices and venous blood ammonia levels/neuropsychological tests scores of patients. All thresholds were set at P<0.05, Bonferroni corrected. Results: Compared to the healthy controls, MHE patients showed both decreased FA and increased MD in the tract connecting the posterior cingulate cortex/precuneus (PCC/PCUN) to left parahippocampal gyrus (PHG), and decreased functional connectivity between the PCC/PCUN and left PHG, and medial prefrontal cortex (MPFC). MD values of the tract connecting PCC/PCUN to the left PHG positively correlated to the ammonia levels, the temporal correlation coefficients between the PCC/PCUN and the MPFC showed positive correlation to the digital symbol tests scores of patients. Conclusion: MHE patients have both disturbed structural and functional connectivity within the DMN. The decreased functional connectivity was also detected between some regions without abnormal structural connectivity, suggesting that the former may be more sensitive in detecting the early abnormalities of MHE. This study extends our understanding of the pathophysiology of MHE.	[Qi, Rongfeng; Zhang, Long Jiang; Zheng, Gang; Zhang, Zhiqiang; Zhong, Yuan; Ni, Ling; Jiao, Qing; Zhang, Zongjun; Lu, Guangming] Nanjing Univ, Jinling Hosp, Sch Clin, Dept Med Imaging,Med Coll, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Qiang] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Sichuan Provinc, Peoples R China; [Wu, Shengyong] Med Imaging Inst Tianjin, Tianjin, Peoples R China; [Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310027, Zhejiang, Peoples R China	Nanjing University; University of Electronic Science & Technology of China; Zhejiang University	Qi, RF (corresponding author), Nanjing Univ, Jinling Hosp, Sch Clin, Dept Med Imaging,Med Coll, Nanjing 210008, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Wu, Shawn/J-8611-2014	Wu, Shawn/0000-0003-3432-9819; Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [30700194, 81101039, 30800264, 30971019]; Chinese key grant [BWS11J063, 10z026]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese key grant	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 30700194 for LJZ, Grant No. 81101039 for GZ, Grant No. 30800264 for Zhiqiang Zhang, and Grant No. 30971019 for QJ], and Chinese key grant for GL (Grant Nos. BWS11J063 and 10z026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chavarria L, 2011, AM J NEURORADIOL, V32, P1510, DOI 10.3174/ajnr.A2533; Chen B, 2008, MAGN RESON IMAGING, V26, P103, DOI 10.1016/j.mri.2007.05.003; Chen HJ, 2011, EUR J RADIOL; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Goel A, 2010, LIVER INT, V30, P1143, DOI 10.1111/j.1478-3231.2010.02289.x; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kale RA, 2006, HEPATOLOGY, V43, P698, DOI 10.1002/hep.21114; Kumar R, 2008, J MAGN RESON IMAGING, V27, P1061, DOI 10.1002/jmri.21342; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mardini H, 2011, J HEPATOL, V54, P1154, DOI 10.1016/j.jhep.2010.09.030; Miese F, 2006, AM J NEURORADIOL, V27, P1019; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Poveda MJ, 2010, NEUROIMAGE, V52, P481, DOI 10.1016/j.neuroimage.2010.04.260; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Sidhu SS, 2011, AM J GASTROENTEROL, V106, P307, DOI 10.1038/ajg.2010.455; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Weissenborn K, 1998, J HEPATOL, V28, P646, DOI 10.1016/S0168-8278(98)80289-4; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	48	48	54	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41376	10.1371/journal.pone.0041376	http://dx.doi.org/10.1371/journal.pone.0041376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911787	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600076
J	Arase, F; Nishitani, H; Egusa, M; Nishimoto, N; Sakurai, S; Sakamoto, N; Kaminaka, H				Arase, Fumi; Nishitani, Hiroko; Egusa, Mayumi; Nishimoto, Nami; Sakurai, Sumiko; Sakamoto, Naho; Kaminaka, Hironori			IAA8 Involved in Lateral Root Formation Interacts with the TIR1 Auxin Receptor and ARF Transcription Factors in Arabidopsis	PLOS ONE			English	Article							BOX PROTEIN TIR1; AUX/IAA GENES; DOMAIN-II; CELL-DEATH; EXPRESSION; FAMILY; DEGRADATION; ENCODES; IDENTIFICATION; LOCALIZATION	The expression of auxin-responsive genes is regulated by the TIR1/AFB auxin receptor-dependent degradation of Aux/IAA transcriptional repressors, which interact with auxin-responsive factors (ARFs). Most of the 29 Aux/IAA genes present in Arabidopsis have not been functionally characterized to date. IAA8 appears to have a distinct function from the other Aux/IAA genes, due to its unique transcriptional response to auxin and the stability of its encoded protein. In this study, we characterized the function of Arabidopsis IAA8 in various developmental processes governed by auxin and in the transcriptional regulation of the auxin response. Transgenic plants expressing estrogen-inducible IAA8 (XVE::IAA8) exhibited significantly fewer lateral roots than the wild type, and an IAA8 loss-of-function mutant exhibited significantly more. Ectopic overexpression of IAA8 resulted in abnormal gravitropism. The strong induction of early auxin-responsive marker genes by auxin treatment was delayed by IAA8 overexpression. GFP-fusion analysis revealed that IAA8 localized not only to the nucleus, but, in contrast to other Aux/IAAs, also to the cytosol. Furthermore, we demonstrated that IAA8 interacts with TIR1, in an auxin-dependent fashion, and with ARF proteins, both in yeast and in planta. Taken together, our results show that IAA8 is involved in lateral root formation, and that this process is regulated through the interaction with the TIR1 auxin receptor and ARF transcription factors in the nucleus.	[Arase, Fumi; Nishitani, Hiroko; Egusa, Mayumi; Nishimoto, Nami; Sakurai, Sumiko; Sakamoto, Naho; Kaminaka, Hironori] Tottori Univ, Fac Agr, Plant Mol Biol Lab, Tottori 680, Japan	Tottori University	Arase, F (corresponding author), Tottori Univ, Fac Agr, Plant Mol Biol Lab, Tottori 680, Japan.	kaminaka@muses.tottori-u.ac.jp	Kaminaka, Hironori/AAD-9894-2020	Kaminaka, Hironori/0000-0002-3685-8688	NIBB Cooperative Research Program [7-342, 8-101, 9-102]; Japanese Ministry of Education, Sports, Culture, Science and Technology [1685101, 23770045]; Saneyoshi Scholarship Foundation; Sumitomo Foundation; Inamori Foundation	NIBB Cooperative Research Program; Japanese Ministry of Education, Sports, Culture, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Saneyoshi Scholarship Foundation; Sumitomo Foundation; Inamori Foundation	This work was carried out partially under the NIBB Cooperative Research Program (7-342, 8-101, 9-102), and supported in part by a Grant-in-Aid for Scientific Research of Priority Areas on 'Organelle Differentiation as the Strategy for Environmental Adaptation in Plants' (no. 1685101) and a Grant-in-Aid for Young Scientists (B) (no. 23770045) from the Japanese Ministry of Education, Sports, Culture, Science and Technology, Saneyoshi Scholarship Foundation, Sumitomo Foundation, and Inamori Foundation to H. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1995, PLANT J, V8, P87, DOI 10.1046/j.1365-313X.1995.08010087.x; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Del Bianco M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001578; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Greenham K, 2011, CURR BIOL, V21, P520, DOI 10.1016/j.cub.2011.02.029; Groover AT, 2003, PLANT MOL BIOL, V51, P427, DOI 10.1023/A:1022039815537; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kawai J, 2003, GENOME RES, V13, P1488, DOI 10.1101/gr.914203; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kieffer M, 2010, CURR OPIN PLANT BIOL, V13, P12, DOI 10.1016/j.pbi.2009.10.006; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Lee YJ, 2001, PLANT CELL, V13, P2175, DOI 10.1105/tpc.13.10.2175; Li JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027364; Maraschin FD, 2009, PLANT J, V59, P100, DOI 10.1111/j.1365-313X.2009.03854.x; Momonoi K, 2009, PLANT J, V59, P437, DOI 10.1111/j.1365-313X.2009.03879.x; Muto H, 2007, PLANT PHYSIOL, V144, P187, DOI 10.1104/pp.107.096628; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Padmanabhan MS, 2006, MOL PLANT MICROBE IN, V19, P864, DOI 10.1094/MPMI-19-0864; Park JY, 2002, PLANT J, V32, P669, DOI 10.1046/j.1365-313X.2002.01459.x; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Prigge MJ, 2010, CURR BIOL, V20, P1907, DOI 10.1016/j.cub.2010.08.050; Rademacher EH, 2011, PLANT J, V68, P597, DOI 10.1111/j.1365-313X.2011.04710.x; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Sato A, 2008, PHYSIOL PLANTARUM, V133, P397, DOI 10.1111/j.1399-3054.2008.01055.x; Shen CJ, 2010, J EXP BOT, V61, P3971, DOI 10.1093/jxb/erq208; Singh T, 2009, PLANT J, V60, P488, DOI 10.1111/j.1365-313X.2009.03970.x; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Tian Q, 1999, DEVELOPMENT, V126, P711; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Uehara T, 2008, PLANT CELL PHYSIOL, V49, P1025, DOI 10.1093/pcp/pcn079; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	58	46	63	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43414	10.1371/journal.pone.0043414	http://dx.doi.org/10.1371/journal.pone.0043414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912871	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700099
J	Gakuya, F; Ombui, J; Heukelbach, J; Maingi, N; Muchemi, G; Ogara, W; Mijele, D; Alasaad, S				Gakuya, Francis; Ombui, Jackson; Heukelbach, Jorg; Maingi, Ndichu; Muchemi, Gerald; Ogara, William; Mijele, Domnic; Alasaad, Samer			Knowledge of Mange among Masai Pastoralists in Kenya	PLOS ONE			English	Article							SARCOPTES-SCABIEI; GENETIC-STRUCTURE; WILD ANIMALS; MITE; EPIDEMIOLOGY; IVERMECTIN; ACARI	Background: Pastoralists in low-income countries usually live in close proximity to their animals and thus represent an important repository of information about livestock disease. Since wild and domestic animals often mix freely whilst grazing, pastoralists are also able to observe first-hand the diseases that are present in wildlife and as such are key informants in disease outbreaks in sylvatic animals. We report here the findings of the first study of the knowledge and role of Masai pastoralists in mange in wildlife and livestock in Masai Mara, Kenya. Methodology/Principal Findings: In this paper we describe the knowledge of mange accrued by 56 Masai pastoralists in Kenya and how they respond to it in both wildlife and livestock. In total, 52 (93%) pastoralists had a clear idea of the clinical appearance of mange, 13 (23%) understood its aetiology and 37 (66%) knew that mites were the causal agent. Thirty-nine (69%) believed that mange cross-infection between domestic and wild animals occurs, while 48 (85%) had observed mange in domestic animals including sheep (77%), goats (57%), dogs (24%) and cattle (14%). The pastoralists had also observed wild animals infected with mange, above all lions (19%), gazelles (14%), cheetahs (12%) and wildebeests (2%). In 68% of cases Masai pastoralists treat mange infection or apply control measures, most commonly via the topical use of acaricides (29%) and/or the reporting of the outbreak to the veterinary authorities (21%). In the period 2007-2011, Kenya Wildlife Service received 24 warnings of 59 wild animals with mange-like lesions from the Masai Mara pastoralist community. The reported species were cheetah, lion, wild dog, Thomson's gazelle and wildebeest. Conclusion: Masai pastoralists have good knowledge of mange epidemiology and treatment. Their observations and the treatments they apply are valuable in the control of this disease in both wild and domestic animals.	[Gakuya, Francis; Mijele, Domnic] Kenya Wildlife Serv, Dept Vet & Capture Serv, Nairobi, Kenya; [Ombui, Jackson; Muchemi, Gerald; Ogara, William] Univ Nairobi, Dept Publ Hlth Pharmacol & Toxicol, Nairobi, Kenya; [Heukelbach, Jorg] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil; [Maingi, Ndichu] Univ Nairobi, Dept Pathol & Microbiol, Nairobi, Kenya; [Alasaad, Samer] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Alasaad, Samer] Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Zurich, Switzerland	University of Nairobi; Universidade Federal do Ceara; University of Nairobi; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Zurich	Gakuya, F (corresponding author), Kenya Wildlife Serv, Dept Vet & Capture Serv, Nairobi, Kenya.	sameralasaad@hotmail.com	Angelone, Samer/G-4727-2013	Angelone, Samer/0000-0003-0868-7276; Heukelbach, Jorg/0000-0002-7845-5510	Kenya Wildlife Service; Projecto de Excelencia (Junta de Andalucia, Spain); Juan de la Cierva Grant	Kenya Wildlife Service; Projecto de Excelencia (Junta de Andalucia, Spain)(Junta de Andalucia); Juan de la Cierva Grant	The research was supported by Kenya Wildlife Service, Projecto de Excelencia (Junta de Andalucia, Spain) and Juan de la Cierva Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasaad S, 2008, PARASITOL RES, V104, P101, DOI 10.1007/s00436-008-1165-3; Alasaad S, 2009, PARASITOL RES, V104, P723, DOI 10.1007/s00436-009-1333-0; Alasaad S, 2009, VET PARASITOL, V159, P181, DOI 10.1016/j.vetpar.2008.10.001; Alasaad S, 2011, VET PARASITOL; Alasaad S, 2012, FORENSIC SCI MED PAT, V8, P280, DOI 10.1007/s12024-011-9268-z; Alasaad S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-151; Alasaad S, 2011, INT J INFECT DIS, V15, pE294, DOI 10.1016/j.ijid.2011.01.012; [Anonymous], 1989, SMALL ANIMAL DERMATO; ARLIAN LG, 1989, ANNU REV ENTOMOL, V34, P139, DOI 10.1146/annurev.en.34.010189.001035; Blood D. C., 1989, VET MED TXB DIS CATT, P1094; Bornstein Set, 2001, P107, DOI 10.1002/9780470377000.ch5; Bradberry Sally M, 2005, Toxicol Rev, V24, P93, DOI 10.2165/00139709-200524020-00003; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; Dagleish MP, 2007, J WILDLIFE DIS, V43, P512, DOI 10.7589/0090-3558-43.3.512; Fain A., 1968, ACTA ZOOL PATHOL ANT, V47, P1; Gakuya F, 2012, PARASITOLOGY, V139, P1587, DOI 10.1017/S0031182012000935; Gakuya F, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-193; Heukelbach J, 2004, B WORLD HEALTH ORGAN, V82, P563; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Kahn CM, 2005, MERCK VET MANUAL, V9th, P742; Leon-Vizcaino L, 2001, J WILDLIFE DIS, V37, P775, DOI 10.7589/0090-3558-37.4.775; Mugera G. M., 1979, DIS CATTLE TROPICAL, P296; Munang'andu HM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-29; Mwanzia Jacob M., 1995, P105; Ngoru B., 2002, CHEETAH ACINONYX JUB; Obasanjo OO, 2001, INFECT CONT HOSP EP, V22, P13, DOI 10.1086/501818; Pence DB, 2002, REV SCI TECH OIE, V21, P385, DOI 10.20506/rst.21.2.1335; Polley L, 2005, INT J PARASITOL, V35, P1279, DOI 10.1016/j.ijpara.2005.07.003; Rasero R, 2010, BIOL CONSERV, V143, P1269, DOI 10.1016/j.biocon.2010.03.001; Sanders A, 2000, MED VET ENTOMOL, V14, P131, DOI 10.1046/j.1365-2915.2000.00223.x; Sanderson H, 2007, AQUAT TOXICOL, V85, P229, DOI 10.1016/j.aquatox.2007.08.011; Serrano E, 2011, EPIDEMIOL INFECT, V139, P1626, DOI 10.1017/S0950268811000951; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 1999, AM J TROP MED HYG, V61, P542, DOI 10.4269/ajtmh.1999.61.542; Walton SF, 1997, MOL BIOCHEM PARASIT, V85, P187, DOI 10.1016/S0166-6851(96)02825-3; Walton SF, 2004, INT J PARASITOL, V34, P839, DOI 10.1016/j.ijpara.2004.04.002; Zahler M, 1999, INT J PARASITOL, V29, P759, DOI 10.1016/S0020-7519(99)00034-X	38	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43342	10.1371/journal.pone.0043342	http://dx.doi.org/10.1371/journal.pone.0043342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912858	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700086
J	Garg, P; Borel, C; Sharp, AJ				Garg, Paras; Borel, Christelle; Sharp, Andrew J.			Detection of Parent-of-Origin Specific Expression Quantitative Trait Loci by Cis-Association Analysis of Gene Expression in Trios	PLOS ONE			English	Article							BIPOLAR AFFECTIVE-DISORDER; GENOME-WIDE ASSOCIATION; POPULATION; TRANSMISSION; PATTERNS	Parent-of-origin (PofO) effects, such as imprinting are a phenomenon in which homologous chromosomes exhibit differential gene expression and epigenetic modifications according to their parental origin. Such non-Mendelian inheritance patterns are generally ignored by conventional association studies, as these tests consider the maternal and paternal alleles as equivalent. To identify regulatory regions that show PofO effects on gene expression (imprinted expression Quantitative Trait Loci, ieQTLs), here we have developed a novel method in which we associate SNP genotypes of defined parental origin with gene expression levels. We applied this method to study 59 HapMap phase II parent-offspring trios. By analyzing mother/father/child trios, rules of Mendelian inheritance allowed the parental origin to be defined for similar to 95% of SNPs in each child. We used 680,475 informative SNPs and corresponding expression data for 92,167 probe sets from Affymetrix GeneChip Human Exon 1.0 ST arrays and performed four independent cis-association analyses with the expression level of RefSeq genes within 1 Mb using PLINK. Independent analyses of maternal and paternal genotypes identified two significant cis-ieQTLs (p<10(-7)) at which expression of genes SFT2D2 and SRRT associated exclusively with maternally inherited SNPs rs3753292 and rs6945374, respectively. 28 additional suggestive cis-associations with only maternal or paternal SNPs were found at a lower stringency threshold of p<10(-6), including associations with two known imprinted genes PEG10 and TRAPPC9, demonstrating the efficacy of our method. Furthermore, comparison of our method that utilizes independent analyses of maternal and paternal genotypes with the Likelihood Ratio Test (LRT) showed it to be more effective for detecting imprinting effects than the LRT. Our method represents a novel approach that can identify imprinted regulatory elements that control gene expression, suggesting novel PofO effects in the human genome.	[Garg, Paras; Borel, Christelle; Sharp, Andrew J.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Garg, P (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA.	andrew.sharp@mssm.edu	borel, christelle/AAC-9645-2019		Fondation Jerome Lejeune	Fondation Jerome Lejeune	This work was supported by a grant from the Fondation Jerome Lejeune to AJS (www.fondationlejeune.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Belonogova NM, 2010, EUR J HUM GENET, V18, P379, DOI 10.1038/ejhg.2009.167; Benyamin B, 2009, PHARMACOGENOMICS, V10, P181, DOI 10.2217/14622416.10.2.181; Carroll WD, 2005, PEDIAT ALLERG IMM-UK, V16, P32, DOI 10.1111/j.1399-3038.2005.00249.x; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Franks S, 2001, HUM REPROD UPDATE, V7, P405, DOI 10.1093/humupd/7.4.405; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013556; Gardner RJ, 2000, HUM MOL GENET, V9, P589, DOI 10.1093/hmg/9.4.589; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kornberg JR, 2000, J AFFECT DISORDERS, V59, P183, DOI 10.1016/S0165-0327(99)00151-2; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Oudejans CBM, 2004, MOL HUM REPROD, V10, P589, DOI 10.1093/molehr/gah080; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Suazo J, 2010, AM J MED GENET A, V152A, P2011, DOI 10.1002/ajmg.a.33528; Sull JW, 2008, GENET EPIDEMIOL, V32, P505, DOI 10.1002/gepi.20323; Sull JW, 2009, HUM GENET, V126, P385, DOI 10.1007/s00439-009-0680-3; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Zeft A, 2008, CLIN RHEUMATOL, V27, P241, DOI 10.1007/s10067-007-0778-8; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41695	10.1371/journal.pone.0041695	http://dx.doi.org/10.1371/journal.pone.0041695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912676	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700006
J	Maciotta, S; Meregalli, M; Cassinelli, L; Parolini, D; Farini, A; Del Fraro, G; Gandolfi, F; Forcato, M; Ferrari, S; Gabellini, D; Bicciato, S; Cossu, G; Torrente, Y				Maciotta, Simona; Meregalli, Mirella; Cassinelli, Letizia; Parolini, Daniele; Farini, Andrea; Del Fraro, Giulia; Gandolfi, Francesco; Forcato, Mattia; Ferrari, Sergio; Gabellini, Davide; Bicciato, Silvio; Cossu, Giulio; Torrente, Yvan			Hmgb3 Is Regulated by MicroRNA-206 during Muscle Regeneration	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; EXPRESSION; DIFFERENTIATION; PATTERNS; MIR-206; MATURATION; SIGNATURE; MODELS; INJURY; MEMBER	Background: MicroRNAs (miRNAs) have been recently involved in most of human diseases as targets for potential strategies to rescue the pathological phenotype. Since the skeletal muscle is a spread-wide highly differentiated and organized tissue, rescue of severely compromised muscle still remains distant from nowadays. For this reason, we aimed to identify a subset of miRNAs major involved in muscle remodelling and regeneration by analysing the miRNA-profile of single fibres isolated from dystrophic muscle, which was here considered as a model of chronic damage. Methodology/Principal Findings: The miRNA-signature associated to regenerating (newly formed) and remodelling (resting) fibres was investigated in animal models of muscular dystrophies and acute damage, in order to distinguish which miRNAs are primary related to muscle regeneration. In this study we identify fourteen miRNAs associated to dystrophic fibres responsible for muscle regeneration and remodelling, and confirm over-expression of the previously identified regeneration-associated myomiR-206. In particular, a functional binding site for myomiR-206 was identified and validated in the 3'untranslated region (3'UTR) of an X-linked member of a family of sequence independent chromatin-binding proteins (Hmgb3) that is preferentially expressed in hematopoietic stem cells. During regeneration of single muscle fibres, Hmgb3 messenger RNA (mRNA) and protein expression was gradually reduced, concurrent with the up-regulation of miR-206. Conclusion/Significance: Our results elucidate a negative feedback circuit in which myomiR-206 represses Hmgb3 expression to modulate the regeneration of single muscle fibres after acute and chronic muscle damage. These findings suggest that myomiR-206 may be a potential therapeutic target in muscle diseases.	[Maciotta, Simona; Meregalli, Mirella; Cassinelli, Letizia; Parolini, Daniele; Farini, Andrea; Del Fraro, Giulia; Torrente, Yvan] Univ Milan, Stem Cell Lab, Dept Pathophysiol & Transplantat, Fdn IRCCS Ca Granda Osped Maggiore Policlin,Ctr D, Milan, Italy; [Gandolfi, Francesco; Forcato, Mattia; Ferrari, Sergio; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, Modena, Italy; [Gabellini, Davide] Ist Sci San Raffaele, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Gabellini, Davide] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy; [Cossu, Giulio] UCL, Dept Cell & Dev Biol, London, England	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universita di Modena e Reggio Emilia; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London	Maciotta, S (corresponding author), Univ Milan, Stem Cell Lab, Dept Pathophysiol & Transplantat, Fdn IRCCS Ca Granda Osped Maggiore Policlin,Ctr D, Milan, Italy.	yvan.torrente@unimi.it	Gabellini, Davide/I-4551-2018; Forcato, Mattia/B-7733-2015; BICCIATO, Silvio/J-4466-2019; Ferrari, Sergio/A-1110-2010; Bicciato, Silvio/C-9825-2009; TORRENTE, YVAN/A-2964-2015	Gabellini, Davide/0000-0002-3811-4121; Forcato, Mattia/0000-0002-7383-6576; BICCIATO, Silvio/0000-0002-1944-7078; Ferrari, Sergio/0000-0002-4822-2521; Bicciato, Silvio/0000-0002-1944-7078; TORRENTE, YVAN/0000-0002-2705-3984; Meregalli, Mirella/0000-0002-5151-607X; Cossu, Giulio/0000-0001-5863-9593; Farini, Andrea/0000-0002-8514-4921	Association Monegasque contre les Myopathies (AMM); EU [223098]; Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele; Associazione Amici del Centro Dino Ferrari; Fondazione Telethon Funding Source: Custom	Association Monegasque contre les Myopathies (AMM); EU(European Commission); Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele; Associazione Amici del Centro Dino Ferrari; Fondazione Telethon(Fondazione Telethon)	This work was supported in part by grants from the Association Monegasque contre les Myopathies (AMM), EU's Framework programme 7 Optistem 223098, the Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele, and by the Associazione Amici del Centro Dino Ferrari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Creuzet S, 1998, EXP CELL RES, V243, P241, DOI 10.1006/excr.1998.4100; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Danieli-Betto D, 2005, AM J PHYSIOL-REG I, V289, pR1328, DOI 10.1152/ajpregu.00673.2004; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Eisenberg I, 2009, J CELL MOL MED, V13, P2, DOI 10.1111/j.1582-4934.2008.00524.x; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Grist CG, 2010, CELL METAB, V12, P425, DOI 10.1016/j.cmet.2010.10.007; Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kurek JB, 1997, MUSCLE NERVE, V20, P815; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Manzur AY, 2009, POSTGRAD MED J, V85, P622, DOI 10.1136/jnnp.2008.158329; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Nie Y, 2011, INT J BIOL SCI, V7, P762, DOI 10.7150/ijbs.7.762; Nielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Singh SK, 2008, FEBS J, V275, P4929, DOI 10.1111/j.1742-4658.2008.06624.x; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Sun M, 2009, AM J PHYSIOL-CELL PH, V301, pC21; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vaccari T, 1998, GENOMICS, V49, P247, DOI 10.1006/geno.1998.5214; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; Wells D J, 2005, Acta Myol, V24, P172; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022	54	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43464	10.1371/journal.pone.0043464	http://dx.doi.org/10.1371/journal.pone.0043464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912879	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700107
J	Wang, GZ; Meng, K; Luo, HY; Wang, YR; Huang, HQ; Shi, PJ; Yang, PL; Zhang, ZF; Yao, B				Wang, Guozeng; Meng, Kun; Luo, Huiying; Wang, Yaru; Huang, Huoqing; Shi, Pengjun; Yang, Peilong; Zhang, Zhifang; Yao, Bin			Phylogenetic Diversity and Environment-Specific Distributions of Glycosyl Hydrolase Family 10 Xylanases in Geographically Distant Soils	PLOS ONE			English	Article							GENE; DISCOVERY; BIODIVERSITY; EXPRESSION; SEQUENCES; COMMUNITY; PROGRAM; CLUSTER; CLONING; FUNGI	Background: Xylan is one of the most abundant biopolymers on Earth. Its degradation is mediated primarily by microbial xylanase in nature. To explore the diversity and distribution patterns of xylanase genes in soils, samples of five soil types with different physicochemical characters were analyzed. Methodology/Principal Findings: Partial xylanase genes of glycoside hydrolase ( GH) family 10 were recovered following direct DNA extraction from soil, PCR amplification and cloning. Combined with our previous study, a total of 1084 gene fragments were obtained, representing 366 OTUs. More than half of the OTUs were novel ( identities of <65% with known xylanases) and had no close relatives based on phylogenetic analyses. Xylanase genes from all the soil environments were mainly distributed in Bacteroidetes, Proteobacteria, Acidobacteria, Firmicutes, Actinobacteria, Dictyoglomi and some fungi. Although identical sequences were found in several sites, habitat-specific patterns appeared to be important, and geochemical factors such as pH and oxygen content significantly influenced the compositions of xylan-degrading microbial communities. Conclusion/Significance: These results provide insight into the GH 10 xylanases in various soil environments and reveal that xylan-degrading microbial communities are environment specific with diverse and abundant populations.	[Wang, Guozeng; Meng, Kun; Luo, Huiying; Wang, Yaru; Huang, Huoqing; Shi, Pengjun; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Wang, Guozeng; Zhang, Zhifang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Wang, GZ (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	zhifangzhang@yahoo.com; binyao@caas.net.cn		Wang, Guozeng/0000-0001-6547-0490	key program of Transgenic Plant Breeding [2008ZX08003-002]; China Modern Agriculture Research System [CARS-42]	key program of Transgenic Plant Breeding; China Modern Agriculture Research System	This work was supported by the key program of Transgenic Plant Breeding (2008ZX08003-002) and the China Modern Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASTAWDE KB, 1992, WORLD J MICROB BIOT, V8, P353, DOI 10.1007/BF01198746; Bentley SD, 2008, J BACTERIOL, V190, P2150, DOI 10.1128/JB.01598-07; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Cowan D, 2005, TRENDS BIOTECHNOL, V23, P321, DOI 10.1016/j.tibtech.2005.04.001; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Downes J, 2006, INT J SYST EVOL MICR, V56, P609, DOI 10.1099/ijs.0.63888-0; Flint HJ, 1997, BBA-PROTEIN STRUCT M, V1337, P161, DOI 10.1016/S0167-4838(96)00213-0; GIBBS MD, 1995, APPL ENVIRON MICROB, V61, P4403, DOI 10.1128/AEM.61.12.4403-4408.1995; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Haegeman A, 2009, MOL PLANT PATHOL, V10, P389, DOI [10.1111/J.1364-3703.2009.00539.X, 10.1111/j.1364-3703.2009.00539.x]; Hattenschwiler S, 2011, CR BIOL, V334, P393, DOI 10.1016/j.crvi.2011.03.001; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hopkins DW, 2010, SOIL MICROBIOLOGY AND SUSTAINABLE CROP PRODUCTION, P59, DOI 10.1007/978-90-481-9479-7_3; Hu Y, 2008, APPL MICROBIOL BIOT, V80, P823, DOI 10.1007/s00253-008-1636-6; Jackson M. L., 1958, Soil Chemical Analysis.; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; LeCleir GR, 2004, APPL ENVIRON MICROB, V70, P6977, DOI 10.1128/AEM.70.12.6977-6983.2004; Lejon DPH, 2007, FEMS MICROBIOL ECOL, V61, P424, DOI 10.1111/j.1574-6941.2007.00365.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo HY, 2010, APPL MICROBIOL BIOT, V86, P1829, DOI 10.1007/s00253-009-2410-0; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Saleh-Lakha S, 2005, J MICROBIOL METH, V63, P1, DOI 10.1016/j.mimet.2005.03.007; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Sunna A, 2003, EXTREMOPHILES, V7, P63, DOI 10.1007/s00792-002-0296-1; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMSON JA, 1993, FEMS MICROBIOL LETT, V104, P65, DOI 10.1111/j.1574-6968.1993.tb05864.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang GZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016731; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; White JR, 2008, BIOINFORMATICS, V24, P462, DOI 10.1093/bioinformatics/btm632	48	18	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43480	10.1371/journal.pone.0043480	http://dx.doi.org/10.1371/journal.pone.0043480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912883	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700111
J	Wu, QL; Li, YP; Tang, M; Wang, DY				Wu, Qiuli; Li, Yiping; Tang, Meng; Wang, Dayong			Evaluation of Environmental Safety Concentrations of DMSA Coated Fe2O3-NPs Using Different Assay Systems in Nematode Caenorhabditis elegans	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; RECYCLING MILL EFFLUENT; LIFE-SPAN; SILVER NANOPARTICLES; TOXICITY EVALUATION; OXIDATIVE DAMAGE; BULK ZNO; EXPOSURE; ECOTOXICITY; LETHALITY	Dimercaptosuccinic acid (DMSA) coating improves the uptake efficiency presumably by engendering the Fe2O3-NPs. In the present study, we investigated the possible environmental safety concentrations of Fe2O3-NPs using different assay systems in nematode Caenorhabditis elegans with lethality, development, reproduction, locomotion behavior, pharyngeal pumping, defecation, intestinal autofluorescence and reactive oxygen species (ROS) production as the endpoints. After exposure from L4-larvae for 24-hr, DMSA coated Fe2O3-NPs at concentrations more than 50 mg/L exhibited adverse effects on nematodes. After exposure from L1-larvae to adult, DMSA coated Fe2O3-NPs at concentrations more than 500 mu g/L had adverse effects on nematodes. After exposure from L1-larvae to day-8 adult, DMSA coated Fe2O3-NPs at concentrations more than 100 mu g/L resulted in the adverse effects on nematodes. Accompanied with the alterations of locomotion behaviors, ROS production was pronouncedly induced by exposure to DMSA coated Fe2O3-NPs in the examined three assay systems, and the close associations of ROS production with lethality, growth, reproduction, locomotion behavior, pharyngeal pumping, defecation, or intestinal autofluorescence in nematodes exposed to DMSA coated Fe2O3-NPs were confirmed by the linear regression analysis. Moreover, mutations of sod-2 and sod-3 genes, encoding Mn-SODs, showed more susceptible properties than wildtype when they were used for assessing the DMSA coated Fe2O3-NPs-induced toxicity, and the safety concentrations for DMSA coated Fe2O3-NPs should be defined as concentrations lower than 10 mu g/L in sod-2 and sod-3 mutant nematodes.	[Wu, Qiuli; Li, Yiping; Wang, Dayong] Southeast Univ, Sch Med, Key Lab Environm Med Engn, Minist Educ,Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Tang, Meng] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Wu, QL (corresponding author), Southeast Univ, Sch Med, Key Lab Environm Med Engn, Minist Educ,Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China.	dayongw@seu.edu.cn			National Basic Research Program of China [2011CB933404]; National Natural Science Foundation of China [81172698]; Postdoctoral Foundation in Jiangsu Province of China; NIH National Center for Research Resource, USA	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation in Jiangsu Province of China; NIH National Center for Research Resource, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Basic Research Program of China (No. 2011CB933404), the National Natural Science Foundation of China (No. 81172698), and the Postdoctoral Foundation in Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The nematode strains used in this study were provided by the Caenorhabditis Genetics Center (funded by the NIH National Center for Research Resource, USA). We thank Prof. Yu Zhang (College of Biological Science and Medical Engineering, Southeast University) for providing the DMSA coated Fe<INF>2</INF>O<INF>3</INF>-NPs.	APOSHIAN HV, 1990, ANNU REV PHARMACOL, V30, P279; Ban M, 2012, TOXICOL LETT, V210, P267, DOI 10.1016/j.toxlet.2012.02.004; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; BRENNER S, 1974, GENETICS, V77, P71; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Cha YJ, 2012, CHEMOSPHERE, V87, P49, DOI 10.1016/j.chemosphere.2011.11.054; DONKIN SG, 1993, ARCH ENVIRON CON TOX, V25, P145, DOI 10.1007/BF00212125; Fidler MC, 2004, BRIT J NUTR, V91, P107, DOI 10.1079/BJN20041018; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; Harmon SM, 2008, CHEMOSPHERE, V70, P1857, DOI 10.1016/j.chemosphere.2007.08.007; Heininger P, 2007, ENVIRON POLLUT, V146, P64, DOI 10.1016/j.envpol.2006.06.023; Helmcke KJ, 2010, TOXICOL APPL PHARM, V248, P156, DOI 10.1016/j.taap.2010.07.023; Hoss S, 2009, ECOTOX ENVIRON SAFE, V72, P1811, DOI 10.1016/j.ecoenv.2009.07.003; Hood E, 2004, ENV HLTH PERSPECT, V112, pA470; Hu YO, 2008, BIOMED ENVIRON SCI, V21, P467, DOI 10.1016/S0895-3988(09)60004-0; Jadhav KB, 2009, J BIOCHEM MOL TOXIC, V23, P9, DOI 10.1002/jbt.20258; Kadar E, 2010, ANAL BIOANAL CHEM, V396, P657, DOI 10.1007/s00216-009-3191-0; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Katsnelson BA, 2011, INT J TOXICOL, V30, P59, DOI 10.1177/1091581810385149; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li HC, 2009, ECOTOX ENVIRON SAFE, V72, P684, DOI 10.1016/j.ecoenv.2008.09.027; Li YX, 2013, NANOTOXICOLOGY, V7, P1004, DOI 10.3109/17435390.2012.689884; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Lim D, 2012, ENVIRON TOXICOL CHEM, V31, P585, DOI 10.1002/etc.1706; Liu PD, 2012, ECOTOX ENVIRON SAFE, V79, P90, DOI 10.1016/j.ecoenv.2011.12.007; Ma H, 2011, ENVIRON POLLUT, V159, P1473, DOI 10.1016/j.envpol.2011.03.013; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1324, DOI 10.1897/08-262.1; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Mutwakil MHAZ, 1997, ARCH ENVIRON CON TOX, V32, P146, DOI 10.1007/s002449900167; Noori A, 2011, AFR J BIOTECHNOL, V10, P1221; O'Brien N, 2010, J ENVIRON SCI HEAL A, V45, P992, DOI 10.1080/10934521003772410; Pei B, 2008, CHEM RES TOXICOL, V21, P1530, DOI 10.1021/tx800074e; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Pluskota A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006622; Qu Y, 2011, NANO LETT, V11, P3174, DOI 10.1021/nl201391e; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Shen LL, 2010, MECH AGEING DEV, V131, P732, DOI 10.1016/j.mad.2010.10.005; Shen LL, 2009, ENVIRON TOXICOL PHAR, V28, P125, DOI 10.1016/j.etap.2009.03.009; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Sochova I, 2006, ENVIRON INT, V32, P374, DOI 10.1016/j.envint.2005.08.031; Sonvico F, 2005, BIOCONJUGATE CHEM, V16, P1181, DOI 10.1021/bc050050z; Tiede K, 2009, J CHROMATOGR A, V1216, P503, DOI 10.1016/j.chroma.2008.09.008; Van Raamsdonk JM, 2010, GENETICS, V185, P559, DOI 10.1534/genetics.110.115378; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P1221, DOI 10.1016/j.ecoenv.2010.05.002; Wang DY, 2010, J ENVIRON SCI, V22, P731, DOI 10.1016/S1001-0742(09)60170-4; Wang HH, 2009, ENVIRON POLLUT, V157, P1171, DOI 10.1016/j.envpol.2008.11.004; [Wang Xiao-na 王晓娜], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P2575; Wang XY, 2008, J ENVIRON SCI, V20, P1373, DOI 10.1016/S1001-0742(08)62235-4; Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; Wu QL, 2012, CHEMOSPHERE, V87, P1281, DOI 10.1016/j.chemosphere.2012.01.035; Wu S, 2011, ENVIRON TOXICOL PHAR, V31, P179, DOI 10.1016/j.etap.2010.10.005; Xing X, 2009, B ENVIRON CONTAM TOX, V83, P530, DOI 10.1007/s00128-009-9816-3; Ye BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014052; Yu SH, 2011, ENVIRON TOXICOL PHAR, V32, P233, DOI 10.1016/j.etap.2011.05.008; Zhang HF, 2011, ENVIRON SCI TECHNOL, V45, P3725, DOI 10.1021/es103309n; Zhang S, 2009, NANOSCALE RES LETT, V4, P70, DOI 10.1007/s11671-008-9204-7; Zhu MT, 2009, TOXICOL SCI, V107, P342, DOI 10.1093/toxsci/kfn245	62	41	45	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43729	10.1371/journal.pone.0043729	http://dx.doi.org/10.1371/journal.pone.0043729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912902	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700130
J	Carson, CG; Halkjaer, LB; Jensen, SM; Bisgaard, H				Carson, Charlotte Giwercman; Halkjaer, Liselotte Brydensholt; Jensen, Signe Marie; Bisgaard, Hans			Alcohol Intake in Pregnancy Increases the Child's Risk of Atopic Dermatitis. The COPSAC Prospective Birth Cohort Study of a High Risk Population	PLOS ONE			English	Article							PRENATAL FACTORS; IMMUNE-SYSTEM; LIFE; ASTHMA; CONSUMPTION; ECZEMA; RHINITIS; DRINKS; WOMEN; ASSOCIATION	Background: Atopic dermatitis has increased four-fold over the recent decades in developed countries, indicating that changes in environmental factors associated with lifestyle may play an important role in this epidemic. It has been proposed that alcohol consumption may be one contributing risk factor in this development. Objective: To analyze the impact of alcohol intake during pregnancy on the development of atopic dermatitis during the first 7 years of life. Method: The COPSAC cohort is a prospective, longitudinal, birth cohort study of 411 children born to mothers with a history of asthma, followed up for 7 years with scheduled visits every 6 months as well as visits for acute exacerbations of atopic dermatitis. Risk of atopic dermatitis from any alcohol consumption during pregnancy was analyzed as time-to-diagnosis and adjusted for known risk factors. Results: 177 of 411 children developed atopic dermatitis before age 7 years. We found a significant effect of alcohol intake during pregnancy on atopic dermatitis development (HR 1.44, 95% CI 1.05-1.99 p = 0.024). This conclusion was unaffected after adjustment for smoking, mother's education and mother's atopic dermatitis. Limitations: The selection of a high-risk cohort, with all mothers suffering from asthma, and all children having a gestational age above 35 weeks with no congenital abnormality, systemic illness, or history of mechanical ventilation or lower airway infection. Conclusion: Alcohol intake by pregnant women with a history of asthma, is significantly associated with an increased risk for the child for developing atopic dermatitis during the first 7 years of life.	[Carson, Charlotte Giwercman; Halkjaer, Liselotte Brydensholt; Jensen, Signe Marie; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark	University of Copenhagen	Carson, CG (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark.	bisgaard@copsac.com	Jensen, Signe/G-1026-2016; Bisgaard, Hans/N-4761-2016; Kronow, Joern/B-1054-2011	Jensen, Signe/0000-0002-7738-5231; Bisgaard, Hans/0000-0003-4131-7592; 	The Lundbeck Foundation; Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council; Danish Pediatric Asthma Centre	The Lundbeck Foundation(Lundbeckfonden); Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Pediatric Asthma Centre	Copenhagen Prospective Studies on Asthma in Childhood is funded by private and public research funds. The Lundbeck Foundation; the Pharmacy Foundation of 1991; Augustinus Foundation; the Danish Medical Research Council and The Danish Pediatric Asthma Centre provided the core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; Bendtsen P, 2008, CLIN EXP ALLERGY, V38, P1179, DOI 10.1111/j.1365-2222.2008.02945.x; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P1355, DOI 10.1016/j.jaci.2009.03.046; Bjerke T, 1994, Pediatr Allergy Immunol, V5, P88, DOI 10.1111/j.1399-3038.1994.tb00223.x; Bjorksten B, 1999, P NUTR SOC, V58, P729, DOI 10.1017/S0029665199000956; Bjorksten B, 1999, LANCET, V353, P167, DOI 10.1016/S0140-6736(05)77212-3; Bjorksten B, 1999, J ALLERGY CLIN IMMUN, V104, P1119; Bohme M, 2003, CLIN EXP ALLERGY, V33, P1226, DOI 10.1046/j.1365-2222.2003.01749.x; Bradley M, 2000, ACTA DERM-VENEREOL, V80, P106; Chawes BLK, 2009, ALLERGY, V64, P1547, DOI 10.1111/j.1398-9995.2009.02085.x; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Ebrahim SH, 1998, OBSTET GYNECOL, V92, P187, DOI 10.1016/S0029-7844(98)00205-1; Fagt S, 2001, DEV DANISH DIET CONS, P38; Giwercman C, 2010, J ALLERGY CLIN IMMUN, V125, P866, DOI 10.1016/j.jaci.2010.01.026; Gonzalez-Quintela A, 1999, ANN ALLERG ASTHMA IM, V83, P61, DOI 10.1016/S1081-1206(10)63514-4; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Harris JM, 2001, BRIT J DERMATOL, V144, P795, DOI 10.1046/j.1365-2133.2001.04135.x; Jones CA, 2000, ALLERGY, V55, P2, DOI 10.1034/j.1398-9995.2000.00109.x; Kazbariene Birute, 2007, Central European Journal of Public Health, V15, P13; Kesmodel U, 2002, AM J EPIDEMIOL, V155, P305, DOI 10.1093/aje/155.4.305; Krause TG, 2002, LANCET, V360, P691, DOI 10.1016/S0140-6736(02)09841-0; Kurzius-Spencer M, 2005, PEDIAT ALLERG IMM-UK, V16, P19, DOI 10.1111/j.1399-3038.2005.00233.x; Law M, 2005, BRIT MED J, V330, P1187, DOI 10.1136/bmj.38435.582975.AE; Linneberg A, 2008, CLIN EXP ALLERGY, V38, P145, DOI 10.1111/j.1365-2222.2007.02837.x; Linneberg A, 2004, CLIN EXP ALLERGY, V34, P1678, DOI 10.1111/j.1365-2222.2004.02101.x; Linneberg A, 2003, CLIN EXP ALLERGY, V33, P192, DOI 10.1046/j.1365-2222.2003.01515.x; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Moore MM, 2004, PEDIATRICS, V113, P468, DOI 10.1542/peds.113.3.468; Nihlen U, 2005, RESP MED, V99, P762, DOI 10.1016/j.rmed.2004.11.010; OGSTON S A, 1992, International Journal of Epidemiology, V21, pS45; Olesen AB, 1997, BRIT MED J, V314, P1003, DOI 10.1136/bmj.314.7086.1003; OLSEN J, 1989, SCAND J SOC MED, V17, P277, DOI 10.1177/140349488901700404; Prescott SL, 2003, CURR OPIN ALLERGY CL, V3, P125, DOI 10.1097/01.all.0000064776.57552.32; RUIZ RGG, 1992, CLIN EXP ALLERGY, V22, P762, DOI 10.1111/j.1365-2222.1992.tb02816.x; Schultz LF, 1992, ACTA DERM-VENEREOL, V176, P7; Schultz LF, 1996, J AM ACAD DERMATOL 1, V34, P760; Vally H, 2000, J ALLERGY CLIN IMMUN, V105, P462, DOI 10.1067/mai.2000.104548; Vally H, 2003, ADDICT BIOL, V8, P3, DOI 10.1080/1355621031000069828; Vally H, 2003, CLIN EXP ALLERGY, V33, P156, DOI 10.1046/j.1365-2222.2003.01604.x; von Hertzen LC, 2004, ALLERGY, V59, P124, DOI 10.1046/j.1398-9995.2003.00433.x; Wadonda-Kabondo N, 2004, ARCH DIS CHILD, V89, P917, DOI 10.1136/adc.2003.034033; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P397, DOI 10.1111/j.1365-2133.1994.tb08531.x; Xu B, 1999, ALLERGY, V54, P829, DOI 10.1034/j.1398-9995.1999.00117.x	46	20	21	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42710	10.1371/journal.pone.0042710	http://dx.doi.org/10.1371/journal.pone.0042710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916148	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600023
J	Bardai, A; Lamberts, RJ; Blom, MT; Spanjaart, AM; Berdowski, J; van der Staal, SR; Brouwer, HJ; Koster, RW; Sander, JW; Thijs, RD; Tan, HL				Bardai, Abdennasser; Lamberts, Robert J.; Blom, Marieke T.; Spanjaart, Anne M.; Berdowski, Jocelyn; van der Staal, Sebastiaan R.; Brouwer, Henk J.; Koster, Rudolph W.; Sander, Josemir W.; Thijs, Roland D.; Tan, Hanno L.			Epilepsy Is a Risk Factor for Sudden Cardiac Arrest in the General Population	PLOS ONE			English	Article							NEURONAL SODIUM-CHANNEL; HEART-RATE-VARIABILITY; UNEXPECTED DEATH; FEBRILE SEIZURES; POTENTIAL ROLE; QT; REPOLARIZATION; MUTATIONS; INSIGHTS; LONG	Background: People with epilepsy are at increased risk for sudden death. The most prevalent cause of sudden death in the general population is sudden cardiac arrest (SCA) due to ventricular fibrillation (VF). SCA may contribute to the increased incidence of sudden death in people with epilepsy. We assessed whether the risk for SCA is increased in epilepsy by determining the risk for SCA among people with active epilepsy in a community-based study. Methods and Results: This investigation was part of the Amsterdam Resuscitation Studies (ARREST) in the Netherlands. It was designed to assess SCA risk in the general population. All SCA cases in the study area were identified and matched to controls (by age, sex, and SCA date). A diagnosis of active epilepsy was ascertained in all cases and controls. Relative risk for SCA was estimated by calculating the adjusted odds ratios using conditional logistic regression (adjustment was made for known risk factors for SCA). We identified 1019 cases of SCA with ECG-documented VF, and matched them to 2834 controls. There were 12 people with active epilepsy among cases and 12 among controls. Epilepsy was associated with a three-fold increased risk for SCA (adjusted OR 2.9 [95% CI 1.1-8.0.], p = 0.034). The risk for SCA in epilepsy was particularly increased in young and females. Conclusion: Epilepsy in the general population seems to be associated with an increased risk for SCA.	[Bardai, Abdennasser; Blom, Marieke T.; Spanjaart, Anne M.; van der Staal, Sebastiaan R.; Tan, Hanno L.] Univ Amsterdam, Heart Failure Res Ctr, Amsterdam, Netherlands; [Bardai, Abdennasser] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Lamberts, Robert J.; Sander, Josemir W.; Thijs, Roland D.] Netherlands Fdn, SEIN Epilepsy Inst, Heemstede, Netherlands; [Berdowski, Jocelyn; Koster, Rudolph W.; Tan, Hanno L.] Univ Amsterdam, Dept Cardiol, Amsterdam, Netherlands; [Brouwer, Henk J.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Thijs, Roland D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Sander, Josemir W.; Thijs, Roland D.] Univ Coll London Inst Neurol, Dept Clin & Expt Epilepsy, London, England	University of Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London	Bardai, A (corresponding author), Univ Amsterdam, Heart Failure Res Ctr, Amsterdam, Netherlands.	h.l.tan@amc.nl	Sander, Josemir W/C-1576-2008; , Bardai/AAL-2340-2020; Thijs, Roland D/AGE-5180-2022	Sander, Josemir W/0000-0001-6041-9661; Thijs, Roland D/0000-0003-1435-8970; Blom, Marieke Tabo/0000-0002-8088-1105	Netherlands Organization for Scientific Research (NWO) [ZonMW Vici 918.86.616, Mozaiek 017.003.084]; Dutch Medicines Evaluation Board (MEB/CBG); National Epilepsy Foundation Netherlands; Physio Control; Netherlands Heart Foundation [2006B179]; National Institutes of Health (National Board of Industrial Health/National Institute of Neurological Disorders and Stroke) [-1P20NS076965-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P20NS076965] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Medicines Evaluation Board (MEB/CBG); National Epilepsy Foundation Netherlands; Physio Control; Netherlands Heart Foundation(Netherlands Heart Foundation); National Institutes of Health (National Board of Industrial Health/National Institute of Neurological Disorders and Stroke); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	HLT was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616), the Dutch Medicines Evaluation Board (MEB/CBG), and the National Epilepsy Foundation Netherlands. The Arrest data collection was supported by an unconditional grant from Physio Control and a grant from the Netherlands Heart Foundation (grant 2006B179). AB was supported by the Netherlands Organization for Scientific Research (NWO, grant Mozaiek 017.003.084). RDT and JWS are part of the Prevention and Risk Identification of SUDEP Mortatlity Consortium which is funded by the National Institutes of Health (National Board of Industrial Health/National Institute of Neurological Disorders and Stroke -1P20NS076965-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2010, HEART RHYTHM, V7, P117, DOI 10.1016/j.hrthm.2009.08.005; [Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], RICHTL DIAGN BEH; Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Aurlien D, 2009, SEIZURE-EUR J EPILEP, V18, P158, DOI 10.1016/j.seizure.2008.07.008; Bardai A, 2011, J AM COLL CARDIOL, V57, P1822, DOI 10.1016/j.jacc.2010.11.054; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Brotherstone R, 2010, EPILEPSIA, V51, P221, DOI 10.1111/j.1528-1167.2009.02281.x; Druschky A, 2001, BRAIN, V124, P2372, DOI 10.1093/brain/124.12.2372; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Hesdorffer DC, 2012, EPILEPSIA, V53, P249, DOI 10.1111/j.1528-1167.2011.03354.x; Hindocha N, 2008, EPILEPSIA, V49, P360, DOI 10.1111/j.1528-1167.2007.01439_2.x; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Johnson JN, 2009, NEUROLOGY, V72, P224, DOI 10.1212/01.wnl.0000335760.02995.ca; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Maier SKG, 2002, P NATL ACAD SCI USA, V99, P4073, DOI 10.1073/pnas.261705699; Makikallio TH, 2001, J AM COLL CARDIOL, V37, P1395, DOI 10.1016/S0735-1097(01)01171-8; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; Nashef L, 2012, EPILEPSIA, V53, P227, DOI 10.1111/j.1528-1167.2011.03358.x; Neufeld G, 2009, CARDIOLOGY, V114, P255, DOI 10.1159/000233236; Rees MI, 2010, SEIZURE-EUR J EPILEP, V19, P680, DOI 10.1016/j.seizure.2010.10.029; ROGERS WJ, 1992, NEW ENGL J MED, V327, P227; Ronkainen E, 2005, J NEUROL NEUROSUR PS, V76, P1382, DOI 10.1136/jnnp.2004.053777; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249; Stollberger C, 2004, EPILEPSY RES, V59, P51, DOI 10.1016/j.eplepsyres.2004.03.008; Sugawara T, 2001, NEUROLOGY, V57, P703, DOI 10.1212/WNL.57.4.703; Surges R, 2010, EPILEPSIA, V51, P738, DOI 10.1111/j.1528-1167.2010.02571.x; Surges R, 2010, NEUROLOGY, V74, P421, DOI 10.1212/WNL.0b013e3181ccc706; Surges R, 2010, EPILEPSIA, V51, P233, DOI 10.1111/j.1528-1167.2009.02330.x; Surges R, 2009, NAT REV NEUROL, V5, P492, DOI 10.1038/nrneurol.2009.118; Teh HS, 2007, NEUROLOGY ASIA S1, P68; Tomson T, 1998, EPILEPSY RES, V30, P77, DOI 10.1016/S0920-1211(97)00094-6; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; van Doormaal FF, 2010, ANN FAM MED, V8, P47, DOI 10.1370/afm.1058; Verkerk AO, 2007, EUROPACE, V9, P571, DOI 10.1093/europace/eum121; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516	46	70	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42749	10.1371/journal.pone.0042749	http://dx.doi.org/10.1371/journal.pone.0042749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916156	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800021
J	Zhang, XM; Zhao, L; Larson-Rabin, Z; Li, DZ; Guo, ZH				Zhang, Xue-Mei; Zhao, Lei; Larson-Rabin, Zachary; Li, De-Zhu; Guo, Zhen-Hua			De Novo Sequencing and Characterization of the Floral Transcriptome of Dendrocalamus latiflorus (Poaceae: Bambusoideae)	PLOS ONE			English	Article							SBP-BOX GENE; HIGH-SALINITY STRESSES; GENOME-WIDE ANALYSIS; FLOWERING-LOCUS-T; ARABIDOPSIS-THALIANA; DNA-BINDING; FUNCTIONAL-ANALYSIS; LEAF SENESCENCE; ORGAN IDENTITY; ABSCISIC-ACID	Background: Transcriptome sequencing can be used to determine gene sequences and transcript abundance in non-model species, and the advent of next-generation sequencing (NGS) technologies has greatly decreased the cost and time required for this process. Transcriptome data are especially desirable in bamboo species, as certain members constitute an economically and culturally important group of mostly semelparous plants with remarkable flowering features, yet little bamboo genomic research has been performed. Here we present, for the first time, extensive sequence and transcript abundance data for the floral transcriptome of a key bamboo species, Dendrocalamus latiflorus, obtained using the Illumina GAII sequencing platform. Our further goal was to identify patterns of gene expression during bamboo flower development. Results: Approximately 96 million sequencing reads were generated and assembled de novo, yielding 146,395 high quality unigenes with an average length of 461 bp. Of these, 80,418 were identified as putative homologs of annotated sequences in the public protein databases, of which 290 were associated with the floral transition and 47 were related to flower development. Digital abundance analysis identified 26,529 transcripts differentially enriched between two developmental stages, young flower buds and older developing flowers. Unigenes found at each stage were categorized according to their putative functional categories. These sequence and putative function data comprise a resource for future investigation of the floral transition and flower development in bamboo species. Conclusions: Our results present the first broad survey of a bamboo floral transcriptome. Although it will be necessary to validate the functions carried out by these genes, these results represent a starting point for future functional research on D. latiflorus and related species.	[Zhang, Xue-Mei; Zhao, Lei; Larson-Rabin, Zachary; Li, De-Zhu; Guo, Zhen-Hua] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, XM (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China.	guozhenhua@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Zhao, Lei/0000-0002-2253-5319	Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-YW-N-067]; National Natural Science Foundation of China [30990244]; NSFC-Yunnan province joint foundation [U1136603]; Young Academic and Technical Leader Raising Foundation of Yunnan Province [2008PY065]; Yunnan Provincial Government; Chinese Academy of Sciences [2010312D11035]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Yunnan province joint foundation; Young Academic and Technical Leader Raising Foundation of Yunnan Province; Yunnan Provincial Government; Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This project was supported by the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-YW-N-067); the National Natural Science Foundation of China (30990244); NSFC-Yunnan province joint foundation (U1136603); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry and the Young Academic and Technical Leader Raising Foundation of Yunnan Province (No. 2008PY065, awarded to Z-HG); Yunnan Provincial Government through an innovation team program; the Western Light Talent Culture Project of the Chinese Academy of Sciences (No. 2010312D11035, awarded to X-MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; Benjamini Y, 2001, ANN STAT, V29, P1165; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bouveret R, 2006, DEVELOPMENT, V133, P1693, DOI 10.1242/dev.02340; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Bystriakova N, 2004, UNEP WCMC BIODIVERSI, V19; Bystriakova N, 2003, UNEP WCMC BIODIVERSI, V14; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Choi D, 2004, PLANT CELL PHYSIOL, V45, P897, DOI 10.1093/pcp/pch098; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Colasanti J, 2009, PLANT PHYSIOL, V149, P56, DOI 10.1104/pp.108.130500; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; DARLINGTON CD, 1945, CHROMOSOME ATLAS CUL; Dennis Elizabeth S., 2009, Journal of Biology (London), V8, P57, DOI 10.1186/jbiol156; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Dreni L, 2011, PLANT CELL, V23, P2850, DOI 10.1105/tpc.111.087007; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gechev TS, 2004, CELL MOL LIFE SCI, V61, P1185, DOI 10.1007/s00018-004-4067-2; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; HARBERD NP, 1989, GENETICS, V121, P827; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hayama R, 2002, PLANT CELL PHYSIOL, V43, P494, DOI 10.1093/pcp/pcf059; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hennig L, 2004, PLANT PHYSIOL, V135, P1765, DOI 10.1104/pp.104.043182; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huang YW, 2010, TECHNOL CANCER RES T, V9, P139, DOI 10.1177/153303461000900203; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; INBAR, 1999, SOC ISS CONSTR BAMB; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Jeon JS, 2000, PLANT CELL, V12, P871, DOI 10.1105/tpc.12.6.871; Jiao YL, 2003, PLANT PHYSIOL, V133, P1480, DOI 10.1104/pp.103.029439; John I, 1997, PLANT MOL BIOL, V33, P641, DOI 10.1023/A:1005746831643; Judziewicz EJ, 1999, AM BAMBOOS; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang HG, 1998, PLANT MOL BIOL, V38, P1021, DOI 10.1023/A:1006051911291; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Li H., 2011, CHINESE B BOT, V46, P74, DOI [10.3724/SP.J.1259.2011.00074, DOI 10.3724/SP.J.1259.2011.00074]; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030987; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XL, 2001, ACTA PHYTOTAXON SIN, V39, P433; Lin EP, 2009, PLANTA, V231, P109, DOI 10.1007/s00425-009-1033-0; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Lin XC, 2010, GENET MOL RES, V9, P1085, DOI 10.4238/vol9-2gmr804; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; NADGAUDA RS, 1990, NATURE, V344, P335, DOI 10.1038/344335a0; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Nobuta K, 2010, METHODS MOL BIOL, V592, P89, DOI 10.1007/978-1-60327-005-2_7; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park SJ, 2008, PLANT J, V56, P1018, DOI 10.1111/j.1365-313X.2008.03667.x; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pilcher H. R., 2004, NATURE, DOI [10.1038/news040510-2, DOI 10.1038/NEWS040510-2]; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Riechmann JL, 1998, BIOL CHEM, V379, P633; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Running MP, 1996, DEVELOPMENT, V122, P1261; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sanda SL, 1996, PLANT PHYSIOL, V111, P641, DOI 10.1104/pp.111.2.641; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Schmitz RJ, 2007, GENETICS, V176, P1359, DOI 10.1534/genetics.107.070649; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; SINGLETON WR, 1946, J HERED, V37, P61, DOI 10.1093/oxfordjournals.jhered.a105582; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Tan QKG, 2006, PLANT PHYSIOL, V140, P1095, DOI 10.1104/pp.105.070565; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Tian B, 2005, CHINESE SCI BULL, V50, P217, DOI 10.1360/982004-304; Tian B, 2006, DNA SEQUENCE, V17, P143, DOI 10.1080/10425170600699877; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; TZVELEV NN, 1989, BOT REV, V55, P141, DOI 10.1007/BF02858328; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; van der Knaap E, 2000, PLANT PHYSIOL, V122, P695, DOI 10.1104/pp.122.3.695; Vandenabeele S, 2004, PLANT J, V39, P45, DOI 10.1111/j.1365-313X.2004.02105.x; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Walter KS, 1998, 1997 IUCN RED LIST T; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; Wu CF, 2008, J NEUROGENET, V22, P1, DOI 10.1080/01677060801918016; Wu Man, 2010, Cotton Science, V22, P387; Wu ZY, 2006, FLORAL CHINA POACEAE; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xu H, 2010, BIOTECHNOL LETT, V32, P1961, DOI 10.1007/s10529-010-0362-1; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zahn LM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r101; Zhang DF, 2008, PLANT SCI, V175, P809, DOI 10.1016/j.plantsci.2008.08.002; Zhang GC, 1985, GUANGDONG FOR SCI TE, V85, P16; ZHANG W, 1990, Forest Research, V3, P250; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463	173	82	98	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42082	10.1371/journal.pone.0042082	http://dx.doi.org/10.1371/journal.pone.0042082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916120	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800008
J	Bacanu, SA; Nelson, MR; Whittaker, JC				Bacanu, Silviu-Alin; Nelson, Matthew R.; Whittaker, John C.			Comparison of Statistical Tests for Association between Rare Variants and Binary Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LOCI; MUTATIONS; DISEASES; LINKAGE	Genome-wide association studies have found thousands of common genetic variants associated with a wide variety of diseases and other complex traits. However, a large portion of the predicted genetic contribution to many traits remains unknown. One plausible explanation is that some of the missing variation is due to the effects of rare variants. Nonetheless, the statistical analysis of rare variants is challenging. A commonly used method is to contrast, within the same region (gene), the frequency of minor alleles at rare variants between cases and controls. However, this strategy is most useful under the assumption that the tested variants have similar effects. We previously proposed a method that can accommodate heterogeneous effects in the analysis of quantitative traits. Here we extend this method to include binary traits that can accommodate covariates. We use simulations for a variety of causal and covariate impact scenarios to compare the performance of the proposed method to standard logistic regression, C-alpha, SKAT, and EREC. We found that i) logistic regression methods perform well when the heterogeneity of the effects is not extreme and ii) SKAT and EREC have good performance under all tested scenarios but they can be computationally intensive. Consequently, it would be more computationally desirable to use a two-step strategy by (i) selecting promising genes by faster methods and ii) analyzing selected genes using SKAT/EREC. To select promising genes one can use (1) regression methods when effect heterogeneity is assumed to be low and the covariates explain a non-negligible part of trait variability, (2) C-alpha when heterogeneity is assumed to be large and covariates explain a small fraction of trait's variability and (3) the proposed trend and heterogeneity test when the heterogeneity is assumed to be non-trivial and the covariates explain a large fraction of trait variability.	[Bacanu, Silviu-Alin; Nelson, Matthew R.] GlaxoSmithKline, Quantitat Sci, Res Triangle Pk, NC USA; [Bacanu, Silviu-Alin] Virginia Commonwealth Univ, Richmond, VA USA; [Whittaker, John C.] GlaxoSmithKline, Quantitat Sci, Stevenage, Herts, England	GlaxoSmithKline; Virginia Commonwealth University; GlaxoSmithKline	Bacanu, SA (corresponding author), GlaxoSmithKline, Quantitat Sci, Res Triangle Pk, NC USA.	sabacanu@vcu.edu	Whittaker, John C/B-8609-2012	Whittaker, John C/0000-0002-3529-2379; Bacanu, Silviu-Alin/0000-0002-4364-1583				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Alcais A, 2001, EUR J HUM GENET, V9, P613, DOI 10.1038/sj.ejhg.5200682; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bacanu SA, 2011, GENET EPIDEMIOL, V35, P226, DOI 10.1002/gepi.20570; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hendy GN, 2009, PROG MOL BIOL TRANSL, V89, P31, DOI 10.1016/S1877-1173(09)89003-0; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johansen CT, 2011, ARTERIOSCLER THROMB, DOI [10.1161/ATV-BAHA.111.226365, DOI 10.1161/ATV-BAHA.111.226365]; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MORRIS AP, 2009, GENET EPIDEMIOL; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tzeng JY, 2011, AM J HUM GENET, V89, P277, DOI 10.1016/j.ajhg.2011.07.007; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	30	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42530	10.1371/journal.pone.0042530	http://dx.doi.org/10.1371/journal.pone.0042530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912707	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000307378500018
J	Ruiz-Rodriguez, M; Valdivia, E; Martin-Vivaldi, M; Martin-Platero, AM; Martinez-Bueno, M; Mendez, M; Peralta-Sanchez, JM; Soler, JJ				Ruiz-Rodriguez, Magdalena; Valdivia, Eva; Martin-Vivaldi, Manuel; Martin-Platero, Antonio M.; Martinez-Bueno, Manuel; Mendez, Maria; Peralta-Sanchez, Juan M.; Soler, Juan J.			Antimicrobial Activity and Genetic Profile of Enteroccoci Isolated from Hoopoes Uropygial Gland	PLOS ONE			English	Article							ANTIBIOTIC-PRODUCING BACTERIA; LACTIC-ACID BACTERIA; STREPTOCOCCUS-FAECALIS; SYMBIOTIC BACTERIA; UPUPA-EPOPS; SUBSTANCES; EVOLUTION; DEFENSE; EMBRYOS; FUNGUS	Symbiotic microorganisms may be directly transferred from parents to offspring or acquired from a particular environment that animals may be able to select. If benefits for hosts vary among microbial strains, natural selection may favour hosts holding the most beneficial one. Enterococci symbionts living in the hoopoe (Upupa epops) uropygial gland are able to synthesise bacteriocins (antimicrobial peptides that inhibit the growth of competitor bacteria). We explored variability in genetic profile (through RAPD-PCR analyses) and antimicrobial properties (by performing antagonistic tests against ten bacterial indicator strains) of the different isolates obtained from the uropygial glands of hoopoe females and nestlings. We found that the genetic profile of bacterial isolates was related to antimicrobial activity, as well as to individual host identity and the nest from which samples were obtained. This association suggest that variation in the inhibitory capacity of Enterococci symbionts should be under selection.	[Ruiz-Rodriguez, Magdalena; Soler, Juan J.] CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain; [Ruiz-Rodriguez, Magdalena; Valdivia, Eva; Martin-Vivaldi, Manuel; Martin-Platero, Antonio M.; Martinez-Bueno, Manuel; Peralta-Sanchez, Juan M.; Soler, Juan J.] Univ Granada, CSIC, Grp Coevoluc, Unidad Asociada, Granada, Spain; [Valdivia, Eva; Martinez-Bueno, Manuel; Peralta-Sanchez, Juan M.] Univ Granada, Dept Microbiol, Granada, Spain; [Martin-Vivaldi, Manuel] Univ Granada, Dept Biol Anim, Granada, Spain; [Mendez, Maria] CSIC, Dept Biol Conservac, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; University of Granada; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Ruiz-Rodriguez, M (corresponding author), CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain.	magda@eeza.csic.es	Ruiz-Rodríguez, Magdalena/D-4226-2014; Martin-Platero, Antonio M/H-3201-2018; Martínez-Bueno, Manuel/N-7021-2016; Ruiz-Rodríguez, Magdalena/AAZ-6384-2021; Valdivia, Eva/R-9978-2018; Peralta-Sanchez, Juan M/L-3159-2017; Soler, J. J./H-2363-2011; Martín-Vivaldi, Manuel/F-8256-2016; Martínez, Manuel Martín-Vivaldi/AAJ-6736-2021	Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Martin-Platero, Antonio M/0000-0003-2822-4885; Martínez-Bueno, Manuel/0000-0002-1488-5642; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Valdivia, Eva/0000-0002-9429-9634; Peralta-Sanchez, Juan M/0000-0003-4648-7988; Soler, J. J./0000-0003-2990-1489; Martín-Vivaldi, Manuel/0000-0002-5432-425X; Martínez, Manuel Martín-Vivaldi/0000-0002-5432-425X	FEDER founds [CGL2010-19233-C03-01, CGL2010-19233-C03-03]; Junta de Andalucia [P09-RNM-4557]; Ministerio de Ciencia e Innovacion (Spanish National Government)	FEDER founds(European Commission); Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia e Innovacion (Spanish National Government)	This work was financed by Ministerio de Ciencia e Innovacion (Spanish National Government) and FEDER founds (projects CGL2010-19233-C03-01, and CGL2010-19233-C03-03), and Junta de Andalucia (P09-RNM-4557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel F, 2005, SYST APPL MICROBIOL, V28, P383, DOI 10.1016/j.syapm.2005.01.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banning JL, 2008, OECOLOGIA, V156, P423, DOI 10.1007/s00442-008-1002-5; Bisson IA, 2007, MICROB ECOL, V54, P65, DOI 10.1007/s00248-006-9173-2; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Devriese LA, 1993, J APPL BACTERIOL, V33, P14; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; GILTURNES MS, 1992, BIOL BULL, V182, P105, DOI 10.2307/1542184; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; GRATIA A, 1946, CR SOC BIOL, V140, P1032; Koch AM, 2004, P NATL ACAD SCI USA, V101, P2369, DOI 10.1073/pnas.0306441101; Lindquist N, 2005, P ROY SOC B-BIOL SCI, V272, P1209, DOI 10.1098/rspb.2005.3082; Martin-Platero AM, 2007, ANAL BIOCHEM, V366, P102, DOI 10.1016/j.ab.2007.03.010; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Martin-Vivaldi M, 2006, J AVIAN BIOL, V37, P467, DOI 10.1111/j.0908-8857.2006.03660.x; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; McGarigal K., 2000, MULTIVARIATE STAT WI; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Price P. W., 1980, EVOLUTIONARY BIOL PA; Rajchard J, 2010, VET MED-CZECH, V55, P413, DOI 10.17221/2981-VETMED; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Rossetti L, 2005, J MICROBIOL METH, V63, P135, DOI 10.1016/j.mimet.2005.03.001; Ruiz-Rodriguez M, 2009, J EXP BIOL, V212, P3621, DOI 10.1242/jeb.031336; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; SCHLEIFER KH, 1984, INT J SYST BACTERIOL, V34, P31, DOI 10.1099/00207713-34-1-31; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Todorov SD, 2006, BIOLOGIA, V61, P269, DOI 10.2478/s11756-006-0049-1; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; YAGI Y, 1980, J BACTERIOL, V143, P966, DOI 10.1128/JB.143.2.966-970.1980	34	26	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41843	10.1371/journal.pone.0041843	http://dx.doi.org/10.1371/journal.pone.0041843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911858	Green Published, gold			2022-12-27	WOS:000306751300077
J	Shin, S; Park, E; Lee, DH; Lee, KJ; Heo, JH; Nam, HS				Shin, Soojeong; Park, Eunjeong; Lee, Dong Hyun; Lee, Ki-Jeong; Heo, Ji Hoe; Nam, Hyo Suk			An Objective Pronator Drift Test Application (iPronator) Using Handheld Device	PLOS ONE			English	Article							LESIONS; STROKE; SPEED	Background: The pronator drift test is widely used to detect mild arm weakness. We developed an application that runs on a handheld device to objectify the pronator drift test and investigated its feasibility in stroke patients. Methods: The iPronator application, which uses the built-in accelerometer in handheld devices, was developed. We enrolled acute ischemic stroke patients (n = 10) with mild arm weakness and healthy controls (n = 10) to validate the iPronator. In addition to conventional neurological examinations, the degree of average, maximum, and oscillation in drift and pronation were measured and compared using the iPronator. Follow-up tests using the iPronator were also conducted in the patient group one week later. Results: There was a strong correlation between the average degree of pronation and drift measured by the iPronator (r = 0.741, p<0.001). The degrees of average and maximum in pronation were greater in the patient group than in the control group [in average, 28.9 degrees, interquartile range (IQR) 18.7-40.3 vs. 3.8 degrees (IQR 0.3-7.5), p<0.001], in maximum, 33.0 degrees (IQR 24.0-52.1) vs. 6.2 degrees (IQR 1.4-9.4), p<0.001]. The degree of oscillation in pronation was not different between the groups (p = 0.166). In drift, the degrees of average, maximum, and oscillation were greater in the patient group. In stroke patients, a follow-up study at one week revealed improvements in the degrees of pronation and drift compared with baseline parameters. Conclusions: The iPronator can reliably detect mild arm weakness of stroke patients and was also useful in detecting functional recovery for one week in patients with acute stroke.	[Shin, Soojeong; Lee, Dong Hyun; Lee, Ki-Jeong; Heo, Ji Hoe; Nam, Hyo Suk] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Eunjeong] Ewha Womans Univ, Dept Comp Sci & Engn, Seoul, South Korea	Yonsei University; Yonsei University Health System; Ewha Womans University	Shin, S (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	hsnam@yuhs.ac		Heo, Ji Hoe/0000-0001-9898-3321; NAM, HYO SUK/0000-0002-4415-3995	Korea Government Ministry of Education, Science and Technology [2009-0069165]; Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [A102065, A085136]; Ewha Womans University; Yonsei University College of Medicine [6-2011-0095]	Korea Government Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea; Ewha Womans University; Yonsei University College of Medicine(General Electric)	This study was supported by a grant from the Korea Government Ministry of Education, Science and Technology under Grant (2009-0069165), the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (A102065, A085136), RP-Grant 2012 of Ewha Womans University, and a faculty research grant from Yonsei University College of Medicine for 2009 (6-2011-0095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NE, 2005, J NEUROL NEUROSUR PS, V76, P545, DOI 10.1136/jnnp.2004.043679; Busis N, 2010, NEUROL CLIN, V28, P395, DOI 10.1016/j.ncl.2009.11.001; Choi-Kwon Smi, 2006, J Clin Neurol, V2, P34, DOI 10.3988/jcn.2006.2.1.34; Dobkin BH, 2011, STROKE, V42, P2246, DOI 10.1161/STROKEAHA.110.611095; Kobori S, 2007, INTERNAL MED, V46, P55, DOI 10.2169/internalmedicine.46.6170; Ledger S, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-46; Lee MH, 2011, HEALTHC INFORM RES, V17, P76, DOI 10.4258/hir.2011.17.1.76; Nam HS, 2012, EUR J NEUROL, V19, P426, DOI 10.1111/j.1468-1331.2011.03530.x; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Teitelbaum JS, 2002, CAN J NEUROL SCI, V29, P337, DOI 10.1017/S0317167100002201; Toomey RJ, 2010, AM J ROENTGENOL, V194, P469, DOI 10.2214/AJR.09.3418; Trelease RB, 2008, ANAT SCI EDUC, V1, P233, DOI 10.1002/ase.58; Weaver DF, 2000, NEUROLOGY, V54, P531, DOI 10.1212/WNL.54.2.531	13	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41544	10.1371/journal.pone.0041544	http://dx.doi.org/10.1371/journal.pone.0041544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911811	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300054
J	Braun, KR; DeWispelaere, AM; Bressler, SL; Fukai, N; Kenagy, RD; Chen, LH; Clowes, AW; Kinsella, MG				Braun, Kathleen R.; DeWispelaere, Allison M.; Bressler, Steven L.; Fukai, Nozomi; Kenagy, Richard D.; Chen, Lihua; Clowes, Alexander W.; Kinsella, Michael G.			Inhibition of PDGF-B Induction and Cell Growth by Syndecan-1 Involves the Ubiquitin and SUMO-1 Ligase, Topors	PLOS ONE			English	Article							TOPOISOMERASE-I-BINDING; HEPARAN-SULFATE PROTEOGLYCAN; RING FINGER PROTEIN; CYTOPLASMIC DOMAIN; PDZ PROTEIN; TYROSINE PHOSPHORYLATION; NUCLEAR-LOCALIZATION; SURFACE; GENE; SUPPRESSION	Syndecans are receptors for soluble ligands, including heparin-binding growth factors, and matrix proteins. However, intracellular targets of syndecan-1 (Sdc-1)-mediated signaling are not fully understood. A yeast two-hybrid protein interaction screening of a mouse embryo library identified the ubiquitin and SUMO-1 E3 ligase, Topors, as a novel ligand of the Sdc-1 cytoplasmic domain (S1CD), a finding confirmed by ligand blotting and co-precipitation with Sdc-1 from cell lysates. Deletion mutagenesis identified an 18-amino acid sequence of Topors required for the interaction with the S1CD. By immunohistochemistry, Topors and Sdc-1 co-localized near the cell periphery in normal murine mammary gland (NMuMG) cells in vitro and in mouse embryonic epithelia in vivo. Finally, siRNA-mediated knockdown of Topors demonstrated that Topors is a growth promoter for murine arterial smooth muscle cells and is required for the inhibitory effect of Sdc-1 on cell growth and platelet-derived growth factor-B induction. These data suggest a novel mechanism for the inhibitory effects of Sdc-1 on cell growth that involves the interaction between the cytoplasmic domain of Sdc-1 and the SUMO-1 E3 ligase, Topors.	[Braun, Kathleen R.; DeWispelaere, Allison M.; Bressler, Steven L.; Kinsella, Michael G.] Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA; [Fukai, Nozomi; Kenagy, Richard D.; Chen, Lihua; Clowes, Alexander W.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Braun, KR (corresponding author), Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA.	mkinsella@benaroyaresearch.org		Kenagy, Richard/0000-0002-2021-5565	American Heart Association [0355478Z]; Pacific Mountain Affiliate of the American Heart Association; National Institutes of Health (NIH) [HL52459, HL30946]; USAMRAA/DOD [W81XWH-07-01-0246]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030946, R37HL052459, R01HL052459, R01HL092928] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Pacific Mountain Affiliate of the American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAMRAA/DOD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant-in-Aid 0355478Z (Dr. Kinsella); Pacific Mountain Affiliate of the American Heart Association (Dr. Fukai) www.heart.org; National Institutes of Health (NIH) grants HL52459 and HL30946 (Dr. Clowes) grants.nih.gov; USAMRAA/DOD grant W81XWH-07-01-0246 (Dr. Kinsella). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; Baciu PC, 2000, J CELL SCI, V113, P315; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BJERRUM OJ, 1989, J CHROMATOGR, V470, P351, DOI 10.1016/S0021-9673(01)83563-9; Bowne SJ, 2008, MOL VIS, V14, P922; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; Fukai N, 2009, ARTERIOSCL THROM VAS, V29, P1356, DOI 10.1161/ATVBAHA.109.190132; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Guan B, 2008, J BIOL CHEM, V283, P4834, DOI 10.1074/jbc.M708630200; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hu YP, 2010, NEOPLASIA, V12, P826, DOI 10.1593/neo.10586; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; JALKANEN M, 1991, BIOCHEM SOC T, V19, P1069, DOI 10.1042/bst0191069; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kikuno K, 1998, BIOCHEM BIOPH RES CO, V253, P519, DOI 10.1006/bbrc.1998.9782; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Kovalszky I, 1998, MOL CELL BIOCHEM, V183, P11, DOI 10.1023/A:1006898920637; Koyama N, 1996, AM J PATHOL, V148, P749; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lemos TA, 2006, CELL BIOCHEM BIOPHYS, V44, P463, DOI 10.1385/CBB:44:3:463; LEPPA S, 1991, CELL REGUL, V2, P1; Lin L, 2005, ONCOGENE, V24, P3385, DOI 10.1038/sj.onc.1208554; Maniatis T, 1982, MOL CLONING LABORATO, P433; MIETTINEN HM, 1994, MOL BIOL CELL, V5, P1325, DOI 10.1091/mbc.5.12.1325; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Ojeh N, 2008, J CELL SCI, V121, P2705, DOI 10.1242/jcs.025643; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; Oyanagi H, 2004, LUNG CANCER, V46, P21, DOI 10.1016/j.lungcan.2004.03.009; POLSON A, 1990, IMMUNOL INVEST, V19, P253; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; Richardson TP, 2001, J CELL SCI, V114, P1613; Ridgway LD, 2011, EXP THER MED, V2, P229, DOI 10.3892/etm.2010.189; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Saleem A, 2004, ONCOGENE, V23, P5293, DOI 10.1038/sj.onc.1207700; Secombe J, 2004, J BIOL CHEM, V279, P17126, DOI 10.1074/jbc.M310097200; Shinbo YM, 2005, INT J ONCOL, V26, P641; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun RJ, 2009, BIOCHEM J, V419, P457, DOI 10.1042/BJ20080515; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Volk R, 1999, J BIOL CHEM, V274, P24417, DOI 10.1074/jbc.274.34.24417; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Yang XM, 2009, J BIOL CHEM, V284, P28775, DOI 10.1074/jbc.M109.017681; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	73	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43701	10.1371/journal.pone.0043701	http://dx.doi.org/10.1371/journal.pone.0043701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912899	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700127
J	Fu, YY; Nergard, JC; Barnette, NK; Wang, YL; Chai, KX; Chen, LM				Fu, Ya-Yuan; Nergard, Jennifer C.; Barnette, Nicole K.; Wang, Yan-Ling; Chai, Karl X.; Chen, Li-Mei			Proteasome Inhibition Augments Cigarette Smoke-Induced GM-CSF Expression in Trophoblast Cells via the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; MATERNAL SMOKING; TOBACCO USE; PREECLAMPSIA; PREGNANCY; WOMEN; ACTIVATION; PLACENTA; MICE	Maternal cigarette smoking has adverse effects on pregnancy outcomes. The granulocyte-macrophage colony-stimulating factor (GM-CSF) is an essential cytokine for a normal pregnancy. We investigated the impact of cigarette smoke extract (CSE) on GM-CSF expression in human cytotrophoblast cells and suggested a cellular mechanism underlying the CSE-induced GM-CSF expression. An immortalized normal human trophoblast cell line (B6Tert-1) was treated with CSE. The viability and proliferation of the CSE-treated B6Tert-1 cells were evaluated, and the expression of GM-CSF in these cells was quantified at the mRNA and the protein levels by means of reverse-transcription and quantitative polymerase chain reaction (RT-qPCR); and enzyme-linked immunosorbent assay (ELISA), respectively. Human trophoblast cells treated with CSE had an increased expression of GM-CSF at both the mRNA and the protein levels. The CSE-induced GM-CSF expression was synergistically enhanced by the addition of the proteasome inhibitor MG-132, but inhibited by AG-1478, an inhibitor of the epidermal growth factor receptor (EGFR) kinase. Furthermore, CSE treatment increased the phosphorylation of the extracellular-signal regulated kinases (ERK1/2) in the trophoblast cells. The expression of other growth factors such as heparin-binding epidermal growth factor-like growth factor (HB-EGF) and vascular endothelial growth factor (VEGF) was also evaluated. Our data suggested that cigarette smoking and proteasome inhibition synergistically up-regulate GM-CSF cytokine expression by activating the EGFR signaling pathway.	[Fu, Ya-Yuan; Wang, Yan-Ling] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Nergard, Jennifer C.; Barnette, Nicole K.; Chai, Karl X.; Chen, Li-Mei] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; State University System of Florida; University of Central Florida	Fu, YY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	lchen@mail.ucf.edu			Florida Department of Health [06NIR-03, 10KT-1]	Florida Department of Health	This work was supported by the Florida Department of Health James & Esther King Biomedical Research Program grants 06NIR-03 to LMC and 10KT-1 (Project 5) to KXC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belo L, 2003, HYPERTENS PREGNANCY, V22, P129, DOI 10.1081/PRG-120021059; BENOWITZ NL, 1988, CLIN PHARMACOL THER, V44, P23, DOI 10.1038/clpt.1988.107; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; Bernhard D, 2003, FASEB J, V17, P2302, DOI 10.1096/fj.03-0312fje; Chaouat G, 1990, J REPROD FERTIL, V89, P4474; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; de Haas J H, 1975, Eur J Obstet Gynecol Reprod Biol, V5, P283, DOI 10.1016/0028-2243(75)90038-6; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; DUFFUS GM, 1968, LANCET, V1, P994; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Gangl K, 2009, ALLERGY, V64, P398, DOI 10.1111/j.1398-9995.2008.01861.x; GARCIALLORET MI, 1994, EXP CELL RES, V214, P46, DOI 10.1006/excr.1994.1232; Gratacos E, 1998, OBSTET GYNECOL, V92, P849, DOI 10.1016/S0029-7844(98)00300-7; GREER IA, 1994, OBSTET GYNECOL, V84, P937; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Hass R, 2003, PLACENTA, V24, P979, DOI 10.1016/S0143-4004(03)00174-7; Hayashi M, 2004, AM J OBSTET GYNECOL, V190, P456, DOI 10.1016/j.ajog.2003.07.032; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Horta BL, 1997, PAEDIATR PERINAT EP, V11, P140, DOI 10.1046/j.1365-3016.1997.d01-17.x; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; JOKHI PP, 1994, HUM REPROD, V9, P1660, DOI 10.1093/oxfordjournals.humrep.a138769; Jonsson Y, 2006, J REPROD IMMUNOL, V70, P83, DOI 10.1016/j.jri.2005.10.007; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; KLONOFFCOHEN H, 1993, OBSTET GYNECOL, V81, P541; Mascia F, 2010, J INVEST DERMATOL, V130, P682, DOI 10.1038/jid.2009.336; Masubuchi T, 1998, AM J PATHOL, V153, P1903, DOI 10.1016/S0002-9440(10)65704-5; Rajakumar A, 2008, PLACENTA, V29, P290, DOI 10.1016/j.placenta.2007.11.015; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Robertson SA, 1999, BIOL REPROD, V60, P251, DOI 10.1095/biolreprod60.2.251; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Salafia C, 1999, PLACENTA, V20, P273, DOI 10.1053/plac.1998.0378; Savion S, 2002, REPRODUCTION, V123, P399, DOI 10.1530/reprod/123.3.399; SCHRECK R, 1990, MOL CELL BIOL, V10, P1281, DOI 10.1128/MCB.10.3.1281; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Shibata T, 2002, IMMUNOL CELL BIOL, V80, P226, DOI 10.1046/j.1440-1711.2002.01079.x; Shiverick KT, 1999, PLACENTA, V20, P265, DOI 10.1053/plac.1998.0377; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; TARTAKOVSKY B, 1991, DEV BIOL, V146, P345, DOI 10.1016/0012-1606(91)90236-V; Wang HJ, 2001, AM J RESP CELL MOL, V25, P772, DOI 10.1165/ajrcmb.25.6.4458; Wang Y, 2006, MOL HUM REPROD, V12, P451, DOI 10.1093/molehr/gal054; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; Wu WKK, 2010, AUTOPHAGY, V6, P228, DOI 10.4161/auto.6.2.11042; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003; Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P1437, DOI 10.1016/j.freeradbiomed.2012.01.024	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43042	10.1371/journal.pone.0043042	http://dx.doi.org/10.1371/journal.pone.0043042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912784	Green Published, gold			2022-12-27	WOS:000308063700033
J	Le Bigot, N; Grosjean, M				Le Bigot, Nathalie; Grosjean, Marc			Effects of Handedness on Visual Sensitivity in Perihand Space	PLOS ONE			English	Article							REACTION-TIME; RIGHT-HANDERS; ATTENTION	Recent studies have shown that changes in visual processing in perihand space are limited to the area around the right hand, at least in right-handers. One explanation for these findings is that perception is altered at locations where action is more likely to occur. To test this notion, we asked both right- and left-handers to perform an unspeeded visual discrimination task under four hand-position configurations: Left hand, right hand, both hands, or no hands near the display. Compared to the no-hands (control) condition, visual sensitivity (d') was higher in the dominant-hand condition for right-handers and higher in the dominant- as well as the non-dominant hand condition for left-handers. When both hands were near the display, sensitivity was similar to that in the dominant- hand condition for right-handers and to that in the non-dominant hand condition for left-handers. This shows that performance differed between the two handedness groups when their non-dominant hand was near the display (both alone and accompanied by their dominant hand). Thus, the pattern for left-handers did not correspond to a mirror image of the pattern for right-handers. In line with studies on bimanual action control, visual processing in perihand space seems to be determined by the different ways in which left- and right-handers use their hands.	[Le Bigot, Nathalie; Grosjean, Marc] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Le Bigot, N (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	lebigot@ifado.de			Deutsche Forschungsgemeinschaft [Ja 747/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (Grant Ja 747/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2008, COGNITION, V107, P1035, DOI 10.1016/j.cognition.2007.09.006; Bridgeman B, 2011, PHYS LIFE REV, V8, P73, DOI 10.1016/j.plrev.2011.01.002; Buckingham G, 2011, CORTEX, V47, P432, DOI 10.1016/j.cortex.2009.11.003; Cosman JD, 2010, PSYCHOL SCI, V21, P1254, DOI 10.1177/0956797610380697; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; COWEY A, 1974, EXP BRAIN RES, V21, P447; Davoli CC, 2010, MEM COGNITION, V38, P555, DOI 10.3758/MC.38.5.555; Dufour A, 2008, EXP BRAIN RES, V190, P91, DOI 10.1007/s00221-008-1453-2; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Franz EA, 2004, J MOTOR BEHAV, V36, P71, DOI 10.3200/JMBR.36.1.71-81; Goble DJ, 2008, NEUROSCI BIOBEHAV R, V32, P598, DOI 10.1016/j.neubiorev.2007.10.006; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Knoblich G., 2006, HUMAN BODY PERCEPTIO; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Lloyd DM, 2010, BRAIN COGNITION, V73, P102, DOI 10.1016/j.bandc.2010.03.006; Macmillan N. A., 1991, DETECTION THEORY USE; Moore CM, 1998, PSYCHOL SCI, V9, P104, DOI 10.1111/1467-9280.00019; Moore CM, 1998, J EXP PSYCHOL HUMAN, V24, P1296, DOI 10.1037/0096-1523.24.4.1296; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; POSNER MI, 1987, NEUROPSYCHOLOGIA, V25, P135, DOI 10.1016/0028-3932(87)90049-2; Prinzmetal W, 2005, J EXP PSYCHOL GEN, V134, P73, DOI 10.1037/0096-3445.134.1.73; Reed CL, 2010, ATTEN PERCEPT PSYCHO, V72, P236, DOI 10.3758/APP.72.1.236; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Shen YC, 2005, J MOTOR BEHAV, V37, P3, DOI 10.3200/JMBR.37.1.3-9; Tseng P, 2011, EXP BRAIN RES, V209, P257, DOI 10.1007/s00221-011-2544-z; Wandell B.A., 1995, FDN VISION	30	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43150	10.1371/journal.pone.0043150	http://dx.doi.org/10.1371/journal.pone.0043150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912813	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700050
J	Salgado, A; Oliver, ALS; Matia-Gonzalez, AM; Sotelo, J; Zarco-Fernandez, S; Munoz-Olivas, R; Camara, C; Rodriguez-Gabriel, MA				Salgado, Alejandro; Lopez-Serrano Oliver, Ana; Matia-Gonzalez, Ana M.; Sotelo, Jael; Zarco-Fernandez, Sonia; Munoz-Olivas, Riansares; Camara, Carmen; Rodriguez-Gabriel, Miguel A.			Response to Arsenate Treatment in Schizosaccharomyces pombe and the Role of Its Arsenate Reductase Activity	PLOS ONE			English	Article							DNA-REPAIR PROCESSES; CELL-CYCLE CONTROL; PROTEIN-KINASE; FISSION YEAST; ARSENITE; METABOLITES; TOLERANCE; PATHWAY; MITOSIS; WATER	Arsenic toxicity has been studied for a long time due to its effects in humans. Although epidemiological studies have demonstrated multiple effects in human physiology, there are many open questions about the cellular targets and the mechanisms of response to arsenic. Using the fission yeast Schizosaccharomyces pombe as model system, we have been able to demonstrate a strong activation of the MAPK Spc1/Sty1 in response to arsenate. This activation is dependent on Wis1 activation and Pyp2 phosphatase inactivation. Using arsenic speciation analysis we have also demonstrated the previously unknown capacity of S. pombe cells to reduce As (V) to As (III). Genetic analysis of several fission yeast mutants point towards the cell cycle phosphatase Cdc25 as a possible candidate to carry out this arsenate reductase activity. We propose that arsenate reduction and intracellular accumulation of arsenite are the key mechanisms of arsenate tolerance in fission yeast.	[Salgado, Alejandro; Matia-Gonzalez, Ana M.; Sotelo, Jael; Rodriguez-Gabriel, Miguel A.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Lopez-Serrano Oliver, Ana; Zarco-Fernandez, Sonia; Munoz-Olivas, Riansares; Camara, Carmen] Univ Complutense Madrid, Fac CC Quim, Dept Quim Analit, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Complutense University of Madrid	Salgado, A (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	marodriguez@cbm.uam.es	Gonzalez, Ana M. Matia/N-3371-2019; Muñoz-Olivas, Riansares/K-4491-2014; Rodriguez-Gabriel, Miguel/L-2425-2013	Gonzalez, Ana M. Matia/0000-0002-8127-4219; Muñoz-Olivas, Riansares/0000-0003-4385-9520; Rodriguez-Gabriel, Miguel/0000-0002-6855-5286; Salgado, Alejandro/0000-0002-9582-3135	Spanish Science and Innovation Ministry [CTQ2008-01031/BQU, BFU2006/01767, BFU2009/09116]; Madrid government; Spanish Ministry of Science and Innovation	Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Madrid government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by Projects CTQ2008-01031/BQU from Spanish Science and Innovation Ministry. JS was supported by Madrid government and AMMG by Spanish Ministry of Science and Innovation. This research was supported by grants awarded to MARG by the Spanish Science and Innovation Ministry (BFU2006/01767 and BFU2009/09116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SA, 2001, ENVIRON HEALTH PERSP, V109, P629, DOI 10.2307/3455038; Bhattacharjee H, 2010, BIOCHEMISTRY-US, V49, P802, DOI 10.1021/bi9019127; Chakraborti D, 2003, ENVIRON HEALTH PERSP, V111, P1194, DOI 10.1289/ehp.5966; Chakraborti D, 2002, TALANTA, V58, P3, DOI 10.1016/S0039-9140(02)00270-9; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Ellis DR, 2006, PLANT PHYSIOL, V141, P1544, DOI 10.1104/pp.106.084079; Hartwig A, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110s5797; Hartwig A, 2003, TOXICOLOGY, V193, P161, DOI 10.1016/j.tox.2003.08.004; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Matia-Gonzalez AM, 2011, YEAST, V28, P9, DOI 10.1002/yea.1816; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Mukhopadhyay R, 1998, FEMS MICROBIOL LETT, V168, P127, DOI 10.1016/S0378-1097(98)00430-3; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Rodriguez-Gabriel MA, 2005, EUKARYOT CELL, V4, P1396, DOI 10.1128/EC.4.8.1396-1402.2005; Sanz E, 2005, J CHROMATOGR A, V1097, P1, DOI 10.1016/j.chroma.2005.08.012; Schwerdtle T, 2003, DNA REPAIR, V2, P1449, DOI 10.1016/j.dnarep.2003.09.001; Schwerdtle T, 2003, CARCINOGENESIS, V24, P967, DOI 10.1093/carcin/bgg018; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; Sotelo J, 2006, EUKARYOT CELL, V5, P1826, DOI 10.1128/EC.00225-06; Tsai SL, 2009, CURR OPIN BIOTECH, V20, P659, DOI 10.1016/j.copbio.2009.09.013; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wysocki R, 2003, BIOCHEM BIOPH RES CO, V304, P293, DOI 10.1016/S0006-291X(03)00584-9; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	24	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43208	10.1371/journal.pone.0043208	http://dx.doi.org/10.1371/journal.pone.0043208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912829	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700061
J	Tong, RJ; Purser, A; Unnithan, V; Guinan, J				Tong, Ruiju; Purser, Autun; Unnithan, Vikram; Guinan, Janine			Multivariate Statistical Analysis of Distribution of Deep-Water Gorgonian Corals in Relation to Seabed Topography on the Norwegian Margin	PLOS ONE			English	Article							LOPHELIA-PERTUSA SCLERACTINIA; PREDICTING SUITABLE HABITAT; FOOD-SUPPLY MECHANISMS; ROCKALL TROUGH MARGIN; CONTINENTAL MARGINS; NE ATLANTIC; PRIMNOA-RESEDAEFORMIS; REEF; GROWTH; BANK	Investigating the relationship between deep-water coral distribution and seabed topography is important for understanding the terrain habitat selection of these species and for the development of predictive habitat models. In this study, the distribution of the deep-water gorgonians, Paragorgia arborea and Primnoa resedaeformis, in relation to terrain variables at multiple scales of 30 m, 90 m and 170 m were investigated at Rost Reef, Traena Reef and Sotbakken Reef on the Norwegian margin, with Ecological Niche Factor Analysis applied. To date, there have been few published studies investigating this aspect of gorgonian distribution. A similar correlation between the distribution of P. arborea and P. resedaeformis and each particular terrain variable was found at each study site, but the strength of the correlation between each variable and distribution differed by reef. The terrain variables of bathymetric position index (BPI) and curvature at analysis scales of 90 m or 170 m were most strongly linked to the distribution of both species at the three geographically distinct study sites. Both gorgonian species tended to inhabit local topographic highs across all three sites, particularly at Sotbakken Reef and Traena Reef, with both species observed almost exclusively on such topographic highs. The tendency for observed P. arborea to inhabit ridge crests at Rost Reef was much greater than was indicated for P. resedaeformis. This investigation identifies the terrain variables which most closely correlate with distribution of these two gorgonian species, and analyzes their terrain habitat selection; further development of predictive habitat models may be considered essential for effective management of these species.	[Tong, Ruiju; Purser, Autun; Unnithan, Vikram] Univ Bremen, D-28359 Bremen, Germany; [Guinan, Janine] Geol Survey Ireland, INFOMAR, Marine & Geophys Programme, Dublin, Ireland	University of Bremen	Tong, RJ (corresponding author), Univ Bremen, D-28359 Bremen, Germany.	r.tong@jacobs-university.de	Unnithan, Vikram/I-2441-2013	Unnithan, Vikram/0000-0002-4656-3824; Purser, Autun/0000-0001-5427-0151	China Scholarship Council; ESSReS (Earth System Science Research School); European Community [226354]	China Scholarship Council(China Scholarship Council); ESSReS (Earth System Science Research School); European Community(European Commission)	This work was funded by a scholarship from China Scholarship Council, and a scholarship prolongation from ESSReS (Earth System Science Research School) to R. Tong. Additional funding to A. Purser was provided through the European Community's Seventh Framework programme (FP7/2007-2013) under the HERMIONE (Hotspot Ecosystem Research and Man's Impact ON European Seas) project, grant agreement no. 226354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani M, 2004, INT J GEOGR INF SCI, V18, P577, DOI 10.1080/13658810410001701987; Andrews AH, 2002, HYDROBIOLOGIA, V471, P101, DOI 10.1023/A:1016501320206; Basille M, 2008, ECOL MODEL, V211, P233, DOI 10.1016/j.ecolmodel.2007.09.006; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; Buhl-Mortensen L, 2005, ERLANGEN EARTH C SER, P849, DOI 10.1007/3-540-27673-4_44; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Buhl-Mortensen P, 2009, ICES J MAR SCI, V66, P2026, DOI 10.1093/icesjms/fsp200; Carlier A, 2009, MAR ECOL PROG SER, V397, P125, DOI 10.3354/meps08361; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; de Haas H, 2009, FACIES, V55, P1, DOI 10.1007/s10347-008-0157-1; Dodds LA, 2009, MAR ECOL PROG SER, V397, P113, DOI 10.3354/meps08143; Dolan MFJ, 2008, DEEP-SEA RES PT I, V55, P1564, DOI 10.1016/j.dsr.2008.06.010; Dolan MFJ, 2009, NORW J GEOL, V89, P17; Dorschel B, 2007, MAR GEOL, V244, P184, DOI 10.1016/j.margeo.2007.06.010; Duineveld GCA, 2004, MAR ECOL PROG SER, V277, P13, DOI 10.3354/meps277013; Duineveld GCA, 2007, B MAR SCI, V81, P449; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; Fossa J.H., 2004, PROTECTION MANAGEMEN; Fossa JH, 2005, ERLANGEN EARTH C SER, P359, DOI 10.1007/3-540-27673-4_18; Fossa Skjoldal H.R, 2010, HDB MARINE FISHERIES, P215; Freiwald A, 1999, SEDIMENT GEOL, V125, P1, DOI 10.1016/S0037-0738(98)00142-0; Freiwald A, 2002, FACIES, V47, P179, DOI 10.1007/BF02667712; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Guinan J, 2009, ECOL INFORM, V4, P83, DOI 10.1016/j.ecoinf.2009.01.004; Guinan J, 2009, MAR ECOL PROG SER, V375, P125, DOI 10.3354/meps07739; Heindel K, 2010, CONT SHELF RES, V30, P1814, DOI 10.1016/j.csr.2010.08.007; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Kiriakoulakis K, 2007, INT J EARTH SCI, V96, P159, DOI 10.1007/s00531-006-0078-6; Leverette TL, 2005, ERLANGEN EARTH C SER, P467, DOI 10.1007/3-540-27673-4_23; Lindberg B, 2007, INT J EARTH SCI, V96, P201, DOI 10.1007/s00531-005-0495-y; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Mienis F, 2009, DEEP-SEA RES PT I, V56, P1026, DOI 10.1016/j.dsr.2009.01.006; Moje A., 2011, EXPEDITION RES VESSE, P32; Mortensen P, 2005, MAR BIOL, V147, P775, DOI 10.1007/s00227-005-1604-y; Mortensen PB, 2009, NORW J GEOL, V89, P163; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2004, MAR BIOL, V144, P1223, DOI 10.1007/s00227-003-1280-8; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Murillo FJ, 2011, ICES J MAR SCI, V68, P319, DOI 10.1093/icesjms/fsq071; Orvik KA, 2001, DEEP-SEA RES PT I, V48, P937, DOI 10.1016/S0967-0637(00)00038-8; Ottesen D, 2008, QUATERNARY SCI REV, V27, P922, DOI 10.1016/j.quascirev.2008.01.014; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2005, ERLANGEN EARTH C SER, P483, DOI 10.1007/3-540-27673-4_24; Roberts JM, 2003, MAR POLLUT BULL, V46, P7, DOI 10.1016/S0025-326X(02)00259-X; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Ruggeberg A, 2011, MAR GEOL, V282, P5, DOI 10.1016/j.margeo.2010.05.009; Sherwood OA, 2009, CAN J FISH AQUAT SCI, V66, P142, DOI 10.1139/F08-195; TENDAL OS, 1992, SARSIA, V77, P213, DOI 10.1080/00364827.1992.10413506; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; Thomsen L, 2000, DEEP-SEA RES PT I, V47, P1881, DOI 10.1016/S0967-0637(00)00003-0; THOMSEN L, 2002, OCEAN MARGIN SYSTEMS, P143; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25; White M, 2007, INT J EARTH SCI, V96, P1, DOI 10.1007/s00531-006-0099-1; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962	62	36	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43534	10.1371/journal.pone.0043534	http://dx.doi.org/10.1371/journal.pone.0043534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912887	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000308063700115
J	Zhou, B; Liu, J; Wang, ZM; Xi, T				Zhou, Bo; Liu, Jing; Wang, Ze-Mu; Xi, Tao			C-Reactive Protein, Interleukin 6 and Lung Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							CIRCULATING LEVELS; INFLAMMATORY MARKERS; TREND ESTIMATION; SURVIVAL; ASSOCIATION; COMMON	Purpose: Epidemiologic findings are inconsistent concerning the associations between C-reactive protein (CRP), interleukin 6 (IL-6) and lung cancer risk. We conducted a meta-analysis of epidemiologic studies to examine these associations. Methods: A systematic literature search up to October 2011 was performed in MEDLINE and EMBASE. Study-specific risk estimates were pooled using a random-effects model. Results: The 10 studies on CRP involved a total of 1918 lung cancer cases. The pooled RR of lung cancer for one unit change in natural logarithm (ln) CRP was 1.28 (95% CI 1.17-1.41). There was no statistically significant heterogeneity among studies (P = 0.116; I-2 = 36.6%). We also found that CRP was significantly associated with increased risk of lung cancer among men (RR 1.18, 95% CI 1.09-1.28) but not among women. The 5 studies on IL-6 involved a total of 924 lung cancer cases. The pooled RR of lung cancer for one unit change in ln IL-6 was 1.28 (95% CI 0.92-1.79), however, statistically significant heterogeneity was found. After excluding the study contributing most to the heterogeneity, the summary estimate was essentially unchanged. Conclusion: CRP was associated with increased risk of lung cancer, especially among men. There was no significant association between IL-6 and lung cancer risk.	[Zhou, Bo; Xi, Tao] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zhou, Bo; Liu, Jing] Nanjing Univ Technol, Jiangsu Ctr Safety Evaluat Drugs, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Ze-Mu] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing Tech University; Nanjing Medical University	Zhou, B (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.	xitao_18@hotmail.com	Wang, Ze-Mu/F-8243-2010	Wang, Ze-Mu/0000-0003-2517-7382; Xi, Tao/0000-0001-8065-2639				Alifano M, 2011, J THORAC CARDIOV SUR, V142, P1161, DOI 10.1016/j.jtcvs.2011.07.021; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Chaturvedi AK, 2010, J CLIN ONCOL, V28, P2719, DOI 10.1200/JCO.2009.27.0454; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P215, DOI 10.1158/1055-9965.EPI-08-0705; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gagnon B, 2010, BRIT J CANCER, V102, P1113, DOI 10.1038/sj.bjc.6605603; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hara M, 2007, ANTICANCER RES, V27, P3001; Hara M, 2010, ANN THORAC CARDIOVAS, V16, P85; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Il'yasova D, 2005, CANCER EPIDEM BIOMAR, V14, P2413, DOI 10.1158/1055-9965.EPI-05-0316; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kasymjanova G, 2010, CURR ONCOL, V17, P52; Koch A, 2009, J THORAC ONCOL, V4, P326, DOI 10.1097/JTO.0b013e31819578c8; Lee S, 2011, J EPIDEMIOL, V21, P161, DOI 10.2188/jea.JE20100128; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mojtahedi Z, 2011, PATHOL ONCOL RES, V17, P7, DOI 10.1007/s12253-010-9261-y; O'Dowd C, 2010, J THORAC ONCOL, V5, P988, DOI 10.1097/JTO.0b013e3181da78f9; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Pine SR, 2011, JNCI-J NATL CANCER I, V103, P1112, DOI 10.1093/jnci/djr216; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Scott HR, 2001, LUNG CANCER, V32, P307, DOI 10.1016/S0169-5002(00)00244-0; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Silva ID, 2010, INT J EPIDEMIOL, V39, P699, DOI 10.1093/ije/dyq012; Suzuki K, 2006, CANCER EPIDEM BIOMAR, V15, P1733, DOI 10.1158/1055-9965.EPI-06-0005; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Travis WD, 2011, SEMIN RESP CRIT CARE, V32, P22, DOI 10.1055/s-0031-1272866; Trichopoulos D, 2006, CANCER EPIDEM BIOMAR, V15, P381, DOI 10.1158/1055-9965.EPI-05-0626; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; Van Hemelrijck M, 2011, CANCER EPIDEM BIOMAR, V20, P428, DOI 10.1158/1055-9965.EPI-10-1190; Wilop S, 2008, ONKOLOGIE, V31, P665, DOI 10.1159/000165054; YANAGAWA H, 1995, BRIT J CANCER, V71, P1095, DOI 10.1038/bjc.1995.212; Yu YY, 2008, ARCH INTERN MED, V168, P2326, DOI 10.1001/archinte.168.21.2326	45	11	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43075	10.1371/journal.pone.0043075	http://dx.doi.org/10.1371/journal.pone.0043075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912790	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700037
J	Kinoshita, SM; Krutzik, PO; Nolan, GP				Kinoshita, Shigemi M.; Krutzik, Peter O.; Nolan, Garry P.			COP9 Signalosome Component JAB1/CSN5 Is Necessary for T Cell Signaling through LFA-1 and HIV-1 Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ADHESION RECEPTOR LFA-1; TRANSCRIPTION FACTORS; PEPTIDE LIBRARIES; TYPE-1 INFECTION; NUCLEAR FACTOR; ACTIVATION; EXPRESSION; INHIBITORS; INTERACTS	To determine critical host factors involved in HIV-1 replication, a dominant effector genetics approach was developed to reveal signaling pathways on which HIV-1 depends for replication. A large library of short peptide aptamers was expressed via retroviral delivery in T cells. Peptides that interfered with T cell activation-dependent processes that might support HIV-1 replication were identified. One of the selected peptides altered signaling, lead to a difference in T cell activation status, and inhibited HIV-1 replication. The target of the peptide was JAB1/CSN5, a component of the signalosome complex. JAB1 expression overcame the inhibition of HIV-1 replication in the presence of peptide and also promoted HIV-1 replication in activated primary CD4(+) T cells. This peptide blocked physiological release of JAB1 from the accessory T cell surface protein LFA-1, downstream AP-1 dependent events, NFAT activation, and HIV-1 replication. Thus, genetic selection for intracellular aptamer inhibitors of host cell processes proximal to signals at the immunological synapse of T cells can define unique mechanisms important to HIV-1 replication.	[Kinoshita, Shigemi M.] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Suita, Osaka, Japan; [Kinoshita, Shigemi M.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Krutzik, Peter O.; Nolan, Garry P.] Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; [Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Osaka University; Jefferson University; Stanford University; Stanford University	Kinoshita, SM (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Suita, Osaka, Japan.	shigemik@biken.osaka-u.ac.jp	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	National Institutes of Health [AI56920]; Ministry of Education, Culture, Sports, Science and Technology, Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI56920 and a grant-in-aid from the 21st Century COE Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Chauchereau A, 2000, J BIOL CHEM, V275, P8540, DOI 10.1074/jbc.275.12.8540; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; DUSTIN ML, 1989, COLD SPRING HARB SYM, V54, P753; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; HARPER JW, 1993, CELL, V75, P805; HILDRETH JEK, 1989, SCIENCE, V244, P1075, DOI 10.1126/science.2543075; Hioe CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023202; Hioe CE, 1998, AIDS RES HUM RETROV, V14, pS247; Hioe CE, 2001, J VIROL, V75, P1077, DOI 10.1128/JVI.75.2.1077-1082.2001; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Kinoshita SM, 2008, P NATL ACAD SCI USA, V105, P15022, DOI 10.1073/pnas.0807269105; Kinsella TM, 2002, J BIOL CHEM, V277, P37512, DOI 10.1074/jbc.M206162200; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Macian F, 1999, MOL CELL BIOL, V19, P3645, DOI 10.1128/mcb.19.5.3645; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; MARKOVITZ DM, 1990, P NATL ACAD SCI USA, V87, P9098, DOI 10.1073/pnas.87.23.9098; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NORCROSS MA, 1984, ANN INST PASTEUR IMM, VD135, P113, DOI 10.1016/S0769-2625(84)81105-8; Nordgard O, 2001, BIOCHIMIE, V83, P969, DOI 10.1016/S0300-9084(01)01329-3; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Peelle B, 2001, CHEM BIOL, V8, P521, DOI 10.1016/S1074-5521(01)00031-X; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; Swift S., 1999, CURRENT PROTOCOL S31; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; Vincenti MP, 2001, J CLIN INVEST, V108, P181; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Xu X, 2001, NAT GENET, V27, P23, DOI 10.1038/83717; ZACK JA, 1988, SCIENCE, V240, P1026, DOI 10.1126/science.2835813; ZAGURY D, 1986, SCIENCE, V231, P850, DOI 10.1126/science.2418502	51	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41725	10.1371/journal.pone.0041725	http://dx.doi.org/10.1371/journal.pone.0041725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911848	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300067
J	Liu, JH; Mak, TCP; Banigesh, A; Desai, K; Wang, R; Wu, LY				Liu, Jianghai; Mak, Timothy Chun-Ping; Banigesh, Ali; Desai, Kaushik; Wang, Rui; Wu, Lingyun			Aldolase B Knockdown Prevents High Glucose-Induced Methylglyoxal Overproduction and Cellular Dysfunction in Endothelial Cells	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-C; NF-KAPPA-B; DEPENDENT PATHWAY; ALDOSE REDUCTASE; OXIDATIVE STRESS; DIABETIC-RATS; GROWTH-FACTOR; NITRIC-OXIDE	We used cultured endothelial cells as a model to examine whether up-regulation of aldolase B and enhanced methylglyoxal (MG) formation play an important role in high glucose-induced overproduction of advanced glycosylation endproducts (AGEs), oxidative stress and cellular dysfunction. High glucose (25 mM) incubation up-regulated mRNA levels of aldose reductase (an enzyme converting glucose to fructose) and aldolase B (a key enzyme that catalyzes MG formation from fructose) and enhanced MG formation in human umbilical vein endothelial cells (HUVECs) and HUVEC-derived EA. hy926 cells. High glucose-increased MG production in EA. hy926 cells was completely prevented by siRNA knockdown of aldolase B, but unaffected by siRNA knockdown of aldolase A, an enzyme responsible for MG formation during glycolysis. In addition, inhibition of cytochrome P450 2E1 or semicarbazide-sensitive amine oxidase which produces MG during the metabolism of lipid and proteins, respectively, did not alter MG production. Both high glucose (25 mM) and MG (30, 100 mu M) increased the formation of N(epsilon)-carboxyethyl-lysine (CEL, a MG-induced AGE), oxidative stress (determined by the generation of oxidized DCF, H2O2, protein carbonyls and 8-oxo-dG), O-GlcNAc modification (product of the hexosamine pathway), membrane protein kinase C activity and nuclear translocation of NF-kappa B in EA. hy926 cells. However, the above metabolic and signaling alterations induced by high glucose were completely prevented by knockdown of aldolase B and partially by application of aminoguanidine (a MG scavenger) or alagebrium (an AGEs breaker). In conclusion, efficient inhibition of aldolase B can prevent high glucose-induced overproduction of MG and related cellular dysfunction in endothelial cells.	[Liu, Jianghai; Mak, Timothy Chun-Ping; Banigesh, Ali; Desai, Kaushik; Wu, Lingyun] Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon, SK S7N 0W0, Canada; [Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; Lakehead University; Lakehead University; Northern Ontario School of Medicine	Liu, JH (corresponding author), Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon, SK S7N 0W0, Canada.	lwu@lakeheadu.ca	Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620; Desai, Kaushik/0000-0001-9355-4528	Canadian Institutes of Health Research; Heart and Stroke Foundation of Saskatchewan; College of Medicine Graduate Scholarship from University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Saskatchewan; College of Medicine Graduate Scholarship from University of Saskatchewan	This work was supported by operating grants from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Saskatchewan to Dr. Wu. Mr. Jianghai Liu was supported by a College of Medicine Graduate Scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bierhaus A, 1997, DIABETES, V46, P1481, DOI 10.2337/diabetes.46.9.1481; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; Chang TJ, 2011, FASEB J, V25, P1746, DOI 10.1096/fj.10-178053; Chung SSM, 2005, CURR DRUG TARGETS, V6, P475, DOI 10.2174/1389450054021891; COX TM, 1994, FASEB J, V8, P62, DOI 10.1096/fasebj.8.1.8299892; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Dhar A, 2008, METABOLISM, V57, P1211, DOI 10.1016/j.metabol.2008.04.014; Dhar A, 2010, BRIT J PHARMACOL, V161, P1843, DOI 10.1111/j.1476-5381.2010.01017.x; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Han JY, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-12; Hanssen KF, 1997, DIABETES, V46, pS101, DOI 10.2337/diab.46.2.S101; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Jia XM, 2006, FASEB J, V20, P1555, DOI 10.1096/fj.05-5478fje; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Mamputu JC, 2002, J DIABETES COMPLICAT, V16, P284, DOI 10.1016/S1056-8727(01)00229-X; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; O'Connor RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011828; Park J, 2011, NEPHROL DIAL TRANSPL; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHILLIPS SA, 1993, BIOCHEM PHARMACOL, V46, P805, DOI 10.1016/0006-2952(93)90488-I; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Riederer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015339; Scalia R, 2007, DIABETES, V56, P1842, DOI 10.2337/db06-1198; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Thallas-Bonke V, 2004, DIABETES, V53, P2921, DOI 10.2337/diabetes.53.11.2921; Wang H, 2009, BIOCHEM PHARMACOL, V77, P1709, DOI 10.1016/j.bcp.2009.02.024; Wang XX, 2004, KIDNEY INT, V66, P2315, DOI 10.1111/j.1523-1755.2004.66034.x; Wautier JL, 1996, J CLIN INVEST, V97, P238, DOI 10.1172/JCI118397; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Wu LY, 2005, CAN J PHYSIOL PHARM, V83, P63, DOI 10.1139/Y04-112; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Yildiz G, 1998, BRIT J PHARMACOL, V124, P905, DOI 10.1038/sj.bjp.0701924	48	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41495	10.1371/journal.pone.0041495	http://dx.doi.org/10.1371/journal.pone.0041495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911800	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300048
J	Pant, A; Lee, II; Lu, ZX; Rueda, BR; Schink, J; Kim, JJ				Pant, Alok; Lee, Irene I.; Lu, Zhenxiao; Rueda, Bo R.; Schink, Julian; Kim, J. Julie			Inhibition of AKT with the Orally Active Allosteric AKT Inhibitor, MK-2206, Sensitizes Endometrial Cancer Cells to Progestin	PLOS ONE			English	Article							WELL-DIFFERENTIATED CARCINOMA; FORKHEAD TRANSCRIPTION FACTOR; GENE-EXPRESSION; RECEPTOR; PATHWAY; GROWTH; ADENOCARCINOMA; HYPERPLASIA; FERTILITY; THERAPY	Progestin resistance is a major obstacle to treating early stage, well-differentiated endometrial cancer as well as recurrent endometrial cancer. The mechanism behind the suboptimal response to progestin is not well understood. The PTEN tumor suppressor gene is frequently mutated in type I endometrial cancers and this mutation results in hyperactivation of the PI3K/AKT pathway. We hypothesized that increased activation of AKT promotes an inadequate response to progestins in endometrial cancer cells. Ishikawa cells stably transfected with progesterone receptor B (PRB23 cells) were treated with the AKT inhibitor, MK-2206, which effectively decreased levels of p(Ser473)-AKT in a dose-dependent (10 nM to 1 uM) and time-dependent manner (0.5 h to 24 h). MK-2206 inhibited levels of p(Thr308)-AKT and a downstream target, p(Thr246)-PRAS40, but did not change levels of p(Thr202/Tyr204) ERK or p(Thr13/Tyr185) SAPK/JNK, demonstrating specificity of MK-2206 for AKT. Additionally, MK-2206 treatment of PRB23 cells resulted in a significant increase in levels of progesterone receptor B (PRB) protein. Microarray analysis of PRB23 cells identified PDK4 as the most highly upregulated gene among 70 upregulated genes in response to R5020. Inhibition of AKT further upregulated progestin-mediated expression of PDK4 but did not affect another progestin-responsive gene, SGK1. Treatment of PRB23 cells with R5020 and MK-2206 independently decreased viability of cells while the combination of R5020 and MK-2206 caused the greatest decrease in cell viability. Furthermore, mice with xenografted tumors treated with MK-2206 alone or with progesterone alone exhibited modest reductions in their tumor volume. The largest decrease in tumor size was observed in the mice treated with both MK-2206 and progesterone; these tumors exhibited the least proliferation (Ki67) and the most apoptosis (cleaved caspase-3) of all the treatment groups. In summary, inhibition of AKT stabilizes the Progesterone Receptor B and augments progesterone response in endometrial cancer cells that have hyperactivated AKT.	[Pant, Alok; Schink, Julian] Northwestern Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA; [Lee, Irene I.; Lu, Zhenxiao; Kim, J. Julie] Northwestern Univ, Div Reprod Biol Res, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Rueda, Bo R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Vincent Ctr Reprod Biol,Dept Obstet & Gynecol, Boston, MA USA	Northwestern University; Northwestern University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Pant, A (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA.	j-kim4@northwestern.edu		Kim, J Julie/0000-0001-9834-8213; Lee, Irene/0000-0002-5749-9389	National Institutes of Health [R21 CA127674]; National Institutes of Health/National Cancer Institute [T32CA09560]; Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE [R21CA127674, R01CA155513, T32CA009560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health R21 CA127674 (JJK), National Institutes of Health/National Cancer Institute training grant T32CA09560, and from the Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (IIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Cheng Y, 2011, MOL CANC THERAPEUTIC; Chiva L, 2008, GYNECOL ONCOL, V111, pS101, DOI 10.1016/j.ygyno.2008.07.056; Dai D, 2002, CANCER RES, V62, P881; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EHRLICH CE, 1988, AM J OBSTET GYNECOL, V158, P796, DOI 10.1016/0002-9378(88)90075-0; Erkanli S, 2010, INT J GYNECOL CANCER, V20, P1170, DOI 10.1111/IGC.0b013e3181e94f5a; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Gu CO, 2011, CANCER SCI, V102, P557, DOI 10.1111/j.1349-7006.2010.01829.x; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin X, 2004, BRIT J CANCER, V91, P1808, DOI 10.1038/sj.bjc.6602214; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Knowles JA, 2011, LARYNGOSCOPE, V121, P2359, DOI 10.1002/lary.22180; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Lewin SN, 2010, OBSTET GYNECOL, V116, P1141, DOI 10.1097/AOG.0b013e3181f39849; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng Jieru, 2010, PLoS One, V5, pe14124, DOI 10.1371/journal.pone.0014124; Montz FJ, 2002, AM J OBSTET GYNECOL, V186, P651, DOI 10.1067/mob.2002.122130; Neubauer Nikki L., 2011, Hormones & Cancer, V2, P170, DOI 10.1007/s12672-011-0065-7; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Ramirez PT, 2004, GYNECOL ONCOL, V95, P133, DOI 10.1016/j.ygyno.2004.06.045; Randall TC, 1997, OBSTET GYNECOL, V90, P434, DOI 10.1016/S0029-7844(97)00297-4; Risinger JI, 1997, CANCER RES, V57, P4736; Smid-Koopman E, 2003, J SOC GYNECOL INVEST, V10, P49, DOI 10.1016/S1071-5576(02)00217-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Terakawa N, 2003, ENDOCR-RELAT CANCER, V10, P203, DOI 10.1677/erc.0.0100203; van der Horst PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030840; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Wheeler DT, 2007, AM J SURG PATHOL, V31, P988, DOI 10.1097/PAS.0b013e31802d68ce; Yap TA, 2011, J CLIN ONCOLOGY OFFI	40	42	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41593	10.1371/journal.pone.0041593	http://dx.doi.org/10.1371/journal.pone.0041593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911820	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300056
J	Nguyen, NP; Chi, A; Betz, M; Almeida, F; Vos, P; Davis, R; Slane, B; Ceizyk, M; Abraham, D; Smith-Raymond, L; Stevie, M; Jang, S; Gelumbauskas, S; Vinh-Hung, V				Nguyen, Nam P.; Chi, Alexander; Betz, Michael; Almeida, Fabio; Vos, Paul; Davis, Rick; Slane, Benjamin; Ceizyk, Misty; Abraham, Dave; Smith-Raymond, Lexie; Stevie, Michelle; Jang, Siyoung; Gelumbauskas, Steven; Vincent Vinh-Hung			Feasibility of Intensity-Modulated and Image-Guided Radiotherapy for Functional Organ Preservation in Locally Advanced Laryngeal Cancer	PLOS ONE			English	Article							CONCURRENT CHEMOTHERAPY; RADIATION-THERAPY; TARGET COVERAGE; ADVANCED HEAD; NECK-CANCER; FOLLOW-UP; CARCINOMA; RECURRENT; IMPACT; COMPLICATIONS	Purpose: The study aims to assess the feasibility of intensity-modulated and image-guided radiotherapy (IMRT, and IGRT, respectively) for functional preservation in locally advanced laryngeal cancer. A retrospective review of 27 patients undergoing concurrent chemoradiation for locally advanced laryngeal cancers (8 IMRT, 19 IGRT) was undertaken. In addition to regular clinical examinations, all patients had PET imaging at 4 months and 10 months after radiotherapy, then yearly. Loco-regional control, speech quality and feeding-tube dependency were assessed during follow-up visits. Results: At a median follow-up of 20 months (range 6-57 months), four out of 27 patients (14.8%) developed local recurrence and underwent salvage total laryngectomy. One patient developed distant metastases following salvage surgery. Among the 23 patients who conserved their larynx with no sign of recurrence at last follow-up, 22 (95%) reported normal or near normal voice quality, allowing them to communicate adequately. Four patients (14.8%) had long-term tube feeding-dependency because of severe dysphagia (2 patients) and chronic aspiration (2 patients, with ensuing death from aspiration pneumonia in one patient). Conclusions and Clinical Relevance: Functional laryngeal preservation is feasible with IMRT and IGRT for locally advanced laryngeal cancer. However, dysphagia and aspiration remain serious complications, due most likely to high radiation dose delivery to the pharyngeal musculatures.	[Nguyen, Nam P.; Davis, Rick; Slane, Benjamin; Ceizyk, Misty; Abraham, Dave; Smith-Raymond, Lexie; Stevie, Michelle; Gelumbauskas, Steven] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA; [Chi, Alexander] W Virginia Univ, Dept Radiat Oncol, Morgantown, WV 26506 USA; [Betz, Michael; Vincent Vinh-Hung] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland; [Almeida, Fabio] SW PET CT Inst, Tucson, AZ USA; [Vos, Paul] E Carolina Univ, Dept Biostat, Greenville, NC USA; [Jang, Siyoung] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA USA	University of Arizona; West Virginia University; University of Geneva; University of North Carolina; East Carolina University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nguyen, NP (corresponding author), Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA.	namphong.nguyen@yahoo.com	Vinh-Hung, Vincent/A-5762-2008	Vinh-Hung, Vincent/0000-0002-6403-6120				Braaksma MMJ, 2003, RADIOTHER ONCOL, V66, P291, DOI 10.1016/S0167-8140(03)00038-0; Brouwer J, 2004, EUR ARCH OTO-RHINO-L, V261, P417, DOI 10.1007/s00405-003-0708-6; Brouwer J, 2008, RADIOTHER ONCOL, V87, P217, DOI 10.1016/j.radonc.2008.02.001; Buntzel J, 2007, ANTICANCER RES, V27, P1953; Caglar HB, 2008, INT J RADIAT ONCOL, V72, P1110, DOI 10.1016/j.ijrobp.2008.02.048; Chen AM, 2011, INT J RADIAT ONCOL, V80, P1423, DOI 10.1016/j.ijrobp.2010.04.011; Clark CH, 2004, RADIOTHER ONCOL, V70, P189, DOI 10.1016/j.radonc.2003.10.012; DESANTO LW, 1995, ANN OTO RHINOL LARYN, V104, P763, DOI 10.1177/000348949510401003; Deshmane Vinay H., 1995, Indian Journal of Cancer, V32, P121; Dogan N, 2003, INT J RADIAT ONCOL, V57, P1480, DOI 10.1016/S0360-3016(03)01569-4; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Gordin A, 2006, LARYNGOSCOPE, V116, P273, DOI 10.1097/01.mlg.0000197930.93582.32; HILGERS FJM, 1990, CLIN OTOLARYNGOL, V15, P421, DOI 10.1111/j.1365-2273.1990.tb00494.x; Hutcheson KA, 2008, ARCH OTOLARYNGOL, V134, P178, DOI 10.1001/archoto.2007.33; Kuntz AL, 1999, LARYNGOSCOPE, V109, P1334, DOI 10.1097/00005537-199908000-00030; Lee NY, 2007, INT J RADIAT ONCOL, V69, P459, DOI 10.1016/j.ijrobp.2007.03.013; Lefebvre JL, 2009, JNCI-J NATL CANCER I, V101, P142, DOI 10.1093/jnci/djn460; Liberman PHP, 2004, ARCH OTOLARYNGOL, V130, P1265, DOI 10.1001/archotol.130.11.1265; Nguyen N.P., 2012, BMC CANC; Nguyen NP, 2007, LUNG, V185, P243, DOI 10.1007/s00408-007-9016-z; Nguyen NP, 2007, ANTICANCER RES, V27, P1669; Nguyen NP, 2007, ORAL ONCOL, V43, P352, DOI 10.1016/j.oraloncology.2006.04.002; Nguyen NP, 2012, ORAL ONCOL, V48, P653, DOI 10.1016/j.oraloncology.2012.01.016; Nguyen NP, 2011, ORAL ONCOL, V47, P900, DOI 10.1016/j.oraloncology.2011.06.004; Nguyen NP, 2007, ORL-J OTO-RHIN-LARYN, V69, P116, DOI 10.1159/000097843; Oe A, 2007, ANN NUCL MED, V21, P9, DOI 10.1007/BF03033994; Penagaricano JA, 2004, DOSIMETRY, V29, P254; Posner MR, 2009, ANN ONCOL, V20, P921, DOI 10.1093/annonc/mdn752; Rogers SN, 1999, HEAD NECK-J SCI SPEC, V21, P394, DOI 10.1002/(SICI)1097-0347(199908)21:5<394::AID-HED3>3.0.CO;2-Q; Salaun PY, 2007, HEAD NECK-J SCI SPEC, V29, P1125; Sanguineti G, 2007, INT J RADIAT ONCOL, V68, P741, DOI 10.1016/j.ijrobp.2007.01.010; Studer G, 2010, INT J RADIAT ONCOL, V77, P1391, DOI 10.1016/j.ijrobp.2009.07.005; TUPCHONG L, 1991, INT J RADIAT ONCOL, V20, P21, DOI 10.1016/0360-3016(91)90133-O; van Hooren ACG, 2009, EUR ARCH OTO-RHINO-L, V266, P1441, DOI 10.1007/s00405-008-0878-3; WARD PH, 1975, LARYNGOSCOPE, V85, P522, DOI 10.1288/00005537-197503000-00009; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402; Zbaren P, 2006, OTOLARYNG HEAD NECK, V135, P838, DOI 10.1016/j.otohns.2006.06.1264; Zevallos JP, 2009, CANCER-AM CANCER SOC, V115, P4636, DOI 10.1002/cncr.24499	38	16	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42729	10.1371/journal.pone.0042729	http://dx.doi.org/10.1371/journal.pone.0042729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916151	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000307733800025
J	Auger, SD; Mullally, SL; Maguire, EA				Auger, Stephen D.; Mullally, Sinead L.; Maguire, Eleanor A.			Retrosplenial Cortex Codes for Permanent Landmarks	PLOS ONE			English	Article							HEAD-DIRECTION CELLS; EPISODIC MEMORY; REAL-WORLD; SPATIAL REPRESENTATION; OBJECTS RELEVANT; HUMAN NAVIGATION; REFERENCE FRAMES; 1.5 T; BRAIN; PLACE	Landmarks are critical components of our internal representation of the environment, yet their specific properties are rarely studied, and little is known about how they are processed in the brain. Here we characterised a large set of landmarks along a range of features that included size, visual salience, navigational utility, and permanence. When human participants viewed images of these single landmarks during functional magnetic resonance imaging (fMRI), parahippocampal cortex (PHC) and retrosplenial cortex (RSC) were both engaged by landmark features, but in different ways. PHC responded to a range of landmark attributes, while RSC was engaged by only the most permanent landmarks. Furthermore, when participants were divided into good and poor navigators, the latter were significantly less reliable at identifying the most permanent landmarks, and had reduced responses in RSC and anterodorsal thalamus when viewing such landmarks. The RSC has been widely implicated in navigation but its precise role remains uncertain. Our findings suggest that a primary function of the RSC may be to process the most stable features in an environment, and this could be a prerequisite for successful navigation.	[Auger, Stephen D.; Mullally, Sinead L.; Maguire, Eleanor A.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England	University of London; University College London	Auger, SD (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England.	e.maguire@ucl.ac.uk		Auger, Stephen/0000-0002-5911-7049; Mullally, Sinead/0000-0002-4234-3445	Wellcome Trust; UCLH/UCL; Department of Health's NIHR Biomedical Research Centres funding scheme	Wellcome Trust(Wellcome TrustEuropean Commission); UCLH/UCL; Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	Dr. Maguire and Dr. Mullally were supported by the Wellcome Trust. Dr. Auger's funding was from UCLH/UCL, who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Aguirre GK, 1998, P NATL ACAD SCI USA, V95, P839, DOI 10.1073/pnas.95.3.839; Amaral David G., 1995, P443; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Baumann O, 2010, J NEUROSCI, V30, P12897, DOI 10.1523/JNEUROSCI.3077-10.2010; Biegler R, 1996, Q J EXP PSYCHOL-B, V49, P307; BIEGLER R, 1993, NATURE, V361, P631, DOI 10.1038/361631a0; BLADES M, 1992, J ENVIRON PSYCHOL, V12, P175, DOI 10.1016/S0272-4944(05)80069-6; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Burnett G., 2001, P ANN C ERG SOC; Caduff D, 2008, COGN PROCESS, V9, P249, DOI 10.1007/s10339-007-0199-2; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; Cooper BG, 2001, J NEUROSCI, V21, P3986, DOI 10.1523/JNEUROSCI.21-11-03986.2001; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Dilks DD, 2011, J NEUROSCI, V31, P11305, DOI 10.1523/JNEUROSCI.1935-11.2011; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Downs R.M., 1977, MAPS MINDS REFLECTIO; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Epstein RA, 2012, NEUROPSYCHOLOGIA, V50, P530, DOI 10.1016/j.neuropsychologia.2011.09.042; Epstein RA, 2011, CURR BIOL, V21, pR437, DOI 10.1016/j.cub.2011.04.037; Gabriel M, 2001, MODEL SYSTEMS AND THE NEUROBIOLOGY OF ASSOCIATIVE LEARNING: A FESTSCHRIFT IN HONOR OF RICHARD F. THOMPSON, P149; Gabriel M., 1993, NEUROBIOLOGY CINGULA, P478; Galati G, 2010, EXP BRAIN RES, V206, P109, DOI 10.1007/s00221-010-2168-8; Gallistel C. R., 1990, ORG LEARNING; Golledge R.G., 1991, ENV COGNITION ACTION; Golomb JD, 2011, CEREB CORTEX, V21, P2094, DOI [10.1093/cercor/bhq292, 10.1093/cercor/bhr357]; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; Henderson JM, 2007, EXP BRAIN RES, V179, P75, DOI 10.1007/s00221-006-0766-2; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Janzen G, 2008, HIPPOCAMPUS, V18, P40, DOI 10.1002/hipo.20364; Keene CS, 2008, BEHAV NEUROSCI, V122, P651, DOI 10.1037/0735-7044.122.3.651; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Lew AR, 2011, PSYCHOL BULL, V137, P484, DOI 10.1037/a0022315; Lynch K., 1982, IMAGEN CITY; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509; Miller J, 2011, PSYCHON B REV, V18, P184, DOI 10.3758/s13423-010-0038-9; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Nasr S, 2011, J NEUROSCI, V31, P13771, DOI 10.1523/JNEUROSCI.2792-11.2011; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Pengas G, 2010, NEUROBIOL AGING, V31, P25, DOI 10.1016/j.neurobiolaging.2008.03.014; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Schinazi VR, 2010, NEUROIMAGE, V53, P725, DOI 10.1016/j.neuroimage.2010.06.065; Smith DM, 2012, HIPPOCAMPUS, V22, P1121, DOI 10.1002/hipo.20958; Smith DM, 2002, J NEUROSCI, V22, P8212; Spiers HJ, 2007, NEUROSCIENCE, V149, P7, DOI 10.1016/j.neuroscience.2007.06.056; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Sugar Jorgen, 2011, Front Neuroinform, V5, P7, DOI 10.3389/fninf.2011.00007; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; TAUBE JS, 1995, J NEUROSCI, V15, P70; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Unknown photographer, 1975, BORN UNGE, V39, P9; VANGROEN T, 1992, J COMP NEUROL, V315, P200, DOI 10.1002/cne.903150207; VANGROEN T, 1990, J COMP NEUROL, V300, P593, DOI 10.1002/cne.903000412; Vann SD, 2005, BEHAV NEUROSCI, V119, P1682, DOI 10.1037/0735-7044.119.6.1682; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wang RF, 2002, TRENDS COGN SCI, V6, P376, DOI 10.1016/S1364-6613(02)01961-7; Ward EJ, 2010, J VISION, V10, DOI 10.1167/10.14.6; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wegman J, 2011, J COGNITIVE NEUROSCI, V23, P3841, DOI 10.1162/jocn_a_00081; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Yoder RM, 2011, TRENDS NEUROSCI, V34, P561, DOI 10.1016/j.tins.2011.08.004	80	132	132	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43620	10.1371/journal.pone.0043620	http://dx.doi.org/10.1371/journal.pone.0043620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912894	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700122
J	Bi, YQ; Tugume, AK; Valkonen, JPT				Bi, Yaqi; Tugume, Arthur K.; Valkonen, Jari P. T.			Small-RNA Deep Sequencing Reveals Arctium tomentosum as a Natural Host of Alstroemeria virus X and a New Putative Emaravirus	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-SPOT-VIRUS; SWEET-POTATO; MOSAIC-VIRUS; ERIOPHYID MITE; SORBUS-AUCUPARIA; WILD; MULTIPARTITE; EVOLUTION; PLANTS	Background: Arctium species (Asteraceae) are distributed worldwide and are used as food and rich sources of secondary metabolites for the pharmaceutical industry, e. g., against avian influenza virus. RNA silencing is an antiviral defense mechanism that detects and destroys virus-derived double-stranded RNA, resulting in accumulation of virus-derived small RNAs (21-24 nucleotides) that can be used for generic detection of viruses by small-RNA deep sequencing (SRDS). Methodology/Principal Findings: SRDS was used to detect viruses in the biennial wild plant species Arctium tomentosum (woolly burdock; family Asteraceae) displaying virus-like symptoms of vein yellowing and leaf mosaic in southern Finland. Assembly of the small-RNA reads resulted in contigs homologous to Alstroemeria virus X (AlsVX), a positive/single-stranded RNA virus of genus Potexvirus (family Alphaflexiviridae), or related to negative/single-stranded RNA viruses of the genus Emaravirus. The coat protein gene of AlsVX was 81% and 89% identical to the two AlsVX isolates from Japan and Norway, respectively. The deduced, partial nucleocapsid protein amino acid sequence of the emara-like virus was only 78% or less identical to reported emaraviruses and showed no variability among the virus isolates characterized. This virus-tentatively named as Woolly burdock yellow vein virus-was exclusively associated with yellow vein and leaf mosaic symptoms in woolly burdock, whereas AlsVX was detected in only one of the 52 plants tested. Conclusions/Significance: These results provide novel information about natural virus infections in Acrtium species and reveal woolly burdock as the first natural host of AlsVX besides Alstroemeria (family Alstroemeriaceae). Results also revealed a new virus related to the recently emerged Emaravirus genus and demonstrated applicability of SRDS to detect negative-strand RNA viruses. SRDS potentiates virus surveys of wild plants, a research area underrepresented in plant virology, and helps reveal natural reservoirs of viruses that cause yield losses in cultivated plants.	[Bi, Yaqi; Tugume, Arthur K.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland	University of Helsinki	Bi, YQ (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	jari.valkonen@helsinki.fi		Tugume, Arthur/0000-0003-3689-6745; Valkonen, Jari/0000-0002-3704-9911	Academy of Finland [1253126]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland grant no. 1253126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bayer Randall J., 2001, Kew Bulletin, V56, P1013, DOI 10.2307/4119317; Bisnieks M, 2006, ACTA AGR SCAND B-S P, V56, P171, DOI 10.1080/09064710500297658; Brant V, 2006, J PLANT DIS PROTECT, P605; Caglayan K, 2010, PLANT DIS, V94, P1448, DOI 10.1094/PDIS-11-09-0771; Cooper I, 2006, ADV VIRUS RES, V67, P1, DOI 10.1016/S0065-3527(06)67001-2; Dees MW, 2007, THESIS NORWEGIAN U L; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Elbeaino T, 2009, ARCH VIROL, V154, P1719, DOI 10.1007/s00705-009-0509-3; Elbeaino T, 2009, J GEN VIROL, V90, P1281, DOI 10.1099/vir.0.008649-0; FLOCK RA, 1955, PHYTOPATHOLOGY, V45, P52; Fuji S, 2005, ARCH VIROL, V150, P2377, DOI 10.1007/s00705-005-0574-1; Fuji S, 2004, ARCH VIROL, V149, P1843, DOI 10.1007/s00705-004-0344-5; Fuji Shin-ichi, 2007, Journal of General Plant Pathology, V73, P216, DOI 10.1007/s10327-007-0009-9; Gammelgard E, 2007, J GEN VIROL, V88, P2337, DOI 10.1099/vir.0.82928-0; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hayashi K, 2010, BIOL PHARM BULL, V33, P1199, DOI 10.1248/bpb.33.1199; HEILMEIER H, 1986, OECOLOGIA, V70, P466, DOI 10.1007/BF00379513; Hsu CL, 2011, PLANT DIS, V95, P735, DOI 10.1094/PDIS-05-10-0353; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Jaiswal R, 2011, FOOD FUNCT, V2, P63, DOI 10.1039/c0fo00125b; Kallinen AK, 2009, PHYTOPATHOLOGY, V99, P344, DOI 10.1094/PHYTO-99-4-0344; Kendall DA, 1996, PLANT PATHOL, V45, P29, DOI 10.1046/j.1365-3059.1996.d01-98.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King A. M., 2012, VIRUS TAXONOMY CLASS; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kulkarni NK, 2002, PLANT DIS, V86, P1297, DOI 10.1094/PDIS.2002.86.12.1297; Laney AG, 2011, J GEN VIROL, V92, P1727, DOI 10.1099/vir.0.031146-0; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Luo H, 2011, ANN APPL BIOL, V159, P339, DOI 10.1111/j.1744-7348.2011.00496.x; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; MATTHEWS REF, 1993, DIAGNOSIS PLANT VIRU; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; McGavin WJ, 2012, J GEN VIROL, V93, P430, DOI 10.1099/vir.0.037937-0; Mielke N, 2007, J GEN VIROL, V88, P1337, DOI 10.1099/vir.0.82715-0; Mielke-Ehret N, 2010, ARCH VIROL, V155, P987, DOI 10.1007/s00705-010-0667-3; Mossberg B, 1997, NORDISKA FLORAN, P472; Pallett DW, 2010, J VIROL METHODS, V168, P223, DOI 10.1016/j.jviromet.2010.06.003; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qu F, 2010, MOL PLANT MICROBE IN, V23, P1248, DOI 10.1094/MPMI-06-10-0124; Rannali M, 2008, PLANT DIS, V92, P1313, DOI 10.1094/PDIS-92-9-1313; Rannali M, 2009, PLANT DIS, V93, P933, DOI 10.1094/PDIS-93-9-0933; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skare JM, 2006, VIROLOGY, V347, P343, DOI 10.1016/j.virol.2005.11.030; Smith EA, 2011, ENVIRON ENTOMOL, V40, P194, DOI 10.1603/EN10246; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tugume AK, 2008, PHYTOPATHOLOGY, V98, P640, DOI 10.1094/PHYTO-98-6-0640; Tugume AK, 2010, MOL ECOL, V19, P3139, DOI 10.1111/j.1365-294X.2010.04682.x; Tugume AK, 2010, J GEN VIROL, V91, P1092, DOI 10.1099/vir.0.016089-0; Valkonen JPT, 2010, PLANT DIS, V94, P921, DOI 10.1094/PDIS-94-7-0921B; Voinnet O, 2008, CURR OPIN PLANT BIOL, V11, P464, DOI 10.1016/j.pbi.2008.04.006; Walia JJ, 2009, PLANT DIS, V93, P4, DOI 10.1094/PDIS-93-1-0004; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034	64	32	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42758	10.1371/journal.pone.0042758	http://dx.doi.org/10.1371/journal.pone.0042758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912734	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700020
J	Chung, DWD; Ponts, N; Prudhomme, J; Rodrigues, EM; Le Roch, KG				Chung, Duk-Won D.; Ponts, Nadia; Prudhomme, Jacques; Rodrigues, Elisandra M.; Le Roch, Karine G.			Characterization of the Ubiquitylating Components of the Human Malaria Parasite's Protein Degradation Pathway	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; PROTEASOME; MEMBRANE; HOMOLOG; SYSTEM; ER; TRANSFORMATION; DISLOCATION	Ubiquitin-dependent protein degradation within malarial parasites is a burgeoning field of interest due to several encouraging reports of proteasome inhibitors that were able to confer antimalarial activity. Despite the growing interest in the Plasmodium proteasome system, relatively little investigation has been done to actually characterize the parasite degradation machinery. In this report, we provide an initial biological investigation of the ubiquitylating components of the endoplasmic reticulum-associated degradation (ERAD) system, which is a major pathway in targeting misfolded proteins from the ER to the cytosol for proteasome degradation. We are able to show that the ERAD system is essential for parasite survival and that the putative Plasmodium HRD1 (E3 ubiquitin ligase), UBC (E2 ubiquitin conjugating enzyme) and UBA1 (E1 ubiquitin activating enzyme) are able to mediate in vitro ubiquitylation. Furthermore, by using immunofluorescence, we report that Plasmodium HRD1 localizes to the ER membranes, while the Plasmodium UBC and UBA1 localize to the cytosol. In addition, our gene disruption experiments indicate that the Plasmodium HRD1 is likely essential. We have conducted an initial characterization of the ubiquitylating components of the Plasmodium ERAD system, a major pathway for protein degradation and parasite maintenance. In conjunction with promising proteasome inhibitor studies, we explore the possibility of targeting the Plasmodium ERAD system for future bottom-up drug development approaches.	[Chung, Duk-Won D.; Ponts, Nadia; Prudhomme, Jacques; Rodrigues, Elisandra M.; Le Roch, Karine G.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Ponts, Nadia] INRA, MycSA UR 1264, F-33883 Villenave Dornon, France	University of California System; University of California Riverside; INRAE	Chung, DWD (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	karine.leroch@ucr.edu	Rodrigues, Elisandra/K-5980-2012	Rodrigues, Elisandra/0000-0002-1609-2507	University of California, Riverside; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [374808-1/2009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085077] Funding Source: NIH RePORTER	University of California, Riverside(University of California System); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the startup funds provided by the University of California, Riverside. Dr. Rodrigues was supported by a postdoctoral fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, contract no. 374808-1/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Certad G, 1999, EXP PARASITOL, V93, P123, DOI 10.1006/expr.1999.4442; Chung Duk-Won Doug, 2010, Infectious Disorders - Drug Targets, V10, P158; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; Edelmann MJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002031; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Garcia LS, 2010, CLIN LAB MED, V30, P93, DOI 10.1016/j.cll.2009.10.001; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hempel F, 2010, MOL MICROBIOL, V76, P793, DOI 10.1111/j.1365-2958.2010.07142.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Li GD, 2000, INT J PARASITOL, V30, P729, DOI 10.1016/S0020-7519(00)00046-1; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; McKibbin C, 2012, BIOCHEM J, V442, P639, DOI 10.1042/BJ20111220; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Melikova M, 2005, CELL BIOL INT; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Prudhomme J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002335; Ramasamy G, 2007, MOL BIOCHEM PARASIT, V152, P139, DOI 10.1016/j.molbiopara.2007.01.002; Reynolds Jennifer M, 2007, BMC Clin Pharmacol, V7, P13, DOI 10.1186/1472-6904-7-13; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; St-Pierre P, 2012, J CELL SCI; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Tcherpakov M, 2009, J BIOL CHEM, V284, P12099, DOI 10.1074/jbc.M808222200; van Vugt M, 2011, FUTURE MICROBIOL, V6, P1485, DOI [10.2217/fmb.11.138, 10.2217/FMB.11.138]; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Xu GW, 2010, BLOOD, V115, P2251, DOI 10.1182/blood-2009-07-231191; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	48	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43477	10.1371/journal.pone.0043477	http://dx.doi.org/10.1371/journal.pone.0043477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912882	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700110
J	Hanlon, SM; Kerby, JL; Parris, MJ				Hanlon, Shane M.; Kerby, Jacob L.; Parris, Matthew J.			Unlikely Remedy: Fungicide Clears Infection from Pathogenic Fungus in Larval Southern Leopard Frogs (Lithobates sphenocephalus)	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; BATRACHOCHYTRIUM-DENDROBATIDIS; METHYL THIOPHANATE; GENE-EXPRESSION; CHYTRID FUNGUS; THYROID-GLAND; CHYTRIDIOMYCOSIS; METAMORPHOSIS; STRESS; INSECTICIDE	Amphibians are often exposed to a wide variety of perturbations. Two of these, pesticides and pathogens, are linked to declines in both amphibian health and population viability. Many studies have examined the separate effects of such perturbations; however, few have examined the effects of simultaneous exposure of both to amphibians. In this study, we exposed larval southern leopard frog tadpoles (Lithobates sphenocephalus) to the chytrid fungus Batrachochytrium dendrobatidis and the fungicide thiophanate-methyl (TM) at 0.6 mg/L under laboratory conditions. The experiment was continued until all larvae completed metamorphosis or died. Overall, TM facilitated increases in tadpole mass and length. Additionally, individuals exposed to both TM and Bd were heavier and larger, compared to all other treatments. TM also cleared Bd in infected larvae. We conclude that TM affects larval anurans to facilitate growth and development while clearing Bd infection. Our findings highlight the need for more research into multiple perturbations, specifically pesticides and disease, to further promote amphibian heath.	[Hanlon, Shane M.; Parris, Matthew J.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Kerby, Jacob L.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA	University of Memphis; University of South Dakota	Hanlon, SM (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	shanlon1@memphis.edu		Hanlon, Shane/0000-0002-4296-9069	NSF [MRI 0923419]	NSF(National Science Foundation (NSF))	Bd analyses were conducted on equipment supplied by NSF grant MRI 0923419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RA, 1988, AM NAT, V131, P91, DOI 10.1086/284775; Belden LK, 2003, FUNCT ECOL, V17, P409, DOI 10.1046/j.1365-2435.2003.00746.x; BENDER J, 1994, FUTURE HARVEST PESTI; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bishop P, 2008, CROP SCI, V48, P1615, DOI 10.2135/cropsci2007.11.0635sc; Boone MD, 2003, OECOLOGIA, V137, P610, DOI 10.1007/s00442-003-1394-1; Boone MD, 2003, ECOL APPL, V13, P829, DOI 10.1890/1051-0761(2003)013[0829:IOAIHA]2.0.CO;2; Boone MD, 2002, ECOL APPL, V12, P307, DOI 10.1890/1051-0761(2002)012[0307:IOAIWC]2.0.CO;2; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brande-Lavridsen N., 2010, OPEN ZOOLOGY J, V3, P7, DOI [DOI 10.2174/1874336601003010007, DOI 10.2174/1874336601003020007]; Capaldo A, 2006, COMP BIOCHEM PHYS C, V143, P86, DOI 10.1016/j.cbpc.2005.12.005; Cheek AO, 1999, ARCH ENVIRON CON TOX, V37, P70, DOI 10.1007/s002449900491; Clements W. H., 2002, COMMUNITY ECOTOXICOL; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Collins J.P., 2009, EXTINCTION OUR TIMES; Crump D, 2002, ENVIRON HEALTH PERSP, V110, P1199, DOI 10.1289/ehp.021101199; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; De Falco M, 2007, ARCH ENVIRON CON TOX, V53, P241, DOI 10.1007/s00244-006-0204-2; Denver RJ, 1997, HORM BEHAV, V31, P169, DOI 10.1006/hbeh.1997.1383; Denver RJ, 1999, ANN NY ACAD SCI, V897, P46, DOI 10.1111/j.1749-6632.1999.tb07877.x; Fellers GM, 2001, COPEIA, P945, DOI 10.1643/0045-8511(2001)001[0945:OCITMY]2.0.CO;2; Fort DJ, 2011, TOXICOL SCI, V121, P292, DOI 10.1093/toxsci/kfr069; Gahl MK, 2011, ECOL APPL, V21, P2521, DOI 10.1890/10-2319.1; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gilliam R, 2006, 1291 US GEOL SURV, P172; Gosner K. L., 1960, Herpetologica, V16, P183; Hanlon SM, 2012, ARCH ENVIRON CON TOX, V63, P137, DOI 10.1007/s00244-011-9744-1; HAYES TB, 1995, J EXP ZOOL, V271, P103, DOI 10.1002/jez.1402710205; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Howe GE, 1998, ENVIRON TOXICOL CHEM, V17, P519, DOI [10.1002/etc.5620170324, 10.1897/1551-5028(1998)017&lt;0519:EOCSAL&gt;2.3.CO;2]; Huang HC, 2001, P NATL ACAD SCI USA, V98, P7348, DOI 10.1073/pnas.131198998; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Jones DK, 2010, ENVIRON TOXICOL CHEM, V29, P2016, DOI 10.1002/etc.240; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; LeNoir JS, 1999, ENVIRON TOXICOL CHEM, V18, P2715, DOI [10.1002/etc.5620181210, 10.1897/1551-5028(1999)018&lt;2715:STOCUP&gt;2.3.CO;2]; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martel A, 2011, MED MYCOL, V49, P143, DOI 10.3109/13693786.2010.508185; Matthews G. A, 1992, PESTICIDE APPL METHO, V2; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; Norris L. A., 1983, PW149 USDA FOR SERV; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Parris MJ, 2006, CAN J ZOOL, V84, P58, DOI 10.1139/Z05-175; Parris MJ, 2004, COPEIA, P344, DOI 10.1643/CE-03-116R1; Payne NJ, 1998, CROP PROT, V17, P171, DOI 10.1016/S0261-2194(97)00092-6; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Relyea RA, 2001, P NATL ACAD SCI USA, V98, P2491, DOI 10.1073/pnas.031076198; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Rose CS, 2005, TRENDS ECOL EVOL, V20, P129, DOI 10.1016/j.tree.2005.01.005; Sadeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015602; Schmidt BR, 2009, AMPHIBIA-REPTILIA, V30, P313, DOI 10.1163/156853809788795245; Sciarrillo R, 2008, ARCH ENVIRON CON TOX, V55, P254, DOI 10.1007/s00244-007-9116-z; Semlitsch RD, 2000, OECOLOGIA, V125, P179, DOI 10.1007/s004420000443; Smith KG, 2007, DIS AQUAT ORGAN, V74, P159, DOI 10.3354/dao074159; Sparling DW, 2009, ENVIRON TOXICOL CHEM, V28, P1696, DOI 10.1897/08-336.1; Sparling DW, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P1, DOI 10.1201/EBK1420064162; Steiner UK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006160; Summermatter S, 2008, FASEB J, V22, P774, DOI 10.1096/fj.07-8972com; THOMAS TH, 1974, ANN APPL BIOL, V76, P237, DOI 10.1111/j.1744-7348.1974.tb07977.x; Van Buskirk J, 1998, BIOL J LINN SOC, V65, P301, DOI 10.1006/bijl.1998.0249; Veldhoen N, 2006, AQUAT TOXICOL, V80, P217, DOI 10.1016/j.aquatox.2006.08.010; Venesky MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024991; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Webb R, 2005, DIS AQUAT ORGAN, V68, P89, DOI 10.3354/dao068089; Wilson GWT, 2008, MYCOLOGIA, V100, P548, DOI 10.3852/08-024R; Yoon CS, 2008, ENVIRON TOXICOL, V23, P131, DOI 10.1002/tox.20338	72	28	29	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43573	10.1371/journal.pone.0043573	http://dx.doi.org/10.1371/journal.pone.0043573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912890	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700118
J	Hu, J; Yao, HJ; Gan, F; Tokarski, A; Wang, YM				Hu, Jing; Yao, Hongjie; Gan, Fei; Tokarski, Anthony; Wang, Yanming			Interaction of OKL38 and p53 in Regulating Mitochondrial Structure and Function	PLOS ONE			English	Article							GROWTH INHIBITOR; EXPRESSION; GENE; ACTIVATION; MEDIATOR; CELLS; PHOSPHORYLATION; UBIQUITINATION; POLYMORPHISM; FISSION	The tumor suppressor p53 is a well-known transcription factor controlling the expression of its target genes involved in cell cycle and apoptosis. In addition, p53 also plays a direct proapoptotic role in mitochondria by regulating cytochrome c release. Recently, we identified a novel downstream target of p53, OKL38, which relocalizes from nucleus to mitochondria upon forced expression to induce apoptosis. However, the mechanism underlying OKL38 targeting to mitochondria and apoptosis induction remains unclear. Here, we found that OKL38 interacts with p53 to regulate mitochondria function. After DNA damage, OKL38 colocalizes with p53 to mitochondria in U2OS cells. Further, p53 and OKL38 are targeted to mitochondria in synergy: forced expression of OKL38 leads to p53 localization to mitochondria while the expression of a mitochondria enriched p53 polymorphic variant, p53(R72), leads to OKL38 enrichment in mitochondria. Biochemical analyses found that OKL38 and p53 interact in vivo and in vitro via multiple domains. In cell biological assays, multiple regions of OKL38 mediate its mitochondria localization and induce mitochondria morphology changes. OKL38 induces formation of megamitochondria and increases cellular levels of reactive oxygen species. Furthermore, OKL38 induces cytochrome c release upon incubation with mitochondria. Taken together, our studies suggest that OKL38 regulates mitochondria morphology and functions during apoptosis together with p53.	[Hu, Jing; Yao, Hongjie; Gan, Fei; Tokarski, Anthony; Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hu, J (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	yuw12@psu.edu	Gan, Fei/I-8599-2017	Wang, Yanming/0000-0002-0710-043X	PSU; TSF seed grant award; NIH [CA136856]; NATIONAL CANCER INSTITUTE [R01CA136856] Funding Source: NIH RePORTER	PSU; TSF seed grant award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research is supported in part by a startup fund from PSU, a TSF seed grant award, and NIH R01 grant CA136856 to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Brooks CL, 2004, CELL CYCLE, V3, P895; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huynh H, 2001, ENDOCRINOLOGY, V142, P3607, DOI 10.1210/en.142.8.3607; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Li RS, 2007, J LIPID RES, V48, P709, DOI 10.1194/jlr.M600501-JLR200; Li SD, 2012, P NATL ACAD SCI USA, V109, P185, DOI 10.1073/pnas.1118560109; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Murphy ME, 2004, CELL CYCLE, V3, P836; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ong CK, 2007, ONCOGENE, V26, P1155, DOI 10.1038/sj.onc.1209896; Ong CK, 2004, J BIOL CHEM, V279, P743, DOI 10.1074/jbc.M308668200; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Wang T, 2005, J BIOL CHEM, V280, P4374, DOI 10.1074/jbc.M408708200; Yao HJ, 2008, J BIOL CHEM, V283, P20060, DOI 10.1074/jbc.M802940200; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	39	25	25	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43362	10.1371/journal.pone.0043362	http://dx.doi.org/10.1371/journal.pone.0043362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912861	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700089
J	Li, YZ; Naveed, H; Kachalo, S; Xu, LX; Liang, J				Li, Yingzi; Naveed, Hammad; Kachalo, Sema; Xu, Lisa X.; Liang, Jie			Mechanisms of Regulating Cell Topology in Proliferating Epithelia: Impact of Division Plane, Mechanical Forces, and Cell Memory	PLOS ONE			English	Article							SPINDLE ORIENTATION; PATTERN-FORMATION; MITOTIC SPINDLE; CANCER; SHAPE; MORPHOGENESIS; INVASION; POLARITY; MODEL; SIZE	Regulation of cell growth and cell division has a fundamental role in tissue formation, organ development, and cancer progression. Remarkable similarities in the topological distributions were found in a variety of proliferating epithelia in both animals and plants. At the same time, there are species with significantly varied frequency of hexagonal cells. Moreover, local topology has been shown to be disturbed on the boundary between proliferating and quiescent cells, where cells have fewer sides than natural proliferating epithelia. The mechanisms of regulating these topological changes remain poorly understood. In this study, we use a mechanical model to examine the effects of orientation of division plane, differential proliferation, and mechanical forces on animal epithelial cells. We find that regardless of orientation of division plane, our model can reproduce the commonly observed topological distributions of cells in natural proliferating animal epithelia with the consideration of cell rearrangements. In addition, with different schemes of division plane, we are able to generate different frequency of hexagonal cells, which is consistent with experimental observations. In proliferating cells interfacing quiescent cells, our results show that differential proliferation alone is insufficient to reproduce the local changes in cell topology. Rather, increased tension on the boundary, in conjunction with differential proliferation, can reproduce the observed topological changes. We conclude that both division plane orientation and mechanical forces play important roles in cell topology in animal proliferating epithelia. Moreover, cell memory is also essential for generating specific topological distributions.	[Li, Yingzi; Xu, Lisa X.] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Li, Yingzi; Xu, Lisa X.] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Li, Yingzi; Naveed, Hammad; Kachalo, Sema; Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Xu, Lisa X.; Liang, Jie] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shanghai Jiao Tong University	Li, YZ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	jliang@uic.edu	Naveed, Hammad/N-8851-2013	Naveed, Hammad/0000-0002-1867-974X	National Institutes of Health [GM079804, GM086145]; National Science Foundation [DBI 1062328, DMS-0800257]; China Scholarship Council; Fulbright Fellowship; Higher Education Commission of Pakistan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM086145, R01GM079804] Funding Source: NIH RePORTER; Direct For Biological Sciences [1062328] Funding Source: National Science Foundation; Division Of Mathematical Sciences [0800257] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); Fulbright Fellowship; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is supported by National Institutes of Health Grants GM079804 and GM086145 (http://www.nih.gov), National Science Foundation Grant DBI 1062328 and DMS-0800257 (http://www.nsf.gov). Y.L. was supported by the China Scholarship Council. H.N. was supported by the Fulbright Fellowship and the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Axelrod JD, 2006, CELL, V126, P643, DOI 10.1016/j.cell.2006.07.018; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Besson S, 2011, P NATL ACAD SCI USA, V108, P6294, DOI 10.1073/pnas.1011866108; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Brodland GW, 2002, J BIOMECH, V35, P673, DOI 10.1016/S0021-9290(02)00006-4; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Cao YF, 2010, P NATL ACAD SCI USA, V107, P18445, DOI 10.1073/pnas.1001455107; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dubertret B, 1998, PHYS REV E, V58, P6368, DOI 10.1103/PhysRevE.58.6368; Dubertret B, 1997, BIOPHYS J, V73, P38, DOI 10.1016/S0006-3495(97)78045-7; Dumais J, 2007, CURR OPIN PLANT BIOL, V10, P58, DOI 10.1016/j.pbi.2006.11.014; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Feldman JL, 2007, PLOS BIOL, V5, P1284, DOI [10.1371/journal.pbio.0050149, 10.1371/journal.pbio.0050286]; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gibson WT, 2009, CURR TOP DEV BIOL, V89, P87, DOI 10.1016/S0070-2153(09)89004-2; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HONDA H, 1978, J THEOR BIOL, V72, P523, DOI 10.1016/0022-5193(78)90315-6; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Ingber DE, 2005, P NATL ACAD SCI USA, V102, P11571, DOI 10.1073/pnas.0505939102; Ingber DE, 2002, DIFFERENTIATION, V70, P547, DOI 10.1046/j.1432-0436.2002.700908.x; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Jiao Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002314; KORN RW, 1973, NEW PHYTOL, V72, P1357, DOI 10.1111/j.1469-8137.1973.tb02114.x; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lewis FT, 1926, ANAT REC, V33, P331, DOI 10.1002/ar.1090330502; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; Li YZ, 2011, IEEE ENG MED BIO, P178, DOI 10.1109/IEMBS.2011.6089923; Martinand-Mari C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004202; Nagpal R, 2008, BIOESSAYS, V30, P260, DOI 10.1002/bies.20722; Naveed H, 2010, IEEE ENG MED BIO, P3808, DOI 10.1109/IEMBS.2010.5627601; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; OSTER GF, 1987, J CELL SCI, P35; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Sahlin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011750; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; SHIMIZU H, 1995, DEV DYNAM, V204, P349, DOI 10.1002/aja.1002040402; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Staple DB, 2010, EUR PHYS J E, V33, P117, DOI 10.1140/epje/i2010-10677-0; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Turner S, 2002, J THEOR BIOL, V216, P85, DOI 10.1006/jtbi.2001.2522; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; WELIKY M, 1990, DEVELOPMENT, V109, P373; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zallen JA, 2004, J PHYS-CONDENS MAT, V16, pS5073, DOI 10.1088/0953-8984/16/44/005	58	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43108	10.1371/journal.pone.0043108	http://dx.doi.org/10.1371/journal.pone.0043108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912800	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700043
J	Maybeno, M; Redeker, A; Welten, SPM; Peters, B; Loughhead, SM; Schoenberger, SP; Sette, A; Arens, R				Maybeno, Matt; Redeker, Anke; Welten, Suzanne P. M.; Peters, Bjoern; Loughhead, Scott M.; Schoenberger, Stephen P.; Sette, Alessandro; Arens, Ramon			Polyfunctional CD4(+) T Cell Responses to Immunodominant Epitopes Correlate with Disease Activity of Virulent Salmonella	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM INFECTION; INNATE IMMUNE ACTIVATION; COMPLETE GENOME SEQUENCE; MURINE HOST PROTECTION; TYPHOID-FEVER; VACCINE DEVELOPMENT; GLOBAL BURDEN; CUTTING EDGE; IFN-GAMMA; IN-VIVO	Salmonella enterica serovars are intracellular bacteria capable of causing typhoid fever and gastroenteritis of significant morbidity and mortality worldwide. Current prophylactic and therapeutic treatment is hampered by the emergence of multidrug-resistant (MDR) strains of Salmonella, and vaccines provide only temporal and partial protection in vaccinees. To develop more effective Salmonella vaccines, it is important to understand the development of protective adaptive immunity to virulent Salmonella. Here we report the identification of novel CD4(+) T cell peptide epitopes, which are conserved among Salmonella serovars. Immunization of Salmonella-infected mice with these peptide epitopes reduces the burden of Salmonella disease. Furthermore, we show that distinct polyfunctional (interferon-gamma(+), tumor necrosis factor(+), and interleukin-2(+)) Salmonella-specific CD4(+) T cell responses develop with respect to magnitude and kinetics. Moreover, we found that CD4(+) T cell responses against immunodominant epitopes are predictive for active Salmonella disease. Collectively, these data could contribute to improved diagnosis of Salmonella-related diseases and rational design of Salmonella vaccines.	[Maybeno, Matt; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Loughhead, Scott M.; Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA USA; [Redeker, Anke; Welten, Suzanne P. M.; Arens, Ramon] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	La Jolla Institute for Immunology; La Jolla Institute for Immunology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Maybeno, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	R.Arens@lumc.nl	Arens, Ramon/V-4010-2018; Redeker, Anke/A-1953-2019; Sette, Alessandro/AFO-8916-2022	Arens, Ramon/0000-0001-5058-4110; Redeker, Anke/0000-0002-5832-6332; Welten, Suzanne/0000-0002-8224-7984	Marie Curie Fellowship from the European Commission; U.S. National Institutes of Health	Marie Curie Fellowship from the European Commission; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Marie Curie Fellowship from the European Commission to R. A. and by grants from the U.S. National Institutes of Health to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz RC, 2006, J IMMUNOL, V177, P3983, DOI 10.4049/jimmunol.177.6.3983; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Arens R, 2011, J VIROL, V85, P390, DOI 10.1128/JVI.01839-10; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017712; Cookson BT, 1997, J IMMUNOL, V158, P4310; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Cummings LA, 2005, J IMMUNOL, V174, P7929, DOI 10.4049/jimmunol.174.12.7929; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; ElNewihi HM, 1996, HEPATOLOGY, V24, P516, DOI 10.1002/hep.510240308; Francis KP, 1997, J BACTERIOL, V179, P4046, DOI 10.1128/jb.179.12.4046-4048.1997; Gonzalez-Quintela A, 2004, REV ESP ENFERM DIG, V96, P559; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hess J, 1996, J IMMUNOL, V156, P3321; Jackson A, 2010, J IMMUNOL, V185, P6198, DOI 10.4049/jimmunol.1001198; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Lee SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002499; LORENTZ K, 1975, CLIN CHIM ACTA, V63, P271, DOI 10.1016/0009-8981(75)90047-9; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mittrucker HW, 2002, INFECT IMMUN, V70, P199, DOI 10.1128/IAI.70.1.199-203.2002; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; PAUL C, 1985, INFECT IMMUN, V48, P40, DOI 10.1128/IAI.48.1.40-43.1985; PAUL CC, 1988, INFECT IMMUN, V56, P2189, DOI 10.1128/IAI.56.8.2189-2192.1988; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Robbins SH, 2003, J IMMUNOL, V170, P5876, DOI 10.4049/jimmunol.170.12.5876; Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101; Ross EA, 2011, J IMMUNOL, V187, P1553, DOI 10.4049/jimmunol.1000502; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Srinivasan A, 2007, J IMMUNOL, V178, P6342, DOI 10.4049/jimmunol.178.10.6342; Taylor PD, 1998, INFECT IMMUN, V66, P3208, DOI 10.1128/IAI.66.7.3208-3217.1998; Vidric M, 2006, INFECT IMMUN, V74, P1050, DOI 10.1128/IAI.74.2.1050-1061.2006; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	63	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43481	10.1371/journal.pone.0043481	http://dx.doi.org/10.1371/journal.pone.0043481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912884	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700112
J	Qiao, HJ; Lin, CT; Ji, LQ; Jiang, ZG				Qiao, Huijie; Lin, Congtian; Ji, Liqiang; Jiang, Zhigang			mMWeb - An Online Platform for Employing Multiple Ecological Niche Modeling Algorithms	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; PREDICTIONS	Background: Predicting the ecological niche and potential habitat distribution of a given organism is one of the central domains of ecological and biogeographical research. A wide variety of modeling techniques have been developed for this purpose. In order to implement these models, the users must prepare a specific runtime environment for each model, learn how to use multiple model platforms, and prepare data in a different format each time. Additionally, often model results are difficult to interpret, and a standardized method for comparing model results across platforms does not exist. We developed a free and open source online platform, the multi-models web-based (mMWeb) platform, to address each of these problems, providing a novel environment in which the user can implement and compare multiple ecological niche model (ENM) algorithms. Methodology: mMWeb combines 18 existing ENMs and their corresponding algorithms and provides a uniform procedure for modeling the potential habitat niche of a species via a common web browser. mMWeb uses Java Native Interface (JNI), Java R Interface to combine the different ENMs and executes multiple tasks in parallel on a super computer. The cross-platform, user-friendly interface of mMWeb simplifies the process of building ENMs, providing an accessible and efficient environment from which to explore and compare different model algorithms.	[Qiao, Huijie; Lin, Congtian; Ji, Liqiang; Jiang, Zhigang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Qiao, Huijie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Qiao, HJ (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014	Jiang, Zhigang/0000-0003-2154-8588; Qiao, Huijie/0000-0002-5345-6234	National Natural Science Foundation of China [31100390]; Ministry of Science and Technology of People's Republic of China [2008BAC39B04]; Chinese Academy of Sciences [KSCX2-EW-Z-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Natural Science Foundation of China (A New Method to Predict the Species Distributions, 31100390), the Science and Technology Supporting Project of Ministry of Science and Technology of People's Republic of China (2008BAC39B04), and the Key Program of Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BUSBY JR, 1986, AUST J ECOL, V11, P1, DOI 10.1111/j.1442-9993.1986.tb00912.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Freeman EA, 2008, J STAT SOFTW, V23, P1; GDAL Development Team, 2011, GDAL GEOSP DAT ABSTR; GeoServer Development Team, 2011, GEOSERVER 2 1 3; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Heikkinen RK, 2011, ECOGRAPHY; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; Miller J, 2010, GEOGR COMPASS, V4, P490, DOI 10.1111/j.1749-8198.2010.00351.x; Munoz MES, 2009, GEOINFORMATICA; OpenLayers Development Team, 2011, OPENLAYERS 2 0; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Qiao HJ, 2010, THESIS GRADUATE U; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Santana FS, 2006, 2006 WORLD C COMP AG; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sutton T, 2007, OSGEO J; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thuiller W, 2010, R FORGE BIOMOD PROJE; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x	34	7	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43327	10.1371/journal.pone.0043327	http://dx.doi.org/10.1371/journal.pone.0043327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912854	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700082
J	Rendon-Anaya, M; Delaye, L; Possani, LD; Herrera-Estrella, A				Rendon-Anaya, Martha; Delaye, Luis; Possani, Lourival D.; Herrera-Estrella, Alfredo			Global Transcriptome Analysis of the Scorpion Centruroides noxius: New Toxin Families and Evolutionary Insights from an Ancestral Scorpion Species	PLOS ONE			English	Article							NA+-CHANNELS; VENOM GLAND; BETA-KTX; PEPTIDES; SEQUENCE; ARACHNIDA; BLOCKER; IDENTIFICATION; PHYLOGENIES; COMPONENTS	Scorpion venoms have been studied for decades, leading to the identification of hundreds of different toxins with medical and pharmacological implications. However, little emphasis has been given to the description of these arthropods from cellular and evolutionary perspectives. In this report, we describe a transcriptomic analysis of the Mexican scorpion Centruroides noxius Hoffmann, performed with a pyrosequencing platform. Three independent sequencing experiments were carried out, each including three different cDNA libraries constructed from RNA extracted from the whole body of the scorpion after telson removal, and from the venom gland before and after venom extraction. Over three million reads were obtained and assembled in almost 19000 isogroups. Within the telson-specific sequences, 72 isogroups (0.4% of total unique transcripts) were found to be similar to toxins previously reported in other scorpion species, spiders and sea anemones. The annotation pipeline also revealed the presence of important elements of the small non-coding RNA processing machinery, as well as microRNA candidates. A phylogenomic analysis of concatenated essential genes evidenced differential evolution rates in this species, particularly in ribosomal proteins and proteasome components. Additionally, statistical comparison of transcript abundance before and after venom extraction showed that 3% and 2% of the assembled isogroups had higher expression levels in the active and replenishing gland, respectively. Thus, our sequencing and annotation strategies provide a general view of the cellular and molecular processes that take place in these arthropods, allowed the discovery of new pharmacological and biotechnological targets and uncovered several regulatory and metabolic responses behind the assembly of the scorpion venom. The results obtained in this report represent the first high-throughput study that thoroughly describes the universe of genes that are expressed in the scorpion Centruroides noxius Hoffmann, a highly relevant organism from medical and evolutionary perspectives.	[Rendon-Anaya, Martha; Herrera-Estrella, Alfredo] Ctr Invest & Estudios Avanzados CINVESTAV, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Delaye, Luis] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico; [Rendon-Anaya, Martha; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico	Rendon-Anaya, M (corresponding author), Ctr Invest & Estudios Avanzados CINVESTAV, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	possani@ibt.unam.mx; aherrera@langebio.cinvestav.mx	Arredondo, Luis José Delaye/A-9574-2015; Herrera-Estrella, Alfredo/F-3185-2011; Herrera-Estrella, Alfredo/J-8210-2019; Possani, Lourival D/J-2397-2013	Arredondo, Luis José Delaye/0000-0003-4193-2720; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870; RENDON ANAYA, MARTHA/0000-0002-8047-223X	Direccion General del Personal Academico of National Autonomous University of Mexico (UNAM); Institute Bioclon S.A. de C.V.	Direccion General del Personal Academico of National Autonomous University of Mexico (UNAM); Institute Bioclon S.A. de C.V.	This work was partially supported by grant number IN204110 from Direccion General del Personal Academico of National Autonomous University of Mexico (UNAM) (http://www.unam.mx), and the support of Institute Bioclon S.A. de C.V. (http://www.bioclon.com.mx) to LDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corona M, 2002, FEBS LETT, V532, P121, DOI 10.1016/S0014-5793(02)03652-9; D'Suze G, 2009, BIOCHIMIE, V91, P1010, DOI 10.1016/j.biochi.2009.05.005; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davila S, 2005, GENE, V360, P92, DOI 10.1016/j.gene.2005.06.008; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; del Rio-Portilla F, 2004, EUR J BIOCHEM, V271, P2504, DOI 10.1111/j.1432-1033.2004.04181.x; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Diego-Garcia E, 2007, PEPTIDES, V28, P31, DOI 10.1016/j.peptides.2006.06.012; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fet Victor, 2003, Euscorpius, V4, P1; Fletcher PL, 2010, J BIOL CHEM, V285, P7405, DOI 10.1074/jbc.M109.028365; Garcia-Valdes J, 2001, FEBS LETT, V505, P369, DOI 10.1016/S0014-5793(01)02791-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gurrola GB, 1999, FASEB J, V13, P953, DOI 10.1096/fasebj.13.8.953; Hansen KD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000525; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Licea AF, 1996, TOXICON, V34, P843, DOI 10.1016/0041-0101(96)00043-8; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Malik S, 2009, J BIOL CHEM, V284, P35714, DOI 10.1074/jbc.M109.035709; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; Nieto AR, 1996, TOXICON, V34, P913, DOI 10.1016/0041-0101(96)00029-3; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; Pardo-Lopez L, 2002, FEBS LETT, V510, P45, DOI 10.1016/S0014-5793(01)03218-5; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; Ramirez-Dominguez ME, 2002, J EXP BIOL, V205, P869; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Rudolf I, 2009, FOLIA MICROBIOL, V54, P419, DOI 10.1007/s12223-009-0059-9; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Soleglad Michael E., 2003, Euscorpius, V11, P1; Soudani N, 2005, BBA-PROTEINS PROTEOM, V1747, P47, DOI 10.1016/j.bbapap.2004.09.020; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	52	49	49	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43331	10.1371/journal.pone.0043331	http://dx.doi.org/10.1371/journal.pone.0043331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912855	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700083
J	Amaral, C; Borges, M; Melo, S; da Silva, ET; Correia-da-Silva, G; Teixeira, N				Amaral, Cristina; Borges, Margarida; Melo, Soraia; da Silva, Elisiario Tavares; Correia-da-Silva, Georgina; Teixeira, Natercia			Apoptosis and Autophagy in Breast Cancer Cells following Exemestane Treatment	PLOS ONE			English	Article							AROMATASE INHIBITORS; MEMBRANE PERMEABILIZATION; POSTMENOPAUSAL WOMEN; TAMOXIFEN-RESISTANT; TRIGGERS APOPTOSIS; CYCLE PROGRESSION; MODIFIED STEROIDS; CROSS-TALK; DEATH; MCF-7	Aromatase inhibitors (AIs), which block the conversion of androgens to estrogens, are used for hormone-dependent breast cancer treatment. Exemestane, a steroidal that belongs to the third-generation of AIs, is a mechanism-based inhibitor that binds covalently and irreversibly, inactivating and destabilizing aromatase. Since the biological effects of exemestane in breast cancer cells are not totally understood, its effects on cell viability, cell proliferation and mechanisms of cell death were studied in an ER-positive aromatase-overexpressing breast cancer cell line (MCF-7aro). The effects of 3-methyladenine (3-MA), an inhibitor of autophagy and of ZVAD-FMK, an apoptotic inhibitor, in exemestane treated cells were also investigated. Our results indicate that exemestane induces a strong inhibition in MCF-7aro cell proliferation in a dose-and time-dependent manner, promoting a significant cell cycle arrest in G(0)/G(1) or in G(2)/M phases after 3 and 6 days of treatment, respectively. This was accompanied by a decrease in cell viability due to activation of cell death by apoptosis, via mitochondrial pathway and the occurrence of autophagy. Inhibition of autophagy by the autophagic inhibitor, 3-MA, resulted in a reduction of cell viability and activation of caspases. All together the results obtained suggest that exemestane induced mitochondrial-mediated apoptosis and autophagy, which act as a pro-survival process regulating breast cancer cell apoptosis.	[Amaral, Cristina; Borges, Margarida; Melo, Soraia; Correia-da-Silva, Georgina; Teixeira, Natercia] Univ Porto, Biochem Lab, Dept Biol Sci, Fac Pharm, P-4100 Oporto, Portugal; [Amaral, Cristina; Borges, Margarida; Correia-da-Silva, Georgina; Teixeira, Natercia] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Oporto, Portugal; [Melo, Soraia] Univ Coimbra, Dept Zool, Fac Sci & Technol, Coimbra, Portugal; [da Silva, Elisiario Tavares] Univ Coimbra, Ctr Pharmaceut Studies, Pharmaceut Chem Lab, Fac Pharm, Coimbra, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra	Amaral, C (corresponding author), Univ Porto, Biochem Lab, Dept Biol Sci, Fac Pharm, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	natercia@ff.up.pt	da Silva, Elisiário José Tavares/A-1759-2014; borges, margarida/GWR-0803-2022; Amaral, Cristina/K-5850-2013; Correia-da-Silva, Georgina/K-4696-2013; Borges, Margarida/E-9021-2013; Teixeira, Natercia A/K-4663-2013	da Silva, Elisiário José Tavares/0000-0002-0390-3403; Amaral, Cristina/0000-0003-1594-2095; Correia-da-Silva, Georgina/0000-0001-5787-9018; Borges, Margarida/0000-0001-6035-4095; Teixeira, Natercia A/0000-0002-3664-1120; Melo, Soraia/0000-0002-0278-0827	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/48190/2008]; FEDER Funds through the Operational Competitiveness Program-COMPETE; National Funds through FCT-Fundacao para a Ciencia e Tecnologia [FCOMP-01-0124-FEDER-020970 (PTDC/QUI-BIQ/120319/2010)]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER Funds through the Operational Competitiveness Program-COMPETE; National Funds through FCT-Fundacao para a Ciencia e Tecnologia	Cristina Amaral is a recipient of a PhD grant of Fundacao para a Ciencia e Tecnologia (FCT) (SFRH/BD/48190/2008). This work was funded by FEDER Funds through the Operational Competitiveness Program-COMPETE and by National Funds through FCT-Fundacao para a Ciencia e Tecnologia under the project FCOMP-01-0124-FEDER-020970 (PTDC/QUI-BIQ/120319/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cepa M, 2008, BIOL CHEM, V389, P1183, DOI 10.1515/BC.2008.134; Cepa M, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-41; Cepa MMDS, 2005, J MED CHEM, V48, P6379, DOI 10.1021/jm050129p; Chen XP, 2010, FREE RADICAL RES, V44, P587, DOI 10.3109/10715761003709802; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; de Medina P, 2009, CELL DEATH DIFFER, V16, P1372, DOI 10.1038/cdd.2009.62; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; de Vries JF, 2007, APOPTOSIS, V12, P181, DOI 10.1007/s10495-006-0526-6; Deeks ED, 2009, DRUGS, V69, P889, DOI 10.2165/00003495-200969070-00007; Detre S, 1999, INT J CANCER, V81, P309, DOI 10.1002/(SICI)1097-0215(19990412)81:2<309::AID-IJC23>3.0.CO;2-S; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Dutta U, 2008, MED ONCOL, V25, P113, DOI 10.1007/s12032-007-9019-x; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Fabian CJ, 2007, INT J CLIN PRACT, V61, P2051, DOI 10.1111/j.1742-1241.2007.01587.x; Ferreira CG, 2000, CANCER RES, V60, P7133; Gluck S, 2010, AM J CLIN ONCOL-CANC, V33, P314, DOI 10.1097/COC.0b013e31819fdf9b; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gross JM, 2003, CANCER METAST REV, V22, P327, DOI 10.1023/A:1023720928680; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Itoh T, 2005, MOL CANCER RES, V3, P203; Kallio A, 2005, APOPTOSIS, V10, P1395, DOI 10.1007/s10495-005-2137-z; Kanematsu S, 2010, ANTICANCER RES, V30, P3381; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kurokawa H, 1999, ONCOL REP, V6, P33; KYPRIANOU N, 1991, CANCER RES, V51, P162; Lemasters JJ, 1998, GASTROENTEROLOGY, V115, P783, DOI 10.1016/S0016-5085(98)70160-X; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Lim KB, 2001, BREAST CANCER RES TR, V68, P127, DOI 10.1023/A:1011929222555; Lonning PE, 2009, EUR J CANCER, V45, P527, DOI 10.1016/j.ejca.2008.10.019; Macedo LF, 2009, ANN NY ACAD SCI, V1155, P162, DOI 10.1111/j.1749-6632.2008.03689.x; Madden DT, 2007, AUTOPHAGY, V3, P519; Masri S, 2008, CANCER RES, V68, P4910, DOI 10.1158/0008-5472.CAN-08-0303; Miller WR, 2008, ONCOLOGIST, V13, P829, DOI 10.1634/theoncologist.2008-0055; Nazarewicz RR, 2007, CANCER RES, V67, P1282, DOI 10.1158/0008-5472.CAN-06-3099; NICHOLSON RI, 1994, BREAST CANCER RES TR, V29, P117, DOI 10.1007/BF00666187; Paglin S, 2001, CANCER RES, V61, P439; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Sun WL, 2011, AUTOPHAGY, V7, P1035, DOI 10.4161/auto.7.9.16521; Sun XZ, 1997, J STEROID BIOCHEM, V63, P29, DOI 10.1016/S0960-0760(97)00068-X; Thiantanawat A, 2003, CANCER RES, V63, P8037; Truchet I, 2000, EXP CELL RES, V254, P241, DOI 10.1006/excr.1999.4756; Wang X, 2006, CANCER RES, V66, P10281, DOI 10.1158/0008-5472.CAN-06-2134; Yan CH, 2007, ACTA PHARMACOL SIN, V28, P540, DOI 10.1111/j.1745-7254.2007.00530.x; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037; ZHOU D, 1990, CANCER RES, V50, P6949	53	46	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42398	10.1371/journal.pone.0042398	http://dx.doi.org/10.1371/journal.pone.0042398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912703	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500100013
J	Ang, KC; Ngu, MS; Reid, KP; Teh, MS; Aida, ZS; Koh, DXR; Berg, A; Oppenheimer, S; Salleh, H; Clyde, MM; Md-Zain, BM; Canfield, VA; Cheng, KC				Ang, Khai C.; Ngu, Mee S.; Reid, Katherine P.; Teh, Mei S.; Aida, Zamzuraida S.; Koh, Danny X. R.; Berg, Arthur; Oppenheimer, Stephen; Salleh, Hood; Clyde, Mahani M.; Md-Zain, Badrul M.; Canfield, Victor A.; Cheng, Keith C.			Skin Color Variation in Orang Asli Tribes of Peninsular Malaysia	PLOS ONE			English	Article							PIGMENTATION; EVOLUTION; PREGNANCY; EUROPEANS; ANCESTRY; ERYTHEMA; SLC24A5; SLC45A2; ALLELE; HUMANS	Pigmentation is a readily scorable and quantitative human phenotype, making it an excellent model for studying multifactorial traits and diseases. Convergent human evolution from the ancestral state, darker skin, towards lighter skin colors involved divergent genetic mechanisms in people of European vs. East Asian ancestry. It is striking that the European mechanisms result in a 10-20-fold increase in skin cancer susceptibility while the East Asian mechanisms do not. Towards the mapping of genes that contribute to East Asian pigmentation there is need for one or more populations that are admixed for ancestral and East Asian ancestry, but with minimal European contribution. This requirement is fulfilled by the Senoi, one of three indigenous tribes of Peninsular Malaysia collectively known as the Orang Asli. The Senoi are thought to be an admixture of the Negrito, an ancestral dark-skinned population representing the second of three Orang Asli tribes, and regional Mongoloid populations of Indo-China such as the Proto-Malay, the third Orang Asli tribe. We have calculated skin reflectance-based melanin indices in 492 Orang Asli, which ranged from 28 (lightest) to 75 (darkest); both extremes were represented in the Senoi. Population averages were 56 for Negrito, 42 for Proto-Malay, and 46 for Senoi. The derived allele frequencies for SLC24A5 and SLC45A2 in the Senoi were 0.04 and 0.02, respectively, consistent with greater South Asian than European admixture. Females and individuals with the A111T mutation had significantly lighter skin (p = 0.001 and 0.0039, respectively). Individuals with these derived alleles were found across the spectrum of skin color, indicating an overriding effect of strong skin lightening alleles of East Asian origin. These results suggest that the Senoi are suitable for mapping East Asian skin color genes.	[Ang, Khai C.; Reid, Katherine P.; Cheng, Keith C.] Penn State Coll Med, Dept Expt Pathol, Hershey, PA USA; [Ang, Khai C.; Reid, Katherine P.; Cheng, Keith C.] Penn State Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA USA; [Ngu, Mee S.; Teh, Mei S.; Aida, Zamzuraida S.; Koh, Danny X. R.; Clyde, Mahani M.; Md-Zain, Badrul M.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia; [Berg, Arthur] Penn State Coll Med, Dept Biostat & Bioinformat, Hershey, PA USA; [Oppenheimer, Stephen] Univ Oxford, Sch Anthropol & Museum Ethnog, Inst Cognit & Evolutionary Anthropol, Oxford, England; [Salleh, Hood] Univ Kebangsaan Malaysia, Acad Heritage Museum, Bangi 43600, Selangor, Malaysia; [Canfield, Victor A.] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Universiti Kebangsaan Malaysia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Oxford; Universiti Kebangsaan Malaysia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ang, KC (corresponding author), Penn State Coll Med, Dept Expt Pathol, Hershey, PA USA.	khaichung@gmail.com; kcheng76@gmail.com	teh, mei sze/N-5404-2017; Ang, Khai C./N-7956-2019	teh, mei sze/0000-0002-8020-3398; Ang, Khai C./0000-0001-7695-9953; Cheng, Keith/0000-0002-5350-5825; Berg, Arthur/0000-0002-4097-7348	National Institutes of Health [5R01 AR052535, 3R01 AR052535-03S1]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Jake Gittlen Cancer Research Foundation of the Penn State Cancer Institute; Universiti Kebangsaan Malaysia (UKM) [UKM-GUP-ASP-07-04-146, UKM-ST-08-FRGS0012-2010]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Jake Gittlen Cancer Research Foundation of the Penn State Cancer Institute; Universiti Kebangsaan Malaysia (UKM); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants 5R01 AR052535 and 3R01 AR052535-03S1 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to KCC, the Jake Gittlen Cancer Research Foundation of the Penn State Cancer Institute, and UKM-GUP-ASP-07-04-146 and UKM-ST-08-FRGS0012-2010 from Universiti Kebangsaan Malaysia (UKM) to BMMZ, MMC, KCA and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaluf S, 2002, PIGM CELL RES, V15, P119, DOI 10.1034/j.1600-0749.2002.1o072.x; Ang KC, 2011, GENET MOL RES, V10, P640, DOI 10.4238/vol10-2gmr1011; Ang KC, 2009, SISTEMATIK MOLEKUL O; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Carey I, 1976, ADM ORANG ASLI, P283; DIFFEY BL, 1984, BRIT J DERMATOL, V111, P663, DOI 10.1111/j.1365-2133.1984.tb14149.x; FIX AG, 1995, AM ANTHROPOL, V97, P313, DOI 10.1525/aa.1995.97.2.02a00090; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fullerton A, 1996, CONTACT DERMATITIS, V35, P1, DOI 10.1111/j.1600-0536.1996.tb02258.x; HOLICK MF, 1981, J INVEST DERMATOL, V77, P51, DOI 10.1111/1523-1747.ep12479237; Hood S, 2006, PEOPLE TRADITION; Howlader N, 2012, SEER CANC STAT REV 1; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; JHEOA (Jabatan Hal Ehwal Orang Asli, 2002, KEH BUD PANT LAR OR; KOHLMEIRER L, 1995, ENDOCRIN METAB CLIN, V24, P15, DOI 10.1016/S0889-8529(18)30052-5; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lim LS, 2010, J BIOL SCI, V10, P71, DOI DOI 10.3923/jbs.2010.71.83; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nakayama K, 2002, J HUM GENET, V47, P92, DOI 10.1007/s100380200007; NICHOLAS C, 2002, INDIGENOUS POLITICS; Nicholas C, 2006, PEOPLES TRADITIONS E, P20; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Oppenheimer S., 2011, DYN HUM DIVERS CASE, V627, P81; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Qiu DM, 2006, JPN J CLIN ONCOL, V36, P533, DOI 10.1093/jjco/hyl085; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; WHITEHEAD M, 1981, BRIT MED J, V283, P10, DOI 10.1136/bmj.283.6283.10; Yuasa I, 2006, ANN HUM GENET, V70, P802, DOI 10.1111/j.1469-1809.2006.00261.x; Yuasa I, 2004, INT J LEGAL MED, V118, P364, DOI 10.1007/s00414-004-0490-z	35	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42752	10.1371/journal.pone.0042752	http://dx.doi.org/10.1371/journal.pone.0042752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912732	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100027
J	Fujieda, Y; Ueno, S; Ogino, R; Kuroda, M; Jonsson, TJ; Guo, LN; Bamba, T; Fukusaki, E				Fujieda, Yusuke; Ueno, Shinya; Ogino, Ryoko; Kuroda, Mariko; Joensson, Thomas J.; Guo, Lining; Bamba, Takeshi; Fukusaki, Eiichiro			Metabolite Profiles Correlate Closely with Neurobehavioral Function in Experimental Spinal Cord Injury in Rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYL-ASPARTATE; ORNITHINE-DECARBOXYLASE; MULTIPLE-SCLEROSIS; BRAIN ISCHEMIA; RECOVERY; DISEASE; ACETYLASPARTATE; METABOLOMICS; MAINTENANCE	Traumatic spinal cord injury (SCI) results in direct physical damage and the generation of local factors contributing to secondary pathogenesis. Untargeted metabolomic profiling was used to uncover metabolic changes and to identify relationships between metabolites and neurobehavioral functions in the spinal cord after injury in rats. In the early metabolic phase, neuronal signaling, stress, and inflammation-associated metabolites were strongly altered. A dynamic inflammatory response consisting of elevated levels of prostaglandin E2 and palmitoyl ethanolamide as well as pro- and anti-inflammatory polyunsaturated fatty acids was observed. N-acetyl-aspartyl-glutamate (NAAG) and N-acetyl-aspartate (NAA) were significantly decreased possibly reflecting neuronal cell death. A second metabolic phase was also seen, consistent with membrane remodeling and antioxidant defense response. These metabolomic changes were consistent with the pathology and progression of SCI. Several metabolites, including NAA, NAAG, and the omega-3 fatty acids docosapentaenoate and docosahexaenoate correlated greatly with the established Basso, Beattie and Bresnahan locomotive score (BBB score). Our findings suggest the possibility of a biochemical basis for BBB score and illustrate that metabolites may correlate with neurobehavior. In particular the NAA level in the spinal cord might provide a meaningful biomarker that could help to determine the degree of injury severity and prognosticate neurologic recovery.	[Fujieda, Yusuke; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Fujieda, Yusuke; Ueno, Shinya; Ogino, Ryoko; Kuroda, Mariko] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Joensson, Thomas J.; Guo, Lining] Metabolon Inc, Durham, NC USA	Osaka University; Asubio Pharma Co., Ltd.; Metabolon	Fujieda, Y (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.	fujieda.yusuke.aw@asubio.co.jp; fukusaki@bio.eng.osaka-u.ac.jp						Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bazan NG, 2006, CELL MOL NEUROBIOL, V26, P901, DOI 10.1007/s10571-006-9064-6; Blamire AM, 2007, MAGN RESON MED, V58, P880, DOI 10.1002/mrm.21382; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; DABNEY A, 2010, Q VALUE Q VALUE ESTI; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; Erschbamer M, 2011, EUR J NEUROSCI, V33, P678, DOI 10.1111/j.1460-9568.2010.07562.x; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Falconer JC, 1996, J NEUROCHEM, V66, P717; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Giroud M, 1996, NEUROL RES, V18, P241; Griffith HR, 2008, ALZ DIS ASSOC DIS, V22, P54, DOI 10.1097/WAD.0b013e3181611011; Hayashi S, 2009, BIOCHEM BIOPH RES CO, V386, P268, DOI 10.1016/j.bbrc.2009.06.041; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kendi ATK, 2004, NEURORADIOLOGY, V46, P764, DOI 10.1007/s00234-004-1231-1; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Marliani AF, 2007, MAGN RESON MED, V57, P160, DOI 10.1002/mrm.21113; Mautes AEM, 1999, NEUROSCI LETT, V264, P153, DOI 10.1016/S0304-3940(99)00197-4; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; SAGER TN, 1995, J CEREBR BLOOD F MET, V15, P639, DOI 10.1038/jcbfm.1995.79; Schott JM, 2010, BRAIN, V133, P3315, DOI 10.1093/brain/awq208; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003; Tator C H, 1996, J Spinal Cord Med, V19, P206; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Vera-Portocarrero LP, 2002, BRAIN RES, V927, P104, DOI 10.1016/S0006-8993(01)03329-7; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007	42	18	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43152	10.1371/journal.pone.0043152	http://dx.doi.org/10.1371/journal.pone.0043152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912814	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100068
J	Pitzer, VE; Atkins, KE; de Blasio, BF; Van Effelterre, T; Atchison, CJ; Harris, JP; Shim, E; Galvani, AP; Edmunds, WJ; Viboud, C; Patel, MM; Grenfell, BT; Parashar, UD; Lopman, BA				Pitzer, Virginia E.; Atkins, Katherine E.; de Blasio, Birgitte Freiesleben; Van Effelterre, Thierry; Atchison, Christina J.; Harris, John P.; Shim, Eunha; Galvani, Alison P.; Edmunds, W. John; Viboud, Cecile; Patel, Manish M.; Grenfell, Bryan T.; Parashar, Umesh D.; Lopman, Ben A.			Direct and Indirect Effects of Rotavirus Vaccination: Comparing Predictions from Transmission Dynamic Models	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; 1ST 2 YEARS; DOUBLE-BLIND; EFFICACY; IMPACT; GASTROENTERITIS; PROTECTION; SAFETY; COMMUNITY; CHILDREN	Early observations from countries that have introduced rotavirus vaccination suggest that there may be indirect protection for unvaccinated individuals, but it is unclear whether these benefits will extend to the long term. Transmission dynamic models have attempted to quantify the indirect protection that might be expected from rotavirus vaccination in developed countries, but results have varied. To better understand the magnitude and sources of variability in model projections, we undertook a comparative analysis of transmission dynamic models for rotavirus. We fit five models to reported rotavirus gastroenteritis (RVGE) data from England and Wales, and evaluated outcomes for short- and long-term vaccination effects. All of our models reproduced the important features of rotavirus epidemics in England and Wales. Models predicted that during the initial year after vaccine introduction, incidence of severe RVGE would be reduced 1.8-2.9 times more than expected from the direct effects of the vaccine alone (28-50% at 90% coverage), but over a 5-year period following vaccine introduction severe RVGE would be reduced only by 1.1-1.7 times more than expected from the direct effects (54-90% at 90% coverage). Projections for the long-term reduction of severe RVGE ranged from a 55% reduction at full coverage to elimination with at least 80% coverage. Our models predicted short-term reductions in the incidence of RVGE that exceeded estimates of the direct effects, consistent with observations from the United States and other countries. Some of the models predicted that the short-term indirect benefits may be offset by a partial shifting of the burden of RVGE to older unvaccinated individuals. Nonetheless, even when such a shift occurs, the overall reduction in severe RVGE is considerable. Discrepancies among model predictions reflect uncertainties about age variation in the risk and reporting of RVGE, and the duration of natural and vaccine-induced immunity, highlighting important questions for future research.	[Pitzer, Virginia E.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Pitzer, Virginia E.; Viboud, Cecile; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Pitzer, Virginia E.; Atkins, Katherine E.; Galvani, Alison P.] Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT 06520 USA; [de Blasio, Birgitte Freiesleben] Univ Oslo, Dept Biostat, Inst Basic Med Sci, Oslo, Norway; [de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Oslo, Norway; [Van Effelterre, Thierry] GlaxoSmithKline Biol, Global Vaccine Dev, Wavre, Belgium; [Atchison, Christina J.; Edmunds, W. John] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Dept Epidemiol & Populat Hlth, London WC1, England; [Harris, John P.] Hlth Protect Agcy, Ctr Infect, Dept Gastrointestinal Emerging & Zoonot Infect, London, England; [Shim, Eunha] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Patel, Manish M.; Parashar, Umesh D.; Lopman, Ben A.] Ctr Dis Control & Prevent, Epidemiol Branch, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Yale University; University of Oslo; Norwegian Institute of Public Health (NIPH); GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Pitzer, VE (corresponding author), Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT 06520 USA.	virginia.pitzer@yale.edu		Harris, John/0000-0001-9606-9480; Atchison, Christina/0000-0001-8304-7389; Pitzer, Virginia/0000-0003-1015-2289	National Institutes of Health [R01 GM083983-01]; Bill and Melinda Gates Foundation; Miriam Weston Trust; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health; GAVI Alliance under a collaborative agreement with the Program for Appropriate Technology in Health (PATH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Miriam Weston Trust; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health; GAVI Alliance under a collaborative agreement with the Program for Appropriate Technology in Health (PATH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01 GM083983-01) (V.E.P. and B.T.G.), the Bill and Melinda Gates Foundation (V.E.P. and B.T.G.), Miriam Weston Trust (K.E.A. and A.P.G.), the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health (V.E.P, B.T.G., K.E.A., and B.F.B.), and the GAVI Alliance under a collaborative agreement with the Program for Appropriate Technology in Health (PATH) (M.M.P., U.D.P., and B.A.L.). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah GE, 2010, LANCET; Atchison CJ, 2010, P ROY SOC B-BIOL SCI, V277, P933, DOI 10.1098/rspb.2009.1755; Atchison C, 2010, VACCINE, V28, P3118, DOI 10.1016/j.vaccine.2010.02.060; Atkins KE, 2012, VACCINE, V30, P552, DOI 10.1016/j.vaccine.2011.11.064; Braeckman T, 2011, PEDIATR INFECT DIS J, V30, pS21, DOI 10.1097/INF.0b013e3181fefc51; Brisson M, 2006, MED DECIS MAKING, V26, P434, DOI 10.1177/0272989X06290485; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Conlan AJK, 2010, J R SOC INTERFACE, V7, P623, DOI 10.1098/rsif.2009.0284; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; Curns AT, 2011, PEDIATR INFECT DIS J, V30, pS54, DOI 10.1097/INF.0b013e3181fefda9; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; de Blasio BF, 2010, VACCINE, V28, P7923, DOI 10.1016/j.vaccine.2010.09.070; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; Fischer TK, 2002, J INFECT DIS, V186, P593, DOI 10.1086/342294; GRINSTEIN S, 1989, AM J EPIDEMIOL, V130, P300, DOI 10.1093/oxfordjournals.aje.a115336; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; HALLORAN ME, 1992, AM J EPIDEMIOL, V136, P328, DOI 10.1093/oxfordjournals.aje.a116498; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Macartney KK, 2011, J PAEDIATR CHILD H, V47, P266, DOI 10.1111/j.1440-1754.2010.01953.x; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Moulton LH, 1998, J INFECT DIS, V178, P1562, DOI 10.1086/314504; Office of National Statistics, 2009, AG STRUCT ENGL WAL; Safadi MAP, 2010, PEDIATR INFECT DIS J, V29, P1019, DOI 10.1097/INF.0b013e3181e7886a; Paulke-Korinek M, 2010, PEDIATR INFECT DIS J, V29, P319, DOI 10.1097/INF.0b013e3181c18434; Payne DC, 2011, CLIN INFECT DIS, V53, P245, DOI 10.1093/cid/cir307; Pitman R, 2011, VACCINE, V29, P3827, DOI 10.1016/j.vaccine.2010.09.052; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Shim E, 2006, J MATH BIOL, V53, P719, DOI 10.1007/s00285-006-0023-0; Shim E, 2009, VACCINE, V27, P4025, DOI 10.1016/j.vaccine.2009.04.030; SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS56, DOI 10.1097/INF.0b013e3181fefdc0; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; van Effelterre T, 2010, EPIDEMIOL INFECT, V138, P884, DOI 10.1017/S0950268809991245; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2004, VACCINE, V22, P2836, DOI 10.1016/j.vaccine.2004.01.044; Wall P G, 1996, Commun Dis Rep CDR Rev, V6, pR93; WARD RL, 1990, J INFECT DIS, V161, P440, DOI 10.1093/infdis/161.3.440; WARD RL, 1992, J INFECT DIS, V166, P1251, DOI 10.1093/infdis/166.6.1251; WARD RL, 1994, J INFECT DIS, V169, P900, DOI 10.1093/infdis/169.4.900; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; White LJ, 2008, J R SOC INTERFACE; Yen C, 2011, PEDIATR INFECT DIS J, V30, pS6, DOI 10.1097/INF.0b013e3181fefa05	50	51	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42320	10.1371/journal.pone.0042320	http://dx.doi.org/10.1371/journal.pone.0042320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912699	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000307500100011
J	Neumann, S; Bidon, T; Branschadel, M; Krippner-Heidenreich, A; Scheurich, P; Doszczak, M				Neumann, Simon; Bidon, Tobias; Branschaedel, Marcus; Krippner-Heidenreich, Anja; Scheurich, Peter; Doszczak, Malgorzata			The Transmembrane Domains of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Receptors 1 and 2 Co-Regulate Apoptotic Signaling Capacity	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CELL-DEATH; CD95; DR4; PALMITOYLATION; COLOCALIZATION; APO2L/TRAIL; RESISTANCE; COMPLEX	TNF-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor (TNF) ligand family that exerts its apoptotic activity in human cells by binding to two transmembrane receptors, TRAILR1 and TRAILR2. In cells co-expressing both receptors the particular contribution of either protein to the overall cellular response is not well defined. Here we have investigated whether differences in the signaling capacities of TRAILR1 and TRAILR2 can be attributed to certain functional molecular subdomains. We generated and characterized various chimeric receptors comprising TRAIL receptor domains fused with parts from other members of the TNF death receptor family. This allowed us to compare the contribution of particular domains of the two TRAIL receptors to the overall apoptotic response and to identify elements that regulate apoptotic signaling. Our results show that the TRAIL receptor death domains are weak apoptosis inducers compared to those of CD95/Fas, because TRAILR-derived constructs containing the CD95/Fas death domain possessed strongly enhanced apoptotic capabilities. Importantly, major differences in the signaling strengths of the two TRAIL receptors were linked to their transmembrane domains in combination with the adjacent extracellular stalk regions. This was evident from receptor chimeras comprising the extracellular part of TNFR1 and the intracellular signaling part of CD95/Fas. Both receptor chimeras showed comparable ligand binding affinities and internalization kinetics. However, the respective TRAILR2-derived molecule more efficiently induced apoptosis. It also activated caspase-8 and caspase-3 more strongly and more quickly, albeit being expressed at lower levels. These results suggest that the transmembrane domains together with their adjacent stalk regions can play a major role in control of death receptor activation thereby contributing to cell type specific differences in TRAILR1 and TRAILR2 signaling.	[Neumann, Simon; Bidon, Tobias; Branschaedel, Marcus; Scheurich, Peter; Doszczak, Malgorzata] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany; [Krippner-Heidenreich, Anja] Newcastle Univ, Fac Med Sci, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Stuttgart; Newcastle University - UK	Neumann, S (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany.	malgorzata.doszczak@izi.uni-stuttgart.de			German Federal Ministry of Education and Research (BMBF) within the FORSYS-Partner program [0315-280A]; German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology at the University of Stuttgart [310/1]	German Federal Ministry of Education and Research (BMBF) within the FORSYS-Partner program(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology at the University of Stuttgart(German Research Foundation (DFG))	This work was supported by the German Federal Ministry of Education and Research (BMBF;www.bmbf.de) within the FORSYS-Partner program (grant nr. 0315-280A) and the German Research Foundation (DFG, www.dfg.de) within the Cluster of Excellence in Simulation Technology (EXC 310/1) at the University of Stuttgart. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Fox NL, 2010, EXPERT OPIN BIOL TH, V10, P1, DOI 10.1517/14712590903319656; Gerspach J, 2011, RECENT PAT ANTI-CANC, V6, P294, DOI 10.2174/157489211796957739; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Krippner-Heidenreich A, 2002, J BIOL CHEM, V277, P44155, DOI 10.1074/jbc.M207399200; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lee HW, 2005, BIOCHEM BIOPH RES CO, V330, P1205, DOI 10.1016/j.bbrc.2005.03.101; Lemke J, 2010, J MOL MED, V88, P729, DOI 10.1007/s00109-010-0619-0; Leverkus M, 2003, MOL CELL BIOL, V23, P777, DOI 10.1128/MCB.23.3.777-790.2003; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muhlenbeck F, 2000, J BIOL CHEM, V275, P32208, DOI 10.1074/jbc.M000482200; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Ouyang W, 2011, INT J ONCOL, V39, P1577, DOI 10.3892/ijo.2011.1129; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reis CR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002808; Rossin A, 2009, BIOCHEM J, V419, P185, DOI 10.1042/BJ20081212; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; van Geelen CMM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-39; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558	36	7	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42526	10.1371/journal.pone.0042526	http://dx.doi.org/10.1371/journal.pone.0042526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22916132	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100119
J	Grandjean, J; D'Ostilio, K; Phillips, C; Balteau, E; Degueldre, C; Luxen, A; Maquet, P; Salmon, E; Collette, F				Grandjean, Julien; D'Ostilio, Kevin; Phillips, Christophe; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Salmon, Eric; Collette, Fabienne			Modulation of Brain Activity during a Stroop Inhibitory Task by the Kind of Cognitive Control Required	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; WORKING-MEMORY CAPACITY; PREFRONTAL CORTEX; ATTENTIONAL CONTROL; CONTROL MECHANISMS; INTERFERENCE; CONFLICT; FACILITATION; METAANALYSIS; PERFORMANCE	This study used a proportion congruency manipulation in the Stroop task in order to investigate, at the behavioral and brain substrate levels, the predictions derived from the Dual Mechanisms of Control (DMC) account of two distinct modes of cognitive control depending on the task context. Three experimental conditions were created that varied the proportion congruency: mostly incongruent (MI), mostly congruent (MC), and mostly neutral (MN) contexts. A reactive control strategy, which corresponds to transient interference resolution processes after conflict detection, was expected for the rare conflicting stimuli in the MC context, and a proactive strategy, characterized by a sustained task-relevant focus prior to the occurrence of conflict, was expected in the MI context. Results at the behavioral level supported the proactive/reactive distinction, with the replication of the classic proportion congruent effect (i.e., less interference and facilitation effects in the MI context). fMRI data only partially supported our predictions. Whereas reactive control for incongruent trials in the MC context engaged the expected fronto-parietal network including dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex, proactive control in the MI context was not associated with any sustained lateral prefrontal cortex activations, contrary to our hypothesis. Surprisingly, incongruent trials in the MI context elicited transient activation in common with incongruent trials in the MC context, especially in DLPFC, superior parietal lobe, and insula. This lack of sustained activity in MI is discussed in reference to the possible involvement of item-specific rather than list-wide mechanisms of control in the implementation of a high task-relevant focus.	[Grandjean, Julien; D'Ostilio, Kevin; Phillips, Christophe; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Salmon, Eric; Collette, Fabienne] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Grandjean, Julien; D'Ostilio, Kevin; Collette, Fabienne] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium	University of Liege; University of Liege; University of Liege	Grandjean, J (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	f.collette@ulg.ac.be	Salmon, Eric/AAE-4901-2020; Phillips, Christophe/M-3025-2017	Salmon, Eric/0000-0003-2520-9241; , Pierre/0000-0003-3106-3357; Phillips, Christophe/0000-0002-4990-425X	National Fund for Scientific Research (Belgium)	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The authors are supported by the National Fund for Scientific Research (Belgium; http://www1.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2011, J COGNITIVE NEUROSCI, V23, P716, DOI 10.1162/jocn.2010.21435; Belanger S, 2010, NEUROPSYCHOLOGIA, V48, P581, DOI 10.1016/j.neuropsychologia.2009.10.021; Blais C, 2007, PSYCHOL REV, V114, P1076, DOI 10.1037/0033-295X.114.4.1076; Blais C, 2010, J COGNITIVE NEUROSCI, V22, P2758, DOI 10.1162/jocn.2009.21365; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Brown TL, 2011, J EXP PSYCHOL HUMAN, V37, P85, DOI 10.1037/a0019252; Bugg JM, 2011, PSYCHON B REV, V18, P930, DOI 10.3758/s13423-011-0112-y; Bugg JM, 2011, J EXP PSYCHOL HUMAN, V37, P1595, DOI 10.1037/a0024670; Bugg JM, 2008, MEM COGNITION, V36, P1484, DOI 10.3758/MC.36.8.1484; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; De Pisapia N, 2006, NEUROCOMPUTING, V69, P1322, DOI 10.1016/j.neucom.2005.12.100; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Hutchison KA, 2011, J EXP PSYCHOL LEARN, V37, P851, DOI 10.1037/a0023437; Jimura K, 2010, CEREB CORTEX, V20, P1420, DOI 10.1093/cercor/bhp206; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; LINDSAY DS, 1994, J EXP PSYCHOL HUMAN, V20, P219, DOI 10.1037/0096-1523.20.2.219; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; Logan GD, 1998, J EXP PSYCHOL HUMAN, V24, P978, DOI 10.1037/0096-1523.24.3.978; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOWE DG, 1982, CAN J PSYCHOL, V36, P684, DOI 10.1037/h0080661; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Rush BK, 2006, AGING NEUROPSYCHOL C, V13, P588, DOI 10.1080/13825580600680703; Savine AC, 2010, J NEUROSCI, V30, P10294, DOI 10.1523/JNEUROSCI.2052-10.2010; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Walsh BJ, 2011, J COGNITIVE NEUROSCI, V23, P2211, DOI 10.1162/jocn.2010.21595	49	44	46	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41513	10.1371/journal.pone.0041513	http://dx.doi.org/10.1371/journal.pone.0041513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22911806	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300051
J	Patel, A; Zhu, YH; Kuzhikandathil, EV; Banks, WA; Siegel, A; Zalcman, SS				Patel, Ankur; Zhu, Youhua; Kuzhikandathil, Eldo V.; Banks, William A.; Siegel, Allan; Zalcman, Steven S.			Soluble Interleukin-6 Receptor Induces Motor Stereotypies and Co-Localizes with Gp130 in Regions Linked to Cortico-Striato-Thalamo-Cortical Circuits	PLOS ONE			English	Article							BETA-PROTEIN ANTIBODY; BLOOD-BRAIN-BARRIER; IL-6 RECEPTOR; CYTOKINE NETWORK; MOUSE MODEL; SCHIZOPHRENIA; AMPHETAMINE; ACTIVATION; COMPLEX; PASSAGE	Soluble cytokine receptors are normal constituents of body fluids that regulate peripheral cytokine and lymphoid activity and whose levels are increased in states of immune activation. Soluble interleukin-6 receptor (sIL-6R) levels positively correlate with disease progression in some autoimmune conditions and psychiatric disorders. Particularly strong links between levels of sIL-6R and the severity of psychotic symptoms occur in schizophrenia, raising the possibility that sIL-6R is involved in this disease. However, there is no evidence that peripheral sIL-6R induces relevant behavioral disturbances. We showed that single subcutaneous injections of sIL-6R (0-1 mu g), stimulated novelty stress-induced exploratory motor behaviors in male Balb/c mice within 20-40-min of injection. A progressive increase in vertical stereotypies was observed 40-80 min post injection, persisting for the remainder of the test session. Paralleling these stimulant-like effects, sIL-6R pretreatment significantly enhanced stereotypy scores following challenge with GBR 12909. We found that peripherally administered sIL-6R crossed the blood-brain barrier, localizing in brain regions associated with cortico-striatal-thalamo-cortical (CSTC) circuits, which are putative neuroanatomical substrates of disorders associated with repetitive stereotypies. Peripherally administered sIL-6R co-localized with gp130, a transmembrane protein involved in IL-6 trans-signaling, in the nucleus accumbens, caudate-putamen, motor and infralimbic cortices, and thalamic nuclei, but not with gp130 in the ventral tegmental area, substantia nigra, or sensorimotor cortex,. The results suggest that peripheral sIL-6R can act as a neuroimmune messenger, crossing the blood brain barrier (BBB) to selectively target CSTC circuits rich in IL-6 trans-signaling protein, and inducing repetitive stereotypies. As such sIL-6R may represent a novel therapeutic agent for relevant psychiatric disorders.	[Patel, Ankur; Siegel, Allan] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Zhu, Youhua; Zalcman, Steven S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; [Kuzhikandathil, Eldo V.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Banks, William A.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Div Gerontol & Geriatr Med, Dept Med,Geriatr Res Educ & Clin Ctr, Seattle, WA 98195 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Patel, A (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, 185 S Orange Ave, Newark, NJ 07103 USA.	dr.ankur@yahoo.com	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	National Institutes of Health [R01 MH74689, T32 5A74309]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant R01 MH74689 (SSZ) and National Institutes of Health Training Fellowship T32 5A74309 (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2005, PEPTIDES, V26, P287, DOI 10.1016/j.peptides.2004.09.016; Banks WA, 2004, CURR PHARM DESIGN, V10, P1365, DOI 10.2174/1381612043384862; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Barille S, 2000, EUR CYTOKINE NETW, V11, P546; CREESE I, 1972, NATURE-NEW BIOL, V238, P247, DOI 10.1038/newbio238247a0; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Lauta VM, 2003, CANCER, V97, P2440, DOI 10.1002/cncr.11072; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Maes M, 1995, INTERLEUKIN 2 INTERL; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Muller N, 2008, EUR ARCH PSY CLIN N, V258, P97, DOI 10.1007/s00406-008-2012-3; Muller N, 1997, NERVENARZT, V68, P11, DOI 10.1007/s001150050092; Muller N, 1996, GEBURTSH FRAUENHEILK, V56, pM82; Novick D, 2007, CYTOKINE GROWTH F R, V18, P525, DOI 10.1016/j.cytogfr.2007.06.024; Peter JC, 2010, J PHARMACOL EXP THER, V333, P478, DOI 10.1124/jpet.109.163279; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Saka E, 2004, J NEUROSCI, V24, P7557, DOI 10.1523/JNEUROSCI.1072-04.2004; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Wang JP, 1998, NEUROCHEM INT, V33, P143, DOI 10.1016/S0197-0186(98)00016-3; ZALCMAN S, 1994, BRAIN RES, V643, P40, DOI 10.1016/0006-8993(94)90006-X; Zalcman S, 1999, BRAIN RES, V847, P276, DOI 10.1016/S0006-8993(99)02063-6; Zalcman S, 1998, BRAIN RES, V811, P111, DOI 10.1016/S0006-8993(98)00904-4; Zalcman SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036316; Zhang DH, 2012, BRAIN BEHAV IMMUN, V26, P521, DOI 10.1016/j.bbi.2012.01.005; Zhang PL, 2004, STEM CELLS, V22, P344, DOI 10.1634/stemcells.22-3-344	31	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41623	10.1371/journal.pone.0041623	http://dx.doi.org/10.1371/journal.pone.0041623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911828	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700127
J	Calvenzani, V; Testoni, B; Gusmaroli, G; Lorenzo, M; Gnesutta, N; Petroni, K; Mantovani, R; Tonelli, C				Calvenzani, Valentina; Testoni, Barbara; Gusmaroli, Giuliana; Lorenzo, Mariangela; Gnesutta, Nerina; Petroni, Katia; Mantovani, Roberto; Tonelli, Chiara			Interactions and CCAAT-Binding of Arabidopsis thaliana NF-Y Subunits	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LEAFY COTYLEDON1; EXPRESSION ANALYSIS; CRYSTAL-STRUCTURE; FACTOR CBF; IDENTIFICATION; COMPLEX; GENES; CONSTANS; DOMAINS	Background: NF-Y is a transcription factor that recognizes with high specificity and affinity the widespread CCAAT box promoter element. It is formed by three subunits: NF-YA and the NF-YB/NF-YC-heterodimer containing histone fold domains (HFDs). We previously identified a large NF-Y gene family in Arabidopsis thaliana, composed of 29 members, and characterized their expression patterns in various plant tissues. Methods: We used yeast Two-hybrids assays (Y2H), pull-down and Electrophoretic Mobility Shift Assay (EMSA) in vitro experiments with recombinant proteins to dissect AtNF-YB/AtNF-YC interactions and DNA-binding with different AtNF-YAs. Results: Consistent with robust conservation within HFDs, we show that heterodimerization is possible among all histone-like subunits, including the divergent and related LEC1/AtNF-YB9 and L1L/AtNF-YB6 required for embryo development. DNA-binding to a consensus CCAAT box was investigated with specific AtNF-YB/AtNF-YC combinations and observed with some, but not all AtNF-YA subunits. Conclusions: Our results highlight (i) the conserved heterodimerization capacity of AtNF-Y histone-like subunits, and (ii) the different affinities of AtNF-YAs for the CCAAT sequence. Because of the general expansion of NF-Y genes in plants, these results most likely apply to other species.	[Calvenzani, Valentina; Testoni, Barbara; Gusmaroli, Giuliana; Lorenzo, Mariangela; Gnesutta, Nerina; Petroni, Katia; Mantovani, Roberto; Tonelli, Chiara] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Milan	Calvenzani, V (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	mantor@unimi.it; chiara.tonelli@unimi.it	Petroni, Katia/K-1159-2018; Gnesutta, Nerina/I-5432-2015; Tonelli, Chiara/F-7969-2015; TESTONI, Barbara/F-3767-2017	Petroni, Katia/0000-0003-3318-0442; Gnesutta, Nerina/0000-0002-2465-8881; Tonelli, Chiara/0000-0002-9505-3118; TESTONI, Barbara/0000-0001-5588-5465	Progetto di Rilevante Interesse Nazionale (PRIN); European Research Area-Plant Genomics; Fondo Italiano Ricerca di Base (ERA-PG FIRB)	Progetto di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); European Research Area-Plant Genomics; Fondo Italiano Ricerca di Base (ERA-PG FIRB)	This work was supported by a Progetto di Rilevante Interesse Nazionale (PRIN) grant to RM and by European Research Area-Plant Genomics, Fondo Italiano Ricerca di Base (ERA-PG FIRB) to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemanno L, 2008, PLANTA, V227, P853, DOI 10.1007/s00425-007-0662-4; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Ito Y, 2011, PLANT SCI, V181, P105, DOI 10.1016/j.plantsci.2011.04.009; James P, 1996, GENETICS, V144, P1425; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; LI XY, 1992, NUCLEIC ACIDS RES, V20, P1087, DOI 10.1093/nar/20.5.1087; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Sinha S, 1996, MOL CELL BIOL, V16, P328; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Xie ZY, 2008, MOL BIOL EVOL, V25, P1581, DOI 10.1093/molbev/msn105; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; XING YY, 1994, P NATL ACAD SCI USA, V91, P3009, DOI 10.1073/pnas.91.8.3009; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yang J, 2005, NEW PHYTOL, V165, P623, DOI 10.1111/j.1469-8137.2004.01260.x; Yazawa K, 2004, PLANT PHYSIOL BIOCH, V42, P215, DOI 10.1016/j.plaphy.2003.12.003; Yazawa K, 2007, J EXP BOT, V58, P3819, DOI 10.1093/jxb/erm238; Zemzoumi K, 1999, J MOL BIOL, V286, P327, DOI 10.1006/jmbi.1998.2496	50	54	61	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42902	10.1371/journal.pone.0042902	http://dx.doi.org/10.1371/journal.pone.0042902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912760	gold, Green Submitted, Green Published			2022-12-27	WOS:000308063700028
J	Alvarenga, JSC; Ligeiro, CM; Gontijo, CMF; Cortes, S; Campino, L; Vago, AR; Melo, MN				Campos Alvarenga, Janaina Sousa; Ligeiro, Carla Maia; Ferreira Gontijo, Celia Maria; Cortes, Sofia; Campino, Lenea; Vago, Annamaria Ravara; Melo, Maria Norma			KDNA Genetic Signatures Obtained by LSSP-PCR Analysis of Leishmania (Leishmania) infantum Isolated from the New and the Old World	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; VIANNIA BRAZILIENSIS; DONOVANI COMPLEX; ISOENZYMATIC ANALYSIS; SEQUENCE-ANALYSIS; GENUS LEISHMANIA; CHAGAS-DISEASE; STRAINS; IDENTIFICATION; POLYMORPHISM	Background: Visceral Leishmaniasis (VL) caused by species from the Leishmania donovani complex is the most severe form of the disease, lethal if untreated. VL caused by Leishmania infantum is a zoonosis with an increasing number of human cases and millions of dogs infected in the Old and the New World. In this study, L. infantum (syn. L. chagasi) strains were isolated from human and canine VL cases. The strains were obtained from endemic areas from Brazil and Portugal and their genetic polymorphism was ascertained using the LSSP-PCR (Low-Stringency Single Specific Primer PCR) technique for analyzing the kinetoplastid DNA (kDNA) minicircles hypervariable region. Principal Findings: KDNA genetic signatures obtained by minicircle LSSP-PCR analysis of forty L. infantum strains allowed the grouping of strains in several clades. Furthermore, LSSP-PCR profiles of L. infantum subpopulations were closely related to the host origin (human or canine). To our knowledge this is the first study which used this technique to compare genetic polymorphisms among strains of L. infantum originated from both the Old and the New World. Conclusions: LSSP-PCR profiles obtained by analysis of L. infantum kDNA hypervariable region of parasites isolated from human cases and infected dogs from Brazil and Portugal exhibited a genetic correlation among isolates originated from the same reservoir, human or canine. However, no association has been detected among the kDNA signatures and the geographical origin of L. infantum strains.	[Campos Alvarenga, Janaina Sousa; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Ligeiro, Carla Maia; Vago, Annamaria Ravara] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil; [Ferreira Gontijo, Celia Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Cortes, Sofia; Campino, Lenea] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Leishmanioses, P-1200 Lisbon, Portugal	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Alvarenga, JSC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	melo@icb.ufmg.br	Cortes, Sofia/I-2800-2012; Gontijo, Celia MF/AAU-7736-2020; Campino, Lenea/I-6375-2012	Cortes, Sofia/0000-0001-5850-6950; Gontijo, Celia MF/0000-0002-7034-535X; Campino, Lenea/0000-0003-4512-9660	European Community (EpiLeishNetSA) [015407]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil; FAPEMIG, Brazil	European Community (EpiLeishNetSA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	For this study, the authors received financial support from the European Community (EpiLeishNetSA - Contract no 015407) and from Brazilian funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). JSCA was supported by a PhD scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil. CML was supported by an undergraduate scholarship from the FAPEMIG, Brazil. The funders had no role in the study design, the data collection and analysis, the decision to publish, or preparation of the manuscript.	Baptista C, 2009, EXP PARASITOL, V121, P317, DOI 10.1016/j.exppara.2008.12.006; Baptista-Fernandes T, 2007, COMP IMMUNOL MICROB, V30, P41, DOI 10.1016/j.cimid.2006.10.001; Barreto G, 1996, AM J HUM GENET, V58, P609; BEVERLEY SM, 1987, P NATL ACAD SCI USA, V84, P484, DOI 10.1073/pnas.84.2.484; Botilde Y, 2006, INFECT GENET EVOL, V6, P440, DOI 10.1016/j.meegid.2006.02.003; Brewster S, 2002, T R SOC TROP MED HYG, V96, pS55, DOI DOI 10.1016/S0035-9203(02)90052-0; Brito CMM, 2008, PARASITOL RES, V103, P1111, DOI 10.1007/s00436-008-1102-5; Bulle B, 2002, J CLIN MICROBIOL, V40, P3391, DOI 10.1128/JCM.40.9.3391-3397.2002; Burgos JM, 2007, INT J PARASITOL, V37, P1319, DOI 10.1016/j.ijpara.2007.04.015; Caiaffa Waleska Teixeira, 2005, Cad. Saúde Pública, V21, P958, DOI 10.1590/S0102-311X2005000300032; Campino L, 2006, TROP MED INT HEALTH, V11, P1708, DOI 10.1111/j.1365-3156.2006.01728.x; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Chicharro C., 2002, T R SOC TROP MED HYG, V96, P93; Cortes S, 2004, T ROY SOC TROP MED H, V98, P12, DOI 10.1016/S0035-9203(03)00002-6; Cortes S, 2011, ZOONOSES PUBLIC HLTH, V58, P234, DOI 10.1111/j.1863-2378.2010.01374.x; Cortes S, 2006, PARASITOL INT, V55, P277, DOI 10.1016/j.parint.2006.07.003; de Oliveira FS, 2010, DIAGN MICR INFEC DIS, V66, P361, DOI 10.1016/j.diagmicrobio.2009.11.004; Desjeux P, 2003, ANN TROP MED PARASIT, V97, P3, DOI 10.1179/000349803225002499; Ferreira GA, 2007, J PARASITOL, V93, P712, DOI 10.1645/GE-958R1.1; Ferroglio E, 2006, T ROY SOC TROP MED H, V100, P636, DOI 10.1016/j.trstmh.2005.09.008; Gallego M, 2001, ARCH DERMATOL, V137, P667; Garcia A. L., 2005, Infection Genetics and Evolution, V5, P109, DOI 10.1016/j.meegid.2004.07.003; Gomes MA, 1997, PARASITOLOGY, V114, P517; GOMES RF, 1995, EXP PARASITOL, V80, P681, DOI 10.1006/expr.1995.1084; Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338; Gontijo CMF, 2002, MEM I OSWALDO CRUZ, V97, P751, DOI 10.1590/S0074-02762002000500029; Hide M, 2008, T ROY SOC TROP MED H, V102, P105, DOI 10.1016/j.trstmh.2007.09.013; Junqueira ACV, 2005, TRENDS PARASITOL, V21, P270, DOI 10.1016/j.pt.2005.04.001; KILLICKKENDRICK R, 1980, ANN TROP MED PARASIT, V74, P563, DOI 10.1080/00034983.1980.11687385; Kuhls K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000261; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lages-Silva E, 2006, J CLIN MICROBIOL, V44, P2167, DOI 10.1128/JCM.02124-05; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; MACEDO AM, 1992, MOL BIOCHEM PARASIT, V53, P63, DOI 10.1016/0166-6851(92)90007-7; Maia C, 2009, J VECTOR DIS, V46, P268; Marquez DS, 2007, EXP PARASITOL, V117, P35, DOI 10.1016/j.exppara.2007.03.007; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Mauricio IL, 2001, PARASITOLOGY, V122, P393, DOI 10.1017/S0031182001007466; Mauricio IL, 2009, AIDS RES HUM RETRO S, V324, P187; Mejía Ana María, 2005, Biomed., V25, P76; MOMEN H, 1987, Memorias do Instituto Oswaldo Cruz, V82, P447, DOI 10.1590/S0074-02761987000300022; Morales MA, 2001, T ROY SOC TROP MED H, V95, P104, DOI 10.1016/S0035-9203(01)90352-9; Morales MA, 2002, J INFECT DIS, V185, P1533, DOI 10.1086/340219; Nasereddin A, 2009, VET PARASITOL, V161, P126, DOI 10.1016/j.vetpar.2008.12.003; Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P1946, DOI 10.1073/pnas.91.5.1946; Pratlong F, 2004, J CLIN MICROBIOL, V42, P4077, DOI 10.1128/JCM.42.9.4077-4082.2004; Quaresma PF, 2009, ACTA TROP, V111, P289, DOI 10.1016/j.actatropica.2009.05.008; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Schantz PM, 2005, JAVMA-J AM VET MED A, V226, P1316, DOI 10.2460/javma.2005.226.1316; Schonian G, 1996, MOL BIOCHEM PARASIT, V77, P19, DOI 10.1016/0166-6851(96)02572-8; Simpson L, 2000, P NATL ACAD SCI USA, V97, P6986, DOI 10.1073/pnas.97.13.6986; Singh S, 2005, EXPERT REV MOL DIAGN, V5, P251, DOI 10.1586/14737159.5.2.251; SNEATH PHA, 1962, NATURE, V193, P855, DOI 10.1038/193855a0; Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005; THIEMANN OH, 1994, EMBO J, V13, P5689, DOI 10.1002/j.1460-2075.1994.tb06907.x; Toledo A, 2002, MOL BIOCHEM PARASIT, V119, P257, DOI 10.1016/S0166-6851(01)00424-8; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Vago AR, 1996, AM J PATHOL, V149, P2153; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; Zafra G, 2011, HUM PATHOL, V42, P1159, DOI 10.1016/j.humpath.2010.11.012; Zemanova E, 2004, AM J TROP MED HYG, V70, P613, DOI 10.4269/ajtmh.2004.70.613	65	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43363	10.1371/journal.pone.0043363	http://dx.doi.org/10.1371/journal.pone.0043363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912862	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700090
J	Fang, WG; St Leger, RJ				Fang, Weiguo; St Leger, Raymond J.			Enhanced UV Resistance and Improved Killing of Malaria Mosquitoes by Photolyase Transgenic Entomopathogenic Fungi	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; REPAIR; GENE; VIRULENCE; PHOTOPRODUCTS; INACTIVATION; PERSISTENCE; INCREASES; PROTEIN	The low survival of microbial pest control agents exposed to UV is the major environmental factor limiting their effectiveness. Using gene disruption we demonstrated that the insect pathogenic fungus Metarhizium robertsii uses photolyases to remove UV-induced cyclobutane pyrimidine dimers (CPD) and pyrimidine (6-4) photoproducts [(6-4) PPs] from its DNA. However, this photorepair is insufficient to fix CPD lesions and prevent the loss of viability caused by seven hours of solar radiation. Expression of a highly efficient archaeal (Halobacterium salinarum) CPD photolyase increased photorepair >30-fold in both M. robertsii and Beauveria bassiana. Consequently, transgenic strains were much more resistant to sunlight and retained virulence against the malaria vector Anopheles gambiae. In the field this will translate into much more efficient pest control over a longer time period. Conversely, our data shows that deleting native photolyase genes will strictly contain M. robertsii to areas protected from sunlight, alleviating safety concerns that transgenic hypervirulent Metarhizium spp will spread from mosquito traps or houses. The precision and malleability of the native and transgenic photolyases allows design of multiple pathogens with different strategies based on the environments in which they will be used.	[Fang, Weiguo] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [St Leger, Raymond J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	Zhejiang University; University System of Maryland; University of Maryland College Park	Fang, WG (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	wfang1@zju.edu.cn	St. Leger, Raymond/N-3219-2013; Fang, Weiguo/G-6680-2012	Fang, Weiguo/0000-0002-8431-8256	1000 Young Talents Program of China	1000 Young Talents Program of China	This work is supported by the "1000 Young Talents Program of China" to WF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Duran E, 2003, FUNGAL GENET BIOL, V40, P159, DOI 10.1016/S1087-1845(03)00089-6; Berrocal-Tito GM, 2007, EUKARYOT CELL, V6, P1682, DOI 10.1128/EC.00208-06; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Chelico L, 2006, J APPL MICROBIOL, V100, P964, DOI 10.1111/j.1365-2672.2006.02844.x; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; COHEN E, 1991, J INVERTEBR PATHOL, V57, P343, DOI 10.1016/0022-2011(91)90138-G; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; Edgington S, 2000, INT J PEST MANAGE, V46, P169, DOI 10.1080/096708700415490; Fan YH, 2012, NAT BIOTECHNOL, V30, P35, DOI 10.1038/nbt.2080; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Fang WG, 2009, J INVERTEBR PATHOL, V102, P155, DOI 10.1016/j.jip.2009.07.013; Fang W, 2009, FUNGAL GENET BIOL, V46, P277, DOI 10.1016/j.fgb.2008.12.001; Fang WG, 2004, J INVERTEBR PATHOL, V85, P18, DOI 10.1016/j.jip.2003.12.003; Fernandes EKK, 2007, J INVERTEBR PATHOL, V96, P237, DOI 10.1016/j.jip.2007.05.007; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; IGNOFFO CM, 1977, ENVIRON ENTOMOL, V6, P411, DOI 10.1093/ee/6.3.411; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Kaiser G, 2009, PLANTA, V230, P505, DOI 10.1007/s00425-009-0962-y; Lin LC, 2011, J MICROBIOL METH, V87, P241, DOI 10.1016/j.mimet.2011.07.018; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; McCready S, 2003, BIOCHEM SOC T, V31, P694, DOI 10.1042/BST0310694; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; Pilz C, 2011, J APPL ENTOMOL, V135, P393, DOI 10.1111/j.1439-0418.2010.01566.x; PRIOR C, 1992, BIOLOGICAL CONTROL OF LOCUSTS AND GRASSHOPPERS, P159; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; SANCAR GB, 1985, J BACTERIOL, V161, P769, DOI 10.1128/JB.161.2.769-771.1985; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Shang YF, 2012, J INVERTEBR PATHOL, V109, P105, DOI 10.1016/j.jip.2011.10.004; Shimura M, 1999, FUNGAL GENET BIOL, V28, P12, DOI 10.1006/fgbi.1999.1158; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Smits N, 1996, FEMS MICROBIOL ECOL, V21, P167, DOI 10.1016/S0168-6496(96)00052-9; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Thomas MB, 1997, PESTIC SCI, V49, P47, DOI 10.1002/(SICI)1096-9063(199701)49:1&lt;47::AID-PS471&gt;3.0.CO;2-O; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Yasui A, 1998, CONT CANC RES, P9	37	69	73	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43069	10.1371/journal.pone.0043069	http://dx.doi.org/10.1371/journal.pone.0043069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912789	gold, Green Submitted, Green Published			2022-12-27	WOS:000308063700036
J	Jia, YL; Jia, MH; Wang, XY; Liu, GJ				Jia, Yulin; Jia, Melissa H.; Wang, Xueyan; Liu, Guangjie			Indica and Japonica Crosses Resulting in Linkage Block and Recombination Suppression on Rice Chromosome 12	PLOS ONE			English	Article							BLAST RESISTANCE GENE; PI-TA; WILD-RICE; MOLECULAR CHARACTERIZATION; MAPPING POPULATION; CULTIVATED RICE; REGISTRATION; LOCUS; INSIGHTS; MARKERS	Understanding linkage block size and molecular mechanisms of recombination suppression is important for plant breeding. Previously large linkage blocks ranging from 14 megabases to 27 megabases were observed around the rice blast resistance gene Pi-ta in rice cultivars and backcross progeny involving an indica and japonica cross. In the present study, the same linkage block was further examined in 456 random recombinant individuals of rice involving 5 crosses ranging from F-2 to F-10 generation, with and without Pi-ta containing genomic indica regions with both indica and japonica germplasm. Simple sequence repeat markers spanning the entire chromosome 12 were used to detect recombination break points and to delimit physical size of linkage blocks. Large linkage blocks ranging from 4.1 megabases to 10 megabases were predicted from recombinant individuals involving genomic regions of indica and japonica. However, a significantly reduced block from less than 800 kb to 2.1megabases was identified from crosses of indica with indica rice regardless of the existence of Pi-ta. These findings suggest that crosses of indica and japonica rice have significant recombination suppression near the centromere on chromosome 12.	[Jia, Yulin; Jia, Melissa H.] ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA; [Wang, Xueyan] China Jiliang Univ, Coll Life Sci, Dept Biol, Hangzhou, Zhejiang, Peoples R China; [Liu, Guangjie] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA	United States Department of Agriculture (USDA); China Jiliang University; University of Arkansas System; University of Arkansas Fayetteville	Jia, YL (corresponding author), ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA.	Yulin.jia@ars.usda.gov	jia, yu/HHR-9047-2022; Jia, Yulin/T-8235-2019; Wang, Xueyan/N-1168-2017	Wang, Xueyan/0000-0002-5635-126X; Jia, Yulin/0000-0002-2132-0498	National Natural Science Foundation of China [31000847]; Science and Technology Department of Zhejiang Province [2011R10038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province	Financial supports of National Natural Science Foundation of China (Grant No. 31000847) and of Science and Technology Department of Zhejiang Province (Grant No. 2011R10038) to XW are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2003, GENETICS, V165, P849; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Beadle GW, 1932, P NATL ACAD SCI USA, V18, P160, DOI 10.1073/pnas.18.2.160; BOLLICH CN, 1985, CROP SCI, V25, P883, DOI 10.2135/cropsci1985.0011183X002500050038x; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chu QR, 2006, CROP SCI, V46, P1417, DOI 10.2135/cropsci2005.0199; Conaway-Bormans CA, 2003, THEOR APPL GENET, V107, P1014, DOI 10.1007/s00122-003-1338-5; Costanzo S, 2009, PLANT SCI, V177, P468, DOI 10.1016/j.plantsci.2009.07.012; Dai YT, 2010, FUNGAL GENET BIOL, V47, P973, DOI 10.1016/j.fgb.2010.08.003; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Huang CL, 2008, GENETICS, V179, P1527, DOI 10.1534/genetics.108.089805; Jain M, 2004, BBA-GENE STRUCT EXPR, V1676, P182, DOI 10.1016/j.bbaexp.2003.11.012; Jain M, 2008, PLANT CELL REP, V27, P767, DOI 10.1007/s00299-007-0491-8; Jia Y, 2003, PLANT DIS, V87, P129, DOI 10.1094/PDIS.2003.87.2.129; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jia Y, 2009, HEREDITY, V103, P333, DOI 10.1038/hdy.2009.95; Jia YL, 2004, EUPHYTICA, V138, P97, DOI 10.1023/B:EUPH.0000047079.42768.4d; Jia YL, 2004, PHYTOPATHOLOGY, V94, P296, DOI 10.1094/PHYTO.2004.94.3.296; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; Jia Y, 2008, MOL PLANT MICROBE IN, V21, P396, DOI 10.1094/MPMI-21-4-0396; Jia YL, 2010, J PLANT REGIST, V4, P163, DOI 10.3198/jpr2009.04.0223crmp; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; LAMBIE EJ, 1986, GENETICS, V114, P769; Lee S, 2009, GENETICS, V183, P1315, DOI 10.1534/genetics.109.108266; Lee SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022312; Linscombe SD, 2000, CROP SCI, V40, P294, DOI 10.2135/cropsci2000.0007rcv; Liu GJ, 2008, EUPHYTICA, V159, P73, DOI 10.1007/s10681-007-9459-6; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Ma JX, 2007, TRENDS GENET, V23, P134, DOI 10.1016/j.tig.2007.01.004; MARCHETTI M, 1998, SALES MARK MANAG APR, P38; Mather K, 1939, GENETICS, V24, P413; Metkar SS, 2004, CURR SCI INDIA, V87, P353; MOLDENHAUER KAK, 1990, CROP SCI, V30, P747, DOI 10.2135/cropsci1990.0011183X003000030065x; Nakamura S, 1997, MOL GEN GENET, V254, P611, DOI 10.1007/s004380050459; NAVEIRA H, 1992, GENETICS, V130, P205; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Roychowdhury M., 2012, Acta Agronomica Sinica, V38, P381, DOI 10.3724/SP.J.1006.2012.00381; Rutger JN, 2005, CROP SCI, V45, P2671, DOI 10.2135/cropsci2005.0216; Tian ZX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-142; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Wang X, 2008, PHYTOPATHOLOGY, V98, P1305, DOI 10.1094/PHYTO-98-12-1305; Wang X, 2010, PLANT BREEDING, V129, P491, DOI 10.1111/j.1439-0523.2009.01706.x; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yulin Jia, 2009, Frontiers of Agriculture in China, V3, P231, DOI 10.1007/s11703-009-0062-6; Zhao K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.010780, DOI 10.1371/JOURNAL.PONE.010780]; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003	48	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43066	10.1371/journal.pone.0043066	http://dx.doi.org/10.1371/journal.pone.0043066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912788	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700035
J	Kiefer, SM; Robbins, L; Rauchman, M				Kiefer, Susan M.; Robbins, Lynn; Rauchman, Michael			Conditional Expression of Wnt9b in Six2-Positive Cells Disrupts Stomach and Kidney Function	PLOS ONE			English	Article							NEPHRON PROGENITOR POPULATION; BETA-CATENIN GENE; DUODENOGASTRIC REFLUX; MOUSE; DISEASE; PROTEIN; MICE; DIFFERENTIATION; TRANSCRIPTION; INACTIVATION	During kidney development, canonical Wnt signaling activates differentiation, while the transcription factor Six2 maintains the progenitor pool. These opposing signals help to regulate nephron formation and ensure the full complement of nephrons are formed. Since these two factors control differing fates in kidney mesenchyme, we hypothesized that overexpression of Wnt9b in Six2-expressing cells would disrupt kidney formation and may alter cell differentiation decisions in other tissues. We created a transgenic mouse that conditionally expressed the canonical Wnt ligand in the developing kidney, Wnt9b. The transgene is activated by cre recombinase and expresses GFP. We first tested its biological activity using Hoxb7-cre and found that transgenic Wnt9b was capable of inducing differentiation genes and of rescuing kidney development in Wnt9b(-/-) homozygous deficient mice. In contrast, expression of Wnt9b in cells using Six2-cre caused gastrointestinal distress and severe renal failure in adult mice. Transgenic kidneys had numerous cystic tubules and elevated creatinine values (0.652 +/- 0.044) compared to wild-type mice (0.119 +/- 0.002). These animals also exhibited a malformed pyloric sphincter, duodenogastric reflux, and a transformation of the distal stomach into proximal fate. The gene expression changes observed for the Wnt9b:EGFP transgene were compared to a stabilized beta-catenin allele to determine that Wnt9b is activating the canonical Wnt pathway in the tissues analyzed. These results demonstrate that expression of Wnt9b in Six2-positive cells disrupts cell fate decisions in the kidney and the gastrointestinal tract.	[Kiefer, Susan M.; Robbins, Lynn; Rauchman, Michael] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA; [Kiefer, Susan M.; Rauchman, Michael] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63103 USA; [Kiefer, Susan M.; Robbins, Lynn; Rauchman, Michael] St Louis Univ, Div Nephrol, John Cochran Vet Affairs Med Ctr, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; Saint Louis University	Kiefer, SM (corresponding author), St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA.	rauchman@slu.edu			National Institutes of Health [R01 DK067222]; American Heart Association [0840117N]; Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01 DK067222 (http://nih.gov/) and the American Heart Association Established Investigator 0840117N (http://www.heart.org) to MR. SK was supported by a Saint Louis University Presidential Research Fund Award (www.slu.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle SC, 2011, DEVELOPMENT, V138, P4245, DOI 10.1242/dev.070433; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Couillard M, 2009, DEV DYNAM, V238, P405, DOI 10.1002/dvdy.21841; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Hermans D, 2003, EUR J PEDIATR, V162, P598, DOI 10.1007/s00431-003-1259-y; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KARAM SM, 1992, ANAT RECORD, V232, P231, DOI 10.1002/ar.1092320208; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kiefer SM, 2008, HUM MUTAT, V29, P1133, DOI 10.1002/humu.20759; Kiefer SM, 2010, DEVELOPMENT, V137, P3099, DOI 10.1242/dev.037812; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li X, 2009, DEV DYNAM, V238, P3205, DOI 10.1002/dvdy.22134; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Patel V, 2009, CURR OPIN NEPHROL HY, V18, P99, DOI 10.1097/MNH.0b013e3283262ab0; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Schmidt-Ott KM, 2007, DEVELOPMENT, V134, P3177, DOI 10.1242/dev.006544; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Self M, 2009, DEV BIOL, V334, P409, DOI 10.1016/j.ydbio.2009.07.039; Smith DM, 2000, DEVELOPMENT, V127, P3671; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; VAEZI MF, 1995, GASTROENTEROLOGY, V108, P1897, DOI 10.1016/0016-5085(95)90156-6; Vaezi MF, 1996, GASTROENTEROLOGY, V111, P1192, DOI 10.1053/gast.1996.v111.pm8898632; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	36	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43098	10.1371/journal.pone.0043098	http://dx.doi.org/10.1371/journal.pone.0043098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912798	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700041
J	Pontiroli, F; Dussurget, O; Zanoni, I; Urbano, M; Beretta, O; Granucci, F; Ricciardi-Castagnoli, P; Cossart, P; Foti, M				Pontiroli, Francesca; Dussurget, Olivier; Zanoni, Ivan; Urbano, Matteo; Beretta, Ottavio; Granucci, Francesca; Ricciardi-Castagnoli, Paola; Cossart, Pascale; Foti, Maria			The Timing of IFN beta Production Affects Early Innate Responses to Listeria monocytogenes and Determines the Overall Outcome of Lethal Infection	PLOS ONE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; I INTERFERON RECEPTOR; NATURAL-KILLER-CELLS; CD8(+) T-CELLS; BACTERIAL-INFECTION; IMMUNE-RESPONSES; ALPHA-BETA; MACROPHAGE ACTIVATION; MONOCLONAL-ANTIBODY; GAMMA-INTERFERON	Dendritic cells (DCs) and natural killer (NK) cells are essential components of the innate immunity and play a crucial role in the first phase of host defense against infections and tumors. Listeria monocytogenes (Lm) is an intracellular pathogen that colonizes the cytosol of eukaryotic cells. Recent findings have shown Lm specifically in splenic CD8a(+) DCs shortly after intravenous infection. We examined gene expression profiles of mouse DCs exposed to Lm to elucidate the molecular mechanisms underlying DCs interaction with Lm. Using a functional genomics approach, we found that Lm infection induced a cluster of late response genes including type I IFNs and interferon responsive genes (IRGs) in DCs. Type I INFs were produced at the maximal level only at 24 h post infection indicating that the regulation of IFNs in the context of Lm infection is delayed compared to the rapid response observed with viral pathogens. We showed that during Lm infection, IFN gamma production and cytotoxic activity were severely impaired in NK cells compared to E. coli infection. These defects were restored by providing an exogenous source of IFN beta during the initial phase of bacterial challenge. Moreover, when treated with IFN beta during early infection, NK cells were able to reduce bacterial titer in the spleen and significantly improve survival of infected mice. These findings show that the timing of IFN beta production is fundamental to the efficient control of the bacterium during the early innate phase of Lm infection.	[Pontiroli, Francesca; Zanoni, Ivan; Urbano, Matteo; Beretta, Ottavio; Granucci, Francesca; Foti, Maria] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Beretta, Ottavio; Foti, Maria] Univ Milano Bicocca, Genopolis Consortium, Milan, Italy; [Dussurget, Olivier; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France; [Dussurget, Olivier; Cossart, Pascale] INSERM, U604, Paris, France; [Ricciardi-Castagnoli, Paola] Singapore Immunol Network, Singapore, Singapore; [Dussurget, Olivier; Cossart, Pascale] INRA, USC2020, Paris, France	University of Milano-Bicocca; University of Milano-Bicocca; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); INRAE	Pontiroli, F (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	maria.foti@unimib.it	GRANUCCI, Francesca/K-6150-2019; Foti, Maria/AAB-9961-2022	granucci, francesca/0000-0002-7046-4914; Dussurget, Olivier/0000-0001-9924-0837; FOTI, MARIA/0000-0002-4481-1900; Zanoni, Ivan/0000-0002-3423-7474	Italian Ministry of Education and Research (COFIN); European Union [TOLERAGE: HEALTH-F4-2008-202156, FIGHT-MG: Health-2009-242210]	Italian Ministry of Education and Research (COFIN)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was supported by the Italian Ministry of Education and Research (COFIN 2009), by grants from the European Union FP7 Program (TOLERAGE: HEALTH-F4-2008-202156; FIGHT-MG: Health-2009-242210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Aoshi T, 2009, EUR J IMMUNOL, V39, P417, DOI 10.1002/eji.200838718; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Bhardwaj V, 1998, J IMMUNOL, V160, P376; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; BORTOLUSSI R, 1991, PEDIATR RES, V29, P400, DOI 10.1203/00006450-199104000-00014; Brzoza-Lewis KL, 2012, CELL IMMUNOL, V273, P41, DOI 10.1016/j.cellimm.2011.11.008; Buchrieser C, 2007, MICROBES INFECT, V9, P1147, DOI 10.1016/j.micinf.2007.05.002; Campisi L, 2011, EUR J IMMUNOL, V41, P1594, DOI 10.1002/eji.201041036; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; CZUPRYNSKI CJ, 1994, INFECT IMMUN, V62, P5161, DOI 10.1128/IAI.62.11.5161-5163.1994; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Edelson BT, 2012, ADV IMMUNOL, V113, P33, DOI 10.1016/B978-0-12-394590-7.00006-3; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Feng HP, 2005, J IMMUNOL, V175, P421, DOI 10.4049/jimmunol.175.1.421; Fischer MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002374; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Granucci F, 2004, J EXP MED, V200, P287, DOI 10.1084/jem.20040370; Hauf N, 1997, P NATL ACAD SCI USA, V94, P9394, DOI 10.1073/pnas.94.17.9394; HAVELL EA, 1993, J INFECT DIS, V167, P1364, DOI 10.1093/infdis/167.6.1364; Hossain H, 2006, CURR OPIN IMMUNOL, V18, P422, DOI 10.1016/j.coi.2006.05.018; Humann J, 2010, J IMMUNOL, V184, P5172, DOI 10.4049/jimmunol.0903759; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kapadia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019376; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Leroy Q, 2009, CLIN MICROBIOL INFEC, V15, P114, DOI 10.1111/j.1469-0691.2008.02189.x; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu Q, 2012, AM J PATHOL; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Mitchell LM, 2011, CELL IMMUNOL, V268, P79, DOI 10.1016/j.cellimm.2011.03.001; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; NAKANE A, 1983, CELL IMMUNOL, V75, P283, DOI 10.1016/0008-8749(83)90326-X; Neuenhahn M, 2007, IMMUNOL LETT, V114, P66, DOI 10.1016/j.imlet.2007.09.007; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Ray JCJ, 2008, J THEOR BIOL, V252, P24, DOI 10.1016/j.jtbi.2008.01.010; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Stockinger S, 2008, IMMUNOBIOLOGY, V213, P889, DOI 10.1016/j.imbio.2008.07.020; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Tchatalbachev S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-275; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Westcott MM, 2010, INFECT IMMUN, V78, P2956, DOI 10.1128/IAI.01027-09; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	71	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43455	10.1371/journal.pone.0043455	http://dx.doi.org/10.1371/journal.pone.0043455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912878	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700106
J	Garcia-Linares, C; Mercade, J; Gel, B; Biayna, J; Terribas, E; Lazaro, C; Serra, E				Garcia-Linares, Carles; Mercade, Jaume; Gel, Bernat; Biayna, Josep; Terribas, Ernest; Lazaro, Conxi; Serra, Eduard			Applying Microsatellite Multiplex PCR Analysis (MMPA) for Determining Allele Copy-Number Status and Percentage of Normal Cells within Tumors	PLOS ONE			English	Article							HETEROZYGOSITY; DNA; QUANTIFICATION; IMBALANCE; LOH; NF1	The study of somatic genetic alterations in tumors contributes to the understanding and management of cancer. Genetic alterations, such us copy number or copy neutral changes, generate allelic imbalances (AIs) that can be determined using polymorphic markers. Here we report the development of a simple set of calculations for analyzing microsatellite multiplex PCR data from control-tumor pairs that allows us to obtain accurate information not only regarding the AI status of tumors, but also the percentage of tumor-infiltrating normal cells, the locus copy-number status and the mechanism involved in AI. We validated this new approach by re-analyzing a set of Neurofibromatosis type 1-associated dermal neurofibromas and comparing newly generated data with results obtained for the same tumors in a previous study using MLPA, Paralog Ratio Analysis and SNP-array techniques. Microsatellite multiplex PCR analysis (MMPA) should be particularly useful for analyzing specific regions of the genome containing tumor suppressor genes and also for determining the percentage of infiltrating normal cells within tumors allowing them to be sorted before they are analyzed by more expensive techniques.	[Garcia-Linares, Carles; Mercade, Jaume; Gel, Bernat; Biayna, Josep; Terribas, Ernest; Serra, Eduard] Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain; [Lazaro, Conxi] Inst Catala Oncol ICO IDIBELL, Lab Recerca Translac, Programa Diagnost Mol Canc Hereditari, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Garcia-Linares, C (corresponding author), Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain.	eserra@imppc.org	Terribas, Ernest/H-8731-2017; Serra, Eduard/K-1332-2013; GARCIA, CONXI LAZARO/Q-2410-2016; Rodriguez, Josep Biayna/AAM-1263-2021; Gel Moreno, Bernat/B-8806-2016	Terribas, Ernest/0000-0002-7921-9683; Serra, Eduard/0000-0003-2895-9857; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Gel Moreno, Bernat/0000-0001-8878-349X; Biayna Rodriguez, josep/0000-0002-0842-7530	Spanish Health Research Foundation: Instituto de Salud Carlos III [PI051155, PI081871, PI10/01422, ISCIII-RTICC RD06/0020/1050, ISCIII-RTICC RD06/0020/1051]; Government of Catalonia [2009SGR290]; Asociacion Espanola Contra el Cancer (AECC)	Spanish Health Research Foundation: Instituto de Salud Carlos III; Government of Catalonia(Generalitat de Catalunya); Asociacion Espanola Contra el Cancer (AECC)	This work was supported by grants from the Spanish Health Research Foundation: Instituto de Salud Carlos III (PI051155, PI081871, PI10/01422 and ISCIII-RTICC RD06/0020/1050; RD06/0020/1051); the Government of Catalonia (2009SGR290); the Asociacion Espanola Contra el Cancer (AECC) that recognizes and supports our group as a Grupo Estable de Investigacion Oncologica 2010. The authors would like to especially acknowledge the Asociacion Espanola de Afectados de Neurofibromatosis for their constant support to our research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bieche I, 1998, INT J CANCER, V78, P661, DOI 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.3.CO;2-9; BRANDT B, 1995, GENE, V159, P29, DOI 10.1016/0378-1119(94)00651-8; CAWKWELL L, 1994, BRIT J CANCER, V70, P813, DOI 10.1038/bjc.1994.404; Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136; Garcia-Linares C, 2011, HUM MUTAT, V32, P78, DOI 10.1002/humu.21387; Goransson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006057; HAHN M, 1995, BIOTECHNIQUES, V18, P1040; Kumps C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-298; Li A, 2011, NUCLEIC ACIDS RES, V39, P4928, DOI 10.1093/nar/gkr014; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Postma C, 2005, J PATHOL, V205, P514, DOI 10.1002/path.1733; Serra E, 2001, NAT GENET, V28, P294, DOI 10.1038/90148; Skotheim RI, 2001, CANCER GENET CYTOGEN, V127, P64, DOI 10.1016/S0165-4608(00)00433-7; Slebos RJC, 2004, LAB INVEST, V84, P649, DOI 10.1038/labinvest.3700076; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0	17	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42682	10.1371/journal.pone.0042682	http://dx.doi.org/10.1371/journal.pone.0042682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916147	Green Submitted, gold, Green Published			2022-12-27	WOS:000307823600022
J	Wu, XH; Wang, Y; Zhuo, Z; Jiang, F; Wu, YD				Wu, Xian-Hui; Wang, Yang; Zhuo, Zhu; Jiang, Fan; Wu, Yun-Dong			Identifying the Hotspots on the Top Faces of WD40-Repeat Proteins from Their Primary Sequences by beta-Bulges and DHSW Tetrads	PLOS ONE			English	Article							WD40 REPEAT DOMAIN; SER/THR-TRP TETRAD; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION; HISTONE H3; HOT-SPOTS; COMPLEX; BINDING; COMMON; IDENTIFICATION	The analysis of 36 available crystal structures of WD40 repeat proteins reveals widespread existence of a beta-bulge formed at the beginning of strand a and the end of strand b, termed as WDb-a bulge: among a total of 259 WD40 blades, there are 243 such beta-bulges. The R-1 positions in these WDb-a bulges have fair distributions of Arg, His, Ile, Leu, Lys, Met, Phe, Trp, Tyr and Val residues. These residues protrude on the top face of the WD40 proteins and can serve as hotspots for protein-protein interactions. An analysis of 29 protein complexes formed by 17 WD proteins reveals that these R-1 residues, along with two other residues (R-1-2 and D-1), are indeed widely involved in protein-protein interactions. Interestingly, these WDb-a bulges can be easily identified by the 4-amino acid sequences of (V, L, I), R-1, R-2, (V, L, I), along with some other significant amino acids. Thus, the hotspots of WD40 proteins on the top face can be readily predicted based on the primary sequences of the proteins. The literature-reported mutagenesis studies for Met30, MDV1, Tup11, COP1 and SPA1, which crystal structures are not available, can be readily understood based on the feature-based method. Applying the method, the twelve potential hotspots on the top face of Tup11 from S. japonicas have been identified. Our ITC measurements confirm seven of them, Tyr382, Arg284, Tyr426, Tyr508, Leu559, Lys575 and Ile601, are essential for recognizing Fep1. The ITC measurements further convinced that the feature-based method provides accurate prediction of hotspots on the top face.	[Wu, Xian-Hui; Wang, Yang; Zhuo, Zhu; Jiang, Fan; Wu, Yun-Dong] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China; [Wu, Yun-Dong] Peking Univ, Coll Chem, Beijing 100871, Peoples R China	Peking University; University Town of Shenzhen; Peking University	Wu, XH (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China.	wuxh@pkusz.edu.cn; wuyd@pkusz.edu.cn	Z, Z/AEN-2153-2022; Wang, Yang/AAN-7740-2020; z, z/HHN-3970-2022; z, z/GXZ-4805-2022; Wu, Yun-Dong/G-8463-2013; Jiang, Fan/E-2771-2012		National Natural Science Foundation of China [21133002]; Shenzhen Graduate School of Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Graduate School of Peking University	The authors are grateful for the financial supports from the National Natural Science Foundation of China(grant No.21133002; http://www.nsfc.gov.cn/Portal0/default152.htm) and the Shenzhen Graduate School of Peking University for Financial Support of this research (www.pkusz.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Axe DD, 1999, J MOL BIOL, V286, P1471, DOI 10.1006/jmbi.1999.2569; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brunson LE, 2005, MOL GENET GENOMICS, V273, P361, DOI 10.1007/s00438-005-1137-6; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Cerna D, 2005, J MOL BIOL, V351, P923, DOI 10.1016/j.jmb.2005.06.025; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chen PY, 2001, PROTEIN SCI, V10, P2063, DOI 10.1110/ps.07101; Cheng ZH, 2004, PROTEIN SCI, V13, P2673, DOI 10.1110/ps.04856504; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; DionSchultz A, 1997, PROTEIN ENG, V10, P263, DOI 10.1093/protein/10.3.263; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Larsen NA, 2004, J MOL BIOL, V344, P885, DOI 10.1016/j.jmb.2004.09.094; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mishra P, 2009, J BIOCHEM, V146, P563, DOI 10.1093/jb/mvp106; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Pickles LM, 2002, STRUCTURE, V10, P751, DOI 10.1016/S0969-2126(02)00768-2; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu XH, 2010, BIOCHEMISTRY-US, V49, P10237, DOI 10.1021/bi101321y; Wu XH, 2010, PROTEINS, V78, P1186, DOI 10.1002/prot.22638; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang JP, 2006, PLANT J, V47, P564, DOI 10.1111/j.1365-313X.2006.02811.x; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Znaidi S, 2004, J BIOL CHEM, V279, P9462, DOI 10.1074/jbc.M312787200; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	61	35	35	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43005	10.1371/journal.pone.0043005	http://dx.doi.org/10.1371/journal.pone.0043005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916195	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600039
J	Yao, JK; Condray, R; Dougherty, GG; Keshavan, MS; Montrose, DM; Matson, WR; McEvoy, J; Kaddurah-Daouk, R; Reddy, RD				Yao, Jeffrey K.; Condray, Ruth; Dougherty, George G., Jr.; Keshavan, Matcheri S.; Montrose, Debra M.; Matson, Wayne R.; McEvoy, Joseph; Kaddurah-Daouk, Rima; Reddy, Ravinder D.			Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia	PLOS ONE			English	Article							SERUM URIC-ACID; NEUROLOGIC EXAMINATION ABNORMALITIES; NEUROLEPTIC-NAIVE; NEUROPSYCHOLOGICAL PERFORMANCE; ACHIEVEMENT BEHAVIOR; SOFT SIGNS; CHOLESTEROL; CATABOLISM; MOTIVATION; RADICALS	Background: The antioxidant defense system, which is known to be dysregulated in schizophrenia, is closely linked to the dynamics of purine pathway. Thus, alterations in the homeostatic balance in the purine pathway may be involved in the pathophysiology of schizophrenia. Methodology/Principal Findings: Breakdown products in purine pathway were measured using high-pressure liquid chromatography coupled with a coulometric multi-electrode array system for 25 first-episode neuroleptic-naive patients with schizophrenia at baseline and at 4-weeks following initiation of treatment with antipsychotic medication. Associations between these metabolites and clinical and neurological symptoms were examined at both time points. The ratio of uric acid and guanine measured at baseline predicted clinical improvement following four weeks of treatment with antipsychotic medication. Baseline levels of purine metabolites also predicted clinical and neurological symtpoms recorded at baseline; level of guanosine was associated with degree of clinical thought disturbance, and the ratio of xanthosine to guanosine at baseline predicted degree of impairment in the repetition and sequencing of actions. Conclusions/Significance: Findings suggest an association between optimal levels of purine byproducts and dynamics in clinical symptoms and adjustment, as well as in the integrity of sensory and motor processing. Taken together, alterations in purine catabolism may have clinical relevance in schizophrenia pathology.	[Yao, Jeffrey K.; Condray, Ruth; Dougherty, George G., Jr.; Reddy, Ravinder D.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15206 USA; [Yao, Jeffrey K.; Condray, Ruth; Dougherty, George G., Jr.; Keshavan, Matcheri S.; Montrose, Debra M.; Reddy, Ravinder D.] Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA; [Yao, Jeffrey K.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Keshavan, Matcheri S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Keshavan, Matcheri S.] Harvard Univ, Boston, MA 02115 USA; [Matson, Wayne R.] Bedford Vet Affairs Med Ctr, Bedford, MA USA; [McEvoy, Joseph; Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Duke University	Yao, JK (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15206 USA.	jkyao@pitt.edu		Kaddurah-Daouk, Rima/0000-0003-1858-5732	Department of Veterans Affairs (VA); Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research Development; Senior Research Career Scientist Award; VA Pittsburgh Healthcare System; National Institutes of Health [MH58141, MH64118, MH45203, MH84941, R24 GM078233, c UL1 RR024153, M01 RR00056]; Metabolomics Research Network; Stanley Medical Research Institute; National Alliance for Research on Schizophrenia and Affective Disorders; Merck; Psychogenics; Roche; Sunovion; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045203, K08MH064118, R01MH058141, R01MH084941] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research Development(US Department of Veterans Affairs); Senior Research Career Scientist Award; VA Pittsburgh Healthcare System(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metabolomics Research Network; Stanley Medical Research Institute; National Alliance for Research on Schizophrenia and Affective Disorders(NARSAD); Merck(Merck & Company); Psychogenics; Roche(Roche Holding); Sunovion; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This material is based on work supported in part by the grants from the Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development [Merit Reviews (JKY) and Senior Research Career Scientist Award (JKY)], VA Pittsburgh Healthcare System (JKY, GGD), National Institutes of Health [MH58141 (JKY), MH64118 (RDR), MH45203 (MSK), MH84941 (RKD), R24 GM078233 (RKD), c UL1 RR024153 and NIH/NCRR/GCRC Grant M01 RR00056], Metabolomics Research Network (RKD); Stanley Medical Research Institute (RKD), and National Alliance for Research on Schizophrenia and Affective Disorders (RKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article do not represent the views of the Department of Veterans Affairs or the United States Government.; Dr. McEvoy received honoraria from Lilly, Merck, and Sunovion, and grant supports from Merck, Psychogenics, Roche, and Sunovion. Dr. Kaddurah-Daouk is a co-inventor on a series of patents in the metabolomics field. (1. One patent Issued (3/20/12) "Lipidomic approaches to determine drug response - Phenotypes in cardiovascular disease" Patent # 8137977, expires 12/10/27. 2. One patent pending: "Lipidomic approaches for central nervous system disorders" Application # 12/091,213 filed 12/10/08, Publication # US 2009/0305323 12/10/09.) All other authors declare no conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Annanmaki T, 2008, PARKINSONISM RELAT D, V14, P576, DOI 10.1016/j.parkreldis.2007.11.001; Arango C, 1999, AM J PSYCHIAT, V156, P1349; BARRERA CM, 1988, BIOL PSYCHIAT, V24, P344, DOI 10.1016/0006-3223(88)90205-3; BARRERA CM, 1989, PHARMACOL BIOCHEM BE, V33, P367, DOI 10.1016/0091-3057(89)90515-7; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bruning J.L., 1987, COMPUTATIONAL HDB ST; BUCHANAN RW, 1989, PSYCHIAT RES, V27, P335, DOI 10.1016/0165-1781(89)90148-0; CADET JL, 1987, INTEGRATIVE PSYCHIAT, V5, P40; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; GUPTA S, 1995, AM J PSYCHIAT, V152, P191; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; ISHAY JS, 1979, PSYCHOPHARMACOLOGY, V65, P299, DOI 10.1007/BF00492219; KASL SV, 1970, J AMER MED ASSOC, V213, P1291, DOI 10.1001/jama.213.8.1291; KASL SV, 1970, J AMER MED ASSOC, V213, P1158, DOI 10.1001/jama.213.7.1158; Keshavan MS, 2003, AM J PSYCHIAT, V160, P1298, DOI 10.1176/appi.ajp.160.7.1298; Kristal Bruce S., 2007, V358, P159, DOI 10.1007/978-1-59745-244-1_10; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Linden J., 2006, BASIC NEUROCHEMISTRY, P303; LOHR JB, 1991, ARCH GEN PSYCHIAT, V48, P1097; Matsuzawa D, 2009, AM J MED GENET B, V150B, P86, DOI 10.1002/ajmg.b.30776; Mohr F, 2003, PSYCHIAT RES, V121, P21, DOI 10.1016/S0165-1781(03)00203-8; Nagamine T, 2010, NEUROPSYCH DIS TREAT, V6, P281; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Reddy R, 2003, SCHIZOPHR RES, V62, P205, DOI 10.1016/S0920-9964(02)00407-3; Reddy RD, 1996, PROSTAG LEUKOTR ESS, V55, P33, DOI 10.1016/S0952-3278(96)90143-X; RUBIN P, 1994, ACTA PSYCHIAT SCAND, V90, P385, DOI 10.1111/j.1600-0447.1994.tb01611.x; Sanders RD, 2006, SCHIZOPHR RES, V86, P172, DOI 10.1016/j.schres.2006.06.012; Sanders RD, 2004, J NEUROPSYCH CLIN N, V16, P480, DOI 10.1176/appi.neuropsych.16.4.480; Sanders RD, 2000, PSYCHIAT RES, V95, P237, DOI 10.1016/S0165-1781(00)00176-1; Schiavo S, 2008, ANAL CHEM, V80, P5912, DOI 10.1021/ac800507y; Shi HL, 2002, ANAL BIOCHEM, V302, P239, DOI 10.1006/abio.2001.5568; STETTEN D, 1959, SCIENCE, V129, P1737, DOI 10.1126/science.129.3365.1737; Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011; Yao JK, 2010, MOL PSYCHIATR, V15, P938, DOI 10.1038/mp.2009.33; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603; Yao JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009508; Yao JK, 1998, PSYCHIAT RES, V80, P29, DOI 10.1016/S0165-1781(98)00051-1	44	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42165	10.1371/journal.pone.0042165	http://dx.doi.org/10.1371/journal.pone.0042165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22916123	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000307500800009
J	Boechat, ND; Ogusku, MM; Boechat, AL; Sadahiro, A				Boechat, Narjara de Oliveira; Ogusku, Mauricio Morish; Boechat, Antonio Luiz; Sadahiro, Aya			Interaction between Smoking and HLA-DRB1*04 Gene Is Associated with a High Cardiovascular Risk in Brazilian Amazon Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							SHARED EPITOPE; ISRAELI JEWS; HLA-DRB1; MORTALITY; DISEASE; CLASSIFICATION; ALLELES; SUSCEPTIBILITY; POLYMORPHISM; CRITERIA	Background: Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints that affects approximately 1% of the population worldwide. The HLA-DRB1 gene locus plays a major role in genetic susceptibility to RA, a condition that has been associated with a high cardiovascular morbidity and mortality in many studies. Methodology/Principal Findings: The aim of this work was to investigate which types of HLA class II genes are associated with RA in patients from the Brazilian Amazon and their influence on high cardiovascular risk status in this population. For this purpose, a case-control study was carried out with a total of 350 non-Indian individuals made up of a cohort of 132 consecutive RA sufferers and 218 healthy controls. A chi(2) test showed that HLADRB1*04 (p<0.0016; OR = 1.89; 95% CI = 1.29-2.79) and HLADRB1*10 (p = 0.0377; OR = 3.81; 95% CI = 1.16-12.50) are the major HLA genes associated with susceptibility to RA. A logistic regression model also showed that the interaction between HLADRB1*04 (p = 0.027; OR = 6.02; 95% CI = 1.21-29.7), age (p = 0.0001; OR = 1.26; 95% CI = 1.13-1.39) and smoking (p = 0.0001; OR = 23.6; 95% CI = 4.25-32.1) is associated with a probability of a high cardiovascular risk status at an early age. Conclusions/Significance: The results of this study show for the first time that HLA class II type is associated with RA in Brazilian Amazon populations and that a specific interaction between the HLA-DRB1*04 gene and smoking is associated with a high cardiovascular risk status, as initially reported in the European population. This study therefore contributes to an understanding of gene-environment interactions in RA patients.	[Boechat, Narjara de Oliveira; Boechat, Antonio Luiz; Sadahiro, Aya] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Inst Ciencias Biol, Manaus, Amazonas, Brazil; [Boechat, Narjara de Oliveira; Boechat, Antonio Luiz] Hosp Geral Adriano Jorge, Clin Artrite Reumatoide, Manaus, Amazonas, Brazil; [Ogusku, Mauricio Morish] INPA, Lab Micobacteriol, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia	Boechat, ND (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Inst Ciencias Biol, Manaus, Amazonas, Brazil.	antonioluiz.boechat@gmail.com	Ogusku, Mauricio Morishi/G-3158-2012; Boechat, A.L./H-8484-2019; Boechat, Antonio Luiz/E-6464-2010	Boechat, A.L./0000-0001-5597-7343; Boechat, Antonio Luiz/0000-0001-5597-7343; Ogusku, Mauricio Morishi/0000-0003-0173-6266				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217; Chang WW, 2010, RHEUMATOLOGY, V49, P652, DOI 10.1093/rheumatology/kep417; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; DEVRIES N, 1993, TISSUE ANTIGENS, V41, P26; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; Farragher TM, 2008, ARTHRITIS RHEUM-US, V58, P359, DOI 10.1002/art.23149; FERRAZ MB, 1990, J RHEUMATOL, V17, P813; Fietta Pieranna, 2009, Acta Biomed, V80, P177; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Gabriel SE, 1999, J RHEUMATOL, V26, P2475; Gabriel SE, 2003, ARTHRITIS RHEUM-US, V48, P54, DOI 10.1002/art.10705; GAO XJ, 1991, J RHEUMATOL, V18, P801; Gonzalez A, 2008, J RHEUMATOL, V35, P1009; Gonzalez A, 2007, ARTHRITIS RHEUM, V56, P3583, DOI 10.1002/art.22979; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2003, AM J MED, V114, P647, DOI 10.1016/S0002-9343(03)00133-5; GUSTINCICH S, 1991, BIOTECHNIQUES, V11, P298; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hot A, 2012, ANN RHEUMATIC DIS; Imboden JB, 2009, ANNU REV PATHOL-MECH, V4, P417, DOI 10.1146/annurev.pathol.4.110807.092254; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Ligeiro D, 2007, ANN RHEUM DIS, V66, P246, DOI 10.1136/ard.2005.051177; Louzada P, 2008, BRAZ J MED BIOL RES, V41, P493, DOI 10.1590/S0100-879X2008005000021; Marder W, 2011, ANN RHEUM DIS, V70, P1550, DOI 10.1136/ard.2010.148031; Mattey DL, 2007, ARTHRITIS RHEUM-US, V56, P1408, DOI 10.1002/art.22527; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Palomino-Morales R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2989; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Pollard L, 2005, CLIN EXP RHEUMATOL, V23, pS43; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; Rodriguez-Rodriguez L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3444; Rodriguez-Rodriguez L, 2011, ATHEROSCLEROSIS, V216, P125, DOI 10.1016/j.atherosclerosis.2010.10.052; Rojas-Villarraga A, 2008, SEMIN ARTHRITIS RHEU, V38, P71, DOI 10.1016/j.semarthrit.2008.01.019; Sokka T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2951; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Taneja V, 2008, J IMMUNOL, V181, P2869, DOI 10.4049/jimmunol.181.4.2869; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Ursum J, 2010, J RHEUMATOL, V37, P1431, DOI 10.3899/jrheum.090913; van der Horst-Bruinsma IE, 1999, HUM IMMUNOL, V60, P152, DOI 10.1016/S0198-8859(98)00101-3; YELAMOS J, 1993, ARTHRITIS RHEUM-US, V36, P811, DOI 10.1002/art.1780360611; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3	50	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e41588	10.1371/journal.pone.0041588	http://dx.doi.org/10.1371/journal.pone.0041588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912672	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500100005
J	Graham, SM; Holte, SE; Dragavon, JA; Ramko, KM; Mandaliya, KN; McClelland, RS; Peshu, NM; Sanders, EJ; Krieger, JN; Coombs, RW				Graham, Susan M.; Holte, Sarah E.; Dragavon, Joan A.; Ramko, Kelly M.; Mandaliya, Kishor N.; McClelland, R. Scott; Peshu, Norbert M.; Sanders, Eduard J.; Krieger, John N.; Coombs, Robert W.			HIV-1 RNA May Decline More Slowly in Semen than in Blood following Initiation of Efavirenz-Based Antiretroviral Therapy	PLOS ONE			English	Article							HIV-1-INFECTED MEN; DRUG CONCENTRATIONS; GENITAL-TRACT; COMPARTMENTS; PLASMA; TRANSMISSION; METAANALYSIS; PENETRATION; LAMIVUDINE; INFECTION	Objectives: Antiretroviral therapy (ART) decreases HIV-1 RNA levels in semen and reduces sexual transmission from HIV-1-infected men. Our objective was to study the time course and magnitude of seminal HIV-1 RNA decay after initiation of efavirenz-based ART among 13 antiretroviral-naive Kenyan men. Methods: HIV-1 RNA was quantified (lower limit of detection, 120 copies/mL) in blood and semen at baseline and over the first month of ART. Median log(10) HIV-1 RNA was compared at each time-point using Wilcoxon Signed Rank tests. Perelson's two-phase viral decay model and nonlinear random effects were used to compare decay rates in blood and semen. Results: Median baseline HIV-1 RNA was 4.40 log(10) copies/mL in blood (range, 3.20-5.08 log(10) copies/mL) and 3.69 log(10) copies/mL in semen (range, <2.08-4.90 log(10) copies/mL). The median reduction in HIV-1 RNA by day 28 was 1.90 log(10) copies/mL in blood (range, 0.56-2.68 log(10) copies/mL) and 1.36 log(10) copies/mL in semen (range, 0-2.66 log(10) copies/mL). ART led to a decrease from baseline by day 7 in blood and day 14 in semen (p = 0.005 and p = 0.006, respectively). The initial modeled decay rate was slower in semen than in blood (p = 0.06). There was no difference in second-phase decay rates between blood and semen. Conclusions: Efavirenz-based ART reduced HIV-1 RNA levels more slowly in semen than in blood. Although this difference was of borderline significance in this small study, our observations suggest that there is suboptimal suppression of seminal HIV-1 RNA for some men in the early weeks of treatment.	[Graham, Susan M.; McClelland, R. Scott; Coombs, Robert W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott; Krieger, John N.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Graham, Susan M.; Ramko, Kelly M.; Peshu, Norbert M.; Sanders, Eduard J.] Kenya Govt Med Res Ctr, Ctr Geog Med & Res Coast, Kilifi, Kenya; [Holte, Sarah E.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Holte, Sarah E.] Fred Hutchinson Canc Res Ctr, Dept Biostat & Biomath, Seattle, WA 98104 USA; [Dragavon, Joan A.; Coombs, Robert W.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Mandaliya, Kishor N.] PathCare Kenya, Mombasa, Kenya; [McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Clin Med, Headington, England; [Krieger, John N.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Krieger, John N.] VA Puget Sound Hlth Care Syst, Dept Urol, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Graham, SM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	grahamsm@u.washington.edu	Graham, Susan/W-6133-2019	Graham, Susan/0000-0001-7847-8686	National Institutes of Health (NIH) [R21 HD-055864, K23 AI-069990, R01 AI-055343, P30 AI027757]; University of Washington Center for AIDS Research (CFAR); NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NCCAM); Kenya Medical Research Institute (KEMRI); International AIDS Vaccine Initiative (IAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K23AI069990, R01AI055343] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Kenya Medical Research Institute (KEMRI); International AIDS Vaccine Initiative (IAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grant R21 HD-055864. Dr. Graham was supported by NIH grant K23 AI-069990, and Dr. Holte was supported by NIH grant R01 AI-055343. Additional funding was provided by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757), which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM). The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.; We would like to thank the research staff who helped make this project a success, the Kenya Medical Research Institute (KEMRI) and the International AIDS Vaccine Initiative (IAVI) for support of E. Sanders and use of clinical space, the Coast Provincial General Hospital for provision of laboratory space, and the KEMRI Director for permission to publish. Special thanks go to the men who participated in this study.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Barroso PF, 2003, JAIDS-J ACQ IMM DEF, V32, P435, DOI 10.1097/00126334-200304010-00014; Calcagno A, 2010, ANTIMICROB AGENTS CH, V54, P2744, DOI 10.1128/AAC.00241-10; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, 6 IAS C HIV PATH TRE; Craigo JK, 2004, AIDS RES HUM RETROV, V20, P1196, DOI 10.1089/aid.2004.20.1196; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Ghosn J, 2004, AIDS, V18, P1958, DOI 10.1097/00002030-200409240-00014; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Graham SM, 2011, SEX TRANSM INFECT, V87, P232, DOI 10.1136/sti.2010.047118; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Li CC, 2005, J CLIN MICROBIOL, V43, P3901, DOI 10.1128/JCM.43.8.3901-3905.2005; Lorello G, 2009, HIV MED, V10, P548, DOI 10.1111/j.1468-1293.2009.00725.x; Lowe SH, 2006, HIV CLIN TRIALS, V7, P285, DOI 10.1310/hct0706-285; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Pereira AS, 2002, J INFECT DIS, V186, P198, DOI 10.1086/341209; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pinheiro J, 2001, MIXED EFFECTS MODELS; Reddy YS, 2002, J INFECT DIS, V186, P1339, DOI 10.1086/344311; Shen CL, 2010, VIROLOGY, V401, P190, DOI 10.1016/j.virol.2010.01.033; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Taylor S, 2001, AIDS, V15, P424, DOI 10.1097/00002030-200102160-00022; Taylor S, 2001, AIDS, V15, P2051, DOI 10.1097/00002030-200110190-00022; Taylor S, 2000, AIDS, V14, P1979, DOI 10.1097/00002030-200009080-00014; UNAIDS, 2010, GLOB REP UNAIDS REP; WHO, 2010, ANT THER HIV INF AD; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	30	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43086	10.1371/journal.pone.0043086	http://dx.doi.org/10.1371/journal.pone.0043086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912795	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500100060
J	Heckman, MG; Soto-Ortolaza, AI; Diehl, NN; Carrasquillo, MM; Uitti, RJ; Wszolek, ZK; Graff-Radford, NR; Ross, OA				Heckman, Michael G.; Soto-Ortolaza, Alexandra I.; Diehl, Nancy N.; Carrasquillo, Minerva M.; Uitti, Ryan J.; Wszolek, Zbigniew K.; Graff-Radford, Neill R.; Ross, Owen A.			Evaluation of the Role of SNCA Variants in Survival without Neurological Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; GENETIC-DETERMINANTS; PARKINSONS-DISEASE; INCREASED RISK; ASSOCIATION; DEMENTIA	Background: A variety of definitions of successful aging have been proposed, many of which relate to longevity, freedom from disease and disability, or preservation of high physical and cognitive function. Many behavioral, biomedical, and psychological factors have been linked with these various measures of successful aging, however genetic predictors are less understood. Parkinson's disease (PD) is an age-related neurodegenerative disorder, and variants in the a-synuclein gene (SNCA) affect susceptibility to PD. This exploratory study examined whether SNCA variants may also promote successful aging as defined by survival without neurological disease. Methods: We utilized 769 controls without neurological disease (Mean age: 79 years, Range: 33-99 years) and examined the frequency of 20 different SNCA variants across age groups using logistic regression models. We also included 426 PD cases to assess the effect of these variants on PD risk. Results: There was a significant decline in the proportion of carriers of the minor allele of rs10014396 as age increased (P = 0.021), from 30% in controls younger than 60 to 14% in controls 90 years of age or older. Findings were similar for rs3775439, where the proportion of carriers of the minor allele declined from 32% in controls less than 60 years old to 19% in those 90 or older (P = 0.025). A number of SNCA variants, not including rs10014396 or rs3775439, were significantly associated with susceptibility to PD. Conclusions: In addition to its documented roles in PD and alpha-synucleinopathies, our results suggest that SNCA has a role in survival free of neurological disease. Acknowledging that our findings would not have withstood correction for multiple testing, validation in an independent series of aged neurologically normal controls is needed.	[Heckman, Michael G.; Diehl, Nancy N.] Mayo Clin, Biostat Unit, Jacksonville, FL 32224 USA; [Soto-Ortolaza, Alexandra I.; Carrasquillo, Minerva M.; Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Uitti, Ryan J.; Wszolek, Zbigniew K.; Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Heckman, MG (corresponding author), Mayo Clin, Biostat Unit, Jacksonville, FL 32224 USA.	heckman.michael@mayo.edu	Ross, Owen/D-7573-2013; Wszolek, Zbigniew K./AAB-1431-2019	Ross, Owen/0000-0003-4813-756X	American Parkinson Disease Association; Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS) [NS072187]; Carl and Susan Bolch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187] Funding Source: NIH RePORTER	American Parkinson Disease Association; Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Carl and Susan Bolch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is funded, in part, by a research grant for the American Parkinson Disease Association, the Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50 #NS072187) and the family of Carl and Susan Bolch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Depp CA, 2006, AM J GERIAT PSYCHIAT, V14, P6, DOI 10.1097/01.JGP.0000192501.03069.bc; Depp Colin A, 2007, Curr Psychiatry Rep, V9, P7, DOI 10.1007/s11920-007-0003-0; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Glatt SJ, 2007, BIOL PSYCHIAT, V62, P282, DOI 10.1016/j.biopsych.2006.09.015; Graff-Radford NR, 2006, ALZ DIS ASSOC DIS, V20, P101, DOI 10.1097/01.wad.0000213813.35424.d2; HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360; Karasik D, 2005, J GERONTOL A-BIOL, V60, P574, DOI 10.1093/gerona/60.5.574; Kirkwood TBL, 1996, BIOESSAYS, V18, P1009, DOI 10.1002/bies.950181211; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Nishioka K, 2010, ARCH NEUROL-CHICAGO, V67, P970, DOI 10.1001/archneurol.2010.177; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Postuma RB, 2009, PARKINSONISM RELAT D, V15, pS105, DOI 10.1016/S1353-8020(09)70793-X; Ross OA, 2006, IRISH J MED SCI, V175, P82, DOI 10.1007/BF03169012; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Ross OA, 2007, MECH AGEING DEV, V128, P378, DOI 10.1016/j.mad.2007.04.002; Ross OA, 2011, MOVEMENT DISORD, V26, P2552, DOI 10.1002/mds.23909; Ross OA, 2010, ANN NEUROL, V67, P414, DOI 10.1002/ana.21786; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014; Walter S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.026; Wu SL, 2010, NEUROSCI LETT, V478, P61, DOI 10.1016/j.neulet.2010.04.063	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42877	10.1371/journal.pone.0042877	http://dx.doi.org/10.1371/journal.pone.0042877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912757	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100040
J	Liu, B; Zhang, JL; Huang, C; Liu, H				Liu, Bei; Zhang, Jinglei; Huang, Chen; Liu, Hui			Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient Prognosis	PLOS ONE			English	Article							HUMAN BREAST-CANCER; RIBOSOMAL-RNA; TELOMERASE ACTIVITY; EXPRESSION; GENES; DKC1; CARCINOGENESIS; CLASSIFICATION; ACCUMULATION; TRANSLATION	Background: Dyskerin (encoded by the DKC1 gene) is an essential nucleolar protein involved in cell proliferation, where it is required for the pseudo-uridylation of ribosomal RNA (rRNA) molecules and the stabilization of the telomerase RNA component. Dyskerin expression has been reported to predict poor survival in some cancer patients. The aim of the present study was to analyze the expression of dyskerin in hepatocellular carcinoma (HCC) and to determine its correlation with clinicopathologic features, including the survival of patients with HCC. Methodology/Principal Findings: Dyskerin protein expression was detected by immunohistochemistry in paraffin sections of 252 HCC cases and 80 noncancerous liver tissues. The correlation was analyzed between dyskerin expression levels and clinicopathologic variables and prognosis. Dyskerin protein was significantly overexpressed in HCC tissues when compared to noncancerous liver tissue. Dyskerin overexpression was positively correlated with the hepatitis B surface antigen status, serum alpha-fetoprotein, and advanced clinical stage in HCC patients. A survival analysis indicated that HCC patients with higher dyskerin expression had a significantly shorter overall survival and 5-year survival time when compared to those with low expression. A multivariate analysis suggested that dyskerin overexpression was an independent factor for prognosis (hazard risk, 2.912; P = 0.007). Expression of DKC1 mRNA was measured by quantitative RT-PCR in 80 HCC and 50 noncancerous tissues. The relationship between DKC1, TERT, MKI67, and MYC mRNA expression in HCC tissues was also evaluated. DKC1 mRNA was significantly overexpressed in HCC tissues and showed a significant correlation with MKI67 and MYC mRNA but a weak correlation with TERT mRNA. Conclusions/Significance: Dyskerin overexpression in HCC patients was correlated with MYC and MKI67 expression and showed a possible involvement in the tumorigenic process. Dyskerin overexpression may be an unfavorable prognostic factor in patients with HCC.	[Liu, Bei] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Dept Pathol, Wuhan, Peoples R China; [Zhang, Jinglei; Liu, Hui] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Huang, Chen] Peking Univ, Hosp 3, Med Res Ctr, Beijing 100871, Peoples R China	Wuhan University of Science & Technology; Naval Medical University; Peking University	Liu, B (corresponding author), Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Dept Pathol, Wuhan, Peoples R China.	candyhuang719@hotmail.com; happyehbh@163.com			Ministry of Science and Technology, China [010S2012ZR0058]; Shanghai Municipal Health Bureau [2008Y077]; Special Program for Military Medicine, China [2010JS15]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Shanghai Municipal Health Bureau; Special Program for Military Medicine, China	This study has been supported by International Science & Technology Cooperation Program of the Ministry of Science and Technology, China (No.010S2012ZR0058), the Fund of Shanghai Municipal Health Bureau (No.2008Y077), and Special Program for Military Medicine, China (No.2010JS15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi F, 2010, MOL CARCINOG; Alawi F, 2007, BIOCHEM BIOPH RES CO, V362, P893, DOI 10.1016/j.bbrc.2007.08.071; Alawi F, 2011, MOL CARCINOGEN, V50, P334, DOI 10.1002/mc.20715; Alawi F, 2011, HEAD NECK-J SCI SPEC, V33, P1041, DOI 10.1002/hed.21579; Alawi F, 2010, CELL CYCLE, V9, P2467, DOI 10.4161/cc.9.12.11922; Angrisani A, 2011, BBA-GEN SUBJECTS, V1810, P1361, DOI 10.1016/j.bbagen.2011.07.012; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Koskimaa HM, 2010, CANCER EPIDEM BIOMAR, V19, P2003, DOI 10.1158/1055-9965.EPI-09-0781; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; McDonald SL, 2004, CANCER BIOL THER, V3, P110, DOI 10.4161/cbt.3.1.662; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Montanaro L, 2008, CELL ONCOL, V30, P483, DOI 10.3233/CLO-2008-0436; Montanaro L, 2010, CANCER RES, V70, P4767, DOI 10.1158/0008-5472.CAN-09-4024; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507; Sieron P, 2009, BRIT J CANCER, V101, P1410, DOI 10.1038/sj.bjc.6605299; Sobin, 2009, UICC TNM CLASSIFICAT; Turano M, 2008, ACTA ONCOL, V47, P1598, DOI 10.1080/02841860801898616; Westermann F, 2007, CLIN CANCER RES, V13, P4695, DOI 10.1158/1078-0432.CCR-06-2818; Witkowska A, 2010, INT J MOL MED, V25, P321, DOI 10.3892/ijmm_00000348	32	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43147	10.1371/journal.pone.0043147	http://dx.doi.org/10.1371/journal.pone.0043147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912812	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100067
J	Sebald, J; Morettini, S; Podhraski, V; Lass-Florl, C; Lusser, A				Sebald, Johanna; Morettini, Stefano; Podhraski, Valerie; Lass-Floerl, Cornelia; Lusser, Alexandra			CHD1 Contributes to Intestinal Resistance against Infection by P. aeruginosa in Drosophila melanogaster	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; HOST-DEFENSE; BACTERIAL-INFECTION; ORAL INFECTION; CHROMATIN; GENE; RECOGNITION; IDENTIFICATION; TRANSCRIPTION	Drosophila SNF2-type ATPase CHD1 catalyzes the assembly and remodeling of nucleosomal arrays in vitro and is involved in H3.3 incorporation in viin vivo during early embryo development. Evidence for a role as transcriptional regulator comes from its colocalization with elongating RNA polymerase II as well as from studies of fly Hsp70 transcription. Here we used microarray analysis to identify target genes of CHD1. We found a fraction of genes that were misregulated in Chd1 mutants to be functionally linked to Drosophila immune and stress response. Infection experiments using different microbial species revealed defects in host defense in Chd1-deficient adults upon oral infection with P. aeruginosa but not upon septic injury, suggesting a so far unrecognized role for CHD1 in intestinal immunity. Further molecular analysis showed that gut-specific transcription of antimicrobial peptide genes was overactivated in the absence of infection in Chd1 mutant flies. Moreover, microbial colonization of the intestine was elevated in Chd1 mutants and oral infection resulted in strong enrichment of bacteria in the body cavity indicating increased microbial passage across intestinal epithelia. However, we did not detect enhanced epithelial damage or alterations of the intestinal stem cell population. Collectively, our data provide evidence that intestinal resistance against infection by P. aeruginosa in Drosophila is linked to maintaining proper balance of gut-microbe interactions and that the chromatin remodeler CHD1 is involved in regulating this aspect.	[Sebald, Johanna; Morettini, Stefano; Podhraski, Valerie; Lusser, Alexandra] Innsbruck Med Univ, Bioctr, Div Mol Biol, Innsbruck, Austria; [Lass-Floerl, Cornelia] Innsbruck Med Univ, Div Hyg & Med Microbiol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Sebald, J (corresponding author), Innsbruck Med Univ, Bioctr, Div Mol Biol, Innsbruck, Austria.	alexandra.lusser@i-med.ac.at	Lass-Flörl, Cornelia/AAA-8449-2020	Lass-Florl, Cornelia/0000-0002-2946-7785; Lusser, Alexandra/0000-0002-2226-9081	Austrian Science Fund (FWF) [START Y275-B12]; Tyrolean Science Fund [TWF-2010-1-1002]; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Tyrolean Science Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF; START Y275-B12 to A. L.) and the Tyrolean Science Fund (TWF-2010-1-1002 to V. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Braun A, 1997, GENETICS, V147, P623; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Kugler SJ, 2011, GENETICS, V188, P127, DOI 10.1534/genetics.111.127795; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morettini S, 2011, NUCLEIC ACIDS RES, V39, P3103, DOI 10.1093/nar/gkq1298; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Piatti P, 2011, INT J MOL SCI, V12, P6544, DOI 10.3390/ijms12106544; Podhraski V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010120; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Stofanko M, 2008, GENETICS, V180, P253, DOI 10.1534/genetics.108.089094; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zaidman-Remy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017231	68	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43144	10.1371/journal.pone.0043144	http://dx.doi.org/10.1371/journal.pone.0043144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912810	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100066
J	Simoes, GF; de Oliveira, ALR				Simoes, Gustavo Ferreira; Rodrigues de Oliveira, Alexandre Leite			Granulocyte-Colony Stimulating Factor Improves MDX Mouse Response to Peripheral Nerve Injury	PLOS ONE			English	Article							PROMOTES FUNCTIONAL RECOVERY; SPINAL-CORD-INJURY; DUCHENNE MUSCULAR-DYSTROPHY; SYNAPTIC PLASTICITY; IN-VITRO; UP-REGULATION; NEURONS; BRAIN; ASTROCYTES; CELLS	Background: G-CSF has been shown to increase neuronal survival, which may positively influence the spinal cord microenvironment during the course of muscular dystrophies. Methodology/Principal Findings: Male MDX mice that were six weeks of age received a left sciatic nerve transection and were treated with intraperitoneal injections of 200 mg/kg/day of G-CSF 7 days before and 7 days after the transection. The axotomy was performed after the cycles of muscular degeneration/regeneration, consistent with previous descriptions of this model of muscular dystrophy. C57BL/10 mice were used as control subjects. Seven days after the surgery, the animals were sacrificed and their lumbar spinal cords were processed for immunohistochemistry (anti-MHC I, anti-Synaptophysin, anti-GFAP and anti-IBA-1) and transmission electron microscopy. MHC I expression increased in both strains of mice after the axotomy. Nevertheless, the MDX mice displayed a significantly smaller MHC I upregulation than the control mice. Regarding GFAP expression, the MDX mice showed a stronger astrogliosis compared with the C57BL/10 mice across all groups. Both groups that were treated with G-CSF demonstrated preservation of synaptophysin expression compared with the untreated and placebo groups. The quantitative analysis of the ultrastructural level showed a preservation of the synaptic covering for the both groups that were treated with G-CSF and the axotomized groups showed a smaller loss of synaptic contact in relation to the treated groups after the lesion. Conclusions/Significance: The reduction of active inputs to the alpha-motoneurons and increased astrogliosis in the axotomized and control groups may be associated with the cycles of muscle degeneration/regeneration that occur postnatally. The G-CSF treated group showed a preservation of the spinal cord microenvironment after the lesion. Moreover, the increase of MHC I expression in the MDX mice that were treated with G-CSF may indicate that this drug performs an active role in regenerative potential after lesions.	[Simoes, Gustavo Ferreira; Rodrigues de Oliveira, Alexandre Leite] Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Simoes, GF (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, Brazil.	alroliv@unicamp.br	Oliveira, Alexandre L. R./C-4436-2012; Oliveira, Alexandre/AAI-6815-2020	Oliveira, Alexandre L. R./0000-0003-4224-4575; Oliveira, Alexandre/0000-0003-4224-4575; Simoes, Gustavo/0000-0001-5362-4085	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/06686-6, 2009/05565-0, 2012/14236-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2009/06686-6, 2009/05565-0 and 2012/14236-3). ALRO receives a fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Anderson CM, 2000, GLIA, V32, P1; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; BEGLEY CG, 1986, BLOOD, V68, P162; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BURGESS AW, 1980, INT J CANCER, V26, P647, DOI 10.1002/ijc.2910260517; Carretta D, 2001, BRAIN RES, V895, P213, DOI 10.1016/S0006-8993(01)02108-4; Conradi S, 1969, Acta Physiol Scand Suppl, V332, P5; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; Daoud F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006574; del Zoppo GJ, 2009, NEUROSCIENCE, V158, P972, DOI 10.1016/j.neuroscience.2008.08.028; Dittgen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029880; Dong F, 1997, LEUKEMIA, V11, P120, DOI 10.1038/sj.leu.2400537; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Emirandetti A, 2006, BRAIN RES, V1095, P35, DOI 10.1016/j.brainres.2006.04.021; GORGEN I, 1992, J IMMUNOL, V149, P918; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Heard SO, 1999, CRIT CARE MED, V27, P1019, DOI 10.1097/00003246-199905000-00051; Henriques A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-25; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hu B, 1997, INT J HEMATOL, V66, P179; Jung KH, 2006, NEUROSCI LETT, V394, P168, DOI 10.1016/j.neulet.2005.10.040; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Koda M, 2007, BRAIN RES, V1149, P223, DOI 10.1016/j.brainres.2007.02.058; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; Lagrota-Candido J, 2002, INT J EXP PATHOL, V83, P121, DOI 10.1046/j.1365-2613.2002.00221.x; Lee JS, 2012, SPINE, V37, P10, DOI 10.1097/BRS.0b013e31823b0440; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; LIDOV HGW, 1993, NEUROSCIENCE, V54, P167, DOI 10.1016/0306-4522(93)90392-S; LINDA H, 1992, EXP BRAIN RES, V91, P284; Lindenau J, 2000, GLIA, V29, P25, DOI 10.1002/(SICI)1098-1136(20000101)29:1<25::AID-GLIA3>3.0.CO;2-G; Luo J, 2009, ACTA NEUROCHIR, V151, P1483, DOI 10.1007/s00701-009-0402-6; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Nonaka I, 1998, LAB ANIM SCI, V48, P8; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Osada T, 2010, J NEUROSURG-SPINE, V13, P516, DOI 10.3171/2010.4.SPINE09973; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Sabha M, 2008, SYNAPSE, V62, P137, DOI 10.1002/syn.20475; Sanli AM, 2010, J CLIN NEUROSCI, V17, P1548, DOI 10.1016/j.jocn.2010.03.043; SBRICCOLI A, 1995, NEUROSCI LETT, V200, P53, DOI 10.1016/0304-3940(95)12079-J; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-36; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Simoes GF, 2010, NEUROPATH APPL NEURO, V36, P55, DOI 10.1111/j.1365-2990.2009.01033.x; Sims NR, 2004, J BIOENERG BIOMEMBR, V36, P329, DOI 10.1023/B:JOBB.0000041763.63958.e7; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Squadrito F, 1997, BRIT J PHARMACOL, V120, P333, DOI 10.1038/sj.bjp.0700904; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Takagi Y, 2005, J PHARMACOL SCI, V99, P45, DOI 10.1254/jphs.FP0040966; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Tanaka M, 2006, J NEUROPATH EXP NEUR, V65, P816, DOI 10.1097/01.jnen.0000232025.84238.e1; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Ward AC, 2007, FRONT BIOSCI-LANDMRK, V12, P608, DOI 10.2741/2086; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Wong BLY, 2002, J CHILD NEUROL, V17, P183, DOI 10.1177/088307380201700306; Zanon RG, 2006, EXP NEUROL, V200, P521, DOI 10.1016/j.expneurol.2006.03.004; Zavala F, 2002, J IMMUNOL, V168, P2011, DOI 10.4049/jimmunol.168.4.2011	73	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42803	10.1371/journal.pone.0042803	http://dx.doi.org/10.1371/journal.pone.0042803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912741	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100033
J	Kolics, B; Acs, Z; Chobanov, DP; Orci, KM; Qiang, LS; Kovacs, B; Kondorosy, E; Decsi, K; Taller, J; Specziar, A; Orban, L; Muller, T				Kolics, Balazs; Acs, Zoltan; Chobanov, Dragan Petrov; Orci, Kirill Mark; Qiang, Lo Shun; Kovacs, Balazs; Kondorosy, Elod; Decsi, Kincso; Taller, Janos; Specziar, Andras; Orban, Laszlo; Mueller, Tamas			Re-Visiting Phylogenetic and Taxonomic Relationships in the Genus Saga (Insecta: Orthoptera)	PLOS ONE			English	Article							RAMMEI KALTENBACH; BUSH-CRICKETS; TETTIGONIIDAE; HYBRIDIZATION; CHROMOSOME; GENETICS; COMPLEX; REVEAL; SONG	Twelve of the 13 bushcricket species of the Saga genus are bisexuals and diploids, except the parthenogenetic and tetraploid bush cricket, Saga pedo. Despite a continuous research effort stretching through the 1900s, the taxonomic relationships of the Saga species are still disputed. In this study, our primary aim was to reveal natural relationships of the European Saga species and three of their Asian relatives, with special attention to the problematic taxonomy of two subspecies: S. campbelli campbelli and S. c. gracilis. Following a phylogenetic analysis of eight species, a comprehensive study was carried out on the above three taxa by using acoustic and morphometric approaches in parallel. Our phylogenetic data showed that European Saga species evolved from a monophyletic lineage. The geographical transitional species S. cappadocica was positioned between European and Asian lineages supporting the idea that the European Saga lineage originated phylogeographically from the Asian clade. The above results showed better agreement with the morphological data than with earlier ones based either on karyology or acoustic information only. After reviewing our data, we concluded that Saga pedo has most likely evolved from S. c. gracilis and not from S. rammei or S. ephippigera, as proposed by earlier studies. S. c. gracilis shares the same ITS2 haplotype with S. pedo, indicating that the latter could have evolved from populations of the former, probably through whole genome duplication. Based on acoustic and morphometric differences, we propose to elevate the two subspecies, S. campbelli campbelli and S. c. gracilis, to species level status, as Saga gracilis Kis 1962, and Saga campbelli Uvarov 1921. The present work sets the stage for future genetic and experimental investigations of Saginae and highlights the need for additional comprehensive analysis involving more Asian Saga species.	[Kolics, Balazs; Decsi, Kincso; Taller, Janos] Univ Pannonia, Dept Plant Sci & Biotechnol, Georgikon Fac, Keszthely, Hungary; [Chobanov, Dragan Petrov] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria; [Acs, Zoltan] Fitolab Ltd, Budapest, Hungary; [Orci, Kirill Mark] Eotvos Lorand Univ, Ecol Res Grp, Hungarian Acad Sci, Budapest, Hungary; [Orci, Kirill Mark] Hungarian Nat Hist Museum, Budapest, Hungary; [Qiang, Lo Shun; Orban, Laszlo] Natl Univ Singapore, Strateg Res Program, Temasek Life Sci Lab, Singapore 117548, Singapore; [Qiang, Lo Shun; Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Kovacs, Balazs; Mueller, Tamas] Szent Istvan Univ, Dept Aquaculture, Fac Agr & Environm Sci, Godollo, Hungary; [Kovacs, Balazs] Szent Istvan Univ, Reg Univ Ctr Excellence Environm Ind Based Nat, Godollo, Hungary; [Kondorosy, Elod; Orban, Laszlo] Univ Pannonia, Dept Anim Sci & Anim Breeding, Georgikon Fac, Keszthely, Hungary; [Specziar, Andras] Hungarian Acad Sci, Balaton Limnol Inst, Ctr Ecol Res, Tihany, Hungary	University of Pannonia; Bulgarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; National University of Singapore; National University of Singapore; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; University of Pannonia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute	Kolics, B (corresponding author), Univ Pannonia, Dept Plant Sci & Biotechnol, Georgikon Fac, Keszthely, Hungary.	bkolics@gmail.com; laszlo@tll.org.sg; muller.tamas@mkk.szie.hu	Specziár, András/N-5656-2019; Chobanov, Dragan/AAB-9475-2020; Orbán, László/A-3030-2009; Kovács, Balázs/K-9372-2015; Taller, Janos/ABB-9586-2021	Specziár, András/0000-0001-6341-636X; Orbán, László/0000-0001-5435-5948; Kovács, Balázs/0000-0002-1090-1334; Orci, Kirill Mark/0000-0002-4076-6700; Chobanov, Dragan/0000-0002-1642-0363; Kondorosy, Elod/0000-0001-7162-0862; Balazs, Kovacs/0000-0003-1753-5098; Muller, Tamas/0000-0002-0512-4315	Bolyai Research Grant of the Hungarian Academy of Sciences; Ministry of Education, Youth and Science of Bulgaria [DO 02-259/08]; United Nations Development Programme [00058373 - PIMS 3728, RFP 79/2009]; European Social Fund through the Ministry of Education, Youth and Science of Bulgaria [BG051PO001-3.3.04/41]; Ministry of Science and Higher Education of Poland [57497 (2009-01-27)];  [TAMOP-4.2.2/B-10/1-2010-0025]	Bolyai Research Grant of the Hungarian Academy of Sciences; Ministry of Education, Youth and Science of Bulgaria; United Nations Development Programme; European Social Fund through the Ministry of Education, Youth and Science of Bulgaria; Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); 	This work supported by Bolyai Research Grant of the Hungarian Academy of Sciences, grant no.: DO 02-259/08 of the Ministry of Education, Youth and Science of Bulgaria, the United Nations Development Programme grant 00058373 - PIMS 3728 (Ref. RFP 79/2009), BG051PO001-3.3.04/41 (European Social Fund through the Ministry of Education, Youth and Science of Bulgaria), grant 57497 (2009-01-27) of the Ministry of Science and Higher Education of Poland and a bilateral agreement between the Bulgarian and Polish Academies of Sciences. The article was made under the project TAMOP-4.2.2/B-10/1-2010-0025. IKR ZRt. provided a DNA extraction Kit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur B, 2006, SAUTERELLES GRILLONS, P140; Burr M, 1923, T ROYAL ENTOMOLOGICA, V71, P110; Cabrero J, 2007, EUR SOC EV BIOL 11 C; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; CANTRALL I J, 1972, Great Lakes Entomologist, V5, P103; Dutrillaux AM, 2009, EUR J ENTOMOL, V106, P477, DOI 10.14411/eje.2009.060; ELLIOTT NG, 1995, J FISH BIOL, V46, P202, DOI 10.1111/j.1095-8649.1995.tb05962.x; Ewing AW, 1989, ARTHROPOD BIOACOUSTI, P1; Goldsohmldt E., 1946, Nature London, V158, P587, DOI 10.1038/158587c0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heller KG, 2006, CONT T ENT, P137; Heller KG, 1998, OKOLOGIE FORSCHUNG A, P1; Huang Renxin, 1986, Entomotaxonomia, V8, P290; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INGRISCH S, 1991, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V64, P269; Kalmring K, 1997, ENTOMOL GEN, V21, P265; Kaltenbach A, 1970, ZOOL BEITR, P158; Kaltenbach A.P., 1990, P280; KALTENBACH ALFRED, 1967, BEITR ENTOMOL, V17, P3; Kis B., 1962, Annales Historico Naturales Musei Nationalis Hungarici, V54, P255; Kolics B, 2008, BIOLOGIA, V63, P254, DOI 10.2478/s11756-008-0028-9; Krauss H, 1878, SITZUNGSBERICHTE MN, V78, P506; Kumar, 2000, MOL EVOLUTION PHYLOG, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehmann GUC, 2011, J ZOOL SYST EVOL RES, V49, P102, DOI 10.1111/j.1439-0469.2010.00588.x; Lemonnier-Darcemont M, 2007, ANN SOC ENTOMOL FR, V43, P249, DOI 10.1080/00379271.2007.10697518; Lemonnier-Darcemont Michele, 2009, Articulata, V24, P15; Lemonnier-Darcemont M, 2008, ANN SOC ENTOMOL FR, V44, P477, DOI 10.1080/00379271.2008.10697583; Lemonnier-Darcemont Michele, 2008, Biocosme Mesogeen, V25, P29; Matthey R, 1939, CR SOC BIOL, V132, P369; MATTHEY R., 1950, ARCH JULIUS KLAUS STIFT, V25, P44; MATTHEY ROBERT, 1948, REV SUISSE ZOOL, V55, P45; MATTHEY ROBERT, 1941, REV SUISSE ZOOL, V48, P91; Nylander J.A.A, 2004, MRMODELTEST V2; Orci KM, 2005, ZOOL ANZ, V244, P31, DOI 10.1016/j.jcz.2004.11.002; Panaram K, 2007, GENETICA, V130, P53, DOI 10.1007/s10709-006-0020-7; Ragge DR, 1998, SONGS GRASSHOPPERS C, P1; Ramme W., 1951, MITTEILUNGENAUS ZOOL, V27, P1, DOI DOI 10.1002/MMNZ.4830270108; Robinson DJ, 2002, ADV INSECT PHYSIOL, V29, P151, DOI 10.1016/S0065-2806(02)29003-7; Rokas A, 2003, MOL PHYLOGENET EVOL, V26, P36, DOI 10.1016/S1055-7903(02)00329-9; Saussure H, 1888, ANN SOC ENTOMOLOGIQU, V8, P127; SENAR JC, 1994, J AVIAN BIOL, V25, P50, DOI 10.2307/3677293; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Walker TJ, 2003, ANN ENTOMOL SOC AM, V96, P433, DOI 10.1603/0013-8746(2003)096[0433:TRCOTG]2.0.CO;2; Warchalowska-Sliwa E, 2007, CARYOLOGIA, V60, P29; Warchalowska-Sliwa E, 2009, EUR J ENTOMOL, V106, P1, DOI 10.14411/eje.2009.001; Werner F, 1905, MITTEILUNGEN NATURWI, V3, P1; WERREN JH, 1993, AM NAT, V142, P224, DOI 10.1086/285536; Willemse Fer, 2008, Articulata Beiheft, V13, P1	51	11	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42229	10.1371/journal.pone.0042229	http://dx.doi.org/10.1371/journal.pone.0042229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22912691	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000307380900026
J	Fu, Y; Lan, JC; Zhang, ZH; Hou, R; Wu, XH; Yang, DY; Zhang, RH; Zheng, WP; Nie, HM; Xie, Y; Yan, N; Yang, Z; Wang, CD; Luo, L; Liu, L; Gu, XB; Wang, SX; Peng, XR; Yang, GY				Fu, Yan; Lan, Jingchao; Zhang, Zhihe; Hou, Rong; Wu, Xuhang; Yang, Deying; Zhang, Runhui; Zheng, Wanpeng; Nie, Huaming; Xie, Yue; Yan, Ning; Yang, Zhi; Wang, Chengdong; Luo, Li; Liu, Li; Gu, Xiaobin; Wang, Shuxian; Peng, Xuerong; Yang, Guangyou			Novel Insights into the Transcriptome of Dirofilaria immitis	PLOS ONE			English	Article							PARASITIC NEMATODE; HAEMONCHUS-CONTORTUS; 2005 GUIDELINES; LIFE-CYCLE; GENES; WOLBACHIA; CANINE; COMPLEMENT; SYSTEM; ENDOSYMBIONT	Background: The heartworm Dirofilaria immitis is the causal agent of cardiopulmonary dirofilariosis in dogs and cats, and also infects a wide range of wild mammals as well as humans. One bottleneck for the design of fundamentally new intervention and management strategies against D. immitis may be the currently limited knowledge of fundamental molecular aspects of D. immitis. Methodology/Principal Findings: A next-generation sequencing platform combining computational approaches was employed to assess a global view of the heartworm transcriptome. A total of 20,810 unigenes (mean length = 1,270 bp) were assembled from 22.3 million clean reads. From these, 15,698 coding sequences (CDS) were inferred, and about 85% of the unigenes had orthologs/homologs in public databases. Comparative transcriptomic study uncovered 4,157 filarial-specific genes as well as 3,795 genes potentially involved in filarial-Wolbachia symbiosis. In addition, the potential intestine transcriptome of D. immitis (1,101 genes) was mined for the first time, which might help to discover 'hidden antigens'. Conclusions/Significance: This study provides novel insights into the transcriptome of D. immitis and sheds light on its molecular processes and survival mechanisms. Furthermore, it provides a platform to discover new vaccine candidates and potential targets for new drugs against dirofilariosis.	[Fu, Yan; Wu, Xuhang; Yang, Deying; Zhang, Runhui; Zheng, Wanpeng; Nie, Huaming; Xie, Yue; Yan, Ning; Gu, Xiaobin; Wang, Shuxian; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China; [Lan, Jingchao; Zhang, Zhihe; Hou, Rong; Yang, Zhi; Wang, Chengdong; Luo, Li; Liu, Li] Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, State Key Lab China, Chengdu, Sichuan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Life & Basic Sci, Dept Chem, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Fu, Y (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China.	guangyou1963@yahoo.com.cn			Research Fund for the Chengdu Giant Panda Breeding and Research Foundation [CPF-08005]; Changjiang Scholars and Innovative Research Team in University [IRT0848]	Research Fund for the Chengdu Giant Panda Breeding and Research Foundation; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Research Fund for the Chengdu Giant Panda Breeding and Research Foundation (Project No. CPF-08005) and Changjiang Scholars and Innovative Research Team in University (Project No. IRT0848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D., 1988, P29; ADDISS DG, 2004, AM J TROP MED HYG  S, V71, P12; Montoya-Alonso JA, 2010, PARASITOL RES, V107, P1265, DOI 10.1007/s00436-010-1987-7; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bowman DD, 2009, GEORGIS PARASITOLOGY, P213; Buttner Dietrich W, 2003, Filaria J, V2, P10, DOI 10.1186/1475-2883-2-10; Canestri-Trotti G., 1997, Parassitologia (Rome), V39, P369; Cantacessi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023590; Cantacessi C, 2011, BIOTECHNOL ADV, V29, P261, DOI 10.1016/j.biotechadv.2010.11.005; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Chirgwin SR, 2002, J PARASITOL, V88, P1248, DOI 10.1645/0022-3395(2002)088[1248:TFEWSI]2.0.CO;2; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Ybanez MRR, 2006, VET REC, V158, P240, DOI 10.1136/vr.158.7.240; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Gamble KC, 1998, J ZOO WILDLIFE MED, V29, P50; Gasser RB, 2011, TOP COMPANION ANIM M, V26, P193, DOI 10.1053/j.tcam.2011.09.003; Genchi C, 2009, VET PARASITOL, V163, P286, DOI 10.1016/j.vetpar.2009.03.026; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HAMADA A, 1988, J CLIN INVEST, V82, P945, DOI 10.1172/JCI113702; HAMMERBERG B, 1985, TROPENMED PARASITOL, V36, pS5; Heider U, 2006, INT J MED MICROBIOL, V296, P287, DOI 10.1016/j.ijmm.2005.12.019; Hoch H, 2008, COMPENDIUM, V30, P133; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kim MK, 2002, J KOREAN MED SCI, V17, P686, DOI 10.3346/jkms.2002.17.5.686; Liotta F, 2010, CURR OPIN INVEST DR, V11, P147; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martin J, 2012, NUCLEIC ACIDS RES, V40, pD720, DOI 10.1093/nar/gkr1194; McCall JW, 2008, ADV PARASIT, V66, P193, DOI 10.1016/S0065-308X(08)00204-2; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGonigle S, 2001, INT J PARASITOL, V31, P1459, DOI 10.1016/S0020-7519(01)00272-7; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neiffer DL, 2002, J ZOO WILDLIFE MED, V33, P242, DOI 10.1638/1042-7260(2002)033[0242:MAWMDA]2.0.CO;2; Nelson CT, 2005, VET PARASITOL, V133, P255, DOI 10.1016/j.vetpar.2005.07.008; Nelson CT, 2005, VET PARASITOL, V133, P267, DOI 10.1016/j.vetpar.2005.07.009; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Otranto D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S2; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Polizopoulou ZS, 2000, VET REC, V146, P466, DOI 10.1136/vr.146.16.466; Riley SPD, 2004, J WILDLIFE DIS, V40, P11, DOI 10.7589/0090-3558-40.1.11; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Scott AL, 2012, PARASITE IMMUNOL, V34, P121, DOI 10.1111/j.1365-3024.2011.01344.x; Sher A., 1988, MBL (Marine Biology Laboratory) Lectures in Biology, V9, P169; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Simon F, 2009, TRENDS PARASITOL, V25, P404, DOI 10.1016/j.pt.2009.06.003; Slatko BE, 2010, SYMBIOSIS, V51, P55, DOI 10.1007/s13199-010-0067-1; STANIUNAS RJ, 1982, J PARASITOL, V68, P809, DOI 10.2307/3280987; Strubing U, 2010, INT J PARASITOL, V40, P1193, DOI 10.1016/j.ijpara.2010.03.004; TANAKA KI, 1993, VET RES COMMUN, V17, P109, DOI 10.1007/BF01839238; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Theis JH, 2001, AM J TROP MED HYG, V64, P317, DOI 10.4269/ajtmh.2001.64.317; VANFLETEREN JR, 1994, MOL PHYLOGENET EVOL, V3, P92, DOI 10.1006/mpev.1994.1012; Wang JS, 2005, VET PARASITOL, V131, P261, DOI 10.1016/j.vetpar.2005.04.041; Wasmuth J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000258; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; Winter AD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000269; Yin Y, 2006, INT J PARASITOL, V36, P829, DOI 10.1016/j.ijpara.2006.03.002; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003	71	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41639	10.1371/journal.pone.0041639	http://dx.doi.org/10.1371/journal.pone.0041639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911833	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700131
J	Carr, IM; Diggle, CP; Khan, K; Inglehearn, C; McKibbin, M; Bonthron, DT; Markham, AF; Anwar, R; Dobbie, A; Pena, SDJ; Ali, M				Carr, Ian M.; Diggle, Christine P.; Khan, Kamron; Inglehearn, Chris; McKibbin, Martin; Bonthron, David T.; Markham, Alexander F.; Anwar, Rashida; Dobbie, Angus; Pena, Sergio D. J.; Ali, Manir			Rapid Visualisation of Microarray Copy Number Data for the Detection of Structural Variations Linked to a Disease Phenotype	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ACROSOME FORMATION; MALE-INFERTILITY; CANCER GENOME; PAX6 GENE; ANIRIDIA; GLOBOZOOSPERMIA; DELETIONS; MUTATION; ARRAYS	Whilst the majority of inherited diseases have been found to be caused by single base substitutions, small insertions or deletions (<1Kb), a significant proportion of genetic variability is due to copy number variation (CNV). The possible role of CNV in monogenic and complex diseases has recently attracted considerable interest. However, until the development of whole genome, oligonucleotide micro-arrays, designed specifically to detect the presence of copy number variation, it was not easy to screen an individual for the presence of unknown deletions or duplications with sizes below the level of sensitivity of optical microscopy (3-5 Mb). Now that currently available oligonucleotide micro-arrays have in excess of a million probes, the problem of copy number analysis has moved from one of data production to that of data analysis. We have developed CNViewer, to identify copy number variation that co-segregates with a disease phenotype in small nuclear families, from genome-wide oligonucleotide micro-array data. This freely available program should constitute a useful addition to the diagnostic armamentarium of clinical geneticists.	[Carr, Ian M.; Diggle, Christine P.; Khan, Kamron; Inglehearn, Chris; McKibbin, Martin; Bonthron, David T.; Markham, Alexander F.; Anwar, Rashida; Ali, Manir] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Markham, Alexander F.; Dobbie, Angus] St James Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England; [McKibbin, Martin] St James Univ Hosp, Dept Ophthalmol, Leeds, W Yorkshire, England; [Pena, Sergio D. J.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Pena, Sergio D. J.] GENE Nucleo Genet Med, Belo Horizonte, MG, Brazil	University of Leeds; Saint James's University Hospital; Saint James's University Hospital; Universidade Federal de Minas Gerais	Carr, IM (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	i.m.carr@leeds.ac.uk	Inglehearn, Chris/GYD-9783-2022; Ali, Manir/ABE-5251-2020	Ali, Manir/0000-0003-3204-3788; Bonthron, David/0000-0001-8132-8179	Sir Jules Thorn Charitable Trust [09/JTA]; Engineering and Physical Sciences Research Council [FP/I000623/1]; Cancer Research UK [600130]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil [472588/2004-5, 401983/2010-2]; Engineering and Physical Sciences Research Council [EP/I000623/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EPSRC [EP/I000623/1] Funding Source: UKRI	Sir Jules Thorn Charitable Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The Sir Jules Thorn Charitable Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding provided by the Sir Jules Thorn Charitable Trust (Grant 09/JTA), the Engineering and Physical Sciences Research Council (Grant FP/I000623/1), Cancer Research UK (Grant 600130) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil (projects 472588/2004-5 and 401983/2010-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Bejjani BA, 2008, ANNU REV GENOM HUM G, V9, P71, DOI 10.1146/annurev.genom.9.081307.164207; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; CHEUNG SW, 1977, CELL BIOL INT REP, V1, P255, DOI 10.1016/0309-1651(77)90050-9; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Dam AHDM, 2007, AM J HUM GENET, V81, P813, DOI 10.1086/521314; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Fan YS, 2007, HUM MUTAT, V28, P1124, DOI 10.1002/humu.20581; FANTES JA, 1992, AM J HUM GENET, V51, P1286; Forer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-318; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Huang Jing, 2004, Human Genomics, V1, P287; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Ware JS, 2012, HEART, V98, P276, DOI 10.1136/heartjnl-2011-300742; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43466	10.1371/journal.pone.0043466	http://dx.doi.org/10.1371/journal.pone.0043466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912880	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700108
J	Dewan, M; Kumar, A; Saxena, A; De, A; Mozumdar, S				Dewan, Manika; Kumar, Ajeet; Saxena, Amit; De, Arnab; Mozumdar, Subho			Biginelli Reaction Catalyzed by Copper Nanoparticles	PLOS ONE			English	Article							ONE-POT SYNTHESIS; IONIC LIQUIDS; EFFICIENT CATALYST; NI-NANOPARTICLES; DIHYDROPYRIMIDINONES; TETRAFLUOROBORATE; TEMPERATURE	We recently reported a novel synthesis of copper nanoparticles from copper sulphate utilizing the charge-compensatory effect of ionic liquid [bmim]BF4 and ethylene glycol. The nanoparticles were characterized and found to be stable for one year. Here we hypothesize that the stabilized nanoparticles should be able to catalyze one-pot multicomponent organic reactions. We show that the nanoparticles catalyzed Biginelli reaction at room temperature to give the product 3,4-dihydopyrimidinone (>90% yield in similar to 15 minutes) from aldehydes, beta-diketoester (ethylacetoacetate) and urea (or thiourea).). Remarkably, such high yields and rapid kinetics was found to be independent of the electronic density on the reactant aryl-aldehyde. This was probably because even the surface-active particles reacted faster in the presence of ionic liquid as compared to conventional methods. The heterocyclic dihydropyrimidinones (DHPMs) and their derivatives are widely used in natural and synthetic organic chemistry due to their wide spectrum of biological and therapeutic properties (resulting from their antibacterial, antiviral, antitumor and anti-inflammatory activities. Our method has an easy work-up procedure and the nanoparticles could be recycled with minimal loss of efficiency.	[Dewan, Manika; Kumar, Ajeet; Saxena, Amit; Mozumdar, Subho] Univ Delhi, Dept Chem, Delhi 110007, India; [De, Arnab] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA	University of Delhi; Columbia University	Dewan, M (corresponding author), Univ Delhi, Dept Chem, Delhi 110007, India.	subhoscom@yahoo.co.in						Ansari IA, 2005, TETRAHEDRON LETT, V46, P7507, DOI 10.1016/j.tetlet.2005.09.013; Antonietti M, 2004, ANGEW CHEM INT EDIT, V43, P4988, DOI 10.1002/anie.200460091; Choudhary VR, 2003, CATAL COMMUN, V4, P449, DOI 10.1016/S1566-7367(03)00111-0; Chu CD, 2007, CATAL COMMUN, V8, P1527, DOI 10.1016/j.catcom.2006.12.024; Dewan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029131; Dewan M, 2010, TETRAHEDRON LETT, V51, P6108, DOI 10.1016/j.tetlet.2010.09.052; Dhas NA, 1998, CHEM MATER, V10, P1446, DOI 10.1021/cm9708269; Germani R, 2007, TETRAHEDRON LETT, V48, P1767, DOI 10.1016/j.tetlet.2007.01.038; Ha SH, 2010, KOREAN J CHEM ENG, V27, P1360, DOI 10.1007/s11814-010-0386-1; Hallett JP, 2011, ROOM TEMPERATURE ION, P3508; Hanusek J, 2007, DYES PIGMENTS, V73, P326, DOI 10.1016/j.dyepig.2006.01.025; He YF, 2008, J PHOTOCH PHOTOBIO A, V197, P253, DOI 10.1016/j.jphotochem.2008.01.001; Holomb R, 2008, J RAMAN SPECTROSC, V39, P793, DOI 10.1002/jrs.1912; Jain SL, 2007, CATAL LETT, V115, P52, DOI 10.1007/s10562-007-9070-4; Jiang C, 2007, CHINESE CHEM LETT, V18, P647, DOI 10.1016/j.cclet.2007.04.002; Kachoosangi RT, 2009, ANAL CHEM, V81, P435, DOI 10.1021/ac801853r; Kamal A, 2007, CATAL COMMUN, V8, P1929, DOI 10.1016/j.catcom.2007.03.009; Kamavaram V, 2008, INT J THERM SCI, V47, P773, DOI 10.1016/j.ijthermalsci.2007.06.012; Kappe CO, 2000, EUR J MED CHEM, V35, P1043, DOI 10.1016/S0223-5234(00)01189-2; Khanna PK, 2007, MATER LETT, V61, P4711, DOI 10.1016/j.matlet.2007.03.014; Kim KS, 2005, KOREAN J CHEM ENG, V22, P717, DOI 10.1007/BF02705788; Kumar A, 2008, CATAL COMMUN, V10, P17, DOI 10.1016/j.catcom.2008.07.030; Kumar A, 2008, CATAL COMMUN, V9, P778, DOI 10.1016/j.catcom.2007.08.021; Kumar A, 2008, CATAL LETT, V122, P98, DOI 10.1007/s10562-007-9349-5; Kumar A, 2012, GREEN CHEM, V14, P1298, DOI 10.1039/c2gc35070j; Kumar A, 2011, TETRAHEDRON LETT, V52, P4835, DOI 10.1016/j.tetlet.2011.07.016; Kumar A, 2010, CATAL COMMUN, V11, P679, DOI 10.1016/j.catcom.2010.01.017; Liu CJ, 2009, MOLECULES, V14, P763, DOI 10.3390/molecules14020763; Liu X, 2006, TRIBOL LETT, V23, P191, DOI 10.1007/s11249-006-9050-7; Paczal A, 2007, MONATSH CHEM, V138, P1115, DOI 10.1007/s00706-007-0759-2; Pasunooti KK, 2011, TETRAHEDRON LETT, V52, P80, DOI 10.1016/j.tetlet.2010.10.150; PATIL AD, 1995, J ORG CHEM, V60, P1182, DOI 10.1021/jo00110a021; Redel E, 2008, CHEM COMMUN, P1789, DOI 10.1039/b718055a; Salavati-Niasari M, 2009, MATER LETT, V63, P441, DOI 10.1016/j.matlet.2008.11.023; Singh K, 2009, MINI-REV MED CHEM, V9, P95, DOI 10.2174/138955709787001686; Swadzba-Kwasny M, 2012, DALTON T, V41, P219, DOI 10.1039/c1dt11578b; Trohalaki S, 2005, QSAR COMB SCI, V24, P485, DOI 10.1002/qsar.200430927; Wang BG, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-259; Wang L, 2007, SCI CHINA SER B, V50, P63, DOI 10.1007/s11426-007-0016-x; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Welton T, 2004, COORDIN CHEM REV, V248, P2459, DOI 10.1016/j.ccr.2004.04.015; WIPF P, 1995, TETRAHEDRON LETT, V36, P7819, DOI 10.1016/0040-4039(95)01660-A; Zhang JD, 2010, J MATER CHEM, V20, P9798, DOI 10.1039/c0jm01970d; Zhang M, 2008, J DISPER SCI TECHNOL, V29, P508, DOI 10.1080/01932690701728734; Zhou Y, 2005, CURR NANOSCI, V1, P35, DOI 10.2174/1573413052953174; Zhu HT, 2005, NANOTECHNOLOGY, V16, P3079, DOI 10.1088/0957-4484/16/12/059; Zhu JM, 2007, J PHYS CHEM C, V111, P7629, DOI 10.1021/jp0711850	47	27	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43078	10.1371/journal.pone.0043078	http://dx.doi.org/10.1371/journal.pone.0043078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912792	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700038
J	Pripuzova, N; Wang, R; Tsai, S; Li, BJ; Hung, GC; Ptak, RG; Lo, SC				Pripuzova, Natalia; Wang, Richard; Tsai, Shien; Li, Bingjie; Hung, Guo-Chiuan; Ptak, Roger G.; Lo, Shyh-Ching			Development of Real-Time PCR Array for Simultaneous Detection of Eight Human Blood-Borne Viral Pathogens	PLOS ONE			English	Article							DISEASES (RAPID)-BIOACTIVE AMPLIFICATION; RELIABLE ASSAY PROTOCOL; B-VIRUS DNA; WEST-NILE-VIRUS; RAPID DETECTION; PROBING BAP; HIV TYPE-1; GROUP-O; IDENTIFICATION; QUANTIFICATION	Background: Real-time PCR array for rapid detection of multiple viral pathogens should be highly useful in cases where the sample volume and the time of testing are limited, i.e. in the eligibility testing of tissue and organ donors. Findings: We developed a real-time PCR array capable of simultaneously detecting eight human viral pathogens: human immunodeficiency virus types 1 and 2 (HIV-1 and -2), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell leukemia virus-1 and -2 (HTLV-1 and -2), vaccinia virus (VACV) and West Nile virus (WNV). One hundred twenty (120) primers were designed using a combination of bioinformatics approaches, and, after experimental testing, 24 primer sets targeting eight viral pathogens were selected to set up the array with SYBR Green chemistry. The specificity and sensitivity of the virus-specific primer sets selected for the array were evaluated using analytical panels with known amounts of viruses spiked into human plasma. The array detected: 10 genome equivalents (geq)/ml of HIV-2 and HCV, 50 geq of HIV-1 (subtype B), HBV (genotype A) and WNV. It detected 100-1,000 geq/ml of plasma of HIV-1 subtypes (A - G), group N and CRF (AE and AG) isolates. Further evaluation with a panel consisting of 28 HIV-1 and HIV-2 clinical isolates revealed no cross-reactivity of HIV-1 or HIV-2 specific primers with another type of HIV. All 28 viral isolates were identified with specific primer sets targeting the most conserved genome areas. The PCR array correctly identified viral infections in a panel of 17 previously quantified clinical plasma samples positive for HIV-1, HCV or HBV at as low as several geq per PCR reaction. Conclusions: The viral array described here demonstrated adequate performance in the testing of donors' clinical samples. Further improvement in its sensitivity for the broad spectrum of HIV-1 subtypes is under development.	[Pripuzova, Natalia; Tsai, Shien; Li, Bingjie; Hung, Guo-Chiuan; Lo, Shyh-Ching] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapy,Ctr Biol Evalu, Bethesda, MD 20014 USA; [Wang, Richard] NIH, Dept Transfus Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Ptak, Roger G.] So Res Inst, Dept Infect Dis Res, Frederick, MD USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA	Pripuzova, N (corresponding author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapy,Ctr Biol Evalu, Bethesda, MD 20014 USA.	ShyhChing.Lo@fda.hhs.gov			CLINICAL CENTER [ZIACL002121] Funding Source: NIH RePORTER	CLINICAL CENTER		ABIMIKU AG, 1994, AIDS RES HUM RETROV, V10, P1581, DOI 10.1089/aid.1994.10.1581; Assal A, 2009, TRANSFUSION, V49, P289, DOI 10.1111/j.1537-2995.2008.01965.x; BEYL W, 1987, MUNCHEN MED WOCHEN, V129, P895; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; CANN AJ, 1990, J VIROL, V64, P4735, DOI 10.1128/JVI.64.10.4735-4742.1990; Cannon GA, 2010, J VIROL METHODS, V163, P17, DOI 10.1016/j.jviromet.2009.07.005; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Daniel HDJ, 2009, INDIAN J MED MICROBI, V27, P111, DOI 10.4103/0255-0857.45362; Food and Drug Administration, 2005, FED REG, V69, P29785; GAO F, 1994, AIDS RES HUM RETROV, V10, P1359, DOI 10.1089/aid.1994.10.1359; Gueudin M, 2011, J CLIN MICROBIOL; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Gurtler L, 1988, INT C AIDS; Hsieh YC, 2005, J VIROL METHODS, V129, P75, DOI 10.1016/j.jviromet.2005.05.009; Ismail AM, 2011, J CLIN MICROBIOL, V49, P3215, DOI 10.1128/JCM.00915-11; Khodakov DA, 2008, BIOTECHNIQUES, V44, P241, DOI 10.2144/000112628; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanier ER, 2010, ANTIMICROB AGENTS CH, V54, P2901, DOI 10.1128/AAC.00068-10; Lee S, 2006, J VIROL METHODS, V137, P287, DOI 10.1016/j.jviromet.2006.07.001; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; Li G, 2005, J GEN VIROL, V86, P2969, DOI 10.1099/vir.0.81331-0; Li SK, 2008, J VIROL METHODS, V149, P35, DOI 10.1016/j.jviromet.2007.12.021; Lin BC, 2004, J CLIN MICROBIOL, V42, P3232, DOI 10.1128/JCM.42.7.3232-3239.2004; Liu Y, 2007, J CLIN MICROBIOL, V45, P553, DOI 10.1128/JCM.00709-06; LOUSSERTAJAKA I, 1995, J VIROL, V69, P5640, DOI 10.1128/JVI.69.9.5640-5649.1995; Mallick TK, 2011, REPORTED INFECT HUMA; Motulsky H.J., 2012, INTUITIVE BIOSTATIST; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; Owen SM, 1998, J VIROL, V72, P5425, DOI 10.1128/JVI.72.7.5425-5432.1998; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004; Phillippy AM, 2009, NUCLEIC ACIDS RES, V37, pW229, DOI 10.1093/nar/gkp286; SCHULZ TF, 1990, J VIROL, V64, P5177, DOI 10.1128/JVI.64.10.5177-5182.1990; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Sire JM, 2011, JAIDS-J ACQ IMM DEF, V56, P239, DOI 10.1097/QAI.0b013e3182099891; Snijders PJF, 2005, METH MOLEC MED, V119, P101; Wang CY, 2008, VET MICROBIOL, V130, P28, DOI 10.1016/j.vetmic.2007.12.015; Wang Su, 2007, Cell and Tissue Banking, V8, P211, DOI 10.1007/s10561-007-9034-3; Whitehouse CA, 2010, APPL ENVIRON MICROB, V76, P1996, DOI 10.1128/AEM.01919-09	43	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43246	10.1371/journal.pone.0043246	http://dx.doi.org/10.1371/journal.pone.0043246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912836	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700066
J	Quintana, A; Morgan, PG; Kruse, SE; Palmiter, RD; Sedensky, MM				Quintana, Albert; Morgan, Philip G.; Kruse, Shane E.; Palmiter, Richard D.; Sedensky, Margaret M.			Altered Anesthetic Sensitivity of Mice Lacking Ndufs4, a Subunit of Mitochondrial Complex I	PLOS ONE			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; D-ASPARTATE RECEPTOR; CAENORHABDITIS-ELEGANS; VOLATILE-ANESTHETICS; GENERAL-ANESTHESIA; INHALED ANESTHETICS; RIGHTING REFLEX; ALZHEIMER MICE; LEIGH-SYNDROME; ISOFLURANE	Anesthetics are in routine use, yet the mechanisms underlying their function are incompletely understood. Studies in vitro demonstrate that both GABA(A) and NMDA receptors are modulated by anesthetics, but whole animal models have not supported the role of these receptors as sole effectors of general anesthesia. Findings in C. elegans and in children reveal that defects in mitochondrial complex I can cause hypersensitivity to volatile anesthetics. Here, we tested a knockout (KO) mouse with reduced complex I function due to inactivation of the Ndufs4 gene, which encodes one of the subunits of complex I. We tested these KO mice with two volatile and two non-volatile anesthetics. KO and wild-type (WT) mice were anesthetized with isoflurane, halothane, propofol or ketamine at post-natal (PN) days 23 to 27, and tested for loss of response to tail clamp (isoflurane and halothane) or loss of righting reflex (propofol and ketamine). KO mice were 2.5 - to 3-fold more sensitive to isoflurane and halothane than WT mice. KO mice were 2-fold more sensitive to propofol but resistant to ketamine. These changes in anesthetic sensitivity are the largest recorded in a mammal.	[Quintana, Albert; Kruse, Shane E.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Quintana, Albert; Kruse, Shane E.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Morgan, Philip G.; Sedensky, Margaret M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Morgan, Philip G.; Sedensky, Margaret M.] Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Quintana, A (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	pgm4@uw.edu	Quintana, Albert/N-5544-2015; kruse, shane/L-8717-2014	Quintana, Albert/0000-0003-1674-7160; kruse, shane/0000-0001-6344-0650	Howard Hughes Medical Institute (HHMI); MICINN postdoctoral mobility program fellowship from the Spanish Ministerio de Ciencia e Innovacion; National Institutes of Health (NIH) [GM58881]; Mitochondrial Research Guild; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); MICINN postdoctoral mobility program fellowship from the Spanish Ministerio de Ciencia e Innovacion; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitochondrial Research Guild; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RDP and AQ were supported by the Howard Hughes Medical Institute (HHMI). AQ was a recipient of MICINN postdoctoral mobility program fellowship from the Spanish Ministerio de Ciencia e Innovacion. PGM and MMS were supported by National Institutes of Health (NIH) grant GM58881. These studies were also supported in part by the Mitochondrial Research Guild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia R, 2009, J NEUROSCI, V29, P7053, DOI 10.1523/JNEUROSCI.1357-08.2009; Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; Alkire MT, 2009, ANESTHESIOLOGY, V110, P766, DOI 10.1097/ALN.0b013e31819c461c; Bianchi SL, 2010, ANESTH ANALG, V110, P427, DOI 10.1213/ANE.0b013e3181b5a292; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Chen XD, 2009, J NEUROSCI, V29, P560, DOI 10.1523/JNEUROSCI.3481-08.2009; Eckel B, 2010, ANESTH ANALG, V110, P438, DOI 10.1213/ANE.0b013e3181b76383; Eger EI, 2006, ANESTH ANALG, V102, P1397, DOI 10.1213/01.ANE.0000219019.91281.51; Falk MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006607; Forman SA, 2008, INT ANESTHESIOL CLIN, V46, P43, DOI 10.1097/AIA.0b013e3181755da5; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; HARRIS RA, 1971, ARCH BIOCHEM BIOPHYS, V142, P435, DOI 10.1016/0003-9861(71)90507-8; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hollmann MW, 2001, ANESTH ANALG, V92, P1182; Humphrey JA, 2002, HUM MOL GENET, V11, P1241, DOI 10.1093/hmg/11.10.1241; Jinks SL, 2008, ANESTHESIOLOGY, V108, P1016, DOI 10.1097/ALN.0b013e3181730297; Kayser EB, 1999, ANESTHESIOLOGY, V90, P545, DOI 10.1097/00000542-199902000-00031; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kilbride SM, 2008, J NEUROCHEM, V106, P826, DOI 10.1111/j.1471-4159.2008.05441.x; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kubo K, 2009, J PHARMACOL EXP THER, V329, P592, DOI 10.1124/jpet.109.151456; Liao M, 2005, ANESTH ANALG, V101, P412, DOI 10.1213/01.ANE.0000154196.86587.35; Liu HT, 2001, ANESTH ANALG, V92, P1173; MORGAN PG, 1994, ANESTHESIOLOGY, V81, P888, DOI 10.1097/00000542-199410000-00016; Morgan PG, 2002, ANESTHESIOLOGY, V96, P1268, DOI 10.1097/00000542-200205000-00036; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Petrenko AB, 2004, ANESTH ANALG, V99, P1136, DOI 10.1213/01.ANE.0000131729.54986.30; Quintana A, 2012, J CLIN INVE IN PRESS; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Scholvinck ML, 2008, NEUROIMAGE, V40, P1460, DOI 10.1016/j.neuroimage.2008.01.032; Singaram VK, 2011, CURR BIOL, V21, P2070, DOI 10.1016/j.cub.2011.10.042; Sonner JM, 2007, ANESTHESIOLOGY, V106, P107, DOI 10.1097/00000542-200701000-00019; Sonner JM, 1999, ANESTH ANALG, V89, P1030, DOI 10.1097/00000539-199910000-00039; Sonner JM, 2000, ANESTH ANALG, V91, P720, DOI 10.1213/00000539-200009000-00042; Suthammarak W, 2010, J BIOL CHEM, V285, P40724, DOI 10.1074/jbc.M110.159608; Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577; Werner DF, 2011, J PHARMACOL EXP THER, V336, P134, DOI 10.1124/jpet.110.170431; Xi J, 2004, J BIOL CHEM, V279, P19628, DOI 10.1074/jbc.M313864200; Zhang Y, 2004, ANESTH ANALG, V99, P85, DOI 10.1213/01.ANE.0000118108.64886.42	45	49	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42904	10.1371/journal.pone.0042904	http://dx.doi.org/10.1371/journal.pone.0042904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912761	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700029
J	Varamini, P; Mansfeld, FM; Blanchfield, JT; Wyse, BD; Smith, MT; Toth, I				Varamini, Pegah; Mansfeld, Friederike M.; Blanchfield, Joanne T.; Wyse, Bruce D.; Smith, Maree T.; Toth, Istvan			Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; OPIOID-PEPTIDES; CROSS-TOLERANCE; IN-VIVO; ENDOMORPHIN-1; MORPHINE; TRANSPORT; ANALOGS; POTENT; ANTINOCICEPTION	To enhance the drug-like properties of the endogenous opioid peptide endomorphin-1 (1 = Tyr-Pro-Trp-Phe-NH2), the N-terminus of the peptide was modified with 2-aminodecanoic acid, resulting in compound 3. Tyr in compound 1 was replaced with 2,6-dimethyltyrosine yielding compound 2. Derivative 2 was also substituted with 2-aminodecanoic acid producing compound, 4. Lipoamino acid-modified derivatives showed improved metabolic stability and membrane permeability while maintaining high m-opioid (MOP) receptor binding affinity and acting as a potent agonist. In vivo studies showed dose-dependent antinociceptive activity following intravenous (i.v.) administration of compounds 3 and 4 in a chronic constriction injury (CCI)-rat model of neuropathic pain with ED50 values of 1.22 (+/-0.93) and 0.99 (+/-0.89) mu mol/kg, respectively. Pre-treatment of animals with naloxone hydrochloride significantly attenuated the anti-neuropathic effects of compound 3, confirming the key role of opioid receptors in mediating antinociception. In contrast to morphine, no significant constipation was produced following i. v. administration of compound 3 at 16 mmol/kg. Furthermore, following chronic administration of equi-potent doses of compound 3 and morphine to rats, there was less antinociceptive tolerance for compound 3 compared with morphine.	[Varamini, Pegah; Mansfeld, Friederike M.; Blanchfield, Joanne T.; Toth, Istvan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Wyse, Bruce D.; Smith, Maree T.] Univ Queensland, Ctr Integrated Preclin Drug Dev, Brisbane, Qld, Australia; [Wyse, Bruce D.; Smith, Maree T.; Toth, Istvan] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Varamini, P (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	i.toth@uq.edu.au	Varamini, Pegah/N-6917-2015; Smith, Maree T/I-4005-2015; Blanchfield, Joanne T/C-1725-2014; Varamini, Pegah/ABB-2824-2020; Toth, Istvan/C-1965-2013	Varamini, Pegah/0000-0001-8658-9722; Smith, Maree T/0000-0003-2281-3734; Blanchfield, Joanne T/0000-0003-1338-7446; Varamini, Pegah/0000-0001-8658-9722; Toth, Istvan/0000-0002-4572-397X	International Postgraduate Research Scholarship (IPRS) at The University of Queensland; Queensland Government Smart State Research Facilities Fund; National Health and Medical Research Council [569855]	International Postgraduate Research Scholarship (IPRS) at The University of Queensland; Queensland Government Smart State Research Facilities Fund; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	PV was supported by an International Postgraduate Research Scholarship (IPRS) at The University of Queensland (www.uq.edu.au). This work was supported by infrastructure purchased with funds from the Queensland Government Smart State Research Facilities Fund (http://www.science.qld.gov.au), and by research funds from the National Health and Medical Research Council Development grant 569855 (http://www.nhmrc.gov.au). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewood P, 1997, METHOD ENZYMOL, V289, P14; Allt G, 2000, BRAIN RES BULL, V52, P1, DOI 10.1016/S0361-9230(00)00230-6; BANKS WA, 1992, PEPTIDES, V13, P1289, DOI 10.1016/0196-9781(92)90037-4; BANKS WA, 1985, BRAIN RES BULL, V15, P287, DOI 10.1016/0361-9230(85)90153-4; Bennett Gary J, 2003, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0914s22; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Blanchfield J, 2004, CURR MED CHEM, V11, P2375, DOI 10.2174/0929867043364621; Csullog E, 2001, PAIN, V94, P31, DOI 10.1016/S0304-3959(01)00338-4; DEY PK, 1976, BRIT J PHARMACOL, V58, P383, DOI 10.1111/j.1476-5381.1976.tb07715.x; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Egleton RD, 1998, J PHARM SCI-US, V87, P1433, DOI 10.1021/js980062b; Gao YF, 2005, BIOORG MED CHEM LETT, V15, P1847, DOI 10.1016/j.bmcl.2005.02.021; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; Gentilucci L, 2004, CURR TOP MED CHEM, V4, P19, DOI 10.2174/1568026043451663; Goldberg IE, 1998, J PHARMACOL EXP THER, V286, P1007; Harrison C, 1999, BRIT J PHARMACOL, V128, P472, DOI 10.1038/sj.bjp.0702798; Horvath G, 2000, PHARMACOL THERAPEUT, V88, P437, DOI 10.1016/S0163-7258(00)00100-5; Hung KC, 2002, EUR J PHARMACOL, V448, P169, DOI 10.1016/S0014-2999(02)01984-2; IdanpaanHeikkila JJ, 1997, J PHARMACOL EXP THER, V282, P1366; Jinsmaa Y, 2006, PHARMACOL BIOCHEM BE, V84, P252, DOI 10.1016/j.pbb.2006.05.005; Koda Y, 2008, BIOORGAN MED CHEM, V16, P6286, DOI 10.1016/j.bmc.2008.04.020; Labuz D, 2002, NEUROSCI LETT, V334, P127, DOI 10.1016/S0304-3940(02)01121-7; Gelman PL, 2010, SALUD MENT, V33, P179; Leon S., 2005, APPL BIOPHARMACEUTIC, V5th; Li TY, 2005, J MED CHEM, V48, P586, DOI 10.1021/jm049384k; Lundquist S, 2002, PHARMACEUT RES, V19, P976, DOI 10.1023/A:1016462205267; Nielsen CK, 2007, PAIN, V132, P289, DOI 10.1016/j.pain.2007.03.022; Perlikowska R, 2010, PEPTIDES, V31, P339, DOI 10.1016/j.peptides.2009.12.002; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; RAPOPORT SI, 1980, SCIENCE, V207, P84, DOI 10.1126/science.7350645; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; Smetanova Libuse, 2011, Acta Medica (Hradec Kralove), V54, P3; Soignier RD, 2000, LIFE SCI, V67, P907, DOI 10.1016/S0024-3205(00)00689-5; Soignier RD, 2004, NEUROSCI LETT, V366, P211, DOI 10.1016/j.neulet.2004.05.046; Spampinato S, 2003, EUR J PHARMACOL, V469, P89, DOI 10.1016/S0014-2999(03)01736-9; Thiel-Demby VE, 2009, MOL PHARMACEUT, V6, P11, DOI 10.1021/mp800122b; TOTH I, 1991, INT J PHARM, V68, P191, DOI 10.1016/0378-5173(91)90141-A; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Tsuji Akira, 2005, NeuroRx, V2, P54, DOI 10.1007/BF03206642; VOJKOVSKY T, 1995, PEPTIDE RES, V8, P236; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	42	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41909	10.1371/journal.pone.0041909	http://dx.doi.org/10.1371/journal.pone.0041909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912681	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700009
J	Zhou, YH; Yao, ZH; Liu, FL; Li, H; Jiang, L; Zhu, JW; Zheng, YT				Zhou, Yan-Heng; Yao, Zhi-Hong; Liu, Feng-Liang; Li, Hong; Jiang, Li; Zhu, Jia-Wu; Zheng, Yong-Tang			High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTION; POPULATIONS; HIV/AIDS; DEHONG; AREA	Objective: To estimate the prevalence of HIV, HCV, HBV and co-infection with 2 or 3 viruses and evaluate risk factors among injecting drug users (IDUs) in Yunnan province, China. Methods: 2080 IDUs were recruited from 5 regions of Yunnan Province, China to detect the infection status of HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Statistical analysis was performed to evaluate risk factors related to HIV, HCV and HBV infections. Results: The infection rates among all participants were 25.5% for HIV, 77.7% for HCV, 19.2% for HBV, 15% for HIV/HCV, 0.3% for HIV/HBV, 7.8% for HCV/HBV and 7.1% for HIV/HCV/HBV. The prevalence of virus infection varied widely by region in Yunnan of China. Statistical analyses indicated that high prevalence of HIV and HCV among IDUs was positively associated with the duration of drug injection and sharing needles/syringes; besides, HCV infection was associated with the frequency of drug injection. Conclusions: HIV, HCV, HBV infections and co-infections were still very prevalent among IDUs in Yunnan province because of drug use behaviors.	[Zhou, Yan-Heng; Yao, Zhi-Hong; Liu, Feng-Liang; Zhu, Jia-Wu; Zheng, Yong-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Kunming, Peoples R China; [Li, Hong; Jiang, Li] Yunnan Ctr Dis Control & Prevent, Kunming, Peoples R China; [Zhou, Yan-Heng; Yao, Zhi-Hong; Zhu, Jia-Wu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, YH (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Kunming, Peoples R China.	zhengyt@mail.kiz.ac.cn	Liu, Feng-Liang/O-4000-2019	Liu, Feng-Liang/0000-0002-5038-5012; jiang, li/0000-0002-2804-6460	Scientific and Technological Program of China [2009ZX10004-902, 2009ZX09501-029, 2012ZX10001-006, 2012ZX10001-007]; Scientific and Technological Program of Yunnan province [2010GA001]; National Basic Research Program of China [2009CB522306]; Chinese Academy of Sciences [KSCX1-YW-10]	Scientific and Technological Program of China; Scientific and Technological Program of Yunnan province; National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by grants from the Scientific and Technological Program of China (2009ZX10004-902, 2009ZX09501-029, 2012ZX10001-006, 2012ZX10001-007) and Yunnan province (2010GA001), National Basic Research Program of China (2009CB522306), and the Chinese Academy of Sciences (KSCX1-YW-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Baozhang T, 1997, EPIDEMIOL INFECT, V119, P343, DOI 10.1017/S0950268897007784; Cheng H, 1993, Zhonghua Liu Xing Bing Xue Za Zhi, V14, P275; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; Jin L, 2005, OCCUPATION HLTH, V21, P1508; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Li JH, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-4; Liu Zhihua, 2006, Int J Med Sci, V3, P57; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Lu L., 2006, J CHIN AIDS STD, V12, P517; Lu L., 2005, J CHINA AIDSSTD, V11, P172; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma Y, 1990, ZHONGHUA LIU XING BI, V11, P184; Ma YL, 2011, J DERMATOL VENEREOL, V33, P230; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tian KL, 2009, CHIN J PUBLIC HLTH, V25, P742; Vickerman P, 2010, ADDICTION, V105, P311, DOI 10.1111/j.1360-0443.2009.02759.x; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Yang JF, 2011, YI YAO QIANYAN, V01, P109; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014; Zhang L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-250; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016349; Zhou YH, 2010, J DERMATOL VENEREOL, V32, P20	34	54	60	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42937	10.1371/journal.pone.0042937	http://dx.doi.org/10.1371/journal.pone.0042937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916185	gold, Green Published, Green Submitted			2022-12-27	WOS:000307824300023
J	Gupta, SK; Rai, AK; Kanwar, SS; Sharma, TR				Gupta, Santosh Kumar; Rai, Amit Kumar; Kanwar, Shamsher Singh; Sharma, Tilak R.			Comparative Analysis of Zinc Finger Proteins Involved in Plant Disease Resistance	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; RACE-SPECIFIC RESISTANCE; FLAX RUST RESISTANCE; NUCLEOTIDE-BINDING; CONFERRING RESISTANCE; AMINO-ACID; DNA-BINDING; FUNCTIONAL COMPLEMENTATION; MOLECULAR-CLONING; THERMAL-STABILITY	A meta-analysis was performed to understand the role of zinc finger domains in proteins of resistance (R) genes cloned from different crops. We analyzed protein sequences of seventy R genes of various crops in which twenty six proteins were found to have zinc finger domains along with nucleotide binding sites - leucine rice repeats (NBS-LRR) domains. We identified thirty four zinc finger domains in the R proteins of nine crops and were grouped into 19 types of zinc fingers. The size of individual zinc finger domain within the R genes varied from 11 to 84 amino acids, whereas the size of proteins containing these domains varied from 263 to 1305 amino acids. The biophysical analysis revealed that molecular weight of Pi54 zinc finger was lowest whereas the highest one was found in rice Pib zinc finger named as Transposes Transcription Factor (TTF). The instability (R-2 = 0.95) and the aliphatic (R-2 = 0.94) indices profile of zinc finger domains follows the polynomial distribution pattern. The pairwise identity analysis showed that the Lin11, Isl-1 & Mec-3 (LIM) zinc finger domain of rice blast resistance protein pi21 have 12.3% similarity with the nuclear transcription factor, X-box binding-like 1 (NFX) type zinc finger domain of Pi54 protein. For the first time, we reported that Pi54 (Pi-k(h)-Tetep), a rice blast resistance (R) protein have a small zinc finger domain of NFX type located on the C-terminal in between NBS and LRR domains of the R-protein. Compositional analysis depicted by the helical wheel diagram revealed the presence of a hydrophobic region within this domain which might help in exposing the LRR region for a possible R-Avr interaction. This domain is unique among all other cloned plant disease resistance genes and might play an important role in broad-spectrum nature of rice blast resistance gene Pi54.	[Gupta, Santosh Kumar; Rai, Amit Kumar; Sharma, Tilak R.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Gupta, Santosh Kumar; Rai, Amit Kumar; Kanwar, Shamsher Singh] Himachal Pradesh Univ, Dept Biotechnol, Summer Hill, Shimla, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Himachal Pradesh University	Gupta, SK (corresponding author), Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India.	trsharma@nrcpb.org	Kanwar, Shamsher S/F-6096-2019	Kanwar, Shamsher Singh/0000-0002-3196-3366; GUPTA, SANTOSH KUMAR/0000-0003-2245-8488	Department of Biotechnology, Government of India [BT/AB/FG-2(PH-II)/2009-3A]; National Agricultural Innovation Project-Indian Council of Agricultural Research [C4/C1071]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Agricultural Innovation Project-Indian Council of Agricultural Research	Financial assistance received from the Department of Biotechnology (F. No. BT/AB/FG-2(PH-II)/2009-3A), Government of India, National Agricultural Innovation Project-Indian Council of Agricultural Research (C4/C1071) by TRS is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 1997, PLANT CELL, V9, P641, DOI 10.1105/tpc.9.4.641; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Arora N, 2009, BIOINFORMATION, V3, P446, DOI 10.6026/97320630003446; Asano T, 2008, PLANT SIGNAL BEHAV, V3, P991, DOI 10.4161/psb.6291; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Boocock GRB, 2006, GENOMICS, V87, P758, DOI 10.1016/j.ygeno.2006.01.010; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Brommonschenkel SH, 2000, MOL PLANT MICROBE IN, V13, P1130, DOI 10.1094/MPMI.2000.13.10.1130; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Cammack R, 1971, BIOCHEM J, V125, P18; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Cornilescu CC, 2008, FEBS LETT, V582, P896, DOI 10.1016/j.febslet.2008.02.023; Costanzo S, 2010, PLANT SCI, V178, P523, DOI 10.1016/j.plantsci.2010.02.014; Das A, 2012, FUNCT INTEGR GENOMIC, V12, P215, DOI 10.1007/s10142-012-0284-1; De Guzman RN, 2005, BIOCHEMISTRY-US, V44, P490, DOI 10.1021/bi048161t; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Epple P, 2003, P NATL ACAD SCI USA, V100, P6831, DOI 10.1073/pnas.1130421100; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Feuillet C, 1997, PLANT J, V11, P45, DOI 10.1046/j.1365-313X.1997.11010045.x; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Giri J, 2011, NEW PHYTOL, V191, P721, DOI 10.1111/j.1469-8137.2011.03740.x; Glowacki S, 2011, CELL MOL BIOL LETT, V16, P1, DOI 10.2478/s11658-010-0024-2; Gourcilleau D, 2011, DNA RES, V18, P77, DOI 10.1093/dnares/dsr001; Gupta SK, 2012, J EXP BOT, V63, P757, DOI 10.1093/jxb/err297; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hacquard S, 2012, MOL PLANT MICROBE IN, V25, P279, DOI 10.1094/MPMI-09-11-0238; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jenkins TH, 2005, PLANTA, V220, P559, DOI 10.1007/s00425-004-1365-8; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Kang XJ, 2005, PLANT CELL, V17, P822, DOI 10.1105/tpc.104.029165; Kim S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-104; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; Klug A, 2005, FEBS LETT, V579, P892, DOI 10.1016/j.febslet.2004.10.104; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Konagaya Ken-ichi, 2004, Journal of General Plant Pathology, V70, P221, DOI 10.1007/s10327-003-0113-4; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kubo K, 1998, NUCLEIC ACIDS RES, V26, P608, DOI 10.1093/nar/26.2.608; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; LAWRENCE GJ, 1995, PLANT CELL, V7, P1195, DOI 10.1105/tpc.7.8.1195; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liao H, 2005, PROTEIN ENG DES SEL, V18, P59, DOI 10.1093/protein/gzi009; Lisso J, 2006, FEBS LETT, V580, P4851, DOI 10.1016/j.febslet.2006.07.079; Liu XQ, 2007, GENETICS, V176, P2541, DOI 10.1534/genetics.107.075465; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Madhav MS, 2009, J PHYTOPATHOL, V157, P322, DOI 10.1111/j.1439-0434.2008.01487.x; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Mattos C, 2002, TRENDS BIOCHEM SCI, V27, P203, DOI 10.1016/S0968-0004(02)02067-4; Meyers BC, 1998, PLANT CELL, V10, P1817, DOI 10.1105/tpc.10.11.1817; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Mussig C, 2010, PLANT BIOLOGY, V12, P381, DOI 10.1111/j.1438-8677.2009.00303.x; Ori N, 1997, PLANT CELL, V9, P521, DOI 10.1105/tpc.9.4.521; Paal J, 2004, PLANT J, V38, P285, DOI 10.1111/j.1365-313X.2004.02047.x; Pack SP, 2004, J BIOTECHNOL, V111, P269, DOI 10.1016/j.jbiotec.2004.01.018; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Parthasarathy S, 2000, PROTEIN ENG, V13, P9, DOI 10.1093/protein/13.1.9; PONNUSWAMY PK, 1982, INT J BIOL MACROMOL, V4, P186, DOI 10.1016/0141-8130(82)90049-6; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Radwan O, 2005, J EXP BOT, V56, P567, DOI 10.1093/jxb/eri030; Rai AK, 2011, J PLANT BIOCHEM BIOT, V20, P55, DOI 10.1007/s13562-010-0026-1; Roy S, 2011, BIOINFORMATION, V6, P315, DOI 10.6026/97320630006315; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Sahay A., 2010, J PROTEONOMICS BIOIN, V3, P148, DOI [https://doi.org/10.4172/jpb.1000134, DOI 10.4172/JPB.1000134, 10.4172/jpb.1000134]; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schumann U, 2007, P NATL ACAD SCI USA, V104, P1069, DOI 10.1073/pnas.0610402104; Sharma TR, 2012, AGR RES, V1, P37, DOI 10.1007/s40003-011-0003-5; Sharma TR, 2010, J PLANT BIOCHEM BIOT, V19, P87, DOI 10.1007/BF03323441; Sharma TR, 2005, MOL GENET GENOMICS, V274, P569, DOI 10.1007/s00438-005-0035-2; Sharma TR, 2005, J PLANT BIOCHEM BIOT, V14, P127, DOI 10.1007/BF03263240; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Sonah H, 2011, BIOTECHNOL ADV, V29, P199, DOI 10.1016/j.biotechadv.2010.11.002; SONG ZM, 1994, J EXP MED, V180, P1763, DOI 10.1084/jem.180.5.1763; Sun SJ, 2010, J EXP BOT, V61, P2807, DOI 10.1093/jxb/erq120; Takahashi H, 2002, PLANT J, V32, P655, DOI 10.1046/j.1365-313X.2002.01453.x; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Vos P, 1998, NAT BIOTECHNOL, V16, P1365, DOI 10.1038/4350; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Xu J, 2001, PROTEIN SCI, V10, P1067, DOI 10.1110/ps.02101; Yu H, 2009, APPL MICROBIOL BIOT, V82, P279, DOI 10.1007/s00253-008-1748-z; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x	109	108	115	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42578	10.1371/journal.pone.0042578	http://dx.doi.org/10.1371/journal.pone.0042578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916136	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600017
J	Neumetzler, L; Humphrey, T; Lumba, S; Snyder, S; Yeats, TH; Usadel, B; Vasilevski, A; Patel, J; Rose, JKC; Persson, S; Bonetta, D				Neumetzler, Lutz; Humphrey, Tania; Lumba, Shelley; Snyder, Stephen; Yeats, Trevor H.; Usadel, Bjoern; Vasilevski, Aleksandar; Patel, Jignasha; Rose, Jocelyn K. C.; Persson, Staffan; Bonetta, Dario			The FRIABLE1 Gene Product Affects Cell Adhesion in Arabidopsis	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; SUSPENSION-CULTURED CELLS; GLUCURONOXYLAN BIOSYNTHESIS; PUTATIVE METHYLTRANSFERASE; PECTIC HOMOGALACTURONAN; CELLULOSE BIOSYNTHESIS; BREFELDIN-A; WALL; XYLOGLUCAN; THALIANA	Cell adhesion in plants is mediated predominantly by pectins, a group of complex cell wall associated polysaccharides. An Arabidopsis mutant, friable1 (frb1), was identified through a screen of T-DNA insertion lines that exhibited defective cell adhesion. Interestingly, the frb1 plants displayed both cell and organ dissociations and also ectopic defects in organ separation. The FRB1 gene encodes a Golgi-localized, plant specific protein with only weak sequence similarities to known proteins (DUF246). Unlike other cell adhesion deficient mutants, frb1 mutants do not have reduced levels of adhesion related cell wall polymers, such as pectins. Instead, FRB1 affects the abundance of galactose- and arabinose-containing oligosaccharides in the Golgi. Furthermore, frb1 mutants displayed alteration in pectin methylesterification, cell wall associated extensins and xyloglucan microstructure. We propose that abnormal FRB1 action has pleiotropic consequences on wall architecture, affecting both the extensin and pectin matrices, with consequent changes to the biomechanical properties of the wall and middle lamella, thereby influencing cell-cell adhesion.	[Neumetzler, Lutz; Usadel, Bjoern; Vasilevski, Aleksandar; Persson, Staffan] Max Planck Inst Mol Plant Physiol, Golm, Germany; [Humphrey, Tania] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada; [Lumba, Shelley; Patel, Jignasha] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Snyder, Stephen; Yeats, Trevor H.; Rose, Jocelyn K. C.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Bonetta, Dario] Univ Ontario Inst Technol, Fac Sci, Oshawa, ON, Canada	Max Planck Society; University of Toronto; Cornell University; Ontario Tech University	Neumetzler, L (corresponding author), Max Planck Inst Mol Plant Physiol, Golm, Germany.	Persson@mpimp-golm.mpg.de; dario.bonetta@uoit.ca	Persson, Staffan/S-8399-2016; Usadel, Björn/E-1932-2011	Persson, Staffan/0000-0002-6377-5132; Usadel, Björn/0000-0003-0921-8041	Natural Sciences and Engineering Research Council of Canada; Max-Planck Gesellschaft; NSF Plant Genome Research Program [DBI-0606595]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Max-Planck Gesellschaft; NSF Plant Genome Research Program	Natural Sciences and Engineering Research Council of Canada; Max-Planck Gesellschaft; NSF Plant Genome Research Program (DBI-0606595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALDWIN TC, 1993, PLANT PHYSIOL, V103, P115, DOI 10.1104/pp.103.1.115; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; Bechtold N, 1998, METH MOL B, V82, P259; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Brandizzi F, 2002, PLANT CELL, V14, P1293, DOI 10.1105/tpc.001586; Brett C. T., 1996, Physiology and biochemistry of plant cell walls.; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cumming CM, 2005, PLANTA, V222, P546, DOI 10.1007/s00425-005-1560-2; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dische Z, 1964, METHODS CARBOHYDRATE; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Francis KE, 2006, PLANT PHYSIOL, V142, P1004, DOI 10.1104/pp.106.085274; Gunl M, 2011, PLANT CELL, V23, P4025, DOI 10.1105/tpc.111.089193; Gunl M, 2011, PLANTA, V233, P707, DOI 10.1007/s00425-010-1330-7; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Harris E.L.V., 1989, PROTEIN PURIFICATION; HEIM DR, 1991, PESTIC BIOCHEM PHYS, V39, P93, DOI 10.1016/0048-3575(91)90129-A; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Iwai H, 2002, P NATL ACAD SCI USA, V99, P16319, DOI 10.1073/pnas.252530499; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Jenks Matthew A, 2002, Arabidopsis Book, V1, pe0016, DOI 10.1199/tab.0016; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krupkova E, 2007, PLANT J, V50, P735, DOI 10.1111/j.1365-313X.2007.03123.x; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Leboeuf E, 2005, J EXP BOT, V56, P3171, DOI 10.1093/jxb/eri314; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; MANIATIS T, 1982, MOL CLONING LAB MANU; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCann MC, 1997, PHYSIOL PLANTARUM, V100, P729, DOI 10.1034/j.1399-3054.1997.1000337.x; McCartney L, 2002, J EXP BOT, V53, P707, DOI 10.1093/jexbot/53.369.707; Mouille G, 2007, PLANT J, V50, P605, DOI 10.1111/j.1365-313X.2007.03086.x; Nawrath C, 2006, CURR OPIN PLANT BIOL, V9, P281, DOI 10.1016/j.pbi.2006.03.001; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Neumetzler L, 2010, IDENTIFICATION CHARA; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Obel N, 2009, MOL PLANT, V2, P922, DOI 10.1093/mp/ssp046; Ordaz-Ortiz JJ, 2009, MOL PLANT, V2, P910, DOI 10.1093/mp/ssp049; Orfila C, 2005, PLANTA, V222, P613, DOI 10.1007/s00425-005-0008-z; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pena MJ, 2004, PLANT PHYSIOL, V134, P443, DOI 10.1104/pp.103.027508; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Persson S, 2007, PLANT CELL, V19, P237, DOI 10.1105/tpc.106.047720; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Ryser U, 2003, PLANTA, V216, P854, DOI 10.1007/s00425-002-0938-7; Sage TL, 1999, AM J BOT, V86, P855, DOI 10.2307/2656706; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sampedro J, 2001, PLANT PHYSIOL, V126, P910, DOI 10.1104/pp.126.2.910; Sampedro J, 2010, PLANT PHYSIOL, V154, P1105, DOI 10.1104/pp.110.163212; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1361; Sieber P, 2000, PLANT CELL, V12, P721, DOI 10.1105/tpc.12.5.721; Singh SK, 2005, PLANT J, V43, P384, DOI 10.1111/j.1365-313X.2005.02455.x; SMALLWOOD M, 1995, PLANTA, V196, P510, DOI 10.1007/BF00203651; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; SWORDS KMM, 1993, PLANT PHYSIOL, V102, P891, DOI 10.1104/pp.102.3.891; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; Toole GA, 2004, CARBOHYD RES, V339, P629, DOI 10.1016/j.carres.2003.11.010; Valentin R, 2010, LANGMUIR, V26, P9891, DOI 10.1021/la100265d; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Varki A., 2022, ESSENTIALS GLYCOBIOL, V4; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Weigel D., 2002, ARABIDOPSIS LAB MANU; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x	92	34	66	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42914	10.1371/journal.pone.0042914	http://dx.doi.org/10.1371/journal.pone.0042914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916179	Green Published, gold			2022-12-27	WOS:000307500800030
J	Wiehagen, KR; Corbo-Rodgers, E; Li, SR; Staub, ES; Hunter, CA; Morrisey, EE; Maltzman, JS				Wiehagen, Karla R.; Corbo-Rodgers, Evann; Li, Shanru; Staub, Elizabeth S.; Hunter, Christopher A.; Morrisey, Edward E.; Maltzman, Jonathan S.			Foxp4 Is Dispensable for T Cell Development, but Required for Robust Recall Responses	PLOS ONE			English	Article							ESSENTIAL TRANSCRIPTIONAL REGULATOR; TOXOPLASMA-GONDII; GENE-EXPRESSION; LUNG; INFLAMMATION; INHIBITION; DEPLETION; IMMUNITY; HELP; CD4+	Transcription factors regulate T cell fates at every stage of development and differentiation. Members of the Foxp family of forkhead transcription factors are essential for normal T lineage development; Foxp3 is required for T regulatory cell generation and function, and Foxp1 is necessary for generation and maintenance of naive T cells. Foxp4, an additional member of the Foxp family, is highly homologous to Foxp1 and has been shown to dimerize with other Foxp proteins. We report the initial characterization of Foxp4 in T lymphocytes. Foxp4 is expressed in both thymocytes and peripheral CD4(+) and CD8(+) T cells. We used a CD4Cre mediated approach to evaluate the cell autonomous role for Foxp4 in murine T lymphocytes. T cell development, peripheral cellularity and cell surface phenotype are normal in the absence of Foxp4. Furthermore, Foxp3(+) T regulatory cells develop normally in Foxp4 deficient animals and naive Foxp4 deficient CD4 T cells can differentiate to inducible T regulatory cells in vitro. In wild-type T cells, expression of Foxp4 increases following activation, but deletion of Foxp4 does not affect T cell proliferative responses or in vitro effector T cell differentiation. In vivo, despite effective control of Toxoplasma gondii and acute lymphocytic choriomeningitis virus infections, effector cytokine production during antigen specific recall responses are reduced in the absence of Foxp4. We conclude that Foxp4 is dispensable for T cell development, but necessary for normal T cell cytokine recall responses to antigen following pathogenic infection.	[Wiehagen, Karla R.; Corbo-Rodgers, Evann; Li, Shanru; Staub, Elizabeth S.; Morrisey, Edward E.; Maltzman, Jonathan S.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Wiehagen, KR (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	maltz@mail.med.upenn.edu		Maltzman, Jonathan/0000-0001-5722-269X	Barra Foundation; University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071589] Funding Source: NIH RePORTER	Barra Foundation; University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the Barra Foundation and by institutional funds from the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO FG, 1992, J IMMUNOL, V149, P3003; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Cai GF, 2000, INFECT IMMUN, V68, P6932, DOI 10.1128/IAI.68.12.6932-6938.2000; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Casciotti L, 2002, INFECT IMMUN, V70, P434, DOI 10.1128/IAI.70.2.434-443.2002; Chokas AL, 2010, J BIOL CHEM, V285, P13304, DOI 10.1074/jbc.M109.088468; Denkers EY, 1999, MICROBES INFECT, V1, P699, DOI 10.1016/S1286-4579(99)80071-9; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2006, IMMUNOL REV, V212, P99, DOI 10.1111/j.0105-2896.2006.00405.x; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Li SR, 2004, SCIENCE, V305, P1619, DOI 10.1126/science.1098674; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Prilliman KR, 2002, J IMMUNOL, V169, P4094, DOI 10.4049/jimmunol.169.8.4094; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; SANDER B, 1993, J IMMUNOL METHODS, V166, P201, DOI 10.1016/0022-1759(93)90361-A; SHARMA SD, 1983, J IMMUNOL, V131, P977; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Teufel A, 2003, BBA-GENE STRUCT EXPR, V1627, P147, DOI 10.1016/S0167-4781(03)00074-5; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3	35	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42273	10.1371/journal.pone.0042273	http://dx.doi.org/10.1371/journal.pone.0042273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912696	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100010
J	Zhang, P; Liu, W; Zhu, CS; Yuan, XY; Li, DG; Gu, WJ; Ma, HM; Xie, X; Gao, TW				Zhang, Ping; Liu, Wei; Zhu, Cansheng; Yuan, Xiaoying; Li, Dongguang; Gu, Weijie; Ma, Huimin; Xie, Xin; Gao, Tianwen			Silencing of GPNMB by siRNA Inhibits the Formation of Melanosomes in Melanocytes in a MITF-Independent Fashion	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MITF; MELANOMA PROTEIN-B; BETA-CATENIN; EXPRESSION; TYROSINASE; GLYCOPROTEIN; GENE; DIFFERENTIATION; IDENTIFICATION; OSTEOACTIVIN	Background: Melanosomes are specialized membrane-surrounded organelles, which are involved in the synthesis, storage and transport of melanin. Glycoprotein (transmembrane) non-metastatic melanoma protein b (GPNMB), a melanosome-specific structural protein, shares significant amino acid sequence homology with Pmel-17. Proteomic analysis demonstrated that GPNMB is present in all stages (I-IV) of melanosomes. However, little is known about the role of GPNMB in melanosomes. Methodology/Principal Findings: Using real-time quantitative PCR, Western blotting and immunofluorescence analysis, we demonstrated that the expression of GPNMB in PIG1 melanocytes was up-regulated by ultraviolet B (UVB) radiation. Transmission electron microscopy analysis showed that the total number of melanosomes in PIG1 melanocytes was sharply reduced by GPNMB-siRNA transfection. Simultaneously, the expression levels of tyrosinase (Tyr), tyrosinase related protein 1 (Trp1), Pmel17/gp100 and ocular albinism type 1 protein (OA1) were all significantly attenuated. But the expression of microphthalmia-associated transcription factor (MITF) was up-regulated. Intriguingly, in GPNMB silenced PIG1 melanocytes, UVB radiation sharply reduced MITF expression. Conclusion: Our present work revealed that the GPNMB was critical for the formation of melanosomes. And GPNMB expression down-regulation attenuated melanosome formation in a MITF-independent fashion.	[Zhang, Ping; Liu, Wei; Yuan, Xiaoying; Li, Dongguang; Gu, Weijie; Ma, Huimin] Gen Hosp AF, Dept Dermatol, Beijing, Peoples R China; [Zhang, Ping; Liu, Wei; Gao, Tianwen] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Zhu, Cansheng] Shaanxi Prov Inst Endem Dis Control, Xian, Peoples R China; [Xie, Xin] Northwest Univ, Fac Life Sci, Reg Lab Tissue Engn, Xian, Peoples R China	Air Force Military Medical University; Northwest University Xi'an	Zhang, P (corresponding author), Gen Hosp AF, Dept Dermatol, Beijing, Peoples R China.	liuweilove5@gmail.com						Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; An SM, 2009, BMB REP, V42, P178, DOI 10.5483/BMBRep.2009.42.3.178; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anghel SI, 2012, PIGMENT CELL MELANOM; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Grabacka M, 2008, PIGM CELL MELANOMA R, V21, P388, DOI 10.1111/j.1755-148X.2008.00460.x; Haraszti T, 2011, PIGM CELL MELANOMA R, V24, P187, DOI 10.1111/j.1755-148X.2010.00788.x; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Jacquemin P, 2001, BIOCHEM BIOPH RES CO, V285, P1200, DOI 10.1006/bbrc.2001.5294; Kim HJ, 2008, J COSMET SCI, V59, P117; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Magina S, 2011, ARCH DERMATOL RES, V303, P201, DOI 10.1007/s00403-011-1126-z; Mizutani Y, 2010, ARCH DERMATOL RES, V302, P283, DOI 10.1007/s00403-009-1007-x; Nishioka E, 1999, MELANOMA RES, V9, P433, DOI 10.1097/00008390-199910000-00002; Okazawa M, 1998, J BIOL CHEM, V273, P12584, DOI 10.1074/jbc.273.20.12584; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Sato S, 1997, ONCOGENE, V14, P3083, DOI 10.1038/sj.onc.1201298; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111	41	33	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42955	10.1371/journal.pone.0042955	http://dx.doi.org/10.1371/journal.pone.0042955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912767	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500100046
J	Jansson, J; Wilson, DP				Jansson, James; Wilson, David P.			Projected Demographic Profile of People Living with HIV in Australia: Planning for an Older Generation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; MORTALITY; EPIDEMIC; DISEASE; RISK; HIV/AIDS; AIDS	Background: Advances in HIV antiretroviral therapy (ART) has reduced mortality in people living with HIV (PLHIV), resulting in an ageing population of PLHIV. Knowledge of demographic details such as age, geographical location and sex, will aid in the planning of training and resource allocation to effectively care for the future complex health needs of PLHIV. Methods: An agent-based, stochastic, geographical model was developed to determine the current and future demographic of PLHIV in Australia. Data and parameters were sourced from Australia's National HIV Registry and peer reviewed literature. Processes that were simulated include progression to AIDS, mortality and internal migration. Findings: The model estimates the mean age of PLHIV in Australia is increasing at a rate of 0.49 years each year. The expected proportion of PLHIV in over 55 years is estimated to increase from 25.3% in 2010 to 44.2% in 2020. Median age is lower in inner-city areas of the capital cities than in rural areas. The areas with the highest prevalence of HIV will continue to be capital cities; however, other areas will have greater percentage growth from 2010 to 2020. Conclusions: The age of the population of people living with HIV is expected to increase considerably in the future. As the population of PLHIV ages, specialist clinical training and resource provision in the aged care sector will also need to be addressed.	[Jansson, James; Wilson, David P.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Jansson, J (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	dwilson@kirby.unsw.edu.au	Wilson, David P/G-4614-2013		National Association of People Living with HIV/AIDS; Australian Research Council [FT0991990, DP1093026]; Australian Government Department of Health and Ageing; University of New South Wales	National Association of People Living with HIV/AIDS; Australian Research Council(Australian Research Council); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); University of New South Wales	This study was funded from the following sources: National Association of People Living with HIV/AIDS; Australian Research Council (FT0991990, DP1093026); the Australian Government Department of Health and Ageing; and the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics (ABS), 2006, STAT GEOGR; Australian Institute of Health Welfare (AIHW), 2010, GRIM GEN REC INC MOR; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Biggar RJ, 2004, JAIDS-J ACQ IMM DEF, V36, P861, DOI 10.1097/00126334-200407010-00014; Cole JW, 2004, STROKE, V35, P51, DOI 10.1161/01.STR.0000105393.57853.11; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Grierson J, 2009, MONOGRAPH SERIES LAT, V74; Hallett TB, 2011, SEXUALLY TRANSMITTED; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hull P, 2011, GAY COMMUNITY PERIOD; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Mallitt K-A, 2011, HIV INCIDENCE TRENDS; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mills EJ, 2011, LANCET, V377, P1131, DOI 10.1016/S0140-6736(10)62180-0; Murray JM, 2009, SEX HEALTH, V6, P83, DOI 10.1071/SH08063; Nakhaee F, 2009, SEX HEALTH, V6, P129, DOI 10.1071/SH08007; National Centre in HIV Epidemiology and Clinical Research, 2010, HIV VIR HEP SEX TRAN; Negin J, 2011, LANCET, V378, P768, DOI 10.1016/S0140-6736(11)61373-1; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; STEWART RB, 1994, DRUG AGING, V4, P449, DOI 10.2165/00002512-199404060-00002; Teweldemedhin E, 2004, AGENT BASED MODELLIN, P154; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4	24	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e38334	10.1371/journal.pone.0038334	http://dx.doi.org/10.1371/journal.pone.0038334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912660	Green Published, Green Submitted, gold			2022-12-27	WOS:000307378500001
J	Koike, MA; Lin, AJ; Pham, J; Nguyen, E; Yeh, JJ; Rahimian, R; Tromberg, BJ; Choi, B; Green, KN; LaFerla, FM				Koike, Maya A.; Lin, Alexander J.; Pham, Jonathan; Elaine Nguyen; Yeh, James J.; Rahimian, Rombod; Tromberg, Bruce J.; Choi, Bernard; Green, Kim N.; LaFerla, Frank M.			APP Knockout Mice Experience Acute Mortality as the Result of Ischemia	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GLOBAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; FAMILY-MEMBERS; BETA PEPTIDES; MODELS; BRAIN; TERRITORY; LACKING; ROLES	The incidence of Alzheimer's disease increases in people who have had an ischemic episode. Furthermore, APP expression is increased following ischemic or hypoxic conditions, as is the production of the A beta peptide. To address the question of why APP and A beta are increased in hypoxic and ischemic conditions we induced an ischemic episode in APP knockout mice (APP-/-) and BACE1 knockout mice (BACE-/-). We find that both APP-/- and BACE-/- mice have a dramatically increased risk of mortality as a result of cerebral ischemia. Furthermore, APP knockout mice have reduced cerebral blood flow in response to hypoxia, while wild-type mice maintain or increase cerebral blood flow to the same conditions. The transcription factor, serum response factor (SRF), and calcium-binding molecule, calsequestrin, both involved in vascular regulation, are significantly altered in the brains of APP-/- mice compared to wild type controls. These results show that APP regulates cerebral blood flow in response to hypoxia, and that it, and its cleavage fragments, are crucial for rapid adaptation to ischemic conditions.	[Koike, Maya A.; Lin, Alexander J.; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA; [Lin, Alexander J.; Pham, Jonathan; Elaine Nguyen; Yeh, James J.; Rahimian, Rombod; Tromberg, Bruce J.; Choi, Bernard] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Laser Microbeam & Med Program, Irvine, CA 92715 USA; [Lin, Alexander J.; Pham, Jonathan; Tromberg, Bruce J.; Choi, Bernard] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Choi, Bernard] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Tech, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Koike, MA (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.	kngreen@uci.edu; laferla@uci.edu		Choi, Bernard/0000-0002-4380-8291	National Institutes of Health (NIH) [1F31NS063650-01A1, 1F30AG039949-01A1, K99AR054695]; LAMMP [P41-RR01192]; NIH/NIA [AG-021982]; Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039949, R01AG021982] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LAMMP; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the National Institutes of Health (NIH) 1F31NS063650-01A1 to MAK, 1F30AG039949-01A1 to AJL, K99AR054695 to MAK, LAMMP P41-RR01192 to BJT, NIH/NIA AG-021982 to FML and the Arnold and Mabel Beckman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Chang J, 2003, CIRCULATION, V108, P407, DOI 10.1161/01.CIR.0000084502.02147.83; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Cuccia DJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088140; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Green KN, 2001, J NEUROCHEM, V77, P953, DOI 10.1046/j.1471-4159.2001.00338.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hitt BD, 2010, BACE1 MICE EXHIBIT S, P1; Hossmann KA, 1998, CARDIOVASC RES, V39, P106, DOI 10.1016/S0008-6363(98)00075-3; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; KAWAI K, 1992, J CEREBR BLOOD F MET, V12, P238, DOI 10.1038/jcbfm.1992.34; Koike MA, 2011, NEUROSCI LETT, V495, P55, DOI 10.1016/j.neulet.2011.03.034; KOIKE MA, 2010, AM J PATHOL; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mazhar A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523373; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; OLSEN TS, 1985, STROKE, V16, P459, DOI 10.1161/01.STR.16.3.459; Panahian N, 2001, CURR PROTOC TOXICOL; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Ramirez-San-Juan JC, 2008, OPT EXPRESS, V16, P3197, DOI 10.1364/OE.16.003197; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Takagi K, 2003, J NEUROSURG, V98, P50, DOI 10.3171/jns.2003.98.1.0050; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	35	31	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42665	10.1371/journal.pone.0042665	http://dx.doi.org/10.1371/journal.pone.0042665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912719	Green Published, gold			2022-12-27	WOS:000307378500023
J	Liu, RJ; Wang, DY; Shi, Q; Fu, Q; Hizon, S; Xiang, YK				Liu, Ruijie; Wang, Dayong; Shi, Qian; Fu, Qin; Hizon, Steven; Xiang, Yang K.			Palmitoylation Regulates Intracellular Trafficking of beta(2) Adrenergic Receptor/Arrestin/Phosphodiesterase 4D Complexes in Cardiomyocytes	PLOS ONE			English	Article							HUMAN BETA-2-ADRENERGIC RECEPTOR; PROTEIN-COUPLED RECEPTORS; PDZ-BINDING MOTIF; BETA(2)-ADRENERGIC RECEPTOR; CARDIAC MYOCYTES; KINASE-A; PHOSPHORYLATION; DESENSITIZATION; INTERNALIZATION; DEGRADATION	beta(2) adrenergic receptor (beta(2)AR) is a prototypical G-protein coupled receptor that stimulates the classic cAMP-protein kinase A (PKA) signaling pathway. Recent studies indicate that the cAMP-PKA activities are spatiotemporally regulated in part due to dynamic association of beta(2)AR with phosphodiesterase 4D (PDE4D), a group of cAMP degradation enzymes. Here, we demonstrate that in cardiomyocytes, palmitoylation of beta(2)AR, the covalent acylation of cysteine residue 341, plays a critical role in shaping subcellular cAMP-PKA activities in cardiomyocytes via regulating beta(2)AR association with arrestin/PDE4D. Replacing cysteine 341 on beta(2)AR with alanine (C341A) leads to an impaired binding to beta arrestin 2. Surprisingly, the C341A mutant is able to internalize via an arrestin-independent pathway at saturated concentration of agonist stimulation; the internalization becomes caveolae-dependent and requires dynamin GTPase. However, the impaired binding to beta arrestin 2 also leads to an impaired recruitment of PDE4D to the C341A mutant. Thus, the mutant C341A beta(2)AR is transported alone from the plasma membrane to the endosome without recruiting PDE4D. This alteration leads to an enhanced cytoplasmic cAMP signal for PKA activation under beta(2)AR stimulation. Functionally, Mutation of the C341 residue or inhibition of palmitoylation modification of beta(2)AR enhances the receptor-induced PKA activities in the cytoplasm and increases in myocyte contraction rate. Our data reveal a novel function of palmitoylation in shaping subcellular cAMP-PKA signaling in cardiomyocytes via modulating the recruitment of b arrestin 2-PDE4D complexes to the agonist-stimulated beta(2)AR.	[Liu, Ruijie; Wang, Dayong; Shi, Qian; Fu, Qin; Hizon, Steven; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis	Liu, RJ (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.	kevinyx@illinois.edu	; Fu, Qin/O-6960-2014	liu, ruijie/0000-0002-2468-0579; Fu, Qin/0000-0002-7954-7708; Shi, Qian/0000-0003-2634-9553; Wang, Dayong/0000-0002-2086-1663	NIH grant [HL082646]; American Heart Association grant [0635331N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant HL082646 and American Heart Association grant 0635331N to YKX. The authors thank the members of the Xiang laboratory for critical reading and comments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; De Arcangelis V, 2009, J BIOL CHEM, V284, P33824, DOI 10.1074/jbc.M109.020388; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Dipilato L, 2009, MOLECULAR BIOSYSTEMS; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Hawtin SR, 2001, J BIOL CHEM, V276, P38139; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Kwiatkowska K, 2003, J CELL SCI, V116, P537, DOI 10.1242/jcs.00254; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; Loisel TP, 1996, BIOCHEMISTRY-US, V35, P15923, DOI 10.1021/bi9611321; Malbon CC, 2007, CURR OPIN DRUG DISC, V10, P573; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; MOFFETT S, 1993, EMBO J, V12, P349, DOI 10.1002/j.1460-2075.1993.tb05663.x; Moffett S, 1996, J BIOL CHEM, V271, P21490, DOI 10.1074/jbc.271.35.21490; Moffett S, 2001, J NEUROCHEM, V76, P269, DOI 10.1046/j.1471-4159.2001.00005.x; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Pleger ST, 2007, J CARD FAIL, V13, P401, DOI 10.1016/j.cardfail.2007.01.003; Plested CP, 2001, EXP PHYSIOL, V86, P303, DOI 10.1113/eph8602187; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Wang DY, 2011, J BIOL CHEM, V286, P31852, DOI 10.1074/jbc.M111.244335; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	40	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42658	10.1371/journal.pone.0042658	http://dx.doi.org/10.1371/journal.pone.0042658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912718	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500022
J	Ray, S; Renu, D; Srivastava, R; Gollapalli, K; Taur, S; Jhaveri, T; Dhali, S; Chennareddy, S; Potla, A; Dikshit, JB; Srikanth, R; Gogtay, N; Thatte, U; Patankar, S; Srivastava, S				Ray, Sandipan; Renu, Durairaj; Srivastava, Rajneesh; Gollapalli, Kishore; Taur, Santosh; Jhaveri, Tulip; Dhali, Snigdha; Chennareddy, Srinivasarao; Potla, Ankit; Dikshit, Jyoti Bajpai; Srikanth, Rapole; Gogtay, Nithya; Thatte, Urmila; Patankar, Swati; Srivastava, Sanjeeva			Proteomic Investigation of Falciparum and Vivax Malaria for Identification of Surrogate Protein Markers	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; PLASMODIUM-FALCIPARUM; PLASMA PROTEOME; BIOMARKERS; HAPTOGLOBIN; ACTIVATION; DISCOVERY; INDICATOR; COMPONENT	This study was conducted to analyze alterations in the human serum proteome as a consequence of infection by malaria parasites Plasmodium falciparum and P. vivax to obtain mechanistic insights about disease pathogenesis, host immune response, and identification of potential protein markers. Serum samples from patients diagnosed with falciparum malaria (FM) (n = 20), vivax malaria (VM) (n = 17) and healthy controls (HC) (n = 20) were investigated using multiple proteomic techniques and results were validated by employing immunoassay-based approaches. Specificity of the identified malaria related serum markers was evaluated by means of analysis of leptospirosis as a febrile control (FC). Compared to HC, 30 and 31 differentially expressed and statistically significant (p<0.05) serum proteins were identified in FM and VM respectively, and almost half (46.2%) of these proteins were commonly modulated due to both of the plasmodial infections. 13 proteins were found to be differentially expressed in FM compared to VM. Functional pathway analysis involving the identified proteins revealed the modulation of different vital physiological pathways, including acute phase response signaling, chemokine and cytokine signaling, complement cascades and blood coagulation in malaria. A panel of identified proteins consists of six candidates; serum amyloid A, hemopexin, apolipoprotein E, haptoglobin, retinol-binding protein and apolipoprotein A-I was used to build statistical sample class prediction models. By employing PLS-DA and other classification methods the clinical phenotypic classes (FM, VM, FC and HC) were predicted with over 95% prediction accuracy. Individual performance of three classifier proteins; haptoglobin, apolipoprotein A-I and retinol-binding protein in diagnosis of malaria was analyzed using receiver operating characteristic (ROC) curves. The discrimination of FM, VM, FC and HC groups on the basis of differentially expressed serum proteins demonstrates the potential of this analytical approach for the detection of malaria as well as other human diseases.	[Ray, Sandipan; Srivastava, Rajneesh; Gollapalli, Kishore; Patankar, Swati; Srivastava, Sanjeeva] Indian Inst Technol, Wadhwani Res Ctr Biosci & Bioengn, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Renu, Durairaj; Potla, Ankit; Dikshit, Jyoti Bajpai] Strand Life Sci Pvt Ltd, Bangalore, Karnataka, India; [Taur, Santosh; Jhaveri, Tulip; Gogtay, Nithya; Thatte, Urmila] Seth GS Med Coll, Dept Clin Pharmacol, Bombay, Maharashtra, India; [Taur, Santosh; Jhaveri, Tulip; Gogtay, Nithya; Thatte, Urmila] King Edward Mem Hosp, Bombay, Maharashtra, India; [Dhali, Snigdha; Srikanth, Rapole] Natl Ctr Cell Sci, Prote Lab, Pune, Maharashtra, India; [Chennareddy, Srinivasarao] Wipro GE Healthcare, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); General Electric	Ray, S (corresponding author), Indian Inst Technol, Wadhwani Res Ctr Biosci & Bioengn, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	sanjeeva@iitb.ac.in	Taur, Santosh/G-5538-2013; Jhaveri, Tulip/ABF-2963-2020; Srivastava, Rajneesh/F-6288-2012; RAY, SANDIPAN/AAQ-4064-2021	Taur, Santosh/0000-0002-6865-230X; Jhaveri, Tulip/0000-0002-8758-3696; Srivastava, Rajneesh/0000-0003-1093-2082; RAY, SANDIPAN/0000-0002-9960-5768; Gollapalli, Kishore/0000-0002-9546-2472	Board of Research in Nuclear Sciences (BRNS) DAE young scientist award [2009/20/37/4/BRNS]; Indian Institute of Technology (IIT) Bombay [09IRCC007]; IIT Bombay fellowship	Board of Research in Nuclear Sciences (BRNS) DAE young scientist award; Indian Institute of Technology (IIT) Bombay; IIT Bombay fellowship	This research was supported by Board of Research in Nuclear Sciences (BRNS) DAE young scientist award (2009/20/37/4/BRNS) and a start-up grant 09IRCC007 from the Indian Institute of Technology (IIT) Bombay to SS. SR is a senior research fellow (Ph.D student) supported by the IIT Bombay fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2009, PROTEOM CLIN APPL, V3, P1314, DOI 10.1002/prca.200900090; Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Bahk YY, 2010, KOREAN J PARASITOL, V48, P203, DOI 10.3347/kjp.2010.48.3.203; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chen JH, 2004, P NATL ACAD SCI USA, V101, P17039, DOI 10.1073/pnas.0407992101; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Fontaine A, 2012, PARASITOL RES, V110, P545, DOI 10.1007/s00436-011-2521-2; Francischetti IMB, 2008, TRENDS PARASITOL, V24, P258, DOI 10.1016/j.pt.2008.03.009; Gollapalli K, 2012, PROTEOMICS, V12, P2378, DOI 10.1002/pmic.201200002; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kappelle PJWH, 2011, ARCH MED RES, V42, P219, DOI 10.1016/j.arcmed.2011.05.002; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Omenn GS, 2004, DIS MARKERS, V20, P131, DOI 10.1155/2004/579363; Pabon A, 2003, CLIN BIOCHEM, V36, P71, DOI 10.1016/S0009-9120(02)00423-X; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; PIED S, 1995, PARASITE, V2, P263, DOI 10.1051/parasite/1995023263; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Ray S, 2012, J PROTEOMICS, V75, P3063, DOI 10.1016/j.jprot.2011.10.018; Ray S, 2011, PROTEOMICS, V11, P2139, DOI 10.1002/pmic.201000460; ROUGEMONT A, 1988, LANCET, V2, P709; Rukmangadachar Lokesh A, 2011, Clin Proteomics, V8, P4, DOI 10.1186/1559-0275-8-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Srivastava R, 2012, J PROTEOMICS, V76, P56, DOI 10.1016/j.jprot.2012.04.007; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Taylor-Robinson Andrew W., 2000, Parasitology International, V48, P297, DOI 10.1016/S1383-5769(99)00029-X; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Verhoeckx KCM, 2005, J PROTEOME RES, V4, P2015, DOI 10.1021/pr050183u; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417; WHO, 2008, WHO LIST KNOWN COMM; WHO, 2008, WHO WORLD MAL REP; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wozniak MA, 2003, J MED GENET, V40, P348, DOI 10.1136/jmg.40.5.348; YERLY S, 1990, ACTA TROP, V47, P237, DOI 10.1016/0001-706X(90)90015-R	47	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41751	10.1371/journal.pone.0041751	http://dx.doi.org/10.1371/journal.pone.0041751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912677	Green Published, Green Submitted, gold			2022-12-27	WOS:000307378500008
J	Tokusumi, Y; Tokusumi, T; Shoue, DA; Schulz, RA				Tokusumi, Yumiko; Tokusumi, Tsuyoshi; Shoue, Douglas A.; Schulz, Robert A.			Gene Regulatory Networks Controlling Hematopoietic Progenitor Niche Cell Production and Differentiation in the Drosophila Lymph Gland	PLOS ONE			English	Article							STEM-CELLS; SIGNALING CENTER; DUAL ROLE; MAINTENANCE; SIZE; MTOR; MELANOGASTER; QUIESCENCE; SUPPRESSOR; PATHWAY	Hematopoiesis occurs in two phases in Drosophila, with the first completed during embryogenesis and the second accomplished during larval development. The lymph gland serves as the venue for the final hematopoietic program, with this larval tissue well-studied as to its cellular organization and genetic regulation. While the medullary zone contains stem-like hematopoietic progenitors, the posterior signaling center (PSC) functions as a niche microenvironment essential for controlling the decision between progenitor maintenance versus cellular differentiation. In this report, we utilize a PSC-specific GAL4 driver and UAS-gene RNAi strains, to selectively knockdown individual gene functions in PSC cells. We assessed the effect of abrogating the function of 820 genes as to their requirement for niche cell production and differentiation. 100 genes were shown to be essential for normal niche development, with various loci placed into subgroups based on the functions of their encoded protein products and known genetic interactions. For members of three of these groups, we characterized loss-and gain-of-function phenotypes. Gene function knockdown of members of the BAP chromatin-remodeling complex resulted in niche cells that do not express the hedgehog (hh) gene and fail to differentiate filopodia believed important for Hh signaling from the niche to progenitors. Abrogating gene function of various members of the insulin-like growth factor and TOR signaling pathways resulted in anomalous PSC cell production, leading to a defective niche organization. Further analysis of the Pten, TSC1, and TSC2 tumor suppressor genes demonstrated their loss-of-function condition resulted in severely altered blood cell homeostasis, including the abundant production of lamellocytes, specialized hemocytes involved in innate immune responses. Together, this cell-specific RNAi knockdown survey and mutant phenotype analyses identified multiple genes and their regulatory networks required for the normal organization and function of the hematopoietic progenitor niche within the lymph gland.	[Tokusumi, Yumiko; Tokusumi, Tsuyoshi; Shoue, Douglas A.; Schulz, Robert A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Tokusumi, Y (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	rschulz@nd.edu		Tokusumi, Tsuyoshi/0000-0001-9494-1888	National Institutes of Health (NIH) [HL071540]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071540] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) HL071540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 2011, DIS MODEL MECH, V4, P439, DOI 10.1242/dmm.007351; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gao HJ, 2009, MOL CELL BIOL, V29, P6086, DOI 10.1128/MCB.00244-09; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kohlmaier A, 2008, CURR OPIN CELL BIOL, V20, P699, DOI 10.1016/j.ceb.2008.10.002; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Napolioni V, 2008, CURR GENOMICS, V9, P475, DOI 10.2174/138920208786241243; Oldham S, 2002, DEVELOPMENT, V129, P4103; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pennetier D, 2012, P NATL ACAD SCI USA, V109, P3389, DOI 10.1073/pnas.1109407109; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Terriente-Felix A, 2009, DEV BIOL, V329, P350, DOI 10.1016/j.ydbio.2009.03.010; Tokusumi T, 2011, DEVELOPMENT, V138, P3879, DOI 10.1242/dev.069336; Tokusumi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006429; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Tokusumi Y, 2010, DEVELOPMENT, V137, P3561, DOI 10.1242/dev.053728; Vilmos P, 2004, DEV COMP IMMUNOL, V28, P555, DOI 10.1016/j.dci.2003.10.001; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	42	46	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41604	10.1371/journal.pone.0041604	http://dx.doi.org/10.1371/journal.pone.0041604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911822	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300057
J	Garcia-Martin, E; Martinez, C; Alonso-Navarro, H; Benito-Leon, J; Lorenzo-Betancor, O; Pastor, P; Lopez-Alburquerque, T; Samaranch, L; Lorenzo, E; Agundez, JAG; Jimenez-Jimenez, FJ				Garcia-Martin, Elena; Martinez, Carmen; Alonso-Navarro, Hortensia; Benito-Leon, Julian; Lorenzo-Betancor, Oswaldo; Pastor, Pau; Lopez-Alburquerque, Tomas; Samaranch, Lluis; Lorenzo, Elena; Agundez, Jose A. G.; Javier Jimenez-Jimenez, Felix			H1-MAPT and the Risk for Familial Essential Tremor	PLOS ONE			English	Article							HISTAMINE-N-METHYLTRANSFERASE; PARKINSONS-DISEASE; GENE; TAU; POLYMORPHISMS; ASSOCIATION; RECEPTOR; MAPT; METAANALYSIS; THR105ILE	The most frequent MAPT H1 haplotype is associated with the risk for developing progressive supranuclear palsy and other neurodegenerative diseases such as Parkinson's disease. A recent report suggests that the MAPT H1 is associated with the risk for developing essential tremor. We wanted to confirm this association in a different population. We analyzed the distribution of allelic and genotype frequencies of rs1052553, which is an H1/H2 SNP, in 200 subjects with familial ET and 291 healthy controls. rs1052553 genotype and allelic frequencies did not differ significantly between subjects with ET and controls and were unrelated with the age at onset of tremor or gender, and with the presence of head, voice, chin, and tongue tremor. Our study suggests that the MAPT H1 rs1052553 is not associated with the risk for developing familial ET in the Spanish population.	[Garcia-Martin, Elena] Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain; [Martinez, Carmen] Univ Extremadura, Dept Pharmacol, Badajoz, Spain; [Alonso-Navarro, Hortensia; Javier Jimenez-Jimenez, Felix] Univ Alcala de Henares, Hosp Principe de Asturias, Dept Med Neurol, Madrid, Spain; [Alonso-Navarro, Hortensia] Hosp Univ Sureste, Neurol Sect, Madrid, Spain; [Benito-Leon, Julian] Univ Complutense, Dept Med, Hosp Doce de Octubre, Serv Neurol, E-28040 Madrid, Spain; [Benito-Leon, Julian; Pastor, Pau] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Lorenzo-Betancor, Oswaldo; Pastor, Pau; Samaranch, Lluis; Lorenzo, Elena; Javier Jimenez-Jimenez, Felix] Univ Navarra, Ctr Appl Med Res, Neurogenet Lab, Div Neurosci, E-31080 Pamplona, Spain; [Lorenzo-Betancor, Oswaldo; Pastor, Pau] Univ Navarra, Sch Med, Dept Neurol, Univ Navarra Clin, E-31080 Pamplona, Spain; [Lopez-Alburquerque, Tomas] Hosp Univ Salamanca, Dept Neurol, Salamanca, Spain; [Agundez, Jose A. G.] Univ Extremadura, Dept Pharmacol, Caceres, Spain	Universidad de Extremadura; Universidad de Extremadura; Prince of Asturias University Hospital; Universidad de Alcala; Complutense University of Madrid; Hospital Universitario 12 de Octubre; CIBERNED; Instituto de Salud Carlos III; University of Navarra; University of Navarra; University of Salamanca; Universidad de Extremadura	Garcia-Martin, E (corresponding author), Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain.	fjavier.jimenez@salud.madrid.org	Agúndez, José A. G./A-5503-2008; Samaranch, Lluis/AAU-8464-2021; Pastor, Pau/C-9834-2009; Lorenzo-Betancor, Oswaldo/J-2753-2019; Benito-León, Julián/AAA-1331-2019; García-Martin, Elena/H-9828-2016	Agúndez, José A. G./0000-0001-6895-9160; Pastor, Pau/0000-0002-7493-8777; Lorenzo-Betancor, Oswaldo/0000-0002-5607-8363; Benito-León, Julián/0000-0002-1769-4809; García-Martin, Elena/0000-0002-8094-046X; Samaranch, Lluis/0000-0001-8151-473X	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain [PS09/00943, PS09/00469, RETICS RD07/0064/0016]; Junta de Extremadura, Merida, Spain [GR10068]; Spanish Ministry of Education and Science [SAF2006-10126]; "Union Tecnica de Empresas" project from the Centro de Investigaciones Medicas Aplicadas, Spain; FEDER	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Merida, Spain; Spanish Ministry of Education and Science(Spanish Government); "Union Tecnica de Empresas" project from the Centro de Investigaciones Medicas Aplicadas, Spain; FEDER(European Commission)	This work was supported in part by Grants PS09/00943, PS09/00469 and RETICS RD07/0064/0016 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain and GR10068 from Junta de Extremadura, Merida, Spain, Grant to PP from the Spanish Ministry of Education and Science (SAF2006-10126: 2006-2009) and "Union Tecnica de Empresas" project from the Centro de Investigaciones Medicas Aplicadas, Spain. Partially financed with FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 1997, AGE AGEING, V26, P147, DOI 10.1093/ageing/26.2.147; Alonso-Navarro H, 2008, TRATADO TRASTORNOS M, P833; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P389, DOI 10.1002/mds.10376; Deng H, 2006, NEUROSCI LETT, V401, P16, DOI 10.1016/j.neulet.2006.02.066; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Ezquerra M, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.09.011; Fekete R, 2011, MOVEMENT DISORD, V26, P391, DOI 10.1002/mds.23512; Garcia-Martin E, 2010, EUR J NEUROL, V17, P879, DOI 10.1111/j.1468-1331.2009.02914.x; Garcia-Martin E, 2011, PHARMACOGENET GENOM, V21, P436, DOI 10.1097/FPC.0b013e328345bec0; Garcia-Martin E, 2011, J NEUROL, V258, P203, DOI 10.1007/s00415-010-5708-z; Garcia-Martin E, 2009, MOVEMENT DISORD, V24, P1910, DOI 10.1002/mds.22518; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jimenez-Jimenez FJ, 2012, J NEUROL SCI, V317, P52, DOI 10.1016/j.jns.2012.02.030; Jimenez-Jimenez Felix Javier, 2012, Tremor Other Hyperkinet Mov (N Y), V2, DOI 10.7916/D8FN14Z6; Keeling BH, 2010, PARKINSONISM RELAT D, V16, P112, DOI 10.1016/j.parkreldis.2009.08.011; LaRoia H, 2011, NEUROEPIDEMIOLOGY, V37, P1, DOI 10.1159/000328866; Ledesma MC, 2008, NEUROMOL MED, V10, P356, DOI 10.1007/s12017-008-8040-3; Lorenz D, 2009, EUR J HUM GENET, V17, P766, DOI 10.1038/ejhg.2008.243; Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Pastor P, 2000, ANN NEUROL, V47, P242; Pastor P, 2001, ANN NEUROL, V49, P263, DOI 10.1002/1531-8249(20010201)49:2<263::AID-ANA50>3.0.CO;2-K; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Thier S, 2011, EUR J NEUROL, V18, P1098, DOI 10.1111/j.1468-1331.2010.03308.x; Vilarino-Guell C, 2011, NEUROLOGY, V76, P670, DOI 10.1212/WNL.0b013e31820c30c1; Wider C, 2011, EUR J NEUROL, V18, P876, DOI 10.1111/j.1468-1331.2010.03297.x	28	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41581	10.1371/journal.pone.0041581	http://dx.doi.org/10.1371/journal.pone.0041581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911817	gold, Green Submitted, Green Published			2022-12-27	WOS:000306687700117
J	McAlister, JS; Moran, AL				McAlister, Justin S.; Moran, Amy L.			Relationships among Egg Size, Composition, and Energy: A Comparative Study of Geminate Sea Urchins	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; REPRODUCTIVE STRATEGIES; PHENOTYPIC PLASTICITY; FERTILIZATION SUCCESS; LARVAL DEVELOPMENT; ECHINOID LARVAE; JELLY COATS; MARINE; CONSEQUENCES; ECHINODERMATA	Egg size is one of the fundamental parameters in the life histories of marine organisms. However, few studies have examined the relationships among egg size, composition, and energetic content in a phylogenetically controlled context. We investigated the associations among egg size, composition, and energy using a comparative system, geminate species formed by the closure of the Central American Seaway. We examined western Atlantic (WA) and eastern Pacific (EP) species in three echinoid genera, Echinometra, Eucidaris, and Diadema. In the genus with the largest difference in egg size between geminates (Echinometra), the eggs of WA species were larger, lipid rich and protein poor compared to the smaller eggs of their EP geminate. In addition, the larger WA eggs had significantly greater total egg energy and summed biochemical constituents yet significantly lower egg energy density (energy-per-unit-volume). However, the genera with smaller (Eucidaris) or no (Diadema) differences in egg size were not significantly different in summed biochemical constituents, total egg energy, or energy density. Theoretical models generally assume a strong tradeoff between egg size and fecundity that limits energetic investment and constrains life history evolution. We show that even among closely-related taxa, large eggs cannot be assumed to be scaled-up small eggs either in terms of energy or composition. Although our data comes exclusively from echinoid echinoderms, this pattern may be generalizable to other marine invertebrate taxa. Because egg composition and egg size do not necessarily evolve in lockstep, selective factors such as sperm limitation could act on egg volume without necessarily affecting maternal or larval energetics.	[McAlister, Justin S.; Moran, Amy L.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University	McAlister, JS (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	jmcalis@clemson.edu	Moran, Amy/F-7072-2011	Moran, Amy/0000-0002-0604-5096	National Science Foundation [OCE-0850764]; Division Of Ocean Sciences [0850764] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by National Science Foundation grant OCE-0850764 to ALM (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton TF, 2000, BIOL BULL-US, V199, P1, DOI 10.2307/1542700; BONNELL BS, 1994, DEV BIOL, V162, P313, DOI 10.1006/dbio.1994.1088; Byrne M, 2008, FUNCT ECOL, V22, P643, DOI 10.1111/j.1365-2435.2008.01427.x; Byrne M, 1999, DEV GENES EVOL, V209, P275, DOI 10.1007/s004270050253; Byrne M, 1999, INVERTEBR REPROD DEV, V36, P195, DOI 10.1080/07924259.1999.9652700; Byrne M, 2006, INTEGR COMP BIOL, V46, P243, DOI 10.1093/icb/icj033; Cerra A, 1999, J MORPHOL, V242, P91, DOI 10.1002/(SICI)1097-4687(199911)242:2<91::AID-JMOR2>3.0.CO;2-#; CHRISTIANSEN FB, 1979, THEOR POPUL BIOL, V16, P267, DOI 10.1016/0040-5809(79)90017-0; Coates Anthony G., 1996, P21; D'Croz L., 1997, P 8 INT COR REEF S, V2, P2053; DuqueCaro H., 1990, PACIFIC NEOGENE EVEN, P101; Emlet R.B., 1987, Echinoderm Studies, V2, P55; Falkner I, 2006, BIOL BULL-US, V211, P204, DOI 10.2307/4134542; Farley GS, 2001, AM NAT, V157, P626, DOI 10.1086/320619; Folin O, 1929, J BIOL CHEM, V83, P121; GEORGE SB, 1990, J EXP MAR BIOL ECOL, V141, P107, DOI 10.1016/0022-0981(90)90217-Z; GLYNN PW, 1982, ADV MAR BIOL, V19, P91, DOI 10.1016/S0065-2881(08)60087-5; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; HADFIELD MG, 1987, AM MALACOL BULL, V5, P197; HART MW, 1994, BIOL BULL, V186, P291, DOI 10.2307/1542275; Herrera JC, 1996, OCEANOL ACTA, V19, P313; HoeghGuldberg O, 1997, BIOL BULL, V192, P27, DOI 10.2307/1542573; Holland D.L., 1978, Biochemical and Biophysical Perspectives in Marine Biology, V4, P85; HOLLAND DL, 1971, J MAR BIOL ASSOC UK, V51, P659, DOI 10.1017/S0025315400015034; Jackson JH, 1999, PROGRESS IN MECHANICAL BEHAVIOUR OF MATERIALS (ICM8), VOL 1, P249; JAECKLE WB, 1989, BIOL BULL, V177, P237, DOI 10.2307/1541939; Jaeckle William B., 1995, P49; Jordan DS, 1908, AM NAT, V42, P73, DOI 10.1086/278905; Keigwin LD, 1982, SCIENCE, V217, P46; KIDD P, 1978, J ULTRA MOL STRUCT R, V64, P204, DOI 10.1016/S0022-5320(78)80038-0; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Lessios H.A., 1985, Echinoderms, V1984, P303; LESSIOS HA, 1981, J EXP MAR BIOL ECOL, V50, P47, DOI 10.1016/0022-0981(81)90062-9; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; LESSIOS HA, 1990, AM NAT, V135, P1, DOI 10.1086/285028; Lessios HA, 1999, EVOLUTION, V53, P806, DOI 10.1111/j.1558-5646.1999.tb05374.x; LESSIOS HA, 1987, J EXP MAR BIOL ECOL, V114, P217; Levin Lisa A., 1995, P1; Levitan DR, 2006, INTEGR COMP BIOL, V46, P298, DOI 10.1093/icb/icj025; Levitan DR, 2001, EVOLUTION, V55, P2479; LEVITAN DR, 1993, AM NAT, V141, P517, DOI 10.1086/285489; Levitan DR, 1996, NATURE, V382, P153, DOI 10.1038/382153a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marko PB, 2001, J PALEONTOL, V75, P590, DOI 10.1666/0022-3360(2001)075<0590:POMDAA>2.0.CO;2; MARSH JB, 1966, J LIPID RES, V7, P574; Marshall DJ, 2006, ECOLOGY, V87, P214, DOI 10.1890/05-0350; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Marshall DJ, 2009, ECOLOGY, V90, P487, DOI 10.1890/08-0320.1; McAlister JS, 2008, EVOLUTION, V62, P1358, DOI 10.1111/j.1558-5646.2008.00368.x; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; MCCLINTOCK JB, 1986, COMP BIOCHEM PHYS A, V85, P341, DOI 10.1016/0300-9629(86)90259-8; MCEDWARD LR, 1987, EVOLUTION, V41, P914, DOI 10.1111/j.1558-5646.1987.tb05865.x; MCEDWARD LR, 1986, J EXP MAR BIOL ECOL, V96, P251, DOI 10.1016/0022-0981(86)90206-6; MCEDWARD LR, 1987, MAR ECOL PROG SER, V37, P159, DOI 10.3354/meps037159; McEdward LR, 2001, BIOL BULL, V200, P33, DOI 10.2307/1543083; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; Meyer E, 2007, MAR BIOL, V152, P179, DOI 10.1007/s00227-007-0672-6; Miner BG, 2005, J EXP MAR BIOL ECOL, V321, P135, DOI 10.1016/j.jembe.2005.01.008; Moran AL, 2004, EVOLUTION, V58, P2718; Moran AL, 2004, J EXP MAR BIOL ECOL, V306, P17, DOI 10.1016/j.jembe.2003.12.021; Moran AL, 2009, BIOL BULL-US, V216, P226, DOI 10.1086/BBLv216n3p226; Moreno G, 1999, J EXP MAR BIOL ECOL, V235, P1, DOI 10.1016/S0022-0981(98)00031-8; Pernet F, 2006, J EXP MAR BIOL ECOL, V329, P265, DOI 10.1016/j.jembe.2005.09.008; Podolsky RD, 2004, AM NAT, V163, P735, DOI 10.1086/382791; Podolsky RD, 1996, AM NAT, V148, P160, DOI 10.1086/285916; Podolsky RD, 2001, EVOLUTION, V55, P2470; Prowse TAA, 2008, MAR BIOL, V153, P337, DOI 10.1007/s00227-007-0809-7; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; Sewell MA, 2004, J EXP MAR BIOL ECOL, V309, P219, DOI 10.1016/j.jembe.2004.03.016; SINERVO B, 1988, EVOLUTION, V42, P885, DOI 10.1111/j.1558-5646.1988.tb02509.x; Strathmann RR, 2000, INVERTEBR BIOL, V119, P319; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V290, P133, DOI 10.1016/S0022-0981(03)00071-6; Thomas FIM, 1999, BIOL BULL, V197, P7, DOI 10.2307/1542991; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Turner R. L., 1979, REPROD ECOLOGY MARIN, P25; TURNER RL, 1976, J EXP MAR BIOL ECOL, V24, P49, DOI 10.1016/0022-0981(76)90042-3; VANCE RR, 1973, AM NAT, V107, P339, DOI 10.1086/282838; VANCE RR, 1973, AM NAT, V107, P353, DOI 10.1086/282839; Vavra J, 1999, BIOL BULL, V196, P177, DOI 10.2307/1542563; Villinski JT, 2002, EVOLUTION, V56, P1764, DOI 10.1111/j.0014-3820.2002.tb00190.x; Wourms JP., 1987, REPRODUCTION MARINE, P50; WRAY GA, 1991, TRENDS ECOL EVOL, V6, P45, DOI 10.1016/0169-5347(91)90121-D	84	29	29	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41599	10.1371/journal.pone.0041599	http://dx.doi.org/10.1371/journal.pone.0041599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911821	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700122
J	Wang, W; Zhang, X; Qin, JJ; Voruganti, S; Nag, SA; Wang, MH; Wang, H; Zhang, RW				Wang, Wei; Zhang, Xu; Qin, Jiang-Jiang; Voruganti, Sukesh; Nag, Subhasree Ashok; Wang, Ming-Hai; Wang, Hui; Zhang, Ruiwen			Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2	PLOS ONE			English	Article							PROMOTES CELL MOTILITY; PROSTATE-CANCER; IN-VITRO; P53-MDM2 INTERACTION; ANTICANCER ACTIVITY; TUMOR-SUPPRESSOR; P53 PROTEIN; ACTIVATION; EXPRESSION; ONCOGENE	Although ginseng and related herbs have a long history of utility for various health benefits, their application in cancer therapy and underlying mechanisms of action are not fully understood. Our recent work has shown that 20(S)-25-methoxyl-dammarane-3 beta, 12 beta, 20-triol (25-OCH3-PPD), a newly identified ginsenoside from Panax notoginseng, exerts activities against a variety of cancer cells in vitro and in vivo. This study was designed to investigate its anti-breast cancer activity and the underlying mechanisms of action. We observed that 25-OCH3-PPD decreased the survival of breast cancer cells by induction of apoptosis and G1 phase arrest and inhibited the growth of breast cancer xenografts in vivo. We further demonstrated that, in a dose-and time-dependent manner, 25-OCH3-PPD inhibited MDM2 expression at both transcriptional and post-translational levels in human breast cancer cells with various p53 statuses (wild type and mutant). Moreover, 25-OCH3-PPD inhibited in vitro cell migration, reduced the expression of epithelial-to-mesenchymal transition (EMT) markers, and prevented in vivo metastasis of breast cancer. In summary, 25-OCH3-PPD is a potential therapeutic and anti-metastatic agent for human breast cancer through down-regulating MDM2. Further preclinical and clinical development of this agent is warranted.	[Wang, Wei; Zhang, Xu; Qin, Jiang-Jiang; Voruganti, Sukesh; Nag, Subhasree Ashok; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Wang, Wei; Wang, Ming-Hai; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA; [Wang, Ming-Hai] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, W (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA.	ruiwen.zhang@ttuhsc.edu	Qin, Jiangjiang/AAM-9553-2020; voruganti, sukesh/B-1524-2016; Nag, subhasree/T-1505-2019	Qin, Jiangjiang/0000-0002-8559-616X; voruganti, sukesh/0000-0003-2240-8114; Nag, subhasree/0000-0001-6933-4349	Susan G. Komen for the Cure [BCTR070731]; NIH [R01 CA112029, R01 CA121211, R01 CA91980]; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2009ZX09102-114, 2009ZX09301-011]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029, R01CA091980] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is mainly supported by a grant (BCTR070731) from Susan G. Komen for the Cure (to H.W. and R.Z.). R.Z. was also supported by NIH grants R01 CA112029 and R01 CA121211. M.W. was supported by NIH grant R01 CA91980. H.W. was supported by the One Hundred Talents Program, Chinese Academy of Sciences, grants from National Nature Science Foundation (30870513, 31070680, 91029715 and 81025017) and Ministry of Science and Technology of China (2007CB947100), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2009ZX09102-114, 2009ZX09301-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helms Steve, 2004, Altern Med Rev, V9, P259; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li M, 2007, CANCER RES, V67, P1988, DOI 10.1158/0008-5472.CAN-06-3066; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Onel K, 2004, MOL CANCER RES, V2, P1; Pan Y, 1999, CANCER RES, V59, P2064; Peng YH, 2001, J BIOL CHEM, V276, P6874, DOI 10.1074/jbc.C000781200; Phelps M, 2003, CANCER RES, V63, P2616; Polanski R, 2010, FEBS LETT, V584, P4695, DOI 10.1016/j.febslet.2010.10.049; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang W, 2008, BRIT J CANCER, V98, P792, DOI 10.1038/sj.bjc.6604227; Wang W, 2008, PROSTATE, V68, P809, DOI 10.1002/pros.20742; Wang W, 2007, CANCER CHEMOTH PHARM, V59, P589, DOI 10.1007/s00280-006-0300-z; Wang W, 2010, BREAST CANCER RES TR, V123, P321, DOI 10.1007/s10549-009-0638-0; Wang W, 2009, LUNG CANCER, V65, P306, DOI 10.1016/j.lungcan.2008.11.016; Wang W, 2009, CLIN CANCER RES, V15, P3511, DOI 10.1158/1078-0432.CCR-08-2689; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xu HX, 2010, J BIOL CHEM, V285, P18407, DOI 10.1074/jbc.M109.059568; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Zhang RW, 2000, CURR PHARM DESIGN, V6, P393, DOI 10.2174/1381612003400911; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100; Zhao Y, 2007, MED CHEM, V3, P51, DOI 10.2174/157340607779317508	45	62	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41586	10.1371/journal.pone.0041586	http://dx.doi.org/10.1371/journal.pone.0041586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911819	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700120
J	Kumar, P; Lehmann, J; Libchaber, A				Kumar, Pradeep; Lehmann, Jean; Libchaber, Albert			Kinetics of Bulge Bases in Small RNAs and the Effect of Pressure on It	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; HYDROTHERMAL VENTS; WATER; SIMULATION; ORIGIN; LIFE; SOLVATION; LENGTH; ORDER; MODEL	Due to their self-catalytic properties, small RNAs with bulge bases are hypothesized to be primordial molecules which could form elementary translation systems. Using molecular dynamics simulations, we study the binding propensity of small RNAs by calculating the free energy barrier corresponding to the looped out conformations of bulge bases, which presumably act as the binding sites for ligands in these small RNAs. We find that base flipping kinetics can proceed at atmospheric pressure but with a very small propensity. Furthermore, the free energy barrier associated with base flipping depends on the stacking with neighboring bases. Next, we studied the base flipping kinetics with pressure. We find that the free energy associated with base looping out increases monotonically as the pressure is increased. Furthermore, we calculate the mean first-passage time of conformational looping out of the bulge base using the diffusion of reaction coordinate associated with the base flipping on the underlying free energy surface. We find that the mean first-passage time associated with bulge looping out increases slowly upon increasing pressures P up to 2000 atm but changes dramatically for P > 2000 atm. Finally, we discuss our results in the light of the role of hydration shell of water around RNA. Our results are relevant for the RNA world hypothesis.	[Kumar, Pradeep; Lehmann, Jean; Libchaber, Albert] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University	Kumar, P (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	pradeep.kumar@rockefeller.edu	Kumar, Pradeep/N-8106-2013	Kumar, Pradeep/0000-0002-7417-9467; Lehmann, Jean/0000-0002-9887-8123	National Academies Keck Future Initiatives award; National Science Foundation [PHY-0848815]	National Academies Keck Future Initiatives award; National Science Foundation(National Science Foundation (NSF))	This work is supported by National Academies Keck Future Initiatives award (http://www.keckfutures.org/) to PK. Authors also acknowledge the support from National Science Foundation grant PHY-0848815. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbaugh HS, 2002, J CHEM PHYS, V116, P2907, DOI 10.1063/1.1436479; Auffinger P, 2007, CURR OPIN STRUC BIOL, V17, P325, DOI 10.1016/j.sbi.2007.05.008; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Barthel A, 2006, BIOPHYS J, V90, P2450, DOI 10.1529/biophysj.105.076158; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Buldyrev SV, 2007, P NATL ACAD SCI USA, V104, P20177, DOI 10.1073/pnas.0708427104; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; Chau PL, 1998, MOL PHYS, V93, P511, DOI 10.1080/002689798169195; Debenedetti PG, 2003, PHYS TODAY, V56, P40, DOI 10.1063/1.1595053; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Errington JR, 2001, NATURE, V409, P318, DOI 10.1038/35053024; Feig M, 2001, BIOPHYS J, V81, P352, DOI 10.1016/S0006-3495(01)75705-0; Franks F, 1972, WATER COMPREHENSIVE, V1-7; Gardiner C., 2009, STOCHASTIC METHODS; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Hermann T, 2000, STRUCTURE, V8, pR47, DOI 10.1016/S0969-2126(00)00110-6; Hummer G, 1996, P NATL ACAD SCI USA, V93, P8951, DOI 10.1073/pnas.93.17.8951; Illangasekare M, 1999, RNA, V5, P1482, DOI 10.1017/S1355838299991264; Kumar P, 2009, P NATL ACAD SCI USA, V106, P22130, DOI 10.1073/pnas.0911094106; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lehmann J, 2007, RNA, V13, P1191, DOI 10.1261/rna.500907; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Lustig B, 1998, NUCLEIC ACIDS RES, V26, P5212, DOI 10.1093/nar/26.22.5212; Maeda YT, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.038301; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; PATEL DJ, 1982, BIOCHEMISTRY-US, V21, P445, DOI 10.1021/bi00532a004; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pradeep Kumar, 2010, DYNAMICS 2D MONOLAYE; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; van Kampen N. G., 1981, STOCHASTIC PROCESSES; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098; Widom B, 2003, PHYS CHEM CHEM PHYS, V5, P3085, DOI 10.1039/b304038k; Woodson SA, 1989, BICHEMISTRY, V28, P4512; WYATT JR, 1989, BIOESSAYS, V11, P100, DOI 10.1002/bies.950110406	36	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42052	10.1371/journal.pone.0042052	http://dx.doi.org/10.1371/journal.pone.0042052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916118	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800016
J	Suenaga, A; Okimoto, N; Hirano, Y; Fukui, K				Suenaga, Atsushi; Okimoto, Noriaki; Hirano, Yoshinori; Fukui, Kazuhiko			An Efficient Computational Method for Calculating Ligand Binding Affinities	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; MOLECULAR-DYNAMICS SIMULATIONS; RAY CRYSTAL-STRUCTURES; GENETIC ALGORITHM; SCORING FUNCTIONS; ACCURATE DOCKING; FLEXIBLE DOCKING; FKBP LIGANDS; FORCE-FIELD; MM-PBSA	Virtual compound screening using molecular docking is widely used in the discovery of new lead compounds for drug design. However, the docking scores are not sufficiently precise to represent the protein-ligand binding affinity. Here, we developed an efficient computational method for calculating protein-ligand binding affinity, which is based on molecular mechanics generalized Born/surface area (MM-GBSA) calculations and Jarzynski identity. Jarzynski identity is an exact relation between free energy differences and the work done through non-equilibrium process, and MM-GBSA is a semimacroscopic approach to calculate the potential energy. To calculate the work distribution when a ligand is pulled out of its binding site, multiple protein-ligand conformations are randomly generated as an alternative to performing an explicit single-molecule pulling simulation. We assessed the new method, multiple random conformation/MM-GBSA (MRC-MMGBSA), by evaluating ligand-binding affinities (scores) for four target proteins, and comparing these scores with experimental data. The calculated scores were qualitatively in good agreement with the experimental binding affinities, and the optimal docking structure could be determined by ranking the scores of the multiple docking poses obtained by the molecular docking process. Furthermore, the scores showed a strong linear response to experimental binding free energies, so that the free energy difference of the ligand binding (Delta Delta G) could be calculated by linear scaling of the scores. The error of calculated Delta Delta G was within approximate to +/- 1.5 kcal.mol(-1) of the experimental values. Particularly, in the case of flexible target proteins, the MRC-MMGBSA scores were more effective in ranking ligands than those generated by the MM-GBSA method using a single protein-ligand conformation. The results suggest that, owing to its lower computational costs and greater accuracy, the MRC-MMGBSA offers efficient means to rank the ligands, in the post-docking process, according to their binding affinities, and to compare these directly with the experimental values.	[Suenaga, Atsushi; Fukui, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan; [Suenaga, Atsushi; Okimoto, Noriaki; Hirano, Yoshinori] RIKEN, Computat Biol Res Core, Quantitat Biol Ctr, Kobe, Hyogo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); RIKEN	Suenaga, A (corresponding author), Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan.	atsushi.suenaga@aist.go.jp	Okimoto, Noriaki/AAI-4656-2020; Hirano, Yoshinori/AAT-1397-2021	Okimoto, Noriaki/0000-0002-2956-1317; Hirano, Yoshinori/0000-0001-8219-7991	RIKEN	RIKEN	AS and NO acknowledge RIKEN's support through the Strategic Programs for R&D (President's Discretionary Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bramson HN, 2001, J MED CHEM, V44, P4339, DOI 10.1021/jm010117d; Case DA., 2010, AMBER 11; Colizzi F, 2010, J AM CHEM SOC, V132, P7361, DOI 10.1021/ja100259r; Cuendet MA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2338535; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dullweber F, 2001, J MOL BIOL, V313, P593, DOI 10.1006/jmbi.2001.5062; DUNTEN P, 1995, PROTEIN SCI, V4, P2327, DOI 10.1002/pro.5560041110; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fujitani H, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1999637; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jiao D, 2008, P NATL ACAD SCI USA, V105, P6290, DOI 10.1073/pnas.0711686105; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; LEE FS, 1992, PROTEIN ENG, V5, P215, DOI 10.1093/protein/5.3.215; Michel J, 2010, J COMPUT AID MOL DES, V24, P639, DOI 10.1007/s10822-010-9363-3; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Payne JW, 2000, ARCH BIOCHEM BIOPHYS, V384, P9, DOI 10.1006/abbi.2000.2084; Pearlman DA, 2001, J MED CHEM, V44, P3417, DOI 10.1021/jm0100279; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Sham YY, 2000, PROTEINS, V39, P393, DOI 10.1002/(SICI)1097-0134(20000601)39:4<393::AID-PROT120>3.3.CO;2-8; Singh N, 2010, PROTEINS, V78, P1705, DOI 10.1002/prot.22687; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Talhout R, 2003, J AM CHEM SOC, V125, P10570, DOI 10.1021/ja034676g; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TURK D, 1991, FEBS LETT, V287, P133, DOI 10.1016/0014-5793(91)80033-Y; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Wyss PC, 2003, J MED CHEM, V46, P2304, DOI 10.1021/jm020495y; Xiong H, 2006, THEOR CHEM ACC, V116, P338, DOI 10.1007/s00214-005-0072-2	48	30	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42846	10.1371/journal.pone.0042846	http://dx.doi.org/10.1371/journal.pone.0042846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916168	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800031
J	Wang, ZQ; Nie, BB; Li, DH; Zhao, ZL; Han, Y; Song, HQ; Xu, JY; Shan, BC; Lu, J; Li, KC				Wang, Zhiqun; Nie, Binbin; Li, Donghong; Zhao, Zhilian; Han, Ying; Song, Haiqing; Xu, Jianyang; Shan, Baoci; Lu, Jie; Li, Kuncheng			Effect of Acupuncture in Mild Cognitive Impairment and Alzheimer Disease: A Functional MRI Study	PLOS ONE			English	Article							RESTING-STATE FMRI; BRAIN NETWORKS; DEFAULT-MODE; HIPPOCAMPAL CONNECTIVITY; PATTERNS; ACTIVATION; RESPONSES; DEMENTIA; THALAMUS; SYSTEM	We aim to clarify the mechanisms of acupuncture in treating mild cognitive impairment (MCI) and Alzheimer disease (AD) by using functional magnetic resonance imaging (fMRI). Thirty-six right-handed subjects (8 MCI patients, 14 AD patients, and 14 healthy elders) participated in this study. Clinical and neuropsychological examinations were performed on all the subjects. MRI data acquisition was performed on a SIEMENS verio 3-Tesla scanner. The fMRI study used a single block experimental design. We first acquired the baseline resting state data in the initial 3 minutes; we then acquired the fMRI data during the procession of acupuncture stimulation on the acupoints of Tai chong and Hegu for the following 3 minutes. Last, we acquired fMRI data for another 10 minutes after the needle was withdrawn. The preprocessing and data analysis were performed using the statistical parametric mapping (SPM8) software. Then the two-sample t-tests were performed between each two groups of different states. We found that during the resting state, brain activities in AD and MCI patients were different from those of control subjects. During the acupuncture and the second resting state after acupuncture, when comparing to resting state, there are several regions showing increased or decreased activities in MCI, AD subjects compared to normal subjects. Most of the regions were involved in the temporal lobe and the frontal lobe, which were closely related to the memory and cognition. In conclusion, we investigated the effect of acupuncture in AD and MCI patients by combing fMRI and traditional acupuncture. Our fMRI study confirmed that acupuncture at Tai chong (Liv3) and He gu (LI4) can activate certain cognitive-related regions in AD and MCI patients.	[Wang, Zhiqun; Zhao, Zhilian; Lu, Jie; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Nie, Binbin; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China; [Li, Donghong; Xu, Jianyang] Gen Hosp Chinese Peoples Armed Police Forces, Beijing, Peoples R China; [Han, Ying; Song, Haiqing] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Capital Medical University	Wang, ZQ (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China.	lujie@xwh.ccmu.edu.cn; likuncheng@xwh.ccmu.edu.cn	Han, Ying/H-7111-2017; Lu, Jie/GNW-3367-2022	Nie, Binbin/0000-0002-8038-7772; Shan, Baoci/0000-0001-7417-5063	Scientific Research Foundation for the Returned Overseas Chinese Scholars; Natural Science Foundation of China [81000606, 61105118, 81141018]; city government [Z101107052210002]	Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); city government	This work was supported by the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the Natural Science Foundation of China (Grant No. 81000606, 61105118, 81141018) and Key Work of Special Project supported by the city government (Z101107052210002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Bai LJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-73; Bai LJ, 2009, PROG NAT SCI-MATER, V19, P827, DOI 10.1016/j.pnsc.2008.09.009; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2008, NEUROPSYCHOLOGIA, V46, P1624, DOI 10.1016/j.neuropsychologia.2007.11.030; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; Feng YY, 2011, MAGN RESON IMAGING, V29, P958, DOI 10.1016/j.mri.2011.04.009; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Li G, 2011, COMPLEMENT THER MED, V19, pS49, DOI 10.1016/j.ctim.2010.11.004; Lu L, 2009, AM J DRUG ALCOHOL AB, V35, P1, DOI 10.1080/00952990802455469; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036838; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; Wang ZQ, 2011, J NEUROL SCI, V309, P79, DOI 10.1016/j.jns.2011.07.017; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang G, 2012, J ALTERN COMPLEM MED, V18, P387, DOI 10.1089/acm.2010.0205; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhong CG, 2012, J MAGN RESON IMAGING, V35, P572, DOI 10.1002/jmri.22887; Zhong XY, 2009, J TRADIT CHIN MED, V29, P174, DOI 10.1016/S0254-6272(09)60058-3; Zhou YL, 2008, ACUPUNCTURE ELECTRO, V33, P9, DOI 10.3727/036012908803861186	37	71	82	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42730	10.1371/journal.pone.0042730	http://dx.doi.org/10.1371/journal.pone.0042730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916152	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800026
J	Zhang, QL; He, JF; Wu, D; Wang, ZJ; Zhong, XG; Zhong, HJ; Ding, F; Liu, ZQ; Wang, SW; Huang, ZY; Zhang, YH; Ke, CW; Yuan, DK; Liang, WJ; Li, DQ; Chen, PH				Zhang Qiaoli; He Jianfeng; Wu De; Wang Zijun; Zhong Xinguang; Zhong Haojie; Ding Fan; Liu Zhiquan; Wang Shiwen; Huang Zhenyu; Zhang Yonghui; Ke Changwen; Yuan Dakang; Liang Wenjia; Li Deqiong; Chen Pinghua			Maiden Outbreak of Chikungunya in Dongguan City, Guangdong Province, China: Epidemiological Characteristics	PLOS ONE			English	Article							VIRUS; REEMERGENCE; INFECTION	Background: This study was conducted to identify epidemiological characteristics of the first documented CHIK fever outbreak in China and evaluate the effect of the preventive measures taken. Methodology/Principal Findings: From September 1 to October 29, 2010, China's first documented outbreak of CHIK fever occurred in the Xincun community of Wanjiang District of Dongguan city, Guangdong province; 253 case-patients were recorded, of which 129 were laboratory confirmed, with an attack rate of 1%. Before September 18th the number of CHIK fever cases remained relatively low in the Xincun community; from September 19th onwards, the number of cases increased drastically, with an outbreak peak on October 4th. Cases were distributed across nine small village groups in the Xincun community, with an attack rate of 0-12% at the village level. The household attack rates ranged between 20% and 100%. No significant difference was found in the attack rate between males and females. There was a significant difference in the attack rate in different age groups (chi-square = 18.35, p = 0.005); highest in patients aged 60 years or older and the lowest in patients aged under 10. The major clinical characteristics of patients are fever (100%), joint pain (79%) and rash (54%). Phylogenetic analysis of the E1 gene on the five earliest confirmed cases showed that the strains of CHIKV isolated from their sera were highly homologous (up to 99%) with isogeneic strains isolated in Thailand in 2009. After control measures were taken, including killing adult mosquitoes and cleaning breeding habitats of Aedes mosquitoes, the Breteau index and Mosq-ovitrap index decreased rapidly, and the outbreak ended on October 29. Conclusion/Significance: The infection source of the outbreak was imported. Cases showed obvious temporal, spatial, and population aggregation during the outbreak. Comprehensive control measures based on reducing the density of Aedes mosquitoes were effective in controlling the epidemic.	[Zhang Qiaoli; Zhong Xinguang; Liu Zhiquan; Huang Zhenyu; Yuan Dakang; Chen Pinghua] Dongguan Municipal CDC, Dongguan, Guangdong, Peoples R China; [He Jianfeng; Wu De; Zhong Xinguang; Zhang Yonghui; Ke Changwen; Liang Wenjia] Guangdong Prov CDC, Guangzhou, Guangdong, Peoples R China; [Wang Zijun; Ding Fan; Wang Shiwen] China CDC, Beijing, Peoples R China; [Li Deqiong] Wanjiang Hosp, Dongguan, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention	Zhang, QL (corresponding author), Dongguan Municipal CDC, Dongguan, Guangdong, Peoples R China.	zql@dg.gov.cn; hjf@vip.sina.com	Wang, Zhiquan/HHS-6768-2022		Provisional Emergency Dedicated Fund of the Dongguan Municipal Government [B10A06008001166]	Provisional Emergency Dedicated Fund of the Dongguan Municipal Government	This study was funded by the Provisional Emergency Dedicated Fund of the Dongguan Municipal Government for the fiscal year 2010 and delivered by the Dongguan Municipal Finance Bureau. The fund code is [2010]37, coded as B10A06008001166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0; Kaur P, 2008, EMERG INFECT DIS, V14, P1623, DOI 10.3201/eid1410.070569; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; Li F, 2007, INT J EPIDEMIOL INFE, V34, P240; Lin M, 2008, CHINESE J FRONTIER H, V4, P221; Ma S-X, 2008, CHIN J ZOONOSES, V24, P188; Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Muyembe-Tamfum J J, 2003, Med Trop (Mars), V63, P637; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Renault P, 2007, AM J TROP MED HYG, V77, P727; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; World Health Organization, 2011, CHIK FEV SIT IND 200; Xianzhao X, 2011, PREVENTION TREATMENT; 吴凡, 2007, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V18, P527	19	13	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42830	10.1371/journal.pone.0042830	http://dx.doi.org/10.1371/journal.pone.0042830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916166	Green Submitted, gold, Green Published			2022-12-27	WOS:000307824300018
J	Zhang, XJ; Li, YS; Li, H; Qin, YY; Bai, C; Xu, F; Zhu, TY; Xu, JF; Wu, MJ; Wang, CX; Wei, LX; He, J				Zhang, Xinji; Li, Yesheng; Li, Hui; Qin, Yingyi; Bai, Chong; Xu, Feng; Zhu, Tianyi; Xu, Jinfang; Wu, Mengjie; Wang, Chaoxiang; Wei, Lixin; He, Jia			Combined EGFR and VEGFR versus Single EGFR Signaling Pathways Inhibition Therapy for NSCLC: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CELL LUNG-CANCER; ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR; DOUBLE-BLIND; TARGETED THERAPIES; GEFITINIB; ERLOTINIB; CHEMOTHERAPY; BEVACIZUMAB; STATISTICS	Background: Lung cancer is a heterogeneous disease with multiple signaling pathways influencing tumor cell survival and proliferation, and it is likely that blocking only one of these pathways allows others to act as salvage or escape mechanisms for cancer cells. Whether combined inhibition therapy has greater anti-tumor activity than single inhibition therapy is a matter of debate. Hence, a meta-analysis comparing therapy inhibiting both VEGFR and EGFR signaling pathways with that inhibiting EGFR signaling pathway alone was performed. Methodology and Principal Findings: We searched PubMed, EMBASE database and the proceedings of major conferences for relevant clinical trials. Outcomes analyzed were objective tumor response rate (ORR), progression-free survival (PFS), overall survival (OS) and toxicity. Besides, subgroup analyses were performed to investigate whether the combined inhibition therapy is best performed using combination of selective agents or a single agent with multiple targets. Six trials recruiting 3,302 patients were included in the analysis. Combined inhibition therapy was associated with a 3% improvement in OS as compared with single-targeted therapy, but this difference was not statistically significant (HR, 0.97; 95% CI, 0.89-1.05; P = 0.472). Patients receiving combined inhibition therapy had significant longer PFS than the group with single-targeted therapy (HR, 0.80; 95% CI, 0.67-0.95; P = 0.011). There was no difference in the ORR between the groups (OR, 1.44; 95% CI, 0.95-2.18; P = 0.085). Subgroup analysis revealed that combined inhibition therapy using combination regimens was associated with statistically significant improvement in both ORR and PFS. Toxicity was greater in combined inhibition therapy. Conclusions: There is no evidence to support the use of combined inhibition therapy in unselected patients with advanced NSCLC. However, given the significant advantage in ORR and PFS, combined inhibition therapy using combination regimens may be considered for further evaluation in subsets of patients who may benefit from this treatment.	[Zhang, Xinji; Li, Hui; Qin, Yingyi; Xu, Jinfang; Wu, Mengjie; Wang, Chaoxiang; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Li, Yesheng; Xu, Feng] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Special Treatment, Shanghai, Peoples R China; [Bai, Chong; Zhu, Tianyi] Second Mil Med Univ, Changhai Hosp, Resp Dept, Shanghai, Peoples R China; [Wei, Lixin] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Zhang, XJ (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com		Wei, Lixin/0000-0002-9526-5348; He, Jia/0000-0002-2338-9501	National Nature Science Foundation of China [30872186, 81072388]; leading talents of science in Shanghai [022]; Program of Shanghai Subject Chief Scientist [09XD1405500]; Second Military Medical University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); leading talents of science in Shanghai; Program of Shanghai Subject Chief Scientist; Second Military Medical University	The work was supported by the National Nature Science Foundation of China (30872186, 81072388), a grant from the leading talents of science in Shanghai 2010 (022), a grant sponsored by Program of Shanghai Subject Chief Scientist (09XD1405500) and a grant from the innovative program for PhD in Second Military Medical University. The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belani CP, 2011, CANC TREAT REV, DOI [10.1016/j.ctrv.2011.1005.1009, DOI 10.1016/J.CTRV.2011.1005.1009]; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Cascone T, 2007, CURR OPIN ONCOL, V19, P98, DOI 10.1097/CCO.0b013e328011beec; Ciardiello F, 2006, ANN ONCOL, V17, pVII109, DOI 10.1093/annonc/mdl962; Ciardiello F, 2004, CLIN CANCER RES, V10, P784, DOI 10.1158/1078-0432.CCR-1100-03; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fontanini G, 1997, CLIN CANCER RES, V3, P861; Govindan R, 2011, SUNITINIB COMBINATIO; Groen HJM, 2010, ANN ONCOL, V21, P139; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson BE, 2010, J CONTRACEPT FERTIL, P28; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kim ES, 2009, J THORAC ONCOL, V4, P444, DOI 10.1097/JTO.0b013e31819d6f91; Kim ES, 2011, CANCER DISCOV, P1, DOI [10.1158/2159-8274.CD-1110-0010, DOI 10.1158/2159-8274.CD-1110-0010]; Leighl NB, 2010, J CONTRACEPT FERTIL, P28; Lynch TJ, 2009, J THORAC ONCOL, V4, P1002, DOI 10.1097/JTO.0b013e3181aba89f; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maione P, 2006, ONCOLOGIST, V11, P274, DOI 10.1634/theoncologist.11-3-274; Martinelli E, CLIN CANC RES, V16, P4990; Miller VA, 2009, J CONTRACEPT FERTIL, P27; Natale RB, 2011, J CLIN ONCOL, V29, P1059, DOI 10.1200/JCO.2010.28.5981; Natale RB, 2009, J CLIN ONCOL, V27, P2523, DOI 10.1200/JCO.2008.18.6015; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pennell NA, 2009, ONCOLOGIST, V14, P399, DOI 10.1634/theoncologist.2008-0276; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2007, ANN ONCOL, V18, P32, DOI 10.1093/annonc/mdm412; Schiller JH, 2010, J CONTRACEPT FERTIL, P28; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Spigel DR, 2011, J CLIN ONCOL, V29, P2582, DOI 10.1200/JCO.2010.30.7678; Spigel DR, 2011, J CONTRACEPT FERTIL, P29; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Wu WJ, 2007, MOL CANCER THER, V6, P471, DOI 10.1158/1535-7163.MCT-06-0416	43	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e40178	10.1371/journal.pone.0040178	http://dx.doi.org/10.1371/journal.pone.0040178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916093	Green Published, gold			2022-12-27	WOS:000307824300002
J	Cruz-Barraza, JA; Carballo, JL; Rocha-Olivares, A; Ehrlich, H; Hog, M				Antonio Cruz-Barraza, Jose; Luis Carballo, Jose; Rocha-Olivares, Axayacatl; Ehrlich, Hermann; Hog, Martin			Integrative Taxonomy and Molecular Phylogeny of Genus Aplysina (Demospongiae: Verongida) from Mexican Pacific	PLOS ONE			English	Article							CHITIN-BASED SCAFFOLDS; PHYLUM PORIFERA; MARINE SPONGES; SPECIES IDENTIFICATION; GENETIC-VARIATION; DNA; CLASSIFICATION; MARKERS; MTDNA; RDNA	Integrative taxonomy provides a major approximation to species delimitation based on integration of different perspectives (e.g. morphology, biochemistry and DNA sequences). The aim of this study was to assess the relationships and boundaries among Eastern Pacific Aplysina species using morphological, biochemical and molecular data. For this, a collection of sponges of the genus Aplysina from the Mexican Pacific was studied on the basis of their morphological, chemical (chitin composition), and molecular markers (mitochondrial COI and nuclear ribosomal rDNA: ITS1-5.8-ITS2). Three morphological species were identified, two of which are new to science. A. clathrata sp. nov. is a yellow to yellow-reddish or -brownish sponge, characterized by external clathrate-like morphology; A. revillagigedi sp. nov. is a lemon yellow to green, cushion-shaped sometimes lobate sponge, characterized by conspicuous oscules, which are slightly elevated and usually linearly distributed on rims; and A. gerardogreeni a known species distributed along the Mexican Pacific coast. Chitin was identified as the main structural component within skeletons of the three species using FTIR, confirming that it is shared among Verongida sponges. Morphological differences were confirmed by DNA sequences from nuclear ITS1-5.8-ITS2. Mitochondrial COI sequences showed extremely low but diagnostic variability for Aplysina revillagigedi sp. nov., thus our results corroborate that COI has limited power for DNA-barcoding of sponges and should be complemented with other markers (e.g. rDNA). Phylogenetic analyses of Aplysina sequences from the Eastern Pacific and Caribbean, resolved two allopatric and reciprocally monophyletic groups for each region. Eastern Pacific species were grouped in general accordance with the taxonomic hypothesis based on morphological characters. An identification key of Eastern Pacific Aplysina species is presented. Our results constitute one of the first approximations to integrative taxonomy, phylogeny and evolutionary biogeography of Eastern Pacific marine sponges; an approach that will significantly contribute to our better understanding of their diversity and evolutionary history.	[Antonio Cruz-Barraza, Jose; Luis Carballo, Jose] UNAM, Unidad Acad Mazatlan, Inst Ciencias Mar & Limnol, Mazatlan Sinaloa, Mexico; [Rocha-Olivares, Axayacatl] CICESE, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Ehrlich, Hermann; Hog, Martin] Tech Univ Dresden, Inst Bioanalyt Chem, Dresden, Germany	Universidad Nacional Autonoma de Mexico; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Technische Universitat Dresden	Cruz-Barraza, JA (corresponding author), UNAM, Unidad Acad Mazatlan, Inst Ciencias Mar & Limnol, Mazatlan Sinaloa, Mexico.	joseantonio@ola.icmyl.unam.mx	Cruz-Barraza, José Antonio/AAD-8317-2020; Carballo, José Luis/C-3198-2018; Rocha-Olivares, Axayacatl/A-9832-2008; Ehrlich, Hermann/J-6698-2012; Ehrlich, Hermann/I-5481-2015	Carballo, José Luis/0000-0002-5146-7597; Rocha-Olivares, Axayacatl/0000-0002-2700-9086; Ehrlich, Hermann/0000-0003-3654-0810; Ehrlich, Hermann/0000-0003-4951-3555	CONACYT = Consejo Nacional de Ciencia y Tecnologia, SEP = Secretaria de Educacion Publica, SEMARNAT = Secretaria de medio ambiente y recursos naturales, PAPIT = Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica. [SEP-CONACYT-102239, SEMARNAT-CONACYT-23390, PAPIT-IT209311-3, IACOD-IB200711]; CICESE (Centro de Investigacion Cientifica y de Educacion superior de Ensenada); German Research Foundation [DFG EH 394/1-1]	CONACYT = Consejo Nacional de Ciencia y Tecnologia, SEP = Secretaria de Educacion Publica, SEMARNAT = Secretaria de medio ambiente y recursos naturales, PAPIT = Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica.; CICESE (Centro de Investigacion Cientifica y de Educacion superior de Ensenada)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); German Research Foundation(German Research Foundation (DFG))	This research has been supported by the projects SEP-CONACYT-102239, SEMARNAT-CONACYT-23390, PAPIT-IT209311-3 and IACOD-IB200711 (CONACYT = Consejo Nacional de Ciencia y Tecnologia, SEP = Secretaria de Educacion Publica, SEMARNAT = Secretaria de medio ambiente y recursos naturales, PAPIT = Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, IACOD = Iniciativa de Apoyo complementario a la realizacion de Obras Determinadas). The first author received financial support from CICESE (Centro de Investigacion Cientifica y de Educacion superior de Ensenada) for an academical stay. Hermann Ehrlich received financial support from the German Research Foundation (DFG EH 394/1-1). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis JS, 2005, ZOOL SCR, V34, P549, DOI 10.1111/j.1463-6409.2005.00211.x; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Austin William C., 1996, Monographiae Biologicae, V75, P237; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; BERGQUIST PR, 1980, NEW ZEAL J ZOOL, V7, P443, DOI 10.1080/03014223.1980.11760680; Bergquist PR, 2002, SYSTEMA PORIFERA GUI, V1, P1081, DOI DOI 10.1007/978-1-4615-0747-5_108; Blanquer A, 2008, INVERTEBR SYST, V22, P489, DOI 10.1071/IS07004; BODEN N, 1985, INSECT BIOCHEM, V15, P19, DOI 10.1016/0020-1790(85)90039-3; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Boury-Esnault N, 1997, SMITHSONIAN CONTRIBU, V596, P1, DOI DOI 10.5479/SI.00810282.596; Bowerbank JS, 1845, ANN LYC NAT HIST, VXVI, P400; Brunner E, 2009, J STRUCT BIOL, V168, P539, DOI 10.1016/j.jsb.2009.06.018; Brusca RC, 1975, CIENC MAR, V2, P37, DOI DOI 10.7773/CM.V2I2.290; Caballero-George CJ, 2010, CURR TRENDS BIOTECHN, V4, P881; Carballo JL, 1994, THESIS U SEVILLA ESP; Cardenas P, 2007, J MAR BIOL ASSOC UK, V87, P1511, DOI 10.1017/S0025315407058286; Cardenas P, 2010, ZOOL SCR, V39, P89, DOI 10.1111/j.1463-6409.2009.00402.x; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; DeLAUBENFELS M. W., 1930, STANFORD UNIV BULL SER 5, V5, P24; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Diaz M.C., 2005, Zootaxa, V1012, P1; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P132, DOI 10.1016/j.ijbiomac.2010.05.007; Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009; Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156; Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521; Ehrlich H, 2010, CHEM MATER, V22, P1462, DOI 10.1021/cm9026607; Ereskovsky AV, 2011, ZOOTAXA, P5, DOI 10.11646/zootaxa.2768.1.2; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erwin PM, 2007, INVERTEBR BIOL, V126, P220, DOI 10.1111/j.1744-7410.2007.00092.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garrone R, 1996, J MICROSC-OXFORD, V8, P581; Gomez Patricia, 1992, Anales del Instituto de Ciencias del Mar y Limnologia Universidad Nacional Autonoma de Mexico, V19, P175; Green G, 1977, ANALES I CIENCIAS MA, V4, P79; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heim Isabel, 2010, Zootaxa, V2422, P1; Heim Isabel, 2007, V28, P361; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hyatt A, 1875, MEMOIRS BOSTON SOC N, V2, P399; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; KREUTER MH, 1992, COMP BIOCHEM PHYS C, V101, P183, DOI 10.1016/0742-8413(92)90217-U; Lamarao FRM, 2010, J MAR BIOL ASSOC UK, V90, P845, DOI 10.1017/S0025315409991202; Laubenfels MW, 1948, A HANCOCK FDN PUBL O, V3; Lopez JV, 2002, J HERED, V93, P27, DOI 10.1093/jhered/93.1.27; Maldonado M, 1998, B MAR SCI, V63, P417; Maldonado M, 2009, BIOL J LINN SOC, V97, P427, DOI 10.1111/j.1095-8312.2009.01202.x; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; Nichols SA, 2005, J EXP MAR BIOL ECOL, V323, P1, DOI 10.1016/j.jembe.2005.02.012; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Olivella I, 1977, MISC ZOOL, V4, P4; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Pinheiro Ulisses dos S., 2007, Zootaxa, V1609, P1; Pires AC, 2010, BIOTA NEOTROP, V10, P339, DOI 10.1590/S1676-06032010000200035; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Redmond NE, 2007, MOL PHYLOGENET EVOL, V43, P344, DOI 10.1016/j.ympev.2006.10.021; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Salcedo Martinez S., 1989, Anales del Instituto de Ciencias del Mar y Limnologia Universidad Nacional Autonoma de Mexico, V15, P73; Schmitt S, 2005, J MOL EVOL, V60, P327, DOI 10.1007/s00239-004-0162-0; Simpson T, 1984, CELL BIOL SPONGES; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; van Oppen M.J.H., 2002, P131; van Soest RWM, 2011, WORLD PORIFERA DATA; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Weis B, 1996, BIOCHEM SYST ECOL, V24, P1, DOI 10.1016/0305-1978(95)00101-8; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiedenmayer F., 1977, Experientia Supplementum (Basel), V28, P1; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1629, DOI 10.1017/S0025315407058274; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019	84	39	42	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42049	10.1371/journal.pone.0042049	http://dx.doi.org/10.1371/journal.pone.0042049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912682	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500100006
J	Mendez, N; Abarzua-Catalan, L; Vilches, N; Galdames, HA; Spichiger, C; Richter, HG; Valenzuela, GJ; Seron-Ferre, M; Torres-Farfan, C				Mendez, Natalia; Abarzua-Catalan, Lorena; Vilches, Nelson; Galdames, Hugo A.; Spichiger, Carlos; Richter, Hans G.; Valenzuela, Guillermo J.; Seron-Ferre, Maria; Torres-Farfan, Claudia			Timed Maternal Melatonin Treatment Reverses Circadian Disruption of the Fetal Adrenal Clock Imposed by Exposure to Constant Light	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; CORTISOL PRODUCTION; GENE-EXPRESSION; DIURNAL RHYTHM; TIMING SYSTEM; RAT; FETUS; GLAND; HYPERTENSION; PINEALECTOMY	Surprisingly, in our modern 24/7 society, there is scant information on the impact of developmental chronodisruption like the one experienced by shift worker pregnant women on fetal and postnatal physiology. There are important differences between the maternal and fetal circadian systems; for instance, the suprachiasmatic nucleus is the master clock in the mother but not in the fetus. Despite this, several tissues/organs display circadian oscillations in the fetus. Our hypothesis is that the maternal plasma melatonin rhythm drives the fetal circadian system, which in turn relies this information to other fetal tissues through corticosterone rhythmic signaling. The present data show that suppression of the maternal plasma melatonin circadian rhythm, secondary to exposure of pregnant rats to constant light along the second half of gestation, had several effects on fetal development. First, it induced intrauterine growth retardation. Second, in the fetal adrenal in vivo it markedly affected the mRNA expression level of clock genes and clock-controlled genes as well as it lowered the content and precluded the rhythm of corticosterone. Third, an altered in vitro fetal adrenal response to ACTH of both, corticosterone production and relative expression of clock genes and steroidogenic genes was observed. All these changes were reversed when the mother received a daily dose of melatonin during the subjective night; supporting a role of melatonin on overall fetal development and pointing to it as a 'time giver' for the fetal adrenal gland. Thus, the present results collectively support that the maternal circadian rhythm of melatonin is a key signal for the generation and/or synchronization of the circadian rhythms in the fetal adrenal gland. In turn, low levels and lack of a circadian rhythm of fetal corticosterone may be responsible of fetal growth restriction; potentially inducing long term effects in the offspring, possibility that warrants further research.	[Mendez, Natalia; Abarzua-Catalan, Lorena; Galdames, Hugo A.; Spichiger, Carlos; Richter, Hans G.; Torres-Farfan, Claudia] Univ Austral Chile, Inst Anat Histol & Patol, Valdivia, Chile; [Vilches, Nelson; Seron-Ferre, Maria] Univ Chile, Fac Med, Programa Fisiopatol, Inst Ciencias Biomed ICBM, Santiago 7, Chile; [Valenzuela, Guillermo J.] Arrowhead Reg Med Ctr, Dept Womens Hlth, Colton, CA USA	Universidad Austral de Chile; Universidad de Chile	Mendez, N (corresponding author), Univ Austral Chile, Inst Anat Histol & Patol, Valdivia, Chile.	claudia.torres@uach.cl	Richter, Hans/D-6273-2013	Richter, Hans/0000-0002-7224-9388; Abarzua Catalan, Lorena/0000-0003-4684-0649	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1080649]; Commission Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Commission Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Grant 1080649 from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT). Dr. Abarzua-Catalan was supported by a PhD-Fellowship from Commission Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysena C, 2009, AUST NZ J OBSTET GYN, V49, P382, DOI 10.1111/j.1479-828X.2009.01010.x; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; Bellavia SL, 2006, PHYSIOL BEHAV, V89, P342, DOI 10.1016/j.physbeh.2006.06.018; Bibeau K, 2010, AM J PHYSIOL-REG I, V298, pR899, DOI 10.1152/ajpregu.00238.2009; Campino C, 2011, HORM METAB RES, V43, P337, DOI 10.1055/s-0031-1271693; Chung S, 2011, ANN NY ACAD SCI, V1220, P71, DOI 10.1111/j.1749-6632.2010.05923.x; Croteau A, 2006, AM J PUBLIC HEALTH, V96, P846, DOI 10.2105/AJPH.2004.058552; DAVIS FC, 1988, AM J PHYSIOL, V255, pR439, DOI 10.1152/ajpregu.1988.255.3.R439; DEGUCHI T, 1975, P NATL ACAD SCI USA, V72, P2814, DOI 10.1073/pnas.72.7.2814; DEPRESBRUMMER P, 1995, AM J PHYSIOL-REG I, V268, pR1111, DOI 10.1152/ajpregu.1995.268.5.R1111; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gozeri E, 2008, NEUROENDOCRINOL LETT, V29, P87; Hammer F, 2006, BEST PRACT RES CL EN, V20, P337, DOI 10.1016/j.beem.2006.07.001; HONMA S, 1984, ENDOCRINOLOGY, V114, P1791, DOI 10.1210/endo-114-5-1791; Jin LZ, 2004, J OCCUP ENVIRON MED, V46, P1144, DOI 10.1097/01.jom.0000145168.21614.21; Jud C, 2006, J BIOL RHYTHM, V21, P149, DOI [10.1177/0748730406286264, 10.1177/0748730405286264]; Kachi T, 2006, CHRONOBIOL INT, V23, P289, DOI 10.1080/07420520600588713; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; KENNAWAY DJ, 1992, J CLIN ENDOCR METAB, V75, P367, DOI 10.1210/jc.75.2.367; Kivimaki M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001138; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; MATSUMOTO T, 1991, AM J OBSTET GYNECOL, V165, P1777, DOI 10.1016/0002-9378(91)90032-M; MCMILLEN IC, 1989, J ENDOCRINOL, V120, P459, DOI 10.1677/joe.0.1200459; Nathanielsz PW, 2006, ILAR J, V47, P73, DOI 10.1093/ilar.47.1.73; Novakova M, 2010, J BIOL RHYTHM, V25, P350, DOI 10.1177/0748730410377967; NOWAK R, 1990, J ENDOCRINOL, V125, P97, DOI 10.1677/joe.0.1250097; NuessleinHildesheim B, 1996, AM J PHYSIOL-REG I, V271, pR1388, DOI 10.1152/ajpregu.1996.271.5.R1388; Okatani Y, 1998, J PINEAL RES, V25, P129, DOI 10.1111/j.1600-079X.1998.tb00550.x; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Pennell CE, 2009, EARLY LIFE ORIGINS OF HUMAN HEALTH AND DISEASE, P205, DOI 10.1159/000221166; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; REPPERT SM, 1986, ENDOCRINOLOGY, V119, P1763, DOI 10.1210/endo-119-4-1763; Richter HG, 2008, ENDOCRINOLOGY, V149, P995, DOI 10.1210/en.2007-1009; Richter HG, 2004, BIOL RES, V37, P11, DOI 10.4067/S0716-97602004000100003; Schenker S, 1998, CLIN NUTR, V17, P159, DOI 10.1016/S0261-5614(98)80052-6; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seron-Ferre M, 2004, PEDIATR RES, V55, P531; Seron-Ferre M, 2012, MOL CELL ENDOCRINOL, V349, P68, DOI 10.1016/j.mce.2011.07.039; Simonneaux V, 2011, ENDOCRINOLOGY, V152, P1734, DOI 10.1210/en.2011-0226; Son GH, 2011, FRONT NEUROENDOCRIN, V32, P451, DOI 10.1016/j.yfrne.2011.07.003; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Torres-Farfan C, 2006, ENDOCRINOLOGY, V147, P4618, DOI 10.1210/en.2006-0628; Torres-Farfan C, 2004, J PHYSIOL-LONDON, V554, P841, DOI 10.1113/jphysiol.2003.056465; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Torres-Farfan C, 2009, ENDOCRINOLOGY, V150, P2717, DOI 10.1210/en.2008-1683; Torres-Farfan C, 2006, J PINEAL RES, V41, P58, DOI 10.1111/j.1600-079X.2006.00331.x; Valenzuela FJ, 2012, ENDOCRINOL DIABETES, V5, P6; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504; WALKER CD, 1986, ENDOCRINOLOGY, V118, P1445, DOI 10.1210/endo-118-4-1445; Witlin AG, 2002, BIOL REPROD, V67, P1025, DOI 10.1095/biolreprod.101.002196; Wotus C, 1998, ENDOCRINOLOGY, V139, P4397, DOI 10.1210/en.139.10.4397; YELLON SM, 1988, BIOL REPROD, V39, P1093, DOI 10.1095/biolreprod39.5.1093	55	80	87	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42713	10.1371/journal.pone.0042713	http://dx.doi.org/10.1371/journal.pone.0042713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912724	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100022
J	Nguyen, QN; Pham, ST; Nguyen, VL; Weinehall, L; Bonita, R; Byass, P; Wall, S				Nguyen, Quang Ngoc; Pham, Son Thai; Nguyen, Viet Lan; Weinehall, Lars; Bonita, Ruth; Byass, Peter; Wall, Stig			Time Trends in Blood Pressure, Body Mass Index and Smoking in the Vietnamese Population: A Meta-Analysis from Multiple Cross-Sectional Surveys	PLOS ONE			English	Article							RISK-FACTORS; WEIGHT-REDUCTION; HYPERTENSION; PREVALENCE; COUNTRIES; OBESITY; LIFE; DISEASE; STROKE; RATES	Introduction: Data for trends in cardiovascular disease (CVD) risk factors are needed to set priorities and evaluate intervention programmes in the community. We estimated time trends in blood pressure ( BP), anthropometric variables and smoking in the Vietnamese population and highlighted the differences between men and women or between rural and urban areas. Methods: A dataset of 23,563 adults aged 25-74 from 5 cross-sectional surveys undertaken within Vietnam from 2001 to 2009 by the Vietnam National Heart Institute was used to estimate mean BP, weight, waist circumference (WC), body mass index (BMI), the prevalence of hypertension, adiposity or smoking, which were standardised to the national age structure of 2009. Multilevel mixed linear models were used to estimate annual changes in the variables of interest, adjusted by age, sex, residential area, with random variations for age and surveyed provinces. Findings: Among the adult population, the age-standardised mean systolic and diastolic BP increased by 0.8 and 0.3 mmHg in women, 1.1 and 0.4 mmHg in men, while the mean BMI increased by 0.1 kgm(-2) in women, 0.2 kgm(-2) in men per year. Consequently, the prevalence of hypertension and adiposity increased by 0.9 and 0.3% in women, 1.1 and 0.9% in men with similar time trends in both rural and urban areas, while smoking prevalence only increased in women by 0.3% per year. A U-shaped association was found between age-adjusted BP and BMI in both sexes and in both areas. Conclusions: From 2001 to 2009, mean BP, weight and WC significantly increased in the Vietnamese population, leading to an increased prevalence of hypertension and adiposity, suggesting the need for the development of multi-sectoral cost-effective population-based interventions to improve CVD management and prevention. The U-shaped relationship between BP and BMI highlighted the hypertension burden in the underweight population, which is usually neglected in CVD interventions.	[Nguyen, Quang Ngoc; Nguyen, Viet Lan] Hanoi Med Univ, Dept Cardiol, Hanoi, Vietnam; [Nguyen, Quang Ngoc; Pham, Son Thai; Nguyen, Viet Lan] Bach Mai Hosp, Vietnam Natl Heart Inst, Hanoi, Vietnam; [Nguyen, Quang Ngoc; Pham, Son Thai; Weinehall, Lars; Byass, Peter; Wall, Stig] Umea Univ, Umea Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, Umea, Sweden; [Bonita, Ruth] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland 1, New Zealand	Hanoi Medical University; Umea University; University of Auckland	Nguyen, QN (corresponding author), Hanoi Med Univ, Dept Cardiol, Hanoi, Vietnam.	quangtm@gmail.com	Nguyen, Quang Ngoc/C-9373-2011	Nguyen, Quang Ngoc/0000-0001-7614-9889; Byass, Peter/0000-0001-5474-4361; Weinehall, Lars/0000-0003-3025-2690	Umea Centre for Global Health Research; FAS; Swedish Council for Working Life and Social Research through SIDA Health Systems Research Programme [2006-1512]; Ministry of Health, Labour and Welfare of Japan; International Medical Centre of Japan (IMCJ) Hospital, Tokyo, Japan	Umea Centre for Global Health Research; FAS; Swedish Council for Working Life and Social Research through SIDA Health Systems Research Programme; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); International Medical Centre of Japan (IMCJ) Hospital, Tokyo, Japan	We would like to express our sincere thanks to all staff from Vietnam National Heart Institute and the corresponding partners involving in all surveys. Support from the Umea Centre for Global Health Research, funded from FAS, the Swedish Council for Working Life and Social Research (grant no. 2006-1512) and through the SIDA Health Systems Research Programme is appreciated.; The World Health Organization (WHO) in the Western Pacific Region (WHO WPRO), the Vietnam Ministry of (MOH) Health and the Vietnam National Heart Institute (VNHI) provided core funding support for NESH and HF-S studies. DM-S study was funded by a grant from Ministry of Health, Labour and Welfare of Japan through a project cooperated between Bach Mai Hospital, Hanoi, Vietnam and The International Medical Centre of Japan (IMCJ) Hospital, Tokyo, Japan. INDEPH network (an International network of field sites for continuous demographic evaluation of populations and their health in developing countries) and FAS (the Swedish Council for Social and Work Life Research) have been the principal funders of the NCDS study. WHOWPRO, MOH, VNHI and Hanoi Medical University (HMU) provided core funding support for HMPS studies. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Aucott L, 2005, HYPERTENSION, V45, P1035, DOI 10.1161/01.HYP.0000165680.59733.d4; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bovet P, 2003, J HYPERTENS, V21, P509, DOI 10.1097/00004872-200303000-00016; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; [Department of Therapeutics Ministry of Health Department of Therapeutics MoH Vietnam], 2010, GUID MAN HYP; Ellat-Adar S, 2005, AM J EPIDEMIOL, V161, P352, DOI 10.1093/aje/kwi045; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; GOPFP - General Office for Population and Family Planning MoH Vietnam, 2011, POP DISTR STRUCT; Inoue S, 2000, ASIA PACIFIC PERSPEC; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kotchen TA, 2010, AM J HYPERTENS, V23, P1170, DOI 10.1038/ajh.2010.172; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lavie CJ, 1997, AM J CARDIOL, V79, P397, DOI 10.1016/S0002-9149(97)89239-9; Milani RV, 2003, AM J CARDIOL, V92, P50, DOI 10.1016/S0002-9149(03)00464-8; Minh HV, 2007, PREV CHRONIC DIS, V4, P2; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Nguyen QN, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/560397; Son PT, 2012, J HUM HYPERTENS, V26, P268, DOI 10.1038/jhh.2011.18; STAMLER R, 1991, HYPERTENSION, V17, P553, DOI 10.1161/01.HYP.17.4.553; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; The General Statistics Office, 2010, 2009 VIETN POP HOUS; Tolonen H, 2002, STROKE, V33, P2367, DOI 10.1161/01.STR.0000033131.27936.7F; TUOMILEHTO J, 1991, AM J MED, V90, pS34, DOI 10.1016/0002-9343(91)90434-Y; Van Minh H, 2008, SCAND J PUBLIC HEALT, V36, P629, DOI 10.1177/1403494807086977; Walls HL, 2009, ASIA PAC J CLIN NUTR, V18, P234; Wang ZW, 2004, HYPERTENS RES, V27, P703, DOI 10.1291/hypres.27.703; World Health Organization, 2005, WHO STEPS SURV MAN W; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	35	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42825	10.1371/journal.pone.0042825	http://dx.doi.org/10.1371/journal.pone.0042825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912747	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500028
J	Berhanu, WM; Hansmann, UHE				Berhanu, Workalemahu M.; Hansmann, Ulrich H. E.			Structure and Dynamics of Amyloid-beta Segmental Polymorphisms	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; PROTEIN AGGREGATION; FORCE-FIELD; EARLY STEPS; FIBRILS; SIMULATIONS; STABILITY; PEPTIDE; A-BETA(1-40)	It is believed that amyloid-beta (A beta) aggregates play a role in the pathogenesis of Alzheimer's disease. A beta molecules form beta-sheet structures with multiple interaction sites. This polymorphism gives rise to differences in morphology, physicochemical property and level of cellular toxicity. We have investigated the conformational stability of various segmental polymorphisms using molecular dynamics simulations and find that the segmental polymorphic models of A beta retain a U-shaped architecture. Our results demonstrate the importance of inter-sheet side chain-side chain contacts, hydrophobic contacts among the strands (beta 1 and beta 2) and of salt bridges in stabilizing the aggregates. Residues in beta-sheet regions have smaller fluctuation while those at the edge and loop region are more mobile. The inter-peptide salt bridges between Asp23 and Lys28 are strong compared to intra-chain salt bridge and there is an exchange of the inter-chain salt-bridge with intra-chain salt bridge. As our results suggest that A beta exists under physiological conditions as an ensemble of distinct segmental polymorphs, it may be necessary to account in the development of therapeutics for Alzheimer's disease the differences in structural stability and aggregation behavior of the various A beta polymorphic forms.	[Berhanu, Workalemahu M.; Hansmann, Ulrich H. E.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Berhanu, WM (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	uhansmann@ou.edu	Hansmann, Ulrich/L-4597-2017	Hansmann, Ulrich/0000-0002-0700-4835	National Institutes of Health [GM62838]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from the National Institutes of Health (grant number GM62838). This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U. S. Department of Energy under contract no. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2011, MOL SIMULAT, V37, P440, DOI 10.1080/08927022.2011.551879; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Baumketner A, 2008, P NATL ACAD SCI USA, V105, P6027, DOI 10.1073/pnas.0708193105; Berhanu WM, 2012, BIOPOLYMERS, V98, P131, DOI 10.1002/bip.21731; Berhanu WM, 2011, BIOPOLYMERS, V95, P573, DOI 10.1002/bip.21611; Berhanu WM, 2012, J MOL MODEL, V18, P1129, DOI 10.1007/s00894-011-1123-3; Berhanu WM, 2012, J MOL MODEL, V18, P891, DOI 10.1007/s00894-011-1030-7; Berhanu WM, 2011, J MOL MODEL, V17, P2423, DOI 10.1007/s00894-010-0912-4; Berhanu WM, 2010, J MOL MODEL, V16, P1093, DOI 10.1007/s00894-009-0610-2; Berryman JT, 2011, BIOPHYS J, V100, P2234, DOI 10.1016/j.bpj.2011.02.060; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chebaro Y, 2012, J PHYS CHEM B, V116, P8412, DOI 10.1021/jp2118778; Chebaro Y, 2009, PROTEINS, V75, P442, DOI 10.1002/prot.22254; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dzubiella J, 2008, J AM CHEM SOC, V130, P14000, DOI 10.1021/ja805562g; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fawzi NL, 2008, BIOPHYS J, V94, P2007, DOI 10.1529/biophysj.107.121467; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Han M, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3586804; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu KN, 2011, BIOPHYS J, V101, P2242, DOI 10.1016/j.bpj.2011.09.051; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Huet A, 2006, BIOPHYS J, V91, P3829, DOI 10.1529/biophysj.106.090993; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Li MS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218101; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Masman MF, 2009, J PHYS CHEM B, V113, P11710, DOI 10.1021/jp901057w; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nguyen PH, 2011, PHYS CHEM CHEM PHYS, V13, P9778, DOI 10.1039/c1cp20323a; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Rojas A, 2010, J MOL BIOL, V404, P537, DOI 10.1016/j.jmb.2010.09.057; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Takeda T, 2008, BIOPHYS J, V95, P1758, DOI 10.1529/biophysj.108.131698; Takeda T, 2007, J MOL BIOL, V368, P1202, DOI 10.1016/j.jmb.2007.02.066; Takeda T, 2009, BIOPHYS J, V96, P4428, DOI 10.1016/j.bpj.2009.03.015; Takeda T, 2009, BIOPHYS J, V96, P442, DOI 10.1016/j.bpj.2008.10.008; Tarus B, 2006, J AM CHEM SOC, V128, P16159, DOI 10.1021/ja064872y; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vitagliano L, 2009, BIOPOLYMERS, V91, P1161, DOI 10.1002/bip.21182; Wei GH, 2007, PRION, V1, P3, DOI 10.4161/pri.1.1.3969; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	68	58	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41479	10.1371/journal.pone.0041479	http://dx.doi.org/10.1371/journal.pone.0041479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911797	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300047
J	Preusse, M; Stastna, M; Freistuhler, H; Peeters, F				Preusse, Martina; Stastna, Marek; Freistuehler, Heinrich; Peeters, Frank			Intrinsic Breaking of Internal Solitary Waves in a Deep Lake	PLOS ONE			English	Article							INSTABILITIES; GENERATION; TURBULENCE	Based on simulations with the Dubreil-Jacotin-Long (DJL) equation, the limiting amplitude and the breaking mechanisms of internal solitary waves of depression (ISWs) are predicted for different background stratifications. These theoretical predictions are compared to the amplitude and the stability of the leading internal solitary waves of more than 200 trains of ISWs observed in the centre of a sub-basin of Lake Constance. The comparison of the model results with the field observations indicates that the simulated limiting amplitude of the ISWs provides an excellent prediction of the critical wave height above which ISWs break in the field. Shear instabilities and convective instabilities are each responsible for about half of the predicted wave breaking events. The data suggest the presence of core-like structures within the convectively unstable waves, but fully developed and stable cores were not observed. The lack of stable trapped cores in the field can be explained by the results from dynamic simulations of ISWs with trapped cores which demonstrate that even slight disturbances of the background stratification cause trapped cores to become unstable.	[Preusse, Martina; Peeters, Frank] Univ Konstanz, Limnol Inst, Constance, Germany; [Stastna, Marek] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Preusse, Martina; Freistuehler, Heinrich] Univ Konstanz, Dept Math & Stat, Constance, Germany	University of Konstanz; University of Waterloo; University of Konstanz	Preusse, M (corresponding author), Univ Konstanz, Limnol Inst, Constance, Germany.	martina.preusse@uni-konstanz.de		Stastna, Marek/0000-0003-1770-2044	German research association (DFG) [PE 701/4-1]; Natural Sciences and Engineering Research Council of Canada	German research association (DFG)(German Research Foundation (DFG)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the German research association (DFG, PE 701/4-1), and the Natural Sciences and Engineering Research Council of Canada (M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barad MF, 2010, J FLUID MECH, V644, P61, DOI 10.1017/S0022112009992035; Boegman L, 2005, LIMNOL OCEANOGR, V50, P1620, DOI 10.4319/lo.2005.50.5.1620; Bourgault D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028462; Carr M, 2008, PHYS FLUIDS, V20; Carr M, 2011, J FLUID MECH, V683, P263, DOI 10.1017/jfm.2011.261; de la Fuente A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005839; Fructus D, 2009, J FLUID MECH, V620, P1, DOI 10.1017/S0022112008004898; Gloor M, 2000, J GEOPHYS RES-OCEANS, V105, P8629, DOI 10.1029/1999JC900303; Helfrich KR, 2010, NONLINEAR PROC GEOPH, V17, P303, DOI 10.5194/npg-17-303-2010; Imberger J, 1998, COAST ESTUAR STUD, V54, P1; King SE, 2011, J FLUID MECH, V666, P477, DOI 10.1017/S0022112010004301; Lamb KG, 2011, J PHYS OCEANOGR, V41, P67, DOI 10.1175/2010JPO4308.1; Lamb KG, 2003, J FLUID MECH, V478, P81, DOI 10.1017/S0022112002003269; Lamb KG, 2002, J FLUID MECH, V451, P109, DOI [10.1017/SO02211200100636X, 10.1017/S002211200100636X]; Lien RC, 2012, J PHYS OCEANOGR, V42, P511, DOI [10.1175/2011JP04578.1, 10.1175/2011JPO4578.1]; Lorke A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004008; Moum JN, 2003, J PHYS OCEANOGR, V33, P2093, DOI 10.1175/1520-0485(2003)033<2093:SAGOTA>2.0.CO;2; Preusse M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007403; Preusse M, 2010, LIMNOL OCEANOGR, V55, P2353, DOI 10.4319/lo.2010.55.6.2353; Scotti A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021052; Soontiens N, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3521532; Stastna M, 2002, PHYS FLUIDS, V14, P2987, DOI 10.1063/1.1496510; Stastna M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004711; van Haren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032535; Wunsch C, 2004, ANNU REV FLUID MECH, V36, P281, DOI 10.1146/annurev.fluid.36.050802.122121	25	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41674	10.1371/journal.pone.0041674	http://dx.doi.org/10.1371/journal.pone.0041674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911842	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700138
J	Liang, XY; Guo, H; Jin, CG; Peng, XX; Zhang, XL				Liang, Xiaoyun; Guo, Hong; Jin, Chenggang; Peng, Xiaoxia; Zhang, Xiulan			The Effect of New Cooperative Medical Scheme on Health Outcomes and Alleviating Catastrophic Health Expenditure in China: A Systematic Review	PLOS ONE			English	Review							SELF-RATED HEALTH; RURAL CHINA; INSURANCE; MORTALITY; ECONOMY; SERVICE; EQUITY; IMPACT; POLICY	Background: In 2002, the Chinese government launched a new rural health financing policy to provide health insurance (New Cooperative Medical Scheme, NCMS) for its rural population. NCMS, jointly financed by governments and individual households, aims to protect households from impoverishment due to catastrophic health expenditure. In 2011, NCMS covered more than 96% of the rural population. We have systematically searched and reviewed available evidence to estimate the effects of NCMS on health outcomes and on alleviating catastrophic health expenditure. Methods: PubMed, Web of Science with Conference Proceedings, ProQuest Digital Dissertations, CMCI, CNKI, and VIP were searched. We also obtained literature from colleague communications. Quasi-experimental studies regarding the effect of NCMS on health outcomes and catastrophic health expenditure were included. Two independent reviewers screened the literature, extracted the data, and assessed the study quality. Results: Fifteen studies out of the 6123 studies in the literature fulfilled criteria and were included in this review. Twelve studies identified the relationship between NCMS and health outcomes, among which six studies measured sickness or injury in the past four weeks, four measured sickness or injury in the past two weeks, and five measured self-reported health status. Four studies focused on the relationship between NCMS and alleviating catastrophic health expenditure. However, the results from these studies were in conflict: individual studies indicated that NCMS had positive, negative, or no effect on health outcomes and/or the incidence of catastrophic health payments, respectively. Conclusions: We still have no clear evidence that NCMS improves the health outcomes and decreases the alleviating catastrophic health expenditure of the China's rural population. In addition, the heterogeneity among individual studies reminds us that provider	[Liang, Xiaoyun; Guo, Hong; Jin, Chenggang; Zhang, Xiulan] Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China; [Peng, Xiaoxia] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China	Beijing Normal University; Capital Medical University	Liang, XY (corresponding author), Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China.	niuniu@ccmu.edu.cn; Zhang99@bnu.edu.cn						Bloom G, 2011, SOC SCI MED, V72, P1302, DOI 10.1016/j.socscimed.2011.02.017; Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836; CCCPC (Central Committee of the Communist Party of China) and State Council, 2005, COMM CENTR COMM CHIN; Chen L, 2011, CAN J DEV STUD, V32, P399, DOI 10.1080/02255189.2011.647445; Chen YY, 2012, J HEALTH ECON, V31, P1, DOI 10.1016/j.jhealeco.2011.11.001; Chu XL, 2010, THESIS ZHEJIANG U CH; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Feng L, 2009, THESIS HUAZHONG AGR; Fox DM, 2005, HEALTH AFFAIR, V24, P114, DOI 10.1377/hlthaff.24.1.114; Gao J, 2002, HEALTH POLICY PLANN, V17, P20, DOI 10.1093/heapol/17.suppl_1.20; Gersten R, 2005, EXCEPT CHILDREN, V71, P149, DOI 10.1177/001440290507100202; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Han B, 2009, ZHONG GUO WEI SHENG, V28, P17; Hu J, 2011, HUBEI JING JI XUE YU, V8, P66; Lei XY, 2009, HEALTH ECON, V18, pS25, DOI 10.1002/hec.1501; Levy H, 2008, ANNU REV PUBL HEALTH, V29, P399, DOI 10.1146/annurev.publhealth.28.021406.144042; Li XY, 2008, HUANAN NONG YE DA XU, V7, P9; Liang XY, 2011, INT J CLIN PHARM-NET, V33, P750, DOI 10.1007/s11096-011-9535-9; Lipow C, 2010, IMPACT NEW COOPERATI; Liu XK, 2006, THESIS ZHENGZHOU U C; LOEVINSOHN BP, 1990, INT J EPIDEMIOL, V19, P788, DOI 10.1093/ije/19.4.788; Meng DF, 2009, JING JI PING LUN, P69; Miao YH, 2008, NONG YE JING JI WEN, V30, P71; Ministry of Health of the People's Republic of China, 2010, GAZETTE MINISTRY HLT, P35; Ministry of Health of the People's Republic of China, 2011, GAZ NAT HLTH DEV CHI; Ministry of Health of the People's Republic of China, 2011, NOT REG NEW COOP MED; Ministry of Health of the People's Republic of China, 2010, AV NCMS FIN PER PERS; Ministry of Health of the People's Republic of China, 2011, REC PROGR NEW COOP M; Peters DH, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7888-5; Shen ZW, 2008, NONG YE JI SHU JING, P58; Shi WX, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-7; SIDEL VW, 1993, AM J PUBLIC HEALTH, V83, P1665, DOI 10.2105/AJPH.83.12.1665; Statistical information center Ministry of Health China, 2007, PROGR IMP EV CHIN NE; Statistical information center MoH, 2007, PROGR IMP EV CHIN NE; Sun XY, 2009, HEALTH ECON, V18, P103, DOI 10.1002/hec.1346; Sun XJ, 2007, ZHONG GUO WEI SHENG, V26, P49; Sun Y, 2005, THESIS SHANXI MED U; The State Council of the People's Republic of China, 2002, RES ADV RUR HLTH SER; The World Bank, 2011, HLTH HARM LIF CHIN S; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Wagstaff A, 2007, 4150 WORLD BANK; Wagstaff A, 2008, J HEALTH ECON, V27, P990, DOI 10.1016/j.jhealeco.2008.02.002; Wagstaff A, 2007, J HEALTH ECON, V26, P505, DOI 10.1016/j.jhealeco.2006.10.006; Wang H, 2009, HEALTH ECON, V18, pS65, DOI 10.1002/hec.1465; Wang LS, 2010, REPORT PILOT PAYMENT; Wang WZ, 2007, ZHONG GUO WEI SHENG, P771; Wu LC, 2010, BIO XIAN YAN JIU, P60; WYSZEWIANSKI L, 1986, INQUIRY-J HEALTH CAR, V23, P382; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu RL, 2006, ZHONG GUO WEI SHENG, V25, P36; Yan JE, 2009, XIAN DAI YU FANG YI, V36, P259; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; You XD, 2009, HEALTH POLICY, V91, P1, DOI 10.1016/j.healthpol.2008.11.012; Yu BR, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-116; Yuan ZK, 2008, ZHONG GEO NONG CUN W, V28, P91; Zhang LX, 2010, IDS BULL-I DEV STUD, V41, P95, DOI 10.1111/j.1759-5436.2010.00156.x	56	41	43	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e40850	10.1371/journal.pone.0040850	http://dx.doi.org/10.1371/journal.pone.0040850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916098	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800004
J	Cabrera-Salazar, MA; DeRiso, M; Bercury, SD; Li, LY; Lydon, JT; Weber, W; Pande, N; Cromwell, MA; Copeland, D; Leonard, J; Cheng, SH; Scheule, RK				Cabrera-Salazar, Mario A.; DeRiso, Matthew; Bercury, Scott D.; Li, Lingyun; Lydon, John T.; Weber, William; Pande, Nilesh; Cromwell, Mandy A.; Copeland, Diane; Leonard, John; Cheng, Seng H.; Scheule, Ronald K.			Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; GLUCOSYLSPHINGOSINE ACCUMULATION; MICROGLIA; ADULT; MICE; NEUROPATHOLOGY; ACTIVATION; PSYCHOSINE; INFANTILE; PHENOTYPE	Neuropathic Gaucher disease (nGD), also known as type 2 or type 3 Gaucher disease, is caused by a deficiency of the enzyme glucocerebrosidase (GC). This deficiency impairs the degradation of glucosylceramide (GluCer) and glucosylsphingosine (GluSph), leading to their accumulation in the brains of patients and mouse models of the disease. These accumulated substrates have been thought to cause the severe neuropathology and early death observed in patients with nGD and mouse models. Substrate accumulation is evident at birth in both nGD mouse models and humans affected with the most severe type of the disease. Current treatment of non-nGD relies on the intravenous delivery of recombinant human glucocerebrosidase to replace the missing enzyme or the administration of glucosylceramide synthase inhibitors to attenuate GluCer production. However, the currently approved drugs that use these mechanisms do not cross the blood brain barrier, and thus are not expected to provide a benefit for the neurological complications in nGD patients. Here we report the successful reduction of substrate accumulation and CNS pathology together with a significant increase in lifespan after systemic administration of a novel glucosylceramide synthase inhibitor to a mouse model of nGD. To our knowledge this is the first compound shown to cross the blood brain barrier and reduce substrates in this animal model while significantly enhancing its lifespan. These results reinforce the concept that systemically administered glucosylceramide synthase inhibitors could hold enhanced therapeutic promise for patients afflicted with neuropathic lysosomal storage diseases.	[Cabrera-Salazar, Mario A.; DeRiso, Matthew; Bercury, Scott D.; Li, Lingyun; Lydon, John T.; Weber, William; Pande, Nilesh; Cromwell, Mandy A.; Copeland, Diane; Leonard, John; Cheng, Seng H.; Scheule, Ronald K.] Genzyme Corp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Cabrera-Salazar, MA (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	Mario.Cabrera@genzyme.com	Cheng, Seng H/AAC-6564-2022		Genzyme Corporation	Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	Mario A. Cabrera-Salazar, Matthew DeRiso, Scott D. Bercury, Lingyun Li, Nilesh Pande, William Weber, Diane Copeland, John Leonard, Seng H. Cheng and Ronald K. Scheule are all employees of Genzyme Corporation (a subsidiary of Sanofi-aventis Group), covering therapeutic applications for GZ-161 and has received an unrestricted study grant from Genzyme Corporation to investigate modulation of sphingolipid metabolism. The described studies were part of the drug development program at Genzyme Corporation. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ashe KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021758; Barranger J. A., 1989, METABOLIC BASIS INHE, P1677; BRENKERT A, 1972, BRAIN RES, V36, P183, DOI 10.1016/0006-8993(72)90774-3; Cabrera-Salazar MA, 2010, EXP NEUROL, V225, P436, DOI 10.1016/j.expneurol.2010.07.023; Chang M, 2008, MOL THER; CONRADI N, 1991, ACTA NEUROPATHOL, V82, P152, DOI 10.1007/BF00293959; CONRADI NG, 1984, ACTA NEUROPATHOL, V65, P99, DOI 10.1007/BF00690463; Davies EH, 2007, J INHERIT METAB DIS, V30, P935, DOI 10.1007/s10545-007-0577-z; Dodge JC, 2009, EXP NEUROL, V215, P349, DOI 10.1016/j.expneurol.2008.10.021; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Goker-Alpan O, 2003, J PEDIATR-US, V143, P273, DOI 10.1067/S0022-3476(03)00302-0; Graler MH, 2002, BBA-MOL CELL BIOL L, V1582, P168, DOI 10.1016/S1388-1981(02)00152-X; Ida H, 1999, HUM GENET, V105, P120, DOI 10.1007/s004390051073; Kingham PJ, 1999, J NEUROCHEM, V73, P538, DOI 10.1046/j.1471-4159.1999.0730538.x; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Marshall J, 2002, MOL THER, V6, P179, DOI 10.1006/mthe.2002.0650; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Pelled D, 2000, J INHERIT METAB DIS, V23, P175, DOI 10.1023/A:1005622001239; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Schueler UH, 2003, NEUROBIOL DIS, V14, P595, DOI 10.1016/j.nbd.2003.08.016; Slepko N, 1996, GLIA, V16, P241; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Vellodi A, 2001, J INHERIT METAB DIS, V24, P319, DOI 10.1023/A:1010514614570; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Zimran A, 2007, J INHERIT METAB DIS, V30, P843, DOI 10.1007/s10545-007-0783-8	32	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43310	10.1371/journal.pone.0043310	http://dx.doi.org/10.1371/journal.pone.0043310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912851	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700079
J	Du, CW; Zhou, JM; Goyne, KW				Du Changwen; Zhou Jianmin; Goyne, Keith W.			Organic and Inorganic Carbon in Paddy Soil as Evaluated by Mid-Infrared Photoacoustic Spectroscopy	PLOS ONE			English	Article							MATTER; BIOGEOCHEMISTRY; PHOSPHORUS; EMISSIONS; METHANE; FOREST	Paddy soils are classified as wetlands which play a vital role in climatic change and food production. Soil carbon (C), especially soil organic C (SOC), in paddy soils has been received considerable attention as of recent. However, considerably less attention has been given to soil inorganic carbon (SIC) in paddy soils and the relationship between SOC and SIC at interface between soil and the atmosphere. The objective of this research was to investigate the utility of applying Fourier transform mid-infrared photoacoustic spectroscopy (FTIR-PAS) to explore SOC and SIC present near the surface (0-10 mu m) of paddy soils. The FTIR-PAS spectra revealed an unique absorption region in the wavenumber range of 1,350-1,500 cm(-1) that was dominated by C-O (carbonate) and C-H bending vibrations (organic materials), and these vibrations were used to represented SIC and SOC, respectively. A circular distribution between SIC and SOC on the surface of paddy soils was determined using principal component analysis (PCA), and the distribution showed no significant relationship with the age of paddy soil. However, SIC and SOC were negatively correlated, and higher SIC content was observed near the soil surface. This relationship suggests that SIC in soil surface plays important roles in the soil C dynamics.	[Du Changwen; Zhou Jianmin] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Goyne, Keith W.] Univ Missouri, Dept Soil Environm & Atmospher Sci, Columbia, MO USA	Chinese Academy of Sciences; Institute of Soil Science, CAS; University of Missouri System; University of Missouri Columbia	Du, CW (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	chwdu@issas.ac.cn	Changwen, Du/E-5239-2013	Changwen, Du/0000-0002-9064-3581	National Natural Science Foundation of China [40871113]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-QN411]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (40871113) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-QN411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Calderon FJ, 2011, SOIL SCI SOC AM J, V75, P568, DOI 10.2136/sssaj2009.0375; Cao ZH, 2006, NATURWISSENSCHAFTEN, V93, P232, DOI 10.1007/s00114-006-0083-4; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Drapcho DL, 1997, APPL SPECTROSC, V51, P453, DOI 10.1366/0003702971940486; Du C, 2008, GEODERMA, V143, P85, DOI 10.1016/j.geoderma.2007.10.012; Du CW, 2007, CHINESE J ANAL CHEM, V35, P119; Du CW, 2007, APPL SPECTROSC, V61, P1063, DOI 10.1366/000370207782217743; Du CW, 2011, J PLANT NUTR SOIL SC, V174, P20, DOI 10.1002/jpln.200900281; Du CW, 2010, J SOIL SEDIMENT, V10, P855, DOI 10.1007/s11368-010-0225-3; Du CW, 2009, VIB SPECTROSC, V49, P32, DOI 10.1016/j.vibspec.2008.04.009; Ellerbrock RH, 2004, EUR J SOIL SCI, V55, P219, DOI 10.1046/j.1365-2389.2004.00593.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Goddard MA, 2009, SOIL SCI SOC AM J, V73, P989, DOI 10.2136/sssaj2008.0004; Griffiths P R., 2006, HDB VIBRATIONAL SPEC; Hirmas DR, 2010, GEODERMA, V154, P486, DOI 10.1016/j.geoderma.2009.05.005; Huang PM, 2005, PEDOBIOLOGIA, V49, P609, DOI 10.1016/j.pedobi.2005.06.006; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Kogel-Knabner I, 2010, GEODERMA, V157, P1, DOI 10.1016/j.geoderma.2010.03.009; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Redeker KR, 2000, SCIENCE, V290, P966, DOI 10.1126/science.290.5493.966; Tatzber M, 2010, APPL SPECTROSC, V64, P1167, DOI 10.1366/000370210792973460; Wang YG, 2010, SCI TOTAL ENVIRON, V408, P1925, DOI 10.1016/j.scitotenv.2010.01.015; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Zhang WR, 2009, PROG ORG COAT, V65, P469, DOI 10.1016/j.porgcoat.2009.04.005; Zoltan B, 2011, APPL SPECTROSC REV, V46, P1, DOI 10.1080/05704928.2010.520178	34	6	6	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43368	10.1371/journal.pone.0043368	http://dx.doi.org/10.1371/journal.pone.0043368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912863	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700091
J	Zhao, YZ; Song, T; Wang, WJ; Wang, J; He, JW; Wu, NN; Tang, M; He, BC; Luo, JY				Zhao, Yingze; Song, Tao; Wang, Wenjuan; Wang, Jin; He, Juanwen; Wu, Ningning; Tang, Min; He, Baicheng; Luo, Jinyong			P38 and ERK1/2 MAPKs Act in Opposition to Regulate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; MARROW STROMAL CELLS; STEM-CELLS; OSTEOBLAST DIFFERENTIATION; GENE-THERAPY; BMP-2 GENE; TRANSCRIPTION FACTOR; SKELETAL DEVELOPMENT; SIGNALING PATHWAYS; OSTEOCALCIN GENE	Although previous studies have demonstrated that BMP9 is highly capable of inducing osteogenic differentiation and bone formation, the precise molecular mechanism involved remains to be fully elucidated. In this current study, we explore the possible involvement and detail effects of p38 and ERK1/2 MAPKs on BMP9-indcued osteogenic differentiation of mesenchymal progenitor cell (MPCs). We find that BMP9 simultaneously stimulates the activation of p38 and ERK1/2 in MPCs. BMP9-induced early osteogenic marker, such as alkaline phosphatase (ALP), and late osteogenic markers, such as matrix mineralization and osteocalcin (OC) are inhibited by p38 inhibitor SB203580, whereas enhanced by ERK1/2 inhibitor PD98059. BMP9-induced activation of Runx2 and Smads signaling are reduced by SB203580, and yet increased by PD98059 in MPCs. The in vitro effects of inhibitors are reproduced with adenoviruses expressing siRNA targeted p38 and ERK1/2, respectively. Using mouse calvarial organ culture and subcutaneous MPCs implantation, we find that inhibition of p38 activity leads to significant decrease in BMP9-induced osteogenic differentiation and bone formation, however, blockage of ERK1/2 results in effective increase in BMP9-indcued osteogenic differentiation in vivo. Together, our results reveal that p38 and ERK1/2 MAPKs are activated in BMP9-induced osteogenic differentiation of MPCs. What is most noteworthy, however, is that p38 and ERK1/2 act in opposition to regulate BMP9-induced osteogenic differentiation of MPCs.	[Zhao, Yingze; Song, Tao; Wang, Wenjuan; Wang, Jin; He, Juanwen; Wu, Ningning; Tang, Min; He, Baicheng; Luo, Jinyong] Chongqing Med Univ, Chinese Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China	Chongqing Medical University	Zhao, YZ (corresponding author), Chongqing Med Univ, Chinese Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China.	luojinyong888@hotmail.com			Natural Science Foundation of China [31071304, 30800658]; Natural Science Foundation Project of Chongqing Science and Technology Commission [2009BB5060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science and Technology Commission(Natural Science Foundation of Chongqing)	This work was supported in part by research grants from the Natural Science Foundation of China (#31071304 and #30800658 to Dr. Luo), and the Natural Science Foundation Project of Chongqing Science and Technology Commission (#2009BB5060 to Dr. Luo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592; Awasthi V, 2000, AM J PHYSIOL-LUNG C, V279, pL942, DOI 10.1152/ajplung.2000.279.5.L942; Bergeron E, 2009, TISSUE ENG PT A, V15, P3341, DOI 10.1089/ten.TEA.2009.0189; Boraiah S, 2009, CLIN ORTHOP RELAT R, V467, P3257, DOI 10.1007/s11999-009-1039-8; Boyle AJ, 2010, METHODS MOL BIOL, V660, P65, DOI 10.1007/978-1-60761-705-1_5; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chen X, 2011, PATHOL ONCOL RES, V17, P257, DOI 10.1007/s12253-010-9307-1; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fan JH, 2009, J CELL PHYSIOL, V220, P72, DOI 10.1002/jcp.21731; Fan YM, 2007, MOL CELLS, V23, P30; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Garrett IR, 2003, METH MOLEC MED, V80, P183; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Greenblatt MB, 2010, ANN NY ACAD SCI, V1192, P385, DOI 10.1111/j.1749-6632.2009.05222.x; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Haynes T, 2007, P NATL ACAD SCI USA, V104, P20380, DOI 10.1073/pnas.0708202104; Heffron DS, 2005, MOL CELL NEUROSCI, V28, P779, DOI 10.1016/j.mcn.2004.12.010; Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307; Kang MH, 2011, EXP CELL RES, V317, P1746, DOI 10.1016/j.yexcr.2011.04.006; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248; Liu H, 2011, J BONE MINER RES, V26, P1122, DOI 10.1002/jbmr.296; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Lou J, 2000, BIOCHEM BIOPH RES CO, V268, P757, DOI 10.1006/bbrc.2000.2210; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Myers TJ, 2010, EXPERT OPIN BIOL TH, V10, P1663, DOI 10.1517/14712598.2010.531257; Nakayama K, 2003, J BONE MINER RES, V18, P827, DOI 10.1359/jbmr.2003.18.5.827; Payne KA, 2010, TISSUE ENG PT A, V16, P3647, DOI 10.1089/ten.TEA.2009.0738; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ploemacher RE, 1999, LEUKEMIA, V13, P428, DOI 10.1038/sj.leu.2401363; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qin W, 2012, INT ENDOD J, V45, P224, DOI 10.1111/j.1365-2591.2011.01965.x; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Rutherford RB, 2003, DRUG NEWS PERSPECT, V16, P5, DOI 10.1358/dnp.2003.16.1.829301; Shields JM, 2002, MOL CELL BIOL, V22, P2304, DOI 10.1128/MCB.22.7.2304-2317.2002; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Varady P, 2002, ACAD RADIOL, V9, P632, DOI 10.1016/S1076-6332(03)80307-0; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Verheyen EM, 2007, DEV CELL, V13, P755, DOI 10.1016/j.devcel.2007.11.006; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wu NN, 2010, ACTA BIOCH BIOPH SIN, V42, P699, DOI 10.1093/abbs/gmq075; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	77	50	63	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43383	10.1371/journal.pone.0043383	http://dx.doi.org/10.1371/journal.pone.0043383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912865	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700093
J	Petty, A; Myshkin, E; Qin, HN; Guo, H; Miao, H; Tochtrop, GP; Hsieh, JT; Page, P; Liu, LL; Lindner, DJ; Acharya, C; MacKerell, AD; Ficker, E; Song, JX; Wang, BC				Petty, Aaron; Myshkin, Eugene; Qin, Haina; Guo, Hong; Miao, Hui; Tochtrop, Gregory P.; Hsieh, Jer-Tsong; Page, Phillip; Liu, Lili; Lindner, Daniel J.; Acharya, Chayan; MacKerell, Alexander D., Jr.; Ficker, Eckhard; Song, Jianxing; Wang, Bingcheng			A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; N-15 RELAXATION; EPHRIN-BINDING; PROTEIN; TARGET; ACTIVATION; DYNAMICS; DOMAIN; PHENOXYBENZAMINE; SUPPRESSES	During tumor progression, EphA2 receptor can gain ligand-independent pro-oncogenic functions due to Akt activation and reduced ephrin-A ligand engagement. The effects can be reversed by ligand stimulation, which triggers the intrinsic tumor suppressive signaling pathways of EphA2 including inhibition of PI3/Akt and Ras/ERK pathways. These observations argue for development of small molecule agonists for EphA2 as potential tumor intervention agents. Through virtual screening and cell-based assays, we report here the identification and characterization of doxazosin as a novel small molecule agonist for EphA2 and EphA4, but not for other Eph receptors tested. NMR studies revealed extensive contacts of doxazosin with EphA2/A4, recapitulating both hydrophobic and electrostatic interactions recently found in the EphA2/ephrin-A1 complex. Clinically used as an alpha 1-adrenoreceptor antagonist (Cardura (R)) for treating hypertension and benign prostate hyperplasia, doxazosin activated EphA2 independent of alpha 1-adrenoreceptor. Similar to ephrin-A1, doxazosin inhibited Akt and ERK kinase activities in an EphA2-dependent manner. Treatment with doxazosin triggered EphA2 receptor internalization, and suppressed haptotactic and chemotactic migration of prostate cancer, breast cancer, and glioma cells. Moreover, in an orthotopic xenograft model, doxazosin reduced distal metastasis of human prostate cancer cells and prolonged survival in recipient mice. To our knowledge, doxazosin is the first small molecule agonist of a receptor tyrosine kinase that is capable of inhibiting malignant behaviors in vitro and in vivo.	[Petty, Aaron; Myshkin, Eugene; Guo, Hong; Miao, Hui; Ficker, Eckhard; Wang, Bingcheng] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, Cleveland, OH 44106 USA; [Qin, Haina; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Tochtrop, Gregory P.; Wang, Bingcheng] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Tochtrop, Gregory P.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Hsieh, Jer-Tsong] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Page, Phillip] Reichert Inc, Depew, NY USA; [Liu, Lili] Case Western Reserve Univ, Sch Med, Dept Med, Div Hematol & Oncol,Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Lindner, Daniel J.] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA; [Acharya, Chayan; MacKerell, Alexander D., Jr.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Wang, Bingcheng] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; MetroHealth System; National University of Singapore; Case Western Reserve University; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore; National University of Singapore; Case Western Reserve University	Petty, A (corresponding author), Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, MetroHlth Campus, Cleveland, OH 44106 USA.	bchsj@nus.edu.sg; bxw14@case.edu	MacKerell, Alex/Y-2469-2019; Song, Jianxing/H-8026-2012; MacKerell, Alex/AAA-2560-2020; Qin, Haina/AAB-7486-2020; Lindner, Daniel/ABB-5440-2020	MacKerell, Alex/0000-0001-8287-6804; Haina, Qin/0000-0002-9175-8014; Song, Jianxing/0000-0003-0224-6322	National Institutes of Health [CA155676-01, DK077876, CA152371]; FAMRI; Singapore National Medical Research Council Grants [NMRC/1216/2009]; Ohio Supercomputer Center; NATIONAL CANCER INSTITUTE [R01CA152371, R01CA155676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; Singapore National Medical Research Council Grants(National Medical Research Council, Singapore); Ohio Supercomputer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health to BW (CA155676-01, DK077876), BW and HM (CA152371), and awards to BW from FAMRI and Prayer From Maria Foundations. JS was supported by Singapore National Medical Research Council Grants NMRC/1216/2009. In silico screening was supported by a grant from the Ohio Supercomputer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; [Anonymous], 1997, Cell, V90, P403; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Benning CM, 2002, CANCER RES, V62, P597; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CONSTANTINE JW, 1980, N-S ARCH PHARMACOL, V314, P149, DOI 10.1007/BF00504531; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Hui HX, 2008, EUR J CANCER, V44, P160, DOI 10.1016/j.ejca.2007.10.002; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kyprianou N, 2000, CANCER RES, V60, P4550; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; Lipinski CA, 2007, J PHARMACOL TOX MET, V44, P235; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Miao H, 2009, INT J BIOCHEM CELL B, V41, P762, DOI 10.1016/j.biocel.2008.07.019; Myshkin E, 2003, J CHEM INF COMP SCI, V43, P1004, DOI 10.1021/ci0256586; NICKERSON M, 1962, ARCH INT PHARMACOD T, V140, P237; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; SMYTH DD, 1984, J PHARMACOL EXP THER, V230, P387; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Walker O, 2004, J MAGN RESON, V168, P336, DOI 10.1016/j.jmr.2004.03.019; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wang BC, 2008, BLOOD, V112, P455, DOI 10.1182/blood-2008-05-152397; Wang BC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002153; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yang G, 1997, PROSTATE, V33, P157; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Zelinski DP, 2001, CANCER RES, V61, P2301	61	93	96	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42120	10.1371/journal.pone.0042120	http://dx.doi.org/10.1371/journal.pone.0042120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916121	Green Published, gold			2022-12-27	WOS:000307823600009
J	Cox, RF; Jenkinson, A; Pohl, K; O'Brien, FJ; Morgan, MP				Cox, Rachel F.; Jenkinson, Allan; Pohl, Kerstin; O'Brien, Fergal J.; Morgan, Maria P.			Osteomimicry of Mammary Adenocarcinoma Cells In Vitro; Increased Expression of Bone Matrix Proteins and Proliferation within a 3D Collagen Environment	PLOS ONE			English	Article							HUMAN BREAST-CANCER; MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; GAG SCAFFOLDS; SIALOPROTEIN; MICROCALCIFICATIONS; MINERALIZATION; CALCIUM; BENIGN	Bone is the most common site of metastasis for breast cancer, however the reasons for this remain unclear. We hypothesise that under certain conditions mammary cells possess osteomimetic capabilities that may allow them to adapt to, and flourish within, the bone microenvironment. Mammary cells are known to calcify within breast tissue and we have recently reported a novel in vitro model of mammary mineralization using murine mammary adenocarcinoma 4T1 cells. In this study, the osteomimetic properties of the mammary adenocarcinoma cell line and the conditions required to induce mineralization were characterized extensively. It was found that exogenous organic phosphate and inorganic phosphate induce mineralization in a dose dependent manner in 4T1 cells. Ascorbic acid and dexamethasone alone have no effect. 4T1 cells also show enhanced mineralization in response to bone morphogenetic protein 2 in the presence of phosphate supplemented media. The expression of several bone matrix proteins were monitored throughout the process of mineralization and increased expression of collagen type 1 and bone sialoprotein were detected, as determined by real-time RT-PCR. In addition, we have shown for the first time that 3D collagen glycosaminoglycan scaffolds, bioengineered to represent the bone microenvironment, are capable of supporting the growth and mineralization of 4T1 adenocarcinoma cells. These 3D scaffolds represent a novel model system for the study of mammary mineralization and bone metastasis. This work demonstrates that mammary cells are capable of osteomimicry, which may ultimately contribute to their ability to preferentially metastasize to, survive within and colonize the bone microenvironment.	[Cox, Rachel F.; Jenkinson, Allan; Pohl, Kerstin; Morgan, Maria P.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland; [O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin	Cox, RF (corresponding author), Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland.	mmorgan@rcsi.ie	O'Brien, Fergal/F-9485-2011	O'Brien, Fergal/0000-0003-2030-8005; Morgan, Maria/0000-0002-7041-3949	Royal College of Surgeons in Ireland Research Committee grant	Royal College of Surgeons in Ireland Research Committee grant	This work was supported by a Royal College of Surgeons in Ireland Research Committee grant to Maria P. Morgan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; Bellahcene A, 1996, LAB INVEST, V75, P203; Bellahcene A, 1996, INT J CANCER, V69, P350; BELLAHCENE A, 1994, CANCER RES, V54, P2823; Bellahcene A, 1996, J BONE MINER RES, V11, P665; BUSING CM, 1981, VIRCHOWS ARCH A, V393, P307, DOI 10.1007/BF00430830; CHEN JK, 1992, J BONE MINER RES, V7, P987; CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492; Clement JH, 2005, INT J ONCOL, V27, P401; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Cox RF, 2012, BRIT J CANCER, V106, P525, DOI 10.1038/bjc.2011.583; Davies Simon R, 2008, J Exp Ther Oncol, V7, P327; FRAPPART L, 1984, HUM PATHOL, V15, P880, DOI 10.1016/S0046-8177(84)80150-1; Gulsun M, 2003, EUR J RADIOL, V47, P227, DOI 10.1016/S0720-048X(02)00181-X; Haka AS, 2002, CANCER RES, V62, P5375; Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955; Hofvind S, 2011, ACTA RADIOL, V52, P481, DOI 10.1258/ar.2011.100357; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619; Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72; Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001; Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y; Kirsch T, 2006, CURR OPIN RHEUMATOL, V18, P174, DOI 10.1097/01.bor.0000209431.59226.46; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Landis W J, 1999, Gravit Space Biol Bull, V12, P15; Landis WJ, 2009, CELLS TISSUES ORGANS, V189, P20, DOI 10.1159/000151454; LEBOY PS, 1989, J BIOL CHEM, V264, P17281; Lee Jae-Mok, 2010, J Periodontal Implant Sci, V40, P39, DOI 10.5051/jpis.2010.40.1.39; Lian JB, 1997, ENDOCRINOLOGY, V138, P2117, DOI 10.1210/en.138.5.2117; Liu FB, 2010, BREAST CANCER RES TR, V122, P87, DOI 10.1007/s10549-009-0535-6; Morgan MP, 2001, MOL CARCINOGEN, V32, P111, DOI 10.1002/mc.1070; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; RADI MJ, 1989, ARCH PATHOL LAB MED, V113, P1367; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207; Wan XC, 2008, BIOCHEM BIOPH RES CO, V373, P488, DOI 10.1016/j.bbrc.2008.06.037; Yavorskyy A, 2010, BIOANALYSIS, V2, P189, DOI 10.4155/BIO.09.163; Yin YX, 2007, CHINESE MED J-PEKING, V120, P204, DOI 10.1097/00029330-200702010-00006	47	59	62	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41679	10.1371/journal.pone.0041679	http://dx.doi.org/10.1371/journal.pone.0041679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911843	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300064
J	Frisell, T; Pawitan, Y; Langstrom, N				Frisell, Thomas; Pawitan, Yudi; Langstrom, Niklas			Is the Association between General Cognitive Ability and Violent Crime Caused by Family-Level Confounders?	PLOS ONE			English	Article							SWEDISH ENLISTMENT BATTERY; CONSTRUCT-VALIDITY; GENETIC INFLUENCES; DELINQUENCY; IQ; INTELLIGENCE; OFFENDERS; TWINS; ADULTHOOD; BEHAVIOR	Background: Research has consistently found lower cognitive ability to be related to increased risk for violent and other antisocial behaviour. Since this association has remained when adjusting for childhood socioeconomic position, ethnicity, and parental characteristics, it is often assumed to be causal, potentially mediated through school adjustment problems and conduct disorder. Socioeconomic differences are notoriously difficult to quantify, however, and it is possible that the association between intelligence and delinquency suffer substantial residual confounding. Methods: We linked longitudinal Swedish total population registers to study the association of general cognitive ability (intelligence) at age 18 (the Conscript Register, 1980-1993) with the incidence proportion of violent criminal convictions (the Crime Register, 1973-2009), among all men born in Sweden 1961-1975 (N = 700,514). Using probit regression, we controlled for measured childhood socioeconomic variables, and further employed sibling comparisons (family pedigree data from the Multi-Generation Register) to adjust for shared familial characteristics. Results: Cognitive ability in early adulthood was inversely associated to having been convicted of a violent crime (beta = 20.19, 95% CI: -0.19; -0.18), the association remained when adjusting for childhood socioeconomic factors (beta = -0.18, 95% CI: -0.18; -0.17). The association was somewhat lower within half-brothers raised apart (beta = -0.16, 95% CI: -0.18; -0.14), within half-brothers raised together (beta = -0.13, 95% CI: (-0.15; -0.11), and lower still in full-brother pairs (beta = -0.10, 95% CI: -0.11; -0.09). The attenuation among half-brothers raised together and full brothers was too strong to be attributed solely to attenuation from measurement error. Discussion: Our results suggest that the association between general cognitive ability and violent criminality is confounded partly by factors shared by brothers. However, most of the association remains even after adjusting for such factors.	[Frisell, Thomas; Pawitan, Yudi; Langstrom, Niklas] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Frisell, Thomas; Langstrom, Niklas] Karolinska Inst, Ctr Violence Prevent, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Frisell, T (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Thomas.Frisell@ki.se	Langstrom, Niklas/C-5615-2009; Frisell, Thomas/E-2772-2017	Langstrom, Niklas/0000-0002-2686-6799; Frisell, Thomas/0000-0002-5735-9626	Swedish Prison and Probation Service RD; Swedish Research Council	Swedish Prison and Probation Service RD; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Frisell and Langstrom were supported by the Swedish Prison and Probation Service R&D. Langstrom further received funding from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews D.A., 2006, PSYCHOL CRIMINAL CON, Vfourth; Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Bezdjian S, 2011, CLIN PSYCHOL REV, V31, P1209, DOI 10.1016/j.cpr.2011.07.005; Bound J, 1999, ECON EDUC REV, V18, P169, DOI 10.1016/S0272-7757(98)00048-X; CARLSTEDT B, 1993, SCAND J PSYCHOL, V34, P353, DOI 10.1111/j.1467-9450.1993.tb01131.x; Carlstedt B, 2000, COGNITIVE ABILITIES; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; Donnellan MB, 2000, J ABNORM PSYCHOL, V109, P396, DOI 10.1037/0021-843X.109.3.396; Dwyer T, 2005, PAEDIATR PERINAT EP, V19, P48, DOI 10.1111/j.1365-3016.2005.00615.x; Farrington D P, 1989, Violence Vict, V4, P79; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P850, DOI 10.1111/j.1469-7610.2005.01472.x; Frisell T, 2011, PSYCHOL MED, V41, P97, DOI 10.1017/S0033291710000462; Frisell T, 2012, EPIDEMIOL IN PRESS; Frisell T, 2012, BEHAV GENET, V42, P3, DOI 10.1007/s10519-011-9483-0; GOODMAN R, 1995, J CHILD PSYCHOL PSYC, V36, P409, DOI 10.1111/j.1469-7610.1995.tb01299.x; GRILICHES Z, 1979, J POLIT ECON, V87, pS37, DOI 10.1086/260822; Groen-Blokhuis MM, 2011, J AM ACAD CHILD PSY, V50, P1247, DOI 10.1016/j.jaac.2011.09.007; Guay JP, 2005, INT J LAW PSYCHIAT, V28, P405, DOI 10.1016/j.ijlp.2004.03.010; Haworth CMA, 2009, BEHAV GENET, V39, P359, DOI 10.1007/s10519-009-9262-3; Healy W., 1936, NEW LIGHT DELINQUENC; HIRSCHI T, 1977, AM SOCIOL REV, V42, P571, DOI 10.2307/2094556; Isen J, 2010, CLIN PSYCHOL REV, V30, P423, DOI 10.1016/j.cpr.2010.02.003; Johansson P, 2005, J PERS DISORD, V19, P357, DOI 10.1521/pedi.2005.19.4.357; Kennedy TD, 2011, AGGRESSIVE BEHAV, V37, P315, DOI 10.1002/ab.20393; Kjellgren C, 2010, ARCH SEX BEHAV, V39, P1161, DOI 10.1007/s10508-009-9572-9; Koenen KC, 2006, J ABNORM PSYCHOL, V115, P787, DOI 10.1037/0021-843X.115.4.787; Levine SZ, 2011, PERS INDIV DIFFER, V50, P1233, DOI 10.1016/j.paid.2011.02.016; LIPSITT PD, 1990, AM J FAM THER, V18, P197; Lussier P, 2005, SEX ABUSE-J RES TR, V17, P269, DOI 10.1007/s11194-005-5057-0; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; Mardberg B, 1998, INT J SELECT ASSESS, V6, P107, DOI 10.1111/1468-2389.00079; McGloin JM, 2004, JUSTICE Q, V21, P603, DOI 10.1080/07418820400095921; McGue M, 2010, PERSPECT PSYCHOL SCI, V5, P546, DOI 10.1177/1745691610383511; MOFFITT TE, 1990, CRIME JUSTICE, V12, P99, DOI 10.1086/449165; MOFFITT TE, 1981, J ABNORM PSYCHOL, V90, P152, DOI 10.1037/0021-843X.90.2.152; MOFFITT TE, 1988, J ABNORM PSYCHOL, V97, P330, DOI 10.1037/0021-843X.97.3.330; Mottus R, 2012, EUR J PERSONALITY, V26, P56, DOI 10.1002/per.820; Munoz LC, 2008, J CHILD PSYCHOL PSYC, V49, P414, DOI 10.1111/j.1469-7610.2007.01847.x; Ross A., 1969, VARNPLIKTIGAS PRESTA; SCHONFELD IS, 1988, CHILD DEV, V59, P993, DOI 10.2307/1130266; Sjolander A, 2012, EPIDEMIOL M IN PRESS; STATTIN H, 1993, J ABNORM PSYCHOL, V102, P369, DOI 10.1037/0021-843X.102.3.369; Susser E, 2010, AM J EPIDEMIOL, V172, P537, DOI 10.1093/aje/kwq196; Vasilopoulos T, 2012, NEUROPSYCHOLOGY, V26, P238, DOI 10.1037/a0026768; Wanklyn SG, 2012, J INTERPERS VIOLENCE, V27, P2128, DOI 10.1177/0886260511432153; WARD DA, 1994, J QUANT CRIMINOL, V10, P189, DOI 10.1007/BF02221210; Wechsler D., 2012, WAIS 4 KASIKIRJA	47	35	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41783	10.1371/journal.pone.0041783	http://dx.doi.org/10.1371/journal.pone.0041783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22911856	Green Published, gold			2022-12-27	WOS:000306751300075
J	Liu, Y; Lv, BT; He, ZM; Zhou, YJ; Han, C; Shi, GD; Gao, R; Wang, C; Yang, LL; Song, HH; Yuan, W				Liu, Yang; Lv, Bitao; He, Zhimin; Zhou, Yujia; Han, Carrie; Shi, Guodong; Gao, Rui; Wang, Ce; Yang, Lili; Song, Haihan; Yuan, Wen			Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma	PLOS ONE			English	Article							MESSENGER-RNA; OSTEOBLASTIC PHENOTYPE; PROPEPTIDE DOMAIN; CORE PROMOTER; LOX GENE; H-RAS; CELLS; BONE; CANCER; EXPRESSION	Despite the knowledge of many genetic alterations present in osteosarcoma, the complexity of this disease precludes placing its biology into a simple conceptual framework. Lysyl oxidase (LOX) catalyzes the cross-linking of elastin and collagen, which is essential for the structural integrity and function of bone tissue. In the current study, we performed genomic sequencing on all seven exons -including the intron-exon splice sites, and the putative promoter region of LOX gene - followed by luciferase reporter assay to analyze the function of newly identified polymorphisms. Associations between LOX polymorphisms and osteosarcoma were then evaluated. Our sequencing data revealed three polymorphisms (-22G/C, 225C/G, and 473G/A) in the exons and promoter region of LOX. The -22G/C polymorphism lies in the downstream core promoter element (DPE) region and caused a decrease in promoter activity of LOX. The prevalence of the -22C allele and 473A allele were significantly increased in osteosarcoma patients compared to controls (odds ratio [OR] = 3.88, 95% confidence interval [CI] = 1.94-7.78, p = 4.18x10(-5), and OR = 1.38, 95% CI = 1.07-1.78, p = 0.013; p 0.0167 was considered significant after Bonferroni correction). Analyzing haplotype showed that the frequency of CCG haplotype (-22, 225, 473) was significantly higher in osteosarcoma cases than in healthy controls after Bonferroni correction (p = 4.46x10(-4)). These results indicate that the -22G/C polymorphism may affect the expression of LOX, and that -22G/C and 473G/A polymorphisms may be new risk factors for osteosarcoma. These findings reveal a potential new pathway by which genetic polymorphisms may affect human diseases.	[Liu, Yang; Lv, Bitao; Shi, Guodong; Gao, Rui; Wang, Ce; Yang, Lili; Yuan, Wen] Second Mil Med Univ, Changzheng Hosp, Dept Spine Surg, Shanghai, Peoples R China; [He, Zhimin] Shanghai 6 Peoples Hosp, Dept Orthoped Surg, Fengxian Branch, Shanghai, Peoples R China; [Zhou, Yujia] Univ Western Ontario, Sch Occupat Therapy, London, ON, Canada; [Han, Carrie] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Song, Haihan] Tongji Univ, Shanghai E Hosp, Emergency Ctr, Shanghai 200092, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Western University (University of Western Ontario); University of Toronto; Tongji University	Liu, Y (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Spine Surg, Shanghai, Peoples R China.	haihansong@126.com; spiineyuanwen@hotmail.com			National Natural Science Foundation of China [81171677]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81171677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212; Buchinger B, 2008, CANCER LETT, V265, P45, DOI 10.1016/j.canlet.2008.02.008; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Gao S, 2007, J BIOL CHEM, V282, P25322, DOI 10.1074/jbc.M610108200; Geiger BJ, 1933, J NUTR, V6, P427, DOI 10.1093/jn/6.5.427; HAJNAL A, 1993, CANCER RES, V53, P4670; HAMALAINEN ER, 1995, J BIOL CHEM, V270, P21590, DOI 10.1074/jbc.270.37.21590; Hameed M, 2011, SEMIN DIAGN PATHOL, V28, P86, DOI 10.1053/j.semdp.2011.02.002; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; KNOTT L, 1995, BIOCHEM J, V310, P1045, DOI 10.1042/bj3101045; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; KRZYZOSIAK WJ, 1992, P NATL ACAD SCI USA, V89, P4879, DOI 10.1073/pnas.89.11.4879; KUIVANIEMI H, 1986, FEBS LETT, V195, P261, DOI 10.1016/0014-5793(86)80172-7; Ma L, 2011, DNA CELL BIOL, V30, P1033, DOI 10.1089/dna.2011.1261; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Pischon N, 2009, CALCIFIED TISSUE INT, V85, P119, DOI 10.1007/s00223-009-9252-8; Posthuma DeBoer J, 2011, CLIN EXP METASTAS, V28, P493, DOI DOI 10.1007/S10585-011-9384-X; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Ren CZ, 1998, CANCER RES, V58, P1285; Shim H, 2003, J NUTR, V133, p1527S, DOI 10.1093/jn/133.5.1527S; Siddikuzzaman, 2011, Inflammopharmacology, V19, P117, DOI 10.1007/s10787-010-0073-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Song B, 2011, RESPIRATION, V82, P439, DOI 10.1159/000329345; Subbiah V, 2011, CURR OPIN ONCOL, V23, P352, DOI 10.1097/CCO.0b013e3283477a94; Wang W, 2011, DNA CELL BIOL, V30, P925, DOI 10.1089/dna.2011.1211; Yamauchi M., 1996, CALCIUM PHOSPHORUS H, P127	32	33	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41610	10.1371/journal.pone.0041610	http://dx.doi.org/10.1371/journal.pone.0041610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911823	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700123
J	Napoli, N; Zardi, E; Strollo, R; Arigliani, M; Daverio, A; Olearo, F; Tosi, D; Dicuonzo, G; Scarpa, F; Pedone, C; Simo, HHT; Mottini, G; Pozzilli, P				Napoli, Nicola; Zardi, Enrico; Strollo, Rocky; Arigliani, Michele; Daverio, Andrea; Olearo, Flaminia; Tosi, Daniele; Dicuonzo, Giordano; Scarpa, Filomena; Pedone, Claudio; Tegue Simo, Herve Hilaire; Mottini, Giovanni; Pozzilli, Paolo			Increased Carotid Thickness in Subjects with Recently-Diagnosed Diabetes from Rural Cameroon	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; IMPAIRED GLUCOSE-TOLERANCE; ARTERY INTIMA; GLYCEMIC CONTROL; RISK; PROGRESSION; COMPLICATIONS; HYPERTENSION; POPULATION; PREVALENCE	Background: We have recently shown a high prevalence of diabetes and obesity in rural Cameroon, despite an improved lifestyle. Diabetes in rural Africa remains underdiagnosed and its role in increasing risk of atherosclerosis in these populations is unknown. We investigated the prevalence of carotid atherosclerosis and cardiovascular risk factors in a population of subjects with recently-diagnosed diabetes from rural Cameroon. Methodology/Principal Findings: In a case-control study, carotid intima-media thickness (IMT) was measured in 74 subjects with diabetes (diagnosed <2 years), aged 47-85 and 109 controls comparable for age and sex. Subjects were recruited during a health campaign conducted in April 2009. Blood glucose control (HbA1c, fasting blood glucose) and major cardiovascular risk factors (complete lipid panel, blood pressure) were also measured. Mean carotid IMT was higher in subjects with diabetes than healthy controls at each scanned segment (common, internal carotid and bulb) (P < 0.05), except the near wall of the left bulb. Vascular stiffness tended to be higher and pressure-strain elastic modulus of the left carotid was increased in subjects with diabetes than controls (P < 0.05), but distensibility was similar between the two groups. At least one plaque >0.9 mm was found in 4%, 45.9% and 20% of diabetic subjects at the common, bulb or internal carotid, respectively. Only 25% of patients had an HbA1c<7%, while over 41.6% presented with marked hyperglycemia (HbA1c>9%). The prevalence of diabetic subjects with abnormal levels of LDL-cholesterol, triglycerides, HDL-cholesterol or blood pressure was 45%, 16.6%, 15% and 65.7%, respectively. Conclusions: Carotid thickness is increased in subjects with diabetes from a rural area of Cameroon, despite the relatively recent diagnosis. These findings and the high rate of uncontrolled diabetes in this population support the increasing concern of diabetes and cardiovascular diseases in African countries and indicate the need for multifaceted health interventions in urban and rural settings.	[Napoli, Nicola; Dicuonzo, Giordano; Scarpa, Filomena] Campus Biomed Univ Rome, Lab Clin Microbiol, Rome, Italy; [Napoli, Nicola] Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO USA; [Tegue Simo, Herve Hilaire] Minist Hlth Dist Baham, Baham, Cameroon; [Pozzilli, Paolo] Queen Mary Univ London, Barts & London Sch Med, Ctr Diabet, London, England	University Campus Bio-Medico - Rome Italy; Washington University (WUSTL); University of London; Queen Mary University London	Napoli, N (corresponding author), Campus Biomed Univ Rome, Lab Clin Microbiol, Rome, Italy.	n.napoli@unicampus.it	Zardi, Enrico Maria/Z-1309-2019; Pedone, Claudio/F-9488-2010; Strollo, Rocky/K-5015-2016; Arigliani, Michele/X-3270-2019; Tosi, Daniele/ABC-3656-2020; Napoli, Nicola/K-8242-2016	Pedone, Claudio/0000-0003-1847-9032; Strollo, Rocky/0000-0001-8967-7613; Arigliani, Michele/0000-0002-5366-4594; Tosi, Daniele/0000-0002-4894-206X; Pozzilli, Paolo/0000-0001-5090-636X; Napoli, Nicola/0000-0002-3091-8205	Farmindustria	Farmindustria	The study was funded by an unconditional grant to University Campus Bio-Medico from Farmindustria. Glucometers and strips were kindly offered by Lifescan Italia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard S, 2005, DIABETES CARE, V28, P1158, DOI 10.2337/diacare.28.5.1158; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P969; Cooper RS, 1998, BMJ-BRIT MED J, V316, P614, DOI 10.1136/bmj.316.7131.614; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Distiller LA, 2006, J DIABETES COMPLICAT, V20, P280, DOI 10.1016/j.jdiacomp.2005.07.012; Distiller LA, 2010, METAB SYNDR RELAT D, V8, P539, DOI 10.1089/met.2010.0036; Faeh D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-163; Faeh D, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-32; Fezeu L, 2010, DIABETES RES CLIN PR, V90, P312, DOI 10.1016/j.diabres.2010.06.029; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; International Diabetes Federation, 2009, DIABETES ATLAS; International Diabetes Federation, 1998, ACC INS REP IDF INS; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; LAURENT S, 1988, J HYPERTENS, V6, pS182, DOI 10.1097/00004872-198812040-00054; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Liu YP, 2007, ENDOCRINE, V31, P289, DOI 10.1007/s12020-007-0035-6; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mayosi B, 2007, Cardiovasc J S Afr, V18, P4; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Mbanya JC, 2003, J CARDIOVASC RISK, V10, P97, DOI [10.1097/00043798-200304000-00004, 10.1097/01.hjr.0000060842.48106.78]; Mbanya JCN, 1997, DIABETOLOGIA, V40, P824, DOI 10.1007/s001250050755; Mbanya JC, 2006, LANCET, V368, P1628, DOI 10.1016/S0140-6736(06)69673-6; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Nambuya AP, 1996, QJM-INT J MED, V89, P705; Napoli N, 2007, AM J CLIN NUTR, V85, P1428, DOI 10.1093/ajcn/85.5.1428; Napoli N, 2010, DIABETES-METAB RES, V26, P10, DOI 10.1002/dmrr.1036; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Reddy KS, 1998, CIRCULATION, V97, P596; Shah AS, 2009, J CLIN ENDOCR METAB, V94, P3740, DOI 10.1210/jc.2008-2039; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shinoda-Tagawa T, 2002, DIABETOLOGIA, V45, P188, DOI 10.1007/s00125-001-0740-2; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004; Touboul PJ, 2005, CEREBROVASC DIS, V19, P57, DOI 10.1159/000081913; Tsivgoulis G, 2006, STROKE, V37, P1913, DOI 10.1161/01.STR.0000226399.13528.0a; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wagenknecht LE, 1998, DIABETES CARE, V21, P1812, DOI 10.2337/diacare.21.11.1812; Wagenknecht LE, 2003, ARTERIOSCL THROM VAS, V23, P1035, DOI 10.1161/01.ATV.0000072273.67342.6D; Yamasaki Y, 2000, DIABETES CARE, V23, P1310, DOI 10.2337/diacare.23.9.1310; Yokoyama H, 2006, STROKE, V37, P2420, DOI 10.1161/01.STR.0000236632.58323.cd	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41316	10.1371/journal.pone.0041316	http://dx.doi.org/10.1371/journal.pone.0041316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916106	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800010
J	Rocha-Martins, M; Njaine, B; Silveira, MS				Rocha-Martins, Mauricio; Njaine, Brian; Silveira, Mariana S.			Avoiding Pitfalls of Internal Controls: Validation of Reference Genes for Analysis by qRT-PCR and Western Blot throughout Rat Retinal Development	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; REAL-TIME PCR; MESSENGER-RNA LEVELS; REVERSE TRANSCRIPTION; BETA-ACTIN; RELATIVE QUANTIFICATION; EXPRESSION PROFILES; PROGENITOR CELLS; TARGET GENES; SELECTION	Background: Housekeeping genes have been commonly used as reference to normalize gene expression and protein content data because of its presumed constitutive expression. In this paper, we challenge the consensual idea that housekeeping genes are reliable controls for expression studies in the retina through the investigation of a panel of reference genes potentially suitable for analysis of different stages of retinal development. Methodology/Principal Findings: We applied statistical tools on combinations of retinal developmental stages to assess the most stable internal controls for quantitative RT-PCR (qRT-PCR). The stability of expression of seven putative reference genes (Actb, B2m, Gapdh, Hprt1, Mapk1, Ppia and Rn18s) was analyzed using geNorm, BestKeeper and Normfinder software. In addition, several housekeeping genes were tested as loading controls for Western blot in the same sample panel, using Image J. Overall, for qRT-PCR the combination of Gapdh and Mapk1 showed the highest stability for most experimental sets. Actb was downregulated in more mature stages, while Rn18s and Hprt1 showed the highest variability. We normalized the expression of cyclin D1 using various reference genes and demonstrated that spurious results may result from blind selection of internal controls. For Western blot significant variation could be seen among four putative internal controls (bactin, cyclophilin b, alpha-tubulin and lamin A/C), while MAPK1 was stably expressed. Conclusion: Putative housekeeping genes exhibit significant variation in both mRNA and protein content during retinal development. Our results showed that distinct combinations of internal controls fit for each experimental set in the case of qRT-PCR and that MAPK1 is a reliable loading control for Western blot. The results indicate that biased study outcomes may follow the use of reference genes without prior validation for qRT-PCR and Western blot.	[Rocha-Martins, Mauricio; Silveira, Mariana S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Dept Neurobiol, BR-21941 Rio De Janeiro, Brazil; [Njaine, Brian] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Cell Therapy & Bioengn Dept, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Rocha-Martins, M (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Dept Neurobiol, BR-21941 Rio De Janeiro, Brazil.	silveira@biof.ufrj.br	Silveira, Mariana/M-4865-2013	Silveira, Mariana/0000-0002-0496-1517; Rocha-Martins, Mauricio/0000-0001-6881-6733	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); CNPq; CAEN/International Society for Neurochemistry	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAEN/International Society for Neurochemistry	This study was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), CNPq, and CAEN/International Society for Neurochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Barnhill Alison E, 2010, BMC Res Notes, V3, P25, DOI 10.1186/1756-0500-3-25; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dijk F, 2004, BRAIN RES, V1026, P194, DOI 10.1016/j.brainres.2004.08.034; Donovan SL, 2005, SEMIN CELL DEV BIOL, V16, P407, DOI 10.1016/j.semcdb.2005.02.012; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Dowling JE, 1987, RETINAL CELLS INFORM; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Egger Denise, 1994, Molecular Biotechnology, V1, P289, DOI 10.1007/BF02921696; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Liu NK, 2006, J NEUROTRAUM, V23, P1794, DOI 10.1089/neu.2006.23.1794; Liu Y, 2010, ACTA PHARMACOL SIN, V31, P10, DOI 10.1038/aps.2009.185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Y, 2011, INVEST OPHTH VIS SCI, V52, P7556, DOI 10.1167/iovs.11-7185; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Matta BP, 2011, DEV GENES EVOL, V221, P49, DOI 10.1007/s00427-011-0356-6; McNeill B, 2012, MOL CELL NEUROSCI, V49, P333, DOI 10.1016/j.mcn.2011.12.008; Njaine B, 2010, EUR J NEUROSCI, V32, P311, DOI 10.1111/j.1460-9568.2010.07286.x; Petrs-Silva H, 2004, J CELL PHYSIOL, V198, P179, DOI 10.1002/jcp.10404; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Seol Dongrim, 2011, BMC Res Notes, V4, P162, DOI 10.1186/1756-0500-4-162; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Sindelka R, 2006, DEV DYNAM, V235, P754, DOI 10.1002/dvdy.20665; Sindelka R, 2008, NUCLEIC ACIDS RES, V36, P387, DOI 10.1093/nar/gkm1024; Spinsanti G, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-32; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; van Wijngaarden P, 2007, MOL VIS, V13, P1508; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	48	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43028	10.1371/journal.pone.0043028	http://dx.doi.org/10.1371/journal.pone.0043028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916200	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800043
J	Carver, FW; Elvevag, B; Altamura, M; Weinberger, DR; Coppola, R				Carver, Frederick W.; Elvevag, Brita; Altamura, Mario; Weinberger, Daniel R.; Coppola, Richard			The Neuromagnetic Dynamics of Time Perception	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; FUNCTIONAL-ANATOMY; PREFRONTAL CORTEX; BRAIN ACTIVATION; BASAL GANGLIA; FMRI; MILLISECONDS; MODULATION; MECHANISMS; COMPONENTS	Examining real-time cortical dynamics is crucial for understanding time perception. Using magnetoencephalography we studied auditory duration discrimination of short (<.5 s) versus long tones (>.5 s) versus a pitch control. Time-frequency analysis of event-related fields showed widespread beta-band (13-30 Hz) desynchronization during all tone presentations. Synthetic aperture magnetometry indicated automatic primarily sensorimotor responses in short and pitch conditions, with activation specific to timing in bilateral inferior frontal gyrus. In the long condition, a right lateralized network was active, including lateral prefrontal cortices, inferior frontal gyrus, supramarginal gyrus and secondary auditory areas. Activation in this network peaked just after attention to tone duration was no longer necessary, suggesting a role in sustaining representation of the interval. These data expand our understanding of time perception by revealing its complex cortical spatiotemporal signature.	[Carver, Frederick W.; Coppola, Richard] NIMH, MEG Core Facil, Bethesda, MD 20892 USA; [Elvevag, Brita; Altamura, Mario; Weinberger, Daniel R.; Coppola, Richard] NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Carver, FW (corresponding author), NIMH, MEG Core Facil, Bethesda, MD 20892 USA.	brita@elvevaag.net	Elvevåg, Brita/ABC-1835-2021	Elvevåg, Brita/0000-0003-0441-3729; Coppola, Richard/0000-0003-0273-0675	National Institute of Mental Health, National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002889, ZIAMH002890, ZICMH002888, ZIAMH002734] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Intramural Research Program of the National Institute of Mental Health, National Institutes of Health: http://intramural.nimh.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P204, DOI 10.1162/jocn.2008.20017; Bueti D, 2010, J NEUROSCI, V30, P4343, DOI 10.1523/JNEUROSCI.2254-09.2010; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Coppola R, 2004, P 14 INT C BIOM, P234; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 2004, COGNITIVE BRAIN RES, V21, P216, DOI 10.1016/j.cogbrainres.2004.02.011; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Elvevag B, 2003, PSYCHOL MED, V33, P1249, DOI 10.1017/S0033291703008122; Ferrandez AM, 2003, NEUROIMAGE, V19, P1532, DOI 10.1016/S1053-8119(03)00159-9; FRAISSE P, 1984, ANNU REV PSYCHOL, V35, P1, DOI 10.1146/annurev.ps.35.020184.000245; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; Gerton BK, 2004, NEUROPSYCHOLOGIA, V42, P1781, DOI 10.1016/j.neuropsychologia.2004.04.023; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Grimm S, 2004, NEUROSCI LETT, V356, P83, DOI 10.1016/j.neulet.2003.11.035; Harrington DL, 2010, CEREB CORTEX, V20, P1274, DOI 10.1093/cercor/bhp194; Harrington DL, 2004, COGNITIVE BRAIN RES, V21, P193, DOI 10.1016/j.cogbrainres.2004.01.010; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; Jones CRG, 2004, EXP BRAIN RES, V158, P366, DOI 10.1007/s00221-004-1912-3; Koch G, 2003, NEUROLOGY, V60, P1844, DOI 10.1212/WNL.60.11.1844; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Malapani C, 2002, J COGNITIVE NEUROSCI, V14, P311, DOI 10.1162/089892902317236920; N'Diaye K, 2004, COGNITIVE BRAIN RES, V21, P250, DOI 10.1016/j.cogbrainres.2004.04.006; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; Pastor MA, 2004, J NEUROSCI, V24, P2585, DOI 10.1523/JNEUROSCI.4210-03.2004; Paul I, 2011, BIOL PSYCHOL, V88, P94, DOI 10.1016/j.biopsycho.2011.06.013; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Pouthas V, 2000, HUM BRAIN MAPP, V10, P49, DOI 10.1002/(SICI)1097-0193(200006)10:2<49::AID-HBM10>3.0.CO;2-8; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rubia K, 1998, NEUROPSYCHOLOGIA, V36, P1283, DOI 10.1016/S0028-3932(98)00038-4; Saad ZS, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1510; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Vallesi A, 2007, CEREB CORTEX, V17, P466, DOI 10.1093/cercor/bhj163; Vallesi A, 2009, J COGNITIVE NEUROSCI, V21, P1116, DOI 10.1162/jocn.2009.21098; Volz HP, 2001, NEUROREPORT, V12, P313, DOI 10.1097/00001756-200102120-00026; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; VRBA J, 1995, IEEE T APPL SUPERCON, V5, P2118, DOI 10.1109/77.403001; Wencil EB, 2010, J NEUROPHYSIOL, V104, P160, DOI 10.1152/jn.00029.2009; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064	55	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42618	10.1371/journal.pone.0042618	http://dx.doi.org/10.1371/journal.pone.0042618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912714	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700016
J	Davis, MPA; Abreu-Goodger, C; van Dongen, S; Lu, D; Tate, PH; Bartonicek, N; Kutter, C; Liu, PT; Skarnes, WC; Enright, AJ; Dunham, I				Davis, Matthew P. A.; Abreu-Goodger, Cei; van Dongen, Stijn; Lu, Dong; Tate, Peri H.; Bartonicek, Nenad; Kutter, Claudia; Liu, Pentao; Skarnes, William C.; Enright, Anton J.; Dunham, Ian			Large-Scale Identification of MicroRNA Targets in Murine Dgcr8-Deficient Embryonic Stem Cell Lines	PLOS ONE			English	Article							RNA-INTERFERENCE; SELF-RENEWAL; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; MESSENGER-RNAS; GENOME-WIDE; C-ELEGANS; ES CELLS; EXPRESSION; MOUSE	Small RNAs such as microRNAs play important roles in embryonic stem cell maintenance and differentiation. A broad range of microRNAs is expressed in embryonic stem cells while only a fraction of their targets have been identified. We have performed large-scale identification of embryonic stem cell microRNA targets using a murine embryonic stem cell line deficient in the expression of Dgcr8. These cells are heavily depleted for microRNAs, allowing us to reintroduce specific microRNA duplexes and identify refined target sets. We used deep sequencing of small RNAs, mRNA expression profiling and bioinformatics analysis of microRNA seed matches in 3' UTRs to identify target transcripts. Consequently, we have identified a network of microRNAs that converge on the regulation of several important cellular pathways. Additionally, our experiments have revealed a novel candidate for Dgcr8-independent microRNA genesis and highlighted the challenges currently facing miRNA annotation.	[Davis, Matthew P. A.; Lu, Dong; Tate, Peri H.; Liu, Pentao; Skarnes, William C.] Wellcome Trust Sanger Inst, Hinxton, England; [Davis, Matthew P. A.; Abreu-Goodger, Cei; van Dongen, Stijn; Bartonicek, Nenad; Enright, Anton J.; Dunham, Ian] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Abreu-Goodger, Cei] CINVESTAV, Natl Lab Genom Biodivers Langebio, Guanajuato, Mexico; [Kutter, Claudia] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Davis, MPA (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	dunham@ebi.ac.uk	Enright, Anton/F-3094-2011; Bartonicek, Nenad/B-6675-2016; Kutter, Claudia/HHD-1391-2022; Abreu-Goodger, Cei/A-1268-2010	Enright, Anton/0000-0002-6090-3100; Bartonicek, Nenad/0000-0003-2144-1887; Abreu-Goodger, Cei/0000-0001-8302-9893; Davis, Matthew/0000-0002-9909-3651; Kutter, Claudia/0000-0002-8047-0058; Dunham, Ian/0000-0003-2525-5598	Wellcome Trust; European Molecular Biology Laboratory European Bioinformatics Institute; Medical Research Council	Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory European Bioinformatics Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust and the European Molecular Biology Laboratory European Bioinformatics Institute. MPD was partially supported by a Medical Research Council studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanina SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001163; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krebs AR, 2010, EMBO REP, V11, P541, DOI 10.1038/embor.2010.75; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lerner M, 2011, CELL CYCLE GEORGETOW, V10; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P1084, DOI 10.1038/nsmb0911-1084a; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040938; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palmer RD, 2010, CANCER RES, V70, P2911, DOI 10.1158/0008-5472.CAN-09-3301; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI [10.4161/rna.7.5.13141, 10.4161/rna.7.4.13141]; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Sridharan R, 2011, CELL STEM CELL, V8, P599, DOI 10.1016/j.stem.2011.05.009; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Xu YF, 2010, J BIOL CHEM, V285, P34439, DOI 10.1074/jbc.M110.152306; Yang CS, 2011, RNA, V17, P1451, DOI 10.1261/rna.2664111	65	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41762	10.1371/journal.pone.0041762	http://dx.doi.org/10.1371/journal.pone.0041762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912678	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700007
J	Leprieur, F; Albouy, C; De Bortoli, J; Cowman, PF; Bellwood, DR; Mouillot, D				Leprieur, Fabien; Albouy, Camille; De Bortoli, Julien; Cowman, Peter F.; Bellwood, David R.; Mouillot, David			Quantifying Phylogenetic Beta Diversity: Distinguishing between 'True' Turnover of Lineages and Phylogenetic Diversity Gradients	PLOS ONE			English	Article							RICHNESS GRADIENTS; SPATIAL TURNOVER; NULL MODELS; EVOLUTIONARY; PATTERNS; BIODIVERSITY; CONSERVATION; DRIVERS; CLIMATE; CONSTRAINTS	The evolutionary dissimilarity between communities (phylogenetic beta diversity PBD) has been increasingly explored by ecologists and biogeographers to assess the relative roles of ecological and evolutionary processes in structuring natural communities. Among PBD measures, the PhyloSor and UniFrac indices have been widely used to assess the level of turnover of lineages over geographical and environmental gradients. However, these indices can be considered as 'broad-sense' measures of phylogenetic turnover as they incorporate different aspects of differences in evolutionary history between communities that may be attributable to phylogenetic diversity gradients. In the present study, we extend an additive partitioning framework proposed for compositional beta diversity to PBD. Specifically, we decomposed the PhyloSor and UniFrac indices into two separate components accounting for 'true' phylogenetic turnover and phylogenetic diversity gradients, respectively. We illustrated the relevance of this framework using simple theoretical and archetypal examples, as well as an empirical study based on coral reef fish communities. Overall, our results suggest that using PhyloSor and UniFrac may greatly over-estimate the level of spatial turnover of lineages if the two compared communities show contrasting levels of phylogenetic diversity. We therefore recommend that future studies use the 'true' phylogenetic turnover component of these indices when the studied communities encompass a large phylogenetic diversity gradient.	[Leprieur, Fabien; Albouy, Camille; De Bortoli, Julien; Mouillot, David] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France; [Cowman, Peter F.; Bellwood, David R.; Mouillot, David] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Cowman, Peter F.; Bellwood, David R.; Mouillot, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Universite de Montpellier; James Cook University; James Cook University	Leprieur, F (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France.	fabien.leprieur@univ-montp2.fr	Leprieur, Fabien/C-4430-2008; albouy, camille/H-9317-2012; Cowman, Peter Francis/G-9998-2017; Leprieur, Fabien/ABA-4433-2020	albouy, camille/0000-0003-1629-2389; Cowman, Peter Francis/0000-0001-5977-5327; 	Marie Curie International Outgoing Fellowship (FISHECO) [IOF-GA-2009-236316]; Australian Research Council; FRB-CESAB project GASPAR	Marie Curie International Outgoing Fellowship (FISHECO)(European Commission); Australian Research Council(Australian Research Council); FRB-CESAB project GASPAR	D.M. was supported by a Marie Curie International Outgoing Fellowship (FISHECO) with agreement number IOF-GA-2009-236316. D. R. B. and P. F. C. were funded by the Australian Research Council. This study was partly supported by the FRB-CESAB project GASPAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew ME, 2012, GLOBAL ECOL BIOGEOGR, V21, P352, DOI 10.1111/j.1466-8238.2011.00676.x; Baselga A, 2012, GLOB ECOL B IN PRESS; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Cunningham SA, 1995, EVOLUTION, V49, P1292, DOI 10.1111/j.1558-5646.1995.tb04460.x; Davies TJ, 2011, PHILOS T R SOC B, V366, P2414, DOI 10.1098/rstb.2011.0058; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; Faith DP, 2009, INT J MOL SCI, V10, P4723, DOI 10.3390/ijms10114723; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Feng G, 2012, CHINESE SCI BULL, V57, P623, DOI 10.1007/s11434-011-4869-1; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Mouchet MA, 2011, BIOL LETTERS, V7, P205, DOI 10.1098/rsbl.2010.0769; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Mouquet N, 2012, BIOL REV IN PRESS; Nipperess DA, 2010, J VEG SCI, V21, P809, DOI 10.1111/j.1654-1103.2010.01192.x; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Parenti Paolo, 2011, Smithiana Bulletin, P29; Pommier T, 2012, BIOL LETT IN PRESS; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Stevens RD, 2011, P ROY SOC B-BIOL SCI, V278, P2528, DOI 10.1098/rspb.2010.2341; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Swenson NG, 2012, ECOLOGY IN PRESS; Team R. D. C, 2011, R LANG ENV STAT COMP; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	55	149	152	9	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42760	10.1371/journal.pone.0042760	http://dx.doi.org/10.1371/journal.pone.0042760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912736	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000308063700021
J	Liu, LS; Cao, B; Aa, JY; Zheng, T; Shi, J; Li, MJ; Wang, XW; Zhao, CY; Xiao, WJ; Yu, XY; Sun, RB; Gu, RR; Zhou, J; Wu, L; Hao, G; Zhu, XX; Wang, GJ				Liu, Linsheng; Cao, Bei; Aa, Jiye; Zheng, Tian; Shi, Jian; Li, Mengjie; Wang, Xinwen; Zhao, Chunyan; Xiao, Wenjing; Yu, Xiaoyi; Sun, Runbin; Gu, Rongrong; Zhou, Jun; Wu, Liang; Hao, Gang; Zhu, Xuanxuan; Wang, Guangji			Prediction of the Pharmacokinetic Parameters of Triptolide in Rats Based on Endogenous Molecules in Pre-Dose Baseline Serum	PLOS ONE			English	Article							HUMAN METABOLIC PHENOTYPES; INDUCED HEPATOTOXICITY; PERSONALIZED MEDICINE; OXIDATIVE STRESS; GLUTATHIONE; MODULATION; TOXICITY; RELEASE; LIVER; FOOD	Background: Individual variances usually affect drug metabolism and disposition, and hence result in either ineffectiveness or toxicity of a drug. In addition to genetic polymorphism, the multiple confounding factors of lifestyles, such as dietary preferences, contribute partially to individual variances. However, the difficulty of quantifying individual diversity greatly challenges the realization of individualized drug therapy. This study aims at quantitative evaluating the association between individual variances and the pharmacokinetics. Methodology/Principal Findings: Molecules in pre-dose baseline serum were profiled using gas chromatography mass spectrometry to represent the individual variances of the model rats provided with high fat diets (HFD), routine chows and calorie restricted (CR) chows. Triptolide and its metabolites were determined using high performance liquid chromatography mass spectrometry. Metabonomic and pharmacokinetic data revealed that rats treated with the varied diets had distinctly different metabolic patterns and showed differential C-max values, AUC and drug metabolism after oral administration of triptolide. Rats with fatty chows had the lowest C-max and AUC values and the highest percentage of triptolide metabolic transformation, while rats with CR chows had the highest C-max and AUC values and the least percentage of triptolide transformation. Multivariate linear regression revealed that in baseline serum, the concentrations of creatinine and glutamic acid, which is the precursor of GSH, were linearly negatively correlated to C-max and AUC values. The glutamic acid and creatinine in baseline serum were suggested as the potential markers to represent individual diversity and as predictors of the disposal and pharmacokinetics of triptolide. Conclusions/Significance: These results highlight the robust potential of metabonomics in characterizing individual variances and identifying relevant markers that have the potential to facilitate individualized drug therapy.	[Liu, Linsheng; Cao, Bei; Aa, Jiye; Zheng, Tian; Shi, Jian; Li, Mengjie; Wang, Xinwen; Zhao, Chunyan; Xiao, Wenjing; Yu, Xiaoyi; Sun, Runbin; Gu, Rongrong; Zhou, Jun; Wu, Liang; Hao, Gang; Wang, Guangji] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Zhu, Xuanxuan] Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University of Chinese Medicine	Liu, LS (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	jiye_2005@yahoo.com.cn; guangjiwang@hotmail.com	Shi, Jian/Y-9055-2019; li, mengjie/GRS-3931-2022; Wang, Xinwen/O-2885-2018; Shi, Jian/Q-1667-2018; liu, linsheng/AGF-5590-2022	Shi, Jian/0000-0003-2609-0094; Shi, Jian/0000-0003-2609-0094; liu, linsheng/0000-0001-5371-3109; Wang, Xinwen/0000-0001-8143-7017	National Natural Science Foundation of the People's Republic of China [81072692/H3110]; Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGP201108-AJY]; National '973' Key Fundamental Program [2011CB505303, 2012CB517606]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; National '973' Key Fundamental Program	This work was supported by the National Natural Science Foundation of the People's Republic of China (81072692/H3110), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (JKGP201108-AJY), and the National '973' Key Fundamental Program (2011CB505303, 2012CB517606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Aa JY, 2011, METABOLOMICS, V7, P217, DOI 10.1007/s11306-010-0241-8; Backshall A, 2011, CLIN CANCER RES, V17, P3019, DOI 10.1158/1078-0432.CCR-10-2474; Bernini P, 2009, J PROTEOME RES, V8, P4264, DOI 10.1021/pr900344m; Bronson SL, 2011, BEHAV BRAIN RES, V220, P55, DOI 10.1016/j.bbr.2010.12.040; Brown BL, 1995, TOXICOL LETT, V81, P39, DOI 10.1016/0378-4274(95)03407-2; Chen BJ, 2001, LEUKEMIA LYMPHOMA, V42, P253, DOI 10.3109/10428190109064582; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Frade J, 2008, J NEUROCHEM, V105, P1144, DOI 10.1111/j.1471-4159.2008.05216.x; Gao Q, 2010, NEPHROL DIAL TRANSPL, V25, P3539, DOI 10.1093/ndt/gfq245; Gowda GAN, 2010, BIOMARK MED, V4, P299, DOI [10.2217/bmm.10.6, 10.2217/BMM.10.6]; Heinzmann SS, 2012, J PROTEOME RES, V11, P643, DOI 10.1021/pr2005764; Hikim APS, 2000, J ANDROL, V21, P431; Huynh PN, 2000, J ANDROL, V21, P689; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Lee D, 2011, CLIN THER, V33, P2038, DOI 10.1016/j.clinthera.2011.10.024; Li HL, 2010, CANCER LETT, V297, P198, DOI 10.1016/j.canlet.2010.05.012; Li J, 2011, HUM MOL GENET, V20, P528, DOI 10.1093/hmg/ddq498; Liu L, 2010, TOXICOLOGY, V271, P57, DOI 10.1016/j.tox.2010.03.004; Mei ZN, 2005, PHARMACOL RES, V51, P345, DOI 10.1016/j.phrs.2004.10.007; Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17; O'Sullivan A, 2011, AM J CLIN NUTR, V93, P314, DOI 10.3945/ajcn.110.000950; OGUMA T, 1991, ANTIMICROB AGENTS CH, V35, P1729, DOI 10.1128/AAC.35.9.1729; Persson M, 2006, EUR J NEUROSCI, V24, P1063, DOI 10.1111/j.1460-9568.2006.04974.x; Phapale PB, 2010, CLIN PHARMACOL THER, V87, P426, DOI 10.1038/clpt.2009.296; Santin K, 2011, BRAIN RES, V1421, P1, DOI 10.1016/j.brainres.2011.08.003; Shao F, 2007, BIOL PHARM BULL, V30, P702, DOI 10.1248/bpb.30.702; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Stella C, 2006, J PROTEOME RES, V5, P2780, DOI 10.1021/pr060265y; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; VANDESTRAAT R, 1987, BIOCHEM PHARMACOL, V36, P2065, DOI 10.1016/0006-2952(87)90132-8; WILLIAMS PEO, 1984, J ANTIMICROB CHEMOTH, V13, P191, DOI 10.1093/jac/13.2.191; Wilson ID, 2009, P NATL ACAD SCI USA, V106, P14187, DOI 10.1073/pnas.0907721106; Winnike JH, 2010, CLIN PHARMACOL THER, V88, P45, DOI 10.1038/clpt.2009.240; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Xu LY, 2008, EUR J PHARM BIOPHARM, V70, P741, DOI 10.1016/j.ejpb.2008.07.017; Xue X, 2011, TOXICOL LETT, V205, P47, DOI 10.1016/j.toxlet.2011.05.003; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Yang SM, 2003, MOL CANCER THER, V2, P65; Yao JC, 2008, BIOL PHARM BULL, V31, P592, DOI 10.1248/bpb.31.592; YOO JSH, 1992, BIOCHEM PHARMACOL, V43, P2535, DOI 10.1016/0006-2952(92)90141-5; Zhang Y, 2010, J IMMUNOL, V184, P3866, DOI 10.4049/jimmunol.0903417; Zhou R, 2005, INT IMMUNOPHARMACOL, V5, P1895, DOI 10.1016/j.intimp.2005.06.009; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302	46	12	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43389	10.1371/journal.pone.0043389	http://dx.doi.org/10.1371/journal.pone.0043389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912866	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700094
J	Schaefer, M; Heinze, HJ; Rotte, M				Schaefer, Michael; Heinze, Hans-Jochen; Rotte, Michael			Close to You: Embodied Simulation for Peripersonal Space in Primary Somatosensory Cortex	PLOS ONE			English	Article							TOUCH; ACTIVATIONS; EMPATHY; NEURONS; BODY; HAND; SI	Background: An increasing body of evidence has demonstrated that in contrast to the classic understanding the primary somatosensory cortex (SI) reflects merely seen touch (in the absence of any real touch on the own body). Based on these results it has been discussed that SI may play a role in understanding touch seen on other bodies. In order to further examine this understanding of observed touch, the current study aimed to test if mirror-like responses in SI are affected by the perspective of the seen touch. Thus, we presented touch on a hand and close to the hand either in first-person-perspective or in third-person-perspective. Principal Findings: Results of functional magnetic resonance imaging (fMRI) revealed stronger vicarious brain responses in SI/BA2 for touch seen in first-person-perspective. Surprisingly, the third-person viewpoint revealed activation in SI both when subjects viewed a hand being stimulated as well as when the space close to the hand was being touched. Conclusions/Significance: Based on these results we conclude that vicarious somatosensory responses in SI/BA2 are affected by the viewpoint of the seen hand. Furthermore, we argue that mirror-like responses in SI do not only reflect seen touch, but also the peripersonal space surrounding this body (in third-person-perspective). We discuss these findings with recent studies on mirror responses for action observation in peripersonal space.	[Schaefer, Michael; Heinze, Hans-Jochen; Rotte, Michael] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany	Otto von Guericke University	Schaefer, M (corresponding author), Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany.	mischa@neuro2.med.uni-magdeburg.de			Deutsche Forschungsgemeinschaft [SCHA105/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MS was supported by the Deutsche Forschungsgemeinschaft (SCHA105/7-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Bolognini N, 2011, CEREBRAL CO IN PRESS; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Ebisch SJ, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI DOI 10.1162/J0CN.2008.20111; Ebisch SJH, 2011, J COGNITIVE NEUROSCI, V23, P1808, DOI 10.1162/jocn.2010.21551; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Galati G, 2001, EUR J NEUROSCI, V14, P737, DOI 10.1046/j.0953-816x.2001.01674.x; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Graziano MS, 1993, AIDS RES HUM RETRO S, V266, P1054; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, P NATL ACAD SCI USA, V99, P11930, DOI 10.1073/pnas.172380399; Gross C.G., 1995, NEUROSCIENTIST, V1, P43, DOI [10.1177/107385849500100107, DOI 10.1177/107385849500100107]; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Mottonen R, 2005, NEUROIMAGE, V24, P731, DOI 10.1016/j.neuroimage.2004.10.011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pihko E, 2010, EUR J NEUROSCI, V31, P1836, DOI 10.1111/j.1460-9568.2010.07192.x; Prinz W, 2006, CORTEX, V42, P515, DOI 10.1016/S0010-9452(08)70389-7; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Rossi S, 2002, CLIN NEUROPHYSIOL, V113, P16, DOI 10.1016/S1388-2457(01)00725-8; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schaefer M, 2009, HUM BRAIN MAPP, V30, P2722, DOI 10.1002/hbm.20701; Serino A, 2011, J COGNITIVE NEUROSCI, V23, P2956, DOI 10.1162/jocn_a_00006; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; Wood R, 2010, NEUROSCI LETT, V473, P28, DOI 10.1016/j.neulet.2010.02.012	36	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42308	10.1371/journal.pone.0042308	http://dx.doi.org/10.1371/journal.pone.0042308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912698	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700013
J	Sipos, B; Massingham, T; Stutz, AM; Goldman, N				Sipos, Botond; Massingham, Tim; Stuetz, Adrian M.; Goldman, Nick			An Improved Protocol for Sequencing of Repetitive Genomic Regions and Structural Variations Using Mutagenesis and Next Generation Sequencing	PLOS ONE			English	Article							EVOLUTION; ALGORITHMS; ALIGNMENT; REPEATS; VELVET; READS	The rise of Next Generation Sequencing (NGS) technologies has transformed de novo genome sequencing into an accessible research tool, but obtaining high quality eukaryotic genome assemblies remains a challenge, mostly due to the abundance of repetitive elements. These also make it difficult to study nucleotide polymorphism in repetitive regions, including certain types of structural variations. One solution proposed for resolving such regions is Sequence Assembly aided by Mutagenesis (SAM), which relies on the fact that introducing enough random mutations breaks the repetitive structure, making assembly possible. Sequencing many different mutated copies permits the sequence of the repetitive region to be inferred by consensus methods. However, this approach relies on molecular cloning in order to isolate and amplify individual mutant copies, making it hard to scale-up the approach for use in conjunction with high-throughput sequencing technologies. To address this problem, we propose NG-SAM, a modified version of the SAM protocol that relies on PCR and dilution steps only, coupled to a NGS workflow. NG-SAM therefore has the potential to be scaled-up, e. g. using emerging microfluidics technologies. We built a realistic simulation pipeline to study the feasibility of NG-SAM, and our results suggest that under appropriate experimental conditions the approach might be successfully put into practice. Moreover, our simulations suggest that NG-SAM is capable of reconstructing robustly a wide range of potential target sequences of varying lengths and repetitive structures.	[Sipos, Botond; Massingham, Tim; Goldman, Nick] European Bioinformat Inst EMBL EBI, Cambridge, England; [Stuetz, Adrian M.] European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Sipos, B (corresponding author), European Bioinformat Inst EMBL EBI, Wellcome Trust Genome Campus, Cambridge, England.	sbotond@ebi.ac.uk		Goldman, Nick/0000-0001-8486-2211; Stuetz, Adrian/0000-0001-7650-3470; Sipos, Botond/0000-0002-9046-3302	European Molecular Biology Laboratory (EMBL) Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions (COFUND, "COFUNDing of regional, national and international programmes")	European Molecular Biology Laboratory (EMBL) Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions (COFUND, "COFUNDing of regional, national and international programmes")	BS was funded by a European Molecular Biology Laboratory (EMBL) Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions (COFUND, "COFUNDing of regional, national and international programmes"). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Blow N, 2009, NAT METHODS, V6, P539, DOI 10.1038/nmeth0709-539; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Garber M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r60; Keith JM, 2004, BIOINFORMATICS, V20, P2401, DOI 10.1093/bioinformatics/bth258; Keith JM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh022; Keith JM, 2002, BIOINFORMATICS, V18, P1494, DOI 10.1093/bioinformatics/18.11.1494; Keith JM, 2007, PERSP BIOANAL, V2, P303, DOI 10.1016/S1871-0069(06)02010-6; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Liu SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015778; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer M., 2010, COLD SPRING HARB PRO; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mitchelson KR, 2011, METHODS MOL BIOL, V687, P75, DOI 10.1007/978-1-60761-944-4_6; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; Stallard N, 2006, J ROY STAT SOC C-APP, V55, P15, DOI 10.1111/j.1467-9876.2005.00517.x; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Treangen T. J., 2011, NAT REV GENET; Waltemath D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001122; Weiss G, 1997, NUCLEIC ACIDS RES, V25, P3082, DOI 10.1093/nar/25.15.3082; Wessler S, 2006, PNAS, V103, P1760; YANG ZB, 1994, J MOL EVOL, V39, P105; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	33	6	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43359	10.1371/journal.pone.0043359	http://dx.doi.org/10.1371/journal.pone.0043359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912860	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700088
J	Zhang, T; Zhao, XQ; Wang, WS; Pan, YJ; Huang, LY; Liu, XY; Zong, Y; Zhu, LH; Yang, DC; Fu, BY				Zhang, Ting; Zhao, Xiuqin; Wang, Wensheng; Pan, Yajiao; Huang, Liyu; Liu, Xiaoyue; Zong, Ying; Zhu, Linghua; Yang, Daichang; Fu, Binying			Comparative Transcriptome Profiling of Chilling Stress Responsiveness in Two Contrasting Rice Genotypes	PLOS ONE			English	Article							ORYZA-SATIVA L.; COLD TOLERANCE; GENE-EXPRESSION; LOW-TEMPERATURE; SEEDLING STAGE; BOOTING STAGE; ABIOTIC STRESSES; MAJOR QTL; ARABIDOPSIS; RESPONSES	Rice is sensitive to chilling stress, especially at the seedling stage. To elucidate the molecular genetic mechanisms of chilling tolerance in rice, comprehensive gene expressions of two rice genotypes (chilling-tolerant LTH and chilling-sensitive IR29) with contrasting responses to chilling stress were comparatively analyzed. Results revealed a differential constitutive gene expression prior to stress and distinct global transcription reprogramming between the two rice genotypes under time-series chilling stress and subsequent recovery conditions. A set of genes with higher basal expression were identified in chilling-tolerant LTH compared with chilling-sensitive IR29, indicating their possible role in intrinsic tolerance to chilling stress. Under chilling stress, the major effect on gene expression was up-regulation in the chilling-tolerant genotype and strong repression in chilling-sensitive genotype. Early responses to chilling stress in both genotypes featured commonly up-regulated genes related to transcription regulation and signal transduction, while functional categories for late phase chilling regulated genes were diverse with a wide range of functional adaptations to continuous stress. Following the cessation of chilling treatments, there was quick and efficient reversion of gene expression in the chilling-tolerant genotype, while the chilling-sensitive genotype displayed considerably slower recovering capacity at the transcriptional level. In addition, the detection of differentially-regulated TF genes and enriched cis-elements demonstrated that multiple regulatory pathways, including CBF and MYBS3 regulons, were involved in chilling stress tolerance. A number of the chilling-regulated genes identified in this study were co-localized onto previously fine-mapped cold-tolerance-related QTLs, providing candidates for gene cloning and elucidation of molecular mechanisms responsible for chilling tolerance in rice.	[Zhang, Ting; Yang, Daichang] Wuhan Univ, Coll Life Sci, Engn Res Ctr Plant Biotechnol & Germplasm Utiliza, Minist Educ,State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Zhang, Ting; Zhao, Xiuqin; Wang, Wensheng; Pan, Yajiao; Huang, Liyu; Liu, Xiaoyue; Zong, Ying; Zhu, Linghua; Fu, Binying] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Wuhan University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, T (corresponding author), Wuhan Univ, Coll Life Sci, Engn Res Ctr Plant Biotechnol & Germplasm Utiliza, Minist Educ,State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	dyang@whu.edu.cn; fuby@caas.net.cn	zhang, ting/ABG-5784-2020	zhang, ting/0000-0001-9231-1604	Ministry of Agriculture [2008ZX001-003, 2009ZX08009-007B]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This study was supported by the Key Project from the Ministry of Agriculture (Grant Nos. 2008ZX001-003 and 2009ZX08009-007B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Arent S, 2008, PLANT PHYSIOL BIOCH, V46, P292, DOI 10.1016/j.plaphy.2007.12.014; Arora R, 1998, PHYSIOL PLANTARUM, V103, P24, DOI 10.1034/j.1399-3054.1998.1030104.x; Baruah AR, 2009, EUPHYTICA, V165, P459, DOI 10.1007/s10681-008-9753-y; Berri S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-120; BINH LT, 1992, PLANT PHYSIOL, V99, P1146, DOI 10.1104/pp.99.3.1146; Bita CE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-384; Bonnecarrere V, 2011, PLANT SCI, V180, P726, DOI 10.1016/j.plantsci.2011.01.023; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Chauhan H, 2011, MOL GENET GENOMICS, V286, P171, DOI 10.1007/s00438-011-0638-8; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-175; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Cominelli E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-162; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Evers D, 2012, PLANT MOL BIOL, V78, P503, DOI 10.1007/s11103-012-9879-0; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; HORISUE N, 1988, TROP AGR RES SER, V21, P76; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Jeong MJ, 2003, BIOCHEM BIOPH RES CO, V300, P555, DOI 10.1016/S0006-291X(02)02892-9; Jones DA, 1997, ADV BOT RES, V24, P89; Kang Y, 2011, PLANT J, V68, P871, DOI 10.1111/j.1365-313X.2011.04738.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Koseki M, 2010, MOL GENET GENOMICS, V284, P45, DOI 10.1007/s00438-010-0548-1; Kosova K, 2012, J PLANT PHYSIOL, V169, P567, DOI 10.1016/j.jplph.2011.12.013; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Kumari S, 2009, FUNCT INTEGR GENOMIC, V9, P109, DOI 10.1007/s10142-008-0088-5; Kuroki M, 2007, THEOR APPL GENET, V115, P593, DOI 10.1007/s00122-007-0589-y; Liu FX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008632; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NAGAMINE T, 1990, JPN J BREED, V40, P449; Pillai MA, 2004, MOL GENET GENOMICS, V271, P141, DOI 10.1007/s00438-003-0963-7; Potters G, 2010, PLANT PHYSIOL BIOCH, V48, P292, DOI 10.1016/j.plaphy.2009.12.007; Qian BJ, 2012, J SCI FOOD AGR, V92, P159, DOI 10.1002/jsfa.4557; Rahman A, 2012, PHYSL PLANT; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Saito K, 2010, PLANT SCI, V179, P97, DOI 10.1016/j.plantsci.2010.04.004; Sanchez MD, 2008, SEMIN CELL DEV BIOL, V19, P537, DOI 10.1016/j.semcdb.2008.07.014; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Shimono H, 2011, CROP SCI, V51, P290, DOI 10.2135/cropsci2010.05.0300; Shirasawa S, 2012, THEOR APPL GENET, V124, P937, DOI 10.1007/s00122-011-1758-6; Shukla N, 2012, PLANT PHYSIOL BIOCH, V54, P78, DOI 10.1016/j.plaphy.2012.02.001; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; Steward N, 2000, NUCLEIC ACIDS RES, V28, P3250, DOI 10.1093/nar/28.17.3250; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Suh JP, 2010, THEOR APPL GENET, V120, P985, DOI 10.1007/s00122-009-1226-8; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Trzcinska-Danielewicz J, 2009, PLANT SCI, V177, P648, DOI 10.1016/j.plantsci.2009.09.001; Tseng T. H., 1985, Journal of Agricultural Research of China, V34, P145; Wei KeSu, 2009, Acta Agronomica Sinica, V35, P18, DOI 10.3724/SP.J.1006.2009.00018; Wi SJ, 2006, PLANT CELL REP, V25, P1111, DOI 10.1007/s00299-006-0160-3; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Ye C, 2010, EUPHYTICA, V176, P291, DOI 10.1007/s10681-010-0226-8; Ye CG, 2008, GLOBAL ISSUES PADDOC; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhao HX, 2012, BIOL PLANTARUM, V56, P64, DOI 10.1007/s10535-012-0017-2; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou YJ, 2010, CHINA COMMUN, V7, P7; Zhu Y, 2012, BBA-GENE REGUL MECH, V1819, P343, DOI 10.1016/j.bbagrm.2011.07.012	80	106	117	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43274	10.1371/journal.pone.0043274	http://dx.doi.org/10.1371/journal.pone.0043274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912843	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700072
J	Srinivasaiah, NM; Anand, VD; Vaidyanathan, S; Sinha, A				Srinivasaiah, Nishant M.; Anand, Vijay D.; Vaidyanathan, Srinivas; Sinha, Anindya			Usual Populations, Unusual Individuals: Insights into the Behavior and Management of Asian Elephants in Fragmented Landscapes	PLOS ONE			English	Article							AFRICAN ELEPHANTS; CONSERVATION; RISK; RELATEDNESS; OCCUPANCY; MOVEMENTS; EXPANSION; SIZE	Background: A dearth in understanding the behavior of Asian elephants (Elephas maximus) at the scale of populations and individuals has left important management issues, particularly related to human-elephant conflict (HEC), unresolved. Evaluation of differences in behavior and decision-making among individual elephants across groups in response to changing local ecological settings is essential to fill this gap in knowledge and to improve our approaches towards the management and conservation of elephants. Methodology/Principal Findings: We hypothesized certain behavioral decisions that would be made by Asian elephants as reflected in their residence time and movement rates, time-activity budgets, social interactions and group dynamics in response to resource availability and human disturbance in their habitat. This study is based on 200 h of behavioral observations on 60 individually identified elephants and a 184-km(2) grid-based survey of their natural and anthropogenic habitats within and outside the Bannerghatta National Park, southern India during the dry season. At a general population level, the behavioral decisions appeared to be guided by the gender, age and group-type of the elephants. At the individual level, the observed variation could be explained only by the idiosyncratic behaviors of individuals and that of their associating conspecific individuals. Recursive partitioning classification trees for residence time of individual elephants indicated that the primary decisions were taken by individuals, independently of their above-mentioned biological and ecological attributes. Conclusions/Significance: Decision-making by Asian elephants thus appears to be determined at two levels, that of the population and, more importantly, the individual. Models based on decision-making by individual elephants have the potential to predict conflict in fragmented landscapes that, in turn, could aid in mitigating HEC. Thus, we must target individuals, in addition to populations, in our efforts to manage and conserve this threatened species, particularly in human-dominated landscapes.	[Srinivasaiah, Nishant M.] Tata Inst Fundamental Res, Postgrad Program Wildlife Biol & Conservat, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Anand, Vijay D.] A Rocha India, Bangalore, Karnataka, India; [Vaidyanathan, Srinivas] Fdn Ecol Res Advocacy & Learning, Pondicherry, India; [Sinha, Anindya] Natl Inst Adv Studies, Sch Nat Sci & Engn, Bangalore, Karnataka, India; [Sinha, Anindya] Nat Conservat Fdn, Mysore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Srinivasaiah, NM (corresponding author), Tata Inst Fundamental Res, Postgrad Program Wildlife Biol & Conservat, Natl Ctr Biol Sci, GKVK Campus, Bangalore, Karnataka, India.	msnishant@gmail.com		Vaidyanathan, Srinivas/0000-0003-3642-0309	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VD, 2009, 2 ROCH IND; [Anonymous], [No title captured]; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Arivazhagan Chelliya, 2008, Gajah, V29, P11; Bhaskaran N, 1998, THESIS BHARATHIDASAN; Bhaskaran N, 2010, KARNATAKA ELEPHANT C; Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Buij R, 2007, BIOL CONSERV, V135, P189, DOI 10.1016/j.biocon.2006.10.028; Burke T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002417; Chiyo PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031382; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; Chiyo PI, 2011, BEHAV ECOL, V22, P552, DOI 10.1093/beheco/arr016; Choudhury A, 2008, IUCN 2011 IUCN RED L; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Douglas-Hamilton I, 1972, ECOLOGY BEHAVIOUR AF; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Gopalakrishna S.P., 2010, Gajah, V33, P47; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; GRASS Development Team, 2007, GRASS 6 2 US MAN; Gubbi S, 2012, BIOL CONSERV, V148, P88, DOI 10.1016/j.biocon.2012.01.046; Hibert F, 2010, BIODIVERS CONSERV, V19, P2003, DOI 10.1007/s10531-010-9822-0; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Martin J, 2010, ECOL APPL, V20, P1173, DOI 10.1890/09-0276.1; Morrison M.L., 1998, WILDLIFE HABITAT REL; Okello MM, 2008, J ARID ENVIRON, V72, P2179, DOI 10.1016/j.jaridenv.2008.07.008; Poole J., 1982, THESIS U CAMBRIDGE C; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; Poole Joyce H., 1994, P331; Pretorius Y, 2011, J ANIM ECOL, V80, P875, DOI 10.1111/j.1365-2656.2011.01819.x; Quantum GIS Development Team, 2009, QUANT GIS 1 4 0 GEOG; R Core Team, 2020, R LANG ENV STAT COMP; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Sokal R.R., 2012, BIOMETRY; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Vidya TNC, 2005, J ETHOL, V23, P205, DOI 10.1007/s10164-005-0144-8; Whyte IJ, 1993, PACHYDERM, V16, P72; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2008, P NATL ACAD SCI USA, V105, P19108, DOI 10.1073/pnas.0801744105; Young KD, 2009, AUSTRAL ECOL, V34, P329, DOI 10.1111/j.1442-9993.2009.01934.x; [No title captured]; [No title captured]; [No title captured]; [No title captured]	53	27	28	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42571	10.1371/journal.pone.0042571	http://dx.doi.org/10.1371/journal.pone.0042571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916135	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600016
J	Ma, SS; Bachan, S; Porto, M; Bohnert, HJ; Snyder, M; Dinesh-Kumar, SP				Ma, Shisong; Bachan, Shawn; Porto, Matthew; Bohnert, Hans J.; Snyder, Michael; Dinesh-Kumar, Savithramma P.			Discovery of Stress Responsive DNA Regulatory Motifs in Arabidopsis	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ELEMENTS; IDENTIFICATION; GENOMES; TARGET; PLATFORM; ROLES; SET	The discovery of DNA regulatory motifs in the sequenced genomes using computational methods remains challenging. Here, we present MotifIndexer - a comprehensive strategy for de novo identification of DNA regulatory motifs at a genome level. Using word-counting methods, we indexed the existence of every 8-mer oligo composed of bases A, C, G, T, r, y, s, w, m, k, n or 12-mer oligo composed of A, C, G, T, n, in the promoters of all predicted genes of Arabidopsis thaliana genome and of selected stress-induced co-expressed genes. From this analysis, we identified number of over-represented motifs. Among these, major critical motifs were identified using a position filter. We used a model based on uniform distribution and the z-scores derived from this model to describe position bias. Interestingly, many motifs showed position bias towards the transcription start site. We extended this model to show biased distribution of motifs in the genomes of both A. thaliana and rice. We also used MotifIndexer to identify conserved motifs in co-expressed gene groups from two Arabidopsis species, A. thaliana and A. lyrata. This new comparative genomics method does not depend on alignments of homologous gene promoter sequences.	[Ma, Shisong; Bachan, Shawn; Porto, Matthew; Dinesh-Kumar, Savithramma P.] Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA; [Ma, Shisong; Bachan, Shawn; Porto, Matthew; Dinesh-Kumar, Savithramma P.] Univ Calif Davis, Coll Biol Sci, Genome Ctr, Davis, CA 95616 USA; [Bohnert, Hans J.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Bohnert, Hans J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Stanford University	Ma, SS (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA.	sma@ucdavis.edu; spdineshkumar@ucdavis.edu	Ma, Shisong/E-7225-2012	Ma, Shisong/0000-0001-5563-448X; Snyder, Michael/0000-0003-0784-7987	National Science Foundation [DBI-0723722, DBI-1042344]; Div Of Biological Infrastructure [1042344] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by National Science Foundation grants DBI-0723722 and DBI-1042344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Gasch AP, 2002, GENOME BIOL, V3; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Liu YY, 2004, GENOME RES, V14, P451, DOI 10.1101/gr.1327604; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Maeda K, 2005, PLANT MOL BIOL, V59, P739, DOI 10.1007/s11103-005-0910-6; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Sumazin P, 2005, BIOINFORMATICS, V21, P31, DOI 10.1093/bioinformatics/bth471; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vandepoele K, 2009, PLANT PHYSIOL, V150, P535, DOI 10.1104/pp.109.136028; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Wang L, 2011, PLANT J, V67, P1029, DOI 10.1111/j.1365-313X.2011.04655.x; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yokoyama KD, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp423; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43198	10.1371/journal.pone.0043198	http://dx.doi.org/10.1371/journal.pone.0043198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912824	Green Published, gold			2022-12-27	WOS:000307500100069
J	Kim, D; Yan, YT; Valencia, CA; Liu, RH				Kim, Dongwook; Yan, Yitang; Valencia, C. Alexander; Liu, Rihe			Heptameric Targeting Ligands against EGFR and HER2 with High Stability and Avidity	PLOS ONE			English	Article							SINGLE-CHAIN FV; ANTIGEN-BINDING; DOMAIN; ANTIBODIES; PEPTABODY; AFFINITY; ALPHA	Multivalency of targeting ligands provides significantly increased binding strength towards their molecular targets. Here, we report the development of a novel heptameric targeting system, with general applications, constructed by fusing a target-binding domain with the heptamerization domain of the Archaeal RNA binding protein Sm1 through a flexible hinge peptide. The previously reported affibody molecules against EGFR and HER2, Z(EGFR) and Z(HER2), were used as target binding moieties. The fusion molecules were highly expressed in E. coli as soluble proteins and efficiently self-assembled into multimeric targeting ligands with the heptamer as the predominant form. We demonstrated that the heptameric molecules were resistant to protease-mediated digestion or heat-and SDS-induced denaturation. Surface plasmon resonance (SPR) analysis showed that both heptameric Z(EGFR) and Z(HER2) ligands have a significantly enhanced binding strength to their target receptors with a nearly 100 to 1000 fold increase relative to the monomeric ligands. Cellular binding assays showed that heptameric ligands maintained their target-binding specificities similar to the monomeric forms towards their respective receptor. The non-toxic property of each heptameric ligand was demonstrated by the cell proliferation assay. In general,, the heptamerization strategy we describe here could be applied to the facile and efficient engineering of other protein domain- or short peptide-based affinity molecules to acquire significantly improved target-binding strengths with potential applications in the targeted delivery of various imaging or therapeutic agents..	[Kim, Dongwook; Yan, Yitang; Valencia, C. Alexander; Liu, Rihe] Univ N Carolina, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Kim, Dongwook; Yan, Yitang; Valencia, C. Alexander; Liu, Rihe] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kim, D (corresponding author), Univ N Carolina, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	rliu@email.unc.edu	Ariel, Pablo/AGJ-4118-2022		National Cancer Institute [CA119343, CA151652]; NATIONAL CANCER INSTITUTE [P30CA016086, U54CA151652, U54CA119343] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute to RL. (CA119343 and CA151652). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck K, 1996, J MOL BIOL, V256, P909, DOI 10.1006/jmbi.1996.0137; Benhabbour SR, 2012, J CONTROL RELEASE, V158, P63, DOI 10.1016/j.jconrel.2011.10.013; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024739; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; Deyev SM, 2008, BIOESSAYS, V30, P904, DOI 10.1002/bies.20805; Duan J, 2007, BIOCHEMISTRY-US, V46, P12656, DOI 10.1021/bi701215e; Fattah OM, 2006, INT J CANCER, V119, P2455, DOI 10.1002/ijc.21541; Friedman M, 2008, J MOL BIOL, V376, P1388, DOI 10.1016/j.jmb.2007.12.060; Gostring L, 2010, INT J ONCOL, V36, P757, DOI 10.3892/ijo_00000551; Govindarajan S, 2012, BIOMATERIALS, V33, P2570, DOI 10.1016/j.biomaterials.2011.12.003; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156; Kubetzko S, 2006, J BIOL CHEM, V281, P35186, DOI 10.1074/jbc.M604127200; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lyakhov I, 2010, CHEMBIOCHEM, V11, P345, DOI 10.1002/cbic.200900532; Nordberg E, 2010, INT J ONCOL, V36, P967, DOI 10.3892/ijo_00000576; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; PACK P, 1995, J MOL BIOL, V246, P28, DOI 10.1006/jmbi.1994.0062; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Stone E, 2007, J IMMUNOL METHODS, V318, P88, DOI 10.1016/j.jim.2006.10.006; Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663; Toro I, 2002, J MOL BIOL, V320, P129, DOI 10.1016/S0022-2836(02)00406-0; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; Trejtnar F, 2002, Q J NUCL MED, V46, P181; YOKOTA T, 1992, CANCER RES, V52, P3402; Zhang JB, 2004, J MOL BIOL, V335, P49, DOI 10.1016/j.jmb.2003.09.034	29	7	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e43077	10.1371/journal.pone.0043077	http://dx.doi.org/10.1371/journal.pone.0043077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912791	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500038
J	Renier, S; Micheau, P; Talon, R; Hebraud, M; Desvaux, M				Renier, Sandra; Micheau, Pierre; Talon, Regine; Hebraud, Michel; Desvaux, Mickael			Subcellular Localization of Extracytoplasmic Proteins in Monoderm Bacteria: Rational Secretomics-Based Strategy for Genomic and Proteomic Analyses	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; HIDDEN-MARKOV-MODEL; ARGININE TRANSLOCATION PATHWAY; LIPOPROTEIN SIGNAL PEPTIDES; LISTERIA-MONOCYTOGENES; SECRETION SYSTEMS; BACILLUS-SUBTILIS; TOPOLOGY PREDICTION; MEMBRANE-PROTEINS; NEGATIVE BACTERIA	Genome-scale prediction of subcellular localization (SCL) is not only useful for inferring protein function but also for supporting proteomic data. In line with the secretome concept, a rational and original analytical strategy mimicking the secretion steps that determine ultimate SCL was developed for Gram-positive (monoderm) bacteria. Based on the biology of protein secretion, a flowchart and decision trees were designed considering (i) membrane targeting, (ii) protein secretion systems, (iii) membrane retention, and (iv) cell-wall retention by domains or post-translocational modifications, as well as (v) incorporation to cell-surface supramolecular structures. Using Listeria monocytogenes as a case study, results were compared with known data set from SCL predictors and experimental proteomics. While in good agreement with experimental extracytoplasmic fractions, the secretomics-based method outperforms other genomic analyses, which were simply not intended to be as inclusive. Compared to all other localization predictors, this method does not only supply a static snapshot of protein SCL but also offers the full picture of the secretion process dynamics: (i) the protein routing is detailed, (ii) the number of distinct SCL and protein categories is comprehensive, (iii) the description of protein type and topology is provided, (iv) the SCL is unambiguously differentiated from the protein category, and (v) the multiple SCL and protein category are fully considered. In that sense, the secretomics-based method is much more than a SCL predictor. Besides a major step forward in genomics and proteomics of protein secretion, the secretomics-based method appears as a strategy of choice to generate in silico hypotheses for experimental testing.	[Renier, Sandra; Micheau, Pierre; Talon, Regine; Hebraud, Michel; Desvaux, Mickael] INRA, Microbiol UR454, F-63122 St Genes Champanelle, France	INRAE	Renier, S (corresponding author), INRA, Microbiol UR454, F-63122 St Genes Champanelle, France.	mickael.desvaux@clermont.inra.fr	DESVAUX, Mickael/A-8333-2008; TALON, Régine/AAZ-4941-2020; TALON, Régine/A-2427-2011; Hébraud, Michel/AAH-6534-2020; HEBRAUD, Michel/D-1009-2009	DESVAUX, Mickael/0000-0003-2986-6417; TALON, Régine/0000-0003-3122-4376; TALON, Régine/0000-0003-3122-4376; HEBRAUD, Michel/0000-0003-0478-2575; Hebraud, Michel/0000-0003-4440-7745	Institut National de la Recherche Agronomique (INRA); European Framework Programme 6 (FP6) with the ProSafeBeef (Advancing Beef Safety and Quality through Research and Innovation) research consortium; INRA (French National Institute for Agronmical Research); Ministere de l'Education Nationale, de l'Education Superieure et de la Recherche	Institut National de la Recherche Agronomique (INRA); European Framework Programme 6 (FP6) with the ProSafeBeef (Advancing Beef Safety and Quality through Research and Innovation) research consortium; INRA (French National Institute for Agronmical Research); Ministere de l'Education Nationale, de l'Education Superieure et de la Recherche	This work was supported in part by the "Institut National de la Recherche Agronomique (INRA)" and the European Framework Programme 6 (FP6) with the ProSafeBeef (Advancing Beef Safety and Quality through Research and Innovation) research consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by INRA (French National Institute for Agronmical Research), and the European Framework Programme 6 (FP6) with the ProSafeBeef (Advancing Beef Safety and Quality through Research and Innovation) research consortium (http://www.prosafebeef.eu/). Sandra Renier is a PhD research fellow granted by the "Ministere de l'Education Nationale, de l'Education Superieure et de la Recherche". The authors are obliged to Valentin Loux (INRA, Jouy-en-Josas, France), Menglong Li (Sichuan University, Chengdu, China) and Manuel A. Patarroyo (Universidad del Rosario, Bogota, Colombia) for batch query against SurfG+, SecretP and NClassG+, respectively. We are grateful to the INRA MIGALE bioinformatics platform (http://migale.jouy.inra.fr) for providing computational resources. The authors are thankful to anonymous reviewers for their very constructive comments.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Bagos PG, 2008, J PROTEOME RES, V7, P5082, DOI 10.1021/pr800162c; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berven FD, 2006, ARCH MICROBIOL, V184, P362, DOI 10.1007/s00203-005-0055-7; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Billion A, 2006, BIOINFORMATICS, V22, P2819, DOI 10.1093/bioinformatics/btl466; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Calvo E, 2005, PROTEOMICS, V5, P433, DOI 10.1002/pmic.200400936; Cao BQ, 2006, BIOINFORMATICS, V22, P303, DOI 10.1093/bioinformatics/bti784; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Desvaux M, 2006, TRENDS MICROBIOL, V14, P157, DOI 10.1016/j.tim.2006.02.009; Desvaux M, 2005, BBA-MOL CELL RES, V1745, P223, DOI 10.1016/j.bbamcr.2005.04.006; Desvaux M, 2005, BBA-BIOMEMBRANES, V1713, P92, DOI 10.1016/j.bbamem.2005.05.002; Desvaux M, 2004, TRENDS MICROBIOL, V12, P306, DOI 10.1016/j.tim.2004.05.002; Desvaux M, 2006, FEMS MICROBIOL REV, V30, P774, DOI 10.1111/j.1574-6976.2006.00035.x; Desvaux M, 2012, TRENDS MICROBIOL, V20, P259, DOI 10.1016/j.tim.2012.03.008; Desvaux M, 2010, J PROTEOME RES, V9, P5076, DOI 10.1021/pr1003642; Desvaux M, 2009, TRENDS MICROBIOL, V17, P338, DOI 10.1016/j.tim.2009.05.008; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Desvaux Mickael, 2008, P359, DOI 10.1201/9781420051414.ch12; Dzeroski S, 2004, MACH LEARN, V54, P255, DOI 10.1023/B.MAC.0000015881.36452.6e; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Fagerlund A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-304; Fariselli P, 2003, BIOINFORMATICS, V19, P2498, DOI 10.1093/bioinformatics/btg360; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Garcia-Del Portillo F, 2011, J BIOL CHEM; Gardy JL, 2006, NAT REV MICROBIOL, V4, P741, DOI 10.1038/nrmicro1494; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Glaser P, 2001, SCIENCE, V294, P849; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Gomi M., 2004, CHEM BIO INFORMATICS, V4, P142, DOI DOI 10.1273/CBIJ.4.142; Goudenege D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-88; Gupta RS, 2011, ANTON LEEUW INT J G, V100, P171, DOI 10.1007/s10482-011-9616-8; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Litou Zoi I., 2008, Journal of Bioinformatics and Computational Biology, V6, P387, DOI 10.1142/S0219720008003382; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; MCGEOCH DJ, 1985, VIRUS RES, V3, P271, DOI 10.1016/0168-1702(85)90051-6; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; ONeill K., 2007, PROTEIN CLUSTERS COL; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plewczynski D, 2007, POLYMER, V48, P5493, DOI 10.1016/j.polymer.2007.07.039; Plyusnin I, 2009, BIOINFORMATICS, V25, P1187, DOI 10.1093/bioinformatics/btp127; Pucciarelli MG, 2005, PROTEOMICS, V5, P4808, DOI 10.1002/pmic.200402075; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Restrepo-Montoya D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-21; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Romine MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S1; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; ROST B, 1995, PROTEIN SCI, V4, P521; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Schaerlaekens K, 2001, J BACTERIOL, V183, P6727, DOI 10.1128/JB.183.23.6727-6732.2001; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; SIMONEN M, 1993, MICROBIOL REV, V57, P109, DOI 10.1128/MMBR.57.1.109-137.1993; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Sutcliffe IC, 2011, ENV MICROBIOL; Sutcliffe IC, 2011, A VANLEEUWENHOEK; Tan KS, 2001, J MED MICROBIOL, V50, P613, DOI 10.1099/0022-1317-50-7-613; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TAYLOR PD, 2006, BIOINFORMATION, V1, P335; Tjalsma H, 2005, PROTEOMICS, V5, P4472, DOI 10.1002/pmic.200402080; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; White SH, 2004, CURR OPIN STRUC BIOL, V14, P397, DOI 10.1016/j.sbi.2004.07.003; Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou HY, 2003, PROTEIN SCI, V12, P1547, DOI 10.1110/ps.0305103; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173	126	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42982	10.1371/journal.pone.0042982	http://dx.doi.org/10.1371/journal.pone.0042982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912771	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500034
J	Guo, RN; Zheng, HZ; Huang, LQ; Zhou, Y; Zhang, X; Liang, CK; Lin, JY; He, JF; Zhang, JQ				Guo, Ru-ning; Zheng, Hui-zhen; Huang, Li-qun; Zhou, Yong; Zhang, Xin; Liang, Chan-kun; Lin, Jin-yan; He, Jian-feng; Zhang, Jin-qing			Epidemiologic and Economic Burden of Influenza in the Outpatient Setting: A Prospective Study in a Subtropical Area of China	PLOS ONE			English	Article							INFECTION	Objectives: To understand the incidence of outpatient influenza cases in a subtropical area of China and the associated economic burden on patients' families. Methods: A hospital-based prospective study was conducted in Zhuhai City during 2008-2009. All outpatient influenza-like illness (ILI) cases were identified in 28 sentinel hospitals. A representative sample of throat swabs from ILI cases were collected for virus isolation using Madin-Darby canine kidney cells. The incidence of outpatient influenza cases in Zhuhai was estimated on the basis of the number of influenza patients detected by the sentinel sites. A telephone survey on the direct costs associated with illness was conducted as a follow-up. Results: The incidence of influenza was estimated to be 4.1 per 1,000 population in 2008 and 19.2 per 1,000 population in 2009. Children aged < 5 years were the most-affected population, suffering from influenza at the highest rates (34.3 per 1,000 population in 2008 and 95.3 per 1,000 population in 2009). A high incidence of 29.2-40.9 per 1000 population was also seen in young people aged 5-24 years in 2009. ILI activity and influenza virus isolations adopted a consistent seasonal pattern, with a summer peak in July 2008 and the longest epidemic period lasting from July-December 2009. The medical costs per episode of influenza among urban patients were higher than those for rural patients. A total of $1.1 million in direct economic losses were estimated to be associated with outpatient influenza during 2008-2009 in Zhuhai community. Conclusions: Influenza attacks children aged < 5 years in greater proportions than children in other age groups. Seasonal influenza 2008 and Pandemic influenza A (H1N1) 2009 had different epidemiological and etiological characteristics. Direct costs (mostly medical costs) impose an enormous burden on the patient family. Vaccination strategies for high-risk groups need to be further strengthened.	[Guo, Ru-ning; Zheng, Hui-zhen; He, Jian-feng; Zhang, Jin-qing] Ctr Dis Control & Prevent, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China; [Huang, Li-qun; Zhou, Yong; Liang, Chan-kun] Zhuhai Municipal Ctr Dis Control & Prevent, Zhuhai, Peoples R China; [Zhang, Xin] Ctr Dis Control & Prevent, Inst Pathogen Microorganisms, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Zheng, HZ (corresponding author), Ctr Dis Control & Prevent, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China.	zhzgdcdc@163.com			World Health Organization [WP/2008/CHN/02/CSR/PE 15.01]; Medical Research Foundation of Guangdong Province, China [A2007079]	World Health Organization(World Health Organization); Medical Research Foundation of Guangdong Province, China	The work was supported by grants from the World Health Organization (WP/2008/CHN/02/CSR/PE 15.01), and Medical Research Foundation of Guangdong Province, China (project number: A2007079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; data S, 2010, STAT YB 2010; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Esteban-Vasallo MD, 2012, EUR J PUBLIC HEALTH, V22, P792, DOI 10.1093/eurpub/ckr171; Grijalva CG, 2010, VACCINE, V29, P123, DOI 10.1016/j.vaccine.2010.08.072; Guo RN, 2011, PUBLIC HEALTH, V125, P389, DOI 10.1016/j.puhe.2011.03.004; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Kiro Amnon, 2008, Harefuah, V147, P960; Kyncl Jan, 2010, Klin Mikrobiol Infekc Lek, V16, P116; Li C, 2009, J SCH NURS, V25, p4S, DOI 10.1177/1059840508330066; Paget WJ, 2010, EUR J PEDIATR, V169, P997, DOI 10.1007/s00431-010-1164-0; Ru-ning G, 2008, CHIN J PUBLIC HLTH, V24, P843; Seligova J, 2011, CENT EUR J PUBL HEAL, V19, P20, DOI 10.21101/cejph.a3593; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Silvennoinen H, 2011, PEDIATR INFECT DIS J, V30, pE24, DOI 10.1097/INF.0b013e3181fe37c8; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tao Z, 2011, CHIN HLTH EC, V30, P25; Turbelin C, 2009, EURO SURVEILL, V14; World Health Organization, 2004, WHO MAN ANIM INFL DI; Zheng H, 2010, MOD PREV MED, V2, P201	20	17	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41403	10.1371/journal.pone.0041403	http://dx.doi.org/10.1371/journal.pone.0041403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911789	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600077
J	Haurigot, V; Villacampa, P; Ribera, A; Bosch, A; Ramos, D; Ruberte, J; Bosch, F				Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Bosch, Assumpcio; Ramos, David; Ruberte, Jesus; Bosch, Fatima			Long-Term Retinal PEDF Overexpression Prevents Neovascularization in a Murine Adult Model of Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EPITHELIUM-DERIVED FACTOR; MATRIX METALLOPROTEINASES; PIGMENTED EPITHELIUM; VISUAL FUNCTION; VITREOUS LEVELS; GENE-TRANSFER; FACTOR-I; EXPRESSION; VEGF	Neovascularization associated with diabetic retinopathy (DR) and other ocular disorders is a leading cause of visual impairment and adult-onset blindness. Currently available treatments are merely palliative and offer temporary solutions. Here, we tested the efficacy of antiangiogenic gene transfer in an animal model that mimics the chronic progression of human DR. Adeno-associated viral (AAV) vectors of serotype 2 coding for antiangiogenic Pigment Epithelium Derived Factor (PEDF) were injected in the vitreous of a 1.5 month-old transgenic model of retinopathy that develops progressive neovascularization. A single intravitreal injection led to long-term production of PEDF and to a striking inhibition of intravitreal neovascularization, normalization of retinal capillary density, and prevention of retinal detachment. This was parallel to a reduction in the intraocular levels of Vascular Endothelial Growth Factor (VEGF). Normalization of VEGF was consistent with a downregulation of downstream effectors of angiogenesis, such as the activity of Matrix Metalloproteinases (MMP) 2 and 9 and the content of Connective Tissue Growth Factor (CTGF). These results demonstrate long-term efficacy of AAV-mediated PEDF overexpression in counteracting retinal neovascularization in a relevant animal model, and provides evidence towards the use of this strategy to treat angiogenesis in DR and other chronic proliferative retinal disorders.	[Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Bosch, Assumpcio; Ramos, David; Ruberte, Jesus; Bosch, Fatima] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Sch Vet Med, Bellaterra, Spain; [Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Bosch, Assumpcio; Bosch, Fatima] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Sch Vet Med, Bellaterra, Spain; [Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Ruberte, Jesus; Bosch, Fatima] CIBER Diabet & Associated Metab Disorders CIBERDE, Barcelona, Spain; [Ramos, David; Ruberte, Jesus] Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Sch Vet Med, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Autonomous University of Barcelona	Haurigot, V (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Sch Vet Med, Bellaterra, Spain.	fatima.bosch@uab.es	Bosch, Assumpcio/C-7593-2015; Villacampa, Pilar/B-1801-2019; Ribera, Albert/K-9744-2014; Ruberte, Jesus/AAS-9240-2021	Bosch, Assumpcio/0000-0002-7205-2796; Villacampa, Pilar/0000-0002-2860-7475; Ribera, Albert/0000-0002-7120-4276; BOSCH, FATIMA/0000-0002-7705-5515; Haurigot, Virginia A./0000-0002-9772-2565; RUBERTE, JESUS/0000-0003-1540-1432	Instituto de Salud Carlos III [PI 061417]; Generalitat de Catalunya, Spain [SGR224]; European Community [CLINIGENE LSHB-CT-2006-018933]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia; Ministerio de Ciencia y Tecnologia	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya, Spain(Generalitat de Catalunya); European Community(European Commission); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by grants from Instituto de Salud Carlos III (PI 061417) and Generalitat de Catalunya (2009 SGR224), Spain, and European Community (CLINIGENE LSHB-CT-2006-018933). PV and AR were recipients of predoctoral fellowships from Fundacion Ramon Areces and Ministerio de Educacion y Ciencia, respectively. AB was recipient of a Ramon y Cajal Program contract, from Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barnstable CJ, 2004, PROG RETIN EYE RES, V23, P561, DOI 10.1016/j.preteyeres.2004.05.002; Bennett J, 1997, INVEST OPHTH VIS SCI, V38, P2857; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Chen LL, 2006, BIOCHEM BIOPH RES CO, V348, P1288, DOI 10.1016/j.bbrc.2006.07.188; Chen YH, 2009, NAT MED, V15, P1215, DOI 10.1038/nm.2025; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Fletcher EL, 2010, DOC OPHTHALMOL, V120, P67, DOI 10.1007/s10633-009-9193-6; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; GRANT M, 1986, DIABETES, V35, P416, DOI 10.2337/diabetes.35.4.416; Haurigot V, 2009, J BIOL CHEM, V284, P22961, DOI 10.1074/jbc.M109.014787; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Inokuchi N, 2001, CURR EYE RES, V23, P368, DOI 10.1076/ceyr.23.5.368.5441; Kozulin P, 2009, MOL VIS, V15, P45; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1994; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Ogata N, 2002, AM J OPHTHALMOL, V134, P348, DOI 10.1016/S0002-9394(02)01568-4; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Raisler BJ, 2002, P NATL ACAD SCI USA, V99, P8909, DOI 10.1073/pnas.122247299; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Salzmann J, 2000, BRIT J OPHTHALMOL, V84, P1091, DOI 10.1136/bjo.84.10.1091; Singh V, 1998, MOL VIS, P4; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stieger K, 2009, MOL THER, V17, P516, DOI 10.1038/mt.2008.283; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; TOMBRANTINK J, 1989, INVEST OPHTH VIS SCI, V30, P1700; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wang JJ, 2006, DIABETES, V55, P1678, DOI 10.2337/db05-1448; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje	48	46	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41511	10.1371/journal.pone.0041511	http://dx.doi.org/10.1371/journal.pone.0041511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911805	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600083
J	Baydoun, HH; Bai, XT; Shelton, S; Nicot, C				Baydoun, Hicham H.; Bai, Xue Tao; Shelton, Shary; Nicot, Christophe			HTLV-I Tax Increases Genetic Instability by Inducing DNA Double Strand Breaks during DNA Replication and Switching Repair to NHEJ	PLOS ONE			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-1 TAX; NF-KAPPA-B; ANAPHASE-PROMOTING COMPLEX; CYCLE REGULATORY GENES; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; SIGNAL-TRANSDUCTION; CATALYTIC-ACTIVITY; ONCOPROTEIN BINDS	Background: Appropriate responses to damaged DNA are indispensible for preserving genome stability and preventing cancer. Tumor viruses often target DNA repair machinery to achieve transformation. The Human T-cell leukemia virus type I (HTLV-I) is the only known transforming human retrovirus and the etiological agent of Adult T-cell Leukemia (ATLL). Although HTLV-I-transformed leukemic cells have numerous genetic lesions, the precise role of the viral tax gene in this process is not fully understood. Results: Our results show a novel function of HTLV-I oncoprotein Tax as an inducer of genomic DNA double strand breaks (DDSB) during DNA replication. We also found that Tax acts as a potent inhibitor of homologous recombination (HR) DNA repair through the activation of the NF-kB pathway. These results were confirmed using HTLV-I molecular clones expressing Tax at physiological levels in a natural context. We further found that HTLV-I-and Tax-transformed cells are not more susceptible to DNA damaging agents and repair DNA lesions at a rate similar to that of normal cells. Finally, we demonstrated that during S phase, Tax-associated DDSB are preferentially repaired using the error-prone non-homologous end joining (NHEJ) pathway. Conclusions: This study provides new insights in Tax effects on DNA repair and genome instability. Although it may not be self sufficient, the creation of DNA breaks and subsequent abnormal use of the non-conservative NHEJ DNA repair during the S phase in HTLV-I-infected Tax-expressing cells may cooperate with other factors to increase genetic and genome instability and favor transformation.	[Baydoun, Hicham H.; Bai, Xue Tao; Shelton, Shary; Nicot, Christophe] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Baydoun, HH (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	cnicot@kumc.edu			National Cancer Institute [CA106258]; NATIONAL CANCER INSTITUTE [R01CA106258] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (CA106258) to C.N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 1996, ONCOGENE, V12, P1645; Belgnaoui SM, 2010, J BIOL CHEM, V285, P32897, DOI 10.1074/jbc.M110.146373; Bellon M, 2010, BLOOD, V115, P2441, DOI 10.1182/blood-2009-08-241117; Bentley J, 2004, NUCLEIC ACIDS RES, V32, P5249, DOI 10.1093/nar/gkh842; Bertrand P, 2004, TRENDS GENET, V20, P235, DOI 10.1016/j.tig.2004.04.003; Boxus M, 2012, BLOOD, V119, P151, DOI 10.1182/blood-2011-05-356790; CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262; Chandhasin C, 2008, J VIROL, V82, P6952, DOI 10.1128/JVI.02331-07; Chatrath P, 2006, BRIT J CANCER, V95, P314, DOI 10.1038/sj.bjc.6603262; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Datta A, 2008, ONCOGENE, V27, P1135, DOI 10.1038/sj.onc.1210718; De La Fuente C, 2000, J VIROL, V74, P7270, DOI 10.1128/JVI.74.16.7270-7283.2000; Ducu RI, 2011, VIROLOGY, V416, P1, DOI 10.1016/j.virol.2011.04.012; Franchini G, 2003, ADV CANCER RES, V89, P69, DOI 10.1016/S0065-230X(03)01003-0; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; GESSAIN A, 1985, LANCET, V2, P407; GREEN JE, 1989, NATURE, V341, P72, DOI 10.1038/341072a0; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Haller K, 2000, AIDS RES HUM RETROV, V16, P1683, DOI 10.1089/08892220050193146; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Iha H, 2003, ONCOGENE, V22, P8912, DOI 10.1038/sj.onc.1207058; JEANG KT, 1990, SCIENCE, V247, P1082, DOI 10.1126/science.2309119; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Kibler KV, 2001, J VIROL, V75, P2161, DOI 10.1128/JVI.75.5.2161-2173.2001; Koike M, 2008, EXP CELL RES, V314, P1061, DOI 10.1016/j.yexcr.2007.11.014; Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054; Lemasson I, 1998, J BIOL CHEM, V273, P23598, DOI 10.1074/jbc.273.36.23598; Lemoine FJ, 2000, AIDS RES HUM RETROV, V16, P1623, DOI 10.1089/08892220050193056; Liang MH, 2002, J VIROL, V76, P4022, DOI 10.1128/JVI.76.8.4022-4033.2002; Linke SP, 2003, CANCER RES, V63, P2596; Liu BY, 2005, P NATL ACAD SCI USA, V102, P63, DOI 10.1073/pnas.0406424101; Liu BY, 2003, MOL CELL BIOL, V23, P5269, DOI 10.1128/MCB.23.15.5269-5281.2003; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Merling R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-35; Neuveut C, 2002, FRONT BIOSCI-LANDMRK, V7, pD157, DOI 10.2741/neuveut; Nicot C, 2000, ONCOGENE, V19, P2155, DOI 10.1038/sj.onc.1203536; Nicot C, 2001, MOL CELL BIOL, V21, P7391, DOI 10.1128/MCB.21.21.7391-7402.2001; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; OSAME M, 1987, ANN NEUROL, V21, P117, DOI 10.1002/ana.410210203; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; ROY LM, 1991, J CELL BIOL, V113, P507, DOI 10.1083/jcb.113.3.507; SARIN PS, 1983, P NATL ACAD SCI-BIOL, V80, P2370, DOI 10.1073/pnas.80.8.2370; SAWAMI H, 1992, J CELL PHYSIOL, V151, P367, DOI 10.1002/jcp.1041510218; Scott IS, 2003, J PATHOL, V201, P187, DOI 10.1002/path.1444; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Suzuki T, 2000, VIROLOGY, V270, P291, DOI 10.1006/viro.2000.0266; Suzuki T, 1996, EMBO J, V15, P1607, DOI 10.1002/j.1460-2075.1996.tb00505.x; TATEWAKI M, 1995, BLOOD, V86, P3109; Windhofer F, 2008, MUTAT RES-FUND MOL M, V638, P56, DOI 10.1016/j.mrfmmm.2007.08.016; Yamazaki J, 2009, BLOOD, V114, P2709, DOI 10.1182/blood-2008-08-174425; Yang C, 2009, MUTAT RES-FUND MOL M, V660, P66, DOI 10.1016/j.mrfmmm.2008.10.019; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Yoshida M, 2000, AIDS RES HUM RETROV, V16, P1639, DOI 10.1089/08892220050193083	68	40	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42226	10.1371/journal.pone.0042226	http://dx.doi.org/10.1371/journal.pone.0042226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916124	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800017
J	Kocalis, HE; Turney, MK; Printz, RL; Laryea, GN; Muglia, LJ; Davies, SS; Stanwood, GD; McGuinness, OP; Niswender, KD				Kocalis, Heidi E.; Turney, Maxine K.; Printz, Richard L.; Laryea, Gloria N.; Muglia, Louis J.; Davies, Sean S.; Stanwood, Gregg D.; McGuinness, Owen P.; Niswender, Kevin D.			Neuron-Specific Deletion of Peroxisome Proliferator-Activated Receptor Delta (PPAR delta) in Mice Leads to Increased Susceptibility to Diet-Induced Obesity	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INSULIN-RESISTANCE; FATTY-ACIDS; TRANSCRIPTIONAL REPRESSION; UNCOUPLING PROTEIN-2; TARGETED DISRUPTION; EXPRESSION; ALPHA; LEPTIN; BRAIN	Central nervous system (CNS) lipid accumulation, inflammation and resistance to adipo-regulatory hormones, such as insulin and leptin, are implicated in the pathogenesis of diet-induced obesity (DIO). Peroxisome proliferator-activated receptors (PPAR alpha, delta, gamma) are nuclear transcription factors that act as environmental fatty acid sensors and regulate genes involved in lipid metabolism and inflammation in response to dietary and endogenous fatty acid ligands. All three PPAR isoforms are expressed in the CNS at different levels. Recent evidence suggests that activation of CNS PPAR alpha and/or PPAR gamma may contribute to weight gain and obesity. PPAR delta is the most abundant isoform in the CNS and is enriched in the hypothalamus, a region of the brain involved in energy homeostasis regulation. Because in peripheral tissues, expression of PPAR delta increases lipid oxidative genes and opposes inflammation, we hypothesized that CNS PPAR delta protects against the development of DIO. Indeed, genetic neuronal deletion using Nes-Cre loxP technology led to elevated fat mass and decreased lean mass on low-fat diet (LFD), accompanied by leptin resistance and hypothalamic inflammation. Impaired regulation of neuropeptide expression, as well as uncoupling protein 2, and abnormal responses to a metabolic challenge, such as fasting, also occur in the absence of neuronal PPAR delta. Consistent with our hypothesis, KO mice gain significantly more fat mass on a high-fat diet (HFD), yet are surprisingly resistant to diet-induced elevations in CNS inflammation and lipid accumulation. We detected evidence of upregulation of PPAR gamma and target genes of both PPARa and PPAR gamma, as well as genes of fatty acid oxidation. Thus, our data reveal a previously underappreciated role for neuronal PPAR delta in the regulation of body composition, feeding responses, and in the regulation of hypothalamic gene expression.	[Kocalis, Heidi E.; Printz, Richard L.; Muglia, Louis J.; McGuinness, Owen P.; Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Niswender, Kevin D.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA; [Turney, Maxine K.; Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN 37212 USA; [Laryea, Gloria N.] Vanderbilt Univ, Neurosci Grad Program, Nashville, TN 37212 USA; [Davies, Sean S.; Stanwood, Gregg D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Muglia, Louis J.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Kocalis, HE (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	kevin.niswender@vanderbilt.edu		Davies, Sean/0000-0001-9879-8062; Stanwood, Gregg/0000-0001-6005-1203	National Institutes of Health [DK085712, DK069927, DK007563, DK083222]; Vanderbilt Diabetes Research and Training Center (DRTC) [DK20593]; DRTC Mouse Metabolic Phenotyping Center [MMPC DK59637]; Vanderbilt University Translation Pathology Shared Resource Core [5U24 DK059637];  [DK058404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK020593, F31DK083222, R01DK069927, P30DK058404, U24DK059637, R01DK085712, U2CDK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913, R01MH079010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Diabetes Research and Training Center (DRTC); DRTC Mouse Metabolic Phenotyping Center; Vanderbilt University Translation Pathology Shared Resource Core; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project is supported by National Institutes of Health grants DK085712, DK069927, DK007563 (KDN) and DK083222 (to HK) and partially by DK058404 (KDN), the Vanderbilt Diabetes Research and Training Center (DRTC) (DK20593 to KDN) and the DRTC Mouse Metabolic Phenotyping Center (MMPC DK59637 to KDN). This work was partially supported by resources of the Vanderbilt University Translation Pathology Shared Resource Core (5U24 DK059637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Alvarez-Guardia D, 2011, BBA-MOL CELL BIOL L, V1811, P59, DOI 10.1016/j.bbalip.2010.11.002; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arsenijevic D, 2006, J CEREBR BLOOD F MET, V26, P433, DOI 10.1038/sj.jcbfm.9600200; Auwerx J, 1996, ATHEROSCLEROSIS, V124, pS29, DOI 10.1016/0021-9150(96)05854-6; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Bugge A, 2010, PPAR RES, V2010, DOI 10.1155/2010/169506; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Coll T, 2010, ENDOCRINOLOGY, V151, P1560, DOI 10.1210/en.2009-1211; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Degasperi GR, 2008, FEBS LETT, V582, P3103, DOI 10.1016/j.febslet.2008.08.006; Diano S, 2011, NAT MED; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Dunn SE, 2010, J EXP MED, V207, P1599, DOI 10.1084/jem.20091663; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; Gustafsson MCU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007046; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kalinin S, 2009, CURR ALZHEIMER RES, V6, P431, DOI 10.2174/156720509789207949; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Konig B, 2009, PPAR RES, V2009, DOI 10.1155/2009/801609; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P2434, DOI 10.1073/pnas.0510815103; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Levin BE, 2002, AM J PHYSIOL-REG I, V283, pR941, DOI 10.1152/ajpregu.00245.2002; Li YQ, 2009, J MOL CELL CARDIOL, V47, P536, DOI 10.1016/j.yjmcc.2009.07.001; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; MARON DJ, 1991, CIRCULATION, V84, P2020, DOI 10.1161/01.CIR.84.5.2020; Miyachi H, 2007, CURR MED CHEM, V14, P2335, DOI 10.2174/092986707781745587; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; MORRISON WR, 1964, J LIPID RES, V5, P600; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; OSCAI LB, 1982, AM J PHYSIOL, V242, pR212, DOI 10.1152/ajpregu.1982.242.3.R212; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Porte D, 2002, NUTR REV, V60, pS20, DOI 10.1301/002966402320634797; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Sasaki T, 2010, ENDOCRINOLOGY, V151, P2556, DOI 10.1210/en.2009-1319; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Schnegg CI, 2011, PPAR RES, V2011, DOI 10.1155/2011/373560; Schwartz MW, 1998, ENDOCRINOLOGY, V139, P2629, DOI 10.1210/en.139.5.2629; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Speed N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025169; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Woods JW, 2003, BRAIN RES, V975, P10, DOI 10.1016/S0006-8993(03)02515-0; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Wu HT, 2011, HORM METAB RES, V43, P631, DOI 10.1055/s-0031-1280781; Xing GQ, 1995, BIOCHEM BIOPH RES CO, V217, P1015, DOI 10.1006/bbrc.1995.2871; Yessoufou A, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13071	74	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42981	10.1371/journal.pone.0042981	http://dx.doi.org/10.1371/journal.pone.0042981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916190	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800039
J	Zhang, K; Han, J; Groesser, T; Fontenay, G; Parvin, B				Zhang, Kai; Han, Ju; Groesser, Torsten; Fontenay, Gerald; Parvin, Bahram			Inference of Causal Networks from Time-Varying Transcriptome Data via Sparse Coding	PLOS ONE			English	Article							GENE-EXPRESSION; SELECTION; DEATH	Temporal analysis of genome-wide data can provide insights into the underlying mechanism of the biological processes in two ways. First, grouping the temporal data provides a richer, more robust representation of the underlying processes that are co-regulated. The net result is a significant dimensional reduction of the genome-wide array data into a smaller set of vocabularies for bioinformatics analysis. Second, the computed set of time-course vocabularies can be interrogated for a potential causal network that can shed light on the underlying interactions. The method is coupled with an experiment for investigating responses to high doses of ionizing radiation with and without a small priming dose. From a computational perspective, inference of a causal network can rapidly become computationally intractable with the increasing number of variables. Additionally, from a bioinformatics perspective, larger networks always hinder interpretation. Therefore, our method focuses on inferring the simplest network that is computationally tractable and interpretable. The method first reduces the number of temporal variables through consensus clustering to reveal a small set of temporal templates. It then enforces simplicity in the network configuration through the sparsity constraint, which is further regularized by requiring continuity between consecutive time points. We present intermediate results for each computational step, and apply our method to a time-course transcriptome dataset for a cell line receiving a challenge dose of ionizing radiation with and without a prior priming dose. Our analyses indicate that (i) the priming dose increases the diversity of the computed templates (e.g., diversity of transcriptome signatures); thus, increasing the network complexity; (ii) as a result of the priming dose, there are a number of unique templates with delayed and oscillatory profiles; and (iii) radiation-induced stress responses are enriched through pathway and subnetwork studies.	[Zhang, Kai; Han, Ju; Groesser, Torsten; Fontenay, Gerald; Parvin, Bahram] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, K (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	B_Parvin@lbl.gov		Groesser, Torsten/0000-0003-3143-1906	U.S. Department of Energy [DE-AC02-05CH11231]; National Cancer Institute [RO1CA140663]; NATIONAL CANCER INSTITUTE [R01CA140663] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Director, Office of Science, Office of Biological and Environmental Research, Radiochemistry and Imaging Instrumentation, Low Dose Radiation program with the U.S. Department of Energy under Contract Nos. DE-AC02-05CH11231, and a grant from the National Cancer Institute (Grant RO1CA140663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahmed A, 2009, P NATL ACAD SCI USA, V106, P11878, DOI 10.1073/pnas.0901910106; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barcellos-Hoff M, 2005, BJR S27, P123; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Celeux G, 2005, STAT MODEL, V5, P243, DOI 10.1191/1471082X05st096oa; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Cinquemani E, 2008, BIOINFORMATICS, V24, P2748, DOI 10.1093/bioinformatics/btn527; Das A, 2001, J BIOL CHEM, V276, P3279, DOI 10.1074/jbc.M008454200; Day TK, 2007, INT J RADIAT BIOL, V83, P523, DOI 10.1080/09553000701420582; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Ellis B, 2008, J AM STAT ASSOC, V103, P778, DOI 10.1198/016214508000000193; Fauer A, 2006, BIOINFORMATICS, V22, P124; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Groesser T, 2011, INT J RADIAT BIOL, V87, P696, DOI 10.3109/09553002.2010.549535; Han J, 2010, MICROSCOPY, V241, P315; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Henao R, 2009, BAYESIAN SPARSE FACT, P736; Hill SM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-94; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kou SC, 2006, ANN STAT, V34, P1581, DOI 10.1214/009053606000000515; Li S, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040009, 10.1371/journal.pcbi.0040009.eor]; Lin W, 2011, GENE DEV, V15, P1833; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McBride William H, 2002, Mil Med, V167, P66; Molller-Levet C, 2003, BIOINOFORMATICS, V19, P834; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nevins J, 1988, CELL GROWTH DIFFER, V9, P585; Pervan M, 2005, MOL CANCER RES, V3, P381, DOI 10.1158/1541-7786.MCR-05-0032; Prise KM, 2006, OCCUP MED-OXFORD, V56, P156, DOI 10.1093/occmed/kql010; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Robin JM, 1999, IMPOSSIBILITY INFERR; Roy L, 2009, ANN I SUPER SANITA, V45, P272; Tapio S, 2007, RADIAT ENVIRON BIOPH, V46, P1, DOI 10.1007/s00411-006-0078-8; Tenazinha N, 2011, IEEE ACM T COMPUT BI, V8, P943, DOI 10.1109/TCBB.2010.117; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turtoi A, 2008, INT J RADIAT BIOL, V84, P375, DOI 10.1080/09553000802029886; Voy BH, 2006, PLOS COMPUT BIOL, V2, P757, DOI 10.1371/journal.pcbi.0020089; WEICHSELBAUM RR, 1994, INT J RADIAT ONCOL, V30, P229, DOI 10.1016/0360-3016(94)90539-8; Worku D, 2008, ANTICANCER RES, V28, P2135; Yang JY, 2006, INT J ONCOL, V29, P643	46	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42306	10.1371/journal.pone.0042306	http://dx.doi.org/10.1371/journal.pone.0042306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916126	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800018
J	Dong, ZS; Danilevskaya, O; Abadie, T; Messina, C; Coles, N; Cooper, M				Dong, Zhanshan; Danilevskaya, Olga; Abadie, Tabare; Messina, Carlos; Coles, Nathan; Cooper, Mark			A Gene Regulatory Network Model for Floral Transition of the Shoot Apex in Maize and Its Dynamic Modeling	PLOS ONE			English	Article							VEGETATIVE PHASE-CHANGE; FLOWERING-TIME; ARABIDOPSIS-THALIANA; INFLORESCENCE ARCHITECTURE; PHOTOPERIOD SENSITIVITY; TRANSCRIPTION FACTOR; CIRCADIAN CLOCK; INBRED LINES; EXPRESSION; RICE	The transition from the vegetative to reproductive development is a critical event in the plant life cycle. The accurate prediction of flowering time in elite germplasm is important for decisions in maize breeding programs and best agronomic practices. The understanding of the genetic control of flowering time in maize has significantly advanced in the past decade. Through comparative genomics, mutant analysis, genetic analysis and QTL cloning, and transgenic approaches, more than 30 flowering time candidate genes in maize have been revealed and the relationships among these genes have been partially uncovered. Based on the knowledge of the flowering time candidate genes, a conceptual gene regulatory network model for the genetic control of flowering time in maize is proposed. To demonstrate the potential of the proposed gene regulatory network model, a first attempt was made to develop a dynamic gene network model to predict flowering time of maize genotypes varying for specific genes. The dynamic gene network model is composed of four genes and was built on the basis of gene expression dynamics of the two late flowering id1 and dlf1 mutants, the early flowering landrace Gaspe Flint and the temperate inbred B73. The model was evaluated against the phenotypic data of the id1 dlf1 double mutant and the ZMM4 overexpressed transgenic lines. The model provides a working example that leverages knowledge from model organisms for the utilization of maize genomic information to predict a whole plant trait phenotype, flowering time, of maize genotypes.	[Dong, Zhanshan; Danilevskaya, Olga; Abadie, Tabare; Messina, Carlos; Coles, Nathan; Cooper, Mark] DuPont Pioneer, Johnston, IA USA	DuPont; Pioneer Hi-Bred International, Inc.	Dong, ZS (corresponding author), DuPont Pioneer, Johnston, IA USA.	zhanshan.dong@pioneer.com	Cooper, Mark/AAG-8551-2019	Cooper, Mark/0000-0002-9418-3359; Coles, Nathan/0000-0002-2008-3283				Akutsu T, 1999, PAC S BIOC, P17, DOI [10.1142/9789814447300_0003, DOI 10.1142/9789814447300_0003]; Alvarez-Buylla ER, 2007, CURR OPIN PLANT BIOL, V10, P83, DOI 10.1016/j.pbi.2006.11.008; Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Andersen CH, 2004, TRENDS PLANT SCI, V9, P105, DOI 10.1016/j.tplants.2004.01.002; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Blazquez MA, 2000, J CELL SCI, V113, P3547; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Bomblies K, 2003, DEVELOPMENT, V130, P2385, DOI 10.1242/dev.00457; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; BONHOMME R, 1994, CROP SCI, V34, P156, DOI 10.2135/cropsci1994.0011183X003400010028x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Colasanti J, 2009, PLANT PHYSIOL, V149, P56, DOI 10.1104/pp.108.130500; Colasanti Joseph, 2009, P41, DOI 10.1007/978-0-387-79418-1_3; Coles ND, 2010, GENETICS, V184, P799, DOI 10.1534/genetics.109.110304; Coneva V, 2007, J EXP BOT, V58, P3679, DOI 10.1093/jxb/erm217; Cooper Mark, 2002, In Silico Biology, V2, P151; Danilevskaya ON, 2008, PLANT PHYSIOL, V147, P2054, DOI 10.1104/pp.107.115261; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Danilevskaya ON, 2010, PLANT PHYSIOL, V153, P238, DOI 10.1104/pp.110.154211; Davidson E, 2002, AIDS RES HUM RETRO S, V295, P1670; Di Paolo EA, 2001, BIOSYSTEMS, V59, P185, DOI 10.1016/S0303-2647(01)00102-2; DIJKHUIS F. J., 1956, Euphytica, V5, P267; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; FERWERDA F. P., 1953, EUPHYTICA, V2, P127; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Genoud T, 1999, TRENDS PLANT SCI, V4, P503, DOI 10.1016/S1360-1385(99)01498-3; Genoud T, 2001, PLANT PHYSIOL, V126, P1430, DOI 10.1104/pp.126.4.1430; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; Hammer GL, 2010, J EXP BOT, V61, P2185, DOI 10.1093/jxb/erq095; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Hayes KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012887; Heuer S, 2001, PLANT PHYSIOL, V127, P33, DOI 10.1104/pp.127.1.33; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hung H-Y, 2012, P NATL ACAD SCI USA, P1; Izawa T, 2003, CURR OPIN PLANT BIOL, V6, P113, DOI 10.1016/S1369-5266(03)00014-1; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kauffman SA, 1993, ORIGINS ORDER SELF O, P734; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Koduru P, 2008, IEEE T EVOLUT COMPUT, V12, P572, DOI 10.1109/TEVC.2008.917202; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Ku LX, 2011, AGR SCI CHINA, V10, P18, DOI 10.1016/S1671-2927(11)60303-9; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Liu C, 2009, DEVELOPMENT, V136, P3379, DOI 10.1242/dev.033076; Malcomber ST, 2006, ADV BOT RES, V44, P425, DOI 10.1016/S0065-2296(06)44011-8; Markelz NH, 2003, PLANT PHYSIOL, V133, P1578, DOI 10.1104/pp.103.029694; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; McClung CR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-55; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; Mena M, 1995, PLANT J, V8, P845, DOI 10.1046/j.1365-313X.1995.8060845.x; Mendoza L, 1998, J THEOR BIOL, V193, P307, DOI 10.1006/jtbi.1998.0701; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Messina CD, 2011, J EXP BOT, V62, P855, DOI 10.1093/jxb/erq329; Miller TA, 2008, PLANTA, V227, P1377, DOI 10.1007/s00425-008-0709-1; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Morishige DT, 2002, PLANT PHYSIOL, V130, P1614, DOI 10.1104/pp.012567; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Park SJ, 2008, PLANT J, V56, P1018, DOI 10.1111/j.1365-313X.2008.03667.x; Pastore JJ, 2011, DEVELOPMENT, V138, P3189, DOI 10.1242/dev.063073; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Poethig RS, 2010, PLANT PHYSIOL, V154, P541, DOI 10.1104/pp.110.161620; Press W, 1992, NUMERICAL RECIPES FO, P933; Ritchie J. T., 1986, CERES MAIZE SIMULATI, P1; Rosenthal WD, 1991, PREDICTING CROP PHEN, P29; Russell W, 1982, CROP SCI, V23, P847; Salvi S, 2002, PLANT MOL BIOL, V48, P601, DOI 10.1023/A:1014838024509; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Salvi S, 2009, MAYDICA, V54, P501; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2008, PLANT SIGNAL BEHAV, V3, P269, DOI 10.4161/psb.3.4.5219; Sawers RJH, 2004, PLANT PHYSIOL, V136, P2771, DOI 10.1104/pp.104.046417; Sawers RJH, 2002, PLANT PHYSIOL, V130, P155, DOI 10.1104/pp.006411; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Sheehan MJ, 2007, PLANT J, V49, P338, DOI 10.1111/j.1365-313X.2006.02962.x; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Strable J, 2008, PLANT J, V56, P1045, DOI 10.1111/j.1365-313X.2008.03661.x; Tadege M, 2003, PLANT BIOTECHNOL J, V1, P361, DOI 10.1046/j.1467-7652.2003.00034.x; Takata N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-126; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Esbroeck GA, 2008, MAYDICA, V53, P117; van Nocker S, 2000, PLANT MOL BIOL, V44, P107, DOI 10.1023/A:1006472929800; Vladutu C, 1999, GENETICS, V153, P993; Wang XT, 2011, PLANT CELL REP, V30, P1261, DOI 10.1007/s00299-011-1036-8; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155; WESTERMAN JM, 1970, HEREDITY, V25, P609, DOI 10.1038/hdy.1970.66; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Wong AYM, 2007, J EXP BOT, V58, P403, DOI 10.1093/jxb/erl206; Wu CY, 2008, P NATL ACAD SCI USA, V105, P12915, DOI 10.1073/pnas.0806019105; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yang L, 2011, DEVELOPMENT, V138, P245, DOI 10.1242/dev.058578; Yin XY, 2010, J EXP BOT, V61, P2171, DOI 10.1093/jxb/erp375; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Yuh CH, 2001, DEVELOPMENT, V128, P617; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	118	69	78	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43450	10.1371/journal.pone.0043450	http://dx.doi.org/10.1371/journal.pone.0043450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912876	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700104
J	Laufer, MK; Thesing, PC; Dzinjalamala, FK; Nyirenda, OM; Masonga, R; Laurens, MB; Stokes-Riner, A; Taylor, TE; Plowe, CV				Laufer, Miriam K.; Thesing, Phillip C.; Dzinjalamala, Fraction K.; Nyirenda, Osward M.; Masonga, Rhoda; Laurens, Matthew B.; Stokes-Riner, Abbie; Taylor, Terrie E.; Plowe, Christopher V.			A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; HEALTHY-VOLUNTEERS; INDUCED PRURITUS; RESISTANCE; PHARMACOKINETICS; ARTEMISININ; EFFICACY; DRUG; METABOLISM; CHILDREN	Background: The predominance of chloroquine-susceptible falciparum malaria in Malawi more than a decade after chloroquine's withdrawal permits contemplation of re-introducing chloroquine for targeted uses. We aimed to compare the ability of different partner drugs to preserve chloroquine efficacy and prevent the re-emergence of resistance. Methodology/Principal Findings: Children with uncomplicated malaria were enrolled at a government health center in Blantyre, Malawi. Participants were randomized to receive chloroquine alone or combined with artesunate, azithromycin or atovaquone-proguanil for all episodes of uncomplicated malaria for one year. The primary outcome was incidence of clinical malaria. Secondary endpoints included treatment efficacy, and incidence of the chloroquine resistance marker pfcrt T76 and of anemia. Of the 640 children enrolled, 628 were included in the intention-to-treat analysis. Malaria incidence (95% confidence interval) was 0.59 (.46-.74), .61 (.49-.76), .63 (.50-.79) and .68 (.54-.86) episodes/person-year for group randomized to receive chloroquine alone or in combination with artesunate, azithromycin or atovaquone-proguanil respectively and the differences were not statistically significant. Treatment efficacy for first episodes was 100% for chloroquine monotherapy and 97.9% for subsequent episodes of malaria. Similar results were seen in each of the chloroquine combination groups. The incidence of pfcrt T76 in pure form was 0%; mixed infections with both K76 and T76 were found in two out of 911 infections. Young children treated with chloroquine-azithromycin had higher hemoglobin concentrations at the study's end than did those in the chloroquine monotherapy group. Conclusion/Significance: Sustained chloroquine efficacy with repeated treatment supports the eventual re-introduction of chloroquine combinations for targeted uses such as intermittent preventive treatment.	[Laufer, Miriam K.; Thesing, Phillip C.; Laurens, Matthew B.; Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Malaria Grp,Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Dzinjalamala, Fraction K.; Nyirenda, Osward M.; Masonga, Rhoda] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Stokes-Riner, Abbie] EMMES Corp, Rockville, MD USA; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; University of Malawi; Emmes Corporation; Michigan State University; Michigan State University College of Osteopathic Medicine	Laufer, MK (corresponding author), Univ Maryland, Sch Med, Howard Hughes Med Inst, Malaria Grp,Ctr Vaccine Dev, Baltimore, MD 21201 USA.	mlaufer@medicine.umaryland.edu	Laurens, Matthew/E-7293-2013	Laurens, Matthew/0000-0003-3874-581X; Laufer, Miriam/0000-0001-8300-9593	National Institute of Allergy and Infectious Diseases [U01AI044824, K23AI059316]; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; Pfizer Global Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI044824, K23AI059316] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pfizer Global Pharmaceuticals(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases [U01AI044824 and K23AI059316]. MKL and CVP are supported by the Doris Duke Charitable Foundation and CVP is supported by the Howard Hughes Medical Institute. Azithromycin was donated by Pfizer, Inc.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MKL received an investigator-initiate grant from Pfizer Global Pharmaceuticals from 2006-2010. Azithromycin was donated by Pfizer, Inc.. ASR is employed by EMMES Corporation. There are no patents, products in development or further marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ademowo OG, 2000, CLIN PHARMACOL THER, V67, P237, DOI 10.1067/mcp.2000.104257; [Anonymous], 2003, ASS MON ANT DRUG EFF; [Anonymous], 2001, ANT DRUG COMB THER; Butcher GA, 2003, AM J TROP MED HYG, V68, P111, DOI 10.4269/ajtmh.2003.68.111; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; Di Paolo A, 2002, PHARMACOL RES, V46, P545, DOI 10.1016/S1043661802002384; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Frosch AEP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-116; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Lefevre G, 2001, AM J TROP MED HYG, V64, P247, DOI 10.4269/ajtmh.2001.64.247; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nyunt MM, 2007, CLIN PHARMACOL THER, V82, P601, DOI 10.1038/sj.clpt.6100361; Onyeji CO, 2001, EUR J PHARM SCI, V13, P195, DOI 10.1016/S0928-0987(01)00108-7; Plowe CV, 2005, CURR TOP MICROBIOL, V295, P55; Quinto L, 2006, TROP MED INT HEALTH, V11, P1741, DOI 10.1111/j.1365-3156.2006.01764.x; Sabchareon A, 1998, T ROY SOC TROP MED H, V92, P201, DOI 10.1016/S0035-9203(98)90749-0; Suputtamongkol Y, 2001, BRIT J CLIN PHARMACO, V52, P655, DOI 10.1046/j.1365-2125.2001.01458.x; Teja-Isavadharm P, 2001, AM J TROP MED HYG, V65, P717, DOI 10.4269/ajtmh.2001.65.717; Zhang SQ, 2001, BRIT J CLIN PHARMACO, V52, P377, DOI 10.1046/j.0306-5251.2001.01461.x	21	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42284	10.1371/journal.pone.0042284	http://dx.doi.org/10.1371/journal.pone.0042284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912697	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700012
J	Poh, YC; Corrias, A; Cheng, N; Buist, ML				Poh, Yong Cheng; Corrias, Alberto; Cheng, Nicholas; Buist, Martin Lindsay			A Quantitative Model of Human Jejunal Smooth Muscle Cell Electrophysiology	PLOS ONE			English	Article							SLOW-WAVE ACTIVITY; MYENTERIC INTERSTITIAL-CELLS; ACTIVATED POTASSIUM CHANNELS; ELECTROGENIC SODIUM PUMP; MOUSE SMALL-INTESTINE; PACEMAKER ACTIVITY; NUMERICAL-SIMULATION; MATHEMATICAL-MODEL; CALCIUM-CHANNEL; CA2+ CHANNEL	Recently, a number of ion channel mutations have been identified in the smooth muscle cells of the human jejunum. Although these are potentially significant in understanding diseases that are currently of unknown etiology, no suitable computational cell model exists to evaluate the effects of such mutations. Here, therefore, a biophysically based single cell model of human jejunal smooth muscle electrophysiology is presented. The resulting cellular description is able to reproduce experimentally recorded slow wave activity and produces realistic responses to a number of perturbations, providing a solid platform on which the causes of intestinal myopathies can be investigated.	[Poh, Yong Cheng; Corrias, Alberto; Cheng, Nicholas; Buist, Martin Lindsay] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Poh, Yong Cheng; Buist, Martin Lindsay] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Ctr Life Sci CeLS, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Poh, YC (corresponding author), Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore.	biebml@nus.edu.sg	Corrias, Alberto/H-5176-2011	Cheng, Nicholas/0000-0001-8227-6243; Corrias, Alberto/0000-0003-2156-713X	Ministry of Education Academic Research Fund [T13-0902-P02]	Ministry of Education Academic Research Fund	Funding support from the Ministry of Education Academic Research Fund (grant T13-0902-P02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev RR, 2000, J THEOR BIOL, V204, P21, DOI 10.1006/jtbi.2000.1069; BENHAM CD, 1986, J PHYSIOL-LONDON, V371, P45, DOI 10.1113/jphysiol.1986.sp015961; Beyder A, 2010, J PHYSIOL-LONDON, V588, P4969, DOI 10.1113/jphysiol.2010.199034; Bielefeldt K, 1997, AM J PHYSIOL-GASTR L, V272, pG1439, DOI 10.1152/ajpgi.1997.272.6.G1439; Carl A, 1996, AM J PHYSIOL-CELL PH, V271, pC9, DOI 10.1152/ajpcell.1996.271.1.C9; CASTEELS R, 1971, J PHYSIOL-LONDON, V217, P297, DOI 10.1113/jphysiol.1971.sp009572; Cho WJ, 2005, AM J PHYSIOL-GASTR L, V288, pG571, DOI 10.1152/ajpgi.00222.2004; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Corrias A, 2008, AM J PHYSIOL-GASTR L, V294, pG989, DOI 10.1152/ajpgi.00528.2007; Corrias A, 2007, ANN BIOMED ENG, V35, P1595, DOI 10.1007/s10439-007-9324-8; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Duridanova DB, 1997, GEN PHYSIOL BIOPHYS, V16, P49; Faber GM, 2007, BIOPHYS J, V92, P1522, DOI 10.1529/biophysj.106.088807; FARRUGIA G, 1995, GASTROENTEROLOGY, V109, P707, DOI 10.1016/0016-5085(95)90377-1; FARRUGIA G, 1993, AM J PHYSIOL, V265, pG873, DOI 10.1152/ajpgi.1993.265.5.G873; Farrugia G, 1996, GASTROENTEROLOGY, V110, P1438, DOI 10.1053/gast.1996.v110.pm8613049; Farrugia G, 1999, ANNU REV PHYSIOL, V61, P45, DOI 10.1146/annurev.physiol.61.1.45; Farrugia G, 1999, GASTROENTEROLOGY, V117, P900, DOI 10.1016/S0016-5085(99)70349-5; Faville RA, 2009, BIOPHYS J, V96, P4834, DOI 10.1016/j.bpj.2009.03.058; Gallagher Tom K, 2009, Ann Surg Innov Res, V3, P4, DOI 10.1186/1750-1164-3-4; Gibbons SJ, 2009, J CELL MOL MED, V13, P4422, DOI 10.1111/j.1582-4934.2008.00623.x; HARA Y, 1986, J PHYSIOL-LONDON, V372, P501, DOI 10.1113/jphysiol.1986.sp016022; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holm AN, 2002, GASTROENTEROLOGY, V122, P178, DOI 10.1053/gast.2002.30346; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Kao C., 2005, CELLULAR ASPECTS SMO; Kito Y, 2003, J PHYSIOL-LONDON, V553, P803, DOI 10.1113/jphysiol.2003.051334; Lee HT, 2007, GASTROENTEROLOGY, V132, P1852, DOI 10.1053/j.gastro.2007.02.049; Lim I, 2005, AM J PHYSIOL-GASTR L, V288, pG7, DOI 10.1152/ajpgi.00205.2004; Locke GR, 2006, AM J GASTROENTEROL, V101, P1299, DOI 10.1111/j.1572-0241.2006.00507.x; Lyford GL, 2002, AM J PHYSIOL-CELL PH, V283, pC1001, DOI 10.1152/ajpcell.00140.2002; MAGARIBUCHI T, 1973, JPN J PHYSIOL, V23, P25; Mazzone A, 2008, J BIOL CHEM, V283, P16537, DOI 10.1074/jbc.M801744200; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; Miftakhov RN, 1996, BIOL CYBERN, V74, P455, DOI 10.1007/BF00206712; Miftakhov RN, 1999, J THEOR BIOL, V197, P89, DOI 10.1006/jtbi.1998.0859; MITRA R, 1985, SCIENCE, V229, P269, DOI 10.1126/science.2409600; Poh YC, 2012, J THEOR BIOL, V293, P41, DOI 10.1016/j.jtbi.2011.09.014; Saito YA, 2008, AM J PHYSL GASTROINT; Sakmann B., 1995, SINGLE CHANNEL RECOR; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; SINGER JJ, 1987, PFLUG ARCH EUR J PHY, V408, P98, DOI 10.1007/BF00581337; SKINNER FK, 1993, BIOPHYS CHEM, V45, P253, DOI 10.1016/0301-4622(93)80007-6; SMITH TK, 1987, AM J PHYSIOL, V252, pC215, DOI 10.1152/ajpcell.1987.252.2.C215; Strege PR, 2010, AM J PHYSIOL-GASTR L, V298, pG706, DOI 10.1152/ajpgi.00437.2009; Strege PR, 2003, AM J PHYSIOL-CELL PH, V284, pC60, DOI 10.1152/ajpcell.00532.2001; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; YOSHINO M, 1988, PFLUG ARCH EUR J PHY, V411, P229, DOI 10.1007/BF00582322; Youm JB, 2006, PHILOS T R SOC A, V364, P1135, DOI 10.1098/rsta.2006.1759	53	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42385	10.1371/journal.pone.0042385	http://dx.doi.org/10.1371/journal.pone.0042385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912702	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700014
J	Siudeja, K; Grzeschik, NA; Rana, A; de Jong, J; Sibon, OCM				Siudeja, Katarzyna; Grzeschik, Nicola A.; Rana, Anil; de Jong, Jannie; Sibon, Ody C. M.			Cofilin/Twinstar Phosphorylation Levels Increase in Response to Impaired Coenzyme A Metabolism	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BETA-TUBULIN ISOTYPE; ACTIN DEPOLYMERIZING FACTOR; LIM-KINASE; COFILIN PHOSPHORYLATION; NEURITE OUTGROWTH; DROSOPHILA HOMOLOG; RETINOIC ACID; RHO GTPASES; FUEL GAUGE	Coenzyme A (CoA) is a pantothenic acid-derived metabolite essential for many fundamental cellular processes including energy, lipid and amino acid metabolism. Pantothenate kinase (PANK), which catalyses the first step in the conversion of pantothenic acid to CoA, has been associated with a rare neurodegenerative disorder PKAN. However, the consequences of impaired PANK activity are poorly understood. Here we use Drosophila and human neuronal cell cultures to show how PANK deficiency leads to abnormalities in F-actin organization. Cells with reduced PANK activity are characterized by abnormally high levels of phosphorylated cofilin, a conserved actin filament severing protein. The increased levels of phospho-cofilin coincide with morphological changes of PANK-deficient Drosophila S2 cells and human neuronal SHSY-5Y cells. The latter exhibit also markedly reduced ability to form neurites in culture - a process that is strongly dependent on actin remodeling. Our results reveal a novel and conserved link between a metabolic biosynthesis pathway, and regulation of cellular actin dynamics.	[Siudeja, Katarzyna; Grzeschik, Nicola A.; Rana, Anil; de Jong, Jannie; Sibon, Ody C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol Radiat & Stress Cell Biol, Groningen, Netherlands	University of Groningen	Siudeja, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol Radiat & Stress Cell Biol, Groningen, Netherlands.	o.c.m.sibon@umcg.nl		Siudeja, Katarzyna/0000-0002-2522-7776; Sibon, Ody/0000-0002-6836-6063	Dutch organization for scientific research (NWO)	Dutch organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO))	Dutch organization for scientific research (NWO) funded the described work in a VICI Grant to Ody Sibon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2001, GENETICS, V157, P1267; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blair A, 2006, DEVELOPMENT, V133, P1789, DOI 10.1242/dev.02320; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; Bosveld Floris, 2008, BMC Res Notes, V1, P75, DOI 10.1186/1756-0500-1-75; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fanarraga ML, 1999, EUR J NEUROSCI, V11, P517; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Ghillebert R, 2011, FEBS J, V278, P3978, DOI 10.1111/j.1742-4658.2011.08315.x; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jovceva E, 2007, J CELL SCI, V120, P1888, DOI 10.1242/jcs.004366; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Matthews BB, 1999, DNA CELL BIOL, V18, P435, DOI 10.1089/104454999315150; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miranda L, 2010, BIOCHEM BIOPH RES CO, V396, P656, DOI 10.1016/j.bbrc.2010.04.151; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Pham H, 2008, DEV BIOL, V318, P82, DOI 10.1016/j.ydbio.2008.03.006; Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; ROSSINO P, 1991, CELL REGUL, V2, P1021, DOI 10.1091/mbc.2.12.1021; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; SMITH CL, 1994, J NEUROSCI, V14, P384; SMITH CL, 1994, J CELL BIOL, V127, P1407, DOI 10.1083/jcb.127.5.1407; Wu ZH, 2009, HUM MOL GENET, V18, P3659, DOI 10.1093/hmg/ddp314; Xu XJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-77; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	54	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43145	10.1371/journal.pone.0043145	http://dx.doi.org/10.1371/journal.pone.0043145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912811	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700049
J	Zhou, R; Wang, SJ; Zhu, XJ				Zhou, Rong; Wang, Shenjun; Zhu, Xuejiang			Prenatal Ethanol Exposure Alters Synaptic Plasticity in the Dorsolateral Striatum of Rat Offspring via Changing the Reactivity of Dopamine Receptor	PLOS ONE			English	Article							LONG-TERM DEPRESSION; ALCOHOL EXPOSURE; ENDOCANNABINOID RELEASE; NEUROMODULATORY ACTIONS; HYPERACTIVITY DISORDER; ATTENTION-DEFICIT; MATERNAL ETHANOL; DORSAL STRIATUM; NERVOUS-SYSTEM; BASAL GANGLIA	Prenatal exposure to high-level ethanol (EtOH) has been reported to produce hyperlocomotion in offspring. Previous studies have demonstrated synaptic plasticity in cortical afferent to the dorsolateral (DL) striatum is involved in the pathogensis of hyperlocomotion. Here, prenatal EtOH-exposed rat offspring were used to investigate whether maternal EtOH exposure affected synaptic plasticity in the DL striatum. We found high-frequency stimulation (HFS) induced a weaker long-term potentiation (LTP) in EtOH rats than that in control rats at postnatal day (PD) 15. The same protocol of HFS induced long-term depression (LTD) in control group but still LTP in EtOH group at PD 30 or PD 40. Furthermore, enhancement of basal synaptic transmission accompanied by the decrease of pair-pulse facilitation (PPF) was observed in PD 30 EtOH offspring. The perfusion with D1-type receptors (D1R) antagonist SCH23390 recovered synaptic transmission and blocked the induction of abnormal LTP in PD 30 EtOH offspring. The perfusion with D2-type receptors (D2R) agonist quinpirole reversed EtOH-induced LTP into D1R- and metabotropic glutamate receptor-dependent LTD. The data provide the functional evidence that prenatal ethanol exposure led to the persistent abnormal synaptic plasticity in the DL striatum via disturbing the balance between D1R and D2R.	[Zhou, Rong; Wang, Shenjun; Zhu, Xuejiang] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, R (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.	zhou-rong@hotmail.com			National Natural Science Foundation of China [30872725, 81071027, 81000482]; Preclinical Medicine Fund of Nanjing Medical University of China [JX10131801058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Preclinical Medicine Fund of Nanjing Medical University of China	This work was supported by National Natural Science Foundation of China (30872725, 81071027, 81000482) and Preclinical Medicine Fund of Nanjing Medical University of China (JX10131801058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 1997, ALCOHOL, V14, P25, DOI 10.1016/S0741-8329(96)00081-X; Artola A, 1996, J NEUROPHYSIOL, V76, P984, DOI 10.1152/jn.1996.76.2.984; Barbier E, 2009, NEUROSCIENCE, V161, P427, DOI 10.1016/j.neuroscience.2009.03.076; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Boggan WO, 1996, NEUROTOXICOL TERATOL, V18, P41, DOI 10.1016/0892-0362(95)02027-6; CALABRESI P, 1994, J NEUROSCI, V14, P4871; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Charpier S, 1999, NEUROSCIENCE, V91, P1209, DOI 10.1016/S0306-4522(98)00719-2; Choi SK, 1997, J NEUROSCI, V17, P8613; Coles CD, 1997, ALCOHOL CLIN EXP RES, V21, P150, DOI 10.1111/j.1530-0277.1997.tb03743.x; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P706, DOI 10.1097/00000374-200005000-00016; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Di Filippo M, 2009, BEHAV BRAIN RES, V199, P108, DOI 10.1016/j.bbr.2008.09.025; Emilien G, 1999, PHARMACOL THERAPEUT, V84, P133, DOI 10.1016/S0163-7258(99)00029-7; FloresHernandez J, 1997, SYNAPSE, V25, P185, DOI 10.1002/(SICI)1098-2396(199702)25:2<185::AID-SYN9>3.0.CO;2-8; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Goodlett CR, 2001, ALCOHOL RES HEALTH, V25, P175; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Guerri C, 1998, ALCOHOL CLIN EXP RES, V22, P304, DOI 10.1111/j.1530-0277.1998.tb03653.x; Hausknecht KA, 2005, BEHAV NEUROSCI, V119, P302, DOI 10.1037/0735-7044.119.1.302; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Levine MS, 1996, SYNAPSE, V24, P65, DOI 10.1002/syn.890240102; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; Marche K, 2011, PSYCHOPHARMACOLOGY, V214, P285, DOI 10.1007/s00213-010-1960-2; MEYER ME, 1993, PHARMACOL BIOCHEM BE, V44, P429, DOI 10.1016/0091-3057(93)90486-D; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NIO E, 1991, DEV BRAIN RES, V62, P51, DOI 10.1016/0165-3806(91)90189-P; O'Leary CM, 2004, J PAEDIATR CHILD H, V40, P2, DOI 10.1111/j.1440-1754.2004.00280.x; O'Malley KD, 2002, CAN J PSYCHIAT, V47, P349, DOI 10.1177/070674370204700405; Olney JW, 2002, NEUROTOXICOLOGY, V23, P659, DOI 10.1016/S0161-813X(01)00092-4; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; PIERCE DR, 1986, ALCOHOL, V3, P269, DOI 10.1016/0741-8329(86)90036-4; Randall S, 1999, NEUROTOXICOL TERATOL, V21, P587, DOI 10.1016/S0892-0362(99)00017-3; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Sobrian SK, 2005, NEUROTOXICOL TERATOL, V27, P73, DOI 10.1016/j.ntt.2004.09.002; STEENAART NAE, 1985, J PHARMACOL METHOD, V14, P199, DOI 10.1016/0160-5402(85)90033-6; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Swanson DJ, 1996, J COMP NEUROL, V364, P104, DOI 10.1002/(SICI)1096-9861(19960101)364:1<104::AID-CNE9>3.0.CO;2-9; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Tepper JM, 1998, DEV NEUROSCI-BASEL, V20, P125, DOI 10.1159/000017308; Thomas JD, 2000, NEUROTOXICOL TERATOL, V22, P703, DOI 10.1016/S0892-0362(00)00097-0; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; WALSH JP, 1993, BRAIN RES, V608, P123, DOI 10.1016/0006-8993(93)90782-I; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; WEST JR, 1981, SCIENCE, V211, P957; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Zhou R, 2010, NEUROSCIENCE, V170, P749, DOI 10.1016/j.neuroscience.2010.07.055; Zhou R, 2011, NEUROPHARMACOLOGY, V60, P789, DOI 10.1016/j.neuropharm.2011.01.031	60	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42443	10.1371/journal.pone.0042443	http://dx.doi.org/10.1371/journal.pone.0042443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916128	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300009
J	Tourabaly, I; Boutron, I; Nizard, R; Ravaud, P				Tourabaly, Idriss; Boutron, Isabelle; Nizard, Remy; Ravaud, Philippe			ASSIST Applicability Scoring of Surgical trials. An Investigator-reported aSsessment Tool	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; EXTERNAL VALIDITY; PREVENTION; VOLUME; HIP	Context: We aimed to develop a new tool for assessing and depicting the applicability of the results of surgical randomized controlled trials (RCTs) from the trial investigators' perspective. Methods: We identified all items related to applicability by a systematic methodological review, and then a sample of surgeons used these items in a web-based survey to evaluate the applicability of their own trial results. For each applicability item, participants had to indicate on a numerical scale that was simplified as a three-item scale: 1) items essential to consider, 2) items requiring attention, and 3) items inconsequential to the applicability of the results of their own RCT to clinical practice. For the final tool, we selected only items that were rated as being essential or requiring attention for at least 25% of the trials evaluated. We propose a specific process to construct the tool and to depict applicability in a graph. We identified all investigators of published and registered ongoing RCTs assessing surgery and invited them to participate in the web-based survey. Results: 148 surgeons assessed applicability for their own trial and participated in the process of item selection. The final tool contains 22 items (4 dedicated to patients, 5 to centers, 5 to surgeons and 8 to the intervention). We proposed a straightforward process of constructing the graphical tool: 1) a multidisciplinary team of investigators or other care providers participating in the trial could independently assess each item, 2) a consensus method could be used, and 3) the investigators could depict their assessment of the applicability of the trial results in 4 graphs related to patients, centers, surgeons and the intervention. Conclusions: This investigator-reported assessment tool could help readers define under what conditions they could reasonably apply the results of a surgical RCT to their clinical practice.	[Tourabaly, Idriss; Boutron, Isabelle; Ravaud, Philippe] INSERM, U738, Paris, France; [Tourabaly, Idriss; Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Tourabaly, Idriss; Boutron, Isabelle; Nizard, Remy; Ravaud, Philippe] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Nizard, Remy] Hop Lariboisiere, AP HP, Serv Chirurg Orthoped & Traumatol, F-75475 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Tourabaly, I (corresponding author), INSERM, U738, Paris, France.	isabelle.boutron@htd.aphp.fr	ravaud, philippe/C-1694-2009; Nizard, Remy/R-5845-2019	Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206	academic grant, "Recherche Sur la Recherche", "Assistance Publique - Hopitaux de Paris" [RSR-08002]; Institut Nationale du Cancer	academic grant, "Recherche Sur la Recherche", "Assistance Publique - Hopitaux de Paris"; Institut Nationale du Cancer	The study was funded by an academic grant, "Recherche Sur la Recherche" (RSR-08002) from the "Assistance Publique - Hopitaux de Paris," and by an academic grant from the Institut Nationale du Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2009, ARTHRIT RHEUM-ARTHR, V61, P361, DOI 10.1002/art.24279; Atkins D, 2011, J CLIN EPIDEMIOL; Balasubramanian SP, 2006, ANN SURG, V244, P663, DOI 10.1097/01.sla.0000217640.11224.05; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Boutron I, 2009, BRIT J SURG, V96, P449, DOI 10.1002/bjs.6611; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Dekkers OM, 2010, INT J EPIDEMIOL, V39, P89, DOI 10.1093/ije/dyp174; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Howard SC, 2006, STROKE, V37, P209, DOI 10.1161/01.STR.0000195125.59349.23; Jacquier I, 2006, ANN SURG, V244, P677, DOI 10.1097/01.sla.0000242707.44007.80; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Petersen MK, 2007, ACTA ORTHOP, V78, P12, DOI 10.1080/17453670610013367; Pibouleau L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4538; Rothwell PM, 2010, INT J EPIDEMIOL, V39, P94, DOI 10.1093/ije/dyp305; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42258	10.1371/journal.pone.0042258	http://dx.doi.org/10.1371/journal.pone.0042258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916125	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600011
J	Presicce, P; Moreno-Fernandez, ME; Rusie, LK; Fichtenbaum, C; Chougnet, CA				Presicce, Pietro; Moreno-Fernandez, Maria E.; Rusie, Laura K.; Fichtenbaum, Carl; Chougnet, Claire A.			In Vitro HIV Infection Impairs the Capacity of Myeloid Dendritic Cells to Induce Regulatory T Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD; TYPE-1; IMMATURE; EXPRESSION; FREQUENCY; ACCUMULATION; REPLICATION; SUPPRESSION; ACTIVATION	Myeloid dendritic cells (mDCs) are the antigen-presenting cells best capable of promoting peripheral induction of regulatory T cells (Tregs), and are among the first targets of HIV. It is thus important to understand whether HIV alters their capacity to promote Treg conversion. Monocyte-derived DCs (moDCs) from uninfected donors induced a Treg phenotype (CD25(+)FOXP3(+)) in autologous conventional T cells. These converted FOXP3(+) cells suppressed the proliferation of responder T cells similarly to circulating Tregs. In contrast, the capacity of moDCs to induce CD25 or FOXP3 was severely impaired by their in vitro infection with CCR5-utilizing virus. MoDC exposure to inactivated HIV was sufficient to impair FOXP3 induction. This DC defect was not dependent on IL-10, TGF-beta or other soluble factors, but was due to preferential killing of Tregs by HIV-exposed/ infected moDCs, through a caspase-dependent pathway. Importantly, similar results were obtained with circulating primary myeloid DCs. Upon infection in vitro, these mDCs also killed Treg through mechanisms at least partially caspase-dependent, leading to a significantly lower proportion of induced Tregs. Taken together, our data suggest that Treg induction may be defective when DCs are exposed to high levels of virus, such as during the acute phase of infection or in AIDS patients.	[Presicce, Pietro; Moreno-Fernandez, Maria E.; Rusie, Laura K.; Chougnet, Claire A.] Univ Cincinnati, Coll Med, Div Cellular & Mol Immunol, Cincinnati Childrens Hosp,Res Fdn, Cincinnati, OH 45221 USA; [Presicce, Pietro; Moreno-Fernandez, Maria E.; Rusie, Laura K.; Chougnet, Claire A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Fichtenbaum, Carl] Univ Cincinnati, Coll Med, Ctr Infect Dis, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Presicce, P (corresponding author), Univ Cincinnati, Coll Med, Div Cellular & Mol Immunol, Cincinnati Childrens Hosp,Res Fdn, Cincinnati, OH 45221 USA.	claire.chougnet@cchmc.org	Presicce, Pietro/AAN-8719-2020	Presicce, Pietro/0000-0002-2690-1814; Fichtenbaum, Carl/0000-0002-6778-7253	Public Health Service [R01 AI068524]; University of Cincinnati Postdoctoral Fellow Research Grant; Center for Excellence in Molecular Hematology [1P30DK090971-01]; Digestive Health Center [AR47363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Cincinnati Postdoctoral Fellow Research Grant; Center for Excellence in Molecular Hematology; Digestive Health Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grant R01 AI068524 (to CAC) and University of Cincinnati Postdoctoral Fellow Research Grant 2010 (to PP). The authors acknowledge the support provided in part by the Center for Excellence in Molecular Hematology Grant 1P30DK090971-01 and Digestive Health Center Grant AR47363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Baatar D, 2007, J IMMUNOL, V178, P4891, DOI 10.4049/jimmunol.178.8.4891; Bacchetta R, 2010, HAEMATOL-HEMATOL J, V95, P2134, DOI 10.3324/haematol.2010.025825; Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Coates PTH, 2003, BLOOD, V102, P2513, DOI 10.1182/blood-2002-09-2929; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Huang JH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-11; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lichtner M, 2004, AIDS RES HUM RETROV, V20, P175, DOI 10.1089/088922204773004897; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; LORE K, 2002, 17 INT AIDS C MEX CI, V16, P683; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Patterson S, 2005, J IMMUNOL, V174, P8200, DOI 10.4049/jimmunol.174.12.8200; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Presicce P, 2011, 17 INT AIDS C MEX CI; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shaw JM, 2011, J VIROL, V85, P11422, DOI 10.1128/JVI.05608-11; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sugita S, 2011, INVEST OPHTH VIS SCI, V52, P2598, DOI 10.1167/iovs.10-6322; Verhasselt V, 2004, EUR J IMMUNOL, V34, P762, DOI 10.1002/eji.200324552; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	60	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42802	10.1371/journal.pone.0042802	http://dx.doi.org/10.1371/journal.pone.0042802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912740	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500100032
J	Bergeron, M; Daneau, G; Ding, T; Sitoe, NE; Westerman, LE; Stokx, J; Jani, IV; Coetzee, LM; Scott, L; De Weggheleire, A; Boel, L; Stevens, WS; Glencross, DK; Peter, TF				Bergeron, Michele; Daneau, Geraldine; Ding, Tao; Sitoe, Nadia E.; Westerman, Larry E.; Stokx, Jocelijn; Jani, Ilesh V.; Coetzee, Lindi M.; Scott, Lesley; De Weggheleire, Anja; Boel, Luc; Stevens, Wendy S.; Glencross, Deborah K.; Peter, Trevor F.			Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; QUALITY ASSESSMENT; ADULTS; INITIATION; AGREEMENT; PROGRAM; CARE	Introduction: Point-of-care (POC) CD4 testing can improve access to treatment by enabling decentralization and reducing patient loss-to-follow-up. As new POC CD4 technologies become available, their performance should be assessed before widespread deployment. This study reports the findings of five independent evaluations of the PointCare NOW CD4 system. Materials/Methods: Evaluations were conducted in Southern Africa (Mozambique, South Africa) and North America (Canada, USA). 492 blood samples (55 from HIV-negative blood donors and 437 from HIV-infected patients, including 20 children aged between 12 and 59 months) were tested with both the PointCare NOW and reference flow cytometry instruments. Assessment of bias, precision and levels of clinical misclassification for absolute and percent CD4 count was conducted. Results: PointCare NOW significantly overestimated CD4 absolute counts with a mean relative bias of +35.0%. Bias was greater in samples with CD4 counts below <= 350cells/mu l (+51.3%) than in the CD4 >350cells/mu l stratum (15.1%). Bias in CD4% had a similar trend with an overall relative mean bias of +25.6% and a larger bias for low CD4 stratum (+40.2%) than the higher CD4 stratum (+5.8%). Relative bias for CD4% in children was -6.8%. In terms of repeatability, PointCare NOW had a coefficient of variation of 11%. Using a threshold of 350cells/mu l, only 47% of patients who qualified for antiretroviral therapy with reference CD4 testing, would have been eligible for treatment with PointCare NOW test results. This was 39% using a 200cells/mu l threshold. Agreement with infant samples was higher, with 90% qualifying at a 25% eligibility threshold. Conclusion: The performance of the PointCare NOW instrument for absolute and percent CD4 enumeration was inadequate for HIV clinical management in adults. In children, the small sample size was not large enough to draw a conclusion. This study also highlights the importance of independent evaluation of new diagnostic technology platforms before deployment.	[Bergeron, Michele; Ding, Tao] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Ottawa, ON, Canada; [Daneau, Geraldine; Boel, Luc] Inst Trop Med, Immunol Unit, B-2000 Antwerp, Belgium; [Sitoe, Nadia E.; Jani, Ilesh V.] Inst Nacl Saude, Maputo, Mozambique; [Westerman, Larry E.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA; [Coetzee, Lindi M.; Scott, Lesley; Stevens, Wendy S.; Glencross, Deborah K.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Peter, Trevor F.] Clinton Hlth Access Initiat, Maputo, Mozambique	Public Health Agency of Canada; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA; University of Witwatersrand	Bergeron, M (corresponding author), Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Ottawa, ON, Canada.	gdaneau@itg.be	De Weggheleire, Anja/C-7345-2018	De Weggheleire, Anja/0000-0001-9377-4766; Daneau, Geraldine/0000-0002-2570-0893; Glencross, Deborah/0000-0001-7106-769X; Sitoe, Nadia/0000-0001-7310-8221; Jani, Ilesh/0000-0002-6880-6655; Scott, Lesley/0000-0001-6573-9525	UNITAID; Absolute Return for Kids; Flemish International Cooperation Agency (VLIR, Flemish inter-university council); USAIDS	UNITAID; Absolute Return for Kids; Flemish International Cooperation Agency (VLIR, Flemish inter-university council); USAIDS	The study in Maputo, Mozambique, was supported by UNITAID and Absolute Return for Kids. The study in Tete, Mozambique, was conducted within a collaborative health project financed by the Flemish International Cooperation Agency (VLIR, Flemish inter-university council). The Centers for Disease Control and Prevention protocol was funded by USAIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron M, 2002, CYTOMETRY, V50, P53, DOI 10.1002/cyto.10092; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Denny TN, 2008, CYTOM PART B-CLIN CY, V74B, pS52, DOI 10.1002/cyto.b.20417; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS40, DOI 10.1002/cyto.b.20384; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Lynen L, 2006, JAIDS-J ACQ IMM DEF, V42, P322, DOI 10.1097/01.qai.0000221682.37316.d5; Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Miiro G, 2010, TROP MED INT HEALTH, V15, P396, DOI 10.1111/j.1365-3156.2010.02471.x; Murtagh M, 2011, HIV AIDS DIAGNOSTIC; Peter TF, 2009, AM J CLIN PATHOL, V131, P867, DOI 10.1309/AJCPCBMOHM7SM3PJ; Peterson K, 2012, EXPERT REV ANTI-INFE, V10, P43, DOI [10.1586/eri.11.151, 10.1586/ERI.11.151]; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Shott JP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/651927; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2010, AD WHO NORM HIV GUID; World Health Organization, 2010, ANT THER HIV INF MFA; World Health Organization, 2006, ANT THER HIV INF AD	23	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41166	10.1371/journal.pone.0041166	http://dx.doi.org/10.1371/journal.pone.0041166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912668	gold, Green Published, Green Submitted			2022-12-27	WOS:000307378500004
J	Yang, LL; Serada, S; Fujimoto, M; Terao, M; Kotobuki, Y; Kitaba, S; Matsui, S; Kudo, A; Naka, T; Murota, H; Katayama, I				Yang, Lingli; Serada, Satoshi; Fujimoto, Minoru; Terao, Mika; Kotobuki, Yorihisa; Kitaba, Shun; Matsui, Saki; Kudo, Akira; Naka, Tetsuji; Murota, Hiroyuki; Katayama, Ichiro			Periostin Facilitates Skin Sclerosis via PI3K/Akt Dependent Mechanism in a Mouse Model of Scleroderma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MYOFIBROBLAST DIFFERENTIATION; MYOCARDIAL-INFARCTION; ANIMAL-MODEL; NULL MICE; FIBROSIS; FIBROBLASTS; EXPRESSION; PROTEIN; REPAIR	Objective: Periostin, a novel matricellular protein, is recently reported to play a crucial role in tissue remodeling and is highly expressed under fibrotic conditions. This study was undertaken to assess the role of periostin in scleroderma. Methods: Using skin from patients and healthy donors, the expression of periostin was assessed by immunohistochemistry and immunoblotting analyses. Furthermore, we investigated periostin (-/-) (PN-/-) and wild-type (WT) mice to elucidate the role of periostin in scleroderma. To induce murine cutaneous sclerosis, mice were subcutaneously injected with bleomycin, while untreated control groups were injected with phosphate-buffered saline. Bleomycin-induced fibrotic changes were compared in PN-/- and WT mice by histological analysis as well as by measurements of profibrotic cytokine and extracellular matrix protein expression levels in vivo and in vitro. To determine the downstream pathway involved in periostin signaling, receptor neutralizing antibody and signal transduction inhibitors were used in vitro. Results: Elevated expression of periostin was observed in the lesional skin of patients with scleroderma compared with healthy donors. Although WT mice showed marked cutaneous sclerosis with increased expression of periostin and increased numbers of myofibroblasts after bleomycin treatment, PN-/- mice showed resistance to these changes. In vitro, dermal fibroblasts from PN-/- mice showed reduced transcript expression of alpha smooth actin and procollagen type-I alpha 1 (Col1 alpha 1) induced by transforming growth factor beta 1 (TGF beta 1). Furthermore, recombinant mouse periostin directly induced Col1 alpha 1 expression in vitro, and this effect was inhibited by blocking the alpha v integrin-mediated PI3K/Akt signaling either with anti-alpha v functional blocking antibody or with the PI3K/Akt kinase inhibitor LY294002. Conclusion: Periostin plays an essential role in the pathogenesis of Bleomycin-induced scleroderma in mice. Periostin may represent a potential therapeutic target for human scleroderma.	[Yang, Lingli; Terao, Mika; Kotobuki, Yorihisa; Kitaba, Shun; Matsui, Saki; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Yang, Lingli; Serada, Satoshi; Fujimoto, Minoru; Kotobuki, Yorihisa; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka, Japan; [Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan	Osaka University; National Institute of Health Sciences - Japan; Tokyo Institute of Technology	Yang, LL (corresponding author), Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan.	h-murota@derma.med.osaka-u.ac.jp	Kudo, Akira/C-7340-2015	Kudo, Akira/0000-0001-6289-3391; yi lang, pian shan/0000-0002-3270-1085; Naka, Tetsuji/0000-0002-1269-3997; Serada, Satoshi/0000-0001-6948-9009; Kotobuki, Yorihisa/0000-0002-6519-5000; FUJIMOTO, MINORU/0000-0002-6390-8863	Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [22591101] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gillan L, 2002, CANCER RES, V62, P5358; Gordon ED, 2012, CLIN EXP ALLERGY, V42, P144, DOI 10.1111/j.1365-2222.2011.03840.x; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Ikonomidis JS, 2005, AM J PHYSIOL-HEART C, V288, pH149, DOI 10.1152/ajpheart.00370.2004; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Kitaba S, 2011, AM J PATHOL; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Lygoe KA, 2007, BIOL CELL, V99, P601, DOI 10.1042/BC20070008; McCann MR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3226; Murota H, 2003, ARTHRITIS RHEUM, V48, P1117, DOI 10.1002/art.10896; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Oku E, 2008, INT J HEMATOL, V88, P57, DOI 10.1007/s12185-008-0095-2; Ontsuka K, 2012, EXP DERMATOL, V21, P331, DOI 10.1111/j.1600-0625.2012.01454.x; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Shimazaki M, 2008, BIOCHEM BIOPH RES CO, V367, P736, DOI 10.1016/j.bbrc.2008.01.009; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tanabe H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012234; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Terao M, 2010, EXP DERMATOL, V19, P38, DOI 10.1111/j.1600-0625.2009.00973.x; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; Tkatchenko TV, 2009, PHYSIOL GENOMICS, V39, P160, DOI 10.1152/physiolgenomics.00078.2009; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183; Zhou HM, 2010, J CELL COMMUN SIGNAL, V4, P99, DOI 10.1007/s12079-010-0090-2	49	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41994	10.1371/journal.pone.0041994	http://dx.doi.org/10.1371/journal.pone.0041994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911870	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300087
J	Biswas, R; Martinez, RE; Gohring, N; Schlag, M; Josten, M; Xia, GQ; Hegler, F; Gekeler, C; Gleske, AK; Gotz, F; Sahl, HG; Kappler, A; Peschel, A				Biswas, Raja; Martinez, Raul E.; Goehring, Nadine; Schlag, Martin; Josten, Michaele; Xia, Guoqing; Hegler, Florian; Gekeler, Cordula; Gleske, Anne-Kathrin; Goetz, Friedrich; Sahl, Hans-Georg; Kappler, Andreas; Peschel, Andreas			Proton-Binding Capacity of Staphylococcus aureus Wall Teichoic Acid and Its Role in Controlling Autolysin Activity	PLOS ONE			English	Article							CELL-WALL; BACILLUS-SUBTILIS; MEMBRANE; COLONIZATION; LOCALIZATION; OPERON	Wall teichoic acid (WTA) or related polyanionic cell wall glycopolymers are produced by most Gram-positive bacterial species and have been implicated in various cellular functions. WTA and the proton gradient across bacterial membranes are known to control the activity of autolysins but the molecular details of these interactions are poorly understood. We demonstrate that WTA contributes substantially to the proton-binding capacity of Staphylococcus aureus cell walls and controls autolysis largely via the major autolysin AtlA whose activity is known to decline at acidic pH values. Compounds that increase or decrease the activity of the respiratory chain, a main source of protons in the cell wall, modulated autolysis rates in WTA-producing cells but did not affect the augmented autolytic activity observed in a WTA-deficient mutant. We propose that WTA represents a cation-exchanger like mesh in the Gram-positive cell envelopes that is required for creating a locally acidified milieu to govern the pH-dependent activity of autolysins.	[Biswas, Raja; Goehring, Nadine; Schlag, Martin; Xia, Guoqing; Gekeler, Cordula; Gleske, Anne-Kathrin; Goetz, Friedrich; Peschel, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Martinez, Raul E.; Hegler, Florian; Kappler, Andreas] Univ Tubingen, Ctr Appl Geosci, Tubingen, Germany; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Pharmaceut Microbiol Unit, IMMIP, Bonn, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Bonn	Biswas, R (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	andreas.peschel@uni-tuebingen.de	Xia, Guoqing/C-2365-2015; Kappler, Andreas/G-7221-2016	Xia, Guoqing/0000-0003-4492-9156; Kappler, Andreas/0000-0002-3558-9500; Gekeler, Cordula/0000-0001-9041-6672	German Research Foundation [TRR34, SFB766]; Bacteria Materials Interaction graduate programme of the University of Tubingen; Humboldt Foundation	German Research Foundation(German Research Foundation (DFG)); Bacteria Materials Interaction graduate programme of the University of Tubingen; Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the German Research Foundation grants TRR34 to A. P. and F. G. and SFB766 to A. P., G. X., and F. G.; by the Bacteria Materials Interaction graduate programme of the University of Tubingen to A. P. and A. K.; and by a fellowship from the Humboldt Foundation to R. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067; BRUCKNER R, 1992, GENE, V122, P187, DOI 10.1016/0378-1119(92)90048-T; Calamita HG, 2002, MOL MICROBIOL, V44, P601, DOI 10.1046/j.1365-2958.2002.02872.x; Calamita HG, 2001, P NATL ACAD SCI USA, V98, P15260, DOI 10.1073/pnas.261483798; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Eugster MR, 2011, MOL MICROBIOL, V81, P1419, DOI 10.1111/j.1365-2958.2011.07774.x; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; JOLLIFFE LK, 1981, CELL, V25, P753, DOI 10.1016/0092-8674(81)90183-5; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Lutzner N, 2009, BIOCHEM BIOPH RES CO, V380, P554, DOI 10.1016/j.bbrc.2009.01.140; Martinez RE, 2002, J COLLOID INTERF SCI, V253, P130, DOI 10.1006/jcis.2002.8541; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Patton TG, 2006, MOL MICROBIOL, V59, P1395, DOI 10.1111/j.1365-2958.2006.05034.x; Penyige A, 2002, BIOCHEM BIOPH RES CO, V290, P1169, DOI 10.1006/bbrc.2001.6317; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Phoenix VR, 2002, APPL ENVIRON MICROB, V68, P4827, DOI 10.1128/AEM.68.10.4827-4834.2002; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Soldo B, 1999, MOL MICROBIOL, V31, P795, DOI 10.1046/j.1365-2958.1999.01218.x; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Xia GQ, 2011, J BACTERIOL, V193, P4006, DOI 10.1128/JB.01412-10; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yamamoto H, 2008, MOL MICROBIOL, V70, P297, DOI 10.1111/j.1365-2958.2008.06397.x; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	40	60	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41415	10.1371/journal.pone.0041415	http://dx.doi.org/10.1371/journal.pone.0041415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911791	gold, Green Submitted, Green Published			2022-12-27	WOS:000306687700087
J	Buitrago-Perez, A; Hachimi, M; Duenas, M; Lloveras, B; Santos, A; Holguin, A; Duarte, B; Santiago, JL; Akgul, B; Rodriguez-Peralto, JL; Storey, A; Ribas, C; Larcher, F; del Rio, M; Paramio, JM; Garcia-Escudero, R				Buitrago-Perez, Agueda; Hachimi, Mariam; Duenas, Marta; Lloveras, Belen; Santos, Almudena; Holguin, Almudena; Duarte, Blanca; Santiago, Juan Luis; Akguel, Baki; Rodriguez-Peralto, Jose L.; Storey, Alan; Ribas, Catalina; Larcher, Fernando; del Rio, Marcela; Paramio, Jesus M.; Garcia-Escudero, Ramon			A Humanized Mouse Model of HPV-Associated Pathology Driven by E7 Expression	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS-CELL CARCINOMA; RETINOBLASTOMA TUMOR-SUPPRESSOR; E6 PROTEINS; EPIDERMODYSPLASIA-VERRUCIFORMIS; CERVICAL-CARCINOMA; GENE-THERAPY; SKIN-CANCER; HIGH-RISK; DIFFERENTIATION	Human papillomavirus (HPV) is the causative agent of human cervical cancer and has been associated with oropharyngeal squamous cell carcinoma development. Although prophylactic vaccines have been developed, there is a need to develop new targeted therapies for individuals affected with malignant infected lesions in these locations, which must be tested in appropriate models. Cutaneous beta HPV types appear to be involved in skin carcinogenesis. Virus oncogenicity is partly achieved by inactivation of retinoblastoma protein family members by the viral E7 gene. Here we show that the E7 protein of cutaneous beta HPV5 binds pRb and promotes its degradation. In addition, we described an in vivo model of HPV-associated disease in which artificial human skin prepared using primary keratinocytes engineered to express the E7 protein is engrafted onto nude mice. Expression of E7 in the transplants was stably maintained for up to 6 months, inducing the appearance of lesions that, in the case of HPV16 E7, histologically resembled human anogenital lesions caused by oncogenic HPVs. Moreover, it was confirmed through biomarker expression analysis via immunodetection and/or quantitative PCR from mRNA and miRNA that the 16E7-modified engrafted skin shares molecular features with human HPV-associated pretumoral and tumoral lesions. Finally, our findings indicate a decrease of the in vitro capacity of HPV5 E7 to reduce pRb levels in vivo, possibly explaining the phenotypical differences when compared with 16E7-grafts. Our model seems to be a valuable platform for basic research into HPV oncogenesis and preclinical testing of HPV-associated antitumor therapies.	[Buitrago-Perez, Agueda; Hachimi, Mariam; Duenas, Marta; Paramio, Jesus M.; Garcia-Escudero, Ramon] CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain; [Lloveras, Belen] Hosp del Mar, Barcelona, Spain; [Santos, Almudena; Ribas, Catalina] Univ Autonoma Barcelona, CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Santos, Almudena; Ribas, Catalina] Univ Autonoma Barcelona, CSIC UAM, Dept Biol Mol, Madrid, Spain; [Santos, Almudena; Ribas, Catalina] Inst Invest Sanitaria Princesa, Madrid, Spain; [Holguin, Almudena; del Rio, Marcela] CIEMAT, Div Biomed, Regenerat Med Unit, E-28040 Madrid, Spain; [Duarte, Blanca; Larcher, Fernando] CIEMAT, Div Biomed, Cutaneous Dis Modeling Unit, E-28040 Madrid, Spain; [Santiago, Juan Luis] Univ Castilla La Mancha, Hosp Gen Ciudad Real, Dept Dermatol, Ciudad Real, Spain; [Akguel, Baki] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Rodriguez-Peralto, Jose L.] Univ Complutense, Hosp Univ Octubre 12, Dept Pathol, E-28040 Madrid, Spain; [Storey, Alan] Univ Complutense, Inst Invest Hosp Octubre i 12 12, Dept Pathol, E-28040 Madrid, Spain; Univ Oxford, John Radcliffe Hosp, Dept Oncol, Oxford OX3 9DU, England	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidad de Castilla-La Mancha; University of Cologne; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario 12 de Octubre; University of Oxford	Buitrago-Perez, A (corresponding author), Hosp Univ La Paz, Hlth Res Inst IdiPAZ, Madrid, Spain.	jesusm.paramio@ciemat.es; ramon.garcia@ciemat.es	Paramio, Jesus M/M-8482-2014; Akgül, Baki/H-5629-2019; Garcia-Escudero, Ramon/A-2735-2012; DEL RIO, MARCELA/H-2796-2015; Larcher, Fernando/J-1527-2016	Paramio, Jesus M/0000-0001-7520-3177; Akgül, Baki/0000-0002-6564-9412; Garcia-Escudero, Ramon/0000-0001-5640-6542; DEL RIO, MARCELA/0000-0003-2910-7189; Larcher, Fernando/0000-0002-6771-3561; Hachimi, Mariam/0000-0002-0962-0850; Storey, Alan/0000-0003-2001-9772; Duenas, Marta/0000-0003-0857-9726; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153	Comunidad Autonoma de Madrid [Oncocycle S2006/BIO-0232]; Ministerio de Ciencia e Innovacion [ISCIII-RETIC RD06/0020, SAF2008-00121]; Fundacion Sandra Ibarra	Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Sandra Ibarra	This work was supported by Comunidad Autonoma de Madrid (Oncocycle S2006/BIO-0232), by Ministerio de Ciencia e Innovacion (ISCIII-RETIC RD06/0020 and SAF2008-00121), and by Fundacion Sandra Ibarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2006, EMBO REP, V7, P334, DOI 10.1038/sj.embor.7400615; Akgul B, 2006, J PATHOL, V208, P165, DOI 10.1002/path.1893; Akgul B, 2005, ARCH VIROL, V150, P145, DOI 10.1007/s00705-004-0398-4; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Azuma M, 2010, METHODS MOL BIOL, V623, P373, DOI 10.1007/978-1-60761-588-0_24; Bavinck JNB, 2010, CANCER RES, V70, P9777, DOI 10.1158/0008-5472.CAN-10-0352; Boyer SN, 1996, CANCER RES, V56, P4620; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Caldeira S, 2003, J VIROL, V77, P2195, DOI 10.1128/JVI.77.3.2195-2206.2003; Caldeira S, 2000, ONCOGENE, V19, P821, DOI 10.1038/sj.onc.1203375; CRUM CP, 1984, NEW ENGL J MED, V310, P880, DOI 10.1056/NEJM198404053101403; de Jong-Tieben LM, 2000, TRANSPLANTATION, V69, P44, DOI 10.1097/00007890-200001150-00009; de Koning MNC, 2009, J GEN VIROL, V90, P1611, DOI 10.1099/vir.0.010017-0; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069; Di Nunzio F, 2008, MOL THER, V16, P1977, DOI 10.1038/mt.2008.204; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Dubina M, 2009, AM J DERMATOPATH, V31, P561, DOI 10.1097/DAD.0b013e3181a58234; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Escamez MJ, 2008, J INVEST DERMATOL, V128, P1565, DOI 10.1038/sj.jid.5701217; Escamez MJ, 2004, J INVEST DERMATOL, V123, P1182, DOI 10.1111/j.0022-202X.2004.23473.x; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gache Y, 2004, HUM GENE THER, V15, P921, DOI 10.1089/hum.2004.15.921; Gewirtzman A, 2008, CURR OPIN INFECT DIS, V21, P141, DOI 10.1097/QCO.0b013e3282f486c9; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Helt AM, 2002, J VIROL, V76, P10559, DOI 10.1128/JVI.76.20.10559-10568.2002; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Iftner T, 2002, EMBO J, V21, P4741, DOI 10.1093/emboj/cdf443; Jackson S, 2000, GENE DEV, V14, P3065, DOI 10.1101/gad.182100; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; Jian YC, 1998, ONCOGENE, V17, P2027, DOI 10.1038/sj.onc.1202142; Jones DL, 1997, VIROLOGY, V239, P97, DOI 10.1006/viro.1997.8851; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; Karim R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017848; Larcher F, 2001, FASEB J, V15, P1529, DOI 10.1096/fj.01-0082com; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Llames Sara, 2006, Cell and Tissue Banking, V7, P47, DOI 10.1007/s10561-004-7253-4; Llames SG, 2004, TRANSPLANTATION, V77, P350, DOI 10.1097/01.TP.0000112381.80964.85; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; Meana A, 1998, BURNS, V24, P621, DOI 10.1016/S0305-4179(98)00107-7; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; Moody CA, 2007, P NATL ACAD SCI USA, V104, P19541, DOI 10.1073/pnas.0707947104; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Ramqvist T, 2011, ANTICANCER RES, V31, P1515; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Riley RR, 2003, CANCER RES, V63, P4862; Ruesch MN, 1998, VIROLOGY, V250, P19, DOI 10.1006/viro.1998.9359; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Santegoets LAM, 2007, INT J CANCER, V121, P759, DOI 10.1002/ijc.22769; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; SCHMITT A, 1994, J VIROL, V68, P7051, DOI 10.1128/JVI.68.11.7051-7059.1994; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; STOLER MH, 1986, HUM PATHOL, V17, P1250, DOI 10.1016/S0046-8177(86)80569-X; Strati K, 2007, CANCER RES, V67, P11585, DOI 10.1158/0008-5472.CAN-07-3007; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Viarisio D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002125; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; YAMASHITA T, 1993, ONCOGENE, V8, P2433; Yang SL, 1999, HUM GENE THER, V10, P123, DOI 10.1089/10430349950019255; Zehbe I, 1999, ONCOGENE, V18, P2201, DOI 10.1038/sj.onc.1202549; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	79	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41743	10.1371/journal.pone.0041743	http://dx.doi.org/10.1371/journal.pone.0041743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911850	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306687700145
J	Javadi, AH; Aichelburg, C				Javadi, Amir Homayoun; Aichelburg, Clarisse			When Time and Numerosity Interfere: The Longer the More, and the More the Longer	PLOS ONE			English	Article							INTRAPARIETAL SULCUS; DURATION COMPARISONS; BRAIN ACTIVATION; PARIETAL CORTEX; YOUNG-CHILDREN; PERCEPTION; NUMBER; SYSTEMS; FMRI; DISCRIMINATION	There is strong evidence that magnitudes in different dimensions can interfere. A majority of previous studies on the interaction of temporal magnitudes on numerosity showed no interfering effect, while many studies have reported the interference of numerosity on judgement of temporal magnitudes. We speculated that this one-way interference is confounded by the magnitudes used in the studies. We used a methodology that allowed us to study this interaction reciprocally. Moreover, we selected magnitudes for two dimensions that enabled us to detect their interfering effects. Participants had to either judge which of two successive sets of items was more numerous (numerosity judgement task), or which set of items was presented longer (duration judgement task). We hypothesised that a longer presentation of a set will be judged as being more numerous, and vice versa, a more numerous set will be judged as being presented longer. Results confirmed our hypothesis. A positive correlation between duration of presentation and judged numerosity as well as a positive correlation between the number of items and judged duration of presentation was found. This observation supports the idea that duration and numerosity judgements are not completely independent and implies the existence of (partly) generalised and abstract components in the magnitude representations.	[Javadi, Amir Homayoun] Tech Univ Dresden, Sect Syst Neurosci, D-01062 Dresden, Germany; [Aichelburg, Clarisse] UCL, Div Psychol & Language Sci, London, England	Technische Universitat Dresden; University of London; University College London	Javadi, AH (corresponding author), Tech Univ Dresden, Sect Syst Neurosci, D-01062 Dresden, Germany.	a.h.javadi@gmail.com	Javadi, Amir-Homayoun/G-8547-2013	Javadi, Amir-Homayoun/0000-0003-0569-6441				Agrillo C, 2010, COGN NEUROSCI-UK, V1, P96, DOI 10.1080/17588921003632537; Alexander I, 2005, COGN NEUROPSYCHOL, V22, P306, DOI 10.1080/02643290442000356; ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Belin P, 2002, NEUROPSYCHOLOGIA, V40, P1956, DOI 10.1016/S0028-3932(02)00062-3; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cappelletti M, 2007, EXP BRAIN RES, V179, P631, DOI 10.1007/s00221-006-0820-0; Cappelletti M, 2009, NEUROPSYCHOLOGIA, V47, P2732, DOI 10.1016/j.neuropsychologia.2009.05.024; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Coslett HB, 2009, BRAIN RES, V1254, P38, DOI 10.1016/j.brainres.2008.11.015; DEHAENE S, 1991, NEUROPSYCHOLOGIA, V29, P1045, DOI 10.1016/0028-3932(91)90076-K; Dehaene S., 2005, CONTROL NONNUMERICAL; Dehaene Stanislas, 2011, NUMBER SENSE MIND CR, DOI 10.1016/C2010-0-66570-9; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Dormal V, 2008, CORTEX, V44, P462, DOI 10.1016/j.cortex.2007.08.011; Dormal V, 2010, NEUROIMAGE, V52, P1677, DOI 10.1016/j.neuroimage.2010.04.254; Dormal V, 2009, HUM BRAIN MAPP, V30, P2466, DOI 10.1002/hbm.20677; Droit-Volet S, 2003, J EXP CHILD PSYCHOL, V84, P63, DOI 10.1016/S0022-0965(02)00180-7; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Ferrandez AM, 2003, NEUROIMAGE, V19, P1532, DOI 10.1016/S1053-8119(03)00159-9; Harrington DL, 1998, J NEUROSCI, V18, P1085; Lemer C, 2003, NEUROPSYCHOLOGIA, V41, P1942, DOI 10.1016/S0028-3932(03)00123-4; LEVIN I, 1979, CHILD DEV, V50, P469, DOI 10.2307/1129425; LEVIN I, 1983, CHILD DEV, V54, P78; Levin I., 1982, DEV PSYCHOL TIME, P47; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; Nichelli P, 1996, NEUROPSYCHOLOGIA, V34, P863, DOI 10.1016/0028-3932(96)00001-2; Nichelli P, 1995, ANN NY ACAD SCI, V769, P183, DOI 10.1111/j.1749-6632.1995.tb38139.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; OYAMA T, 1981, PERCEPT PSYCHOPHYS, V29, P106, DOI 10.3758/BF03207273; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2006, BRAIN RES, V1106, P177, DOI 10.1016/j.brainres.2006.05.104; Polk TA, 2001, BRAIN COGNITION, V47, P545, DOI 10.1006/brcg.2001.1486; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Roitman JD, 2007, ACTA PSYCHOL, V124, P296, DOI 10.1016/j.actpsy.2006.03.008; Tirosh D, 2000, STUDENTS MIS UNDERST; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Walsh V, 2003, TRENDS COGN SCI, V7, P335, DOI 10.1016/S1364-6613(03)00166-9; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	50	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41496	10.1371/journal.pone.0041496	http://dx.doi.org/10.1371/journal.pone.0041496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911801	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600082
J	Freschauf, LR; McLane, J; Sharma, H; Khine, M				Freschauf, Lauren R.; McLane, Jolie; Sharma, Himanshu; Khine, Michelle			Shrink-Induced Superhydrophobic and Antibacterial Surfaces in Consumer Plastics	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; ESCHERICHIA-COLI; RESISTANCE; ARRAYS	Structurally modified superhydrophobic surfaces have become particularly desirable as stable antibacterial surfaces. Because their self-cleaning and water resistant properties prohibit bacteria growth, structurally modified superhydrophobic surfaces obviate bacterial resistance common with chemical agents, and therefore a robust and stable means to prevent bacteria growth is possible. In this study, we present a rapid fabrication method for creating such superhydrophobic surfaces in consumer hard plastic materials with resulting antibacterial effects. To replace complex fabrication materials and techniques, the initial mold is made with commodity shrink-wrap film and is compatible with large plastic roll-to-roll manufacturing and scale-up techniques. This method involves a purely structural modification free of chemical additives leading to its inherent consistency over time and successive recasting from the same molds. Finally, antibacterial properties are demonstrated in polystyrene (PS), polycarbonate (PC), and polyethylene (PE) by demonstrating the prevention of gram-negative Escherichia coli (E. coli) bacteria growth on our structured plastic surfaces.	[Freschauf, Lauren R.; McLane, Jolie; Khine, Michelle] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA; [Sharma, Himanshu; Khine, Michelle] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Freschauf, LR (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	mkhine@uci.edu			Undergraduate Research Opportunities Program (UROP); Division of Undergraduate Education at the University of California, Irvine [442870-19900]; Integrative Graduate Education and Research Traineeship Program (IGERT); National Science Foundation (NSF) [NSFIGERT DGE 0549479]; Defense Advanced Research Projects Agency (DARPA) N/MEMS S&T Fundamentals Program, Space and Naval Warfare Systems Center Pacific (SPAWAR) [N66001-1-4003]	Undergraduate Research Opportunities Program (UROP); Division of Undergraduate Education at the University of California, Irvine(University of California System); Integrative Graduate Education and Research Traineeship Program (IGERT); National Science Foundation (NSF)(National Science Foundation (NSF)); Defense Advanced Research Projects Agency (DARPA) N/MEMS S&T Fundamentals Program, Space and Naval Warfare Systems Center Pacific (SPAWAR)	This research was supported by the Undergraduate Research Opportunities Program (UROP) sponsored by the Division of Undergraduate Education at the University of California, Irvine (442870-19900) and by the Integrative Graduate Education and Research Traineeship Program (IGERT) sponsored by the National Science Foundation (NSF) (NSFIGERT DGE 0549479). Additional support is due to the Defense Advanced Research Projects Agency (DARPA) N/MEMS S&T Fundamentals Program under grant no. N66001-1-4003 issued by the Space and Naval Warfare Systems Center Pacific (SPAWAR) to the Micro/nano Fluidics Fundamentals Focus (MF3)Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Brooke JS, 2009, J ENVIRON HEALTH, V71, P17; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Cheng YT, 2006, NANOTECHNOLOGY, V17, P1359, DOI 10.1088/0957-4484/17/5/032; Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071; Cortese B, 2008, LANGMUIR, V24, P2712, DOI 10.1021/la702764x; Erbil HY, 2003, SCIENCE, V299, P1377, DOI 10.1126/science.1078365; Flores GE, 2011, PLOS ONE, V6, P11; Fu CC, 2009, ADV MATER, V21, P1; Gaidelyte A, 2006, PLOS ONE, V2, P11; Genzer J, 2000, SCIENCE, V290, P2130, DOI 10.1126/science.290.5499.2130; GETCHELLWHITE SI, 1989, INFECT CONT HOSP EP, V10, P402, DOI 10.1086/646061; Gomez GB, 2010, LANGMUIR, V26, P7248; Goral VN, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/1/017002; Guo SS, 2007, MICROELECTRON ENG, V84, P1673, DOI 10.1016/j.mee.2007.01.190; Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297; Helbig R, 2011, PLOS ONE, V6, P9; Hou SY, 2007, APPL ENVIRON MICROB, V73, P4300, DOI 10.1128/AEM.02633-06; Jokinen V, 2008, ADV MATER, V20, P3453, DOI 10.1002/adma.200800160; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002; Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o; Padma Srikanth, 2010, Journal of Infection Prevention, V11, P87; PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321, DOI 10.1128/AEM.51.6.1321-1325.1986; Privett BJ, 2011, LANGMUIR, V27, P9597, DOI 10.1021/la201801e; Scott RD, 2008, DIRECT MED COSTS HEA; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stalder AF, 2010, COLLOID SURFACE A, V364, P72, DOI 10.1016/j.colsurfa.2010.04.040; Temenoff JS, 2008, BIOMATERIALS INTERSE; Vaquette C, 2006, BIO-MED MATER ENG, V16, pS131; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Whitney HM, 2011, PLOS ONE, V6, P3; Wu J, 2010, PLOS ONE, V5, P12, DOI DOI 10.1371/ANNOTATION/F67A90FB-3E4E-4484-BFFE-FCFAFBFE88C7; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xu QF, 2010, ACS NANO, V4, P2201, DOI 10.1021/nn901581j; Yang H, 2008, J COLLOID INTERF SCI, V325, P588, DOI 10.1016/j.jcis.2008.06.034; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]; Zeus Industrial Products Inc, 2005, BIOC PLAST; Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009; Zhu LB, 2005, LANGMUIR, V21, P11208, DOI 10.1021/la051410+	41	90	96	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e40987	10.1371/journal.pone.0040987	http://dx.doi.org/10.1371/journal.pone.0040987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916100	gold, Green Published			2022-12-27	WOS:000307733800006
J	Keelan, JA; Mattes, E; Tan, HW; Dinan, A; Newnham, JP; Whitehouse, AJO; Jacoby, P; Hickey, M				Keelan, Jeffrey A.; Mattes, Eugen; Tan, HaiWei; Dinan, Andrew; Newnham, John P.; Whitehouse, Andrew J. O.; Jacoby, Peter; Hickey, Martha			Androgen Concentrations in Umbilical Cord Blood and Their Association with Maternal, Fetal and Obstetric Factors	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; GROWTH-FACTOR-I; FREE TESTOSTERONE; MASS-SPECTROMETRY; STEROID-HORMONES; DEHYDROEPIANDROSTERONE-SULFATE; PREECLAMPTIC PREGNANCIES; CHORIONIC-GONADOTROPIN; SERUM TESTOSTERONE; AMNIOTIC-FLUID	The aim of this study was to measure umbilical blood androgen concentrations in a birth cohort using a highly specific liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay and assesses the effects of sex, labor, and gestational age on fetal androgen levels at birth. We performed a prospective cohort study of androgen concentrations in mixed arterial and venous umbilical cord serum from 803 unselected singleton pregnancies from a general obstetric population in Western Australia. Total testosterone (TT), Delta 4-androstenedione, and dehydroepiandrosterone were extracted from archived cord serum samples and measured using LC-MS/MS. SHBG was measured by ELISA; free testosterone (FT) and bioavailable testosterone (BioT) values were also calculated. Median values for all three androgens were generally lower than previously published values. Levels of TT, FT, BioT, and SHBG were significantly higher in male verses female neonates (P<0.0001), while dehydroepiandrosterone levels were higher in females (P<0.0001). Labor was associated with a significant (similar to 15-26%) decrease in median cord blood TT and FT levels (both sexes combined), but a modest (similar to 16-31%) increase in SHBG, Delta 4-androstenedione, and dehydroepiandrosterone concentrations. TT and FT were significantly negatively correlated with gestational age at delivery, while SHBG, Delta 4-androstenedione, and dehydroepiandrosterone were positively correlated. Antenatal glucocorticoid administration also had a significant effect in the multiple regression models. This is the first study to report umbilical cord androgen levels in a large unselected population of neonates using LC-MS/MS. Our findings suggest that previous studies have over-estimated cord androgen levels, and that fetal, maternal, and obstetric factors influence cord androgen levels differentially. Caution should be exercised when interpreting previously-published data that have not taken all of these factors into account.	[Keelan, Jeffrey A.; Newnham, John P.] Univ Western Australia, Sch Womens & Infants Hlth, King Edward Mem Hosp, Perth, WA 6009, Australia; [Mattes, Eugen; Whitehouse, Andrew J. O.; Jacoby, Peter] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Tan, HaiWei; Dinan, Andrew] CPR Pharma Serv Pty Ltd, BioSA Incubator, Thebarton, SA, Australia; [Hickey, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Womens Hosp, Melbourne, Vic, Australia	King Edward Memorial Hospital; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Melbourne	Keelan, JA (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, King Edward Mem Hosp, Perth, WA 6009, Australia.	jeff.keelan@uwa.edu.au	Study, Raine/K-4517-2013; Keelan, JA/G-2170-2011; Whitehouse, Andrew J.O./AGJ-2519-2022; Study, Raine/G-9547-2015	Keelan, JA/0000-0002-5403-6266; Whitehouse, Andrew J.O./0000-0001-8722-1575; Newnham, John/0000-0001-9983-7457; Mattes, Eugen/0000-0003-2708-0445; Hickey, Martha/0000-0002-3941-082X	Rotary Mental Health Australia; Raine Medical Research Foundation at The University of Western Australia (UWA); National Health and Medical Research Council of Australia (NHMRC) [1004065]; Telstra Foundation; Women and Infants Research Foundation; Curtin University; UWA Faculty of Medicine, Dentistry and Health Sciences	Rotary Mental Health Australia; Raine Medical Research Foundation at The University of Western Australia (UWA); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Telstra Foundation; Women and Infants Research Foundation; Curtin University; UWA Faculty of Medicine, Dentistry and Health Sciences	This study was funded by a competitive grant to EM and MH from Rotary Mental Health Australia. The Raine Study is funded by the Raine Medical Research Foundation at The University of Western Australia (UWA), the National Health and Medical Research Council of Australia (NHMRC), the Telstra Foundation, the Women and Infants Research Foundation, Curtin University, and the UWA Faculty of Medicine, Dentistry and Health Sciences. JAK is funded by the Women and Infants Research Foundation; MH is funded by an NHMRC Clinical Career Development Award; and AJOW is funded by a NHMRC Career Development Fellowship (# 1004065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT ED, 1990, ENDOCR REV, V11, P124, DOI 10.1210/edrv-11-1-124; Anderson H, 2010, J CLIN ENDOCR METAB, V95, P2180, DOI 10.1210/jc.2009-2651; ARAI K, 1977, AM J OBSTET GYNECOL, V127, P879, DOI 10.1016/0002-9378(77)90123-5; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Barry JA, 2010, J OBSTET GYNAECOL, V30, P444, DOI 10.3109/01443615.2010.485254; BERGER NG, 1984, OBSTET GYNECOL, V63, P260; BOLELLI G, 1995, CANCER EPIDEM BIOMAR, V4, P509; BOLTON NJ, 1989, CLIN ENDOCRINOL, V31, P201, DOI 10.1111/j.1365-2265.1989.tb01243.x; Carlsen SM, 2003, SCAND J CLIN LAB INV, V63, P23, DOI 10.1080/00365510310000457; CARTLIDGE PHT, 1986, ARCH DIS CHILD, V61, P657, DOI 10.1136/adc.61.7.657; Chen TH, 2011, CANCER EPIDEM BIOMAR, V20, P324, DOI 10.1158/1055-9965.EPI-10-0857; Clifton VL, 2007, J CHROMATOGR B, V855, P249, DOI 10.1016/j.jchromb.2007.05.041; Demers LM, 2010, MATURITAS, V67, P39, DOI 10.1016/j.maturitas.2010.04.019; Gemer O, 1997, ARCH GYNECOL OBSTET, V259, P139, DOI 10.1007/s004040050148; Hart R, 2010, FERTIL STERIL, V94, P1544, DOI 10.1016/j.fertnstert.2009.12.060; Hickey M, 2009, J CLIN ENDOCR METAB, V94, P3714, DOI 10.1210/jc.2009-0544; Hill M, 2010, J STEROID BIOCHEM, V121, P594, DOI 10.1016/j.jsbmb.2009.10.012; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Kari MA, 1996, PEDIATR RES, V40, P319, DOI 10.1203/00006450-199608000-00021; Krogh C, 2011, PEDIATRICS, V127, pE197, DOI 10.1542/peds.2010-2127; LAATIKAINEN T, 1980, J CLIN ENDOCR METAB, V50, P489, DOI 10.1210/jcem-50-3-489; Lagiou P, 2011, ANN ONCOL, V22, P1102, DOI 10.1093/annonc/mdq565; LESLIE KK, 1994, PLACENTA, V15, P79, DOI 10.1016/S0143-4004(05)80238-3; Ly LP, 2010, CLIN ENDOCRINOL, V73, P382, DOI 10.1111/j.1365-2265.2010.03804.x; Ly LP, 2005, EUR J ENDOCRINOL, V152, P471, DOI 10.1530/eje.1.01844; Maffeis C, 1999, INT J OBESITY, V23, P943, DOI 10.1038/sj.ijo.0801023; Manikkam M, 2006, ENDOCRINOLOGY, V147, P1997, DOI 10.1210/en.2005-1338; MATHUR RS, 1980, J CLIN ENDOCR METAB, V51, P1235, DOI 10.1210/jcem-51-6-1235; Nagata C, 2007, CANCER SCI, V98, P869, DOI 10.1111/j.1349-7006.2007.00464.x; NORMAN RJ, 1984, BRIT J OBSTET GYNAEC, V91, P776, DOI 10.1111/j.1471-0528.1984.tb04849.x; Procopio M, 2006, EUR ARCH PSY CLIN N, V256, P77, DOI 10.1007/s00406-005-0604-8; Rohrmann S, 2009, CANCER EPIDEM BIOMAR, V18, P1484, DOI 10.1158/1055-9965.EPI-08-0817; Romanowicz Lech, 2009, Atherosclerosis, V204, pe44, DOI 10.1016/j.atherosclerosis.2008.11.008; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; SAKAI LM, 1991, DEV PSYCHOBIOL, V24, P559, DOI 10.1002/dev.420240804; Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171; SIMMONS D, 1995, J CLIN ENDOCR METAB, V80, P2217, DOI 10.1210/jc.80.7.2217; SIMMONS D, 1994, BIOL NEONATE, V65, P287; Smith LM, 2003, NICOTINE TOB RES, V5, P369, DOI 10.1080/146222031000094196; Soldin OP, 2005, FERTIL STERIL, V84, P701, DOI 10.1016/j.fertnstert.2005.02.045; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Stanczyk FZ, 2006, SEMIN REPROD MED, V24, P78, DOI 10.1055/s-2006-939566; Stanczyk FZ, 2004, CLIN CHEM, V50, P2219, DOI 10.1373/clinchem.2004.038505; Stanczyk FZ, 2003, STEROIDS, V68, P1173, DOI 10.1016/j.steroids.2003.08.012; Steier JA, 2002, OBSTET GYNECOL, V100, P552, DOI 10.1016/S0029-7844(02)02088-4; Stroud LR, 2007, PSYCHONEUROENDOCRINO, V32, P140, DOI 10.1016/j.psyneuen.2006.11.008; Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P452; Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P1268; Troisi R, 2003, CANCER CAUSE CONTROL, V14, P347, DOI 10.1023/A:1023934518975; Troisi R, 2008, CANCER EPIDEM BIOMAR, V17, P224, DOI 10.1158/1055-9965.EPI-07-0536; van de Beek C, 2004, HORM BEHAV, V46, P663, DOI 10.1016/j.yhbeh.2004.06.010; Varvarigou AA, 2009, J PERINAT MED, V37, P364, DOI 10.1515/JPM.2009.028; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vicente FB, 2006, CLIN CHEM LAB MED, V44, P70, DOI 10.1515/CCLM.2006.014; Weinstock M, 2010, ISR J PSYCHIATR REL, V47, P36; Whitehouse AJO, 2012, J CHILD PSYCHOL PSYC, V53, P726, DOI 10.1111/j.1469-7610.2011.02523.x; Whitehouse AJO, 2010, PSYCHONEUROENDOCRINO, V35, P1259, DOI 10.1016/j.psyneuen.2010.02.007; ZLOTKIN SH, 1987, CLIN CHEM, V33, P411	58	67	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42827	10.1371/journal.pone.0042827	http://dx.doi.org/10.1371/journal.pone.0042827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916165	gold, Green Published			2022-12-27	WOS:000307733800030
J	Gonzalez-Gonzalez, M; Munoz-Bellvis, L; Mackintosh, C; Fontanillo, C; Gutierrez, ML; Abad, MM; Bengoechea, O; Teodosio, C; Fonseca, E; Fuentes, M; De Las Rivas, J; Orfao, A; Sayagues, JM				Gonzalez-Gonzalez, Maria; Munoz-Bellvis, Luis; Mackintosh, Carlos; Fontanillo, Celia; Laura Gutierrez, M.; Mar Abad, M.; Bengoechea, Oscar; Teodosio, Cristina; Fonseca, Emilio; Fuentes, Manuel; De Las Rivas, Javier; Orfao, Alberto; Maria Sayagues, Jose			Prognostic Impact of del(17p) and del(22q) as Assessed by Interphase FISH in Sporadic Colorectal Carcinomas	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LIVER METASTASIS; TUMOR-SUPPRESSOR; CHROMOSOME 22Q13; HUMAN BREAST; CANCER; ADENOCARCINOMA; INSTABILITY; PROGRESSION; EXPRESSION	Background: Most sporadic colorectal cancer (sCRC) deaths are caused by metastatic dissemination of the primary tumor. New advances in genetic profiling of sCRC suggest that the primary tumor may contain a cell population with metastatic potential. Here we compare the cytogenetic profile of primary tumors from liver metastatic versus non-metastatic sCRC. Methodology/Principal Findings: We prospectively analyzed the frequency of numerical/structural abnormalities of chromosomes 1, 7, 8, 13, 14, 17, 18, 20, and 22 by iFISH in 58 sCRC patients: thirty-one non-metastatic (54%) vs. 27 metastatic (46%) disease. From a total of 18 probes, significant differences emerged only for the 17p11.2 and 22q11.2 chromosomal regions. Patients with liver metastatic sCRC showed an increased frequency of del(17p11.2) (10% vs. 67%; p<.001) and del(22q11.2) (0% vs. 22%; p=.02) versusnon-metastatic cases. Multivariate analysis of prognostic factors for overall survival (OS) showed that the only clinical and cytogenetic parameters that had an independent adverse impact on patient outcome were the presence of del(17p) with a 17p11.2 breakpoint and del(22q11.2). Based on these two cytogenetic variables, patients were classified into three groups: low- (no adverse features), intermediate- (one adverse feature) and high-risk (two adverse features)-with significantly different OS rates at 5-years (p<.001): 92%, 53% and 0%, respectively. Conclusions/Significance: Our results unravel the potential implication of del(17p11.2) in sCRC patients with liver metastasis as this cytogenetic alteration appears to be intrinsically related to an increased metastatic potential and a poor outcome, providing additional prognostic information to that associated with other cytogenetic alterations such as del(22q11.2). Additional prospective studies in larger series of patients would be required to confirm the clinical utility of the new prognostic markers identified.	[Gonzalez-Gonzalez, Maria; Laura Gutierrez, M.; Teodosio, Cristina; Fuentes, Manuel; Orfao, Alberto; Maria Sayagues, Jose] Univ Salamanca, Hosp Univ Salamanca IBSAL, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain; [Gonzalez-Gonzalez, Maria; Laura Gutierrez, M.; Teodosio, Cristina; Fuentes, Manuel; Orfao, Alberto; Maria Sayagues, Jose] Univ Salamanca, Hosp Univ Salamanca IBSAL, Ctr Invest Canc IBMCC CSIC USAL, E-37008 Salamanca, Spain; [Munoz-Bellvis, Luis] Hosp Univ Salamanca IBSAL, Dept Cirugia, Unidad Cirugia Hepatobiliopancreat, Salamanca, Spain; [Fontanillo, Celia; De Las Rivas, Javier] Univ Salamanca, Ctr Invest Canc IBMCC CSIC USAL, Grp Invest Bioinformat & Genom Func, E-37008 Salamanca, Spain; [Mar Abad, M.; Bengoechea, Oscar] Hosp Univ Salamanca IIBSAL, Dept Patol, Salamanca, Spain; [Fonseca, Emilio] Hosp Univ Salamanca IBSAL, Dept Oncol Med, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Gonzalez-Gonzalez, M (corresponding author), Univ Salamanca, Hosp Univ Salamanca IBSAL, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain.	orfao@usal.es; ppmari@usal.es	Muñoz-Bellvis, Luis/A-2245-2016; Gutiérrez, María Laura/AAY-9195-2020; De Las Rivas, Javier/G-5936-2014; Fuentes, Manuel/B-5957-2017; Orfao, Alberto/B-5801-2017; Gutiérrez, María Laura ML/J-4313-2016; Muñoz-Bellvis, Luis/AAU-7364-2021	Muñoz-Bellvis, Luis/0000-0002-7809-5201; Gutiérrez, María Laura/0000-0003-2997-6317; De Las Rivas, Javier/0000-0002-0984-9946; Fuentes, Manuel/0000-0002-7305-3766; Gutiérrez, María Laura ML/0000-0003-2997-6317; Muñoz-Bellvis, Luis/0000-0002-7809-5201; , Maria Gonzalez-Gonzalez/0000-0001-8115-1086; Mackintosh, Carlos/0000-0002-6786-9558; Teodosio, Cristina/0000-0002-2097-7199; Fontanillo, Celia/0000-0002-3631-7881	Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain [SAN673/SA39/08, SAN/103/2011]; Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social), Burgos, Spain; Grupo Excelencia de Castilla y Leon [GR37]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) from the Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo, Madrid, Spain [PI12/02053-FIS, RD06/0020/0035-FEDER]; ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain [CP05/00321, FI08/00721]; Caja de Burgos - Obra Social	Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain(Junta de Castilla y Leon); Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social), Burgos, Spain; Grupo Excelencia de Castilla y Leon; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) from the Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo, Madrid, Spain; ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Caja de Burgos - Obra Social	This work has been partially supported by grants from the Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain (SAN673/SA39/08 and SAN/103/2011), Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain, Caja de Burgos (Obra Social), Burgos, Spain, Grupo Excelencia de Castilla y Leon (GR37) and the Red Tematica de Investigacion Cooperativa en Cancer (RTICC) from the Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo, Madrid, Spain (PI12/02053-FIS and RD06/0020/0035-FEDER). JM Sayagues and M Gonzalez are supported by grants (CP05/00321 and FI08/00721, respectively) from the ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain.; The authors have the following competing interests: The study was partly funded by Caja de Burgos - Obra Social. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Al-Mulla F, 1999, GENE CHROMOSOME CANC, V24, P306, DOI 10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Asghar U, 2010, CLIN COLORECTAL CANC, V9, P274, DOI 10.3816/CCC.2010.n.040; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Castells A, 1999, GASTROENTEROLOGY, V117, P831, DOI 10.1016/S0016-5085(99)70341-0; Castells A, 2000, CANCER RES, V60, P2836; Chang SC, 2005, INT J ONCOL, V26, P65; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; Garcia J, 2003, CYTOM PART B-CLIN CY, V51B, P14, DOI 10.1002/cyto.b.10006; Ghadimi BM, 2006, CELL ONCOL, V28, P273; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Hu XT, 2008, ONCOL REP, V19, P441; IINO H, 1994, CANCER, V73, P1324, DOI 10.1002/1097-0142(19940301)73:5<1324::AID-CNCR2820730503>3.0.CO;2-W; Jia M, 2010, PROTEOM CLIN APPL, V4, P816, DOI 10.1002/prca.201000006; KHINE K, 1994, CANCER, V73, P28, DOI 10.1002/1097-0142(19940101)73:1<28::AID-CNCR2820730107>3.0.CO;2-3; Kim DH, 2011, BLOOD, V117, P6906, DOI 10.1182/blood-2011-01-329797; Liu YL, 2010, J GASTROEN HEPATOL, V25, P1800, DOI 10.1111/j.1440-1746.2010.06352.x; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Liu YL, 2011, J SURG ONCOL, V103, P283, DOI 10.1002/jso.21802; Losi L, 2004, ONCOL REP, V12, P1221; Mackintosh C, 2012, ONCOGENE, V31, P1287, DOI 10.1038/onc.2011.317; Maltzman T, 2001, GASTROENTEROLOGY, V121, P302, DOI 10.1053/gast.2001.26278; Sayagues JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013752; Sayagues JM, 2010, J PATHOL, V221, P308, DOI 10.1002/path.2712; Munoz-Bellvis L, 2012, MOD PATHOL; Paredes-Zaglul A, 1998, CLIN CANCER RES, V4, P879; Popat S, 2007, ANTICANCER RES, V27, P627; Poulogiannis G, 2010, J PATHOL, V220, P338, DOI 10.1002/path.2640; Re M, 2011, INT J IMMUNOPATH PH, V24, P603, DOI 10.1177/039463201102400306; Risio M, 2003, CANCER GENET CYTOGEN, V147, P44, DOI 10.1016/S0165-4608(03)00188-2; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Seicean R, 2011, HEPATO-GASTROENTEROL, V58, P1490, DOI 10.5754/hge11130; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Sher RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023498; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; World Health Organization. WHO, 1981, INT HIST CLASS TUM V; YANA I, 1995, INT J CANCER, V60, P174, DOI 10.1002/ijc.2910600207; Yashiro M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-303	40	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42683	10.1371/journal.pone.0042683	http://dx.doi.org/10.1371/journal.pone.0042683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912721	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700017
J	Tran, TP; Tu, HY; Liu, JX; Muelleman, RL; Li, YL				Tran, Thai P.; Tu, Huiyin; Liu, Jinxu; Muelleman, Robert L.; Li, Yu-Long			Mitochondria-Derived Superoxide Links to Tourniquet-Induced Apoptosis in Mouse Skeletal Muscle	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; ISCHEMIA-REPERFUSION INJURY; CELL-DEATH; HEART-FAILURE; STEM-CELLS; COMPLEX-I; CONNEXIN-43; ISCHEMIA/REPERFUSION; CARDIOPROTECTION; NECROSIS	Our previous study has reported that superoxide mediates ischemia-reperfusion (IR)-induced necrosis in mouse skeletal muscle. However, it remains poorly understood whether IR induces apoptosis and what factors are involved in IR-induced apoptosis in skeletal muscle. Using a murine model of tourniquet-induced hindlimb IR, we investigated the relationship between mitochondrial dysfunction and apoptosis in skeletal muscle. Hindlimbs of C57/BL6 mice were subjected to 3 h ischemia and 4 h reperfusion via placement and release of a rubber tourniquet at the greater trochanter. Compared to sham treatment, tourniquet-induced IR significantly elevated mitochondria-derived superoxide production, activated opening of mitochondrial permeability transition pore (mPTP), and caused apoptosis in the gastrocnemius muscles. Pretreatment with a superoxide dismutase mimetic (tempol, 50 mg/kg) or a mitochondrial antioxidant (co-enzyme Q(10), 50 mg/kg) not only decreased mitochondria-derived superoxide production, but also inhibited mPTP opening and apoptosis in the IR gastrocnemius muscles. Additionally, an inhibitor of mPTP (cyclosporine A, 50 mg/kg) also inhibited both mPTP opening and apoptosis in the IR gastrocnemius muscles. These results suggest that mitochondria-derived superoxide overproduction triggers the mPTP opening and subsequently causes apoptosis in tourniquet-induced hindlimb IR.	[Tran, Thai P.; Tu, Huiyin; Liu, Jinxu; Muelleman, Robert L.; Li, Yu-Long] Univ Nebraska Med Ctr, Dept Emergency Med, Omaha, NE 68198 USA; [Li, Yu-Long] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tran, TP (corresponding author), Univ Nebraska Med Ctr, Dept Emergency Med, Omaha, NE 68198 USA.	yulongli@unmc.edu		, HUIYIN/0000-0002-1662-2088	National Heart, Lung, and Blood Institute [HL-098503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098503] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this study was in part provided by a grant from National Heart, Lung, and Blood Institute (HL-098503) to Y-L. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; BELLAMY RF, 1984, MIL MED, V149, P55; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Boengler K, 2006, HEART, V92, P1724, DOI 10.1136/hrt.2005.066878; Bopassa JC, 2006, CARDIOVASC RES, V69, P178, DOI 10.1016/j.cardiores.2005.07.014; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Carey ME, 1996, J TRAUMA, V40, pS165, DOI 10.1097/00005373-199603001-00036; Cowled PA, 2001, EUR J VASC ENDOVASC, V21, P28, DOI 10.1053/ejvs.2000.1209; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; Dalla Libera L, 1999, AM J PHYSIOL-CELL PH, V277, pC982, DOI 10.1152/ajpcell.1999.277.5.C982; Dalla Libera L, 2001, CIRCULATION, V103, P2195; Di Lisa F, 2007, HEART FAIL REV, V12, P249, DOI 10.1007/s10741-007-9028-z; Doyle GS, 2008, PREHOSP EMERG CARE, V12, P241, DOI 10.1080/10903120801907570; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halestrap AP, 2006, CIRC RES, V99, P10, DOI 10.1161/01.RES.0000233145.94073.b8; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Knight KR, 1999, INT J EXP PATHOL, V80, P169, DOI 10.1046/j.1365-2613.1999.00111.x; Kroemer G, 2003, CURR MED CHEM, V10, P1469, DOI 10.2174/0929867033457232; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lee C, 2007, EMERG MED J, V24, P584, DOI 10.1136/emj.2007.046359; Lee YM, 2011, J CARDIOVASC PHARM, V58, P133, DOI 10.1097/FJC.0b013e31821a5078; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Li Y, 2011, BRAIN RES, V1382, P252, DOI 10.1016/j.brainres.2011.01.023; Li YL, 2007, CARDIOVASC RES, V75, P546, DOI 10.1016/j.cardiores.2007.04.006; Linkermann A, 2012, KIDNEY INT, V10; Lopez-Neblina F, 2005, J INVEST SURG, V18, P335, DOI 10.1080/08941930500328862; Lu G, 2012, REGEN MED, V7, P323, DOI [10.2217/RME.12.13, 10.2217/rme.12.13]; Lu G, 2012, ANTIOXID REDOX SIGN, V16, P217, DOI 10.1089/ars.2011.4112; Lu G, 2010, CARDIOVASC RES, V88, P277, DOI 10.1093/cvr/cvq293; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; MAJNO G, 1995, AM J PATHOL, V146, P3; Matsuyama S, 2000, CELL DEATH DIFFER, V7, P1155, DOI 10.1038/sj.cdd.4400779; MATTOX KL, 1989, ANN SURG, V209, P698, DOI 10.1097/00000658-198906000-00007; Miles MV, 2007, MITOCHONDRION, V7, pS72, DOI 10.1016/j.mito.2007.02.012; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; SCHMITNEUERBURG KP, 1985, ACTA CHIR BELG, V85, P239; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Suzuki H, 1995, J CLIN INVEST, V96, P2892, DOI 10.1172/JCI118360; Tran TP, 2011, EUR J PHARMACOL, V650, P328, DOI 10.1016/j.ejphar.2010.10.037; Tu HY, 2012, J NEUROPHYSIOL, V107, P591, DOI 10.1152/jn.00754.2011; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; Wang WZ, 2008, J ORTHOP RES, V26, P351, DOI 10.1002/jor.20493; Wang WZ, 2011, J SURG RES, V171, P175, DOI 10.1016/j.jss.2011.07.015; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yao HP, 2007, CELL RES, V17, P565, DOI 10.1038/cr.2007.6; Yin JX, 2010, AM J PHYSIOL-CELL PH, V298, pC857, DOI 10.1152/ajpcell.00313.2009	56	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43410	10.1371/journal.pone.0043410	http://dx.doi.org/10.1371/journal.pone.0043410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912870	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700098
J	Yang, HJ; Wang, Y; Cheryan, VT; Wu, WJ; Cui, CQ; Polin, LA; Pass, HI; Dou, QP; Rishi, AK; Wali, A				Yang, Huanjie; Wang, Ying; Cheryan, Vino T.; Wu, Wenjuan; Cui, Cindy Qiuzhi; Polin, Lisa A.; Pass, Harvey I.; Dou, Q. Ping; Rishi, Arun K.; Wali, Anil			Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo	PLOS ONE			English	Article							APOPTOSIS-REGULATORY PROTEIN-1; MALIGNANT PLEURAL MESOTHELIOMA; COMPOUND WITHAFERIN; CANCER CELLS; KAPPA-B; GROWTH; TUMOR; CYCLE; RECEPTOR; MEDIATOR	The medicinal plant Withania somnifera has been used for over centuries in Indian Ayurvedic Medicine to treat a wide spectrum of disorders. Withaferin A (WA), a bioactive compound that is isolated from this plant, has anti-inflammatory, immuno-modulatory, anti-angiogenic, and anti-cancer properties. Here we investigated malignant pleural mesothelioma (MPM) suppressive effects of WA and the molecular mechanisms involved. WA inhibited growth of the murine as well as patient-derived MPM cells in part by decreasing the chymotryptic activity of the proteasome that resulted in increased levels of ubiquitinated proteins and pro-apoptotic proteasome target proteins (p21, Bax, I kappa B alpha). WA suppression of MPM growth also involved elevated apoptosis as evidenced by activation of pro-apoptotic p38 stress activated protein kinase (SAPK) and caspase-3, elevated levels of pro-apoptotic Bax protein and cleavage of poly-(ADP-ribose)-polymerase (PARP). Our studies including gene-array based analyses further revealed that WA suppressed a number of cell growth and metastasis-promoting genes including c-myc. WA treatments also stimulated expression of the cell cycle and apoptosis regulatory protein (CARP)-1/CCAR1, a novel transducer of cell growth signaling. Knock-down of CARP-1, on the other hand, interfered with MPM growth inhibitory effects of WA. Intra-peritoneal administration of 5 mg/kg WA daily inhibited growth of murine MPM cell-derived tumors in vivo in part by inhibiting proteasome activity and stimulating apoptosis. Together our in vitro and in vivo studies suggest that WA suppresses MPM growth by targeting multiple pathways that include blockage of proteasome activity and stimulation of apoptosis, and thus holds promise as an anti-MPM agent.	[Yang, Huanjie; Wang, Ying; Cui, Cindy Qiuzhi; Pass, Harvey I.; Dou, Q. Ping; Rishi, Arun K.; Wali, Anil] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; [Cheryan, Vino T.; Wu, Wenjuan; Rishi, Arun K.; Wali, Anil] Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI USA; [Cheryan, Vino T.; Wu, Wenjuan; Polin, Lisa A.; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Pass, Harvey I.] NYU, Ctr Canc, New York, NY USA; [Yang, Huanjie] Harbin Inst Technol, Dept Life Sci & Engn, Harbin 150006, Peoples R China	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University; New York University; Harbin Institute of Technology	Yang, HJ (corresponding author), Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA.	doup@karmanos.org; Rishia@Karmanos.org	Wu, wenjuan/GPX-6968-2022	Dou, Qingping/0000-0002-6465-1473; Pass, Harvey/0000-0003-3222-3471	Department of Veterans Affairs Merit Review; Mesothelioma Applied Research Foundation (MARF); National Cancer Institute [CA120009, CA112625]; National Cancer Institute at the National Institutes of Health (NCI/NIH) Cancer Center; NATIONAL CANCER INSTITUTE [R01CA120009, R03CA112625] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Mesothelioma Applied Research Foundation (MARF); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute at the National Institutes of Health (NCI/NIH) Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Veterans Affairs Merit Review grants (AKR and AW), Mesothelioma Applied Research Foundation (MARF) support (AW), and National Cancer Institute Grants CA120009, CA112625 (QPD), and the National Cancer Institute at the National Institutes of Health (NCI/NIH) Cancer Center Support Grant to Karmanos Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bhattacharya SK, 2002, PHYTOMEDICINE, V9, P167, DOI 10.1078/0944-7113-00089; CHOWDHURY K, 1975, BIOCHEM PHARMACOL, V24, P919, DOI 10.1016/0006-2952(75)90165-3; Devi P. Uma, 1996, Indian Journal of Experimental Biology, V34, P927; Dou Q Ping, 2003, Prog Cell Cycle Res, V5, P441; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Gordon GJ, 2007, J PATHOL, V211, P439, DOI 10.1002/path.2120; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Malara N, 2008, CELL CYCLE, V7, P3235, DOI 10.4161/cc.7.20.6832; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Odaka M, 2001, CANCER RES, V61, P6201; Oh JH, 2008, EUR J PHARMACOL, V599, P11, DOI 10.1016/j.ejphar.2008.09.017; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Su S, 2009, SEMIN THORAC CARDIOV, V21, P125, DOI 10.1053/j.semtcvs.2009.07.006; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Wang Y, 2011, MOL CELL BIOCHEM, V357, P83, DOI 10.1007/s11010-011-0878-2; Wang Y, 2010, CANCER CHEMOTH PHARM, V66, P455, DOI 10.1007/s00280-009-1181-8; Yang H, 2008, CURR PROTEIN PEPT SC, V9, P227, DOI 10.2174/138920308784533998; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	34	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41214	10.1371/journal.pone.0041214	http://dx.doi.org/10.1371/journal.pone.0041214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912669	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700003
J	Grau, I; Ardanuy, C; Calatayud, L; Rolo, D; Domenech, A; Linares, J; Pallares, R				Grau, Imma; Ardanuy, Carmen; Calatayud, Laura; Rolo, Dora; Domenech, Arnau; Linares, Josefina; Pallares, Roman			Invasive Pneumococcal Disease in Healthy Adults: Increase of Empyema Associated with the Clonal-Type Sweden(1)-ST306	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SEROTYPE REPLACEMENT; PENICILLIN; SUSCEPTIBILITY; EPIDEMIOLOGY; MORTALITY; BARCELONA; ERA	Background: Adult invasive pneumococcal disease (IPD) occurs mainly in the elderly and patients with co-morbidities. Little is known about the clinical characteristics, serotypes and genotypes causing IPD in healthy adults. Methods: We studied 745 culture-proven cases of IPD in adult patients aged 18-64 years (1996-2010). Patients were included in two groups: 1.) adults with co-morbidities, and 2.) healthy adults, who had no prior or coincident diagnosis of a chronic or immunosuppressive underlying disease. Microbiological studies included pneumococcal serotyping and genotyping. Results: Of 745 IPD episodes, 525 (70%) occurred in patients with co-morbidities and 220 (30%) in healthy adults. The healthy adults with IPD were often smokers (56%) or alcohol abusers (18%). As compared to patients with co-morbidities, the healthy adults had (P<0.05): younger age (43.5+/-13.1 vs. 48.7+/-11.3 years); higher proportions of women (45% vs. 24%), pneumonia with empyema (15% vs. 7%) and infection with non-PCV7 serotypes including serotypes 1 (25% vs. 5%), 7F (13% vs. 4%), and 5 (7% vs. 2%); and lower mortality (5% vs. 20%). Empyema was more frequently caused by serotype 1. No death occurred among 79 patients with serotype 1 IPD. There was an emergence of virulent clonal-types Sweden(1)-ST306 and Netherlands(7F)-ST191. The vaccine serotype coverage with the PCV13 was higher in healthy adults than in patients with co-morbidities: 82% and 56%, respectively, P<0.001. Conclusion: In this clinical study, one-third of adults with IPD had no underlying chronic or immunosuppressive diseases (healthy adults). They were often smokers and alcohol abusers, and frequently presents with pneumonia and empyema caused by virulent clones of non-PCV7 serotypes such as the Sweden(1)-ST306. Thus, implementing tobacco and alcohol abuse-cessation measures and a proper pneumococcal vaccination, such as PCV13 policy, in active smokers and alcohol abusers may diminish the burden of IPD in adults.	[Grau, Imma; Pallares, Roman] Univ Barcelona, Dept Infect Dis, Bellvitge Hosp, Idibell,Ciberes, Barcelona, Spain; [Ardanuy, Carmen; Calatayud, Laura; Rolo, Dora; Domenech, Arnau; Linares, Josefina] Univ Barcelona, Dept Microbiol, Bellvitge Hosp, Idibell,Ciberes, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Grau, I (corresponding author), Univ Barcelona, Dept Infect Dis, Bellvitge Hosp, Idibell,Ciberes, Barcelona, Spain.	rpallares@ub.edu	PALLARES, Roman/B-5710-2008; Liñares, Josefina/N-9450-2014; Rolo, Dora/AAI-4326-2021; Rolo, Dora/G-4236-2015; Ardanuy, Carmen/C-4463-2015	PALLARES, Roman/0000-0003-3262-8508; Ardanuy, Carmen/0000-0003-0225-607X; Domenech, Arnau/0000-0002-0829-511X; Rolo, Dora/0000-0003-2704-8648; Rolo, Dora/0000-0003-4327-2279; Grau, Imma/0000-0002-3040-8184	Ministry of Health, Madrid, Spain [FIS-081922]; CIBER de Enfermedades Respiratorias [CIBERES - CB06/06/0037]; ISCIII - Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain; FPU (Formacion Profesorado Universitario), Ministry of Education, Madrid, Spain	Ministry of Health, Madrid, Spain; CIBER de Enfermedades Respiratorias; ISCIII - Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain; FPU (Formacion Profesorado Universitario), Ministry of Education, Madrid, Spain	This study was supported in part by a grant from the Ministry of Health (FIS-081922), Madrid, Spain, and by CIBER de Enfermedades Respiratorias (CIBERES - CB06/06/0037), an initiative of the ISCIII - Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain. A. Domenech was supported by a grant from FPU (Formacion Profesorado Universitario), Ministry of Education, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Immunization Practices, 2012, Ann Intern Med, V156, P211, DOI 10.7326/0003-4819-156-3-201202070-00388; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Burgos J, 2011, CLIN INFECT DIS, V53, P254, DOI 10.1093/cid/cir354; Clinical and Laboratory Standard Institute, 2009, M7A8 CLSINCCLS, V29; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; de Lencastre H, 2002, J ANTIMICROB CHEMOTH, V50, P75, DOI 10.1093/jac/dkf511; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Esteva C, 2011, CLIN MICROBIOL INFEC, V17, P1441, DOI 10.1111/j.1469-0691.2011.03526.x; Fenoll A, 2010, ANTIMICROB AGENTS CH, V54, P5387, DOI 10.1128/AAC.00217-10; Fiore MC, 2012, NEW ENGL J MED, V366, P1172, DOI 10.1056/NEJMp1115176; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Klemets P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-96; Kyaw MH, 2005, J INFECT DIS, V192, P377, DOI 10.1086/431521; Marimon JM, 2009, CLIN MICROBIOL INFEC, V15, P875, DOI 10.1111/j.1469-0691.2009.02883.x; Marrie TJ, 2011, MEDICINE, V90, P171, DOI 10.1097/MD.0b013e31821a5a76; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Munoz R, 1999, MOL MICROBIOL, V31, P703, DOI 10.1046/j.1365-2958.1999.01211.x; Musher DM, 2000, MEDICINE, V79, P210, DOI 10.1097/00005792-200007000-00002; Normark BH, 2001, J INFECT DIS, V184, P861, DOI 10.1086/323339; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; Picazo J, 2011, PEDIATR INFECT DIS J, V30, P471, DOI 10.1097/INF.0b013e31820a418a; Ritchie ND, 2012, FUTURE MICROBIOL, V7, P33, DOI [10.2217/fmb.11.146, 10.2217/FMB.11.146]; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Weinstein MP, 2009, CLIN INFECT DIS, V48, P1596, DOI 10.1086/598975; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	39	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42595	10.1371/journal.pone.0042595	http://dx.doi.org/10.1371/journal.pone.0042595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912711	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100016
J	Lafortune, M; Gagnon, JF; Latreille, V; Vandewalle, G; Martin, N; Filipini, D; Doyon, J; Carrier, J				Lafortune, Marjolaine; Gagnon, Jean-Francois; Latreille, Veronique; Vandewalle, Gilles; Martin, Nicolas; Filipini, Daniel; Doyon, Julien; Carrier, Julie			Reduced Slow-Wave Rebound during Daytime Recovery Sleep in Middle-Aged Subjects	PLOS ONE			English	Article							VIGILANCE TASK-PERFORMANCE; EEG POWER-DENSITY; YOUNG-ADULTS; HOMEOSTATIC REGULATION; MEMORY CONSOLIDATION; POSTMENOPAUSAL WOMEN; SYNAPTIC HOMEOSTASIS; TIME-COURSE; DEPRIVATION; PRESSURE	Cortical synchronization during NREM sleep, characterized by electroencephalographic slow waves (SW <4Hz and >75 mu V), is strongly related to the number of hours of wakefulness prior to sleep and to the quality of the waking experience. Whether a similar increase in wakefulness length leads to a comparable enhancement in NREM sleep cortical synchronization in young and older subjects is still a matter of debate in the literature. Here we evaluated the impact of 25-hours of wakefulness on SW during a daytime recovery sleep episode in 29 young (27y +/-5), and 34 middle-aged (51y +/-5) subjects. We also assessed whether age-related changes in NREM sleep cortical synchronization predicts the ability to maintain sleep during daytime recovery sleep. Compared to baseline sleep, sleep efficiency was lower during daytime recovery sleep in both age-groups but the effect was more prominent in the middle-aged than in the young subjects. In both age groups, SW density, amplitude, and slope increased whereas SW positive and negative phase duration decreased during daytime recovery sleep compared to baseline sleep, particularly in anterior brain areas. Importantly, compared to young subjects, middle-aged participants showed lower SW density rebound and SW positive phase duration enhancement after sleep deprivation during daytime recovery sleep. Furthermore, middle-aged subjects showed lower SW amplitude and slope enhancements after sleep deprivation than young subjects in frontal and prefrontal derivations only. None of the SW characteristics at baseline were associated with daytime recovery sleep efficiency. Our results support the notion that anterior brain areas elicit and may necessitate more intense recovery and that aging reduces enhancement of cortical synchronization after sleep loss, particularly in these areas. Age-related changes in the quality of wake experience may underlie age-related reduction in markers of cortical synchronization enhancement after sustained wakefulness.	[Lafortune, Marjolaine; Gagnon, Jean-Francois; Latreille, Veronique; Vandewalle, Gilles; Martin, Nicolas; Filipini, Daniel; Carrier, Julie] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Vandewalle, Gilles; Martin, Nicolas; Doyon, Julien; Carrier, Julie] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Lafortune, Marjolaine; Latreille, Veronique; Vandewalle, Gilles; Martin, Nicolas; Doyon, Julien; Carrier, Julie] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Gagnon, Jean-Francois] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal	Lafortune, M (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada.	julie.carrier.1@umontreal.ca	Martin, Nicholas/R-9235-2019	Martin, Nicholas/0000-0003-4069-8020; Vandewalle, Gilles/0000-0003-2483-2752; Carrier, Julie/0000-0001-5311-2370	Canadian Institutes of Health Research (CIHR); Fonds de recherche en Sante du Quebec (FRSQ); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by grants (to J.C.) from the Canadian Institutes of Health Research (CIHR), the Fonds de recherche en Sante du Quebec (FRSQ), and the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2006, SLEEP, V29, P55, DOI 10.1093/sleep/29.1.55; AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Barnes CA, 2003, PHILOS T R SOC B, V358, P765, DOI 10.1098/rstb.2002.1244; Bersagliere A, 2010, J SLEEP RES, V19, P228, DOI 10.1111/j.1365-2869.2009.00775.x; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; BRENDEL DH, 1990, PSYCHOPHYSIOLOGY, V27, P677, DOI 10.1111/j.1469-8986.1990.tb03193.x; Brunner DP, 1996, J SLEEP RES, V5, P155, DOI 10.1046/j.1365-2869.1996.00009.x; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; Cajochen C, 1999, Sleep Res Online, V2, P65; Campbell IG, 2005, NEUROBIOL AGING, V26, P135, DOI 10.1016/j.neurobiolaging.2004.02.021; Cantero JL, 2002, BEHAV BRAIN RES, V128, P53, DOI 10.1016/S0166-4328(01)00269-8; Carrier J, 2001, PSYCHOPHYSIOLOGY, V38, P232, DOI 10.1111/1469-8986.3820232; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Carrier J, 2009, SLEEP MED, V10, P1016, DOI 10.1016/j.sleep.2009.01.001; CARSKADON MA, 1985, SLEEP, V8, P207, DOI 10.1093/sleep/8.3.207; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Darchia N, 2007, SLEEP, V30, P71, DOI 10.1093/sleep/30.1.71; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Drapeau C, 2004, SLEEP, V27, P55, DOI 10.1093/sleep/27.1.55; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Duffy JF, 2009, J AM GERIATR SOC, V57, P1245, DOI 10.1111/j.1532-5415.2009.02303.x; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Elavs S, 2007, MENOPAUSE, V14, P535, DOI 10.1097/01.gme.0000243568.70946.d4; Fathi D, 2010, CLIN NEUROPHYSIOL, V121, P90, DOI 10.1016/j.clinph.2009.07.048; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Gaudreau H, 2001, NEUROBIOL AGING, V22, P461, DOI 10.1016/S0197-4580(00)00251-7; Harrison Y, 2000, SLEEP, V23, P1067; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Karakorpi M, 2006, NEUROPSYCHOPHARMACOL, V31, P2079, DOI 10.1038/sj.npp.1301056; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kumar A, 2007, J NEUROPHYSIOL, V98, P594, DOI 10.1152/jn.00249.2007; Lira FS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-113; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Mander BA, 2010, J NEUROSCI, V30, P2686, DOI 10.1523/JNEUROSCI.4010-09.2010; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mongrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022679; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Munch M, 2004, EUR J NEUROSCI, V20, P1402, DOI 10.1111/j.1460-9568.2004.03580.x; Munch M, 2007, SLEEP, V30, P781, DOI 10.1093/sleep/30.6.781; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Oliviero A, 2006, NEUROSCI RES, V55, P74, DOI 10.1016/j.neures.2006.02.002; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Robillard R, 2010, J SLEEP RES, V19, P455, DOI 10.1111/j.1365-2869.2010.00820.x; Seugnet L, 2006, P NATL ACAD SCI USA, V103, P19913, DOI 10.1073/pnas.0609463104; Shiromani PJ, 2000, AM J PHYSIOL-REG I, V278, pR125, DOI 10.1152/ajpregu.2000.278.1.R125; Silva EJ, 2010, SLEEP, V33, P481, DOI 10.1093/sleep/33.4.481; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P1, DOI 10.1176/appi.neuropsych.18.1.1; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tucker AM, 2009, SLEEP, V32, P1393, DOI 10.1093/sleep/32.10.1393; Urrila AS, 2007, BEHAV BRAIN RES, V180, P42, DOI 10.1016/j.bbr.2007.02.019; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wilson JK, NEUROBIOLOG IN PRESS; Wu JC, 2006, NEUROPSYCHOPHARMACOL, V31, P2783, DOI 10.1038/sj.npp.1301166	63	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43224	10.1371/journal.pone.0043224	http://dx.doi.org/10.1371/journal.pone.0043224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912833	gold, Green Published			2022-12-27	WOS:000307500100074
J	Mutika, GN; Marin, C; Parker, AG; Boucias, DG; Vreysen, MJB; Abd-Alla, AMM				Mutika, Gratian N.; Marin, Carmen; Parker, Andrew G.; Boucias, Drion G.; Vreysen, Marc J. B.; Abd-Alla, Adly M. M.			Impact of Salivary Gland Hypertrophy Virus Infection on the Mating Success of Male Glossina pallidipes: Consequences for the Sterile Insect Technique	PLOS ONE			English	Article							MORSITANS-CENTRALIS DIPTERA; TSETSE-FLY; DNA VIRUS; ULTRASTRUCTURAL-CHANGES; FEMALE TSETSE; BEHAVIOR; POPULATIONS; RADIATION	Many species of tsetse flies are infected by a virus (GpSGHV) that causes salivary gland hypertrophy (SGH). Female Glossina pallidipes (Austen) with SGH symptoms (SGH+) have reduced fecundity and SGH+ male G. pallidipes are unable to inseminate female flies. Consequently, G. pallidipes laboratory colonies with a high prevalence of SGH have been difficult to maintain and have collapsed on several occasions. To assess the potential impact of the release of SGH+ sterile male G. pallidipes on the efficacy of an integrated control programme with a sterile insect technique (SIT) component, we examined the mating efficiency and behaviour of male G. pallidipes in field cages in relation to SGH prevalence. The results showed in a field cage setting a significantly reduced mating frequency of 19% for a male G. pallidipes population with a high prevalence of SGH (83%) compared to 38% for a male population with a low prevalence of SGH (7%). Premating period and mating duration did not vary significantly with SGH status. A high percentage (>80%) of females that had mated with SGH+ males had empty spermathecae. The remating frequency of female G. pallidipes was very low irrespective of the SGH status of the males in the first mating. These results indicate that a high prevalence of SGH+ in G. pallidipes not only affects colony stability and performance but, in view of their reduced mating propensity and competitiveness, releasing SGH+ sterile male G. pallidipes will reduce the efficiency of a sterile male release programme.	[Mutika, Gratian N.; Marin, Carmen; Parker, Andrew G.; Vreysen, Marc J. B.; Abd-Alla, Adly M. M.] Joint FAO IAEA Programme Nucl Techn Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Boucias, Drion G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	International Atomic Energy Agency; State University System of Florida; University of Florida	Mutika, GN (corresponding author), Joint FAO IAEA Programme Nucl Techn Food & Agr, Insect Pest Control Lab, Vienna, Austria.	a.m.m.abd-alla@iaea.org		ABD-ALLA, Adly/0000-0001-7540-4462; Parker, Andrew Gordon/0000-0001-8187-1278				Abd-Alla A, 2007, J VIROL METHODS, V139, P143, DOI 10.1016/j.jviromet.2006.09.018; Abd-Alla AMM, 2010, VIRUS RES, V150, P103, DOI 10.1016/j.virusres.2010.03.001; Abd-Alla AMM, 2009, VIRUS RES, V139, P48, DOI 10.1016/j.virusres.2008.10.006; Aksoy S, 2005, INSECT BIOCHEM MOLEC, V35, P691, DOI 10.1016/j.ibmb.2005.02.012; Bonomi A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001190; Burand JP, 2006, ANN ENTOMOL SOC AM, V99, P969, DOI 10.1603/0013-8746(2006)99[969:MPAMBO]2.0.CO;2; Burand John P., 2009, Virologica Sinica, V24, P428, DOI 10.1007/s12250-009-3046-z; Burand JP, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.6; Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10; CURTIS CF, 1968, J INSECT PHYSIOL, V14, P1365, DOI 10.1016/0022-1910(68)90172-8; DAME DA, 1968, B ENTOMOL RES, V58, P213, DOI 10.1017/S0007485300056789; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; GILLOTT C, 1981, PHYSIOL ENTOMOL, V6, P269, DOI 10.1111/j.1365-3032.1981.tb00271.x; Glasgow JP, 1963, DISTRIBUTION ABUNDAN; Gooding R. H., 1997, The molecular biology of insect disease vectors: a methods manual., P41; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; JAENSON TGT, 1978, T ROY SOC TROP MED H, V72, P234, DOI 10.1016/0035-9203(78)90200-6; JAENSON TGT, 1986, ENTOMOL EXP APPL, V41, P265, DOI 10.1007/BF00221256; Jordan A, 1986, TRYPANOSOMIASIS CONT; Jordan A. M., 1958, Bulletin of Entomological Research London, V49, P35, DOI 10.1017/S0007485300053402; Jura WGZO, 1992, BIOL CONTROL, V2, P188, DOI 10.1016/1049-9644(92)90058-L; JURA WGZO, 1989, CURR MICROBIOL, V18, P1, DOI 10.1007/BF01568821; JURA WGZO, 1988, J INVERTEBR PATHOL, V52, P1, DOI 10.1016/0022-2011(88)90095-X; KOKWARO ED, 1990, J INVERTEBR PATHOL, V56, P337, DOI 10.1016/0022-2011(90)90120-U; Leak SGA., 1998, TSETSE BIOL ECOLOGY, DOI [10.1079/9780851993003.0000, DOI 10.1079/9780851993003.0000]; LEEGWATERVANDERLINDEN ME, 1984, ENTOMOL EXP APPL, V35, P283, DOI 10.1007/BF00369145; Lietze VU, 2011, ANNU REV ENTOMOL, V56, P63, DOI 10.1146/annurev-ento-120709-144841; Minitab Inc, 2000, MIN REL 13 32 MIN IN; Mutika GN, 2001, B ENTOMOL RES, V91, P281, DOI 10.1079/BER2001102; ODINDO MO, 1982, INSECT SCI APPL, V3, P59, DOI 10.1017/S1742758400001910; ODINDO MO, 1988, INSECT SCI APPL, V9, P399, DOI 10.1017/S1742758400006408; Pollock J.N., 1982, TRAINING MANUAL TSET, V1; Sang RC, 1996, J INVERTEBR PATHOL, V68, P253, DOI 10.1006/jipa.1996.0093; Sang RC, 1999, CURR MICROBIOL, V38, P349, DOI 10.1007/PL00006815; Sang RC, 1998, MEM I OSWALDO CRUZ, V93, P861, DOI 10.1590/S0074-02761998000600030; Sokal R.R., 2012, BIOMETRY; STEELMAN CD, 1976, ANNU REV ENTOMOL, V21, P155, DOI 10.1146/annurev.en.21.010176.001103; Thornhill R., 1983, pi; VANDERVLOEDT AMV, 1978, INT J APPL RADIAT IS, V29, P713, DOI 10.1016/0020-708X(78)90117-5; Vreysen M. J. B., 1992, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V45, P303; *WHO, 2003, REP SCI WORK GROUP M	42	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42188	10.1371/journal.pone.0042188	http://dx.doi.org/10.1371/journal.pone.0042188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912687	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100007
J	Sharan, RN; Mehrotra, R; Choudhury, Y; Asotra, K				Sharan, Rajeshwar N.; Mehrotra, Ravi; Choudhury, Yashmin; Asotra, Kamlesh			Association of Betel Nut with Carcinogenesis: Revisit with a Clinical Perspective	PLOS ONE			English	Article							ORAL SUBMUCOUS FIBROSIS; SQUAMOUS-CELL CARCINOMA; BUCCAL MUCOSAL FIBROBLASTS; SINGLE NUCLEOTIDE POLYMORPHISM; HUMAN GINGIVAL FIBROBLASTS; INDEPENDENT RISK-FACTOR; NECROSIS-FACTOR-ALPHA; MALE ARECA CHEWERS; GROWTH-FACTOR-I; NF-KAPPA-B	Betel nut (BN), betel quid (BQ) and products derived from them are widely used as a socially endorsed masticatory product. The addictive nature of BN/BQ has resulted in its widespread usage making it the fourth most abused substance by humans. Progressively, several additives, including chewing tobacco, got added to simple BN preparations. This addictive practice has been shown to have strong etiological correlation with human susceptibility to cancer, particularly oral and oropharyngeal cancers. The PUBMED database was searched to retrieve all relevant published studies in English on BN and BQ, and its association with oral and oropharyngeal cancers. Only complete studies directly dealing with BN/BQ induced carcinogenesis using statistically valid and acceptable sample size were analyzed. Additional relevant information available from other sources was also considered. This systematic review attempts to put in perspective the consequences of this widespread habit of BN/BQ mastication, practiced by approximately 10% of the world population, on oral cancer with a clinical perspective. BN/BQ mastication seems to be significantly associated with susceptibility to oral and oropharyngeal cancers. Addition of tobacco to BN has been found to only marginally increase the cancer risk. Despite the widespread usage of BN/BQ and its strong association with human susceptibility to cancer, no serious strategy seems to exist to control this habit. The review, therefore, also looks at various preventive efforts being made by governments and highlights the multifaceted intervention strategies required to mitigate and/or control the habit of BN/BQ mastication.	[Sharan, Rajeshwar N.] NE Hill Univ, Dept Biochem, Radiat & Mol Biol Unit, Shillong 793014, Meghalaya, India; [Mehrotra, Ravi] Moti Lal Nehru Med Coll, Ctr Oral Canc & Precancer, Div Cytopathol, Allahabad, Uttar Pradesh, India; [Choudhury, Yashmin] Assam Univ, Dept Biotechnol, Silchar, Assam, India; [Asotra, Kamlesh] Ganeshiva Consultants, Los Angeles, CA USA	North Eastern Hill University; Moti Lal Nehru Medical College; Assam University	Sharan, RN (corresponding author), NE Hill Univ, Dept Biochem, Radiat & Mol Biol Unit, Shillong 793014, Meghalaya, India.	rnsharan@nehu.ac.in	Mehrotra, Ravi/E-3285-2010; Sharan, Rajeshwar Nath/L-3007-2016; Choudhury, Yashmin/AAC-5778-2019	Mehrotra, Ravi/0000-0001-9453-1408; Sharan, Rajeshwar Nath/0000-0002-7120-8023; 	North Eastern Hill University; UPE (NEHU); DST	North Eastern Hill University; UPE (NEHU); DST(Department of Science & Technology (India))	Part funding from North Eastern Hill University, UPE (NEHU) and DST, which where utilized for some of the works mentioned in the manuscript, are acknowledged. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe HK, 2010, ORAL ONCOL, V46, P297, DOI 10.1016/j.oraloncology.2010.01.017; Angadi PV, 2011, ORAL MAXILLOFAC SURG, V15, P1, DOI 10.1007/s10006-010-0219-8; Ariyawardana A, 2006, J ORAL PATHOL MED, V35, P197, DOI 10.1111/j.1600-0714.2006.00400.x; Aziz S R, 1997, J N J Dent Assoc, V68, P17; Balachandran B, 1995, RAD RES 1895 1995, V1, P165; Bartsch H, 1996, ENVIRON HEALTH PERSP, V104, P569, DOI 10.2307/3432825; Benegal V, 2008, DRUG ALCOHOL DEPEN, V97, P114, DOI 10.1016/j.drugalcdep.2008.03.016; Bhisey RA, 1999, INT J CANCER, V83, P679, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;679::AID-IJC19&gt;3.0.CO;2-E; Burnell AC, 1903, HOBSON JOBSON GLOSSA; Chandra PS, 2002, DRUG ALCOHOL DEPEN, V69, P1; Chang IH, 2011, J CHIN MED ASSOC, V74, P561, DOI 10.1016/j.jcma.2011.09.014; Chang KW, 2004, BRIT J CANCER, V91, P1551, DOI 10.1038/sj.bjc.6602186; Chang Y C, 2001, Clin Oral Investig, V5, P51, DOI 10.1007/s007840000085; Chang YC, 2001, J ORAL PATHOL MED, V30, P458, DOI 10.1034/j.1600-0714.2001.030008458.x; Changrani Jyotsna, 2005, J Immigr Health, V7, P103, DOI 10.1007/s10903-005-2643-7; Chen MK, 2011, ORAL ONCOL, V47, P577, DOI 10.1016/j.oraloncology.2011.04.008; Chen PH, 2011, ORAL ONCOL, V47, P594, DOI 10.1016/j.oraloncology.2011.04.024; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chen YJ, 2011, HEAD NECK-J SCI SPEC, V33, P257, DOI 10.1002/hed.21442; Chiang CP, 2004, ORAL ONCOL, V40, P720, DOI 10.1016/j.oraloncology.2003.12.015; Chiang SL, 2007, TOXICOL SCI, V100, P66, DOI 10.1093/toxsci/kfm201; Chiang WF, 2011, ORAL DIS, V17, P53, DOI 10.1111/j.1601-0825.2010.01702.x; Chiba I, 1998, INT J CANCER, V77, P839, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;839::AID-IJC7&gt;3.0.CO;2-V; Chiu CF, 2008, ORAL ONCOL, V44, P898, DOI 10.1016/j.oraloncology.2007.11.007; Chiu CJ, 2002, CANCER EPIDEM BIOMAR, V11, P646; Chiu CJ, 2001, J DENT RES, V80, P2055, DOI 10.1177/00220345010800120601; Choudhury Y, 2009, ENVIRON TOXICOL PHAR, V31, P57; Choudhury Y, 2010, MICROSC RES TECHNIQ, V73, P530, DOI 10.1002/jemt.20791; Choudhury Y, 2009, ENVIRON TOXICOL PHAR, V27, P127, DOI 10.1016/j.etap.2008.09.003; Chu NS, 2002, ADDICT BIOL, V7, P111, DOI 10.1080/13556210120091473; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; Cicenas J, 2008, INT J BIOL MARKER, V23, P1, DOI 10.1177/172460080802300101; Deb S, 1998, MUTAGENESIS, V13, P243, DOI 10.1093/mutage/13.3.243; Deng YT, 2011, ORAL ONCOL, V47, P256, DOI 10.1016/j.oraloncology.2011.01.005; Desai SS, 1996, CANCER LETT, V109, P9, DOI 10.1016/S0304-3835(96)04390-X; Goan YG, 2005, CANCER SCI, V96, P758, DOI 10.1111/j.1349-7006.2005.00115.x; Gupta PC, 2004, ANN ACAD MED SINGAP, V33, P31; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HARVEY W, 1986, ARCH ORAL BIOL, V31, P45, DOI 10.1016/0003-9969(86)90112-3; Ho TJ, 2000, ORAL ONCOL, V36, P432, DOI 10.1016/S1368-8375(00)00031-2; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hou YY, 2011, ORAL SURG ORAL MED O, V112, P484, DOI 10.1016/j.tripleo.2011.03.036; Hsieh CH, 2011, HEAD NECK-J SCI SPEC, V33, P1758, DOI 10.1002/hed.21665; Hsieh LL, 2001, CARCINOGENESIS, V22, P1497, DOI 10.1093/carcin/22.9.1497; Huang JS, 2001, J ORAL PATHOL MED, V30, P53, DOI 10.1034/j.1600-0714.2001.300109.x; Huang PL, 2010, FOOD CHEM TOXICOL, V48, P306, DOI 10.1016/j.fct.2009.10.014; Huang SF, 2009, ORAL ONCOL, V45, P16, DOI 10.1016/j.oraloncology.2008.03.006; Huang SH, 2010, ORAL SURG ORAL MED O, V109, P883, DOI 10.1016/j.tripleo.2009.12.019; Hung KF, 2009, ORAL ONCOL, V45, P543, DOI 10.1016/j.oraloncology.2008.10.004; IARC, 1985, IARC MON EV CARC RIS, V37, P263; IARC, 2004, IARC MON EV CARC RIS, V85, P39; Ihsan R, 2011, DNA CELL BIOL, V30, P163, DOI 10.1089/dna.2010.1119; Ihsan R, 2010, J GASTROEN HEPATOL, V25, P1456, DOI 10.1111/j.1440-1746.2010.06354.x; Jacob BJ, 2004, ORAL ONCOL, V40, P697, DOI 10.1016/j.oraloncology.2004.01.005; JAJU RJ, 1992, CANCER LETT, V65, P221, DOI 10.1016/0304-3835(92)90235-N; Jeng JH, 2000, CARCINOGENESIS, V21, P1365, DOI 10.1093/carcin/21.7.1365; JENG JH, 1994, J DENT RES, V73, P1043, DOI 10.1177/00220345940730050501; Jeng JH, 2003, CARCINOGENESIS, V24, P1301, DOI 10.1093/carcin/bgg083; Jeng JH, 2001, ORAL ONCOL, V37, P477, DOI 10.1016/S1368-8375(01)00003-3; Jeng JH, 1996, J ORAL PATHOL MED, V25, P371, DOI 10.1111/j.1600-0714.1996.tb00281.x; Joshi MS, 2011, ASIA-PAC J PUBLIC HE, V23, P852, DOI 10.1177/1010539511419838; Kannan K, 1999, INT J ONCOL, V15, P1133; Kao SY, 2002, J ORAL PATHOL MED, V31, P505, DOI 10.1034/j.1600-0714.2002.00158.x; Kato K, 2005, J CANCER RES CLIN, V131, P340, DOI 10.1007/s00432-004-0654-8; Kaushal M, 2010, DIS ESOPHAGUS, V23, P71, DOI 10.1111/j.1442-2050.2009.00975.x; Khanna Sunali S, 2006, Head Face Med, V2, P33, DOI 10.1186/1746-160X-2-33; KHRIME RD, 1991, INDIAN J MED RES-B, V94, P119; Kietthubthew S, 2001, ENVIRON MOL MUTAGEN, V37, P111, DOI 10.1002/em.1018; Kumpawat K, 2003, MUTAT RES-GEN TOX EN, V538, P1, DOI 10.1016/S1383-5718(03)00048-2; KUTTAN NAA, 1995, ORAL ONCOL, V31B, P169, DOI 10.1016/0964-1955(94)00051-5; Lai KC, 2006, MUTAT RES-FUND MOL M, V599, P66, DOI 10.1016/j.mrfmmm.2006.01.005; Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809; Lee HC, 2001, MUTAT RES-GEN TOX EN, V493, P67, DOI 10.1016/S1383-5718(01)00160-7; Lee JJ, 2005, ORAL SURG ORAL MED O, V99, P471, DOI 10.1016/j.tripleo.2004.10.018; Lee PH, 2006, TOXICOLOGY, V220, P81, DOI 10.1016/j.tox.2005.07.026; Lee SS, 2011, J ORAL PATHOL MED, V40, P390, DOI 10.1111/j.1600-0714.2010.00998.x; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035078; Lin CC, 2009, ENVIRON MOL MUTAGEN, V50, P367, DOI 10.1002/em.20463; Lin KH, 2011, J AGR FOOD CHEM, V59, P3420, DOI 10.1021/jf104831n; Lin PC, 2011, J TOXICOL ENV HEAL A, V74, P737, DOI 10.1080/15287394.2011.539123; Lin SC, 2005, INT J CANCER, V116, P526, DOI 10.1002/ijc.21104; Lin SC, 2002, ORAL ONCOL, V38, P266, DOI 10.1016/S1368-8375(01)00054-9; Lin SC, 2006, CANCER LETT, V243, P47, DOI 10.1016/j.canlet.2005.11.019; Lin YC, 2008, ORAL ONCOL, V44, P798, DOI 10.1016/j.oraloncology.2007.10.006; Lin YS, 2005, ORL-J OTO-RHIN-LARYN, V67, P230, DOI 10.1159/000089214; Liu CJ, 2000, CAN MED ASSOC J, V162, P359; Liu SY, 2007, ORAL ONCOL, V43, P1026, DOI 10.1016/j.oraloncology.2006.11.018; Liu SY, 2008, J BIOMED SCI, V15, P823, DOI 10.1007/s11373-008-9273-8; Liu SY, 2005, J FORMOS MED ASSOC, V104, P113; Liu TY, 2004, MUTAT RES-GEN TOX EN, V559, P59, DOI 10.1016/j.mrgentox.2003.12.013; Lu HH, 2008, J DENT RES, V87, P1069, DOI 10.1177/154405910808701111; Lu HH, 2010, AUTOPHAGY, V6, P725, DOI 10.4161/auto.6.6.12423; Lu SY, 2006, CARCINOGENESIS, V27, P1273, DOI 10.1093/carcin/bgi357; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; MEGHJI S, 1987, ARCH ORAL BIOL, V32, P213, DOI 10.1016/0003-9969(87)90138-5; Mehrotra R, 2008, ASIAN PAC J CANCER P, V9, P263; Merchant A, 2000, INT J CANCER, V86, P128, DOI 10.1002/(SICI)1097-0215(20000401)86:1&lt;128::AID-IJC20&gt;3.0.CO;2-M; Miyazaki M, 2005, MUTAT RES-GEN TOX EN, V581, P165, DOI 10.1016/j.mrgentox.2004.12.002; Moutasim KA, 2011, J PATHOL, V223, P366, DOI 10.1002/path.2786; NAIR J, 1985, CARCINOGENESIS, V6, P295, DOI 10.1093/carcin/6.2.295; Nair U, 2004, MUTAGENESIS, V19, P251, DOI 10.1093/mutage/geh036; NAIR UJ, 1992, ENVIRON HEALTH PERSP, V98, P203, DOI 10.2307/3431271; NAIR UJ, 1987, CHEM-BIOL INTERACT, V63, P157, DOI 10.1016/0009-2797(87)90095-0; Nair UJ, 1999, CARCINOGENESIS, V20, P743, DOI 10.1093/carcin/20.5.743; Ni WF, 2007, ORAL ONCOL, V43, P557, DOI 10.1016/j.oraloncology.2006.06.007; Norton SA, 1998, J AM ACAD DERMATOL, V38, P81, DOI 10.1016/S0190-9622(98)70543-2; Pandya S, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-10; PANIGRAHI GB, 1986, CARCINOGENESIS, V7, P37, DOI 10.1093/carcin/7.1.37; Perera MWS, 2007, J ORAL PATHOL MED, V36, P273, DOI 10.1111/j.1600-0714.2007.00523.x; Phukan RK, 2001, BRIT J CANCER, V85, P661, DOI 10.1054/bjoc.2001.1920; PICKWELL SM, 1994, WESTERN J MED, V160, P326; Ralhan R, 2001, ORAL ONCOL, V37, P243, DOI 10.1016/S1368-8375(00)00092-0; Ramachandran S, 2006, ORAL ONCOL, V42, P350, DOI 10.1016/j.oraloncology.2005.08.010; Ramchandani AG, 1998, INT J CANCER, V75, P225, DOI 10.1002/(SICI)1097-0215(19980119)75:2<225::AID-IJC10>3.0.CO;2-C; RANASINGHE AW, 1993, ORAL ONCOL, V29B, P147, DOI 10.1016/0964-1955(93)90038-G; Ranganathan K, 2004, J ORAL PATHOL MED, V33, P274, DOI 10.1111/j.0904-2512.2004.00116.x; Reichart PA, 2007, ORAL ONCOL, V43, P958, DOI 10.1016/j.oraloncology.2007.01.020; Reichart PA, 2006, J ORAL PATHOL MED, V35, P410, DOI 10.1111/j.1600-0714.2006.00431.x; Rooban T, 2006, Indian J Med Sci, V60, P95; Saikia Jr, 1999, CANCER LETT, V139, P59, DOI 10.1016/S0304-3835(99)00008-7; Sharan RN, 2010, ENVIRONMENTAL FACTORS, GENES, AND THE DEVELOPMENT OF HUMAN CANCERS, P401, DOI 10.1007/978-1-4419-6752-7_15; Sharan RN, 1996, CANCER J - FRANCE, V9, P13; SHARAN RN, 1992, MUTAT RES, V278, P271, DOI 10.1016/S0165-1218(10)80007-2; SHARAN RN, 1994, ORAL ONCOL, V3, P190; Shieh DH, 2003, ORAL ONCOL, V39, P728, DOI 10.1016/S1368-8375(03)00101-5; Shieh TM, 2009, J ORAL PATHOL MED, V38, P109, DOI 10.1111/j.1600-0714.2008.00695.x; Shin MN, 2000, BRIT J CANCER, V82, P1871, DOI 10.1054/bjoc.2000.1208; Shwe Myint, 2001, Journal of Medical and Dental Sciences, V48, P113; SPITZ MR, 1993, CANCER-AM CANCER SOC, V72, P991, DOI 10.1002/1097-0142(19930801)72:3+<991::AID-CNCR2820721307>3.0.CO;2-5; STICH HF, 1989, MUTAT RES, V214, P47, DOI 10.1016/0027-5107(89)90197-8; SUNDQVIST K, 1989, CANCER RES, V49, P5294; Takeshima M, 2008, J ORAL PATHOL MED, V37, P475, DOI 10.1111/j.1600-0714.2008.00644.x; Tang DW, 2003, J ORAL PATHOL MED, V32, P522, DOI 10.1034/j.1600-0714.2003.00182.x; THOMAS S, 1994, CANCER RES, V54, P3588; Thongsuksai P, 2003, CANCER LETT, V201, P1, DOI 10.1016/S0304-3835(03)00417-8; Tilakaratne WM, 2006, ORAL ONCOL, V42, P561, DOI 10.1016/j.oraloncology.2005.08.005; Topcu Z, 2002, CARCINOGENESIS, V23, P595, DOI 10.1093/carcin/23.4.595; Tran TN, 2005, J ORAL PATHOL MED, V34, P150, DOI 10.1111/j.1600-0714.2004.00292.x; Trivedy C, 2001, J ORAL PATHOL MED, V30, P465, DOI 10.1034/j.1600-0714.2001.030008465.x; Trivedy CR, 2002, ADDICT BIOL, V7, P115, DOI 10.1080/13556210120091482; Trivedy CR, 2000, J ORAL PATHOL MED, V29, P241, DOI 10.1034/j.1600-0714.2000.290601.x; Tsai CH, 2005, ORAL ONCOL, V41, P940, DOI 10.1016/j.oraloncology.2005.05.006; Tsai CH, 2005, J ORAL PATHOL MED, V34, P100, DOI 10.1111/j.1600-0714.2004.00288.x; Tsai CH, 2004, ORAL DIS, V10, P360, DOI 10.1111/j.1601-0825.2004.01041.x; Tsai CH, 2003, J ORAL PATHOL MED, V32, P146, DOI 10.1034/j.1600-0714.2003.00004.x; Tsai CH, 2007, ORAL ONCOL, V43, P680, DOI 10.1016/j.oraloncology.2006.08.009; Tsai YS, 2008, TOXICOLOGY, V249, P230, DOI 10.1016/j.tox.2008.05.007; Tsai YS, 2011, TOXICOL SCI, V123, P480, DOI 10.1093/toxsci/kfr182; Tseng YH, 2007, ORAL ONCOL, V43, P670, DOI 10.1016/j.oraloncology.2006.08.003; Tseng YH, 2012, HEAD NECK-J SCI SPEC, V34, P245, DOI 10.1002/hed.21726; Tseng YH, 2011, J ORAL PATHOL MED, V40, P160, DOI 10.1111/j.1600-0714.2010.00978.x; Tsou YA, 2010, ANTICANCER RES, V30, P4205; Tu HF, 2006, J ORAL PATHOL MED, V35, P99, DOI 10.1111/j.1600-0714.2006.00370.x; Tu HF, 2007, J ORAL PATHOL MED, V36, P409, DOI 10.1111/j.1600-0714.2007.00552.x; VANWYK CW, 1993, S AFR MED J, V83, P425; Walker DM, 2003, PATHOLOGY, V35, P376, DOI 10.1080/00310290310001602558; Wang YC, 2010, ORAL ONCOL, V46, P255, DOI 10.1016/j.oraloncology.2010.01.003; Warnakulasuriya S, 2002, BMJ-BRIT MED J, V324, P799, DOI 10.1136/bmj.324.7341.799; WARY KK, 1991, INT J CANCER, V47, P396, DOI 10.1002/ijc.2910470315; WARY KK, 1988, J CANCER RES CLIN, V114, P579, DOI 10.1007/BF00398180; Wen CP, 2010, CANCER CAUSE CONTROL, V21, P1427, DOI 10.1007/s10552-010-9570-1; Weng CJ, 2012, J DENT RES, V91, P358, DOI 10.1177/0022034512438402; Weng CJ, 2011, ANN SURG ONCOL, V18, P805, DOI 10.1245/s10434-010-1432-2; Winstock A, 2002, ADDICT BIOL, V7, P133, DOI 10.1080/13556210120091509; Winstock AR, 2000, ADDICT BIOL, V5, P173, DOI 10.1080/13556210050003766; Wong YK, 1998, J ORAL PATHOL MED, V27, P243, DOI 10.1111/j.1600-0714.1998.tb01950.x; Wu HT, 2009, J ORAL PATHOL MED, V38, P206, DOI 10.1111/j.1600-0714.2008.00659.x; Wu MT, 2001, BRIT J CANCER, V85, P658, DOI 10.1054/bjoc.2001.1927; Yadav DS, 2010, GENET TEST MOL BIOMA, V14, P715, DOI 10.1089/gtmb.2010.0087; Yang CM, 2011, ARCH ORAL BIOL, V56, P1162, DOI 10.1016/j.archoralbio.2011.03.009; Yang CY, 2002, PROSTAG OTH LIPID M, V67, P181, DOI 10.1016/S0090-6980(02)00002-3; Yang SC, 2003, J ORAL PATHOL MED, V32, P600, DOI 10.1034/j.1600-0714.2003.00199.x; Yen AMF, 2008, J ORAL PATHOL MED, V37, P417, DOI 10.1111/j.1600-0714.2008.00652.x; Zavras AI, 2011, ANN SURG ONCOL, V18, P1478, DOI 10.1245/s10434-010-1431-3	174	110	115	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42759	10.1371/journal.pone.0042759	http://dx.doi.org/10.1371/journal.pone.0042759			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912735	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500100029
J	Vallve, JC; Serra, N; Zalba, G; Fortuno, A; Beloqui, O; Ferre, R; Ribalta, J; Masana, L				Vallve, Joan-Carles; Serra, Noemi; Zalba, Guillermo; Fortuno, Ana; Beloqui, Oscar; Ferre, Raimon; Ribalta, Josep; Masana, Lluis			Two Variants in the Fibulin2 Gene Are Associated with Lower Systolic Blood Pressure and Decreased Risk of Hypertension	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EXTRACELLULAR-MATRIX; PUBLIC-HEALTH; EXPRESSION; PREVENTION; MOUSE	Arterial stiffness is an important factor in hypertension. Fibulin 2 is an extracellular matrix scaffold protein involved in arterial stiffness and, hence, the fibulin 2 (FBLN2) gene may be a candidate for hypertension susceptibility. 4 single nucleotide polymorphisms (SNPs) of FBLN2 were evaluated in an association case-control study containing 447 hypertensive patients and 344 normotensive control subjects. The minor allele frequencies of rs3732666 and rs1061376 were significantly lower in hypertensives. The odds ratios (OR) for having the protective G (rs3732666) and T (rs1061376) alleles were 0.75 (95%CI: 0.58 to 0.96) and 0.83 (95%CI: 0.66 to 1.02), respectively. For rs3732666, the OR for hypertension in AG+GG subjects, compared with AA, was 0.71 (95%CI: 0.52 to 0.95). The protective genotype AG+GG was associated with significantly lower systolic blood pressure (SBP) [-3.6 mmHg (P = 0.048)]. There was a significant age interaction with rs3732666; the effect decreasing with increasing age. For rs1061376, TT subjects had an OR for hypertension of 0.53 (95%CI: 0.32 to 0.87) compared with CC subjects, with reduced SBP (-7.91 mmHg; P = 0.008) and diastolic BP (DBP) (-3.69 mmHg; P = 0.015). The presence of a G allele was an independent predictor of intima-media thickness (IMT); G carrier's having lower mean IMT (-0.037 mm, P = 0.027) compared with AA. Our results provide the first evidence for FBLN2 as a new gene associated with hypertension.	[Vallve, Joan-Carles; Serra, Noemi; Ferre, Raimon; Ribalta, Josep; Masana, Lluis] Univ Rovira & Virgili, Hosp St Joan, Fac Med URLA, IISPV,CIBERDEM, E-43201 Reus, Catalonia, Spain; [Zalba, Guillermo; Fortuno, Ana] Univ Navarra, Div Cardiovasc Sci, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Beloqui, Oscar] Univ Navarra, Univ Clin, Dept Internal Med, E-31080 Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Navarra; University of Navarra	Vallve, JC (corresponding author), Univ Rovira & Virgili, Hosp St Joan, Fac Med URLA, IISPV,CIBERDEM, C St Llorenc 21, E-43201 Reus, Catalonia, Spain.	jc.vallve@urv.cat	Fortuño, Ana/C-6921-2017; Ribalta, Josep/AAD-4859-2020; MASANA, LUIS/M-7002-2019; Vallvé, Joan-Carles/T-6742-2019; ZALBA, GUILLERMO/AAB-6231-2019	Fortuño, Ana/0000-0002-0796-4879; Ribalta, Josep/0000-0002-8879-4719; MASANA, LUIS/0000-0002-0789-4954; Vallvé, Joan-Carles/0000-0001-8711-9618; ZALBA, GUILLERMO/0000-0003-4616-1523; Serra, Noemi/0000-0002-2277-351X	Instituto de Salud Carlos III [PI030786, PI10/02547]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	The study was funded by grants from The Instituto de Salud Carlos III (PI030786 and PI10/02547) (www.isciii.es) and from Fondo Europeo de Desarrollo Regional (FEDER) (europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BRILLA CG, 1992, EUR HEART J, V13, P24, DOI 10.1093/eurheartj/13.suppl_D.24; Briones AM, 2010, CURR OPIN NEPHROL HY, V19, P187, DOI 10.1097/MNH.0b013e328335eec9; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; DiBona GF, 2002, CURR OPIN NEPHROL HY, V11, P197, DOI 10.1097/00041552-200203000-00011; Dumler F, 2009, J RENAL NUTR, V19, P57, DOI 10.1053/j.jrn.2008.10.006; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Fassler R, 1996, EXP CELL RES, V222, P111, DOI 10.1006/excr.1996.0014; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Fritsche L, 2010, AM J PHYSL ENDOCRINO; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; HAVLIK RJ, 1979, AM J EPIDEMIOL, V110, P304, DOI 10.1093/oxfordjournals.aje.a112815; Hermann Matthias, 2006, J Clin Hypertens (Greenwich), V8, P17, DOI 10.1111/j.1524-6175.2006.06032.x; Howard G, 2006, STROKE, V37, P1171, DOI 10.1161/01.STR.0000217222.09978.ce; Hultgardh-Nilsson A, 2007, CURR OPIN LIPIDOL, V18, P540, DOI 10.1097/MOL.0b013e3282ef77e9; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Lacolley P, 2009, CARDIOVASC RES, V81, P637, DOI 10.1093/cvr/cvn353; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lee HW, 2008, CURR DIABETES REP, V8, P208, DOI 10.1007/s11892-008-0036-8; Lemaire R, 2004, J INVEST DERMATOL, V123, P1063, DOI 10.1111/j.0022-202X.2004.23471.x; Lemarie CA, 2010, J MOL CELL CARDIOL, V48, P433, DOI 10.1016/j.yjmcc.2009.09.018; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu YF, 2005, NEW ENGL J MED, V352, P2294, DOI 10.1056/NEJMoa042480; London G M, 1997, Blood Press Suppl, V2, P48; Miosge N, 1996, HISTOCHEM J, V28, P109, DOI 10.1007/BF02331415; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; PAN TC, 1993, J CELL BIOL, V123, P1269, DOI 10.1083/jcb.123.5.1269; Payne RA, 2010, HYPERTENSION, V55, P9, DOI 10.1161/HYPERTENSIONAHA.107.090464; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rafiq S, 2010, J CARDIOVASC TRANSL, V3, P189, DOI 10.1007/s12265-010-9183-9; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Schultheis M, 2007, CELL MOL NEUROBIOL, V27, P11, DOI 10.1007/s10571-006-9113-1; Sharma A. K., 2006, V1, P1; Sharma JN, 2009, CURR HYPERTENS REP, V11, P178, DOI 10.1007/s11906-009-0032-7; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Touyz RM, 2000, CAN J CARDIOL, V16, P1137; Utani A, 1997, J BIOL CHEM, V272, P2814, DOI 10.1074/jbc.272.5.2814; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478; Zalba G, 2005, ARTERIOSCL THROM VAS, V25, P1452, DOI 10.1161/01.ATV.0000168411.72483.08	53	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43051	10.1371/journal.pone.0043051	http://dx.doi.org/10.1371/journal.pone.0043051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912785	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100057
J	Kuo, HC; Wang, TY; Hsu, HH; Lee, SH; Chen, YM; Tsai, TJ; Ou, MC; Ku, HT; Lee, GB; Chen, TY				Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Lee, Szu-Hsien; Chen, Young-Mao; Tsai, Tieh-Jung; Ou, Ming-Chang; Ku, Hsiao-Tung; Lee, Gwo-Bin; Chen, Tzong-Yueh			An Automated Microfluidic Chip System for Detection of Piscine Nodavirus and Characterization of Its Potential Carrier in Grouper Farms	PLOS ONE			English	Article							NERVOUS NECROSIS VIRUS; LARVAL STRIPED JACK; EPINEPHELUS-COIOIDES; VERTICAL TRANSMISSION; PSEUDOCARANX-DENTEX; ATLANTIC HALIBUT; SEA BASS; BETANODAVIRUS; BROODFISH; FISH	Groupers of the Epinephelus spp. are an important aquaculture species of high economic value in the Asia Pacific region. They are susceptible to piscine nodavirus infection, which results in viral nervous necrosis disease. In this study, a rapid and sensitive automated microfluidic chip system was implemented for the detection of piscine nodavirus; this technology has the advantage of requiring small amounts of sample and has been developed and applied for managing grouper fish farms. Epidemiological investigations revealed an extremely high detection rate of piscine nodavirus (89% of fish samples) from 5 different locations in southern Taiwan. In addition, positive samples from the feces of fish-feeding birds indicated that the birds could be carrying the virus between fish farms. In the present study, we successfully introduced this advanced technology that combines engineering and biological approaches to aquaculture. In the future, we believe that this approach will improve fish farm management and aid in reducing the economic loss experienced by fish farmers due to widespread disease outbreaks.	[Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Chen, Young-Mao; Tsai, Tieh-Jung; Ou, Ming-Chang; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Inst Biotechnol, Mol Genet Lab, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Translat Ctr Marine Biotechnol, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Agr Biotechnol Res Ctr, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Res Ctr Ocean Environm & Technol, Tainan 70101, Taiwan; [Lee, Szu-Hsien; Lee, Gwo-Bin] Natl Cheng Kung Univ, Inst Nanotechnol & Microsyst Engn, Tainan 70101, Taiwan; [Lee, Szu-Hsien; Lee, Gwo-Bin] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan; [Ku, Hsiao-Tung] Taiwan Inst Econ Res, Res Div 1, Taipei, Taiwan; [Ku, Hsiao-Tung] Natl Sci Council, Off Energy Strategy Dev, Taipei, Taiwan; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Tsing Hua University	Kuo, HC (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Mol Genet Lab, Tainan 70101, Taiwan.	gwobin@pme.nthu.edu.tw; ibcty@mail.ncku.edu.tw	Lee, Gwo-Bin Vincent/D-3032-2012	Lee, Gwo-Bin Vincent/0000-0001-6910-9133	Fish Breeding Association Taiwan; Council of Agriculture, Taiwan [94AS-14.2.1-FA-F1, 96AS-14.2.1-BQ-B2[28], 97AS-14.2.1-BQ-B1[8]]	Fish Breeding Association Taiwan; Council of Agriculture, Taiwan	This work was supported by grants from Fish Breeding Association Taiwan and Council of Agriculture, Taiwan (94AS-14.2.1-FA-F1, 96AS-14.2.1-BQ-B2[28], and 97AS-14.2.1-BQ-B1[8]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breuil G, 2002, J FISH DIS, V25, P697, DOI 10.1046/j.1365-2761.2002.00406.x; Chen YM, 2006, FISH SHELLFISH IMMUN, V20, P58, DOI 10.1016/j.fsi.2005.04.001; Chi SC, 1999, J FISH DIS, V22, P173, DOI 10.1046/j.1365-2761.1999.00152.x; Frerichs GN, 2000, AQUACULTURE, V185, P13, DOI 10.1016/S0044-8486(99)00337-3; Huang FC, 2006, ELECTROPHORESIS, V27, P3297, DOI 10.1002/elps.200600458; Johansen R, 2004, J FISH DIS, V27, P327, DOI 10.1111/j.1365-2761.2004.00548.x; Kai YH, 2008, VACCINE, V26, P1450, DOI 10.1016/j.vaccine.2007.12.043; Kai YH, 2010, VACCINE, V28, P996, DOI 10.1016/j.vaccine.2009.10.132; KAMEI Y, 1987, FISH PATHOL, V22, P147, DOI 10.3147/jsfp.22.147; Kuo HC, 2011, J CLIN MICROBIOL, V49, P1090, DOI 10.1128/JCM.01016-10; Lee S. H., 2007, SOL STAT SENS ACT MI, P943; Lee YF, 2009, BIOSENS BIOELECTRON, V25, P745, DOI 10.1016/j.bios.2009.08.020; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; Munday BL, 1997, WORLD J MICROB BIOT, V13, P375, DOI 10.1023/A:1018516014782; MUNDAY BL, 1994, AUST VET J, V71, P384, DOI 10.1111/j.1751-0813.1994.tb00937.x; Nerland AH, 2007, DIS AQUAT ORGAN, V73, P201, DOI 10.3354/dao073201; Ole BS, 2006, DIS AQUAT ORGAN, V71, P239; Ou MC, 2007, BIOCHEM BIOPH RES CO, V361, P634, DOI 10.1016/j.bbrc.2007.07.075; Sano M, 2011, FISH DIS DISORDERS, P198; Skliris GP, 2001, VIRUS RES, V75, P59, DOI 10.1016/S0168-1702(01)00225-8; Tanaka S, 1998, FISH PATHOL, V33, P31, DOI 10.3147/jsfp.33.31	22	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42203	10.1371/journal.pone.0042203	http://dx.doi.org/10.1371/journal.pone.0042203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912690	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500012
J	Liemburg, EJ; van der Meer, L; Swart, M; Curcic-Blake, B; Bruggeman, R; Knegtering, H; Aleman, A				Liemburg, Edith J.; van der Meer, Lisette; Swart, Marte; Curcic-Blake, Branislava; Bruggeman, Richard; Knegtering, Henderikus; Aleman, Andre			Reduced Connectivity in the Self-Processing Network of Schizophrenia Patients with Poor Insight	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CORTICAL MIDLINE STRUCTURES; ANTERIOR CINGULATE CORTEX; RESTING-STATE NETWORKS; DEFAULT-MODE NETWORK; EVENT-RELATED FMRI; FUNCTIONAL CONNECTIVITY; 1ST-EPISODE SCHIZOPHRENIA; SOCIAL COGNITION; BIPOLAR DISORDER	Lack of insight (unawareness of illness) is a common and clinically relevant feature of schizophrenia. Reduced levels of self-referential processing have been proposed as a mechanism underlying poor insight. The default mode network (DMN) has been implicated as a key node in the circuit for self-referential processing. We hypothesized that during resting state the DMN network would show decreased connectivity in schizophrenia patients with poor insight compared to patients with good insight. Patients with schizophrenia were recruited from mental health care centers in the north of the Netherlands and categorized in groups having good insight (n = 25) or poor insight (n = 19). All subjects underwent a resting state fMRI scan. A healthy control group (n = 30) was used as a reference. Functional connectivity of the anterior and posterior part of the DMN, identified using Independent Component Analysis, was compared between groups. Patients with poor insight showed lower connectivity of the ACC within the anterior DMN component and precuneus within the posterior DMN component compared to patients with good insight. Connectivity between the anterior and posterior part of the DMN was lower in patients than controls, and qualitatively different between the good and poor insight patient groups. As predicted, subjects with poor insight in psychosis showed decreased connectivity in DMN regions implicated in self-referential processing, although this concerned only part of the network. This finding is compatible with theories implying a role of reduced self-referential processing as a mechanism contributing to poor insight.	[Liemburg, Edith J.; van der Meer, Lisette; Swart, Marte; Curcic-Blake, Branislava; Knegtering, Henderikus; Aleman, Andre] Univ Groningen, Dept Neurosci, Univ Med Ctr Groningen, Groningen, Netherlands; [Liemburg, Edith J.; van der Meer, Lisette; Swart, Marte; Curcic-Blake, Branislava; Knegtering, Henderikus; Aleman, Andre] Univ Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands; [Liemburg, Edith J.; Knegtering, Henderikus] Univ Med Ctr Groningen, Rob Giel Res Ctr, NL-9713 AV Groningen, Netherlands; [van der Meer, Lisette; Swart, Marte; Bruggeman, Richard; Knegtering, Henderikus] Lentis, Ctr Mental Healthcare, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Liemburg, EJ (corresponding author), Univ Groningen, Dept Neurosci, Univ Med Ctr Groningen, Groningen, Netherlands.	E.J.Liemburg@umcg.nl		Curcic-Blake, Branislava/0000-0003-0817-1894; Bruggeman, Richard/0000-0002-3238-8471	European Science Foundation European Young Investigators (EURYI) award (N.W.O.) [044035001]; Eli Lilly; Astra Zeneca; Janssen-Cilag; BMS	European Science Foundation European Young Investigators (EURYI) award (N.W.O.); Eli Lilly(Eli Lilly); Astra Zeneca(AstraZeneca); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); BMS(Bristol-Myers Squibb)	This work was supported by the European Science Foundation European Young Investigators (EURYI) award (N.W.O. number 044035001) awarded to A.A. The website link: http://www.esf.org/activities/euryi.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; E.J. Liemburg, MSc reports no financial relationships with commercial interests. Dr. L. van der Meer reports no financial relationships with commercial interests. M. Swart, MSc reports no financial relationships with commercial interests. Dr. B. Curcic-Blake reports no financial relationships with commercial interests. Dr. R. Bruggeman reports no financial relationships with commercial interests. Dr. H. Knegtering is on the speakers list of Janssen-Cilag, BMS and Eli Lilly, and received unrestricted research grants from Eli Lilly, Astra Zeneca, Janssen-Cilag and BMS. These companies had no further role in the selection of literature and interpretation of data; in the writing of the review; and in the decision to submit the manuscript for publication. Dr. A. Aleman reports no financial relationships with commercial interests. Lentis Center for Mental Health Care is not a commercial organization, but a local public health care center without profit-making activities. Being an employee of Lentis does not alter those authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors declare their adherence to all the PLoS ONE policies on sharing data and materials.	Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Antonius D, 2011, SCHIZOPHR RES, V128, P76, DOI 10.1016/j.schres.2011.02.020; ATKINSON R, 1961, J ABNORM SOC PSYCH, V62, P322, DOI 10.1037/h0049307; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Brune M, 2008, NEUROPSYCHOLOGIA, V46, P1992, DOI 10.1016/j.neuropsychologia.2008.01.023; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Cole MW, 2011, BIOL PSYCHIAT, V70, P43, DOI 10.1016/j.biopsych.2011.02.010; Cooke MA, 2008, SCHIZOPHR RES, V103, P40, DOI 10.1016/j.schres.2008.04.022; David A. S, 2004, INSIGHT PSYCHOSIS AW; David A. S., 2004, INSIGHT PSYCHOSIS AW, P359; Dickerson FB, 1997, PSYCHIATR SERV, V48, P195; Drake RJ, 2003, SCHIZOPHR RES, V62, P165, DOI 10.1016/S0920-9964(02)00382-1; Flashman LA, 2004, INSIGHT PSYCHOSIS AW; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Frith C. D., 1995, COGNITIVE NEUROPSYCH; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Giel R, 1996, SCAN 2 1 SCEDULES CL; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Holt DJ, 2011, BIOL PSYCHIAT, V69, P415, DOI 10.1016/j.biopsych.2010.10.003; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kay S, 1987, SCHIZOPHR B, V13, P231; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kemp R, 1996, BRIT J PSYCHIAT, V169, P444, DOI 10.1192/bjp.169.4.444; Kuhn S., 2011, SCHIZOPHR B; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Li Y, 2006, P ISBI; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Lysaker PH, 2005, ACTA PSYCHIAT SCAND, V112, P64, DOI 10.1111/j.1600-0447.2005.00514.x; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Mintz AR, 2003, SCHIZOPHR RES, V61, P75, DOI 10.1016/S0920-9964(02)00316-X; Modinos G, 2011, NEUROPSYCHOLOGY, V25, P295, DOI 10.1037/a0021747; Morgan KD, 2010, BRIT J PSYCHIAT, V197, P141, DOI 10.1192/bjp.bp.109.070888; Nelson B, 2009, EARLY INTERV PSYCHIA, V3, P83, DOI 10.1111/j.1751-7893.2009.00112.x; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orfei MD, 2012, SOC COGN AFFECT NEUR; Parellada M, 2011, SCHIZOPHRENIA BULL, V37, P38, DOI 10.1093/schbul/sbq109; Parnas J, 2003, COMPR PSYCHIAT, V44, P121, DOI 10.1053/comp.2003.50017; Philippi CL, 2012, J COGNITIVE NEUROSCI, V24, P475, DOI 10.1162/jocn_a_00138; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Pinkham AE, 2008, SCHIZOPHRENIA BULL, V34, P688, DOI 10.1093/schbul/sbn031; Pyne JM, 2001, J NERV MENT DIS, V189, P146, DOI 10.1097/00005053-200103000-00002; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Raballo A, 2011, SCHIZOPHRENIA BULL, V37, P344, DOI 10.1093/schbul/sbp056; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ries ML, 2007, J INT NEUROPSYCH SOC, V13, P450, DOI 10.1017/S1355617707070488; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Salvador Raymond, 2010, Front Neuroinform, V4, P115, DOI 10.3389/fninf.2010.00115; Sanz M, 1998, PSYCHOL MED, V28, P437, DOI 10.1017/S0033291797006296; Sass LA, 2003, SCHIZOPHRENIA BULL, V29, P427, DOI 10.1093/oxfordjournals.schbul.a007017; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schwartz RC, 1998, PSYCHIAT QUART, V69, P1, DOI 10.1023/A:1022141322657; Shad MU, 2006, PSYCHIAT RES-NEUROIM, V146, P35, DOI 10.1016/j.pscychresns.2005.11.001; Shad MU, 2004, NEUROIMAGE, V22, P1315, DOI 10.1016/j.neuroimage.2004.03.016; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Startup M, 1997, SCHIZOPHR RES, V26, P203, DOI 10.1016/S0920-9964(97)00050-9; Stefanopoulou E, 2009, PSYCHIAT QUART, V80, P155, DOI 10.1007/s11126-009-9103-9; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Tie YM, 2008, NEUROIMAGE, V42, P1214, DOI 10.1016/j.neuroimage.2008.05.028; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Verhage F., 1984, INTELLIGENTIE LEEFTI; Wang LA, 2011, SCHIZOPHR RES, V125, P136, DOI 10.1016/j.schres.2010.11.012; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; Wolf ND, 2011, J PSYCHIATR NEUROSCI, V36, P366, DOI 10.1503/jpn.110008; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Yen CF, 2005, PSYCHIAT CLIN NEUROS, V59, P403, DOI 10.1111/j.1440-1819.2005.01392.x; Zhang DG, 2012, BRAIN IMAGING BEHAV, V6, P27, DOI 10.1007/s11682-011-9138-z	90	39	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42707	10.1371/journal.pone.0042707	http://dx.doi.org/10.1371/journal.pone.0042707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912723	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500024
J	Walton, JC; Pyter, LM; Weil, ZM; Nelson, RJ				Walton, James C.; Pyter, Leah M.; Weil, Zachary M.; Nelson, Randy J.			Photoperiod Mediated Changes in Olfactory Bulb Neurogenesis and Olfactory Behavior in Male White-Footed Mice (Peromyscus leucopus)	PLOS ONE			English	Article							GONADAL HORMONE MODULATION; DENTATE GYRUS; ADULT MALE; HIPPOCAMPAL NEUROGENESIS; MICROTUS-PENNSYLVANICUS; REPRODUCTIVE RESPONSES; CELL-PROLIFERATION; MEADOW VOLES; NEURONS; DEATH	Brain plasticity, in relation to new adult mammalian neurons generated in the subgranular zone of the hippocampus, has been well described. However, the functional outcome of new adult olfactory neurons born in the subventricular zone of the lateral ventricles is not clearly defined, as manipulating neurogenesis through various methods has given inconsistent and conflicting results in lab mice. Several small rodent species, including Peromyscus leucopus, display seasonal (photoperiodic) brain plasticity in brain volume, hippocampal function, and hippocampus-dependent behaviors; plasticity in the olfactory system of photoperiodic rodents remains largely uninvestigated. We exposed adult male P. leucopus to long day lengths (LD) and short day lengths (SD) for 10 to 15 weeks and then examined olfactory bulb cell proliferation and survival using the thymidine analog BrdU, olfactory bulb granule cell morphology using Golgi-Cox staining, and behavioral investigation of same-sex conspecific urine. SD mice did not differ from LD counterparts in granular cell morphology of the dendrites or in dendritic spine density. Although there were no differences due to photoperiod in habituation to water odor, SD mice rapidly habituated to male urine, whereas LD mice did not. In addition, short day induced changes in olfactory behavior were associated with increased neurogenesis in the caudal plexiform and granule cell layers of the olfactory bulb, an area known to preferentially respond to water-soluble odorants. Taken together, these data demonstrate that photoperiod, without altering olfactory bulb neuronal morphology, alters olfactory bulb neurogenesis and olfactory behavior in Peromyscus leucopus.	[Walton, James C.; Pyter, Leah M.; Weil, Zachary M.; Nelson, Randy J.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Walton, JC (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.	walton.315@osu.edu	Pyter, Leah/AFR-8698-2022; Weil, Zachary M/A-2439-2008; Weil, Zachary M/B-5003-2008; Walton, James C/F-7435-2010	Weil, Zachary M/0000-0003-3758-1809; Weil, Zachary M/0000-0003-3758-1809; Walton, James C/0000-0002-3049-1029; Pyter, Leah/0000-0001-8189-0663; Nelson, Randy/0000-0002-8194-4016	National Institutes of Health [R01MH057535]; National Research Service Award (NRSA) [MH73375]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH073375, R01MH057535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health R01MH057535 and National Research Service Award (NRSA) MH73375. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bartkowska K, 2008, EUR J NEUROSCI, V27, P1710, DOI 10.1111/j.1460-9568.2008.06133.x; Borowski Z, 2010, NATURWISSENSCHAFTEN, V97, P487, DOI 10.1007/s00114-010-0663-1; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; CLANCY AN, 1986, BIOL REPROD, V35, P1202, DOI 10.1095/biolreprod35.5.1202; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; FERKIN MH, 1992, PHYSIOL BEHAV, V51, P1087, DOI 10.1016/0031-9384(92)90098-M; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Goel N, 2004, CHRONOBIOL INT, V21, P691, DOI 10.1081/CBI-200025989; Heth G, 1996, PHYSIOL BEHAV, V60, P963; Huang LY, 1998, J NEUROBIOL, V36, P410, DOI 10.1002/(SICI)1097-4695(19980905)36:3<410::AID-NEU8>3.0.CO;2-Z; Institute of Laboratory Animal Resources (U.S.), 1996, GUID CAR US LAB AN, p[xii, 125]; Johnson BA, 2007, J COMP NEUROL, V502, P468, DOI 10.1002/cne.21322; Kageyama R, 2012, BEHAV BRAIN RES, V227, P459, DOI 10.1016/j.bbr.2011.04.038; King JA, 1968, BIOL PEROMYSCUS RODE, p[xiii, 593]; Lavenex P, 2000, EUR J NEUROSCI, V12, P643, DOI 10.1046/j.1460-9568.2000.00949.x; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; LYNCH GR, 1973, COMP BIOCHEM PHYSIOL, V44, P1373, DOI 10.1016/0300-9629(73)90277-6; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; NELSON RJ, 1994, J PINEAL RES, V17, P123, DOI 10.1111/j.1600-079X.1994.tb00123.x; NELSON RJ, 1990, PHYSIOL BEHAV, V48, P403, DOI 10.1016/0031-9384(90)90335-2; Nelson RJ, 2010, PHOTOPERIODISM BIOL, pxiii; Nissant A, 2011, EUR J NEUROSCI, V33, P1069, DOI 10.1111/j.1460-9568.2011.07605.x; Ormerod BK, 2003, NEUROSCI LETT, V346, P25, DOI 10.1016/S0304-3940(03)00546-9; Peretto P, 1999, BRAIN RES BULL, V49, P221, DOI 10.1016/S0361-9230(99)00037-4; Perrot-Sinal T, 2000, PSYCHONEUROENDOCRINO, V25, P259, DOI 10.1016/S0306-4530(99)00054-2; PIEPER DR, 1984, BRAIN RES, V321, P183, DOI 10.1016/0006-8993(84)90699-1; PINCHING AJ, 1974, BRAIN RES, V82, P195, DOI 10.1016/0006-8993(74)90598-8; Prendergast BJ, 2009, BEHAV BRAIN RES, V198, P159, DOI 10.1016/j.bbr.2008.10.032; Pyter LM, 2005, J NEUROSCI, V25, P4521, DOI 10.1523/JNEUROSCI.0795-05.2005; Pyter LM, 2005, AM J PHYSIOL-REG I, V288, pR891, DOI 10.1152/ajpregu.00680.2004; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Sawada M, 2011, J NEUROSCI, V31, P11587, DOI 10.1523/JNEUROSCI.0614-11.2011; Seguy M, 2005, PHYSIOL BEHAV, V84, P23, DOI 10.1016/j.physbeh.2004.10.019; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Smith MT, 2001, HORM BEHAV, V39, P11, DOI 10.1006/hbeh.2000.1630; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Walton JC, 2011, NEUROSCIENCE, V175, P127, DOI 10.1016/j.neuroscience.2010.12.004; Walton JC, 2011, FRONT NEUROENDOCRIN, V32, P303, DOI 10.1016/j.yfrne.2010.12.003; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wilson DA, 2009, NEUROBIOL LEARN MEM, V92, P199, DOI 10.1016/j.nlm.2008.07.010; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; WOLFF JO, 1986, J MAMMAL, V67, P409, DOI 10.2307/1380900	51	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42743	10.1371/journal.pone.0042743	http://dx.doi.org/10.1371/journal.pone.0042743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912730	Green Published, gold			2022-12-27	WOS:000307378500026
J	Xu, CJ; Ladouceur, M; Dastani, Z; Richards, JB; Ciampi, A; Greenwood, CMT				Xu, ChangJiang; Ladouceur, Martin; Dastani, Zari; Richards, J. Brent; Ciampi, Antonio; Greenwood, Celia M. T.			Multiple Regression Methods Show Great Potential for Rare Variant Association Tests	PLOS ONE			English	Article							LEAST-SQUARES REGRESSION; GENETIC-VARIANTS; DIMENSION; COMMON	The investigation of associations between rare genetic variants and diseases or phenotypes has two goals. Firstly, the identification of which genes or genomic regions are associated, and secondly, discrimination of associated variants from background noise within each region. Over the last few years, many new methods have been developed which associate genomic regions with phenotypes. However, classical methods for high-dimensional data have received little attention. Here we investigate whether several classical statistical methods for high-dimensional data: ridge regression (RR), principal components regression (PCR), partial least squares regression (PLS), a sparse version of PLS (SPLS), and the LASSO are able to detect associations with rare genetic variants. These approaches have been extensively used in statistics to identify the true associations in data sets containing many predictor variables. Using genetic variants identified in three genes that were Sanger sequenced in 1998 individuals, we simulated continuous phenotypes under several different models, and we show that these feature selection and feature extraction methods can substantially outperform several popular methods for rare variant analysis. Furthermore, these approaches can identify which variants are contributing most to the model fit, and therefore both goals of rare variant analysis can be achieved simultaneously with the use of regression regularization methods. These methods are briefly illustrated with an analysis of adiponectin levels and variants in the ADIPOQ gene.	[Xu, ChangJiang; Ladouceur, Martin; Dastani, Zari; Richards, J. Brent; Greenwood, Celia M. T.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Xu, ChangJiang; Dastani, Zari; Richards, J. Brent; Ciampi, Antonio; Greenwood, Celia M. T.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Ladouceur, Martin] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Richards, J. Brent] Kings Coll London, London WC2R 2LS, England; [Greenwood, Celia M. T.] McGill Univ, Dept Oncol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; University of London; King's College London; McGill University	Xu, CJ (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	celia.greenwood@mcgill.ca	Richards, J Brent/AAF-4225-2019	Richards, J Brent/0000-0002-3746-9086; Greenwood, Celia/0000-0002-2427-5696	Canadian Institutes for Health Research [MOP-115110]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The authors are indebtted to GlaxoSmithKline for the provision of genotype data used in simulations. We thank GlaxoSmithKline and the co-PIs of the CoLaus study, Gerard Waeber and Peter Vollenweider, for the use of this anonymized resequencing data, and Drs. Matthew R. Nelson and Margaret G. Ehm for their helpful suggestions as well. This work was supported by the Canadian Institutes for Health Research grant number MOP-115110.; This work was supported by the Canadian Institutes for Health Research grant number MOP-115110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Ayers Kristin L, 2011, BMC Proc, V5 Suppl 9, pS92, DOI 10.1186/1753-6561-5-S9-S92; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Biswas S, 2012, BIOMETRICS, V68, P587, DOI 10.1111/j.1541-0420.2011.01680.x; Brennan Jennifer S, 2011, BMC Proc, V5 Suppl 9, pS100, DOI 10.1186/1753-6561-5-S9-S100; Carbonetto P, 2011, BAYESIAN ANAL, V6, P1; Chen Han, 2011, BMC Proc, V5 Suppl 9, pS113, DOI 10.1186/1753-6561-5-S9-S113; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Dastani Z, 2012, PLOS GENETI IN PRESS; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gusev A, 2011, AM J HUM GENET, V88, P706, DOI 10.1016/j.ajhg.2011.04.023; Hastie T., 2009, UNSUPERVISED LEARNIN; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Kazma Remi, 2011, BMC Proc, V5 Suppl 9, pS29, DOI 10.1186/1753-6561-5-S9-S29; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Linhart H., 1986, MODEL SELECTION; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Luo L, 2011, GENOME RES, V21, P1099, DOI 10.1101/gr.115998.110; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; MASSY WF, 1965, J AM STAT ASSOC, V60, P234, DOI 10.2307/2283149; McQuarrie A. D, 1998, REGRESSION TIME SERI; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nussbaum R. L., 2007, THOMPSON THOMPSON GE; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; R Development Core Team, 2012, R LANG ENV STAT COMP; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Scholz Markus, 2011, BMC Proc, V5 Suppl 9, pS49, DOI 10.1186/1753-6561-5-S9-S49; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shao J, 1997, STAT SINICA, V7, P221; Song KNM, 2011, PHARMACOGENOMICS; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turkmen Asuman S, 2011, BMC Proc, V5 Suppl 9, pS19, DOI 10.1186/1753-6561-5-S9-S19; Wold H., 1985, ENCY STAT SCI, P581, DOI DOI 10.1002/0471667196; Wold H., 1975, PERSPECTIVES PROBABI, V12, P117, DOI [10.1017/s0021900200047604, DOI 10.1017/S0021900200047604, 10.1017/S0021900200047604]; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhou H, 2010, BIOINFORMATICS, V26, P2375, DOI 10.1093/bioinformatics/btq448; Zhu QQ, 2011, AM J HUM GENET, V88, P458, DOI 10.1016/j.ajhg.2011.03.008	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41694	10.1371/journal.pone.0041694	http://dx.doi.org/10.1371/journal.pone.0041694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22916111	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100014
J	Chang, K; Deng, SL; Lu, WP; Wang, F; Jia, SR; Li, FK; Yu, LL; Chen, M				Chang, Kai; Deng, Shaoli; Lu, Weiping; Wang, Feng; Jia, Shuangrong; Li, Fake; Yu, Lili; Chen, Ming			Association between CD209-336A/G and-871A/G Polymorphisms and Susceptibility of Tuberculosis: A Meta-Analysis	PLOS ONE			English	Article							DC-SIGN CD209; MYCOBACTERIUM-TUBERCULOSIS; GENE POLYMORPHISMS; RECEPTOR; PROMOTER; UPDATE; RISK; VARIANTS; DISEASE; HIV	Background: The association between CD209 promoter polymorphisms (-336A/G, -871A/G) and tuberculosis (TB) risk has been widely reported, but results of previous studies remain controversial and ambiguous. To assess the association between CD209 polymorphisms and TB risk, a meta-analysis was performed. Methods: Based on comprehensive searches of the PubMed, Embase, Web of Science, Weipu, and CBM databases, we identified outcome data from all articles estimating the association between CD209 polymorphisms and TB risk. The pooled odds ratio (OR) with 95% confidence intervals (CIs) were calculated. Results: A total of 14 studies with 3,610 cases and 3,539 controls were identified. There was no significant association between CD209 -336A/G polymorphism and TB risk (OR = 1.04, 95% CI = 0.91-1.19 for G vs. A; OR = 1.13, 95% CI = 0.84-1.53 for GG vs. AA; OR = 1.04, 95% CI = 0.87-1.24 for GG+AG vs. AA; OR = 1.11, 95% CI = 0.88-1.39 for GG vs. AG+AA). However, the significant association was revealed for Asians in GG vs. AA (OR = 2.48, 95% CI = 1.46-4.22, P = 0.0008) and GG vs. AG+AA (OR = 2.10, 95% CI = 1.33-3.32, P = 0.001). For the CD209 -871A/G polymorphism, lack of an association was also found (OR = 0.81, 95% CI = 0.70-0.95 for G vs. A; OR = 1.00, 95% CI = 0.52-1.93 for GG vs. AA; OR = 0.73, 95% CI = 0.60-0.89 for GG+AG vs. AA; OR = 1.09, 95% CI = 0.57-2.10 for GG vs. AG+AA). Conclusion: The present meta-analysis suggested that CD209 promoter polymorphisms (-336A/G, -871A/G) were unlikely to substantially contribute to TB susceptibility. However, the GG genotype of CD209 -336A/G polymorphism might be a genetic risk factor that increases TB susceptibility for Asians in GG vs. AA and GG vs. AG+AA.	[Chang, Kai; Deng, Shaoli; Lu, Weiping; Wang, Feng; Jia, Shuangrong; Li, Fake; Chen, Ming] Third Mil Med Univ, Daping Hosp, Dept Lab Med, Inst Surg Res, Chongqing, Peoples R China; [Yu, Lili] Third Mil Med Univ, Daping Hosp, Dept Obstet & Gynecol, Inst Surg Res, Chongqing, Peoples R China	Army Medical University; Army Medical University	Chang, K (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Lab Med, Inst Surg Res, Chongqing, Peoples R China.	lililiyuyu@sina.com; chenming1971@yahoo.com	Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	Major Project Chinese National Programs for High Technology Research and Development (863 Program) [2007AA02Z416]; Chinese National Natural Science Foundation [81071428, 30400107]; National Infectious Disease Prevention and Cure Special Project of China [2008ZX10003-012]	Major Project Chinese National Programs for High Technology Research and Development (863 Program)(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Infectious Disease Prevention and Cure Special Project of China	The Major Project Chinese National Programs for High Technology Research and Development (863 Program, 2007AA02Z416), the Chinese National Natural Science Foundation (No. 81071428, 30400107), and the National Infectious Disease Prevention and Cure Special Project of China (No. 2008ZX10003-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Ben-Ali M, 2007, HUM IMMUNOL, V68, P908, DOI 10.1016/j.humimm.2007.09.003; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Connell DW, 2011, EUR RESPIR REV, V20, P71, DOI 10.1183/09059180.00000511; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; de Wit E, 2011, MAMM GENOME, V22, P100, DOI 10.1007/s00335-010-9280-8; Denholm JT, 2010, CLIN EXP IMMUNOL, V162, P84, DOI 10.1111/j.1365-2249.2010.04221.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gomez LM, 2006, HUM IMMUNOL, V67, P808, DOI 10.1016/j.humimm.2006.07.003; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Jepson A, 2001, INFECT IMMUN, V69, P3989, DOI 10.1128/IAI.69.6.3989-3994.2001; Kobayashi K, 2011, HUM IMMUNOL, V72, P741, DOI 10.1016/j.humimm.2011.04.004; Li XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015831; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ogarkov O, 2012, INFECT GENET EVOL, V12, P732, DOI 10.1016/j.meegid.2011.10.005; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Sadki K, 2009, INT J HUM GENET, V9, P239, DOI 10.1080/09723757.2009.11886073; Selvaraj P, 2009, INFECT GENET EVOL, V9, P256, DOI 10.1016/j.meegid.2008.12.003; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tian C, 2011, HUM IMMUNOL, V72, P1137, DOI 10.1016/j.humimm.2011.07.310; Vannberg FO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001388; Wang Q, 2012, MOL BIOL REP, V39, P3393, DOI 10.1007/s11033-011-1110-x; World Health Organization, 2010, WHOHTMTB20107; Xiao J, 2010, FEMS IMMUNOL MED MIC, V60, P165, DOI 10.1111/j.1574-695X.2010.00735.x; Yew WW, 2011, AM J RESP CRIT CARE, V184, P180, DOI 10.1164/rccm.201102-0325UP; Zhang J, 2011, INT J TUBERC LUNG D, V15, P594, DOI 10.5588/ijtld.09.0703; Zheng RJ, 2011, HUM IMMUNOL, V72, P183, DOI 10.1016/j.humimm.2010.11.004; Zhuang B, 2009, CLIN J PUBLIC HLTH, V25, P517	36	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41519	10.1371/journal.pone.0041519	http://dx.doi.org/10.1371/journal.pone.0041519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911807	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300052
J	Kitada, K; Nakano, D; Liu, Y; Fujisawa, Y; Hitomi, H; Shibayama, Y; Shibata, H; Nagai, Y; Mori, H; Masaki, T; Kobori, H; Nishiyama, A				Kitada, Kento; Nakano, Daisuke; Liu, Ya; Fujisawa, Yoshihide; Hitomi, Hirofumi; Shibayama, Yuki; Shibata, Hirotaka; Nagai, Yukiko; Mori, Hirohito; Masaki, Tsutomu; Kobori, Hiroyuki; Nishiyama, Akira			Oxidative Stress-Induced Glomerular Mineralocorticoid Receptor Activation Limits the Benefit of Salt Reduction in Dahl Salt-Sensitive Rats	PLOS ONE			English	Article							RENAL INJURY; INDUCED HYPERTENSION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; PODOCYTE INJURY; CALCIUM-CHANNEL; DIETARY SALT; RAC1 GTPASE; TIME-COURSE; ALDOSTERONE	Background: Mineralocorticoid receptor (MR) antagonists attenuate renal injury in salt-sensitive hypertensive rats with low plasma aldosterone levels. We hypothesized that oxidative stress causes MR activation in high-salt-fed Dahl salt-sensitive rats. Furthermore, we determined if MR activation persisted and induced renal injury, even after switching from a high- to a normal-salt diet. Methods and Findings: High-salt feeding for 4 weeks increased dihydroethidium fluorescence (DHE, an oxidant production marker), p22phox (a NADPH oxidase subunit) and serum and glucocorticoid-regulated kinase-1 (SGK1, an MR transcript) in glomeruli, compared with normal-salt feeding, and these changes persisted 4 weeks after salt withdrawal. Tempol treatment (0.5 mmol/L) during high-salt feeding abolished the changes in DHE fluorescence, p22phox and SGK1. Dietary salt reduction after a 4-week high-salt diet decreased both blood pressure and proteinuria, but was associated with significantly higher proteinuria than in normal control rats at 4 weeks after salt reduction. Administration of tempol during high-salt feeding, or eplerenone, an MR antagonist (100 mg/kg/day), started after salt reduction, recovered proteinuria to normal levels at 4 weeks after salt reduction. Paraquat, a reactive oxygen species generator, enhanced MR transcriptional activity in cultured rat mesangial cells and mouse podocytes. Conclusions: These results suggest that oxidative stress plays an important role in glomerular MR activation in Dahl salt-sensitive rats. Persistent MR activation even after reducing salt intake could limit the beneficial effects of salt restriction.	[Kitada, Kento; Nakano, Daisuke; Liu, Ya; Hitomi, Hirofumi; Shibayama, Yuki; Kobori, Hiroyuki; Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Takamatsu, Kagawa 760, Japan; [Fujisawa, Yoshihide; Nagai, Yukiko] Kagawa Univ, Life Sci Res Ctr, Takamatsu, Kagawa 760, Japan; [Shibata, Hirotaka] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Mori, Hirohito; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol, Takamatsu, Kagawa 760, Japan	Kagawa University; Kagawa University; Keio University; Kagawa University	Kitada, K (corresponding author), Kagawa Univ, Dept Pharmacol, Takamatsu, Kagawa 760, Japan.	dnakano@med.kagawa-u.ac.jp	Hitomi, Hirofumi/ABA-2086-2021; Kobori, Hiroyuki/F-1994-2014	Kitada, Kento/0000-0002-6738-1253; Nishiyama, Akira/0000-0001-5971-820X; Kobori, Hiroyuki/0000-0001-5128-5059	Kagawa University Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan [23590303]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072408] Funding Source: NIH RePORTER	Kagawa University Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant-in-aid for the fund for Kagawa University Young Scientists 2011 to YN, scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to AN (23590303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova K, 2011, JAMA-J AM MED ASSOC, V306, P1083, DOI 10.1001/jama.2011.1291; [Anonymous], 1988, BMJ, V297, P319; Bayorh MA, 2006, CLIN EXP HYPERTENS, V28, P121, DOI 10.1080/10641960500468276; Bhargava A, 2004, TRENDS ENDOCRIN MET, V15, P147, DOI 10.1016/j.tem.2004.03.009; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Bomback AS, 2008, AM J KIDNEY DIS, V51, P199, DOI 10.1053/j.ajkd.2007.10.040; Du J, 2009, AM J PHYSIOL-RENAL, V297, pF802, DOI 10.1152/ajprenal.00197.2009; Fan YY, 2010, J HYPERTENS, V28, P1034, DOI 10.1097/HJH.0b013e328336ade3; FERGUSON RK, 1977, CLIN PHARMACOL THER, V21, P62; Flack JM, 2003, J AM COLL CARDIOL, V41, P1148, DOI 10.1016/S0735-1097(03)00054-8; Funder JW, 2007, HYPERTENSION, V50, P840, DOI 10.1161/HYPERTENSIONAHA.107.098012; Funder JW, 2009, HYPERTENSION, V53, P286, DOI 10.1161/HYPERTENSIONAHA.108.119966; Gertner RA, 2004, J AM SOC NEPHROL, V15, P558, DOI 10.1097/01.ASN.0000113244.37857.AC; Gomez-Sanchez EP, 2004, ENDOCRINOLOGY, V145, P4796, DOI 10.1210/en.2004-0295; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Halimi JM, 1995, J HYPERTENS, V13, P1801; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; Hisaki R, 2005, AM J HYPERTENS, V18, P707, DOI 10.1016/j.amjhyper.2004.11.045; Hodge G, 2002, ACTA PHYSIOL SCAND, V174, P209, DOI 10.1046/j.1365-201x.2002.00937.x; Hood SJ, 2007, CIRCULATION, V116, P268, DOI 10.1161/CIRCULATIONAHA.107.690396; Ito K, 2010, J HYPERTENS, V28, P1449, DOI 10.1097/HJH.0b013e328338bb37; Kawarazaki H, 2010, NEPHROL DIAL TRANSPL, V25, P2879, DOI 10.1093/ndt/gfq197; Kimura S, 2005, J HYPERTENS, V23, P1887, DOI 10.1097/01.hjh.0000182523.29193.e3; Liu G, 2010, J HYPERTENS, V28, P536, DOI 10.1097/HJH.0b013e3283346b62; Meng SM, 2003, HYPERTENSION, V41, P1346, DOI 10.1161/01.HYP.0000070028.99408.E8; Mihailidou AS, 2009, HYPERTENSION, V54, P1306, DOI 10.1161/HYPERTENSIONAHA.109.136242; Mori T, 2008, J AM SOC NEPHROL, V19, P1472, DOI 10.1681/ASN.2007121271; Mori T, 2009, EUR J PHARMACOL, V623, P84, DOI 10.1016/j.ejphar.2009.09.005; Morizane S, 2012, ARTERIOSCL THROM VAS, V32, P1194, DOI 10.1161/ATVBAHA.111.242719; Nagai Y, 2005, J AM SOC NEPHROL, V16, P703, DOI 10.1681/ASN.2004080649; Nagase M, 2011, CURR DIABETES REV, V7, P8, DOI 10.2174/157339911794273919; Nagase M, 2010, CLIN EXP NEPHROL, V14, P303, DOI 10.1007/s10157-010-0298-8; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Nishimura M, 1999, AM J KIDNEY DIS, V33, P261, DOI 10.1016/S0272-6386(99)70298-2; Nishiyama A, 2005, HYPERTENSION, V45, P710, DOI 10.1161/01.HYP.0000154681.38944.9a; Nishiyama A, 2004, J AM SOC NEPHROL, V15, P306, DOI 10.1097/01.ASN.0000108523.02100.E0; Nishiyama A, 2010, J PHARMACOL EXP THER, V332, P1072, DOI 10.1124/jpet.109.158113; Oki K, 2011, CLIN EXP PHARM PHYSL; Quinkler M, 2005, CIRCULATION, V112, P1435, DOI 10.1161/CIRCULATIONAHA.105.539122; Rafiq K, 2011, J PHARMACOL SCI, V115, P1, DOI 10.1254/jphs.10R07CR; Rafiq K, 2011, J HYPERTENS, V29, P290, DOI 10.1097/HJH.0b013e32834103a9; Rebholz CM, 2011, JAMA-J AM MED ASSOC, V306, P1083, DOI 10.1001/jama.2011.1292; Rebholz CM, 2011, JAMA-J AM MED ASSOC, V306, P1086; Rickard AJ, 2007, ENDOCRINOLOGY, V148, P4829, DOI 10.1210/en.2007-0209; ROGACZ S, 1990, HYPERTENSION, V15, P376, DOI 10.1161/01.HYP.15.4.376; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Tian N, 2005, HYPERTENSION, V45, P934, DOI 10.1161/01.HYP.0000160404.08866.5a; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; Udani SM, 2009, CURR HYPERTENS REP, V11, P368, DOI 10.1007/s11906-009-0061-2; Vallon V, 2005, AM J PHYSIOL-REG I, V289, pR395, DOI 10.1152/ajpregu.00731.2004; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200; Zhang MM, 2010, AM J NEPHROL, V31, P75, DOI 10.1159/000256665; Zhang MM, 2009, RENAL FAILURE, V31, P726, DOI 10.3109/08860220903134571; Zhou MS, 2004, HYPERTENSION, V44, P186, DOI 10.1161/01.HYP.0000136395.06810.cf; Zhou MS, 2003, HYPERTENSION, V42, P945, DOI 10.1161/01.HYP.0000094220.06020.C8	59	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41896	10.1371/journal.pone.0041896	http://dx.doi.org/10.1371/journal.pone.0041896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911865	Green Submitted, gold, Green Published			2022-12-27	WOS:000306751300082
J	Shull, AY; Latham-Schwark, A; Ramasamy, P; Leskoske, K; Oroian, D; Birtwistle, MR; Buckhaults, PJ				Shull, Austin Y.; Latham-Schwark, Alicia; Ramasamy, Poornema; Leskoske, Kristin; Oroian, Dora; Birtwistle, Marc R.; Buckhaults, Phillip J.			Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma	PLOS ONE			English	Article							NEGATIVE FEEDBACK-AMPLIFIER; MST2 PATHWAY; HUMAN CANCER; BRAF; AKT; INHIBITION; (V600E)BRAF; MECHANISMS; RESISTANCE; APOPTOSIS	Background: BRAF(V600) inhibitors have offered a new gateway for better treatment of metastatic melanoma. However, the overall efficacy of BRAF(V600) inhibitors has been lower than expected in clinical trials, and many patients have shown resistance to the drug's effect. We hypothesized that somatic mutations in the Phosphoinositide 3-Kinase (PI3K) pathway, which promotes proliferation and survival, may coincide with BRAF(V600) mutations and contribute to chemotherapeutic resistance. Methods: We performed a somatic mutation profiling study using the 454 FLX pyrosequencing platform in order to identify candidate cancer genes within the MAPK and PI3K pathways of melanoma patients. Somatic mutations of theses candidate cancer genes were then confirmed using Sanger sequencing. Results: As expected, BRAF(V600) mutations were seen in 51% of the melanomas, whereas NRAS mutations were seen in 19% of the melanomas. However, PI3K pathway mutations, though more heterogeneous, were present in 41% of the melanoma, with PTEN being the highest mutated PI3K gene in melanomas (22%). Interestingly, several novel PI3K pathway mutations were discovered in MTOR, IRS4, PIK3R1, PIK3R4, PIK3R5, and NFKB1. PI3K pathway mutations co-occurred with BRAF(V600) mutations in 17% of the tumors and co-occurred with 9% of NRAS mutant tumors, implying cooperativity between these pathways in terms of melanoma progression. Conclusions: These novel PI3K pathway somatic mutations could provide alternative survival and proliferative pathways for metastatic melanoma cells. They therefore may be potential chemotherapeutic targets for melanoma patients who exhibit resistance to BRAF(V600) inhibitors.	[Shull, Austin Y.; Latham-Schwark, Alicia; Ramasamy, Poornema; Leskoske, Kristin; Oroian, Dora; Birtwistle, Marc R.; Buckhaults, Phillip J.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA; [Latham-Schwark, Alicia] Med Univ S Carolina, Coll Med, Charleston, SC 29425 USA; [Leskoske, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University System of Georgia; Augusta University; Medical University of South Carolina; University of California System; University of California Berkeley	Shull, AY (corresponding author), Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA.	phillip.buckhaults@gmail.com		Birtwistle, Marc/0000-0002-0341-0705	NIH [3P20RR017698-07]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support for this project was provided by NIH grant # 3P20RR017698-07 Bench-to-bedside award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AM, 2012, CLIN CANCER RES, V18, P33, DOI 10.1158/1078-0432.CCR-11-0997; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Atefi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028973; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Birtwistle MR, 2011, CELL CYCLE, V10, P2069, DOI 10.4161/cc.10.13.16245; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng W, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00950.x; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Greger J, 2012, MOL CANC THERAPEUTIC; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Inamdar GS, 2010, BIOCHEM PHARMACOL, V80, P624, DOI 10.1016/j.bcp.2010.04.029; Ling J, 2012, CANC LETT; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Romano D, 2010, CANCER RES, V70, P1195, DOI 10.1158/0008-5472.CAN-09-3147; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sanchez-Hernandez I, 2012, CANCER LETT, V314, P244, DOI 10.1016/j.canlet.2011.09.037; Shimizu T, 2012, CLIN CANC RES OFFICI; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Wang Y, 2007, CURR CANCER DRUG TAR, V7, P591, DOI 10.2174/156800907781662248; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250	37	61	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43369	10.1371/journal.pone.0043369	http://dx.doi.org/10.1371/journal.pone.0043369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912864	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700092
J	Guo, HT; Xu, CX; Zhou, TL; Block, TM; Guo, JT				Guo, Haitao; Xu, Chunxiao; Zhou, Tianlun; Block, Timothy M.; Guo, Ju-Tao			Characterization of the Host Factors Required for Hepadnavirus Covalently Closed Circular (ccc) DNA Formation	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; REVERSE TRANSCRIPTION; VIRAL-DNA; INFECTED LIVER; CELL-CULTURES; REPLICATION; GENOME; INTERMEDIATE; INTEGRATION; LAMIVUDINE	Synthesis of the covalently closed circular (ccc) DNA is a critical, but not well-understood step in the life cycle of hepadnaviruses. Our previous studies favor a model that removal of genome-linked viral DNA polymerase occurs in the cytoplasm and the resulting deproteinized relaxed circular DNA (DP-rcDNA) is subsequently transported into the nucleus and converted into cccDNA. In support of this model, our current study showed that deproteinization of viral double-stranded linear (dsl) DNA also took place in the cytoplasm. Furthermore, we demonstrated that Ku80, a component of non-homologous end joining DNA repair pathway, was essential for synthesis of cccDNA from dslDNA, but not rcDNA. In an attempt to identify additional host factors regulating cccDNA biosynthesis, we found that the DP-rcDNA was produced in all tested cell lines that supported DHBV DNA replication, but cccDNA was only synthesized in the cell lines that accumulated high levels of DP-rcDNA, except for NCI-H322M and MDBK cells, which failed to synthesize cccDNA despite of the existence of nuclear DP-rcDNA. The results thus imply that while removal of the genome-linked viral DNA polymerase is most likely catalyzed by viral or ubiquitous host function(s), nuclear factors required for the conversion of DP-rcDNA into cccDNA and/or its maintenance are deficient in the above two cell lines, which could be useful tools for identification of the elusive host factors essential for cccDNA biosynthesis or maintenance.	[Guo, Haitao; Xu, Chunxiao; Block, Timothy M.; Guo, Ju-Tao] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA; [Zhou, Tianlun; Block, Timothy M.] Hepatitis B Fdn, Inst Hepatitis & Virus Res, Doylestown, PA USA	Drexel University	Guo, HT (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA.	Haitao.Guo@drexelmed.edu; ju-tao.guo@drexelmed.edu			National Institutes of Health [AI094474]; Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by National Institutes of Health (AI094474), Hepatitis B Foundation and appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; GERLICH WH, 1980, J VIROL, V36, P787, DOI 10.1128/JVI.36.3.787-795.1980; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Guo HT, 2005, J VIROL, V79, P2729, DOI 10.1128/JVI.79.5.2729-2742.2005; Guo JT, 2003, J VIROL, V77, P1885, DOI 10.1128/JVI.77.3.1885-1893.2003; Guo JT, 2007, ANTIVIR RES, V76, P232, DOI 10.1016/j.antiviral.2007.06.015; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Kann M, 2007, WORLD J GASTROENTERO, V13, P39, DOI 10.3748/wjg.v13.i1.39; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Lai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559; LIEN JM, 1986, J VIROL, V57, P229, DOI 10.1128/JVI.57.1.229-236.1986; Liu N, 2003, P NATL ACAD SCI USA, V100, P1984, DOI 10.1073/pnas.0436218100; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; MOLNARKIMBER KL, 1983, J VIROL, V45, P165, DOI 10.1128/JVI.45.1.165-172.1983; NEWBOLD JE, 1995, J VIROL, V69, P3350, DOI 10.1128/JVI.69.6.3350-3357.1995; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Schmitz A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000741; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sohn JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008093; STAPRANS S, 1991, J VIROL, V65, P1255, DOI 10.1128/JVI.65.3.1255-1262.1991; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/pnas.72.11.4597; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; TAVIS JE, 1994, J VIROL, V68, P3536, DOI 10.1128/JVI.68.6.3536-3543.1994; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; WANG GH, 1993, J VIROL, V67, P6507, DOI 10.1128/JVI.67.11.6507-6512.1993; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Xu CX, 2010, J VIROL, V84, P9332, DOI 10.1128/JVI.00918-10; YANG WG, 1995, J VIROL, V69, P4029, DOI 10.1128/JVI.69.7.4029-4036.1995; Yang WG, 1999, J VIROL, V73, P9710, DOI 10.1128/JVI.73.12.9710-9717.1999; Yang WG, 1996, J VIROL, V70, P4567, DOI 10.1128/JVI.70.7.4567-4575.1996; Zhou TL, 2006, ANTIVIR RES, V72, P116, DOI 10.1016/j.antiviral.2006.05.006; Zhu Y, 2001, J VIROL, V75, P311, DOI 10.1128/JVI.75.1.311-322.2001; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	42	43	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43270	10.1371/journal.pone.0043270	http://dx.doi.org/10.1371/journal.pone.0043270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912842	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100075
J	Kim, HE; Kim, DG; Lee, KJ; Son, JG; Song, MY; Park, YM; Kim, JJ; Cho, SW; Chi, SG; Cheong, HS; Shin, HD; Lee, SW; Lee, JK				Kim, Hye-Eun; Kim, Dae-Ghon; Lee, Kyung Jin; Son, Jang Geun; Song, Min-Young; Park, Young-Mi; Kim, Jae-Jung; Cho, Sung-Won; Chi, Sung-Gil; Cheong, Hyun Sub; Shin, Hyoung Doo; Lee, Sang-Wook; Lee, Jong-Keuk			Frequent Amplification of CENPF, GMNN and CDK13 Genes in Hepatocellular Carcinomas	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; COPY NUMBER ALTERATIONS; CANCER GENES; GEMININ; EXPRESSION; GENOME; DNA; ASSOCIATION; ABERRATIONS; PROTEIN	Genomic changes frequently occur in cancer cells during tumorigenesis from normal cells. Using the Illumina Human NS-12 single-nucleotide polymorphism (SNP) chip to screen for gene copy number changes in primary hepatocellular carcinomas (HCCs), we initially detected amplification of 35 genes from four genomic regions (1q21-41, 6p21.2-24.1, 7p13 and 8q13-23). By integrated screening of these genes for both DNA copy number and gene expression in HCC and colorectal cancer, we selected CENPF (centromere protein F/mitosin), GMNN (geminin, DNA replication inhibitor), CDK13 (cyclin-dependent kinase 13), and FAM82B (family with sequence similarity 82, member B) as common cancer genes. Each gene exhibited an amplification frequency of similar to 30% (range, 20-50%) in primary HCC (n = 57) and colorectal cancer (n = 12), as well as in a panel of human cancer cell lines (n = 70). Clonogenic and invasion assays of NIH3T3 cells transfected with each of the four amplified genes showed that CENPF, GMNN, and CDK13 were highly oncogenic whereas FAM82B was not. Interestingly, the oncogenic activity of these genes (excluding FAM82B) was highly correlated with gene-copy numbers in tumor samples (correlation coefficient, r>0.423), indicating that amplifications of CENPF, GMNN, and CDK13 genes are tightly linked and coincident in tumors. Furthermore, we confirmed that CDK13 gene copy number was significantly associated with clinical onset age in patients with HCC (P = 0.0037). Taken together, our results suggest that coincidently amplified CDK13, GMNN, and CENPF genes can play a role as common cancer-driver genes in human cancers.	[Kim, Hye-Eun; Lee, Kyung Jin; Son, Jang Geun; Song, Min-Young; Park, Young-Mi; Kim, Jae-Jung; Lee, Jong-Keuk] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea; [Kim, Dae-Ghon] Chonbuk Natl Univ, Med Sch & Hosp, Dept Internal Med, Chonju, Chonbuk, South Korea; [Cho, Sung-Won] Ajou Univ, Sch Med, Suwon 441749, South Korea; [Chi, Sung-Gil] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Cheong, Hyun Sub; Shin, Hyoung Doo] SNP Genet, Seoul, South Korea; [Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Lee, Sang-Wook] Univ Ulsan, Coll Med, Dept Radiat Oncol, Seoul, South Korea	University of Ulsan; Jeonbuk National University; Ajou University; Korea University; SNP Genetics; Sogang University; University of Ulsan	Kim, HE (corresponding author), Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea.	cookie_jklee@hotmail.com			Ministry of Health & Welfare, Republic of Korea [0720200]; Asan Institute for Life Sciences, Seoul, Korea [2010-419]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Asan Institute for Life Sciences, Seoul, Korea	This work was supported by a grant (#0720200) from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea, and a grant (No. 2010-419) from the Asan Institute for Life Sciences, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Bae JS, 2008, BIOCHEM BIOPH RES CO, V373, P593, DOI 10.1016/j.bbrc.2008.06.083; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; Evans DM, 2008, EUR J HUM GENET, V16, P718, DOI 10.1038/sj.ejhg.5202011; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Gardner L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2884; Green BM, 2010, SCIENCE, V329, P943, DOI 10.1126/science.1190966; Huang WC, 2002, DNA CELL BIOL, V21, P707, DOI 10.1089/104454902760599681; Ku Ja-Lok, 2005, Cancer Res Treat, V37, P1, DOI 10.4143/crt.2005.37.1.1; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Lee JH, 1999, WORLD J GASTROENTERO, V5, P289; Lee KJ, 2006, FOOD CHEM TOXICOL, V44, P1890, DOI 10.1016/j.fct.2006.06.009; Liu WN, 2006, GENE CHROMOSOME CANC, V45, P1018, DOI 10.1002/gcc.20369; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Montanari M, 2005, J CELL PHYSIOL, V202, P215, DOI 10.1002/jcp.20120; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; O'Brien SL, 2007, INT J CANCER, V120, P1434, DOI 10.1002/ijc.22413; Oishi K, 2007, J CELL BIOL, V179, P1149, DOI 10.1083/jcb.200705108; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	29	79	82	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43223	10.1371/journal.pone.0043223	http://dx.doi.org/10.1371/journal.pone.0043223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912832	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500100073
J	Sahraeian, SME; Yoon, BJ				Sahraeian, Sayed Mohammad Ebrahim; Yoon, Byung-Jun			A Network Synthesis Model for Generating Protein Interaction Network Families	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; GLOBAL ALIGNMENT; BIOLOGICAL NETWORKS; SYSTEMATIC IDENTIFICATION; EVOLUTION; DYNAMICS; GENOMES; SCALE; YEAST; TOOL	In this work, we introduce a novel network synthesis model that can generate families of evolutionarily related synthetic protein-protein interaction (PPI) networks. Given an ancestral network, the proposed model generates the network family according to a hypothetical phylogenetic tree, where the descendant networks are obtained through duplication and divergence of their ancestors, followed by network growth using network evolution models. We demonstrate that this network synthesis model can effectively create synthetic networks whose internal and cross-network properties closely resemble those of real PPI networks. The proposed model can serve as an effective framework for generating comprehensive benchmark datasets that can be used for reliable performance assessment of comparative network analysis algorithms. Using this model, we constructed a large-scale network alignment benchmark, called NAPAbench, and evaluated the performance of several representative network alignment algorithms. Our analysis clearly shows the relative performance of the leading network algorithms, with their respective advantages and disadvantages. The algorithm and source code of the network synthesis model and the network alignment benchmark NAPAbench are publicly available at http://www.ece.tamu.edu/bjyoon/NAPAbench/.	[Sahraeian, Sayed Mohammad Ebrahim; Yoon, Byung-Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sahraeian, SME (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	bjyoon@ece.tamu.edu	Yoon, Byung-Jun/B-1466-2008	Yoon, Byung-Jun/0000-0001-9328-1101	National Science Foundation through NSF Award [CCF-1149544]; Division of Computing and Communication Foundations [1149544] Funding Source: National Science Foundation	National Science Foundation through NSF Award(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported in part by the National Science Foundation through NSF Award CCF-1149544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2010, MOL BIOSYST, V6, P2296, DOI 10.1039/c004430j; Ali W, 2009, BIOINFORMATICS, V25, P3166, DOI 10.1093/bioinformatics/btp569; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2004, PHYS REV E, DOI DOI 10.1103/PhysRevE.70.056131; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ay F, 2011, J COMPUT BIOL, V18, P219, DOI 10.1089/cmb.2010.0280; Bandyopadhyay S, 2006, GENOME RES, V16, P428, DOI 10.1101/gr.4526006; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baudot A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r76; Bayati M, 2009, IEEE DATA MINING, P705, DOI 10.1109/ICDM.2009.135; Bebek G, 2007, LECT NOTES COMPUT SC, V4023, P119; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Berg J, 2006, P NATL ACAD SCI USA, V103, P10967, DOI 10.1073/pnas.0602294103; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Bradde S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/37009; Bruckner S, 2010, J COMPUT BIOL, V17, P237, DOI 10.1089/cmb.2009.0170; Chindelevitch L, 2010, BIOCOMPUT-PAC SYM, P123; Colak R, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P178; Coolen ACC, 2011, HANDBOOK OF STATISTICAL SYSTEMS BIOLOGY, P309; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; D'Antonio M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002029; Deng MH, 2002, GENOME RES, V12, P1540, DOI 10.1101/gr.153002; Denielou YP, 2009, LECT NOTES COMPUT SC, V5577, P263, DOI 10.1007/978-3-642-02441-2_23; Dost B, 2008, J COMPUT BIOL, V15, P913, DOI 10.1089/cmb.2007.0172; Dutkowski J, 2007, BIOINFORMATICS, V23, pI149, DOI 10.1093/bioinformatics/btm194; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Erten S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-333; Evlampiev K, 2008, P NATL ACAD SCI USA, V105, P9863, DOI 10.1073/pnas.0804119105; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; Flannick J, 2009, J COMPUT BIOL, V16, P1001, DOI 10.1089/cmb.2009.0099; Ge H, 2000, Nucleic Acids Res, V28, pe3, DOI 10.1093/nar/28.2.e3; Goh KI, 2005, J KOREAN PHYS SOC, V46, P551; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; Guo X, 2009, BIOINFORMATICS, V25, pI240, DOI 10.1093/bioinformatics/btp202; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hormozdiari F, 2007, PLOS COMPUT BIOL, V3, P1373, DOI 10.1371/journal.pcbi.0030118; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Kalaev M, 2008, BIOINFORMATICS, V24, P594, DOI 10.1093/bioinformatics/btm630; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Klau GW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S59; Knuth D.E., 1997, FUNDAMENTAL ALGORITH, VI; Koyuturk M, 2006, J COMPUT BIOL, V13, P182, DOI 10.1089/cmb.2006.13.182; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Middendorf M., 2005, P NATL ACAD SCI USA, V102, p3192 3197, DOI DOI 10.1073/pnas.0409515102; Navlakha S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001119; Ohno S., 1970, EVOLUTION GENE DUPLI; Park D, 2011, NUCLEIC ACIDS RES, V39, pD295, DOI 10.1093/nar/gkq1234; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pinter RY, 2005, BIOINFORMATICS, V21, P3401, DOI 10.1093/bioinformatics/bti554; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Przulj N, 2010, BIOCOMPUT-PAC SYM, P178; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Qian XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008070; Qian XN, 2009, J COMPUT BIOL, V16, P145, DOI 10.1089/cmb.2008.02TT; Ratmann O, 2007, PLOS COMPUT BIOL, V3, P2266, DOI 10.1371/journal.pcbi.0030230; Rzhetsky A, 2001, BIOINFORMATICS, V17, P988, DOI 10.1093/bioinformatics/17.10.988; Sahraeian SME, 2012, BIOINFORMATICS, V28, P2129, DOI 10.1093/bioinformatics/bts341; Sahraeian SME, 2011, INT CONF ACOUST SPEE, P6008; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vazquez A, 2004, P NATL ACAD SCI USA, V101, P17940, DOI 10.1073/pnas.0406024101; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Zaslavskiy M, 2009, BIOINFORMATICS, V25, pI259, DOI 10.1093/bioinformatics/btp196; Zhang A, 2009, PROTEIN INTERACTION NETWORKS: COMPUTATIONAL ANALYSIS, P1, DOI 10.1017/CBO9780511626593; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	87	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e41474	10.1371/journal.pone.0041474	http://dx.doi.org/10.1371/journal.pone.0041474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912671	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100004
J	Szmaragd, C; Green, LE; Medley, GF; Browne, WJ				Szmaragd, Camille; Green, Laura E.; Medley, Graham F.; Browne, William J.			Impact of Imperfect Test Sensitivity on Determining Risk Factors: The Case of Bovine Tuberculosis	PLOS ONE			English	Article							CATTLE HERDS; DIAGNOSTIC-TESTS; ENGLAND; FRAMEWORK; FARMS	Background: Imperfect diagnostic testing reduces the power to detect significant predictors in classical cross-sectional studies. Assuming that the misclassification in diagnosis is random this can be dealt with by increasing the sample size of a study. However, the effects of imperfect tests in longitudinal data analyses are not as straightforward to anticipate, especially if the outcome of the test influences behaviour. The aim of this paper is to investigate the impact of imperfect test sensitivity on the determination of predictor variables in a longitudinal study. Methodology/Principal Findings: To deal with imperfect test sensitivity affecting the response variable, we transformed the observed response variable into a set of possible temporal patterns of true disease status, whose prior probability was a function of the test sensitivity. We fitted a Bayesian discrete time survival model using an MCMC algorithm that treats the true response patterns as unknown parameters in the model. We applied our approach to epidemiological data of bovine tuberculosis outbreaks in England and investigated the effect of reduced test sensitivity in the determination of risk factors for the disease. We found that reduced test sensitivity led to changes to the collection of risk factors associated with the probability of an outbreak that were chosen in the 'best' model and to an increase in the uncertainty surrounding the parameter estimates for a model with a fixed set of risk factors that were associated with the response variable. Conclusions/Significance: We propose a novel algorithm to fit discrete survival models for longitudinal data where values of the response variable are uncertain. When analysing longitudinal data, uncertainty surrounding the response variable will affect the significance of the predictors and should therefore be accounted for either at the design stage by increasing the sample size or at the post analysis stage by conducting appropriate sensitivity analyses.	[Szmaragd, Camille; Browne, William J.] Univ Bristol, Sch Vet Sci, Langford, Devon, England; [Green, Laura E.; Medley, Graham F.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Bristol; University of Warwick	Szmaragd, C (corresponding author), Univ Bristol, Sch Vet Sci, Langford, Devon, England.	camille.szmaragd@bristol.ac.uk	Green, Laura/G-8345-2011; Medley, Graham/B-7289-2008; Browne, William J/A-8686-2010	Green, Laura/0000-0003-2957-8773; Medley, Graham/0000-0002-0030-7278; Browne, William J/0000-0002-6659-6885	Defra [SE3239]	Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by Defra (http:\\www.defra.gov.uk) under the Animal Health and Welfare call (project number SE3239). Defra had some input in the design of the initial field trial and in the collection and original analysis of the data. They did not actually have any input in the design and modelling/analysis of the data as presented in the paper. The authors provided with the data by AHVLA, came up with a new modelling approach (described in the paper), reformatting the data to the format required for the analysis, analysed and wrote the paper without any help by the funder. The authors sent Defra the draft manuscript prior to submission for comments as required by the term of their funding. The funders had no role in the data selection, preparation and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2012, VET MICROBIOL, V155, P38, DOI 10.1016/j.vetmic.2011.07.034; Animal Health Defra, 2010, DEAL TB YOUR HERD; Cannon RM, 2001, PREV VET MED, V49, P141, DOI 10.1016/S0167-5877(01)00184-2; Carrique-Mas JJ, 2008, PREV VET MED, V84, P85, DOI 10.1016/j.prevetmed.2007.11.001; Christley RM, 2011, PREV VET MED, V100, P126, DOI 10.1016/j.prevetmed.2011.02.005; Clegg TA, 2011, VET MICROBIOL, V151, P68, DOI 10.1016/j.vetmic.2011.02.027; Cox D.R., 1996, MULTIVARIATE DEPENDE; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Defra, 2011, HIST OVERVIEW BOVINE; Diggle PJ, 2011, EPIDEMIOLOGY RES INT, V2011; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green LE, 2005, PREV VET MED, V70, P293, DOI 10.1016/j.prevetmed.2005.05.005; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Independent Scientific Group on Cattle TB, 2007, VELEST USERS GUIDE S; Independent Scientific Review Group, 1997, VELEST USERS GUIDE S; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; Ramirez-Villaescusa AM, 2010, PREV VET MED, V95, P224, DOI 10.1016/j.prevetmed.2010.03.009; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Steele F, 2008, J R STAT SOC A STAT, V171, P5; Thom A, 2004, VET IMMUNOL IMMUNOP, V102, P399, DOI 10.1016/j.vetimm.2004.08.005; Wolfe DM, 2009, PREV VET MED, V92, P99, DOI 10.1016/j.prevetmed.2009.07.012	25	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43116	10.1371/journal.pone.0043116	http://dx.doi.org/10.1371/journal.pone.0043116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912804	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100063
J	Kelly, SD; Hansen, BC; Clark, DT				Kelly, Spencer D.; Hansen, Bruce C.; Clark, David T.			"Slight'' of Hand: The Processing of Visually Degraded Gestures with Speech	PLOS ONE			English	Article							REACTION-TIME; PERCEPTION; FACES; RECOGNITION; LATENCY; MODEL	Co-speech hand gestures influence language comprehension. The present experiment explored what part of the visual processing system is optimized for processing these gestures. Participants viewed short video clips of speech and gestures (e.g., a person saying "chop'' or "twist'' while making a chopping gesture) and had to determine whether the two modalities were congruent or incongruent. Gesture videos were designed to stimulate the parvocellular or magnocellular visual pathways by filtering out low or high spatial frequencies (HSF versus LSF) at two levels of degradation severity (moderate and severe). Participants were less accurate and slower at processing gesture and speech at severe versus moderate levels of degradation. In addition, they were slower for LSF versus HSF stimuli, and this difference was most pronounced in the severely degraded condition. However, exploratory item analyses showed that the HSF advantage was modulated by the range of motion and amount of motion energy in each video. The results suggest that hand gestures exploit a wide range of spatial frequencies, and depending on what frequencies carry the most motion energy, parvocellular or magnocellular visual pathways are maximized to quickly and optimally extract meaning.	[Kelly, Spencer D.; Hansen, Bruce C.; Clark, David T.] Colgate Univ, Dept Psychol, Hamilton, NY 13346 USA; [Kelly, Spencer D.; Hansen, Bruce C.; Clark, David T.] Colgate Univ, Neurosci Program, Hamilton, NY 13346 USA; [Kelly, Spencer D.] Colgate Univ, Ctr Language & Brain, Hamilton, NY 13346 USA	Colgate University; Colgate University; Colgate University	Kelly, SD (corresponding author), Colgate Univ, Dept Psychol, Hamilton, NY 13346 USA.	skelly@colgate.edu	Hansen, Bruce/E-8516-2010	Hansen, Bruce/0000-0002-8898-1688				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Belardinelli A, 2009, LECT NOTES ARTIF INT, V5395, P112; Bosworth RG, 2006, J OPT SOC AM A, V23, P2085, DOI 10.1364/JOSAA.23.002085; BREITMEYER BG, 1975, VISION RES, V15, P1411, DOI 10.1016/0042-6989(75)90200-X; Bullier J, 2001, TRENDS COGN SCI, V5, P369, DOI 10.1016/S1364-6613(00)01730-7; Callan DE, 2004, J COGNITIVE NEUROSCI, V16, P805, DOI 10.1162/089892904970771; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Cassagrande VA, 2003, VISUAL NEUROSCIENCES; Clark H.H., 1996, USING LANGUAGE; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Goffaux V, 2009, VISION RES, V49, P774, DOI 10.1016/j.visres.2009.02.009; Hansen BC, 2008, VISION RES, V48, P2523, DOI 10.1016/j.visres.2008.08.016; HARWERTH RS, 1978, VISION RES, V18, P1579, DOI 10.1016/0042-6989(78)90014-7; HEEGER DJ, 1987, J OPT SOC AM A, V4, P1455, DOI 10.1364/JOSAA.4.001455; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hostetter AB, 2011, PSYCHOL BULL, V137, P297, DOI 10.1037/a0022128; Hubbard AL, 2009, HUM BRAIN MAPP, V30, P1028, DOI 10.1002/hbm.20565; Kaplan E, 2004, VISUAL NEUROSCIENCES; Kelly SD, 2008, LANG LINGUIST COMPAS, V2, DOI 10.1111/j.1749-818x.2008.00067.x; Kelly SD, 2010, PSYCHOL SCI, V21, P260, DOI 10.1177/0956797609357327; Kelly SD, 2010, J COGNITIVE NEUROSCI, V22, P683, DOI 10.1162/jocn.2009.21254; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; McNeill D., 1992, HAND MIND WHAT GESTU; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Munhall KG, 2004, PERCEPT PSYCHOPHYS, V66, P574, DOI 10.3758/BF03194902; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; Obermeier C, 2012, CORTEX, V48, P857, DOI 10.1016/j.cortex.2011.02.007; PARKER DM, 1987, VISION RES, V27, P1279, DOI 10.1016/0042-6989(87)90204-5; Pilz KS, 2009, VIS COGN, V17, P716, DOI 10.1080/13506280802340588; RIEDL TR, 1988, J OPT SOC AM A, V5, P606, DOI 10.1364/JOSAA.5.000606; Rogers W.T., 1978, HUM COMMUN RES, V5, P54, DOI [10.1111/j.1468-2958.1978.tb00622.x, DOI 10.1111/J.1468-2958.1978.TB00622.X]; RYAN TA, 1959, PSYCHOL BULL, V56, P394, DOI 10.1037/h0041280; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; Vassilev A, 2002, VISION RES, V42, P851, DOI 10.1016/S0042-6989(01)00300-5; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322	42	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42620	10.1371/journal.pone.0042620	http://dx.doi.org/10.1371/journal.pone.0042620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986WZ	22912715	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500021
J	Krysl, P; Hawkins, AD; Schilt, C; Cranford, TW				Krysl, Petr; Hawkins, Anthony D.; Schilt, Carl; Cranford, Ted W.			Angular Oscillation of Solid Scatterers in Response to Progressive Planar Acoustic Waves: Do Fish Otoliths Rock?	PLOS ONE			English	Article							DIRECTIONAL HEARING; COD; DISCRIMINATION; STIMULI; SOUND	Fish can sense a wide variety of sounds by means of the otolith organs of the inner ear. Among the incompletely understood components of this process are the patterns of movement of the otoliths vis-a-vis fish head or whole-body movement. How complex are the motions? How does the otolith organ respond to sounds from different directions and frequencies? In the present work we examine the responses of a dense rigid scatterer (representing the otolith) suspended in an acoustic fluid to low-frequency planar progressive acoustic waves. A simple mechanical model, which predicts both translational and angular oscillation, is formulated. The responses of simple shapes (sphere and hemisphere) are analyzed with an acoustic finite element model. The hemispherical scatterer is found to oscillate both in the direction of the propagation of the progressive waves and also in the plane of the wavefront as a result of angular motion. The models predict that this characteristic will be shared by other irregularly-shaped scatterers, including fish otoliths, which could provide the fish hearing mechanisms with an additional component of oscillation and therefore one more source of acoustical cues.	[Krysl, Petr] Univ Calif San Diego, La Jolla, CA 92093 USA; [Hawkins, Anthony D.] Loughine Ltd, Kincraig Blairs, Aberdeen, Scotland; [Schilt, Carl] Bigleaf Sci Serv, N Bonneville, WA USA; [Cranford, Ted W.] Quantitat Morphol Consulting Inc, San Diego, CA USA	University of California System; University of California San Diego	Krysl, P (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	pkrysl@ucsd.edu		Krysl, Petr/0000-0003-1761-5047	Office of Naval research [N00014-09-1-0611]	Office of Naval research(Office of Naval Research)	The research was funded by the Office of Naval research, grant number N00014-09-1-0611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman C, 1974, COMP BIOCH PHYSL, P371; CHAPMAN CJ, 1974, J EXP BIOL, V61, P521; DeVRIES H., 1950, ACTA OTO LARYNGOL, V38, P262, DOI 10.3109/00016485009118384; DEVRIES H, 1956, PROG BIOPHYS MOL BIO, V6, P208, DOI 10.1016/S0096-4174(18)30108-2; Fan ZW, 2008, J ACOUST SOC AM, V124, P2727, DOI 10.1121/1.2977733; FLOCK A, 1965, ACTA OTO LARYNG ST S, V199, P1; Hawkins A.D., 1976, Developments Aquacult Fish Sci, V5, P149; HAWKINS AD, 1977, J COMP PHYSIOL, V122, P1, DOI 10.1007/BF00611244; Hearing Pumphrey R., 1950, S SOC EXP BIOL, P1; HICKLING R, 1966, J ACOUST SOC AM, V39, P276, DOI 10.1121/1.1909887; Howe M. S., 2006, HYDRODYNAMICS SOUND; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Krysl P, 2008, INT J NUMER METH ENG, V74, P754, DOI 10.1002/nme.2192; Krysl P, 2011, THERMAL STRESS ANAL; OLSSON P, 1985, J ACOUST SOC AM, V78, P2132, DOI 10.1121/1.392673; Popper Arthur N., 2003, P3, DOI 10.1007/978-0-387-22628-6_1; Rodgers G, 2011, EXPT STUDY ACOUSTICA; SAND O, 1978, J COMP PHYSIOL, V123, P85, DOI 10.1007/BF00657346; Sand O, 2000, PHILOS T ROY SOC B, V355, P1295, DOI 10.1098/rstb.2000.0687; Sand O, 2008, J ACOUST SOC AM, V121; Sand Olav, 2008, V32, P183; Schilt C. R., 2011, J ACOUST SOC AM, V129, P2472; SCHUIJF A, 1983, NATURE, V302, P143, DOI 10.1038/302143a0; SCHUIJF A, 1972, Netherlands Journal of Zoology, V22, P81; SCHUIJF A, 1975, J COMP PHYSIOL, V98, P333, DOI 10.1007/BF00709804; SMITH WE, 1972, AUST J PHYS, V25, P275, DOI 10.1071/PH720275; Webb JF., 2008, FISH BIOACOUSTICS	27	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42591	10.1371/journal.pone.0042591	http://dx.doi.org/10.1371/journal.pone.0042591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912710	Green Published, Green Submitted, gold			2022-12-27	WOS:000307378500020
J	Yan, J; Guo, XL; Jin, Z; Sun, JF; Shen, LW; Tong, SB				Yan, Jing; Guo, Xiaoli; Jin, Zheng; Sun, Junfeng; Shen, Liwei; Tong, Shanbao			Cognitive Alterations in Motor Imagery Process after Left Hemispheric Ischemic Stroke	PLOS ONE			English	Article							MENTAL ROTATION; PREMOTOR CORTEX; BRAIN POTENTIALS; LEFT PARIETAL; UPPER-LIMB; SYNCHRONIZATION; ACTIVATION; ATTENTION; MOVEMENT; TASK	Background: Motor imagery training is a promising rehabilitation strategy for stroke patients. However, few studies had focused on the neural mechanisms in time course of its cognitive process. This study investigated the cognitive alterations after left hemispheric ischemic stroke during motor imagery task. Methodology/Principal Findings: Eleven patients with ischemic stroke in left hemisphere and eleven age-matched control subjects participated in mental rotation task (MRT) of hand pictures. Behavior performance, event-related potential (ERP) and event-related (de)synchronization (ERD/ERS) in beta band were analyzed to investigate the cortical activation. We found that: (1) The response time increased with orientation angles in both groups, called "angle effect", however, stoke patients' responses were impaired with significantly longer response time and lower accuracy rate; (2) In early visual perceptual cognitive process, stroke patients showed hypo-activations in frontal and central brain areas in aspects of both P200 and ERD; (3) During mental rotation process, P300 amplitude in control subjects decreased while angle increased, called "amplitude modulation effect", which was not observed in stroke patients. Spatially, patients showed significant lateralization of P300 with activation only in contralesional (right) parietal cortex while control subjects showed P300 in both parietal lobes. Stroke patients also showed an overall cortical hypo-activation of ERD during this sub-stage; (4) In the response sub-stage, control subjects showed higher ERD values with more activated cortical areas particularly in the right hemisphere while angle increased, named "angle effect", which was not observed in stroke patients. In addition, stroke patients showed significant lower ERD for affected hand (right) response than that for unaffected hand. Conclusions/Significance: Cortical activation was altered differently in each cognitive sub-stage of motor imagery after left hemispheric ischemic stroke. These results will help to understand the underlying neural mechanisms of mental rotation following stroke and may shed light on rehabilitation based on motor imagery training.	[Yan, Jing; Guo, Xiaoli; Sun, Junfeng; Tong, Shanbao] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Jin, Zheng; Shen, Liwei] Fifth Peoples Hosp Shanghai, Dept Neurol, Shanghai, Peoples R China; [Sun, Junfeng; Tong, Shanbao] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, J (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	stong@sjtu.edu.cn	Sun, Junfeng/D-1590-2010	Sun, Junfeng/0000-0002-7614-7127; Jin, Zheng/0000-0002-9499-934X	National Natural Science Foundation of China [60901025, 61001015]; National Basic Research Program of China (973 Program) [2011CB013304]; International Science & Technology Cooperation Program of China [2011DFA10950]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); International Science & Technology Cooperation Program of China	This work was supported by National Natural Science Foundation of China (No. 60901025, 61001015), National Basic Research Program of China (973 Program) (No. 2011CB013304), and International Science & Technology Cooperation Program of China (No. 2011DFA10950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Bajric J, 1999, PSYCHOPHYSIOLOGY, V36, P399, DOI 10.1017/S0048577299981647; Berthoz A, 1996, COGNITIVE BRAIN RES, V3, P101, DOI 10.1016/0926-6410(95)00035-6; Binkofski F, 2006, J PHYSIOL-PARIS, V99, P396, DOI 10.1016/j.jphysparis.2006.03.005; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; CORBALLIS MC, 1988, PSYCHOL REV, V95, P115, DOI 10.1037/0033-295X.95.1.115; Creem-Regehr SH, 2009, NEUROBIOL LEARN MEM, V91, P166, DOI 10.1016/j.nlm.2008.10.004; Crosbie JH, 2004, CLIN REHABIL, V18, P60, DOI 10.1191/0269215504cr702oa; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Decety Jean, 1995, Behavioural Brain Research, V72, P127, DOI 10.1016/0166-4328(96)00141-6; Dijkerman HC, 2004, CLIN REHABIL, V18, P538, DOI 10.1191/0269215504cr769oa; DUNCOMBE ME, 1994, NEUROPSYCHOLOGIA, V32, P1383, DOI 10.1016/0028-3932(94)00071-9; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; HAALAND KY, 1994, BRAIN COGNITION, V24, P104, DOI 10.1006/brcg.1994.1006; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P414, DOI 10.1017/S0048577202001105; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; Heil M, 1997, J EXP PSYCHOL HUMAN, V23, P681, DOI 10.1037/0096-1523.23.3.681; Heil M, 1998, ACTA PSYCHOL, V99, P217, DOI 10.1016/S0001-6918(98)00012-2; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Johnson SH, 2002, J COGNITIVE NEUROSCI, V14, P841, DOI 10.1162/089892902760191072; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; KURATA K, 1994, BEHAV BRAIN RES, V61, P135, DOI 10.1016/0166-4328(94)90154-6; Lamm C, 2007, NEUROIMAGE, V36, P1374, DOI 10.1016/j.neuroimage.2007.04.012; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Liesefeld HR, 2011, BRAIN COGNITION, V75, P101, DOI 10.1016/j.bandc.2010.10.012; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Lu CF, 2011, CLIN NEUROPHYSIOL, V122, P1569, DOI 10.1016/j.clinph.2011.01.050; Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661; Page S J, 2001, Top Stroke Rehabil, V8, P54; Page SJ, 2005, ARCH PHYS MED REHAB, V86, P399, DOI 10.1016/j.apmr.2004.10.002; Page SJ, 2001, CLIN REHABIL, V15, P233, DOI 10.1191/026921501672063235; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; PERONNET F, 1989, BRAIN COGNITION, V9, P279, DOI 10.1016/0278-2626(89)90037-7; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1998, ELECTROMYOGR MOTOR C, V109, P154, DOI 10.1016/S0924-980X(97)00070-2; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Porro CA, 1996, J NEUROSCI, V16, P7688; Porro CA, 2000, EUR J NEUROSCI, V12, P3059, DOI 10.1046/j.1460-9568.2000.00182.x; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Tomasino B, 2005, NEUROREPORT, V16, P1795, DOI 10.1097/01.wnr.0000185957.65723.52; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P452, DOI 10.1111/j.1469-8986.1989.tb01951.x; Windischberger C, 2003, NEUROIMAGE, V20, P225, DOI 10.1016/S1053-8119(03)00235-0; Wraga M, 2003, BRAIN COGNITION, V52, P135, DOI 10.1016/S0278-2626(03)00033-2; Yoshino A, 2000, COGNITIVE BRAIN RES, V9, P121, DOI 10.1016/S0926-6410(99)00046-4	64	25	34	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42922	10.1371/journal.pone.0042922	http://dx.doi.org/10.1371/journal.pone.0042922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912763	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500032
J	Vafia, K; Groth, S; Beckmann, T; Hirose, M; Dworschak, J; Recke, A; Ludwig, RJ; Hashimoto, T; Zillikens, D; Schmidt, E				Vafia, Katerina; Groth, Stephanie; Beckmann, Tina; Hirose, Misa; Dworschak, Jenny; Recke, Andreas; Ludwig, Ralf J.; Hashimoto, Takashi; Zillikens, Detlef; Schmidt, Enno			Pathogenicity of Autoantibodies in Anti-p200 Pemphigoid	PLOS ONE			English	Article							DERMAL-EPIDERMAL SEPARATION; EPIDERMOLYSIS-BULLOSA ACQUISITA; VII-COLLAGEN; PASSIVE TRANSFER; BASEMENT-MEMBRANE; XVII COLLAGEN; HUMAN SKIN; SUBEPIDERMAL BLISTERS; ANTIBODIES; ANTIGEN	Recently, the C-terminus of laminin gamma 1 has been identified as target antigen in anti-p200 pemphigoid and the disease was renamed as anti-laminin gamma 1 pemphigoid. However, the pathogenic relevance of these autoantibodies has not yet been demonstrated. Therefore, we employed an ex vivo model of autoantibody-mediated leukocyte-dependent neutrophil activation and dermal-epidermal separation (DES) using cryosections of human skin. We showed that anti-p200 pemphigoid sera (n = 7) induced DES in a time-dependent manner, in contrast to sera from healthy controls. Furthermore, laminin gamma 1-specific IgG and serum depleted from anti-laminin gamma 1 reactivity were generated using the recombinant C-terminus of laminin gamma 1 (LAMC1-term; amino acids 1364 to 1609). Interestingly, both fractions labeled the dermal-epidermal-junction (DEJ) by indirect immunofluorescence microscopy on human foreskin and recognized a 200 kDa protein by immunoblotting with dermal extract. Human and rabbit IgG against LAMC1-cterm failed to attract neutrophils at the DEJ and to induce DES. In contrast, patient serum depleted from LAMC1-cterm reactivity led to the same extent of DES as non-depleted IgG. Repeated injection of rabbit anti-murine LAMC1-cterm IgG into both neonatal and adult C57BL/6mice as well as repetitive immunization of various mouse strains with murine LAMC1-cterm failed to induce macro-and microscopic lesions. In all mice, circulating anti-LAMC1-cterm antibodies were present, but only in some mice, IgG deposits were seen at the DEJ. We conclude that autoantibodies in anti-p200 pemphigoid sera are pathogenic while pathogenicity is not mediated by autoantibodies against laminin gamma 1. Further studies are needed to identify the pathogenically relevant autoantigen in anti-p200 pemphigoid.	[Vafia, Katerina; Groth, Stephanie; Beckmann, Tina; Hirose, Misa; Dworschak, Jenny; Recke, Andreas; Ludwig, Ralf J.; Zillikens, Detlef; Schmidt, Enno] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Schmidt, Enno] Med Univ Lubeck, Comprehens Ctr Inflammat Med, D-23538 Lubeck, Germany	University of Lubeck; Kurume University; University of Lubeck	Vafia, K (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	enno.schmidt@uk-sh.de	Ludwig, Ralf/F-3996-2018; Schmidt, Enno/C-4008-2009; Zillikens, Detlef/C-8572-2011; Ludwig, Ralf J/A-2629-2008; Hashimoto, Takashi/H-6947-2019; Goletz, Stephanie/K-1358-2014; Recke, Andreas/C-8963-2009; Hirose, Misa/A-2858-2014	Ludwig, Ralf/0000-0002-1394-1737; Schmidt, Enno/0000-0002-1206-8913; Ludwig, Ralf J/0000-0002-1394-1737; Hashimoto, Takashi/0000-0002-0144-3255; Recke, Andreas/0000-0002-7674-1804; 	Schleswig-Holstein Cluster of Excellence in Inflammation Research (DFG) [EXC 306/1]; Medical Faculty of the University of Luebeck [E24-2010]	Schleswig-Holstein Cluster of Excellence in Inflammation Research (DFG)(German Research Foundation (DFG)); Medical Faculty of the University of Luebeck	Support was granted by the Schleswig-Holstein Cluster of Excellence in Inflammation Research (DFG EXC 306/1) to ES, DZ and RL and the Medical Faculty of the University of Luebeck (E24-2010) to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KR, 1996, BRIT J DERMATOL, V134, P340; Dainichi T, 2010, J DERMATOL, V37, P231, DOI 10.1111/j.1346-8138.2009.00793.x; Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Dilling A, 2007, J DERMATOL, V34, P1, DOI 10.1111/j.1346-8138.2007.00208.x; GAMMON WR, 1982, J INVEST DERMATOL, V78, P285, DOI 10.1111/1523-1747.ep12507222; Groth S, 2011, BRIT J DERMATOL, V164, P76, DOI 10.1111/j.1365-2133.2010.10056.x; Hirose M, 2011, J IMMUNOL, V187, P1176, DOI 10.4049/jimmunol.1100596; Hofmann SC, 2008, J INVEST DERMATOL, V128, P87, DOI 10.1038/sj.jid.5700952; Iwata H, 2009, J INVEST DERMATOL, V129, P919, DOI 10.1038/jid.2008.305; LABIB RS, 1986, J IMMUNOL, V136, P1231; Lazarova Z, 2000, J INVEST DERMATOL, V114, P178, DOI 10.1046/j.1523-1747.2000.00829.x; Lazarova Z, 1996, J CLIN INVEST, V98, P1509, DOI 10.1172/JCI118942; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Ludwig RJ, 2011, J INVEST DERMATOL, V131, P167, DOI 10.1038/jid.2010.248; Mihai S, 2007, J CELL MOL MED, V11, P1117, DOI 10.1111/j.1582-4934.2007.00081.x; MUELLER S, 1989, J INVEST DERMATOL, V92, P33, DOI 10.1111/1523-1747.ep13070476; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Schmidt E, 2000, J INVEST DERMATOL, V115, P842, DOI 10.1046/j.1523-1747.2000.00141.x; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Shimanovich I, 2003, J INVEST DERMATOL, V121, P1402, DOI 10.1111/j.1523-1747.2003.12609.x; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sitaru C, 2002, AM J PATHOL, V161, P301, DOI 10.1016/S0002-9440(10)64182-X; Sitaru C, 2002, J INVEST DERMATOL, V118, P664, DOI 10.1046/j.1523-1747.2002.01720.x; Sitaru C, 2006, J IMMUNOL, V177, P3461, DOI 10.4049/jimmunol.177.5.3461; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Woodley DT, 2006, J INVEST DERMATOL, V126, P1323, DOI 10.1038/sj.jid.5700254; Woodley DT, 2005, J INVEST DERMATOL, V124, P958, DOI 10.1111/j.0022-202X.2005.23702.x; Yamamoto K, 2002, J INVEST DERMATOL, V118, P485, DOI 10.1046/j.0022-202x.2001.01683.x; Zillikens D, 1996, J INVEST DERMATOL, V106, P1332, DOI 10.1111/1523-1747.ep12349283; Zillikens D, 2000, BRIT J DERMATOL, V143, P1043, DOI 10.1046/j.1365-2133.2000.03841.x	31	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41769	10.1371/journal.pone.0041769	http://dx.doi.org/10.1371/journal.pone.0041769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911854	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300072
J	Xu, Y; Wang, YH; Besnard, V; Ikegami, M; Wert, SE; Heffner, C; Murray, SA; Donahue, LR; Whitsett, JA				Xu, Yan; Wang, Yanhua; Besnard, Valerie; Ikegami, Machiko; Wert, Susan E.; Heffner, Caleb; Murray, Stephen A.; Donahue, Leah Rae; Whitsett, Jeffrey A.			Transcriptional Programs Controlling Perinatal Lung Maturation	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; DEVELOPING MOUSE LUNG; SURFACTANT PROTEIN-A; PROBE LEVEL DATA; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; STRUCTURAL ASPECTS; EPITHELIAL-CELLS; DOWN-REGULATION	The timing of lung maturation is controlled precisely by complex genetic and cellular programs. Lung immaturity following preterm birth frequently results in Respiratory Distress Syndrome (RDS) and Broncho-Pulmonary Dysplasia (BPD), which are leading causes of mortality and morbidity in preterm infants. Mechanisms synchronizing gestational length and lung maturation remain to be elucidated. In this study, we designed a genome-wide mRNA expression time-course study from E15.5 to Postnatal Day 0 (PN0) using lung RNAs from C57BL/6J (B6) and A/J mice that differ in gestational length by similar to 30 hr (B6, A/J). Comprehensive bioinformatics and functional genomics analyses were used to identify key regulators, bioprocesses and transcriptional networks controlling lung maturation. We identified both temporal and strain dependent gene expression patterns during lung maturation. For time dependent changes, cell adhesion, vasculature development, and lipid metabolism/transport were major bioprocesses induced during the saccular stage of lung development at E16.5-E17.5. CEBPA, PPARG, VEGFA, CAV1 and CDH1 were found to be key signaling and transcriptional regulators of these processes. Innate defense/immune responses were induced at later gestational ages (E18.5-20.5), STAT1, AP1, and EGFR being important regulators of these responses. Expression of RNAs associated with the cell cycle and chromatin assembly was repressed during prenatal lung maturation and was regulated by FOXM1, PLK1, chromobox, and high mobility group families of transcription factors. Strain dependent lung mRNA expression differences peaked at E18.5. At this time, mRNAs regulating surfactant and innate immunity were more abundantly expressed in lungs of B6 (short gestation) than in A/J (long gestation) mice, while expression of genes involved in chromatin assembly and histone modification were expressed at lower levels in B6 than in A/J mice. The present study systemically mapped key regulators, bioprocesses, and transcriptional networks controlling lung maturation, providing the basis for new therapeutic strategies to enhance lung function in preterm infants.	[Xu, Yan; Wang, Yanhua; Besnard, Valerie; Ikegami, Machiko; Wert, Susan E.; Whitsett, Jeffrey A.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45221 USA; [Xu, Yan; Wang, Yanhua; Besnard, Valerie; Ikegami, Machiko; Wert, Susan E.; Whitsett, Jeffrey A.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Sect Neonatol Perinatal & Pulm Biol, Cincinnati, OH USA; [Heffner, Caleb; Murray, Stephen A.; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Jackson Laboratory	Xu, Y (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45221 USA.	yan.xu@cchmc.org		Heffner, Caleb/0000-0002-2631-6201; Besnard, Valerie/0000-0002-2614-629X; , Yan/0000-0003-2025-027X	March of Dimes [6-FY109-235, HL105433, HL095469]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by March of Dimes (Dr. Whitsett, Dr. Xu), 6-FY109-235 (Dr. Ikegami), HL105433 (Dr. Xu, Dr. Whitsett, Dr. Ikegami) and HL095469 (Dr. Ikegami, Dr. Xu, Dr. Whitsett). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-415; Arman E, 1999, P NATL ACAD SCI USA, V96, P11895, DOI 10.1073/pnas.96.21.11895; Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Besnard V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026682; Besnard V, 2009, J BIOL CHEM, V284, P4018, DOI 10.1074/jbc.M805388200; Bonner AE, 2003, J MED GENET, V40, P408, DOI 10.1136/jmg.40.6.408; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Bruno MD, 2000, J BIOL CHEM, V275, P1043, DOI 10.1074/jbc.275.2.1043; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Cox B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100151; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Dave V, 2004, J BIOL CHEM, V279, P34578, DOI 10.1074/jbc.M404296200; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; DUBIN SB, 1990, CLIN CHEM, V36, P1867; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ferner K, 2009, ANAT REC, V292, P190, DOI 10.1002/ar.20825; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; FURST DE, 1989, ARTHRITIS RHEUM, V32, P584, DOI 10.1002/anr.1780320512; Garmany TH, 2008, PEDIATR RES, V63, P645, DOI 10.1203/PDR.0b013e31816fdbeb; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Grenache DG, 2006, CLIN BIOCHEM, V39, P1, DOI 10.1016/j.clinbiochem.2005.10.008; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; HAZEN PG, 1977, ARCH DERMATOL, V113, P689, DOI 10.1001/archderm.113.5.689; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Huqun, 2007, AM J RESP CRIT CARE, V175, P263, DOI 10.1164/rccm.200609-1274OC; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kho AT, 2009, AM J RESP CELL MOL, V40, P47, DOI 10.1165/rcmb.2008-0048OC; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; Kook H, 2003, TRENDS CARDIOVAS MED, V13, P261, DOI 10.1016/S1050-1738(03)00107-5; La Rosa S, 2010, VIRCHOWS ARCH, V457, P497, DOI 10.1007/s00428-010-0954-0; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Lin S, 2008, DEV BIOL, V316, P441, DOI 10.1016/j.ydbio.2008.02.003; Liu C, 2002, J BIOL CHEM, V277, P4519, DOI 10.1074/jbc.M107585200; Londhe VA, 2008, DEV DYNAM, V237, P328, DOI 10.1002/dvdy.21413; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Maina JN, 2002, ADV ANAT EMBRYOL CEL, V163, P1; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; McMurtry IF, 2002, AM J PHYSIOL-LUNG C, V282, pL341, DOI 10.1152/ajplung.00445.2001; Metzger DE, 2007, DEV DYNAM, V236, P1175, DOI 10.1002/dvdy.21133; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Murray SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012418; Naltner A, 2000, J BIOL CHEM, V275, P56, DOI 10.1074/jbc.275.1.56; Nemir M, 2008, J MOL CELL CARDIOL, V45, P495, DOI 10.1016/j.yjmcc.2008.02.273; Nguyen NM, 2002, DEV BIOL, V246, P231, DOI 10.1006/dbio.2002.0658; Ni ZY, 2007, J IMMUNOL, V178, P345, DOI 10.4049/jimmunol.178.1.345; Perl AKT, 1999, CLIN GENET, V56, P14, DOI 10.1034/j.1399-0004.1999.560103.x; Prince LS, 2004, AM J PHYSIOL-LUNG C, V287, pL999, DOI 10.1152/ajplung.00111.2004; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Ray DW, 1996, CANCER RES, V56, P3276; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Salanova B, 2007, J BIOL CHEM, V282, P27960, DOI 10.1074/jbc.M704039200; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Szdzuy K, 2009, J EXP ZOOL PART B, V312B, P555, DOI 10.1002/jez.b.21228; Taira T, 1999, J BIOL CHEM, V274, P24270, DOI 10.1074/jbc.274.34.24270; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tirosh I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.84; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Wan H, 2005, J BIOL CHEM; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Webster JI, 2004, ANN NY ACAD SCI, V1024, P9, DOI 10.1196/annals.1321.003; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Whitsett JA, 2006, PEDIATR CLIN N AM, V53, P873, DOI 10.1016/j.pcl.2006.08.009; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Xu Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-451; Yang M, 2001, J IMMUNOL, V166, P6885, DOI 10.4049/jimmunol.166.11.6885; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514	92	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e37046	10.1371/journal.pone.0037046	http://dx.doi.org/10.1371/journal.pone.0037046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916088	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800001
J	Haddad, D; Chen, CH; Carlin, S; Silberhumer, G; Chen, NG; Zhang, Q; Longo, V; Carpenter, SG; Mittra, A; Carson, J; Au, J; Gonen, M; Zanzonico, PB; Szalay, AA; Fong, YM				Haddad, Dana; Chen, Chun-Hao; Carlin, Sean; Silberhumer, Gerd; Chen, Nanhai G.; Zhang, Qian; Longo, Valerie; Carpenter, Susanne G.; Mittra, Arjun; Carson, Joshua; Au, Joyce; Gonen, Mithat; Zanzonico, Pat B.; Szalay, Aladar A.; Fong, Yuman			Imaging Characteristics, Tissue Distribution, and Spread of a Novel Oncolytic Vaccinia Virus Carrying the Human Sodium Iodide Symporter	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ENGINEERED MEASLES-VIRUS; REPLICATING ADENOVIRUS; VIRAL THERAPY; GENE-THERAPY; NUDE-MICE; CANCER; RADIOVIROTHERAPY; MYELOMA; ERADICATION	Introduction: Oncolytic viruses show promise for treating cancer. However, to assess therapy and potential toxicity, a noninvasive imaging modality is needed. This study aims to determine the in vivo biodistribution, and imaging and timing characteristics of a vaccinia virus, GLV-1h153, encoding the human sodium iodide symporter (hNIS. Methods: GLV-1h153 was modified from GLV-1h68 to encode the hNIS gene. Timing of cellular uptake of radioiodide I-131 in human pancreatic carcinoma cells PANC-1 was assessed using radiouptake assays. Viral biodistribution was determined in nude mice bearing PANC-1 xenografts, and infection in tumors confirmed histologically and optically via Green Fluorescent Protein (GFP) and bioluminescence. Timing characteristics of enhanced radiouptake in xenografts were assessed via I-124-positron emission tomography (PET). Detection of systemic administration of virus was investigated with both I-124-PET and 99m-technecium gamma-scintigraphy. Results: GLV-1h153 successfully facilitated time-dependent intracellular uptake of I-131 in PANC-1 cells with a maximum uptake at 24 hours postinfection (P < 0.05). In vivo, biodistribution profiles revealed persistence of virus in tumors 5 weeks postinjection at 10(9) plaque-forming unit (PFU)/gm tissue, with the virus mainly cleared from all other major organs. Tumor infection by GLV-1h153 was confirmed via optical imaging and histology. GLV-1h153 facilitated imaging virus replication in tumors via PET even at 8 hours post radiotracer injection, with a mean % ID/gm of 3.82 +/- 60.46 (P < 0.05) 2 days after intratumoral administration of virus, confirmed via tissue radiouptake assays. One week post systemic administration, GLV1h153-infected tumors were detected via I-124-PET and 99m-technecium-scintigraphy. Conclusion: GLV-1h153 is a promising oncolytic agent against pancreatic cancer with a promising biosafety profile. GLV-1h153 facilitated time-dependent hNIS-specific radiouptake in pancreatic cancer cells, facilitating detection by PET with both intratumoral and systemic administration. Therefore, GLV-1h153 is a promising candidate for the noninvasive imaging of virotherapy and warrants further study into longterm monitoring of virotherapy and potential radiocombination therapies with this treatment and imaging modality.	[Haddad, Dana; Chen, Chun-Hao; Silberhumer, Gerd; Carpenter, Susanne G.; Mittra, Arjun; Carson, Joshua; Au, Joyce; Fong, Yuman] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Haddad, Dana; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Wurzburg, Bavaria, Germany; [Carlin, Sean] Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiopharmaceut Chem Serv, New York, NY 10021 USA; [Chen, Nanhai G.; Zhang, Qian; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Longo, Valerie; Zanzonico, Pat B.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Chen, Nanhai G.; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Oncol, San Diego, CA 92103 USA	Memorial Sloan Kettering Cancer Center; University of Wurzburg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego	Haddad, D (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	aaszalay@genelux.com; fongy@mskcc.org	Gonen, Mithat/E-4826-2012	Gonen, Mithat/0000-0001-8683-8477; Haddad, Dana/0000-0002-8176-0102; Carlin, Sean/0000-0002-5401-0648	Genelux Corporation (Research & Development facility in San Diego, California, United States of America); University of Wuerzburg; Genelux Corporation and Memorial Sloan-Kettering Cancer Center	Genelux Corporation (Research & Development facility in San Diego, California, United States of America); University of Wuerzburg; Genelux Corporation and Memorial Sloan-Kettering Cancer Center	This work was supported by grants from Genelux Corporation (Research & Development facility in San Diego, California, United States of America). DH, visitor at Memorial Sloan-Kettering Cancer Center, is a graduate student in AAS's laboratory in the Department of Biochemistry and Graduate School of Life Sciences, University of Wurzburg, Germany, and is supported by a graduate stipend from The University of Wuerzburg as well as travel grants from Genelux Corporation and Memorial Sloan-Kettering Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2007, ANN SURG ONCOL, V14, P258, DOI 10.1245/s10434-006-9127-4; Baker C. H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P167, DOI 10.2174/1568008043339839; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Blechacz B, 2006, HEPATOLOGY, V44, P1465, DOI 10.1002/hep.21437; Bruno R, 2004, J ENDOCRINOL INVEST, V27, P1010, DOI 10.1007/BF03345302; Carlson SK, 2009, AM J ROENTGENOL, V192, P279, DOI 10.2214/AJR.08.1205; CARRASCO N, 1993, BIOCHIM BIOPHYS ACTA, V1154, P65, DOI 10.1016/0304-4157(93)90017-I; Chen NH, 2009, MOL MED, V15, P144, DOI 10.2119/molmed.2009.00014; Chen NG, 2010, FUTURE VIROL, V5, P763, DOI 10.2217/FVL.10.58; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; FENNER F, 1989, RES VIROLOGY, V140, P465, DOI 10.1016/S0923-2516(89)80126-8; Fenner F, 1989, RES VIROLOGY, V140, P487; Galasso D, 2010, EUR REV MED PHARMACO, V14, P375; Gentschev I, 2009, CANCER GENE THER, V16, P320, DOI 10.1038/cgt.2008.87; Gentschev I, 2010, J ONCOL, V2010, DOI 10.1155/2010/736907; Goel A, 2007, BLOOD, V110, P2342, DOI 10.1182/blood-2007-01-065573; Haddad D, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-36; Hasegawa K, 2006, CLIN CANCER RES, V12, P1868, DOI 10.1158/1078-0432.CCR-05-1803; Hingorani M, 2010, CURR CANCER DRUG TAR, V10, P242, DOI 10.2174/156800910791054194; Jezek Z, 1988, HUMAN MONKEYPOX; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Kelly KJ, 2009, INT J CANCER, V124, P911, DOI 10.1002/ijc.24037; Kuruppu D, 2007, CANCER RES, V67, P3295, DOI 10.1158/0008-5472.CAN-06-4062; Lin SF, 2007, SURGERY, V142, P976, DOI 10.1016/j.surg.2007.09.017; Lin SF, 2008, J CLIN ENDOCR METAB, V93, P4403, DOI 10.1210/jc.2008-0316; Liu CS, 2010, MOL THER, V18, P1155, DOI 10.1038/mt.2010.43; Merron A, 2007, GENE THER, V14, P1731, DOI 10.1038/sj.gt.3303043; Moss B., 2001, POXVIRIDAE VIRUSES T; Msaouel P, 2009, MOL THER, V17, P2041, DOI 10.1038/mt.2009.218; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Penheiter AR, 2010, AM J ROENTGENOL, V195, P341, DOI 10.2214/AJR.09.3672; Schmidt FI, 2012, CURR OPIN VIROL, V2, P20, DOI 10.1016/j.coviro.2011.11.007; Serganova I, 2005, NUCL MED BIOL, V32, P763, DOI 10.1016/j.nucmedbio.2005.05.008; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Squadroni M, 2010, EUR REV MED PHARMACO, V14, P386; Thorne SH, 2005, CURR OPIN MOL THER, V7, P359; Thorne SH, 2005, CURR GENE THER, V5, P429, DOI 10.2174/1566523054546215; Thorne SH, 2008, CURR OPIN MOL THER, V10, P387; Thorne Steve H., 2009, V542, P635, DOI 10.1007/978-1-59745-561-9_32; Trujillo MA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2342; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zanzonico P, 2004, SEMIN NUCL MED, V34, P87, DOI 10.1053/j.semnuclmed.2003.12.002; Zanzonico P, 1995, CLIN SPECT IMAGING, P7; Zanzonico PB, 2000, J NUCL MED, V41, P297; Zanzonico PB, 1995, PRINCIPLES NUCL MED, V2nd, P106; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	48	21	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41647	10.1371/journal.pone.0041647	http://dx.doi.org/10.1371/journal.pone.0041647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912675	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700005
J	Kua, LF; Ross, S; Lee, SC; Mimura, K; Kono, K; Goh, BC; Yong, WP				Kua, Ley-Fang; Ross, Soo; Lee, Soo-Chin; Mimura, Kousaku; Kono, Koji; Goh, Boon-Cher; Yong, Wei-Peng			UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; UDP-GLUCURONOSYLTRANSFERASE; CIGARETTE-SMOKING; GENETIC POLYMORPHISMS; 1A6 PHARMACOGENETICS; BRONCHIAL EPITHELIUM; TOTAL EXPOSURE; BREAST-CANCER; ASSOCIATION; UGT1A1-ASTERISK-28	Uridine diphosphoglucuronosyltransferases (UGTs) 1A6 is the only UGT1A isoform expressed in lung tissue. It is responsible for the detoxification of carcinogens such as benezo[a]pyrene from cigarette smoke. The purpose of this study was to evaluate the association of UGT1A6 polymorphisms and haplotypes with lung cancer risk and to evaluate the functional significance of UGT1A6 polymorphisms. Genomic DNA was isolated from leukocytes. Eight UGT1A6 polymorphisms were sequenced in a test set of 72 Chinese lung cancer patients and 62 healthy controls. Potential risk modifying alleles were validated in a separate set of 95 Chinese lung cancer patients and 100 healthy controls. UGT1A6 19T>G, 541A>G and 552A>C showed significant association with increased lung cancer risk, while UGT1A6 105C>T and IVS1+130G>T were significantly associated with reduced lung cancer risk. Multivariate logistic regression analysis demonstrated a significant association of lung cancer with UGT1A6 541A>G (OR: 3.582, 95% CI: 1.27-10.04, p = 0.015), 552A>C (OR: 5.364, 95% CI: 1.92-14.96, p = 0.001) and IVS1+130G>T (OR: 0.191, 95% CI: 0.09-0.36, p<0.001). Functional test demonstrated that UGT1A6 105C>T increased mRNA stability, providing a plausible explanation of its association with reduced lung cancer risk. Thus UGT1A6 polymorphisms may be used to identify people with increased risk of developing lung cancer.	[Kua, Ley-Fang; Ross, Soo; Lee, Soo-Chin; Goh, Boon-Cher; Yong, Wei-Peng] Natl Univ Singapore, Canc Inst Singapore, Dept Haematol Oncol, Singapore 117548, Singapore; [Ross, Soo; Lee, Soo-Chin; Kono, Koji; Goh, Boon-Cher; Yong, Wei-Peng] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Mimura, Kousaku; Kono, Koji] Natl Univ Singapore, Dept Sugery, Yong Loo Lin Sch Med, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Kua, LF (corresponding author), Natl Univ Singapore, Canc Inst Singapore, Dept Haematol Oncol, Singapore 117548, Singapore.	wei_peng_yong@nuhs.edu.sg	Lee, Soo Chin/S-9111-2016; Yong, Wei-Peng/Y-7260-2018	Lee, Soo Chin/0000-0002-5835-6419; Yong, Wei-Peng/0000-0003-4404-3777; Goh, Boon Cher/0000-0002-4107-102X	National Healthcare Group (Singapore) [NHG-SIG/06007]	National Healthcare Group (Singapore)	This work was supported by the National Healthcare Group (Singapore) small innovative grant [NHG-SIG/06007]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki J, 2005, EUR J CANCER, V41, P2360, DOI 10.1016/j.ejca.2005.04.043; AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; AUERBACH O, 1957, NEW ENGL J MED, V256, P97, DOI 10.1056/NEJM195701172560301; Chan AT, 2005, JNCI-J NATL CANCER I, V97, P457, DOI 10.1093/jnci/dji066; Ciotti M, 1997, PHARMACOGENETICS, V7, P485, DOI 10.1097/00008571-199712000-00007; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Fang JL, 2004, CANCER EPIDEM BIOMAR, V13, P102, DOI 10.1158/1055-9965.EPI-03-0070; Fang JL, 2002, CANCER RES, V62, P1978; Gallagher CJ, 2007, CANCER EPIDEM BIOMAR, V16, P823, DOI 10.1158/1055-9965.EPI-06-0823; GSCHAIDMEIER H, 1995, BIOCHEM PHARMACOL, V49, P1601, DOI 10.1016/0006-2952(95)00095-H; Guillemette C, 2000, CANCER RES, V60, P950; Guillemette C, 2001, CANCER EPIDEM BIOMAR, V10, P711; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOFFMANN D, 1995, J NATL CANCER I, V87, P1862, DOI 10.1093/jnci/87.24.1862; HOFFMANN D, 1987, JNCI-J NATL CANCER I, V79, P1281; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; JIN CJ, 1993, CARCINOGENESIS, V14, P2637, DOI 10.1093/carcin/14.12.2637; Kohle C, 2003, BIOCHEM PHARMACOL, V65, P1521, DOI 10.1016/S0006-2952(03)00074-1; Krishnaswamy S, 2005, J PHARMACOL EXP THER, V313, P1331, DOI 10.1124/jpet.104.081950; Krishnaswamy S, 2005, J PHARMACOL EXP THER, V313, P1340, DOI 10.1124/jpet.104.081968; Krishnaswamy S, 2004, DRUG METAB DISPOS, V32, P862, DOI 10.1124/dmd.32.8.862; Krishnaswamy S, 2003, DRUG METAB DISPOS, V31, P133, DOI 10.1124/dmd.31.1.133; Lampe JW, 1999, PHARMACOGENETICS, V9, P341, DOI 10.1097/00008571-199906000-00009; Lubin JH, 2007, EPIDEMIOLOGY, V18, P639, DOI 10.1097/EDE.0b013e31812717fe; Lubin JH, 2006, CANCER EPIDEM BIOMAR, V15, P517, DOI 10.1158/1055-9965.EPI-05-0863; MACKENZIE PI, 1993, CANCER RES, V53, P1529; Nagar S, 2004, PHARMACOGENETICS, V14, P487, DOI 10.1097/01.fpc.0000114771.78957.cb; Pacheco PR, 2009, MOL DIAGN THER, V13, P261, DOI 10.2165/11317170-000000000-00000; Richie JP, 1997, CANCER EPIDEM BIOMAR, V6, P783; Saeki M, 2006, PHARMACOGENOMICS J, V6, P63, DOI 10.1038/sj.tpj.6500335; Saeki Mayumi, 2005, Drug Metab Pharmacokinet, V20, P85, DOI 10.2133/dmpk.20.85; SHIELDS PG, 1993, CANCER RES, V53, P3486; Swauger JE, 2002, REGUL TOXICOL PHARM, V35, P142, DOI 10.1006/rtph.2001.1521; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yea SS, 2008, THER DRUG MONIT, V30, P23, DOI 10.1097/FTD.0b013e3181633824; Zhang W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000396; Zheng Z, 2001, JNCI-J NATL CANCER I, V93, P1411, DOI 10.1093/jnci/93.18.1411	38	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42873	10.1371/journal.pone.0042873	http://dx.doi.org/10.1371/journal.pone.0042873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912755	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700027
J	Oblessuc, PR; Borges, A; Chowdhury, B; Caldas, DGG; Tsai, SM; Camargo, LEA; Melotto, M				Oblessuc, Paula Rodrigues; Borges, Aline; Chowdhury, Bablu; Gomes Caldas, Danielle Gregorio; Tsai, Siu Mui; Aranha Camargo, Luis Eduardo; Melotto, Maeli			Dissecting Phaseolus vulgaris Innate Immune System against Colletotrichum lindemuthianum Infection	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; ANTHRACNOSE RESISTANCE; DISEASE RESISTANCE; DEFENSE RESPONSES; MESSENGER-RNA; HOST-DEFENSE; COMMON; GENE; PROTEINS; LOCUS	Background: The genus Colletotrichum is one of the most economically important plant pathogens, causing anthracnose on a wide range of crops including common beans (Phaseolus vulgaris L.). Crop yield can be dramatically decreased depending on the plant cultivar used and the environmental conditions. This study aimed to identify potential genetic components of the bean immune system to provide environmentally friendly control measures against this fungus. Methodology and Principal Findings: As the common bean is not amenable to reverse genetics to explore functionality and its genome is not fully curated, we used putative Arabidopsis orthologs of bean expressed sequence tag (EST) to perform bioinformatic analysis and experimental validation of gene expression to identify common bean genes regulated during the incompatible interaction with C. lindemuthianum. Similar to model pathosystems, Gene Ontology (GO) analysis indicated that hormone biosynthesis and signaling in common beans seem to be modulated by fungus infection. For instance, cytokinin and ethylene responses were up-regulated and jasmonic acid, gibberellin, and abscisic acid responses were down-regulated, indicating that these hormones may play a central role in this pathosystem. Importantly, we have identified putative bean gene orthologs of Arabidopsis genes involved in the plant immune system. Based on experimental validation of gene expression, we propose that hypersensitive reaction as part of effector-triggered immunity may operate, at least in part, by down-regulating genes, such as FLS2-like and MKK5-like, putative orthologs of the Arabidopsis genes involved in pathogen perception and downstream signaling. Conclusions/Significance: We have identified specific bean genes and uncovered metabolic processes and pathways that may be involved in the immune response against pathogens. Our transcriptome database is a rich resource for mining novel defense-related genes, which enabled us to develop a model of the molecular components of the bean innate immune system regulated upon pathogen attack.	[Oblessuc, Paula Rodrigues; Chowdhury, Bablu; Melotto, Maeli] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Borges, Aline; Gomes Caldas, Danielle Gregorio; Tsai, Siu Mui] Univ Sao Paulo, CENA, Piracicaba, SP, Brazil; [Aranha Camargo, Luis Eduardo] Univ Sao Paulo, ESALQ, Dept Fitopatol, Piracicaba, SP, Brazil	University of Texas System; University of Texas Arlington; Universidade de Sao Paulo; Universidade de Sao Paulo	Oblessuc, PR (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	melotto@uta.edu	Camargo, Luis Eduardo Aranha/Y-9954-2019; Tsai, Siu Mui/C-2793-2012; Caldas, Danielle/D-5685-2012; Oblessuc, Paula Rodrigues/AAJ-7755-2020; Oblessuc, Paula R/M-1184-2016; Camargo, Luis Eduardo A/C-2735-2012	Camargo, Luis Eduardo Aranha/0000-0002-5650-5695; Tsai, Siu Mui/0000-0002-3733-6312; Oblessuc, Paula Rodrigues/0000-0002-4977-3317; Oblessuc, Paula R/0000-0002-4977-3317; Camargo, Luis Eduardo A/0000-0002-5650-5695; Melotto, Maeli/0000-0001-6021-9803	University of Texas at Arlington	University of Texas at Arlington	This study was supported in part by The University of Texas at Arlington startup funds to MM. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid G, 2011, PLANT CELL TISS ORG, V107, P341, DOI 10.1007/s11240-011-9986-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado-Gutierrez A, 2008, PHYSIOL MOL PLANT P, V72, P111, DOI 10.1016/j.pmpp.2008.04.005; Aoki KF, 2005, CURR PROTOC BIOINFOR, V1, P1; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Astier J, 2011, ANN PLANT REV NITROG, P147; Azaiez A, 2009, MOL PLANT MICROBE IN, V22, P190, DOI 10.1094/MPMI-22-2-0190; Bailey J. A., 1992, Colletotrichum: biology, pathology and control., P88; Balardin RS, 1998, J AM SOC HORTIC SCI, V123, P1038, DOI 10.21273/JASHS.123.6.1038; Blair MW, 2011, PLANT GENOME-US, V4, P204, DOI 10.3835/plantgenome2011.02.0093; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-171; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; BOLWELL GP, 1985, EUR J BIOCHEM, V149, P411, DOI 10.1111/j.1432-1033.1985.tb08941.x; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Boudart G, 1998, PLANTA, V206, P86, DOI 10.1007/s004250050377; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; D'Ovidio R, 2004, PLANT PHYSIOL, V135, P2424, DOI 10.1104/pp.104.044644; David P, 2008, MOL GENET GENOMICS, V280, P521, DOI 10.1007/s00438-008-0384-8; David P, 2010, THEOR APPL GENET, V121, P87, DOI 10.1007/s00122-010-1293-x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dufresne M, 2000, PLANT CELL, V12, P1579, DOI 10.1105/tpc.12.9.1579; EDWARDS K, 1985, P NATL ACAD SCI USA, V82, P6731, DOI 10.1073/pnas.82.20.6731; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI 10.1111/J.1364-3703.2007.00419.X; Ferrier-Cana E, 2003, THEOR APPL GENET, V106, P251, DOI 10.1007/s00122-002-1032-z; Fisher Ronald A., 1973, STAT METHODS SCI INF; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fraire-Velazquez S, 2003, PHYSIOL MOL PLANT P, V63, P79, DOI 10.1016/j.pmpp.2003.10.004; Garcia RAV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-41; Geffroy V, 1998, THEOR APPL GENET, V96, P494, DOI 10.1007/s001220050766; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Geffroy V, 2009, GENETICS, V181, P405, DOI 10.1534/genetics.108.093583; Gibertia S, 2011, J PLANT PHYSL, V169, P249; Hanai LR, 2010, MOL BREEDING, V25, P25, DOI 10.1007/s11032-009-9306-7; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Knogge W, 2009, MYCOTA, P337; LatundeDada AO, 1996, MYCOL RES, V100, P1133, DOI 10.1016/S0953-7562(96)80226-7; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; Lopes DB, 2001, PHYTOPATHOLOGY, V91, P212, DOI 10.1094/PHYTO.2001.91.2.212; Lopez CE, 2003, PHYTOPATHOLOGY, V93, P88, DOI 10.1094/PHYTO.2003.93.1.88; MAHE A, 1993, MOL PLANT MICROBE IN, V6, P423, DOI 10.1094/MPMI-6-423; Masoudi-Nejad A, 2007, PLANT PHYSIOL, V144, P857, DOI 10.1104/pp.106.095059; McConnell M, 2010, THEOR APPL GENET, V121, P1103, DOI 10.1007/s00122-010-1375-9; Melotto M, 2000, EUPHYTICA, V116, P143, DOI 10.1023/A:1004005001049; Melotto M, 2005, GENOME, V48, P562, DOI 10.1139/G05-010; Melotto M, 2004, THEOR APPL GENET, V109, P690, DOI 10.1007/s00122-004-1697-6; Melotto M, 2000, COLLETOTRICHUM, P346; Melotto M, 2001, THEOR APPL GENET, V103, P508, DOI 10.1007/s001220100609; Melotto M, 2012, PROKARYOTES IN PRESS; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Mohammed Yesuf, 2007, Tropical Science, V47, P96, DOI 10.1002/ts.202; Mysore KS, 2002, PLANT J, V32, P299, DOI 10.1046/j.1365-313X.2002.01424.x; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nuss L, 1996, PHYSIOL MOL PLANT P, V48, P83, DOI 10.1006/pmpp.1996.0008; OCONNELL RJ, 1985, PHYSIOL PLANT PATHOL, V27, P75, DOI 10.1016/0048-4059(85)90058-X; Park CJ, 2004, PLANTA, V219, P797, DOI 10.1007/s00425-004-1290-x; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinto JMA, 2012, PHYTOPATHOLOGY, V102, P490, DOI 10.1094/PHYTO-06-11-0179; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramirez M, 2005, PLANT PHYSIOL, V137, P1211, DOI 10.1104/pp.104.054999; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; SKIPP RA, 1972, PHYSIOL PLANT PATHOL, V2, P357, DOI 10.1016/S0048-4059(72)80007-9; Tavernier V, 2007, J EXP BOT, V58, P3351, DOI 10.1093/jxb/erm182; Thibivilliers S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-46; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Vallad G, 2001, THEOR APPL GENET, V103, P1046, DOI 10.1007/s001220100705; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Zhong G, 2003, PLANT MOL BIOL, V53, P117, DOI 10.1023/B:PLAN.0000009270.81977.ef; WALTER MH, 1990, MOL GEN GENET, V222, P353, DOI 10.1007/BF00633840; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Young RA, 1998, THEOR APPL GENET, V96, P87, DOI 10.1007/s001220050713; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zhou LC, 2012, OMICS, V16, P208, DOI 10.1089/omi.2011.0111	82	21	21	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43161	10.1371/journal.pone.0043161	http://dx.doi.org/10.1371/journal.pone.0043161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912818	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700054
J	van Helden, SFG; Anthony, EC; Dee, R; Hordijk, PL				van Helden, Suzanne F. G.; Anthony, Eloise C.; Dee, Rob; Hordijk, Peter L.			Rho GTPase Expression in Human Myeloid Cells	PLOS ONE			English	Article							TYPE-2 MACROPHAGES; DENDRITIC CELLS; IN-VIVO; PROTEIN; GENE; OSTEOCLASTS; ACTIVATION; FAMILY; PODOSOMES; ADHESION	Myeloid cells are critical for innate immunity and the initiation of adaptive immunity. Strict regulation of the adhesive and migratory behavior is essential for proper functioning of these cells. Rho GTPases are important regulators of adhesion and migration; however, it is unknown which Rho GTPases are expressed in different myeloid cells. Here, we use a qPCR-based approach to investigate Rho GTPase expression in myeloid cells. We found that the mRNAs encoding Cdc42, RhoQ, Rac1, Rac2, RhoA and RhoC are the most abundant. In addition, RhoG, RhoB, RhoF and RhoV are expressed at low levels or only in specific cell types. More differentiated cells along the monocyte-lineage display lower levels of Cdc42 and RhoV, while RhoC mRNA is more abundant. In addition, the Rho GTPase expression profile changes during dendritic cell maturation with Rac1 being upregulated and Rac2 downregulated. Finally, GM-CSF stimulation, during macrophage and osteoclast differentiation, leads to high expression of Rac2, while M-CSF induces high levels of RhoA, showing that these cytokines induce a distinct pattern. Our data uncover cell type specific modulation of the Rho GTPase expression profile in hematopoietic stem cells and in more differentiated cells of the myeloid lineage.	[van Helden, Suzanne F. G.; Anthony, Eloise C.; Hordijk, Peter L.] Sanquin Res, Dept Mol Cell Biol, Amsterdam, Netherlands; [van Helden, Suzanne F. G.; Anthony, Eloise C.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Dee, Rob] Sanquin Diagnost, Dept Immunocytol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van Helden, SFG (corresponding author), Sanquin Res, Dept Mol Cell Biol, Amsterdam, Netherlands.	s.vanhelden@sanquin.nl		Hordijk, Peter/0000-0002-3348-078X	Sanquin	Sanquin	This project was funded by Sanquin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brugger W, 1996, Curr Opin Hematol, V3, P235; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; DALLERY E, 1995, ONCOGENE, V10, P2171; DalleryPrudhomme E, 1997, GENOMICS, V43, P89, DOI 10.1006/geno.1997.4788; de Vries IJM, 2003, CANCER RES, V63, P12; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Foster R, 1996, MOL CELL BIOL, V16, P2689; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; James DE, 2010, J IMMUNOL, V185, P1265, DOI 10.4049/jimmunol.0902808; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Linder S, 2000, J CELL SCI, V113, P4165; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mazzolari E, 2009, AM J HEMATOL, V84, P473, DOI 10.1002/ajh.21447; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Permaul P, 2009, IMMUNOL RES, V44, P89, DOI 10.1007/s12026-008-8085-2; Roos D, 1986, Methods Enzymol, V132, P225; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saras J, 2004, EXP CELL RES, V299, P356, DOI 10.1016/j.yexcr.2004.05.029; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Shutes A, 2004, CURR BIOL, V14, P2052, DOI 10.1016/j.cub.2004.11.011; Stenbeck G, 2000, J CELL SCI, V113, P1577; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024	48	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42563	10.1371/journal.pone.0042563	http://dx.doi.org/10.1371/journal.pone.0042563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916134	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300011
J	Boyer, S; Toty, C; Jacquet, M; Lemperiere, G; Fontenille, D				Boyer, Sebastien; Toty, Celine; Jacquet, Maxime; Lemperiere, Guy; Fontenille, Didier			Evidence of Multiple Inseminations in the Field in Aedes albopictus	PLOS ONE			English	Article							MICROSATELLITE MARKERS; DIPTERA-CULICIDAE; VECTOR; DENGUE; CHIKUNGUNYA; SURVIVAL; AEGYPTI; POPULATION; DISPERSAL; WOLBACHIA	Studies on the biology and mating behaviour of male mosquitoes are of major importance in a frame of a Sterile Insect Technique which could be used against mosquito vector species. Most particularly, the assumption of possible multiple inseminations in mosquito species must be investigated in order to optimize alternative mosquito control methods (Sterile Insect Techniques with genetically modified mosquitoes, cytoplasmic incompatibility, radiation ... ). The occurrence of multiple insemination events was investigated after 2 field samplings of Aedes albopictus (Diptera: Culicidae) in La Reunion Island using microsatellite markers. Respectively, 14 and 13 females after the first and the second sampling laid eggs. Seven wild females out of the 27 laying females were found with a progeny involving more than one father. This result is important for the new alternative mosquito control methods and raises the importance of pre- and post-copulatory competition.	[Boyer, Sebastien; Toty, Celine; Jacquet, Maxime; Lemperiere, Guy; Fontenille, Didier] Univ Montpellier I, Inst Rech Dev IRD UMR 224, MIVEGEC, Ctr Natl Rech Sci CNRS 5290, Montpellier, France; [Boyer, Sebastien; Toty, Celine; Jacquet, Maxime; Lemperiere, Guy; Fontenille, Didier] Univ Montpellier 2, Inst Rech Dev IRD UMR 224, MIVEGEC, Ctr Natl Rech Sci CNRS 5290, Montpellier, France; [Boyer, Sebastien; Toty, Celine; Jacquet, Maxime; Lemperiere, Guy] Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boyer, S (corresponding author), Univ Montpellier I, Inst Rech Dev IRD UMR 224, MIVEGEC, Ctr Natl Rech Sci CNRS 5290, Montpellier, France.	sebastien.boyer@ird.fr	FONTENILLE, didier/G-4091-2013	/0000-0001-5073-6217; FONTENILLE, didier/0000-0002-0544-3885; Boyer, Sebastien/0000-0002-2946-586X; Jacquet, Maxime/0000-0003-0690-1232	French Ministry of Health; FEDER Convergence Reunion programme; French Ministry of Health; FEDER Convergence Reunion programme	French Ministry of Health; FEDER Convergence Reunion programme; French Ministry of Health; FEDER Convergence Reunion programme	The IRD Sterile Insect Technique Project was financially supported by the French Ministry of Health and the FEDER Convergence Reunion 2007-2013 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank Pierre Olivier Maquart for his contribution in the field work. The IRD Sterile Insect Technique Project was financially supported by the French Ministry of Health and the FEDER Convergence Reunion 2007-2013 programme.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2007, J ECON ENTOMOL, V100, P1642, DOI 10.1603/0022-0493(2007)100[1642:MIRBMR]2.0.CO;2; Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154; Black WC, 2011, TRENDS PARASITOL, V27, P362, DOI 10.1016/j.pt.2011.04.004; Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x; BULLINI L, 1976, B ENTOMOL RES, V65, P683, DOI 10.1017/S0007485300006374; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Edwards Keith J., 1998, P22; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; FRENCH W. L., 1963, Proceedings. New Jersey Mosquito Extermination Association, V50, P374; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1972, MOSQ NEWS, V32, P219; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Helinski MEH, 2009, ACTA TROP, V109, P64, DOI 10.1016/j.actatropica.2008.10.002; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; HUANG Y-M, 1972, Contributions of the American Entomological Institute, V9, P1; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x; Ravel S, 2002, ACTA TROP, V82, P39, DOI 10.1016/S0001-706X(02)00028-1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SNIJDERS E. P., 1931, American Journal of Tropical Medicine, V11, P171; Tripet F, 2003, AM J TROP MED HYG, V68, P1; VILLARREAL C, 1994, J AM MOSQUITO CONTR, V10, P67; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; YUVAL B, 1994, B ENTOMOL RES, V84, P137, DOI 10.1017/S0007485300032326; ZALOM FG, 1981, MOSQ NEWS, V41, P154	33	30	32	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42040	10.1371/journal.pone.0042040	http://dx.doi.org/10.1371/journal.pone.0042040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916116	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600007
J	Badve, S; Goswami, C; Gokmen-Polar, Y; Nelson, RP; Henley, J; Miller, N; Zaheer, NA; Sledge, GW; Li, L; Kesler, KA; Loehrer, PJ				Badve, Sunil; Goswami, Chirayu; Goekmen-Polar, Yesim; Nelson, Robert P., Jr.; Henley, John; Miller, Nick; Zaheer, Narjis A.; Sledge, George W., Jr.; Li, Lang; Kesler, Kenneth A.; Loehrer, Patrick J., Sr.			Molecular Analysis of Thymoma	PLOS ONE			English	Article							GENETIC ABERRATIONS; EXPRESSION ANALYSIS; CANCER; MALIGNANCIES; CARCINOMAS; TUMORS; STAGE; RISK; B10	Histologic classification of thymomas has significant limitations with respect to both subtype definitions and consistency. In order to better understand the biology of the disease processes, we performed whole genome gene expression analysis. RNA was extracted from fresh frozen tumors from 34 patients with thymomas and followup data was available. Using the Illumina BeadStudio (R) platform and Human Ref-8 Beadchip, gene expression data was analyzed with Partek Genomics Suite (R), and Ingenuity Pathways Analysis (IPA). Unsupervised clustering of gene expression data, representing one of the largest series in literature, resulted in identification of four molecular clusters of tumors (C1-C4), which correlated with histology (P = 0.002). However, neither histology nor clusters correlated with clinical outcomes. Correlation of gene expression data with clinical data showed that a number of genes were associated with either advanced stage at diagnosis or development of recurrence or metastases. The top pathways associated with metastases were amino acid metabolisms, biosynthesis of steroids and glycosphingolipids, cell cycle checkpoint proteins and Notch signaling. The differential expression of some of the top genes related to both metastases and stage was confirmed by RT-PCR in all cases of metastases and matched nonmetastatic cases. A number of potential candidates for therapeutics were also identified.	[Badve, Sunil; Zaheer, Narjis A.; Sledge, George W., Jr.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Badve, Sunil; Goekmen-Polar, Yesim; Nelson, Robert P., Jr.; Miller, Nick; Sledge, George W., Jr.; Loehrer, Patrick J., Sr.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Goswami, Chirayu; Li, Lang] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Kesler, Kenneth A.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN USA; [Badve, Sunil; Sledge, George W., Jr.; Loehrer, Patrick J., Sr.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Henley, John] Columbus Reg Hosp, Columbus, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Badve, S (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.	sbadve@iupui.edu	Gokmen-Polar, Yesim/AAX-4001-2021	Gokmen-Polar, Yesim/0000-0001-9927-4893; Badve, Sunil/0000-0001-8861-9980	Barbara P. Hochberg Foundation; William P. Loehrer Family Research Fund	Barbara P. Hochberg Foundation; William P. Loehrer Family Research Fund	This work was supported in part by the Barbara P. Hochberg Foundation and William P. Loehrer Family Research Fund. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Casey EM, 2008, HEMATOL ONCOL CLIN N, V22, P457, DOI 10.1016/j.hoc.2008.03.010; Chong IW, 2006, ONCOL REP, V16, P981; Chung YT, 2012, MOD PATHOL; DALCIN P, 1993, GENE CHROMOSOME CANC, V6, P243; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; FORNASIERO A, 1990, J CLIN ONCOL, V8, P1419, DOI 10.1200/JCO.1990.8.8.1419; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Girard N, 2009, CLIN CANCER RES, V15, P6790, DOI 10.1158/1078-0432.CCR-09-0644; Granato F, 2012, HISTOPATHOLOGY, V60, P437, DOI 10.1111/j.1365-2559.2011.04111.x; Heringlake S, 2010, J HEPATOL, V52, P220, DOI 10.1016/j.jhep.2009.11.005; Inoue M, 2003, CANCER RES, V63, P3708; Jain RK, 2010, MODERN PATHOL, V23, P1641, DOI 10.1038/modpathol.2010.172; KRISTOFFERSSON U, 1989, CANCER GENET CYTOGEN, V41, P93, DOI 10.1016/0165-4608(89)90112-X; LATTES R, 1962, CANCER, V15, P1224, DOI 10.1002/1097-0142(196211/12)15:6<1224::AID-CNCR2820150621>3.0.CO;2-V; Lee GY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-305; Liu JH, 2009, RECENT PAT ANTI-CANC, V4, P246, DOI 10.2174/157489209789206931; Ma J, 2008, J BIOL CHEM, V283, P3418, DOI 10.1074/jbc.M707650200; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Okereke IC, 2010, ANN THORAC SURG, V89, P1071, DOI 10.1016/j.athoracsur.2010.01.026; Rosai J., 1999, HISTOLOGICAL TYPING, V2nd; Sasaki H, 2002, INT J CANCER, V101, P342, DOI 10.1002/ijc.10624; Thomas CR, 1999, J CLIN ONCOL, V17, P2280, DOI 10.1200/JCO.1999.17.7.2280; Travis WD., 2004, TRAVIS WB WHO CLASSI; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x	25	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42669	10.1371/journal.pone.0042669	http://dx.doi.org/10.1371/journal.pone.0042669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912720	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100021
J	Comar, M; Zanotta, N; Croci, E; Murru, I; Marci, R; Pancaldi, C; Dolcet, O; Luppi, S; Martinelli, M; Giolo, E; Ricci, G; Tognon, M				Comar, Manola; Zanotta, Nunzia; Croci, Eleonora; Murru, Immacolata; Marci, Roberto; Pancaldi, Cecilia; Dolcet, Ornella; Luppi, Stefania; Martinelli, Monica; Giolo, Elena; Ricci, Giuseppe; Tognon, Mauro			Association between the JC Polyomavirus Infection and Male Infertility	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HUMAN-PAPILLOMAVIRUS INFECTION; BK VIRUS; GENOTYPES; SEQUENCES; PROSTATE; SEMEN; EPIDEMIOLOGY; PREVALENCE; REGION	In recent years the incidence of male infertility has increased. Many risk factors have been taken into consideration, including viral infections. Investigations into viral agents and male infertility have mainly been focused on human papillomaviruses, while no reports have been published on polyomaviruses and male infertility. The aim of this study was to verify whether JC virus and BK virus are associated with male infertility. Matched semen and urine samples from 106 infertile males and 100 fertile males, as controls, were analyzed. Specific PCR analyses were carried out to detect and quantify large T (Tag) coding sequences of JCV and BKV. DNA sequencing, carried out in Tag JCV-positive samples, was addressed to viral protein 1 (VP1) coding sequences. The prevalence of JCV Tag sequences in semen and urine samples from infertile males was 34% (72/212), whereas the BKV prevalence was 0.94% (2/212). Specifically, JCV Tag sequences were detected in 24.5% (26/106) of semen and 43.4% (46/106) of urine samples from infertile men. In semen and urine samples from controls the prevalence was 11% and 28%, respectively. A statistically significant difference (p<0.05) in JCV prevalence was disclosed in semen and urine samples of cases vs. controls. A higher JC viral DNA load was detected in samples from infertile males than in controls. In samples from infertile males the JC virus type 2 strain, subtype 2b, was more prevalent than ubiquitous type 1. JCV type 2 strain infection has been found to be associated with male infertility. These data suggest that the JC virus should be taken into consideration as an infectious agent which is responsible for male infertility.	[Comar, Manola; Zanotta, Nunzia; Croci, Eleonora; Murru, Immacolata; Dolcet, Ornella; Luppi, Stefania; Martinelli, Monica; Giolo, Elena; Ricci, Giuseppe] Univ Trieste, Inst Maternal & Child Hlth, IRCCS Burlo Garofolo Trieste, Trieste, Italy; [Marci, Roberto] Univ Ferrara, Sch Med & Surg, Sect Obstet & Gynaecol, I-44100 Ferrara, Italy; [Pancaldi, Cecilia; Tognon, Mauro] Univ Ferrara, Sch Med & Surg, Sect Cell Biol & Mol Genet, I-44100 Ferrara, Italy	IRCCS Burlo Garofolo; University of Trieste; University of Ferrara; University of Ferrara	Comar, M (corresponding author), Univ Trieste, Inst Maternal & Child Hlth, IRCCS Burlo Garofolo Trieste, Trieste, Italy.	tgm@unife.it	Marci, Roberto/G-6927-2012; Zanotta, Nunzia/K-4539-2016; Comar, Manola/K-4613-2016; Ricci, Giuseppe/AAC-3332-2022; Luppi, Stefania/K-1810-2018; COMAR, Manola/K-4613-2016	Marci, Roberto/0000-0002-9230-6685; Zanotta, Nunzia/0000-0002-6458-1946; Comar, Manola/0000-0001-6310-3320; Ricci, Giuseppe/0000-0002-8031-1102; Martinelli, Monica/0000-0002-1277-1713; COMAR, Manola/0000-0002-9487-861X	Ricerca Corrente of the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Burlo-Garofalo Hospital, Trieste; Emilia-Romagna Region, Bologna; University of Trieste; University of Ferrara	Ricerca Corrente of the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Burlo-Garofalo Hospital, Trieste; Emilia-Romagna Region, Bologna(Regione Emilia Romagna); University of Trieste; University of Ferrara	This investigation was supported in part by grants from the Ricerca Corrente of the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Burlo-Garofalo Hospital, Trieste, the Emilia-Romagna Region, Bologna and the Universities of Trieste and Ferrara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini H T, 1998, J Hum Virol, V1, P200; Agostini HT, 1997, P NATL ACAD SCI USA, V94, P14542, DOI 10.1073/pnas.94.26.14542; Agostini HT, 2001, J GEN VIROL, V82, P1221, DOI 10.1099/0022-1317-82-5-1221; Agostini HT, 2000, J NEUROVIROL, V6, pS101; [Anonymous], 1999, WHO LAB MAN EX HUM S; [Anonymous], 2010, WHO LAB MAN EX PROC; Barbanti-Brodano G, 2006, ADV EXP MED BIOL, V577, P319; Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109; Bofill-Mas S, 2001, J VIROL, V75, P10290, DOI 10.1128/JVI.75.21.10290-10299.2001; Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000; Boldorini R, 2008, PATHOLOGY, V40, P72, DOI 10.1080/00313020701716458; Boldorini R, 2011, J GEN VIROL, V92, P1044, DOI 10.1099/vir.0.028571-0; Comar M, 2011, J MED VIROL, V83, P1770, DOI 10.1002/jmv.22184; Comar M, 2010, J MED VIROL, V82, P1236, DOI 10.1002/jmv.21786; Das D, 2004, ONCOGENE, V23, P7031, DOI 10.1038/sj.onc.1207920; Das D, 2008, J VIROL, V82, P2705, DOI 10.1128/JVI.02461-07; Delbue S, 2009, J NEUROVIROL, V15, P51, DOI 10.1080/13550280802425467; Dubois V, 2001, J INFECT DIS, V183, P213, DOI 10.1086/317927; Garolla A, 2011, CURR OPIN OBSTET GYN, V23, P232, DOI 10.1097/GCO.0b013e328348a3a4; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Gray-Swain MR, 2006, CURR OPIN OBSTET GYN, V18, P503, DOI 10.1097/01.gco.0000242952.87125.69; Haggerty CL, 2011, INFECT DIS OBSTET GY, V2011; Hermonat PL, 1997, VIRUS GENES, V14, P13; Jobes DV, 2001, ARCH VIROL, V146, P2097, DOI 10.1007/s007050170023; Kapranos N, 2003, FERTIL STERIL, V79, P1566, DOI 10.1016/S0015-0282(03)00370-4; Knowles WA, 2006, ADV EXP MED BIOL, V577, P19; Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9; Martini F, 2004, CANCER INVEST, V22, P697, DOI 10.1081/CNV-200032937; Martini F, 1996, CANCER RES, V56, P4820; MONINI P, 1995, VIROLOGY, V214, P273, DOI 10.1006/viro.1995.9928; Monini P, 1996, INT J CANCER, V66, P717, DOI 10.1002/(SICI)1097-0215(19960611)66:6<717::AID-IJC1>3.3.CO;2-N; Oger P, 2011, REPROD BIOMED ONLINE, V23, P207, DOI 10.1016/j.rbmo.2011.04.008; Pagani E, 2003, J NEUROVIROL, V9, P559, DOI 10.1080/13550280390241269; Pancaldi C, 2011, BLOOD, V117, P7099, DOI 10.1182/blood-2010-09-310557; Perino A, 2011, FERTIL STERIL, V95, P1845, DOI 10.1016/j.fertnstert.2010.11.047; Rohde V, 1999, FERTIL STERIL, V72, P814, DOI 10.1016/S0015-0282(99)00363-5; Rossi A, 2007, J MED VIROL, V79, P408, DOI 10.1002/jmv.20829; Sala M, 2001, J GEN VIROL, V82, P899, DOI 10.1099/0022-1317-82-4-899; Santulli P, 2011, FERTIL STERIL, V95, P507, DOI 10.1016/j.fertnstert.2010.09.018; Stephens Amanda J, 2011, Infect Dis Obstet Gynecol, V2011, P525182, DOI 10.1155/2011/525182; Zambrano A, 2002, PROSTATE, V53, P263, DOI 10.1002/pros.10157	41	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42880	10.1371/journal.pone.0042880	http://dx.doi.org/10.1371/journal.pone.0042880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912758	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100041
J	Dang, BN; Westbrook, RA; Rodriguez-Barradas, MC; Giordano, TP				Dang, Bich N.; Westbrook, Robert A.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.			Identifying Drivers of Overall Satisfaction in Patients Receiving HIV Primary Care: A Cross-Sectional Study	PLOS ONE			English	Article							SCREENING-TEST; HOSPITAL-CARE; UNITED-STATES; ADHERENCE; QUESTION; PERFORMANCE; PHYSICIANS; PROVIDER; OUTCOMES; QUALITY	Objective: This study seeks to understand the drivers of overall patient satisfaction in a predominantly low-income, ethnic-minority population of HIV primary care patients. The study's primary aims were to determine 1) the component experiences which contribute to patients' evaluations of their overall satisfaction with care received, and 2) the relative contribution of each component experience in explaining patients' evaluation of overall satisfaction. Methods: We conducted a cross-sectional study of 489 adult patients receiving HIV primary care at two clinics in Houston, Texas, from January 13-April 21, 2011. The participation rate among eligible patients was 94%. The survey included 15 questions about various components of the care experience, 4 questions about the provider experience and 3 questions about overall care. To ensure that the survey was appropriately tailored to our clinic population and the list of component experiences reflected all aspects of the care experience salient to patients, we conducted in-depth interviews with key providers and clinic staff and pre-tested the survey instrument with patients. Results: Patients' evaluation of their provider correlated the strongest with their overall satisfaction (standardized beta = 0.445, p<0.001) and accounted for almost half of the explained variance. Access and availability, like clinic hours and ease of calling the clinic, also correlated with overall satisfaction, but less strongly. Wait time and parking, despite receiving low patient ratings, did not correlate with overall satisfaction. Conclusions: The patient-provider relationship far exceeds other component experiences of care in its association with overall satisfaction. Our study suggests that interventions to improve overall patient satisfaction should focus on improving patients' evaluation of their provider.	[Dang, Bich N.; Giordano, Thomas P.] Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX USA; [Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Dang, Bich N.; Giordano, Thomas P.] Harris Cty Hosp Dist, Houston, TX USA; [Westbrook, Robert A.] Rice Univ, Jesse H Jones Grad Sch Business, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Rice University	Dang, BN (corresponding author), Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX USA.	bndang@bcm.edu		Giordano, Thomas/0000-0002-9346-5530	Houston Veterans Affairs Health Services Research and Development Center of Excellence [HFP90-020]; Michael E. DeBakey Veterans Affairs Medical Center; Harris County Hospital District, Houston, Texas, United States of America	Houston Veterans Affairs Health Services Research and Development Center of Excellence; Michael E. DeBakey Veterans Affairs Medical Center; Harris County Hospital District, Houston, Texas, United States of America	This project was supported in part by the facilities and resources of the Houston Veterans Affairs Health Services Research and Development Center of Excellence (HFP90-020), Michael E. DeBakey Veterans Affairs Medical Center and the Harris County Hospital District, Houston, Texas, United States of America.	Abramowitz S, 1987, QRB Qual Rev Bull, V13, P122; ANDREWS FM, 1976, SOC INDIC RES, V3, P1, DOI 10.1007/BF00286161; Baker R, 1996, BRIT J GEN PRACT, V46, P601; Barbosa CD, 2012, PATIENT PREFER ADHER, V6, P39, DOI 10.2147/PPA.S24752; BARTLETT EE, 1984, J CHRON DIS, V37, P755, DOI 10.1016/0021-9681(84)90044-4; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Boulding W, 2011, AM J MANAG CARE, V17, P41; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Cleary P D, 1989, QRB Qual Rev Bull, V15, P172; Crow R, 2002, Health Technol Assess, V6, P1; Davies AR, 1981, R2711HHS RAND CORP; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dholakia UM, 2010, REV MARKET RES, V7, P145, DOI 10.1108/S1548-6435(2010)0000007009; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; Garman Andrew N, 2004, Qual Manag Health Care, V13, P75; Giordano LA, 2010, MED CARE RES REV, V67, P27, DOI 10.1177/1077558709341065; Gossey JT, 2008, HLTH LITERACY PATIEN; Hair J., 2010, MULTIVARIATE DATA AN, V7; HAZZARD A, 1990, J PEDIATR PSYCHOL, V15, P543, DOI 10.1093/jpepsy/15.4.543; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Huba GJ, 1996, MODULE 64 SELF EFFIC; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Kane RL, 2005, UNDERSTANDING HLTH C, P159; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Liu W, 2011, J CONSUM RES, V38, P242, DOI 10.1086/658884; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; MARQUIS MS, 1983, MED CARE, V21, P821, DOI 10.1097/00005650-198308000-00006; Mittal V, 1998, J MARKETING, V62, P33, DOI 10.2307/1251801; Mittal V., 2010, MSI FAST FORWARD SER; MORRELL DC, 1986, BMJ-BRIT MED J, V292, P870, DOI 10.1136/bmj.292.6524.870; Oliver RL, 2010, SATISFACTION BEHAV P, DOI DOI 10.4324/9781315700892; PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Pilpel D, 1996, J GEN INTERN MED, V11, P312, DOI 10.1007/BF02598274; Roberts KJ, 2002, AIDS PATIENT CARE ST, V16, P43, DOI 10.1089/108729102753429398; Safran DG, 1998, J FAM PRACTICE, V47, P213; Safran DG, 2001, J FAM PRACTICE, V50, P130; Safran DG, 2006, J GEN INTERN MED, V21, P13, DOI 10.1111/j.1525-1497.2005.00311.x; Schneider J, 2004, J GEN INTERN MED, V19, P1096, DOI 10.1111/j.1525-1497.2004.30418.x; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Smith P.C., 1969, MEASUREMENT SATISFAC; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Tull D.S., 1993, MARKETING RES MEASUR; Watkins CL, 2007, CLIN REHABIL, V21, P846, DOI 10.1177/0269215507079846; Weaver M, 1997, AM J MANAG CARE, V3, P579; WESTBROOK RA, 1981, J RETAILING, V57, P68; Willis G.B, 2004, COGNITIVE INTERVIEWI; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; Woodside A G, 1989, J Health Care Mark, V9, P5; Zikmund W., 2012, ESSENTIALS MARKETING	51	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42980	10.1371/journal.pone.0042980	http://dx.doi.org/10.1371/journal.pone.0042980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OJ	22912770	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100047
J	Lai, CY; Tsai, AC; Chen, MC; Chang, LH; Sun, HL; Chang, YL; Chen, CC; Teng, CM; Pan, SL				Lai, Chin-Yu; Tsai, An-Chi; Chen, Mei-Chuan; Chang, Li-Hsun; Sun, Hui-Lung; Chang, Ya-Ling; Chen, Chien-Chih; Teng, Che-Ming; Pan, Shiow-Lin			Aciculatin Induces p53-Dependent Apoptosis via MDM2 Depletion in Human Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							WILD-TYPE P53; P73 FUNCTION; PROTEIN; ACTIVATION; DNA; THERAPY; PATHWAY; EXPRESSION; FLAVONOIDS; ONCOGENE	Aciculatin, a natural compound extracted from the medicinal herb Chrysopogon aciculatus, shows potent anti-cancer potency. This study is the first to prove that aciculatin induces cell death in human cancer cells and HCT116 mouse xenografts due to G1 arrest and subsequent apoptosis. The primary reason for cell cycle arrest and cell death was p53 accumulation followed by increased p21 level, dephosphorylation of Rb protein, PUMA expression, and induction of apoptotic signals such as cleavage of caspase-9, caspase-3, and PARP. We demonstrated that p53 allele-null (-/-) (p53-KO) HCT116 cells were more resistant to aciculatin than cells with wild-type p53 (+/+). The same result was achieved by knocking down p53 with siRNA in p53 wild-type cells, indicating that p53 plays a crucial role in aciculatin-induced apoptosis. Although DNA damage is the most common event leading to p53 activation, we found only weak evidence of DNA damage after aciculatin treatment. Interestingly, the aciculatin-induced downregulation of MDM2, an important negative regulator of p53, contributed to p53 accumulation. The anti-cancer activity and importance of p53 after aciculatin treatment were also confirmed in the HCT116 xenograft models. Collectively, these results indicate that aciculatin treatment induces cell cycle arrest and apoptosis via inhibition of MDM2 expression, thereby inducing p53 accumulation without significant DNA damage and genome toxicity.	[Lai, Chin-Yu; Chen, Mei-Chuan; Chang, Li-Hsun; Sun, Hui-Lung; Chang, Ya-Ling; Teng, Che-Ming] Natl Taiwan Univ, Inst Pharmacol, Coll Med, Taipei 10764, Taiwan; [Tsai, An-Chi; Pan, Shiow-Lin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town, Taiwan; [Chen, Chien-Chih] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; Hungkuang University	Lai, CY (corresponding author), Natl Taiwan Univ, Inst Pharmacol, Coll Med, Taipei 10764, Taiwan.	cmteng@ntu.edu.tw; apan0826@nhri.org.tw	Pan, Shiow-Lin/C-1372-2010; Huang, James/ADK-6342-2022	TENG, CHE-MING/0000-0002-9719-7334	National Science Council of the Republic of China [NSC 99-2628-B-002-024-MY3, NSC 99-2320-B-400-008-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of the Republic of China (NSC 99-2628-B-002-024-MY3 and NSC 99-2320-B-400-008-MY3)(http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd MT, 2000, J BIOL CHEM, V275, P31883, DOI 10.1074/jbc.M004252200; CARTE BK, 1991, TETRAHEDRON, V47, P1815; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chang LH, 2011, J CELL PHYSIOL, V226, P1060, DOI 10.1002/jcp.22428; Chen MC, 2011, CANC SCI; Chen TH, 2008, CLIN CANCER RES, V14, P4250, DOI 10.1158/1078-0432.CCR-07-4578; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cheok CF, 2010, CELL DEATH DIFFER, V17, P1486, DOI 10.1038/cdd.2010.18; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Gu HY, 2008, MOL CANCER THER, V7, P3298, DOI 10.1158/1535-7163.MCT-08-0212; Hsieh IN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-28; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kanakis CD, 2007, CELL BIOCHEM BIOPHYS, V49, P29, DOI 10.1007/s12013-007-0037-2; KRAUSE JA, 1991, ACTA CRYSTALLOGR C, V47, P2595, DOI 10.1107/S0108270191006170; Kravchenko JE, 2008, P NATL ACAD SCI USA, V105, P6302, DOI 10.1073/pnas.0802091105; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Lee DH, 2008, BIOCHEM PHARMACOL, V75, P2020, DOI 10.1016/j.bcp.2008.02.023; Li M, 2005, CANCER RES, V65, P8200, DOI 10.1158/0008-5472.CAN-05-1302; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Plaumann B, 1996, ONCOGENE, V13, P1605; Rong JJ, 2009, CANCER LETT, V284, P102, DOI 10.1016/j.canlet.2009.04.011; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xia M, 2011, ONCOGENE, V30, P346, DOI 10.1038/onc.2010.413; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814	33	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42192	10.1371/journal.pone.0042192	http://dx.doi.org/10.1371/journal.pone.0042192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912688	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500100008
J	Mutze, U; Beblo, S; Kortz, L; Matthies, C; Koletzko, B; Bruegel, M; Rohde, C; Thiery, J; Kiess, W; Ceglarek, U				Muetze, Ulrike; Beblo, Skadi; Kortz, Linda; Matthies, Claudia; Koletzko, Berthold; Bruegel, Mathias; Rohde, Carmen; Thiery, Joachim; Kiess, Wieland; Ceglarek, Uta			Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FISH-OIL SUPPLEMENTATION; LIQUID-CHROMATOGRAPHY; DOCOSAHEXAENOIC ACID; MASS-SPECTROMETRY; ARACHIDONIC-ACID; PLATELET SIZE; TERM INFANTS; SERUM-LIPIDS; CHILDREN	Background: Patients with phenylketonuria (PKU) have to follow a lifelong phenylalanine restricted diet. This type of diet markedly reduces the intake of saturated and unsaturated fatty acids especially long chain polyunsaturated fatty acids (LC-PUFA). Long-chain saturated fatty acids are substrates of mitochondrial fatty acid oxidation for acetyl-Co Aproduction. LC-PUFA are discussed to affect inflammatory and haemostaseological processes in health and disease. The influence of the long term PKU diet on fatty acid metabolism with a special focus on platelet eicosanoid metabolism has been investigated in the study presented here. Methodology/Principal findings: 12 children with PKU under good metabolic control and 8 healthy controls were included. Activated fatty acids (acylcarnitines C6-C18) in dried blood and the cholesterol metabolism in serum were analyzed by liquid chromatographic tandem mass spectrometry (LC-MS/MS). Fatty acid composition of plasma glycerophospholipids was determined by gas chromatography. LC-PUFA metabolites were analyzed in supernatants by LC-MS/MS before and after platelet activation and aggregation using a standardized protocol. Patients with PKU had significantly lower free carnitine and lower activated fatty acids in dried blood compared to controls. Phytosterols as marker of cholesterol (re-) absorption were not influenced by the dietary fatty acid restriction. Fatty acid composition in glycerophospholipids was comparable to that of healthy controls. However, patients with PKU showed significantly increased concentrations of y-linolenic acid (C18:3n-6) a precursor of arachidonic acid. In the PKU patients significantly higher platelet counts were observed. After activation with collagen platelet aggregation and thromboxane B-2 and thromboxane B-3 release did not differ from that of healthy controls. Conclusion/Significance: Long-term dietary fatty acid restriction influenced the intermediates of mitochondrial beta-oxidation. No functional influence on unsaturated fatty acid metabolism and platelet aggregation in patients with PKU was detected.	[Muetze, Ulrike; Beblo, Skadi; Rohde, Carmen; Kiess, Wieland] Univ Leipzig, Dept Women & Child Hlth, Hosp Children & Adolescents, Univ Hosp, Leipzig, Germany; [Kortz, Linda; Thiery, Joachim; Ceglarek, Uta] Univ Leipzig, Univ Hosp, Inst Lab Med, Leipzig, Germany; [Kortz, Linda; Ceglarek, Uta] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Matthies, Claudia; Koletzko, Berthold] Univ Munich, Dr von Hauner Childrens Hosp, Div Metab Dis & Nutr Med, Munich, Germany; [Bruegel, Mathias] Univ Munich, Inst Lab Med, Munich, Germany	Leipzig University; Leipzig University; Leipzig University; University of Munich; University of Munich	Mutze, U (corresponding author), Univ Leipzig, Dept Women & Child Hlth, Hosp Children & Adolescents, Univ Hosp, Leipzig, Germany.	Ulrike.Muetze@medizin.uni-leipzig.de	Ceglarek, Uta/GOE-5561-2022		Medical Faculty; University of Leipzig, Germany; LIFE - Leipzig Research Center for Civilization Diseases; Universitat Leipzig; European Social Fund and the Free State of Saxony; Commission of the European Communities; RTD Programme; NUTRIMENTHE [FP7-212652]	Medical Faculty; University of Leipzig, Germany; LIFE - Leipzig Research Center for Civilization Diseases; Universitat Leipzig; European Social Fund and the Free State of Saxony; Commission of the European Communities(European Commission); RTD Programme; NUTRIMENTHE	Junior research grant by the Medical Faculty, University of Leipzig, Germany. This publication is supported by LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig. This project was funded by means of the European Social Fund and the Free State of Saxony. Further support was received from the Commission of the European Communities, specific RTD Programme "Quality of Life and Management of Living Resources'', within the 7th Framework Programme NUTRIMENTHE, FP7-212652. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA PB, 1973, J AM DIET ASSOC, V63, P631; Agostoni C, 1997, PROSTAG LEUKOTR ESS, V56, P219, DOI 10.1016/S0952-3278(97)90538-X; [Anonymous], [No title captured]; [Anonymous], 2000, REF NARST; Bath PMW, 1996, BLOOD COAGUL FIBRIN, V7, P157, DOI 10.1097/00001721-199603000-00011; Beblo S, 2001, NEUROLOGY, V57, P1488, DOI 10.1212/WNL.57.8.1488; Beblo S, 2007, J PEDIATR-US, V150, P479, DOI 10.1016/j.jpeds.2006.12.011; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; Birch EE, 1998, PEDIATR RES, V44, P201, DOI 10.1203/00006450-199808000-00011; BOHLES H, 1991, EUR J PEDIATR, V150, P425, DOI 10.1007/BF02093725; Brauer R, 2011, METABOLOMICS, V7, P344, DOI 10.1007/s11306-010-0256-1; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; CASTILLO M, 1988, NEUROCHEM RES, V13, P551, DOI 10.1007/BF00973296; Colome C, 2001, CLIN BIOCHEM, V34, P373, DOI 10.1016/S0009-9120(01)00249-1; Dame C, 2005, BRIT J HAEMATOL, V129, P165, DOI 10.1111/j.1365-2141.2004.05329.x; DECSI T, 1994, EUR J PEDIATR, V153, P520, DOI 10.1007/s004310050184; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Fischer GM, 2000, BBA-MOL BASIS DIS, V1501, P200, DOI 10.1016/S0925-4439(00)00023-5; GALLI C, 1991, J PEDIATR-US, V119, P562, DOI 10.1016/S0022-3476(05)82405-9; Galluzzo CR, 1985, J INHERIT METAB D S2, V2, P129; Glaser C, 2010, J PEDIATR-US, V157, P826, DOI 10.1016/j.jpeds.2010.05.001; Glaser C, 2010, J LIPID RES, V51, P216, DOI 10.1194/jlr.D000547; Koletzko B, 1999, J MAMMARY GLAND BIOL, V4, P269, DOI 10.1023/A:1018749913421; Koletzko B, 2007, J INHERIT METAB DIS, V30, P326, DOI 10.1007/s10545-007-0491-4; Koletzko B, 1999, LIPIDS, V34, P215, DOI 10.1007/s11745-999-0356-x; Kortz L, 2009, LABORATORIUMSMEDIZIN, V33, P341, DOI 10.1515/JLM.2009.057; LAWSON JA, 1986, ANAL BIOCHEM, V155, P198, DOI 10.1016/0003-2697(86)90247-2; Lembcke J, 2005, J LIPID RES, V46, P21, DOI 10.1194/jlr.C400004-JLR200; Loeber JG, 2007, J INHERIT METAB DIS, V30, P430, DOI 10.1007/s10545-007-0644-5; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; Mensink GBM, 2007, ERNAHRUNGSSTUDIE KIG, P100; Moseley K, 2002, J INHERIT METAB DIS, V25, P56, DOI 10.1023/A:1015142001578; NEEDLEMAN P, 1976, NATURE, V261, P558, DOI 10.1038/261558a0; Poge AP, 1998, J INHERIT METAB DIS, V21, P373, DOI 10.1023/A:1005350523826; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Rohde C, 2012, EUR J CLIN NUTR; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SCHULPIS KH, 1990, ACTA PAEDIATR SCAND, V79, P930, DOI 10.1111/j.1651-2227.1990.tb11354.x; Schulpis KH, 2004, CLIN NUTR, V23, P401, DOI 10.1016/j.clnu.2003.09.006; Shefer S, 2000, J NEUROSCI RES, V61, P549, DOI 10.1002/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0; SUTOR AH, 1999, PEDIAT HEMATOLOGY, P455; THOMPSON CB, 1983, J LAB CLIN MED, V101, P205; VILASECA MA, 1993, J INHERIT METAB DIS, V16, P101, DOI 10.1007/BF00711322; Vizioli L, 2009, INT J CLIN PRACT, V63, P1509, DOI 10.1111/j.1742-1241.2009.02070.x; Weigel C, 2008, ANN NUTR METAB, V53, P91, DOI 10.1159/000165356	47	19	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43021	10.1371/journal.pone.0043021	http://dx.doi.org/10.1371/journal.pone.0043021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912778	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100051
J	Onomoto, K; Jogi, M; Yoo, JS; Narita, R; Morimoto, S; Takemura, A; Sambhara, S; Kawaguchi, A; Osari, S; Nagata, K; Matsumiya, T; Namiki, H; Yoneyama, M; Fujita, T				Onomoto, Koji; Jogi, Michihiko; Yoo, Ji-Seung; Narita, Ryo; Morimoto, Shiho; Takemura, Azumi; Sambhara, Suryaprakash; Kawaguchi, Atushi; Osari, Suguru; Nagata, Kyosuke; Matsumiya, Tomoh; Namiki, Hideo; Yoneyama, Mitsutoshi; Fujita, Takashi			Critical Role of an Antiviral Stress Granule Containing RIG-I and PKR in Viral Detection and Innate Immunity	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; PROTEIN-KINASE-R; NF-KAPPA-B; VIRUS-INFECTION; NS1 PROTEIN; ADAPTER PROTEIN; INTERFERON; RECOGNITION; ACTIVATION	Retinoic acid inducible gene I (RIG-I)-like receptors (RLRs) function as cytoplasmic sensors for viral RNA to initiate antiviral responses including type I interferon (IFN) production. It has been unclear how RIG-I encounters and senses viral RNA. To address this issue, we examined intracellular localization of RIG-I in response to viral infection using newly generated anti-RIG-I antibody. Immunohistochemical analysis revealed that RLRs localized in virus-induced granules containing stress granule (SG) markers together with viral RNA and antiviral proteins. Because of similarity in morphology and components, we termed these aggregates antiviral stress granules (avSGs). Influenza A virus (IAV) deficient in non-structural protein 1 (NS1) efficiently generated avSGs as well as IFN, however IAV encoding NS1 produced little. Inhibition of avSGs formation by removal of either the SG component or double-stranded RNA (dsRNA)-dependent protein kinase (PKR) resulted in diminished IFN production and concomitant enhancement of viral replication. Furthermore, we observed that transfection of dsRNA resulted in IFN production in an avSGs-dependent manner. These results strongly suggest that the avSG is the locus for non-self RNA sensing and the orchestration of multiple proteins is critical in the triggering of antiviral responses.	[Onomoto, Koji; Jogi, Michihiko; Yoo, Ji-Seung; Narita, Ryo; Morimoto, Shiho; Takemura, Azumi; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Onomoto, Koji] Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan; [Jogi, Michihiko; Yoo, Ji-Seung; Fujita, Takashi] Kyoto Univ, Mol Cell Biol Lab, Grad Sch Biostudies, Kyoto, Japan; [Onomoto, Koji; Jogi, Michihiko; Yoneyama, Mitsutoshi] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chuo Ku, Chiba, Japan; [Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Kawaguchi, Atushi; Osari, Suguru; Nagata, Kyosuke] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atushi; Osari, Suguru; Nagata, Kyosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atushi] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan; [Matsumiya, Tomoh] Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Inst Brain Sci, Aomori, Japan; [Onomoto, Koji; Namiki, Hideo] Waseda Univ, Grad Sch Sci & Engn, Tokyo, Japan; [Yoneyama, Mitsutoshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Kyoto University; Waseda University; Kyoto University; Chiba University; Centers for Disease Control & Prevention - USA; University of Tsukuba; University of Tsukuba; Kitasato University; Hirosaki University; Waseda University; Japan Science & Technology Agency (JST)	Onomoto, K (corresponding author), Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chuo Ku, Chiba, Japan.	myoneyam@faculty.chiba-u.jp; tfujita@virus.kyoto-u.ac.jp	Matsumiya, Tomoh/ABA-5861-2021; Sambhara, Suryaprakash/AAC-4428-2021; Yoneyama, Mitsutoshi/D-8244-2017; Yoo, Ji-Seung/P-9688-2019	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Yoo, Ji-Seung/0000-0002-3708-8240; Kawaguchi, Atsushi/0000-0002-5485-1578	Ministry of Education, Culture, Sports, Science and Technology in Japan [20112009]; Ministry of Health, Labour and Welfare of Japan; PRESTO Japan Science and Technology Agency; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takaeda Science Foundation; Naito Foundation; Nippon Boehringer Ingelheim; Grants-in-Aid for Scientific Research [23249023] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); PRESTO Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takaeda Science Foundation; Naito Foundation(Naito Memorial Foundation); Nippon Boehringer Ingelheim(Boehringer Ingelheim); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Ministry of Education, Culture, Sports, Science and Technology in Japan (Innovative Areas "RNA regulation'' (No. 20112009), Scientific Research "A'', and Research Activity Start-up) (http://www.mext.go.jp/english/), the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/index.html), the PRESTO Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/index_e.html), the Uehara Memorial Foundation (http://www.ueharazaidan.com/), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/), the Takaeda Science Foundation (http://www.takeda-sci.or.jp/index.html), the Naito Foundation (http://www.naito-f.or.jp/), and Nippon Boehringer Ingelheim (http://www.boehringer-ingelheim.co.jp/com/Home/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carpentier PA, 2007, GLIA, V55, P239, DOI 10.1002/glia.20450; DALY C, 1993, MOL CELL BIOL, V13, P3756, DOI 10.1128/MCB.13.6.3756; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jo S, 2010, MICROBES INFECT, V12, P1079, DOI 10.1016/j.micinf.2010.06.011; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Khaperskyy DA, 2011, FASEB J; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; McAllister CS, 2009, J BIOL CHEM, V284, P1644, DOI 10.1074/jbc.M807888200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Ouda R, 2011, J BIOL CHEM, V286, P26210, DOI 10.1074/jbc.M111.229856; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Simpson-Holley M, 2011, J VIROL, V85, P1581, DOI 10.1128/JVI.02247-10; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	57	237	245	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43031	10.1371/journal.pone.0043031	http://dx.doi.org/10.1371/journal.pone.0043031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912779	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100053
J	Passmore, HA; Bruna, EM; Heredia, SM; Vasconcelos, HL				Passmore, Heather A.; Bruna, Emilio M.; Heredia, Sylvia M.; Vasconcelos, Heraldo L.			Resilient Networks of Ant-Plant Mutualists in Amazonian Forest Fragments	PLOS ONE			English	Article							POLLINATOR INTERACTIONS; WEB; SPECIALIZATION; DIVERSITY; CONNECTANCE; ASYMMETRIES; ROBUSTNESS; SPACE; WORLD; TIME	Background: The organization of networks of interacting species, such as plants and animals engaged in mutualisms, strongly influences the ecology and evolution of partner communities. Habitat fragmentation is a globally pervasive form of spatial heterogeneity that could profoundly impact the structure of mutualist networks. This is particularly true for biodiversity-rich tropical ecosystems, where the majority of plant species depend on mutualisms with animals and it is thought that changes in the structure of mutualist networks could lead to cascades of extinctions. Methodology/Principal Findings: We evaluated effects of fragmentation on mutualistic networks by calculating metrics of network structure for ant-plant networks in continuous Amazonian forests with those in forest fragments. We hypothesized that networks in fragments would have fewer species and higher connectance, but equal nestedness and resilience compared to forest networks. Only one of the nine metrics we compared differed between continuous forest and forest fragments, indicating that networks were resistant to the biotic and abiotic changes that accompany fragmentation. This is partially the result of the loss of only specialist species with one connection that were lost in forest fragments. Conclusions/Significance: We found that the networks of ant-plant mutualists in twenty-five year old fragments are similar to those in continuous forest, suggesting these interactions are resistant to the detrimental changes associated with habitat fragmentation, at least in landscapes that are a mosaic of fragments, regenerating forests, and pastures. However, ant-plant mutualistic networks may have several properties that may promote their persistence in fragmented landscapes. Proactive identification of key mutualist partners may be necessary to focus conservation efforts on the interactions that insure the integrity of network structure and the ecosystems services networks provide.	[Passmore, Heather A.; Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA; [Bruna, Emilio M.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL USA; [Heredia, Sylvia M.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Vasconcelos, Heraldo L.] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil; [Bruna, Emilio M.; Heredia, Sylvia M.; Vasconcelos, Heraldo L.] Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Bruna, Emilio M.; Heredia, Sylvia M.; Vasconcelos, Heraldo L.] Smithsonian Trop Res Inst, Manaus, Amazonas, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Riverside; Universidade Federal de Uberlandia; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute	Passmore, HA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA.	embruna@ufl.edu	Bruna, Emilio M/H-2769-2012; Vasconcelos, Heraldo L/C-3353-2013	Bruna, Emilio M/0000-0003-3381-8477; Vasconcelos, Heraldo L/0000-0001-6969-7131	United States National Science Foundation [DEB-0453631, DEB-0309819]	United States National Science Foundation(National Science Foundation (NSF))	This research was supported by grants DEB-0453631 and DEB-0309819 from the United States National Science Foundation (http://nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Banasek-Richter C, 2004, J THEOR BIOL, V226, P23, DOI 10.1016/S0022-5193(03)00305-9; Banasek-Richter C, 2009, ECOLOGY, V90, P1470, DOI 10.1890/08-2207.1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bascompte J, 2009, PHILOS T R SOC B, V364, P1781, DOI 10.1098/rstb.2008.0226; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bezerra ELS, 2009, J ANIM ECOL, V78, P1096, DOI 10.1111/j.1365-2656.2009.01567.x; BIERREGAARD RO, 2002, LESSONS AMAZONIA ECO; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bruna EM, 2005, BIOL CONSERV, V124, P209, DOI 10.1016/j.biocon.2005.01.026; Bruna EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022937; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Davies KF, 2004, ECOLOGY, V85, P265, DOI 10.1890/03-0110; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; FEARNSIDE PM, 2002, LESSONS AMAZONIA ECO, P291; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; FONSECA CR, 1994, J ECOL, V82, P833, DOI 10.2307/2261447; Fonseca CR, 1996, J ANIM ECOL, V65, P339, DOI 10.2307/5880; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Galeano J, 2009, ENVIRON MODELL SOFTW, V24, P1342, DOI 10.1016/j.envsoft.2009.05.014; Gilbert AJ, 2009, ECOL INDIC, V9, P72, DOI 10.1016/j.ecolind.2008.01.010; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Gonzalez A, 2011, AM J BOT, V98, P503, DOI 10.3732/ajb.1000424; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; JANZEN DH, 1974, NAT HIST, V83, P48; JANZEN DH, 1969, ECOLOGY, V50, P147, DOI 10.2307/1934677; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kaartinen R, 2011, J ANIM ECOL, V80, P622, DOI 10.1111/j.1365-2656.2011.01811.x; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Laurance W. F., 2001, LESSONS AMAZONIA ECO, P158; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Passmore HA, 2012, DRYAD DIGITAL REPOSI, DOI 105061/dryadpf2r0; Piazzon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019637; Ramos-Jiliberto R, 2009, OECOLOGIA, V160, P697, DOI 10.1007/s00442-009-1344-7; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; Sodhi NS, 2005, ANIM CONSERV, V8, P217, DOI 10.1017/S1367943005001927; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Valladares G, 2012, OIKOS, V121, P299, DOI 10.1111/j.1600-0706.2011.19671.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1	59	25	25	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e40803	10.1371/journal.pone.0040803	http://dx.doi.org/10.1371/journal.pone.0040803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912666	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500003
J	Xu, JZ; Li, K; Smith, RA; Waterton, JC; Zhao, P; Chen, HD; Does, MD; Manning, HC; Gore, JC				Xu, Junzhong; Li, Ke; Smith, R. Adam; Waterton, John C.; Zhao, Ping; Chen, Heidi; Does, Mark D.; Manning, H. Charles; Gore, John C.			Characterizing Tumor Response to Chemotherapy at Various Length Scales Using Temporal Diffusion Spectroscopy	PLOS ONE			English	Article							BRAIN; GRADIENT; MRI; COEFFICIENT; CANCER; CELLULARITY; BIOMARKER; DENSITY; SYSTEMS; CELLS	Measurements of apparent diffusion coefficient (ADC) using magnetic resonance imaging (MRI) have been suggested as potential imaging biomarkers for monitoring tumor response to treatment. However, conventional pulsed-gradient spin echo (PGSE) methods incorporate relatively long diffusion times, and are usually sensitive to changes in cell density and necrosis. Diffusion temporal spectroscopy using the oscillating gradient spin echo (OGSE) sequence is capable of probing short length scales, and may detect significant intracellular microstructural changes independent of gross cell density changes following anti-cancer treatment. To test this hypothesis, SW620 xenografts were treated by barasertib (AZD1152), a selective inhibitor of Aurora B kinase which causes SW620 cancer cells to develop polyploidy and increase in size following treatment, ultimately leading to cell death through apoptosis. Following treatment, the ADC values obtained by both the PGSE and low frequency OGSE methods increased. However, the ADC values at high gradient frequency (i.e. short diffusion times) were significantly lower in treated tumors, consistent with increased intracellular restrictions/hindrances. This suggests that ADC values at long diffusion times are dominated by tumor microstructure at long length scales, and may not convey unambiguous information of subcellular space. While the diffusion temporal spectroscopy provides more comprehensive means to probe tumor microstructure at various length scales. This work is the first study to probe intracellular microstructural variations due to polyploidy following treatment using diffusion MRI in vivo. It is also the first observation of post-treatment ADC changes occurring in opposite directions at short and long diffusion times. The current study suggests that temporal diffusion spectroscopy potentially provides pharmacodynamic biomarkers of tumor early response which distinguish microstructural variations following treatment at both the subcellular and supracellular length scales.	[Xu, Junzhong; Li, Ke; Smith, R. Adam; Zhao, Ping; Does, Mark D.; Manning, H. Charles; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA; [Xu, Junzhong; Li, Ke; Smith, R. Adam; Zhao, Ping; Does, Mark D.; Manning, H. Charles; Gore, John C.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN USA; [Waterton, John C.] AstraZeneca, Alderley Pk, Cheshire, England; [Chen, Heidi] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Does, Mark D.; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Gore, John C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; AstraZeneca; Vanderbilt University; Vanderbilt University; Vanderbilt University	Xu, JZ (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA.	junzhong.xu@vanderbilt.edu	Waterton, John Charles/A-8565-2008; Xu, junzhong/E-6731-2010	Waterton, John Charles/0000-0002-7734-2290; Xu, junzhong/0000-0001-7895-4232	National Institutes of Health [R01CA109106, R01CA140628, P50CA128323, U24CA126588]; AstraZeneca; In Vivo Cellular and Molecular Imaging Center (ICMIC) at Vanderbilt University; NATIONAL CANCER INSTITUTE [U24CA126588, R01CA109106, R01CA140628, P50CA128323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); In Vivo Cellular and Molecular Imaging Center (ICMIC) at Vanderbilt University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge financial support from National Institutes of Health Grant #R01CA109106, #R01CA140628, #P50CA128323 and #U24CA126588. This work was also part-funded by AstraZeneca. JX was supported by a career development award from the In Vivo Cellular and Molecular Imaging Center (ICMIC) at Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2012, MAGN RESON MED, V67, P98, DOI 10.1002/mrm.22981; Aksel B, 2007, MAGN RESON MED, V58, P134, DOI 10.1002/mrm.21263; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Colvin DC, 2008, CANCER RES, V68, P5941, DOI 10.1158/0008-5472.CAN-08-0832; Colvin DC, 2011, MAGN RESON MED, V65, P796, DOI 10.1002/mrm.22666; Colvin DC, 2011, MAGN RESON IMAGING, V29, P315, DOI 10.1016/j.mri.2010.10.003; Does MD, 2003, MAGN RESON MED, V49, P206, DOI 10.1002/mrm.10385; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; Gore JC, 2010, NMR BIOMED, V23, P745, DOI 10.1002/nbm.1531; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; HONG XL, 1992, J MAGN RESON, V99, P561, DOI 10.1016/0022-2364(92)90210-X; Hosey TP, 2003, DIFFUSION TENSOR IMA, P2123; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; MAKI JH, 1991, MAGNET RESON MED, V17, P95, DOI 10.1002/mrm.1910170114; McHugh DJ, 2011, PROBING TISSUE MICRO, P1147; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Mori S, 1998, MAGNET RESON MED, V40, P511, DOI 10.1002/mrm.1910400403; Moroz MA, 2011, CLIN CANCER RES, V17, P1099, DOI 10.1158/1078-0432.CCR-10-1430; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Parsons EC, 2006, MAGNET RESON MED, V55, P75, DOI 10.1002/mrm.20732; Parsons EC, 2002, NUCL MAGNETIC RESONA; RIGHINI A, 1994, MAGN RESON IMAGING, V12, P865, DOI 10.1016/0730-725X(94)92027-3; Ross BD, 2003, MOL CANCER THER, V2, P581; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; STEPISNIK J, 1981, PHYSICA B & C, V104, P350, DOI 10.1016/0378-4363(81)90182-0; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; TSURUDA JS, 1991, MAGNET RESON MED, V19, P316, DOI 10.1002/mrm.1910190221; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Xu JZ, 2011, MAGN RESON MED, V65, P920, DOI 10.1002/mrm.22704; Xu JZ, 2011, MAGN RESON IMAGING, V29, P380, DOI 10.1016/j.mri.2010.10.002; Xu J, 2009, MAGN RESON MED, V61, P828, DOI 10.1002/mrm.21793; Zhao M, 1996, BRIT J CANCER, V73, P61, DOI 10.1038/bjc.1996.11	37	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41714	10.1371/journal.pone.0041714	http://dx.doi.org/10.1371/journal.pone.0041714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911846	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300065
J	Buler, JJ; Randall, LA; Fleskes, JP; Barrow, WC; Bogart, T; Kluver, D				Buler, Jeffrey J.; Randall, Lori A.; Fleskes, Joseph P.; Barrow, Wylie C., Jr.; Bogart, Tianna; Kluver, Daria			Mapping Wintering Waterfowl Distributions Using Weather Surveillance Radar	PLOS ONE			English	Article							CALIFORNIA CENTRAL-VALLEY; FEMALE NORTHERN PINTAILS; BIRD MOVEMENTS; SATELLITE TELEMETRY; SPRING MIGRATION; VISIBILITY BIAS; AERIAL SURVEYS; GREAT-LAKES; PATTERNS; WSR-88D	The current network of weather surveillance radars within the United States readily detects flying birds and has proven to be a useful remote-sensing tool for ornithological study. Radar reflectivity measures serve as an index to bird density and have been used to quantitatively map landbird distributions during migratory stopover by sampling birds aloft at the onset of nocturnal migratory flights. Our objective was to further develop and validate a similar approach for mapping wintering waterfowl distributions using weather surveillance radar observations at the onset of evening flights. We evaluated data from the Sacramento, CA radar (KDAX) during winters 1998-1999 and 1999-2000. We determined an optimal sampling time by evaluating the accuracy and precision of radar observations at different times during the onset of evening flight relative to observed diurnal distributions of radio-marked birds on the ground. The mean time of evening flight initiation occurred 23 min after sunset with the strongest correlations between reflectivity and waterfowl density on the ground occurring almost immediately after flight initiation. Radar measures became more spatially homogeneous as evening flight progressed because birds dispersed from their departure locations. Radars effectively detected birds to a mean maximum range of 83 km during the first 20 min of evening flight. Using a sun elevation angle of -5 degrees (28 min after sunset) as our optimal sampling time, we validated our approach using KDAX data and additional data from the Beale Air Force Base, CA (KBBX) radar during winter 1998-1999. Bias-adjusted radar reflectivity of waterfowl aloft was positively related to the observed diurnal density of radio-marked waterfowl locations on the ground. Thus, weather radars provide accurate measures of relative wintering waterfowl density that can be used to comprehensively map their distributions over large spatial extents.	[Buler, Jeffrey J.] Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE 19716 USA; [Randall, Lori A.; Barrow, Wylie C., Jr.] US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA USA; [Fleskes, Joseph P.] US Geol Survey, Western Ecol Res Ctr, Dixon, CA USA; [Bogart, Tianna; Kluver, Daria] Univ Delaware, Dept Geog, Newark, DE USA	University of Delaware; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Delaware	Buler, JJ (corresponding author), Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE 19716 USA.	jbuler@udel.edu	Buler, Jeffrey/H-3207-2019	Buler, Jeffrey/0000-0002-2696-847X; Bogart, Tianna/0000-0003-0296-8798	United States Department of Agriculture Natural Resources Conservation Service	United States Department of Agriculture Natural Resources Conservation Service	Financial support was provided by the United States Department of Agriculture Natural Resources Conservation Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 1996, J AVIAN BIOL, V27, P95, DOI 10.2307/3677138; ANDRIEU H, 1995, J APPL METEOROL, V34, P225, DOI 10.1175/1520-0450(1995)034&lt;0225:IOVPOR&gt;2.0.CO;2; [Anonymous], 1993, DOPPLER RADAR WEATHE; BALDASSARRE GA, 1984, J WILDLIFE MANAGE, V48, P63, DOI 10.2307/3808453; Bech J, 2003, J ATMOS OCEAN TECH, V20, P845, DOI 10.1175/1520-0426(2003)020<0845:TSOSPW>2.0.CO;2; Black JE, 1999, WEATHER FORECAST, V14, P1039, DOI 10.1175/1520-0434(1999)014<1039:CODOBM>2.0.CO;2; Bonter DN, 2009, CONSERV BIOL, V23, P440, DOI 10.1111/j.1523-1739.2008.01085.x; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Buler JJ, 2011, J ORNITHOL, V152, P101, DOI 10.1007/s10336-010-0640-7; Buler JJ, 2009, IEEE T GEOSCI REMOTE, V47, P2741, DOI 10.1109/TGRS.2009.2014463; Chrisman J., 1995, WSR 88D CLUTTER SUPP; Cox RR, 1996, CONDOR, V98, P810, DOI 10.2307/1369861; Cressie N., 2011, STAT SPATIO TEMPORAL; CRUM TD, 1993, B AM METEOROL SOC, V74, P1669, DOI 10.1175/1520-0477(1993)074<1669:TWATWO>2.0.CO;2; Diehl RH, 2003, AUK, V120, P278, DOI 10.1642/0004-8038(2003)120[0278:ROOBMO]2.0.CO;2; DIEHL RH, 2005, BIRD CONSERVATION IM, P876; ELY CR, 1992, CONDOR, V94, P857, DOI 10.2307/1369283; Fleskes J.P., 2005, WATERFOWL DISTRIBUTI; Fleskes JP, 2007, J WILDLIFE MANAGE, V71, P2238, DOI 10.2193/2005-634; Fleskes JP, 2002, J WILDLIFE MANAGE, V66, P138, DOI 10.2307/3802880; GAUTHREA.SA, 1971, AUK, V88, P343, DOI 10.2307/4083884; Gauthreaux SA, 2003, AVIAN MIGRATION, P335; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Gauthreaux SA, 1998, WEATHER FORECAST, V13, P453, DOI 10.1175/1520-0434(1998)013<0453:DOBMOT>2.0.CO;2; Gauthreaux SA, 1999, WEATHER FORECAST, V14, P1041, DOI 10.1175/1520-0434(1999)014<1041:R>2.0.CO;2; Haig SM, 1998, CONSERV BIOL, V12, P749, DOI 10.1046/j.1523-1739.1998.97102.x; HEBRARD J J, 1971, Ibis, V113, P8, DOI 10.1111/j.1474-919X.1971.tb05119.x; HEDENSTROM A, 1992, J EXP BIOL, V164, P19; JOHNSON FA, 1989, WILDLIFE SOC B, V17, P222; Kucera PA, 2004, J ATMOS OCEAN TECH, V21, P995, DOI 10.1175/1520-0426(2004)021<0995:RBOSUG>2.0.CO;2; Littlefield CD, 2000, CONSERVATION ASSESSM; MILLER M R, 1985, Wildfowl, V36, P53; Miller MR, 2005, WILSON BULL, V117, P364, DOI 10.1676/04-114.1; Miller MR, 2005, CAN J ZOOL, V83, P1314, DOI 10.1139/Z05-125; O'Neal BJ, 2010, J FIELD ORNITHOL, V81, P71, DOI 10.1111/j.1557-9263.2009.00263.x; ORIANS GH, 1961, ECOL MONOGR, V31, P285, DOI 10.2307/1948556; PAULUS S L, 1988, P135; POLLOCK KH, 1987, J WILDLIFE MANAGE, V51, P502, DOI 10.2307/3801040; Randall LA, 2011, J WILDLIFE MANAGE, V75, P1324, DOI 10.1002/jwmg.173; RAVELING DG, 1972, WILSON BULL, V84, P278; Russell KR, 1998, J FIELD ORNITHOL, V69, P316; Ruth JM, 2008, MANAGEMENT RES APPL; SEIBERT HENRI C., 1951, AUK, V68, P63; Shuford WD, 1998, CONDOR, V100, P227, DOI 10.2307/1370264; Silverman B.W., 1986, DENSITY ESTIMATION S; Stafford JD, 2010, WETLANDS, V30, P565, DOI 10.1007/s13157-010-0049-3; TAMISIER A, 1976, Wildfowl, V27, P19; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; U.S. Fish and Wildlife Service, 1978, CONC PLAN WAT WINT H; Warnock SE, 1995, AUK, V112, P920, DOI 10.2307/4089023	50	24	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41571	10.1371/journal.pone.0041571	http://dx.doi.org/10.1371/journal.pone.0041571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911816	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700114
J	Khare, S; Lawhon, SD; Drake, KL; Nunes, JES; Figueiredo, JF; Rossetti, CA; Gull, T; Everts, RE; Lewin, HA; Galindo, CL; Garner, HR; Adams, LG				Khare, Sangeeta; Lawhon, Sara D.; Drake, Kenneth L.; Nunes, Jairo E. S.; Figueiredo, Josely F.; Rossetti, Carlos A.; Gull, Tamara; Everts, Robin E.; Lewin, Harris A.; Galindo, Cristi L.; Garner, Harold R.; Adams, Leslie Garry			Systems Biology Analysis of Gene Expression during In Vivo Mycobacterium avium paratuberculosis Enteric Colonization Reveals Role for Immune Tolerance	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; SUBSP-PARATUBERCULOSIS; JOHNES-DISEASE; GAMMA-INTERFERON; PEYERS-PATCHES; CROHNS-DISEASE; RECEPTOR GENES; M CELLS; INFECTION; TUBERCULOSIS	Survival and persistence of Mycobacterium avium subsp. paratuberculosis (MAP) in the intestinal mucosa is associated with host immune tolerance. However, the initial events during MAP interaction with its host that lead to pathogen survival, granulomatous inflammation, and clinical disease progression are poorly defined. We hypothesize that immune tolerance is initiated upon initial contact of MAP with the intestinal Peyer's patch. To test our hypothesis, ligated ileal loops in neonatal calves were infected with MAP. Intestinal tissue RNAs were collected (0.5, 1, 2, 4, 8 and 12 hrs post-infection), processed, and hybridized to bovine gene expression microarrays. By comparing the gene transcription responses of calves infected with the MAP, informative complex patterns of expression were clearly visible. To interpret these complex data, changes in the gene expression were further analyzed by dynamic Bayesian analysis, and genes were grouped into the specific pathways and gene ontology categories to create a holistic model. This model revealed three different phases of responses: i) early (30 min and 1 hr post-infection), ii) intermediate (2, 4 and 8 hrs post-infection), and iii) late (12 hrs post-infection). We describe here the data that include expression profiles for perturbed pathways, as well as, mechanistic genes (genes predicted to have regulatory influence) that are associated with immune tolerance. In the Early Phase of MAP infection, multiple pathways were initiated in response to MAP invasion via receptor mediated endocytosis and changes in intestinal permeability. During the Intermediate Phase, perturbed pathways involved the inflammatory responses, cytokine-cytokine receptor interaction, and cell-cell signaling. During the Late Phase of infection, gene responses associated with immune tolerance were initiated at the level of T-cell signaling. Our study provides evidence that MAP infection resulted in differentially regulated genes, perturbed pathways and specifically modified mechanistic genes contributing to the colonization of Peyer's patch.	[Khare, Sangeeta; Lawhon, Sara D.; Nunes, Jairo E. S.; Figueiredo, Josely F.; Rossetti, Carlos A.; Gull, Tamara; Adams, Leslie Garry] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Drake, Kenneth L.] Seralogix Ltd, Austin, TX USA; [Everts, Robin E.; Lewin, Harris A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Sch, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA	Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Southwestern Medical Center Dallas	Khare, S (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	gadams@cvm.tamu.edu	LEWIN, HARRIS/HGC-6543-2022; Khare, SangeetA/Q-5470-2019; Lawhon, Sara D./G-5147-2011	LEWIN, HARRIS/0000-0002-1043-7287; Khare, SangeetA/0000-0002-9496-6636; Lawhon, Sara D./0000-0001-9154-8909	U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program [2004-35605-14243, Q6286224133]; Texas AM University; Texas A&M University Life Sciences Task Force; National Institutes of Health (U.S.) NIH-NIAID [AI060933]; NIH NIAID SBIR [2R44AI058362-02, R43AI084223-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI084223, R44AI058362, K08AI060933] Funding Source: NIH RePORTER	U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program; Texas AM University; Texas A&M University Life Sciences Task Force; National Institutes of Health (U.S.) NIH-NIAID; NIH NIAID SBIR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by funds to Sangeeta Khare from the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program (2004-35605-14243 sub-award Q6286224133) and Animal Health formula funds through Texas A&M University. This study was also supported by funds awarded to Leslie Garry Adams from the Texas A&M University Life Sciences Task Force. Sara D. Lawhon was supported by National Institutes of Health (U.S.) NIH-NIAID AI060933. The computational analysis work was supported in part by NIH NIAID SBIR grants 2R44AI058362-02 and R43AI084223-01 awarded to Kenneth L. Drake. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L Garry, 2011, BMC Proc, V5 Suppl 4, pS6, DOI 10.1186/1753-6561-5-S4-S6; Alzuherri HM, 1997, RES VET SCI, V63, P139, DOI 10.1016/S0034-5288(97)90007-2; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BARTHALAY Y, 1990, EMBO J, V9, P3603, DOI 10.1002/j.1460-2075.1990.tb07571.x; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; BENDIXEN PH, 1977, AM J VET RES, V38, P2027; Berger ST, 2006, IMMUNOL CELL BIOL, V84, P349, DOI 10.1111/j.1440-1711.2006.01431.x; Bermudez LE, 2010, INFECT IMMUN, V78, P3570, DOI 10.1128/IAI.01411-09; Boyce JA, 2003, J ALLERGY CLIN IMMUN, V111, P24, DOI 10.1067/mai.2003.60; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chamberlin WM, 2006, MED SCI MONITOR, V12, pRA27; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Courtemanche C, 2004, J IMMUNOL, V173, P3186, DOI 10.4049/jimmunol.173.5.3186; Crawford GC, 2006, J WILDLIFE DIS, V42, P715, DOI 10.7589/0090-3558-42.4.715; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; Everts RE, 2005, VET IMMUNOL IMMUNOP, V105, P235, DOI 10.1016/j.vetimm.2005.02.003; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Fooksman DR, 2011, ANN REV IMMUNOLOGY; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Greenwell-Wild T, 2002, J IMMUNOL, V169, P6286, DOI 10.4049/jimmunol.169.11.6286; Gwozdz JM, 2001, J COMP PATHOL, V124, P317, DOI 10.1053/jcpa.2001.0468; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; Hwang IY, 2010, GENES IMMUN, V11, P384, DOI 10.1038/gene.2010.27; Khare S, 2004, J CLIN MICROBIOL, V42, P1075, DOI 10.1128/JCM.42.3.1075-1081.2004; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kirkwood CD, 2009, INFLAMM BOWEL DIS, V15, P1643, DOI 10.1002/ibd.20967; Knosel T, 2009, PATHOL RES PRACT, V205, P223, DOI 10.1016/j.prp.2008.04.018; Krajinovic M, 2004, J IMMUNOL, V173, P3186; Kusner DJ, 1996, J EXP MED, V184, P585, DOI 10.1084/jem.184.2.585; LARSEN AB, 1975, AM J VET RES, V36, P255; Lawhon SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026869; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Lei LY, 2007, VET IMMUNOL IMMUNOP, V120, P177, DOI 10.1016/j.vetimm.2007.06.031; Lidar M, 2009, ISR MED ASSOC J, V11, P558; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Missler M, 1998, J NEUROSCI, V18, P3630; Missler M, 1998, J NEUROCHEM, V71, P1339; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; MOMOTANI E, 1988, VET PATHOL, V25, P131, DOI 10.1177/030098588802500205; Murphy JT, 2006, PHYSIOL GENOMICS, V28, P67, DOI 10.1152/physiolgenomics.00098.2006; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Olsen I, 2005, INFECT IMMUN, V73, P5628, DOI 10.1128/IAI.73.9.5628-5635.2005; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Pierce ES, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-17; Plattner BL, 2011, VET PATHOL, V48, P584, DOI 10.1177/0300985810383874; Polymeros D, 2006, GASTROENTEROLOGY, V131, P85, DOI 10.1053/j.gastro.2006.04.021; Purdie AC, 2012, COMP IMMUNOL MICROB, V35, P151, DOI 10.1016/j.cimid.2011.12.007; Rosales C., 2005, MOL MECH PHAGOCYTOSI; Rossetti CA, 2011, RES VET SCI, V91, P40, DOI 10.1016/j.rvsc.2010.09.002; Ruiz-Larranaga O, 2011, J DAIRY SCI, V94, P3635, DOI 10.3168/jds.2010-3788; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sartor RB, 2005, GUT, V54, P896, DOI 10.1136/gut.2004.055889; Sartor RB, 2003, CURR OPIN GASTROEN, V19, P358, DOI 10.1097/00001574-200307000-00006; Scanu AM, 2007, J CLIN MICROBIOL, V45, P3883, DOI 10.1128/JCM.01371-07; Sechi LA, 2007, WORLD J GASTROENTERO, V13, P5731, DOI 10.3748/wjg.v13.i43.5731; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Shi L, 2009, INFECT IMMUN, V77, P3227, DOI 10.1128/IAI.00063-09; Singh Udai P, 2008, BMC Immunol, V9, P25, DOI 10.1186/1471-2172-9-25; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Sommer S, 2009, VET IMMUNOL IMMUNOP, V128, P44, DOI 10.1016/j.vetimm.2008.10.294; Souza CD, 2007, MICROBES INFECT, V9, P1545, DOI 10.1016/j.micinf.2007.08.008; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taylor DL, 2008, VET IMMUNOL IMMUNOP, V124, P132, DOI 10.1016/j.vetimm.2008.02.021; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; Waddell LA, 2008, CAN J PUBLIC HEALTH, V99, P145, DOI 10.1007/BF03405464; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Weiss DJ, 2008, VET PATHOL, V45, P829, DOI 10.1354/vp.45-6-829; Weiss DJ, 2006, VET PATHOL, V43, P127, DOI 10.1354/vp.43-2-127; Weiss DJ, 2001, INFECT IMMUN, V69, P1002, DOI 10.1128/IAI.69.2.1002-1008.2001; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490; Young LS, 1998, IMMUNOL TODAY, V19, P502, DOI 10.1016/S0167-5699(98)01340-1	87	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42127	10.1371/journal.pone.0042127	http://dx.doi.org/10.1371/journal.pone.0042127			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912686	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700011
J	Morsello, C; Ruiz-Mallen, I; Diaz, MDM; Reyes-Garcia, V				Morsello, Carla; Ruiz-Mallen, Isabel; Montoya Diaz, Maria Dolores; Reyes-Garcia, Victoria			The Effects of Processing Non-Timber Forest Products and Trade Partnerships on People's Well-Being and Forest Conservation in Amazonian Societies	PLOS ONE			English	Article							TROPICAL FORESTS; AGRICULTURAL CHANGE; PROPENSITY SCORE; RAIN-FOREST; INCOME; MARKETS; LIVELIHOODS; MANAGEMENT; GENDER; COMMERCIALIZATION	This study evaluated whether processing non-timber forest products (NTFPs) and establishing trade partnerships between forest communities and companies enhance the outcomes of NTFP commercialization. In particular, we evaluated whether product processing, partnerships, or their combination was associated with a number of outcomes related to the well-being of forest inhabitants and forest conservation. We based our analyses on ethnographic and quantitative data (i.e., survey and systematic observations) gathered at seven communities from five societies of the Brazilian and Bolivian Amazon. Our results indicated that product processing and partnerships do not represent a silver bullet able to improve the results of NTFP commercialization in terms of well-being and conservation indicators. Compared with cases without interventions, households adopting partnerships but not product processing were most often associated with improved economic proxies of well-being (total income, NTFP income, food consumption and gender equality in income). In comparison, the combination of product processing and partnerships was associated with similar outcomes. Unexpectedly, product processing alone was associated with negative outcomes in the economic indicators of well-being. All of the investigated strategies were associated with less time spent in social and cultural activities. With respect to forest conservation, the strategies that included a partnership with or without processing produced similar results: while household deforestation tended to decrease, the hunting impact increased. Processing alone was also associated with higher levels of hunting, though it did not reduce deforestation. Our results indicate that establishing partnerships may enhance the outcomes of NTFP trade in terms of the financial outcomes of local communities, but practitioners need to use caution when adopting the processing strategy and they need to evaluate potential negative results for indicators of social and cultural activities. With respect to conservation, the three strategies are promising for reducing deforestation, but more pervasive impacts, such as hunting, might increase.	[Morsello, Carla] Univ Sao Paulo, EACH, Sao Paulo, Brazil; [Ruiz-Mallen, Isabel; Reyes-Garcia, Victoria] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, E-08193 Barcelona, Spain; [Montoya Diaz, Maria Dolores] Univ Sao Paulo, Fac Econ Adm & Contabilidade, Sao Paulo, Brazil; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, ICREA, E-08193 Barcelona, Spain	Universidade de Sao Paulo; Autonomous University of Barcelona; Universidade de Sao Paulo; Autonomous University of Barcelona; ICREA	Morsello, C (corresponding author), Univ Sao Paulo, EACH, Sao Paulo, Brazil.	morsello@usp.br	Diaz, Maria Dolores M./F-3198-2013; Morsello, Carla/D-7393-2012; Ruiz-Mallen, Isabel/E-9614-2018; Reyes-Garcia, Victoria/C-4552-2008	Diaz, Maria Dolores M./0000-0003-2385-2073; Morsello, Carla/0000-0001-7548-6541; Ruiz-Mallen, Isabel/0000-0002-9679-3329; Reyes-Garcia, Victoria/0000-0002-2914-8055	Rainforest Alliance (USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil) [Fapesp 2005/01288-1, 2007/06844]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil) [CAPES AUX-PE-DGU 744/2010]; National Science Foundation-Anthropology (USA); Direccion General das Universidades Espanholas (Spain) [HBP2009-0014]; ICREA Funding Source: Custom	Rainforest Alliance (USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Science Foundation-Anthropology (USA); Direccion General das Universidades Espanholas (Spain); ICREA(ICREA)	Research in Brazil was financed by a Kleinhans Award from Rainforest Alliance (USA; see http://http://www.rainforest-alliance.org/fellowships) to Morsello, scholarships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil; Fapesp 2005/01288-1, 2007/06844; see http://www.fapesp.org) and scholarships and collaboration funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil; CAPES AUX-PE-DGU 744/2010). In Bolivia, financing came through National Science Foundation-Anthropology (USA; see http://www.nsf.org) and a scholarship from Direccion General das Universidades Espanholas (Spain; HBP2009-0014; see http://www.micinn.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen A., 2003, EXPLORING FOREST POV, V40, P1; Arnold J. E. M., 1998, Incomes from the forest: methods for the development and conservation of forest products for local communities., P17; Arnold JEM, 2001, ECOL ECON, V39, P437, DOI 10.1016/S0921-8009(01)00236-1; BEHRENS CA, 1992, HUM ECOL, V20, P435, DOI 10.1007/BF00890429; Belcher B, 2005, WORLD DEV, V33, P1435, DOI 10.1016/j.worlddev.2004.10.007; Belcher B., 2004, FOREST PRODUCTS LIVE, V1, P1; Belcher BM, 2005, INT FOREST REV, V7, P82, DOI 10.1505/ifor.2005.7.2.82; Belcher B, 2007, DEV POLICY REV, V25, P355, DOI 10.1111/j.1467-7679.2007.00374.x; BLUMBERG RL, 1988, J FAM ISSUES, V9, P51, DOI 10.1177/019251388009001004; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Brites AD, 2010, THESIS U SAO PAULO S; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Chandramohan B, 2008, 12 BIENN C INT ASS S; Clay J, 1992, CULTURAL SURVIVAL Q, V16, P31; Clay J, 1992, BUYING FORESTS NEW P, P400; Clement C.R., 1993, SELECTED SPECIES STR; Coad L, 2010, CONSERV BIOL, V24, P1510, DOI 10.1111/j.1523-1739.2010.01525.x; Coomes OT, 2004, ECOL ECON, V51, P47, DOI 10.1016/j.ecolecon.2004.04.004; Counsell Simon, 1992, RAINFOREST HARVEST; Demmer J, 2002, BIODIVERS CONSERV, V11, P1845, DOI 10.1023/A:1020305903156; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Duchelle AE, 2012, FOREST ECOL MANAG, V268, P39, DOI 10.1016/j.foreco.2011.05.023; Faria RBMd, 2007, THESIS U SAO PAULO S; Ferraro PJ, 2011, CONSERV BIOL, V25, P1134, DOI 10.1111/j.1523-1739.2011.01791.x; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Ferrer-i-Carbonell A, 2005, J PUBLIC ECON, V89, P997, DOI 10.1016/j.jpubeco.2004.06.003; Freese CH, 1997, HARVESTING WILD SPEC, P1; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Godoy R, 1997, CURR ANTHROPOL, V38, P875, DOI 10.1086/204676; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Gubbi S, 2008, ORYX, V42, P222, DOI 10.1017/S0030605308071111; Guo S. Y., 2009, PROPENSITY SCORE ANA; HAMMOND DS, 1995, HUM ECOL, V23, P335, DOI 10.1007/BF01190136; Henrich J, 1997, HUM ECOL, V25, P319, DOI 10.1023/A:1021982324396; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Humphries S, 2012, ECOL ECON, V77, P62, DOI 10.1016/j.ecolecon.2011.10.018; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; KAINER KA, 1992, ECON BOT, V46, P408, DOI 10.1007/BF02866513; Kanmegne J, 2007, J FOOD AGRIC ENVIRON, V5, P243; Kusters K, 2006, ECOL SOC, V11; Marshall E., 2006, COMMERCIALIZATION NO; Mayers J, 2002, CO COMMUNITY FORESTR, P25; Mayers J., 2002, CO COMMUNITY FORESTR; Morsello C, 2006, FOREST POLICY ECON, V8, P485, DOI 10.1016/j.forpol.2005.08.010; Morsello C., 2007, PARTNERSHIPS SUSTAIN, P147, DOI [10.1163/ej.9789004153394.i-329.65, DOI 10.1163/EJ.9789004153394.I-329.65]; Neumann R.P., 2000, COMMERCIALISATION NO; Nugent Stephen, 1993, AMAZONIAN CABOCLO SO; Parry L, 2009, BIOL CONSERV, V142, P1777, DOI 10.1016/j.biocon.2009.03.018; Pattanayak SK., 2009, ROUGH GUIDE IMPACT E; PETERS CM, 1989, NATURE, V339, P655, DOI 10.1038/339655a0; Piperata BA, 2011, AM J PHYS ANTHROPOL, V146, P1, DOI 10.1002/ajpa.21459; Pokorny B, 2012, GEOFORUM, V43, P387, DOI 10.1016/j.geoforum.2010.08.002; Ravallion M, 2008, HBK ECON, V9, P3787, DOI 10.1016/S1573-4471(07)04059-4; Ribeiro FN, 2009, THESIS U SAO PAULO S; Rizek MB, HUM ECOL IN PRESS; Ros-Tonen M. A. F., 2005, Forests, Trees and Livelihoods, V15, P129; Ros-Tonen MA., 2007, PARTNERSHIPS SUSTAIN, P3; Ros-Tonen MAF, 2008, FOREST ECOL MANAG, V256, P1482, DOI 10.1016/j.foreco.2008.02.044; Russell Bernard, 1998, HDB METHODS CULTURAL, P301; Sahlins M., 1972, STONE AGE EC; Scherr S.J., 2003, NEW AGENDA FOREST CO; Shackleton C, 2004, S AFR J SCI, V100, P658; Shackleton CM, 2007, FOREST POLICY ECON, V9, P558, DOI 10.1016/j.forpol.2006.03.004; Shackleton S, 2002, DEVOLUTION COMMUNITY; Shepard Glenn Harvey, 2004, TERRAS INDIGENAS UNI, P129; Shively GE, 2001, LAND ECON, V77, P268, DOI 10.2307/3147094; Sills E, 2011, NON-TIMBER FOREST PRODUCTS IN THE GLOBAL CONTEXT, P23, DOI 10.1007/978-3-642-17983-9_2; Siren AH, 2006, ECOL SOC, V11; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; Tu D, 2004, FOREST PRODUCTS LIVE, P107; Vadez V, 2004, HUM ECOL, V32, P635, DOI 10.1007/s10745-004-6100-3; Vadez V., 2003, FIELD METHOD, V15, P289; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7; Wilkie DS, 2001, CONSERV BIOL, V15, P761, DOI 10.1046/j.1523-1739.2001.015003761.x; Wong GY, 2003, WORLD DEV, V31, P1405, DOI 10.1016/S0305-750X(03)00099-8	81	17	18	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43055	10.1371/journal.pone.0043055	http://dx.doi.org/10.1371/journal.pone.0043055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912787	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700034
J	Torpey, K; Mandala, J; Kasonde, P; Bryan-Mofya, G; Bweupe, M; Mukundu, J; Zimba, C; Mwale, C; Lumano, H; Welsh, M				Torpey, Kwasi; Mandala, Justin; Kasonde, Prisca; Bryan-Mofya, Gail; Bweupe, Maximillian; Mukundu, Jonathan; Zimba, Chilunje; Mwale, Catherine; Lumano, Hilary; Welsh, Michael			Analysis of HIV Early Infant Diagnosis Data to Estimate Rates of Perinatal HIV Transmission in Zambia	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SINGLE-DOSE NEVIRAPINE; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; PREVENTION; ZIDOVUDINE; PROPHYLAXIS; PROGRAMS; INTRAPARTUM; LAMIVUDINE	Background: Mother-to-child transmission of HIV (MTCT) remains the most prevalent source of pediatric HIV infection. Most PMTCT (prevention of mother-to-child transmission of HIV) programs have concentrated monitoring and evaluation efforts on process rather than on outcome indicators. In this paper, we review service data from 28,320 children born to HIV-positive mothers to estimate MTCT rates. Method: This study analyzed DNA PCR results and PMTCT data from perinatally exposed children zero to 12 months of age from five Zambian provinces between September 2007 and July 2010. Results: The majority of children (58.6%) had a PCR test conducted between age six weeks and six months. Exclusive breastfeeding (56.8%) was the most frequent feeding method. An estimated 45.9% of mothers were below 30 years old and 93.3% had disclosed their HIV status. In terms of ARV regimen for PMTCT, 32.7% received AZT+single dose NVP (sdNVP), 30.9% received highly active antiretroviral treatment (HAART), 19.6% received sdNVP only and 12.9% received no ARVs. Transmission rates at six weeks when ARVs were received by both mother and baby, mother only, baby only, and none were 5.8%, 10.5%, 15.8% and 21.8% respectively. Transmission rates at six weeks where mother received HAART, AZT+sd NVP, sdNVP, and no intervention were 4.2%, 6.8%, 8.7% and 20.1% respectively. Based on adjusted analysis including ARV exposures and non ARV-related parameters, lower rates of positive PCR results were associated with 1) both mother and infant receiving prophylaxis, 2) children never breastfed and 3) mother being 30 years old or greater. Overall between September 2007 and July 2010, 12.2% of PCR results were HIV positive. Between September 2007 and January 2009, then between February 2009 and July 2010, proportions of positive PCR results were 15.1% and 11% respectively, a significant difference. Conclusion: The use of ARV drugs reduces vertical transmission of HIV in a program setting. Non-chemoprophylactic factors also play a significant role in HIV transmission. The overall change in the proportions of positive PCR results over time is more likely an indication of better PMTCT implementation. Determination of the outcomes of PMTCT in program settings is feasible but requires accurate documentation and analysis.	[Torpey, Kwasi; Mandala, Justin; Kasonde, Prisca; Mukundu, Jonathan; Zimba, Chilunje; Mwale, Catherine; Welsh, Michael] FHI 360, Durham, NC USA; [Bryan-Mofya, Gail; Lumano, Hilary] Management Sci Hlth, Cambridge, MA USA; [Bweupe, Maximillian] Minist Hlth Zambia, Lusaka, Zambia	FHI 360	Torpey, K (corresponding author), FHI 360, Durham, NC USA.	KTorpey@sidhas.org		Torpey, Kwasi/0000-0003-1628-2922	Family Health International/Zambia; U.S. President's Emergency Plan for AIDS Relief through U.S. Agency for International Development Cooperative Agreement [690-A-00-04-00319-00]	Family Health International/Zambia; U.S. President's Emergency Plan for AIDS Relief through U.S. Agency for International Development Cooperative Agreement(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for this paper was provided by Family Health International/Zambia with funding from the U.S. President's Emergency Plan for AIDS Relief through U.S. Agency for International Development Cooperative Agreement No. 690-A-00-04-00319-00. The funder played no role in design, data collection and analysis.	[Anonymous], 2011, WORLD AIDS DAY REP; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Dabis F, 2005, AIDS, V19, P309; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Malyuta R, 2006, EUR J PUBLIC HEALTH, V16, P123, DOI 10.1093/eurpub/cki150; Maru S, 2009, AIDS CARE, V21, P1114, DOI 10.1080/09540120802705842; Matovu A, 2008, East Afr Med J, V85, P162; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Ministry of Health, 2010, NAT PROT GUID INT PR; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Ostergaard Lise Rosendal, 2010, Afr J Reprod Health, V14, P213; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Sherman GG, 2004, SAMJ S AFR MED J, V94, P289; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Torpey K, 2011, J INT ASS PHYS AIDS, V11, P26; Torpey K, 2010, JAIDS-J ACQ IMM DEF, V54, P415, DOI 10.1097/QAI.0b013e3181e36616; UNICEF World Health Organization UNAIDS Vanderbilt University School of Medicine, 2009, CONS M EV IMP PREV M; WHO, 2012, US ANT DRUGS TREAT P; World Health Organization, 2010, GUID HIV INF FEED PR; World Health Organization, 2010, PMTCT STRAT VIS 2010; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, UN ACC SCAL PRIOR HI	29	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42859	10.1371/journal.pone.0042859	http://dx.doi.org/10.1371/journal.pone.0042859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912752	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700025
J	Benowitz, KM; Brodie, ED; Formica, VA				Benowitz, Kyle M.; Brodie, Edmund D., III; Formica, Vincent A.			Morphological Correlates of a Combat Performance Trait in the Forked Fungus Beetle, Bolitotherus cornutus	PLOS ONE			English	Article							BODY-SIZE; INDIVIDUAL-DIFFERENCES; ANTIPREDATOR BEHAVIOR; SEXUAL-DIMORPHISM; SELECTION; COLEOPTERA; EVOLUTION; CONSISTENCY; FITNESS	Combat traits are thought to have arisen due to intense male-male competition for access to females. While large and elaborate weapons used in attacking other males have often been the focus of sexual selection studies, defensive traits (both morphological and performance) have received less attention. However, if defensive traits help males restrict access to females, their role in the process of sexual selection could also be important. Here we examine the morphological correlates of grip strength, a defensive combat trait involved in mate guarding, in the tenebrionid beetle Bolitotherus cornutus. We found that grip strength was repeatable and differed between the sexes. However, these differences in performance were largely explained by body size and a non-additive interaction between size and leg length that differed between males and females. Our results suggest that leg size and body size interact as part of an integrated suite of defensive combat traits.	[Benowitz, Kyle M.; Brodie, Edmund D., III] Univ Virginia, Dept Biol, Mt Lake Biol Stn, Charlottesville, VA 22903 USA; [Formica, Vincent A.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	University of Virginia; Swarthmore College	Benowitz, KM (corresponding author), Univ Virginia, Dept Biol, Mt Lake Biol Stn, Charlottesville, VA 22903 USA.	vince.formica@gmail.com	Brodie, Edmund D/B-2335-2013		National Science Foundation [IOS-1027251]; Mountain Lake Biological Station REU Program (National Science Foundation) [DBI-0453380]	National Science Foundation(National Science Foundation (NSF)); Mountain Lake Biological Station REU Program (National Science Foundation)	Funding was provided by the National Science Foundation IOS-1027251 to EDB and the Mountain Lake Biological Station REU Program (National Science Foundation DBI-0453380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BOAKE CRB, 1989, EVOL ECOL, V3, P173, DOI 10.1007/BF02270919; Brodie ED, 1999, ANIM BEHAV, V57, P445, DOI 10.1006/anbe.1998.0990; BRODIE ED, 1993, ANIM BEHAV, V45, P851, DOI 10.1006/anbe.1993.1106; CONNER J, 1988, EVOLUTION, V42, P736, DOI 10.1111/j.1558-5646.1988.tb02492.x; CONNER J, 1989, EVOLUTION, V43, P1378, DOI 10.1111/j.1558-5646.1989.tb02589.x; CONNER JF, 1995, ETHOL ECOL EVOL, V7, P277, DOI 10.1080/08927014.1995.9522958; Darwin C., 1874, DESCENT MAN SELECTIO; Eberhard WG, 2000, P ROY SOC B-BIOL SCI, V267, P1129, DOI 10.1098/rspb.2000.1118; Emlen DJ, 1996, EVOLUTION, V50, P1219, DOI [10.1111/j.1558-5646.1996.tb02362.x, 10.2307/2410662]; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Formica VA, 2011, EVOLUTION, V65, P2771, DOI 10.1111/j.1558-5646.2011.01340.x; Herrel A, 2010, BIOL J LINN SOC, V100, P287, DOI 10.1111/j.1095-8312.2010.01433.x; Husak JF, 2009, BIOL J LINN SOC, V96, P840, DOI 10.1111/j.1095-8312.2008.01176.x; Kingsolver JG, 2003, INTEGR COMP BIOL, V43, P361, DOI 10.1093/icb/43.3.361; Kingsolver JG, 2003, INTEGR COMP BIOL, V43, P470, DOI 10.1093/icb/43.3.470; Knell RJ, 2010, P ROY SOC B-BIOL SCI, V277, P2347, DOI 10.1098/rspb.2010.0257; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Lailvaux SP, 2005, FUNCT ECOL, V19, P632, DOI 10.1111/j.1365-2435.2005.01024.x; LILES M. PFERRER, 1956, OHIO JOUR SCI, V56, P329; PACE ANNE E., 1967, OCCAS PAP MUS ZOOL UNIV MICH, V653, P1; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SHUSTER SM, 2003, MG BEH ECOL, pR7; Wellborn GA, 2000, AM MIDL NAT, V143, P212, DOI 10.1674/0003-0031(2000)143[0212:SOASDT]2.0.CO;2; Wikelski M, 2003, INTEGR COMP BIOL, V43, P376, DOI 10.1093/icb/43.3.376	28	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42738	10.1371/journal.pone.0042738	http://dx.doi.org/10.1371/journal.pone.0042738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916153	Green Published, gold			2022-12-27	WOS:000307823600027
J	Bonthuis, M; van Stralen, KJ; Verrina, E; Edefonti, A; Molchanova, EA; Hokken-Koelega, ACS; Schaefer, F; Jager, KJ				Bonthuis, Marjolein; van Stralen, Karlijn J.; Verrina, Enrico; Edefonti, Alberto; Molchanova, Elena A.; Hokken-Koelega, Anita C. S.; Schaefer, Franz; Jager, Kitty J.			Use of National and International Growth Charts for Studying Height in European Children: Development of Up-To-Date European Height-For-Age Charts	PLOS ONE			English	Article							BODY-MASS INDEX; PUBERTAL DEVELOPMENT; REFERENCE VALUES; HORMONE THERAPY; SECULAR CHANGES; WEIGHT; REFERENCES; UK; STANDARDS; COUNTRIES	Background: Growth charts based on data collected in different populations and time periods are key tools to assess children's linear growth. We analyzed the impact of geographic factors and the secular trend on height-for-age charts currently used in European populations, developed up-to-date European growth charts, and studied the effect of using different charts in a sample of growth retarded children. Methods and Findings: In an international survey we obtained 18 unique national height-for-age charts from 28 European countries and compared them with charts from the World Health Organization (WHO), Euro-Growth reference, and Centers of Disease Control and Prevention (CDC). As an example, we obtained height data from 3,534 children with end-stage renal disease (ESRD) from 13 countries via the ESPN/ERA-EDTA registry, a patient group generally suffering from growth retardation. National growth charts showed a clear secular trend in height (mean height increased on average 0.6 cm/decade) and a North-South height gradient in Europe. For countries without a recent (>1990) national growth chart novel European growth charts were constructed from Northern and Southern European reference populations, reflecting geographic height differences in mean final height of 3.9 cm in boys and 3.8 cm in girls. Mean height SDS of 2- to 17-year-old ESRD patients calculated from recent national or derived European growth charts (-1.91, 95% CI: -1.97 to -1.85) was significantly lower than when using CDC or WHO growth charts (-1.55, 95% CI: -1.61 to -1.49) (P<0.0001). Conclusion: Differences between height-for-age charts may reflect true population differences, but are also strongly affected by the secular trend in height. The choice of reference charts substantially affects the clinical decision whether a child is considered short-for-age. Therefore, we advocate using recent national or European height-for-age charts derived from recent national data when monitoring growth of healthy and diseased European children.	[Bonthuis, Marjolein; van Stralen, Karlijn J.; Jager, Kitty J.] Univ Amsterdam, Acad Med Ctr, European Dialysis & Transplant Assoc Registry,Dep, European Soc Pediat Nephrol,European Renal Assoc, NL-1105 AZ Amsterdam, Netherlands; [Verrina, Enrico] Gaslini Childrens Hosp, Genoa, Italy; [Edefonti, Alberto] Fdn Ca Granda IRCCS Osped Maggiore Policlin, Milan, Italy; [Molchanova, Elena A.] Russian Childrens Clin Hosp, Dept Kidney Transplantat, Moscow, Russia; [Hokken-Koelega, Anita C. S.] Erasmus Univ, Sophia Childrens Hosp, Subdivis Endocrinol, Dept Paediat,Med Ctr, Rotterdam, Netherlands; [Schaefer, Franz] Univ Childrens Hosp, Heidelberg, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca Granda Ospedale Maggiore Policlinico; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bonthuis, M (corresponding author), Univ Amsterdam, Acad Med Ctr, European Dialysis & Transplant Assoc Registry,Dep, European Soc Pediat Nephrol,European Renal Assoc, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.j.vanstralen@amc.uva.nl	Schaefer, Franz/G-4365-2010; Verrina, Enrico/AAA-7317-2020; Edefonti, Alberto/I-6964-2015	Edefonti, Alberto/0000-0003-3106-4915; van Stralen, Karlijn/0000-0002-3243-2970; Verrina, Enrico Eugenio/0000-0002-5178-1949	ESPN; ERA; EDTA; NephroQUEST project; European Union [2006114]; Amgen	ESPN; ERA; EDTA; NephroQUEST project; European Union(European Commission); Amgen(Amgen)	The European Society for Pediatric Nephrology (ESPN)/European Renal Association (ERA)-European Dialysis and Transplant Association (EDTA) registry is funded by ESPN, the ERA and EDTA and the NephroQUEST project. The NephroQUEST project has received funding from the European Union in the framework of the Public Health Program (project number 2006114). Amgen has provided an unrestricted educational grant to assist the ESPN in the financial support of the Registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Amgen awarded a (sic) 10,000 grant to the European Society for Pediatric Nephrology (ESPN) to assist the start of the ESPN/ERA-EDTA Registry. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersen E, 1982, Ugeskr Laeger, V144, P1760; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bocca-Tjeertes IF, 2012, J PEDIAT; Butte NF, 2007, J NUTR, V137, P153, DOI 10.1093/jn/137.1.153; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Carrascosa Lezcano A, 2008, An Pediatr (Barc), V68, P552; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Chiotis D., 2003, ANN CLIN PAEDIAT U A, V50, P136; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, P NUTR SOC, V59, P317, DOI 10.1017/S0029665100000355; Council of the European Union, 2006, 2733 EMPL SOC POL HL; Danubio ME, 2008, J ANTHROPOL SCI, V86, P91; De Onis M, 2004, J PEDIATR-US, V144, P461, DOI 10.1016/j.jpeds.2003.12.034; de Onis M, 2004, FOOD NUTR BULL, V25, pS89; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Foote JM, 2011, J PEDIATR NURS, V26, P312, DOI 10.1016/j.pedn.2010.09.002; Foster BJ, 2004, AM J CLIN NUTR, V80, P801, DOI 10.1093/ajcn/80.4.801; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2004, ACTA PAEDIATR, V93, P817, DOI 10.1111/j.1651-2227.2004.tb03024.x; Fredriks AM, 2003, EUR J PEDIATR, V162, P788, DOI 10.1007/s00431-003-1292-x; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514; Gohlke B, 2009, DTSCH ARZTEBL INT, V106, P377, DOI 10.3238/arztebl.2009.0377; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Grunberg H, 1998, TARTU; Haas JD, 2006, FOOD NUTR BULL, V27, pS212, DOI 10.1177/15648265060274S505; Haschke F, 2000, J PEDIATR GASTR NUTR, V31, pS14, DOI 10.1097/00005176-200007001-00003; Hauspie RC, 1997, ACTA PAEDIATR, V86, P20; Hermanussen M, 2012, ACTA PAEDIATR, V101, P78, DOI 10.1111/j.1651-2227.2011.02415.x; Hermanussen M, 2010, ANN HUM BIOL, V37, P57, DOI 10.3109/03014460903173379; Hughes IP, 2010, CLIN ENDOCRINOL, V73, P760, DOI 10.1111/j.1365-2265.2010.03874.x; Johnson T S, 1999, Pediatr Nurs, V25, P13; Joubert K, 2006, GYERMEKGYOGYASZAT, V5, P517; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Juliusson Petur B, 2009, Tidsskr Nor Laegeforen, V129, P281, DOI 10.4045/tidsskr.09.32473; Kirk J, 2012, ARCH DIS CHILD, V97, P63, DOI 10.1136/adc.2010.186205; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Kuczmarski R J, 2000, Adv Data, P1; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Larnkjaer A, 2006, ACTA PAEDIATR, V95, P754, DOI 10.1080/08035250500527323; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Mazurin AV, 1985, PROPEDEUTICS CHILD D; MJONES S, 1987, ANN HUM BIOL, V14, P337, DOI 10.1080/03014468700009121; National Kidney Foundation, 2009, AM J KIDNEY DIS S, V53, pS1; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; Redlefsen T, 2007, ANTHROPOL ANZ, V65, P263, DOI 10.1127/anthranz/65/2007/263; Richmond E, 2010, ENDOCR DEV, V18, P92, DOI 10.1159/000316130; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; SCHMIDT IM, 1995, ANN HUM BIOL, V22, P57, DOI 10.1080/03014469500003702; Sempe M., 1979, AUXOLOGIE METHODE SE; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P490, DOI 10.1111/j.1651-2227.1990.tb11502.x; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P498, DOI 10.1111/j.1651-2227.1990.tb11503.x; Tutkuviene J, 2005, ACTA MED LITUANICA, V12, P9; van Buuren S, 2008, ARCH DIS CHILD, V93, P549, DOI 10.1136/adc.2007.136010; van't Hof MA, 2000, J PEDIATR GASTR NUTR, V31, pS3, DOI 10.1097/00005176-200007001-00002; WHO, 2006, WHO CHILD GROWTH STA; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; World Health Organization, 1995, WHO TECHN REP SER, V854, P161; Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854; Wright CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1140; Ziegler EE, 2010, NESTLE NUTR WORKS SE, V65, P197, DOI 10.1159/000281166	65	73	75	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42506	10.1371/journal.pone.0042506	http://dx.doi.org/10.1371/journal.pone.0042506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916131	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600014
J	Kaindl, T; Rieger, H; Kaschel, LM; Engel, U; Schmaus, A; Sleeman, J; Tanaka, M				Kaindl, Thomas; Rieger, Harden; Kaschel, Lisa-Mareike; Engel, Ulrike; Schmaus, Anja; Sleeman, Jonathan; Tanaka, Motomu			Spatio-Temporal Patterns of Pancreatic Cancer Cells Expressing CD44 Isoforms on Supported Membranes Displaying Hyaluronic Acid Oligomers Arrays	PLOS ONE			English	Article							PROSTATE-CANCER; BINDING; VARIANT; PROTEINS; METASTASIS; ADHESION; SURFACE	In this paper, we designed a quantitative model of biological membranes by the deposition of planar lipid membranes on solid substrates (called supported membranes), and immobilized biotinylated oligomers of hyaluronic acid (oligo-HA, 6-8 disaccharide units in length) to the membrane surface via neutravidin cross-linkers. By controlling the self-assembly of biotinylated lipid anchors, the mean distance between the oligo-HA molecules on the membrane could be controlled to nm accuracy. The adhesion and motility of pancreatic adenocarcinoma cells expressing different splice variants of the HA-binding cell surface receptor CD44 on these surfaces were investigated quantitatively. The combination of label-free, time-lapse imaging of living cells and statistical analysis suggests that the static morphology (global shape and cytoskeleton remodeling) of cells, their stochastic morphological dynamics, and the probability of directed motion reflect the metastatic behaviour of the cancer cells.	[Kaindl, Thomas; Rieger, Harden; Kaschel, Lisa-Mareike; Tanaka, Motomu] Heidelberg Univ, Inst Phys Chem, D-6900 Heidelberg, Germany; [Schmaus, Anja; Sleeman, Jonathan; Tanaka, Motomu] Karlsruhe Inst Technol, Inst Tox & Genet, Karlsruhe, Germany; [Sleeman, Jonathan] Heidelberg Univ, Ctr Biomed & Med Technol Mannheim CBTM, Med Fac Mannheim, D-6800 Mannheim, Germany; [Engel, Ulrike] Heidelberg Univ, BIOQUANT, Nikon Imaging Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; Nikon Corporation; Ruprecht Karls University Heidelberg	Kaindl, T (corresponding author), Heidelberg Univ, Inst Phys Chem, Neuenheimer Feld 253, D-6900 Heidelberg, Germany.	sleeman@medma.uni-heidelberg.de; tanaka@uni-heidelberg.de	Engel, Ulrike/AAO-7719-2020; Tanaka, Motomu/S-5949-2016; Sleeman, Jonathan P/H-2515-2013; Engel, Ulrike/E-5456-2014	Engel, Ulrike/0000-0002-6953-6845; Tanaka, Motomu/0000-0003-3663-9554; Sleeman, Jonathan P/0000-0003-1718-7687; 	Helmholtz Association	Helmholtz Association(Helmholtz Association)	This work was supported by Helmholtz Association within the framework of "BioInterface'' program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Enegd B, 2002, NEUROSURGERY, V50, P1311, DOI 10.1097/00006123-200206000-00023; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Gao AC, 1998, CANCER RES, V58, P2350; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hiraiwa T, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/20001; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; KERN W, 1970, RCA REV, V31, P187; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; Lipowsky R., 1995, P521; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; MATZKU S, 1989, CANCER RES, V49, P1294; McHardy LM, 2005, MOL CANCER THER, V4, P772, DOI 10.1158/1535-7163.MCT-04-0310; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; RADLER J, 1993, J PHYS II, V3, P727; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Sherman L, 1996, CURR TOP MICROBIOL, V213, P249; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Sleeman JP, 2007, CLIN EXP METASTAS, V24, P707, DOI 10.1007/s10585-007-9122-6; Sleeman JP, 1996, CANCER RES, V56, P3134; Sleeman JP, 1997, J BIOL CHEM, V272, P31837, DOI 10.1074/jbc.272.50.31837; Stern R, 2005, PATHOL BIOL, V53, P372, DOI 10.1016/j.patbio.2004.12.021; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; SY MS, 1991, J EXP MED, V174, P859, DOI 10.1084/jem.174.4.859; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Tanaka M, 2007, LANGMUIR, V23, P5638, DOI 10.1021/la0628219; Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2; TOLG C, 1993, NUCLEIC ACIDS RES, V21, P1225, DOI 10.1093/nar/21.5.1225; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; YANG BH, 1995, ANAL BIOCHEM, V228, P299, DOI 10.1006/abio.1995.1354; ZHANG LR, 1995, CANCER RES, V55, P428; Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5	41	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42991	10.1371/journal.pone.0042991	http://dx.doi.org/10.1371/journal.pone.0042991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916191	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800035
J	Morrison, NA; Stephens, AA; Osato, M; Polly, P; Tan, TC; Yamashita, N; Doecke, JD; Pasco, J; Fozzard, N; Jones, G; Ralston, SH; Sambrook, PN; Prince, RL; Nicholson, GC				Morrison, Nigel A.; Stephens, Alexandre A.; Osato, Motomi; Polly, Patsie; Tan, Timothy C.; Yamashita, Namiko; Doecke, James D.; Pasco, Julie; Fozzard, Nicolette; Jones, Graeme; Ralston, Stuart H.; Sambrook, Philip N.; Prince, Richard L.; Nicholson, Geoff C.			Glutamine Repeat Variants in Human RUNX2 Associated with Decreased Femoral Neck BMD, Broadband Ultrasound Attenuation and Target Gene Transactivation	PLOS ONE			English	Article							BONE; MUTATIONS; RECEPTOR; CBFA1; WOMEN; FRACTURE; ALLELES; LENGTH; PERIMENOPAUSAL; POLYMORPHISMS	RUNX2 is an essential transcription factor required for skeletal development and cartilage formation. Haploinsufficiency of RUNX2 leads to cleidocranial displaysia (CCD) a skeletal disorder characterised by gross dysgenesis of bones particularly those derived from intramembranous bone formation. A notable feature of the RUNX2 protein is the polyglutamine and polyalanine (23Q/17A) domain coded by a repeat sequence. Since none of the known mutations causing CCD characterised to date map in the glutamine repeat region, we hypothesised that Q-repeat mutations may be related to a more subtle bone phenotype. We screened subjects derived from four normal populations for Q-repeat variants. A total of 22 subjects were identified who were heterozygous for a wild type allele and a Q-repeat variant allele: (15Q, 16Q, 18Q and 30Q). Although not every subject had data for all measures, Q-repeat variants had a significant deficit in BMD with an average decrease of 0.7SD measured over 12 BMD-related parameters (p = 0.005). Femoral neck BMD was measured in all subjects (-0.6SD, p = 0.0007). The transactivation function of RUNX2 was determined for 16Q and 30Q alleles using a reporter gene assay. 16Q and 30Q alleles displayed significantly lower transactivation function compared to wild type (23Q). Our analysis has identified novel Q-repeat mutations that occur at a collective frequency of about 0.4%. These mutations significantly alter BMD and display impaired transactivation function, introducing a new class of functionally relevant RUNX2 mutants.	[Morrison, Nigel A.; Stephens, Alexandre A.; Doecke, James D.; Fozzard, Nicolette] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Osato, Motomi] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Polly, Patsie; Tan, Timothy C.] Univ New S Wales, Dept Pathol & Inflammat, Sch Med Sci, Sydney, NSW, Australia; [Polly, Patsie; Tan, Timothy C.] Univ New S Wales, Infect Res Ctr, Sch Med Sci, Sydney, NSW, Australia; [Yamashita, Namiko] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Pasco, Julie] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Jones, Graeme] Menzies Inst, Hobart, Tas, Australia; [Ralston, Stuart H.] Univ Edinburgh, Ctr Mol Med, Edinburgh, Midlothian, Scotland; [Sambrook, Philip N.] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Prince, Richard L.] Sir Charles Gairdner Hosp, Western Australian Inst Med Res, Perth, WA 6000, Australia; [Prince, Richard L.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA 6000, Australia; [Nicholson, Geoff C.] Univ Queensland, Rural Clin Sch, Sch Med, Toowoomba, Qld, Australia	Griffith University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of New South Wales Sydney; University of New South Wales Sydney; National University of Singapore; Deakin University; University of Tasmania; Menzies Institute for Medical Research; University of Edinburgh; Royal North Shore Hospital; University of Sydney; University of Western Australia; University of Western Australia; University of Queensland	Morrison, NA (corresponding author), Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia.	N.Morrison@mailbox.gu.edu.au	Osato, Motomi/N-5056-2014; Stephens, Alexandre S/P-1396-2016; Morrison, Nigel A/F-4082-2012; Nicholson, Geoffrey C/F-1901-2010; Doecke, James D/A-5361-2009	Osato, Motomi/0000-0003-3982-9054; Stephens, Alexandre S/0000-0003-2465-8117; Morrison, Nigel A/0000-0003-4774-3808; Nicholson, Geoffrey C/0000-0002-0152-1153; Doecke, James D/0000-0003-2863-0293; Tan, Timothy/0000-0003-4449-1457	Griffith University	Griffith University(Griffith University)	Alex Stephens and James Doecke were supported by Griffith University postgraduate scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ONL MEND INH MAN OMI; Atanesyan L, 2012, BIOL CHEM, V393, P63, DOI 10.1515/BC-2011-252; Bustamante M, 2007, CALCIFIED TISSUE INT, V81, P327, DOI 10.1007/s00223-007-9069-2; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chan MY, 2012, CALCIFIED TISSUE INT, V90, P128, DOI 10.1007/s00223-011-9556-3; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Ding C, 2008, ANN RHEUM DIS, V67, P1256, DOI 10.1136/ard.2007.082651; Doecke JD, 2006, J BONE MINER RES, V21, P265, DOI 10.1359/JBMR; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Ermakov S, 2008, ANN HUM GENET, V72, P510, DOI 10.1111/j.1469-1809.2008.00441.x; Finsterer J, 2010, J NEUROL SCI, V298, P1, DOI 10.1016/j.jns.2010.08.025; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Henry MJ, 2000, J CLIN DENSITOM, V3, P261, DOI 10.1385/JCD:3:3:261; Hood G.M., 2010, POPTOOLS VERSION 3 2; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee HJ, 2009, CALCIFIED TISSUE INT, V84, P439, DOI 10.1007/s00223-009-9246-6; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; MacDonald HM, 2001, J BONE MINER RES, V16, P1634, DOI 10.1359/jbmr.2001.16.9.1634; Makovey J, 2007, J BONE MINER RES, V22, P1773, DOI 10.1359/JBMR.070708; McGuigan FEA, 2002, J BONE MINER RES, V17, P1273, DOI 10.1359/jbmr.2002.17.7.1273; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morrison NA, 2005, PHARMACOGENET GENOM, V15, P127, DOI 10.1097/01213011-200502000-00008; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Napierala D, 2005, MOL GENET METAB, V86, P257, DOI 10.1016/j.ymgme.2005.07.012; Ogawa H, 2008, COMPUT BIOL CHEM, V32, P102, DOI 10.1016/j.compbiolchem.2007.11.001; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Pasco JA, 2006, OSTEOPOROSIS INT, V17, P1404, DOI 10.1007/s00198-006-0135-9; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Pineda B, 2010, J BONE MINER METAB, V28, P696, DOI 10.1007/s00774-010-0183-2; Polly P, 2000, FASEB J, V14, P1455, DOI 10.1096/fj.14.10.1455; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Sanders KM, 1999, OSTEOPOROSIS INT, V10, P240, DOI 10.1007/s001980050222; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; TILYARD MW, 1992, NEW ENGL J MED, V326, P357, DOI 10.1056/NEJM199202063260601; Vaughan T, 2004, BONE, V34, P1029, DOI 10.1016/j.bone.2004.02.004; Vaughan T, 2002, J BONE MINER RES, V17, P1527, DOI 10.1359/jbmr.2002.17.8.1527; Whan V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-654; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhang YW, 2000, GENE, V244, P21, DOI 10.1016/S0378-1119(99)00558-2	48	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42617	10.1371/journal.pone.0042617	http://dx.doi.org/10.1371/journal.pone.0042617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912713	Green Published, gold			2022-12-27	WOS:000307500100018
J	Liou, TG; Adler, FR; Keogh, RH; Li, YP; Jensen, JL; Walsh, W; Packer, K; Clark, T; Carveth, H; Chen, J; Rogers, SL; Lane, C; Moore, J; Sturrock, A; Paine, R; Cox, DR; Hoidal, JR				Liou, Theodore G.; Adler, Frederick R.; Keogh, Ruth H.; Li, Yanping; Jensen, Judy L.; Walsh, William; Packer, Kristyn; Clark, Teresa; Carveth, Holly; Chen, Jun; Rogers, Shaunessy L.; Lane, Christen; Moore, James; Sturrock, Anne; Paine, Robert, III; Cox, David R.; Hoidal, John R.			Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MOBILITY GROUP BOX-1; PSEUDOMONAS-AERUGINOSA; LUNG TRANSPLANTATION; AIRWAY INFLAMMATION; PULMONARY-FUNCTION; GM-CSF; EXPRESSION; SURVIVAL; DISEASE	Lung function, acute pulmonary exacerbations (APE), and weight are the best clinical predictors of survival in cystic fibrosis (CF); however, underlying mechanisms are incompletely understood. Biomarkers of current disease state predictive of future outcomes might identify mechanisms and provide treatment targets, trial endpoints and objective clinical monitoring tools. Such CF-specific biomarkers have previously been elusive. Using observational and validation cohorts comprising 97 non-transplanted consecutively-recruited adult CF patients at the Intermountain Adult CF Center, University of Utah, we identified biomarkers informative of current disease and predictive of future clinical outcomes. Patients represented the majority of sputum producers. They were recruited March 2004-April 2007 and followed through May 2011. Sputum biomarker concentrations were measured and clinical outcomes meticulously recorded for a median 5.9 (interquartile range 5.0 to 6.6) years to study associations between biomarkers and future APE and time-to-lung transplantation or death. After multivariate modeling, only high mobility group box-1 protein (HMGB-1, mean = 5.84 [log ng/ml], standard deviation [SD] = 1.75) predicted time-to-first APE (hazard ratio [HR] per log-unit HMGB-1 = 1.56, p-value = 0.005), number of future APE within 5 years (0.338 APE per log-unit HMGB-1, p<0.001 by quasi-Poisson regression) and time-to-lung transplantation or death (HR = 1.59, p = 0.02). At APE onset, sputum granulocyte macrophage colony stimulating factor (GM-CSF, mean 4.8 [log pg/ml], SD = 1.26) was significantly associated with APE-associated declines in lung function (-10.8 FEV1% points per log-unit GM-CSF, p, 0.001 by linear regression). Evaluation of validation cohorts produced similar results that passed tests of mutual consistency. In CF sputum, high HMGB-1 predicts incidence and recurrence of APE and survival, plausibly because it mediates long-term airway inflammation. High APE-associated GM-CSF identifies patients with large acute declines in FEV1%, possibly providing a laboratory-based objective decision-support tool for determination of an APE diagnosis. These biomarkers are potential CF reporting tools and treatment targets for slowing long-term progression and reducing short-term severity.	[Liou, Theodore G.; Li, Yanping; Jensen, Judy L.; Walsh, William; Packer, Kristyn; Carveth, Holly; Chen, Jun; Rogers, Shaunessy L.; Lane, Christen; Sturrock, Anne; Paine, Robert, III; Hoidal, John R.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA; [Liou, Theodore G.; Li, Yanping; Jensen, Judy L.; Walsh, William; Packer, Kristyn; Carveth, Holly; Chen, Jun; Rogers, Shaunessy L.; Lane, Christen; Sturrock, Anne; Paine, Robert, III] Univ Utah, Div Resp Crit Care & Occupat Pulm Med, Salt Lake City, UT USA; [Liou, Theodore G.; Li, Yanping; Jensen, Judy L.; Walsh, William; Packer, Kristyn; Clark, Teresa; Carveth, Holly; Chen, Jun; Rogers, Shaunessy L.; Lane, Christen] Univ Utah, Intermt Adult CF Ctr, Salt Lake City, UT USA; [Adler, Frederick R.; Moore, James] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Adler, Frederick R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Keogh, Ruth H.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Cox, David R.] Univ Oxford Nuffield Coll, Oxford OX1 1NF, England; [Cox, David R.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; MRC Biostatistics Unit; University of Oxford; University of Oxford	Liou, TG (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA.	ted.liou@utah.edu	Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847; Keogh, Ruth/0000-0001-6504-3253	NIH/NHLBI [HL03656, HL084341]; CF Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003656, R21HL084341] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CF Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH/NHLBI (HL03656 and HL084341), a Harry Shwachman Clinical Investigator Award, a Clinical Research Award from the CF Foundation and by generous support from the Claudia Ruth Goodrich Stevens Research Endowment in Cystic Fibrosis in the Department of Internal Medicine, University of Utah and the Ben B. and Iris M. Margolis Family Foundation of Utah. The funding entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2004, AM J RESP CRIT CARE, V169, P811, DOI 10.1164/rccm.200309-1306OC; American Thoracic Society, 1991, AM REV RESP DIS, V144, P1202; [Anonymous], 2010, R LANG ENV STAT COMP; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; CARP H, 1982, P NATL ACAD SCI-BIOL, V79, P2041, DOI 10.1073/pnas.79.6.2041; Cox D. R., 1984, ANAL SURVIVAL DATA; Cox DR, 2004, INT STAT REV, V72, P285, DOI 10.1111/j.1751-5823.2004.tb00237.x; COX DR, 1972, J R STAT SOC B, V34, P187; Cystic Fibrosis Foundation, 2011, CYST FIBR FDN PAT RE; Cystic Fibrosis Foundation, 1997, CLIN PRACT GUID CYST; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; HIBBS MS, 1987, J CLIN INVEST, V80, P1644, DOI 10.1172/JCI113253; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Hubeau C, 2004, CLIN EXP IMMUNOL, V135, P528, DOI 10.1111/j.1365-2249.2003.02385.x; KAO RC, 1988, J CLIN INVEST, V82, P1963, DOI 10.1172/JCI113816; Kelly MM, 2001, EUR RESPIR J, V18, P685, DOI 10.1183/09031936.01.00098501; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; Liou TG, 2007, NEW ENGL J MED, V357, P2143, DOI 10.1056/NEJMoa066359; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Mayer-Hamblett N, 2007, AM J RESP CRIT CARE, V175, P822, DOI 10.1164/rccm.200609-1354OC; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Molfino NA, CLIN EXPT ALLERGY; Moser C, 2005, APMIS, V113, P400, DOI 10.1111/j.1600-0463.2005.apm_142.x; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; RAO NV, 1991, J BIOL CHEM, V266, P9540; Rosenfeld M, 2001, J PEDIATR-US, V139, P359, DOI 10.1067/mpd.2001.117288; Rowe SM, 2008, AM J RESP CRIT CARE, V178, P822, DOI 10.1164/rccm.200712-1894OC; Saba S, 2002, AM J RESP CELL MOL, V27, P561, DOI 10.1165/rcmb.2002-0019OC; Sagel Scott D, 2007, Proc Am Thorac Soc, V4, P406, DOI 10.1513/pats.200703-044BR; Sagel SD, 2005, PEDIATR PULM, V39, P224, DOI 10.1002/ppul.20165; Saha S, 2009, THORAX, V64, P671, DOI 10.1136/thx.2008.108290; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Stressmann FA, 2012, THORAX; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Venables W, 2010, MODERN APPL STAT S; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; YANG YP, 1995, NAT MED, V1, P890, DOI 10.1038/nm0995-890	51	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42748	10.1371/journal.pone.0042748	http://dx.doi.org/10.1371/journal.pone.0042748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22916155	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000307380900065
J	Huang, XY; Yuan, F; Liang, MH; Lo, HW; Shinohara, ML; Robertson, C; Zhong, P				Huang, Xiaoyi; Yuan, Fang; Liang, Meihua; Lo, Hui-Wen; Shinohara, Mari L.; Robertson, Cary; Zhong, Pei			M-HIFU Inhibits Tumor Growth, Suppresses STAT3 Activity and Enhances Tumor Specific Immunity in a Transplant Tumor Model of Prostate Cancer	PLOS ONE			English	Article							INTENSITY-FOCUSED ULTRASOUND; HUMAN HEPATOCELLULAR-CARCINOMA; MURINE MELANOMA MODEL; LONG-TERM MORTALITY; ANTITUMOR IMMUNITY; TARGETED DISRUPTION; BREAST-CANCER; CYCLIN D1; BCL-XL; DENDRITIC CELLS	Objective: In this study, we explored the use of mechanical high intensity focused ultrasound (M-HIFU) as a neo-adjuvant therapy prior to surgical resection of the primary tumor. We also investigated the role of signal transducer and activator of transcription 3 (STAT3) in M-HIFU elicited anti-tumor immune response using a transplant tumor model of prostate cancer. Methods: RM-9, a mouse prostate cancer cell line with constitutively activated STAT3, was inoculated subcutaneously in C57BL/6J mice. The tumor-bearing mice (with a maximum tumor diameter of 5 similar to 6 mm) were treated by M-HIFU or sham exposure two days before surgical resection of the primary tumor. Following recovery, if no tumor recurrence was observed in 30 days, tumor rechallenge was performed. The growth of the rechallenged tumor, survival rate and anti-tumor immune response of the animal were evaluated. Results: No tumor recurrence and distant metastasis were observed in both treatment groups employing M-HIFU + surgery and surgery alone. However, compared to surgery alone, M-HIFU combined with surgery were found to significantly inhibit the growth of rechallenged tumors, down-regulate intra-tumoral STAT3 activities, increase cytotoxic T cells in spleens and tumor draining lymph nodes (TDLNs), and improve the host survival. Furthermore, M-HIFU combined with surgery was found to significantly decrease the level of immunosuppression with concomitantly increased number and activities of dendritic cells, compared to surgery alone. Conclusion: Our results demonstrate that M-HIFU can inhibit STAT3 activities, and when combined synergistically with surgery, may provide a novel and promising strategy for the treatment of prostate cancers.	[Huang, Xiaoyi; Yuan, Fang; Zhong, Pei] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA; [Liang, Meihua; Lo, Hui-Wen] Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Durham, NC USA; [Shinohara, Mari L.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Shinohara, Mari L.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Robertson, Cary; Zhong, Pei] Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Huang, XY (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA.	huiwen.lo@duke.edu; mari.shinohara@duke.edu; pzhong@duke.edu		Lo, Hui-Wen/0000-0002-0681-7914; Huang, Xiaoyi/0000-0002-2355-5688; Shinohara, Mari/0000-0002-6808-9844	National Institutes of Health [5R21CA135221-02]; Duke Comprehensive Cancer Center; DoD [PC100266]; CONCERN Foundation; Morris Foundation; NATIONAL CANCER INSTITUTE [R21CA135221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Comprehensive Cancer Center; DoD(United States Department of Defense); CONCERN Foundation; Morris Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health through grant #: 5R21CA135221-02 (http://www.nih.gov/), by a Prostate Cancer Pre-SPORE grant from the Duke Comprehensive Cancer Center, by a grant from DoD (PC100266), by a grant from the CONCERN Foundation, and by a grant from the Morris Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GW, 2007, CANCER-AM CANCER SOC, V110, P1405, DOI 10.1002/cncr.22940; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Brayer J, 2010, IMMUNOL LETT, V131, P126, DOI 10.1016/j.imlet.2010.03.004; Chen LL, 1998, ULTRASOUND MED BIOL, V24, P1475, DOI 10.1016/S0301-5629(98)00134-3; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gelet A, 2004, J UROLOGY, V171, P271, DOI 10.1016/S0022-5347(18)38264-8; Gelet A, 2001, EUR UROL, V40, P124, DOI 10.1159/000049761; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; Hu Z, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-34; Hu ZL, 2005, BIOCHEM BIOPH RES CO, V335, P124, DOI 10.1016/j.bbrc.2005.07.071; Huang H, 2009, OLIGONUCLEOTIDES, V19, P151, DOI 10.1089/oli.2008.0174; JAIN RK, 1987, CANCER RES, V47, P3039; Jung KH, 2010, J CELL BIOCHEM, V110, P687, DOI 10.1002/jcb.22579; Kennedy JE, 2005, NAT REV CANCER, V5, P321, DOI 10.1038/nrc1591; Kim JK, 2009, INT J ONCOL, V35, P1257, DOI 10.3892/ijo_00000442; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Lo HW, 2010, DISCOV MED, V10, P44; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; Merglen A, 2007, ARCH INTERN MED, V167, P1944, DOI 10.1001/archinte.167.18.1944; Pallandre JR, 2007, J IMMUNOL, V179, P7593, DOI 10.4049/jimmunol.179.11.7593; PETERS G, 1994, J CELL SCI, P89; Pilon-Thomas S, 2006, J IMMUNOTHER, V29, P381, DOI 10.1097/01.cji.0000199199.20717.67; Roach M, 2008, ARCH INTERN MED, V168, P1351, DOI 10.1001/archinte.168.12.1351; Selvendiran K, 2010, CANCER BIOL THER, V10, P386, DOI 10.4161/cbt.10.4.12448; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; TERHAAR G, 1995, ULTRASOUND MED BIOL, V21, P1089, DOI 10.1016/0301-5629(95)02010-1; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wang X, 2002, CHINESE MED J-PEKING, V115, P1332; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wu F, 2007, INT J HYPERTHER, V23, P165, DOI 10.1080/02656730701206638; Wu F, 2003, ULTRASOUND MED BIOL, V29, P1487, DOI 10.1016/S0301-5629(03)01034-2; Wu F, 2007, ANN SURG ONCOL, V14, P1237, DOI 10.1245/s10434-006-9275-6; Wu F, 2006, AM J SURG, V192, P179, DOI 10.1016/j.amjsurg.2006.03.014; Xing YF, 2008, BIOCHEM BIOPH RES CO, V375, P645, DOI 10.1016/j.bbrc.2008.08.072; YANG R, 1992, J PEDIATR SURG, V27, P246, DOI 10.1016/0022-3468(92)90321-W; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang T, 2011, CANCER RES, V71, P2066, DOI 10.1158/0008-5472.CAN-10-3200; Zhong P, 2011, AIP CONF PROC, V1359, P289, DOI 10.1063/1.3607920; Zhou YF, 2006, J ACOUST SOC AM, V120, P676, DOI 10.1121/1.2214131; Zhu H, 2010, CANCER LETT, V294, P101, DOI 10.1016/j.canlet.2010.01.028	53	36	37	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41632	10.1371/journal.pone.0041632	http://dx.doi.org/10.1371/journal.pone.0041632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911830	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300059
J	Shi, WF; Freitas, IT; Zhu, CD; Zheng, W; Hall, WW; Higgins, DG				Shi, Weifeng; Freitas, Ines T.; Zhu, Chaodong; Zheng, Wei; Hall, William W.; Higgins, Desmond G.			Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype Recombinants	PLOS ONE			English	Article							LARGE PHYLOGENETIC TREES; MAXIMUM-LIKELIHOOD; DETECTING RECOMBINATION; MITOCHONDRIAL-DNA; MOSAIC STRUCTURE; SEQUENCES; GENOTYPES; POPULATIONS; INFECTION; THERAPY	Recombination in Hepatitis C virus (HCV) is considered to be rare. In this study, we performed a phylogenetic analysis of 1278 full-length HCV genome sequences to identify potential recombination events. Nine inter-genotype recombinants were identified, all of which have been previously reported. This confirms the rarity of inter-genotype HCV recombinants. The analysis also identified five inter-subtype recombinants, four of which are documented for the first time (EU246930, EU246931, EU246932, and EU246937). Specifically, the latter represent four different novel recombination types (6a/6o, 6e/6o, 6e/6h, and 6n/6o), and this was well supported by seven independent methods embedded in RDP. The breakpoints of the four novel HCV recombinants are located within the NS5B coding region and were different from all previously reported breakpoints. While the locations of the breakpoints identified by RDP were not identical, they are very close. Our study suggests that while recombination in HCV is rare, this warrants further investigation.	[Shi, Weifeng; Freitas, Ines T.; Higgins, Desmond G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Zhu, Chaodong; Zheng, Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Zheng, Wei] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Zheng, Wei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hall, William W.] Univ Coll Dublin, Natl Virus Reference Lab, Dublin 2, Ireland	University College Dublin; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University College Dublin	Shi, WF (corresponding author), Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China.	wfshi.tsmc@gmail.com	ZHU, Chao-Dong/E-5961-2011; Higgins, des g/J-6314-2012	ZHU, Chao-Dong/0000-0002-9347-3178; Higgins, Des/0000-0002-3952-3285	Science Foundation Ireland (PI) [07/IN.1/B1783]; UK Wellcome Trust [097427/Z/11/Z]; National Science Foundation, China [31172048, J0930004]	Science Foundation Ireland (PI)(Science Foundation Ireland); UK Wellcome Trust(Wellcome Trust); National Science Foundation, China(National Natural Science Foundation of China (NSFC))	This study was supported by Science Foundation Ireland (PI grant 07/IN.1/B1783). I.T. Freitas was funded by the UK Wellcome Trust (097427/Z/11/Z). C. Zhu and W. Zheng were supported by the National Science Foundation, China (Grants Nos. 31172048, J0930004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2003, GUT, V52, P900, DOI 10.1136/gut.52.6.900; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Burke DS, 1997, EMERG INFECT DIS, V3, P253, DOI 10.3201/eid0303.970301; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0; Demetriou VL, 2011, ADV VIROL, V2011, DOI 10.1155/2011/710438; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Giannini C, 1999, J LAB CLIN MED, V134, P68, DOI 10.1016/S0022-2143(99)90055-0; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kurbanov F, 2008, HEPATOL RES, V38, P457, DOI 10.1111/j.1872-034X.2007.00293.x; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Matsubara T, 1996, J PEDIATR GASTR NUTR, V22, P79, DOI 10.1097/00005176-199601000-00013; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Morel V, 2011, J VIRAL HEPATITIS, V18, P77, DOI 10.1111/j.1365-2893.2010.01367.x; Moreno MP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-87; Noppornpath S, 2008, J GEN VIROL, V89, P1276, DOI 10.1099/vir.0.83593-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Raghwani J, 2012, J VIROL, V86, P2212, DOI 10.1128/JVI.06184-11; Ross RS, 2008, EVOL BIOINFORM, V4, P249; Schijman A, 2004, CLIN DIAGN LAB IMMUN, V11, P433, DOI 10.1128/CDLI.11.2.433-435.2004; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sentandreu V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003239; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; SMITH JM, 1992, J MOL EVOL, V34, P126; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; STAMATAKIS A., 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Tallo T, 2007, J MED VIROL, V79, P374, DOI 10.1002/jmv.20828; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Toyoda H, 1998, CLIN INFECT DIS, V26, P440, DOI 10.1086/516332; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Yun AB, 1996, J MED VIROL, V49, P155, DOI 10.1002/(SICI)1096-9071(199607)49:3<155::AID-JMV1>3.0.CO;2-3	53	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41997	10.1371/journal.pone.0041997	http://dx.doi.org/10.1371/journal.pone.0041997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911872	Green Submitted, gold, Green Published			2022-12-27	WOS:000306751300088
J	Slotta-Huspenina, J; Berg, D; Bauer, K; Wolff, C; Malinowsky, K; Bauer, L; Drecoll, E; Bettstetter, M; Feith, M; Walch, A; Hofler, H; Becker, KF; Langer, R				Slotta-Huspenina, Julia; Berg, Daniela; Bauer, Karina; Wolff, Claudia; Malinowsky, Katharina; Bauer, Lukas; Drecoll, Enken; Bettstetter, Marcus; Feith, Marcus; Walch, Axel; Hoefler, Heinz; Becker, Karl-Friedrich; Langer, Rupert			Evidence of Prognostic Relevant Expression Profiles of Heat-Shock Proteins and Glucose-Regulated Proteins in Oesophageal Adenocarcinomas	PLOS ONE			English	Article							HISTOPATHOLOGICAL TUMOR-REGRESSION; NEOADJUVANT CHEMOTHERAPY; CANCER; HSP90; GRP78; ASSOCIATION; THERAPY; HSP70; HSP27; MICROARRAYS	A high percentage of oesophageal adenocarcinomas show an aggressive clinical behaviour with a significant resistance to chemotherapy. Heat-shock proteins (HSPs) and glucose-regulated proteins (GRPs) are molecular chaperones that play an important role in tumour biology. Recently, novel therapeutic approaches targeting HSP90/GRP94 have been introduced for treating cancer. We performed a comprehensive investigation of HSP and GRP expression including HSP27, phosphorylated (p)-HSP27((Ser15)), p-HSP27((Ser78)), p-HSP27((Ser82)), HSP60, HSP70, HSP90, GRP78 and GRP94 in 92 primary resected oesophageal adenocarcinomas by using reverse phase protein arrays (RPPA), immunohistochemistry (IHC) and real-time quantitative RTPCR (qPCR). Results were correlated with pathologic features and survival. HSP/GRP protein and mRNA expression was detected in all tumours at various levels. Unsupervised hierarchical clustering showed two distinct groups of tumours with specific protein expression patterns: The hallmark of the first group was a high expression of p-HSP27((Ser15, Ser78, Ser82)) and low expression of GRP78, GRP94 and HSP60. The second group showed the inverse pattern with low p-HSP27 and high GRP78, GRP94 and HSP60 expression. The clinical outcome for patients from the first group was significantly improved compared to patients from the second group, both in univariate analysis (p = 0.015) and multivariate analysis (p = 0.029). Interestingly, these two groups could not be distinguished by immunohistochemistry or qPCR analysis. In summary, two distinct and prognostic relevant HSP/GRP protein expression patterns in adenocarcinomas of the oesophagus were detected by RPPA. Our approach may be helpful for identifying candidates for specific HSP/GRP-targeted therapies.	[Slotta-Huspenina, Julia; Berg, Daniela; Bauer, Karina; Wolff, Claudia; Malinowsky, Katharina; Bauer, Lukas; Drecoll, Enken; Hoefler, Heinz; Becker, Karl-Friedrich; Langer, Rupert] Tech Univ Munich, Inst Pathol, Munich, Germany; [Feith, Marcus] Tech Univ Munich, Dept Surg, Munich, Germany; [Walch, Axel; Hoefler, Heinz] Helmholtz Zentrum Munchen, Inst Pathol, Oberschleissheim, Germany; [Langer, Rupert] Univ Bern, Inst Pathol, Bern, Switzerland; [Bettstetter, Marcus] Teilgemeinschaftspraxis Molekularpathol, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bern	Slotta-Huspenina, J (corresponding author), Tech Univ Munich, Inst Pathol, Munich, Germany.	slotta.huspenina@lrz.tum.de	Langer, Rupert/AAU-1174-2021; Walch, Axel/B-4554-2012; Becker, Karl-Friedrich/D-3636-2015	Langer, Rupert/0000-0001-9491-3609; Walch, Axel/0000-0001-5578-4023; Becker, Karl-Friedrich/0000-0002-6801-4498	Deutsche Forschungsgemeinschaft (DFG) [LA 2706]; NGFN (Nationales Genomforschungsnetz) project of BMBF (Bundesministerium fur Bildung und Forschung) [01GR0805]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NGFN (Nationales Genomforschungsnetz) project of BMBF (Bundesministerium fur Bildung und Forschung)	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, grant no. LA 2706) and the NGFN (Nationales Genomforschungsnetz) project of the BMBF (Bundesministerium fur Bildung und Forschung; grant no. 01GR0805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu Y, 2011, ANN SURG ONCOL, V18, P832, DOI 10.1245/s10434-010-1128-7; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Bauer K, 2012, CELL ONCOL DORDR; Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Becker K, 2011, ANN SURG, V253, P934, DOI 10.1097/SLA.0b013e318216f449; Berg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023985; Berg D, 2011, METHODS MOL BIOL, V785, P109, DOI 10.1007/978-1-61779-286-1_8; Berg D, 2010, EUR J CANCER, V46, P47, DOI 10.1016/j.ejca.2009.10.016; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; DeMeester SR, 2006, ANN SURG ONCOL, V13, P12, DOI 10.1245/ASO.2005.12.025; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Fukuyo Y, 2010, CANCER LETT, V290, P24, DOI 10.1016/j.canlet.2009.07.010; Gonzalez-Angulo Ana M, 2011, Clin Proteomics, V8, P11, DOI 10.1186/1559-0275-8-11; Gulmann C, 2006, J PATHOL, V208, P595, DOI 10.1002/path.1958; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Jego G, 2010, CANC LETT; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797; Lagarde SM, 2006, J CLIN ONCOL, V24, P4347, DOI 10.1200/JCO.2005.04.9445; Langer R, 2009, MODERN PATHOL, V22, P1555, DOI 10.1038/modpathol.2009.123; Langer R, 2008, CLIN CANCER RES, V14, P8279, DOI 10.1158/1078-0432.CCR-08-0679; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lim SO, 2005, WORLD J GASTROENTERO, V11, P2072, DOI 10.3748/wjg.v11.i14.2072; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lordick F, 2004, BRIT J SURG, V91, P540, DOI 10.1002/bjs.4575; Moore HM, 2011, BIOPRESERV BIOBANK, V9, P57, DOI 10.1089/bio.2010.0036; Nanjundan M, 2010, J THORAC ONCOL, V5, P1894, DOI 10.1097/JTO.0b013e3181f2a266; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Paweletz CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026459; Pfister K, 2007, CANCER-AM CANCER SOC, V110, P926, DOI 10.1002/cncr.22864; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Robb JA, 2008, JAMA-J AM MED ASSOC, V300, P650, DOI 10.1001/jama.300.6.650-c; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Schneider PM, 2005, ANN SURG, V242, P684, DOI 10.1097/01.sla.0000186170.38348.7b; Sharma V, 2012, MOL CELL PROTEOMICS; Sinha A, 2007, LIFE SCI, V80, P1345, DOI 10.1016/j.lfs.2006.12.005; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Tan SS, 2011, J PATHOL, V223, P81, DOI 10.1002/path.2795; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Uckun FM, 2011, BRIT J HAEMATOL, V153, P741, DOI 10.1111/j.1365-2141.2011.08671.x; Usmani SZ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-40; Wang XP, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/212537; Wolff C, 2010, J PATHOL; Wolff C, 2011, METHODS MOL BIOL, V785, P123, DOI 10.1007/978-1-61779-286-1_9; Wolff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016353; Wu X, 2009, BRIT J CANCER, V100, P334, DOI 10.1038/sj.bjc.6604855	54	22	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41420	10.1371/journal.pone.0041420	http://dx.doi.org/10.1371/journal.pone.0041420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911792	gold, Green Submitted, Green Published			2022-12-27	WOS:000306751300038
J	Goropashnaya, AV; Fedorov, VB; Seifert, B; Pamilo, P				Goropashnaya, Anna V.; Fedorov, Vadim B.; Seifert, Bernhard; Pamilo, Pekka			Phylogenetic Relationships of Palaearctic Formica Species (Hymenoptera, Formicidae) Based on Mitochondrial Cytochrome b Sequences	PLOS ONE			English	Article							ANTS HYMENOPTERA; GENETIC DIFFERENTIATION; CHROMOSOME-NUMBERS; TAXONOMIC REVISION; WOOD ANTS; EVOLUTION; DNA; POPULATIONS; RUFA; DIVERSIFICATION	Ants of genus Formica demonstrate variation in social organization and represent model species for ecological, behavioral, evolutionary studies and testing theoretical implications of the kin selection theory. Subgeneric division of the Formica ants based on morphology has been questioned and remained unclear after an allozyme study on genetic differentiation between 13 species representing all subgenera was conducted. In the present study, the phylogenetic relationships within the genus were examined using mitochondrial DNA sequences of the cytochrome b and a part of the NADH dehydrogenase subunit 6. All 23 Formica species sampled in the Palaearctic clustered according to the subgeneric affiliation except F. uralensis that formed a separate phylogenetic group. Unlike Coptoformica and Formica s. str., the subgenus Serviformica did not form a tight cluster but more likely consisted of a few small clades. The genetic distances between the subgenera were around 10%, implying approximate divergence time of 5 Myr if we used the conventional insect divergence rate of 2% per Myr. Within-subgenus divergence estimates were 6.69% in Serviformica, 3.61% in Coptoformica, 1.18% in Formica s. str., which supported our previous results on relatively rapid speciation in the latter subgenus. The phylogeny inferred from DNA sequences provides a necessary framework against which the evolution of social traits can be compared. We discuss implications of inferred phylogeny for the evolution of social traits.	[Goropashnaya, Anna V.] Uppsala Univ, EBC, Dept Ecol & Genet, Uppsala, Sweden; [Goropashnaya, Anna V.; Fedorov, Vadim B.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Seifert, Bernhard] Senckenberg Museum Nat Hist, Gorlitz, Germany; [Pamilo, Pekka] Univ Helsinki, Dept Biosci, Helsinki, Finland	Uppsala University; University of Alaska System; University of Alaska Fairbanks; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Helsinki	Goropashnaya, AV (corresponding author), Uppsala Univ, EBC, Dept Ecol & Genet, Uppsala, Sweden.	agoropashnaya@alaska.edu			Natural Science Research Councils of Sweden; Natural Science Research Councils of Finland; Sven and Lilly Lawski's Foundation; European Comission	Natural Science Research Councils of Sweden; Natural Science Research Councils of Finland; Sven and Lilly Lawski's Foundation; European Comission(European CommissionEuropean Commission Joint Research Centre)	The study has been supported by grants from the Natural Science Research Councils of Sweden and Finland, Sven and Lilly Lawski's Foundation, and from the European Comission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, NEW GEN CATALOGUE AN; Bernasconi C, 2011, MYRMECOL NEWS, V14, P37; Boomsma JJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P85, DOI 10.1007/s002650050415; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; Chapuisat M, 1997, EVOLUTION, V51, P475, DOI 10.1111/j.1558-5646.1997.tb02435.x; CHERIX D, 1991, ETHOL ECOL EVOL, P61; DESALLE R, 1987, J MOL EVOL, V26, P157, DOI 10.1007/BF02111289; Dlussky GM, 2008, PALEONTOL J+, V42, P500, DOI 10.1134/S0031030108050055; Dlussky G.M., 1967, ANTS GENUS FORMICA H; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Goropashnaya AV, 2007, ANN ZOOL FENN, V44, P462; Goropashnaya AV, 2004, MOL PHYLOGENET EVOL, V32, P198, DOI 10.1016/j.ympev.2003.11.016; Goropashnaya AV, 2004, MOL ECOL, V13, P1849, DOI 10.1111/j.1365-294X.2004.02189.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Goropashnaya AV, 2003, THESIS UPPSALA U UPP; Gyllenstrand N, 2005, J EVOLUTION BIOL, V18, P978, DOI 10.1111/j.1420-9101.2005.00908.x; Gyllenstrand N, 2004, INSECT SOC, V51, P139, DOI 10.1007/s00040-003-0720-2; Hasegawa E, 2002, ANN ZOOL FENN, V39, P267; Helantera H, 2007, AM NAT, V170, pE14, DOI 10.1086/518185; Holldobler B., 1990, pi; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Johnson RN, 2003, MOL PHYLOGENET EVOL, V29, P317, DOI 10.1016/S1055-7903(03)00114-3; Keane TM, 2007, NUCLEIC ACIDS RES, V35, pW33, DOI 10.1093/nar/gkm359; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kulmuni J, 2010, P NATL ACAD SCI USA, V107, P7371, DOI 10.1073/pnas.0912409107; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kutter H., 1977, Insecta Helvetica Catalogus, V6, P1; Liautard C, 2001, EVOLUTION, V55, P2484, DOI 10.1111/j.0014-3820.2001.tb00763.x; Lorite P, 2002, SOCIOBIOLOGY, V40, P331; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; PAMILO P, 1984, BIOL J LINN SOC, V21, P331, DOI 10.1111/j.1095-8312.1984.tb00370.x; PAMILO P, 1992, INSECT SOC, V39, P15, DOI 10.1007/BF01240528; PAMILO P, 1979, ANN ENTOMOL FENN, V45, P65; Rich PV, 1997, FOSSIL BOOK RECORD P; ROSENGREN M, 1980, HEREDITAS, V92, P321; Rosengren Rainer, 1993, P308; ROSS KG, 1991, J EVOLUTION BIOL, V4, P117, DOI 10.1046/j.1420-9101.1991.4010117.x; Savolainen R, 2003, P NATL ACAD SCI USA, V100, P7169, DOI 10.1073/pnas.1036825100; Seifert B, 2004, ORG DIVERS EVOL, V4, P295, DOI 10.1016/j.ode.2004.04.005; Seifert B., 1991, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V65, P1; Seifert Bernhard, 2004, Myrmecologische Nachrichten, V6, P29; Seifert B, 2010, EVOL ECOL, V24, P1219, DOI 10.1007/s10682-010-9371-8; Seifert Bernhard, 2000, Zoosystema, V22, P517; Seifert B, 2009, MYRMECOL NEWS, V12, P255; Seifert B, 2009, MYRMECOL NEWS, V12, P67; Sundstrom L, 2003, EVOLUTION, V57, P1552, DOI 10.1111/j.0014-3820.2003.tb00363.x; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TINAUT A, 1989, EOS-Revista Espanola de Entomologia, V65, P280	49	24	27	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41697	10.1371/journal.pone.0041697	http://dx.doi.org/10.1371/journal.pone.0041697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911845	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700141
J	Guerra, P; Sanchez-Adam, A; Anllo-Vento, L; Ramirez, I; Vila, J				Guerra, Pedro; Sanchez-Adam, Alicia; Anllo-Vento, Lourdes; Ramirez, Isabel; Vila, Jaime			Viewing Loved Faces Inhibits Defense Reactions: A Health-Promotion Mechanism?	PLOS ONE			English	Article							ROMANTIC LOVE; NEURAL BASIS; EMOTION; MOTIVATION; BRAIN; RESPONSES; FAMILIAR; SUPPORT; LIFE	We have known for decades that social support is associated with positive health outcomes. And yet, the neurophysiological mechanisms underlying this association remain poorly understood. The link between social support and positive health outcomes is likely to depend on the neurophysiological regulatory mechanisms underlying reward and defensive reactions. The present study examines the hypothesis that emotional social support (love) provides safety cues that activate the appetitive reward system and simultaneously inhibit defense reactions. Using the startle probe paradigm, 54 undergraduate students (24 men) viewed black and white photographs of loved (romantic partner, father, mother, and best friend), neutral (unknown), and unpleasant (mutilated) faces. Eye-blink startle, zygomatic major activity, heart rate, and skin conductance responses to the faces, together with subjective ratings of valence, arousal, and dominance, were obtained. Viewing loved faces induced a marked inhibition of the eye-blink startle response accompanied by a pattern of zygomatic, heart rate, skin conductance, and subjective changes indicative of an intense positive emotional response. Effects were similar for men and women, but the startle inhibition and the zygomatic response were larger in female participants. A comparison between the faces of the romantic partner and the parent who shares the partner's gender further suggests that this effect is not attributable to familiarity or arousal. We conclude that this inhibitory capacity may contribute to the health benefits associated with social support.	[Guerra, Pedro; Sanchez-Adam, Alicia; Anllo-Vento, Lourdes; Vila, Jaime] Univ Granada, Dept Personal, Granada, Spain; [Ramirez, Isabel] Spanish Natl Open Univ, Dept Personal, Madrid, Spain; [Anllo-Vento, Lourdes] Univ Granada, F Oloriz Inst Neurosci, Granada, Spain	University of Granada; University of Granada	Guerra, P (corresponding author), Univ Granada, Dept Personal, Granada, Spain.	jvila@ugr.es	Guerra, Pedro/ABF-1291-2020; Vila, Jaime/F-9719-2010; Guerra, Pedro/ABH-1639-2020; Ramirez-Ucles, Isabel/F-5559-2015	Vila, Jaime/0000-0002-1767-8606; Guerra, Pedro/0000-0003-0614-629X; Ramirez-Ucles, Isabel/0000-0002-3689-5999	Junta de Andalucia (Spain) [P07-SEJ-02964]	Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission)	This research was funded by grant P07-SEJ-02964 from Junta de Andalucia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Arbiol I, 2007, PERS RELATIONSHIP, V14, P45, DOI 10.1111/j.1475-6811.2006.00141.x; Alpers GW, 2011, INT J PSYCHOPHYSIOL, V80, P173, DOI 10.1016/j.ijpsycho.2011.01.010; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anokhin AP, 2010, BIOL PSYCHOL, V83, P37, DOI 10.1016/j.biopsycho.2009.10.001; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bobes MA, 2007, BIOL PSYCHOL, V75, P146, DOI 10.1016/j.biopsycho.2007.01.006; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Cacioppo JT, 2000, PSYCHOL BULL, V126, P829, DOI 10.1037//0033-2909.126.6.829; De la Revilla L., 2005, MED FAM, V6, P10, DOI DOI 10.1157/13102357; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Grasso DJ, 2009, BIOL PSYCHOL, V81, P95, DOI 10.1016/j.biopsycho.2009.03.001; Guerra P, 2011, BIOL PSYCHOL, V88, P196, DOI 10.1016/j.biopsycho.2011.08.002; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Herzmann G, 2004, PSYCHOPHYSIOLOGY, V41, P688, DOI 10.1111/j.1469-8986.2004.00196.x; Hess U, 2007, PSYCHOPHYSIOLOGY, V44, P431, DOI 10.1111/j.1469-8986.2007.00516.x; Krantz DS, 2002, ANNU REV PSYCHOL, V53, P341, DOI 10.1146/annurev.psych.53.100901.135208; Lang P.J., 2008, A8 U FLOR; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Langeslag SJE, 2007, BIOL PSYCHOL, V76, P109, DOI 10.1016/j.biopsycho.2007.06.007; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Mikulincer M., 2006, DYNAMICS ROMANTIC LO, DOI [10.1002/per.405, DOI 10.1002/PER.405]; Perez-Albeniz A, 2003, PSICOTHEMA, V15, P267; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; Rocha KB, 2011, INT J CLIN HLTH PSYC, V11, P125; Sandin B, 1999, PSICOTHEMA, V11, P37; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; SIMONS RF, 1986, PSYCHOPHYSIOLOGY, V23, P461; Spangler G, 2001, INT J PSYCHOPHYSIOL, V41, P155, DOI 10.1016/S0167-8760(01)00127-1; Taylor SE, 2010, P NATL ACAD SCI USA, V107, P8507, DOI 10.1073/pnas.1003890107; Vico C, 2010, NEUROPSYCHOLOGIA, V48, P2894, DOI 10.1016/j.neuropsychologia.2010.05.031; Voss JL, 2006, J NEUROSCI, V26, P926, DOI 10.1523/JNEUROSCI.3931-05.2006; Way BM, 2010, PSYCHOSOM MED, V72, P107, DOI 10.1097/PSY.0b013e3181ce6a7d; Xu JP, 2010, HEALTH PSYCHOL, V29, P9, DOI 10.1037/a0016767; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Yovel G, 2004, NEUROIMAGE, V21, P789, DOI 10.1016/j.neuroimage.2003.09.034	47	24	24	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41631	10.1371/journal.pone.0041631	http://dx.doi.org/10.1371/journal.pone.0041631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22911829	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700129
J	Aamir, UB; Badar, N; Mehmood, MR; Nisar, N; Suleman, RM; Shaukat, S; Sharif, S; Kamran, J; Zaidi, SSZ; Kazi, BM; Gubareva, L; Xu, XY; Garten, R; Klimov, A				Aamir, Uzma Bashir; Badar, Nazish; Mehmood, Muhammad Rashid; Nisar, Nadia; Suleman, Rana Muhammad; Shaukat, Shehzad; Sharif, Salman; Kamran, Jaleel; Zaidi, Syed Sohail Zahoor; Kazi, Birjees Mazher; Gubareva, Larisa; Xu, Xiyan; Garten, Rebecca; Klimov, Alexander			Molecular Epidemiology of Influenza A(H1N1)pdm09 Viruses from Pakistan in 2009-2010	PLOS ONE			English	Article							SWINE; H1N1; EMERGENCE	Background: In early 2009, a novel influenza A(H1N1) virus that emerged in Mexico and United States rapidly disseminated worldwide. The spread of this virus caused considerable morbidity with over 18000 recorded deaths. The new virus was found to be a reassortant containing gene segments from human, avian and swine influenza viruses. Methods/Results: The first case of human infection with A(H1N1)pdm09 in Pakistan was detected on 18th June 2009. Since then, 262 laboratory-confirmed cases have been detected during various outbreaks with 29 deaths (as of 31st August 2010). The peak of the epidemic was observed in December with over 51% of total respiratory cases positive for influenza. Representative isolates from Pakistan viruses were sequenced and analyzed antigenically. Sequence analysis of genes coding for surface glycoproteins HA and NA showed high degree of high levels of sequence identity with corresponding genes of regional viruses circulating South East Asia. All tested viruses were sensitive to Oseltamivir in the Neuraminidase Inhibition assays. Conclusions: Influenza A(H1N1) pdm09 viruses from Pakistan form a homogenous group of viruses. Their HA genes belong to clade 7 and show antigenic profile similar to the vaccine strain A/California/07/2009. These isolates do not show any amino acid changes indicative of high pathogenicity and virulence. It is imperative to continue monitoring of these viruses for identification of potential variants of high virulence or drug resistance.	[Aamir, Uzma Bashir; Badar, Nazish; Mehmood, Muhammad Rashid; Nisar, Nadia; Suleman, Rana Muhammad; Shaukat, Shehzad; Sharif, Salman; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Publ Hlth Labs Div, Islamabad, Pakistan; [Gubareva, Larisa; Xu, Xiyan; Garten, Rebecca; Klimov, Alexander] Ctr Dis Control, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Aamir, UB (corresponding author), Natl Inst Hlth, Dept Virol, Publ Hlth Labs Div, Islamabad, Pakistan.	sohail.zaidi56@gmail.com	Zaidi, Syed Sohail Zahoor/F-7432-2015		NIH-CDC [U50/CCU024406]	NIH-CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institutes of Health (NIH) - USA)	This work was supported under the NIH-CDC cooperative agreement no. U50/CCU024406 for Development Influenza Surveillance Network in Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BR, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-133; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P305; Barr IG, 2010, EURO SURVEILL, V15; Brockwell-Staats C, 2009, INFLUENZA OTHER RESP, V3, P207, DOI 10.1111/j.1750-2659.2009.00096.x; Chang LY, 2009, J FORMOS MED ASSOC, V108, P526, DOI 10.1016/S0929-6646(09)60369-7; Ciblak MA, 2009, EUROSURVEILLANCE, V14, P2; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Gomez J, 2009, EURO SURVEILL, V4; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Nelson Martha, 2009, PLoS Curr, V1, pRRN1126; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; PALMER DF, 1975, IMMUNOLOGY SERIES, V6, P51; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez Daniel Roberto, 2009, PLoS Curr, V1, pRRN1011; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; World Health Organization, 2009, HUM INF PAND H1N1 20; World Health Organization (WHO) CDC Real time RTPCR (rRTPCR), CDC REAL TIM RTPCR R; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41866	10.1371/journal.pone.0041866	http://dx.doi.org/10.1371/journal.pone.0041866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916112	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800013
J	Shu, CC; Wu, VC; Yang, FJ; Pan, SC; Lai, TS; Wang, JY; Wang, JT; Lee, LN				Shu, Chin-Chung; Wu, Vin-Cent; Yang, Feng-Jung; Pan, Sung-Ching; Lai, Tai-Shuan; Wang, Jann-Yuan; Wang, Jann-Tay; Lee, Li-Na			Predictors and Prevalence of Latent Tuberculosis Infection in Patients Receiving Long-Term Hemodialysis and Peritoneal Dialysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; GAMMA RELEASE ASSAY; CHRONIC KIDNEY-DISEASE; QUANTIFERON-TB GOLD; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; SKIN-TEST; RISK; DIAGNOSIS; ASSOCIATION	Background: Tuberculosis is a common infectious disease in long-term dialysis patients. The prevalence of latent tuberculosis infection (LTBI) in this population is unclear, particularly in those receiving peritoneal dialysis (PD). This study investigated the prevalence of LTBI in patients receiving either hemodialysis (HD) or PD to determine predictors of LTBI and indeterminate results of interferon-gamma release assay. Methods: Patients receiving long-term (>= 3 months) HD or PD from March 2011 to February 2012 in two medical centers were prospectively enrolled. QuantiFERON-Gold in tube (QFT) test was used to determine the status of LTBI after excluding active tuberculosis. The LTBI prevalence was determined in patients receiving different dialysis modes to obtain predictors of LTBI and QFT-indeterminate results. Results: Of 427 patients enrolled (124 PD and 303 HD), 91 (21.3%) were QFT-positive, 316 (74.0%) QFT-negative, and 20 (4.7%) QFT-indeterminate. The prevalence of LTBI was similar in the PD and HD groups. Independent predictors of LTBI were old age (OR: 1.034 [1.013-1.056] per year increment), TB history (OR: 6.467 [1.985-21.066]), and current smoker (OR: 2.675 [1.061-6.747]). Factors associated with indeterminate QFT results were HD (OR: 10.535 [1.336-83.093]), dialysis duration (OR: 1.113 [1.015-1.221] per year increment), anemia (OR: 8.760 [1.014-75.651]), and serum albumin level (OR: 0.244 [0.086-0.693] per 1 g/dL increment). Conclusion: More than one-fifth of dialysis patients have LTBI. The LTBI prevalence is similar in PD and HD patients but is higher in the elderly, current smokers, and those with prior TB history. Such patients require closer follow-up. Repeated or alternative test may be required for malnutrition patients who received long length of HD.	[Shu, Chin-Chung] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Yun Lin County, Taiwan; [Shu, Chin-Chung; Wu, Vin-Cent; Wang, Jann-Yuan; Wang, Jann-Tay] Natl Taiwan Univ, Coll Internal Med, Taipei 10764, Taiwan; [Yang, Feng-Jung] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Taipei 100, Yun Lin County, Taiwan; [Lai, Tai-Shuan] Natl Taiwan Univ Hosp, Dept Internal Med, Bei Hu Branch, Taipei 100, Yun Lin County, Taiwan; [Lee, Li-Na] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Yun Lin County, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Shu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Yun Lin County, Taiwan.	jywang@ntu.edu.tw	Yang, Feng-Jung/AAK-9946-2020; Yang, Feng-Jung/GYU-9337-2022	Yang, Feng-Jung/0000-0003-1235-1943; PAN, SUNG-CHING/0000-0003-3154-6690; LEE, LI-NA/0000-0002-7654-2450; SHU, CHIN-CHUNG/0000-0003-0311-5148; Lai, Tai-Shuan/0000-0002-0552-372X; WANG, JANN-TAY/0000-0002-0924-3469; WANG, JANN-YUAN/0000-0003-3406-366X; WU, VIN-CENT/0000-0001-7935-0991	Institute of Biotechnology and Medicine Industry in Taiwan	Institute of Biotechnology and Medicine Industry in Taiwan	This study was funded by Institute of Biotechnology and Medicine Industry in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1997, AM J KIDNEY DIS, V30, pS15; Banach DB, 2011, INT J TUBERC LUNG D, V15, P1623, DOI 10.5588/ijtld.11.0017; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; BROCK I, 2004, AM J RESP CRIT CARE, V170, P65; Centers of Disease Control DoH R. O. C. (Taiwan), 2010, CDC ANN REP 2011; Chavers BM, 2007, J AM SOC NEPHROL, V18, P952, DOI 10.1681/ASN.2006040406; Christopoulos AI, 2006, INT UROL NEPHROL, V38, P745, DOI 10.1007/s11255-006-9051-3; Chung WK, 2010, CLIN MICROBIOL INFEC, V16, P960, DOI 10.1111/j.1469-0691.2009.02949.x; de Cal M, 2008, BLOOD PURIFICAT, V26, P249, DOI 10.1159/000122110; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Dobler CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029563; Dyrhol-Riise AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-57; Fabrizi F, 2012, DIGEST DIS SCI, V57, P1366, DOI 10.1007/s10620-011-1987-1; Fang HC, 2004, INT J TUBERC LUNG D, V8, P92; Hill CJ, 2012, J RENAL CARE, V38, P12, DOI 10.1111/j.1755-6686.2012.00273.x; Jasmer RM, 2000, AM J RESP CRIT CARE, V162, P1648, DOI 10.1164/ajrccm.162.5.2003028; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lange B, 2010, EUR RESPIR J, V35, P1179, DOI 10.1183/09031936.00122109; Lee SSJ, 2009, INFECTION, V37, P96, DOI 10.1007/s15010-008-8082-3; Lee SSJ, 2010, CLIN J AM SOC NEPHRO, V5, P1451, DOI 10.2215/CJN.01790210; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Lukowsky LR, 2012, AM J NEPHROL, V35, P548, DOI 10.1159/000338673; LUNDIN AP, 1979, AM J MED, V67, P597, DOI 10.1016/0002-9343(79)90240-7; Palomar R, 2011, NEFROLOGIA, V31, P169, DOI 10.3265/Nefrologia.pre2011.Jan.10765; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rose DN, 2000, ARCH INTERN MED, V160, P1513, DOI 10.1001/archinte.160.10.1513; Sester M, 2004, KIDNEY INT, V65, P1826, DOI 10.1111/j.1523-1755.2004.00586.x; Shu CC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-48; Shu CC, 2010, MEDICINE, V89, P53, DOI 10.1097/MD.0b013e3181cafcd3; Simsek H, 2010, JPN J INFECT DIS, V63, P99; Smirnoff M, 1998, CHEST, V113, P25, DOI 10.1378/chest.113.1.25; Stevens LA, 2010, ADV CHRONIC KIDNEY D, V17, P293, DOI 10.1053/j.ackd.2010.03.010; Triverio PA, 2009, NEPHROL DIAL TRANSPL, V24, P1952, DOI 10.1093/ndt/gfn748; Vacher-Coponat H, 2008, NEPHROL DIAL TRANSPL, V23, P1406, DOI 10.1093/ndt/gfm596; Venkata RKC, 2007, CLIN NEPHROL, V67, P217; Wang JY, 2012, J INFECTION, V64, P291, DOI 10.1016/j.jinf.2011.11.028; Yu MC, 1999, J FORMOS MED ASSOC, V98, P496	40	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42592	10.1371/journal.pone.0042592	http://dx.doi.org/10.1371/journal.pone.0042592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916137	gold, Green Submitted, Green Published			2022-12-27	WOS:000307733800021
J	Bupha-Intr, T; Haizlip, KM; Janssen, PML				Bupha-Intr, Tepmanas; Haizlip, Kaylan M.; Janssen, Paul M. L.			Role of Endothelin in the Induction of Cardiac Hypertrophy In Vitro	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT KINASE-II; SLOW FORCE RESPONSE; GENE-EXPRESSION; STRETCH; CARDIOMYOCYTES; CONTRACTION; CA2+; MYOCARDIUM; ATRIAL; HEART	Endothelin (ET-1) is a peptide hormone mediating a wide variety of biological processes and is associated with development of cardiac dysfunction. Generally, ET-1 is regarded as a molecular marker released only in correlation with the observation of a hypertrophic response or in conjunction with other hypertrophic stress. Although the cardiac hypertrophic effect of ET-1 is demonstrated, inotropic properties of cardiac muscle during chronic ET-1-induced hypertrophy remain largely unclear. Through the use of a novel in vitro multicellular culture system, changes in contractile force and kinetics of rabbit cardiac trabeculae in response to 1 nM ET-1 for 24 hours can be observed. Compared to the initial force at t = 0 hours, ET-1 treated muscles showed a similar to 2.5 fold increase in developed force after 24 hours without any effect on time to peak contraction or time to 90% relaxation. ET-1 increased muscle diameter by 12.5 +/- 3.2% from the initial size, due to increased cell width compared to non-ET-1 treated muscles. Using specific signaling antagonists, inhibition of NCX, CaMKII, MAPKK, and IP3 could attenuate the effect of ET-1 on increased developed force. However, among these inhibitions only IP3 receptor blocker could not prevent the increase muscle size by ET-1. Interestingly, though calcineurin-NFAT inhibition could not suppress the effect of ET-1 on force development, it did prevent muscle hypertrophy. These findings suggest that ET-1 provokes both inotropic and hypertrophic activations on myocardium in which both activations share the same signaling pathway through MAPK and CaMKII in associated with NCX activity.	[Bupha-Intr, Tepmanas] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, D Davis Heart Lung Res Inst, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Bupha-Intr, T (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	janssen.10@osu.edu	Janssen, Paul ML/E-3307-2011	Janssen, Paul/0000-0002-9682-3014	American Heart Association	American Heart Association(American Heart Association)	Work supported by American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez BV, 1999, CIRC RES, V85, P716, DOI 10.1161/01.RES.85.8.716; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Baudet S, 2001, CARDIOVASC RES, V50, P486, DOI 10.1016/S0008-6363(01)00225-5; Berra-Romani R, 2010, BIOCHEM BIOPH RES CO, V395, P126, DOI 10.1016/j.bbrc.2010.03.153; Bers DM, 2001, CIRC RES, V89, P373, DOI 10.1161/res.89.5.373; Bupha-Intr T, 2007, AM J PHYSIOL-HEART C, V293, pH3759, DOI 10.1152/ajpheart.01267.2006; Bupha-Intr T, 2009, AM J PHYSIOL-HEART C, V296, pH806, DOI 10.1152/ajpheart.01058.2008; Castillo SS, 2004, CANCER RES, V64, P2782, DOI 10.1158/0008-5472.CAN-03-1530; Chase A, 2010, J MOL CELL CARDIOL; Choukroun G, 1999, J CLIN INVEST, V104, P391, DOI 10.1172/JCI6350; Choukroun G, 1998, J CLIN INVEST, V102, P1311, DOI 10.1172/JCI3512; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Dulce RA, 2006, J MOL CELL CARDIOL, V41, P807, DOI 10.1016/j.yjmcc.2006.05.016; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Fujita S, 1996, J Card Fail, V2, pS45, DOI 10.1016/S1071-9164(96)80058-3; Guterl KA, 2007, AM J PHYSIOL-HEART C, V293, pH3707, DOI 10.1152/ajpheart.00296.2007; Haizlip KM, 2012, AM J PHYSIOL-HEART C, V302, pH2509, DOI 10.1152/ajpheart.00660.2011; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Hidaka Ikuhiro, 2009, Hiroshima Journal of Medical Sciences, V58, P9; Ito N, 1997, J CLIN INVEST, V99, P125, DOI 10.1172/JCI119123; James AF, 2007, BRIT J PHARMACOL, V152, P417, DOI 10.1038/sj.bjp.0707438; Janssen PML, 2009, PHARMACOLOGY, V83, P141, DOI 10.1159/000187428; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1092, DOI 10.1152/ajpheart.00417.2010; Janssen PML, 1998, AM J PHYSIOL-HEART C, V274, pH1481, DOI 10.1152/ajpheart.1998.274.5.H1481; Janssen PML, 1999, J MOL CELL CARDIOL, V31, P1419, DOI 10.1006/jmcc.1999.0978; Janssen PML, 2002, CARDIOVASC RES, V55, P300, DOI 10.1016/S0008-6363(02)00406-6; Janssen PML, 2002, AM J PHYSIOL-HEART C, V282, pH349, DOI 10.1152/ajpheart.00024.2001; Janssen PML, 2010, AM J PHYSL HEART CIR; JONES LG, 1992, AM J PHYSIOL, V263, pH1447, DOI 10.1152/ajpheart.1992.263.5.H1447; Kennedy RA, 2006, J MOL CELL CARDIOL, V41, P236, DOI 10.1016/j.yjmcc.2006.04.011; Kerkela R, 2011, AM J PHYSIOL-REG I, V300, pR140, DOI 10.1152/ajpregu.00853.2009; Kockskamper J, 2008, PROG BIOPHYS MOL BIO, V97, P250, DOI 10.1016/j.pbiomolbio.2008.02.026; Komukai K, 2010, AM J PHYSIOL-HEART C, V298, pH1902, DOI 10.1152/ajpheart.01141.2009; Lehnart SE, 2000, AM J PHYSIOL-HEART C, V279, pH986, DOI 10.1152/ajpheart.2000.279.3.H986; Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu CQ, 2008, EUR J PHARMACOL, V590, P250, DOI 10.1016/j.ejphar.2008.05.009; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Rohini A, 2009, PHARM RES, V61, P269; Schunkert H, 1999, J MOL MED-JMM, V77, P623, DOI 10.1007/s001099900035; Sugden Peter H., 2005, Current Vascular Pharmacology, V3, P343, DOI 10.2174/157016105774329390; Ueno M, 1999, AM J PHYSIOL-REG I, V277, pR1321, DOI 10.1152/ajpregu.1999.277.5.R1321; von Lewinski D, 2003, CARDIOVASC RES, V57, P1052, DOI 10.1016/S0008-6363(02)00830-1; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Xiao L, 2008, CIRC RES, V103, P733, DOI 10.1161/CIRCRESAHA.108.171157; Yamazaki T, 1996, J Card Fail, V2, pS7, DOI 10.1016/S1071-9164(96)80053-4; Zhu WD, 2000, J BIOL CHEM, V275, P15239, DOI 10.1074/jbc.275.20.15239; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	49	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43179	10.1371/journal.pone.0043179	http://dx.doi.org/10.1371/journal.pone.0043179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912821	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700057
J	de Moura, MB; Vincent, G; Fayewicz, SL; Bateman, NW; Hood, BL; Sun, M; Suhan, J; Duensing, S; Yin, Y; Sander, C; Kirkwood, JM; Becker, D; Conrads, TP; Van Houten, B; Moschos, SJ				de Moura, Michelle Barbi; Vincent, Garret; Fayewicz, Shelley L.; Bateman, Nicholas W.; Hood, Brian L.; Sun, Mai; Suhan, Joseph; Duensing, Stefan; Yin, Yan; Sander, Cindy; Kirkwood, John M.; Becker, Dorothea; Conrads, Thomas P.; Van Houten, Bennett; Moschos, Stergios J.			Mitochondrial Respiration - An Important Therapeutic Target in Melanoma	PLOS ONE			English	Article							CELL LINES; METABOLISM; EXPRESSION; FLUX; LIPOGENESIS; SURVIVAL; GROWTH; OXYGEN	The importance of mitochondria as oxygen sensors as well as producers of ATP and reactive oxygen species (ROS) has recently become a focal point of cancer research. However, in the case of melanoma, little information is available to what extent cellular bioenergetics processes contribute to the progression of the disease and related to it, whether oxidative phosphorylation (OXPHOS) has a prominent role in advanced melanoma. In this study we demonstrate that compared to melanocytes, metastatic melanoma cells have elevated levels of OXPHOS. Furthermore, treating metastatic melanoma cells with the drug, Elesclomol, which induces cancer cell apoptosis through oxidative stress, we document by way of stable isotope labeling with amino acids in cell culture (SILAC) that proteins participating in OXPHOS are downregulated. We also provide evidence that melanoma cells with high levels of glycolysis are more resistant to Elesclomol. We further show that Elesclomol upregulates hypoxia inducible factor 1-alpha (HIF-1 alpha), and that prolonged exposure of melanoma cells to this drug leads to selection of melanoma cells with high levels of glycolysis. Taken together, our findings suggest that molecular targeting of OXPHOS may have efficacy for advanced melanoma.	[de Moura, Michelle Barbi; Bateman, Nicholas W.; Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Vincent, Garret; Fayewicz, Shelley L.; Yin, Yan; Sander, Cindy; Kirkwood, John M.; Moschos, Stergios J.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Hood, Brian L.; Conrads, Thomas P.] Inova Hlth Syst, Womens Hlth Integrated Res Ctr, Gynecol Canc Ctr Excellence, Annandale, VA USA; [Sun, Mai] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Suhan, Joseph] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Duensing, Stefan] Urol Univ Klin Heidelberg, Sekt Mol Uroonkol, Heidelberg, Germany; [Becker, Dorothea] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Inova Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Ruprecht Karls University Heidelberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	de Moura, MB (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	stergios_moschos@med.unc.edu	Van Houten, Bennett/K-2284-2019	Sun, Mai/0000-0003-0489-1616	Career Development Award of a SPORE in Skin Cancer [P50CA121973]; Pennsylvania Department of Health PA CURE award; NATIONAL CANCER INSTITUTE [P50CA121973] Funding Source: NIH RePORTER	Career Development Award of a SPORE in Skin Cancer; Pennsylvania Department of Health PA CURE award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Career Development Award of a SPORE in Skin Cancer (P50CA121973) to SJM, and a Pennsylvania Department of Health PA CURE award to BVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MV, 2010, REJUV RES, V13, P139, DOI 10.1089/rej.2009.0948; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Blackman RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029798; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Dykstra KM, 2010, MOL BIOL CELL, V21, P1556, DOI 10.1091/mbc.E09-12-1002; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Farmer PJ, 2003, PIGM CELL RES, V16, P273, DOI 10.1034/j.1600-0749.2003.00046.x; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Flint MS, 2009, PSYCHONEUROENDOCRINO, V34, P1533, DOI 10.1016/j.psyneuen.2009.05.008; Foley KP, 2007, AACR NCI EORTC S MOL; Ganter B, 2008, CURR OPIN DRUG DISC, V11, P86; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hauschild A, 2009, ASCO ANN M ORL FL; Hersey P, 2009, CLIN CANCER RES, V15, P6490, DOI 10.1158/1078-0432.CCR-09-0251; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; KALLINOWSKI F, 1989, CANCER RES, V49, P3759; Kirshner JR, 2008, MOL CANCER THER, V7, P2319, DOI 10.1158/1535-7163.MCT-08-0298; Kong Q, 2000, MED HYPOTHESES, V55, P29, DOI 10.1054/mehy.1999.0982; Kuphal S, 2010, EUR J CANCER, V46, P1159, DOI 10.1016/j.ejca.2010.01.031; Manola J, 2000, J CLIN ONCOL, V18, P3782, DOI 10.1200/JCO.2000.18.22.3782; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x; Moschos SJ, 2009, CANCER BIOL THER, V8, P1815, DOI 10.4161/cbt.8.19.9435; Nakajima EC, 2012, MOL CARCINOG; O'Day S, 2009, J CLIN ONCOL, V27, P5452, DOI 10.1200/JCO.2008.17.1579; PARCE JW, 1989, SCIENCE, V246, P243, DOI 10.1126/science.2799384; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Silverthorn CF, 2010, MELANOMA RES, V20, P61, DOI 10.1097/CMR.0b013e328333d8c2; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wang XH, 2011, CANCER RES, V71, P7410, DOI 10.1158/0008-5472.CAN-10-1134; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Zhuang LQ, 2010, MODERN PATHOL, V23, P45, DOI 10.1038/modpathol.2009.129	47	77	77	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e40690	10.1371/journal.pone.0040690	http://dx.doi.org/10.1371/journal.pone.0040690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912665	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000308063700001
J	Fallah, A; Akl, EA; Ebrahim, S; Ibrahim, GM; Mansouri, A; Foote, CJ; Zhang, Y; Fehlings, MG				Fallah, Aria; Akl, Elie A.; Ebrahim, Shanil; Ibrahim, George M.; Mansouri, Alireza; Foote, Clary J.; Zhang, Yuqing; Fehlings, Michael G.			Anterior Cervical Discectomy with Arthroplasty versus Arthrodesis for Single-Level Cervical Spondylosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							INVESTIGATIONAL DEVICE EXEMPTION; 2-YEAR FOLLOW-UP; DISC-ARTHROPLASTY; CLINICAL-OUTCOMES; RANDOMIZED-TRIALS; ARTIFICIAL DISC; FUSION; REPLACEMENT; ADJACENT; MULTICENTER	Objective: To estimate the effectiveness of anterior cervical discectomy with arthroplasty (ACDA) compared to anterior cervical discectomy with fusion (ACDF) for patient-important outcomes for single-level cervical spondylosis. Data sources: Electronic databases (MEDLINE, EMBASE, Cochrane Register for Randomized Controlled Trials, BIOSIS and LILACS), archives of spine meetings and bibliographies of relevant articles. Study selection: We included RCTs of ACDF versus ACDA in adult patients with single-level cervical spondylosis reporting at least one of the following outcomes: functionality, neurological success, neck pain, arm pain, quality of life, surgery for adjacent level degeneration (ALD), reoperation and dysphonia/dysphagia. We used no language restrictions. We performed title and abstract screening and full text screening independently and in duplicate. Data synthesis: We used random-effects model to pool data using mean difference (MD) for continuous outcomes and relative risk (RR) for dichotomous outcomes. We used GRADE to evaluate the quality of evidence for each outcome. Results: Of 2804 citations, 9 articles reporting on 9 trials (1778 participants) were eligible. ACDA is associated with a clinically significant lower incidence of neurologic failure (RR = 0.53, 95% CI = 0.37-0.75, p = 0.0004) and improvement in the Neck pain visual analogue scale (VAS) (MD = 6.56, 95% CI = 3.22-9.90, p = 0.0001; Minimal clinically important difference (MCID) = 2.5. ACDA is associated with a statistically but not clinically significant improvement in Arm pain VAS and SF-36 physical component summary. ACDA is associated with non-statistically significant higher improvement in the Neck Disability Index Score and lower incidence of ALD requiring surgery, reoperation, and dysphagia/dysphonia. Conclusions: There is no strong evidence to support the routine use of ACDA over ACDF in single-level cervical spondylosis. Current trials lack long-term data required to assess safety as well as surgery for ALD. We suggest that ACDA in patients with single level cervical spondylosis is an option although its benefits and indication over ACDF remain in question.	[Fallah, Aria; Ibrahim, George M.; Mansouri, Alireza; Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Fallah, Aria; Akl, Elie A.; Ebrahim, Shanil; Foote, Clary J.; Zhang, Yuqing] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Ibrahim, George M.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Foote, Clary J.] McMaster Univ, Div Orthoped Surg, Hamilton, ON, Canada; [Zhang, Yuqing] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Fehlings, Michael G.] Toronto Western Hosp, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada; [Fehlings, Michael G.] Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada	University of Toronto; McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto; McMaster University; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fallah, A (corresponding author), Univ Toronto, Div Neurosurg, Toronto, ON, Canada.	aria.fallah@mail.utoronto.ca	Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Akl, Elie A/0000-0002-3444-8618; Mansouri, Alireza/0000-0002-7442-7539; Fehlings, Michael/0000-0002-5722-6364; Fallah, Aria/0000-0002-9703-0964				Abibtol JJ, 2008, ABSTR SPIN GEN C, VC74, P46; Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; Anakwenze OA, 2009, SPINE, V34, P2001, DOI 10.1097/BRS.0b013e3181b03fe6; Anderson PA, 2008, SPINE, V33, P1305, DOI 10.1097/BRS.0b013e31817329a1; Anderson PA, 2009, SPINE, V34, P176, DOI 10.1097/BRS.0b013e3181913cba; Auerbach JD, 2011, SPINE, V36, pE1593, DOI 10.1097/BRS.0b013e31821cfd47; Bartels RHMA, 2010, NEUROSURGERY, V66, P1153, DOI 10.1227/01.NEU.0000369189.09182.5F; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Botelho RV, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1032; Burkus JK, 2010, J NEUROSURG-SPINE, V13, P308, DOI 10.3171/2010.3.SPINE09513; Carette S, 2005, NEW ENGL J MED, V353, P392, DOI 10.1056/NEJMcp043887; Carreon LY, 2010, SPINE J, V10, P469, DOI 10.1016/j.spinee.2010.02.007; Cepoiu-Martin M, 2011, SPINE PHILA PA 1976; Chen J, 2012, EUR SPINE J, V21, P674, DOI 10.1007/s00586-011-2094-x; Coric D, 2006, J NEUROSURG-SPINE, V4, P31, DOI 10.3171/spi.2006.4.1.31; Coric D, 2011, J NEUROSURG-SPINE, V15, P348, DOI 10.3171/2011.5.SPINE10769; Coric D, 2010, J NEUROSURG-SPINE, V13, P715, DOI 10.3171/2010.5.SPINE09852; Deeks J., 2011, COCHRANE HDB SYST RE, V5; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Garrido BJ, 2010, J SPINAL DISORD TECH, V23, P367, DOI 10.1097/BSD.0b013e3181bb8568; Guyatt GH, 2011, MODIFICATION COCHRAN; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Guyer R, 2008, ABSTR SPIN GEN C, VC73, P45; Hacker RJ, 2005, J NEUROSURG-SPINE, V3, P424, DOI 10.3171/spi.2005.3.6.0424; Heller JG, 2009, SPINE, V34, P101, DOI 10.1097/BRS.0b013e31818ee263; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hisey MS, 2011, EUROSPINE 2011; Jawahar A, 2010, SPINE J, V10, P1043, DOI 10.1016/j.spinee.2010.08.014; Jiang H, 2012, ARCH ORTHOP TRAUM SU, V132, P141, DOI 10.1007/s00402-011-1401-7; Lefebvre C, 2001, SYSTEMATIC REV HEALT; Marzluff J, 2010, NASS C; McAfee PC, 2010, J SPINAL DISORD TECH, V23, P1, DOI 10.1097/BSD.0b013e31819e2ab8; McAfee PC, 2011, SPINE PHILA PA 1976; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mummaneni PV, 2007, J NEUROSURG-SPINE, V6, P198, DOI 10.3171/spi.2007.6.3.198; Murrey D, 2009, SPINE J, V9, P275, DOI 10.1016/j.spinee.2008.05.006; Nabhan A, 2007, EUR SPINE J, V16, P423, DOI 10.1007/s00586-006-0226-5; Nabhan A, 2011, EUR SPINE J, V20, P934, DOI 10.1007/s00586-010-1588-2; Nabhan A, 2007, J Long Term Eff Med Implants, V17, P229; Nabhan A, 2007, SPINE, V32, P1935, DOI 10.1097/BRS.0b013e31813162d8; Park DK, 2011, SPINE, V36, P721, DOI 10.1097/BRS.0b013e3181df10fc; Peng-Fei S, 2008, INT ORTHOP, V32, P103, DOI 10.1007/s00264-006-0287-4; Reitman CA, 2004, SPINE, V29, pE221, DOI 10.1097/00007632-200406010-00022; Robertson JT, 2005, J NEUROSURG-SPINE, V3, P417, DOI 10.3171/spi.2005.3.6.0417; Sasso RC, 2008, J SPINAL DISORD TECH, V21, P393, DOI 10.1097/BSD.0b013e318150d121; Sasso RC, 2007, SPINE, V32, P2933, DOI 10.1097/BRS.0b013e31815d0034; Sasso RC, 2007, J SPINAL DISORD TECH, V20, P481, DOI 10.1097/BSD.0b013e3180310534; Sasso RC, 2011, J BONE JOINT SURG AM, V93A, P1684, DOI [10.2106/JBJS.J.00476, 10.2106/JBJSJ.00476]; Sasso RC, 2011, SPINE, V36, P991, DOI 10.1097/BRS.0b013e3182076d70; Upadhyaya CD, 2011, J NEUROSURG SPINE; Upadhyaya CD, 2012, J NEUROSURG-SPINE, V16, P216, DOI 10.3171/2011.6.SPINE10623; Xu JX, 2009, SPINE, V34, P1012, DOI 10.1097/BRS.0b013e31819c4a5b; Young IA, 2010, AM J PHYS MED REHAB, V89, P831, DOI 10.1097/PHM.0b013e3181ec98e6; Yu L, 2011, ORTHOPEDICS, V34, pE651, DOI 10.3928/01477447-20110826-09	54	61	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43407	10.1371/journal.pone.0043407	http://dx.doi.org/10.1371/journal.pone.0043407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912869	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700097
J	Lang, M; Kojonazarov, B; Tian, X; Kalymbetov, A; Weissmann, N; Grimminger, F; Kretschmer, A; Stasch, JP; Seeger, W; Ghofrani, HA; Schermuly, RT				Lang, Michaela; Kojonazarov, Baktybek; Tian, Xia; Kalymbetov, Anuar; Weissmann, Norbert; Grimminger, Friedrich; Kretschmer, Axel; Stasch, Johannes-Peter; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo			The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; NITRIC-OXIDE; PHOSPHODIESTERASE TYPE-5; THERAPEUTIC-EFFICACY; INHIBITION; SILDENAFIL; CIRCULATION; ACTIVATION; EXPRESSION; DISCOVERY	Background: The nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) signal-transduction pathway is impaired in many cardiovascular diseases, including pulmonary arterial hypertension (PAH). Riociguat (BAY 63-2521) is a stimulator of sGC that works both in synergy with and independently of NO to increase levels of cGMP. The aims of this study were to investigate the role of NO-sGC-cGMP signaling in a model of severe PAH and to evaluate the effects of sGC stimulation by riociguat and PDE5 inhibition by sildenafil on pulmonary hemodynamics and vascular remodeling in severe experimental PAH. Methods and Results: Severe angioproliferative PAH was induced in rats by combined exposure to the vascular endothelial growth factor receptor antagonist SU5416 and hypoxia (SUHx). Twenty-one days thereafter rats were randomized to receive either riociguat (10 mg/kg/day), sildenafil (50 mg/kg/day) or vehicle by oral gavage, for 14 days until the day of the terminal hemodynamic measurements. Administration of riociguat or sildenafil significantly decreased right ventricular systolic pressure (RVSP). Riociguat significantly decreased RV hypertrophy (RVH) (0.55 +/- 0.02, p<0.05), increased cardiac output (60.8 +/-.8 mL/minute, p<0.05) and decreased total pulmonary resistance (4.03 +/- 0.3 mmHg min(-1) ml(-1) 100 g BW, p<0.05), compared with sildenafil and vehicle. Both compounds significantly decreased the RV collagen content and improved RV function, but the effects of riociguat on tricuspid annular plane systolic excursion and RV myocardial performance were significantly better than those of sildenafil (p<0.05). The proportion of occluded arteries was significantly lower in animals receiving riociguat than in those receiving vehicle (p<0.05); furthermore, the neointima/media ratio was significantly lower in those receiving riociguat than in those receiving sildenafil or vehicle (p<0.05). Conclusion: Riociguat and sildenafil significantly reduced RVSP and RVH, and improved RV function compared with vehicle. Riociguat had a greater effect on hemodynamics and RVH than sildenafil.	[Lang, Michaela; Kojonazarov, Baktybek; Tian, Xia; Kalymbetov, Anuar; Weissmann, Norbert; Grimminger, Friedrich; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo] Univ Giessen, Giessen, Germany; [Lang, Michaela; Kojonazarov, Baktybek; Tian, Xia; Kalymbetov, Anuar; Weissmann, Norbert; Grimminger, Friedrich; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo] Marburg Lung Ctr, Giessen, Germany; [Kretschmer, Axel; Stasch, Johannes-Peter] Bayer HealthCare, Wuppertal, Germany; [Seeger, Werner; Schermuly, Ralph Theo] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany	Justus Liebig University Giessen; Bayer AG; Bayer Healthcare Pharmaceuticals; Max Planck Society	Lang, M (corresponding author), Univ Giessen, Giessen, Germany.	ralph.schermuly@innere.med.uni-giessen.de	Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Kalymbetov, Anuar/AAT-7178-2021	Ghofrani, Ardeschir/0000-0002-2029-4419; Grimminger, Friedrich/0000-0001-8725-6276; Seeger, Werner/0000-0003-1946-0894; Schermuly, Ralph/0000-0002-5167-6970; Weissmann, Norbert/0000-0003-2675-3871	Deutsche Forschungsgemeinschaft [GR1081/7-1]; University of Giessen; University Marburg Lung Center within the LOEWE programme of the state of Hesse; Bayer Healthcare; Excellence Cluster Cardiopulmonary System; German Research Foundation; University of Giessen and Marburg Lung Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Giessen; University Marburg Lung Center within the LOEWE programme of the state of Hesse; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); University of Giessen and Marburg Lung Center	This work was supported by Deutsche Forschungsgemeinschaft, GR1081/7-1, the Universities of Giessen and Marburg Lung Center within the LOEWE programme of the state of Hesse and by an unrestricted research grant from Bayer Healthcare, who also provided study material. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JPS is employee of Bayer HealthCare, who also provided an unrestricted research grant. RTS declares he has been a consultant for Bayer Healthcare and has received speakers bureau (honoraria) from Bayer Healthcare. RTS also declares he has received grant/research support from Bayer HealthCare, Excellence Cluster Cardiopulmonary System, German Research Foundation, and the University of Giessen and Marburg Lung Center. HAG declares he has been a consultant for Bayer Healthcare and has received speakers bureau (honoraria) from Bayer Healthcare. HAG also declares he has received unrestricted research grant from Bayer Healthcare (related to this study), supports/grants Excellence Cluster Cardiopulmonary System, German Research Foundation, and the University of Giessen and Marburg Lung Center. FG declares he has been a consultant for Bayer Healthcare and has received grant/research support from Excellence Cluster Cardiopulmonary System, German Research Foundation, and the University of Giessen and Marburg Lung Center. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. ML, BK, NW and WS have declared that no competing interests exist.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Bauer NR, 2007, AM J PHYSIOL-LUNG C, V293, pL580, DOI 10.1152/ajplung.00281.2007; Bhatia S, 2003, MAYO CLIN PROC, V78, P1207, DOI 10.4065/78.10.1207; Black SM, 2001, AM J PHYSIOL-LUNG C, V281, pL1051, DOI 10.1152/ajplung.2001.281.5.L1051; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Chockalingam A, 2005, INT J CARDIOL, V99, P91, DOI 10.1016/j.ijcard.2003.12.023; Dahal BK, 2010, EUR RESPIR J, V36, P808, DOI 10.1183/09031936.00140309; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Evgenov OV, 2004, CIRCULATION, V110, P2253, DOI 10.1161/01.CIR.0000144469.01521.8A; Fagan KA, 1999, AM J PHYSIOL-LUNG C, V277, pL472, DOI 10.1152/ajplung.1999.277.3.L472; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Geschka S, PLOS ONE, V6, pe21853; Ghofrani HA, 2010, EUR RESPIR J, V36, P792, DOI 10.1183/09031936.00182909; Ghofrani HA, 2004, J AM COLL CARDIOL, V43, p68S, DOI 10.1016/j.jacc.2004.02.031; Grimminger F, 2009, EUR RESPIR J, V33, P785, DOI 10.1183/09031936.00039808; KITABATAKE A, 1983, CIRCULATION, V68, P302, DOI 10.1161/01.CIR.68.2.302; Kosanovic D, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-87; Li DC, 1999, AM J PHYSIOL-LUNG C, V277, pL841, DOI 10.1152/ajplung.1999.277.4.L841; Li DC, 2001, AM J PHYSIOL-LUNG C, V281, pL369, DOI 10.1152/ajplung.2001.281.2.L369; MacLean MR, 1997, J PHARMACOL EXP THER, V283, P619; Michelakis ED, 2003, ADV EXP MED BIOL, V543, P293; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schermuly RT, 2004, CIRC RES, V94, P1101, DOI 10.1161/01.RES.0000126050.41296.8E; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Schymura Y, 2011, AM J RESP CRIT CARE, V183; Sharkovska Y, J HYPERTENS, V28, P1666; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Taraseviciene-Stewart L, 2006, AM J PHYSIOL-LUNG C, V291, pL668, DOI 10.1152/ajplung.00491.2005; Tei C, 1995, J Cardiol, V26, P357; Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, pL401, DOI 10.1152/ajplung.00114.2010; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC	42	96	101	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43433	10.1371/journal.pone.0043433	http://dx.doi.org/10.1371/journal.pone.0043433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912874	Green Published, gold			2022-12-27	WOS:000308063700102
J	Timm, S; Mielewczik, M; Florian, A; Frankenbach, S; Dreissen, A; Hocken, N; Fernie, AR; Walter, A; Bauwe, H				Timm, Stefan; Mielewczik, Michael; Florian, Alexandra; Frankenbach, Silja; Dreissen, Anne; Hocken, Nadine; Fernie, Alisdair R.; Walter, Achim; Bauwe, Hermann			High-to-Low CO2 Acclimation Reveals Plasticity of the Photorespiratory Pathway and Indicates Regulatory Links to Cellular Metabolism of Arabidopsis	PLOS ONE			English	Article							LEAF GROWTH; CHLOROPHYLL FLUORESCENCE; GENE-EXPRESSION; PHOTOSYSTEM-II; MUTANTS; GLYOXYLATE; DEFICIENT; CYCLE; HYDROXYPYRUVATE; THALIANA	Background: Photorespiratory carbon metabolism was long considered as an essentially closed and nonregulated pathway with little interaction to other metabolic routes except nitrogen metabolism and respiration. Most mutants of this pathway cannot survive in ambient air and require CO2-enriched air for normal growth. Several studies indicate that this CO2 requirement is very different for individual mutants, suggesting a higher plasticity and more interaction of photorespiratory metabolism as generally thought. To understand this better, we examined a variety of high-and low-level parameters at 1% CO2 and their alteration during acclimation of wild-type plants and selected photorespiratory mutants to ambient air. Methodology and Principal Findings: The wild type and four photorespiratory mutants of Arabidopsis thaliana (Arabidopsis) were grown to a defined stadium at 1% CO2 and then transferred to normal air (0.038% CO2). All other conditions remained unchanged. This approach allowed unbiased side-by-side monitoring of acclimation processes on several levels. For all lines, diel (24 h) leaf growth, photosynthetic gas exchange, and PSII fluorescence were monitored. Metabolite profiling was performed for the wild type and two mutants. During acclimation, considerable variation between the individual genotypes was detected in many of the examined parameters, which correlated with the position of the impaired reaction in the photorespiratory pathway. Conclusions: Photorespiratory carbon metabolism does not operate as a fully closed pathway. Acclimation from high to low CO2 was typically steady and consistent for a number of features over several days, but we also found unexpected short-term events, such as an intermittent very massive rise of glycine levels after transition of one particular mutant to ambient air. We conclude that photorespiration is possibly exposed to redox regulation beyond known substrate-level effects. Additionally, our data support the view that 2-phosphoglycolate could be a key regulator of photosynthetic-photorespiratory metabolism as a whole.	[Timm, Stefan; Frankenbach, Silja; Bauwe, Hermann] Univ Rostock, Dept Plant Physiol, Rostock, Germany; [Mielewczik, Michael; Walter, Achim] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Mielewczik, Michael; Dreissen, Anne; Hocken, Nadine; Walter, Achim] Forschungszentrum Julich, Inst Bio & Geosci IBG 2, D-52425 Julich, Germany; [Florian, Alexandra; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	University of Rostock; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Research Center Julich; Max Planck Society	Timm, S (corresponding author), Univ Rostock, Dept Plant Physiol, Rostock, Germany.	hermann.bauwe@uni-rostock.de	Walter, Achim/N-8392-2013; Timm, Stefan/HII-7311-2022; Mielewczik, Michael/H-6491-2015; Frankenbach, Silja/W-7020-2018	Timm, Stefan/0000-0003-3105-6296; Mielewczik, Michael/0000-0002-3796-4183; Frankenbach, Silja/0000-0001-7481-2325; Walter, Achim/0000-0001-7753-9643	Deutsche Forschungsgemeinschaft (Photorespiration Network PROMICS) [FOR 1186]	Deutsche Forschungsgemeinschaft (Photorespiration Network PROMICS)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Photorespiration Network PROMICS, FOR 1186) to AW, ARF and HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan WL, 2009, BIOCHEM J, V423, P15, DOI 10.1042/BJ20090826; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ANDERSON LE, 1971, BIOCHIM BIOPHYS ACTA, V235, P237, DOI 10.1016/0005-2744(71)90051-9; Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Barak S, 2001, PLANT MOL BIOL, V45, P399, DOI 10.1023/A:1010688804719; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Biskup B, 2009, PLANT PHYSIOL, V149, P1452, DOI 10.1104/pp.108.134486; BLACKWELL RD, 1988, PHOTOSYNTH RES, V16, P155, DOI 10.1007/BF00039491; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Boldt R, 2005, PLANT CELL, V17, P2413, DOI 10.1105/tpc.105.033993; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Bykova NV, 2005, PLANTA, V222, P130, DOI 10.1007/s00425-005-1505-9; CHOLLET R, 1975, BOT REV, V41, P137, DOI 10.1007/BF02860828; Collakova E, 2008, PLANT CELL, V20, P1818, DOI 10.1105/tpc.108.058701; Cousins AB, 2008, PLANT PHYSIOL, V148, P786, DOI 10.1104/pp.108.122622; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Engel N, 2011, PLANT PHYSIOL, V157, P1711, DOI 10.1104/pp.111.184564; Fahnenstich H, 2008, PLANT PHYSIOL, V148, P719, DOI 10.1104/pp.108.126789; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fernie AR, 2009, PHYTOCHEMISTRY, V70, P828, DOI 10.1016/j.phytochem.2009.04.023; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; GIVAN CV, 1992, PLANT PHYSIOL, V100, P552, DOI 10.1104/pp.100.2.552; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; HALL NP, 1987, PHOTOSYNTH RES, V11, P89, DOI 10.1007/BF00117676; Hausler RE, 1996, PLANTA, V200, P388, DOI 10.1007/BF00231394; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Ho CL, 2001, AMINO ACIDS, V20, P243, DOI 10.1007/s007260170042; HOFSTRA G, 1969, PLANTA, V85, P228, DOI 10.1007/BF00389400; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; JOHNSON LN, 1970, J MOL BIOL, V47, P93, DOI 10.1016/0022-2836(70)90404-3; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; KELLY GJ, 1976, FEBS LETT, V68, P55, DOI 10.1016/0014-5793(76)80403-6; KEYS AJ, 1978, NATURE, V275, P741, DOI 10.1038/275741a0; KLECZKOWSKI LA, 1994, ANNU REV PLANT PHYS, V45, P339, DOI 10.1146/annurev.pp.45.060194.002011; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Morison JIL, 1998, J EXP BOT, V49, P443, DOI 10.1093/jexbot/49.suppl_1.443; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; MURRAY AJS, 1989, PLANT PHYSIOL, V91, P395, DOI 10.1104/pp.91.1.395; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Noctor G, 2002, ANN BOT-LONDON, V89, P841, DOI 10.1093/aob/mcf096; Noctor G, 1999, J EXP BOT, V50, P1157, DOI 10.1093/jexbot/50.336.1157; Novitskaya L, 2002, PLANT CELL ENVIRON, V25, P821, DOI 10.1046/j.1365-3040.2002.00866.x; Nunes-Nesi A, 2011, PLANT PHYSIOL, V155, P101, DOI 10.1104/pp.110.163816; OBERHUBER W, 1993, PLANT PHYSIOL, V101, P507, DOI 10.1104/pp.101.2.507; Potters G, 2002, PLANT PHYSIOL BIOCH, V40, P537, DOI 10.1016/S0981-9428(02)01414-6; Pracharoenwattana I, 2010, PLANT MOL BIOL, V72, P101, DOI 10.1007/s11103-009-9554-2; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Reumann S, 2006, BBA-MOL CELL RES, V1763, P1496, DOI 10.1016/j.bbamcr.2006.09.008; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Sage RF, 2000, STUD PLAN S, V7, P13; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Schwarte S, 2007, PLANT PHYSIOL, V144, P1580, DOI 10.1104/pp.107.099192; SOMERVILLE CR, 1981, PLANT PHYSIOL, V67, P666, DOI 10.1104/pp.67.4.666; SOMERVILLE CR, 1980, P NATL ACAD SCI-BIOL, V77, P2684, DOI 10.1073/pnas.77.5.2684; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; SOMERVILLE CR, 1979, NATURE, V280, P833, DOI 10.1038/280833a0; SOMERVILLE CR, 1982, TRENDS BIOCHEM SCI, V7, P171, DOI 10.1016/0968-0004(82)90130-X; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Takahashi S, 2007, PLANT PHYSIOL, V144, P487, DOI 10.1104/pp.107.097253; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Timm S, 2008, PLANT CELL, V20, P2848, DOI 10.1105/tpc.108.062265; Timm S, 2011, PLANT PHYSIOL, V155, P694, DOI 10.1104/pp.110.166538; Tolbert N. E., 1973, CURRENT TOPICS CELLU, P21; Tolbert NE, 1963, PHOTOSYNTHETIC MECHA, V1145, P648; TROUGHTON JH, 1969, AUST J BIOL SCI, V22, P815, DOI 10.1071/BI9690815; Voll LM, 2006, PLANT PHYSIOL, V140, P59, DOI 10.1104/pp.105.071399; Walter A, 2005, GLOBAL CHANGE BIOL, V11, P1207, DOI 10.1111/j.1365-2486.2005.00990.x; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Wiese A, 2007, NEW PHYTOL, V174, P752, DOI 10.1111/j.1469-8137.2007.02053.x; Wingler A, 1999, PLANTA, V207, P518, DOI 10.1007/s004250050512; Zelitch I, 2009, PLANT PHYSIOL, V149, P195, DOI 10.1104/pp.108.128439	76	66	69	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42809	10.1371/journal.pone.0042809	http://dx.doi.org/10.1371/journal.pone.0042809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912743	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700024
J	Vargas, M; Karamsetty, R; Leppla, SH; Chaudry, GJ				Vargas, Micaela; Karamsetty, Raghavendra; Leppla, Stephen H.; Chaudry, G. Jilani			Broad Expression Analysis of Human ANTXR1/TEM8 Transcripts Reveals Differential Expression and Novel Splizce Variants	PLOS ONE			English	Article							ANTHRAX LETHAL FACTOR; PROTECTIVE ANTIGEN; CAPILLARY MORPHOGENESIS; FACTOR CLEAVES; KINASE-KINASE; TOXIN; RECEPTOR; BINDING; CELLS; APOPTOSIS	Tumor endothelial marker 8 (TEM8; ANTXR1) is one of two anthrax toxin receptors; the other is capillary morphogenesis gene 2 protein (CMG2; ANTXR2). TEM8 shows enhanced expression in certain tumor endothelia, and is thought to be a player in tumor vasculature formation. However, a comprehensive expression profile of individual TEM8 variants in normal or cancerous tissues is lacking. In this work we carried out an extensive analysis of all splice variants of human TEM8 in 12 digestive tissues, and 8 each fetal and adult tissues, 6 of them cognate pairs. Using variant-specific primers, we first ascertained the status of full-length transcripts by nested PCR. We then carried out quantitative analysis of each transcript by real-time PCR. Three splice variants of TEM8 were reported before, two single-pass integral membrane forms (V1 and V2) and one secreted (V3). Our analysis has revealed two new variants, one encoding a membrane-bound form of the receptor and the other secreted, which we have designated V4 and V5, respectively. All tissues had V1, V2, V3, and V4, but only prostate had V5. Real-time PCR revealed that all variants are present at different levels in various tissues. V3 appeared the most abundant of all. To ascertain its functionality for anthrax toxin, we expressed the newly identified form V4 in a receptor-negative host cell, and included V1 and V2 for comparison. Cytotoxicity, toxin binding, and internalization assays showed V4 to be as efficient a receptor as V1 and V2.	[Vargas, Micaela; Karamsetty, Raghavendra; Chaudry, G. Jilani] Univ Texas San Antonio, Dept Biol, Cell & Mol Biol Program, San Antonio, TX USA; [Leppla, Stephen H.] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas at San Antonio (UTSA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Vargas, M (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA.	jilani.chaudry@utsa.edu			University of Texas at San Antonio; San Antonio Area Foundation; National Institute of Allergy and Infectious Diseases/National Institute of General Medical Sciences [SC1AI081654]; Minority Biomedical Research Support-Research Initiative for Scientific Enhancement [GM60655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032, SC1AI081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060655] Funding Source: NIH RePORTER	University of Texas at San Antonio; San Antonio Area Foundation; National Institute of Allergy and Infectious Diseases/National Institute of General Medical Sciences; Minority Biomedical Research Support-Research Initiative for Scientific Enhancement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided to GJC by The University of Texas at San Antonio, San Antonio Area Foundation, and National Institute of Allergy and Infectious Diseases/National Institute of General Medical Sciences grant SC1AI081654 (Minority Biomedical Research Support-Support of Competitive Research). MV was supported for her PhD by the Minority Biomedical Research Support-Research Initiative for Scientific Enhancement grant GM60655 to the University of Texas at San Antonio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; ARORA N, 1992, J BIOL CHEM, V267, P15542; Bell SE, 2001, J CELL SCI, V114, P2755; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chaudry GJ, 2002, TRENDS MICROBIOL, V10, P58, DOI 10.1016/S0966-842X(01)02294-6; De Preter K, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-11; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Go MY, 2009, INFECT IMMUN, V77, P52, DOI 10.1128/IAI.01073-08; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Leppla SH, 2000, HANDB EXP PHARM, V145, P445; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SQ, 2009, CHEM J CHINESE U, V30, P106; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Oberthuer A, 2005, GENE, V363, P41, DOI 10.1016/j.gene.2005.07.038; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Popov SG, 2002, BIOCHEM BIOPH RES CO, V293, P349, DOI 10.1016/S0006-291X(02)00227-9; Premanandan C, 2006, MICROB PATHOGENESIS, V41, P193, DOI 10.1016/j.micpath.2006.05.003; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Rmali KA, 2005, BIOCHEM BIOPH RES CO, V334, P231, DOI 10.1016/j.bbrc.2005.06.085; Rmali KA, 2004, INT J MOL MED, V14, P75; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; St Croix B, 2000, SCIENCE, V289, P1197; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Yang MY, 2010, BIOCHIM BIOPHYS ACTA, V1813, P39; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	46	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43174	10.1371/journal.pone.0043174	http://dx.doi.org/10.1371/journal.pone.0043174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912819	Green Published, gold			2022-12-27	WOS:000308063700055
J	Xie, F; Zhang, XJ; Li, H; Zheng, T; Xu, F; Shen, RX; Yan, L; Yang, JM; He, J				Xie, Feng; Zhang, Xinji; Li, Hui; Zheng, Tao; Xu, Feng; Shen, Rongxi; Yan, Long; Yang, Jiamei; He, Jia			Adoptive Immunotherapy in Postoperative Hepatocellular Carcinoma: A Systemic Review	PLOS ONE			English	Review							ACTIVATED KILLER-CELLS; RESECTION; CHEMOEMBOLIZATION; RECURRENCE; TRIALS	Purpose: The effectiveness of immunotherapy for postoperative hepatocellular carcinoma patients is still controversial. To address this issue, we did a systemic review of the literatures and analyzed the data with emphasis on the recurrence and survival. Methods: We searched six randomized controlled trials that included adoptive immunotherapy in the postoperative management of hepatocellular carcinoma and compared with non-immunotherapy postoperation. A meta-analysis was carried out to examine one-and 3-year recurrence and survival. Results: The overall analysis revealed significantly reduced risk of 1-year recurrence in patients receiving adoptive immunotherapy (OR = 0.35; 95% CI, 0.17 to 0.71; p = 0.003), in that the risk of 3-year recurrence with a pooled OR estimated at 0.31 (95% CI 0.16 to 0.61; p = 0.001). However, no statistically significant difference was observed for 3-year survival between groups with adoptive immunotherapy and without adjuvant treatment (OR = 0.91; 95% CI, 0.45 to 1.84; P = 0.792). Conclusions: Adjuvant immunotherapy with cytokine induced killer cells or lymphokine activated killer cells may reduce recurrence in postoperative hepatocellular carcinoma patients, but may not improve survival.	[Xie, Feng; Zhang, Xinji; Li, Hui; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Xie, Feng; Zheng, Tao; Xu, Feng; Shen, Rongxi; Yan, Long; Yang, Jiamei] Second Mil Med Univ, Dept Special Treatment & Liver Transplantat, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Xie, F (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	jiameiyang@gmail.com; hejia63@yahoo.com		He, Jia/0000-0002-2338-9501	China Postdoctoral Science Fund [20100470107]; China Postdoctoral Science Special Fund [201104750]; CSCO Fund [Y-B2011-006]; Fund of Ministry of Science and Technology of China [2008ZX10002-018]	China Postdoctoral Science Fund(China Postdoctoral Science Foundation); China Postdoctoral Science Special Fund; CSCO Fund; Fund of Ministry of Science and Technology of China	This work was supported in part by grants from the China Postdoctoral Science Fund (20100470107), China Postdoctoral Science Special Fund (201104750), CSCO Fund (Y-B2011-006) and the Fund of the Ministry of Science and Technology of China (2008ZX10002-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chang HH, 2010, INT IMMUNOPHARMACOL, V10, P239, DOI 10.1016/j.intimp.2009.10.017; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; Dong H, 2009, DIGEST LIVER DIS, V41, P36, DOI 10.1016/j.dld.2008.04.007; GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823; Haruta I, 1996, J IMMUNOTHER, V19, P218, DOI 10.1097/00002371-199605000-00006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Kanai T, 1993, Gan To Kagaku Ryoho, V20, P1457; KAWATA A, 1995, AM J CLIN ONCOL-CANC, V18, P257, DOI 10.1097/00000421-199506000-00014; Kubo S, 2000, CANCER-AM CANCER SOC, V88, P1016, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V; Ladhams A, 2002, J GASTROEN HEPATOL, V17, P889, DOI 10.1046/j.1440-1746.2002.02817.x; LAFRENIERE R, 1985, CANCER RES, V45, P3735; Linn YC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/435745; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Lu B, 2008, J MED FORUM, V29, P69; LYGIDAKIS NJ, 1995, ANTICANCER RES, V15, P543; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Shi M, 2004, WORLD J GASTROENTERO, V10, P1146; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Tan A, 2010, ONCOLOGY-BASEL, V78, P161, DOI 10.1159/000315577; Xie L, 2000, Zhonghua Gan Zang Bing Za Zhi, V8, P142; Zhong JH, 2010, HEPATOL RES, V40, P943, DOI 10.1111/j.1872-034X.2010.00710.x; Zhou W., 2002, CHINESE GERMAN J CLI, V1, P163, DOI [10.1007/BF02851714, DOI 10.1007/BF02851714]	28	34	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42879	10.1371/journal.pone.0042879	http://dx.doi.org/10.1371/journal.pone.0042879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916174	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600031
J	Li, Y; Shi, ZT; Cai, Y; Feng, Y; Ma, GS; Shen, CX; Li, ZY; Liu, NF				Li, Yang; Shi, Zhengtao; Cai, Yan; Feng, Yi; Ma, Genshan; Shen, Chengxing; Li, Zhiyong; Liu, Naifeng			Impact of Coronary Tortuosity on Coronary Pressure: Numerical Simulation Study	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; INTRALUMINAL THROMBUS; FLOW RESERVE; ARTERIES; WALL; PERFUSION; STEADY	Background: Coronary tortuosity (CT) is a common coronary angiographic finding. Whether CT leads to an apparent reduction in coronary pressure distal to the tortuous segment of the coronary artery is still unknown. The purpose of this study is to determine the impact of CT on coronary pressure distribution by numerical simulation. Methods: 21 idealized models were created to investigate the influence of coronary tortuosity angle (CTA) and coronary tortuosity number (CTN) on coronary pressure distribution. A 2D incompressible Newtonian flow was assumed and the computational simulation was performed using finite volume method. CTA of 30 degrees, 60 degrees, 90 degrees, 120 degrees and CTN of 0, 1, 2, 3, 4, 5 were discussed under both steady and pulsatile conditions, and the changes of outlet pressure and inlet velocity during the cardiac cycle were considered. Results: Coronary pressure distribution was affected both by CTA and CTN. We found that the pressure drop between the start and the end of the CT segment decreased with CTA, and the length of the CT segment also declined with CTA. An increase in CTN resulted in an increase in the pressure drop. Conclusions: Compared to no-CT, CT can results in more decrease of coronary blood pressure in dependence on the severity of tortuosity and severe CT may cause myocardial ischemia.	[Li, Yang; Feng, Yi; Ma, Genshan; Liu, Naifeng] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Shi, Zhengtao; Cai, Yan; Li, Zhiyong] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Shen, Chengxing] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China	Southeast University - China; Southeast University - China; Shanghai Jiao Tong University	Li, Y (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	zylicam@gmail.com; liunf@seu.edu.cn	Li, Zhi-Yong/G-9701-2011; Liu, Nai-feng/AAM-7836-2020; Li, Zhi-Yong/G-9701-2011	Li, Zhi-Yong/0000-0002-6814-9165; Li, Zhi-Yong/0000-0003-3039-8833				Bernad Sandor I, 2012, J Clin Med Res, V4, P177, DOI 10.4021/jocmr843w; Finol Ender A, 2002, Comput Methods Biomech Biomed Engin, V5, P319, DOI 10.1080/1025584021000009751; Finol Ender A, 2002, Comput Methods Biomech Biomed Engin, V5, P309, DOI 10.1080/1025584021000009742; Gaibazzi N, 2011, AM J CARDIOL, V108, P973, DOI 10.1016/j.amjcard.2011.05.030; Gaibazzi N, 2011, INT J CARDIOL, V148, P385, DOI 10.1016/j.ijcard.2010.12.001; Groves Samuel S, 2009, W V Med J, V105, P14; HUTCHINS GM, 1977, AM HEART J, V94, P196, DOI 10.1016/S0002-8703(77)80280-9; Jakob M, 1996, CATHETER CARDIO DIAG, V38, P25; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Kern MJ, 2006, CIRCULATION, V114, P1321, DOI 10.1161/CIRCULATIONAHA.106.177276; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024232; Li Z., 2006, Journal of Medical Engineering & Technology, V30, P283, DOI 10.1080/03091900500217406; Li ZY, 2008, J VASC SURG, V47, P928, DOI 10.1016/j.jvs.2008.01.006; Meimoun P, 2008, EUR J ECHOCARDIOGR, V9, P449, DOI 10.1093/ejechocard/jen004; Morris L, 2006, MED ENG PHYS, V28, P19, DOI 10.1016/j.medengphy.2005.04.012; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Turgut O, 2007, INT J CARDIOVAS IMAG, V23, P671, DOI 10.1007/s10554-006-9186-4; Turgut O, 2010, INT J CARDIOL, V142, pE38, DOI 10.1016/j.ijcard.2008.11.160; Wang Li-jun, 2008, Zhonghua Wai Ke Za Zhi, V46, P1658; Wieneke H, 2000, J AM COLL CARDIOL, V35, P1713, DOI 10.1016/S0735-1097(00)00639-2; Yu SCM, 1999, J MED ENG TECHNOL, V23, P228, DOI 10.1080/030919099294096; Zegers ES, 2007, NETH HEART J, V15, P191, DOI 10.1007/BF03085979	22	55	60	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42558	10.1371/journal.pone.0042558	http://dx.doi.org/10.1371/journal.pone.0042558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916199	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800017
J	Lucas, EK; Dougherty, SE; McMeekin, LJ; Trinh, AT; Reid, CS; Cowell, RM				Lucas, Elizabeth K.; Dougherty, Sarah E.; McMeekin, Laura J.; Trinh, Alisa T.; Reid, Courtney S.; Cowell, Rita M.			Developmental Alterations in Motor Coordination and Medium Spiny Neuron Markers in Mice Lacking PGC-1 alpha	PLOS ONE			English	Article							HUNTINGTONS-DISEASE BRAIN; TRANSGENIC MOUSE MODEL; DOPAMINE-RECEPTOR GENE; BASAL GANGLIA; MITOCHONDRIAL DYSFUNCTION; MUTANT HUNTINGTIN; IMMUNOREACTIVE NEURONS; GABAERGIC INTERNEURONS; PARKINSONS-DISEASE; STRIATAL NEURONS	Accumulating evidence implicates the transcriptional coactivator peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC-1 alpha) in the pathophysiology of Huntington Disease (HD). Adult PGC-1 alpha (-/-) mice exhibit striatal neurodegeneration, and reductions in the expression of PGC-1 alpha have been observed in striatum and muscle of HD patients as well as in animal models of the disease. However, it is unknown whether decreased expression of PGC-1 alpha alone is sufficient to lead to the motor phenotype and striatal pathology characteristic of HD. For the first time, we show that young PGC-1 alpha (-/-) mice exhibit severe rotarod deficits, decreased rearing behavior, and increased occurrence of tremor in addition to the previously described hindlimb clasping. Motor impairment and striatal vacuolation are apparent in PGC-1 alpha (-/-) mice by four weeks of age and do not improve or decline by twelve weeks of age. The behavioral and pathological phenotype of PGC-1 alpha (-/-) mice can be completely recapitulated by conditional nervous system deletion of PGC-1 alpha, indicating that peripheral effects are not responsible for the observed abnormalities. Evaluation of the transcriptional profile of PGC-1 alpha (-/-) striatal neuron populations and comparison to striatal neuron profiles of R6/2 HD mice revealed that PGC-1 alpha deficiency alone is not sufficient to cause the transcriptional changes observed in this HD mouse model. In contrast to R6/2 HD mice, PGC-1 alpha (-/-) mice show increases in the expression of medium spiny neuron (MSN) markers with age, suggesting that the observed behavioral and structural abnormalities are not primarily due to MSN loss, the defining pathological feature of HD. These results indicate that PGC-1 alpha is required for the proper development of motor circuitry and transcriptional homeostasis in MSNs and that developmental disruption of PGC-1 alpha leads to long-term alterations in motor functioning.	[Lucas, Elizabeth K.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Lucas, Elizabeth K.; Dougherty, Sarah E.; McMeekin, Laura J.; Trinh, Alisa T.; Reid, Courtney S.; Cowell, Rita M.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	Icahn School of Medicine at Mount Sinai; University of Alabama System; University of Alabama Birmingham	Lucas, EK (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	rcowell@uab.edu	Cowell, Rita/J-5083-2013	Cowell, Rita/0000-0001-5814-9412; Lucas, Elizabeth/0000-0002-0632-4538	National Institutes of Health (NIH) [5R01NS070009-02, 5MH077955-05]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH077955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070009] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NIH) Grants 5R01NS070009-02 (R.M.C.) and 5MH077955-05 (R.M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Ariano MA, 2002, J NEUROSCI RES, V68, P716, DOI 10.1002/jnr.10272; Berardelli A, 1999, MOVEMENT DISORD, V14, P398, DOI 10.1002/1531-8257(199905)14:3<398::AID-MDS1003>3.0.CO;2-F; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Che HV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-1; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Cipriani S, 2008, EXP NEUROL, V213, P163, DOI 10.1016/j.expneurol.2008.05.015; Cowell RM, 2007, J COMP NEUROL, V502, P1, DOI 10.1002/cne.21211; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1985, P NATL ACAD SCI USA, V82, P8780, DOI 10.1073/pnas.82.24.8780; GERFEN CR, 1991, J NEUROSCI, V11, P1016; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Guttenberg ND, 1996, NEUROREPORT, V7, P2119, DOI 10.1097/00001756-199609020-00011; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; KITA H, 1988, BRAIN RES, V447, P346, DOI 10.1016/0006-8993(88)91138-9; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; KUBOTA Y, 1993, NEUROREPORT, V5, P205, DOI 10.1097/00001756-199312000-00004; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; LEMOINE C, 1990, P NATL ACAD SCI USA, V87, P230, DOI 10.1073/pnas.87.1.230; LEMOINE C, 1991, P NATL ACAD SCI USA, V88, P4205, DOI 10.1073/pnas.88.10.4205; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lucas EK, 2010, J NEUROSCI, V30, P7227, DOI 10.1523/JNEUROSCI.0698-10.2010; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Ma D, 2010, J BIOL CHEM, V285, P39087, DOI 10.1074/jbc.M110.151688; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Menalled L, 2000, EXP NEUROL, V162, P328, DOI 10.1006/exnr.1999.7327; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Sun Z, 2002, NEUROBIOL DIS, V11, P369, DOI 10.1006/nbdi.2002.0554; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Taherzadeh-Fard E, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-10; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Tsunemi T, 2011, PROG NEUROBIOL; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3; Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	61	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42878	10.1371/journal.pone.0042878	http://dx.doi.org/10.1371/journal.pone.0042878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916173	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800026
J	Hill, MM; Daud, NH; Aung, CS; Loo, D; Martin, S; Murphy, S; Black, DM; Barry, R; Simpson, F; Liu, LB; Pilch, PF; Hancock, JF; Parat, MO; Parton, RG				Hill, Michelle M.; Daud, Noor Huda; Aung, Cho Sanda; Loo, Dorothy; Martin, Sally; Murphy, Samantha; Black, Debra M.; Barry, Rachael; Simpson, Fiona; Liu, Libin; Pilch, Paul F.; Hancock, John F.; Parat, Marie-Odile; Parton, Robert G.			Co-Regulation of Cell Polarization and Migration by Caveolar Proteins PTRF/Cavin-1 and Caveolin-1	PLOS ONE			English	Article							KINASE-C-ALPHA; BREAST-CANCER; ENDOTHELIAL-CELLS; POLYMERASE-I; LUNG-CANCER; LIPID RAFTS; EXPRESSION; OVEREXPRESSION; GROWTH; METASTASIS	Caveolin-1 and caveolae are differentially polarized in migrating cells in various models, and caveolin-1 expression has been shown to quantitatively modulate cell migration. PTRF/cavin-1 is a cytoplasmic protein now established to be also necessary for caveola formation. Here we tested the effect of PTRF expression on cell migration. Using fluorescence imaging, quantitative proteomics, and cell migration assays we show that PTRF/cavin-1 modulates cellular polarization, and the subcellular localization of Rac1 and caveolin-1 in migrating cells as well as PKC alpha caveola recruitment. PTRF/cavin-1 quantitatively reduced cell migration, and induced mesenchymal epithelial reversion. Similar to caveolin-1, the polarization of PTRF/cavin-1 was dependent on the migration mode. By selectively manipulating PTRF/cavin-1 and caveolin-1 expression (and therefore caveola formation) in multiple cell systems, we unveil caveola-independent functions for both proteins in cell migration.	[Hill, Michelle M.; Loo, Dorothy; Black, Debra M.; Barry, Rachael; Simpson, Fiona] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Hill, Michelle M.; Martin, Sally; Murphy, Samantha; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Daud, Noor Huda; Aung, Cho Sanda; Parat, Marie-Odile] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Liu, Libin; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Boston University; University of Queensland	Hill, MM (corresponding author), Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.	m.parat@uq.edu.au; r.parton@uq.edu.au	Parton, Robert G/C-5673-2009; Hill, Michelle Mei Chih/G-4417-2010; Parat, Marie-Odile/G-4410-2010; Simpson, Fiona/J-2721-2012; Martin, Sally/A-7150-2010; Liu, Libin/ABH-6019-2020; Simpson, Fiona/ABE-1276-2020	Parton, Robert G/0000-0002-7494-5248; Hill, Michelle Mei Chih/0000-0003-1134-0951; Parat, Marie-Odile/0000-0003-4895-7381; Simpson, Fiona/0000-0002-0271-781X; Martin, Sally/0000-0001-9294-5404; Simpson, Fiona/0000-0002-0271-781X; Pilch, Paul/0000-0003-1997-0499; Barry, Rachael/0000-0001-8168-3226; Hancock, John/0000-0003-0542-4710	National Health and Medical Research Council of Australia [569512, 546155, 51105]; Australian Cancer Research Fund; Prostate Cancer Foundation Australia; Heart Foundation Australia; Cancer Council Queensland	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund; Prostate Cancer Foundation Australia; Heart Foundation Australia; Cancer Council Queensland(Cancer Council Queensland)	This study was supported by the National Health and Medical Research Council of Australia (MMH CDA no. 569512, FS CDA no. 546155, RGP Program Grant no. 51105), the Australian Cancer Research Fund and the Prostate Cancer Foundation Australia (MMH, RGP). MOP is supported by Heart Foundation Australia and Cancer Council Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Buitrago C, 2010, J STEROID BIOCHEM, V121, P169, DOI 10.1016/j.jsbmb.2010.03.002; Campbell L, 2003, BRIT J CANCER, V89, P1909, DOI 10.1038/sj.bjc.6601359; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Fang K, 2007, CELL CYCLE, V6, P199, DOI 10.4161/cc.6.2.3740; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Inder KL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012245; Ito Y, 2002, J SYN ORG CHEM JPN, V60, P1, DOI 10.5059/yukigoseikyokaishi.60.1; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; Ko YG, 1998, J CELL BIOCHEM, V71, P524, DOI 10.1002/(SICI)1097-4644(19981215)71:4<524::AID-JCB7>3.3.CO;2-2; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Lin CW, 2010, J CELL PHYSIOL, V225, P472, DOI 10.1002/jcp.22226; Liu J, 2001, AM J PHYSIOL-CELL PH, V280, pC823, DOI 10.1152/ajpcell.2001.280.4.C823; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Nakashima H, 2007, CANCER SCI, V98, P512, DOI 10.1111/j.1349-7006.2007.00419.x; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Prevostel C, 2000, J CELL SCI, V113, P2575; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; Santilman Virginie, 2007, Angiogenesis, V10, P297, DOI 10.1007/s10456-007-9083-z; Santilman V, 2006, CELL MOTIL CYTOSKEL, V63, P673, DOI 10.1002/cm.20153; Shatz M, 2010, EXP CELL RES; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Silverman-Gavrila R, 2011, AM J PATHOL, V178, P895, DOI 10.1016/j.ajpath.2010.10.001; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; Song KS, 1997, CELL MOL BIOL, V43, P293; Sowa G, 2001, P NATL ACAD SCI USA, V98, P14072, DOI 10.1073/pnas.241409998; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Tanase CP, 2008, EXPERT REV MOL DIAGN, V8, P395, DOI 10.1586/14737159.8.4.395; Thomas NBP, 2010, BREAST CANCER RES TR, V119, P575, DOI 10.1007/s10549-009-0355-8; Thompson TC, 2010, PROSTATE CANCER P D, V13, P6, DOI 10.1038/pcan.2009.29; Verma P, 2010, MOL BIOL CELL, V21, P2226, DOI 10.1091/mbc.E09-05-0417; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wu P, 2008, BIOCHEM BIOPH RES CO, V376, P215, DOI 10.1016/j.bbrc.2008.08.146; Yeh DM, 2009, ANAT REC, V292, P1584, DOI 10.1002/ar.20974; Zhang W, 2000, J BIOL CHEM, V275, P20717, DOI 10.1074/jbc.M909895199; Zhang ZB, 2009, PATHOL ONCOL RES, V15, P495, DOI 10.1007/s12253-008-9144-7; Zhu H, 2004, FEBS LETT, V576, P369, DOI 10.1016/j.febslet.2004.09.041	51	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43041	10.1371/journal.pone.0043041	http://dx.doi.org/10.1371/journal.pone.0043041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912783	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500100056
J	Krol, E; van Kessel, SP; van Bezouwen, LS; Kumar, N; Boekema, EJ; Scheffers, DJ				Krol, Ewa; van Kessel, Sebastiaan P.; van Bezouwen, Laura S.; Kumar, Neeraj; Boekema, Egbert J.; Scheffers, Dirk-Jan			Bacillus subtilis SepF Binds to the C-Terminus of FtsZ	PLOS ONE			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSZ; CYTOSKELETAL PROTEIN; RING; ZIPA; MINC; SITE; POLYMERIZATION; PROTOFILAMENTS; LOCALIZATION	Bacterial cell division is mediated by a multi-protein machine known as the "divisome", which assembles at the site of cell division. Formation of the divisome starts with the polymerization of the tubulin-like protein FtsZ into a ring, the Z-ring. Z-ring formation is under tight control to ensure bacteria divide at the right time and place. Several proteins bind to the Z-ring to mediate its membrane association and persistence throughout the division process. A conserved stretch of amino acids at the C-terminus of FtsZ appears to be involved in many interactions with other proteins. Here, we describe a novel pull-down assay to look for binding partners of the FtsZ C-terminus, using a HaloTag affinity tag fused to the C-terminal 69 amino acids of B. subtilis FtsZ. Using lysates of Escherichia coli overexpressing several B. subtilis cell division proteins as prey we show that the FtsZ C-terminus specifically pulls down SepF, but not EzrA or MinC, and that the interaction depends on a conserved 16 amino acid stretch at the extreme C-terminus. In a reverse pull-down SepF binds to full-length FtsZ but not to a FtsZ Delta C16 truncate or FtsZ with a mutation of a conserved proline in the C-terminus. We show that the FtsZ C-terminus is required for the formation of tubules from FtsZ polymers by SepF rings. An alanine-scan of the conserved 16 amino acid stretch shows that many mutations affect SepF binding. Combined with the observation that SepF also interacts with the C-terminus of E. coli FtsZ, which is not an in vivo binding partner, we propose that the secondary and tertiary structure of the FtsZ C-terminus, rather than specific amino acids, are recognized by SepF.	[Krol, Ewa; van Kessel, Sebastiaan P.; Kumar, Neeraj; Scheffers, Dirk-Jan] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [van Bezouwen, Laura S.; Boekema, Egbert J.] Univ Groningen, Dept Electron Microscopy, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; University of Groningen	Krol, E (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	d.j.scheffers@rug.nl	Kumar, Neeraj/S-5654-2018; Cendrowicz, Ewa/AAT-9419-2021; Scheffers, Dirk-Jan/B-9475-2008	Kumar, Neeraj/0000-0001-6713-2129; Cendrowicz, Ewa/0000-0002-8854-228X; Scheffers, Dirk-Jan/0000-0002-9439-9168; van Kessel, Sebastiaan Pieter/0000-0002-9462-0141; Kumar, Neeraj/0000-0003-0769-1564	Netherlands Organisation for Scientific Research (NWO) [864.09.010]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by a VIDI grant (864.09.010) from the Netherlands Organisation for Scientific Research (NWO) (www.nwo.nl) to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Corbin BD, 2007, J BACTERIOL, V189, P3026, DOI 10.1128/JB.01581-06; Datta P, 2002, J BIOL CHEM, V277, P24983, DOI 10.1074/jbc.M203847200; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; de Oliveira IFF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012048; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Gundogdu ME, 2011, EMBO J, V30, P617, DOI 10.1038/emboj.2010.345; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Wu LJ, 2009, EMBO J, V28, P1940, DOI 10.1038/emboj.2009.144; Yang DC, 2011, P NATL ACAD SCI USA, V108, pE1052, DOI 10.1073/pnas.1107780108	34	38	38	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43293	10.1371/journal.pone.0043293	http://dx.doi.org/10.1371/journal.pone.0043293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912848	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100076
J	Ozen, E; Gozukizil, A; Erdal, E; Uren, A; Bottaro, DP; Atabey, N				Ozen, Evin; Gozukizil, Aysim; Erdal, Esra; Uren, Aykut; Bottaro, Donald P.; Atabey, Nese			Heparin Inhibits Hepatocyte Growth Factor Induced Motility and Invasion of Hepatocellular Carcinoma Cells through Early Growth Response Protein 1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EGR-1; FACTOR SCATTER FACTOR; SIGNALING PATHWAY; IN-VIVO; MELANOMA-CELLS; UP-REGULATION; EXPRESSION; PTEN; GENE; CLASSIFICATION	The Hepatocyte Growth Factor (HGF)/c-Met signaling pathway regulates hepatocyte proliferation, and pathway aberrations are implicated in the invasive and metastatic behaviors of hepatocellular carcinoma (HCC). In addition to c-Met, heparin acts as a co-receptor to modulate pathway activity. Recently, anti-metastatic and anti-cancer effects of heparin have been reported. However, the role of heparin in the regulation of HGF signaling remains controversial and the effects of heparin on HGF-induced biological responses during hepatocarcinogenesis is not yet defined. In this study we determined the effects of heparin on HGF-induced activities of HCC cells and the underlying molecular mechanisms. Here, we report for the first time that heparin inhibits HGF-induced adhesion, motility and invasion of HCC cells. In addition, heparin reduced HGF-induced activation of c-Met and MAPK in a dose-dependent manner, as well as decreased transcriptional activation and expression of Early growth response factor 1 (Egr1). HGF-induced MMP-2 and MMP-9 activation, and MT1-MMP expression, also were inhibited by heparin. Stable knockdown of Egr1 caused a significant decrease in HGF-induced invasion, as well as the activation and expression of MMPs. Parallel to these findings, the overexpression of Egr1 increased the invasiveness of HCC cells. Our results suggest that Egr1 activates HGF-induced cell invasion through the regulation of MMPs in HCC cells and heparin inhibits HGF-induced cellular invasion via the downregulation of Egr1. Therefore, heparin treatment might be a therapeutic approach to inhibit invasion and metastasis of HCC, especially for patients with active HGF/c-Met signaling.	[Ozen, Evin; Gozukizil, Aysim; Erdal, Esra; Atabey, Nese] Dokuz Eylul Univ, Dept Med Biol & Genet, Sch Med, Izmir, Turkey; [Uren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Dokuz Eylul University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ozen, E (corresponding author), Dokuz Eylul Univ, Dept Med Biol & Genet, Sch Med, Izmir, Turkey.	nese.atabey@deu.edu.tr	Atabey, Nese/A-1853-2018; Bottaro, Donald P/AAF-3853-2020; Erdal, Esra/AAE-1339-2019; Erdal, Esra/T-9057-2018; Bottaro, Donald P/F-8550-2010	Atabey, Nese/0000-0003-4966-2980; Bottaro, Donald P/0000-0002-5057-5334; Erdal, Esra/0000-0001-7264-0574; Erdal, Esra/0000-0001-7264-0574; Bottaro, Donald P/0000-0002-5057-5334	Turkish Scientific and Technological Research Council (TUBITAK) [SBAG - 110S349]; Dokuz Eylul University Research Foundation [2008-KB-SAG-02]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Cancer Center Support Grant from NIH/NCI [P30 CA051008]; NATIONAL CANCER INSTITUTE [ZIABC011124, P30CA051008] Funding Source: NIH RePORTER	Turkish Scientific and Technological Research Council (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Dokuz Eylul University Research Foundation(Dokuz Eylul University); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant from NIH/NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by grants to Prof. Dr. Atabey from Turkish Scientific and Technological Research Council (TUBITAK, SBAG - 110S349) and Dokuz Eylul University Research Foundation (2008-KB-SAG-02). This work was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and by the Cancer Center Support Grant (P30 CA051008) from NIH/NCI for the use of Biacore Molecular Interaction Shared Resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2011, COCHRANE DB SYST REV, V11; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Bouchard F, 2010, BLOOD, V116, P759, DOI 10.1182/blood-2009-12-257030; Chalkiadaki G, 2011, CANCER LETT, V312, P235, DOI 10.1016/j.canlet.2011.08.016; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Damm S, 2010, J INVEST DERMATOL, V130, P1893, DOI 10.1038/jid.2010.45; Deakin JA, 1999, J CELL SCI, V112, P1999; Dussmann P, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-28; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaggioli C, 2005, ONCOGENE, V24, P1423, DOI 10.1038/sj.onc.1208318; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao MW, 2002, WORLD J GASTROENTERO, V8, P203; Heideman DAM, 2005, CANCER GENE THER, V12, P954, DOI 10.1038/sj.cgt.7700856; Henry JC, 2010, BIOCHEM BIOPH RES CO, V403, P120, DOI 10.1016/j.bbrc.2010.10.130; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kawashita Y, 1999, HUM GENE THER, V10, P1509, DOI 10.1089/10430349950017842; Kragh M, 2005, ONCOL REP, V14, P99; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Kudo M, 2011, DIGEST DIS, V29, P273, DOI 10.1159/000327558; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lee KH, 2009, CLIN EXP METASTAS, V26, P685, DOI 10.1007/s10585-009-9266-7; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Livraghi T, 2011, SCAND J SURG, V100, P22, DOI 10.1177/145749691110000105; Lyon M, 2002, J BIOL CHEM, V277, P1040, DOI 10.1074/jbc.M107506200; Ma LX, 2012, INVEST NEW DRUG, V30, P508, DOI 10.1007/s10637-010-9578-0; Marx-Stoelting P, 2009, INT J CANCER, V124, P1767, DOI 10.1002/ijc.24167; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Nagy Z, 2009, PATHOL ONCOL RES, V15, P689, DOI 10.1007/s12253-009-9204-7; Ogunwobi OO, 2011, CLIN EXP METASTAS, V28, P721, DOI 10.1007/s10585-011-9404-x; Ozaki I, 2003, HEPATOL RES, V27, P288, DOI 10.1016/S1386-6346(03)00268-7; Peng WX, 2010, ANAT REC, V293, P414, DOI 10.1002/ar.21086; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pignatelli M, 2003, BIOCHEM J, V373, P739, DOI 10.1042/BJ20021918; Quinones A, 2003, LIFE SCI, V72, P2975, DOI 10.1016/S0024-3205(03)00230-3; Recio JA, 2003, CANCER RES, V63, P1576; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; Sakata H, 1997, J BIOL CHEM, V272, P9457; Sayan AE, 2001, ONCOGENE, V20, P5111, DOI 10.1038/sj.onc.1204669; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Steffan JJ, 2011, CURR PROTEIN PEPT SC, V12, P12; Ushio K, 2009, MOL CANCER RES, V7, P1179, DOI 10.1158/1541-7786.MCR-08-0289; van Doormaal FF, 2011, J CLIN ONCOL, V29, P2071, DOI 10.1200/JCO.2010.31.9293; van Malenstein H, 2011, EUR J CANCER, V47, P1789, DOI 10.1016/j.ejca.2011.04.027; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang SW, 2007, CANCER LETT, V257, P87, DOI 10.1016/j.canlet.2007.07.002; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang ZM, 2011, WORLD J GASTROENTERO, V17, P1685, DOI 10.3748/wjg.v17.i13.1685	61	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42717	10.1371/journal.pone.0042717	http://dx.doi.org/10.1371/journal.pone.0042717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912725	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100023
J	Ripoll, C; Rivals, I; Yahya-Graison, EA; Dauphinot, L; Paly, E; Mircher, C; Ravel, A; Grattau, Y; Blehaut, H; Megarbane, A; Dembour, G; de Freminville, B; Touraine, R; Creau, N; Potier, MC; Delabar, JM				Ripoll, Clementine; Rivals, Isabelle; Yahya-Graison, Emilie Ait; Dauphinot, Luce; Paly, Evelyne; Mircher, Clothilde; Ravel, Aime; Grattau, Yann; Blehaut, Henri; Megarbane, Andre; Dembour, Guy; de Freminville, Benedicte; Touraine, Renaud; Creau, Nicole; Potier, Marie Claude; Delabar, Jean Maurice			Molecular Signatures of Cardiac Defects in Down Syndrome Lymphoblastoid Cell Lines Suggest Altered Ciliome and Hedgehog Pathways	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; DEVELOPMENTAL DEFECTS; SYNDROME PROJECT; PRIMARY CILIUM; HUMAN FETUSES; EXPRESSION; MOUSE; GENES; HUMAN-CHROMOSOME-21; ANOMALIES	Forty percent of people with Down syndrome exhibit heart defects, most often an atrioventricular septal defect (AVSD) and less frequently a ventricular septal defect (VSD) or atrial septal defect (ASD). Lymphoblastoid cell lines (LCLs) were established from lymphocytes of individuals with trisomy 21, the chromosomal abnormality causing Down syndrome. Gene expression profiles generated from DNA microarrays of LCLs from individuals without heart defects (CHD-; n = 22) were compared with those of LCLs from patients with cardiac malformations (CHD+; n = 21). After quantile normalization, principal component analysis revealed that AVSD carriers could be distinguished from a combined group of ASD or VSD (ASD+VSD) carriers. From 9,758 expressed genes, we identified 889 and 1,016 genes differentially expressed between CHD- and AVSD and CHD- and ASD+VSD, respectively, with only 119 genes in common. A specific chromosomal enrichment was found in each group of affected genes. Among the differentially expressed genes, more than 65% are expressed in human or mouse fetal heart tissues (GEO dataset). Additional LCLs from new groups of AVSD and ASD+VSD patients were analyzed by quantitative PCR; observed expression ratios were similar to microarray results. Analysis of GO categories revealed enrichment of genes from pathways regulating clathrin-mediated endocytosis in patients with AVSD and of genes involved in semaphorin-plexin-driven cardiogenesis and the formation of cytoplasmic microtubules in patients with ASD-VSD. A pathway-oriented search revealed enrichment in the ciliome for both groups and a specific enrichment in Hedgehog and Jak-stat pathways among ASD+VSD patients. These genes or related pathways are therefore potentially involved in normal cardiogenesis as well as in cardiac malformations observed in individuals with trisomy 21.	[Ripoll, Clementine; Yahya-Graison, Emilie Ait; Paly, Evelyne; Creau, Nicole; Delabar, Jean Maurice] Univ Paris Diderot, Unite Biol Fonct & Adaptat, EAC4413, CNRS, Paris, France; [Rivals, Isabelle] ESPCI ParisTech, Equipe Stat Appl, Paris, France; [Dauphinot, Luce; Potier, Marie Claude] UPMC Hop Pitie Salpetriere, CRICM, CNRS, UMR7225,INSERM,UMR975, Paris, France; [Paly, Evelyne; Ravel, Aime; Grattau, Yann; Blehaut, Henri; Megarbane, Andre] Inst Med Jerome Lejeune & Fdn Jerome, Paris, France; [Megarbane, Andre] Univ St Joseph, Unite Genet Med, Fac Med, Beirut, Lebanon; [Dembour, Guy] Clin Univ St Luc, B-1200 Brussels, Belgium; [de Freminville, Benedicte; Touraine, Renaud] Ctr Hosp Univ St Etienne, Serv Genet, St Etienne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Saint Joseph University Beirut; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU de St Etienne	Ripoll, C (corresponding author), Univ Paris Diderot, Unite Biol Fonct & Adaptat, EAC4413, CNRS, Sorbonne Paris Cite, Paris, France.	delabar@univ-paris-diderot.fr	Megarbane, Andre/ABD-5574-2021; Touraine, Renaud/AAV-1605-2020; Rivals, Isabelle/AAE-7971-2022	Rivals, Isabelle/0000-0002-8736-7010; Ait Yahya Graison, Emilie/0000-0002-7205-2649; Potier, Marie-Claude/0000-0003-2462-7150	European Union integrated AnEUploidy project [037627]	European Union integrated AnEUploidy project	This work was supported by the European Union integrated AnEUploidy project (contract no. 037627). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanhaanen WTJ, 2011, BIRTH DEFECTS RES A, V91, P565, DOI 10.1002/bdra.20826; Anderson RH, 2003, HEART, V89, P949, DOI 10.1136/heart.89.8.949; Bean LJH, 2011, BIRTH DEFECTS RES A, V91, P885, DOI 10.1002/bdra.22848; Boyle J, 2011, EUR J HUM GENET, V19, P857, DOI 10.1038/ejhg.2011.59; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; de Mooij YM, 2009, PRENATAL DIAG, V29, P840, DOI 10.1002/pd.2316; Delabar JM, 2006, THESCIENTIFICWORLDJO, V6, P1945, DOI 10.1100/tsw.2006.322; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; DURHAM NM, 1989, J MENT DEFIC RES, V33, P343; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044; Fredouille C, 2005, ARCH MAL COEUR VAISS, V98, P549; Freeman SB, 2008, GENET MED, V10, P173, DOI 10.1097/GIM.0b013e3181634867; Freeman SB, 1998, AM J MED GENET, V80, P213, DOI 10.1002/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-8; Goddeeris MM, 2008, DEVELOPMENT, V135, P1887, DOI 10.1242/dev.016147; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hills CB, 2011, PEDIATR CARDIOL, V32, P977, DOI 10.1007/s00246-011-0006-9; Hoffmann AD, 2009, DEVELOPMENT, V136, P1761, DOI 10.1242/dev.034157; Hyett J, 1997, AM J MED GENET, V69, P207, DOI 10.1002/(SICI)1096-8628(19970317)69:2<207::AID-AJMG18>3.0.CO;2-P; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Jang JW, 2011, BIOCHEM BIOPH RES CO, V410, P183, DOI 10.1016/j.bbrc.2011.05.011; Johnson AN, 2011, DEVELOPMENT, V138, P4627, DOI 10.1242/dev.071464; Kallen B, 1996, AM J MED GENET, V65, P160; LaFramboise WA, 2010, J PROTEOMICS, V73, P992, DOI 10.1016/j.jprot.2009.12.013; Laumonnier F, 2010, MOL PSYCHIATR, V15, P767, DOI 10.1038/mp.2009.14; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Liu CH, 2011, HUM GENET, V130, P623, DOI 10.1007/s00439-011-0980-2; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Mao R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r107; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Moore CS, 2006, MAMM GENOME, V17, P1005, DOI 10.1007/s00335-006-0032-8; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Obermann-Borst SA, 2011, EUR J CLIN INVEST, V41, P143, DOI 10.1111/j.1365-2362.2010.02388.x; Paladini D, 2000, ULTRASOUND OBST GYN, V15, P104, DOI 10.1046/j.1469-0705.2000.00027.x; Papavassiliou P, 2009, AM J MED GENET A, V149A, P573, DOI 10.1002/ajmg.a.32729; Parisot P, 2011, BIRTH DEFECTS RES A, V91, P477, DOI 10.1002/bdra.20803; Roper RJ, 2009, MECH DEVELOP, V126, P212, DOI 10.1016/j.mod.2008.11.002; Sato M, 2006, DEV BIOL, V298, P12, DOI 10.1016/j.ydbio.2006.05.033; Schule B, 2007, AM J HUM GENET, V81, P492, DOI 10.1086/520063; Shetty J, 2007, GENE, V396, P93, DOI 10.1016/j.gene.2007.02.031; Slough J, 2008, DEV DYNAM, V237, P2304, DOI 10.1002/dvdy.21669; Snider P, 2007, THESCIENTIFICWORLDJO, V7, P1090, DOI 10.1100/tsw.2007.189; Stoll C, 1998, ANN GENET-PARIS, V41, P44; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Torfs CP, 1999, EPIDEMIOLOGY, V10, P264, DOI 10.1097/00001648-199905000-00013; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; Torrioli MG, 2010, AM J MED GENET A, V152A, P1420, DOI 10.1002/ajmg.a.33484; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Venugopalan P, 2003, Indian Pediatr, V40, P398; Vida VL, 2005, CARDIOL YOUNG, V15, P286, DOI 10.1017/S1047951105000582; Williams AD, 2008, DEV DYNAM, V237, P426, DOI 10.1002/dvdy.21416; Xu HS, 2007, SEMIN CELL DEV BIOL, V18, P77, DOI 10.1016/j.semcdb.2006.11.011; Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000	62	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41616	10.1371/journal.pone.0041616	http://dx.doi.org/10.1371/journal.pone.0041616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912673	Green Published, Green Submitted, gold			2022-12-27	WOS:000307378500006
J	Ma, JY; Li, M; Ge, ZJ; Luo, YB; Ou, XH; Song, SH; Tian, DM; Yang, J; Zhang, B; Ou-Yang, YC; Hou, Y; Liu, ZH; Schatten, H; Sun, QY				Ma, Jun-Yu; Li, Mo; Ge, Zhao-Jia; Luo, Yibo; Ou, Xiang-Hong; Song, Shuhui; Tian, Dongmei; Yang, Jin; Zhang, Bing; Ou-Yang, Ying-Chun; Hou, Yi; Liu, Zhonghua; Schatten, Heide; Sun, Qing-Yuan			Whole Transcriptome Analysis of the Effects of Type I Diabetes on Mouse Oocytes	PLOS ONE			English	Article							TO-CELL COMMUNICATION; MOLECULAR-MECHANISMS; PATERNAL GENOME; MATURATION; OVULATION; EXPRESSION; STREPTOZOTOCIN; FERTILIZATION; DEMETHYLATION; MELLITUS	In mouse ovarian follicles, granulosa cells but not oocytes take up glucose to provide the oocyte with nourishments for energy metabolism. Diabetes-induced hyperglycemia or glucose absorption inefficiency consistently causes granulosa cell apoptosis and further exerts a series of negative impacts on oocytes including reduced meiosis resumption rate, low oocyte quality and preimplantation embryo degeneration. Here we compared the transcriptome of mouse oocytes from genetically derived NOD diabetic mice or chemically induced STZ diabetic mice with that of corresponding normal mice. Differentially expressed genes were extracted from the two diabetic models. Gene set enrichment analysis showed that genes associated with metabolic and developmental processes were differentially expressed in oocytes from both models of diabetes. In addition, NOD diabetes also affected the expression of genes associated with ovulation, cell cycle progression, and preimplantation embryo development. Notably, Dnmt1 expression was significantly down-regulated, but Mbd3 expression was up-regulated in diabetic mouse oocytes. Our data not only revealed the mechanisms by which diabetes affects oocyte quality and preimplantation embryo development, but also linked epigenetic hereditary factors with metabolic disorders in germ cells.	[Ma, Jun-Yu; Li, Mo; Ge, Zhao-Jia; Luo, Yibo; Ou, Xiang-Hong; Ou-Yang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Ma, Jun-Yu; Liu, Zhonghua] NE Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Song, Shuhui; Tian, Dongmei; Yang, Jin; Zhang, Bing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Agricultural University - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Missouri System; University of Missouri Columbia	Ma, JY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	song, shuhui/D-6015-2014		National Basic Research Program of China [2012CB944404, 2011CB944501]; National Natural Science Foundation of China [30930065]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2012CB944404, 2011CB944501) and National Natural Science Foundation of China (No. 30930065) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEBE LFS, 1991, DIABETES, V40, P457, DOI 10.2337/diabetes.40.4.457; BONNEVIENIELSEN V, 1981, DIABETES, V30, P424, DOI 10.2337/diabetes.30.5.424; Chang AS, 2005, ENDOCRINOLOGY, V146, P2445, DOI 10.1210/en.2004-1472; DEKEL N, 1981, DEV BIOL, V86, P356, DOI 10.1016/0012-1606(81)90193-7; DIAMOND MP, 1989, J REPROD FERTIL, V86, P1; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; Hara K, 2006, GENES CELLS, V11, P1281, DOI 10.1111/j.1365-2443.2006.01019.x; Heikinheimo O, 1998, MOL HUM REPROD, V4, P745, DOI 10.1093/molehr/4.8.745; Holt JE, 2011, DEVELOPMENT, V138, P905, DOI 10.1242/dev.059022; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jawerbaum A, 2010, ENDOCR REV, V31, P680, DOI 10.1210/er.2009-0038; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Manoli T, 2006, BIOINFORMATICS, V22, P2500, DOI 10.1093/bioinformatics/btl424; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MOLEY KH, 1991, J REPROD FERTIL, V93, P325; Moore RK, 2004, TRENDS ENDOCRIN MET, V15, P356, DOI 10.1016/j.tem.2004.08.008; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Russell DL, 2007, HUM REPROD UPDATE, V13, P289, DOI 10.1093/humupd/dml062; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Thomas HE, 2000, DIABETES-METAB RES, V16, P251, DOI 10.1002/1520-7560(200007/08)16:4<251::AID-DMRR126>3.3.CO;2-3; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Q, 2012, AM J PHYSL ENDOCRINO; Wang Q, 2012, ENDOCRINOLOGY, V153, P1984, DOI 10.1210/en.2011-1815; Wang QA, 2010, MITOCHONDRION, V10, P403, DOI 10.1016/j.mito.2010.03.002; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Yoon JW, 2001, ANN NY ACAD SCI, V928, P200	43	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41981	10.1371/journal.pone.0041981	http://dx.doi.org/10.1371/journal.pone.0041981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911868	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300085
J	Lu, YC; Vaarhorst, A; Merry, AHH; Dolle, MET; Hovenier, R; Imholz, S; Schouten, LJ; Heijmans, BT; Muller, M; Slagboom, PE; van den Brandt, PA; Gorgels, APM; Boer, JMA; Feskens, EJM				Lu, Yingchang; Vaarhorst, Anika; Merry, Audrey H. H.; Dolle, Martijn E. T.; Hovenier, Robert; Imholz, Sandra; Schouten, Leo J.; Heijmans, Bastiaan T.; Mueller, Michael; Slagboom, P. Eline; van den Brandt, Piet A.; Gorgels, Anton P. M.; Boer, Jolanda M. A.; Feskens, Edith J. M.			Markers of Endogenous Desaturase Activity and Risk of Coronary Heart Disease in the CAREMA Cohort Study	PLOS ONE			English	Article							DIETARY ARACHIDONIC-ACID; GENOME-WIDE ASSOCIATION; N-6 FATTY-ACIDS; GENETIC-VARIATION; LOCI; METABOLISM; EXPRESSION; VARIANTS; DELTA-5; CLONING	Background: Intakes of n-3 polyunsaturated fatty acids (PUFAs), especially EPA (C20:5n-3) and DHA (C22:6n-3), are known to prevent fatal coronary heart disease (CHD). The effects of n-6 PUFAs including arachidonic acid (C20: 4n-6), however, remain unclear. delta-5 and delta-6 desaturases are rate-limiting enzymes for synthesizing long-chain n-3 and n-6 PUFAs. C20:4n-6 to C20:3n-6 and C18:3n-6 to C18:2n-6 ratios are markers of endogenous delta-5 and delta-6 desaturase activities, but have never been studied in relation to incident CHD. Therefore, the aim of this study was to investigate the relation between these ratios as well as genotypes of FADS1 rs174547 and CHD incidence. Methods: We applied a case-cohort design within the CAREMA cohort, a large prospective study among the general Dutch population followed up for a median of 12.1 years. Fatty acid profile in plasma cholesteryl esters and FADS1 genotype at baseline were measured in a random subcohort (n = 1323) and incident CHD cases (n = 537). Main outcome measures were hazard ratios (HRs) of incident CHD adjusted for major CHD risk factors. Results: The AA genotype of rs174547 was associated with increased plasma levels of C204n-6, C20:5n-3 and C22:6n-3 and increased delta-5 and delta-6 desaturase activities, but not with CHD risk. In multivariable adjusted models, high baseline delta-5 desaturase activity was associated with reduced CHD risk (P for trend = 0.02), especially among those carrying the high desaturase activity genotype (AA): HR (95% CI) = 0.35 (0.15-0.81) for comparing the extreme quintiles. High plasma DHA levels were also associated with reduced CHD risk. Conclusion: In this prospective cohort study, we observed a reduced CHD risk with an increased C20:4n-6 to C20:3n-6 ratio, suggesting that delta-5 desaturase activity plays a role in CHD etiology. This should be investigated further in other independent studies.	[Lu, Yingchang; Hovenier, Robert; Mueller, Michael; Feskens, Edith J. M.] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; [Lu, Yingchang; Dolle, Martijn E. T.; Imholz, Sandra; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Vaarhorst, Anika; Heijmans, Bastiaan T.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Merry, Audrey H. H.; van den Brandt, Piet A.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Schouten, Leo J.; van den Brandt, Piet A.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands; [Gorgels, Anton P. M.] Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Lu, YC (corresponding author), Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands.	kevin.lu@wur.nl; edith.feskens@wur.nl	Muller, Michael/M-5724-2019; Slagboom, P. Eline/R-4790-2016; Schouten, Leo J/G-3713-2012; Schouten, Leo J/AAB-2275-2019; Muller, Michael/B-5795-2008; Feskens, Edith/ABI-1446-2020	Muller, Michael/0000-0002-5930-9905; Slagboom, P. Eline/0000-0002-2875-4723; Schouten, Leo J/0000-0003-3361-7560; Muller, Michael/0000-0002-5930-9905; Feskens, Edith/0000-0001-5819-2488; van den Brandt, Piet/0000-0001-8781-8099	Netherlands Heart Foundation [2006B195]; Ministry of Public Health, Welfare and Sports of the Netherlands	Netherlands Heart Foundation(Netherlands Heart Foundation); Ministry of Public Health, Welfare and Sports of the Netherlands	This study was supported by grant 2006B195 of the Netherlands Heart Foundation. The monitoring project on cardiovascular disease risk factors was financially supported by the Ministry of Public Health, Welfare and Sports of the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, NETH J CARDIOL; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Burdge G, 2004, CURR OPIN CLIN NUTR, V7, P137, DOI 10.1097/00075197-200403000-00006; Cai JW, 2004, BIOMETRICS, V60, P1015, DOI 10.1111/j.0006-341X.2004.00257.x; Calder PC, 2007, BRIT J NUTR, V98, P451, DOI 10.1017/S0007114507761779; Calder PC, 2010, BRIT J NUTR, V104, P1575, DOI 10.1017/S0007114510004253; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Ferretti A, 1997, LIPIDS, V32, P435, DOI 10.1007/s11745-997-0057-5; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harris WS, 2007, ATHEROSCLEROSIS, V193, P1, DOI 10.1016/j.atherosclerosis.2007.03.018; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Joensen AM, 2011, CIRCULATION, V124, P1232, DOI 10.1161/CIRCULATIONAHA.110.987057; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; KATTERMANN R, 1984, J CLIN CHEM CLIN BIO, V22, P245; Kelley DS, 1997, LIPIDS, V32, P449, DOI 10.1007/s11745-997-0059-3; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kusumoto A, 2007, BRIT J NUTR, V98, P626, DOI 10.1017/S0007114507734566; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Lu YC, 2010, AM J CLIN NUTR, V92, P258, DOI 10.3945/ajcn.2009.29130; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mozaffarian D, 2008, AM J CLIN NUTR, V87, p1991S, DOI 10.1093/ajcn/87.6.1991S; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nelson GJ, 1997, LIPIDS, V32, P421, DOI 10.1007/s11745-997-0055-7; Nelson GJ, 1997, LIPIDS, V32, P427, DOI 10.1007/s11745-997-0056-6; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Raatz SK, 2001, J NUTR, V131, P231; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SEYBERTH HW, 1975, CLIN PHARMACOL THER, V18, P521; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vaarhorst AAM, 2012, CIRC-CARDIOVASC GENE, V5, P202, DOI 10.1161/CIRCGENETICS.111.960708; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	55	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41681	10.1371/journal.pone.0041681	http://dx.doi.org/10.1371/journal.pone.0041681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911844	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700140
J	Reyes, LM; Garcia, RG; Ruiz, SL; Camacho, PA; Ospina, MB; Aroca, G; Accini, JL; Lopez-Jaramillo, P				Reyes, Laura M.; Garcia, Ronald G.; Ruiz, Silvia L.; Camacho, Paul A.; Ospina, Maria B.; Aroca, Gustavo; Accini, Jose L.; Lopez-Jaramillo, Patricio			Risk Factors for Preeclampsia in Women from Colombia: A Case-Control Study	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; C-REACTIVE PROTEIN; MATERNAL-FETAL OUTCOMES; BODY-MASS INDEX; LATIN-AMERICA; CARBOHYDRATE INTOLERANCE; REGIONAL DIFFERENCES; GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; FAMILY-HISTORY	Background: Preeclampsia (PE) is a multi-causal disease characterized by the development of hypertension and proteinuria in the second half of pregnancy. Multiple risk factors have been associated with the development of PE. Moreover, it is known that these risk factors vary between populations from developed and developing countries. The aim of this study is to identify which risk factors are associated with the development of preeclampsia (PE) among Colombian women. Methods: A multi-centre case-control study was conducted between September 2006 and July 2009 in six Colombian cities. Cases included women with PE (n = 201); controls were aged-matched pregnant women (n = 201) without cardiovascular or endocrine diseases for a case-control ratio of 1:1. A complete medical chart, physical examination and biochemical analysis were completed before delivery. Multivariable logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) of potential risk factors associated with PE. Results: The presence of factors present in the metabolic syndrome cluster such as body mass index > 31 Kg/m2 (OR = 2.18; 1.14-4.14 95% CI), high-density lipoprotein < 1.24 mmol/L (OR = 2.42; 1.53-3.84 95% CI), triglycerides > 3.24 mmol/L (OR = 1.60; 1.04-2.48 95% CI) and glycemia > 4.9 mmol/L (OR = 2.66; 1.47-4.81 95% CI) as well as being primigravidae (OR = 1.71; 1.07-2.73 95% CI) were associated with the development of PE, after adjusting for other variables. Conclusion: Factors present in the cluster of metabolic syndrome and primigravidity were associated with a greater risk of PE among Colombian women. Understanding the role of this cluster of risk factors in the development of PE is of crucial importance to prevent PE and remains to be determined.	[Reyes, Laura M.; Garcia, Ronald G.; Ruiz, Silvia L.; Camacho, Paul A.] Fdn Cardiovasc Colombia, Dept Res, Floridablanca, Santander, Colombia; [Ospina, Maria B.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Aroca, Gustavo] Clin Costa, Barranquilla, Atlantico, Colombia; [Accini, Jose L.] Hosp Univ Barranquilla, Barranquilla, Atlantico, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander UDES, Fac Med, Dept Res, Bucaramanga, Santander, Colombia; [Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander Clin Carlos Ardila Lulle F, Dept Res, Floridablanca, Santander, Colombia	University of Alberta; Universidad Industrial de Santander	Reyes, LM (corresponding author), Fdn Cardiovasc Colombia, Dept Res, Floridablanca, Santander, Colombia.	jplopezj@gmail.com	Aroca, Gustavo/P-9173-2016; Aroca Martinez, Gustavo/N-9133-2013; Reyes, Laura M./AAA-1581-2019; Garcia, Ronald G./AAU-8608-2020	Aroca, Gustavo/0000-0002-9222-3257; Aroca Martinez, Gustavo/0000-0002-9222-3257; Reyes, Laura M./0000-0003-4207-0480; Garcia, Ronald G./0000-0002-8325-9944; Ospina, Maria/0000-0002-1627-4781; Camacho, Paul Anthony/0000-0002-6233-9582; Ospina, Maria/0000-0001-9305-7521; Lopez-Jaramillo, Patricio/0000-0002-9122-8742	COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) [6566-04-18061]	COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) Grant number: 6566-04-18061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, THEORETICAL EPIDEMIO; Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Cekmen MB, 2003, CLIN BIOCHEM, V36, P575, DOI 10.1016/S0009-9120(03)00099-7; Chavarro JE, 2009, EUR J CLIN NUTR, V63, P78, DOI 10.1038/sj.ejcn.1602904; Christiansen LR, 2006, AM J FOREN MED PATH, V27, P11, DOI 10.1097/01.paf.0000203154.50648.33; Crane JMG, 2009, J OBSTET GYNAECOL CA, V31, P28, DOI 10.1016/S1701-2163(16)34050-6; Dane B, 2009, ARCH GYNECOL OBSTET, V280, P921, DOI 10.1007/s00404-009-1029-9; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Driul L, 2008, ARCH GYNECOL OBSTET, V278, P23, DOI 10.1007/s00404-007-0524-0; Druzin ML, 2008, CURR OPIN OBSTET GYN, V20, P91, DOI 10.1097/GCO.0b013e3282f7335a; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Garcia RG, 2007, AM J HYPERTENS, V20, P98, DOI 10.1016/j.amjhyper.2006.06.001; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Herrera JA, 2001, MED HYPOTHESES, V57, P393, DOI 10.1054/mehy.2001.1378; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Kaaja R, 2008, Minerva Ginecol, V60, P421; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KUHL C, 1991, DIABETES, V40, P18, DOI 10.2337/diab.40.2.S18; Lopez-Jarami P, 2008, AM J HYPERTENS, V21, P527, DOI 10.1038/ajh.2007.86; Lopez-Jaramillo P, 2005, J HYPERTENS, V23, P1121, DOI 10.1097/01.hjh.0000170371.49010.4a; Lopez-Jaramillo P, 2008, J HYPERTENS, V26, P1886, DOI 10.1097/HJH.0b013e328308ba8d; Lopez-Jaramillo P, 2007, REV ESP CARDIOL, V60, P168, DOI 10.1157/13099463; Lopez-Jaramillo P, 2009, COLOMB MEDICA, V40, P226; Lopez-Jaramillo P, 2009, REV ESP CARDIOL, V62, P670, DOI 10.1016/S0300-8932(09)71334-X; Martin U, 1999, CLIN SCI, V96, P421, DOI 10.1042/CS19980326; Ness RB, 2003, OBSTET GYNECOL, V102, P1366, DOI 10.1016/j.obstetgynecol.2003.08.011; Nordin NM, 2006, J OBSTET GYNAECOL RE, V32, P107, DOI 10.1111/j.1447-0756.2006.00360.x; Osungbade KO, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/481095; Qiu CF, 2003, HYPERTENSION, V41, P408, DOI 10.1161/01.HYP.0000056996.25503.F5; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Reyes LM, 2012, GROWTH FACTORS, V30, P158, DOI 10.3109/08977194.2012.674035; Reyes L, 2012, J OBSTET GYNAECOL RE, V38, P498, DOI 10.1111/j.1447-0756.2011.01763.x; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Rueda-Clausen CF, 2008, INT J CARDIOL, V125, P111, DOI 10.1016/j.ijcard.2006.12.092; Saldana TM, 2004, AM J CLIN NUTR, V79, P479; SERMER M, 1995, AM J OBSTET GYNECOL, V173, P146, DOI 10.1016/0002-9378(95)90183-3; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Sierra-Laguado J, 2007, AM J HYPERTENS, V20, P437, DOI 10.1016/j.amjhyper.2006.10.009; Vambergue A, 2002, EUR J OBSTET GYN R B, V102, P31, DOI 10.1016/S0301-2115(01)00556-5; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514	44	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41622	10.1371/journal.pone.0041622	http://dx.doi.org/10.1371/journal.pone.0041622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911827	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700126
J	Wang, W; Fu, W; Wu, J; Ma, XC; Sun, XL; Huang, Y; Hashimoto, K; Gao, CG				Wang, Wei; Fu, Wei; Wu, Jin; Ma, Xian-cang; Sun, Xue-li; Huang, Yi; Hashimoto, Kenji; Gao, Cheng-ge			Prevalence of PTSD and Depression among Junior Middle School Students in a Rural Town Far from the Epicenter of the Wenchuan Earthquake in China	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDRENS REVISED IMPACT; TSUNAMI-AFFECTED AREAS; MENTAL-HEALTH PROBLEMS; EVENT SCALE; ADOLESCENTS; COMORBIDITY; SURVIVORS; SYMPTOMS; VALIDITY	Context: On May12th 2008, a devastating earthquake measuring 8.0 on the Richter scale, struck Wenchuan county and surrounding areas in China. The prevalence of mental illness among children and adolescents in a rural town far from the earthquake epicenter is unknown. Objective: To assess the prevalence of posttraumatic stress disorder (PTSD) and depression among junior middle school students in a rural town Ningqiang county, 327 km from the earthquake epicenter. Design, Setting, and Participants: A population-based mental health survey was conducted in March, 2009. Main Outcome Measure: Survey Self-designed General Condition Survey Scale, Children's Revised Impact of Event Scale (CRIES-13), and the Depression Self-rating Scale for Children (DSRSC) were used to sample 1,841 junior middle school students in Ningqiang county, ten months after the Wenchuan earthquake. Results: The prevalence rate of a high-risk for PTSD was 28.4%, with 32.7% among females, 23.8% among males (female vs. male, p < 0.001), 38.6% in the severe exposure group and 24.3% in the mild exposure group (severe vs. mild exposure, p < 0.001). For depressive symptoms, the overall prevalence was 19.5%, with 24.0% among females, 14.7% among males, 24.5% in the severe exposure group and 17.5% in the mild exposure group (female vs. male, p < 0.001; severe vs. mild exposure, p < 0.001, respectively). In multivariate analysis, factors such as "having felt despair", or "danger" and "having own house destroyed or damaged" were significantly associated with PTSD symptoms. Female gender and delayed evacuation in females, and earthquake related experiences in males were significantly associated with depression. Conclusion: Traumatic events experienced during the earthquake were significantly associated with symptoms of PTSD and depression in children and adolescents, ten months after the Wenchuan earthquake. These data highlight a need for mental health services for children and adolescents in rural areas, far from earthquake epicenters.	[Wang, Wei; Fu, Wei; Ma, Xian-cang; Gao, Cheng-ge] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Peoples R China; [Sun, Xue-li; Huang, Yi] Sichuan Univ, W China Hosp, Mental Hlth Ctr, Chengdu 610064, Peoples R China; [Wu, Jin; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Xi'an Jiaotong University; Sichuan University; Chiba University	Gao, CG (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Peoples R China.	hashimoto@faculty.chiba-u.jp; yaogaow@163.com	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439				Ayub M, 2012, CHILD PSYCHIAT HUM D, V43, P323, DOI 10.1007/s10578-011-0267-9; BIRLESON P, 1981, J CHILD PSYCHOL PSYC, V22, P73, DOI 10.1111/j.1469-7610.1981.tb00533.x; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Davidson J. R. T., 1993, POSTTRAUMATIC STRESS, P57; Davidson JRT, 2006, J CLIN PSYCHIAT, V67, P9; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; Eksi A, 2007, INT J PSYCHIAT CLIN, V11, P190, DOI 10.1080/13651500601017548; Eksi A, 2009, EUR CHILD ADOLES PSY, V18, P384, DOI 10.1007/s00787-009-0745-9; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; GERSONS BPR, 1992, BRIT J PSYCHIAT, V161, P742, DOI 10.1192/bjp.161.6.742; Giannopoulou I, 2006, EUR PSYCHIAT, V21, P160, DOI 10.1016/j.eurpsy.2005.09.005; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; GOENJIAN AK, 1995, J AM ACAD CHILD PSY, V34, P1174, DOI 10.1097/00004583-199509000-00015; Goenjian AK, 2005, AM J PSYCHIAT, V162, P2302, DOI 10.1176/appi.ajp.162.12.2302; Goenjian AK, 2011, J AFFECT DISORDERS, V133, P509, DOI 10.1016/j.jad.2011.04.053; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; GREEN BL, 1990, AM J ORTHOPSYCHIAT, V60, P43, DOI 10.1037/h0079168; HAGSTROM R, 1995, J TRAUMA STRESS, V8, P391, DOI 10.1007/BF02102965; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jaycox LH, 2010, J TRAUMA STRESS, V23, P223, DOI 10.1002/jts.20518; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P1117, DOI 10.1001/archpsyc.60.11.1117; Kolaitis G, 2003, EUR CHILD ADOLES PSY, V12, P273, DOI 10.1007/s00787-003-0339-x; Li L, 2007, CHINA J HLTH PSYCHOL, V15, P526; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; Liu ZY, 2010, BIOSCI TRENDS, V4, P96; Ma EYM, 2007, EXPLORATORY FACTOR A; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Papadatou D, 2012, J TRAUMA STRESS, V25, P57, DOI 10.1002/jts.21656; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Quinn KM, 1995, POSTTRAUMATIC STRESS, P85; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; [苏林雁 Sun Linyan], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P547; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Tucker P, 2000, J BEHAV HEALTH SER R, V27, P406, DOI 10.1007/BF02287822; Uemoto M, 2012, INT J BEHAV MED, V19, P243, DOI 10.1007/s12529-011-9184-3; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Zhang N, 2011, SCAND J PSYCHOL, V52, P236, DOI 10.1111/j.1467-9450.2010.00867.x; Zhang Z, 2011, PSYCHOL MED, V13, P1; Zheng YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029404	44	51	54	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41665	10.1371/journal.pone.0041665	http://dx.doi.org/10.1371/journal.pone.0041665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22911838	Green Published, gold			2022-12-27	WOS:000306687700135
J	Xu, PX; Garczynski, SF; Atungulu, E; Syed, Z; Choo, YM; Vidal, DM; Zitelli, CHL; Leal, WS				Xu, Pingxi; Garczynski, Stephen F.; Atungulu, Elizabeth; Syed, Zainulabeuddin; Choo, Young-Moo; Vidal, Diogo M.; Zitelli, Caio H. L.; Leal, Walter S.			Moth Sex Pheromone Receptors and Deceitful Parapheromones	PLOS ONE			English	Article							NAVEL ORANGEWORM LEPIDOPTERA; ANTHERAEA-PERNYI; IDENTIFICATION; HELIOTHIS; COMMUNICATION; COMPONENTS; SENSILLA; ANTENNAE	The insect's olfactory system is so selective that male moths, for example, can discriminate female-produced sex pheromones from compounds with minimal structural modifications. Yet, there is an exception for this "lock-and-key'' tight selectivity. Formate analogs can be used as replacement for less chemically stable, long-chain aldehyde pheromones, because male moths respond physiologically and behaviorally to these parapheromones. However, it remained hitherto unknown how formate analogs interact with aldehyde-sensitive odorant receptors (ORs). Neuronal responses to semiochemicals were investigated with single sensillum recordings. Odorant receptors (ORs) were cloned using degenerate primers, and tested with the Xenopus oocyte expression system. Quality, relative quantity, and purity of samples were evaluated by gas chromatography and gas chromatography-mass spectrometry. We identified olfactory receptor neurons (ORNs) housed in trichoid sensilla on the antennae of male navel orangeworm that responded equally to the main constituent of the sex pheromone, (11Z,13Z)-hexadecadienal (Z11Z13-16Ald), and its formate analog, (9Z,11Z)-tetradecen-1-yl formate (Z9Z11-14OFor). We cloned an odorant receptor co-receptor (Orco) and aldehyde-sensitive ORs from the navel orangeworm, one of which (AtraOR1) was expressed specifically in male antennae. AtraOR1 center dot AtraOrco-expressing oocytes responded mainly to Z11Z13-16Ald, with moderate sensitivity to another component of the sex pheromone, (11Z,13Z)-hexadecadien-1-ol. Surprisingly, this receptor was more sensitive to the related formate than to the natural sex pheromone. A pheromone receptor from Heliothis virescens, HR13 (=HvirOR13) showed a similar profile, with stronger responses elicited by a formate analog than to the natural sex pheromone, (11Z)-hexadecenal thus suggesting this might be a common feature of moth pheromone receptors.	[Xu, Pingxi; Atungulu, Elizabeth; Syed, Zainulabeuddin; Choo, Young-Moo; Vidal, Diogo M.; Zitelli, Caio H. L.; Leal, Walter S.] Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA; [Garczynski, Stephen F.] USDA ARS, Yakima Agr Res Lab, Wapato, WA USA	University of California System; University of California Davis; United States Department of Agriculture (USDA)	Xu, PX (corresponding author), Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Vidal, Diogo M/G-4262-2011; Leal, Walter/ABC-6940-2021; Vidal, Diogo/P-5151-2019; syed, zainulabeuddin/L-4961-2016	Vidal, Diogo M/0000-0002-1157-4179; Vidal, Diogo/0000-0002-1157-4179; syed, zainulabeuddin/0000-0002-6235-7115; Leal Filho, Walter/0000-0002-1241-5225; Lopes Zitelli, Caio Henrique/0000-0002-5109-1470; Leal, Walter/0000-0002-6800-1240	National Science Foundation [0918177]; AFRI competitive from USDA-NIFA [2010-65105-20582]; National Institutes of Health [1R01AI095514-01A1]; NRI grant from USDA-NIFA [2008-35302-18839]; Washington Tree Fruit Commission; CAPES; Direct For Biological Sciences [0918177] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095514] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); AFRI competitive from USDA-NIFA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRI grant from USDA-NIFA; Washington Tree Fruit Commission; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Science Foundation grant 0918177, AFRI competitive grant 2010-65105-20582 from USDA-NIFA, and National Institutes of Health, 1R01AI095514-01A1 to W.S.L. S.F.G. was supported by NRI grant 2008-35302-18839 from USDA-NIFA and grants from the Washington Tree Fruit Commission. D.M.V. and C.H.L.Z. were supported by CAPES undergraduate scholarship. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TC, 2009, INTEGRATED PEST MANAGEMENT: CONCEPTS, TACTICS, STRATEGIES AND CASE STUDIES, P273; Boeckh J., 1960, Zoologische Jahrbuecher Jena Anatomie, V78, P559; Carde R. T., 2007, P122, DOI 10.1017/CBO9780511752353.006; COFFELT JA, 1979, J CHEM ECOL, V5, P955, DOI 10.1007/BF00990218; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Garczynski SF, 2012, INSECT SCI, V19, P64, DOI 10.1111/j.1744-7917.2011.01423.x; GRANT AJ, 1989, J CHEM ECOL, V15, P2625, DOI 10.1007/BF01014721; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; HUMMEL HE, 1973, SCIENCE, V181, P873, DOI 10.1126/science.181.4102.873; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; KAISSLING KE, 1987, WRIGHT LECT INSECT O; Kanno H, 2010, J CHEM ECOL, V36, P584, DOI 10.1007/s10886-010-9799-x; KEIL TA, 1984, ZOOMORPHOLOGY, V104, P147, DOI 10.1007/BF00312133; Kuenen LPS, 2010, J ECON ENTOMOL, V103, P314, DOI 10.1603/EC09177; LANDOLT PJ, 1982, J ECON ENTOMOL, V75, P547, DOI 10.1093/jee/75.3.547; Leal WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007235; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, NATURWISSENSCHAFTEN, V92, P139, DOI 10.1007/s00114-004-0598-5; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; McLaughlin JR, 1972, ENVIRON ENTOMOL, V62, P1520; MENG LZ, 1989, J COMP PHYSIOL A, V165, P139, DOI 10.1007/BF00619188; MITCHELL ER, 1975, ENVIRON ENTOMOL, V4, P577, DOI 10.1093/ee/4.4.577; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Renou M, 2000, ANNU REV ENTOMOL, V45, P605, DOI 10.1146/annurev.ento.45.1.605; SHOREY HH, 1974, J ECON ENTOMOL, V67, P347, DOI 10.1093/jee/67.3.347; Syed Z, 2011, JOVE-J VIS EXP, DOI 10.3791/2489; TODD JL, 1992, J CHEM ECOL, V18, P2331, DOI 10.1007/BF00984953; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104	30	29	33	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41653	10.1371/journal.pone.0041653	http://dx.doi.org/10.1371/journal.pone.0041653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911835	gold, Green Published			2022-12-27	WOS:000306644600088
J	Sorice, R; Ruggiero, D; Nutile, T; Aversano, M; Husemoen, L; Linneberg, A; Bourgain, C; Leutenegger, AL; Ciullo, M				Sorice, Rossella; Ruggiero, Daniela; Nutile, Teresa; Aversano, Mario; Husemoen, Lotte; Linneberg, Allan; Bourgain, Catherine; Leutenegger, Anne-Louise; Ciullo, Marina			Genetic and Environmental Factors Influencing the Placental Growth Factor (PGF) Variation in Two Populations	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; LINKAGE ANALYSIS; ANGIOGENESIS; EXPRESSION; RISK; NEOVASCULARIZATION; INHIBITION; CARCINOMA; VEGF; REVASCULARIZATION	Placental Growth Factor (PGF) is a key molecule in angiogenesis. Several studies have revealed an important role of PGF primarily in pathological conditions (e.g.: ischaemia, tumour formation, cardiovascular diseases and inflammatory processes) suggesting its use as a potential therapeutic agent. However, to date, no information is available regarding the genetics of PGF variability. Furthermore, even though the effect of environmental factors (e.g.: cigarette smoking) on angiogenesis has been explored, no data on the influence of these factors on PGF levels have been reported so far. Here we have first investigated PGF variability in two cohorts focusing on non-genetic risk factors: a study sample from two isolated villages in the Cilento region, South Italy (N = 871) and a replication sample from the general Danish population (N = 1,812). A significant difference in PGF mean levels was found between the two cohorts. However, in both samples, we observed a strong correlation of PGF levels with ageing and sex, men displaying PGF levels significantly higher than women. Interestingly, smoking was also found to influence the trait in the two populations, although differently. We have then focused on genetic risk factors. The association between five single nucleotide polymorphisms (SNPs) located in the PGF gene and the plasma levels of the protein was investigated. Two polymorphisms (rs11850328 and rs2268614) were associated with the PGF plasma levels in the Cilento sample and these associations were strongly replicated in the Danish sample. These results, for the first time, support the hypothesis of the presence of genetic and environmental factors influencing PGF plasma variability.	[Sorice, Rossella; Ruggiero, Daniela; Nutile, Teresa; Aversano, Mario; Ciullo, Marina] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Husemoen, Lotte; Linneberg, Allan] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Bourgain, Catherine] Univ Paris Sud, INSERM, U669, Villejuif, France; [Leutenegger, Anne-Louise] INSERM, U946, Paris, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sorice, R (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy.	ciullo@igb.cnr.it	Leutenegger, Anne-Louise/B-5597-2009; ruggiero, daniela/K-5638-2016; Ciullo, Marina/AAE-3041-2020; Bourgain, Catherine/L-1505-2017	Leutenegger, Anne-Louise/0000-0002-1302-4357; ruggiero, daniela/0000-0003-3898-7827; Ciullo, Marina/0000-0002-9621-9984; Linneberg, Allan/0000-0002-0994-0184; Bourgain, Catherine/0000-0002-6761-0140; NUTILE, TERESA/0000-0001-7062-8352	EU [Vasoplus-037254]; Italian Ministry of Universities [FIRB -RBIN064YAT, RBNE08NKH7]; Assessorato Ricerca Regione Campania; Ente Parco Nazionale del Cilento e Vallo di Diano; Fondazione Banco di Napoli	EU(European Commission); Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); Assessorato Ricerca Regione Campania(Regione Campania); Ente Parco Nazionale del Cilento e Vallo di Diano; Fondazione Banco di Napoli	This work was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT, RBNE08NKH7), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano and the Fondazione Banco di Napoli to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 2002, CANCER RES, V62, P2749; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292; Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cassidy A, 2009, ARTERIOSCL THROM VAS, V29, P134, DOI 10.1161/ATVBAHA.108.171066; Colonna V, 2009, EUR J HUM GENET, V17, P1635, DOI 10.1038/ejhg.2009.97; Conklin BS, 2002, AM J PATHOL, V160, P413, DOI 10.1016/S0002-9440(10)64859-6; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Debette S, 2011, CIRC RES, V109, P554, DOI 10.1161/CIRCRESAHA.111.243790; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Donnini S, 1999, J PATHOL, V189, P66, DOI 10.1002/(SICI)1096-9896(199909)189:1<66::AID-PATH390>3.0.CO;2-X; Ejaz S, 2005, DRUG CHEM TOXICOL, V28, P447, DOI 10.1080/01480540500262862; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Heeschen C, 2004, JAMA-J AM MED ASSOC, V291, P435, DOI 10.1001/jama.291.4.435; Hildebrandt VA, 2001, ENDOCRINOLOGY, V142, P2050, DOI 10.1210/en.142.5.2050; Ho MC, 2007, CANCER LETT, V250, P237, DOI 10.1016/j.canlet.2006.10.005; ISHIJI T, 1992, EMBO J, V11, P2271, DOI 10.1002/j.1460-2075.1992.tb05286.x; Ivnitski-Steele I, 2005, CARDIOVASC TOXICOL, V5, P215, DOI 10.1385/CT:5:2:215; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; Kaneko KJ, 1998, DEV GENET, V22, P43, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;43::AID-DVG5&gt;3.0.CO;2-7; Karumanchi SA, 2008, CURR HYPERTENS REP, V10, P305, DOI 10.1007/s11906-008-0057-3; Khaliq A, 1998, LAB INVEST, V78, P109; Lenderink T, 2006, J AM COLL CARDIOL, V47, P307, DOI 10.1016/j.jacc.2005.08.063; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Odorisio T, 2006, J DERMATOL SCI, V41, P11, DOI 10.1016/j.jdermsci.2005.08.008; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P820, DOI 10.3109/14767050903366119; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Siervo M, 2010, J INTERN MED, V268, P338, DOI 10.1111/j.1365-2796.2010.02255.x; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Suzumori N, 2003, HUM REPROD, V18, P2595, DOI 10.1093/humrep/deg491; TAKAHASHI A, 1994, CANCER RES, V54, P4233; Traglia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007554; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yoo SA, 2009, ARTHRITIS RHEUM-US, V60, P345, DOI 10.1002/art.24289	44	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42537	10.1371/journal.pone.0042537	http://dx.doi.org/10.1371/journal.pone.0042537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916133	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800020
J	Williams, PT				Williams, Paul T.			Distance Walked and Run as Improved Metrics over Time-Based Energy Estimation in Epidemiological Studies and Prevention; Evidence from Medication Use	PLOS ONE			English	Article							VIGOROUS PHYSICAL-ACTIVITY; SELF-REPORT MEASURES; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; OF-SPORTS-MEDICINE; 7-YEAR FOLLOW-UP; WEIGHT-GAIN; CARDIORESPIRATORY FITNESS; WALKING DISTANCE	Purpose: The guideline physical activity levels are prescribed in terms of time, frequency, and intensity (e.g., 30 minutes brisk walking, five days a week or its energy equivalence) and assume that different activities may be combined to meet targeted goals (exchangeability premise). Habitual runners and walkers may quantify exercise in terms of distance (km/day), and for them, the relationship between activity dose and health benefits may be better assessed in terms of distance rather than time. Analyses were therefore performed to test: 1) whether time-based or distance-based estimates of energy expenditure provide the best metric for relating running and walking to hypertensive, high cholesterol, and diabetes medication use (conditions known to be diminished by exercise), and 2) the exchangeability premise. Methods: Logistic regression analyses of medication use (dependent variable) vs. metabolic equivalent hours per day (METhr/d) of running, walking and other exercise (independent variables) using cross-sectional data from the National Runners' (17,201 male, 16,173 female) and Walkers' Health Studies (3,434 male, 12,384 female). Results: Estimated METhr/d of running and walking activity were 38% and 31% greater, respectively, when calculated from self-reported time than distance in men, and 43% and 37% greater in women, respectively. Percent reductions in the odds for hypertension and high cholesterol medication use per METhr/d run or per METhr/d walked were >= 2-fold greater when estimated from reported distance (km/wk) than from time (hr/wk). The per METhr/d odds reduction was significantly greater for the distance-than the time-based estimate for hypertension (runners: P < 10(-5) for males and P = 0.003 for females; walkers: P = 0.03 for males and P < 10(-4) for females), high cholesterol medication use in runners (P < 10(-4) for males and P = 0.02 for females) and male walkers (P = 0.01 for males and P = 0.08 for females) and for diabetes medication use in male runners (P < 10(-3)). Conclusions: Although causality between greater exercise and lower prevalence of hypertension, high cholesterol and diabetes cannot be inferred from these cross-sectional data, the results do suggest that distance-based estimates of METhr/d run or walked provide superior metrics for epidemiological analyses to their traditional time-based estimates.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Institutes of Health (NIH) [HL094717]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grant HL094717. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; BARANOWSKI T, 1988, RES Q EXERCISE SPORT, V59, P314, DOI 10.1080/02701367.1988.10609379; Bassett DR, 2000, MED SCI SPORT EXER, V32, P1018; Buchowski MS, 1999, OBES RES, V7, P23, DOI 10.1002/j.1550-8528.1999.tb00387.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colley Rachel C, 2011, Health Rep, V22, P7; Duncan GE, 2001, PREV MED, V33, P18, DOI 10.1006/pmed.2001.0847; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HEATH GW, 1989, AM J PREV MED, V5, P347, DOI 10.1016/S0749-3797(18)31055-9; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; KLESGES RC, 1990, MED SCI SPORT EXER, V22, P690, DOI 10.1249/00005768-199010000-00022; Knuiman MW, 1998, ANN EPIDEMIOL, V8, P56, DOI 10.1016/S1047-2797(97)00107-5; KOPLAN JP, 1995, MED SCI SPORT EXER, V27, P1180; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lubin F, 2003, J NUTR, V133, P1180, DOI 10.1093/jn/133.4.1180; Luke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-387; Mensink GBM, 1996, EPIDEMIOLOGY, V7, P391, DOI 10.1097/00001648-199607000-00009; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sarkin JA, 2000, MED SCI SPORT EXER, V32, P149; STEPHENS T, 1985, PUBLIC HEALTH REP, V100, P147; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; U.S. Department of Health and Human Services, 2008, ODPHP PUBL; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Department of Health and Human Services, 1999, PHYS ACT HLTH REP SU; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; Washburn RA, 2000, RES Q EXERCISE SPORT, V71, pS104, DOI 10.1080/02701367.2000.11082793; Williams PT, 2008, AM J GASTROENTEROL, V103, P2239, DOI 10.1111/j.1572-0241.2008.01944.x; Williams PT, 2008, MED SCI SPORT EXER, V40, P998, DOI 10.1249/MSS.0b013e31816722a9; Williams PT, 2008, AM J CLIN NUTR, V87, P1480, DOI 10.1093/ajcn/87.5.1480; Williams PT, 2008, MED SCI SPORT EXER, V40, P433, DOI 10.1249/MSS.0b013e31815f38f1; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, MED SCI SPORT EXER, V39, P1933, DOI 10.1249/mss.0b013e318145b337; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2010, ATHEROSCLEROSIS, V209, P524, DOI 10.1016/j.atherosclerosis.2009.09.018; Williams PT, 2009, MED SCI SPORT EXER, V41, P1566, DOI 10.1249/MSS.0b013e31819e420f; Williams PT, 2009, MED SCI SPORT EXER, V41, P1042, DOI 10.1249/MSS.0b013e318192d02d; Williams PT, 2009, STROKE, V40, P1921, DOI 10.1161/STROKEAHA.108.535427; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P101, DOI 10.1167/iovs.08-2165; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P95, DOI 10.1167/iovs.08-1797; Williams PJ, 2005, NATION, V281, P13; Williams PT, 2005, MED SCI SPORT EXER, V37, P1893, DOI 10.1249/01.mss.0000175860.51204.85; Williams PT, 2005, MED SCI SPORT EXER, V37, P1329, DOI 10.1249/01.mss.0000174894.05236.45; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2012, MED SCI SPO IN PRESS; Williams PT, 2012, PLOS ONE IN PRESS; Winzenberg T, 2009, BRIT J GEN PRACT, V59, P850, DOI 10.3399/bjgp09X472818; World Health Organization, 2006, GLOB STRAT DIET PHYS; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502	60	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41906	10.1371/journal.pone.0041906	http://dx.doi.org/10.1371/journal.pone.0041906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916114	gold, Green Submitted, Green Published			2022-12-27	WOS:000307733800014
J	Chen, LJ; Li, XS; Yang, YF				Chen, Lijing; Li, Xingshan; Yang, Yufang			Focus, Newness and Their Combination: Processing of Information Structure in Discourse	PLOS ONE			English	Article							RELATIVE CLAUSE SENTENCES; EYE-MOVEMENTS; LANGUAGE COMPREHENSION; LINGUISTIC FOCUS; SPOKEN DISCOURSE; WORD REPETITION; COREFERENCE; CHINESE; TEXT; REPRESENTATIONS	The relationship between focus and new information has been unclear despite being the subject of several information structure studies. Here, we report an eye-tracking experiment that explored the relationship between them in on-line discourse processing in Chinese reading. Focus was marked by the Chinese focus-particle "shi", which is equivalent to the cleft structure "it was. who." in English. New information was defined as the target word that was not present in previous contexts. Our results show that, in the target region, focused information was processed more quickly than non-focused information, while new information was processed more slowly than given information. These results reveal differences in processing patterns between focus and newness, and suggest that they are different concepts that relate to different aspects of cognitive processing. In addition, the effect of new/given information occurred in the post-target region for the focus condition, but not for the non-focus condition, suggesting a complex relationship between focus and newness in the discourse integration stage.	[Chen, Lijing; Li, Xingshan; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Lijing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, LJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	yangyf@psych.ac.cn	Li, Xingshan/HHM-6328-2022	Chen, Lijing/0000-0002-0507-7694	National Natural Science Foundation of China [31070989, 60775026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant number: 31070989) and National Natural Science Foundation of China (Grant number: 60775026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almor A, 1999, PSYCHOL REV, V106, P748, DOI 10.1037/0033-295X.106.4.748; Almor A, 2008, LANG COGNITIVE PROC, V23, P201, DOI 10.1080/01690960701330936; Anderson JE, 2005, BRAIN LANG, V94, P200, DOI 10.1016/j.bandl.2005.01.001; Beaver D, 2007, LANGUAGE, V83, P245, DOI 10.1353/lan.2007.0053; BIRCH SL, 1995, J MEM LANG, V34, P232, DOI 10.1006/jmla.1995.1011; Birch S, 2010, MEM COGNITION, V38, P740, DOI 10.3758/MC.38.6.740; BLUTNER R, 1988, J MEM LANG, V27, P359, DOI 10.1016/0749-596X(88)90061-7; Bornkessel I, 2003, J EXP PSYCHOL LEARN, V29, P871, DOI 10.1037/0278-7393.29.5.871; Camblin CC, 2007, BRAIN RES, V1146, P172, DOI 10.1016/j.brainres.2006.07.033; Camblin CC, 2007, J MEM LANG, V56, P103, DOI 10.1016/j.jml.2006.07.005; CARR TH, 1990, J EXP PSYCHOL LEARN, V16, P731, DOI 10.1037/0278-7393.16.4.731; Cowles HW, 2007, BRAIN LANG, V102, P228, DOI 10.1016/j.bandl.2007.04.004; CUTLER A, 1979, COGNITION, V7, P49, DOI 10.1016/0010-0277(79)90010-6; Drenhaus H, 2011, J NEUROLINGUIST, V24, P320, DOI 10.1016/j.jneuroling.2010.10.004; Fang Mei, 1995, ZHONGGUO YUWEN, V4, P279; Fery C, 2008, UNITY DIVERSITY LANG, P123, DOI DOI 10.1075/Z.141.13KRI; Fery C, 2009, J LINGUIST, V45, P285, DOI 10.1017/S0022226709005702; Filik R, 2008, COGNITION, V106, P1038, DOI 10.1016/j.cognition.2007.04.006; Filik R, 2009, PSYCHON B REV, V16, P678, DOI 10.3758/PBR.16.4.678; Foraker S, 2007, J MEM LANG, V56, P357, DOI 10.1016/j.jml.2006.07.004; GIVON T, 1992, LINGUISTICS, V30, P5, DOI 10.1515/ling.1992.30.1.5; GORDON PC, 1993, COGNITIVE SCI, V17, P311, DOI 10.1207/s15516709cog1703_1; Gundel J.K., 1999, FOCUS LINGUISTIC COG, P293; Halliday MAK, 1967, BELGIAN J LINGUISTIC, V3, P199; IRWIN DE, 1982, J VERB LEARN VERB BE, V21, P307, DOI 10.1016/S0022-5371(82)90637-5; Kaakinen JK, 2010, J EXP PSYCHOL LEARN, V36, P1561, DOI 10.1037/a0020693; Katz J, 2012, LANGUAGE IN PRESS; Kiss KE, 1998, LANGUAGE, V74, P245, DOI 10.2307/417867; Klin CM, 2009, MEM COGNITION, V37, P556, DOI 10.3758/MC.37.5.556; Klin CM, 2004, MEM COGNITION, V32, P511, DOI 10.3758/BF03195843; Ledoux K, 2007, MEM COGNITION, V35, P801, DOI 10.3758/BF03193316; Li XQ, 2008, J COGNITIVE NEUROSCI, V20, P906, DOI 10.1162/jocn.2008.20512; Li XS, 2011, VISION RES, V51, P1146, DOI 10.1016/j.visres.2011.03.004; Liversedge SP, 2003, PSYCHON B REV, V10, P667, DOI 10.3758/BF03196530; Liversedge SP, 2002, Q J EXP PSYCHOL-A, V55, P225, DOI 10.1080/02724980143000253; Morris RK, 1998, MEM COGNITION, V26, P1313, DOI 10.3758/BF03201203; Ni WJ, 1996, LANG COGNITIVE PROC, V11, P283, DOI 10.1080/016909696387196; Paterson KB, 1999, Q J EXP PSYCHOL-A, V52, P717, DOI 10.1080/027249899391025; Paterson KB, 2007, Q J EXP PSYCHOL, V60, P1423, DOI 10.1080/17470210601100563; Prince Ellen, 1992, DISCOURSE DESCRIPTIO, P295, DOI DOI 10.1075/PBNS.16.12PRI; Raney GE, 2003, PSYCHON B REV, V10, P15, DOI 10.3758/BF03196466; RANEY GE, 1995, CAN J EXP PSYCHOL, V49, P151, DOI 10.1037/1196-1961.49.2.151; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2004, J EXP PSYCHOL LEARN, V30, P1290, DOI 10.1037/0278-7393.30.6.1290; Rooth Mats, 1992, NAT LANG SEMANT, V1, P75, DOI [10.1007/BF02342617a, DOI 10.1007/BF02342617A, DOI 10.1007/BF02342617]; Sanford AJS, 2006, DISCOURSE PROCESS, V42, P109, DOI 10.1207/s15326950dp4202_2; Sanford AJS, 2009, MEM COGNITION, V37, P880, DOI 10.3758/MC.37.6.880; Schwarzschild Roger, 1999, NAT LANG SEMANT, V7, P141, DOI [DOI 10.1023/A:1008370902407, 10.1023/A:1008370902407]; Sedivy JC, 2002, J MEM LANG, V46, P341, DOI 10.1006/jmla.2001.2812; Selkirk E., 2002, SPEECH PROSODY 2002, P643; Selkirk EO, 2008, ACTA LINGUIST HUNGAR, V55, P331, DOI 10.1556/ALing.55.2008.3-4.8; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Stolterfoht B, 2007, COGNITION, V104, P565, DOI 10.1016/j.cognition.2006.08.001; Sturt P, 2004, PSYCHON B REV, V11, P882, DOI 10.3758/BF03196716; TENPENNY PL, 1995, PSYCHON B REV, V2, P339, DOI 10.3758/BF03210972; Traxler MJ, 2000, J PSYCHOLINGUIST RES, V29, P581, DOI 10.1023/A:1026416225168; Van Berkum JJA, 2007, BRAIN RES, V1146, P158, DOI 10.1016/j.brainres.2006.06.091; van Gompel RPG, 2004, COGNITION, V90, P255, DOI 10.1016/S0010-0277(03)00161-6; VANPETTEN C, 1991, J COGNITIVE NEUROSCI, V3, P131, DOI 10.1162/jocn.1991.3.2.131; Wang L, 2009, BRAIN RES, V1282, P50, DOI 10.1016/j.brainres.2009.05.069; Ward P, 2007, MEM COGNITION, V35, P73, DOI 10.3758/BF03195944; Yang CL, 1999, LANG COGNITIVE PROC, V14, P715, DOI 10.1080/016909699386248; ZIMMER HD, 1981, PSYCHOL RES-PSYCH FO, V43, P375, DOI 10.1007/BF00309223	63	13	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42533	10.1371/journal.pone.0042533	http://dx.doi.org/10.1371/journal.pone.0042533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912708	gold, Green Submitted, Green Published			2022-12-27	WOS:000308063700015
J	Freeman, LR; Zhang, L; Dasuri, K; Fernandez-Kim, SO; Bruce-Keller, AJ; Keller, JN				Freeman, Linnea R.; Zhang, Le; Dasuri, Kalavathi; Fernandez-Kim, Sun-Ok; Bruce-Keller, Annadora J.; Keller, Jeffrey N.			Mutant Amyloid Precursor Protein Differentially Alters Adipose Biology under Obesogenic and Non-Obesogenic Conditions	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; INSULIN-RESISTANCE; TRANSCRIPTIONAL REGULATION; METABOLIC SYNDROME; LEPTIN PROMOTER; SKELETAL-MUSCLE; GENE-EXPRESSION; ADIPOCYTE SIZE	Mutations in amyloid precursor protein (APP) have been most intensely studied in brain tissue for their link to Alzheimer's disease (AD) pathology. However, APP is highly expressed in a variety of tissues including adipose tissue, where APP is also known to exhibit increased expression in response to obesity. In our current study, we analyzed the effects of mutant APP (E693Q, D694N, K670N/M671L) expression toward multiple aspects of adipose tissue homeostasis. These data reveal significant hypoleptinemia, decreased adiposity, and reduced adipocyte size in response to mutant APP, and this was fully reversed upon high fat diet administration. Additionally, mutant APP was observed to significantly exacerbate insulin resistance, triglyceride elevations, and macrophage infiltration of adipose tissue in response to a high fat diet. Taken together, these data have significant implications for linking mutant APP expression to adipose tissue dysfunction and global changes in endocrine and metabolic function under both obesogenic and non-obesogenic conditions.	[Freeman, Linnea R.; Zhang, Le; Dasuri, Kalavathi; Fernandez-Kim, Sun-Ok; Bruce-Keller, Annadora J.; Keller, Jeffrey N.] Pennington Biomed Res Ctr LSU Syst, Baton Rouge, LA USA		Freeman, LR (corresponding author), Pennington Biomed Res Ctr LSU Syst, Baton Rouge, LA USA.	Jeffrey.Keller@pbrc.edu	DASURI, KALAVATHI/E-7381-2012; Bruce-Keller, Annadora/N-1954-2017; Keller, Jeffrey N/N-1975-2017	keller, jeffrey/0000-0002-9892-7423	COBRE (National Institutes of Health [NIH] [2P20-RR021945)]; NORC center grants from the NIH [NIH 2P30-DK072476]; Pennington Animal Metabolism and Behavior Core; Hibernia National Bank/Edward G Schleider Chair; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	COBRE (National Institutes of Health [NIH]; NORC center grants from the NIH; Pennington Animal Metabolism and Behavior Core; Hibernia National Bank/Edward G Schleider Chair; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work utilized the facilities of the Cell Biology and Bioimaging Core that are supported in part by COBRE (National Institutes of Health [NIH] 2P20-RR021945) and NORC (NIH 2P30-DK072476) center grants from the NIH, the Pennington Animal Metabolism and Behavior Core, and funds from the Hibernia National Bank/Edward G Schleider Chair (JNK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Garcia-Lara JMA, 2010, REV INVEST CLIN, V62, P343; BEER J, 1995, NEURODEGENERATION, V4, P51, DOI 10.1006/neur.1995.0006; Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588; Bradley JS, 2009, BIOFACTORS, V35, P258, DOI 10.1002/biof.41; Bullo M, 2007, PUBLIC HEALTH NUTR, V10, P1164, DOI 10.1017/S1368980007000663; Cahova M, 2007, PHYSIOL RES, V56, P1, DOI 10.33549/physiolres.930882; Chen WM, 2012, OCEAN ENG, V42, P7, DOI 10.1016/j.oceaneng.2011.12.019; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farnier C, 2003, INT J OBESITY, V27, P1178, DOI 10.1038/sj.ijo.0802399; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fox NW, 1997, BIOCHEM BIOPH RES CO, V240, P759, DOI 10.1006/bbrc.1997.7728; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Guo QX, 2012, CELL RES, V22, P78, DOI 10.1038/cr.2011.116; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harvey J, 2010, CLIN CHEM, V56, P696, DOI 10.1373/clinchem.2010.144006; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Kumar-Singh S, 2008, GENES BRAIN BEHAV, V7, P67, DOI 10.1111/j.1601-183X.2007.00380.x; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Luchsinger JA, 2011, ALZ DIS ASSOC DIS, V26, P101; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; Meakin PJ, 2012, BIOCHEM J, V441, P285, DOI 10.1042/BJ20110512; Meissner U, 2003, BIOCHEM BIOPH RES CO, V303, P707, DOI 10.1016/S0006-291X(03)00401-7; Moussa CEH, 2006, FASEB J, V20, P2165, DOI 10.1096/fj.06-5763fje; Mouton PR, 2009, NEUROSCI LETT, V464, P184, DOI 10.1016/j.neulet.2009.08.038; Nishimura Satoshi, 2009, Discov Med, V8, P55; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Puig KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030378; Richardson James A, 2002, ILAR J, V43, P89; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Senechal Y, 2008, BEHAV BRAIN RES, V186, P126, DOI 10.1016/j.bbr.2007.08.003; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; Sommer G, 2009, J CELL BIOCHEM, V108, P1418, DOI 10.1002/jcb.22382; Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Van Nostrand WE, 2000, MOL MED TODAY, V6, P373, DOI 10.1016/S1357-4310(00)01762-7; Van Nostrand WE, 2010, STROKE, V41, pS135, DOI 10.1161/STROKEAHA.110.595272; Van Vickle GD, 2008, AM J PATHOL, V173, P483, DOI 10.2353/ajpath.2008.071191; Villemagne VL, 2012, EUR J NUCL MED MOL I, V39, P209, DOI 10.1007/s00259-011-2045-0; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; Wang ZL, 2012, CURR ALZHEIMER RES, V9, P217, DOI 10.2174/156720512799361691; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Zhang L, 2011, AM J PHYSIOL-ENDOC M, V301, pE599, DOI 10.1152/ajpendo.00059.2011; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200	62	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43193	10.1371/journal.pone.0043193	http://dx.doi.org/10.1371/journal.pone.0043193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912823	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700059
J	Sorek, M; Levy, O				Sorek, Michal; Levy, Oren			Influence of the Quantity and Quality of Light on Photosynthetic Periodicity in Coral Endosymbiotic Algae	PLOS ONE			English	Article							CIRCADIAN CLOCK; ARABIDOPSIS-THALIANA; CRYPTOCHROME GENES; ACTION SPECTRUM; EXPRESSION; RHYTHM; PHYTOCHROME; EVOLUTION; PROTEIN; PHOTORECEPTORS	Symbiotic corals, which are benthic organisms intimately linked with their environment, have evolved many ways to deal with fluctuations in the local marine environment. One possible coping mechanism is the endogenous circadian clock, which is characterized as free running, maintaining a similar to 24 h periodicity of circuits under constant stimuli or in the absence of external cues. The quantity and quality of light were found to be the most influential factors governing the endogenous clock for plants and algae. Unicellular dinoflagellate algae are among the best examples of organisms that exhibit circadian clocks using light as the dominant signal. This study is the first to examine the effects of light intensity and quality on the rhythmicity of photosynthesis in the symbiotic dinoflagellate Symbiodinium sp., both as a free-living organism and in symbiosis with the coral Stylophora pistillata. Oxygen production measurements in Symbiodinium cultures exhibited rhythmicity with a periodicity of approximately 24 h under constant high light (LL), whereas under medium and low light, the cycle time increased. Exposing Symbiodinium cultures and corals to spectral light revealed different effects of blue and red light on the photosynthetic rhythm, specifically shortening or increasing the cycle time respectively. These findings suggest that the photosynthetic rhythm is entrained by different light cues, which are wired to an endogenous circadian clock. Furthermore, we provide evidence that mRNA expression was higher under blue light for two potential cryptochrome genes and higher under red light for a phytochrome gene isolated from Symbiodinium. These results offer the first evidence of the impact of the intensity and quality of light on the photosynthetic rhythm in algal cells living freely or as part of a symbiotic association. Our results indicate the presence of a circadian oscillator in Symbiodinium governing the photosynthetic apparatus through a light-induced signaling pathway that has yet to be described.	[Sorek, Michal; Levy, Oren] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Sorek, M (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	sorekm@gmail.com; Oren.levy@biu.ac.il			Israeli Science Foundation [243/10]	Israeli Science Foundation(Israel Science Foundation)	This work represents partial fulfillment of the requirements for a PhD thesis for MS at Bar-Ilan University, Faculty of Life Sciences, Israel. This study was partially funded by an Israeli Science Foundation (No. 243/10) grant to OL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Delvin P, 2000, PLANT CELL, V12, P2499, DOI [10.1105/tpc.12.12.2499, DOI 10.1105/TPC.12.12.2499]; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Eriksson ME, 2003, PLANT PHYSIOL, V132, P732, DOI 10.1104/pp.103.022343; Falkowski P.G., 1990, P89; FREDEEN AL, 1991, PLANT PHYSIOL, V97, P415, DOI 10.1104/pp.97.1.415; Goosey L, 1997, PLANT PHYSIOL, V115, P959, DOI 10.1104/pp.115.3.959; GORDON HR, 1989, LIMNOL OCEANOGR, V34, P1389, DOI 10.4319/lo.1989.34.8.1389; Granbom M, 2001, J PHYCOL, V37, P1020, DOI 10.1046/j.1529-8817.2001.01040.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; HARRIS PJC, 1976, PLANTA, V129, P253, DOI 10.1007/BF00398267; HASTINGS JW, 1960, J GEN PHYSIOL, V43, P697, DOI 10.1085/jgp.43.4.697; HASTINGS JW, 1958, BIOL BULL, V115, P440, DOI 10.2307/1539108; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; Hoffman PD, 1996, MOL GEN GENET, V253, P259, DOI 10.1007/s004380050321; Imaizumi T, 2000, PLANT CELL, V12, P81, DOI 10.1105/tpc.12.1.81; JERLOV NG, 1955, TELLUS, V7, P218; Kanegae T, 1998, MOL GEN GENET, V259, P345, DOI 10.1007/s004380050821; KONDO T, 1991, PLANT PHYSIOL, V95, P197, DOI 10.1104/pp.95.1.197; LAVALMARTIN DL, 1979, PLANT PHYSIOL, V63, P495, DOI 10.1104/pp.63.3.495; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Luning K, 2001, J PHYCOL, V37, P52, DOI 10.1046/j.1529-8817.2001.037001052.x; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Ninu L, 1999, PLANT J, V18, P551, DOI 10.1046/j.1365-313X.1999.00466.x; Perrotta G, 2000, PLANT MOL BIOL, V42, P765, DOI 10.1023/A:1006371130043; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; ROENNEBERG T, 1988, NATURE, V334, P432, DOI 10.1038/334432a0; ROENNEBERG T, 1988, NATURWISSENSCHAFTEN, V75, P206, DOI 10.1007/BF00735584; Roenneberg T, 1997, PLANTA, V202, P494, DOI 10.1007/s004250050154; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Roenneberg T, 1993, OSCILLATIONS MORPHOG, P399; Roenneberg T, 1994, EVOLUTION CIRCADIAN, P3; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; SMALL GD, 1995, PLANT MOL BIOL, V28, P443, DOI 10.1007/BF00020393; SMITH RC, 1981, APPL OPTICS, V20, P177, DOI 10.1364/AO.20.000177; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; SOMERS DE, 1995, PLANT J, V7, P413, DOI 10.1046/j.1365-313X.1995.7030413.x; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; SWEENEY BM, 1979, PLANT PHYSIOL, V64, P341, DOI 10.1104/pp.64.2.341; Sweeney BM., 1987, RHYTHMIC PHENOMENA P; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467	49	23	24	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43264	10.1371/journal.pone.0043264	http://dx.doi.org/10.1371/journal.pone.0043264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912840	gold, Green Submitted, Green Published			2022-12-27	WOS:000308063700070
J	Farook, MF; DeCuypere, M; Hyland, K; Takumi, T; LeDoux, MS; Reiter, LT				Farook, M. Febin; DeCuypere, Michael; Hyland, Keith; Takumi, Toru; LeDoux, Mark S.; Reiter, Lawrence T.			Altered Serotonin, Dopamine and Norepinepherine Levels in 15q Duplication and Angelman Syndrome Mouse Models	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; UBIQUITIN LIGASE; AUTISM; TRANSPORTER; GENE; BEHAVIOR; UBE3A; MUTATIONS; MICE; INHIBITORS	Childhood neurodevelopmental disorders like Angelman syndrome and autism may be the result of underlying defects in neuronal plasticity and ongoing problems with synaptic signaling. Some of these defects may be due to abnormal monoamine levels in different regions of the brain. Ube3a, a gene that causes Angelman syndrome (AS) when maternally deleted and is associated with autism when maternally duplicated has recently been shown to regulate monoamine synthesis in the Drosophila brain. Therefore, we examined monoamine levels in striatum, ventral midbrain, frontal cerebral cortex, cerebellar cortex and hippocampus in Ube3a deficient and Ube3a duplication animals. We found that serotonin (5HT), a monoamine affected in autism, was elevated in the striatum and cortex of AS mice. Dopamine levels were almost uniformly elevated compared to control littermates in the striatum, midbrain and frontal cortex regardless of genotype in Ube3a deficient and Ube3a duplication animals. In the duplication 15q autism mouse model, paternal but not maternal duplication animals showed a decrease in 5HT levels when compared to their wild type littermates, in accordance with previously published data. However, maternal duplication animals show no significant changes in 5HT levels throughout the brain. These abnormal monoamine levels could be responsible for many of the behavioral abnormalities observed in both AS and autism, but further investigation is required to determine if any of these changes are purely dependent on Ube3a levels in the brain.	[Farook, M. Febin; LeDoux, Mark S.; Reiter, Lawrence T.] UTHSC, Dept Neurol, Memphis, TN USA; [DeCuypere, Michael] UTHSC, Dept Neurosurg, Memphis, TN USA; [Hyland, Keith] Med Neurogenet LCC, Atlanta, GA USA; [Takumi, Toru] Hiroshima Univ, Sch Med, Hiroshima, Japan; [LeDoux, Mark S.; Reiter, Lawrence T.] UTHSC, Dept Anat & Neurobiol, Memphis, TN USA; [Reiter, Lawrence T.] UTHSC, Dept Pediat, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Hiroshima University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Farook, MF (corresponding author), UTHSC, Dept Neurol, Memphis, TN USA.	lreiter@uthsc.edu	Reiter, Lawrence/H-4161-2019; DeCuypere, Michael/GMX-4926-2022	Reiter, Lawrence/0000-0002-4100-2630; DeCuypere, Michael/0000-0002-4598-8644	NIH NINDS [R01NS059902]; Core Research for Evolutional Science; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059902] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Core Research for Evolutional Science(Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH (http://www.nih.gov/) NINDS R01NS059902 to LTR. TT is supported by grants from Core Research for Evolutional Science and Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allensworth M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-7; Anderson GM, 2002, J AM ACAD CHILD PSY, V41, P1513, DOI 10.1097/00004583-200212000-00025; ANDERSON GM, 1984, PSYCHIAT RES, V11, P133, DOI 10.1016/0165-1781(84)90097-0; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bryant JL, 2010, EUR J NEUROSCI, V32, P41, DOI 10.1111/j.1460-9568.2010.07244.x; Cheron G, 2005, NEUROSCIENCE, V130, P631, DOI 10.1016/j.neuroscience.2004.09.013; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Cook EH, 1997, AM J HUM GENET, V60, P928; Croonenberghs J, 2000, NEUROPSYCHOPHARMACOL, V22, P275, DOI 10.1016/S0893-133X(99)00131-1; Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; Depienne C, 2009, BIOL PSYCHIAT, V66, P349, DOI 10.1016/j.biopsych.2009.01.025; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Ferdousy F, 2011, NEUROBIOL DIS, V41, P669, DOI 10.1016/j.nbd.2010.12.001; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; HOWELLS DW, 1987, CLIN CHIM ACTA, V167, P23, DOI 10.1016/0009-8981(87)90081-7; Hranilovic D, 2009, J NEURAL TRANSM, V116, P493, DOI 10.1007/s00702-009-0192-2; Janusonis S, 2006, J NEUROCHEM, V99, P1019, DOI 10.1111/j.1471-4159.2006.04150.x; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kolevzon A, 2006, J CLIN PSYCHIAT, V67, P407, DOI 10.4088/JCP.v67n0311; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Makkonen I, 2008, DEV MED CHILD NEUROL, V50, P593, DOI 10.1111/j.1469-8749.2008.03027.x; Marazziti D, 2000, PHARMACOPSYCHIATRY, V33, P165, DOI 10.1055/s-2000-7588; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mukand J, 1996, ARCH PHYS MED REHAB, V77, P1309, DOI 10.1016/S0003-9993(96)90198-7; Nahas Z, 1998, J NEUROPSYCH CLIN N, V10, P453, DOI 10.1176/jnp.10.4.453; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Pelc Karine, 2008, Neuropsychiatr Dis Treat, V4, P577; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Reiter LA, 2006, BIOORG MED CHEM LETT, V16, P5822, DOI 10.1016/j.bmcl.2006.08.066; Robinson WP, 2000, CLIN GENET, V57, P349, DOI 10.1034/j.1399-0004.2000.570505.x; Scoles HA, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-19; Scoppetta M, 2005, Eur Rev Med Pharmacol Sci, V9, P343; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Stecker MM, 2003, CLIN NEUROL NEUROSUR, V105, P183, DOI 10.1016/S0303-8467(03)00005-2; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Tamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015126; TANI Y, 1994, NEUROSCI LETT, V181, P169, DOI 10.1016/0304-3940(94)90586-X; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Veenstra-VanderWeele J, 2012, P NATL ACAD SCI USA, V109, P5469, DOI 10.1073/pnas.1112345109; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	55	33	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43030	10.1371/journal.pone.0043030	http://dx.doi.org/10.1371/journal.pone.0043030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916201	Green Submitted, gold, Green Published			2022-12-27	WOS:000307824300025
J	Butt, AM; Nasrullah, I; Tahir, S; Tong, YG				Butt, Azeem Mehmood; Nasrullah, Izza; Tahir, Shifa; Tong, Yigang			Comparative Genomics Analysis of Mycobacterium ulcerans for the Identification of Putative Essential Genes and Therapeutic Candidates	PLOS ONE			English	Article							RNA SYNTHETASE INHIBITORS; DRUG TARGETS; MYCOPLASMA-GENITALIUM; METABOLIC ENZYMES; BURULI ULCER; PREDICTION; BIOSYNTHESIS; TUBERCULOSIS; GROWTH; COMBINATION	Mycobacterium ulcerans, the causative agent of Buruli ulcer, is the third most common mycobacterial disease after tuberculosis and leprosy. The present treatment options are limited and emergence of treatment resistant isolates represents a serious concern and a need for better therapeutics. Conventional drug discovery methods are time consuming and labor-intensive. Unfortunately, the slow growing nature of M. ulcerans in experimental conditions is also a barrier for drug discovery and development. In contrast, recent advancements in complete genome sequencing, in combination with cheminformatics and computational biology, represent an attractive alternative approach for the identification of therapeutic candidates worthy of experimental research. A computational, comparative genomics workflow was defined for the identification of novel therapeutic candidates against M. ulcerans, with the aim that a selected target should be essential to the pathogen, and have no homology in the human host. Initially, a total of 424 genes were predicted as essential from the M. ulcerans genome, via homology searching of essential genome content from 20 different bacteria. Metabolic pathway analysis showed that the most essential genes are associated with carbohydrate and amino acid metabolism. Among these, 236 proteins were identified as non-host and essential, and could serve as potential drug and vaccine candidates. Several drug target prioritization parameters including druggability were also calculated. Enzymes from several pathways are discussed as potential drug targets, including those from cell wall synthesis, thiamine biosynthesis, protein biosynthesis, and histidine biosynthesis. It is expected that our data will facilitate selection of M. ulcerans proteins for successful entry into drug design pipelines.	[Butt, Azeem Mehmood] Univ Punjab, Natl Ctr Excellence Mol Biol CEMB, Lahore, Pakistan; [Nasrullah, Izza] Quaid I Azam Univ, Dept Biochem, Fac Biol Sci, Islamabad, Pakistan; [Tahir, Shifa] Quaid I Azam Univ, Fac Biol Sci, Natl Ctr Bioinformat, Islamabad, Pakistan; [Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	University of Punjab; Quaid I Azam University; Quaid I Azam University; Beijing Institute of Microbiology & Epidemiology	Butt, AM (corresponding author), Univ Punjab, Natl Ctr Excellence Mol Biol CEMB, Lahore, Pakistan.	azeem@cemb.edu.pk; tong.yigang@gmail.com	Butt, Azeem Mehmood/B-6249-2014	Butt, Azeem Mehmood/0000-0001-5897-6848; Tong, Yigang/0000-0002-8503-8045	National Natural Science Foundation of China [81072350]; China Mega-Project on Major Drug Development [2011ZX09401-023]; China Mega-Project on Infectious Disease Prevention [2011ZX10004-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Mega-Project on Major Drug Development; China Mega-Project on Infectious Disease Prevention	This work was supported by the National Natural Science Foundation of China (No. 81072350), China Mega-Project on Major Drug Development (No. 2011ZX09401-023), China Mega-Project on Infectious Disease Prevention (No. 2011ZX10004-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadio AKR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-75; Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amineni U, 2010, J Chem Biol, V3, P165, DOI 10.1007/s12154-010-0039-1; Aspinall TV, 2002, J INFECT DIS, V185, P1637, DOI 10.1086/340577; Barh Debmalya, 2009, In Silico Biology, V9, P225, DOI 10.3233/ISB-2009-0399; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Beyer D, 2004, ANTIMICROB AGENTS CH, V48, P525, DOI 10.1128/AAC.48.2.525-532.2004; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Butt AM, 2011, BIOINFORMATION, V7, P299; Butt AM, 2012, INFECT GENET EVOL, V12, P53, DOI 10.1016/j.meegid.2011.10.017; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Chhabra G, 2010, BIOINFORMATION, V4, P278, DOI 10.6026/97320630004278; Cho Y, 2008, J MED CHEM, V51, P5984, DOI 10.1021/jm800328v; Chong Chan-Eng, 2006, In Silico Biology, V6, P341; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Du WS, 2000, J BACTERIOL, V182, P4146, DOI 10.1128/JB.182.15.4146-4152.2000; Duffield M, 2010, MOL BIOSYST, V6, P2482, DOI 10.1039/c0mb00001a; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; Feltcher ME, 2010, FUTURE MICROBIOL, V5, P1581, DOI [10.2217/fmb.10.112, 10.2217/FMB.10.112]; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; FULLER AT, 1971, NATURE, V234, P416, DOI 10.1038/234416a0; Gallant P, 2000, EMERG THER TARGETS, V4(, P1; Galperin MY, 1999, CURR OPIN BIOTECH, V10, P571, DOI 10.1016/S0958-1669(99)00035-X; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021683; Gardy JL, 2006, NAT REV MICROBIOL, V4, P741, DOI 10.1038/nrmicro1494; Gautam A, 2011, CRIT REV BIOTECHNOL, V31, P295, DOI 10.3109/07388551.2010.525498; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Henriksen ST, 2010, BIOORGAN MED CHEM, V18, P5148, DOI 10.1016/j.bmc.2010.05.060; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Huber CA, 2008, CLIN VACCINE IMMUNOL, V15, P598, DOI 10.1128/CVI.00472-07; Hurdle JG, 2005, ANTIMICROB AGENTS CH, V49, P4821, DOI 10.1128/AAC.49.12.4821-4833.2005; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.0020108; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li W, 2006, BIOCHEM BIOPH RES CO, V342, P170, DOI 10.1016/j.bbrc.2006.01.130; Lin H, 2010, MOL DIVERS, V14, P667, DOI 10.1007/s11030-009-9205-1; Lin Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00053; Lin Y, 2010, BIOCHEM BIOPH RES CO, V396, P472, DOI 10.1016/j.bbrc.2010.04.119; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; Macarron R, 2000, ANAL BIOCHEM, V284, P183, DOI 10.1006/abio.2000.4665; Marsollier L, 2003, ANTIMICROB AGENTS CH, V47, P1228, DOI 10.1128/AAC.47.4.1228-1232.2003; MELO A, 1968, J BIOL CHEM, V243, P1475; Morya V.K., 2010, J COMPUT SCI SYST BI, V3; Muller IB, 2010, TRENDS PARASITOL, V26, P35, DOI 10.1016/j.pt.2009.10.006; Nzila A, 2006, DRUG DISCOV TODAY, V11, P939, DOI 10.1016/j.drudis.2006.08.003; Perumal Deepak, 2007, In Silico Biology, V7, P453; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pohlmann J., 2004, Current Drug Targets - Infectious Disorders, V4, P261, DOI 10.2174/1568005043340515; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Raczniak G, 2001, TOXICOLOGY, V160, P181, DOI 10.1016/S0300-483X(00)00454-6; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Saha S, 2006, GENET MOL RES, V5, P224; Sakharkar Kishore R, 2004, In Silico Biol, V4, P355; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Shanmugam A, 2010, BIOINFORMATION, V4, P392, DOI 10.6026/97320630004392; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Smith HO, 2002, GYNECOL ONCOL, V84, P140, DOI 10.1006/gyno.2001.6482; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Tao JS, 2000, P NATL ACAD SCI USA, V97, P783, DOI 10.1073/pnas.97.2.783; Thompson Denis B, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS61, DOI 10.1016/S0035-9203(08)70017-8; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Umashankar V, 2007, BIOINFORMATION, V2, P62; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wang JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-174; Wilson M D, 2011, Ghana Med J, V45, P31; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang TY, 2010, ANTIMICROB AGENTS CH, V54, P2806, DOI 10.1128/AAC.00400-10; Zuccotto F, 1998, J COMPUT AID MOL DES, V12, P241, DOI 10.1023/A:1016085005275	87	50	52	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43080	10.1371/journal.pone.0043080	http://dx.doi.org/10.1371/journal.pone.0043080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912793	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100059
J	Buu, TN; van Soolingen, D; Huyen, MNT; Lan, NTN; Quy, HT; Tiemersma, EW; Kremer, K; Borgdorff, MW; Cobelens, FGJ				Buu, Tran N.; van Soolingen, Dick; Huyen, Mai N. T.; Lan, Nguyen T. N.; Quy, Hoang T.; Tiemersma, Edine W.; Kremer, Kristin; Borgdorff, Martien W.; Cobelens, Frank G. J.			Increased Transmission of Mycobacterium tuberculosis Beijing Genotype Strains Associated with Resistance to Streptomycin: A Population-Based Study	PLOS ONE			English	Article							DRUG-RESISTANCE; MOLECULAR EPIDEMIOLOGY; TREATMENT FAILURE; SOUTH; MUTATIONS; SPREAD; IDENTIFICATION; INFECTION; DIAGNOSIS; GENETICS	Background: Studies have shown that the Mycobacterium tuberculosis Beijing genotype is an emerging pathogen that is frequently associated with drug resistance. This suggests that drug resistant Beijing strains have a relatively high transmission fitness compared to other drug-resistant strains. Methods and Findings: We studied the relative transmission fitness of the Beijing genotype in relation to anti-tuberculosis drug resistance in a population-based study of smear-positive tuberculosis patients prospectively recruited and studied over a 4-year period in rural Vietnam. Transmission fitness was analyzed by clustering of cases on basis of three DNA typing methods. Of 2531 included patients, 2207 (87%) were eligible for analysis of whom 936 (42%) were in a DNA fingerprint cluster. The clustering rate varied by genotype with 292/786 (37%) for the Beijing genotype, 527/802 (67%) for the East-African Indian (EAI) genotype, and 117/619 (19%) for other genotypes. Clustering was associated with the EAI compared to the Beijing genotype (adjusted odds ratio (ORadj) 3.4: 95% CI 2.8-4.4). Patients infected with streptomycin-resistant strains were less frequently clustered than patients infected with streptomycin-susceptible strains when these were of the EAI genotype (ORadj 0.6, 95% CI 0.4-0.9), while this pattern was reversed for strains of the Beijing genotype (ORadj 1.3, 95% CI 1.0-1.8, p for difference 0.002). The strong association between Beijing and MDR-TB (ORadj 7.2; 95% CI 4.2-12.3) existed only if streptomycin resistance was present. Conclusions: Beijing genotype strains showed less overall transmissibility than EAI strains, but when comparisons were made within genotypes, Beijing strains showed increased transmission fitness when streptomycin-resistant, while the reverse was observed for EAI strains. The association between MDR-TB and Beijing genotype in this population was strongly dependent on resistance to streptomycin. Streptomycin resistance may provide Beijing strains with a fitness advantage over other genotypes and predispose to multidrug resistance in patients infected with Beijing strains.	[Buu, Tran N.] Pham Ngoc Thach Hosp, TB Control Dept, Ho Chi Minh City, Vietnam; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Huyen, Mai N. T.; Lan, Nguyen T. N.] Pham Ngoc Thach Hosp, Dept Microbiol, Ho Chi Minh City, Vietnam; [van Soolingen, Dick] Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Quy, Hoang T.] Pham Ngoc Thach Hosp, Dept Med, Ho Chi Minh City, Vietnam; [Tiemersma, Edine W.] KNCV TB Fdn, Asia Dept, The Hague, Netherlands; [Tiemersma, Edine W.; Cobelens, Frank G. J.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Kremer, Kristin] WHO, Reg Off Europe, Div Communicable Dis Hlth Secur & Environm, DK-2100 Copenhagen, Denmark; [Borgdorff, Martien W.] Amsterdam Municipal Hlth Serv, Amsterdam, Netherlands; [Cobelens, Frank G. J.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; KNCV Tuberculosis Foundation; World Health Organization; University of Amsterdam; Academic Medical Center Amsterdam	Buu, TN (corresponding author), Pham Ngoc Thach Hosp, TB Control Dept, Ho Chi Minh City, Vietnam.	f.cobelens@aighd.org		Cobelens, Frank/0000-0002-4367-1133; Tran Ngoc, Buu/0000-0003-3554-1176	KNCV Tuberculosis Foundation; Medical Committee Netherlands-Vietnam; World Health Organization; TBadapt project [037919]	KNCV Tuberculosis Foundation; Medical Committee Netherlands-Vietnam; World Health Organization(World Health Organization); TBadapt project	Financial support for this study was provided by KNCV Tuberculosis Foundation, the Medical Committee Netherlands-Vietnam, the World Health Organization and the TBadapt project (037919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DD, 2000, EMERG INFECT DIS, V6, P302; [Anonymous], 2009, GUID SURV DRUG RES T; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 1994, GLOB TUB PROGR GLOB; [Anonymous], 2005, MINISTRY HLTH HIV AI; Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Buu TN, 2010, CLIN INFECT DIS, V51, P879, DOI 10.1086/656410; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; DeRiemer K, 2007, AM J RESP CRIT CARE, V176, P936, DOI 10.1164/rccm.200603-440OC; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Githui WA, 2004, INT J TUBERC LUNG D, V8, P352; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Glynn JR, 2005, EMERG INFECT DIS, V11, P150, DOI 10.3201/eid1101.040869; Heersma HF, 1998, METHODS MOL BIOL, V101; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Houben RMGJ, 2009, T ROY SOC TROP MED H, V103, P1187, DOI 10.1016/j.trstmh.2009.03.013; Huong NT, 2006, J INFECT DIS, V194, P1226, DOI 10.1086/507906; Huyen MNT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-149; Institute de Biologie, 2005, I BIOL I PASTCUR L M; Jou RW, 2005, J CLIN MICROBIOL, V43, P95, DOI 10.1128/JCM.43.1.95-100.2005; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kubica T, 2004, INT J TUBERC LUNG D, V8, P1107; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Samper S, 2005, J CLIN MICROBIOL, V43, P1220, DOI 10.1128/JCM.43.3.1220-1227.2005; Sun YJ, 2010, CLIN MICROBIOL INFEC, V16, P287, DOI 10.1111/j.1469-0691.2009.02800.x; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; WHO, 2003, GLOB TUB PROGR TREAT; WHO, 2010, GLOB TUB CONTR 2010	47	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42323	10.1371/journal.pone.0042323	http://dx.doi.org/10.1371/journal.pone.0042323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912700	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100012
J	Plaisier, MA; Smeets, JBJ				Plaisier, Myrthe A.; Smeets, Jeroen B. J.			Mass Is All That Matters in the Size-Weight Illusion	PLOS ONE			English	Article							PERCEPTION; CUES; OBJECTS	An object in outer space is weightless due to the absence of gravity, but astronauts can still judge whether one object is heavier than another one by accelerating the object. How heavy an object feels depends on the exploration mode: an object is perceived as heavier when holding it against the pull of gravity than when accelerating it. At the same time, perceiving an object's size influences the percept: small objects feel heavier than large objects with the same mass (size-weight illusion). Does this effect depend on perception of the pull of gravity? To answer this question, objects were suspended from a long wire and participants were asked to push an object and rate its heaviness. This way the contribution of gravitational forces on the percept was minimised. Our results show that weight is not at all necessary for the illusion because the size-weight illusion occurred without perception of weight. The magnitude of the illusion was independent of whether inertial or gravitational forces were perceived. We conclude that the size-weight illusion does not depend on prior knowledge about weights of object, but instead on a more general knowledge about the mass of objects, independent of the contribution of gravity. Consequently, the size-weight illusion will have the same magnitude on Earth as it should have on the Moon or even under conditions of weightlessness.	[Plaisier, Myrthe A.] Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany; [Plaisier, Myrthe A.; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands	University of Bielefeld; Vrije Universiteit Amsterdam	Plaisier, MA (corresponding author), Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany.	myrthe.plaisier@uni-bielefeld.de	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579	Netherlands Organization for Scientific Research [MaGW 453-08-004]; NWO in collaboration with the Marie Curie Cofund [MAGW 446-10-012]; Marie Curie Cofund [MAGW 446-10-012]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO in collaboration with the Marie Curie Cofund; Marie Curie Cofund	Funding provided by VICI grant (MaGW 453-08-004) for JBJS from the Netherlands Organization for Scientific Research. Rubicon grant from NWO in collaboration with the Marie Curie Cofund (MAGW 446-10-012) for MAP. www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazeen EL, 1996, J EXP PSYCHOL HUMAN, V22, P213, DOI 10.1037/0096-1523.22.1.213; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Buckingham G, 2010, EXP BRAIN RES, V205, P283, DOI 10.1007/s00221-010-2353-9; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; GORDON AM, 1991, EXP BRAIN RES, V83, P477; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; ROSS H, 1984, SCIENCE, V225, P219, DOI 10.1126/science.6729479; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; Tiest WMB, 2010, ATTEN PERCEPT PSYCHO, V72, P1144, DOI 10.3758/APP.72.4.1144; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Zhu Q, 2011, EVOL HUM BEHAV, V32, P288, DOI 10.1016/j.evolhumbehav.2010.11.005; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	20	23	23	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42518	10.1371/journal.pone.0042518	http://dx.doi.org/10.1371/journal.pone.0042518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912704	gold, Green Published, Green Submitted			2022-12-27	WOS:000307378500017
J	Zhou, ZB; Meng, FG; Chae, SR; Huang, GC; Fu, WJ; Jia, XS; Li, SY; Chen, GH				Zhou, Zhongbo; Meng, Fangang; Chae, So-Ryong; Huang, Guocheng; Fu, Wenjie; Jia, Xiaoshan; Li, Shiyu; Chen, Guang-Hao			Microbial Transformation of Biomacromolecules in a Membrane Bioreactor: Implications for Membrane Fouling Investigation	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; EXTRACELLULAR POLYMERIC SUBSTANCES; EXCITATION-EMISSION MATRIX; PARALLEL FACTOR-ANALYSIS; FLUORESCENCE EXCITATION; WASTE-WATER; ACTIVATED-SLUDGE; BIODEGRADABILITY; DEGRADATION; PRODUCTS	Background: The complex characteristics and unclear biological fate of biomacromolecules (BMM), including colloidal and soluble microbial products (SMP), extracellular polymeric substances (EPS) and membrane surface foulants (MSF), are crucial factors that limit our understanding of membrane fouling in membrane bioreactors (MBRs). Findings: In this study, the microbial transformation of BMM was investigated in a lab-scale MBR by well-controlled bioassay tests. The results of experimental measurements and mathematical modeling show that SMP, EPS, and MSF had different biodegradation behaviors and kinetic models. Based on the multi-exponential G models, SMP were mainly composed of slowly biodegradable polysaccharides (PS), proteins (PN), and non-biodegradable humic substances (HS). In contrast, EPS contained a large number of readily biodegradable PN, slowly biodegradable PS and HS. MSF were dominated by slowly biodegradable PS, which had a degradation rate constant similar to that of SMP-PS, while degradation behaviors of MSF-PN and MSF-HS were much more similar to those of EPS-PN and EPS-HS, respectively. In addition, the large-molecular weight (MW) compounds (>100 kDa) in BMM were found to have a faster microbial transformation rate compared to the small-MW compounds (<5 kDa). The parallel factor (PARAFAC) modeling of three-dimensional fluorescence excitation-emission matrix (EEM) spectra showed that the tryptophan-like PN were one of the major fractions in the BMM and they were more readily biodegradable than the HS. Besides microbial mineralization, humification and hydrolysis could be viewed as two important biotransformation mechanisms of large-MW compounds during the biodegradation process. Significance: The results of this work can aid in tracking the origin of membrane foulants from the perspective of the biotransformation behaviors of SMP, EPS, and MSF.	[Zhou, Zhongbo; Meng, Fangang; Huang, Guocheng; Fu, Wenjie; Jia, Xiaoshan; Li, Shiyu; Chen, Guang-Hao] Sun Yat Sen Univ, SYSU HKUST Res Ctr Innovat Environm Technol SHRCI, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Zhongbo; Meng, Fangang; Huang, Guocheng; Fu, Wenjie; Jia, Xiaoshan; Li, Shiyu] Guangdong Prov Key Lab Environm Pollut Control &, Guangzhou, Guangdong, Peoples R China; [Chae, So-Ryong] Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia; [Chen, Guang-Hao] Hong Kong Univ Sci & Technol, Dept Civil & Environm Engn, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Sun Yat Sen University; University of Sydney; Hong Kong University of Science & Technology	Meng, FG (corresponding author), Sun Yat Sen Univ, SYSU HKUST Res Ctr Innovat Environm Technol SHRCI, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China.	fgmeng80@126.com	Zhou, Zhongbo/F-3365-2013; Chae, Soryong/A-3334-2013; Meng, Fangang/AAV-1870-2020; Chen, Guanghao/G-8980-2016; Zhou, Zhongbo/U-5358-2017	Meng, Fangang/0000-0002-7976-9722; Zhou, Zhongbo/0000-0001-5694-5319; Chen, G.H./0000-0002-1353-8585; Chae, Soryong/0000-0002-2382-4075	opening Laboratory Fund of Sun Yat-sen University [KF201013]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100171120014]; Fundamental Research Funds for the Central Universities [2010380003161541]; New Century Excellent Talents in University from the Ministry of Education of China [NCET-11-0537]	opening Laboratory Fund of Sun Yat-sen University; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); New Century Excellent Talents in University from the Ministry of Education of China	The project was supported by the opening Laboratory Fund of Sun Yat-sen University (No. KF201013, http://soeasy.sysu.edu.cn/dela/), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20100171120014, http://www.dost.moe.edu.cn/), the financial support of the Fundamental Research Funds for the Central Universities (No. 2010380003161541, http://home3.sysu.edu.cn/kjc), and the New Century Excellent Talents in University from the Ministry of Education of China (NCET-11-0537, http://www.dost.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Halbouni D, 2009, WATER RES, V43, P97, DOI 10.1016/j.watres.2008.10.008; Al-Halbouni D, 2008, WATER RES, V42, P1475, DOI 10.1016/j.watres.2007.10.026; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; Baghoth SA, 2011, WATER RES, V45, P797, DOI 10.1016/j.watres.2010.09.005; Barker DJ, 1999, WATER RES, V33, P2499, DOI 10.1016/S0043-1354(98)00489-8; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Chinese-NEPA, 1997, WAT WAST MON METH; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Drews A, 2007, WATER RES, V41, P3850, DOI 10.1016/j.watres.2007.05.046; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Gruenheid S, 2008, WATER SCI TECHNOL, V57, P987, DOI 10.2166/wst.2008.207; Harmon ME, 2009, GLOBAL CHANGE BIOL, V15, P1320, DOI 10.1111/j.1365-2486.2008.01837.x; Henderson RK, 2009, WATER RES, V43, P863, DOI 10.1016/j.watres.2008.11.027; Huang GC, 2011, APPL MICROBIOL BIOT, V90, P1795, DOI 10.1007/s00253-011-3251-1; Hudson N, 2007, RIVER RES APPL, V23, P631, DOI 10.1002/rra.1005; Hwang BK, 2008, ENVIRON SCI TECHNOL, V42, P3963, DOI 10.1021/es7029784; Jiang T, 2008, WATER RES, V42, P4955, DOI 10.1016/j.watres.2008.09.037; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Laspidou CS, 2002, WATER RES, V36, P2711, DOI 10.1016/S0043-1354(01)00413-4; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Liang S, 2007, WATER RES, V41, P95, DOI 10.1016/j.watres.2006.10.008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malamis S, 2009, BIORESOURCE TECHNOL, V100, P3350, DOI 10.1016/j.biortech.2009.01.053; Meng FG, 2013, AICHE J, V59, P46, DOI 10.1002/aic.13799; Meng FG, 2011, WATER RES, V45, P4661, DOI 10.1016/j.watres.2011.06.026; Meng FG, 2009, ENVIRON SCI TECHNOL, V43, P8821, DOI 10.1021/es9019996; Menniti A, 2010, WATER RES, V44, P5240, DOI 10.1016/j.watres.2010.06.040; Menniti A, 2009, WATER RES, V43, P4305, DOI 10.1016/j.watres.2009.06.052; Murphy KR, 2011, ENVIRON SCI TECHNOL, V45, P2909, DOI 10.1021/es103015e; Namour P, 1998, WATER RES, V32, P2224, DOI 10.1016/S0043-1354(97)00428-4; Ni BJ, 2010, WATER RES, V44, P2292, DOI 10.1016/j.watres.2009.12.025; Okamura D, 2010, ENVIRON SCI TECHNOL, V44, P8644, DOI 10.1021/es102321m; Stedmon CA, 2005, LIMNOL OCEANOGR, V50, P1415, DOI 10.4319/lo.2005.50.5.1415; Stedmon CA, 2003, MAR CHEM, V82, P239, DOI 10.1016/S0304-4203(03)00072-0; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Vahatalo AV, 2010, BIOGEOCHEMISTRY, V100, P227, DOI 10.1007/s10533-010-9419-4; Wang ZW, 2007, APPL MICROBIOL BIOT, V74, P462, DOI 10.1007/s00253-006-0686-x; Wang ZW, 2009, WATER RES, V43, P2504, DOI 10.1016/j.watres.2009.02.026; Wu J, 2011, WATER RES, V45, P1711, DOI 10.1016/j.watres.2010.11.022; YAMAGIWA K, 1994, BIORESOURCE TECHNOL, V50, P131, DOI 10.1016/0960-8524(94)90065-5; Yamashita Y, 2008, ENVIRON SCI TECHNOL, V42, P7374, DOI 10.1021/es801357h; Yamashita Y, 2008, LIMNOL OCEANOGR, V53, P1900, DOI 10.4319/lo.2008.53.5.1900; Yavich AA, 2004, WATER RES, V38, P2839, DOI 10.1016/j.watres.2004.03.040; Yu GH, 2010, WATER RES, V44, P797, DOI 10.1016/j.watres.2009.10.021; Zhang XQ, 2003, CHEMOSPHERE, V50, P63, DOI 10.1016/S0045-6535(02)00319-3; Zhou ZB, 2012, RSC ADV, V2, P453, DOI 10.1039/c1ra00420d	46	20	22	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42270	10.1371/journal.pone.0042270	http://dx.doi.org/10.1371/journal.pone.0042270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912694	Green Published, Green Submitted, gold			2022-12-27	WOS:000307378500014
J	Chimalapati, S; Cohen, JM; Camberlein, E; MacDonald, N; Durmort, C; Vernet, T; Hermans, PWM; Mitchell, T; Brown, JS				Chimalapati, Suneeta; Cohen, Jonathan M.; Camberlein, Emilie; MacDonald, Nathanael; Durmort, Claire; Vernet, Thierry; Hermans, Peter W. M.; Mitchell, Timothy; Brown, Jeremy S.			Effects of Deletion of the Streptococcus pneumoniae Lipoprotein Diacylglyceryl Transferase Gene lgt on ABC Transporter Function and on Growth In Vivo	PLOS ONE			English	Article							SIGNAL PEPTIDASE II; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; IRON UPTAKE; LIPID MODIFICATION; PNEUMOCOCCAL PNEUMONIA; LISTERIA-MONOCYTOGENES; IMMUNE ACTIVATION; BACILLUS-SUBTILIS; VIRULENCE FACTORS	Lipoproteins are an important class of surface associated proteins that have diverse roles and frequently are involved in the virulence of bacterial pathogens. As prolipoproteins are attached to the cell membrane by a single enzyme, prolipoprotein diacylglyceryl transferase (Lgt), deletion of the corresponding gene potentially allows the characterisation of the overall importance of lipoproteins for specific bacterial functions. We have used a Delta lgt mutant strain of Streptococcus pneumoniae to investigate the effects of loss of lipoprotein attachment on cation acquisition, growth in media containing specific carbon sources, and virulence in different infection models. Immunoblots of triton X-114 extracts, flow cytometry and immunofluorescence microscopy confirmed the Delta lgt mutant had markedly reduced lipoprotein expression on the cell surface. The Delta lgt mutant had reduced growth in cation depleted medium, increased sensitivity to oxidative stress, reduced zinc uptake, and reduced intracellular levels of several cations. Doubling time of the Delta lgt mutant was also increased slightly when grown in medium with glucose, raffinose and maltotriose as sole carbon sources. These multiple defects in cation and sugar ABC transporter function for the Delta lgt mutant were associated with only slightly delayed growth in complete medium. However the Delta lgt mutant had significantly reduced growth in blood or bronchoalveolar lavage fluid and a marked impairment in virulence in mouse models of nasopharyngeal colonisation, sepsis and pneumonia. These data suggest that for S. pneumoniae loss of surface localisation of lipoproteins has widespread effects on ABC transporter functions that collectively prevent the Delta lgt mutant from establishing invasive infection.	[Chimalapati, Suneeta; Cohen, Jonathan M.; Camberlein, Emilie; MacDonald, Nathanael; Brown, Jeremy S.] Royal Free & Univ Coll Med Sch, Rayne Inst, Ctr Resp Res, Dept Med, London WC1E 6BT, England; [Cohen, Jonathan M.] UCL Inst Child Hlth, Infect Dis & Microbiol Unit, London, England; [Durmort, Claire; Vernet, Thierry] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Durmort, Claire; Vernet, Thierry] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Durmort, Claire; Vernet, Thierry] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Mitchell, Timothy] Univ Glasgow, Div Infect & Immun, IBLS, Glasgow, Lanark, Scotland	University of London; King's College London; University College London; University of London; University College London; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Radboud University Nijmegen; University of Glasgow	Chimalapati, S (corresponding author), Royal Free & Univ Coll Med Sch, Rayne Inst, Ctr Resp Res, Dept Med, London WC1E 6BT, England.	jeremy.brown@ucl.ac.uk	Durmort, Claire/L-4380-2013; Cohen, Jonathan/C-4588-2008; Vernet, Thierry/G-1118-2012; Hermans, Peter W.M./H-8042-2014	Cohen, Jonathan/0000-0002-3966-3640; Brown, Jeremy/0000-0002-5650-5361; Cohen, Jonathan/0000-0003-1004-5598; Mitchell, Timothy/0000-0002-8309-5556	Department of Health's NIHR Biomedical Research Centre's funding scheme; UCL Charities funding; Wellcome Trust [076442]; Medical Research Council [G0700829, G0600410]; Region Rhone-Alpes; Academy of Medical Sciences (AMS) [AMS-SGCL5-Cohen] Funding Source: researchfish; National Institute for Health Research [CL-2009-18-010] Funding Source: researchfish; MRC [G0600410, G0700829] Funding Source: UKRI	Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR)); UCL Charities funding; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken at UCLH/UCL, who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme, and was supported by the UCL Charities funding and grants from the Wellcome Trust (grant reference 076442) and the Medical Research Council (grants G0700829 and G0600410). Financial support from the Region Rhone-Alpes through the "Explo'ra pro 2010'' programme to CD is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2008, ORAL MICROBIOL IMMUN, V23, P515, DOI 10.1111/j.1399-302X.2008.00455.x; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Baumgartner M, 2007, J BACTERIOL, V189, P313, DOI 10.1128/JB.00976-06; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bray BA, 2009, MICROBIOL-SGM, V155, P1451, DOI 10.1099/mic.0.025213-0; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Chimalapati S, 2011, INFECT IMMUN, V79, P4965, DOI 10.1128/IAI.05923-11; Cockayne A, 1998, INFECT IMMUN, V66, P3767, DOI 10.1128/IAI.66.8.3767-3774.1998; Cohen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025558; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; Desrosiers DC, 2010, INFECT IMMUN, V78, P5163, DOI 10.1128/IAI.00732-10; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Eriksson EMY, 2007, CURR PROTEIN PEPT SC, V8, P412; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; GAN K, 1993, J BIOL CHEM, V268, P16544; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Hamilton A, 2006, INFECT IMMUN, V74, P6907, DOI 10.1128/IAI.01116-06; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; Hiron A, 2010, MOL MICROBIOL, V77, P1246, DOI 10.1111/j.1365-2958.2010.07287.x; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; INOUYE S, 1983, SCIENCE, V221, P59, DOI 10.1126/science.6344218; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Janulczyk R, 1999, MOL MICROBIOL, V34, P596, DOI 10.1046/j.1365-2958.1999.01626.x; Jomaa M, 2005, INFECT IMMUN, V73, P6852, DOI 10.1128/IAI.73.10.6852-6859.2005; Jonsson IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014209; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Khandavilli S, 2008, MOL MICROBIOL, V67, P541, DOI 10.1111/j.1365-2958.2007.06065.x; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koedel U, 2003, J IMMUNOL, V170, P438, DOI 10.4049/jimmunol.170.1.438; Lacks SA, 2000, MOL MICROBIOL, V35, P1089, DOI 10.1046/j.1365-2958.2000.01777.x; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Leskela S, 1999, MOL MICROBIOL, V31, P1075, DOI 10.1046/j.1365-2958.1999.01247.x; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Marriott HM, 2008, AM J RESP CRIT CARE, V177, P887, DOI 10.1164/rccm.200707-990OC; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; Molzen TE, 2011, INFECT IMMUN, V79, P288, DOI 10.1128/IAI.00631-10; Orihuela CJ, 2001, INFECT IMMUN, V69, P7565, DOI 10.1128/IAI.69.12.7565-7571.2001; Overweg K, 2000, INFECT IMMUN, V68, P4180, DOI 10.1128/IAI.68.7.4180-4188.2000; Petit CM, 2001, FEMS MICROBIOL LETT, V200, P229, DOI 10.1111/j.1574-6968.2001.tb10720.x; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Pezza RJ, 2002, NUCLEIC ACIDS RES, V30, P4700, DOI 10.1093/nar/gkf606; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samen U, 2004, J BACTERIOL, V186, P1398, DOI 10.1128/JB.186.5.1398-1408.2004; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; SEGAL AW, 1980, FEBS LETT, V110, P111, DOI 10.1016/0014-5793(80)80035-4; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tjalsma H, 1999, J BIOL CHEM, V274, P1698, DOI 10.1074/jbc.274.3.1698; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; van Rossum AMC, 2005, INFECT IMMUN, V73, P7718, DOI 10.1128/IAI.73.11.7718-7726.2005; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; YAMAGATA H, 1983, MOL GEN GENET, V192, P10, DOI 10.1007/BF00327640; Yoshimura A, 1999, J IMMUNOL, V163, P1	82	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41393	10.1371/journal.pone.0041393	http://dx.doi.org/10.1371/journal.pone.0041393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911788	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000306751300036
J	Rajasekaran, S; Vaz, M; Reddy, SP				Rajasekaran, Subbiah; Vaz, Michelle; Reddy, Sekhar P.			Fra-1/AP-1 Transcription Factor Negatively Regulates Pulmonary Fibrosis In Vivo	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; TGF-BETA; EXPRESSION; MICE; CELLS; AP-1; ACTIVATION; PROMOTER	The Fra-1/AP-1 transcription factor plays a key role in tumor epithelial cell progression; however, its role in pathogenic lung fibrosis remains unclear. In the present study, using a genetic approach (Fra-1 deficient mice), we have demonstrated a novel regulatory (protective) role for Fra-1 in lung fibrosis. We found greater levels of progressive interstitial fibrosis, characterized by increased levels of inflammation, collagen accumulation, and profibrotic and fibrotic gene expression in the lungs of Fra-1(Delta/Delta) mice than in those of Fra-1(+/+) mice following bleomycin treatment. Fra-1 knockdown in human lung epithelial cells caused the upregulation of mesenchymal marker N-cadherin, concomitant with a downregulation of the epithelial phenotype marker E-cadherin, under basal conditions and in response to bleomycin and TGF-beta 1. Furthermore, Fra-1 knockdown caused an enhanced expression of type 1 collagen and the downregulation of collagenase (MMP-1 and MMP-13) gene expression in human lung epithelial cells. Collectively, our findings demonstrate that Fra-1 mediates anti-fibrotic effects in the lung through the modulation of proinflammatory, profibrotic and fibrotic gene expression, and suggests that the Fra-1 transcription factor may be a potential target for pulmonary fibrosis, a progressive disorder with poor prognosis and treatment.	[Rajasekaran, Subbiah; Reddy, Sekhar P.] Univ Illinois, Dept Pediat, Chicago, IL 60607 USA; [Rajasekaran, Subbiah; Vaz, Michelle; Reddy, Sekhar P.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rajasekaran, S (corresponding author), Univ Illinois, Dept Pediat, Chicago, IL 60607 USA.	sreddy03@uic.edu		Subbiah, Rajasekaran/0000-0003-2303-3246	National Institutes of Health (NIH) [RO1 ES11863, RO1 HL66109, R21 ES18998]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES018998, R01ES011863] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the National Institutes of Health (NIH) grants RO1 ES11863, RO1 HL66109, R21 ES18998 (to SPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2008, J CELL PHYSIOL, V216, P405, DOI 10.1002/jcp.21410; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Asano Y, 2006, CLIN EXP RHEUMATOL, V24, P394; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Cailes JB, 1996, EUR RESPIR J, V9, P992, DOI 10.1183/09031936.96.09050992; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Cobelens PM, 2010, CRIT CARE, V14, DOI 10.1186/cc9232; Cutroneo KR, 2003, J CELL BIOCHEM, V90, P1, DOI 10.1002/jcb.10599; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; JANICKBUCKNER D, 1989, TOXICOL APPL PHARM, V100, P465, DOI 10.1016/0041-008X(89)90294-9; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Jones HA, 1998, AM J RESP CRIT CARE, V158, P620, DOI 10.1164/ajrccm.158.2.9711075; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Keane MP, 1999, J IMMUNOL, V162, P5511; Kim HT, 1997, BIOCHEM J, V324, P547, DOI 10.1042/bj3240547; Kireva T, 2011, HEPATOLOGY, V53, P1259, DOI 10.1002/hep.24175; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Liu JY, 1998, AM J PATHOL, V153, P1839, DOI 10.1016/S0002-9440(10)65698-2; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Mejlvang J, 2007, EXP CELL RES, V313, P380, DOI 10.1016/j.yexcr.2006.10.017; Mitsuhashi H, 1996, AM J RESP CRIT CARE, V153, P369, DOI 10.1164/ajrccm.153.1.8542145; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Ortiz LA, 2002, AM J PHYSIOL-LUNG C, V282, pL1209, DOI 10.1152/ajplung.00144.2001; Pardo A, 2003, AM J RESP CRIT CARE, V167, P925, DOI 10.1164/rccm.200209-1007OC; Pardo A, 2002, INT J BIOCHEM CELL B, V34, P1534, DOI 10.1016/S1357-2725(02)00091-2; PHAN SH, 1983, CHEST, V83, pS44; Piao CQ, 2005, CARCINOGENESIS, V26, P725, DOI 10.1093/carcin/bgi016; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; SMITH RE, 1994, J IMMUNOL, V153, P4704; Smith RE, 1998, J LEUKOCYTE BIOL, V64, P528, DOI 10.1002/jlb.64.4.528; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Swiderski RE, 1998, AM J PATHOL, V152, P821; Takada Y, 2011, ONCOGENE, V30, P3821, DOI 10.1038/onc.2011.101; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tan RJ, 2006, AM J RESP CELL MOL, V35, P289, DOI 10.1165/rcmb.2005-0471OC; Tower GB, 2003, EUR J BIOCHEM, V270, P4216, DOI 10.1046/j.1432-1033.2003.03821.x; Vaz M, 2012, AM J RESP CELL MOL, V46, P55, DOI 10.1165/rcmb.2011-0169OC; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Yamaguchi T, 2009, J BONE MINER RES, V24, P2056, DOI [10.1359/JBMR.090603, 10.1359/jbmr.090603]; Yan Sheng, 2005, Hepatobiliary Pancreat Dis Int, V4, P569; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; ZHANG K, 1995, AM J PATHOL, V147, P352	62	29	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41611	10.1371/journal.pone.0041611	http://dx.doi.org/10.1371/journal.pone.0041611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911824	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300058
J	Rivero-Juarez, A; Morgaz, J; Camacho, A; Munoz-Rascon, P; Dominguez, JM; Sanchez-Cespedes, R; Torre-Cisneros, J; Rivero, A				Rivero-Juarez, Antonio; Morgaz, Juan; Camacho, Angela; Munoz-Rascon, Pilar; Manuel Dominguez, Juan; Sanchez-Cespedes, Raquel; Torre-Cisneros, Julian; Rivero, Antonio			Liver Stiffness Using Transient Elastography is Applicable to Canines for Hepatic Disease Models	PLOS ONE			English	Article							C VIRUS; FIBROSIS; DIAGNOSIS; KEY	Background: The objectives of this study were to evaluate the best position and best exploration probe for determining liver stiffness (LS) in dogs using transient liver elastography (TE). Thirteen dogs were used in the study. Methodology/Principal Findings: Morphometric measurements taken were thoracic circumference, weight and height. Elastographic measurements were taken in 4 anatomical positions using two different probes: medium (M) and small (S). The exploration was considered correct when the success rate was above 60% and the interquartile range of the measurements did not exceed 30%. The best measurements were obtained in the middle of the 6th-9th intercostal spaces, with the dog in the left lateral position and using probe M for preference in adults and probe S mandatory for animals <2 years. The correlation between probes was 99%. Intra-observer variability showed an intra-class correlation of 97.6%. Conclusions/Significance: TE is a technique that is reproducible in dogs.	[Rivero-Juarez, Antonio; Camacho, Angela; Torre-Cisneros, Julian; Rivero, Antonio] Univ Hosp Reina Sofia, Infect Dis Unit, Inst Maimonides Invest Biomed IMIBIC, Cordoba, Spain; [Morgaz, Juan; Munoz-Rascon, Pilar; Manuel Dominguez, Juan] Vet Sch Cordoba, Dept Anim Med & Surg, Cordoba, Spain; [Sanchez-Cespedes, Raquel] Vet Sch Cordoba, Dept Comparat Pathol, Cordoba, Spain		Rivero-Juarez, A (corresponding author), Univ Hosp Reina Sofia, Infect Dis Unit, Inst Maimonides Invest Biomed IMIBIC, Cordoba, Spain.	ariveror@gmail.com	Sánchez-Céspedes, Raquel/A-7467-2018; MORGAZ, JUAN/L-1056-2014; Rivero, Antonio/ABE-5294-2020; DE LA TORRE CISNEROS, JULIAN/AAL-5723-2021; Dominguez Perez, Juan Manuel/AGG-5203-2022; Espejo, Angela Camacho/AAM-9991-2021; Rivero-Juarez, Antonio/E-4528-2019	Sánchez-Céspedes, Raquel/0000-0003-3282-7187; MORGAZ, JUAN/0000-0002-5512-1622; Rivero-Juarez, Antonio/0000-0002-5813-6889; Rivero, Antonio/0000-0001-5005-8268; Rivero Roman, Antonio/0000-0002-8643-4250				Abenavoli L, 2008, INT J CLIN PRACT, V62, P1108, DOI 10.1111/j.1742-1241.2007.01680.x; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Ding CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022921; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Ingiliz P, 2009, WORLD J GASTROENTERO, V15, P3398, DOI 10.3748/wjg.15.3398; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Kim KM, 2007, J GASTROENTEROL, V42, P382, DOI 10.1007/s00535-007-2016-1; Laflamme D, 1997, CANINE PRACT, V22, P10; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lucidarme D, 2007, HEPATOLOGY, V46, p318A; McGivern DR, 2011, GASTROENTEROLOGY, V141, P806, DOI 10.1053/j.gastro.2011.07.028; Neukam K, 2010, EUROPEAN J GASTROENT, V15, P93; Pietschmann T, 2009, NATURE, V457, P797, DOI 10.1038/457797a; Pineda JA, 2009, JAIDS-J ACQ IMM DEF, V51, P445, DOI 10.1097/QAI.0b013e3181acb675; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Takeda T, 2006, WORLD J GASTROENTERO, V12, P7768, DOI 10.3748/wjg.v12.i48.7768; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; Verstrepen BE, 2011, J INFECT DIS, V204, P837, DOI 10.1093/infdis/jir423	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41557	10.1371/journal.pone.0041557	http://dx.doi.org/10.1371/journal.pone.0041557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911813	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600086
J	Takeda, E; Nakagawa, S; Nakaya, Y; Tanaka, A; Miyazawa, T; Yasuda, J				Takeda, Eri; Nakagawa, So; Nakaya, Yuki; Tanaka, Atsushi; Miyazawa, Takayuki; Yasuda, Jiro			Identification and Functional Analysis of Three Isoforms of Bovine BST-2	PLOS ONE			English	Article							CELL-SURFACE; IMMUNODEFICIENCY-VIRUS; MOLECULAR-CLONING; DOWN-REGULATION; HIV-1 RELEASE; TETHERIN; PROTEIN; BST-2/TETHERIN; RESTRICTION; ALIGNMENT	Human BST-2 (hBST-2) has been identified as a cellular antiviral factor that blocks the release of various enveloped viruses. Orthologues of BST-2 have been identified in several species, including human, monkeys, pig, mouse, cat and sheep. All have been reported to possess antiviral activity. Duplication of the BST-2 gene has been observed in sheep and the paralogues are referred to as ovine BST-2A and BST2-B, although only a single gene corresponding to BST-2 has been identified in most species. In this study, we identified three isoforms of bovine BST-2, named bBST-2A1, bBST-2A2 and bBST-2B, in bovine cells treated with type I interferon, but not in untreated cells. Both bBST-2A1 and bBST-2A2 are posttranslationally modified by N-linked glycosylation and a GPI-anchor as well as hBST-2, while bBST-2B has neither of these modifications. Exogenous expression of bBST-2A1 or bBST-2A2 markedly reduced the production of bovine leukemia virus and vesicular stomatitis virus from cells, while the antiviral activity of bBST-2B was much weaker than those of bBST-2A1 and bBST-2A2. Our data suggest that bBST-2A1 and bBST-2A2 function as part of IFN-induced innate immunity against virus infection. On the other hand, bBST-2B may have a different physiological function from bBST-2A1 and bBST-2A2.	[Takeda, Eri; Yasuda, Jiro] Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med, Nagasaki 852, Japan; [Nakagawa, So] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Nakagawa, So] Natl Inst Genet, DNA Data Bank Japan DDBJ, Mishima, Shizuoka 411, Japan; [Nakagawa, So] Japan Soc Promot Sci, Tokyo, Japan; [Nakaya, Yuki; Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Signal Transduct, Kyoto 606, Japan; [Tanaka, Atsushi] Gunma Univ, Dept Virol & Prevent Med, Grad Sch Med, Maebashi, Gunma 371, Japan	Nagasaki University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Society for the Promotion of Science; Kyoto University; Gunma University	Takeda, E (corresponding author), Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med, Nagasaki 852, Japan.	j-yasuda@nagasaki-u.ac.jp	Nakagawa, So/Q-2712-2015; Nakaya, Yuki/AAD-1553-2020	Nakagawa, So/0000-0003-1760-3839; Nakaya, Yuki/0000-0002-0888-204X; Miyazawa, Takayuki/0000-0003-1938-9661; Yasuda, Jiro/0000-0001-9928-5621	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	Funding for this study was provided by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Arnaud F, 2010, J VIROL, V84, P4415, DOI 10.1128/JVI.00029-10; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DEVARE SG, 1976, SCIENCE, V194, P1428, DOI 10.1126/science.188129; Dietrich I, 2011, J VIROL, V85, P5840, DOI 10.1128/JVI.00071-11; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fukuma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018247; Goffinet C, 2010, J VIROL, V84, P11374, DOI 10.1128/JVI.01067-10; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011904; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Urata S, 2006, J VIROL, V80, P4191, DOI 10.1128/JVI.80.8.4191-4195.2006; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Xu FW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-198; YASUDA J, 1993, ARCH VIROL, V133, P283, DOI 10.1007/BF01313769; YASUDA J, 1994, J VIROL, V68, P8141, DOI 10.1128/JVI.68.12.8141-8146.1994; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41483	10.1371/journal.pone.0041483	http://dx.doi.org/10.1371/journal.pone.0041483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911799	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600081
J	Seufi, AM; Galal, FH; Hafez, EE				Seufi, AlaaEddeen M.; Galal, Fatma H.; Hafez, Elsayed E.			Characterization of Multisugar-Binding C-Type Lectin (Spli Lec) from a Bacterial-Challenged Cotton Leafworn, Spodoptera littoralis	PLOS ONE			English	Article							MANDUCA-SEXTA; ANTIBACTERIAL ACTIVITY; IMMUNE-RESPONSES; HEMOLYMPH; PURIFICATION; INSECT; LIPOPOLYSACCHARIDE; RECOGNITION; INNATE; CLONING	Background:Various proteins that display carbohydrate-binding activity in a Ca2+-dependent manner are classified into the C-type lectin family. They have one or two C-type carbohydrate-recognition domains (CRDs) composed of 110-130 amino acid residues in common. C-type lectins mediate cell adhesion, non-self recognition, and immuno-protection processes in immune responses and thus play significant roles in clearance of invaders, either as cell surface receptors for microbial carbohydrates or as soluble proteins existing in tissue fluids. The lectin of Spodoptera littoralis is still uncharacterized. Methodology: A single orf encoding a deduced polypeptide consisting of an 18-residue signal peptide and a 291-residue mature peptide, termed SpliLec, was isolated from the haemolymph of the cotton leafworm, S. littoralis, after bacterial challenge using RACE-PCR. Sequence analyses of the data revealed that SpliLec consists of two CRDs. Short-form CRD1 and long-form CRD2 are stabilized by two and three highly conserved disulfide bonds, respectively. SpliLec shares homology with some dipteran lectins suggesting possible common ancestor. The purified SpliLec exhibited a 140-kDa molecular mass with a subunit molecular mass of 35 kDa. The hemagglutination assays of the SpliLec confirmed a thermally stable, multisugar-binding C-type lectin that binds different erythrocytes. The purified SpliLec agglutinated microorganisms and exhibited comparable antimicrobial activity against gram (+) and gram (-) bacteria too. Conclusions: Our results suggested an important role of the SpliLec gene in cell adhesion and non-self recognition. It may cooperate with other AMPs in clearance of invaders of Spodoptera littoralis.	[Seufi, AlaaEddeen M.; Galal, Fatma H.] Cairo Univ, Fac Sci, Dept Entomol, Giza, Egypt; [Hafez, Elsayed E.] City Sci Res & Technol Applicat, ALCADRI, Dept Plant Protect & Mol Diag, New Borg ElArab, Alex, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City)	Seufi, AM (corresponding author), Cairo Univ, Fac Sci, Dept Entomol, Giza, Egypt.	alaaseufi@yahoo.com	hafez, elsayed/ABG-2456-2021; Seufi, AlaaEddeen/A-8722-2015	hafez, elsayed/0000-0003-4044-5103; Seufi, AlaaEddeen/0000-0002-6261-1873; Galal, Fatma/0000-0002-6819-3422	Cairo University [CU-008-08]	Cairo University(Cairo University)	This work is supported partially by Cairo University grant no. CU-008-08. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaad Tahany H., 2009, Egyptian Academic Journal of Biological Sciences A Entomology, V2, P55; Basseri HR, 2002, IRAN J PUBLIC HEALTH, V31, P69; BRADLEY RS, 1989, J INSECT PHYSIOL, V35, P353, DOI 10.1016/0022-1910(89)90108-X; CHEN CL, 1993, BIOCHEM J, V294, P181, DOI 10.1042/bj2940181; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; DRIF L, 1994, INSECT BIOCHEM MOLEC, V24, P283, DOI 10.1016/0965-1748(94)90008-6; ELDEFRAWI ME, 1964, J ECON ENTOMOL, V57, P591, DOI 10.1093/jee/57.4.591; Eslin P, 2000, J INSECT PHYSIOL, V46, P1161, DOI 10.1016/S0022-1910(99)00227-9; FAVEL A, 1994, PLANTA MED, V60, P50, DOI 10.1055/s-2006-959407; Goh EB, 2005, J BACTERIOL, V187, P4890, DOI 10.1128/JB.187.14.4890-4899.2005; Gul Nursel, 2002, Turkish Journal of Biology, V26, P49; HAPNER KD, 1981, INSECT BIOCHEM, V11, P287, DOI 10.1016/0020-1790(81)90006-8; Haq S, 1996, J BIOL CHEM, V271, P20213, DOI 10.1074/jbc.271.33.20213; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LEVINSON HZ, 1969, J INSECT PHYSIOL, V15, P591, DOI 10.1016/0022-1910(69)90257-1; LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mello CB, 1999, EXP PARASITOL, V91, P289, DOI 10.1006/expr.1998.4385; NCCLS, 1993, APPR STAND NCCLS PUB; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pendland JC, 1996, CELL TISSUE RES, V285, P57, DOI 10.1007/s004410050620; Pinheiro VB, 2006, CELL MICROBIOL, V8, P545, DOI 10.1111/j.1462-5822.2006.00693.x; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Riera AS, 2003, BIOCELL, V27, P37; Santana FA, 2006, AN ACAD BRAS CIENC, V78, P69, DOI 10.1590/S0001-37652006000100008; Santos AFS, 2009, PROCESS BIOCHEM, V44, P504, DOI 10.1016/j.procbio.2009.01.002; Seufi AM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-47; SHANGARY S, 1995, PHYTOCHEMISTRY, V40, P449, DOI 10.1016/0031-9422(95)00229-Z; SHARON N, 1977, SCI AM, V236, P108, DOI 10.1038/scientificamerican0677-108; Shin SW, 2000, FEBS LETT, V467, P70, DOI 10.1016/S0014-5793(00)01127-3; Soo C, 2002, PLAST RECONSTR SURG, V110, P787, DOI 10.1097/01.PRS.0000019717.64418.E6; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Varki A, 2009, ESSENTIALS GLYCOBIOL; Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8; Wang H, 2007, MOL IMMUNOL, V44, P722, DOI 10.1016/j.molimm.2006.04.015; Wang Q, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-9; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Wilson R, 1999, J IMMUNOL, V162, P1590; Yu XQ, 2006, INSECT MOL BIOL, V15, P119, DOI 10.1111/j.1365-2583.2006.00618.x; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zelensky AN, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-51; Zhu SY, 2000, TOXICON, V38, P1653, DOI 10.1016/S0041-0101(00)00081-7	57	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42795	10.1371/journal.pone.0042795	http://dx.doi.org/10.1371/journal.pone.0042795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916161	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800029
J	Ruiz, C; Martins, JR; Rudin, F; Schneider, S; Dietsche, T; Fischer, CA; Tornillo, L; Terracciano, LM; Schreiber, R; Bubendorf, L; Kunzelmann, K				Ruiz, Christian; Martins, Joana Raquel; Rudin, Florian; Schneider, Sandra; Dietsche, Tanja; Fischer, Claude A.; Tornillo, Luigi; Terracciano, Luigi M.; Schreiber, Rainer; Bubendorf, Lukas; Kunzelmann, Karl			Enhanced Expression of ANO1 in Head and Neck Squamous Cell Carcinoma Causes Cell Migration and Correlates with Poor Prognosis	PLOS ONE			English	Article							TISSUE MICROARRAY ANALYSIS; ION CHANNELS; TRANSCRIPTOME ANALYSIS; AMPLIFICATION; CANCER; GENE; TMEM16A; MARKER; DOG1; PROLIFERATION	Head and neck squamous cell carcinoma (HNSCC) has the potential for early metastasis and is associated with poor survival. Ano1 (Dog1) is an established and sensitive marker for the diagnosis of gastrointestinal stromal tumors (GIST) and has recently been identified as a Ca2+ activated Cl- channel. Although the ANO1 gene is located on the 11q13 locus, a region which is known to be amplified in different types of human carcinomas, a detailed analysis of Ano1 amplification and expression in HNSCC has not been performed. It is thus still unclear how Ano1 contributes to malignancy in HNSCC. We analyzed genomic amplification of the 11q13 locus and Ano1 together with Ano1-protein expression in a large collection of HNSCC samples. We detected a highly significant correlation between amplification and expression of Ano1 and showed that HNSCC patients with Ano1 protein expression have a poor overall survival. We further analyzed the expression of the Ano1 protein in more than 49000 human samples from 80 different tumor types and 76 normal tissue types and detected that besides HNSCC and GISTs, Ano1 was rarely expressed in other tumor samples or healthy human tissues. In HNSCC cell lines, expression of Ano1 caused Ca2+ activated Cl- currents, which induced cell motility and cell migration in wound healing and in real time migration assays, respectively. In contrast, knockdown of Ano1 did not affect intracellular Ca2+ signaling and surprisingly did not reduce cell proliferation in BHY cells. Further, expression and activity of Ano1 strongly correlated with the ability of HNSCC cells to regulate their volume. Thus, poor survival in HNSCC patients is correlated with the presence of Ano1. Our results further suggest that Ano1 facilitates regulation of the cell volume and causes cell migration, which both can contribute to metastatic progression in HNSCC.	[Ruiz, Christian; Rudin, Florian; Schneider, Sandra; Dietsche, Tanja; Tornillo, Luigi; Terracciano, Luigi M.; Bubendorf, Lukas] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Fischer, Claude A.] Kantonsspital Graubunden, Dept Otolaryngol Head & Neck Surg, Chur, Switzerland; [Martins, Joana Raquel; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, Regensburg, Germany	University of Basel; Kantonsspital Graubunden; University of Regensburg	Ruiz, C (corresponding author), Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.	christian.ruiz@unibas.ch	Martins, Joana/L-2965-2016; Terracciano, Luigi M./AAB-5335-2022; Bubendorfl, Lukas/H-5880-2011; Bubendorf, Lukas/G-5299-2015; Tornillo, Luigi/I-1732-2019	Martins, Joana/0000-0002-3784-9775; Terracciano, Luigi M./0000-0002-9393-9660; Bubendorf, Lukas/0000-0001-5970-1803; Kunzelmann, Karl/0000-0002-4583-7037; Tornillo, Luigi/0000-0003-3610-3733	Deutsche Krebshilfe [109438]; DFG [SFB699]; Krebsliga Schweiz [KFS-02780-02-2011]	Deutsche Krebshilfe(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); Krebsliga Schweiz	Supported by Deutsche Krebshilfe Projekt 109438 and DFG SFB699 Project A7, and by Krebsliga Schweiz KFS-02780-02-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Ardeleanu C, 2009, APPL IMMUNOHISTO M M, V17, P413, DOI 10.1097/PAI.0b013e31819e4dc5; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Fischer C, 2008, HUM PATHOL, V39, P1527, DOI 10.1016/j.humpath.2008.03.001; Fischer CA, 2011, HEAD NECK-J SCI SPEC, V33, P267, DOI 10.1002/hed.21440; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Hwang DG, 2011, AM J CLIN PATHOL, V135, P448, DOI 10.1309/AJCP0PPKOBNDT9LB; Klausen TK, 2007, J CELL PHYSIOL, V210, P831, DOI 10.1002/jcp.20918; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Lugli A, 2003, HUM PATHOL, V34, P994, DOI 10.1053/S0046-8177(03)00339-3; Nimeus E, 2004, ORAL ONCOL, V40, P624, DOI 10.1016/j.oraloncology.2003.12.014; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Rahim S, 2011, JOVE-J VIS EXP, DOI 10.3791/2792; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Schreiber R, 2005, J MEMBRANE BIOL, V205, P129, DOI 10.1007/s00232-005-0778-z; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SCHWAB A, 1994, J CLIN INVEST, V93, P1631, DOI 10.1172/JCI117144; Schwab A, 2001, NEWS PHYSIOL SCI, V16, P29, DOI 10.1152/physiologyonline.2001.16.1.29; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Shiu KK, 2010, FUTURE ONCOL, V6, P967, DOI [10.2217/fon.10.56, 10.2217/FON.10.56]; Simon R, 2003, EXPERT REV MOL DIAGN, V3, P421, DOI 10.1586/14737159.3.4.421; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Tada T, 2005, INT J CANCER, V116, P253, DOI 10.1002/ijc.21008; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zaharieva BM, 2003, J PATHOL, V201, P603, DOI 10.1002/path.1481	44	118	123	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43265	10.1371/journal.pone.0043265	http://dx.doi.org/10.1371/journal.pone.0043265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912841	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700071
J	Zeeshan, M; Alam, MT; Vinayak, S; Bora, H; Tyagi, RK; Alam, MS; Choudhary, V; Mittra, P; Lumb, V; Bharti, PK; Udhayakumar, V; Singh, N; Jain, V; Singh, PP; Sharma, YD				Zeeshan, Mohammad; Alam, Mohammad Tauqeer; Vinayak, Sumiti; Bora, Hema; Tyagi, Rupesh Kumar; Alam, Mohd Shoeb; Choudhary, Vandana; Mittra, Pooja; Lumb, Vanshika; Bharti, Praveen Kumar; Udhayakumar, Venkatachalam; Singh, Neeru; Jain, Vidhan; Singh, Pushpendra Pal; Sharma, Yagya Dutta			Genetic Variation in the Plasmodium falciparum Circumsporozoite Protein in India and Its Relevance to RTS,S Malaria Vaccine	PLOS ONE			English	Article							CELL EPITOPE POLYMORPHISMS; PHASE 2A TRIAL; NATURAL-SELECTION; CANDIDATE ANTIGENS; EXPANDED-PROGRAM; NAIVE ADULTS; EFFICACY; SEQUENCE; SAFETY; IMMUNOGENICITY	RTS,S is the most advanced malaria vaccine candidate, currently under phase-III clinical trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region and the complete C-terminal T cell epitope region (Th2R and Th3R) of the circumsporozoite protein (CSP). Since naturally occurring polymorphisms at the vaccine candidate loci are critical determinants of the protective efficacy of the vaccines, it is imperative to investigate these polymorphisms in field isolates. In this study we have investigated the genetic diversity at the central repeat, C-terminal T cell epitope (Th2R and Th3R) and N-terminal T cell epitope regions of the CSP, in P. falciparum isolates from Madhya Pradesh state of India. These isolates were collected through a 5-year prospective study aimed to develop a well-characterized field-site for the future evaluation of malaria vaccine in India. Our results revealed that the central repeat (63 haplotypes, n = 161) and C-terminal Th2R/Th3R epitope (24 haplotypes, n = 179) regions were highly polymorphic, whereas N-terminal non-repeat region was less polymorphic (5 haplotypes, n = 161) in this population. We did not find any evidence of the role of positive natural selection in maintaining the genetic diversity at the Th2R/Th3R regions of CSP. Comparative analysis of the Th2R/Th3R sequences from this study to the global isolates (n = 1160) retrieved from the GenBank database revealed two important points. First, the majority of the sequences (similar to 61%, n = 179) from this study were identical to the Dd2/Indochina type, which is also the predominant Th2R/Th3R haplotype in Asia (similar to 59%, n = 974). Second, the Th2R/Th3R sequences in Asia, South America and Africa are geographically distinct with little allele sharing between continents. In conclusion, this study provides an insight on the existing polymorphisms in the CSP in a parasite population from India that could potentially influence the efficacy of RTS, S vaccine in this region.	[Zeeshan, Mohammad; Alam, Mohammad Tauqeer; Vinayak, Sumiti; Bora, Hema; Tyagi, Rupesh Kumar; Alam, Mohd Shoeb; Choudhary, Vandana; Mittra, Pooja; Lumb, Vanshika; Sharma, Yagya Dutta] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Bharti, Praveen Kumar; Singh, Neeru; Jain, Vidhan; Singh, Pushpendra Pal] Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India; [Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA	All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Centers for Disease Control & Prevention - USA	Zeeshan, M (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	ydsharma_aiims@yahoo.com	Singh, Puspendra/R-5135-2019; Singh, Puspendra/P-1772-2017; Vinayak, Sumiti/F-9395-2013; Singh, Pushpendra/T-4248-2018; Singh, Puspendra/F-5751-2012; Singh, Pushpendra P./P-6421-2018; alam, mohammed/GXH-3645-2022	Singh, Puspendra/0000-0003-2616-9309; Singh, Pushpendra/0000-0002-7277-115X; Singh, Pushpendra P./0000-0003-3813-4322; 	Biotechnology Information System (BTIS) of the Department of Biotechnology at the All India Institute of Medical Sciences; Indian Council of Medical Research	Biotechnology Information System (BTIS) of the Department of Biotechnology at the All India Institute of Medical Sciences; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	We are grateful to all patients who donated their blood samples for this study. We also acknowledge the supports provided by the Biotechnology Information System (BTIS) of the Department of Biotechnology at the All India Institute of Medical Sciences, and Mrs. Shalini Narang during the preparation of this manuscript.; Financial support was provided by the Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aide P, 2011, VACCINE, V29, P6059, DOI 10.1016/j.vaccine.2011.03.041; Aide P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013838; ALEY SB, 1986, J EXP MED, V164, P1915, DOI 10.1084/jem.164.6.1915; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alloueche A, 2000, MOL BIOCHEM PARASIT, V106, P273, DOI 10.1016/S0166-6851(99)00221-2; Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; de Stricker K, 2000, MOL BIOCHEM PARASIT, V111, P123, DOI 10.1016/S0166-6851(00)00304-2; DOOLAN DL, 1992, INFECT IMMUN, V60, P675, DOI 10.1128/IAI.60.2.675-682.1992; ENEA V, 1984, SCIENCE, V225, P628, DOI 10.1126/science.6204384; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Escalante AA, 1998, GENETICS, V149, P189; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; FU YX, 1993, GENETICS, V133, P693; Garg S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-154; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HUGHES AL, 1991, GENETICS, V127, P345; Jalloh A, 2006, J CLIN MICROBIOL, V44, P1229, DOI 10.1128/JCM.44.4.1229-1235.2006; Jalloh A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-120; JONGWUTIWES S, 1994, AM J TROP MED HYG, V51, P659, DOI 10.4269/ajtmh.1994.51.659; Jongwutiwes S, 2010, VACCINE; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Leach A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-224; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Putaporntip C, 2008, GENE, V427, P51, DOI 10.1016/j.gene.2008.09.009; Putaporntip C, 2009, INFECT GENET EVOL, V9, P567, DOI 10.1016/j.meegid.2009.02.006; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Roggero MA, 1995, MOL IMMUNOL, V32, P1301, DOI 10.1016/0161-5890(95)00136-0; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SHI YP, 1993, INFECT IMMUN, V61, P2425, DOI 10.1128/IAI.61.6.2425-2433.1993; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe K, 2004, SCIENCE, V303, P493, DOI 10.1126/science.1092077; Udhayakumar V, 1997, EUR J IMMUNOL, V27, P1952, DOI 10.1002/eji.1830270819; Vinayak S, 2006, MOL BIOCHEM PARASIT, V147, P101, DOI 10.1016/j.molbiopara.2006.01.013; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; WHO, 2010, WORLD MALARIA REPORT 2010, P1; YOSHIDA N, 1990, EXP PARASITOL, V71, P386, DOI 10.1016/0014-4894(90)90064-J; Zakeri S, 2007, AM J TROP MED HYG, V76, P1046, DOI 10.4269/ajtmh.2007.76.1046	57	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43430	10.1371/journal.pone.0043430	http://dx.doi.org/10.1371/journal.pone.0043430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912873	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700101
J	Endo, T; Kobayashi, T				Endo, Toyoshi; Kobayashi, Tetsuro			Dominant Negative Effect of Mutated Thyroid Stimulating Hormone Receptor (P556L) Causes Hypothyroidism in C.RF-Tshr(hyt/wild) Mice	PLOS ONE			English	Article							THYROTROPIN RECEPTOR; TSH RECEPTOR; HYT/HYT MOUSE; OLIGOMERIZATION; BINDING; DOMAIN	C.RF-Tshr(hyt/hyt) mice have a mutated thyroid stimulating hormone receptor (P556L-TSHR) and these mice develop severe hypothyroidism. We found that C.RF-Tshr(hyt/wild) heterozygous mice are also in a hypothyroid state. Thyroid glands from C.RF-Tshr(hyt/wild) mice are smaller than those from wild-type mice, and I-125 uptake activities of the former are significantly lower than those in the latter. When TSHR (TSHR(W)) and P556L-TSHR (TSHR(M)) cDNAs were cloned and co-transfected into HEK 293 cells, the cells retained I-125-TSH binding activity, but cAMP response to TSH was decreased to about 20% of HEK 293 cells transfected with TSHR(W) cDNA. When TSHR(W) and TSHR(M) were tagged with eCFP or eYFP, we observed fluorescence resonance energy transfer (FRET) in HEK 293 cells expressing TSHR(W)-eCFP and TSHR(W)-eYFP in the absence of TSH, but not in the presence of TSH. In contrast, we obtained FRET in HEK 293 cells expressing TSHR(W)-eCFP and TSHR (M)-eYFP, regardless of the presence or absence of TSH. These results suggest that P556L TSHR has a dominant negative effect on TSHR(W) by impairing polymer to monomer dissociation, which decreases TSH responsiveness and induces hypothyroidism in C.RF-Tshr(hyt/wild) mice.	[Endo, Toyoshi; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo City, Yamanashi, Japan	University of Yamanashi	Endo, T (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo City, Yamanashi, Japan.	endot@yamanashi.ac.jp						Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; BEAMER WG, 1981, SCIENCE, V212, P61, DOI 10.1126/science.7209519; Calebiro D, 2005, HUM MOL GENET, V14, P2991, DOI 10.1093/hmg/ddi329; COLLINS WT, 1980, VIRCHOWS ARCH B, V33, P213, DOI 10.1007/BF02899183; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; ENDO T, 1993, BIOCHEM BIOPH RES CO, V190, P774, DOI 10.1006/bbrc.1993.1116; Endo T, 2008, AM J PHYSIOL-ENDOC M, V295, pE514, DOI 10.1152/ajpendo.90433.2008; GU WX, 1995, ENDOCRINOLOGY, V136, P3146, DOI 10.1210/en.136.7.3146; Inoue M, 1998, THYROID, V8, P1059, DOI 10.1089/thy.1998.8.1059; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; Latif R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009449; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; OMALLEY BW, 1995, HEARING RES, V88, P181, DOI 10.1016/0378-5955(95)00111-G; Sprenkle PM, 2001, JARO-J ASSOC RES OTO, V2, P312, DOI 10.1007/s101620010076; STEIN SA, 1994, MOL ENDOCRINOL, V8, P129, DOI 10.1210/me.8.2.129; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686	17	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42358	10.1371/journal.pone.0042358	http://dx.doi.org/10.1371/journal.pone.0042358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916127	Green Submitted, gold, Green Published			2022-12-27	WOS:000307824300008
J	Hughes, HC; Caplovitz, GP; Loucks, RA; Fendrich, R				Hughes, Howard C.; Caplovitz, Gideon Paul; Loucks, Rebecca A.; Fendrich, Robert			Attentive and Pre-Attentive Processes in Change Detection and Identification	PLOS ONE			English	Article							SHORT-TERM-MEMORY; VISUAL WORKING-MEMORY; LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; CHANGE-BLINDNESS; TIME-COURSE; INFORMATIONAL PERSISTENCE; BINOCULAR INTERACTION; SELECTIVE ATTENTION; ICONIC MEMORY	In studies of change blindness, observers often have the phenomenological impression that the blindness is overcome all at once, so that change detection, localization and identification apparently occur together. Three experiments are described that explore dissociations between these processes using a discrete trial procedure in which 2 visual frames are presented sequentially with no intervening inter-frame-interval. The results reveal that change detection and localization are essentially perfect under these conditions regardless of the number of elements in the display, which is consistent with the idea that change detection and localization are mediated by pre-attentive parallel processes. In contrast, identification accuracy for an item before it changes is generally poor, and is heavily dependent on the number of items displayed. Identification accuracy after a change is substantially better, but depends on the new item's duration. This suggests that the change captures attention, which substantially enhances the likelihood of correctly identifying the new item. However, the results also reveal a limited capacity to identify unattended items. Specifically, we provide evidence that strongly suggests that, at least under these conditions, observers were able to identify two items without focused attention. Our results further suggest that spatial pre-cues that attract attention to an item before the change occurs simply ensure that the cued item is one of the two whose identity is encoded.	[Hughes, Howard C.; Loucks, Rebecca A.; Fendrich, Robert] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Caplovitz, Gideon Paul] Univ Nevada, Dept Psychol, Reno, NV 89557 USA	Dartmouth College; Nevada System of Higher Education (NSHE); University of Nevada Reno	Hughes, HC (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	Howard.C.Hughes@Dartmouth.edu			Dartmouth College	Dartmouth College	This work was supported by internal funds from Dartmouth College provided to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1980, J EXP PSYCHOL HUMAN, V6, P486, DOI 10.1037/0096-1523.6.3.486; AGOSTINELLI G, 1986, J EXP PSYCHOL HUMAN, V12, P445, DOI 10.1037/0096-1523.12.4.445; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; AVERBACH E, 1961, AT&T TECH J, V40, P309, DOI 10.1002/j.1538-7305.1961.tb03987.x; Averbach E, 1961, S INFORMATION THEORY, P196, DOI DOI 10.1007/S00213-010-1823-X; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Becker MW, 2007, PERCEPTION, V36, P1179, DOI 10.1068/p5750; Becker MW, 2000, PERCEPTION, V29, P273; Boot WR, 2005, PSYCHON B REV, V12, P662, DOI 10.3758/BF03196755; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Caplovitz GP, 2008, CONSCIOUS COGN, V17, P877, DOI 10.1016/j.concog.2007.08.006; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chun MM, 2000, VIS COGN, V7, P65, DOI 10.1080/135062800394685; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; COLTHEART M, 1980, PHILOS T ROY SOC B, V290, P57, DOI 10.1098/rstb.1980.0082; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Davis G, 2005, MEM COGNITION, V33, P185, DOI 10.3758/BF03195307; DRIVER J, 1992, J EXP PSYCHOL HUMAN, V18, P22, DOI 10.1037/0096-1523.18.1.22; EFRON R, 1971, AM J PSYCHOL, V84, P365, DOI 10.2307/1420468; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Henderson JM, 1999, PSYCHOL SCI, V10, P438, DOI 10.1111/1467-9280.00183; Hopf JM, 2002, COGNITIVE BRAIN RES, V15, P17, DOI 10.1016/S0926-6410(02)00213-6; Huang LQ, 2007, PSYCHOL REV, V114, P599, DOI 10.1037/0033-295X.114.3.599; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hughes HC, 1998, PSYCHOL SCI, V9, P53, DOI 10.1111/1467-9280.00010; IRWIN DE, 1986, J EXP PSYCHOL HUMAN, V12, P343, DOI 10.1037/0096-1523.12.3.343; IRWIN DE, 1987, CAN J PSYCHOL, V41, P317, DOI 10.1037/h0084162; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kawahara J, 2001, J EXP PSYCHOL HUMAN, V27, P969, DOI 10.1037//0096-1523.27.4.969; Lachter J, 2004, PSYCHOL REV, V111, P880, DOI 10.1037/0033-295x.111.4.880; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; LEVICK WR, 1970, J PHYSIOL-LONDON, V206, P677, DOI 10.1113/jphysiol.1970.sp009037; LOFTUS GR, 1992, J EXP PSYCHOL HUMAN, V18, P530, DOI 10.1037/0096-1523.18.2.530; Luck SJ, 1998, P NATL ACAD SCI USA, V95, P825, DOI 10.1073/pnas.95.3.825; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Lupianez J, 2001, Q J EXP PSYCHOL-A, V54, P753, DOI 10.1080/02724980042000453; Mance I, 2011, J EXP PSYCHOL HUM PE; McConkie GW, 1996, J EXP PSYCHOL HUMAN, V22, P563, DOI 10.1037/0096-1523.22.3.563; Mondy S, 2000, VIS COGN, V7, P281, DOI 10.1080/135062800394810; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; O'Regan JK, 2000, VIS COGN, V7, P191, DOI 10.1080/135062800394766; OGMEN H, 1993, NEURAL NETWORKS, V6, P245, DOI 10.1016/0893-6080(93)90020-W; Ogmen H, 2006, VISION RES, V46, P4726, DOI 10.1016/j.visres.2006.09.006; Omtzigt D, 2004, VISION RES, V44, P1927, DOI 10.1016/j.visres.2004.03.010; PERRY VH, 1984, NEUROSCIENCE, V12, P1101, DOI 10.1016/0306-4522(84)90006-X; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; SCHILLER PH, 1983, VISION RES, V23, P1631, DOI 10.1016/0042-6989(83)90177-3; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; SHERK H, 1984, J NEUROSCI, V4, P381; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Simons DJ, 2000, PERCEPTION, V29, P1143, DOI 10.1068/p3104; SINGER W, 1974, EXP BRAIN RES, V19, P507; Sokolov E.N., 1975, NEURONAL MECH ORIENT; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Steinman BA, 1997, VISION RES, V37, P17, DOI 10.1016/S0042-6989(96)00151-4; Suchow JW, 2011, CURR BIOL, V21, P140, DOI 10.1016/j.cub.2010.12.019; Theeuwes J, 2004, PSYCHON B REV, V11, P60, DOI 10.3758/BF03206461; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; TOLHURST DJ, 1975, VISION RES, V15, P1143, DOI 10.1016/0042-6989(75)90013-9; TOWNSEND JT, 1990, PSYCHOL SCI, V1, P46, DOI 10.1111/j.1467-9280.1990.tb00067.x; TREISMAN A, 1985, COMPUT VISION GRAPH, V31, P156, DOI 10.1016/S0734-189X(85)80004-9; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TSAL Y, 1983, J EXP PSYCHOL HUMAN, V9, P523, DOI 10.1037/0096-1523.9.4.523; Tse PU, 2006, NEUROIMAGE, V31, P766, DOI 10.1016/j.neuroimage.2005.12.029; Turatto M, 2005, EXP BRAIN RES, V167, P595, DOI 10.1007/s00221-005-0056-4; Turatto M, 2000, VISION RES, V40, P1639, DOI 10.1016/S0042-6989(00)00061-4; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Watanabe K, 2003, COGNITION, V88, P243, DOI 10.1016/S0010-0277(03)00025-8; WATSON DG, 1995, PERCEPT PSYCHOPHYS, V57, P583, DOI 10.3758/BF03213264; Wolfe JM, 2006, VIS COGN, V14, P749, DOI 10.1080/13506280500195292; Wolfe JM, 2001, PERCEPT PSYCHOPHYS, V63, P381, DOI 10.3758/BF03194406	82	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42851	10.1371/journal.pone.0042851	http://dx.doi.org/10.1371/journal.pone.0042851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AN	22916170	gold, Green Published, Green Submitted			2022-12-27	WOS:000307824300019
J	Chao, WS; Dogramaci, M; Foley, ME; Horvath, DP; Anderson, JV				Chao, Wun S.; Dogramaci, Muenevver; Foley, Michael E.; Horvath, David P.; Anderson, James V.			Selection and Validation of Endogenous Reference Genes for qRT-PCR Analysis in Leafy Spurge (Euphorbia esula)	PLOS ONE			English	Article							TIME RT-PCR; HOUSEKEEPING GENES; QUANTITATIVE PCR; NORMALIZATION; QUANTIFICATION; IDENTIFICATION; TRANSCRIPTOME; DORMANCY; MODEL; SEEDS	Quantitative real-time polymerase chain reaction (qRT-PCR) is the most important tool in measuring levels of gene expression due to its accuracy, specificity, and sensitivity. However, the accuracy of qRT-PCR analysis strongly depends on transcript normalization using stably expressed reference genes. The aim of this study was to find internal reference genes for qRT-PCR analysis in various experimental conditions for seed, adventitious underground bud, and other organs of leafy spurge. Eleven candidate reference genes (BAM4, PU1, TRP-like, FRO1, ORE9, BAM1, SEU, ARF2, KAPP, ZTL, and MPK4) were selected from among 171 genes based on expression stabilities during seed germination and bud growth. The other ten candidate reference genes were selected from three different sources: (1) 3 stably expressed leafy spurge genes (60S, bZIP21, and MD-100) identified from the analyses of leafy spurge microarray data; (2) 3 orthologs of Arabidopsis "general purpose" traditional reference genes (GAPDH_1, GAPDH_2, and UBC); and (3) 4 orthologs of Arabidopsis stably expressed genes (UBC9, SAND, PTB, and F-box) identified from Affymetrix ATH1 whole-genome GeneChip studies. The expression stabilities of these 21 genes were ranked based on the C-T values of 72 samples using four different computation programs including geNorm, Normfinder, BestKeeper, and the comparative Delta C-T method. Our analyses revealed SAND, PTB, ORE9, and ARF2 to be the most appropriate reference genes for accurate normalization of gene expression data. Since SAND and PTB were obtained from 4 orthologs of Arabidopsis, while ORE9 and ARF2 were selected from 171 leafy spurge genes, it was more efficient to identify good reference genes from the orthologs of other plant species that were known to be stably expressed than that of randomly testing endogenous genes. Nevertheless, the two newly identified leafy spurge genes, ORE9 and ARF2, can serve as orthologous candidates in the search for reference genes from other plant species.	[Chao, Wun S.; Dogramaci, Muenevver; Foley, Michael E.; Horvath, David P.; Anderson, James V.] USDA ARS, Biosci Res Lab, Sunflower & Plant Biol Res Unit, Fargo, ND 58105 USA	United States Department of Agriculture (USDA)	Chao, WS (corresponding author), USDA ARS, Biosci Res Lab, Sunflower & Plant Biol Res Unit, Fargo, ND 58105 USA.	wun.chao@ars.usda.gov		Anderson, James/0000-0002-1801-5767; Horvath, David/0000-0002-8458-7691	United States Department of Agriculture Agricultural Research Service CRIS Project [5442-21220-026-00]	United States Department of Agriculture Agricultural Research Service CRIS Project	This work was supported by United States Department of Agriculture Agricultural Research Service CRIS Project # 5442-21220-026-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson JV, 2007, WEED SCI, V55, P193, DOI 10.1614/WS-06-138.1; Applied Biosystems, 2002, TAQMAN UN PCR MAST M; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chao WS, 2011, FUNCT INTEGR GENOMIC, V11, P637, DOI 10.1007/s10142-011-0253-0; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Foley ME, 2008, WEED SCI, V56, P516, DOI 10.1614/WS-07-179.1; Foley ME, 2010, PLANT MOL BIOL, V73, P131, DOI 10.1007/s11103-009-9569-8; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Leitch J.A., 1994, IMPACT ASSESSMENT, V14, P419, DOI DOI 10.1080/07349165.1996.9725915; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779	36	43	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42839	10.1371/journal.pone.0042839	http://dx.doi.org/10.1371/journal.pone.0042839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916167	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800024
J	Akong-Moore, K; Chow, OA; von Kockritz-Blickwede, M; Nizet, V				Akong-Moore, Kathryn; Chow, Ohn A.; von Koeckritz-Blickwede, Maren; Nizet, Victor			Influences of Chloride and Hypochlorite on Neutrophil Extracellular Trap Formation	PLOS ONE			English	Article							MYELOPEROXIDASE; CHOLESTEROL; PROTEINS; KILL	Background: The release by neutrophils of DNA-based extracellular traps (NETs) is a recently recognized innate immune phenomenon that contributes significantly to control of bacterial pathogens at tissue foci of infection. NETs have also been implicated in the pathogenesis of non-infectious diseases such as small vessel vasculitis, lupus and cystic fibrosis lung disease. Reactive oxygen species (ROS) are important mediators of NET generation (NETosis). Neutrophils with reduced ROS production, such as those from patients with chronic granulomatous disease or myeloperoxidase (MPO) deficiency, produce fewer NETs in response to inflammatory stimuli. To better understand the roles of various ROS in NETosis, we explore the role of MPO, its substrates chloride ion (Cl-) and hydrogen peroxide (H2O2), and its product hypochlorite (HOCl) in NETosis. Findings: In human peripheral blood neutrophils, pharmacologic inhibition of MPO decreased NETosis. Absence of extracellular Cl-, a substrate for MPO, also reduced NETosis. While exogenous addition of H2O2 and HOCl stimulated NETosis, only exogenous HOCl could rescue NETosis in the setting of MPO inhibition. Neither pharmacological inhibition nor genetic deletion of MPO in murine neutrophils blocked NETosis, in contrast to findings in human neutrophils. Conclusions: Our results pinpoint HOCl as the key ROS involved in human NETosis. This finding has implications for understanding innate immune function in diseases in which Cl- homeostasis is disturbed, such as cystic fibrosis. Our results also reveal an example of significant species-specific differences in NET phenotypes, and the need for caution in extrapolation to humans from studies of murine NETosis.	[Akong-Moore, Kathryn; Chow, Ohn A.; von Koeckritz-Blickwede, Maren; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Akong-Moore, Kathryn; Nizet, Victor] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Akong-Moore, K (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	UCSD Pediatric Pulmonary Medicine Fellowship Program; NIH [AI077780, AI090863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090863, R01AI077780] Funding Source: NIH RePORTER	UCSD Pediatric Pulmonary Medicine Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	K.A.-M. received the support of the UCSD Pediatric Pulmonary Medicine Fellowship Program. Research was funded by NIH grants AI077780 and AI090863 (VN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Carr AC, 1996, ARCH BIOCHEM BIOPHYS, V332, P63, DOI 10.1006/abbi.1996.0317; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HEINECKE JW, 1994, BIOCHEMISTRY-US, V33, P10127, DOI 10.1021/bi00199a041; Kang JI, 2008, CHEM RES TOXICOL, V21, P1028, DOI 10.1021/tx7003486; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Zavodnik IB, 2001, FREE RADICAL BIO MED, V30, P363, DOI 10.1016/S0891-5849(00)00479-2	17	87	94	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42984	10.1371/journal.pone.0042984	http://dx.doi.org/10.1371/journal.pone.0042984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912772	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100048
J	Heber, S; Briskie, JV; Apiolaza, LA				Heber, Sol; Briskie, James V.; Apiolaza, Luis A.			A Test of the 'Genetic Rescue' Technique Using Bottlenecked Donor Populations of Drosophila melanogaster	PLOS ONE			English	Article							ADDERS VIPERA-BERUS; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; CONSERVATION BIOLOGY; FLORIDA PANTHER; EXTINCTION RISK; MEXICAN WOLVES; NEW-ZEALAND; MANAGEMENT; RESTORATION	We produced replicated experimental lines of inbred fruit flies Drosophila melanogaster to test the effects of crossing different bottlenecked populations as a method of 'genetic rescue' for endangered species lacking outbred donor populations. Two strains differing in the origin of the founders were maintained as isolated populations in a laboratory environment. After two generations of controlled full-sib matings, the resulting inbred fruit flies had significantly reduced breeding success and survival rates. However, crosses between the two bottlenecked strains reversed the effects of inbreeding and led to increases in breeding success and survival that persisted into the second generation of hybrid offspring. In contrast, crosses within each strain (but between different replicate lines) resulted in only slight improvements in some fitness components, and this positive trend was reversed in the second generation. This experiment highlights the potential value of translocations between different inbred populations of endangered species as a tool to mitigate the negative effects of inbreeding, but this benefit may depend upon the origin of the populations. Our results also confirm the importance of maintaining adequate levels of genetic variation within populations and that severely bottlenecked populations should not be discounted as possible donors in genetic rescue programs for endangered species.	[Heber, Sol; Briskie, James V.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Apiolaza, Luis A.] Univ Canterbury, Sch Forestry, Christchurch 1, New Zealand	University of Canterbury; University of Canterbury	Heber, S (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	sol.heber@pg.canterbury.ac.nz		Apiolaza, Luis/0000-0003-0958-3540	University of Canterbury; Brian Mason Science and Technical Trust	University of Canterbury; Brian Mason Science and Technical Trust	This project was funded by the University of Canterbury and the Brian Mason Science and Technical Trust (http://www.brianmasontrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardern SL, 1997, MOL ECOL, V6, P21, DOI 10.1046/j.1365-294X.1997.00147.x; ARMSTRONG DP, 1995, BIOL CONSERV, V71, P281, DOI 10.1016/0006-3207(94)00038-R; Bijlsma R, 2010, CONSERV GENET, V11, P449, DOI 10.1007/s10592-010-0058-z; BRISCOE DA, 1992, CONSERV BIOL, V6, P416, DOI 10.1046/j.1523-1739.1992.06030416.x; Brook BW, 2002, CONSERV ECOL, V6; Bryant EH, 1999, CONSERV BIOL, V13, P1487, DOI 10.1046/j.1523-1739.1999.98440.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; Goldberg TL, 2005, CONSERV BIOL, V19, P455, DOI 10.1111/j.1523-1739.2005.00091.x; Groombridge JJ, 2000, NATURE, V403, P616, DOI 10.1038/35001148; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Henderson C. R, 1984, APPL LINEAR MODELS A; Holand AM, 2011, 42001 NORW U SCI TEC; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ingvarsson PK, 2002, NATURE, V420, P472, DOI 10.1038/420472a; Jamieson IG, 2006, CONSERV BIOL, V20, P38, DOI 10.1111/j.1523-1739.2005.00282.x; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Madsen T, 2004, BIOL CONSERV, V120, P145, DOI 10.1016/j.biocon.2004.01.022; Madsen T, 1996, BIOL CONSERV, V75, P113, DOI 10.1016/0006-3207(95)00067-4; Marr AB, 2002, EVOLUTION, V56, P131; Marshall TC, 2000, ANIM CONSERV, V3, P241, DOI 10.1111/j.1469-1795.2000.tb00109.x; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; MOLINAFREANER F, 1993, EVOLUTION, V47, P1472, DOI 10.2307/2410161; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Newman D, 2001, CONSERV BIOL, V15, P1054, DOI 10.1046/j.1523-1739.2001.0150041054.x; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Pimm SL, 2006, ANIM CONSERV, V9, P115, DOI 10.1111/j.1469-1795.2005.00010.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; SPIELMAN D, 1992, ZOO BIOL, V11, P343, DOI 10.1002/zoo.1430110506; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; Therneau T, 2011, SURVIVAL SURVIVAL AN; Weeks AR, 2011, EVOLUTIONARY APPL, P1; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Wisley SM, 2008, CONSERV GENET, V9, P389	46	8	8	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43113	10.1371/journal.pone.0043113	http://dx.doi.org/10.1371/journal.pone.0043113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912802	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100062
J	Mei, F; Guo, S; He, YT; Wang, LY; Wang, HK; Niu, JQ; Kong, JM; Li, XM; Wu, YZ; Xiao, L				Mei, Feng; Guo, Sheng; He, Yangtao; Wang, Linyun; Wang, Hongkai; Niu, Jianqin; Kong, Jiming; Li, Xinmin; Wu, Yuzhang; Xiao, Lan			Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; PROGENITOR CELLS; RECEPTOR; REMYELINATION; ACTIVATION; DIFFERENTIATION; ABNORMALITIES; INFLAMMATION; EXPRESSION	Quetiapine (Que), a commonly used atypical antipsychotic drug (APD), can prevent myelin from breakdown without immune attack. Multiple sclerosisis (MS), an autoimmune reactive inflammation demyelinating disease, is triggered by activated myelin-specific T lymphocytes (T cells). In this study, we investigated the potential efficacy of Que as an immune-modulating therapeutic agent for experimental autoimmune encephalomyelitis (EAE), a mouse model for MS. Que treatment was initiated on the onset of MOG(35-55) peptide induced EAE mice and the efficacy of Que on modulating the immune response was determined by Flow Cytometry through analyzing CD4(+)/CD8(+) populations and the proliferation of effector T cells (CD4(+) CD25(-)) in peripheral immune organs. Our results show that Que dramatically attenuates the severity of EAE symptoms. Que treatment decreases the extent of CD4(+)/CD8(+) T cell infiltration into the spinal cord and suppresses local glial activation, thereby diminishing the loss of mature oligodendrocytes and myelin breakdown in the spinal cord of EAE mice. Our results further demonstrate that Que treatment decreases the CD4(+)/CD8(+) T cell populations in lymph nodes and spleens of EAE mice and inhibits either MOG(35-55) or anti-CD3 induced proliferation as well as IL-2 production of effector T cells (CD4(+) CD25(-)) isolated from EAE mice spleen. Together, these findings suggest that Que displays an immune-modulating role during the course of EAE, and thus may be a promising candidate for treatment of MS.	[Mei, Feng; He, Yangtao; Wang, Linyun; Wang, Hongkai; Niu, Jianqin; Xiao, Lan] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Histol & Embryol, Chongqing, Peoples R China; [Guo, Sheng; Wu, Yuzhang] Third Mil Med Univ, Dept Immunol, Chongqing, Peoples R China; [Kong, Jiming] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Li, Xinmin] Univ Manitoba, Dept Psychiat, Winnipeg, MB R3T 2N2, Canada	Army Medical University; Army Medical University; University of Manitoba; University of Manitoba	Mei, F (corresponding author), Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Histol & Embryol, Chongqing, Peoples R China.	xiaolan35@hotmail.com		Mei, Feng/0000-0003-4125-1570; Kong, Jiming/0000-0002-2859-9831; Wu, Yuzhang/0000-0002-4049-0214	National Natural Science Foundation of China (NSCF) [81071084]; International Science & Technology Cooperation Program of China [2010DFB30820]; Natural Science Foundation Project of Chongqing (CQ CSTC) [2009BB5157, 2010BB5157]	National Natural Science Foundation of China (NSCF)(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Natural Science Foundation Project of Chongqing (CQ CSTC)	This work is in part supported by the National Natural Science Foundation of China (NSCF, 81071084), International Science & Technology Cooperation Program of China (2010DFB30820) and Natural Science Foundation Project of Chongqing (CQ CSTC, 2009BB5157, 2010BB5157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2008, P NATL ACAD SCI USA, V105, P11358, DOI 10.1073/pnas.0804632105; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Bian Q, 2008, PROG NEURO-PSYCHOPH, V32, P42, DOI 10.1016/j.pnpbp.2007.06.031; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; CHANG JF, 1991, J IMMUNOL, V147, P860; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; De SP, 2008, J IMMUNOL, V181, P338; Dutta R, 2011, ANN NEUROL, V69, P445, DOI 10.1002/ana.22337; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Franco PG, 2008, EXP NEUROL, V212, P458, DOI 10.1016/j.expneurol.2008.04.039; Freire-Garabal M, 2003, NEUROSCI LETT, V342, P33, DOI 10.1016/S0304-3940(03)00215-5; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Inoue M, 2011, INT IMMUNOPHARMACOL, V11, P67, DOI 10.1016/j.intimp.2010.10.007; Janardhan V, 2002, J NEUROL SCI, V205, P51, DOI 10.1016/S0022-510X(02)00312-X; Jones HM, 2000, AM J PSYCHIAT, V157, P148, DOI 10.1176/ajp.157.1.148; JONES RE, 1990, J NEUROIMMUNOL, V30, P61, DOI 10.1016/0165-5728(90)90053-P; Kanwar JR, 2004, BRAIN, V127, P1313, DOI 10.1093/brain/awh156; Kerns D, 2010, SCHIZOPHR RES, V120, P150, DOI 10.1016/j.schres.2010.04.012; Konradi C, 2012, NEUROBIOL DIS, V45, P37, DOI 10.1016/j.nbd.2011.01.025; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Liu LP, 2010, J NEUROSCI, V30, P9074, DOI 10.1523/JNEUROSCI.1238-10.2010; Makar TK, 2008, J NEUROIMMUNOL, V196, P67, DOI 10.1016/j.jneuroim.2008.02.014; Maruo S, 1996, J IMMUNOL, V156, P1748; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Mostert JP, 2008, J NEUROL NEUROSUR PS, V79, P1027, DOI 10.1136/jnnp.2007.139345; Nakane H, 2004, INFLAMM RES, V53, P324, DOI 10.1007/s00011-004-1264-2; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Rasmussen S, 2011, ANN NEUROL, V69, P878, DOI 10.1002/ana.22299; Ray LA, 2010, DRUG ALCOHOL REV, V29, P568, DOI 10.1111/j.1465-3362.2010.00185.x; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wei ZL, 2003, J NEUROSCI RES, V74, P942, DOI 10.1002/jnr.10832; Xiao L, 2008, MOL PSYCHIATR, V13, P697, DOI 10.1038/sj.mp.4002064; Xu HY, 2008, FEBS J, V275, P3718, DOI 10.1111/j.1742-4658.2008.06519.x; Zhang YB, 2008, SCHIZOPHR RES, V106, P182, DOI 10.1016/j.schres.2008.09.013	35	35	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42746	10.1371/journal.pone.0042746	http://dx.doi.org/10.1371/journal.pone.0042746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912731	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100026
J	Sanchez, CEG; Garcia, CAV; Saez, RGT				Garcia Sanchez, Carlos Eduardo; Vargas Garcia, Cesar Augusto; Torres Saez, Rodrigo Gonzalo			Predictive Potential of Flux Balance Analysis of Saccharomyces cerevisiae Using as Optimization Function Combinations of Cell Compartmental Objectives	PLOS ONE			English	Article							METABOLIC FLUXES; GROWTH; MODEL; IDENTIFICATION	Background: The main objective of flux balance analysis (FBA) is to obtain quantitative predictions of metabolic fluxes of an organism, and it is necessary to use an appropriate objective function to guarantee a good estimation of those fluxes. Methodology: In this study, the predictive performance of FBA was evaluated, using objective functions arising from the linear combination of different cellular objectives. This approach is most suitable for eukaryotic cells, owing to their multiplicity of cellular compartments. For this reason, Saccharomyces cerevisiae was used as model organism, and its metabolic network was represented using the genome-scale metabolic model iMM904. As the objective was to evaluate the predictive performance from the FBA using the kind of objective function previously described, substrate uptake and oxygen consumption were the only input data used for the FBA. Experimental information about microbial growth and exchange of metabolites with the environment was used to assess the quality of the predictions. Conclusions: The quality of the predictions obtained with the FBA depends greatly on the knowledge of the oxygen uptake rate. For the most of studied classifications, the best predictions were obtained with "maximization of growth'', and with some combinations that include this objective. However, in the case of exponential growth with unknown oxygen exchange flux, the objective function "maximization of growth, plus minimization of NADH production in cytosol, plus minimization of NAD(P)H consumption in mitochondrion'' gave much more accurate estimations of fluxes than the obtained with any other objective function explored in this study.	[Garcia Sanchez, Carlos Eduardo] Univ Ind Santander, Grp Invest Bioquim & Microbiol, Escuela Ingn Quim, Bucaramanga, Santander, Colombia; [Vargas Garcia, Cesar Augusto] Univ Ind Santander, Grp Invest Ingn Biomed, Escuela Ingn Sistemas & Informat, Bucaramanga, Santander, Colombia; [Torres Saez, Rodrigo Gonzalo] Univ Ind Santander, Grp Invest Bioquim & Microbiol, Escuela Quim, Bucaramanga, Santander, Colombia	Universidad Industrial de Santander; Universidad Industrial de Santander; Universidad Industrial de Santander	Sanchez, CEG (corresponding author), Univ Ind Santander, Grp Invest Bioquim & Microbiol, Escuela Ingn Quim, Bucaramanga, Santander, Colombia.	carlos.garcia6@correo.uis.edu.co	Vargas-Garcia, Cesar/J-8090-2017	Vargas-Garcia, Cesar/0000-0002-4286-8882; Torres, Rodrigo/0000-0003-1113-3020; Garcia Sanchez, Carlos Eduardo/0000-0003-1543-1498	Universidad Industrial de Santander; Grupo de Investigacion en Bioquimica y Microbiologia of the Universidad Industrial de Santander	Universidad Industrial de Santander; Grupo de Investigacion en Bioquimica y Microbiologia of the Universidad Industrial de Santander	CEGS and CAVG received funding from a scholarship of the Universidad Industrial de Santander. Development of the study was supported by the Grupo de Investigacion en Bioquimica y Microbiologia of the Universidad Industrial de Santander. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 1996, APPL ENVIRON MICROB, V62, P3187, DOI 10.1128/AEM.62.9.3187-3195.1996; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Burgard AP, 2003, BIOTECHNOL BIOENG, V82, P670, DOI 10.1002/bit.10617; Cakir T, 2007, BIOTECHNOL PROGR, V23, P320, DOI 10.1021/bp060272r; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Franzen CJ, 2003, YEAST, V20, P117, DOI 10.1002/yea.956; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Gianchandani EP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-43; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Heyland J, 2009, MICROBIOL-SGM, V155, P3827, DOI 10.1099/mic.0.030213-0; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jouhten P, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-60; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Knorr AL, 2007, BIOINFORMATICS, V23, P351, DOI 10.1093/bioinformatics/btl619; Koffas M, 1999, ANNU REV BIOMED ENG, V1, P535, DOI 10.1146/annurev.bioeng.1.1.535; Llaneras F, 2008, J BIOSCI BIOENG, V105, P1, DOI 10.1263/jbb.105.1; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; Ostergaard S, 2001, BIOTECHNOL BIOENG, V73, P412, DOI 10.1002/bit.1075; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Ramakrishna R, 2001, AM J PHYSIOL-REG I, V280, pR695, DOI 10.1152/ajpregu.2001.280.3.R695; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Van Hoek P, 1998, APPL ENVIRON MICROB, V64, P4226; van Winden WA, 2005, FEMS YEAST RES, V5, P559, DOI 10.1016/j.femsyr.2004.10.007; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Wiebe MG, 2008, FEMS YEAST RES, V8, P140, DOI 10.1111/j.1567-1364.2007.00234.x; Wiechert W, 2002, J BIOTECHNOL, V94, P37, DOI 10.1016/S0168-1656(01)00418-7; Zomorrodi AR, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-178	37	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e43006	10.1371/journal.pone.0043006	http://dx.doi.org/10.1371/journal.pone.0043006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912775	Green Published, gold			2022-12-27	WOS:000307378500036
J	Barat, S; Steeb, B; Maze, A; Bumann, D				Barat, Somedutta; Steeb, Benjamin; Maze, Alain; Bumann, Dirk			Extensive In Vivo Resilience of Persistent Salmonella	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS PERSISTENCE; ESCHERICHIA-COLI; TYPHIMURIUM; VIRULENCE; REPLICATION; INFECTION; METABOLISM; DYNAMICS; MUTANTS; DUBLIN	Chronic infections caused by persistent pathogens represent an important health problem. Here, we establish a simple practical mouse Salmonella infection model for identifying bacterial maintenance functions that are essential for persistency. In this model, a substantial fraction of Salmonella survived even several days of treatment with a potent fluoroquinolone antibiotic indicating stringency of the model. Evaluation of twelve metabolic defects revealed dramatically different requirements for Salmonella during persistency as compared to acute infections. Disrupted synthesis of unsaturated/cyclopropane fatty acids was the only defect that resulted in rapid Salmonella clearance suggesting that this pathway might contain suitable targets for antimicrobial chemotherapy of chronic infection.	[Barat, Somedutta; Steeb, Benjamin; Maze, Alain; Bumann, Dirk] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland	University of Basel	Barat, S (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.	Dirk.Bumann@unibas.ch		Maze, Alain/0000-0003-0873-3690	Deutsche Forschungsgemeinschaft (European Research Training Group) [1273]; Schweizerischer Nationalfonds [31003A-121834]	Deutsche Forschungsgemeinschaft (European Research Training Group); Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF))	This work was supported by Deutsche Forschungsgemeinschaft (European Research Training Group 1273) and Schweizerischer Nationalfonds (31003A-121834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dubois-Brissonnet F, 2011, APPL ENVIRON MICROB, V77, P906, DOI 10.1128/AEM.01480-10; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Griffin A, 2009, J IMMUNOL, V183, P1263, DOI 10.4049/jimmunol.0900772; Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; John AK, 2011, ANTIMICROB AGENTS CH, V55, P3510, DOI 10.1128/AAC.00172-11; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Machutta CA, 2010, J BIOL CHEM, V285, P6161, DOI 10.1074/jbc.M109.077909; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; Meredith TC, 2005, J BACTERIOL, V187, P6936, DOI 10.1128/JB.187.20.6936-6942.2005; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Monack DM, 2011, CURR OPIN MICROBIOL, V2011, P30; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nath G, 2010, J INFECT DEV COUNTR, V4, P259, DOI 10.3855/jidc.820; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Thierauf Anne, 2009, V501, P267, DOI 10.1007/978-1-60327-164-6_23; Tierrez A, 2005, CELL MICROBIOL, V7, P901, DOI 10.1111/j.1462-5822.2005.00540.x; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; Turner AK, 2003, INFECT IMMUN, V71, P3392, DOI 10.1128/IAI.71.6.3392-3401.2003; VANCUTSEM PM, 1990, CORNELL VET, V80, P173; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	47	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e42007	10.1371/journal.pone.0042007	http://dx.doi.org/10.1371/journal.pone.0042007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911873	Green Published, gold, Green Accepted			2022-12-27	WOS:000306751300089
J	Kanno, H; Nishihara, H; Narita, T; Yamaguchi, S; Kobayashi, H; Tanino, M; Kimura, T; Terasaka, S; Tanaka, S				Kanno, Hiromi; Nishihara, Hiroshi; Narita, Takuhito; Yamaguchi, Shigeru; Kobayashi, Hiroyuki; Tanino, Mishie; Kimura, Taichi; Terasaka, Shunsuke; Tanaka, Shinya			Prognostic Implication of Histological Oligodendroglial Tumor Component: Clinicopathological Analysis of 111 Cases of Malignant Gliomas	PLOS ONE			English	Article							ARMS 1P; SURVIVAL; GLIOBLASTOMAS; ASTROCYTOMAS; DIAGNOSIS; PATHOLOGY; OUTCOMES; GRADE; 19Q	The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (GBM) with oligodendroglioma component (GBMO) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. In this study, we performed a histopathology-based reevaluation of 111 cases of high grade gliomas according to the latest World Health Organization (WHO), and compared the clinical outcomes between oligodendroglial tumors and pure astrocytic tumors. The survival analysis revealed that the patients with high grade oligodendroglial tumor including GBMO significantly indicated better prognosis compared to the patients with high grade pure astrocytic tumors (GBM and AA, anaplastic astrocytoma) as expected, and the obtained survival curves were almost identical to those from the patients with conventional Grade III or Grade IV tumors, respectively. Moreover, if the cases of oligodendroglial tumor were histopathologically excluded, the patients with AA exhibited extremely poor prognosis which was similar to that of GBM, suggesting that the histological identification of oligodendroglial tumor component, even partially, prescribe the prognosis of high grade glioma patients. This is the prominent report of retrospective clinicopathological analysis for high-grade gliomas throughout Grade III and IV, especially referring to the prognostic value of histological oligodendroglial tumor component; in addition, our results might offer an alternative aspect for the grading of high-grade astrocytic/oligodendroglial tumors.	[Kanno, Hiromi; Narita, Takuhito; Tanino, Mishie; Kimura, Taichi; Tanaka, Shinya] Hokkaido Univ, Sch Med, Dept Pathol, Canc Res Lab, Sapporo, Hokkaido 060, Japan; [Nishihara, Hiroshi] Hokkaido Univ, Sch Med, Lab Translat Pathol, Sapporo, Hokkaido 060, Japan; [Yamaguchi, Shigeru; Kobayashi, Hiroyuki; Terasaka, Shunsuke] Hokkaido Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Kanno, H (corresponding author), Hokkaido Univ, Sch Med, Dept Pathol, Canc Res Lab, Sapporo, Hokkaido 060, Japan.	hnishihara@s5.dion.ne.jp	KOBAYASHI, Hiroyuki/G-8990-2012; Yamaguchi, Shigeru/G-5419-2012; Tanaka, Shinya/AAO-8771-2021; Tanaka, Shinya/D-3586-2011	Yamaguchi, Shigeru/0000-0003-3710-5888; Tanaka, Shinya/0000-0001-6470-3301; 				Aldape K, 2007, ARCH PATHOL LAB MED, V131, P242; Burger PC, 2001, MODERN PATHOL, V14, P842, DOI 10.1038/modpathol.3880400; Donahue B, 1997, INT J RADIAT ONCOL, V38, P911, DOI 10.1016/S0360-3016(97)00126-0; Fuller CE, 2003, J NEUROPATH EXP NEUR, V62, P1118, DOI 10.1093/jnen/62.11.1118; Hartmann C, 2004, J MOL MED, V82, P638, DOI 10.1007/s00109-004-0565-9; Hilton DA, 2004, HISTOPATHOLOGY, V44, P555, DOI 10.1111/j.1365-2559.2004.01887.x; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Kraus JA, 2001, ACTA NEUROPATHOL, V101, P311; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; McDonald JM, 2005, CANCER-AM CANCER SOC, V104, P1468, DOI 10.1002/cncr.21338; Miller CR, 2006, J CLIN ONCOL, V24, P5419, DOI 10.1200/JCO.2006.08.1497; Perry A, 2007, WHO CLASSIFICATION T, P164; Pinto LW, 2008, VIRCHOWS ARCH, V452, P481, DOI 10.1007/s00428-007-0562-9; Salminen E, 1996, EUR J CANCER, V32A, P1918, DOI 10.1016/0959-8049(96)00211-0; Salvati M, 2009, J NEURO-ONCOL, V94, P129, DOI 10.1007/s11060-009-9815-6; Shaw EG, 1997, J NEURO-ONCOL, V31, P273, DOI 10.1023/A:1005715703598; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Tortosa A, 2003, CANCER, V97, P1063, DOI 10.1002/cncr.11120; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497	20	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41669	10.1371/journal.pone.0041669	http://dx.doi.org/10.1371/journal.pone.0041669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911839	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300062
J	Xie, JB; Tang, LS; Wang, ZY; Xu, GQ; Li, Y				Xie, Jiangbo; Tang, Lisong; Wang, Zhongyuan; Xu, Guiqing; Li, Yan			Distinguishing the Biomass Allocation Variance Resulting from Ontogenetic Drift or Acclimation to Soil Texture	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; RELATIVE GROWTH; WATER; ALLOMETRY; PLANTS; ROOT; LEAF; PATTERNS; LIGHT; PRODUCTIVITY	In resource-poor environments, adjustment in plant biomass allocation implies a complex interplay between environmental signals and plant development rather than a delay in plant development alone. To understand how environmental factors influence biomass allocation or the developing phenotype, it is necessary to distinguish the biomass allocations resulting from environmental gradients or ontogenetic drift. Here, we compared the development trajectories of cotton plants (Gossypium herbaceum L.), which were grown in two contrasting soil textures during a 60-d period. Those results distinguished the biomass allocation pattern resulting from ontogenetic drift and the response to soil texture. The soil texture significantly changed the biomass allocation to leaves and roots, but not to stems. Soil texture also significantly changed the development trajectories of leaf and root traits, but did not change the scaling relationship between basal stem diameter and plant height. Results of nested ANOVAs of consecutive plant-size categories in both soil textures showed that soil gradients explained an average of 63.64-70.49% of the variation of biomass allocation to leaves and roots. Ontogenetic drift explained 77.47% of the variation in biomass allocation to stems. The results suggested that the environmental factors governed the biomass allocation to roots and leaves, and ontogenetic drift governed the biomass allocation to stems. The results demonstrated that biomass allocation to metabolically active organs (e. g., roots and leaves) was mainly governed by environmental factors, and that biomass allocation to metabolically non-active organs (e. g., stems) was mainly governed by ontogenetic drift. We concluded that differentiating the causes of development trajectories of plant traits was important to the understanding of plant response to environmental gradients.	[Xie, Jiangbo; Tang, Lisong; Wang, Zhongyuan; Xu, Guiqing; Li, Yan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Xie, Jiangbo; Wang, Zhongyuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xie, JB (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	liyan@ms.xjb.ac.cn		wang, zhongyuan/0000-0001-6018-4647	National Natural Science Foundation of China [31000166, 40725002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Grant no. 31000166 and 40725002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Biondini M, 2008, J THEOR BIOL, V251, P35, DOI 10.1016/j.jtbi.2007.11.018; Bond BJ, 2000, TRENDS PLANT SCI, V5, P349, DOI 10.1016/S1360-1385(00)01691-5; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P361; BROUWER R, 1983, NETH J AGR SCI, V31, P335; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P399; Cambui CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019211; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen SY, 2010, CHINESE SCI BULL, V55, P1135, DOI 10.1007/s11434-010-0107-5; Cheng DL, 2010, BIOL LETTERS, V6, P715, DOI 10.1098/rsbl.2010.0070; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; Coleman MD, 2004, TREE PHYSIOL, V24, P1347, DOI 10.1093/treephys/24.12.1347; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; Evans GC., 1972, QUANTITATIVE ANAL PL; Gedroc JJ, 1996, FUNCT ECOL, V10, P44, DOI 10.2307/2390260; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Gunn S, 1999, FUNCT ECOL, V13, P3, DOI 10.1046/j.1365-2435.1999.00002.x; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; Hacke UG, 2000, OECOLOGIA, V124, P495, DOI 10.1007/PL00008875; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Huang YX, 2010, BOTANY, V88, P13, DOI 10.1139/B09-095; Huang YX, 2009, NORD J BOT, V27, P539, DOI 10.1111/j.1756-1051.2009.00382.x; Ichihashi R, 2010, PLANT ECOL, V211, P181, DOI 10.1007/s11258-010-9783-0; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; LEDIG FT, 1970, BOT GAZ, V131, P349, DOI 10.1086/336552; Li Y, 2005, PLANT CELL ENVIRON, V28, P492, DOI 10.1111/j.1365-3040.2005.01291.x; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028601; Liu GF, 2010, NEW PHYTOL, V188, P543, DOI 10.1111/j.1469-8137.2010.03388.x; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; McKenna MF, 1999, ECOSCIENCE, V6, P286, DOI 10.1080/11956860.1999.11682529; Moriuchi KS, 2005, NEW PHYTOL, V166, P149, DOI 10.1111/j.1469-8137.2005.01346.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Niinemets U, 2004, NEW PHYTOL, V162, P683, DOI 10.1111/j.1469-8137.2004.01071.x; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Overman AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028515; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Shemesh H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010824; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Sugiura D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022236; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Taskinen S, 2011, BIOMETRICAL J, V53, P652, DOI 10.1002/bimj.201000018; Warton D, 2006, BIOL REV, V81, P1; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Weigelt A, 2005, PLANT ECOL, V176, P57, DOI 10.1007/s11258-004-0016-2; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Wright IJ, 2000, FUNCT ECOL, V14, P97, DOI 10.1046/j.1365-2435.2000.00393.x; Wright Sarah D., 2002, Plant Species Biology, V17, P119, DOI 10.1046/j.1442-1984.2002.00082.x; Wu Rongling, 2004, BMC Ecology, V4, P14, DOI 10.1186/1472-6785-4-14; Xu H, 2007, PLANT CELL ENVIRON, V30, P399, DOI 10.1111/j.1365-3040.2006.001626.x	56	64	78	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41502	10.1371/journal.pone.0041502	http://dx.doi.org/10.1371/journal.pone.0041502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911802	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300049
J	de la Estrella, M; Mateo, RG; Wieringa, JJ; Mackinder, B; Munoz, J				de la Estrella, Manuel; Mateo, Ruben G.; Wieringa, Jan J.; Mackinder, Barbara; Munoz, Jesus			Legume Diversity Patterns in West Central Africa: Influence of Species Biology on Distribution Models	PLOS ONE			English	Article							EQUATORIAL-GUINEA ANNOBON; SAMPLE-SIZE; PLANT DIVERSITY; INDICATOR GROUPS; CLIMATE-CHANGE; BIODIVERSITY; LEGUMINOSAE; PERFORMANCE; NICHE; ACCURACY	Objectives: Species Distribution Models (SDMs) are used to produce predictions of potential Leguminosae diversity in West Central Africa. Those predictions are evaluated subsequently using expert opinion. The established methodology of combining all SDMs is refined to assess species diversity within five defined vegetation types. Potential species diversity is thus predicted for each vegetation type respectively. The primary aim of the new methodology is to define, in more detail, areas of species richness for conservation planning. Methodology: Using Maxent, SDMs based on a suite of 14 environmental predictors were generated for 185 West Central African Leguminosae species, each categorised according to one of five vegetation types: Afromontane, coastal, non-flooded forest, open formations, or riverine forest. The relative contribution of each environmental variable was compared between different vegetation types using a nonparametric Kruskal-Wallis analysis followed by a post-hoc Kruskal-Wallis Paired Comparison contrast. Legume species diversity patterns were explored initially using the typical method of stacking all SDMs. Subsequently, five different ensemble models were generated by partitioning SDMs according to vegetation category. Ecological modelers worked with legume specialists to improve data integrity and integrate expert opinion in the interpretation of individual species models and potential species richness predictions for different vegetation types. Results/Conclusions: Of the 14 environmental predictors used, five showed no difference in their relative contribution to the different vegetation models. Of the nine discriminating variables, the majority were related to temperature variation. The set of variables that played a major role in the Afromontane species diversity model differed significantly from the sets of variables of greatest relative important in other vegetation categories. The traditional approach of stacking all SDMs indicated overall centers of diversity in the region but the maps indicating potential species richness by vegetation type offered more detailed information on which conservation efforts can be focused.	[de la Estrella, Manuel] Univ Cordoba, Dept Bot Ecol & Fisiol Vegetal, Cordoba, Spain; [de la Estrella, Manuel] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada; [de la Estrella, Manuel] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Mateo, Ruben G.; Munoz, Jesus] Real Jardin Bot RJB CSIC, Madrid, Spain; [Mateo, Ruben G.] Univ Liege, Inst Bot, Liege, Belgium; [Wieringa, Jan J.] Wageningen Univ, Herbarium Vadense WAG, Netherlands Ctr Biodivers Naturalis, Sect NHN, Wageningen, Netherlands; [Munoz, Jesus] Univ Tecnol Indoamer, Ambato, Ecuador	Universidad de Cordoba; Universite de Montreal; Universite de Montreal; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Liege; Wageningen University & Research	de la Estrella, M (corresponding author), Univ Cordoba, Dept Bot Ecol & Fisiol Vegetal, Cordoba, Spain.	rubeng.mateo@gmail.com	Wieringa, Jan J./D-9517-2015; de la Estrella, Manuel/I-4926-2013; Munoz, Jesus/B-7809-2008; Mateo, Rubén/M-3545-2015	Wieringa, Jan J./0000-0003-0566-372X; de la Estrella, Manuel/0000-0002-4484-3566; Mateo, Rubén/0000-0001-8577-001X; Munoz, Jesus/0000-0002-9266-2268	Spanish Juan de la Cierva grant [JCI-2009-05243]; Ministry of Science and Technology [CGL2011-28613-C03-02, CGL2009-07405-BOS]; Ministry of Science and Technology of Spain [CGL2009-09530-BOS]	Spanish Juan de la Cierva grant; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	ME was funded by a Spanish Juan de la Cierva grant JCI-2009-05243 and projects CGL2011-28613-C03-02 and CGL2009-07405-BOS of the Ministry of Science and Technology. Grant CGL2009-09530-BOS also of the Ministry of Science and Technology of Spain funded JM's research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Baselga A, 2010, J BIOGEOGR, V37, P1842, DOI 10.1111/j.1365-2699.2010.02341.x; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Beentje H.J., 1994, CTR PLANT DIVERSITY, V1, P227; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bourg NA, 2005, ECOLOGY, V86, P2793, DOI 10.1890/04-1666; Breteler FJ, 1994, WAGENINGEN AGR U PAP, V94-4, P1; Breteler FJ., 1999, WAGENINGEN AGR U PAP, V99-3, P1; Breteler FJ, 2010, PLANT ECOL EVOL, V143, P70, DOI 10.5091/plecevo.2010.369; Burkill MH, 1995, USEFUL PLANTS W TR 3; Cable S, 1998, PLANTS MOUNT CAMEROO; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; Cheek M., 2004, PLANTS KUPE MWANENGU; Cheek M, 2000, PLANTS MOUNT OKU IJI; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; de la Estrella M, 2012, S AFR J BOT, V78, P257, DOI 10.1016/j.sajb.2011.04.006; De la Estrella M, 2006, BOT J LINN SOC, V151, P541, DOI 10.1111/j.1095-8339.2006.00538.x; de la Estrella M, 2010, SYST BOT, V35, P296, DOI 10.1600/036364410791638414; Edwards TC, 2006, ECOL MODEL, V199, P132, DOI 10.1016/j.ecolmodel.2006.05.016; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Estrella M, 2005, BELG J BOT, V138, P11; Estrella M, 2012, NORD J BOT, V30, P136; Estrella M, 2010, FOLIA GEOBOT, V45, P1; EXELL A W, 1973, Garcia De Orta Serie de Botanica, V1, P3; Feria TP, 2002, DIVERS DISTRIB, V8, P49, DOI 10.1046/j.1472-4642.2002.00127.x; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Flather CH, 1997, ECOL APPL, V7, P531, DOI 10.1890/1051-0761(1997)007[0531:IGICNO]2.0.CO;2; Gelfand AE, 2005, J R STAT SOC C-APPL, V54, P1, DOI 10.1111/j.1467-9876.2005.00466.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holmgren M., 2004, Biodiversity of West African forests: an ecological atlas of woody plant species, P73, DOI 10.1079/9780851997346.0073; Hortal J, 2008, J BIOGEOGR, V35, P1335, DOI 10.1111/j.1365-2699.2008.01955.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Johnson CJ, 2005, ENVIRON CONSERV, V32, P117, DOI 10.1017/S0376892905002171; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kenicer G, 2005, ENDINB J BOT, V62, P195; Kuper W, 2006, BOT J LINN SOC, V150, P355, DOI 10.1111/j.1095-8339.2006.00494.x; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Lebrun Jean-Pierre, 1998, Candollea, V53, P365; Lehmann A, 2002, BIODIVERS CONSERV, V11, P2217, DOI 10.1023/A:1021398729516; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Lughadha EN, 2005, PHILOS T ROY SOC B, V360, P359, DOI 10.1098/rstb.2004.1596; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Mackinder B, 2010, KEW B, V65, P1; Mackinder B. A., 2010, Systematics and conservation of African plants. Proceedings of the 18th AETFAT Congress, Yaounde, Cameroun, 26 February to 2 March 2007, P43; Mackinder B. A., 2006, Edinburgh Journal of Botany, V63, P161, DOI 10.1017/S0960428606000631; Mackinder B.A., 2011, SYST BOT MONOGR, V91, P1; Maharjan SK, 2011, BIOTROPICA, V43, P552, DOI 10.1111/j.1744-7429.2010.00747.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mateo RG, 2008, MODELOS PREDICTIVOS; Mateo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032586; Mateo RG, 2011, REV CHIL HIST NAT, V84, P217, DOI 10.4067/S0716-078X2011000200008; Mateo RG, 2010, J VEG SCI, V21, P908, DOI 10.1111/j.1654-1103.2010.01198.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; Urbina-Cardona JN, 2010, CONSERV BIOL, V24, P1031, DOI 10.1111/j.1523-1739.2009.01432.x; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PETERS D, 1998, NR002 COMM AUSTR PAR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pickesgill B, 1996, ADV LEGUME SYSTEMA 8; Pineda E, 2009, J ANIM ECOL, V78, P182, DOI 10.1111/j.1365-2656.2008.01471.x; Polhill R. M., 1981, ADV LEGUME SYSTEMA 1; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rowe RJ, 2005, J BIOGEOGR, V32, P1883, DOI 10.1111/j.1365-2699.2005.01346.x; Sarkar S, 2009, BIODIVERS CONSERV, V18, P1793, DOI 10.1007/s10531-008-9559-1; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sosef M.S.M., 2006, SCRIPTA BOT BELG, V35, P1; Sprent J.I., 2001, NODULATION LEGUMES; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van der Burgt Xander M., 2012, Kew Bulletin, V67, P51, DOI 10.1007/s12225-012-9345-9; Velayos M, 2010, FLORA GUINEA ECUATOR, VV, P529; Wieringa J.J., 1999, WAGENINGEN AGR U PAP, V99, P1; Wieringa JJ, 2012, NORD J BOT, V30, P144, DOI 10.1111/j.1756-1051.2011.01260.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	95	24	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41526	10.1371/journal.pone.0041526	http://dx.doi.org/10.1371/journal.pone.0041526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911808	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700100
J	Reekie, J; Kowalska, JD; Karpov, I; Rockstroh, J; Karlsson, A; Rakhmanova, A; Horban, A; Kirk, O; Lundgren, JD; Mocroft, A				Reekie, Joanne; Kowalska, Justyna D.; Karpov, Igor; Rockstroh, Jurgen; Karlsson, Anders; Rakhmanova, Aza; Horban, Andrzej; Kirk, Ole; Lundgren, Jens D.; Mocroft, Amanda		EuroSIDA EuroCoord	Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; DEATH; ADHERENCE; HEPATITIS; PEOPLE; ADULTS	Background: Differences in access to care and treatment have been reported in Eastern Europe, a region with one of the fastest growing HIV epidemics, compared to the rest of Europe. This analysis aimed to establish whether there are regional differences in the mortality rate of HIV-positive individuals across Europe, and Argentina. Methods: 13,310 individuals under follow-up were included in the analysis. Poisson regression investigated factors associated with the risk of death. Findings: During 82,212 person years of follow-up (PYFU) 1,147 individuals died (mortality rate 14.0 per 1,000 PYFU (95% confidence interval [CI] 13.1-14.8). Significant differences between regions were seen in the rate of all-cause, AIDS and non-AIDS related mortality (global p < 0.0001 for all three endpoints). Compared to South Europe, after adjusting for baseline demographics, laboratory measurements and treatment, a higher rate of AIDS related mortality was observed in East Europe (IRR 2.90, 95% CI 1.97-4.28, p <.0001), and a higher rate of non-AIDS related mortality in North Europe (IRR 1.51, 95% CI 1.24-1.82, p <.0001). The differences observed in North Europe decreased over calendar-time, in 2009-2011, the higher rate of non-AIDS related mortality was no longer significantly different to South Europe (IRR 1.07, 95% CI 0.66-1.75, p = 0.77). However, in 2009-2011, there remained a higher rate of AIDS-related mortality (IRR 2.41, 95% CI 1.11-5.25, p = 0.02) in East Europe compared to South Europe in adjusted analysis. Interpretations: There are significant differences in the rate of all-cause mortality among HIV-positive individuals across different regions of Europe and Argentina. Individuals in Eastern Europe had an increased risk of mortality from AIDS related causes and individuals in North Europe had the highest rate of non-AIDS related mortality. These findings are important for understanding and reviewing HIV treatment strategies and policies across the European region.	[Reekie, Joanne; Mocroft, Amanda] UCL, Sch Med, London, England; [Kowalska, Justyna D.; Kirk, Ole; Lundgren, Jens D.] Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark; [Karpov, Igor] Belarus State Med Univ, Minsk, BELARUS; [Rockstroh, Jurgen] Univ Bonn, Bonn, Germany; [Karlsson, Anders] Venhaelsan Sodersjukhuset, Stockholm, Sweden; [Rakhmanova, Aza] Med Acad Botkin Hosp, St Petersburg, Russia; [Horban, Andrzej] Warsaw Med Univ, Hosp Infect Dis, Warsaw, Poland; [Kirk, Ole; Lundgren, Jens D.] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	University of London; University College London; UCL Medical School; University of Copenhagen; University of Bonn; Medical University of Warsaw; Rigshospitalet; University of Copenhagen	Reekie, J (corresponding author), UCL, Sch Med, London, England.	j.reekie@ucl.ac.uk	Kowalska, Justyna D./E-9423-2013; Castagna, Antonella/K-3280-2018; Mitsura, Viktar/G-2457-2017; kirk, ole/ABB-4746-2021; Lundgren, Jens/AAE-6876-2019; Ostergaard, Lars/AAA-3020-2020; Vandekerckhove, Linos/J-6420-2013; Begovac, Josip/AAI-5672-2021; Soriano, Vicente/O-5730-2018; Grzeszczuk, Anna/R-7844-2018; LAZZARIN, Adriano/K-3607-2018; Flisiak, Robert/S-5356-2018	Castagna, Antonella/0000-0002-8338-9714; Mitsura, Viktar/0000-0002-0449-5026; Ostergaard, Lars/0000-0003-2459-0511; Vandekerckhove, Linos/0000-0002-8600-1631; Begovac, Josip/0000-0003-2641-4327; Soriano, Vicente/0000-0002-4624-5199; Gianotti, Nicola/0000-0002-7182-5080; Grzeszczuk, Anna/0000-0002-6420-5545; Jevtovic, Dorde/0000-0003-1127-6072; Ristola, Matti/0000-0001-5115-2811; Lundgren, Jens/0000-0001-8901-7850; LAZZARIN, Adriano/0000-0003-2551-7754; Podlekareva, Daria/0000-0003-3187-0597; Flisiak, Robert/0000-0003-3394-1635; Anna, Vassilenko/0000-0003-1907-2322; Ostergaard, Lars/0000-0002-7619-605X; Leen, Clifford/0000-0001-8439-7719; Benfield, Thomas/0000-0003-0698-9385; Katzenstein, Terese L/0000-0002-2233-500X	European Commission [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632, 260694]; Swiss National Science Foundation [108787]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773) and the 6th Framework (LSHP-CT-2006-018632), and the 7th Framework (FP7/2007-2013, EuroCoord no 260694) programmes. The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braitstein P, 2006, AIDS, V20, P323, DOI 10.1097/01.aids.0000198091.70325.f4; Chiesi A, 1999, AIDS, V13, P2281, DOI 10.1097/00002030-199911120-00010; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Hamers FF, 2003, LANCET, V361, P1035, DOI 10.1016/S0140-6736(03)12831-0; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, FACT SHEET N AM W CE; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kowalska JD, 2011, HIV CLIN TRIALS, V12, P109, DOI 10.1310/hct1202-109; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; Podlekareva D, 2008, INDICATORS USE HEALT; Podlekareva Daria, 2008, Central European Journal of Public Health, V16, P99; Saranga A, 2008, INT J DRUG POLICY, V19, pS25, DOI 10.1016/j.drugpo.2007.11.008; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; UNAIDS, 2009, ARG COUNT SIT 2009; UNAIDS, 2008, 08 REP GLOB AIDS EP; UNAIDS, 2009, FACT SHEETS E EUR CE; UNAIDS, 2010, GLOB REP UNAIDS REP; [UNAIDS World Health Organization], 2009, 09 AIDS EP UPD, P1; Van Asten LC, 2003, EUR J PUBLIC HEALTH, V13, P347, DOI 10.1093/eurpub/13.4.347; Vollset SE, 2010, SCAND J PUBLIC HEALT, V38, P127, DOI 10.1177/1403494810379893; Wood E, 2003, CAN MED ASSOC J, V169, P656	30	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41673	10.1371/journal.pone.0041673	http://dx.doi.org/10.1371/journal.pone.0041673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911841	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306687700137
J	Domingues, MN; de Campos, BM; de Oliveira, MLP; de Mello, UQ; Benedetti, CE				Domingues, Mariane Noronha; de Campos, Bruna Medeia; Peixoto de Oliveira, Maria Luiza; de Mello, Uli Quirino; Benedetti, Celso Eduardo			TAL Effectors Target the C-Terminal Domain of RNA Polymerase II (CTD) by Inhibiting the Prolyl-Isomerase Activity of a CTD-Associated Cyclophilin	PLOS ONE			English	Article							PRE-MESSENGER-RNA; XANTHOMONAS-CITRI; TRANSCRIPTION TERMINATION; PATHOGENICITY GENE; UBIQUITIN LIGASE; DNA RECOGNITION; ESS1; PROTEINS; PTHA; UBIQUITYLATION	Transcriptional activator-like (TAL) effectors of plant pathogenic bacteria function as transcription factors in plant cells. However, how TAL effectors control transcription in the host is presently unknown. Previously, we showed that TAL effectors of the citrus canker pathogen Xanthomonas citri, named PthAs, targeted the citrus protein complex comprising the thioredoxin CsTdx, ubiquitin-conjugating enzymes CsUev/Ubc13 and cyclophilin CsCyp. Here we show that CsCyp complements the function of Cpr1 and Ess1, two yeast cyclophilins that regulate transcription by the isomerization of proline residues of the regulatory C-terminal domain (CTD) of RNA polymerase II. We also demonstrate that CsCyp, CsTdx, CsUev and four PthA variants interact with the citrus CTD and that CsCyp co-immunoprecipitate with the CTD in citrus cell extracts and with PthA2 transiently expressed in sweet orange epicotyls. The interactions of CsCyp with the CTD and PthA2 were inhibited by cyclosporin A (CsA), a cyclophilin inhibitor. Moreover, we present evidence that PthA2 inhibits the peptidyl-prolyl cis-trans isomerase (PPIase) activity of CsCyp in a similar fashion as CsA, and that silencing of CsCyp, as well as treatments with CsA, enhance canker lesions in X. citri-infected leaves. Given that CsCyp appears to function as a negative regulator of cell growth and that Ess1 negatively regulates transcription elongation in yeast, we propose that PthAs activate host transcription by inhibiting the PPIase activity of CsCyp on the CTD.	[Domingues, Mariane Noronha; de Campos, Bruna Medeia; Peixoto de Oliveira, Maria Luiza; de Mello, Uli Quirino; Benedetti, Celso Eduardo] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil		Domingues, MN (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil.	celso.benedetti@lnbio.org.br	Citros, Inct/I-2442-2013	Benedetti, Celso/0000-0002-4602-0256; Domingues, Mariane/0000-0003-0229-8261	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saadi A, 2007, MOL PLANT MICROBE IN, V20, P934, DOI 10.1094/MPMI-20-8-0934; Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; Cernadas RA, 2009, PLANT SCI, V177, P190, DOI 10.1016/j.plantsci.2009.05.006; Chapman RD, 2004, NUCLEIC ACIDS RES, V32, P35, DOI 10.1093/nar/gkh172; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Daulny A, 2009, DNA REPAIR, V8, P444, DOI 10.1016/j.dnarep.2009.01.017; de Souza TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032305; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Domingues MN, 2010, MOL PLANT PATHOL, V11, P663, DOI [10.1111/J.1364-3703.2010.00636.X, 10.1111/j.1364-3703.2010.00636.x]; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gullerova M, 2006, RNA, V12, P631, DOI 10.1261/rna.2226106; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Hani J, 1999, J BIOL CHEM, V274, P108, DOI 10.1074/jbc.274.1.108; James P, 1996, GENETICS, V144, P1425; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong SJ, 2005, J MICROBIOL, V43, P516; Jouvet N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-92; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; de Oliveira MLP, 2009, PLANT CELL REP, V28, P387, DOI 10.1007/s00299-008-0646-2; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Wu XY, 2003, GENETICS, V165, P1687; Wu XY, 2001, CURR GENET, V40, P234, DOI 10.1007/s00294-001-0257-8; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	55	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41553	10.1371/journal.pone.0041553	http://dx.doi.org/10.1371/journal.pone.0041553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911812	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600085
J	Siam, R; Mustafa, GA; Sharaf, H; Moustafa, A; Ramadan, AR; Antunes, A; Bajic, VB; Stingl, U; Marsis, NGR; Coolen, MJL; Sogin, M; Ferreira, AJS; El Dorry, H				Siam, Rania; Mustafa, Ghada A.; Sharaf, Hazem; Moustafa, Ahmed; Ramadan, Adham R.; Antunes, Andre; Bajic, Vladimir B.; Stingl, Uli; Marsis, Nardine G. R.; Coolen, Marco J. L.; Sogin, Mitchell; Ferreira, Ari J. S.; El Dorry, Hamza			Unique Prokaryotic Consortia in Geochemically Distinct Sediments from Red Sea Atlantis II and Discovery Deep Brine Pools	PLOS ONE			English	Article							METALLIFEROUS SEDIMENTS; MICROBIAL COMMUNITIES; SEAWATER INTERFACE; METHANE; DIVERSITY; KEBRIT; OXIDATION; SEQUENCE; ARCHAEA; SHABAN	The seafloor is a unique environment, which allows insights into how geochemical processes affect the diversity of biological life. Among its diverse ecosystems are deep-sea brine pools - water bodies characterized by a unique combination of extreme conditions. The 'polyextremophiles' that constitute the microbial assemblage of these deep hot brines have not been comprehensively studied. We report a comparative taxonomic analysis of the prokaryotic communities of the sediments directly below the Red Sea brine pools, namely, Atlantis II, Discovery, Chain Deep, and an adjacent brine-influenced site. Analyses of sediment samples and high-throughput pyrosequencing of PCR-amplified environmental 16S ribosomal RNA genes (16S rDNA) revealed that one sulfur (S)-rich Atlantis II and one nitrogen (N)-rich Discovery Deep section contained distinct microbial populations that differed from those found in the other sediment samples examined. Proteobacteria, Actinobacteria, Cyanobacteria, Deferribacteres, and Euryarchaeota were the most abundant bacterial and archaeal phyla in both the S-and N-rich sections. Relative abundance-based hierarchical clustering of the 16S rDNA pyrotags assigned to major taxonomic groups allowed us to categorize the archaeal and bacterial communities into three major and distinct groups; group I was unique to the S-rich Atlantis II section (ATII-1), group II was characteristic for the N-rich Discovery sample (DD-1), and group III reflected the composition of the remaining sediments. Many of the groups detected in the S-rich Atlantis II section are likely to play a dominant role in the cycling of methane and sulfur due to their phylogenetic affiliations with bacteria and archaea involved in anaerobic methane oxidation and sulfate reduction.	[Siam, Rania; Mustafa, Ghada A.; Sharaf, Hazem; Moustafa, Ahmed; Marsis, Nardine G. R.; Ferreira, Ari J. S.; El Dorry, Hamza] Amer Univ Cairo, Biotechnol Grad Program, Cairo, Egypt; [Siam, Rania; Moustafa, Ahmed; Ferreira, Ari J. S.; El Dorry, Hamza] Amer Univ Cairo, Dept Biol, Cairo, Egypt; [Siam, Rania; Mustafa, Ghada A.; El Dorry, Hamza] Amer Univ Cairo, Sci & Technol Res Ctr, Cairo, Egypt; [Ramadan, Adham R.] Amer Univ Cairo, Dept Chem, Cairo, Egypt; [Antunes, Andre; Stingl, Uli] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Bajic, Vladimir B.] KAUST, CBRC, Thuwal, Saudi Arabia; [Coolen, Marco J. L.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; [Sogin, Mitchell] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA USA	Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole	Siam, R (corresponding author), Amer Univ Cairo, Biotechnol Grad Program, Cairo, Egypt.	rsiam@aucegypt.edu	Sogin, Mitchell/AAE-7186-2019; Moustafa, Ahmed/C-5234-2009; Moustafa, Ahmed/AAZ-3991-2020; Stingl, Uli/H-1191-2014; Coolen, Marco J. L./B-8263-2015; Sharaf, Hazem/ABG-5995-2021; Antunes, André/A-8711-2012; Ferreira, Ari J S/C-2266-2015; Bajic, Vladimir/D-2810-2009	Moustafa, Ahmed/0000-0002-0111-3555; Moustafa, Ahmed/0000-0002-0111-3555; Stingl, Uli/0000-0002-0684-2597; Coolen, Marco J. L./0000-0002-0417-920X; Sharaf, Hazem/0000-0002-6728-1631; Antunes, André/0000-0001-7668-9842; Ferreira, Ari J S/0000-0002-7526-5543; Bajic, Vladimir/0000-0001-5435-4750	King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program; Division Of Ocean Sciences [0825020] Funding Source: National Science Foundation	King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; BACKER H, 1972, NATURE-PHYS SCI, V240, P153, DOI 10.1038/physci240153a0; Bertram C, 2011, RESOUR POLICY, V36, P315, DOI 10.1016/j.resourpol.2011.09.001; Bower A, 2009, WOODS HOLE OCEANOGRA; DANIELSSON LG, 1980, GEOCHIM COSMOCHIM AC, V44, P2051, DOI 10.1016/0016-7037(80)90203-3; Eder W, 2002, ENVIRON MICROBIOL, V4, P758, DOI 10.1046/j.1462-2920.2002.00351.x; Eder W, 2001, APPL ENVIRON MICROB, V67, P3077, DOI 10.1128/AEM.67.7.3077-3085.2001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faber E, 1998, ORG GEOCHEM, V29, P363, DOI 10.1016/S0146-6380(98)00155-7; FIALA G, 1990, ARCH MICROBIOL, V154, P120, DOI 10.1007/BF00423320; Hartmann M, 1998, MAR GEOL, V144, P311, DOI 10.1016/S0025-3227(97)00055-8; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Kendall MM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P244, DOI 10.1007/0-387-30743-5_12; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lio P, 1998, GENOME RES, V8, P1233, DOI 10.1101/gr.8.12.1233; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Lloyd KG, 2011, ENVIRON MICROBIOL, V13, P2548, DOI 10.1111/j.1462-2920.2011.02526.x; Lloyd KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008738; MILLER AR, 1966, GEOCHIM COSMOCHIM AC, V30, P341, DOI 10.1016/0016-7037(66)90007-X; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Pratscher J, 2011, PNAS, P1; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Reeburgh W. S., 1993, P1; Ryan WBF, 2011, RED SEA; Schmidt M, 2003, CHEM GEOL, V200, P359, DOI 10.1016/S0009-2541(03)00206-7; Singh SK, 2010, RES MICROBIOL, V161, P177, DOI 10.1016/j.resmic.2010.01.008; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Takacs CD, 2001, FEMS MICROBIOL ECOL, V35, P123, DOI 10.1016/S0168-6496(00)00119-7; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Wang Y, 2011, INT CONF ACOUST SPEE, P1, DOI 10.1109/PLASMA.2011.5993071; Winckler G, 2000, GEOCHIM COSMOCHIM AC, V64, P1567, DOI 10.1016/S0016-7037(99)00441-X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	35	35	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42872	10.1371/journal.pone.0042872	http://dx.doi.org/10.1371/journal.pone.0042872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916172	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800034
J	Zhang, H; Yu, H; Wang, X; Zheng, WW; Yang, B; Pi, JB; He, GS; Qu, WD				Zhang, Hao; Yu, Huan; Wang, Xia; Zheng, Weiwei; Yang, Bei; Pi, Jingbo; He, Gengsheng; Qu, Weidong			(S)-alpha-Chlorohydrin Inhibits Protein Tyrosine Phosphorylation through Blocking Cyclic AMP - Protein Kinase A Pathway in Spermatozoa	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; MOUSE SPERM CAPACITATION; ALPHA-CHLOROHYDRIN; BOAR SPERM; IN-VITRO; HYPERACTIVATED MOTILITY; ANTIFERTILITY COMPOUNDS; MAMMALIAN SPERMATOZOA; ACROSOME REACTION; RAT SPERM	alpha-Chlorohydrin is a common contaminant in food. Its (S)-isomer, (S)-alpha-chlorohydrin (SACH), is known for causing infertility in animals by inhibiting glycolysis of spermatozoa. The aim of present work was to examine the relationship between SACH and protein tyrosine phosphorylation (PTP), which plays a critical role in regulating mammalian sperm capacitation. In vitro exposure of SACH 50 mu M to isolated rat epididymal sperm inhibited PTP. Sperm-specific glyceraldehyde 3-phosphate dehydrogenase (GAPDS) activities, the intracellular adenosine 5'-triphosphate (ATP) levels, 3'-5'-cyclic adenosine monophosphate (cAMP) levels and phosphorylation of protein kinase A (PKA) substrates in rat sperm were diminished dramatically, indicating that both glycolysis and the cAMP/PKA signaling pathway were impaired by SACH. The inhibition of both PTP and phosphorylation of PKA substrates by SACH could be restored by addition of cAMP analog dibutyryl-cAMP (dbcAMP) and phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX). Moreover, addition of glycerol protected glycolysis, ATP levels, phosphorylation of PKA substrates and PTP against the influence of SACH. These results suggested SACH inhibited PTP through blocking cAMP/PKA pathway in sperm, and PTP inhibition may play a role in infertility associated with SACH.	[Zhang, Hao; Wang, Xia; Zheng, Weiwei; He, Gengsheng; Qu, Weidong] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Dept Environm Hlth,Sch Publ Hlth, Shanghai 200433, Peoples R China; [Yu, Huan] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Yang, Bei; Pi, Jingbo] Hamner Inst Hlth Sci, Inst Chem Safety Sci, Res Triangle Pk, NC USA; [Yang, Bei] China Med Univ, Dept Histol & Embryol, Basic Med Coll, Shenyang, Peoples R China	Fudan University; Fudan University; The Hamner Institutes for Health Sciences; China Medical University	Zhang, H (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Dept Environm Hlth,Sch Publ Hlth, Shanghai 200433, Peoples R China.	gshe@shmu.edu.cn; wdqu@fudan.edu.cn	PI, JINGBO/GWC-2514-2022	PI, JINGBO/0000-0003-0227-8041	National Natural Science Fund [30571539, 30972438]; Shanghai Rising Star program [03QD14011]; Shanghai Municipal Health Bureau Leading Academic Discipline Project [08GWD14]; Dawn Scholarship Project [07SG01]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Shanghai Rising Star program; Shanghai Municipal Health Bureau Leading Academic Discipline Project; Dawn Scholarship Project	This research was supported by grants from the National Natural Science Fund (No. 30571539 and 30972438), Shanghai Rising Star program (No. 03QD14011), Shanghai Municipal Health Bureau Leading Academic Discipline Project (No. 08GWD14), and Dawn Scholarship Project (No. 07SG01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1998, BIOL REPROD, V58, P186, DOI 10.1095/biolreprod58.1.186; Arcelay E, 2008, INT J DEV BIOL, V52, P463, DOI 10.1387/ijdb.072555ea; Baer I, 2010, ANAL BIOANAL CHEM, V396, P443, DOI 10.1007/s00216-009-3177-y; Bailey JL, 2005, THERIOGENOLOGY, V63, P599, DOI 10.1016/j.theriogenology.2004.09.034; Bone W, 2000, INT J ANDROL, V23, P284; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; COONEY SJ, 1988, J REPROD FERTIL, V82, P309; COOPER TG, 1981, J REPROD FERTIL, V61, P163, DOI 10.1530/jrf.0.0610163; Crews C, 2001, FOOD ADDIT CONTAM, V18, P271, DOI 10.1080/02652030010021512; Duan C, 2003, CYTOGENET GENOME RES, V103, P352, DOI 10.1159/000076824; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; FORD WCL, 1986, J REPROD FERTIL, V77, P537; FORD WCL, 1977, J REPROD FERTIL, V51, P105; Frayne J, 2009, J BIOL CHEM, V284, P22703, DOI 10.1074/jbc.M109.004648; Hamlet CG, 2002, FOOD ADDIT CONTAM A, V19, P619, DOI 10.1080/02652030210132391; Hamlet CG, 2011, EUR J LIPID SCI TECH, V113, P279, DOI 10.1002/ejlt.201000480; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; HOPPE PC, 1976, BIOL REPROD, V15, P39, DOI 10.1095/biolreprod15.1.39; Hung PH, 2008, BIOL REPROD, V79, P367, DOI 10.1095/biolreprod.107.066357; Jelks K, 2001, REPROD TOXICOL, V15, P11; JEULIN C, 1992, CELL MOTIL CYTOSKEL, V21, P210, DOI 10.1002/cm.970210305; JOHNSON LA, 1972, J ANIM SCI, V34, P241; JONES AR, 1969, NATURE, V224, P83, DOI 10.1038/224083a0; Jones AR, 1998, J REPROD FERTIL, P227; JONES AR, 1983, AUST J BIOL SCI, V36, P333; Jones AR, 1999, INT J ANDROL, V22, P130; JONES AR, 1992, J REPROD FERTIL, V94, P129, DOI 10.1530/jrf.0.0940129; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kaneto M, 2008, MOL REPROD DEV, V75, P1045, DOI 10.1002/mrd.20839; KIRTON KT, 1970, J REPROD FERTIL, V21, P275; Kota V, 2009, PROTEOMICS, V9, P1809, DOI 10.1002/pmic.200800519; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; KREIDER JL, 1970, J ANIM SCI, V31, P95, DOI 10.2527/jas1970.31195x; Lin CY, 2009, REPROD TOXICOL, V28, P75, DOI 10.1016/j.reprotox.2009.03.005; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Liu DY, 2006, HUM REPROD, V21, P1002, DOI 10.1093/humrep/dei435; Macarthur R, 2000, FOOD ADDIT CONTAM, V17, P903, DOI 10.1080/026520300750038072; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mohanarao GJ, 2011, ANIM REPROD SCI, V123, P40, DOI 10.1016/j.anireprosci.2010.11.013; MOHRI H, 1967, J REPROD FERTIL, V14, P179, DOI 10.1530/jrf.0.0140179; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Naaby-Hansen S, 2002, DEV BIOL, V242, P236, DOI 10.1006/dbio.2001.0527; Nascimento JM, 2008, J CELL PHYSIOL, V217, P745, DOI 10.1002/jcp.21549; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Nienow AM, 2009, CHEMOSPHERE, V75, P1015, DOI 10.1016/j.chemosphere.2009.01.053; NIWA K, 1978, J REPROD FERTIL, V53, P267, DOI 10.1530/jrf.0.0530267; O'Flaherty C, 2004, MOL HUM REPROD, V10, P355, DOI 10.1093/molehr/gah046; Reece P, 2005, ORIGIN FORMATION 3 M; Roberts KP, 2003, BIOL REPROD, V69, P572, DOI 10.1095/biolreprod.102.013771; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; Samojlik E, 1970, Biol Reprod, V2, P299, DOI 10.1095/biolreprod2.2.299; Schilter B, 2011, EUR J LIPID SCI TECH, V113, P309, DOI 10.1002/ejlt.201000311; Sepideh Jabbari, 2009, J Reprod Infertil, V10, P185; Signorelli J, 2012, CELL TISSUE IN PRESS; Siva AB, 2006, REPROD TOXICOL, V22, P702, DOI 10.1016/j.reprotox.2006.04.013; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; STENGEL D, 1984, ANN NY ACAD SCI, V438, P18, DOI 10.1111/j.1749-6632.1984.tb38272.x; STEVENSON D, 1984, INT J ANDROL, V7, P79, DOI 10.1111/j.1365-2605.1984.tb00762.x; Terrell KA, 2011, BIOL REPROD, V84, P1198, DOI 10.1095/biolreprod.110.090225; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; Urner F, 2003, REPRODUCTION, V125, P17, DOI 10.1530/rep.0.1250017; Urner F, 2001, BIOL REPROD, V64, P1350, DOI 10.1095/biolreprod64.5.1350; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WARD WS, 1991, BIOL REPROD, V44, P569, DOI 10.1095/biolreprod44.4.569; Weisshaar R, 2008, EUR J LIPID SCI TECH, V110, P671, DOI 10.1002/ejlt.200800154; Welch JE, 2000, J ANDROL, V21, P328; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; Williams AC, 2001, J ANDROL, V22, P680; Wong KO, 2006, FOOD CONTROL, V17, P408, DOI 10.1016/j.foodcont.2005.01.010	76	15	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43004	10.1371/journal.pone.0043004	http://dx.doi.org/10.1371/journal.pone.0043004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916194	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800040
J	Gao, WL; Dang, SN; Yan, H; Wang, DL				Gao, Wenlong; Dang, Shaonong; Yan, Hong; Wang, Duolao			Care-Seeking Pattern for Diarrhea among Children under 36 Months Old in Rural Western China	PLOS ONE			English	Article							CHILDHOOD DIARRHEA; BEHAVIOR; MALARIA; MANAGEMENT; DISTANCE; SERVICES; ILLNESS; POLICY	Objective: To explore the caretakers' care-seeking pattern and its determinants among children under 36 months old with diarrhea in rural western China. Methods: The data of 14112 households was collected in 45 counties of 10 provinces of western China from June to August 2005. A generalized estimated equation (GEE) linear model was used to identify the determinants of the care-seeking. Results: Village-level and township-level care were sought for childhood diarrhea by 67.02% of the caretakers. GEE model analysis shows that compared with the caretakers of the children delivered at county-level or above hospitals, those of the children delivered at home seldom sought a higher level care (-0.23, 95% CI: -0.45,-0.01, p = 0.040); that the age of the children was negatively associated with seeking a higher level care (12 vs 36 months: 0.35, 95% CI: 0.16,0.55, p < 0.001; 24 vs 36 months: 0.26, 95% CI: 0.08, 0.44, p = 0.004); that the more danger signs of diarrhea the caretakers recognized, the higher level care they sought for their children with diarrhea (0.04, 95% CI: 0.00,0.07, p = 0.037); that the children with breastfeeding were given a higher level care than those without (0.15, 95% CI: 0.01,0.28, p = 0.035); that the mothers with a higher education sought the higher level care than those with only primary education (0.29, 95% CI: 0.03,0.56, p = 0.032); and that the farther the villages where these caretakers lived were from their townships, the lower level care for their children with diarrhea they sought (-0.09, 95% CI: -0.18,-0.01, p = 0.039). Conclusion: Village-level and township-level care were sought for childhood diarrhea by most of the caretakers. Birth settings, the distance from village to township, maternal education, caretakers' awareness of the danger signs of diarrhea, breastfeeding status and age of children affected the care-seeking. These findings may have some implications for the improvement of health care services and care-seeking intervention against childhood diarrhea in rural western China.	[Gao, Wenlong; Dang, Shaonong; Yan, Hong] Xi An Jiao Tong Univ, Sch Publ Hlth, Coll Med, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China; [Wang, Duolao] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	Xi'an Jiaotong University; University of London; London School of Hygiene & Tropical Medicine	Gao, WL (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Coll Med, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China.	xjtu_yh.paper@yahoo.com.cn	Gao, Wenlong/E-5687-2013; Shaonong, Dang/J-7421-2019	Shaonong, Dang/0000-0002-6980-8169	Chinese Ministry of Health; United Nations Children's Fund	Chinese Ministry of Health; United Nations Children's Fund	The study was supported financially by the Chinese Ministry of Health and the United Nations Children's Fund. Neither of the funding sources had any role in the study design, the collection, analysis, interpretation of data and the writing of the report, nor did in the decision to submit the paper for publication.	Awoyemi T. T., 2011, Journal of Human Ecology, V35, P1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Danso-Appiah A, 2010, PLOS NEGLECT TROP D, V4, P1; Das A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-377; Dong LF, 2011, J PUBLIC HLTH, DOI [10.1093/pubmed/fdr019:1-6, DOI 10.1093/PUBMED/FDR019:1-6]; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Dong LF, 2010, J EPIDEMIOL COMMUN H, V64, P549, DOI 10.1136/jech.2008.085415; Enzley S, 1997, GLOBAL REV DIARRHEAL; Granich R, 1999, SOC SCI MED, V48, P489, DOI 10.1016/S0277-9536(98)00356-6; Heuveline P, 2000, SOC SCI MED, V50, P345, DOI 10.1016/S0277-9536(99)00282-8; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kalton G, 1983, SAGE U PAPER SERIES, p[07, 38]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Malik EM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-60; Mondal Md. Nazrul Islam, 2009, Journal of Human Ecology, V26, P31; Mongolia MoH, 2000, CAR PRACT YOUNG CHIL; Ogunlesi TA, 2010, J TROP PEDIATRICS, V56, P379, DOI 10.1093/tropej/fmq009; Omotade OO, 2000, J HEALTH POPUL NUTR, V18, P139; Rao KV, 1998, NATL FAMILY HLTH SUR; Rutstein SO, 2004, DHS COMP REPORTS, P8; Salako LA, 2001, J TROP PEDIATRICS, V47, P230, DOI 10.1093/tropej/47.4.230; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; UNICEF/WHO, 2009, DIARRH WHY CHILDR AR; Wei XL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-103; Yadav SP, 2010, J VECTOR DIS, V47, P235; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zhang Jing, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P989	29	15	17	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43103	10.1371/journal.pone.0043103	http://dx.doi.org/10.1371/journal.pone.0043103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912799	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700042
J	Johnson, AJ; Hirson, GD; Ebeler, SE				Johnson, Arielle J.; Hirson, Gregory D.; Ebeler, Susan E.			Perceptual Characterization and Analysis of Aroma Mixtures Using Gas Chromatography Recomposition-Olfactometry	PLOS ONE			English	Article							EXTRACT DILUTION ANALYSIS; ODOR; REPRESENTATIVENESS; COMPONENTS; OMISSION; QUALITY; IMPACT; WINES; FOODS; L.	This paper describes the design of a new instrumental technique, Gas Chromatography Recomposition-Olfactometry (GC-R), that adapts the reconstitution technique used in flavor chemistry studies by extracting volatiles from a sample by headspace solid-phase microextraction (SPME), separating the extract on a capillary GC column, and recombining individual compounds selectively as they elute off of the column into a mixture for sensory analysis (Figure 1). Using the chromatogram of a mixture as a map, the GC-R instrument allows the operator to "cut apart" and recombine the components of the mixture at will, selecting compounds, peaks, or sections based on retention time to include or exclude in a reconstitution for sensory analysis. Selective recombination is accomplished with the installation of a Deans Switch directly in-line with the column, which directs compounds either to waste or to a cryotrap at the operator's discretion. This enables the creation of, for example, aroma reconstitutions incorporating all of the volatiles in a sample, including instrumentally undetectable compounds as well those present at concentrations below sensory thresholds, thus correcting for the "reconstitution discrepancy" sometimes noted in flavor chemistry studies. Using only flowering lavender (Lavandula angustifola 'Hidcote Blue') as a source for volatiles, we used the instrument to build mixtures of subsets of lavender volatiles in-instrument and characterized their aroma qualities with a sensory panel. We showed evidence of additive, masking, and synergistic effects in these mixtures and of "lavender' aroma character as an emergent property of specific mixtures. This was accomplished without the need for chemical standards, reductive aroma models, or calculation of Odor Activity Values, and is broadly applicable to any aroma or flavor.	[Johnson, Arielle J.; Hirson, Gregory D.; Ebeler, Susan E.] Univ Calif Davis, Dept Viticulture & Enol, Agr & Environm Chem Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis	Johnson, AJ (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Agr & Environm Chem Grad Grp, Davis, CA 95616 USA.	seebeler@ucdavis.edu		Johnson, Arielle/0000-0001-9216-558X; Ebeler, Susan/0000-0002-8394-6736	National Science Foundation [DGE-1148897]; Walter and Erika Jennings Graduate Fellowship	National Science Foundation(National Science Foundation (NSF)); Walter and Erika Jennings Graduate Fellowship	Jim McCurry of Agilent Technologies provided the auxiliary pressure controller used for the modified instrument design. Financial support for AJJ was partially provided by an National Science Foundation Graduate Research Fellowship, grant number DGE-1148897. GDH was partially supported by a Walter and Erika Jennings Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABBOTT N, 1993, J AGR FOOD CHEM, V41, P777, DOI 10.1021/jf00029a019; Acena L, 2010, J CHROMATOGR A, V1217, P7781, DOI 10.1016/j.chroma.2010.10.030; ACREE TE, 1984, FOOD CHEM, V14, P273, DOI 10.1016/0308-8146(84)90082-7; Aftel M., 2004, ESSENCE ALCHEMY NATU; An M, 2001, J CHROMATOGR A, V917, P245, DOI 10.1016/S0021-9673(01)00657-4; Axel R, 2004, SCENTS SENSIBILITY M, V2004, P234; Buck LB, 2004, UNRAVELING SENSE SME, V2004, P267; Bult JHF, 2001, CHEM SENSES, V26, P459, DOI 10.1093/chemse/26.5.459; Escudero A, 2004, J AGR FOOD CHEM, V52, P3516, DOI 10.1021/jf035341l; Etievant PX, 1993, DEV FOOD SCI, P179; Ferreira V, 2002, MOLEC METH PLAN ANAL, V21, P89; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; GROSCH W, 1993, TRENDS FOOD SCI TECH, V4, P68, DOI 10.1016/0924-2244(93)90187-F; GUADAGNI DG, 1966, J SCI FOOD AGR, V17, P142, DOI 10.1002/jsfa.2740170311; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; Le Berre E, 2008, CHEM SENSES, V33, P389, DOI 10.1093/chemse/bjn006; Le Berre E, 2008, CHEM SENSES, V33, P193, DOI 10.1093/chemse/bjm080; Patton S., 1957, J FOOD RES, V22, P316, DOI DOI 10.1111/J.1365-2621.1957.TB17017.X; Perez-Silva A, 2006, FOOD CHEM, V99, P728, DOI 10.1016/j.foodchem.2005.08.050; Pineau B, 2007, J AGR FOOD CHEM, V55, P4103, DOI 10.1021/jf070120r; Plutowska B, 2008, FOOD CHEM, V107, P449, DOI 10.1016/j.foodchem.2007.08.058; Poinot P, 2007, FOOD RES INT, V40, P1170, DOI 10.1016/j.foodres.2007.06.011; Ryan D, 2008, TRENDS FOOD SCI TECH, V19, P383, DOI 10.1016/j.tifs.2008.01.007; San-Juan F, 2010, FOOD CHEM, V123, P188, DOI 10.1016/j.foodchem.2010.03.129; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Steinhaus M, 2009, J AGR FOOD CHEM, V57, P2882, DOI 10.1021/jf803728n; van Ruth SM, 2004, HDB FLAVOR CHARACTER, P303; Wilson D. A., 2006, LEARNING SMELL	28	19	19	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42693	10.1371/journal.pone.0042693	http://dx.doi.org/10.1371/journal.pone.0042693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912722	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700018
J	Jonker, FAM; Calis, JCJ; van Hensbroek, MB; Phiri, K; Geskus, RB; Brabin, BJ; Leenstra, T				Jonker, Femkje A. M.; Calis, Job C. J.; van Hensbroek, Michael Boele; Phiri, Kamija; Geskus, Ronald B.; Brabin, Bernard J.; Leenstra, Tjalling			Iron Status Predicts Malaria Risk in Malawian Preschool Children	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; SEVERE ANEMIA; FOLIC-ACID; DEFICIENCY; SUPPLEMENTATION; INFECTION; IMPACT; CHILDHOOD; MORTALITY; PATTERNS	Introduction: Iron deficiency is highly prevalent in pre-school children in developing countries and an important health problem in sub-Saharan Africa. A debate exists on the possible protective effect of iron deficiency against malaria and other infections; yet consensus is lacking due to limited data. Recent studies have focused on the risks of iron supplementation but the effect of an individual's iron status on malaria risk remains unclear. Studies of iron status in areas with a high burden of infections often are exposed to bias. The aim of this study was to assess the predictive value of baseline iron status for malaria risk explicitly taking potential biases into account. Methods and materials: We prospectively assessed the relationship between baseline iron deficiency (serum ferritin <30 mu g/L) and malaria risk in a cohort of 727 Malawian preschool children during a year of follow-up. Data were analyzed using marginal structural Cox regression models and confounders were selected using causal graph theory. Sensitivity of results to bias resulting from misclassification of iron status by concurrent inflammation and to bias from unmeasured confounding were assessed using modern causal inference methods. Results and Conclusions: The overall incidence of malaria parasitemia and clinical malaria was 1.9 (95%CI 1.8-2.0) and 0.7 (95%CI 0.6-0.8) events per person-year, respectively. Children with iron deficiency at baseline had a lower incidence of malaria parasitemia and clinical malaria during a year of follow-up; adjusted hazard ratio's 0.55 (95%-CI: 0.41-0.74) and 0.49 (95%-CI: 0.33-0.73), respectively. Our results suggest that iron deficiency protects against malaria parasitemia and clinical malaria in young children. Therefore the clinical importance of treating iron deficiency in a pre-school child should be weighed carefully against potential harms. In malaria endemic areas treatment of iron deficiency in children requires sustained prevention of malaria.	[Jonker, Femkje A. M.; Calis, Job C. J.; van Hensbroek, Michael Boele; Brabin, Bernard J.] Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Phiri, Kamija] Coll Med, Dept Community Hlth, Blantyre, Malawi; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Brabin, Bernard J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Leenstra, Tjalling] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Ctr Trop Med & Travel Med,Dept Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Leenstra, Tjalling] Netherlands Minist Def, The Hague, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Malawi; University of Amsterdam; Academic Medical Center Amsterdam; Liverpool School of Tropical Medicine; University of Liverpool; University of Amsterdam; Academic Medical Center Amsterdam	Jonker, FAM (corresponding author), Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Emma Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	femkje.jonker@live.nl	Brabin, Bernard/AAJ-7389-2020	Phiri, Kamija/0000-0003-1753-2727; Boele van Hensbroek, Michael/0000-0003-1907-5427; Brabin, Bernard/0000-0001-6860-2508	Wellcome Trust [064722]; Nutricia Research Foundation; Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences; Dr. P.C. Flu Foundation; JANIVO Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Nutricia Research Foundation(Danone Nutricia); Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences; Dr. P.C. Flu Foundation; JANIVO Foundation	This study was supported by a grant (064722) from the Wellcome Trust and by independent grants from the Nutricia Research Foundation, the Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences, the Dr. P.C. Flu Foundation and JANIVO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; [Anonymous], 2000, WHOFCHCSH001; Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326; Beesley R, 2000, T ROY SOC TROP MED H, V94, P295, DOI 10.1016/S0035-9203(00)90329-8; Brumback BA, 2004, STAT MED, V23, P749, DOI 10.1002/sim.1657; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Carter JY, 2005, AM J TROP MED HYG, V73, P166, DOI 10.4269/ajtmh.2005.73.166; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; COENEN JLLM, 1991, CLIN CHEM, V37, P560; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Denic S, 2007, NUTRITION, V23, P603, DOI 10.1016/j.nut.2007.05.002; Doherty CP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002133; Doherty CP, 2002, J PEDIATR GASTR NUTR, V34, P346, DOI 10.1097/00005176-200204000-00004; English M, 2006, LANCET, V367, P90, DOI 10.1016/S0140-6736(06)67939-7; Franchini M, 2008, HEPATOL INT, V2, P335, DOI 10.1007/s12072-008-9076-z; Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261, DOI 10.1093/ajcn/84.6.1261; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Iron Deficiency Project Advisory Service, 163660 IR DEF PROJ A; Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555; Kabyemela ER, 2008, J INFECT DIS, V198, P163, DOI 10.1086/589512; Klungsoyr O, 2009, LIFETIME DATA ANAL, V15, P278, DOI 10.1007/s10985-008-9109-x; Lash TL, 2000, EPIDEMIOLOGY, V11, P544, DOI 10.1097/00001648-200009000-00010; Matsuzaki-Moriya C, 2011, EUR J IMMUNOL, V41, P1365, DOI 10.1002/eji.201040942; Mebrahtu T, 2004, J NUTR, V134, P3037, DOI 10.1093/jn/134.11.3037; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; MURAKAWA H, 1987, BLOOD, V69, P1464; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; Mutero CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-21; Nweneka CV, 2010, T ROY SOC TROP MED H, V104, P175, DOI 10.1016/j.trstmh.2009.08.007; Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331; Okebe JU, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub3; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Pearl J, 2000, ART SCI CAUSE EFFECT, P331; Phiri KS, 2009, J CLIN PATHOL, V62, P1103, DOI 10.1136/jcp.2009.066498; Phiri KS, 2009, J CLIN PATHOL, V62, P685, DOI 10.1136/jcp.2009.064451; Raiten DJ, 2011, INT J VITAM NUTR RES, V81, P57, DOI 10.1024/0300-9831/a000051; Richard SA, 2006, AM J TROP MED HYG, V75, P126, DOI 10.4269/ajtmh.2006.75.1.0750126; Robins JM, 1999, STAT MODELS EPIDEMIO, P1; Rowe AK, 2011, AM J PUBLIC HEALTH, V101, P2333, DOI 10.2105/AJPH.2010.300068; Rubin DB, 1987, HDB STAT MODELING SO; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Sullivan AD, 1996, PARASITOLOGY, V112, P285, DOI 10.1017/S003118200006580X; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Trey JE, 1995, CRIT REV ONCOL HEMAT, V21, P1, DOI 10.1016/1040-8428(94)00141-3; Van Buuren S., 2011, MICE MULTIVARIATE IM; van der Wal WM, 2011, J STAT SOFTW, V43, P1; Wander K, 2009, AM J HUM BIOL, V21, P172, DOI 10.1002/ajhb.20839; Weinberg ED, 1996, BIOMETALS, V9, P393; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO, 2007, CONCL REC WHO CONS P	61	54	55	39	223	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42670	10.1371/journal.pone.0042670	http://dx.doi.org/10.1371/journal.pone.0042670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916146	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000307824300014
J	Yamanaka, W; Takeshita, T; Shibata, Y; Matsuo, K; Eshima, N; Yokoyama, T; Yamashita, Y				Yamanaka, Wataru; Takeshita, Toru; Shibata, Yukie; Matsuo, Kazuki; Eshima, Nobuoki; Yokoyama, Takeshi; Yamashita, Yoshihisa			Compositional Stability of a Salivary Bacterial Population against Supragingival Microbiota Shift following Periodontal Therapy	PLOS ONE			English	Article							FLORA	Supragingival plaque is permanently in contact with saliva. However, the extent to which the microbiota contributes to the salivary bacterial population remains unclear. We compared the compositional shift in the salivary bacterial population with that in supragingival plaque following periodontal therapy. Samples were collected from 19 patients with periodontitis before and after periodontal therapy (mean sample collection interval, 25.8+/-2.6 months), and their bacterial composition was investigated using barcoded pyrosequencing analysis of the 16S rRNA gene. Phylogenetic community analysis using the UniFrac distance metric revealed that the overall bacterial community composition of saliva is distinct from that of supragingival plaque, both pre- and post-therapy. Temporal variation following therapy in the salivary bacterial population was significantly smaller than in the plaque microbiota, and the post-therapy saliva sample was significantly more similar to that pre-therapy from the same individual than to those from other subjects. Following periodontal therapy, microbial richness and biodiversity were significantly decreased in the plaque microbiota, but not in the salivary bacterial population. The operational taxonomic units whose relative abundances changed significantly after therapy were not common to the two microbiotae. These results reveal the compositional stability of salivary bacterial populations against shifts in the supragingival microbiota, suggesting that the effect of the supragingival plaque microbiota on salivary bacterial population composition is limited.	[Yamanaka, Wataru; Takeshita, Toru; Shibata, Yukie; Matsuo, Kazuki; Yamashita, Yoshihisa] Kyushu Univ, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan; [Matsuo, Kazuki; Yokoyama, Takeshi] Kyushu Univ, Sect Dent Anesthesiol, Div Maxillofacial Diagnost & Surg Sci, Fac Dent Sci, Fukuoka 812, Japan; [Eshima, Nobuoki] Oita Univ, Fac Med, Dept Biostat, Yufu City, Oita, Japan	Kyushu University; Kyushu University; Oita University	Yamanaka, W (corresponding author), Kyushu Univ, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan.	yoshi@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [23792517, 20192403]; Grants-in-Aid for Scientific Research [22500260, 23659986] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by Grants-in Aid for Young Scientist 23792517 (T. T.) and by Grants-in Aid for Scientific Research 20192403 (Y.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farrell JJ, 2012, GUT, V61, P582, DOI 10.1136/gutjnl-2011-300784; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Gura T, 2008, NAT MED, V14, P706, DOI 10.1038/nm0708-706; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Paju S, 2009, J CLIN MICROBIOL, V47, P235, DOI 10.1128/JCM.01824-08; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Development Core Team, 2007, R LANG ENV STAT COMP; Rasiah IA, 2005, ARCH ORAL BIOL, V50, P779, DOI 10.1016/j.archoralbio.2005.02.001; Sakamoto M, 2003, J MED MICROBIOL, V52, P79, DOI 10.1099/jmm.0.04991-0; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Takeshita T, 2007, ORAL MICROBIOL IMMUN, V22, P419, DOI 10.1111/j.1399-302X.2007.00384.x; Takeshita T, 2011, APPL ENVIRON MICROB, V77, P6739, DOI 10.1128/AEM.00651-11; Takeshita T, 2010, APPL ENVIRON MICROB, V76, P2806, DOI 10.1128/AEM.02304-09; Takeshita T, 2009, ISME J, V3, P65, DOI 10.1038/ismej.2008.91; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	29	46	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42806	10.1371/journal.pone.0042806	http://dx.doi.org/10.1371/journal.pone.0042806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916162	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300017
J	Fernandes, HL; Stevenson, IH; Kording, KP				Fernandes, Hugo L.; Stevenson, Ian H.; Kording, Konrad P.			Generalization of Stochastic Visuomotor Rotations	PLOS ONE			English	Article							MOTOR CORTEX; UNCERTAINTY; ADAPTATION; REPRESENTATION; DIRECTION; DYNAMICS; TRANSFORMATIONS; DETERMINES; KINEMATICS; KINETICS	Generalization studies examine the influence of perturbations imposed on one movement onto other movements. The strength of generalization is traditionally interpreted as a reflection of the similarity of the underlying neural representations. Uncertainty fundamentally affects both sensory integration and learning and is at the heart of many theories of neural representation. However, little is known about how uncertainty, resulting from variability in the environment, affects generalization curves. Here we extend standard movement generalization experiments to ask how uncertainty affects the generalization of visuomotor rotations. We find that although uncertainty affects how fast subjects learn, the perturbation generalizes independently of uncertainty.	[Fernandes, Hugo L.; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Fernandes, Hugo L.; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Fernandes, Hugo L.] Inst Gulbenkian Ciencias, PDBC, Oeiras, Portugal; [Fernandes, Hugo L.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Stevenson, Ian H.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Kording, Konrad P.] Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; University of California System; University of California Berkeley; Northwestern University; Northwestern University	Fernandes, HL (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	hugoguh@gmail.com	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	Fundacao para a Ciencia e Tecnologia [SFRH/BD/33525/2008]; National Institutes of Heatlh [1R01NS063399, 2P01NS044393]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393, R01NS063399] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institutes of Heatlh; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	HLF was supported by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/); SFRH/BD/33525/2008. This work was supported by National Institutes of Heatlh 1R01NS063399 and 2P01NS044393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Christopoulos VN, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000538; Cisek P, 2002, J NEUROPHYSIOL, V87, P1149, DOI 10.1152/jn.00443.2001; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Donchin O, 2003, J NEUROSCI, V23, P9032; Fernandes HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020290; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Graham KM, 2003, J NEUROPHYSIOL, V89, P2667, DOI 10.1152/jn.00742.2002; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hinton GE, 1983, OPTIMAL PERCEPTUAL I, P448; Hoyer PO, 2003, ADV NEURAL INFORM PR, V15, P293; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Hwang EJ, 2006, EXP BRAIN RES, V169, P496, DOI 10.1007/s00221-005-0163-2; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2010, VISION RES, V50, P2308, DOI 10.1016/j.visres.2010.08.035; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Paz R, 2005, EXP BRAIN RES, V161, P209, DOI 10.1007/s00221-004-2061-4; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Pearson TS, 2010, J NEUROPHYSIOL, V103, P2938, DOI 10.1152/jn.01089.2009; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rickert J, 2009, J NEUROSCI, V29, P13870, DOI 10.1523/JNEUROSCI.5441-08.2009; Sahani M, 2003, NEURAL COMPUT, V15, P2255, DOI 10.1162/089976603322362356; Saijo N, 2012, J NEUROPHYSIOL, V107, P1576, DOI 10.1152/jn.00204.2011; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Shadmehr R, 2004, HUM MOVEMENT SCI, V23, P543, DOI 10.1016/j.humov.2004.04.003; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2000, J NEUROSCI, V20, P7807; SHEA CH, 1990, RES Q EXERCISE SPORT, V61, P169, DOI 10.1080/02701367.1990.10608671; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Taylor JA, 2011, ADV COMPUTATIONAL MO, V10; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Turnham EJA, 2012, J NEUROPHYSIOL, V107, P1111, DOI 10.1152/jn.00635.2011; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Verstynen T, 2011, J NEUROSCI, V31, P10050, DOI 10.1523/JNEUROSCI.6525-10.2011; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Zar J., 1999, BIOSTATISTICAL ANAL, V4; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	56	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43016	10.1371/journal.pone.0043016	http://dx.doi.org/10.1371/journal.pone.0043016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916198	Green Published, gold			2022-12-27	WOS:000307500800037
J	Yin, ZY; Fan, LN; Wei, LP; Gao, HK; Zhang, RQ; Tao, L; Cao, F; Wang, HC				Yin, Zhiyong; Fan, Linni; Wei, Liping; Gao, Haokao; Zhang, Rongqing; Tao, Ling; Cao, Feng; Wang, Haichang			FTY720 Protects Cardiac Microvessels of Diabetes: A Critical Role of S1P1/3 in Diabetic Heart Disease	PLOS ONE			English	Article							SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR; SPHINGOSINE 1-PHOSPHATE RECEPTORS; ENDOTHELIAL GROWTH-FACTOR; MICROVASCULAR DISEASE; THERAPEUTIC ANGIOGENESIS; LYMPHOCYTE EGRESS; COUPLED RECEPTORS; ISCHEMIC DISEASE; MICE; PREVENTION	Background: Diabetes is associated with an increased risk of cardiac microvascular disease. The mechanisms by which this damage occurs are unknown. However, research suggests that signaling through the sphingosine-1-phosphates receptor 1 and 3 (S1P1/3) by FTY720, a sphiongolipid drug that is structually similar to SIP, may play a role in the treatment on cardiac microvascular dysfunction in diabetes. We hypothesized that FTY720 might exert the cardioprotective effects of S1P1 and S1P3 viaprotein kinase C-beta (PKC beta II) signaling pathway. Methodology/Principal Findings: Transthoracic echocardiography was performed to detect the change of cardiac function. Scanning and transmission electron microscope with lanthanum tracer were used to determine microvascular ultrastructure and permeability in vivo. Apoptosis was detected by TUNEL and CD31 dual labeling in paraffin-embedded sections. Laser capture miscrodissection was used to assess cardiac micovascular endothelial cells (CMECs) in vivo. RT-PCR and Western blot analysis were used to determine the mRNA levels and protein expression of S1P1, S1P3, and PKC beta II. In the diabetic rats vs. controls, cardiac capillaries showed significantly higher density; CD31 positive endothelial cells were significantly reduced; the apoptosis index of cardiac endothlial cells was significantly higher. And FTY720 could increase the expressional level of S1P1 and boost S1P3 trasnslocation from membrane to nuclear, then ameliorate cardiac microvascular barrier impairment and pathologic angiogenesis induced by diabetes. In addition, overexpression of PKC beta II significantly decreased the protective effect of FTY720. Conclusions: Our study represents that the deregulation of S1P1 and S1P3 is an important signalresponsible for cardiac microvascular dysfunction in diabetes. FTY720 might be competent to serve as a potential therapeutic approach for diabetic heart disease through ameliorating cardiac microvascular barrier impairment and pathologic angiogenesis, which might be partly dependent on PKC beta II-mediated signaling pathway.	[Yin, Zhiyong; Gao, Haokao; Zhang, Rongqing; Tao, Ling; Cao, Feng; Wang, Haichang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Fan, Linni] Fourth Mil Med Univ, Dept Pathol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Wei, Liping] Tianjin Union Med Ctr, Dept Cardiol, Tianjin, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Yin, ZY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China.	wanghc@fmmu.edu.cn	wei, li/GSD-3630-2022; 黎, 伟/GXM-4040-2022					Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; BISHOP MA, 1985, CELL TISSUE RES, V239, P131, DOI 10.1007/BF00214912; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Del Bo R, 2006, IMMUNOGENETICS, V58, P107, DOI 10.1007/s00251-006-0089-2; Del Canizo Gomez F. J., 2011, ENDOCRINOL NUTR, V58, P163, DOI DOI 10.1016/J.ENDONU.2011.01.006; Dragun D, 2004, TRANSPL P, V36, p544S, DOI 10.1016/j.transproceed.2003.12.048; Egom EEA, 2010, J MOL CELL CARDIOL, V48, P406, DOI 10.1016/j.yjmcc.2009.10.009; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Flores-Le Roux JA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-39; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hofmann U, 2010, BRIT J PHARMACOL, V160, P1243, DOI 10.1111/j.1476-5381.2010.00767.x; Kendall MR, 2008, DIABETES OBES METAB, V10, P802, DOI 10.1111/j.1463-1326.2008.00910.x; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Laakso M, 2011, DIABETES CARE, V34, pS145, DOI 10.2337/dc11-s209; Li CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032380; Liao JJ, 2007, J BIOL CHEM, V282, P1964, DOI 10.1074/jbc.M608597200; Liesz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021312; Lim HS, 2005, ATHEROSCLEROSIS, V180, P113, DOI 10.1016/j.atherosclerosis.2004.11.004; Liu LS, 2007, MICROSURG, V27, P300, DOI 10.1002/micr.20360; Liu Y, 2011, ANTIOXID REDOX SIGN, V15, P1769, DOI 10.1089/ars.2010.3764; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Machado DE, 2008, FERTIL STERIL, V90, P148, DOI 10.1016/j.fertnstert.2007.05.076; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Maki T, 2002, TRANSPLANTATION, V74, P1684, DOI 10.1097/01.TP.0000038969.72218.0F; Marcovecchio ML, 2011, PEDIATR NEPHROL, V26, P365, DOI 10.1007/s00467-010-1624-9; Martinet W, 2004, J PATHOL, V202, P382, DOI 10.1002/path.1525; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; NISHIDA M, 1993, AM J PHYSIOL, V264, pH639, DOI 10.1152/ajpheart.1993.264.2.H639; Penaranda C, 2010, DIABETES, V59, P1461, DOI 10.2337/db09-1129; Popovic J, 2004, PEDIATR DIABETES, V5, P3, DOI 10.1111/j.1399-543X.2004.00036.x; Raposo C, 2007, BRAIN RES, V1149, P18, DOI 10.1016/j.brainres.2007.02.086; Retnakaran R, 2008, LANCET, V371, P1790, DOI 10.1016/S0140-6736(08)60767-9; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Verli FD, 2008, SCANNING, V30, P414, DOI 10.1002/sca.20122; Waeber C, 2004, DRUG NEWS PERSPECT, V17, P365, DOI 10.1358/dnp.2004.17.6.829028; Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70; Wei LP, 2010, MICROVASC RES, V80, P158, DOI 10.1016/j.mvr.2010.01.003; Wei LP, 2010, APOPTOSIS, V15, P488, DOI 10.1007/s10495-009-0439-2; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359	49	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42900	10.1371/journal.pone.0042900	http://dx.doi.org/10.1371/journal.pone.0042900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916176	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800028
J	Cadete, RM; Melo, MA; Dussan, KJ; Rodrigues, RCLB; Silva, SS; Zilli, JE; Vital, MJS; Gomes, FCO; Lachance, MA; Rosa, CA				Cadete, Raquel M.; Melo, Monaliza A.; Dussan, Kelly J.; Rodrigues, Rita C. L. B.; Silva, Silvio S.; Zilli, Jerri E.; Vital, Marcos J. S.; Gomes, Fatima C. O.; Lachance, Marc-Andre; Rosa, Carlos A.			Diversity and Physiological Characterization of D-Xylose-Fermenting Yeasts Isolated from the Brazilian Amazonian Forest	PLOS ONE			English	Article							SUGARCANE BAGASSE HYDROLYSATE; XYLITOL PRODUCTION; ETHANOL-PRODUCTION; ALCOHOLIC FERMENTATION; SP-NOV.; SACCHAROMYCES-CEREVISIAE; CANDIDA-TROPICALIS; BEETLES; WOOD; MIXTURES	Background: This study is the first to investigate the Brazilian Amazonian Forest to identify new D-xylose-fermenting yeasts that might potentially be used in the production of ethanol from sugarcane bagasse hemicellulosic hydrolysates. Methodology/Principal Findings: A total of 224 yeast strains were isolated from rotting wood samples collected in two Amazonian forest reserve sites. These samples were cultured in yeast nitrogen base (YNB)-D-xylose or YNB-xylan media. Candida tropicalis, Asterotremella humicola, Candida boidinii and Debaryomyces hansenii were the most frequently isolated yeasts. Among D-xylose-fermenting yeasts, six strains of Spathaspora passalidarum, two of Scheffersomyces stipitis, and representatives of five new species were identified. The new species included Candida amazonensis of the Scheffersomyces clade and Spathaspora sp. 1, Spathaspora sp. 2, Spathaspora sp. 3, and Candida sp. 1 of the Spathaspora clade. In fermentation assays using D-xylose (50 g/L) culture medium, S. passalidarum strains showed the highest ethanol yields (0.31 g/g to 0.37 g/g) and productivities (0.62 g/L.h to 0.75 g/L.h). Candida amazonensis exhibited a virtually complete D-xylose consumption and the highest xylitol yields (0.55 g/g to 0.59 g/g), with concentrations up to 25.2 g/L. The new Spathaspora species produced ethanol and/or xylitol in different concentrations as the main fermentation products. In sugarcane bagasse hemicellulosic fermentation assays, S. stipitis UFMG-XMD-15.2 generated the highest ethanol yield (0.34 g/g) and productivity (0.2 g/L.h), while the new species Spathaspora sp. 1 UFMG-XMD-16.2 and Spathaspora sp. 2 UFMG-XMD-23.2 were very good xylitol producers. Conclusions/Significance: This study demonstrates the promise of using new D-xylose-fermenting yeast strains from the Brazilian Amazonian Forest for ethanol or xylitol production from sugarcane bagasse hemicellulosic hydrolysates.	[Cadete, Raquel M.; Melo, Monaliza A.; Rosa, Carlos A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Dussan, Kelly J.; Rodrigues, Rita C. L. B.; Silva, Silvio S.] Univ Sao Paulo, Dept Biotecnol, Escola Engn Lorena, Sao Paulo, Brazil; [Zilli, Jerri E.] Embrapa Agrobiol, Rio De Janeiro, Brazil; [Vital, Marcos J. S.] Univ Fed Roraima, Dept Biol, Boa Vista, Brazil; [Gomes, Fatima C. O.] Ctr Fed Educ Tecnol Minas Gerais, Dept Quim, Belo Horizonte, MG, Brazil; [Lachance, Marc-Andre] Univ Western Ontario, Dept Biol, London, ON, Canada	Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Roraima; Western University (University of Western Ontario)	Cadete, RM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.	carlrosa@icb.ufmg.br	da Silva, Silvio Silvério/H-8960-2012; Medina, Kelly Johana Dussan/H-6956-2013; de Cássia Lacerda Brambilla Rodrigues, Rita/B-5201-2013	da Silva, Silvio Silvério/0000-0003-0669-2784; Medina, Kelly Johana Dussan/0000-0003-1810-5313; de Cássia Lacerda Brambilla Rodrigues, Rita/0000-0003-0387-5083	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil) [560715/2010-2]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57926-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [2280/2008]; Natural Science and Engineering Research Council of Canada	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil, process 560715/2010-2), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, process 2008/57926-4), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Procad-NF, process 2280/2008) and the Natural Science and Engineering Research Council of Canada (M. A. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Agbogbo FK, 2007, J IND MICROBIOL BIOT, V34, P723, DOI 10.1007/s10295-007-0247-z; Agbogbo FK, 2006, PROCESS BIOCHEM, V41, P2333, DOI 10.1016/j.procbio.2006.05.004; Alves LA, 1998, APPL BIOCHEM BIOTECH, V70-2, P89, DOI 10.1007/BF02920126; Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; Bhadra B, 2008, CURR MICROBIOL, V56, P489, DOI 10.1007/s00284-008-9108-x; Branco RD, 2011, BIOMASS BIOENERG, V35, P3241, DOI 10.1016/j.biombioe.2011.02.014; BRUINENBERG PM, 1984, APPL MICROBIOL BIOT, V19, P256, DOI 10.1007/BF00251847; Cadete RM, 2012, INT J SYST EVOL MICR, V62, P1438, DOI 10.1099/ijs.0.036715-0; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Carvalho W, 2002, APPL BIOCHEM BIOTECH, V98, P489, DOI 10.1385/ABAB:98-100:1-9:489; Chandel A.K., 2010, J COMMER BIOTECHNOL, V16, P239, DOI [10.1057/JCB.2010.5/TABLES/6, DOI 10.1057/JCB.2010.5/TABLES/6, DOI 10.1057/JCB.2010.5]; Chandel AK, 2011, BIOTECHNOL MOL BIOL, V6, P08; Chandel AK, 2007, BIORESOURCE TECHNOL, V98, P1947, DOI 10.1016/j.biortech.2006.07.047; da Cunha-Pereira F, 2011, BIORESOURCE TECHNOL, V102, P4218, DOI 10.1016/j.biortech.2010.12.060; Du Preez J, 2009, NEW BIOTECHNOL, V25, pS52, DOI 10.1016/j.nbt.2009.06.265; DUPREEZ JC, 1986, APPL MICROBIOL BIOT, V23, P228, DOI 10.1007/BF00261920; Ferreira AD, 2011, YEAST, V28, P547, DOI 10.1002/yea.1858; Fonseca C, 2007, APPL MICROBIOL BIOT, V75, P303, DOI 10.1007/s00253-006-0830-7; Hahn-Hagerdal B, 2004, APPL BIOCHEM BIOTECH, V113, P1207; Hou X, 2012, APPL MICROBIOL BIOT, V94, P205, DOI 10.1007/s00253-011-3694-4; JEFFRIES TW, 1985, TRENDS BIOTECHNOL, V3, P208, DOI 10.1016/0167-7799(85)90048-4; JEFFRIES TW, 1981, BIOTECHNOL LETT, V3, P213, DOI 10.1007/BF00154647; JEFFRIES TW, 1994, ENZYME MICROB TECH, V16, P922, DOI 10.1016/0141-0229(94)90001-9; Jindamorakot S, 2007, FEMS YEAST RES, V7, P1409, DOI 10.1111/j.1567-1364.2007.00305.x; Kim S, 2005, BIOMASS BIOENERG, V29, P426, DOI 10.1016/j.biombioe.2005.06.004; Kim TB, 2003, BIOTECHNOL LETT, V25, P2085, DOI 10.1023/B:BILE.0000007069.74876.0c; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P521, DOI 10.1016/B978-0-444-52149-1.00042-2; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Lachance MA, 1999, CAN J MICROBIOL, V45, P172, DOI 10.1139/cjm-45-2-172; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P987, DOI 10.1016/B978-0-444-52149-1.00090-2; Liu YR, 2011, ANTON LEEUW INT J G, V99, P643, DOI 10.1007/s10482-010-9537-y; Lopes MDB, 1996, APPL ENVIRON MICROB, V62, P4514, DOI 10.1128/AEM.62.12.4514-4520.1996; MORAIS PB, 1995, J IND MICROBIOL, V14, P531, DOI 10.1007/BF01573969; MORAIS PB, 1995, APPL ENVIRON MICROB, V61, P4251, DOI 10.1128/AEM.61.12.4251-4257.1995; Nakamura N, 2008, ENZYME MICROB TECH, V43, P233, DOI 10.1016/j.enzmictec.2008.04.003; Nguyen NH, 2006, MYCOL RES, V110, P1232, DOI 10.1016/j.mycres.2006.07.002; NIGAM JN, 1985, APPL ENVIRON MICROB, V50, P1486, DOI 10.1128/AEM.50.6.1486-1489.1985; NIGAM P, 1995, PROCESS BIOCHEM, V30, P117, DOI 10.1016/0032-9592(95)95709-R; Peres CA, 2010, BIOL CONSERV, V143, P2314, DOI 10.1016/j.biocon.2010.01.021; Pires JM, 1972, THESIS USP BRAZIL; Pokhrel CP, 2008, SCI WORLD, V6, P19; Rao RS, 2008, LETT APPL MICROBIOL, V47, P19, DOI 10.1111/j.1472-765X.2008.02380.x; Rao RS, 2006, BIORESOURCE TECHNOL, V97, P1974, DOI 10.1016/j.biortech.2005.08.015; Rosa CA, 2007, INT J SYST EVOL MICR, V57, P161, DOI 10.1099/ijs.0.64624-0; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; SALATI E, 1984, SCIENCE, V225, P129, DOI 10.1126/science.225.4658.129; Sanchez S, 2008, WORLD J MICROB BIOT, V24, P709, DOI 10.1007/s11274-007-9527-z; Santos R, 2011, ANTON LEEUW INT J G, V99, P635, DOI 10.1007/s10482-010-9536-z; Schmidell W, 2001, MODELADEM MATEMATICA, P123; Silva CJSM, 2001, LETT APPL MICROBIOL, V32, P248, DOI 10.1046/j.1472-765X.2001.00899.x; Silva SS, 1998, APPL BIOCHEM BIOTECH, V70-2, P331, DOI 10.1007/BF02920149; Smith MT, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P959, DOI 10.1016/B978-0-444-52149-1.00087-2; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; Suzuki M, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P785, DOI 10.1016/B978-0-444-52149-1.00067-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOIVOLA A, 1984, APPL ENVIRON MICROB, V47, P1221, DOI 10.1128/AEM.47.6.1221-1223.1984; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Vital MJS, 2002, BRAZ J MICROBIOL, V33, P230, DOI 10.1590/S1517-83822002000300008; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108	61	79	80	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43135	10.1371/journal.pone.0043135	http://dx.doi.org/10.1371/journal.pone.0043135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912807	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100065
J	De Langhe, E; Vande Velde, G; Hostens, J; Himmelreich, U; Nemery, B; Luyten, FP; Vanoirbeek, J; Lories, RJ				De langhe, Ellen; Vande Velde, Greetje; Hostens, Jeroen; Himmelreich, Uwe; Nemery, Benoit; Luyten, Frank P.; Vanoirbeek, Jeroen; Lories, Rik J.			Quantification of Lung Fibrosis and Emphysema in Mice Using Automated Micro-Computed Tomography	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; IN-VIVO; MODELS; TISSUE; CT	Background: In vivo high-resolution micro-computed tomography allows for longitudinal image-based measurements in animal models of lung disease. The combination of repetitive high resolution imaging with fully automated quantitative image analysis in mouse models of lung fibrosis lung benefits preclinical research. This study aimed to develop and validate such an automated micro-computed tomography analysis algorithm for quantification of aerated lung volume in mice; an indicator of pulmonary fibrosis and emphysema severity. Methodology: Mice received an intratracheal instillation of bleomycin (n = 8), elastase (0.25U elastase n = 9, 0.5U elastase n = 8) or saline control (n = 6 for fibrosis, n = 5 for emphysema). A subset of mice was scanned without intervention, to evaluate potential radiation-induced toxicity (n = 4). Some bleomycin-instilled mice were treated with imatinib for proof of concept (n = 8). Mice were scanned weekly, until four weeks after induction, when they underwent pulmonary function testing, lung histology and collagen quantification. Aerated lung volumes were calculated with our automated algorithm. Principal Findings: Our automated image-based aerated lung volume quantification method is reproducible with low intra-subject variability. Bleomycin-treated mice had significantly lower scan-derived aerated lung volumes, compared to controls. Aerated lung volume correlated with the histopathological fibrosis score and total lung collagen content. Inversely, a dose-dependent increase in lung volume was observed in elastase-treated mice. Serial scanning of individual mice is feasible and visualized dynamic disease progression. No radiation-induced toxicity was observed. Three-dimensional images provided critical topographical information. Conclusions: We report on a high resolution in vivo micro-computed tomography image analysis algorithm that runs fully automated and allows quantification of aerated lung volume in mice. This method is reproducible with low inherent measurement variability. We show that it is a reliable quantitative tool to investigate experimental lung fibrosis and emphysema in mice. Its non-invasive nature has the unique benefit to allow dynamic 4D evaluation of disease processes and therapeutic interventions.	[De langhe, Ellen; Luyten, Frank P.; Lories, Rik J.] Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Skeletal Dev & Joint Disorders, Louvain, Belgium; [De langhe, Ellen; Luyten, Frank P.; Lories, Rik J.] Univ Hosp Leuven, Dept Rheumatol, Louvain, Belgium; [Vande Velde, Greetje; Himmelreich, Uwe] Katholieke Univ Leuven, Dept Imaging & Pathol, Biomed NMR Unit, MoSAIC, Louvain, Belgium; [Hostens, Jeroen] SkyScan, Kontich, Belgium; [Nemery, Benoit; Vanoirbeek, Jeroen] Katholieke Univ Leuven, Dept Publ Hlth, Res Unit Lung Toxicol, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven	De Langhe, E (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Skeletal Dev & Joint Disorders, Louvain, Belgium.	Ellen.delanghe@uzleuven.be	Vanoirbeek, Jeroen/D-5183-2016; Velde, Greetje Vande/O-9161-2016; Lories, Rik/T-2196-2017; Nemery, Benoit/D-1224-2013; Nemery, Benoit/N-3155-2019; Luyten, Frank/GPS-7793-2022; Lories, Rik/Q-8328-2019	Vanoirbeek, Jeroen/0000-0001-5508-3518; Velde, Greetje Vande/0000-0002-5633-3993; Lories, Rik/0000-0002-5986-3092; Nemery, Benoit/0000-0003-0571-4689; Lories, Rik/0000-0002-5986-3092; Himmelreich, Uwe/0000-0002-2060-8895	Centre of Excellence Grant of KU Leuven (MOSAIC); Flanders Research Foundation (F.W.O. Vlaanderen) [G.0592.09]; European Commission FP7-NMP VIBRANT [228933]; KU Leuven 'IMIR' PF [10/017]; F.W.O [G.0804.11]	Centre of Excellence Grant of KU Leuven (MOSAIC); Flanders Research Foundation (F.W.O. Vlaanderen)(FWO); European Commission FP7-NMP VIBRANT; KU Leuven 'IMIR' PF; F.W.O(FWO)	This study was supported by a Centre of Excellence Grant of KU Leuven (MOSAIC, www.saic.be). E. D. L. is the recipient of an "Aspirant" PhD fellowship and a research grant [G.0592.09] from the Flanders Research Foundation (F.W.O. Vlaanderen, www.fwo.be). G. V. is a postdoctoral researcher, supported by European Commission FP7-NMP VIBRANT [228933], KU Leuven 'IMIR' PF [10/017] and F.W.O [G.0804.11]. J.V. is a postdoctoral fellow of the F.W.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artaechevarria X, 2011, EUR RADIOL, V21, P954, DOI 10.1007/s00330-010-1982-5; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Badea CT, 2012, AM J PHYSIOL-LUNG C, V302, pL1088, DOI 10.1152/ajplung.00359.2011; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cavanaugh D, 2006, ACAD RADIOL, V13, P1505, DOI 10.1016/j.acra.2006.08.011; Ford NL, 2007, J APPL PHYSIOL, V102, P2046, DOI 10.1152/japplphysiol.00629.2006; Fushiki H, 2009, CANCER SCI, V100, P1544, DOI 10.1111/j.1349-7006.2009.01199.x; Jin GY, 2011, EUROPEAN J RADIOLOGY; Johnston SM, 2010, P SOC PHOTOOPTICAL I, V7622; Lederlin M, 2010, EUR RADIOL, V20, P128, DOI 10.1007/s00330-009-1541-0; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Plathow C, 2004, INVEST RADIOL, V39, P600, DOI 10.1097/01.rli.0000138134.89050.a5; Roberts SJ, 2011, BIOMATERIALS, V32, P4393, DOI 10.1016/j.biomaterials.2011.02.047; Rodt T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-181; Shofer S, 2008, J APPL PHYSIOL, V105, P669, DOI 10.1152/japplphysiol.00980.2007; Shofer S, 2007, EXP LUNG RES, V33, P169, DOI 10.1080/01902140701364458; Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	24	70	70	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43123	10.1371/journal.pone.0043123	http://dx.doi.org/10.1371/journal.pone.0043123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912805	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100064
J	Funston, G; Goh, W; Wei, SJ; Tng, QS; Brown, C; Tong, LJ; Verma, C; Lane, D; Ghadessy, F				Funston, Garth; Goh, Walter; Wei, Siau Jia; Tng, Quah Soo; Brown, Christopher; Tong, Loh Jiah; Verma, Chandra; Lane, David; Ghadessy, Farid			Binding of Translationally Controlled Tumour Protein to the N-Terminal Domain of HDM2 Is Inhibited by Nutlin-3	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; CANCER CELLS; ANTIAPOPTOTIC ACTIVITY; DNA-DAMAGE; IN-VIVO; TCTP; P53; MDM2; GROWTH; UBIQUITINATION	Translationally Controlled Tumour Protein (TCTP), a highly conserved protein present in all eukaryotic organisms, has a number of intracellular and extracellular functions including an anti-apoptotic role. TCTP was recently shown to interact with both p53 and HDM2, inhibiting auto-ubiquitination of the latter and thereby promoting p53 degradation. In this study, we further investigated the interaction between TCTP and HDM2, mapping the reciprocal binding sites of TCTP and HDM2. TCTP primarily interacts with the N-terminal, p53-binding region of HDM2 through its highly basic domain 2. Furthermore, we discovered that Nutlin-3, a small molecule known to promote apoptosis and cell cycle arrest by blocking binding between HDM2 and p53, has a similar inhibitory effect on the interaction of HDM2 and TCTP. This result may provide an additional explanation of how Nutlin-derived compounds currently in clinical trials function to promote apoptosis in cancer cells.	[Funston, Garth] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 2QQ, England; [Goh, Walter; Wei, Siau Jia; Tng, Quah Soo; Brown, Christopher; Lane, David; Ghadessy, Farid] ASTAR, p53Lab, Singapore, Singapore; [Tong, Loh Jiah; Verma, Chandra] ASTAR, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Funston, G (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 2QQ, England.	fghadessy@p53Lab.a-star.edu.sg		Lane, David/0000-0003-0551-3545; Funston, Garth/0000-0002-4156-6401	Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science, Technology and Research (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens E, 2002, BIOCHEM PHARMACOL, V64, P797, DOI 10.1016/S0006-2952(02)01141-3; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; Bheekha-Escura R, 2000, BLOOD, V96, P2191; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Brown CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024122; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen YJ, 2011, J BIOL CHEM, V286, P32575, DOI 10.1074/jbc.M110.217836; Gachet Y, 1999, J CELL SCI, V112, P1257; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; TAKAHASHI T, 1992, CANCER RES, V52, P2340; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vonakis BM, 2003, J IMMUNOL, V171, P3742, DOI 10.4049/jimmunol.171.7.3742; Wallace M, 2006, AM BOOK REV, V27, P3, DOI 10.1353/abr.2006.0081; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhu WL, 2008, ANTICANCER RES, V28, P1575	34	11	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42642	10.1371/journal.pone.0042642	http://dx.doi.org/10.1371/journal.pone.0042642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912717	gold, Green Published			2022-12-27	WOS:000307500100020
J	Colomb, J; Reiter, L; Blaszkiewicz, J; Wessnitzer, J; Brembs, B				Colomb, Julien; Reiter, Lutz; Blaszkiewicz, Jedrzej; Wessnitzer, Jan; Brembs, Bjoern			Open Source Tracking and Analysis of Adult Drosophila Locomotion in Buridan's Paradigm with and without Visual Targets	PLOS ONE			English	Article							CENTRAL COMPLEX; MUSHROOM BODIES; MELANOGASTER; BEHAVIOR; MUTANT; BRAIN; ORIENTATION; DOPAMINE; FIXATION; PORTRAIT	Background: Insects have been among the most widely used model systems for studying the control of locomotion by nervous systems. In Drosophila, we implemented a simple test for locomotion: in Buridan's paradigm, flies walk back and forth between two inaccessible visual targets [1]. Until today, the lack of easily accessible tools for tracking the fly position and analyzing its trajectory has probably contributed to the slow acceptance of Buridan's paradigm. Methodology/Principal Findings: We present here a package of open source software designed to track a single animal walking in a homogenous environment (Buritrack) and to analyze its trajectory. The Centroid Trajectory Analysis (CeTrAn) software is coded in the open source statistics project R. It extracts eleven metrics and includes correlation analyses and a Principal Components Analysis (PCA). It was designed to be easily customized to personal requirements. In combination with inexpensive hardware, these tools can readily be used for teaching and research purposes. We demonstrate the capabilities of our package by measuring the locomotor behavior of adult Drosophila melanogaster (whose wings were clipped), either in the presence or in the absence of visual targets, and comparing the latter to different computer-generated data. The analysis of the trajectories confirms that flies are centrophobic and shows that inaccessible visual targets can alter the orientation of the flies without changing their overall patterns of activity. Conclusions/Significance: Using computer generated data, the analysis software was tested, and chance values for some metrics (as well as chance value for their correlation) were set. Our results prompt the hypothesis that fixation behavior is observed only if negative phototaxis can overcome the propensity of the flies to avoid the center of the platform. Together with our companion paper, we provide new tools to promote Open Science as well as the collection and analysis of digital behavioral data.	[Colomb, Julien; Reiter, Lutz; Blaszkiewicz, Jedrzej; Brembs, Bjoern] Free Univ Berlin, FB Biol, Inst Biol Neurobiol, Berlin, Germany; [Wessnitzer, Jan] Univ Edinburgh, Inst Percept Act & Behav, Sch Informat, Edinburgh, Midlothian, Scotland; [Brembs, Bjoern] Univ Leipzig, Dept Genet, Leipzig, Germany	Free University of Berlin; University of Edinburgh; Leipzig University	Colomb, J (corresponding author), Free Univ Berlin, FB Biol, Inst Biol Neurobiol, Berlin, Germany.	J.Cjulien.colomb@fu-berlin.de	Brembs, Björn/A-9970-2008	Brembs, Björn/0000-0001-7824-7650; Colomb, Julien/0000-0002-3127-5520	Swiss National Fund [PA00P3_124141]; Engineering and Physical Sciences Research Council [EP/F030673/1]; EPSRC [EP/F030673/1] Funding Source: UKRI	Swiss National Fund(Swiss National Science Foundation (SNSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JC was supported by the Swiss National Fund for research grant PA00P3_124141, and JW by the Engineering and Physical Sciences Research Council EP/F030673/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler U, 1983, NEURAL BASIS ELEMENT; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; BUELTHOFF H, 1982, Journal of Comparative Physiology A Sensory Neural and Behavioral Physiology, V148, P471; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; Gomez-Marin A, 2011, PLOS ONE; GOTZ KG, 1985, J COMP PHYSIOL A, V156, P329, DOI 10.1007/BF00610726; Gotz KG, 1980, DEV NEUROBIOLOGY DRO, P391; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; Mronz M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3559, DOI 10.1109/IROS.2008.4650587; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; OSORIO D, 1990, J EXP BIOL, V149, P281; Phillips AM, 2005, GENE, V351, P131, DOI 10.1016/j.gene.2005.03.013; Pielage J, 2002, DEV BIOL, V249, P283, DOI 10.1006/dbio.2002.0770; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Romero-Pozuelo J, 2007, EUR J NEUROSCI, V26, P2428, DOI 10.1111/j.1460-9568.2007.05877.x; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Sorribes A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002075; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRAUSS R, 1992, J NEUROGENET, V8, P125, DOI 10.3109/01677069209083444; Strauss R, 2001, J COMP PHYSIOL A, V187, P617, DOI 10.1007/s003590100234; Strauss R, 1998, J COMP PHYSIOL A, V182, P411, DOI 10.1007/s003590050190; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Venables WN., 2002, MODERN APPL STAT S 4; WEHNER R, 1972, J INSECT PHYSIOL, V18, P1531, DOI 10.1016/0022-1910(72)90232-6; Xiong Y, 2010, FLY, V4, P194, DOI 10.4161/fly.12668	34	55	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42247	10.1371/journal.pone.0042247	http://dx.doi.org/10.1371/journal.pone.0042247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912692	Green Published, Green Submitted, gold			2022-12-27	WOS:000307378500013
J	Terradas, R; Grau, S; Blanch, J; Riu, M; Saballs, P; Castells, X; Horcajada, JP; Knobel, H				Terradas, Roser; Grau, Santiago; Blanch, Jordi; Riu, Marta; Saballs, Pere; Castells, Xavier; Pablo Horcajada, Juan; Knobel, Hernando			Eosinophil Count and Neutrophil-Lymphocyte Count Ratio as Prognostic Markers in Patients with Bacteremia: A Retrospective Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; ACUTE-INFLAMMATION; RELIABLE MARKER; CARE-UNIT; MORTALITY; SEPSIS; PROCALCITONIN; ASSOCIATION	Introduction: There is scarce evidence on the use of eosinophil count as a marker of outcome in patients with infection. The aim of this study was to evaluate whether changes in eosinophil count, as well as the neutrophil-lymphocyte count ratio (NLCR), could be used as clinical markers of outcome in patients with bacteremia. Methods: We performed a retrospective study of patients with a first episode of community-acquired or healthcare-related bacteremia during hospital admission between 2004 and 2009. A total of 2,311 patients were included. Cox regression was used to analyze the behaviour of eosinophil count and the NLCR in survivors and non-survivors. Results: In the adjusted analysis, the main independent risk factor for mortality was persistence of an eosinophil count below 0.0454.10(3)/ul (HR = 4.20; 95% CI 2.66-6.62). An NLCR value >7 was also an independent risk factor but was of lesser importance. The mean eosinophil count in survivors showed a tendency to increase rapidly and to achieve normal values between the second and third day. In these patients, the NLCR was <7 between the second and third day. Conclusion: Both sustained eosinopenia and persistence of an NLCR >7 were independent markers of mortality in patients with bacteremia.	[Terradas, Roser; Blanch, Jordi; Riu, Marta; Castells, Xavier] Hosp del Mar, Dept Epidemiol & Hlth Serv Evaluat, Barcelona, Spain; [Terradas, Roser] Univ Autonoma Barcelona, PhD Programme Med, E-08193 Barcelona, Spain; [Grau, Santiago] Hosp del Mar, Dept Pharm, Barcelona, Spain; [Blanch, Jordi; Riu, Marta; Castells, Xavier] CIBERESP, Barcelona, Spain; [Saballs, Pere; Pablo Horcajada, Juan; Knobel, Hernando] Hosp del Mar, Dept Internal Med & Infect Dis, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Terradas, R (corresponding author), Hosp del Mar, Dept Epidemiol & Hlth Serv Evaluat, Barcelona, Spain.	MTerradas@hospitaldelmar.cat	Knobel, Hernando/AAD-3582-2020; Knobel, Hernando/B-5223-2016; Blanch, Jordi/U-1407-2019; Blanch, Jordi/K-1685-2017; Horcajada, Juan P./AAU-7717-2021; Castells, Xavier/S-7798-2016	Knobel, Hernando/0000-0003-3186-6416; Knobel, Hernando/0000-0003-3186-6416; Blanch, Jordi/0000-0001-8211-3292; Blanch, Jordi/0000-0001-8211-3292; Horcajada, Juan P./0000-0001-9873-5459; Castells, Xavier/0000-0002-2528-0382; Terradas-Robledo, Roser/0000-0002-7689-1183; Riu, Marta/0000-0003-4702-3472				Abidi K, 2008, CRIT CARE, V12, DOI 10.1186/cc6883; Abidi K, 2011, INTENS CARE MED, V37, P1136, DOI 10.1007/s00134-011-2170-z; Arendrup MC, 2011, J CLIN MICROBIOL, V49, P3300, DOI 10.1128/JCM.00179-11; BASS DA, 1975, J CLIN INVEST, V55, P1229, DOI 10.1172/JCI108041; BASS DA, 1980, J CLIN INVEST, V65, P1265, DOI 10.1172/JCI109789; Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Cook Emily J, 2007, Int J Surg, V5, P27, DOI 10.1016/j.ijsu.2006.05.013; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Gil H, 2003, REV MED INTERNE, V24, P431, DOI 10.1016/S0248-8663(03)00138-3; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Ho KM, 2009, ANAESTH INTENS CARE, V37, P450, DOI 10.1177/0310057X0903700319; Holland M, 2010, RESPIROLOGY, V15, P165, DOI 10.1111/j.1440-1843.2009.01651.x; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jensen US, 2011, CLIN MICROBIOL INFEC, V17, P1148, DOI 10.1111/j.1469-0691.2011.03587.x; Kim DY, 2011, CANCER RES TREAT, V43, P176, DOI 10.4143/crt.2011.43.3.176; Kleinbaum DG, 2005, SERIES STAT BIOL HLT; LIPKIN WI, 1979, ARCH INTERN MED, V139, P490, DOI 10.1001/archinte.139.4.490; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; Consuegra ILDM, 2010, MED INTENSIVA, V34, P246, DOI 10.1016/j.medin.2009.11.007; Moosig F, 1998, ARTHRITIS RHEUM, V41, P566, DOI 10.1002/1529-0131(199803)41:3<566::AID-ART30>3.0.CO;2-U; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Setterberg MJ, 2004, CLIN INFECT DIS, V38, P460, DOI 10.1086/380846; Shaaban H, 2010, J CRIT CARE, V25, P570, DOI 10.1016/j.jcrc.2010.03.002; Simon CE, 1922, MANUAL CLIN DIAGNOSI; Smithson A, 2009, CRIT CARE, V13, DOI 10.1186/cc7877; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Weller PF, 1996, CLIN IMMUNOLOGY PRIN, P1022; Wibrow BA, 2011, ANAESTH INTENS CARE, V39, P224, DOI 10.1177/0310057X1103900211; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335; Zhang Z, 2011, ANAESTH INTENS CARE, V39, P854, DOI 10.1177/0310057X1103900509	34	108	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42860	10.1371/journal.pone.0042860	http://dx.doi.org/10.1371/journal.pone.0042860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912753	Green Published, Green Submitted, gold			2022-12-27	WOS:000307378500031
J	Vilar, S; Harpaz, R; Santana, L; Uriarte, E; Friedman, C				Vilar, Santiago; Harpaz, Rave; Santana, Lourdes; Uriarte, Eugenio; Friedman, Carol			Enhancing Adverse Drug Event Detection in Electronic Health Records Using Molecular Structure Similarity: Application to Pancreatitis	PLOS ONE			English	Article							PHARMACOVIGILANCE; ENTECAVIR; DATABASES; DIAGNOSIS; THERAPY; SAFETY	Background: Adverse drug events (ADEs) detection and assessment is at the center of pharmacovigilance. Data mining of systems, such as FDA's Adverse Event Reporting System (AERS) and more recently, Electronic Health Records (EHRs), can aid in the automatic detection and analysis of ADEs. Although different data mining approaches have been shown to be valuable, it is still crucial to improve the quality of the generated signals. Objective: To leverage structural similarity by developing molecular fingerprint-based models (MFBMs) to strengthen ADE signals generated from EHR data. Methods: A reference standard of drugs known to be causally associated with the adverse event pancreatitis was used to create a MFBM. Electronic Health Records (EHRs) from the New York Presbyterian Hospital were mined to generate structured data. Disproportionality Analysis (DPA) was applied to the data, and 278 possible signals related to the ADE pancreatitis were detected. Candidate drugs associated with these signals were then assessed using the MFBM to find the most promising candidates based on structural similarity. Results: The use of MFBM as a means to strengthen or prioritize signals generated from the EHR significantly improved the detection accuracy of ADEs related to pancreatitis. MFBM also highlights the etiology of the ADE by identifying structurally similar drugs, which could follow a similar mechanism of action. Conclusion: The method proposed in this paper provides evidence of being a promising adjunct to existing automated ADE detection and analysis approaches.	[Vilar, Santiago; Harpaz, Rave; Friedman, Carol] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10027 USA; [Vilar, Santiago; Santana, Lourdes; Uriarte, Eugenio] Univ Santiago de Compostela, Dept Organ Chem, Fac Pharm, Santiago De Compostela, Spain	Columbia University; Universidade de Santiago de Compostela	Vilar, S (corresponding author), Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10027 USA.	sav7003@dbmi.columbia.edu	Santana, Lourdes/L-2981-2014; Uriarte, Eugenio EU/F-5691-2012	Santana, Lourdes/0000-0001-6056-8253; Uriarte, Eugenio EU/0000-0001-6218-2899; Vilar Varela, Santiago/0000-0003-2663-4370	National Library of Medicine, "Plan Galego de Investigacion, Innovacion e Crecemento (I2C)'' [R01 LM010016, R01 LM010016-0S1, R01 LM010016-0S2, R01 LM008635, T15 LM007079]; European Social Fund (ESF); Angeles Alvarino program from Xunta de Galicia (Spain); NATIONAL LIBRARY OF MEDICINE [T15LM007079, R01LM010016, R01LM008635] Funding Source: NIH RePORTER	National Library of Medicine, "Plan Galego de Investigacion, Innovacion e Crecemento (I2C)''; European Social Fund (ESF)(European Social Fund (ESF)); Angeles Alvarino program from Xunta de Galicia (Spain); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants R01 LM010016 (Dr. Friedman), R01 LM010016-0S1 (Dr. Friedman), R01 LM010016-0S2 (Dr. Friedman), R01 LM008635(Dr. Friedman), and T15 LM007079 (Dr. Harpaz) from the National Library of Medicine, "Plan Galego de Investigacion, Innovacion e Crecemento 2011-2015 (I2C)'', European Social Fund (ESF) and Angeles Alvarino program from Xunta de Galicia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOE VERS 2011 10; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Catalan I, 1999, An Med Interna, V16, P47; De Waele JJ, 2003, CLIN INFECT DIS, V37, P208, DOI 10.1086/375603; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Durval A, 2011, MINERVA ANESTESIOL, V77, P1018; Eltookhy A, 2006, CAN PHARM J, V139, P58, DOI 10.1177/171516350613900611; Epelde F, 1996, ANN PHARMACOTHER, V30, P1339, DOI 10.1177/106002809603001121; FDA U.S. Food and Drug Administration, US FOOD DRUG ADM ADV; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Harpaz R, 2011, CLIN PHARMACOL THER, V89, P243, DOI 10.1038/clpt.2010.285; Harpaz Rave, 2010, AMIA Annu Symp Proc, V2010, P281; Hauben M, 2003, DRUG SAFETY, V26, P159, DOI 10.2165/00002018-200326030-00003; Hauben Manfred, 2005, Expert Opin Drug Saf, V4, P929, DOI 10.1517/14740338.4.5.929; Holmes AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021132; Howaizi M, 2000, GASTROEN CLIN BIOL, V24, P589; Khanna V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S10; Kim H, 2008, GUT LIVER, V2, P74, DOI 10.5009/gnl.2008.2.2.74; Kim S, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-26; Koller EA, 2003, PHARMACOTHERAPY, V23, P1123, DOI 10.1592/phco.23.10.1123.32759; Lee HM, 2011, PANCREAS, V40, P780, DOI 10.1097/MPA.0b013e31821fa52f; LOTT JA, 1991, CLIN CHEM, V37, P361; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Mehrotra T N, 1981, J Assoc Physicians India, V29, P489; MUNGALL IPF, 1975, POSTGRAD MED J, V51, P855, DOI 10.1136/pgmj.51.602.855; Munoz A, 2000, AM FAM PHYSICIAN, V62, P164; Nisius B, 2009, CHEMMEDCHEM, V4, P1859, DOI 10.1002/cmdc.200900243; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Red Book Online, 2011, MICR HEALTHC SER; Reese JA, 2010, BLOOD, V116, P2127, DOI 10.1182/blood-2010-03-276691; Sato K, 2007, CLIN THER, V29, P1468, DOI 10.1016/j.clinthera.2007.07.012; Steffen A, 2009, J CHEM INF MODEL, V49, P338, DOI 10.1021/ci800326z; Stephenson WP, 2007, PHARMACOEPIDEM DR S, V16, P359, DOI 10.1002/pds.1323; Stuecklin-Utsch A, 2002, MYCOSES, V45, P170, DOI 10.1046/j.1439-0507.2002.00744.x; Vilar S, 2011, J AM MED INFORM ASSN, V18, pI73, DOI 10.1136/amiajnl-2011-000417; Wang XY, 2009, J AM MED INFORM ASSN, V16, P328, DOI 10.1197/jamia.M3028; Williams C, 2006, MOL DIVERS, V10, P311, DOI 10.1007/s11030-006-9039-z; Yao GB, 2007, HEPATOL INT, V1, P365, DOI 10.1007/s12072-007-9009-2	38	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41471	10.1371/journal.pone.0041471	http://dx.doi.org/10.1371/journal.pone.0041471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911794	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300045
J	Moilanen, AM; Rysa, J; Serpi, R; Mustonen, E; Szabo, Z; Aro, J; Napankangas, J; Tenhunen, O; Sutinen, M; Salo, T; Ruskoaho, H				Moilanen, Anne-Mari; Rysa, Jaana; Serpi, Raisa; Mustonen, Erja; Szabo, Zoltan; Aro, Jani; Napankangas, Juha; Tenhunen, Olli; Sutinen, Meeri; Salo, Tuula; Ruskoaho, Heikki			(Pro)renin Receptor Triggers Distinct Angiotensin II-Independent Extracellular Matrix Remodeling and Deterioration of Cardiac Function	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; IN-VIVO; TRANSGENIC RATS; HEART-FAILURE; GENE-TRANSFER; RENIN/PRORENIN RECEPTOR; MYOCARDIAL-INFARCTION; NATRIURETIC-PEPTIDE; PRORENIN RECEPTOR; PROTEIN-KINASE	Background: Activation of the renin-angiotensin-system (RAS) plays a key pathophysiological role in heart failure in patients with hypertension and myocardial infarction. However, the function of (pro)renin receptor ((P)RR) is not yet solved. We determined here the direct functional and structural effects of (P)RR in the heart. Methodology/Principal Findings: (P)RR was overexpressed by using adenovirus-mediated gene delivery in normal adult rat hearts up to 2 weeks. (P)RR gene delivery into the anterior wall of the left ventricle decreased ejection fraction (P<0.01), fractional shortening (P<0.01), and intraventricular septum diastolic and systolic thickness, associated with approximately 2-fold increase in left ventricular (P)RR protein levels at 2 weeks. To test whether the worsening of cardiac function and structure by (P)RR gene overexpression was mediated by angiotensin II (Ang II), we infused an AT(1) receptor blocker losartan via osmotic minipumps. Remarkably, cardiac function deteriorated in losartan-treated (P)RR overexpressing animals as well. Intramyocardial (P)RR gene delivery also resulted in Ang II-independent activation of extracellular-signal-regulated kinase1/2 phosphorylation and myocardial fibrosis, and the expression of transforming growth factor-beta 1 and connective tissue growth factor genes. In contrast, activation of heat shock protein 27 phosphorylation and apoptotic cell death by (P)RR gene delivery was Ang II-dependent. Finally, (P)RR overexpression significantly increased direct protein-protein interaction between (P)RR and promyelocytic zinc-finger protein. Conclusions/Significance: These results indicate for the first time that (P)RR triggers distinct Ang II-independent myocardial fibrosis and deterioration of cardiac function in normal adult heart and identify (P)RR as a novel therapeutic target to optimize RAS blockade in failing hearts.	[Moilanen, Anne-Mari; Rysa, Jaana; Serpi, Raisa; Mustonen, Erja; Szabo, Zoltan; Aro, Jani; Tenhunen, Olli; Ruskoaho, Heikki] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Napankangas, Juha] Univ Oulu, Dept Pathol, Inst Diagnost, Oulu, Finland; [Sutinen, Meeri; Salo, Tuula] Univ Oulu, Oulu Univ Hosp, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Salo, Tuula] Univ Helsinki, Inst Dent, FIN-00014 Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; University of Helsinki	Moilanen, AM (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland.	heikki.ruskoaho@oulu.fi	, tuula/ABG-2051-2021	Napankangas, Juha/0000-0003-3088-5180; Serpi, Raisa/0000-0002-8207-4673; Szabo, Zoltan/0000-0003-0778-1113; Salo, Tuula/0000-0001-6039-0088; Rysa, Jaana/0000-0003-2205-6323	Academy of Finland (Center of Excellence); Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research	Academy of Finland (Center of Excellence)(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research	This work was supported by the Academy of Finland (Center of Excellence; http://www.aka.fi/en-GB/A/), Sigrid Juselius Foundation(http://www.sigridjuselius.fi/foundation), and Finnish Foundation for Cardiovascular Research (http://www.sydantutkimussaatio.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Burckle CA, 2006, HYPERTENSION, V47, P552, DOI 10.1161/01.HYP.0000199912.47657.04; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Connelly KA, 2011, J HYPERTENS, V29, P1175, DOI 10.1097/HJH.0b013e3283462674; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Feldt S, 2008, J AM SOC NEPHROL, V19, P743, DOI 10.1681/ASN.2007091030; FRENCH BA, 1994, CIRCULATION, V90, P2414, DOI 10.1161/01.CIR.90.5.2414; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; GUZMAN RJ, 1993, CIRC RES, V73, P1202, DOI 10.1161/01.RES.73.6.1202; Hautala N, 2001, CIRCULATION, V103, P730; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hirose T, 2009, PEPTIDES, V30, P2316, DOI 10.1016/j.peptides.2009.09.015; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kaneshiro Y, 2006, KIDNEY INT, V70, P641, DOI 10.1038/sj.ki.5001627; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Lako-Futo Z, 2003, CIRCULATION, V108, P2414, DOI 10.1161/01.CIR.0000093193.63314.D9; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; Magga J, 1997, CIRC RES, V81, P694; Mahmud H, 2012, J CELL MOL MED, V16, P722, DOI 10.1111/j.1582-4934.2011.01377.x; Moilanen AM, 2011, CIRC-HEART FAIL, V4, P483, DOI 10.1161/CIRCHEARTFAILURE.110.958033; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2011, CLIN SCI, V120, P169, DOI 10.1042/CS20100432; Nyberg P, 2003, J BIOL CHEM, V278, P22404, DOI 10.1074/jbc.M210325200; RUSKOAHO H, 1992, PHARMACOL REV, V44, P479; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Rysa J, 2010, CIRC-HEART FAIL, V3, P440, DOI 10.1161/CIRCHEARTFAILURE.109.889642; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Serpi R, 2009, CTS-CLIN TRANSL SCI, V2, P422, DOI 10.1111/j.1752-8062.2009.00163.x; Soini Y, 1996, BRIT J CANCER, V73, P1025, DOI 10.1038/bjc.1996.199; Szatkowski ML, 2001, J CLIN INVEST, V107, P191, DOI 10.1172/JCI9862; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; van Esch JHM, 2011, HYPERTENSION, V57, P852, DOI 10.1161/HYPERTENSIONAHA.110.169060; Walsh K, 2007, J CLIN INVEST, V117, P3176, DOI 10.1172/JCI34126; Weig HJ, 2000, CIRCULATION, V101, P1578, DOI 10.1161/01.CIR.101.13.1578; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Zhao TQ, 2010, MICROVASC RES, V80, P188, DOI 10.1016/j.mvr.2010.03.014	45	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41404	10.1371/journal.pone.0041404	http://dx.doi.org/10.1371/journal.pone.0041404			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911790	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700085
J	Dinh, HQ; Dubin, M; Sedlazeck, FJ; Lettner, N; Scheid, OM; von Haeseler, A				Dinh, Huy Q.; Dubin, Manu; Sedlazeck, Fritz J.; Lettner, Nicole; Scheid, Ortrun Mittelsten; von Haeseler, Arndt			Advanced Methylome Analysis after Bisulfite Deep Sequencing: An Example in Arabidopsis	PLOS ONE			English	Article							DNA METHYLATION	Deep sequencing after bisulfite conversion (BS-Seq) is the method of choice to generate whole genome maps of cytosine methylation at single base-pair resolution. Its application to genomic DNA of Arabidopsis flower bud tissue resulted in the first complete methylome, determining a methylation rate of 6.7% in this tissue. BS-Seq reads were mapped onto an in silico converted reference genome, applying the so-called 3-letter genome method. Here, we present BiSS (Bisufite Sequencing Scorer), a new method applying Smith-Waterman alignment to map bisulfite-converted reads to a reference genome. In addition, we introduce a comprehensive adaptive error estimate that accounts for sequencing errors, erroneous bisulfite conversion and also wrongly mapped reads. The re-analysis of the Arabidopsis methylome data with BiSS mapped substantially more reads to the genome. As a result, it determines the methylation status of an extra 10% of cytosines and estimates the methylation rate to be 7.7%. We validated the results by individual traditional bisulfite sequencing for selected genomic regions. In addition to predicting the methylation status of each cytosine, BiSS also provides an estimate of the methylation degree at each genomic site. Thus, BiSS explores BS-Seq data more extensively and provides more information for downstream analysis.	[Dinh, Huy Q.; Sedlazeck, Fritz J.; von Haeseler, Arndt] Univ Vienna, Max F Perutz Labs, Ctr Integrat Bioinformat Vienna, Vienna, Austria; [Dinh, Huy Q.; Sedlazeck, Fritz J.; von Haeseler, Arndt] Med Univ Vienna, Vienna, Austria; [Dinh, Huy Q.; Dubin, Manu; Lettner, Nicole; Scheid, Ortrun Mittelsten] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1010 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Dinh, HQ (corresponding author), Univ Vienna, Max F Perutz Labs, Ctr Integrat Bioinformat Vienna, Vienna, Austria.	ortrun.mittelsten_scheid@gmi.oeaw.ac.at; arndt.von.haeseler@univie.ac.at	Dinh, Huy/M-8646-2016; Sedlazeck, Fritz J/E-4548-2018; von Haeseler, Arndt/HCI-9958-2022	Dinh, Huy/0000-0002-3307-1126; Sedlazeck, Fritz J/0000-0001-6040-2691; von Haeseler, Arndt/0000-0002-3366-4458; Dubin, Manu/0000-0003-2374-2456; Mittelsten Scheid, Ortrun/0000-0002-7757-4809	Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); Austrian Science Fund [FWF M1369]	Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by a grant from the Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF) to AvH and the Austrian Science Fund (FWF M1369) to MD and OMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chatterjee A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks150; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Coarfa C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-572; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Foerster AM, 2010, METHODS MOL BIOL, V631, P1, DOI 10.1007/978-1-60761-646-7_1; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Harris EY, 2010, BIOINFORMATICS, V26, P572, DOI 10.1093/bioinformatics/btp706; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Kakutani T, 1999, GENETICS, V151, P831; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pedersen B, 2011, BIOINFORMATICS, V27, P2435, DOI 10.1093/bioinformatics/btr394; Rozhon W, 2008, ANAL BIOCHEM, V375, P354, DOI 10.1016/j.ab.2008.01.001; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	21	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41528	10.1371/journal.pone.0041528	http://dx.doi.org/10.1371/journal.pone.0041528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911809	Green Submitted, Green Published, gold			2022-12-27	WOS:000306644600084
J	Han, X; Fang, XF; Lou, XY; Hua, DS; Ding, WC; Foltz, G; Hood, L; Yuan, Y; Lin, BY				Han, Xu; Fang, Xuefeng; Lou, Xiaoyan; Hua, Dasong; Ding, Wenchao; Foltz, Gregory; Hood, Leroy; Yuan, Ying; Lin, Biaoyang			Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC Patients	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; BETA-CATENIN; STEM-CELLS; COLORECTAL-CANCER; BREAST-CANCER; E-CADHERIN; MATRIX METALLOPROTEINASES; TUMOR-METASTASIS; DOWN-REGULATION; CHIP-SEQ	SOX2 is an important stem cell marker and plays important roles in development and carcinogenesis. However, the role of SOX2 in Epithelial-Mesenchymal Transition has not been investigated. We demonstrated, for the first time, that SOX2 is involved in the Epithelial-Mesenchymal Transition (EMT) process as knock downof SOX2 in colorectal cancer (CRC) SW620 cells induced a Mesenchymal-Epithelial Transition (MET) process with recognized changes in the expression of key genes involved in the EMT process including E-cadherin and vimentin. In addition, we provided a link between SOX2 activity and the WNT pathway by showing that knock down of SOX2 reduced the WNT pathway activity in colorectal cancer (CRC) cells. We further demonstrated that SOX2 is involved in cell migration and invasion in vitro and in metastasis in vivo for CRC cells, and that the process might be mediated through the MMP2 activity. Finally, an IHC analysis of 44 cases of colorectal cancer patients suggested that SOX2 is a prognosis marker for metastasis of colorectal cancers.	[Han, Xu; Lou, Xiaoyan; Hua, Dasong; Ding, Wenchao; Lin, Biaoyang] Zhejiang Univ, Zhejiang California Int Nanosyst Inst, Syst Biol Div, Hangzhou 310003, Zhejiang, Peoples R China; [Foltz, Gregory; Lin, Biaoyang] Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA; [Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Fang, Xuefeng; Yuan, Ying] Zhejiang Univ, Hosp 2, Coll Med, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA	Zhejiang University; Swedish Medical Center; Institute for Systems Biology (ISB); Zhejiang University; University of Washington; University of Washington Seattle	Yuan, Y (corresponding author), Zhejiang Univ, Hosp 2, Coll Med, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	yuanying1999@zju.edu.cn; biaoylin@gmail.com	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407	Ministry of Science and Technology of China [2006AA02A303, 2006AA02Z4A2, 2006DFA32950, 2007DFC30360]; National Natural Science Foundation of China [81101580]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by grants to BL from the Ministry of Science and Technology of China [grant 2006AA02A303, 2006AA02Z4A2, 2006DFA32950 and 2007DFC30360], and grant to XF from the National Natural Science Foundation of China (No. 81101580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Bates RC, 2005, CANCER BIOL THER, V4, P365; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Fang XF, 2010, OMICS, V14, P369, DOI 10.1089/omi.2010.0053; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Hajra KM, 2002, CANCER RES, V62, P1613; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li XL, 2004, INT J ONCOL, V24, P257; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mariadason JM, 2001, CANCER RES, V61, P3465; Micalizzi DS, 2009, FUTURE ONCOL, V5, P1129, DOI 10.2217/FON.09.94; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Picanco-Castro V, 2011, STEM CELLS DEV, V20, P169, DOI 10.1089/scd.2009.0424; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Subbarayan V, 2000, J CLIN INVEST, V105, P387, DOI 10.1172/JCI8150; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang C, 2003, DEVELOPMENT, V130, P5609, DOI 10.1242/dev.00798; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	49	111	116	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41335	10.1371/journal.pone.0041335	http://dx.doi.org/10.1371/journal.pone.0041335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912670	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700004
J	Herwig, JN; Depczynski, M; Roberts, JD; Semmens, JM; Gagliano, M; Heyward, AJ				Herwig, Jade N.; Depczynski, Martial; Roberts, John D.; Semmens, Jayson M.; Gagliano, Monica; Heyward, Andrew J.			Using Age-Based Life History Data to Investigate the Life Cycle and Vulnerability of Octopus cyanea	PLOS ONE			English	Article							GROWTH; MOLLUSCA; VULGARIS; SOUTH; GRAY; CEPHALOPODA; TEMPERATURE; STYLETS; BORDERS; WATERS	Octopus cyanea is taken as an unregulated, recreationally fished species from the intertidal reefs of Ningaloo, Western Australia. Yet despite its exploitation and importance in many artisanal fisheries throughout the world, little is known about its life history, ecology and vulnerability. We used stylet increment analysis to age a wild O. cyanea population for the first time and gonad histology to examine their reproductive characteristics. O. cyanea conforms to many cephalopod life history generalisations having rapid, non-asymptotic growth, a short life-span and high levels of mortality. Males were found to mature at much younger ages and sizes than females with reproductive activity concentrated in the spring and summer months. The female dominated sex-ratios in association with female brooding behaviours also suggest that larger conspicuous females may be more prone to capture and suggests that this intertidal octopus population has the potential to be negatively impacted in an unregulated fishery. Size at age and maturity comparisons between our temperate bordering population and lower latitude Tanzanian and Hawaiian populations indicated stark differences in growth rates that correlate with water temperatures. The variability in life history traits between global populations suggests that management of O. cyanea populations should be tailored to each unique set of life history characteristics and that stylet increment analysis may provide the integrity needed to accurately assess this.	[Herwig, Jade N.; Depczynski, Martial; Heyward, Andrew J.] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Perth, WA 6009, Australia; [Roberts, John D.; Gagliano, Monica] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Perth, WA 6009, Australia; [Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Res, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia; [Gagliano, Monica] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia	Australian Institute of Marine Science; University of Western Australia; University of Western Australia; University of Tasmania; University of Western Australia	Herwig, JN (corresponding author), Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Perth, WA 6009, Australia.	m.depczynski@aims.gov.au	Gagliano, Monica/A-3129-2012; depczynski, martial/B-7689-2008	Gagliano, Monica/0000-0002-2414-6990; depczynski, martial/0000-0001-8723-0076; Semmens, Jayson/0000-0003-1742-6692	West Australian Marine Science Institute (WAMSI) via the Australian Institute of Marine Science (WA); University of Western Australia	West Australian Marine Science Institute (WAMSI) via the Australian Institute of Marine Science (WA); University of Western Australia	Funding for this research was provided by the West Australian Marine Science Institute (WAMSI) via the Australian Institute of Marine Science (WA) and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2009, MAR ECOL PROG SER, V374, P167, DOI 10.3354/meps07736; Araujo R, 2011, J PHYCOL, V47, P451, DOI 10.1111/j.1529-8817.2011.00986.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Avila-Poveda OH, 2009, BIOL BULL-US, V216, P94, DOI 10.1086/BBLv216n1p94; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Boyle PR, 1991, UFAW HDB CARE MANAGE; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Diamantidis AD, 2008, J APPL ENTOMOL, V132, P695, DOI 10.1111/j.1439-0418.2008.01325.x; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Doubleday ZA, 2011, ICES J MAR SCI, V68, P2059, DOI 10.1093/icesjms/fsr135; Fischer P, 1999, J FISH BIOL, V54, P1231, DOI 10.1006/jfbi.1999.0956; Forsythe John W., 1993, P133; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Gray J. E., 1849, CATALOGUE MOLLUSCA C, p[i, 1]; Guard M, 2002, AMBIO, V31, P528, DOI 10.1639/0044-7447(2002)031[0528:TAFFOC]2.0.CO;2; Guard M, 2003, THESIS U ABERDEEN SC; Hanlon RT, 2008, MAR FRESHW BEHAV PHY, V41, P19, DOI 10.1080/10236240701661123; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; HARTWICK EB, 1984, MAR BEHAV PHYSIOL, V11, P95, DOI 10.1080/10236248409387038; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Hernaman V, 2005, MAR ECOL PROG SER, V290, P207, DOI 10.3354/meps290207; Hewit DA, 2007, T AM FISH SOC, V136, P1030, DOI 10.1577/T06-078.1; HOENIG JM, 1983, FISH B-NOAA, V81, P898; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Humber F., 2006, SEASONAL CLOSURES NO; IRIBARNE OO, 1991, J ZOOL, V223, P549, DOI 10.1111/j.1469-7998.1991.tb04387.x; Jones T, 2009, NINGALOO COAST REGIO; King M, 1995, FISHERIES BIOL ASSES; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; MAGINNIS.LA, 1969, J EXP BIOL, V51, P607; Mather JA, 2004, J ZOOL, V263, P89, DOI 10.1017/S0952836904004911; NORMAN MD, 1991, B MAR SCI, V49, P20; Norman MD, 2000, CEPHALOPODS WORLD GU; PAPINI MR, 1991, J COMP PSYCHOL, V105, P107, DOI 10.1037/0735-7036.105.2.107; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Reis CS, 2002, B MAR SCI, V71, P1099; Rodriguez-Rua A, 2005, MAR BIOL, V147, P927, DOI 10.1007/s00227-005-1621-x; Sauer WHH, 2011, AFR J MAR SCI, V33, P181, DOI 10.2989/1814232X.2011.572386; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; SMALE MJ, 1981, MAR BIOL, V65, P1, DOI 10.1007/BF00397061; Stearns S.C., 1992, pi; Thomson D.P., 2009, STOCK ASSESSMENT TAR; Van Heukelem WF, 1966, THESIS U HAWAII US; VANHEUKE.WF, 1973, J ZOOL, V169, P299; VANHEUKELEM WF, 1976, THESIS U HAWAII HAWA; WELLS MJ, 1970, J ZOOL, V161, P65, DOI 10.1111/j.1469-7998.1970.tb02170.x; Wood JB, 2000, MAR BIOL, V136, P91, DOI 10.1007/s002270050012; YARNALL JL, 1969, ANIM BEHAV, V17, P747, DOI 10.1016/S0003-3472(69)80022-9	49	18	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43679	10.1371/journal.pone.0043679	http://dx.doi.org/10.1371/journal.pone.0043679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912898	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700126
J	Keane, E; Layte, R; Harrington, J; Kearney, PM; Perry, IJ				Keane, Eimear; Layte, Richard; Harrington, Janas; Kearney, Patricia M.; Perry, Ivan J.			Measured Parental Weight Status and Familial Socio-Economic Status Correlates with Childhood Overweight and Obesity at Age 9	PLOS ONE			English	Article							BODY-MASS INDEX; PREDICTING OBESITY; ENERGY-INTAKE; CHILDREN; FOOD; ASSOCIATIONS; ENVIRONMENT; PREVALENCE; ADULTHOOD; BMI	Background: Parental obesity is a predominant risk factor for childhood obesity. Family factors including socio-economic status (SES) play a role in determining parent weight. It is essential to unpick how shared family factors impact on child weight. This study aims to investigate the association between measured parent weight status, familial socio-economic factors and the risk of childhood obesity at age 9. Methodology/Principal Findings: Cross sectional analysis of the first wave (2008) of the Growing Up in Ireland (GUI) study. GUI is a nationally representative study of 9-year-old children (N = 8,568). Schools were selected from the national total (response rate 82%) and age eligible children (response rate 57%) were invited to participate. Children and their parents had height and weight measurements taken using standard methods. Data were reweighted to account for the sampling design. Childhood overweight and obesity prevalence were calculated using International Obesity Taskforce definitions. Multinomial logistic regression examined the association between parent weight status, indicators of SES and child weight. Overall, 25% of children were either overweight (19.3%) or obese (6.6%). Parental obesity was a significant predictor of child obesity. Of children with normal weight parents, 14.4% were overweight or obese whereas 46.2% of children with obese parents were overweight or obese. Maternal education and household class were more consistently associated with a child being in a higher body mass index category than household income. Adjusted regression indicated that female gender, one parent family type, lower maternal education, lower household class and a heavier parent weight status significantly increased the odds of childhood obesity. Conclusions/Significance: Parental weight appears to be the most influential factor driving the childhood obesity epidemic in Ireland and is an independent predictor of child obesity across SES groups. Due to the high prevalence of obesity in parents and children, population based interventions are required.	[Keane, Eimear; Harrington, Janas; Kearney, Patricia M.; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Layte, Richard] Sir John Rogersons Quay, Econ & Social Res Inst, Dublin, Ireland	University College Cork; Economic & Social Research Institute (ESRI)	Keane, E (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland.	eimear.keane@ucc.ie	Harrington, Janas/AAV-8123-2021	Harrington, Janas/0000-0002-6238-7031; Kearney, Patricia/0000-0001-9599-3540; Layte, Richard/0000-0002-3170-767X; Perry, Ivan/0000-0002-4965-9792	Government of Ireland through the Department of Children and Youth Affairs; Department of Social Protection; Central Statistics Office; National Children's Research Centre, Crumlin, Dublin	Government of Ireland through the Department of Children and Youth Affairs; Department of Social Protection; Central Statistics Office; National Children's Research Centre, Crumlin, Dublin	The Growing Up in Ireland study is funded by the Government of Ireland through the Department of Children and Youth Affairs in association with the Department of Social Protection and the Central Statistics Office. This present research is funded by the National Children's Research Centre, Crumlin, Dublin (http://www.nationalchildrensresearchcentre.ie/project/view/35). The funders of this present research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; Burke V, 2001, INT J OBESITY, V25, P147, DOI 10.1038/sj.ijo.0801538; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; GARN SM, 1989, AM J CLIN NUTR, V50, P1308, DOI 10.1093/ajcn/50.6.1308; Gibson LY, 2007, MED J AUSTRALIA, V186, P591, DOI 10.5694/j.1326-5377.2007.tb01061.x; Gluckman PD, 2010, J DEV ORIG HLTH DIS, V1, P6, DOI 10.1017/S2040174409990171; Grunert KG, 2012, TRENDS FOOD IN PRESS; Hannon PA, 2003, APPETITE, V40, P77, DOI 10.1016/S0195-6663(02)00140-X; Harrington J, 2011, PUBLIC HEALTH NUTR, V1, P1; Hesketh K, 2007, INT J PEDIATR OBES, V2, P86, DOI 10.1080/17477160601148554; Hesketh K, 2009, INT J PEDIATR OBES, V4, P45, DOI 10.1080/17477160802191122; Irish Social Sciences Data Archive, 2010, SAMPL DES RESP WAV 1; Juliusson PB, 2010, ACTA PAEDIATR, V99, P900, DOI 10.1111/j.1651-2227.2010.01730.x; Knai C, 2012, INT J ENV RES PUB HE, V9, P1472, DOI 10.3390/ijerph9041472; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Layte R, 2011, J EPIDEMIOL COMMUN H, V65, P881, DOI 10.1136/jech.2010.116749; Lazzeri G, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-76; Lioret S, 2009, OBESITY, V17, P1092, DOI 10.1038/oby.2008.619; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Moschonis G, 2010, PUBLIC HEALTH NUTR, V13, P1693, DOI 10.1017/S1368980010002247; Murray A, 2011, GROWING IRELAND DESI; Ochoa MC, 2009, REV ESP OBES, V7, P395; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Rosenkranz RR, 2008, NUTR REV, V66, P123, DOI 10.1111/j.1753-4887.2008.00017.x; Semmler C, 2009, OBESITY, V17, P814, DOI 10.1038/oby.2008.621; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Wake M, 2007, INT J OBESITY, V31, P1044, DOI 10.1038/sj.ijo.0803503; Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Whelton H, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-187; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; WHO, 2000, OB PREV MAN GLOB EP; Williams J, 2009, 1 OFF MIN CHILDR YOU	42	58	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43503	10.1371/journal.pone.0043503	http://dx.doi.org/10.1371/journal.pone.0043503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912886	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700114
J	Shetty, AK; Hattiangady, B; Rao, MS; Shuai, B				Shetty, Ashok K.; Hattiangady, Bharathi; Rao, Muddanna S.; Shuai, Bing			Neurogenesis Response of Middle-Aged Hippocampus to Acute Seizure Activity	PLOS ONE			English	Article							ECTOPIC GRANULE CELLS; RAT DENTATE GYRUS; ADULT NEUROGENESIS; STATUS EPILEPTICUS; OLD-AGE; STIMULATES NEUROGENESIS; STEM/PROGENITOR CELLS; SUBVENTRICULAR ZONE; NEURONS; GROWTH	Acute Seizure (AS) activity in young adult age conspicuously modifies hippocampal neurogenesis. This is epitomized by both increased addition of new neurons to the granule cell layer (GCL) by neural stem/progenitor cells (NSCs) in the dentate subgranular zone (SGZ), and greatly enhanced numbers of newly born neurons located abnormally in the dentate hilus (DH). Interestingly, AS activity in old age does not induce such changes in hippocampal neurogenesis. However, the effect of AS activity on neurogenesis in the middle-aged hippocampus is yet to be elucidated. We examined hippocampal neurogenesis in middle-aged F344 rats after a continuous AS activity for >4 hrs, induced through graded intraperitoneal injections of the kainic acid. We labeled newly born cells via daily intraperitoneal injections of the 5'-bromodeoxyuridine (BrdU) for 12 days, commencing from the day of induction of AS activity. AS activity enhanced the addition of newly born BrdU+ cells by 5.6 fold and newly born neurons (expressing both BrdU and doublecortin [DCX]) by 2.2 fold to the SGZ-GCL. Measurement of the total number of DCX+ newly born neurons also revealed a similar trend. Furthermore, AS activity increased DCX+ newly born neurons located ectopically in the DH (2.7 fold increase and 17% of total newly born neurons). This rate of ectopic migration is however considerably less than what was observed earlier for the young adult hippocampus after similar AS activity. Thus, the plasticity of hippocampal neurogenesis to AS activity in middle age is closer to its response observed in the young adult age. However, the extent of abnormal migration of newly born neurons into the DH is less than that of the young adult hippocampus after similar AS activity. These results also point out a highly divergent response of neurogenesis to AS activity between middle age and old age.	[Shetty, Ashok K.; Hattiangady, Bharathi; Rao, Muddanna S.; Shuai, Bing] Vet Affairs Med Ctr Durham, Res Serv, Durham, NC USA; [Shetty, Ashok K.; Hattiangady, Bharathi; Rao, Muddanna S.; Shuai, Bing] Vet Affairs Med Ctr Durham, Res Serv, Temple, TX USA; [Shetty, Ashok K.; Hattiangady, Bharathi; Shuai, Bing] Texas A&M Hlth Sci Ctr Coll Med Scott & White, Inst Regenerat Med, Temple, TX USA; [Shetty, Ashok K.; Hattiangady, Bharathi; Shuai, Bing] Texas A&M Hlth Sci Ctr Coll Med, Dept Mol & Cellular Med, College Stn, TX USA; [Shetty, Ashok K.; Hattiangady, Bharathi; Rao, Muddanna S.; Shuai, Bing] Duke Univ, Med Ctr, Dept Surg Neurosurg, Durham, NC USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Duke University	Shetty, AK (corresponding author), Vet Affairs Med Ctr Durham, Res Serv, Durham, NC USA.	Shetty@medicine.tamhsc.edu	Shetty, Ashok/AAT-7273-2020; Shetty, Ashok K/A-2428-2008	Shetty, Ashok/0000-0001-5049-6671; Shetty, Ashok K/0000-0001-5049-6671; Hattiangady, Bharathi/0000-0002-0432-1894	Department of Veterans Affairs (VA); National Institute of Neurological Disorders and Stroke [R01 NS054780]; National Institute for Aging [R01 AG20924]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020924] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA)(US Department of Veterans Affairs); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the Department of Veterans Affairs (VA Merit Review Award to AKS), the National Institute of Neurological Disorders and Stroke (R01 NS054780 to AKS), and the National Institute for Aging (R01 AG20924 to AKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Ben-Ari Yehezkel, 2006, Critical Reviews in Neurobiology, V18, P135; Cameron MC, 2011, J COMP NEUROL, V519, P2175, DOI 10.1002/cne.22623; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dashtipour K, 2001, BRAIN RES, V890, P261, DOI 10.1016/S0006-8993(00)03119-X; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1016/S0893-133X(99)00045-7; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hattiangady B, 2008, AGING CELL, V7, P207, DOI 10.1111/j.1474-9726.2007.00363.x; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hattiangady B, 2011, AGING DIS, V2, P1; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jessberger S, 2007, J NEUROSCI, V27, P5967, DOI 10.1523/JNEUROSCI.0110-07.2007; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jung KH, 2004, EUR J NEUROSCI, V19, P3219, DOI 10.1111/j.0953-816X.2004.03412.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuruba R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024493; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Liu JL, 1998, J NEUROSCI, V18, P7768; Mattiesen WRC, 2009, ACTA NEUROPATHOL, V117, P525, DOI 10.1007/s00401-009-0509-0; McCloskey DP, 2006, EUR J NEUROSCI, V24, P2203, DOI 10.1111/j.1460-9568.2006.05101.x; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Murphy BL, 2011, J NEUROSCI, V31, P105, DOI 10.1523/JNEUROSCI.2728-10.2011; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 1997, J NEUROSCI, V17, P3727; Pekcec A, 2007, NEUROBIOL DIS, V27, P54, DOI 10.1016/j.nbd.2007.04.002; Pierce JP, 2005, EXP NEUROL, V196, P316, DOI 10.1016/j.expneurol.2005.08.007; Rai KS, 2007, EUR J NEUROSCI, V26, P1765, DOI 10.1111/j.1460-9568.2007.05820.x; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rao MS, 2008, HIPPOCAMPUS, V18, P931, DOI 10.1002/hipo.20449; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Shapiro LA, 2006, EPILEPSY RES, V69, P53, DOI 10.1016/j.eplepsyres.2005.12.003; Shapiro LA, 2011, AGING DIS, V2, P286; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Shetty AK, 2005, J NEUROSCI, V25, P8391, DOI 10.1523/JNEUROSCI.1538-05.2005; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shetty AK, 2000, J NEUROSCI, V20, P8788; Shetty AK, 2007, STEM CELLS, V25, P2396, DOI 10.1634/stemcells.2007-0313; Shetty AK, 2011, HIPPOCAMPUS, V21, P631, DOI 10.1002/hipo.20776; Sivilia S, 2008, NEUROPATH APPL NEURO, V34, P52, DOI 10.1111/j.1365-2990.2007.00863.x; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sun YJ, 2006, DEV BIOL, V289, P329, DOI 10.1016/j.ydbio.2005.10.016; Tan YF, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00163; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Walter J, 2010, NEUROSCIENCE, V169, P1279, DOI 10.1016/j.neuroscience.2010.05.035; Woods AG, 1998, NEUROSCIENCE, V83, P663	76	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43286	10.1371/journal.pone.0043286	http://dx.doi.org/10.1371/journal.pone.0043286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912847	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700076
J	Pino, C; Boutron, I; Ravaud, P				Pino, Cecile; Boutron, Isabelle; Ravaud, Philippe			Outcomes in Registered, Ongoing Randomized Controlled Trials of Patient Education	PLOS ONE			English	Article							CLINICAL-TRIALS; INTERVENTIONS	Background: With the increasing prevalence of chronic noncommunicable diseases, patient education is becoming important to strengthen disease prevention and control. We aimed to systematically determine the extent to which registered, ongoing randomized controlled trials (RCTs) evaluated an educational intervention focus on patient-important outcomes (i.e., outcomes measuring patient health status and quality of life). Methods: On May 6, 2009, we searched for all ongoing RCTs registered in the World Health Organization International Clinical Trials Registry platform. We used a standardized data extraction form to collect data and determined whether the outcomes assessed were 1) patient-important outcomes such as clinical events, functional status, pain, or quality of life or 2) surrogate outcomes, such as biological outcome, treatment adherence, or patient knowledge. Principal Findings: We selected 268 of the 642 potentially eligible studies and assessed a random sample of 150. Patient-important outcomes represented 54% (178 of 333) of all primary outcomes and 46% (286 of 623) of all secondary outcomes. Overall, 69% of trials (104 of 150) used at least one patient-important outcome as a primary outcome and 66% (99 of 150) as a secondary outcome. Finally, for 31% of trials (46 of 150), primary outcomes were only surrogate outcomes. The results varied by medical area. In neuropsychiatric disorders, patient important outcomes represented 84% (51 of 61) of primary outcomes, as compared with 54% (32 of 59) in malignant neoplasm and 18% (4 of 22) in diabetes mellitus trials. In addition, only 35% assessed the long-term impact of interventions (i.e., >6 months). Conclusions: There is a need to improve the relevance of outcomes and to assess the long term impact of educational interventions in RCTs.	[Pino, Cecile; Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, AP HP, INSERM, Ctr Epidemiol Clin,U738, F-75181 Paris, France; [Pino, Cecile; Boutron, Isabelle; Ravaud, Philippe] Univ Paris 05, Fac Med, Paris, France; [Ravaud, Philippe] APHP, INSERM, HAS, Ctr Cochrane Francais,EHESP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm)	Pino, C (corresponding author), Hop Hotel Dieu, AP HP, INSERM, Ctr Epidemiol Clin,U738, F-75181 Paris, France.	cecile.pino@htd.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241	Assistance Publique - Hopitaux de Paris	Assistance Publique - Hopitaux de Paris	This study was funded by a grant "Recherche infirmiere - offre de formation doctorat" from the "Assistance Publique - Hopitaux de Paris". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson JK, BRO JO CLIN PHARM; Boers M, 2005, CLIN EXP RHEUMATOL, V23, pS10; Coster S, 2009, INT J NURS STUD, V46, P508, DOI 10.1016/j.ijnurstu.2008.09.009; Coulter A, 2006, PATIENT FOCUSED INTE; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Garrido MV, 2009, INT J TECHNOL ASSESS, V25, P315, DOI 10.1017/S0266462309990213; Glasgow RE, 2006, HEALTH EDUC RES, V21, P688, DOI 10.1093/her/cyl081; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; McIver B., 1996, Diabetologia, V39, pA193; Montori VM, 2006, DIABETES CARE, V29, P1833, DOI 10.2337/dc06-0077; Morriss RK, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004854.pub2; Pino C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-63; Sinha IP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006276; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; WHO, 2002, RED RISKS PROM HLTH; WITTES J, 1989, STAT MED, V8, P415, DOI 10.1002/sim.4780080405	18	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42934	10.1371/journal.pone.0042934	http://dx.doi.org/10.1371/journal.pone.0042934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AN	22916183	Green Submitted, Green Published, gold			2022-12-27	WOS:000307824300022
J	Polyzos, KA; Mavros, MN; Vardakas, KZ; Makris, MC; Rafailidis, PI; Falagas, ME				Polyzos, Konstantinos A.; Mavros, Michael N.; Vardakas, Konstantinos Z.; Makris, Marinos C.; Rafailidis, Petros I.; Falagas, Matthew E.			Efficacy and Safety of Telavancin in Clinical Trials: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GRAM-POSITIVE BACTERIA; SOFT-TISSUE INFECTIONS; IN-VITRO ACTIVITY; COMPLICATED SKIN; STANDARD THERAPY; VANCOMYCIN; LIPOGLYCOPEPTIDE; PNEUMONIA	Introduction: The epidemiology and antibiotic resistance of Staphylococcus aureus have evolved, underscoring the need for novel antibiotics, particularly against methicillin-resistant S. aureus (MRSA). Telavancin is a bactericidal lipoglycopeptide with potent activity against Gram-positive pathogens. Objective: To systematically review and synthesize the available evidence from randomized controlled trials (RCTs) evaluating telavancin in the treatment of patients with infections due to Gram-positive organisms with the methodology of meta-analysis. Results: Six RCTs comparing telavancin with vancomycin were included; 4 (2229 patients) referred to complicated skin and soft tissue infections (cSSTIs) and 2 (1503 patients) to hospital-acquired pneumonia (HAP). Regarding cSSTIs, telavancin and vancomycin showed comparable efficacy in clinically evaluable patients (odds ratio [OR] = 1.10 [95% confidence intervals: 0.82-1.48]). Among patients with MRSA infection, telavancin showed higher eradication rates (OR = 1.71 [1.08-2.70]) and a trend towards better clinical response (OR = 1.55 [0.93-2.58]). Regarding HAP, telavancin was non-inferior to vancomycin in terms of clinical response in two Phase III RCTs; mortality rates for the pooled trials were comparable with telavancin (20%) and vancomycin (18.6%). Pooled data from cSSTIs and HAP studies on telavancin 10 mg/kg indicated higher rates of serum creatinine increases (OR = 2.22 [1.38-3.57]), serious adverse events (OR = 1.53 [1.05-2.24]), and adverse event-related withdrawals (OR = 1.49 [1.14-1.95]) among telavancin recipients. Conclusion: Telavancin might be an alternative to vancomycin in cases of difficult-to-treat MRSA infections. The potent antistaphylococcal activity of telavancin should be weighted against the potential for nephrotoxicity.	[Polyzos, Konstantinos A.; Mavros, Michael N.; Vardakas, Konstantinos Z.; Makris, Marinos C.; Rafailidis, Petros I.; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Rafailidis, Petros I.; Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Henry Dunant Hospital; Tufts University	Polyzos, KA (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Mavros, M/AAS-3154-2020; Rafailidis, PI/AAO-8679-2021; Vardakas, Konstantinos/M-5253-2019; Rafailidis, Petros/AAI-1376-2021	Polyzos, Konstantinos/0000-0003-4720-5604				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; [Anonymous], 2008, TEL TREATM COMPL SKI; [Anonymous], 2011, REV MAN REVMAN; Burriere S, 2004, J CLIN PHARMACOL, V44, P689, DOI 10.1177/0091270004266620; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P565; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P322; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P902; Chang MH, 2010, CLIN THER, V32, P2160, DOI 10.1016/S0149-2918(11)00020-8; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Corey GR, 2007, 17 EUR C CLIN MICR I; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eckman C, 2010, EUR J MED RES, V15, P554; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; European Medicines Agency, 2011, ASS REP VIB INT NONP; Falagas ME, 2008, LANCET INFECT DIS, V8, P53, DOI 10.1016/S1473-3099(07)70312-2; Hague NZ, 2010, CHEST, V138, P1356, DOI 10.1378/chest.09-2453; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128/AAC.49.3.1127-1134.2005; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Leonard SN, 2011, INT J ANTIMICROB AG, V37, P558, DOI 10.1016/j.ijantimicag.2011.02.007; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Logman JFS, 2010, CURR MED RES OPIN, V26, P1565, DOI 10.1185/03007995.2010.481251; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marcos LA, 2012, J ANTIMICROB CHEMOTH, V67, P723, DOI 10.1093/jac/dkr518; Mendes RE, 2011, DIAGN MICR INFEC DIS, V71, P93, DOI 10.1016/j.diagmicrobio.2011.05.012; Pace JL, 2003, ANTIMICROB AGENTS CH, V47, P3602, DOI 10.1128/AAC.47.11.3602-3604.2003; Pfaller MA, 2010, J CHEMOTHERAPY, V22, P304, DOI 10.1179/joc.2010.22.5.304; Pfaller MA, 2010, J ANTIMICROB CHEMOTH, V65, P2396, DOI 10.1093/jac/dkq335; Rubinstein E, 2011, EXPERT OPIN PHARMACO, V12, P2737, DOI 10.1517/14656566.2011.633511; Rubinstein E, 2011, CLIN INFECT DIS, V52, P31, DOI 10.1093/cid/ciq031; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Slover CM, 2011, 51 ICAAC INT C ANT A; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Stryjewski ME, 2008, CLIN INFECT DIS, V46, P1683, DOI 10.1086/587896; Stryjewski ME, 2012, J ANTIMICROB CHEMOTH, V67, P1496, DOI 10.1093/jac/dks081; Stryjewski ME, 2005, CLIN INFECT DIS, V40, P1601, DOI 10.1086/429914; Stryjewski ME, 2006, ANTIMICROB AGENTS CH, V50, P862, DOI 10.1128/AAC.50.3.862-867.2006; Stryjewski ME, 2011, 51 ICAAC INT C ANT A; Styers David, 2006, Ann Clin Microbiol Antimicrob, V5, P2; Tarchini G, 2011, CLIN INFECT DIS, V52, P1390, DOI 10.1093/cid/cir189; U.S. Department of Health and Human Services Food and Drug Administration, 2010, GUID IND AC BACT SKI; U.S. Department of Health and Human Services Food and Drug Administration, 2005, REV GUID COND CLIN S; Vardakas KZ, 2012, MAYO CLIN PROC, V87, P349, DOI 10.1016/j.mayocp.2011.12.011; Wang GQ, 2006, J CLIN MICROBIOL, V44, P3883, DOI 10.1128/JCM.01388-06; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895	45	45	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e41870	10.1371/journal.pone.0041870	http://dx.doi.org/10.1371/journal.pone.0041870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916113	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300007
J	Calvo, R; Zheng, YH; Kumar, S; Olgiati, A; Berkman, L				Calvo, Rocio; Zheng, Yuhui; Kumar, Santosh; Olgiati, Analia; Berkman, Lisa			Well-Being and Social Capital on Planet Earth: Cross-National Evidence from 142 Countries	PLOS ONE			English	Article							HAPPINESS; HEALTH; LIFE; TRUST; HAPPY	High levels of social trust and social support are associated with life satisfaction around the world. However, it is not known whether this association extends to other indicators of social capital and of subjective well-being globally. We examine associations between three measures of social capital and three indicators of subjective well-being in 142 low-, middle- dand high-income countries. Furthermore, we explore whether positive and negative feelings mirror each other or if they are separate constructs that behave differently in relation to social capital. Data comes from the Gallup World Poll, an international cross-sectional comparable survey conducted yearly from 2005 to 2009 for those 15 years of age and over. The poll represents 95% of the world's population. Social capital was measured with self-reports of access to support from relatives and friends, of volunteering to an organization in the past month, and of trusting others. Subjective well-being was measured with self-reports of life satisfaction, positive affect, and negative affect. We first estimate random coefficient (multi-level) models and then use multivariate (individual-level) Ordinary Least Square (OLS) regression to model subjective well-being as a function of social support, volunteering and social trust, controlling for age, gender, education, marital status, household income and religiosity. We found that having somebody to count on in case of need and reporting high levels of social trust are associated with better life evaluations and more positive feelings and an absence of negative feelings in most countries around the world. Associations, however, are stronger for high- and middle-income countries. Volunteering is also associated with better life evaluations and a higher frequency of positive emotions. There is not an association, however, between volunteering and experiencing negative feelings, except for low-income countries. Finally, we present evidence that the two affective components of subjective well-being behave differently in relation to different indicators of social capital and social support across countries.	[Calvo, Rocio] Boston Coll, Dept Global Practice, Grad Sch Social Work, Chestnut Hill, MA 02167 USA; [Calvo, Rocio; Zheng, Yuhui; Olgiati, Analia; Berkman, Lisa] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Kumar, Santosh] Univ Washington, Sch Publ Hlth, Inst Hlth Metr & Evaluat, Dept Global Hlth, Seattle, WA 98195 USA; [Berkman, Lisa] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Berkman, Lisa] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Berkman, Lisa] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Boston College; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Calvo, R (corresponding author), Boston Coll, Dept Global Practice, Grad Sch Social Work, Chestnut Hill, MA 02167 USA.	lberkman@hsph.harvard.edu	Calvo, Rocio/V-5499-2019; Calvo, Rocío/AAF-8428-2020	Calvo, Rocío/0000-0002-6303-9215	Bell postdoctoral fellowship	Bell postdoctoral fellowship	YZ, RC, SK and AO were supported by the Bell postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornskov C, 2003, KYKLOS, V56, P3, DOI 10.1111/1467-6435.00207; Blanchflower DG, 2008, J HEALTH ECON, V27, P218, DOI 10.1016/j.jhealeco.2007.06.002; Blanchflower DG, 2004, J PUBLIC ECON, V88, P1359, DOI 10.1016/S0047-2727(02)00168-8; Bourdieu P, 1993, SOCIOLOGY QUESTION, P143; Brockmann H, 2009, J HAPPINESS STUD, V10, P387, DOI 10.1007/s10902-008-9095-4; Cramm JM, 2012, SOC INDIC RES, V105, P581, DOI 10.1007/s11205-011-9790-0; Cramm JM, 2010, J HEALTH PSYCHOL, V15, P1012, DOI 10.1177/1359105310367833; Delhey J, 2011, AM SOCIOL REV, V76, P786, DOI 10.1177/0003122411420817; Delhey J, 2010, SOC INDIC RES, V97, P65, DOI 10.1007/s11205-009-9558-y; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Diener E, 2009, WELL BEING PUBLIC PO, P67; Diener E., 2009, PSIHOL TEME, V18, P213; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Diener E, 2010, J PERS SOC PSYCHOL, V99, P52, DOI 10.1037/a0018066; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Easterlin RA., 1974, NATIONS HOUSEHOLDS E, V89, P89; Fischer J. A., 2009, 16619 MPRA; Gallup, 2012, WORLDW RES METH COD; Gallup, 2008, STAT WORLD 2008 ANN; Han S, 2013, SOC INDIC RES, V111, P185, DOI 10.1007/s11205-011-9990-7; Handy F, 2010, NONPROF VOLUNT SEC Q, V39, P498, DOI 10.1177/0899764009344353; Helliwell J., 2013, WORLD HAPPINESS REPO; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Helliwell JF, 2008, 14507 NBER; Helliwell JF, 2010, CAN J ECON, V43, P729, DOI 10.1111/j.1540-5982.2010.01592.x; Helliwell JF, 2009, STAT SCI INTERDISC R, V5, P3; Helliwell JohnF., 2010, INT DIFFERENCES WELL, P291, DOI [DOI 10.1093/ACPR0F:0S0/9780199732739.003.0010, DOI 10.1093/ACPROF:OSO/9780199732739.003.0010]; Hooghe M, 2011, SOC INDIC RES, V100, P17, DOI 10.1007/s11205-010-9600-0; Inglehart R, 2000, WASH QUART, V23, P215, DOI 10.1162/016366000560665; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kumar S, 2012, SOC SCI MED, V74, P696, DOI 10.1016/j.socscimed.2011.11.017; Layard R, 2010, SCIENCE, V327, P534, DOI 10.1126/science.1186315; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Maddala G.S., 1986, LTD DEPENDENT QUALIT; Maslow A.H., 1954, MOTIVATION PERSONALI; McMahan EA, 2011, SOC INDIC RES, V103, P93, DOI 10.1007/s11205-010-9698-0; Oishi Shigehiro., 2010, INT DIFFERENCES WELL, P34, DOI DOI 10.1093/ACPROF:OSO/9780199732739.003.0003; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Park N, 2004, ANN AM ACAD POLIT SS, V591, P25, DOI 10.1177/0002716203260078; Piliavin JA, 2008, COOPERATION POLITICA; Putnam RD, 1993, MAKING DEMOCRACY WOR, p[xv, 258]; Putnam Robert, 1996, AMERICAN PROSPECT, P66; Ram R, 2010, J HAPPINESS STUD, V11, P409, DOI 10.1007/s10902-009-9148-3; Reeskens T, 2008, SOC INDIC RES, V85, P515, DOI 10.1007/s11205-007-9100-z; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Schimmack U., 2008, SCI SUBJECTIVE WELL, P97, DOI DOI 10.5860/CHOICE.45-5867; Sheldon K. M., 2011, OXFORD HDB HAPPINESS; Steptoe A, 2005, NEUROBIOL AGING, V26, pS108, DOI 10.1016/j.neurobiolaging.2005.08.016; Stevenson B., 2008, BROOKINGS PAPERS EC, P88; Tay L, 2011, J PERS SOC PSYCHOL, V101, P354, DOI 10.1037/a0023779; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Tov W, 2009, SOC INDIC RES SER, V37, P155, DOI 10.1007/978-90-481-2350-6_7; Tshililo AR, 2009, NURSING HLTH SCI; Wang S., 2010, 15911 NBER; Wills-Herrera E., 2011, Journal of Socio-Economics, V40, P88, DOI 10.1016/j.socec.2010.08.002; Winkelmann R, 2009, J HAPPINESS STUD, V10, P421, DOI 10.1007/s10902-008-9097-2; Yamaoka K, 2008, SOC SCI MED, V66, P885, DOI 10.1016/j.socscimed.2007.10.024; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027; Ziemek S., 2006, J SOCIO-ECON, V35, P532, DOI [10.1016/j.socec.2005.11.064, DOI 10.1016/J.SOCEC.2005.11.064, DOI 10.1016/J.S0CEC.2005.11.064]	62	49	50	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42793	10.1371/journal.pone.0042793	http://dx.doi.org/10.1371/journal.pone.0042793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22916160	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600028
J	Twiner, MJ; Flewelling, LJ; Fire, SE; Bowen-Stevens, SR; Gaydos, JK; Johnson, CK; Landsberg, JH; Leighfield, TA; Mase-Guthrie, B; Schwacke, L; Van Dolah, FM; Wang, ZH; Rowles, TK				Twiner, Michael J.; Flewelling, Leanne J.; Fire, Spencer E.; Bowen-Stevens, Sabrina R.; Gaydos, Joseph K.; Johnson, Christine K.; Landsberg, Jan H.; Leighfield, Tod A.; Mase-Guthrie, Blair; Schwacke, Lori; Van Dolah, Frances M.; Wang, Zhihong; Rowles, Teresa K.			Comparative Analysis of Three Brevetoxin-Associated Bottlenose Dolphin (Tursiops truncatus) Mortality Events in the Florida Panhandle Region (USA)	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; FORMERLY GYMNODINIUM-BREVE; SENSITIVE SODIUM-CHANNELS; GULF-OF-MEXICO; DOMOIC ACID; RED-TIDE; KARENIA-BREVIS; SARASOTA BAY; SEA LIONS; EXPOSURE	In the Florida Panhandle region, bottlenose dolphins (Tursiops truncatus) have been highly susceptible to large-scale unusual mortality events (UMEs) that may have been the result of exposure to blooms of the dinoflagellate Karenia brevis and its neurotoxin, brevetoxin (PbTx). Between 1999 and 2006, three bottlenose dolphin UMEs occurred in the Florida Panhandle region. The primary objective of this study was to determine if these mortality events were due to brevetoxicosis. Analysis of over 850 samples from 105 bottlenose dolphins and associated prey items were analyzed for algal toxins and have provided details on tissue distribution, pathways of trophic transfer, and spatial-temporal trends for each mortality event. In 1999/2000, 152 dolphins died following extensive K. brevis blooms and brevetoxin was detected in 52% of animals tested at concentrations up to 500 ng/g. In 2004, 105 bottlenose dolphins died in the absence of an identifiable K. brevis bloom; however, 100% of the tested animals were positive for brevetoxin at concentrations up to 29,126 ng/mL. Dolphin stomach contents frequently consisted of brevetoxin-contaminated menhaden. In addition, another potentially toxigenic algal species, Pseudo-nitzschia, was present and low levels of the neurotoxin domoic acid (DA) were detected in nearly all tested animals (89%). In 2005/2006, 90 bottlenose dolphins died that were initially coincident with high densities of K. brevis. Most (93%) of the tested animals were positive for brevetoxin at concentrations up to 2,724 ng/mL. No DA was detected in these animals despite the presence of an intense DA-producing Pseudo-nitzschia bloom. In contrast to the absence or very low levels of brevetoxins measured in live dolphins, and those stranding in the absence of a K. brevis bloom, these data, taken together with the absence of any other obvious pathology, provide strong evidence that brevetoxin was the causative agent involved in these bottlenose dolphin mortality events.	[Twiner, Michael J.; Fire, Spencer E.; Leighfield, Tod A.; Van Dolah, Frances M.; Wang, Zhihong] NOAA, Marine Biotoxins Program, Natl Ocean Serv, Charleston, SC USA; [Twiner, Michael J.] Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA; [Flewelling, Leanne J.; Landsberg, Jan H.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL USA; [Bowen-Stevens, Sabrina R.] Natl Ocean & Atmospher Adm Fisheries, SE Fisheries Sci Ctr, Panama City Lab, Panama City, FL USA; [Bowen-Stevens, Sabrina R.; Mase-Guthrie, Blair] NOAA, Natl Marine Fisheries Serv, SE Fisheries Sci Ctr, Miami, FL USA; [Gaydos, Joseph K.; Johnson, Christine K.] Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; [Schwacke, Lori] NOAA, Natl Ocean Serv, Cooperat Ctr Marine Anim Hlth, Hollings Marine Lab, Charleston, SC USA; [Rowles, Teresa K.] Natl Ocean & Atmospher Adm Fisheries, Cooperat Ctr Marine Anim Hlth, Silver Spring, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of Michigan System; University of Michigan; Florida Fish & Wildlife Conservation Commission; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA	Twiner, MJ (corresponding author), NOAA, Marine Biotoxins Program, Natl Ocean Serv, Charleston, SC USA.	mtwiner@umd.umich.edu	Fire, Spencer/P-6040-2014	Fire, Spencer/0000-0002-1657-790X; Gaydos, Joseph/0000-0001-6599-8797	National Oceanographic and Atmospheric Administration Marine Biotoxins Program; state of Florida; National Oceanographic and Atmospheric Administration Center for Sponsored Coastal Ocean Research Harmful Algal Bloom Event Response Fund	National Oceanographic and Atmospheric Administration Marine Biotoxins Program; state of Florida; National Oceanographic and Atmospheric Administration Center for Sponsored Coastal Ocean Research Harmful Algal Bloom Event Response Fund	This work was supported by the National Oceanographic and Atmospheric Administration Marine Biotoxins Program, the state of Florida, and the National Oceanographic and Atmospheric Administration Center for Sponsored Coastal Ocean Research Harmful Algal Bloom Event Response Fund (2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D, 2000, WHOI20002011; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; [Anonymous], 2000, P AM ASS ZOO VET INT; APHA, 1970, SUBC LAB METH EX SHE; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; BADEN DG, 1984, SEAFOOD TOXINS, P359; Baden DG, 1996, MR148 NAT I ENV HLTH; Bargu S, 2002, MAR ECOL PROG SER, V237, P209, DOI 10.3354/meps237209; Barros N.B., 1990, P309; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Benson JM, 2006, TOXICON, V48, P1018, DOI 10.1016/j.toxicon.2006.08.008; Blanco J, 2002, AQUAT TOXICOL, V60, P111, DOI 10.1016/S0166-445X(01)00274-0; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; Bowen-Stevens SR, 2011, DIET BOTTLENOSE DOLP; CATTERALL WA, 1981, MOL PHARMACOL, V19, P345; CATTET M, 1993, TOXICON, V31, P1483, DOI 10.1016/0041-0101(93)90214-4; DICKEY RW, 1992, TOXICON, V30, P355, DOI 10.1016/0041-0101(92)90877-8; Fairey ER, 2001, ENVIRON HEALTH PERSP, V109, P717, DOI 10.2307/3454789; Ferdin ME, 2002, TOXICON, V40, P1259, DOI 10.1016/S0041-0101(02)00129-0; Fernandez S, 1998, FISH B-NOAA, V96, P357; Fire SE, 2011, COOCCURRENCE MULTIPL; Fire SE, 2008, MAR ECOL PROG SER, V368, P283, DOI 10.3354/meps07643; Fire SE, 2008, MAR MAMMAL SCI, V24, P831, DOI 10.1111/j.1748-7692.2008.00221.x; Fire SE, 2007, MAR BIOL, V152, P827, DOI 10.1007/s00227-007-0733-x; Flaherty KE, 2011, ESTUAR COAST, V34, P417, DOI 10.1007/s12237-010-9350-x; Flewelling L.J., 2008, VECTORS BREVETOXINS; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FRYXELL G.A., 1990, BEIH NOVA HEDWIGIA, V100, P171; FWC, 2008, FLOR MAN TRICH MAN L, P52; Gannon DP, 2009, MAR ECOL PROG SER, V378, P171, DOI 10.3354/meps07853; Gaydos JK, 2006, NMFSOPR32 NOAA, P46; GUNTER G, 1948, ECOL MONOGR, V18, P309, DOI 10.2307/1948575; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hampson David R., 1998, Natural Toxins, V6, P153, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<153::AID-NT16>3.0.CO;2-1; HUANG JMC, 1984, J PHARMACOL EXP THER, V229, P615; IRVINE AB, 1981, FISH B-NOAA, V79, P671; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Landsberg JH, 2009, HARMFUL ALGAE, V8, P598, DOI 10.1016/j.hal.2008.11.010; Landsberg JH, 2000, S HARMF MAR ALG US M, P44; Lefebvre KA, 1999, NAT TOXINS, V7, P85, DOI 10.1002/(SICI)1522-7189(199905/06)7:3<85::AID-NT39>3.0.CO;2-Q; Liefer JD, 2009, HARMFUL ALGAE, V8, P706, DOI 10.1016/j.hal.2009.02.003; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; Maucher JM, 2007, ENVIRON SCI TECHNOL, V41, P563, DOI 10.1021/es0612605; Maucher JM, 2005, ENVIRON HEALTH PERSP, V113, P461, DOI 10.1289/ehp.7649; McFARREN E. F., 1965, TOXICON, V3, P111, DOI 10.1016/0041-0101(65)90005-X; Naar J, 2002, ENVIRON HEALTH PERSP, V110, P179, DOI 10.1289/ehp.02110179; Naar JP, 2007, TOXICON, V50, P707, DOI 10.1016/j.toxicon.2007.06.005; NOAA, 2007, INT REP BOTTL DOLPH; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pan YL, 2001, MAR ECOL PROG SER, V220, P83, DOI 10.3354/meps220083; Parsons ML, 1999, J PHYCOL, V35, P1368, DOI 10.1046/j.1529-8817.1999.3561368.x; Pierce R, 2008, CONT SHELF RES, V28, P45, DOI 10.1016/j.csr.2007.04.012; PIERCE RH, 1992, B ENVIRON CONTAM TOX, V49, P479; Plakas SM, 2004, TOXICON, V44, P677, DOI 10.1016/j.toxicon.2004.07.027; POLI MA, 1995, J AOAC INT, V78, P538; Poli MA, 2000, TOXICON, V38, P981, DOI 10.1016/S0041-0101(99)00191-9; POLI MA, 1986, MOL PHARMACOL, V30, P129; QUILLIAM MA, 1989, ANAL CHEM, V61, pA1053, DOI 10.1021/ac00193a745; Radwan FFY, 2006, TOXICOL SCI, V89, P57, DOI 10.1093/toxsci/kfj013; Radwan FFY, 2005, TOXICOL SCI, V85, P839, DOI 10.1093/toxsci/kfi138; Ramsdell John S., 2008, P519; READ AJ, 1993, J ZOOL, V231, P107, DOI 10.1111/j.1469-7998.1993.tb05356.x; Rossini GP, 2010, EXPERIENTIA SUPPL, V100, P65; Roth PB, 2007, TOXICON, V50, P1175, DOI 10.1016/j.toxicon.2007.08.003; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwacke LH, 2012, P ROY SOC B-BIOL SCI, V279, P48, DOI 10.1098/rspb.2011.0665; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Shea D, 1997, ELECTROPHORESIS, V18, P277, DOI 10.1002/elps.1150180216; STEIDINGER K, 1972, MARINE PHARMACOGNOSY, P179; Steidinger K.A., 1999, HARMFUL MICROALGAE A; Steidinger KA, 2008, NOVA HEDWIGIA, P269; Steidinger Karen A., 1998, NATO ASI Series Series G Ecological Sciences, V41, P133; Twiner MJ, 2007, ANAL BIOCHEM, V369, P128, DOI 10.1016/j.ab.2007.06.031; Twiner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017394; Van Dolah FM, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P85; Van Dolah FM, 2003, N P TOX ENV, P247; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wang ZH, 2004, TOXICON, V43, P455, DOI 10.1016/j.toxicon.2004.02.017; Wang ZH, 2007, J CHROMATOGR A, V1163, P169, DOI 10.1016/j.chroma.2007.06.054; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; WOODCOCK AH, 1948, J MAR RES, V7, P56; Woofter R, 2003, ENVIRON HEALTH PERSP, V111, P1595, DOI 10.1289/ehp.6166; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54	84	43	47	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42974	10.1371/journal.pone.0042974	http://dx.doi.org/10.1371/journal.pone.0042974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916189	Green Submitted, gold, Green Published			2022-12-27	WOS:000307823600036
J	Veeregowda, DH; Busscher, HJ; Vissink, A; Jager, DJ; Sharma, PK; van der Mei, HC				Veeregowda, Deepak H.; Busscher, Henk J.; Vissink, Arjan; Jager, Derk-Jan; Sharma, Prashant K.; van der Mei, Henny C.			Role of Structure and Glycosylation of Adsorbed Protein Films in Biolubrication	PLOS ONE			English	Article							QUALITY-OF-LIFE; HUMAN-SALIVA; TEAR FILM; LUBRICATION; SURFACES; FORCES; MUCIN; ADSORPTION; PRESSURES; FRICTION	Water forms the basis of lubrication in the human body, but is unable to provide sufficient lubrication without additives. The importance of biolubrication becomes evident upon aging and disease, particularly under conditions that affect secretion or composition of body fluids. Insufficient biolubrication, may impede proper speech, mastication and swallowing, underlie excessive friction and wear of articulating cartilage surfaces in hips and knees, cause vaginal dryness, and result in dry, irritated eyes. Currently, our understanding of biolubrication is insufficient to design effective therapeutics to restore biolubrication. Aim of this study was to establish the role of structure and glycosylation of adsorbed protein films in biolubrication, taking the oral cavity as a model and making use of its dynamics with daily perturbations due to different glandular secretions, speech, drinking and eating, and tooth brushing. Using different surface analytical techniques (a quartz crystal microbalance with dissipation monitoring, colloidal probe atomic force microscopy, contact angle measurements and X-ray photo-electron spectroscopy), we demonstrated that adsorbed salivary conditioning films in vitro are more lubricious when their hydrophilicity and degree of glycosylation increase, meanwhile decreasing their structural softness. High-molecular-weight, glycosylated proteins adsorbing in loops and trains, are described as necessary scaffolds impeding removal of water during loading of articulating surfaces. Comparing in vitro and in vivo water contact angles measured intra-orally, these findings were extrapolated to the in vivo situation. Accordingly, lubricating properties of teeth, as perceived in 20 volunteers comprising of equal numbers of male and female subjects, could be related with structural softness and glycosylation of adsorbed protein films on tooth surfaces. Summarizing, biolubrication is due to a combination of structure and glycosylation of adsorbed protein films, providing an important clue to design effective therapeutics to restore biolubrication in patients with insufficient biolubrication.	[Veeregowda, Deepak H.; Busscher, Henk J.; Sharma, Prashant K.; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; [Vissink, Arjan; Jager, Derk-Jan] Univ Med Ctr Groningen, Dept Oral Maxillofacial Surg, NL-9713 AV Groningen, Netherlands; [Veeregowda, Deepak H.; Busscher, Henk J.; Vissink, Arjan; Jager, Derk-Jan; Sharma, Prashant K.; van der Mei, Henny C.] Univ Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Veeregowda, DH (corresponding author), Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.	p.k.sharma@umcg.nl	Jager, Derk Jan/W-1045-2019; Busscher, Henk/AAU-2113-2020; Jager, Derk-Jan/H-5737-2012	Jager, Derk Jan/0000-0002-3006-2128; Busscher, Henk/0000-0002-3644-5533; Sharma, Prashant/0000-0002-8342-8939				ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90, DOI 10.1128/AEM.46.1.90-97.1983; Akpek EK, 2011, OPHTHALMOLOGY, V118, P1242, DOI 10.1016/j.ophtha.2010.12.016; Bongaerts JHH, 2007, TRIBOL LETT, V27, P277, DOI 10.1007/s11249-007-9232-y; Busscher Henk J., 2002, Journal of Clinical Dentistry, V13, P38; Chen M, 2009, SCIENCE, V323, P1698, DOI 10.1126/science.1169399; Coles JM, 2010, CURR OPIN COLLOID IN, V15, P406, DOI 10.1016/j.cocis.2010.07.002; Davidson HJ, 2004, VET OPHTHALMOL, V7, P71, DOI 10.1111/j.1463-5224.2004.00325.x; Dejak B, 2003, J PROSTHET DENT, V90, P591, DOI 10.1016/j.prosdent.2003.08.009; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Hahnel S, 2009, SUPPORT CARE CANCER, V17, P1331, DOI 10.1007/s00520-009-0671-x; Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271; Iwasaki LR, 2003, AM J ORTHOD DENTOFAC, V123, P408, DOI 10.1067/mod.2003.61; Jones CS, 2004, BRIT DENT J, V196, P42, DOI 10.1038/sj.bdj.4810881; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; KLEIN J, 1993, MACROMOLECULES, V26, P5552, DOI 10.1021/ma00073a004; Lee S, 2008, SCIENCE, V319, P575, DOI 10.1126/science.1153273; Mariotti A, 2007, XPHARM COMPREHENSIVE, P1; McGlone R E, 1972, Cleft Palate J, V9, P229; Meijer JM, 2009, RHEUMATOLOGY, V48, P1077, DOI 10.1093/rheumatology/kep141; Morrell KC, 2005, P NATL ACAD SCI USA, V102, P14819, DOI 10.1073/pnas.0507117102; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; PEASE CT, 1993, BRIT J RHEUMATOL, V32, P609; Perdok JF, 1991, BIOFOULING, V3, P209; Pettersson T, 2008, LANGMUIR, V24, P3336, DOI 10.1021/la703229n; Pettersson T, 2008, J COLLOID INTERF SCI, V324, P246, DOI 10.1016/j.jcis.2008.04.055; Pettersson T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2779215; Pramanik R, 2010, EUR J ORAL SCI, V118, P245, DOI 10.1111/j.1600-0722.2010.00728.x; Pratt-Terpstra HI, 1991, BIOFOULING, V3, P199; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Schipper R, 2007, J CHROMATOGR B, V847, P45, DOI 10.1016/j.jchromb.2006.10.005; Schoofs N, 2003, JOGNN, V32, P589, DOI 10.1177/0884217503257142; SHARMA A, 1993, BIOPHYS CHEM, V47, P87, DOI 10.1016/0301-4622(93)80036-I; Stewart CM, 2008, J AM DENT ASSOC, V139, P291, DOI 10.14219/jada.archive.2008.0158; Svendsen IE, 2008, J COLLOID INTERF SCI, V321, P52, DOI 10.1016/j.jcis.2008.01.041; van der Mei HC, 2012, CLIN ORAL INVEST, V16, P109, DOI 10.1007/s00784-011-0514-2; Veerman ECI, 1996, EUR J ORAL SCI, V104, P346, DOI 10.1111/j.1600-0722.1996.tb00090.x; VISSINK A, 1986, J DENT RES, V65, P1121, DOI 10.1177/00220345860650090301; Vroman L, 2008, COLLOID SURFACE B, V62, P1, DOI 10.1016/j.colsurfb.2007.11.017; Walz A, 2006, PROTEOMICS, V6, P1631, DOI 10.1002/pmic.200500125; WATANABE S, 1990, J DENT RES, V69, P1150, DOI 10.1177/00220345900690050601; Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006; Yakubov GE, 2009, LANGMUIR, V25, P2313, DOI 10.1021/la8018666; Zappone B, 2007, BIOPHYS J, V92, P1693, DOI 10.1529/biophysj.106.088799	45	33	33	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42600	10.1371/journal.pone.0042600	http://dx.doi.org/10.1371/journal.pone.0042600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916138	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600018
J	Dunford, L; Carr, MJ; Dean, J; Waters, A; Nguyen, LT; Thu, HTT; Lan, ABT; Do, HD; Thu, TDT; Nguyen, HT; Trinh, TDD; Luu, QP; Connell, J; Coughlan, S; Nguyen, HT; Hall, WW; Lan, ANT				Dunford, Linda; Carr, Michael J.; Dean, Jonathan; Waters, Allison; Linh Thuy Nguyen; Thu Hong Ta Thi; Lan Anh Bui Thi; Huy Duong Do; Thu Thuy Duong Thi; Ha Thu Nguyen; Trinh Thi Diem Do; Quynh Phuong Luu; Connell, Jeff; Coughlan, Suzie; Hien Tran Nguyen; Hall, William W.; Lan Anh Nguyen Thi			Hepatitis C Virus in Vietnam: High Prevalence of Infection in Dialysis and Multi-Transfused Patients Involving Diverse and Novel Virus Variants	PLOS ONE			English	Article							HO-CHI-MINH; COMMERCIAL SEX WORKERS; INJECTION-DRUG USERS; HUMAN-IMMUNODEFICIENCY-VIRUS; B-VIRUS; HEPATOCELLULAR-CARCINOMA; RISK-FACTORS; GENOTYPE 6; MOLECULAR EPIDEMIOLOGY; GLOBAL EPIDEMIOLOGY	Hepatitis C virus (HCV) is a genetically diverse pathogen infecting approximately 2-3% of the world's population. Herein, we describe results of a large, multicentre serological and molecular epidemiological study cataloguing the prevalence and genetic diversity of HCV in five regions of Vietnam; Ha Noi, Hai Phong, Da Nang, Khanh Hoa and Can Tho. Individuals (n = 8654) with varying risk factors for infection were analysed for the presence of HCV Ab/Ag and, in a subset of positive specimens, for HCV RNA levels (n = 475) and genotype (n = 282). In lower risk individuals, including voluntary blood donors, military recruits and pregnant women, the prevalence of infection was 0.5% (n = 26/5250). Prevalence rates were significantly higher (p < 0.001) in intravenous drug users (IDUs; 55.6%, n = 556/1000), dialysis patients (26.6%, n = 153/575) commercial sex workers (CSWs; 8.7%, n = 87/1000), and recipients of multiple blood transfusions (6.0%, n = 32/529). The prevalence of HCV in dialysis patients varied but remained high in all regions (11-43%) and was associated with the receipt of blood transfusions [OR: 2.08 (1.85-2.34), p = 0.001], time from first transfusion [OR: 1.07 (1.01-1.13), p = 0.023], duration of dialysis [OR: 1.31 (1.19-1.43), p < 0.001] and male gender [OR: 1.60 (1.06-2.41), p = 0.026]. Phylogenetic analysis revealed high genetic diversity, particularly amongst dialysis and multi-transfused patients, identifying subtypes 1a (33%), 1b (27%), 2a (0.4%), 3a (0.7%), 3b (1.1%), 6a (18.8%), 6e (6.0%), 6h (4.6%), 6l (6.4%) and 2 clusters of novel genotype 6 variants (2.1%). HCV genotype 1 predominated in Vietnam (60%, n = 169/282) but the proportion of infections attributable to genotype 1 varied between regions and risk groups and, in the Southern part of Vietnam, genotype 6 viruses dominated in dialysis and multi-transfused patients (73.9%). This study confirms a high prevalence of HCV infection in Vietnamese IDUs and, notably, reveals high levels of HCV infection associated with dialysis and blood transfusion.	[Dunford, Linda; Carr, Michael J.; Dean, Jonathan; Waters, Allison; Linh Thuy Nguyen; Thu Hong Ta Thi; Lan Anh Bui Thi; Huy Duong Do; Thu Thuy Duong Thi; Ha Thu Nguyen; Trinh Thi Diem Do; Quynh Phuong Luu; Connell, Jeff; Coughlan, Suzie; Hien Tran Nguyen; Hall, William W.; Lan Anh Nguyen Thi] Ireland Vietnam Blood Borne Virus Initiat IVVI, Dublin, Ireland; [Dunford, Linda; Carr, Michael J.; Dean, Jonathan; Waters, Allison; Linh Thuy Nguyen; Thu Hong Ta Thi; Lan Anh Bui Thi; Huy Duong Do; Thu Thuy Duong Thi; Ha Thu Nguyen; Trinh Thi Diem Do; Quynh Phuong Luu; Connell, Jeff; Coughlan, Suzie; Hien Tran Nguyen; Hall, William W.; Lan Anh Nguyen Thi] Ireland Vietnam Blood Borne Virus Initiat IVVI, Hanoi, Vietnam; [Dunford, Linda; Carr, Michael J.; Dean, Jonathan; Waters, Allison; Connell, Jeff; Coughlan, Suzie; Hall, William W.] Univ Coll Dublin, Natl Virus Reference Lab, Dublin 2, Ireland; [Linh Thuy Nguyen; Thu Hong Ta Thi; Lan Anh Bui Thi; Huy Duong Do; Thu Thuy Duong Thi; Ha Thu Nguyen; Trinh Thi Diem Do; Quynh Phuong Luu; Hien Tran Nguyen; Lan Anh Nguyen Thi] Natl Inst Hyg & Epidemiol, Lab Mol Diagnost, Hanoi, Vietnam	University College Dublin; National Institute of Hygiene & Epidemiology (NIHE)	Dunford, L (corresponding author), Ireland Vietnam Blood Borne Virus Initiat IVVI, Dublin, Ireland.	William.hall@ucd.ie; lananh_2003@yahoo.com	lan, A/HHZ-6588-2022	Waters, Allison/0000-0002-5048-5021; Carr, Michael/0000-0003-0011-6209	Irish Aid, the Government of Ireland; Atlantic Philanthropies	Irish Aid, the Government of Ireland; Atlantic Philanthropies	The Ireland Vietnam Blood-Borne Virus Initiative is supported by Irish Aid, the Government of Ireland's programme of assistance to developing countries, and by the Atlantic Philanthropies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-193; Alter MJ, 2011, SEMIN LIVER DIS, V31, P340, DOI 10.1055/s-0031-1297923; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Australia National Centre in HIV Epidemiology and Clinical Research, 2010, AUSTR NSP SURV NAT D; Burland T G, 2000, Methods Mol Biol, V132, P71; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; Cho LY, 2011, INT J CANCER, V128, P176, DOI 10.1002/ijc.25321; Clatts MC, 2010, J URBAN HEALTH, V87, P278, DOI 10.1007/s11524-009-9417-9; Daniel HDJ, 2008, DIAGN MICR INFEC DIS, V61, P415, DOI 10.1016/j.diagmicrobio.2008.04.001; El-Ottol AEY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-210; Ferrero S, 2003, ACTA OBSTET GYN SCAN, V82, P229, DOI 10.1034/j.1600-0412.2003.00107.x; Fissell RB, 2004, KIDNEY INT, V65, P2335, DOI 10.1111/j.1523-1755.2004.00649.x; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Garcia-Garcia JA, 2006, AIDS RES HUM RETROV, V22, P1236, DOI 10.1089/aid.2006.22.1236; Gasim GI, 2012, J MED VIROL, V84, P52, DOI 10.1002/jmv.22256; Gish RG, 2012, J GASTROEN HEPATOL, V27, P238, DOI 10.1111/j.1440-1746.2011.06974.x; Hall TA, 1999, NUCL ACIDS S SER, V41, P91; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Jadoul M, 2004, NEPHROL DIAL TRANSPL, V19, P904, DOI 10.1093/ndt/gfh012; Johnson DW, 2009, NEPHROL DIAL TRANSPL, V24, P1598, DOI 10.1093/ndt/gfn684; Kakumu S, 1998, J MED VIROL, V54, P243, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;243::AID-JMV2&gt;3.0.CO;2-4; Kallman JB, 2011, J VIRAL HEPATITIS, V18, P70, DOI 10.1111/j.1365-2893.2010.01278.x; Kumar M, 2007, J GASTROEN HEPATOL, V22, P1104, DOI 10.1111/j.1440-1746.2007.04908.x; Kweon SS, 2006, AM J TROP MED HYG, V74, P1117, DOI 10.4269/ajtmh.2006.74.1117; Laurent C, 2001, INT J EPIDEMIOL, V30, P872, DOI 10.1093/ije/30.4.872; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Lu L, 2008, J GEN VIROL, V89, P444, DOI 10.1099/vir.0.83460-0; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin P, 2008, J HEPATOL, V49, P613, DOI 10.1016/j.jhep.2008.06.003; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; NAKATA S, 1994, J GASTROEN HEPATOL, V9, P416, DOI 10.1111/j.1440-1746.1994.tb01265.x; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Ohsawa M, 2010, J EPIDEMIOL, V20, P30, DOI 10.2188/jea.JE20090043; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; PERZ JF, 2004, 42 ANN M INF DIS SOC; Pham DA, 2009, ASIAN PAC J ALLERGY, V27, P153; Pham VH, 2011, JPN J INFECT DIS, V64, P537; POWER JP, 1995, LANCET, V345, P1211, DOI 10.1016/S0140-6736(95)91993-7; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SONG P, 1994, CLIN DIAGN LAB IMMUN, V1, P413, DOI 10.1128/CDLI.1.4.413-418.1994; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tahan V, 2005, AM J GASTROENTEROL, V100, P821, DOI 10.1111/j.1572-0241.2005.40879.x; Taketa K, 2003, HEPATOL RES, V27, P6, DOI 10.1016/S1386-6346(03)00163-3; Tanimoto T, 2010, J MED VIROL, V82, P1355, DOI 10.1002/jmv.21787; Thanachartwet V, 2007, NEPHROLOGY, V12, P399, DOI 10.1111/j.1440-1797.2007.00815.x; Todd CS, 2010, AIDS, V24, pS69, DOI 10.1097/01.aids.0000386736.25296.8d; Tran HTT, 2003, HEPATOL RES, V26, P275, DOI 10.1016/S1386-6346(03)00166-9; Wang YZ, 2009, J CLIN VIROL, V44, P195, DOI 10.1016/j.jcv.2008.12.009; WHO, 2008, GLOB DAT BLOOD SAF S; WHO, 2010, VIRAL HEPATITIS; Yan YX, 2011, EPIDEMIOL INFECT, V139, P354, DOI 10.1017/S0950268810001597; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zhou J, 2007, J GASTROEN HEPATOL, V22, P1510, DOI 10.1111/j.1440-1746.2007.05062.x	61	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e41266	10.1371/journal.pone.0041266	http://dx.doi.org/10.1371/journal.pone.0041266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916104	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800004
J	Ribeiro, HV; Zunino, L; Lenzi, EK; Santoro, PA; Mendes, RS				Ribeiro, Haroldo V.; Zunino, Luciano; Lenzi, Ervin K.; Santoro, Perseu A.; Mendes, Renio S.			Complexity-Entropy Causality Plane as a Complexity Measure for Two-Dimensional Patterns	PLOS ONE			English	Article							PERMUTATION ENTROPY	Complexity measures are essential to understand complex systems and there are numerous definitions to analyze one-dimensional data. However, extensions of these approaches to two or higher-dimensional data, such as images, are much less common. Here, we reduce this gap by applying the ideas of the permutation entropy combined with a relative entropic index. We build up a numerical procedure that can be easily implemented to evaluate the complexity of two or higher-dimensional patterns. We work out this method in different scenarios where numerical experiments and empirical data were taken into account. Specifically, we have applied the method to i) fractal landscapes generated numerically where we compare our measures with the Hurst exponent; ii) liquid crystal textures where nematic-isotropic-nematic phase transitions were properly identified; iii) 12 characteristic textures of liquid crystals where the different values show that the method can distinguish different phases; iv) and Ising surfaces where our method identified the critical temperature and also proved to be stable.	[Ribeiro, Haroldo V.; Lenzi, Ervin K.; Santoro, Perseu A.; Mendes, Renio S.] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Ribeiro, Haroldo V.; Lenzi, Ervin K.; Santoro, Perseu A.; Mendes, Renio S.] Univ Estadual Maringa, Natl Inst Sci & Technol Complex Syst, Maringa, Parana, Brazil; [Zunino, Luciano] CONICET La Plata CIC, Ctr Invest Opt, CC 3, Gonnet, Argentina; [Zunino, Luciano] Univ Nacl La Plata, Fac Ingn, Dept Ciencias Basicas, La Plata, Argentina	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Centro de Investigaciones Opticas (CIOP); National University of La Plata	Ribeiro, HV (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.	hvr@dfi.uem.br	Ribeiro, Haroldo Valentin/C-8614-2012; Lenzi, Ervin Kaminski/N-1767-2019; Mendes, Renio/F-9261-2017; Zunino, Luciano/AAX-9198-2021	Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Lenzi, Ervin Kaminski/0000-0003-3853-1790; Zunino, Luciano/0000-0002-2852-3263	agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Consejo Nacional de Investigaciones Cientificas y Tecnicas; CAPES [5678-11-0]	agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been supported by the agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Consejo Nacional de Investigaciones Cientificas y Tecnicas. HVR also thank the financial support of CAPES (Grant 5678-11-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrienko YA, 2000, EUR PHYS J B, V15, P539, DOI 10.1007/s100510051157; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Barreiro M, 2011, CHAOS, V21, DOI 10.1063/1.3545273; BOON JP, 1995, CHAOS, V5, P501, DOI 10.1063/1.166145; Brito AF, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031130; Brito AF, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046106; Cai ZJ, 2006, INT J BIFURCAT CHAOS, V16, P3235, DOI 10.1142/S0218127406016756; Canovas JS, 2011, PHYSICA D, V240, P1199, DOI 10.1016/j.physd.2011.04.010; Consolini G, 2009, ASTRON ASTROPHYS, V506, P1381, DOI 10.1051/0004-6361/200811074; Feldman DP, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051104; FOURNIER A, 1982, COMMUN ACM, V25, P371, DOI 10.1145/358523.358553; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Khader M, 2011, IEEE T INF TECHNOL B, V15, P681, DOI 10.1109/TITB.2011.2159806; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lamberti PW, 2004, PHYSICA A, V334, P119, DOI 10.1016/j.physa.2003.11.005; Li XL, 2010, NEUROIMAGE, V52, P497, DOI 10.1016/j.neuroimage.2010.05.003; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Lovallo M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/03/P03029; Lyapunov A. M., 1992, GEN PROBLEM STABILIT; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Martin MT, 2006, PHYSICA A, V369, P439, DOI 10.1016/j.physa.2005.11.053; Masoller C, 2011, PHILOS T R SOC A, V369, P425, DOI 10.1098/rsta.2010.0281; Mendes RS, 2008, ECOGRAPHY, V31, P450, DOI 10.1111/j.0906-7590.2008.05469.x; Nicolaou N, 2011, CLIN EEG NEUROSCI, V42, P24, DOI 10.1177/155005941104200107; Nicolaou N, 2012, EXPERT SYST APPL, V39, P202, DOI 10.1016/j.eswa.2011.07.008; Ouyang GX, 2010, CLIN NEUROPHYSIOL, V121, P694, DOI 10.1016/j.clinph.2009.12.030; Parrott L, 2005, ECOL COMPLEX, V2, P175, DOI 10.1016/j.ecocom.2004.11.004; Parrott L, 2010, ECOL INDIC, V10, P1069, DOI 10.1016/j.ecolind.2010.03.014; Ribeiro HV, 2012, PHYSICA A, V391, P2421, DOI 10.1016/j.physa.2011.12.009; Rosso OA, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061114; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; SCHWARZ U, 1993, ASTRON ASTROPHYS, V277, P215; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Su ZY, 2006, PHYSICA D, V221, P188, DOI 10.1016/j.physd.2006.08.001; YU LJ, 1980, PHYS REV LETT, V45, P1000, DOI 10.1103/PhysRevLett.45.1000	40	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e40689	10.1371/journal.pone.0040689	http://dx.doi.org/10.1371/journal.pone.0040689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916097	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800003
J	Costessi, A; Mahrour, N; Sharma, V; Stunnenberg, R; Stoel, MA; Tijchon, E; Conaway, JW; Conaway, RC; Stunnenberg, HG				Costessi, Adalberto; Mahrour, Nawel; Sharma, Vikram; Stunnenberg, Rieka; Stoel, Marieke A.; Tijchon, Esther; Conaway, Joan W.; Conaway, Ronald C.; Stunnenberg, Hendrik G.			The Human EKC/KEOPS Complex Is Recruited to Cullin2 Ubiquitin Ligases by the Human Tumour Antigen PRAME	PLOS ONE			English	Article							PREFERENTIALLY EXPRESSED ANTIGEN; MYELOID-LEUKEMIA; MELANOMA PRAME; BREAST-CANCER; KEOPS COMPLEX; PROTEIN; PRPK; IDENTIFICATION; PROGRESSION; RELEVANCE	The human tumour antigen PRAME (preferentially expressed antigen in melanoma) is frequently overexpressed during oncogenesis, and high PRAME levels are associated with poor clinical outcome in a variety of cancers. However, the molecular pathways in which PRAME is implicated are not well understood. We recently characterized PRAME as a BC-box subunit of a Cullin2-based E3 ubiquitin ligase. In this study, we mined the PRAME interactome to a deeper level and identified specific interactions with OSGEP and LAGE3, which are human orthologues of the ancient EKC/KEOPS complex. By characterizing biochemically the human EKC complex and its interactions with PRAME, we show that PRAME recruits a Cul2 ubiquitin ligase to EKC. Moreover, EKC subunits associate with PRAME target sites on chromatin. Our data reveal a novel link between the oncoprotein PRAME and the conserved EKC complex and support a role for both complexes in the same pathways.	[Costessi, Adalberto; Sharma, Vikram; Stunnenberg, Rieka; Stoel, Marieke A.; Tijchon, Esther; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Mahrour, Nawel; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	Radboud University Nijmegen; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Costessi, A (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	H.Stunnenberg@ncmls.ru.nl	Stunnenberg, Hendrik G./D-6875-2012; Tijchon, Esther/A-1679-2016	Stunnenberg, Hendrik G./0000-0002-0066-1576; Conaway, Joan/0000-0002-2786-0663	Dutch Cancer Society KWF; National Institute of General Medical Sciences [GM41628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	Dutch Cancer Society KWF(KWF Kankerbestrijding); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratories was funded by Dutch Cancer Society KWF (to HGS) and by Grant GM41628 from the National Institute of General Medical Sciences (to RCC and JWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Allander SV, 2002, AM J PATHOL, V161, P1587, DOI 10.1016/S0002-9440(10)64437-9; Alpen B, 2002, GENE, V297, P141, DOI 10.1016/S0378-1119(02)00879-X; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; Doolan P, 2008, BREAST CANCER RES TR, V109, P359, DOI 10.1007/s10549-007-9643-3; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; Epping MT, 2008, BRIT J CANCER, V99, P398, DOI 10.1038/sj.bjc.6604494; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Facchin S, 2007, CELL MOL LIFE SCI, V64, P2680, DOI 10.1007/s00018-007-7179-7; Facchin S, 2003, FEBS LETT, V549, P63, DOI 10.1016/S0014-5793(03)00770-1; Galperin MY, 2008, ENVIRON MICROBIOL, V10, P281, DOI 10.1111/j.1462-2920.2007.01552.x; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hecker A, 2008, EMBO J, V27, P2340, DOI 10.1038/emboj.2008.157; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V296, P785, DOI 10.1016/S0006-291X(02)00939-7; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Miyoshi A, 2003, BIOCHEM BIOPH RES CO, V303, P399, DOI 10.1016/S0006-291X(03)00333-4; Oberthuer A, 2004, CLIN CANC RES; Partheen K, 2008, INT J CANCER, V123, P2130, DOI 10.1002/ijc.23758; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Santamaria C, 2008, HAEMATOL-HEMATOL J, V93, P1797, DOI 10.3324/haematol.13214; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Steinbach D, 2007, CANCER GENET CYTOGEN, V177, P51, DOI 10.1016/j.cancergencyto.2007.05.011; Tajeddine N, 2005, CANCER RES, V65, P7348, DOI 10.1158/0008-5472.CAN-04-4011; Tanaka N, 2011, LEUKEMIA RES, V35, P1219, DOI 10.1016/j.leukres.2011.04.005; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	35	35	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42822	10.1371/journal.pone.0042822	http://dx.doi.org/10.1371/journal.pone.0042822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912744	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100034
J	Fradet, S; Pierredon, S; Ribaux, P; Epiney, M; Ya, KS; Irion, O; Cohen, M				Fradet, Sarah; Pierredon, Sandra; Ribaux, Pascale; Epiney, Manuella; Ya, Kazuo Shin; Irion, Olivier; Cohen, Marie			Involvement of Membrane GRP78 in Trophoblastic Cell Fusion	PLOS ONE			English	Article							PLACENTAL BEWO CELLS; INTERCELLULAR FUSION; DIFFERENTIATION; PROTEIN; SYNCYTIN; CYTOTROPHOBLAST; PREECLAMPSIA; APOPTOSIS; CANCER; SYNCYTIALISATION	Background: Glucose-regulated protein 78 (GRP78) is highly expressed in first trimester cytrophoblastic cells (CTBs), especially in syncytiotrophoblast (STB). However, the role of GRP78 in these cells has never been investigated. Methodology/Principal Findings: In this study, we have examined the role of GRP78 in trophoblast fusion using the Bewo choriocarcinoma cell line as a model of cytotrophoblast fusion. Down regulation of GRP78 by siRNA or chemical inhibitors and use of antibodies against GRP78 in culture medium significantly decreased forskolin-induced fusion capacity of Bewo cells suggesting the involvement of membrane GRP78 in trophoblast fusion. GRP78 expression was also studied in preeclamptic (PE) CTBs which are known to have lower fusion capacity compared to control CTBs. Interestingly, despite the increase of GRP78 mRNA in PE CTBs, membrane GRP78 is significantly decreased in PE CTBs compared to control CTBs, suggesting that relocation of GRP78 from the endoplasmic reticulum to cell surface is probably altered in PE CTBs. Conclusions: Our results imply that membrane GRP78 could play an important role in syncytialisation. They also suggest that deregulation of GRP78 expression or relocation at cell surface might be involved in pregnancy complication associated with defective syncytialisation, such as preeclampsia.	[Fradet, Sarah; Pierredon, Sandra; Ribaux, Pascale; Epiney, Manuella; Irion, Olivier; Cohen, Marie] Fac Med, Dept Gynecol, Geneva, Switzerland; [Ya, Kazuo Shin] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan	University of Geneva; National Institute of Advanced Industrial Science & Technology (AIST)	Fradet, S (corresponding author), Fac Med, Dept Gynecol, Geneva, Switzerland.	marie.cohen@hcuge.ch	Shin-ya, Kazuo/L-9613-2018	Shin-ya, Kazuo/0000-0002-4702-0661; cohen, marie/0000-0003-4621-5464	Swiss National Funds [31003A-127392]; HUG [PRD 10-I-11]	Swiss National Funds(Swiss National Science Foundation (SNSF)); HUG	This work was supported by the Swiss National Funds (31003A-127392; www.snf.ch) and HUG (PRD 10-I-11). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ADLER RR, 1995, BIOL REPROD, V53, P905, DOI 10.1095/biolreprod53.4.905; Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; ALEXANDRE S, 1991, MOL ENDOCRINOL, V5, P1862, DOI 10.1210/mend-5-12-1862; Arnaudeau S, 2009, PROTEOMICS, V9, P5316, DOI 10.1002/pmic.200800865; Bischof P, 1995, Early Pregnancy, V1, P263; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; Delidaki M, 2011, MOL CELL ENDOCRINOL, V332, P213, DOI 10.1016/j.mce.2010.10.013; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Handwerger S, 2010, MOL CELL ENDOCRINOL, V323, P94, DOI 10.1016/j.mce.2009.12.015; Keryer G, 1998, J BIOL CHEM, V273, P34594, DOI 10.1074/jbc.273.51.34594; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; Kudo Y, 2003, BBA-MOL CELL RES, V1640, P25, DOI 10.1016/S0167-4889(03)00004-1; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Laverriere A, 2009, MOL HUM REPROD, V15, P569, DOI 10.1093/molehr/gap037; Lee AS, 2009, CANCER BIOL THER, V8, P2103, DOI 10.4161/cbt.8.22.10140; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; Vaillancourt C, 2009, MINI-REV MED CHEM, V9, P962, DOI 10.2174/138955709788681663; Vargas A, 2011, REPROD SCI; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Yoshie M, 2010, HUM REPROD, V25, P2229, DOI 10.1093/humrep/deq190; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e40596	10.1371/journal.pone.0040596	http://dx.doi.org/10.1371/journal.pone.0040596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912664	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500002
J	Picard, M; Wright, KJ; Ritchie, D; Thomas, MM; Hepple, RT				Picard, Martin; Wright, Kathryn J.; Ritchie, Darmyn; Thomas, Melissa M.; Hepple, Russell T.			Mitochondrial Function in Permeabilized Cardiomyocytes Is Largely Preserved in the Senescent Rat Myocardium	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CYTOCHROME-C RELEASE; CALORIC RESTRICTION; BROWN-NORWAY; AGING HEART; INTERFIBRILLAR MITOCHONDRIA; OXIDATIVE DAMAGE; SKELETAL-MUSCLE; FISCHER-344; CARDIOMYOPATHY	The aging heart is characterized by a progressive decline in contractile function and diastolic relaxation. Amongst the factors implicated in these changes is a progressive replacement fibrosis secondary to cardiomyoctye death, oxidative damage, and energetic deficit, each of which may be secondary to impaired mitochondrial function. Here, we performed an in-depth examination of mitochondrial function in saponin-permeabilized cardiomyocyte bundles, a preparation where all mitochondria are represented and their structure intact, from young adult (YA) and senescent (SEN) rats (n = 8 per group). When accounting for increased fibrosis (+19%, P<0.01) and proportional decrease in citrate synthase activity in the SEN myocardium (-23%, P<0.05), mitochondrial respiration and reactive oxygen species (H2O2) emission across a range of energized states was similar between age groups. Accordingly, the abundance of electron transport chain proteins was also unchanged. Likewise, except for CuZnSOD (-37%, P<0.05), the activity of antioxidant enzymes was unaltered with aging. Although time to mitochondrial permeability transition pore (mPTP) opening was decreased (-25%, P<0.05) in the SEN heart, suggesting sensitization to apoptotic stimuli, this was not associated with a difference in apoptotic index measured by ELISA. Collectively, our results suggest that the function of existing cardiac ventricular mitochondria is relatively preserved in SEN rat heart when measured in permeabilized cells.	[Picard, Martin; Hepple, Russell T.] McGill Univ, Dept Med, Dept Kinesiol, Montreal, PQ, Canada; [Wright, Kathryn J.; Ritchie, Darmyn; Thomas, Melissa M.] Univ Calgary, Fac Kinesiol, Muscle & Aging Lab, Calgary, AB, Canada	McGill University; University of Calgary	Picard, M (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.	russell.hepple@mcgill.ca		Jacob, Kathryn/0000-0001-8373-5915; Picard, Martin/0000-0003-2835-0478; Hepple, Russell/0000-0003-3640-486X	Canadian Institutes for Health Research [MOP 57808, IAO 84673]; Natural Sciences and Engineering Research Council (NSERC)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the Canadian Institutes for Health Research (MOP 57808 and IAO 84673 to Dr. Hepple). Dr. Picard is a CIHR fellow in Systems Biology and in Psychosocial Oncology and is supported by a scholarship from the Natural Sciences and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; ANVERSA P, 1990, CIRC RES, V67, P871, DOI 10.1161/01.RES.67.4.871; Bancroft J.D., 1996, THEORY PRACTICE HIST, VVolume 6; Betik AC, 2009, AM J PHYSIOL-REG I, V297, pR744, DOI 10.1152/ajpregu.90959.2008; Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010; Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004; Corsetti G, 2008, AM J CARDIOL, V101, p26E, DOI 10.1016/j.amjcard.2008.02.078; Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508; FROLKIS VV, 1988, GERONTOLOGY, V34, P64, DOI 10.1159/000212932; Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; Hagen TM, 2002, ANN NY ACAD SCI, V959, P491, DOI 10.1111/j.1749-6632.2002.tb02119.x; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hofer T, 2009, MECH AGEING DEV, V130, P297, DOI 10.1016/j.mad.2009.01.004; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hua YN, 2011, BASIC RES CARDIOL, V106, P1173, DOI 10.1007/s00395-011-0222-8; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kakarla SK, 2010, J GERONTOL A-BIOL, V65, P147, DOI 10.1093/gerona/glp203; Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lemieux H, 2010, J GERONTOL A-BIOL, DOI [DOI 10.1093/GERONA/GLQ1141, 10.1093/gerona/glq1141]; Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P37, DOI 10.1006/jmcc.2000.1273; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; Lipman RD, 1996, J GERONTOL A-BIOL, V51, pB54, DOI 10.1093/gerona/51A.1.B54; Ljubicic V, 2010, MECH AGEING DEV, V131, P79, DOI 10.1016/j.mad.2009.12.004; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; MANZELMANN MS, 1987, MECH AGEING DEV, V39, P281, DOI 10.1016/0047-6374(87)90067-4; Miro O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X; Niemann B, 2010, CARDIOVASC RES, V88, P267, DOI 10.1093/cvr/cvq273; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Petrosillo G, 2010, J PINEAL RES, V48, P340, DOI 10.1111/j.1600-079X.2010.00758.x; Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001; Picard M, 2011, J AGING RES, V2011; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tweedie C, 2011, AM J PHYSIOL-REG I, V300, pR544, DOI 10.1152/ajpregu.00250.2010; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483; Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535; Zhang D, 2005, CARDIOVASC PATHOL, V14, P61, DOI 10.1016/j.carpath.2005.01.006	57	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e43003	10.1371/journal.pone.0043003	http://dx.doi.org/10.1371/journal.pone.0043003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912774	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500035
J	Ratzka, C; Forster, F; Liang, CG; Kupper, M; Dandekar, T; Feldhaar, H; Gross, R				Ratzka, Carolin; Foerster, Frank; Liang, Chunguang; Kupper, Maria; Dandekar, Thomas; Feldhaar, Heike; Gross, Roy			Molecular Characterization of Antimicrobial Peptide Genes of the Carpenter Ant Camponotus floridanus	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; INSECT DEFENSIN; DROSOPHILA-MELANOGASTER; SEQUENCE ALIGNMENT; IMMUNE-RESPONSE; DRAFT GENOME; ALPHA-FACTOR; EVOLUTION; BLOCHMANNIA; TREE	The production of antimicrobial peptides (AMPs) is a major defense mechanism against pathogen infestation and of particular importance for insects relying exclusively on an innate immune system. Here, we report on the characterization of three AMPs from the carpenter ant Camponotus floridanus. Due to sequence similarities and amino acid composition these peptides can be classified into the cysteine-rich (e.g. defensin) and glycine-rich (e.g. hymenoptaecin) AMP groups, respectively. The gene and cDNA sequences of these AMPs were established and their expression was shown to be induced by microbial challenge. We characterized two different defensin genes. The defensin-2 gene has a single intron, whereas the defensin-1 gene has two introns. The deduced amino acid sequence of the C. floridanus defensins is very similar to other known ant defensins with the exception of a short C-terminal extension of defensin-1. The hymenoptaecin gene has a single intron and a very peculiar domain structure. The corresponding precursor protein consists of a signal- and a pro-sequence followed by a hymenoptaecin-like domain and six directly repeated hymenoptaecin domains. Each of the hymenoptaecin domains is flanked by an EAEP-spacer sequence and a RR-site known to be a proteolytic processing site. Thus, proteolytic processing of the multipeptide precursor may generate several mature AMPs leading to an amplification of the immune response. Bioinformatical analyses revealed the presence of hymenoptaecin genes with similar multipeptide precursor structure in genomes of other ant species suggesting an evolutionary conserved important role of this gene in ant immunity.	[Ratzka, Carolin; Kupper, Maria; Gross, Roy] Univ Wurzburg, Dept Microbiol, Bioctr, Wurzburg, Germany; [Foerster, Frank; Liang, Chunguang; Dandekar, Thomas] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany; [Feldhaar, Heike] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany	University of Wurzburg; University of Wurzburg; University of Bayreuth	Ratzka, C (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, Wurzburg, Germany.	carolin.ratzka@biozentrum.uni-wuerzburg.de	Dandekar, Thomas/A-4431-2017; Gross, Roy/I-3360-2014; Feldhaar, Heike/AAB-8678-2020; Förster, Frank/A-2181-2010	Dandekar, Thomas/0000-0003-1886-7625; Förster, Frank/0000-0003-4166-5423; Gross, Roy/0000-0002-5878-873X; Feldhaar, Heike/0000-0001-6797-5126	Deutsche Forschungsgemeinschaft (DFG) [GR1243/8-1]; EU COST (European Cooperation in Science and Technology) [FA0701]; Chancengleichheit fur Frauen in Forschung und Lehre; "Open Access Publishing'' program of the DFG; University of Wurzburg;  [SFB567/C2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU COST (European Cooperation in Science and Technology); Chancengleichheit fur Frauen in Forschung und Lehre; "Open Access Publishing'' program of the DFG; University of Wurzburg; 	This work was funded by the priority program SFB567/C2 and the grant GR1243/8-1 of the Deutsche Forschungsgemeinschaft (DFG), and by the EU COST (European Cooperation in Science and Technology) action FA0701 "Arthropod symbioses: from fundamental studies to pest management''. C. Ratzka was kindly supported by the program "Chancengleichheit fur Frauen in Forschung und Lehre''. The publication of this manuscript was funded by the "Open Access Publishing'' program of the DFG and the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; CASTEELSJOSSON K, 1993, EMBO J, V12, P1569, DOI 10.1002/j.1460-2075.1993.tb05801.x; Choi YS, 2008, COMP BIOCHEM PHYS B, V150, P141, DOI 10.1016/j.cbpb.2008.02.007; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; DMOCHOWSKA A, 1987, CELL, V50, P573, DOI 10.1016/0092-8674(87)90030-4; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Froy O, 2003, TRENDS GENET, V19, P684, DOI 10.1016/j.tig.2003.10.010; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Gao B, 2010, PROCESS BIOCHEM, V45, P139, DOI 10.1016/j.procbio.2009.08.017; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gruber CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032559; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; HEINZE J, 1994, NATURWISSENSCHAFTEN, V81, P34; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; MagetDana R, 1997, BIOPHYS J, V73, P2527, DOI 10.1016/S0006-3495(97)78281-X; MASCHWITZ U, 1970, J INSECT PHYSIOL, V16, P387, DOI 10.1016/0022-1910(70)90180-0; MONNER DA, 1971, J BACTERIOL, V107, P420, DOI 10.1128/JB.107.2.420-432.1971; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Ratzka C, 2011, INSECT BIOCHEM MOLEC, V41, P529, DOI 10.1016/j.ibmb.2011.03.002; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Sauer C, 2002, APPL ENVIRON MICROB, V68, P4187, DOI 10.1128/AEM.68.9.4187-4193.2002; Schluns H, 2009, MYRMECOL NEWS, V12, P237; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Street TO, 2006, J MOL BIOL, V360, P258, DOI 10.1016/j.jmb.2006.05.024; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Viljakainen L, 2005, INSECT MOL BIOL, V14, P335, DOI 10.1111/j.1365-2583.2005.00564.x; Viljakainen L, 2008, J MOL EVOL, V67, P643, DOI 10.1007/s00239-008-9173-6; Wernegreen JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-292; Xu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004239	56	17	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e43036	10.1371/journal.pone.0043036	http://dx.doi.org/10.1371/journal.pone.0043036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912782	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500037
J	Arias-Gonzalez, JR				Ricardo Arias-Gonzalez, J.			Entropy Involved in Fidelity of DNA Replication	PLOS ONE			English	Article							NONEQUILIBRIUM FLUCTUATIONS; POLYMERASE FIDELITY; SINGLE-MOLECULE; THERMODYNAMICS; INFORMATION; COMPUTATION; MODEL; DISSIPATION; MECHANISM; DYNAMICS	Information has an entropic character which can be analyzed within the framework of the Statistical Theory in molecular systems. R. Landauer and C. H. Bennett showed that a logical copy can be carried out in the limit of no dissipation if the computation is performed sufficiently slowly. Structural and recent single-molecule assays have provided dynamic details of polymerase machinery with insight into information processing. Here, we introduce a rigorous characterization of Shannon Information in biomolecular systems and apply it to DNA replication in the limit of no dissipation. Specifically, we devise an equilibrium pathway in DNA replication to determine the entropy generated in copying the information from a DNA template in the absence of friction. Both the initial state, the free nucleotides randomly distributed in certain concentrations, and the final state, a polymerized strand, are mesoscopic equilibrium states for the nucleotide distribution. We use empirical stacking free energies to calculate the probabilities of incorporation of the nucleotides. The copied strand is, to first order of approximation, a state of independent and non-indentically distributed random variables for which the nucleotide that is incorporated by the polymerase at each step is dictated by the template strand, and to second order of approximation, a state of non-uniformly distributed random variables with nearest-neighbor interactions for which the recognition of secondary structure by the polymerase in the resultant double-stranded polymer determines the entropy of the replicated strand. Two incorporation mechanisms arise naturally and their biological meanings are explained. It is known that replication occurs far from equilibrium and therefore the Shannon entropy here derived represents an upper bound for replication to take place. Likewise, this entropy sets a universal lower bound for the copying fidelity in replication.	[Ricardo Arias-Gonzalez, J.] Inst Madrileno Estudios Avanzados Nanociencia, Madrid, Spain; [Ricardo Arias-Gonzalez, J.] Ctr Nacl Biotecnol, Dept Macromol Struct, Madrid, Spain; [Ricardo Arias-Gonzalez, J.] Ctr Nacl Biotecnol, Inst Madrileno Estudios Avanzados Nanociencia, Associated Unit, Unidad Nanobiotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Arias-Gonzalez, JR (corresponding author), Inst Madrileno Estudios Avanzados Nanociencia, Madrid, Spain.	ricardo.arias@imdea.org	Arias-Gonzalez, J. Ricardo/L-8538-2014	Arias-Gonzalez, J. Ricardo/0000-0001-6802-0874	Spanish Ministry of Science and Innovation [2007-01765]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministry of Science and Innovation (www.micinn.es) under the "Ramon y Cajal" program (Grant No. RYC- 2007-01765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allawi HT, 1998, BIOCHEMISTRY-US, V37, P9435, DOI 10.1021/bi9803729; Andrieux D, 2008, P NATL ACAD SCI USA, V105, P9516, DOI 10.1073/pnas.0802049105; Andrieux D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050099; BENNETT CH, 1979, BIOSYSTEMS, V11, P85, DOI 10.1016/0303-2647(79)90003-0; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; BENNETT CH, 1973, IBM J RES DEV, V17, P525, DOI 10.1147/rd.176.0525; Berut A, 2012, NATURE, V483, P187, DOI 10.1038/nature10872; Cover TM, 1991, ELEMENTS OF INFORMAT; DAVIS BK, 1965, NATURE, V206, P183, DOI 10.1038/206183a0; Gaspard P, 2007, CR PHYS, V8, P598, DOI 10.1016/j.crhy.2007.05.002; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hormeno S, 2006, BIOL CELL, V98, P679, DOI 10.1042/BC20060036; Hormeno S, 2012, BIOPOLYMERS, V97, P199, DOI 10.1002/bip.21728; Huguet JM, 2010, P NATL ACAD SCI USA, V107, P15431, DOI 10.1073/pnas.1001454107; Ibarra B, 2009, EMBO J, V28, P2794, DOI 10.1038/emboj.2009.219; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Julicher F, 1998, BIOPHYS J, V74, P1169, DOI 10.1016/S0006-3495(98)77833-6; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Klump H. H., 2009, Transactions of the Royal Society of South Africa, V64, P73; Korzheva N, 2003, MOL MOTORS, P153; LANDAUER R, 1988, NATURE, V335, P779, DOI 10.1038/335779a0; Landauer R, 1961, ADV CHEM PHYS, V5, P183; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; Maxwell JC, 1871, THEORY OF HEAT; Morin JA, 2012, P NATL ACAD SCI USA, V109, P8115, DOI 10.1073/pnas.1204759109; Parrondo JMR, 2002, APPL PHYS A-MATER, V75, P179, DOI 10.1007/s003390201332; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; Ritort F, 2008, ADV CHEM PHYS, V137, P31; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; VOLKENST.MV, 1961, DOKL AKAD NAUK SSSR+, V136, P1216; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	37	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42272	10.1371/journal.pone.0042272	http://dx.doi.org/10.1371/journal.pone.0042272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912695	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500015
J	Zhang, WP; Yie, SM; Yue, BS; Zhou, JL; An, RX; Yang, JD; Chen, WL; Wang, CD; Zhang, L; Shen, FJ; Yang, GY; Hou, R; Zhang, ZH				Zhang, Wenping; Yie, Shangmian; Yue, Bisong; Zhou, Jielong; An, Renxiong; Yang, Jiangdong; Chen, Wangli; Wang, Chengdong; Zhang, Liang; Shen, Fujun; Yang, Guangyou; Hou, Rong; Zhang, Zhihe			Determination of Baylisascaris schroederi Infection in Wild Giant Pandas by an Accurate and Sensitive PCR/CESSCP Method	PLOS ONE			English	Article							CAPILLARY-ELECTROPHORESIS; QUANTIFICATION; POPULATION; FECES; PARASITES; BEAR; DNA	It has been recognized that other than habitat loss, degradation and fragmentation, the infection of the roundworm Baylisascaris schroederi (B. schroederi) is one of the major causes of death in wild giant pandas. However, the prevalence and intensity of the parasite infection has been inconsistently reported through a method that uses sedimentation-floatation followed by a microscope examination. This method fails to accurately determine infection because there are many bamboo residues and/or few B. schroederi eggs in the examined fecal samples. In the present study, we adopted a method that uses PCR and capillary electrophoresis combined with a single-strand conformation polymorphism analysis (PCR/CE-SSCP) to detect B. schroederi infection in wild giant pandas at a nature reserve, and compared it to the traditional microscope approach. The PCR specifically amplified a single band of 279-bp from both fecal samples and positive controls, which was confirmed by sequence analysis to correspond to the mitochondrial COII gene of B. schroederi. Moreover, it was demonstrated that the amount of genomic DNA was linearly correlated with the peak area of the CE-SSCP analysis. Thus, our adopted method can reliably detect the infectious prevalence and intensity of B. schroederi in wild giant pandas. The prevalence of B. schroederi was found to be 54% in the 91 fecal samples examined, and 48% in the fecal samples of 31 identified individual giant pandas. Infectious intensities of the 91 fecal samples were detected to range from 2.8 to 959.2 units/gram, and from 4.8 to 959.2 units/gram in the fecal samples of the 31 identified giant pandas. For comparison, by using the traditional microscope method, the prevalence of B. schroederi was found to be only 33% in the 91 fecal samples, 32% in the fecal samples of the 31 identified giant pandas, and no reliable infectious intensity was observed.	[Zhang, Wenping; Yie, Shangmian; An, Renxiong; Wang, Chengdong; Zhang, Liang; Shen, Fujun; Hou, Rong; Zhang, Zhihe] Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan, Peoples R China; [Yue, Bisong] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Peoples R China; [Zhou, Jielong] SW Forestry Univ, Coll Life Sci, Kunming, Peoples R China; [Yang, Jiangdong; Yang, Guangyou] Sichuan Agr Univ, Coll Anim Sci, Yaan, Peoples R China; [Chen, Wangli] Tangjiahe Natl Nat Reserve, Guangyuan, Peoples R China	Sichuan University; Sichuan Agricultural University	Zhang, WP (corresponding author), Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan, Peoples R China.	bsyue@yahoo.com; zhang_zoology@163.com			Sichuan Youth Science and Technology Foundation [09ZQ026-042]; National Basic Research Program of China (973 Project) [2009CB426311]; National Science and Technology Supporting Program [2012BAC01B06]	Sichuan Youth Science and Technology Foundation; National Basic Research Program of China (973 Project)(National Basic Research Program of China); National Science and Technology Supporting Program	This research was funded by Sichuan Youth Science and Technology Foundation (09ZQ026-042), National Basic Research Program of China (973 Project: 2009CB426311), and National Science and Technology Supporting Program (2012BAC01B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2011, CURR ZOOL, V57, P568, DOI 10.1093/czoolo/57.5.568; Carlsgart J, 2009, PARASITOL RES, V104, P939, DOI 10.1007/s00436-008-1307-7; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; Hu JC, 2001, RES GIANT PANDA; Lai Conglong, 1993, Chinese Journal of Veterinary Medicine, V19, P10; McINTOSH ALLEN, 1939, ZOOLOGICA [NEW YORK], V24, P355; Nielsen MK, 2010, VET PARASITOL, V174, P77, DOI 10.1016/j.vetpar.2010.08.007; Nielsen MK, 2008, INT J PARASITOL, V38, P443, DOI 10.1016/j.ijpara.2007.07.014; Park YS, 2006, ELECTROPHORESIS, V27, P3836, DOI 10.1002/elps.200600225; Rosalino LM, 2006, EUR J WILDLIFE RES, V52, P202, DOI 10.1007/s10344-006-0033-7; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Sambrook J., 2002, MOL CLONING LAB MANU; Schaller GB, 1984, GIANT PANDAS WOLONG; Shin GW, 2008, ANAL BIOCHEM, V383, P31, DOI 10.1016/j.ab.2008.08.021; Shin GW, 2010, BIOTECHNOL BIOENG, V106, P167, DOI 10.1002/bit.22646; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Tang YW, 1997, CLIN CHEM, V43, P2021; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Wu J, 1987, CHINESE J VET MED, V07, P9; WU J, 1985, VET SCI CHINA, V6, P21; Xie Y, 2011, GENE, V482, P59, DOI 10.1016/j.gene.2011.05.004; Xue KM, 1987, PAPERS DIS GIANT PAN; Yang JD, 2011, CURR ZOOL, V57, P717, DOI 10.1093/czoolo/57.6.717; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhang JS, 2008, ECOHEALTH, V5, P6, DOI 10.1007/s10393-007-0139-8; Zhang L, 2011, J WILDLIFE DIS, V47, P164, DOI 10.7589/0090-3558-47.1.164; Zhang WP, 2009, ZOO BIOL, V28, P49, DOI 10.1002/zoo.20227; Zhang Z, 2006, GIANT PANDA EX SITU; Zhang Ze-Jun, 2002, Acta Ecologica Sinica, V22, P990	29	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41995	10.1371/journal.pone.0041995	http://dx.doi.org/10.1371/journal.pone.0041995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22911871	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200144
J	Zhang, D; Li, XH; Chen, CC; Li, YY; Zhao, L; Jing, YY; Liu, W; Wang, XY; Zhang, Y; Xia, HF; Chang, YN; Gao, X; Yan, J; Ying, H				Zhang, Duo; Li, Xihua; Chen, Chuchu; Li, Yuyin; Zhao, Lei; Jing, Yanyan; Liu, Wei; Wang, Xiaoyun; Zhang, Ying; Xia, Hongfeng; Chang, Yaning; Gao, Xiang; Yan, Jun; Ying, Hao			Attenuation of p38-Mediated miR-1/133 Expression Facilitates Myoblast Proliferation during the Early Stage of Muscle Regeneration	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SKELETAL-MUSCLE; CELL-PROLIFERATION; SATELLITE CELLS; SMALL RNAS; EXTRACELLULAR-MATRIX; MUSCULAR-DYSTROPHY; STEM-CELLS; DIFFERENTIATION; MICRORNAS	Myoblast proliferation following myotrauma is regulated by multiple factors including growth factors, signal pathways, transcription factors, and miRNAs. However, the molecular mechanisms underlying the orchestration of these regulatory factors remain unclear. Here we show that p38 signaling is required for miR-1/133a clusters transcription and both p38 activity and miR-1/133 expression are attenuated during the early stage of muscle regeneration in various animal models. Additionally, we show that both miR-1 and miR-133 reduce Cyclin D1 expression and repress myoblast proliferation by inducing G1 phase arrest. Furthermore, we demonstrate that miR-133 inhibits mitotic progression by targeting Sp1, which mediates Cyclin D1 transcription, while miR-1 suppresses G1/S phase transition by targeting Cyclin D1. Finally, we reveal that proproliferative FGF2, which is elevated during muscle regeneration, attenuates p38 signaling and miR-1/133 expression. Taken together, our results suggest that downregulation of p38-mediated miR-1/133 expression by FGF2 and subsequent upregulation of Sp1/Cyclin D1 contribute to the increased myoblast proliferation during the early stage of muscle regeneration.	[Zhang, Duo; Li, Yuyin; Jing, Yanyan; Liu, Wei; Wang, Xiaoyun; Zhang, Ying; Xia, Hongfeng; Ying, Hao] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Li, Xihua; Zhao, Lei] Fudan Univ, Childrens Hosp, Dept Neuromuscular Dis, Shanghai 200433, Peoples R China; [Chen, Chuchu; Chang, Yaning] E China Univ Sci & Technol, Sch Biotechnol, Shanghai 200237, Peoples R China; [Gao, Xiang; Yan, Jun] Nanjing Univ, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang; Yan, Jun] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Yan, Jun] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; East China University of Science & Technology; Nanjing University; Nanjing University; Wenzhou Medical University	Zhang, D (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	yinghao@sibs.ac.cn	Zhang, Duo/U-6203-2019; Zhang, Duo/GYU-8678-2022; Yan, Jun/Q-3031-2017; Zhang, Duo/S-2034-2016	Yan, Jun/0000-0002-1303-1952; Wang, Xiaoyun/0000-0002-9900-740X; Zhang, Duo/0000-0003-0361-4174	Chinese Academy of Sciences [KSCX2-EW-R-09]; Ministry of Science and Technology of China [2009CB919000, 2010CB912500, 2010CB945100]; National Natural Science Foundation [30970587, 31070679]; Science and Technology Commission of Shanghai Municipality [10ZR1435000]; Fundamental Research Funds for the Central Universities; Shanghai Charity Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Charity Foundation	This work was supported by grants from the One Hundred Talents Program of the Chinese Academy of Sciences, the Ministry of Science and Technology of China (973 Program 2009CB919000, 2010CB912500, 2010CB945100), the National Natural Science Foundation (30970587, 31070679), the Science and Technology Commission of Shanghai Municipality (10ZR1435000), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-09), the Fundamental Research Funds for the Central Universities (Jun Yan), and Shanghai Charity Foundation (The Special Fund for DMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1995, EXP CELL RES, V216, P325, DOI 10.1006/excr.1995.1041; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Calguner E, 2003, ANAT HISTOL EMBRYOL, V32, P54, DOI 10.1046/j.1439-0264.2003.00439.x; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; CLARKE MSF, 1993, J CELL SCI, V106, P121; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; HAUGK KL, 1995, J ANIM SCI, V73, P1972; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; JOHNSON SE, 1995, EXP CELL RES, V219, P449, DOI 10.1006/excr.1995.1251; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lefaucheur JP, 1995, NEUROSCI LETT, V202, P121, DOI 10.1016/0304-3940(95)12223-0; Lemischka I, 1999, P NATL ACAD SCI USA, V96, P14193, DOI 10.1073/pnas.96.25.14193; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; MALEY MAL, 1995, EXP CELL RES, V219, P169, DOI 10.1006/excr.1995.1217; Milasincic DJ, 1996, MOL CELL BIOL, V16, P5964; Perdiguero E, 2007, CELL CYCLE, V6, P1298, DOI 10.4161/cc.6.11.4315; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Xiao F, 2011, CELL RES, V21, P350, DOI 10.1038/cr.2010.144; Yablonka-Reuveni Z, 1999, J HISTOCHEM CYTOCHEM, V47, P23, DOI 10.1177/002215549904700104; Ying H, 2006, J CLIN INVEST, V116, P2972, DOI 10.1172/JCI28598; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012	40	79	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41478	10.1371/journal.pone.0041478	http://dx.doi.org/10.1371/journal.pone.0041478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911796	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300046
J	Hillebrand, A; Post, JJ; Wurbs, D; Wahler, D; Lenders, M; Krzyzanek, V; Prufer, D; Gronover, CS				Hillebrand, Andrea; Post, Janina J.; Wurbs, David; Wahler, Daniela; Lenders, Malte; Krzyzanek, Vladislav; Pruefer, Dirk; Gronover, Christian Schulze			Down-Regulation of Small Rubber Particle Protein Expression Affects Integrity of Rubber Particles and Rubber Content in Taraxacum brevicorniculatum	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; ELONGATION-FACTOR; PARTHENIUM-ARGENTATUM; SILENCING AFFECTS; LATEX; PRENYLTRANSFERASE; STABILITY; CDNA	The biosynthesis of rubber is thought to take place on the surface of rubber particles in laticifers, highly specialized cells that are present in more than 40 plant families. The small rubber particle protein (SRPP) has been supposed to be involved in rubber biosynthesis, and recently five SRPPs (TbSRPP1-5) were identified in the rubber-producing dandelion species Taraxacum brevicorniculatum. Here, we demonstrate by immunogold labeling that TbSRPPs are localized to rubber particles, and that rubber particles mainly consist of TbSRPP3, 4 and 5 as shown by high-resolution two-dimensional gel electrophoresis and mass spectrometric analysis. We also carried out an RNA-interference approach in transgenic plants to address the function of TbSRPPs in rubber biosynthesis as well as rubber particle morphology and stability. TbSRPP-RNAi transgenic T. brevicorniculatum plants showed a 40-50% reduction in the dry rubber content, but neither the rubber weight average molecular mass nor the polydispersity of the rubber were affected. Although no phenotypical differences to wildtype particles could be observed in vivo, rubber particles from the TbSRPP-RNAi transgenic lines were less stable and tend to rapidly aggregate in expelling latex after wounding of laticifers. Our results prove that TbSRPPs are very crucial for rubber production in T. brevicorniculatum, probably by contributing to a most favourable and stable rubber particle architecture for efficient rubber biosynthesis and eventually storage.	[Hillebrand, Andrea; Post, Janina J.; Wurbs, David; Wahler, Daniela; Lenders, Malte; Pruefer, Dirk] Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany; [Krzyzanek, Vladislav] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Hillebrand, Andrea; Pruefer, Dirk; Gronover, Christian Schulze] Fraunhofer Inst Mol Biol & Appl Ecol, Aachen, Germany; [Krzyzanek, Vladislav] Acad Sci Czech Republ, Inst Sci Instruments, Vvi, CS-61264 Brno, Czech Republic	University of Munster; University of Munster; Fraunhofer Gesellschaft; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences	Hillebrand, A (corresponding author), Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany.	christian.schulze.gronover@ime.fraunhofer.de	Krzyzanek, Vladislav/C-6275-2008	Krzyzanek, Vladislav/0000-0002-7996-2979; Kanel, Andrea/0000-0002-1653-562X; Schulze Gronover, Christian/0000-0001-6398-2265	European Union Framework Program 7 [212827]; Deutsche Bundesstiftung Umwelt [AZ13255]; Ministry of Science and Education of Germany [FKZ 0315971C]	European Union Framework Program 7; Deutsche Bundesstiftung Umwelt; Ministry of Science and Education of Germany	This work was supported by a grant from the European Union Framework Program 7 (project no. 212827, EU-PEARLS), the Deutsche Bundesstiftung Umwelt (AZ13255) and the Ministry of Science and Education of Germany (grant no. FKZ 0315971C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER BL, 1963, BIOCHEM J, V89, P565, DOI 10.1042/bj0890565; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORNISH K, 1990, PHYTOCHEMISTRY, V29, P3809, DOI 10.1016/0031-9422(90)85337-F; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; DENNIS MS, 1989, J BIOL CHEM, V264, P18618; DENNIS MS, 1989, J BIOL CHEM, V264, P18608; Freitas AM, 2001, J COLLOID INTERF SCI, V233, P73, DOI 10.1006/jcis.2000.7218; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Genovese DB, 2001, FOOD HYDROCOLLOID, V15, P1, DOI 10.1016/S0268-005X(00)00053-9; Giasson S, 1998, LANGMUIR, V14, P891, DOI 10.1021/la960747w; GOMEZ J B, 1989, Journal of Natural Rubber Research, V4, P204; Grasso D., 2002, Re/Views in Environmental Science and Bio/Technology, V1, P17, DOI 10.1023/A:1015146710500; HELLER W, 1960, J POLYM SCI, V47, P203, DOI 10.1002/pol.1960.1204714918; HO CC, 1989, COLLOID POLYM SCI, V267, P643, DOI 10.1007/BF01410442; Jucker BA, 1998, ENVIRON SCI TECHNOL, V32, P2909, DOI 10.1021/es980211s; Kharel Y, 2003, NAT PROD REP, V20, P111, DOI 10.1039/b108934j; Kim IJ, 2004, J EXP BOT, V55, P377, DOI 10.1093/jxb/erh039; Kirschner J, 2013, GENET RESOUR CROP EV, V60, P455, DOI 10.1007/s10722-012-9848-0; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Oh SK, 1999, J BIOL CHEM, V274, P17132, DOI 10.1074/jbc.274.24.17132; Peng CC, 2003, BIOTECHNOL PROGR, V19, P1623, DOI 10.1021/bp034129z; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; POULTER CD, 1978, ACCOUNTS CHEM RES, V11, P307, DOI 10.1021/ar50128a004; POULTER CD, 1976, BIOCHEMISTRY-US, V15, P1079, DOI 10.1021/bi00650a019; Priya P, 2007, PLANT CELL REP, V26, P1833, DOI 10.1007/s00299-007-0402-z; Riddick T. M., 1968, ZETA METER MANUAL; Sando T, 2009, PLANTA, V230, P215, DOI 10.1007/s00425-009-0936-0; Sansatsadeekul J, 2011, J BIOSCI BIOENG, V111, P628, DOI 10.1016/j.jbiosc.2011.01.013; Schmidt T, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-11; Schmidt T, 2010, PLANT MOL BIOL REP, V28, P277, DOI 10.1007/s11105-009-0145-9; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siler DJ, 1997, PLANT PHYSIOL BIOCH, V35, P881; SILER DJ, 1993, PHYTOCHEMISTRY, V32, P1097, DOI 10.1016/S0031-9422(00)95072-6; Singh AP, 2003, J EXP BOT, V54, P985, DOI 10.1093/jxb/erg107; TZEN JTC, 1992, J CELL BIOL, V117, P327, DOI 10.1083/jcb.117.2.327; VERWEY EJW, 1947, J PHYS COLLOID CHEM, V51, P631, DOI 10.1021/j150453a001; Wahler D, 2012, PROTEOMICS, V12, P901, DOI 10.1002/pmic.201000778; Wahler D, 2009, PLANT PHYSIOL, V151, P334, DOI 10.1104/pp.109.138743; Wood DF, 2000, INT J PLANT SCI, V161, P435, DOI 10.1086/314269	41	60	71	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41874	10.1371/journal.pone.0041874	http://dx.doi.org/10.1371/journal.pone.0041874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911861	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700161
J	Bartels, P; Hirsch, PE; Svanback, R; Eklov, P				Bartels, Pia; Hirsch, Philipp E.; Svanback, Richard; Eklov, Peter			Water Transparency Drives Intra-Population Divergence in Eurasian Perch (Perca fluviatilis)	PLOS ONE			English	Article							ROACH RUTILUS-RUTILUS; DISSOLVED ORGANIC-CARBON; DREISSENA-POLYMORPHA; VISUAL CONDITIONS; GENETIC-EVIDENCE; STABLE ISOTOPES; SPECIES PAIR; CICHLID FISH; SAGINAW BAY; LAKE-HURON	Trait combinations that lead to a higher efficiency in resource utilization are important drivers of divergent natural selection and adaptive radiation. However, variation in environmental features might constrain foraging in complex ways and therefore impede the exploitation of critical resources. We tested the effect of water transparency on intra-population divergence in morphology of Eurasian perch (Perca fluviatilis) across seven lakes in central Sweden. Morphological divergence between near-shore littoral and open-water pelagic perch substantially increased with increasing water transparency. Reliance on littoral resources increased strongly with increasing water transparency in littoral populations, whereas littoral reliance was not affected by water transparency in pelagic populations. Despite the similar reliance on pelagic resources in pelagic populations along the water transparency gradient, the utilization of particular pelagic prey items differed with variation in water transparency in pelagic populations. Pelagic perch utilized cladocerans in lakes with high water transparency and copepods in lakes with low water transparency. We suggest that under impaired visual conditions low utilization of littoral resources by littoral perch and utilization of evasive copepods by pelagic perch may lead to changes in morphology. Our findings indicate that visual conditions can affect population divergence in predator populations through their effects on resource utilization.	[Bartels, Pia; Hirsch, Philipp E.; Svanback, Richard; Eklov, Peter] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden	Uppsala University	Bartels, P (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	pia.bartels@emg.umu.se	Hirsch, Philipp/F-4895-2012	Hirsch, Philipp Emanuel/0000-0002-6927-2368	Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS); Swedish Research Council (VR); Uppsala Graduate School; Malmens Foundation	Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council); Uppsala Graduate School; Malmens Foundation	This study was financed by grants from the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS) to PB and PE, the Swedish Research Council (VR) to PE and RS, the Uppsala Graduate School to PEH, and the Malmens Foundation to PB and PEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2006, ARCH HYDROBIOL, V167, P447, DOI 10.1127/0003-9136/2006/0167-0447; Baumgartner D, 2003, INT REV HYDROBIOL, V88, P453, DOI 10.1002/iroh.200310632; Bohman IM, 2006, HYDROBIOLOGIA, V556, P99, DOI 10.1007/s10750-005-1052-1; Bonsdorff E, 1997, OCEANOL ACTA, V20, P319; Borkman DG, 1998, ICES J MAR SCI, V55, P668, DOI 10.1006/jmsc.1998.0380; BOTRELL HH, 1976, NORW J ZOOL, V24, P419; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter MW, 2010, T AM FISH SOC, V139, P353, DOI 10.1577/T08-159.1; DAVIESCOLLEY RJ, 1987, LIMNOL OCEANOGR, V32, P416, DOI 10.4319/lo.1987.32.2.0416; DRENNER RW, 1978, J FISH RES BOARD CAN, V35, P1370, DOI 10.1139/f78-215; EHLINGER TJ, 1988, P NATL ACAD SCI USA, V85, P1878, DOI 10.1073/pnas.85.6.1878; Eriksson L., 2006, MULTI AND MEGAVARIAT; Estlander S, 2010, J FISH BIOL, V77, P241, DOI 10.1111/j.1095-8649.2010.02682.x; Fahnenstiel GL, 1995, J GREAT LAKES RES, V21, P465, DOI 10.1016/S0380-1330(95)71059-0; GREGORY RS, 1993, CAN J FISH AQUAT SCI, V50, P233, DOI 10.1139/f93-026; Harvey BC, 2008, T AM FISH SOC, V137, P1756, DOI 10.1577/T08-039.1; Heubel KU, 2006, J FISH BIOL, V68, P555, DOI 10.1111/j.0022-1112.2006.00941.x; Hongve D, 2004, AQUAT SCI, V66, P231, DOI 10.1007/s00027-004-0708-7; HURVICH CM, 1991, BIOMETRIKA, V78, P499; Jarvenpaa M, 2004, P ROY SOC B-BIOL SCI, V271, P2361, DOI 10.1098/rspb.2004.2870; Johnston TA, 1999, FRESHWATER BIOL, V41, P653, DOI 10.1046/j.1365-2427.1999.00400.x; Jonsson M, 2011, J FISH BIOL, V79, P290, DOI 10.1111/j.1095-8649.2011.03004.x; Jonsson M, 2012, ECOL FRESHW FISH, V21, P461, DOI 10.1111/j.1600-0633.2012.00565.x; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; KENT C, 1982, CAN J FISH AQUAT SCI, V39, P847, DOI 10.1139/f82-115; KIRK JTO, 1977, AUST J MAR FRESH RES, V28, P497, DOI 10.1071/MF9770497; Lind Owen T., 2003, Archiv fuer Hydrobiologie Supplement, V139, P327; Ljunggren L, 2007, J FISH BIOL, V70, P1319, DOI 10.1111/j.1095-8649.2007.01412.x; Lowe RL, 1995, J GREAT LAKES RES, V21, P558, DOI 10.1016/S0380-1330(95)71066-8; Lythgoe J.N., 1979, ECOLOGY VISION; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402, DOI 10.1139/z84-201; MEYER A, 1989, OECOLOGIA, V80, P431, DOI 10.1007/BF00379047; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; O'Keefe TC, 1998, J PLANKTON RES, V20, P973; PERSSON L, 1990, ECOLOGY, V71, P44, DOI 10.2307/1940246; PERSSON L, 1987, OECOLOGIA, V73, P170, DOI 10.1007/BF00377504; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Rohlf F. J., 2005, TPSRELW RELATIVE WAR; SCHLUTER D, 1984, AM NAT, V123, P175, DOI 10.1086/284196; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; SMOCK LA, 1980, FRESHWATER BIOL, V10, P375, DOI 10.1111/j.1365-2427.1980.tb01211.x; Sondergaard M, 2007, J APPL ECOL, V44, P1095, DOI 10.1111/j.1365-2664.2007.01363.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Svanback R, 2004, FUNCT ECOL, V18, P503, DOI 10.1111/j.0269-8463.2004.00858.x; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; UIBLEIN F, 1992, ENVIRON BIOL FISH, V33, P47, DOI 10.1007/BF00002552; Utne-Palm AC, 2002, MAR FRESHW BEHAV PHY, V35, P111, DOI 10.1080/10236240290025644; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; [No title captured]	61	30	30	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43641	10.1371/journal.pone.0043641	http://dx.doi.org/10.1371/journal.pone.0043641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912895	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700123
J	Ku, BJ; Kim, TH; Lee, JH; Buras, ED; White, LD; Stevens, RD; Ilkayeva, OR; Bain, JR; Newgard, CB; DeMayo, FJ; Jeong, JW				Ku, Bon Jeong; Kim, Tae Hoon; Lee, Jae Hee; Buras, Eric D.; White, Lisa D.; Stevens, Robert D.; Ilkayeva, Olga R.; Bain, James R.; Newgard, Christopher B.; DeMayo, Francesco J.; Jeong, Jae-Wook			Mig-6 Plays a Critical Role in the Regulation of Cholesterol Homeostasis and Bile Acid Synthesis	PLOS ONE			English	Article							GENE-EXPRESSION; LIVER; METABOLISM; INDUCTION; IDENTIFICATION; DEFICIENCY; RECEPTORS; GLUCOSE; CDC42	The disruption of cholesterol homeostasis leads to an increase in cholesterol levels which results in the development of cardiovascular disease. Mitogen Inducible Gene 6 (Mig-6) is an immediate early response gene that can be induced by various mitogens, stresses, and hormones. To identify the metabolic role of Mig-6 in the liver, we conditionally ablated Mig-6 in the liver using the Albumin-Cre mouse model (Alb(cre/+) Mig-6(f/f); Mig-6(d/d)). Mig-6(d/d) mice exhibit hepatomegaly and fatty liver. Serum levels of total, LDL, and HDL cholesterol and hepatic lipid were significantly increased in the Mig-6(d/d) mice. The daily excretion of fecal bile acids was significantly decreased in the Mig-6(d/d) mice. DNA microarray analysis of mRNA isolated from the livers of these mice showed alterations in genes that regulate lipid metabolism, bile acid, and cholesterol synthesis, while the expression of genes that regulate biliary excretion of bile acid and triglyceride synthesis showed no difference in the Mig-6(d/d) mice compared to Mig-6(f/f) controls. These results indicate that Mig-6 plays an important role in cholesterol homeostasis and bile acid synthesis. Mice with liver specific conditional ablation of Mig-6 develop hepatomegaly and increased intrahepatic lipid and provide a novel model system to investigate the genetic and molecular events involved in the regulation of cholesterol homeostasis and bile acid synthesis. Defining the molecular mechanisms by which Mig-6 regulates cholesterol homeostasis will provide new insights into the development of more effective ways for the treatment and prevention of cardiovascular disease.	[Ku, Bon Jeong; Buras, Eric D.; DeMayo, Francesco J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Ku, Bon Jeong] Chungnam Natl Univ, Dept Internal Med, Sch Med, Taejon, South Korea; [Kim, Tae Hoon; Lee, Jae Hee; Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [White, Lisa D.] Baylor Coll Med, Microarray Core Facil, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stevens, Robert D.; Ilkayeva, Olga R.; Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Stevens, Robert D.; Ilkayeva, Olga R.; Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Baylor College of Medicine; Chungnam National University; Michigan State University; Baylor College of Medicine; Duke University; Duke University	Ku, BJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	JaeWook.Jeong@hc.msu.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Ku, Bon Jeong/0000-0002-3414-8949; Bain, James R./0000-0002-8917-9187	National Institutes of Health (NIH) [P01DK59820, R01HD057873, U19-DK62434]; Korean Diabetes Association Research Grant; Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare Family Affairs [A100588]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057873] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, U19DK062434] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Diabetes Association Research Grant; Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare Family Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grant P01DK59820 (to FJD), NIH Grant R01HD057873 (to JWJ), NIH Grant U19-DK62434 (CBN), and 2009 Korean Diabetes Association Research Grant and The Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs A100588 (to BJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CADILLA C, 1992, GENE, V118, P223, DOI 10.1016/0378-1119(92)90192-R; CHACE DH, 1995, CLIN CHEM, V41, P62; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durrington P, 2003, LANCET, V362, P717, DOI 10.1016/S0140-6736(03)14234-1; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fuchs M, 2003, AM J PHYSIOL-GASTR L, V284, pG551, DOI 10.1152/ajpgi.00468.2002; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jeong JW, 2005, ENDOCRINOLOGY, V146, P3490, DOI 10.1210/en.2005-0016; Jin N, 2007, GENESIS, V45, P716, DOI 10.1002/dvg.20348; Keeton AB, 2004, BBA-GENE STRUCT EXPR, V1679, P248, DOI 10.1016/j.bbaexp.2004.07.002; KENT TA, 1994, ENDOCRINOLOGY, V134, P2237, DOI 10.1210/en.134.5.2237; Kim TH, 2010, ONCOGENE, V29, P3770, DOI 10.1038/onc.2010.126; Kim TH, 2010, J ONCOL, V2010, DOI 10.1155/2010/139087; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li T, HEPTAOLOGY, V52, P678; Mahgoub MA, 1998, MOL CELL BIOCHEM, V180, P59, DOI 10.1023/A:1006834922035; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; MOHN KL, 1990, J BIOL CHEM, V265, P21914; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; PACKARD CJ, 1982, J LIPID RES, V23, P1081; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; van Laar T, 2001, MOL CARCINOGEN, V31, P63, DOI 10.1002/mc.1040; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928; Zhang YW, 2005, P NATL ACAD SCI USA, V102, P11740, DOI 10.1073/pnas.0505171102	51	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42915	10.1371/journal.pone.0042915	http://dx.doi.org/10.1371/journal.pone.0042915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912762	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700030
J	Ma, DL; Chan, DSH; Fu, WC; He, HZ; Yang, H; Yan, SC; Leung, CH				Ma, Dik-Lung; Chan, Daniel Shiu-Hin; Fu, Wai-Chung; He, Hong-Zhang; Yang, Hui; Yan, Siu-Cheong; Leung, Chung-Hang			Discovery of a Natural Product-Like c-myc G-Quadruplex DNA Groove-Binder by Molecular Docking	PLOS ONE			English	Article							PROMOTER REGION; DOWN-REGULATION; LIGAND; RECOGNITION; IDENTIFICATION; STABILIZATION; TARGET	The natural product-like carbamide (1) has been identified as a stabilizer of the c-myc G-quadruplex through high-throughput virtual screening. NMR and molecular modeling experiments revealed a groove-binding mode for 1. The biological activity of 1 against the c-myc G-quadruplex was confirmed by its ability to inhibit Taq polymerase-mediated DNA extension and c-myc expression in vitro, demonstrating that 1 is able to control c-myc gene expression at the transcriptional level presumably through the stabilization of the c-myc promoter G-quadruplex. Furthermore, the interaction between carbamide analogues and the c-myc G-quadruplex was also investigated by in vitro experiments in order to generate a brief structure-activity relationship (SAR) for the observed potency of carbamide 1.	[Ma, Dik-Lung; Chan, Daniel Shiu-Hin; Fu, Wai-Chung; He, Hong-Zhang; Yang, Hui] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Yan, Siu-Cheong] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, Taipa, Peoples R China; [Leung, Chung-Hang] Univ Macau, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China	Hong Kong Baptist University; Hong Kong Polytechnic University; University of Macau; University of Macau	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk; DuncanLeung@umac.mo	Fu, Wai-Chung/C-4487-2013; Fu, Wai Chung/HGC-1135-2022	Fu, Wai-Chung/0000-0002-7181-0057; Fu, Wai Chung/0000-0002-7181-0057; Yan, Siu-cheoong/0000-0001-7486-3069; Ma, Dik-Lung/0000-0002-9515-340X	Hong Kong Baptist University [FRG2/10-11/008, FRG2/11-12/009]; Environment and Conservation Fund (ECF) [3/2010]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Research Fund for the Control of Infectious Diseases [RFCID/11101212]; Research Grants Council [HKBU/201811]; University of Macau [MYRG091(Y1-L2)-ICMS12-LCH, MYRG121(Y1-L3)-ICMS12-LCH]	Hong Kong Baptist University; Environment and Conservation Fund (ECF); Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Research Fund for the Control of Infectious Diseases; Research Grants Council(Hong Kong Research Grants Council); University of Macau	This work is supported by Hong Kong Baptist University (FRG2/10-11/008 and FRG2/11-12/009), Environment and Conservation Fund (ECF Project 3/2010), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Research Fund for the Control of Infectious Diseases (RFCID/11101212) and the Research Grants Council (HKBU/201811), the University of Macau (Start-up Research Grant to C.-H. Leung), MYRG091(Y1-L2)-ICMS12-LCH and MYRG121(Y1-L3)-ICMS12-LCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blay G, 2000, STUD NAT PROD CHEM, V24, P53, DOI DOI 10.1016/S1572-5995(00)80044-7; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Chen Q, 1996, P NATL ACAD SCI USA, V93, P2635, DOI 10.1073/pnas.93.7.2635; Cheng JY, 1998, J PHYS CHEM B, V102, P5542, DOI 10.1021/jp9820424; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dash J, 2008, J AM CHEM SOC, V130, P15950, DOI 10.1021/ja8046552; Franke L, 2007, J MED CHEM, V50, P2640, DOI 10.1021/jm060655w; Hwang SH, 2011, J MED CHEM, V54, P3037, DOI 10.1021/jm2001376; Lee HM, 2010, CHEM COMMUN, V46, P4680, DOI 10.1039/b926359d; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Ma DL, 2008, CHEMMEDCHEM, V3, P881, DOI 10.1002/cmdc.200700342; Maiti S, 2003, BIOCHEM BIOPH RES CO, V310, P505, DOI 10.1016/j.bbrc.2003.09.052; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Totrov M, 1997, PROTEINS, P215; Trotta R, 2011, BIOCHIMIE, V93, P1280, DOI 10.1016/j.biochi.2011.05.021; White EW, 2007, BIOPHYS CHEM, V126, P140, DOI 10.1016/j.bpc.2006.06.006; Wu P, 2009, CHEM-EUR J, V15, P13008, DOI 10.1002/chem.200901943	24	39	39	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43278	10.1371/journal.pone.0043278	http://dx.doi.org/10.1371/journal.pone.0043278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912844	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700073
J	Zhao, JM; Huang, X; Ouyang, XH; Chen, WL; Du, AP; Zhu, L; Wang, SG; Deng, XW; Li, SG				Zhao, Junming; Huang, Xi; Ouyang, Xinhao; Chen, Weilan; Du, Anping; Zhu, Ling; Wang, Shiguang; Deng, Xing Wang; Li, Shigui			OsELF3-1, an Ortholog of Arabidopsis EARLY FLOWERING 3, Regulates Rice Circadian Rhythm and Photoperiodic Flowering	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; AMBIENT-TEMPERATURE; RESPONSE REGULATOR; NATURAL VARIATION; ORYZA-SATIVA; CLOCK; GENE; PROTEIN; ELF3; TIME	Arabidopsis thaliana EARLY FLOWERING 3 (ELF3) as a zeitnehmer (time taker) is responsible for generation of circadian rhythm and regulation of photoperiodic flowering. There are two orthologs (OsELF3-1 and OsELF3-2) of ELF3 in rice (Oryza sativa), but their roles have not yet been fully identified. Here, we performed a functional characterization of OsELF3-1 and revealed it plays a more predominant role than OsELF3-2 in rice heading. Our results suggest OsELF3-1 can affect rice circadian systems via positive regulation of OsLHY expression and negative regulation of OsPRR1, OsPRR37, OsPRR73 and OsPRR95 expression. In addition, OsELF3-1 is involved in blue light signaling by activating EARLY HEADING DATE 1 (Ehd1) expression to promote rice flowering under short-day (SD) conditions. Moreover, OsELF3-1 suppresses a flowering repressor GRAIN NUMBER, PLANT HEIGHT AND HEADING DATE 7 (Ghd7) to indirectly accelerate flowering under long-day (LD) conditions. Taken together, our results indicate OsELF3-1 is essential for circadian regulation and photoperiodic flowering in rice.	[Zhao, Junming; Ouyang, Xinhao; Chen, Weilan; Du, Anping; Zhu, Ling; Wang, Shiguang; Li, Shigui] Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China; [Zhao, Junming; Ouyang, Xinhao; Chen, Weilan; Du, Anping; Zhu, Ling; Wang, Shiguang; Li, Shigui] Sichuan Agr Univ, State Key Lab Hybrid Rice, Chengdu, Sichuan, Peoples R China; [Huang, Xi] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Huang, Xi; Ouyang, Xinhao; Deng, Xing Wang] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Beijing 100871, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Beijing Normal University; Peking University	Zhao, JM (corresponding author), Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China.	oyxh1983@126.com; lishigui@sicau.edu.cn	du, anping/AAK-3544-2020; Deng, Xing Wang/ABF-4107-2020		China Postdoctoral Science Foundation Grant [2012M510266]; Postdoctoral Fellowship at Center for Life Sciences; National Natural Science Foundation of China [30971763, 31025017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850] Funding Source: NIH RePORTER	China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation); Postdoctoral Fellowship at Center for Life Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	China Postdoctoral Science Foundation Grant (2012M510266) and The Postdoctoral Fellowship at Center for Life Sciences to XO (http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx) (http://www.cls.edu.cn/). and National Natural Science Foundation of China (30971763 and 31025017) to SL (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Fu C, 2009, PLANT BIOLOGY, V11, P751, DOI 10.1111/j.1438-8677.2008.00156.x; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; He CK, 2009, PLANT BIOTECHNOL J, V7, P227, DOI 10.1111/j.1467-7652.2008.00393.x; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Herrero E., 2012, PLANT CELL; Herrero E, 2012, MOL PLANT, V5, P554, DOI 10.1093/mp/sss010; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Izawa T, 2007, INT REV CYTOL, V256, P191, DOI 10.1016/S0074-7696(07)56006-7; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jiao YL, 2005, PLANT CELL, V17, P3239, DOI 10.1105/tpc.105.035840; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kolmos E, 2011, PLANT CELL, V23, P3230, DOI 10.1105/tpc.111.088195; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Lee SY, 2004, PLANT J, V38, P754, DOI 10.1111/j.1365-313X.2004.02082.x; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Reed JW, 2000, PLANT PHYSIOL, V122, P1149, DOI 10.1104/pp.122.4.1149; Ryu CH, 2009, PLANT CELL ENVIRON, V32, P1412, DOI 10.1111/j.1365-3040.2009.02008.x; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Somers DE, 1998, DEVELOPMENT, V125, P485; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zust T, 2011, PLANT CELL, V23, P3230	64	73	91	7	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43705	10.1371/journal.pone.0043705	http://dx.doi.org/10.1371/journal.pone.0043705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912900	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700128
J	McMullen, SM; Meade, M; Rose, L; Burns, K; Mehta, S; Doyle, R; Henzler, D				McMullen, Sarah M.; Meade, Maureen; Rose, Louise; Burns, Karen; Mehta, Sangeeta; Doyle, Robert; Henzler, Dietrich		CCCTG	Partial Ventilatory Support Modalities in Acute Lung Injury and Acute Respiratory Distress Syndrome-A Systematic Review	PLOS ONE			English	Review							PRESSURE RELEASE VENTILATION; PROPORTIONAL-ASSIST VENTILATION; POSITIVE AIRWAY PRESSURE; INTERMITTENT MANDATORY VENTILATION; END-EXPIRATORY PRESSURE; ADJUSTABLE GAIN FACTORS; CONTROLLED MECHANICAL VENTILATION; CRITICALLY-ILL PATIENTS; GAS-EXCHANGE; BREATHING PATTERN	Purpose: The efficacy of partial ventilatory support modes that allow spontaneous breathing in patients with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is unclear. The objective of this scoping review was to assess the effects of partial ventilatory support on mortality, duration of mechanical ventilation, and both hospital and intensive care unit (ICU) lengths of stay (LOS) for patients with ALI and ARDS; the secondary objective was to describe physiologic effects on hemodynamics, respiratory system and other organ function. Methods: MEDLINE (1966-2009), Cochrane, and EmBase (1980-2009) databases were searched using common ventilator modes as keywords and reference lists from retrieved manuscripts hand searched for additional studies. Two researchers independently reviewed and graded the studies using a modified Oxford Centre for Evidence-Based Medicine grading system. Studies in adult ALI/ARDS patients were included for primary objectives and pre-clinical studies for supporting evidence. Results: Two randomized controlled trials (RCTs) were identified, in addition to six prospective cohort studies, one retrospective cohort study, one case control study, 41 clinical physiologic studies and 28 pre-clinical studies. No study was powered to assess mortality, one RCT showed shorter ICU length of stay, and the other demonstrated more ventilator free days. Beneficial effects of preserved spontaneous breathing were mainly physiological effects demonstrated as improvement of gas exchange, hemodynamics and non-pulmonary organ perfusion and function. Conclusions: The use of partial ventilatory support modalities is often feasible in patients with ALI/ARDS, and may be associated with short-term physiological benefits without appreciable impact on clinically important outcomes.	[McMullen, Sarah M.; Doyle, Robert; Henzler, Dietrich] Dalhousie Univ, Dept Anesthesiol & Crit Care Med, Halifax, NS, Canada; [Meade, Maureen] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Meade, Maureen] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Rose, Louise] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Burns, Karen] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Burns, Karen] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Burns, Karen] Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Mehta, Sangeeta] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Mehta, Sangeeta] Univ Toronto, Mt Sinai Hosp, Interdept Div Crit Care Med, Toronto, ON M5G 1X5, Canada	Dalhousie University; McMaster University; McMaster University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	McMullen, SM (corresponding author), Dalhousie Univ, Dept Anesthesiol & Crit Care Med, Halifax, NS, Canada.	mail@d-henzler.de	Mehta, Sangeeta/C-4623-2015; Rose, Louise/F-4723-2011	Rose, Louise/0000-0003-1700-3972; Henzler, Dietrich/0000-0001-5511-6885	Dalhousie University, Faculty of Medicine; Canadian Institutes of Health Research	Dalhousie University, Faculty of Medicine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by Dalhousie University, Faculty of Medicine. KB holds a Clinician Scientist Phase 2 Award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou C, 2007, INTENS CARE MED, V33, P1139, DOI 10.1007/s00134-007-0630-2; Allo JC, 2006, CRIT CARE MED, V34, P2997, DOI 10.1097/01.CCM.0000242520.50665.9F; AMATO MBP, 1992, CHEST, V102, P1225, DOI 10.1378/chest.102.4.1225; Appendini L, 1999, AM J RESP CRIT CARE, V159, P1510, DOI 10.1164/ajrccm.159.5.9804130; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Beck J, 2008, INTENS CARE MED, V34, P316, DOI 10.1007/s00134-007-0882-x; Beck J, 2007, PEDIATR RES, V61, P289, DOI 10.1203/01.pdr.0000257324.22406.93; Berger KI, 1996, CHEST, V109, P1320, DOI 10.1378/chest.109.5.1320; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; BEYDON L, 1991, ANESTHESIOLOGY, V75, P730, DOI 10.1097/00000542-199111000-00003; Bigatello LM, 1997, CRIT CARE MED, V25, P267, DOI 10.1097/00003246-199702000-00012; Bosma K, 2007, CRIT CARE MED, V35, P1048, DOI 10.1097/01.CCM.0000260055.64235.7C; Brander L, 2009, CHEST, V135, P695, DOI 10.1378/chest.08-1747; Brander L, 2009, INTENS CARE MED, V35, P1979, DOI 10.1007/s00134-009-1626-x; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CALZIA E, 1994, AM J RESP CRIT CARE, V150, P904, DOI 10.1164/ajrccm.150.4.7921461; CANE RD, 1991, CHEST, V100, P460, DOI 10.1378/chest.100.2.460; Carvalho AR, 2009, ANESTH ANALG, V109, P856, DOI 10.1213/ane.0b013e3181aff245; Cereda M, 2000, CRIT CARE MED, V28, P1269, DOI 10.1097/00003246-200005000-00002; CHIANG AA, 1994, CRIT CARE MED, V22, P1431, DOI 10.1097/00003246-199409000-00013; CHIN WDN, 1985, CHEST, V88, P503, DOI 10.1378/chest.88.4.503; Chiumello D, 2002, EUR RESPIR J, V20, P925, DOI 10.1183/09031936.02.01552001; Colombo D, 2008, INTENS CARE MED, V34, P2010, DOI 10.1007/s00134-008-1208-3; Dart BW, 2005, J TRAUMA, V59, P71, DOI 10.1097/00005373-200507000-00010; DAVIS K, 1993, ARCH SURG-CHICAGO, V128, P1348; de Abreu MG, 2008, CRIT CARE MED, V36, P818, DOI 10.1097/01.CCM.0000299736.55039.3A; Delaere S, 2003, INTENS CARE MED, V29, P949, DOI 10.1007/s00134-003-1704-4; Dembinski R, 2002, ANESTH ANALG, V94, P1570, DOI 10.1097/00000539-200206000-00037; DOWNS JB, 1974, ARCH SURG-CHICAGO, V109, P519; DUNN RB, 1995, ARCH PHYS MED REHAB, V76, P266, DOI 10.1016/S0003-9993(95)80614-8; El-Khatib M, 2009, RESPIRATION, V77, P154, DOI 10.1159/000139155; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Fan Eddy, 2008, J Intensive Care Med, V23, P376, DOI 10.1177/0885066608324293; Franz AR, 2001, AM J RESP CRIT CARE, V164, P36, DOI 10.1164/ajrccm.164.1.2006164; Giannouli E, 1999, AM J RESP CRIT CARE, V159, P1716, DOI 10.1164/ajrccm.159.6.9704025; Gonzalez M, 2010, INTENS CARE MED, V36, P817, DOI 10.1007/s00134-010-1837-1; Grasso S, 2000, AM J RESP CRIT CARE, V161, P819, DOI 10.1164/ajrccm.161.3.9902065; GROEGER JS, 1989, CRIT CARE MED, V17, P607, DOI 10.1097/00003246-198907000-00002; Henzler D, 2004, INTENS CARE MED, V30, P935, DOI 10.1007/s00134-003-2146-8; Henzler D, 2010, AM J RESP CRIT CAR S, V181, pA3002; Henzler D, 2006, CRIT CARE MED, V34, P1738, DOI 10.1097/01.CCM.0000218809.49883.54; Henzler D, 2011, CRIT CARE, V15, DOI 10.1186/cc9419; Hering R, 2005, CHEST, V128, P2991, DOI 10.1378/chest.128.4.2991; Hering R, 2003, ANESTHESIOLOGY, V99, P1137, DOI 10.1097/00000542-200311000-00021; Hering R, 2002, INTENS CARE MED, V28, P1426, DOI 10.1007/s00134-002-1442-z; Hering R, 2008, INTENS CARE MED, V34, P523, DOI 10.1007/s00134-007-0957-8; Hormann C, 1997, ACTA ANAESTH SCAND, V41, P152; JOUSELA I, 1992, INTENS CARE MED, V18, P299, DOI 10.1007/BF01706479; Kaplan LJ, 2001, CRIT CARE, V5, P221, DOI 10.1186/cc1027; Kiehl M, 1996, CRIT CARE MED, V24, P780, DOI 10.1097/00003246-199605000-00009; Kondili E, 2006, INTENS CARE MED, V32, P692, DOI 10.1007/s00134-006-0110-0; Kondili E, 2006, ANESTHESIOLOGY, V105, P703, DOI 10.1097/00000542-200610000-00015; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lamontagne F, 2010, CRIT CARE MED, V38, P2401, DOI 10.1097/CCM.0b013e3181fa0468; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Marantz S, 1996, J APPL PHYSIOL, V80, P397, DOI 10.1152/jappl.1996.80.2.397; MATHRU M, 1983, CRIT CARE MED, V11, P359, DOI 10.1097/00003246-198305000-00008; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Navalesi P, 1996, AM J RESP CRIT CARE, V154, P1330, DOI 10.1164/ajrccm.154.5.8912744; Neumann P, 2005, CRIT CARE MED, V33, P1090, DOI 10.1097/01.CCM.0000163226.34868.0A; Neumann P, 2002, INTENS CARE MED, V28, P1742, DOI 10.1007/s00134-002-1522-0; Neumann P, 2001, ANESTH ANALG, V92, P950; *OXF CTR EV BAS ME, 2010, LEV EV; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Passam F, 2003, RESPIRATION, V70, P355, DOI 10.1159/000072897; Pedersen T, 2001, ACTA ANAESTH SCAND, V45, P267, DOI 10.1034/j.1399-6576.2001.045003267.x; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; PUTENSEN C, 1994, ANESTHESIOLOGY, V81, P921, DOI 10.1097/00000542-199410000-00018; Putensen C, 2004, CRIT CARE, V8, P492, DOI 10.1186/cc2919; Putensen C, 2005, CURR OPIN CRIT CARE, V11, P63, DOI 10.1097/00075198-200502000-00010; PUTENSEN C, 1994, AM J RESP CRIT CARE, V150, P101, DOI 10.1164/ajrccm.150.1.8025733; Putensen C, 2001, AM J RESP CRIT CARE, V164, P43, DOI 10.1164/ajrccm.164.1.2001078; Putensen C, 1999, AM J RESP CRIT CARE, V159, P1241, DOI 10.1164/ajrccm.159.4.9806077; RASANEN J, 1991, CRIT CARE MED, V19, P1234; Rose L, 2008, INTENS CARE MED, V34, P1766, DOI 10.1007/s00134-008-1216-3; ROUBY JJ, 1992, INTENS CARE MED, V18, P69, DOI 10.1007/BF01705035; Saddy F, 2010, INTENS CARE MED, V36, P1417, DOI 10.1007/s00134-010-1808-6; SMITH RA, 1995, CHEST, V107, P805, DOI 10.1378/chest.107.3.805; Spieth PM, 2009, ANESTHESIOLOGY, V110, P342, DOI 10.1097/ALN.0b013e318194d06e; STOCK MC, 1987, CRIT CARE MED, V15, P462, DOI 10.1097/00003246-198705000-00002; Sydow M, 1999, INTENS CARE MED, V25, P634, DOI 10.1007/s001340050917; Tassaux D, 2002, CRIT CARE MED, V30, P801, DOI 10.1097/00003246-200204000-00014; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; TOKIOKA H, 1989, INTENS CARE MED, V15, P364; Uyar M, 2005, ANAESTH INTENS CARE, V33, P218, DOI 10.1177/0310057X0503300210; Varelmann D, 2008, CRIT CARE, V12, DOI 10.1186/cc7108; Varpula T, 2004, ACTA ANAESTH SCAND, V48, P722, DOI 10.1111/j.0001-5172.2004.00411.x; Varpula T, 2003, ACTA ANAESTH SCAND, V47, P516, DOI 10.1034/j.1399-6576.2003.00109.x; Wrigge H, 2003, ANESTHESIOLOGY, V99, P376, DOI 10.1097/00000542-200308000-00019; Xirouchaki N, 2008, INTENS CARE MED, V34, P2026, DOI 10.1007/s00134-008-1209-2; YOUNES M, 1992, AM REV RESPIR DIS, V145, P121, DOI 10.1164/ajrccm/145.1.121; YOUNES M, 1992, AM REV RESPIR DIS, V145, P114, DOI 10.1164/ajrccm/145.1.114; Zakynthinos SG, 1997, J CRIT CARE, V12, P161, DOI 10.1016/S0883-9441(97)90027-7	94	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e40190	10.1371/journal.pone.0040190	http://dx.doi.org/10.1371/journal.pone.0040190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916094	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300003
J	Ota, MOC; Roca, A; Bottomley, C; Hill, PC; Egere, U; Greenwood, B; Adegbola, RA				Ota, Martin O. C.; Roca, Anna; Bottomley, Christian; Hill, Philip C.; Egere, Uzochukwu; Greenwood, Brian; Adegbola, Richard A.			Pneumococcal Antibody Concentrations of Subjects in Communities Fully or Partially Vaccinated with a Seven-Valent Pneumococcal Conjugate Vaccine	PLOS ONE			English	Article							NASOPHARYNGEAL CARRIAGE; STREPTOCOCCUS-PNEUMONIAE; GAMBIAN CHILDREN; SUSCEPTIBILITY PATTERNS; SYSTEMATIC ANALYSIS; IMMUNOGENICITY; EFFICACY; SEROTYPE; DISEASE; REDUCTION	Background: A recent trial with PCV-7 in a rural Gambian community showed reduced vaccine-type pneumococcal carriage in fully vaccinated compared with control communities. We measured pneumococcal polysaccharide antibody concentrations in this trial to understand further the mechanisms underlying the observed changes. Methods: A single-blind, cluster-randomized (by village) trial was conducted in 21 Gambian villages. In 11 villages, all residents received PCV-7 (Vaccine group); in 10 control villages only children <30 months old or those born during the study received PCV-7. Subjects over the age of 30 months resident in vaccine villages received a single dose of PCV-7 whilst those in control villages received a single dose of a serogroup C meningococcal conjugate vaccine. Serum antibody concentrations against specific pneumococcal polysaccharides were measured in approximately 200 age-stratified subjects before, 4-6, 12 and 24 months following vaccination. Results: Baseline pneumococcal antibody concentrations were generally high and increased with age up to 10 years. One dose of PCV-7 increased geometric mean antibody concentrations (GMC) in vaccinated versus control villages for vaccine serotypes 6B and 18C, and 4 and 18C, in the young (under 5 years) and older age groups (5+ years) respectively. There were significantly higher proportions of subjects in the vaccinated than in the control communities with an antibody concentration believed to protect against carriage (>5.0 mu g/mL) for all but serotype 9V of the PCV-7 serotypes in the older group, but not in the younger age group. Conclusion: Higher antibodies in vaccinated communities provide an explanation for the lower pneumococcal carriage rates in fully vaccinated compared to control communities.	[Ota, Martin O. C.; Roca, Anna; Hill, Philip C.; Egere, Uzochukwu; Adegbola, Richard A.] MRC Unit, Banjul, Gambia; [Roca, Anna] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Hill, Philip C.] Univ Otago, Sch Med, Ctr Int Hlth, Dunedin, New Zealand; [Adegbola, Richard A.] GlaxoSmithKline Biol, Wavre, Belgium; [Bottomley, Christian] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1, England; [Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Otago; GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Ota, MOC (corresponding author), MRC Unit, Banjul, Gambia.	mota@mrc.gm	Egere, Uzochukwu/AET-1704-2022	Bottomley, Christian/0000-0002-5241-8412	United Kingdom Medical Research Council; MRC [G0700837, MC_U190071468, MC_UP_A900_1122, MC_U190085849] Funding Source: UKRI; Medical Research Council [MC_U190085849, MC_U190071468, G0700837, MC_UP_A900_1122] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the United Kingdom Medical Research Council. Study vaccines were donated by Wyeth Lederle Vaccines (Pfizer) and they played no role in the design of the study, writing or decision to publish this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Cheung YB, 2008, TROP MED INT HEALTH, V13, P603, DOI 10.1111/j.1365-3156.2008.02050.x; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Dagan R, 1997, PEDIATR INFECT DIS J, V16, P1060, DOI 10.1097/00006454-199711000-00011; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; Deubzer HE, 2004, J INFECT DIS, V190, P1758, DOI 10.1086/424597; Douglas RM, 1999, CLIN INFECT DIS, V28, P192, DOI 10.1086/515112; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Hanquet G, 2010, EMERG INFECT DIS, V16, P1428, DOI 10.3201/eid1609.100102; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Mulholland K, 1999, VACCINE, V17, pS79, DOI 10.1016/S0264-410X(99)00112-7; Obaro SK, 2004, PEDIATR INFECT DIS J, V23, P1023, DOI 10.1097/01.inf.0000143651.54880.09; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; Peltola H, 2003, LANCET, V361, P2170, DOI 10.1016/S0140-6736(03)13784-1; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rivera-Olivero IA, 2007, CLIN INFECT DIS, V45, P1427, DOI 10.1086/522984; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Russell FM, 2009, VACCINE, V27, P5685, DOI 10.1016/j.vaccine.2009.06.098; Saaka M, 2008, VACCINE, V26, P3719, DOI 10.1016/j.vaccine.2008.04.066; Shann F, 1999, LANCET S2, V354, pSII7; Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006; Usinger WR, 1999, INFECT IMMUN, V67, P2366, DOI 10.1128/IAI.67.5.2366-2370.1999; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42997	10.1371/journal.pone.0042997	http://dx.doi.org/10.1371/journal.pone.0042997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916192	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000307500800036
J	Iglesias, DM; El-Kares, R; Taranta, A; Bellomo, F; Emma, F; Besouw, M; Levtchenko, E; Toelen, J; van den Heuvel, L; Chu, LL; Zhao, J; Young, YK; Eliopoulos, N; Goodyer, P				Iglesias, Diana M.; El-Kares, Reyhan; Taranta, Anna; Bellomo, Francesco; Emma, Francesco; Besouw, Martine; Levtchenko, Elena; Toelen, Jaan; van den Heuvel, Lambertus; Chu, LeeLee; Zhao, Jing; Young, Yoon Kow; Eliopoulos, Nicoletta; Goodyer, Paul			Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cystine Accumulation In Vitro	PLOS ONE			English	Article							NEPHROPATHIC CYSTINOSIS; DIMETHYL ESTER; KIDNEY INJURY; LEUKOCYTES; TRANSPLANTATION; IDENTIFICATION; COMMUNICATION; FIBROBLASTS; CYSTEAMINE; MEDIATORS	Cystinosis is a rare disease caused by homozygous mutations of the CTNS gene, encoding a cystine efflux channel in the lysosomal membrane. In Ctns knockout mice, the pathologic intralysosomal accumulation of cystine that drives progressive organ damage can be reversed by infusion of wildtype bone marrow-derived stem cells, but the mechanism involved is unclear since the exogeneous stem cells are rarely integrated into renal tubules. Here we show that human mesenchymal stem cells, from amniotic fluid or bone marrow, reduce pathologic cystine accumulation in co-cultured CTNS mutant fibroblasts or proximal tubular cells from cystinosis patients. This paracrine effect is associated with release into the culture medium of stem cell microvesicles (100-400 nm diameter) containing wildtype cystinosin protein and CTNS mRNA. Isolated stem cell microvesicles reduce target cell cystine accumulation in a dose-dependent, Annexin V-sensitive manner. Microvesicles from stem cells expressing CTNSRed transfer tagged CTNS protein to the lysosome/endosome compartment of cystinotic fibroblasts. Our observations suggest that exogenous stem cells may reprogram the biology of mutant tissues by direct microvesicle transfer of membrane-associated wildtype molecules.	[Iglesias, Diana M.; El-Kares, Reyhan; Chu, LeeLee; Goodyer, Paul] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Taranta, Anna; Bellomo, Francesco; Emma, Francesco] Osped Pediat Bambino Gesu, UOC Nefrol & Dialisi, Rome, Italy; [Besouw, Martine; Levtchenko, Elena; Toelen, Jaan; van den Heuvel, Lambertus] Katholieke Univ Leuven, Pediat Lab, Univ Hosp, Dept Pediat Nephrol, Louvain, Belgium; [Zhao, Jing; Young, Yoon Kow; Eliopoulos, Nicoletta] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Eliopoulos, Nicoletta] McGill Univ, Dept Surg, Div Surg Res, Montreal, PQ H3A 2T5, Canada; [Eliopoulos, Nicoletta] McGill Univ, Dept Oncol, Montreal, PQ, Canada	McGill University; IRCCS Bambino Gesu; KU Leuven; Lady Davis Institute; McGill University; McGill University; McGill University	Iglesias, DM (corresponding author), McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada.	paul.goodyer@mcgill.ca	van den Heuvel, Lambertus/AAM-1772-2021; Emma, Francesco/H-2116-2012; Taranta, Anna/AAA-6113-2020; Bellomo, Francesco/K-2142-2012; Levtchenko, Elena/AAO-7125-2020; van den Heuvel, L.P.W.J./H-8044-2014	van den Heuvel, Lambertus/0000-0003-3917-6727; Emma, Francesco/0000-0002-0383-3468; Bellomo, Francesco/0000-0003-2912-8764; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Taranta, Anna/0000-0002-7606-9085	Cystinosis Research Foundation; Genome Quebec; Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec [PSR-SIIRI-450]; Cystinosis Awareness and Research Effort; James McGill Research Chair	Cystinosis Research Foundation; Genome Quebec; Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec; Cystinosis Awareness and Research Effort; James McGill Research Chair	This work was supported by the Cystinosis Research Foundation (http://www.natalieswish.org/); Genome Quebec (http://www.genomequebec.com/); Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec (Grant PSR-SIIRI-450; http://www.mdeie.gouv.qc.ca/); and Cystinosis Awareness and Research Effort (http://www.cystinosis.ca/). Dr. P. Goodyer is the recipient of a James McGill Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Anikster Y, 1999, MOL GENET METAB, V66, P111, DOI 10.1006/mgme.1998.2790; Asanuma H, 2010, J UROLOGY, V184, P26, DOI 10.1016/j.juro.2010.03.050; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Choi DS, 2011, PROTEOMICS, V11, P2745, DOI 10.1002/pmic.201100022; Collino F, 2011, VITAM HORM, V87, P291, DOI 10.1016/B978-0-12-386015-6.00033-0; Eliopoulos N, 2010, AM J PHYSIOL-RENAL, V299, pF1288, DOI 10.1152/ajprenal.00671.2009; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; GAHL WA, 1982, J BIOL CHEM, V257, P9570; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WA, 2007, ANN INTERN MED, V147, P242, DOI 10.7326/0003-4819-147-4-200708210-00006; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Gilfix BM, 1997, CLIN CHEM, V43, P687; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Mahoney CP, 2000, PEDIATR NEPHROL, V15, P50, DOI 10.1007/PL00013448; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; Nesterova G, 2008, PEDIATR NEPHROL, V23, P863, DOI 10.1007/s00467-007-0650-8; Park MA, 2006, J AM SOC NEPHROL, V17, P3167, DOI 10.1681/ASN.2006050474; Prasad VK, 2008, BLOOD, V112, P2979, DOI 10.1182/blood-2008-03-140830; SCHNEIDE.JA, 1968, PEDIATR RES, V2, P441, DOI 10.1203/00006450-196811000-00001; SCHNEIDER JA, 1967, SCIENCE, V157, P1321, DOI 10.1126/science.157.3794.1321; STEINHERZ R, 1982, P NATL ACAD SCI-BIOL, V79, P4446, DOI 10.1073/pnas.79.14.4446; STEINHERZ R, 1982, NEW ENGL J MED, V306, P1468, DOI 10.1056/NEJM198206173062407; Syres K, 2009, BLOOD, V114, P2542, DOI 10.1182/blood-2009-03-213934; Taranta A, 2008, AM J PHYSIOL-RENAL, V294, pF1101, DOI 10.1152/ajprenal.00413.2007; Wilmer MJ, 2011, BBA-MOL BASIS DIS, V1812, P643, DOI 10.1016/j.bbadis.2011.02.010; Yeagy BA, 2011, KIDNEY INT, V79, P1198, DOI 10.1038/ki.2010.537	32	56	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42840	10.1371/journal.pone.0042840	http://dx.doi.org/10.1371/journal.pone.0042840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912749	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100037
J	Petersen, H; Matrosovich, M; Pleschka, S; Rautenschlein, S				Petersen, Henning; Matrosovich, Mikhail; Pleschka, Stephan; Rautenschlein, Silke			Replication and Adaptive Mutations of Low Pathogenic Avian Influenza Viruses in Tracheal Organ Cultures of Different Avian Species	PLOS ONE			English	Article							A VIRUSES; RECEPTOR-BINDING; HONG-KONG; HOST-RANGE; H9N2; HEMAGGLUTININ; PIGEONS; INFECTION; CHICKENS; SUSCEPTIBILITY	Transmission of avian influenza viruses (AIV) between different avian species may require genome mutations that allow efficient virus replication in a new species and could increase virulence. To study the role of domestic poultry in the evolution of AIV we compared replication of low pathogenic (LP) AIV of subtypes H9N2, H7N7 and H6N8 in tracheal organ cultures (TOC) and primary embryo fibroblast cultures of chicken, turkey, Pekin duck and homing pigeon. Virus strain-dependent and avian species-related differences between LPAIV were observed in growth kinetics and induction of ciliostasis in TOC. In particular, our data demonstrate high susceptibility to LPAIV of turkey TOC contrasted with low susceptibility of homing pigeon TOC. Serial virus passages in the cells of heterologous host species resulted in adaptive mutations in the AIV genome, especially in the receptor-binding site and protease cleavage site of the hemagglutinin. Our data highlight differences in susceptibility of different birds to AIV viruses and emphasizes potential role of poultry in the emergence of new virus variants.	[Petersen, Henning; Rautenschlein, Silke] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany; [Matrosovich, Mikhail] Univ Marburg, Inst Virol, D-3550 Marburg, Germany; [Pleschka, Stephan] Univ Giessen, Inst Med Virol, Giessen, Germany	University of Veterinary Medicine Hannover, Foundation; Philipps University Marburg; Justus Liebig University Giessen	Petersen, H (corresponding author), Univ Vet Med Hannover, Clin Poultry, Hannover, Germany.	Silke.Rautenschlein@tiho-hannover.de	Pleschka, Stephan/HGU-9354-2022	Matrosovich, Mikhail/0000-0003-1618-2083; Pleschka, Stephan/0000-0002-7372-7089	FluResearchNet - Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses; Federal Ministry of Education and Research [01KI07133, 01KI07136]; European Commission FP7 project FLUPIG	FluResearchNet - Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission FP7 project FLUPIG	This work was supported by the FluResearchNet - Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses, funded by the Federal Ministry of Education and Research (01KI07133 to S. Rautenschlein and 01KI07136 to S. Pleschka) and European Commission FP7 project FLUPIG (to M. Matrosovich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2007, VIRUS GENES, V34, P37, DOI 10.1007/s11262-006-0007-6; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bi JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013063; BLASKOVIC P, 1972, ARCH GES VIRUSFORSCH, V37, P104, DOI 10.1007/BF01241156; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Brown IH, 2006, DEV BIOLOGICALS, V124, P45; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Capua I, 2003, AVIAN DIS, V47, P839, DOI 10.1637/0005-2086-47.s3.839; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Fang TH, 2006, AVIAN DIS, V50, P269, DOI 10.1637/7437-090905R.1; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Garten Wolfgang, 2008, V27, P156; Gronesova P, 2009, ACTA VIROL, V53, P213, DOI 10.4149/av_2009_03_213; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Kaleta EF, 2005, DEUT TIERARZTL WOCH, V112, P448; Kaleta EF, 2004, DEUT TIERARZTL WOCH, V111, P467; Klopfleisch R, 2006, VET PATHOL, V43, P463, DOI 10.1354/vp.43-4-463; Ladman BS, 2008, AVIAN DIS, V52, P623, DOI 10.1637/8282-031208-Reg.1; Li JL, 2010, VIRUS RES, V147, P40, DOI 10.1016/j.virusres.2009.10.002; Li OTW, 2007, J VIROL METHODS, V142, P218, DOI 10.1016/j.jviromet.2007.01.015; Liu M, 2003, AVIAN DIS, V47, P849, DOI 10.1637/0005-2086-47.s3.849; LIU YP, 2007, J JISHOU UNIV, V28, P1; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matrosovich Mikhail N., 2008, V27, P134; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Moresco KA, 2010, AVIAN DIS, V54, P622, DOI 10.1637/8837-040309-Reg.1; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Panigrahy B, 1996, AVIAN DIS, V40, P600, DOI 10.2307/1592270; Penski N, 2011, J VIROL, V85, P7730, DOI 10.1128/JVI.00063-11; Perk S, 2006, DEV BIOLOGICALS, V124, P201; Perkins LEL, 2002, AVIAN DIS, V46, P53, DOI 10.1637/0005-2086(2002)046[0053:POAHKO]2.0.CO;2; Pillai SPS, 2010, AVIAN DIS, V54, P522, DOI 10.1637/8770-033109-Review.1; Pillai SPS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-5; Reemers SS, 2009, VET IMMUNOL IMMUNOP, V132, P91, DOI 10.1016/j.vetimm.2009.04.021; Reperant LA, 2012, VACCINE; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; SCHMIDT RC, 1974, J INFECT DIS, V129, P28, DOI 10.1093/infdis/129.1.28; SEKELLICK MJ, 1986, METHOD ENZYMOL, V119, P115; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Suarez DL, 2000, VET MICROBIOL, V74, P15, DOI 10.1016/S0378-1135(00)00161-9; Swayne D.E., 2008, DIS POULTRY, P153; Tumpey TM, 2004, AVIAN DIS, V48, P167, DOI 10.1637/7103; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Wang ZF, 2010, J VIROL, V84, P11323, DOI 10.1128/JVI.01034-10; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Winter C, 2008, MICROBES INFECT, V10, P367, DOI 10.1016/j.micinf.2007.12.009; WOfAH OIE, 2009, MAN DIAGN TESTS VACC; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Yassine Hadi M., 2010, Animal Health Research Reviews, V11, P53, DOI 10.1017/S1466252310000137; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024	64	30	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42260	10.1371/journal.pone.0042260	http://dx.doi.org/10.1371/journal.pone.0042260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912693	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100009
J	Polus, S; Lerberg, P; Vogel, J; Watananirun, K; Souza, JP; Mathai, M; Gulmezoglu, AM				Polus, Stephanie; Lerberg, Priya; Vogel, Joshua; Watananirun, Kanokwaroon; Souza, Joao Paulo; Mathai, Matthews; Guelmezoglu, A. Metin			Appraisal of WHO Guidelines in Maternal Health Using the AGREE II Assessment Tool	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; APPROPRIATENESS; RECOMMENDATIONS; RELIABILITY; INSTRUMENT; SURGERY; PANEL	In 2007, the World Health Organization (WHO) received a criticism for a lack of transparency and systematic methods in the development of guidelines, which were at that time perceived as substantially driven by expert opinion. In this paper we assessed the quality of maternal and perinatal health guidelines developed since then. We used the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool to evaluate the quality of methodological rigour and transparency of four different WHO guidelines published between 2007 and 2011. Our findings showed high scores among the most recent guidelines on maternal and perinatal health suggesting higher quality. However, there is still potential for improvement, especially in including different stakeholder views, transparency of guidelines regarding the role of the funding body and presentation of the guideline document.	[Polus, Stephanie] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Bavaria, Germany; [Polus, Stephanie; Lerberg, Priya; Vogel, Joshua; Watananirun, Kanokwaroon; Souza, Joao Paulo; Guelmezoglu, A. Metin] World Hlth Org, UNDP UNFPA WHO World Bank Special Programme Res D, Dept Reprod Hlth & Res, Geneva, Switzerland; [Lerberg, Priya] Univ Oslo, Dept Community Med, Oslo, Norway; [Vogel, Joshua] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Watananirun, Kanokwaroon] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Mathai, Matthews] World Hlth Org, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland	University of Munich; United Nations Population Fund; World Health Organization; University of Oslo; University of Western Australia; Mahidol University; World Health Organization	Polus, S (corresponding author), Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Bavaria, Germany.	souzaj@who.int	Souza, João Paulo/G-1982-2010; Vogel, Joshua/K-7649-2019	Souza, João Paulo/0000-0002-2288-4244; Vogel, Joshua/0000-0002-3214-7096				[Anonymous], 2009, WHO GUID MAN POSTP H; Ayanian JZ, 1998, NEW ENGL J MED, V338, P1896, DOI 10.1056/NEJM199806253382608; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Fitch K, 1999, EUR J PUBLIC HEALTH, V9, P181, DOI 10.1093/eurpub/9.3.181; Goonewardene M, 2011, REPROD HLTH LIB GUID; Herrin J, 1997, HEALTH POLICY, V42, P67, DOI 10.1016/S0168-8510(97)00055-9; MacDermid JC, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-18; Mathai M, 2007, B WORLD HEALTH ORGAN, V85, P322, DOI 10.2471/BLT.07.041962; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Oxman, 2007, LANCET, V2, P1883; Raine R, 2004, LANCET, V364, P429, DOI 10.1016/S0140-6736(04)16766-4; The AGREE Collaboration, APPR GUID RES EV; Vader JP, 2000, SPINE, V25, P1831, DOI 10.1097/00007632-200007150-00015; WHO, 2010, WHO HDB GUID DEV; WHO, 2011, WHO REC IND LAB; WHO, 2009, GUID REV COMM GUID REV COMM; World Health Organization, 2003, 24 GLOB PROGR EV HLT; World Health Organization, 2011, REPR HLTH LIB; World Health Organization, 2011, WHO REC PREV TREATM; World Health Organization (WHO), 2007, WHO REC PREV POSTP H	21	43	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e38891	10.1371/journal.pone.0038891	http://dx.doi.org/10.1371/journal.pone.0038891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912662	gold, Green Published			2022-12-27	WOS:000307500100002
J	Yan, G; Zhang, YC; Yu, JL; Yu, Y; Zhang, F; Zhang, ZZ; Wu, AM; Yan, XH; Zhou, Y; Wang, FD				Yan, Guang; Zhang, Yuchao; Yu, Junlei; Yu, Yu; Zhang, Fan; Zhang, Zhuzhen; Wu, Aimin; Yan, Xianghua; Zhou, Yi; Wang, Fudi			Slc39a7/zip7 Plays a Critical Role in Development and Zinc Homeostasis in Zebrafish	PLOS ONE			English	Article							X-RAY-FLUORESCENCE; ACRODERMATITIS-ENTEROPATHICA; SIGNALING PATHWAYS; LIV-1 SUBFAMILY; TRANSPORTER; CELLS; GENE; EXPRESSION; MOUSE; PROTEINS	Background: Slc39a7/Zip7, also known as Ke4, is a member of solute carrier family 39 (Slc39a) and plays a critical role in regulating cell growth and death. Because the function of Zip7 in vivo was unclear, the present study investigated the function of zip7 in vertebrate development and zinc metabolism using zebrafish as a model organism. Principal Finding: Using real-time PCR to determine the gene expression pattern of zip7 during zebrafish development, we found that zip7 mRNA is expressed throughout embryonic development and into maturity. Interestingly, whole mount in situ hybridization revealed that while zip7 mRNA is ubiquitously expressed until 12 hours post-fertilization (hpf); at 24 hpf and beyond, zip7 mRNA was specifically detected only in eyes. Morpholino-antisense (MO) gene knockdown assay revealed that downregulation of zip7 expression resulted in several morphological defects in zebrafish including decreased head size, smaller eyes, shorter palates, and shorter and curved spinal cords. Analysis by synchrotron radiation X-ray fluorescence (SR-XRF) showed reduced concentrations of zinc in brain, eyes, and gills of zip7-MO-injected embryos. Furthermore, incubation of the zip7 knockdown embryos in a zinc-supplemented solution was able to rescue the MO-induced morphological defects. Significance: Our data suggest that zip7 is required for eye, brain, and skeleton formation during early embryonic development in zebrafish. Moreover, zinc supplementation can partially rescue defects resulting from zip7 gene knockdown. Taken together, our data provide critical insight into a novel function of zip7 in development and zinc homeostasis in vivo in zebrafish.	[Yan, Guang; Zhang, Yuchao; Yu, Junlei; Yu, Yu; Zhang, Fan; Zhang, Zhuzhen; Wu, Aimin; Wang, Fudi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Grp Biomet Metab,Key Lab Nutr & Metab,Grad Sch, Shanghai, Peoples R China; [Zhang, Yuchao; Yan, Xianghua] Huazhong Agr Univ, Minist Agr, Key Lab Swine Genet & Breeding, Coll Anim Sci & Technol, Wuhan, Peoples R China; [Yu, Junlei] Nanchang Univ, Sch Life Engn, Nanchang, Peoples R China; [Yu, Junlei] Nanchang Univ, Sch Food Engn, Nanchang, Peoples R China; [Zhou, Yi] Harvard Univ, Sch Med, Childrens Hosp Boston, Stem Cell Program, Boston, MA USA; [Zhou, Yi] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA USA; [Zhou, Yi] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Nanchang University; Nanchang University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Yan, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Grp Biomet Metab,Key Lab Nutr & Metab,Grad Sch, Shanghai, Peoples R China.	wangfd@sibs.ac.cn	Wang, Fudi/L-7888-2018	Wang, Fudi/0000-0001-8730-0003; Zhang, Zhuzhen/0000-0001-6787-3920; Yan, Guang/0000-0001-6784-0010	Ministry of Science and Technology of China (973 Program) [2009CB941400, 2011CB966200]; National Natural Science Foundation of China [10979071, 30970665, 31030039, 30901193]; Science & Technology Commission of Shanghai Municipality grant [10JC1416800]; Chinese Academy of Sciences Hundred Talents Program [KSCX2-YW-R-141]	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences Hundred Talents Program(Chinese Academy of Sciences)	This work was supported by research grants from the Ministry of Science and Technology of China (973 Program) (grant numbers 2009CB941400, 2011CB966200 to FW); the National Natural Science Foundation of China (grant numbers 10979071, 30970665, 31030039 to FW, 30901193 to YY); Science & Technology Commission of Shanghai Municipality grant (grant number 10JC1416800 to FW) and Chinese Academy of Sciences Hundred Talents Program (grant number KSCX2-YW-R-141 to FW). FW is a scholar of the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 1996, GENOMICS, V35, P600, DOI 10.1006/geno.1996.0405; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2011, J INORG BIOCH; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Doerr TD, 1998, NUTRITION, V14, P489, DOI 10.1016/S0899-9007(98)00036-7; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Feeney GP, 2005, BBA-GENE STRUCT EXPR, V1732, P88, DOI 10.1016/j.bbaexp.2005.12.002; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Guo L, 2010, P NATL ACAD SCI USA, V107, P2818, DOI 10.1073/pnas.0914941107; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Kawasaki E, 2012, ENDOCR J; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LAI F, 1994, GENOMICS, V23, P338, DOI 10.1006/geno.1994.1509; Lasswell J, 2000, PLANT CELL, V12, P2395, DOI 10.1105/tpc.12.12.2395; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2003, J NUTR, V133, P342, DOI 10.1093/jn/133.2.342; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Prasad AS, 2001, NUTRITION, V17, P67, DOI 10.1016/S0899-9007(00)00469-X; PRASAD AS, 1995, NUTRITION, V11, P93; Punshon T, 2009, ANN BOT-LONDON, V103, P665, DOI 10.1093/aob/mcn264; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Rungby J, 2010, DIABETOLOGIA, V53, P1549, DOI 10.1007/s00125-010-1793-x; Sehgal VN, 2000, CLIN DERMATOL, V18, P745, DOI 10.1016/S0738-081X(00)00150-4; Stathakis DG, 1999, GENETICS, V153, P361; Sun Yan, 2008, Chinese Journal of Pathology, V37, P660; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Urbanczyk A, 2011, BIOCHEM J, V433, P43, DOI 10.1042/BJ20101111; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang HAO, 2011, ANAL CHEM, V83, P6259, DOI 10.1021/ac200899x; Weaver BP, 2007, BIOL CHEM, V388, P1301, DOI 10.1515/BC.2007.149; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0	56	36	37	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42939	10.1371/journal.pone.0042939	http://dx.doi.org/10.1371/journal.pone.0042939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912764	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500100043
J	Ye, JH; Rong, XM; Xiang, YQ; Xing, YG; Tang, YM				Ye, Jianhong; Rong, Xiaoming; Xiang, Yanqun; Xing, Yigang; Tang, Yamei			A Study of Radiation-Induced Cerebral Vascular Injury in Nasopharyngeal Carcinoma Patients with Radiation-Induced Temporal Lobe Necrosis	PLOS ONE			English	Article							CAROTID-ARTERY STENOSIS; RADIOTHERAPY; IRRADIATION	Purpose: To investigate radiation-induced carotid and cerebral vascular injury and its relationship with radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma (NPC) patients. Methods and Materials: Fifty eight NPC patients with radiation-induced temporal lobe necrosis (TLN) were recruited in the study. Duplex ultrasonography was used to scan bilateral carotid arterials to evaluate the intima-media thickness (IMT) and occurrence of plaque formation. Flow velocities of bilateral middle cerebral arteries (MCAs), internal carotid arteries (ICAs) and basal artery (BA) were estimated through Transcranial Color Doppler (TCD). The results were compared with data from 33 patients who were free from radiation-induced temporal lobe necrosis after radiotherapy and 29 healthy individuals. Results: Significant differences in IMT, occurrence of plaques of ICAs and flow velocities of both MCAs and ICAs were found between patients after radiotherapy and healthy individuals (p<.05). IMT had positive correlation with post radiation interval (p = 0.049). Compared with results from patients without radiation-induced TLN, the mean IMT was significantly thicker in patients with TLN (p<0.001). Plaques were more common in patients with TLN than patients without TLN (p = 0.038). In addition, flow velocities of MCAs and ICAs in patients with TLN were much faster (p<0.001, p<0.001). Among patients with unilateral TLN, flow velocity of MCAs was significantly different between ipsilateral and contralateral sides to the lesion (p = 0.001). Conclusion: Thickening of IMT, occurrence of plaque formation and hemodynamic abnormality are more common in patients after radiotherapy, especially in those with TLN, compared with healthy individuals.	[Ye, Jianhong; Rong, Xiaoming; Xing, Yigang; Tang, Yamei] Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Rong, Xiaoming; Tang, Yamei] Sun Yat Sen Univ, Guangdong Higher Educ Inst, Key Lab Malignant Tumor Gene Regulat & Target The, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Yanqun] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ye, JH (corresponding author), Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	yameitang@hotmail.com		Tang, Yamei/0000-0002-6353-6107	National Natural Science Foundation of China [81072242]; Natural Science Foundation of Guangdong Province [S2011010004708]; Fundamental Research Funds for the Central Universities; Funds for Pearl River Science & Technology Star of Guangzhou City	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Funds for Pearl River Science & Technology Star of Guangzhou City	This work was supported by National Natural Science Foundation of China (No. 81072242), the Natural Science Foundation of Guangdong Province (No. S2011010004708), the Fundamental Research Funds for the Central Universities and Funds for Pearl River Science & Technology Star of Guangzhou City to Yamei Tang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 2004, ORAL ONCOL, V40, P872, DOI 10.1016/j.oraloncology.2003.12.005; Chang YJ, 2009, J VASC SURG, V50, P280, DOI 10.1016/j.jvs.2009.01.033; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Cheng SWK, 2000, ARCH OTOLARYNGOL, V126, P517, DOI 10.1001/archotol.126.4.517; Dorresteijn LDA, 2005, EUR J CANCER, V41, P1026, DOI 10.1016/j.ejca.2005.01.020; Favre JP, 2008, J VASC SURG, V48, P852, DOI 10.1016/j.jvs.2008.05.069; Gianicolo ME, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-8; Kablak-Ziembicka A, 2005, KARDIOL POL, V63, P390; Kablak-Ziembicka Anna, 2005, Kardiol Pol, V63, P381; Lam WMM, 2001, CANCER, V92, P2357, DOI 10.1002/1097-0142(20011101)92:9<2357::AID-CNCR1583>3.0.CO;2-K; Lam WWM, 2003, J ULTRAS MED, V22, P1055, DOI 10.7863/jum.2003.22.10.1055; Lawrence YR, 2010, INT J RADIAT ONCOL, V76, pS20, DOI 10.1016/j.ijrobp.2009.02.091; LEE AWM, 1988, CANCER-AM CANCER SOC, V61, P1535, DOI 10.1002/1097-0142(19880415)61:8<1535::AID-CNCR2820610809>3.0.CO;2-E; Li CS, 2010, CLIN NEUROL NEUROSUR, V112, P682, DOI 10.1016/j.clineuro.2010.05.007; Lyubimova N, 2004, BRIT J RADIOL, V77, P488, DOI 10.1259/bjr/15169876; Man BL, 2009, STROKE, V40, P3211, DOI 10.1161/STROKEAHA.109.557041; Marcel M, 2005, NEUROLOGY, V65, P959, DOI 10.1212/01.wnl.0000176033.64896.c6; Muzaffar K, 2000, LARYNGOSCOPE, V110, P1811, DOI 10.1097/00005537-200011000-00007; Lima MNP, 2011, RADIOTHER ONCOL, V101, P449, DOI 10.1016/j.radonc.2010.03.026; Shichita T, 2009, ANGIOLOGY, V60, P276, DOI 10.1177/0003319709335905; Tang YM, 2010, J NEURO-OPHTHALMOL, V30, P315, DOI 10.1097/WNO.0b013e3181dee914; Thomas GN, 2008, CEREBROVASC DIS, V25, P261, DOI 10.1159/000116303	22	18	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42890	10.1371/journal.pone.0042890	http://dx.doi.org/10.1371/journal.pone.0042890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912759	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100042
J	Choi, JN; Kim, J; Kim, J; Jung, WH; Lee, CH				Choi, Jung Nam; Kim, Jeongmi; Kim, Jiyoung; Jung, Won Hee; Lee, Choong Hwan			Influence of Iron Regulation on the Metabolome of Cryptococcus neoformans	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; CANDIDA-ALBICANS; INOSITOL; MYOINOSITOL; SPECTROMETRY; PATHOGENESIS; ASSOCIATION; DEGRADATION; DEFICIENCY	Iron is an essential nutrient for virtually all organisms and acts as a cofactor for many key enzymes of major metabolic pathways. Furthermore, iron plays a critical role in pathogen-host interactions. In this study, we analyzed metabolomic changes associated with iron availability and the iron regulatory protein Cir1 in a human fungal pathogen Cryptococcus neoformans. Our metabolite analysis revealed that Cir1 influences the glycolytic pathway, ergosterol biosynthesis and inositol metabolism, which require numerous iron-dependent enzymes and play important roles in pathogenesis and antifungal sensitivity of the fungus. Moreover, we demonstrated that increased cellular iron content and altered gene expression in the cir1 mutant contributed to metabolite changes. Our study provides a new insight into iron regulation and the role of Cir1 in metabolome of C. neoformans.	[Choi, Jung Nam; Kim, Jiyoung; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Kim, Jeongmi; Jung, Won Hee] Chung Ang Univ, Dept Biotechnol, Anseong, Gyeonggi Do, South Korea	Konkuk University; Chung Ang University	Choi, JN (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	chlee123@konkuk.ac.kr			National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0027204, MEST 2010-0019306, 20110005810]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by awards from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology 2010-0027204 and MEST 2010-0019306 (CHL), and the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology 20110005810 (WHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Choi YH, 2004, J NAT PROD, V67, P953, DOI 10.1021/np049919c; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Gao XF, 2009, ANAL BIOCHEM, V393, P163, DOI 10.1016/j.ab.2009.06.036; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; HITCHCOCK CA, 1987, J MED VET MYCOL, V25, P29; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Jung WH, 2009, EUKARYOT CELL, V8, P1511, DOI 10.1128/EC.00166-09; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kim DH, 2010, ANALYST, V135, P1235, DOI 10.1039/b923046g; Kouskoumvekaki I, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/525497; Kusano M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-53; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Philpott C.C., 2012, BIOCH BIOPHYS ACTA; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Reynolds TB, 2009, MICROBIOL-SGM, V155, P1386, DOI 10.1099/mic.0.025718-0; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Scherling C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012569; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Shetty HU, 1996, CLIN CHEM, V42, P298; SPECTOR R, 1975, AM J PHYSIOL, V228, P1510, DOI 10.1152/ajplegacy.1975.228.5.1510; SPECTOR R, 1975, J NEUROCHEM, V25, P353, DOI 10.1111/j.1471-4159.1975.tb06980.x; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Villas-Boas SG, 2006, ANAL BIOCHEM, V349, P297, DOI 10.1016/j.ab.2005.11.019; Wang YN, 2011, EUKARYOT CELL, V10, P618, DOI 10.1128/EC.00327-10; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Xue CY, 2010, MBIO, V1, DOI 10.1128/mBio.00084-10	33	52	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41654	10.1371/journal.pone.0041654	http://dx.doi.org/10.1371/journal.pone.0041654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911836	Green Published, gold			2022-12-27	WOS:000306687700133
J	Gismondi, E; Beisel, JN; Cossu-Leguille, C				Gismondi, Eric; Beisel, Jean-Nicolas; Cossu-Leguille, Carole			Polymorphus Minutus Affects Antitoxic Responses of Gammarus Roeseli Exposed to Cadmium	PLOS ONE			English	Article							PARASITE POMPHORHYNCHUS-LAEVIS; ACANTHOCEPHALAN PARASITES; MICROSPORIDIA PARASITES; VERTICAL TRANSMISSION; BIOLOGICAL INVASION; CAROTENOID-PIGMENTS; ENZYME-ACTIVITIES; FIELD EVIDENCE; DAPHNIA-MAGNA; SEX-RATIO	The acanthocephalan parasite Polymorphus minutus is a manipulator of its intermediate host Gammarus roeseli, which favours its transmission to the final host, a water bird. In contaminated environments, G. roeseli have to cope with two stresses, i.e. P. minutus infection and pollutants. As P. minutus survival relies on its host's survival, we investigated the influence of P. minutus on the antitoxic defence capacities and the energy reserves of G. roeseli females after cadmium exposure. In parallel, malondialdehyde, a toxic effect biomarker, was measured in G. roeseli females and in P. minutus. The results revealed that infected females displayed higher cell damage than uninfected ones, despite an apparent increase in reduced glutathione and metallothionein production. In fact, the increase of these antitoxic systems could be counterbalanced by carotenoid intake by the parasite, so that the overall defence system seemed less efficient in infected females than in uninfected ones. In addition, we demonstrated that cadmium induced cell damage in P. minutus, probably linked with cadmium accumulation in the parasite. Altogether, we observed a paradoxical pattern of responses suggesting that P. minutus increases cadmium toxicity in G. roeseli females although (i) it tends to increase several host antitoxic defence capacities and (ii) it bears part of the pollutant, as reflected by cell damage in the parasite.	[Gismondi, Eric; Beisel, Jean-Nicolas; Cossu-Leguille, Carole] Univ Lorraine, CNRS UMR 7146, LIEBE, Metz, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Gismondi, E (corresponding author), Univ Lorraine, CNRS UMR 7146, LIEBE, Metz, France.	eric.gismondi@hotmail.fr	Beisel, Jean-Nicolas/H-4392-2011; Gismondi, Eric/ABC-4356-2020	Beisel, Jean-Nicolas/0000-0002-1935-7689; Cossu-Leguille, Carole/0000-0002-6284-4415; Gismondi, Eric/0000-0003-3102-3443	French Ministry of Education and Research (Ministere de 458 l'Enseignement Superieur et de la Recherche)	French Ministry of Education and Research (Ministere de 458 l'Enseignement Superieur et de la Recherche)	This study was supported by the French Ministry of Education and Research (Ministere de 458 l'Enseignement Superieur et de la Recherche), which the authors sincerely thank here. The present work is part of the research program EC2CO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhama J, 2006, J CHROMATOGR A, V1107, P52, DOI 10.1016/j.chroma.2005.11.057; Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; Babin A, 2010, AM NAT, V176, P234, DOI 10.1086/653670; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; BARRETT J, 1968, COMP BIOCHEM PHYSIOL, V27, P575, DOI 10.1016/0010-406X(68)90254-5; Baudrimont M, 2006, MAR POLLUT BULL, V52, P494, DOI 10.1016/j.marpolbul.2005.09.035; BEHRENS WA, 1991, LIPIDS, V26, P232, DOI 10.1007/BF02543977; Bigot A, 2011, ENVIRON TOXICOL, V26, P623, DOI 10.1002/tox.20599; Bollache L, 2002, J INVERTEBR PATHOL, V79, P102, DOI 10.1016/S0022-2011(02)00027-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARGILL AS, 1985, FRESHWATER BIOL, V15, P455, DOI 10.1111/j.1365-2427.1985.tb00215.x; Cezilly F, 2005, BEHAV PROCESS, V68, P223, DOI 10.1016/j.beproc.2004.08.013; Cornet S, 2010, PARASITOLOGY, V137, P137, DOI 10.1017/S0031182009991077; Cornet S, 2009, INT J PARASITOL, V39, P221, DOI 10.1016/j.ijpara.2008.06.007; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Forrow DM, 2000, ENVIRON TOXICOL CHEM, V19, P2100, DOI 10.1002/etc.5620190820; Gaillard M, 2004, COMP BIOCHEM PHYS B, V139, P129, DOI 10.1016/j.cbpc.2004.07.001; GILCHRIST BM, 1972, COMP BIOCHEM PHYSIOL, V42, P263, DOI 10.1016/0305-0491(72)90273-8; Gismondi E, 2012, PARASITOLOGY, V139, P1054, DOI 10.1017/S0031182012000315; Gismondi E, 2012, ECOTOXICOLOGY, V21, P1188, DOI 10.1007/s10646-012-0873-8; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Haine ER, 2007, PARASITOLOGY, V134, P1363, DOI 10.1017/S0031182007002715; Haine ER, 2004, INT J PARASITOL, V34, P1137, DOI 10.1016/j.ijpara.2004.06.006; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1, DOI 10.2277/ 0521850088; Lagrue C, 2007, ECOLOGY, V88, P2839, DOI 10.1890/06-2105.1; Langston W.J., 1998, METAL METABOLISM AQU; LEE WY, 1981, WATER AIR SOIL POLL, V15, P185, DOI 10.1007/BF00161252; LEROY P, 1993, CHROMATOGRAPHIA, V36, P130, DOI 10.1007/BF02263849; Marcogliese DJ, 2005, DIS AQUAT ORGAN, V63, P77, DOI 10.3354/dao063077; Medoc V, 2006, INT J PARASITOL, V36, P1351, DOI 10.1016/j.ijpara.2006.07.001; Medoc V, 2011, OIKOS, V120, P1452, DOI 10.1111/j.1600-0706.2011.19585.x; Medoc V, 2009, NATURWISSENSCHAFTEN, V96, P513, DOI 10.1007/s00114-008-0503-8; Minguez L, 2011, ECOTOXICOLOGY; Minguez L, 2009, ENVIRON RES, V109, P843, DOI 10.1016/j.envres.2009.07.012; Negre-Sadargues G, 2000, COMP BIOCHEM PHYS A, V127, P293, DOI 10.1016/S1095-6433(00)00258-0; PALOZZA P, 1992, METHOD ENZYMOL, V213, P403; Parmentier C, 1998, J CHROMATOGR B, V719, P37, DOI 10.1016/S0378-4347(98)00414-9; Paul-Pont I, 2010, ENVIRON POLLUT, V158, P3401, DOI 10.1016/j.envpol.2010.07.028; Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1; Rauque CA, 2009, J INVERTEBR PATHOL, V100, P35, DOI 10.1016/j.jip.2008.10.001; Rigaud T, 2003, PARASITOLOGY, V127, P571, DOI 10.1017/S0031182003004050; ROESIJADI G, 1992, AQUAT TOXICOL, V22, P81, DOI 10.1016/0166-445X(92)90026-J; Siddall R, 1998, PARASITOL RES, V84, P573, DOI 10.1007/s004360050451; Sparkes TC, 1996, OECOLOGIA, V106, P166, DOI 10.1007/BF00328595; Sroda S, 2011, ECOTOXICOLOGY, V20, P264, DOI 10.1007/s10646-010-0578-9; STILLMAN MJ, 1995, COORDIN CHEM REV, V144, P461, DOI 10.1016/0010-8545(95)01173-M; Sures B, 2007, J HELMINTHOL, V81, P191, DOI 10.1017/S0022149X07751465; SURES B, 1995, PARASITOL RES, V81, P494, DOI 10.1007/BF00931792; Sures B, 1999, PARASITOL TODAY, V15, P16, DOI 10.1016/S0169-4758(98)01358-1; Sures B, 2005, ENVIRON RES, V98, P83, DOI 10.1016/j.envres.2004.05.010; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Sures B, 2002, ENVIRON POLLUT, V119, P333, DOI 10.1016/S0269-7491(01)00340-2; Taraschewski H, 2000, ADV PARASIT, V46, P1, DOI 10.1016/S0065-308X(00)46008-2; Terry RS, 2004, P ROY SOC B-BIOL SCI, V271, P1783, DOI 10.1098/rspb.2004.2793; Thomas F, 2000, J PARASITOL, V86, P650, DOI 10.1645/0022-3395(2000)086[0650:DPTEIG]2.0.CO;2; THOMAS F, 1995, OECOLOGIA, V104, P259, DOI 10.1007/BF00328591; Vasseur P, 2004, ENVIRON TOXICOL, V19, P433, DOI 10.1002/tox.20024	57	14	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41475	10.1371/journal.pone.0041475	http://dx.doi.org/10.1371/journal.pone.0041475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911795	gold, Green Published			2022-12-27	WOS:000306644600079
J	Iyer, P; Lalane, R; Morris, C; Challa, P; Vann, R; Rao, PV				Iyer, Padma; Lalane, Robert, III; Morris, Corey; Challa, Pratap; Vann, Robin; Rao, Ponugoti Vasantha			Autotaxin-Lysophosphatidic Acid Axis Is a Novel Molecular Target for Lowering Intraocular Pressure	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INCREASES OUTFLOW RESISTANCE; HUMAN AQUEOUS-HUMOR; TRABECULAR MESHWORK; EXTRACELLULAR-MATRIX; LYSOPHOSPHOLIPASE-D; INCREASED LEVEL; EYES; MODULATION; FACILITY	Primary open-angle glaucoma is the second leading cause of blindness in the United States and is commonly associated with elevated intraocular pressure (IOP) resulting from diminished aqueous humor (AH) drainage through the trabecular pathway. Developing effective therapies for increased IOP in glaucoma patients requires identification and characterization of molecular mechanisms that regulate IOP and AH outflow. This study describes the identification and role of autotaxin (ATX), a secretory protein and a major source for extracellular lysophosphatidic acid (LPA), in regulation of IOP in a rabbit model. Quantitative proteomics analysis identified ATX as an abundant protein in both human AH derived from non-glaucoma subjects and in AH from different animal species. The lysophospholipase D (LysoPLD) activity of ATX was found to be significantly elevated (by similar to 1.8 fold; n = 20) in AH derived from human primary open angle glaucoma patients as compared to AH derived from age-matched cataract control patients. Immunoblotting analysis of conditioned media derived from primary cultures of human trabecular meshwork (HTM) cells has confirmed secretion of ATX and the ability of cyclic mechanical stretch of TM cells to increase the levels of secreted ATX. Topical application of a small molecular chemical inhibitor of ATX (S32826), which inhibited AH LysoPLD activity in vitro (by >90%), led to a dose-dependent and significant decrease of IOP in Dutch-Belted rabbits. Single intracameral injection of S32826 (similar to 2 mu M) led to significant reduction of IOP in rabbits, with the ocular hypotensive response lasting for more than 48 hrs. Suppression of ATX expression in HTM cells using small-interfering RNA (siRNA) caused a decrease in actin stress fibers and myosin light chain phosphorylation. Collectively, these observations indicate that the ATX-LPA axis represents a potential therapeutic target for lowering IOP in glaucoma patients.	[Iyer, Padma; Lalane, Robert, III; Morris, Corey; Challa, Pratap; Vann, Robin; Rao, Ponugoti Vasantha] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA; [Rao, Ponugoti Vasantha] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; Duke University	Iyer, P (corresponding author), Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA.	rao00011@mc.duke.edu	Vann, Robin/AAU-7051-2020	Vann, Robin/0000-0002-8209-4746	National Eye Institute, National Institutes of Health [RO1 EY18950, EY18950]	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, National Institutes of Health grants RO1 EY18950 and EY18950 ARRA stimulus supplement to PVR. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Chudgar SM, 2006, MOL VIS, V12, P1117; Clair T, 2003, CANCER RES, V63, P5446; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Ederer F, 2000, ARCH OPHTHALMOL-CHIC, V118, P1639; Fautsch MP, 2006, INVEST OPHTH VIS SCI, V47, P213, DOI 10.1167/iovs.05-0334; Ferry G, 2008, J PHARMACOL EXP THER, V327, P809, DOI 10.1124/jpet.108.141911; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Gijsbers R, 2003, FEBS LETT, V538, P60, DOI 10.1016/S0014-5793(03)00133-9; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Howell KG, 2010, J GLAUCOMA, V19, P569, DOI 10.1097/IJG.0b013e3181d13020; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Knepper PA, 2002, INVEST OPHTH VIS SCI, V43, P133; Kumar J, 2011, J CELL BIOCHEM, V112, P600, DOI 10.1002/jcb.22950; Lee AJ, 2011, EXPERT OPIN EMERG DR, V16, P137, DOI 10.1517/14728214.2011.521631; Liton PB, 2005, BIOCHEM BIOPH RES CO, V337, P1229, DOI 10.1016/j.bbrc.2005.09.182; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; MacKay EO, 2008, VET OPHTHALMOL, V11, P177, DOI 10.1111/j.1463-5224.2008.00617.x; Maddala R, 2011, DEV BIOL, V357, P179, DOI 10.1016/j.ydbio.2011.06.036; Mettu PS, 2004, INVEST OPHTH VIS SCI, V45, P2263, DOI 10.1167/iovs.03-0960; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Pattabiraman PP, 2012, AM J PHYSIOL-CELL PH, V302, pC979, DOI 10.1152/ajpcell.00396.2011; Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Stamer WD, 2009, EXP EYE RES, V89, P980, DOI 10.1016/j.exer.2009.08.008; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tamm ER, 2007, SURV OPHTHALMOL, V52, pS101, DOI 10.1016/j.survophthal.2007.08.002; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Toris CB, 2010, CURR MOL MED, V10, P824; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wiederholt M, 2000, PROG RETIN EYE RES, V19, P271, DOI 10.1016/S1350-9462(99)00015-4	47	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42627	10.1371/journal.pone.0042627	http://dx.doi.org/10.1371/journal.pone.0042627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916143	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800023
J	Attwood, AS; Scott-Samuel, NE; Stothart, G; Munafo, MR				Attwood, Angela S.; Scott-Samuel, Nicholas E.; Stothart, George; Munafo, Marcus R.			Glass Shape Influences Consumption Rate for Alcoholic Beverages	PLOS ONE			English	Article							DRINKING; PSYCHOPHYSICS; VOLUME; JUDGMENTS; CONTEXT; SAMPLE; HEALTH; WINE; CUES	Background: High levels of alcohol consumption and increases in heavy episodic drinking (binge drinking) are a growing public concern, due to their association with increased risk of personal and societal harm. Alcohol consumption has been shown to be sensitive to factors such as price and availability. The aim of this study was to explore the influence of glass shape on the rate of consumption of alcoholic and non-alcoholic beverages. Methods: This was an experimental design with beverage (lager, soft drink), glass (straight, curved) and quantity (6 fl oz, 12 fl oz) as between-subjects factors. Social male and female alcohol consumers (n = 159) attended two experimental sessions, and were randomised to drink either lager or a soft drink from either a curved or straight-sided glass, and complete a computerised task identifying perceived midpoint of the two glasses (order counterbalanced). Ethical approval was granted by the Faculty of Science Research Ethics Committee at the University of Bristol. The primary outcome measures were total drinking time of an alcoholic or non-alcoholic beverage, and perceptual judgement of the half-way point of a straight and curved glass. Results: Participants were 60% slower to consume an alcoholic beverage from a straight glass compared to a curved glass. This effect was only observed for a full glass and not a half-full glass, and was not observed for a non-alcoholic beverage. Participants also misjudged the half-way point of a curved glass to a greater degree than that of a straight glass, and there was a trend towards a positive association between the degree of error and total drinking time. Conclusions: Glass shape appears to influence the rate of drinking of alcoholic beverages. This may represent a modifiable target for public health interventions.	[Attwood, Angela S.; Scott-Samuel, Nicholas E.; Stothart, George; Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England	University of Bristol	Attwood, AS (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	angela.attwood@bristol.ac.uk	Attwood, Angela S/F-7071-2011; Munafo, Marcus/AAE-2306-2020	Attwood, Angela S/0000-0003-3696-4349; Munafo, Marcus/0000-0002-4049-993X; Stothart, George/0000-0003-1323-1580; Scott-Samuel, Nicholas/0000-0002-8270-8437	Alcohol Education and Research small grant [SG 09/10 134]	Alcohol Education and Research small grant	This research was funded by an Alcohol Education and Research small grant SG 09/10 134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHN MJ, 1995, ALCOHOL CLIN EXP RES, V19, P600, DOI 10.1111/j.1530-0277.1995.tb01554.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunstrom JM, 2011, P NUTR SOC, V70, P155, DOI 10.1017/S002966511000491X; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; Dantzer C, 2006, J AM COLL HLTH, V55; FOY DW, 1978, ADDICT BEHAV, V3, P39, DOI 10.1016/0306-4603(78)90009-6; FRAYMAN BJ, 1981, PERCEPT PSYCHOPHYS, V29, P56, DOI 10.3758/BF03198840; Gill JS, 2004, HEALTH EDUC RES, V19, P485, DOI 10.1093/her/cyg059; Higgs S, 2008, ALCOHOL ALCOHOLISM, V43, P630, DOI 10.1093/alcalc/agn053; HUANG CD, 2003, ECONOMETRIC MODELS A; Kahrimanovic M, 2010, ACTA PSYCHOL, V134, P385, DOI 10.1016/j.actpsy.2010.03.011; Kerr WC, 2005, ALCOHOL CLIN EXP RES, V29, P2015, DOI 10.1097/01.alc.0000187596.92804.bd; Munafo MR, 2011, ADDICTION, V106, P1505, DOI 10.1111/j.1360-0443.2011.03430.x; Nees F, 2012, ADDICT BIOL, V17, P441, DOI 10.1111/j.1369-1600.2011.00347.x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petit G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037466; Piaget J, 1968, AIDS RES HUM RETR S1, V162; Raghubir P, 1999, J MARKETING RES, V36, P313, DOI 10.2307/3152079; Room R, 2004, ADDICTION, V99, P1083, DOI 10.1111/j.1360-0443.2004.00803.x; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Smith L, 2009, DRINKING UK EXPLORAT; STANEK RJ, 1968, PSYCHON SCI, V11, P121; Tobin C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-58; Wansink B, 2005, BRIT MED J, V331, P1512, DOI 10.1136/bmj.331.7531.1512; Weitzman ER, 2003, J ADOLESCENT HEALTH, V32, P26, DOI 10.1016/S1054-139X(02)00457-3	26	41	41	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43007	10.1371/journal.pone.0043007	http://dx.doi.org/10.1371/journal.pone.0043007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912776	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700032
J	Lim, U; Turner, SD; Franke, AA; Cooney, RV; Wilkens, LR; Ernst, T; Albright, CL; Novotny, R; Chang, LD; Kolonel, LN; Murphy, SP; Le Marchand, L				Lim, Unhee; Turner, Stephen D.; Franke, Adrian A.; Cooney, Robert V.; Wilkens, Lynne R.; Ernst, Thomas; Albright, Cheryl L.; Novotny, Rachel; Chang, Linda; Kolonel, Laurence N.; Murphy, Suzanne P.; Le Marchand, Loic			Predicting Total, Abdominal, Visceral and Hepatic Adiposity with Circulating Biomarkers in Caucasian and Japanese American Women	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; MAGNETIC-RESONANCE-SPECTROSCOPY; INSULIN-RESISTANCE; METABOLIC SYNDROME; LIVER FAT; WAIST CIRCUMFERENCE; SUBCUTANEOUS FAT; MEASUREMENT SITE; RISK-FACTOR; OBESITY	Background: Characterization of abdominal and intra-abdominal fat requires imaging, and thus is not feasible in large epidemiologic studies. Objective: We investigated whether biomarkers may complement anthropometry (body mass index [BMI], waist circumference [WC], and waist-hip ratio [WHR]) in predicting the size of the body fat compartments by analyzing blood biomarkers, including adipocytokines, insulin resistance markers, sex steroid hormones, lipids, liver enzymes and gastro-neuropeptides. Methods: Fasting levels of 58 blood markers were analyzed in 60 healthy, Caucasian or Japanese American postmenopausal women who underwent anthropometric measurements, dual energy X-ray absorptiometry (DXA), and abdominal magnetic resonance imaging. Total, abdominal, visceral and hepatic adiposity were predicted based on anthropometry and the biomarkers using Random Forest models. Results: Total body fat was well predicted by anthropometry alone (R-2 = 0.85), by the 5 best predictors from the biomarker model alone (leptin, leptin-adiponectin ratio [LAR], free estradiol, plasminogen activator inhibitor-1 [PAI1], alanine transaminase [ALT]; R-2 = 0.69), or by combining these 5 biomarkers with anthropometry (R-2 = 0.91). Abdominal adiposity (DXA trunk-to-periphery fat ratio) was better predicted by combining the two types of predictors (R-2 = 0.58) than by anthropometry alone (R-2 = 0.53) or the 5 best biomarkers alone (25(OH)-vitamin D-3, insulin-like growth factor binding protein-1 [IGFBP1], uric acid, soluble leptin receptor [sLEPR], Coenzyme Q10; R-2 = 0.35). Similarly, visceral fat was slightly better predicted by combining the predictors (R-2 = 0.68) than by anthropometry alone (R-2 = 0.65) or the 5 best biomarker predictors alone (leptin, C-reactive protein [CRP], LAR, lycopene, vitamin D-3; R-2 = 0.58). Percent liver fat was predicted better by the 5 best biomarker predictors (insulin, sex hormone binding globulin [SHBG], LAR, alpha-tocopherol, PAI1; R-2 = 0.42) or by combining the predictors (R-2 = 0.44) than by anthropometry alone (R-2 = 0.29). Conclusion: The predictive ability of anthropometry for body fat distribution may be enhanced by measuring a small number of biomarkers. Studies to replicate these data in men and other ethnic groups are warranted.	[Lim, Unhee; Wilkens, Lynne R.; Novotny, Rachel; Kolonel, Laurence N.; Murphy, Suzanne P.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Turner, Stephen D.] Univ Virginia, Sch Med, Bioinformat Core, Charlottesville, VA 22908 USA; [Franke, Adrian A.] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA; [Cooney, Robert V.] Univ Hawaii, John A Burns Sch Med, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Ernst, Thomas; Chang, Linda] Univ Hawaii, John A Burns Sch Med, Div Neurol, Honolulu, HI 96822 USA; [Albright, Cheryl L.] Univ Hawaii, Ctr Canc, Prevent & Control Program, Honolulu, HI 96822 USA; [Albright, Cheryl L.] Univ Hawaii, Sch Nursing, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Virginia; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii System; University of Hawaii System; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii System	Lim, U (corresponding author), Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA.	ulim@cc.hawaii.edu	Turner, Stephen/GXM-4654-2022; Lim, Unhee/AEA-8591-2022	Lim, Unhee/0000-0001-6221-7190	University of Hawaii Cancer Center; National Cancer Institute [R37 CA54281, P30 CA71789]; National Institutes of Health [5P20-RR11091, G12-RR003061]; National Institutes of Health - National Center for Research Resources [P20 RR11091]; NATIONAL CANCER INSTITUTE [P30CA071789, R37CA054281] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR011091] Funding Source: NIH RePORTER	University of Hawaii Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this study was provided in part by the University of Hawaii Cancer Center (SPM, RN, LLM) and individual research funds (UL, LLM), as well as by the National Cancer Institute for the Multiethnic Cohort (R37 CA54281: LNK) and for the University of Hawaii Cancer Center's Shared Resources (P30 CA71789), the National Institutes of Health for the University of Hawaii-Queen's Medical Center MR Research Center (5P20-RR11091 and G12-RR003061: TE and LC), and the National Institutes of Health - National Center for Research Resources for the University of Hawaii Clinical Research Center (P20 RR11091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bea JW, 2011, CLIN CHEM LAB MED, V49, P817, DOI 10.1515/CCLM.2011.122; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Carroll JF, 2009, OBESITY, V17, P1420, DOI 10.1038/oby.2008.657; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Fierbinteanu-Braticevici C, 2010, WORLD J GASTROENTERO, V16, P4784, DOI 10.3748/wjg.v16.i38.4784; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Guiu B, 2009, EUR RADIOL, V19, P1786, DOI 10.1007/s00330-009-1330-9; Harrell FE, 2001, REGRESSION MODELING; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Indulekha K, 2011, CLIN BIOCHEM, V44, P281, DOI 10.1016/j.clinbiochem.2010.12.015; Ishii M, 2005, TOHOKU J EXP MED, V206, P23, DOI 10.1620/tjem.206.23; Ix JH, 2009, J CLIN ENDOCR METAB, V94, P4492, DOI 10.1210/jc.2009-0916; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Koh SJ, 2008, CLIN CHIM ACTA, V389, P45, DOI 10.1016/j.cca.2007.11.017; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Kuk JL, 2006, DIABETES CARE, V29, P679, DOI 10.2337/diacare.29.03.06.dc05-1500; Kumagai S, 2005, METAB SYNDR RELAT D, V3, P85, DOI 10.1089/met.2005.3.85; Lee CG, 2009, J CLIN ENDOCR METAB, V94, P1104, DOI 10.1210/jc.2008-0701; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Li CY, 2009, AM J CLIN NUTR, V90, P1457, DOI 10.3945/ajcn.2009.28141; Lim U, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.2; Lim U, 2012, J ACAD NUTR IN PRESS; Loomba R, 2010, GASTROENTEROLOGY, V139, P836, DOI 10.1053/j.gastro.2010.06.009; Ludescher B, 2009, INVEST RADIOL, V44, P712, DOI 10.1097/RLI.0b013e3181afbb1e; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Nakamura Y, 2009, OBESITY, V17, P1269, DOI 10.1038/oby.2009.3; Nielsen TL, 2007, J CLIN ENDOCR METAB, V92, P2696, DOI 10.1210/jc.2006-1847; Nobili V, 2006, EUR J ENDOCRINOL, V155, P735, DOI 10.1530/eje.1.02288; Oh TH, 2008, J GASTROEN HEPATOL, V23, P411, DOI 10.1111/j.1440-1746.2007.05125.x; Rodenburg W, 2008, PHYSIOL GENOMICS, V33, P78, DOI 10.1152/physiolgenomics.00167.2007; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Sorensen HT, 2003, J CLIN GASTROENTEROL, V36, P356, DOI 10.1097/00004836-200304000-00015; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tanko LB, 2004, CIRCULATION, V110, P2246, DOI 10.1161/01.CIR.0000144470.55149.E5; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Tonjes A, 2010, CURR PHARM DESIGN, V16, P1921, DOI 10.2174/138161210791208938; Turer AT, 2012, J CLIN ENDOCRINOL ME; van Dijk SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014422; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Wajchenberg BL, 2002, HORM METAB RES, V34, P616, DOI 10.1055/s-2002-38256; Wang S, 2009, INT J OBESITY, V33, P481, DOI 10.1038/ijo.2008.277; Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079	58	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43502	10.1371/journal.pone.0043502	http://dx.doi.org/10.1371/journal.pone.0043502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912885	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700113
J	Pais, R; Bhowmick, S; Chattopadhyay, S; Lemire, Y; Sharafieh, R; Yadav, R; O'Rourke, J; Cone, RE				Pais, Roshan; Bhowmick, Sourojit; Chattopadhyay, Subhasis; Lemire, Yen; Sharafieh, Roshanak; Yadav, Rajwahrdan; O'Rourke, James; Cone, Robert E.			An Intracameral Injection of Antigen Induces In Situ Chemokines and Cytokines Required for the Generation of Circulating Immunoregulatory Monocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; IMMUNE DEVIATION ACAID; ANTERIOR-CHAMBER; TGF-BETA; T-CELLS; DIVERGENT ROLES; BONE-MARROW; INFLAMMATORY MONOCYTES; PRESENTING CELLS	Anterior Chamber-Associated Immune Deviation (ACAID) induced by an intracameral injection of antigen generates antigen-specific regulatory splenic T cells that suppress specifically cell-mediated immunity specific for the injected antigen. Circulating F4/80(+) cells recovered from mice receiving an intracameral injection of antigen are thought to be ocular in origin and induce the development of thymic and splenic regulatory T cells. We have shown previously that after the intracameral injection of antigen there is a CCR2/CCL2-dependent infiltration of circulating F4/80(+) cells into the anterior chamber associated with the generation of circulating, ACAID-inducing F4/80(+) monocytes. Here we tested the hypothesis that the intracameral injection of antigen induces events in the anterior chamber that are associated with the induction of circulating immunoregulatory monocytes that induce the suppression of cell-mediated immunity. The intracameral injection of antigen resulted in aqueous humor (i) a time-dependent increase of CCL2 and CCL7, (ii) a transient increase in TNF-alpha, and (iii) an infiltration of CD11b(hi), Gr1(hi) and F4/80(+) as well as F4/80(-) and Gr1(hi) peripheral blood cells into the anterior chamber. Further characterization of these F4/80(+) cells revealed that they are Ly 6C(hi), LY6G(lo) or negative, 7/4 (LY6B)(hi), CD115(+), CD45(+), CD49B(+), and CD62 L+. Antibody-mediated neutralization of TGF-beta in situ in the anterior chamber prevented the induction of circulating, ACAID-inducing monocytes and ACAID. These cells did not increase in the irides of ACAID-refractory CCR2-/- and CCL2-/- mice that received an intracameral injection of antigen. Our results extend our suggestion that ACAID is initiated as the result of a mild proinflammatory response to intracameral injection that results in the infiltration of a CCR2(+) subset of monocytes into the anterior chamber where there is a TGF-beta-dependent induction of an immunosuppressive phenotype in the infiltrated monocytes that recirculate to induce antigen-specific regulatory T cells.	[Pais, Roshan; Bhowmick, Sourojit; Chattopadhyay, Subhasis; Lemire, Yen; Sharafieh, Roshanak; Yadav, Rajwahrdan; O'Rourke, James; Cone, Robert E.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA	University of Connecticut	Pais, R (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	Cone@UCHC.EDU	Pais, Roshan/AAV-3585-2021		United States Public Health Service/National Eye Institute [EY017289, EY017537]; Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY017537, R01EY017289] Funding Source: NIH RePORTER	United States Public Health Service/National Eye Institute; Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Work in this laboratory is supported by United States Public Health Service/National Eye Institute grants EY017289, EY017537 (p://www.nei.nih.gov) and the Connecticut Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armant M, 1999, J EXP MED, V190, P1175, DOI 10.1084/jem.190.8.1175; Ashour HM, 2006, J IMMUNOL, V177, P8331, DOI 10.4049/jimmunol.177.12.8331; Augier S, 2010, J IMMUNOL, V185, P7165, DOI 10.4049/jimmunol.0902583; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; Bian ZM, 2004, INVEST OPHTH VIS SCI, V45, P1887, DOI 10.1167/iovs.03-0608; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Camelo S, 2003, INVEST OPHTH VIS SCI, V44, P5212, DOI 10.1167/iovs.03-0181; Cone RE, 2009, OPHTHALMOLOGY EYE DI, V2009, P133; Cone RE, 2010, OPHTHALMOL EYE DIS, V2, P57, DOI 10.4137/OED.S6113; Cone Robert E., 2008, V94, P138, DOI 10.1159/000154998; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Dullforce PA, 2004, J IMMUNOL, V172, P6701, DOI 10.4049/jimmunol.172.11.6701; FERGUSON TA, 1994, INVEST OPHTH VIS SCI, V35, P2643; Ferguson TA, 1994, INVEST OPHTH VIS SCI, V35, P085; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gelman AE, 2010, AM J TRANSPLANT, V10, P1189, DOI 10.1111/j.1600-6143.2010.03101.x; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; HARA Y, 1993, J IMMUNOL, V151, P5162; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kezuka T, 2004, OCUL IMMUNOL INFLAMM, V12, P17, DOI 10.1076/ocii.12.1.17.28066; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1803; Khera TK, 2010, PROG RETIN EYE RES, V29, P610, DOI 10.1016/j.preteyeres.2010.08.003; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Kruger Bernd, 2008, Transplant Rev (Orlando), V22, P131, DOI 10.1016/j.trre.2007.12.002; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Li X, 2006, IMMUNOLOGY, V117, P566, DOI 10.1111/j.1365-2567.2006.02333.x; Liss C, 2001, INT J CANCER, V93, P781, DOI 10.1002/ijc.1407; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Ma HL, 2010, ARTHRITIS RHEUM-US, V62, P430, DOI 10.1002/art.27203; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Masli S, 2006, INT IMMUNOL, V18, P689, DOI 10.1093/intimm/dxl006; Masli S, 2009, IMMUNOLOGY, V127, P62, DOI 10.1111/j.1365-2567.2008.02933.x; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Niederkorn JY, 2002, CRIT REV IMMUNOL, V22, P13; Ohta K, 2000, INVEST OPHTH VIS SCI, V41, P2591; Peschon JJ, 1998, J IMMUNOL, V160, P943; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sakamoto T, 2000, GENE THER, V7, P1915, DOI 10.1038/sj.gt.3301320; Schilling M, 2009, BRAIN RES, V1289, P79, DOI 10.1016/j.brainres.2009.06.054; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Turner SJ, 1998, J BIOL CHEM, V273, P25987, DOI 10.1074/jbc.273.40.25987; Vega JL, 2009, AM J PATHOL, V175, P1218, DOI 10.2353/ajpath.2009.090264; Wang YF, 2001, J LEUKOCYTE BIOL, V69, P741; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; WILBANKS GA, 1991, J IMMUNOL, V146, P3018; Wilbanks GA, 1992, EUR J IMMUNOL, V22, P031; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Xu YY, 2008, BRIT J HAEMATOL, V142, P192, DOI 10.1111/j.1365-2141.2008.07130.x; Yamagami S, 2004, INVEST OPHTH VIS SCI, V45, P515, DOI 10.1167/iovs.03-0912; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Zamiri P, 2007, OCUL IMMUNOL INFLAMM, V15, P279, DOI 10.1080/09273940701382432	74	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43182	10.1371/journal.pone.0043182	http://dx.doi.org/10.1371/journal.pone.0043182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912822	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700058
J	Zhou, WJ; Chen, LG; Paul, J; Yang, SF; Li, FZ; Sampson, K; Woodgett, JR; Beaulieu, JM; Gamble, KL; Li, XH				Zhou, Wenjun; Chen, Ligong; Paul, Jodi; Yang, Sufen; Li, Fuzeng; Sampson, Karen; Woodgett, Jim R.; Beaulieu, Jean Martin; Gamble, Karen L.; Li, Xiaohua			The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; 5-HT1B RECEPTORS; IN-VIVO; AGGRESSIVE-BEHAVIOR; SIGNAL-TRANSDUCTION; ADENYLATE-CYCLASE; FRONTAL-CORTEX; CELL-SURVIVAL; ANXIETY-LIKE; OPEN-FIELD	Glycogen synthase kinase-3 (GSK3) is a constitutively active protein kinase in brain. Increasing evidence has shown that GSK3 acts as a modulator in the serotonin neurotransmission system, including direct interaction with serotonin 1B (5-HT1B) receptors in a highly selective manner and prominent modulating effect on 5-HT1B receptor activity. In this study, we utilized the serotonin neuron-selective GSK3 beta knockout (snGSK3 beta-KO) mice to test if GSK3 beta in serotonin neurons selectively modulates 5-HT1B autoreceptor activity and function. The snGSK3 beta-KO mice were generated by crossbreeding GSK3 beta-floxed mice and ePet1-Cre mice. These mice had normal growth and physiological characteristics, similar numbers of tryptophan hydroxylase-2 (TpH2)-expressing serotonin neurons, and the same brain serotonin content as in littermate wild type mice. However, the expression of GSK3 beta in snGSK3 beta-KO mice was diminished in TpH2-expressing serotonin neurons. Compared to littermate wild type mice, snGSK3 beta-KO mice had a reduced response to the 5-HT1B receptor agonist anpirtoline in the regulation of serotonergic neuron firing, cAMP production, and serotonin release, whereas these animals displayed a normal response to the 5-HT1A receptor agonist 8-OH-DPAT. The effect of anpirtoline on the horizontal, center, and vertical activities in the open field test was differentially affected by GSK3 beta depletion in serotonin neurons, wherein vertical activity, but not horizontal activity, was significantly altered in snGSK3 beta-KO mice. In addition, there was an enhanced anti-immobility response to anpirtoline in the tail suspension test in snGSK3 beta-KO mice. Therefore, results of this study demonstrated a serotonin neuron-targeting function of GSK3 beta by regulating 5-HT1B autoreceptors, which impacts serotonergic neuron firing, serotonin release, and serotonin-regulated behaviors.	[Zhou, Wenjun; Chen, Ligong; Paul, Jodi; Yang, Sufen; Li, Fuzeng; Gamble, Karen L.; Li, Xiaohua] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Sampson, Karen] Univ Laval, Dept Phys, Fac Sci & Engn, Quebec City, PQ G1K 7P4, Canada; [Woodgett, Jim R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Beaulieu, Jean Martin] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada	University of Alabama System; University of Alabama Birmingham; Laval University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Laval University	Zhou, WJ (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	xiaohua.li@stvhs.com	Woodgett, Jim/F-1087-2010; Beaulieu, Jean-Martin/A-7598-2008; Zhou, Wenjun/H-2824-2016	Woodgett, Jim/0000-0003-3731-5797; Beaulieu, Jean-Martin/0000-0002-0446-7447; Zhou, Wenjun/0000-0003-4042-4329; Zhou, wenjun/0000-0002-8268-0251; Gamble, Karen/0000-0003-3813-8577	National Institutes of Health (NIH) [MH86622]; Canadian Institutes of Health Research (CIHR) [MOP74711]; CIHR [NSA93798]; NIH [GM086683]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM086683, K99GM086683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH086622] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) grant MH86622 (XL), Canadian Institutes of Health Research (CIHR) grant MOP74711 (JRW), CIHR grant NSA93798 (JMB), and NIH grant GM086683 (KLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohamad H, 2005, BIOL PSYCHIAT, V57, P533, DOI 10.1016/j.biopsych.2004.11.036; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Blier P, 1998, ANN NY ACAD SCI, V861, P204, DOI 10.1111/j.1749-6632.1998.tb10192.x; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; BOUHELAL R, 1988, EUR J PHARMACOL, V151, P189, DOI 10.1016/0014-2999(88)90799-6; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; Chaouloff F, 1999, PSYCHOPHARMACOLOGY, V141, P326, DOI 10.1007/s002130050841; CHEETHAM SC, 1993, BRIT J PHARMACOL, V110, P1621, DOI 10.1111/j.1476-5381.1993.tb14010.x; Chen L, 2011, MOL PHARMACOL, V79, P974, DOI 10.1124/mol.111.071092; Chen LG, 2009, MOL PHARMACOL, V76, P1150, DOI 10.1124/mol.109.056994; Chenu F, 2008, J PSYCHIATR NEUROSCI, V33, P541; Clark M S, 2001, Psychopharmacol Bull, V35, P170; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Drago A, 2010, EUR J CLIN PHARMACOL, V66, P5, DOI 10.1007/s00228-009-0724-6; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Evans AK, 2008, EUR J PHARMACOL, V590, P136, DOI 10.1016/j.ejphar.2008.06.014; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hoyer D, 1997, NEUROPHARMACOLOGY, V36, P419, DOI 10.1016/S0028-3908(97)00036-1; Johnson-Farley NN, 2006, J PHARMACOL EXP THER, V316, P1062, DOI 10.1124/jpet.105.094433; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kearn C.S., 2004, IMMUNOFLUORESCENT MA; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Li XH, 2007, INT J NEUROPSYCHOPH, V10, P7, DOI 10.1017/S1461145706006547; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Lione AM, 2000, J NEUROCHEM, V75, P934, DOI 10.1046/j.1471-4159.2000.0750934.x; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Mai L, 2002, J NEUROCHEM, V82, P75, DOI 10.1046/j.1471-4159.2002.00939.x; Massot O, 1999, NEUROPSYCHOPHARMACOL, V21, P530, DOI 10.1016/S0893-133X(99)00042-1; Miczek KA, 2004, ANN NY ACAD SCI, V1036, P336, DOI 10.1196/annals.1330.021; Nunemaker Craig S., 2003, Biological Procedures Online, V5, P53, DOI 10.1251/bpo46; O'Brien WT, 2011, J CLIN INVEST, V121, P3756, DOI 10.1172/JCI45194; ONeill MF, 1996, PHARMACOL BIOCHEM BE, V53, P535, DOI 10.1016/0091-3057(95)02047-0; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Polter A, 2010, NEUROPSYCHOPHARMACOL, V35, P1761, DOI 10.1038/npp.2010.43; Polter AM, 2012, CELL SIGNAL, V24, P265, DOI 10.1016/j.cellsig.2011.09.009; Polter AM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00031; PRANZATELLI MR, 1987, PHARMACOL BIOCHEM BE, V27, P497, DOI 10.1016/0091-3057(87)90354-6; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rao R, 2010, J AM SOC NEPHROL, V21, P428, DOI 10.1681/ASN.2009060672; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Roh MS, 2007, EXP MOL MED, V39, P353, DOI 10.1038/emm.2007.39; Ruf BM, 2009, CURR DRUG TARGETS, V10, P1118, DOI 10.2174/138945009789735192; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Thompson BJ, 2011, P NATL ACAD SCI USA, V108, P3785, DOI 10.1073/pnas.1011920108; Trillat AC, 1997, J NEUROCHEM, V69, P2019; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yao HB, 2002, J CHEM NEUROANAT, V23, P291, DOI 10.1016/S0891-0618(02)00014-5	67	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43262	10.1371/journal.pone.0043262	http://dx.doi.org/10.1371/journal.pone.0043262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912839	Green Published, gold			2022-12-27	WOS:000308063700069
J	Bark, SJ; Wegrzyn, J; Taupenot, L; Ziegler, M; O'Connor, DT; Ma, Q; Smoot, M; Ideker, T; Hook, V				Bark, Steven J.; Wegrzyn, Jill; Taupenot, Laurent; Ziegler, Michael; O'Connor, Daniel T.; Ma, Qi; Smoot, Michael; Ideker, Trey; Hook, Vivian			The Protein Architecture of Human Secretory Vesicles Reveals Differential Regulation of Signaling Molecule Secretion by Protein Kinases	PLOS ONE			English	Article							CATECHOLAMINE STORAGE-VESICLES; CLATHRIN-COATED VESICLES; TANDEM MASS-SPECTRA; LARGE DENSE-CORE; CHROMAFFIN GRANULES; BIOLOGICAL NETWORKS; PROTEOMIC ANALYSIS; BETA-SECRETASE; SYSTEMS BIOLOGY; ADRENAL-MEDULLA	Secretory vesicles are required for release of chemical messengers to mediate intercellular signaling among human biological systems. It is necessary to define the organization of the protein architecture of the 'human' dense core secretory vesicles (DCSV) to understand mechanisms for secretion of signaling molecules essential for cellular regulatory processes. This study, therefore, conducted extensive quantitative proteomics and systems biology analyses of human DCSV purified from human pheochromocytoma. Over 600 human DCSV proteins were identified with quantitative evaluation of over 300 proteins, revealing that most proteins participate in producing peptide hormones and neurotransmitters, enzymes, and the secretory machinery. Systems biology analyses provided a model of interacting DCSV proteins, generating hypotheses for differential intracellular protein kinases A and C signaling pathways. Activation of cellular PKA and PKC pathways resulted in differential secretion of neuropeptides, catecholamines, and beta-amyloid of Alzheimer's disease for mediating cell-cell communication. This is the first study to define a model of the protein architecture of human DCSV for human disease and health.	[Bark, Steven J.; Wegrzyn, Jill; Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Taupenot, Laurent; Ziegler, Michael; O'Connor, Daniel T.; Smoot, Michael; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ma, Qi] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Bark, SJ (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	stevenjbark@central.uh.edu; vhook@ucsd.edu	Wegrzyn, Jill/H-3745-2019; Ma, Qi/C-9716-2015; Ziegler, Michael/L-4728-2019	Wegrzyn, Jill/0000-0001-5923-0888; Ma, Qi/0000-0002-8705-4460; Taupenot, Laurent/0000-0003-2316-3825; Ideker, Trey/0000-0002-1708-8454	National Institutes of Health (NIH) [R01DA04271, PO1HL58120, R01MH077305, K01DA023065, P41RR031228, R01GM070743, P01HL58120]; Alzheimer's Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR031228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA023065, R01DA004271] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors appreciate support of this research by grants from the National Institutes of Health (NIH) (R01DA04271, PO1HL58120, R01MH077305) and the Alzheimer's Association to V. Hook, NIH grant K01DA023065 to S. Bark, NIH grants P41RR031228 and R01GM070743 to T. Ideker, and NIH grant P01HL58120 to D. T. O'Connor. The grant agencies' websites are: http://www.nih.gov/ and http://www.alz.org/. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of this manuscript.	Andreyev AY, 2010, MOL CELL PROTEOMICS, V9, P388, DOI 10.1074/mcp.M900432-MCP200; Bark SJ, 2007, J PROTEOME RES, V6, P4511, DOI 10.1021/pr070294o; Bark SJ, 2009, ANAL BIOCHEM, V389, P18, DOI 10.1016/j.ab.2009.03.010; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; CHIDGEY MAJ, 1993, BIOESSAYS, V15, P317, DOI 10.1002/bies.950150505; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Efthimiopoulos S, 1998, J NEUROCHEM, V71, P2365; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; GAINER H, 1985, NEUROENDOCRINOLOGY, V40, P171, DOI 10.1159/000124070; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gauthier DJ, 2008, PROTEOMICS, V8, P3848, DOI 10.1002/pmic.200700969; Geer LY, J PROTEOME RES, V3, P958; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Gorelick F, 2008, J GASTROEN HEPATOL, V23, pS37, DOI 10.1111/j.1440-1746.2007.05282.x; GRATZL M, 1981, BIOCHIM BIOPHYS ACTA, V649, P355, DOI 10.1016/0005-2736(81)90425-9; Gross J. H., 2004, MASS SPECTROMETRY; Gupta N, 2010, J PROTEOME RES, V9, P5065, DOI 10.1021/pr100358b; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; Hook V, 2008, NEUROPEPTIDES, V42, P503, DOI 10.1016/j.npep.2008.05.001; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; HOOK VYH, 1984, FEBS LETT, V172, P212, DOI 10.1016/0014-5793(84)81128-X; Hook VYH, 2002, J NEUROCHEM, V81, P237; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Jethwaney D, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-12; KELLY R B, 1991, Current Opinion in Cell Biology, V3, P654, DOI 10.1016/0955-0674(91)90037-Y; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Lodish H., 2004, MOL CELL BIOL, P701; OCONNOR DT, 1984, J BIOL CHEM, V259, P3237; OCONNOR DT, 1983, J CLIN ENDOCR METAB, V56, P582, DOI 10.1210/jcem-56-3-582; PARMER RJ, 1988, J HYPERTENS, V6, P187, DOI 10.1097/00004872-198803000-00002; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Scott MS, 2005, PLOS COMPUT BIOL, V1, P518, DOI 10.1371/journal.pcbi.0010066; SEAMON KB, 1983, J MED CHEM, V26, P436, DOI 10.1021/jm00357a021; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel GJ, 1999, BASIC NEUROCHEMISTRY, P191; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; SUIZDAK G, 2003, EXPANDING ROLE MASS; Takahashi M, 2003, J PHARMACOL SCI, V93, P41, DOI 10.1254/jphs.93.41; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tarcea VG, 2009, NUCLEIC ACIDS RES, V37, pD642, DOI 10.1093/nar/gkn722; Wegrzyn J, 2007, J PROTEOME RES, V6, P1652, DOI 10.1021/pr060503p; Wegrzyn JL, 2010, J PROTEOME RES, V9, P5002, DOI 10.1021/pr1003104; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winkler H, 1998, CELL MOL NEUROBIOL, V18, P193, DOI 10.1023/A:1022516919932; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Yasothornsrikul S, 1998, J NEUROCHEM, V70, P153; Yin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028679; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	66	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e41134	10.1371/journal.pone.0041134	http://dx.doi.org/10.1371/journal.pone.0041134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916103	Green Submitted, Green Published, gold			2022-12-27	WOS:000307824300005
J	Gradin, VB; Waiter, G; Kumar, P; Stickle, C; Milders, M; Matthews, K; Reid, I; Hall, J; Steele, JD				Gradin, Victoria B.; Waiter, Gordon; Kumar, Poornima; Stickle, Catriona; Milders, Maarten; Matthews, Keith; Reid, Ian; Hall, Jeremy; Steele, J. Douglas			Abnormal Neural Responses to Social Exclusion in Schizophrenia	PLOS ONE			English	Article							PREFRONTAL CORTEX; MENTAL-ILLNESS; SELF-ESTEEM; FMRI; METAANALYSIS; ATTRIBUTION; PERSPECTIVE; REJECTION; PSYCHOSIS; OSTRACISM	Social exclusion is an influential concept in politics, mental health and social psychology. Studies on healthy subjects have implicated the medial prefrontal cortex (mPFC), a region involved in emotional and social information processing, in neural responses to social exclusion. Impairments in social interactions are common in schizophrenia and are associated with reduced quality of life. Core symptoms such as delusions usually have a social content. However little is known about the neural underpinnings of social abnormalities. The aim of this study was to investigate the neural substrates of social exclusion in schizophrenia. Patients with schizophrenia and healthy controls underwent fMRI while participating in a popular social exclusion paradigm. This task involves passing a 'ball' between the participant and two cartoon representations of other subjects. The extent of social exclusion (ball not being passed to the participant) was parametrically varied throughout the task. Replicating previous findings, increasing social exclusion activated the mPFC in controls. In contrast, patients with schizophrenia failed to modulate mPFC responses with increasing exclusion. Furthermore, the blunted response to exclusion correlated with increased severity of positive symptoms. These data support the hypothesis that the neural response to social exclusion differs in schizophrenia, highlighting the mPFC as a potential substrate of impaired social interactions.	[Gradin, Victoria B.; Matthews, Keith; Steele, J. Douglas] Univ Dundee, Med Res Inst, Dundee, Scotland; [Waiter, Gordon] Univ Aberdeen, Biomed Imaging Ctr, Aberdeen, Scotland; [Kumar, Poornima] Univ Oxford, Dept Psychiat, Oxford, England; [Stickle, Catriona; Reid, Ian] Univ Aberdeen, Inst Mental Hlth, Aberdeen, Scotland; [Milders, Maarten] Univ Aberdeen, Dept Psychol, Aberdeen, Scotland; [Hall, Jeremy] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland	University of Dundee; University of Aberdeen; University of Oxford; University of Aberdeen; University of Aberdeen; University of Edinburgh	Gradin, VB (corresponding author), Univ Dundee, Med Res Inst, Dundee, Scotland.	v.gradin@dundee.ac.uk	Waiter, Gordon/AAA-1141-2020; Steele, Douglas/AAB-9889-2019; Steele, J Douglas/A-8972-2017; Milders, Maarten/GWD-1508-2022; Kumar, Poornima/ABF-3826-2020	Steele, Douglas/0000-0002-9822-8753; Steele, J Douglas/0000-0002-9822-8753; Waiter, Gordon/0000-0002-5313-9845; Matthews, Keith/0000-0002-4478-5888; Hall, Jeremy/0000-0002-0403-3278	Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE); Miller McKenzie Trust; Chief Scientist Office, Scotland; Medical Research Council [G0801418B] Funding Source: researchfish	Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE); Miller McKenzie Trust; Chief Scientist Office, Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	VBG was supported by a studentship from Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE). The Miller McKenzie Trust and Chief Scientist Office, Scotland, funded scanning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Angermeyer MC, 2003, ACTA PSYCHIAT SCAND, V108, P304, DOI 10.1034/j.1600-0447.2003.00150.x; BAZIRE S, 2001, PSYCHOTROPIC DRUG DI; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bolling DZ, 2011, NEUROIMAGE, V54, P2462, DOI 10.1016/j.neuroimage.2010.10.049; Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Brune M, 2010, PSYCHIAT RES; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Eisenberger NI, 2007, EMOTION, V7, P745, DOI 10.1037/1528-3542.7.4.745; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Goto Y, 2007, INTEGRATING NEUROBIO; Gunther Moor B, 2011, NEUROIMAGE; Huxley P, 2003, BRIT J PSYCHIAT, V182, P289, DOI 10.1192/bjp.182.4.289; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192; Kumar P, 2009, HUM BRAIN MAPP, V30, P1421, DOI 10.1002/hbm.20611; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Perry Y, 2010, BR J CLIN PSYCHOL; Romaniuk L, 2010, ARCH GEN PSYCHIAT, V67, P1246, DOI 10.1001/archgenpsychiatry.2010.169; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sebastian C. L., 2010, NEUROIMAGE; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Spielberger C. D., 1983, MIND GARDEN; Steele JD, 2004, NEUROIMAGE, V21, P868, DOI 10.1016/j.neuroimage.2003.09.066; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	45	26	27	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42608	10.1371/journal.pone.0042608	http://dx.doi.org/10.1371/journal.pone.0042608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AN	22916139	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000307824300012
J	Liu, X; Sano, T; Guan, YS; Nagata, S; Hoffmann, JA; Fukuyama, H				Liu, Xi; Sano, Teruyuki; Guan, Yongsheng; Nagata, Shigekazu; Hoffmann, Jules A.; Fukuyama, Hidehiro			Drosophila EYA Regulates the Immune Response against DNA through an Evolutionarily Conserved Threonine Phosphatase Motif	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; BRANCHIOOTORENAL BOR SYNDROME; INDEPENDENT GENE INDUCTION; ABSENT MUTANTS REVEALS; EYES ABSENT; RETINAL DETERMINATION; MAMMALIAN DNA; INNATE IMMUNITY; HOST-DEFENSE; SINE-OCULIS	Innate immune responses against DNA are essential to counter both pathogen infections and tissue damages. Mammalian EYAs were recently shown to play a role in regulating the innate immune responses against DNA. Here, we demonstrate that the unique Drosophila eya gene is also involved in the response specific to DNA. Haploinsufficiency of eya in mutants deficient for lysosomal DNase activity (DNaseII) reduces antimicrobial peptide gene expression, a hallmark for immune responses in flies. Like the mammalian orthologues, Drosophila EYA features a N-terminal threonine and C-terminal tyrosine phosphatase domain. Through the generation of a series of mutant EYA fly strains, we show that the threonine phosphatase domain, but not the tyrosine phosphatase domain, is responsible for the innate immune response against DNA. A similar role for the threonine phosphatase domain in mammalian EYA4 had been surmised on the basis of in vitro studies. Furthermore EYA associates with IKK beta and full-length RELISH, and the induction of the IMD pathway-dependent antimicrobial peptide gene is independent of SO. Our data provide the first in vivo demonstration for the immune function of EYA and point to their conserved immune function in response to endogenous DNA, throughout evolution.	[Liu, Xi; Guan, Yongsheng; Fukuyama, Hidehiro] Inst Biol Mol & Cellulaire, INSERM Equipe Avenir, CNRS UPR9022, F-67084 Strasbourg, France; [Liu, Xi; Hoffmann, Jules A.] Univ Strasbourg, Strasbourg, France; [Sano, Teruyuki; Nagata, Shigekazu] Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto, Japan; [Sano, Teruyuki; Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto, Japan; [Sano, Teruyuki; Nagata, Shigekazu] Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Kyoto, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Liu, X (corresponding author), Inst Biol Mol & Cellulaire, INSERM Equipe Avenir, CNRS UPR9022, F-67084 Strasbourg, France.	snagata@mfour.med.kyoto-u.ac.jp; h.fukuyama@unistra.fr	Fukuyama, Hidehiro/N-5276-2018; Fukuyama, Hidehiro/AAY-6256-2021; Nagata, Shigekazu/AAG-3203-2019	Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Nagata, Shigekazu/0000-0001-9758-8426	Avenir; Institut National de la Sante et de la Recherche Medicale, France; Chinese Scholarship Council, China; Solution Oriented Research for Science and Technology; Japan Science and Technology Agency, Japan; Centre National de la Recherche Scientifique, France; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Avenir; Institut National de la Sante et de la Recherche Medicale, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Chinese Scholarship Council, China(China Scholarship Council); Solution Oriented Research for Science and Technology; Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST)); Centre National de la Recherche Scientifique, France(Centre National de la Recherche Scientifique (CNRS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by Avenir, Institut National de la Sante et de la Recherche Medicale, France (HF), Chinese Scholarship Council, China (XL), Solution Oriented Research for Science and Technology, Japan Science and Technology Agency, Japan (SN) and Centre National de la Recherche Scientifique, France (HF and JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Bui QT, 2000, GENETICS, V155, P709; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kenyon KL, 2005, DEV BIOL, V286, P158, DOI 10.1016/j.ydbio.2005.07.017; Kumar S, 1998, HUM MUTAT, V11, P443, DOI 10.1002/(SICI)1098-1004(1998)11:6<443::AID-HUMU4>3.3.CO;2-J; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morillo SA, 2012, DEV BIOL, V365, P267, DOI 10.1016/j.ydbio.2012.02.030; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Okabe Y, 2008, EUR J IMMUNOL, V38, P3150, DOI 10.1002/eji.200838559; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Soker T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-118; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zimmerman JE, 2000, GENETICS, V154, P237	55	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42725	10.1371/journal.pone.0042725	http://dx.doi.org/10.1371/journal.pone.0042725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916150	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600024
J	Ono, M; Hamada, Y; Horiuchi, Y; Matsuo-Takasaki, M; Imoto, Y; Satomi, K; Arinami, T; Hasegawa, M; Fujioka, T; Nakamura, Y; Noguchi, E				Ono, Mizuho; Hamada, Yuko; Horiuchi, Yasue; Matsuo-Takasaki, Mami; Imoto, Yoshimasa; Satomi, Kaishi; Arinami, Tadao; Hasegawa, Mamoru; Fujioka, Tsuyoshi; Nakamura, Yukio; Noguchi, Emiko			Generation of Induced Pluripotent Stem Cells from Human Nasal Epithelial Cells Using a Sendai Virus Vector	PLOS ONE			English	Article							INDUCTION; DERIVATION	The generation of induced pluripotent stem cells (iPSCs) by introducing reprogramming factors into somatic cells is a promising method for stem cell therapy in regenerative medicine. Therefore, it is desirable to develop a minimally invasive simple method to create iPSCs. In this study, we generated human nasal epithelial cells (HNECs)-derived iPSCs by gene transduction with Sendai virus (SeV) vectors. HNECs can be obtained from subjects in a noninvasive manner, without anesthesia or biopsy. In addition, SeV carries no risk of altering the host genome, which provides an additional level of safety during generation of human iPSCs. The multiplicity of SeV infection ranged from 3 to 4, and the reprogramming efficiency of HNECs was 0.08-0.10%. iPSCs derived from HNECs had global gene expression profiles and epigenetic states consistent with those of human embryonic stem cells. The ease with which HNECs can be obtained, together with their robust reprogramming characteristics, will provide opportunities to investigate disease pathogenesis and molecular mechanisms in vitro, using cells with particular genotypes.	[Ono, Mizuho; Hamada, Yuko; Arinami, Tadao; Noguchi, Emiko] Univ Tsukuba, Fac Med, Dept Med Genet, Tsukuba, Ibaraki, Japan; [Horiuchi, Yasue] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Matsuo-Takasaki, Mami] Univ Tsukuba, Dept Regenerat Med & Stem Cell Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Imoto, Yoshimasa] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan; [Satomi, Kaishi] Univ Tsukuba, Dept Diagnost Pathol, Fac Med, Tsukuba, Ibaraki, Japan; [Hasegawa, Mamoru] DNAVEC Res Inc, Tsukuba, Ibaraki, Japan; [Fujioka, Tsuyoshi; Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	University of Tsukuba; Johns Hopkins University; University of Tsukuba; University of Fukui; University of Tsukuba; DNAVEC Corporation; RIKEN; Japan Science & Technology Agency (JST)	Ono, M (corresponding author), Univ Tsukuba, Fac Med, Dept Med Genet, Tsukuba, Ibaraki, Japan.	enoguchi@md.tsukuba.ac.jp	Nakamura, Yukio/A-5263-2016; Horiuchi, Yasue/ABC-6248-2021	Nakamura, Yukio/0000-0001-8056-4946; Horiuchi, Yasue/0000-0003-0597-2514	Japan Science and Technology Agency, Japan	Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	This study was supported by research grants from the Japan Science and Technology Agency, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Liu T, 2012, STEM CELLS DEV; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Miyoshi K, 2010, J BIOSCI BIOENG, V110, P345, DOI 10.1016/j.jbiosc.2010.03.004; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Yonemitsu Y, 2000, NAT BIOTECHNOL, V18, P970, DOI 10.1038/79463; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zaehres H, 2007, CELL, V131, P834, DOI 10.1016/j.cell.2007.11.020	20	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42855	10.1371/journal.pone.0042855	http://dx.doi.org/10.1371/journal.pone.0042855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912751	Green Published, gold			2022-12-27	WOS:000307500100038
J	Webber, L; Kilpi, F; Marsh, T; Rtveladze, K; Brown, M; McPherson, K				Webber, Laura; Kilpi, Fanny; Marsh, Tim; Rtveladze, Ketevan; Brown, Martin; McPherson, Klim			High Rates of Obesity and Non-Communicable Diseases Predicted across Latin America	PLOS ONE			English	Article							NUTRITION TRANSITION; ECONOMIC BURDEN; WORLDWIDE; TRENDS; CHILE; RISK	Non-communicable diseases (NCDs) such as cardiovascular disease and stroke are a major public health concern across Latin America. A key modifiable risk factor for NCDs is overweight and obesity highlighting the need for policy to reduce prevalence rates and ameliorate rising levels of NCDs. A cross-sectional regression analysis was used to project BMI and related disease trends to 2050. We tested the extent to which interventions that decrease body mass index (BMI) have an effect upon the number of incidence cases avoided for each disease. Without intervention obesity trends will continue to rise across much of Latin America. Effective interventions are necessary if rates of obesity and related diseases are to be reduced.	[Webber, Laura; Kilpi, Fanny; Marsh, Tim; Rtveladze, Ketevan; Brown, Martin] Natl Heart Forum, London, England; [McPherson, Klim] Univ Oxford, New Coll, Oxford, England	University of Oxford	Webber, L (corresponding author), Natl Heart Forum, London, England.	laura.webber@heartforum.org.uk		Kilpi, Fanny/0000-0002-3551-2829	GlaxoSmithKline [27875780]	GlaxoSmithKline(GlaxoSmithKline)	This research was funded by a non-discretionary educational grant from GlaxoSmithKline (number 27875780). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; Ares Valdes Yolanda, 2009, Arch Esp Urol, V62, P201; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Brundenius C, 2009, LAT AM PERSPECT, V36, P31, DOI 10.1177/0094582X09331968; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Fenger RV, 2012, CLIN EXP ALLERGY, V42, P1237, DOI 10.1111/j.1365-2222.2012.03972.x; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Frenk J, 1991, Health Transit Rev, V1, P21; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Kopelman P, 2007, OBES REV, V8, pVI; McPherson K, 2007, TACKLING OBESITIES F; National Cancer Institute, SEER CANC STAT REV 1; OMRAN AR, 1983, J TROP PEDIATRICS, V29, P305, DOI 10.1093/tropej/29.6.305; Ortiz-Barboza A, 2011, IARC Sci Publ, P85; PAHO website, PAHO PREV CONTR CHRO; Pena M, 2010, OBESITY POVERTY NEW; Porrata C, 2000, OBESIDAD POBREZA NUE, P57; Pratt M, 2011, FOOD NUTR BULL, V25, P183; Secretaria de Salud, HEART DIS STROK STAT; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; Viani GA, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-24; Vio F, 2008, PUBLIC HEALTH NUTR, V11, P405, DOI 10.1017/S136898000700050X; Vio F, 2000, PUBLIC HEALTH NUTR, V3, P49, DOI 10.1017/S1368980000000070; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization, WHO GLOB INF; Yusuf E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3894	29	67	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e39589	10.1371/journal.pone.0039589	http://dx.doi.org/10.1371/journal.pone.0039589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912663	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100003
J	Lynch, AG; Chin, SF; Dunning, MJ; Caldas, C; Tavare, S; Curtis, C				Lynch, Andy G.; Chin, Suet-Feung; Dunning, Mark J.; Caldas, Carlos; Tavare, Simon; Curtis, Christina			Calling Sample Mix-Ups in Cancer Population Studies	PLOS ONE			English	Article							COPY NUMBER; POLYMORPHISMS; PROBES; SYSTEM	Sample tracking errors have been and always will be a part of the practical implementation of large experiments. It has recently been proposed that expression quantitative trait loci (eQTLs) and their associated effects could be used to identify sample mix-ups and this approach has been applied to a number of large population genomics studies to illustrate the prevalence of the problem. We had adopted a similar approach, termed 'BADGER', in the METABRIC project. METABRIC is a large breast cancer study that may have been the first in which eQTL-based detection of mismatches was used during the study, rather than after the event, to aid quality assurance. We report here on the particular issues associated with large cancer studies performed using historical samples, which complicate the interpretation of such approaches. In particular we identify the complications of using tumour samples, of considering cellularity and RNA quality, of distinct subgroups existing in the study population (including family structures), and of choosing eQTLs to use. We also present some results regarding the design of experiments given consideration of these matters. The eQTL-based approach to identifying sample tracking errors is seen to be of value to these studies, but requiring care in its implementation.	[Lynch, Andy G.; Chin, Suet-Feung; Caldas, Carlos; Tavare, Simon] Univ Cambridge, Dept Oncol, Cambridge, England; [Lynch, Andy G.; Chin, Suet-Feung; Dunning, Mark J.; Caldas, Carlos; Tavare, Simon] Canc Res UK, Cambridge Res Inst, Cambridge, England; [Curtis, Christina] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Southern California	Lynch, AG (corresponding author), Univ Cambridge, Dept Oncol, Cambridge, England.	andy.lynch@cancer.org.uk	Caldas, Carlos/A-7543-2008; Caldas, Carlos/U-7250-2019	Caldas, Carlos/0000-0003-3547-1489; chin, suet-feung/0000-0001-5697-1082; Curtis, Christina/0000-0003-0166-3802; Lynch, Andy/0000-0002-7876-7338; Dunning, Mark/0000-0002-8853-9435	University of Cambridge [C14303/A10825]; Hutchison Whampoa Limited; Cancer Research UK; Cancer Research UK [19556] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	University of Cambridge(University of Cambridge); Hutchison Whampoa Limited; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by The University of Cambridge, Cancer Research UK grant C14303/A10825, www.cancerresearchuk.org, and Hutchison Whampoa Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; da Silva CC, 2009, GENET MOL BIOL, V32, P354, DOI 10.1590/S1415-47572009000200023; Duan SW, 2008, BIOINFORMATION, V2, P469, DOI 10.6026/97320630002469; Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Stears RL, 2003, NAT MED, V9, P140, DOI 10.1038/nm0103-140; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Walter M, 2010, BIOTECHNIQUES, V48, P371, DOI 10.2144/000113421; Wang Y, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-8; Westra HJ, 2011, BIOINFORMATICS, V27, P2104, DOI 10.1093/bioinformatics/btr323; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41815	10.1371/journal.pone.0041815	http://dx.doi.org/10.1371/journal.pone.0041815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912679	gold, Green Published, Green Submitted			2022-12-27	WOS:000307378500009
J	Welsh, TN; McDougall, LM				Welsh, Timothy N.; McDougall, Laura M.			Negative Priming in a Joint Selection Task	PLOS ONE			English	Article							INHIBITORY MECHANISMS; ATTENTION; OBJECTS; OTHERS	Recent studies have suggested that the observation of another individual executing a movement activates representations of the observed movement in the observer. These representations are thought to be used by other systems to facilitate a variety of social cognitive processes, such as social searches. Previous research on social searches has primarily involved contexts where targets were presented in isolation. Typical environments, however, contain targets and non-targets and one must select the correct information for task completion. To gain insight into the processes underlying social searches, participants completed negative priming tasks alone and in pairs. Results indicated that there were no differences in the negative priming effects resulting from the participants observed or performed the preceding selection task. Further, the correlations between individual and joint negative priming suggest that similar processes were activated on these tasks. The findings support the co-representation hypothesis and provide insight into the processes underlying selection in individual and social settings.	[Welsh, Timothy N.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [McDougall, Laura M.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	University of Toronto; University of Calgary	Welsh, TN (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	t.welsh@utoronto.ca			Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Alberta Ingenuity Fund; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Ingenuity Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded through grants to T.N.W. from the Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation, and the Alberta Ingenuity Fund and a scholarship to L.M.M. from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Frischen A, 2009, COGNITION, V111, P212, DOI 10.1016/j.cognition.2009.02.003; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Houghton George, 1994, P53; MAYLOR EA, 1985, J EXP PSYCHOL HUMAN, V11, P777, DOI 10.1037/0096-1523.11.6.777; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Ray M, 2012, HUM MOVEMEN IN PRESS; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; ROSENBAUM DA, 1987, MEM COGNITION, V15, P217, DOI 10.3758/BF03197719; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; TIPPER SP, 1990, J EXP PSYCHOL HUMAN, V16, P492, DOI 10.1037/0096-1523.16.3.492; TIPPER SP, 1991, J EXP PSYCHOL LEARN, V17, P681, DOI 10.1037/0278-7393.17.4.681; TIPPER SP, 1992, J EXP PSYCHOL HUMAN, V18, P891, DOI 10.1037/0096-1523.18.4.891; Tipper SP, 2002, VIS COGN, V9, P591, DOI 10.1080/13506280143000593; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Welsh TN, 2007, HUM MOVEMENT SCI, V26, P853, DOI 10.1016/j.humov.2007.06.003; Welsh TN, 2009, BRAIN COGNITION, V71, P64, DOI 10.1016/j.bandc.2009.04.001; Welsh TN, 2005, NEUROSCI LETT, V385, P99, DOI 10.1016/j.neulet.2005.05.013	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42963	10.1371/journal.pone.0042963	http://dx.doi.org/10.1371/journal.pone.0042963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986WZ	22912769	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500033
J	Jeseta, M; Marin, M; Tichovska, H; Melicharova, P; Cailliau-Maggio, K; Martoriati, A; Lescuyer-Rousseau, A; Beaujois, R; Petr, J; Sedmikova, M; Bodart, JF				Jeseta, Michal; Marin, Matthieu; Tichovska, Hana; Melicharova, Petra; Cailliau-Maggio, Katia; Martoriati, Alain; Lescuyer-Rousseau, Arlette; Beaujois, Remy; Petr, Jaroslav; Sedmikova, Marketa; Bodart, Jean-Francois			Nitric Oxide-Donor SNAP Induces Xenopus Eggs Activation	PLOS ONE			English	Article							CA2+ SIGNALING DIFFERENTIATION; SEA-URCHIN EGGS; OOCYTE MATURATION; PORCINE OOCYTES; SODIUM-NITROPRUSSIDE; LAEVIS EGGS; PIG OOCYTES; INOSITOL TRISPHOSPHATE; CALCIUM MICRODOMAINS; RYANODINE RECEPTORS	Nitric oxide (NO) is identified as a signaling molecule involved in many cellular or physiological functions including meiotic maturation and parthenogenetic activation of mammalian oocytes. We observed that nitric oxide donor SNAP was potent to induce parthenogenetic activation in Xenopus eggs. NO-scavenger CPTIO impaired the effects of SNAP, providing evidence for the effects of the latter to be specific upon NO release. In Xenopus eggs, SNAP treatment induced pigment rearrangement, pronucleus formation and exocytosis of cortical granules. At a biochemical level, SNAP exposure lead to MAPK and Rsk inactivation within 30 minutes whereas MPF remained active, in contrast to calcium ionophore control where MPF activity dropped rapidly. MAPK inactivation could be correlated to pronuclear envelope reformation observed. In SNAP-treated eggs, a strong increase in intracellular calcium level was observed. NO effects were impaired in calcium-free or calcium limited medium, suggesting that that parthenogenetic activation of Xenopus oocytes with a NO donor was mainly calcium-dependent.	[Jeseta, Michal] Vet Res Inst, Dept Genet & Reprod, CS-62132 Brno, Czech Republic; [Tichovska, Hana; Melicharova, Petra; Sedmikova, Marketa] Czech Univ Life Sci, Dept Vet Sci, Prague, Czech Republic; [Marin, Matthieu; Cailliau-Maggio, Katia; Martoriati, Alain; Lescuyer-Rousseau, Arlette; Beaujois, Remy; Bodart, Jean-Francois] Univ Lille 1, Lab Regulat Signaux Div EA 4479, F-59655 Villeneuve Dascq, France; [Marin, Matthieu; Beaujois, Remy; Bodart, Jean-Francois] Interdisciplinary Res Inst USR 3078 CNRS, Villeneuve Dascq, France; [Petr, Jaroslav] Res Inst Anim Prod, Prague, Czech Republic	Czech Veterinary Research Institute; Czech University of Life Sciences Prague; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Czech Research Institute of Animal Science	Jeseta, M (corresponding author), Vet Res Inst, Dept Genet & Reprod, CS-62132 Brno, Czech Republic.	jeseta@vri.cz	Sedmíková, Markéta/B-5768-2018; Jeseta, Michal/A-3159-2013; Bodart, Jean-François Laurent/AAZ-2075-2021	Sedmíková, Markéta/0000-0003-0947-4256; Jeseta, Michal/0000-0003-1778-3454; Bodart, Jean-François Laurent/0000-0002-6113-7700; Cailliau, Katia/0000-0001-7993-8437; cailliau, katia/0000-0003-1772-1034; Martoriati, Alain/0000-0002-5684-1728	Czech Science Fundation [GACR 523/08/H064]; ministry of education youth and sports of Czech Republic [MSM 6046070901]; Czech ministry of agriculture [MZe 0002716202]; Econet [18857PA]	Czech Science Fundation; ministry of education youth and sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech ministry of agriculture(Ministry of Agriculture, Czech Republic); Econet	This work was supported by a grant from the Czech Science Fundation (GACR 523/08/H064), the ministry of education youth and sports of Czech Republic (MSM 6046070901), the Czech ministry of agriculture (MZe 0002716202) and Econet grant 18857PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmat MT, 2011, ZYGOTE, V19, P171, DOI 10.1017/S0967199410000444; Amano T, 2005, THERIOGENOLOGY, V64, P261, DOI 10.1016/j.theriogenology.2004.12.001; BATES JN, 1991, BIOCHEM PHARMACOL, V42, pS157, DOI 10.1016/0006-2952(91)90406-U; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1996, CELL CALCIUM, V20, P95, DOI 10.1016/S0143-4160(96)90098-6; Betts DH, 2008, MOL HUM REPROD, V14, P445, DOI 10.1093/molehr/gan035; Bian K, 2003, FRONT BIOSCI-LANDMRK, V8, pD264, DOI 10.2741/997; Biswas S, 1998, J REPROD FERTIL, V114, P157, DOI 10.1530/jrf.0.1140157; Bodart JF, 2002, MOL REPROD DEV, V61, P570, DOI 10.1002/mrd.10112; Bodart JF, 1999, EXP CELL RES, V253, P413, DOI 10.1006/excr.1999.4662; Bodart JFL, 2005, DEV BIOL, V283, P373, DOI 10.1016/j.ydbio.2005.04.031; Bu S, 2007, MOL CELL ENDOCRINOL, V207, P21; BUSA WB, 1985, J CELL BIOL, V100, P1325, DOI 10.1083/jcb.100.4.1325; BUSA WB, 1985, J CELL BIOL, V101, P677, DOI 10.1083/jcb.101.2.677; BUTLER AR, 1987, CHEM SOC REV, V16, P361, DOI 10.1039/cs9871600361; Castro A, 2001, MOL BIOL CELL, V12, P2660, DOI 10.1091/mbc.12.9.2660; Chesnel F, 2006, CELL CYCLE, V5, P1687, DOI 10.4161/cc.5.15.3123; Chmelikova E, 2009, CZECH J ANIM SCI, V54, P137, DOI 10.17221/1742-CJAS; Chmelikova E, 2010, ZYGOTE, V18, P235, DOI 10.1017/S0967199409990268; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Doran SA, 2003, AM J PHYSIOL-REG I, V285, pR348, DOI 10.1152/ajpregu.00634.2002; El-Jouni W, 2005, DEV BIOL, V288, P514, DOI 10.1016/j.ydbio.2005.10.034; Erickson ES, 2004, BIOPHYS CHEM, V112, P1, DOI 10.1016/j.bpc.2004.06.010; Fan HY, 2003, BIOL REPROD, V68, P968, DOI 10.1095/biolreprod.102.008839; Fattaey A, 1997, Prog Cell Cycle Res, V3, P233; Flament S, 2000, ZYGOTE, V8, P3, DOI 10.1017/S0967199400000770; Gundersen CB, 2002, J CELL SCI, V115, P1313; Hattori MA, 2000, J MOL ENDOCRINOL, V24, P65, DOI 10.1677/jme.0.0240065; Hyslop LA, 2001, DEV BIOL, V234, P216, DOI 10.1006/dbio.2001.0252; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; JablonkaShariff A, 1997, ENDOCRINOLOGY, V138, P460, DOI 10.1210/en.138.1.460; Kumar S, 2010, FREE RADICAL BIO MED, V48, P851, DOI 10.1016/j.freeradbiomed.2010.01.004; Kuo RK, 2000, NATURE, V406, P633, DOI 10.1038/35020577; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Leckie C, 2003, J BIOL CHEM, V278, P12247, DOI 10.1074/jbc.M210770200; LORCA T, 1991, MOL CELL BIOL, V11, P1171, DOI 10.1128/MCB.11.2.1171; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; Marin M, 2012, ADV EXPT ME IN PRESS, V740, P875; Marin M, 2010, J MEMBRANE BIOL, V236, P233, DOI 10.1007/s00232-010-9290-1; MARKS GS, 1995, DRUG METAB DISPOS, V23, P1248; Megson IL, 2000, DRUG FUTURE, V25, P701, DOI 10.1358/dof.2000.025.07.858691; MEHTA JL, 1995, J LAB CLIN MED, V125, P370; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nishikimi A, 2001, REPRODUCTION, V122, P957, DOI 10.1530/reprod/122.6.957; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; NORBURY C, 1990, CIBA F SYMP, V150, P168; Petr J, 2005, MOL CELL ENDOCRINOL, V242, P16, DOI 10.1016/j.mce.2005.05.004; Petr J, 2005, MOL REPROD DEV, V71, P115, DOI 10.1002/mrd.20248; Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001; Pires PRL, 2009, ANIM REPROD SCI, V116, P233, DOI 10.1016/j.anireprosci.2009.02.019; Reyes R, 2004, ARCH ANDROLOGY, V50, P303, DOI 10.1080/01485010490448471; Rolfe M, 1997, J MOL MED-JMM, V75, P5, DOI 10.1007/s001090050081; Sengoku K, 2001, MOL REPROD DEV, V58, P262, DOI 10.1002/1098-2795(200103)58:3&lt;262::AID-MRD3&gt;3.0.CO;2-8; Song T, 2008, BIOCHEM J, V412, P223, DOI 10.1042/BJ20071195; STEINHAR.RA, 1974, P NATL ACAD SCI USA, V71, P1915, DOI 10.1073/pnas.71.5.1915; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Stricker SA, 2011, REPRODUCTION, V142, P29, DOI 10.1530/REP-10-0509; Sun L, 2008, BIOL REPROD, V78, P726, DOI 10.1095/biolreprod.107.063693; Suzuki T, 2010, DEVELOPMENT, V137, P3281, DOI 10.1242/dev.052480; Takata T, 2011, NITRIC OXIDE-BIOL CH, V25, P145, DOI 10.1016/j.niox.2011.01.004; Tatemoto H, 2001, ZYGOTE, V9, P15, DOI 10.1017/S0967199401001034; Tichovska H, 2011, ANIMAL, V5, P1398, DOI 10.1017/S1751731111000565; Ullah G, 2007, CELL CALCIUM, V42, P556, DOI 10.1016/j.ceca.2007.01.010; Viana KS, 2007, ANIM REPROD SCI, V102, P217, DOI 10.1016/j.anireprosci.2006.11.004; Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yamamoto T, 2000, P SOC EXP BIOL MED, V225, P200, DOI 10.1046/j.1525-1373.2000.22525.x; Yanagimachi R., 1988, PHYSL REPROD, P230; Yang JZ, 2005, CELL BIOL INT, V29, P785, DOI 10.1016/j.cellbi.2005.05.005; Zini A, 1996, BIOL REPROD, V55, P935, DOI 10.1095/biolreprod55.5.935	74	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41509	10.1371/journal.pone.0041509	http://dx.doi.org/10.1371/journal.pone.0041509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911804	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700096
J	Van Rooij, P; Martel, A; D'Herde, K; Brutyn, M; Croubels, S; Ducatelle, R; Haesebrouck, F; Pasmans, F				Van Rooij, Pascale; Martel, An; D'Herde, Katharina; Brutyn, Melanie; Croubels, Siska; Ducatelle, Richard; Haesebrouck, Freddy; Pasmans, Frank			Germ Tube Mediated Invasion of Batrachochytrium dendrobatidis in Amphibian Skin Is Host Dependent	PLOS ONE			English	Article							FROGS LITORIA-CAERULEA; AFRICAN CLAWED FROG; CHYTRID FUNGUS; XENOPUS-LAEVIS; PEPTIDE DEFENSES; SP-NOV; CHYTRIDIOMYCOSIS; PATHOGENESIS; DECLINES; POPULATIONS	Batrachochytrium dendrobatidis (Bd) is the causative agent of chytridiomycosis, a fungal skin disease in amphibians and driver of worldwide amphibian declines. We focussed on the early stages of infection by Bd in 3 amphibian species with a differential susceptibility to chytridiomycosis. Skin explants of Alytes muletensis, Litoria caerulea and Xenopus leavis were exposed to Bd in an Ussing chamber for 3 to 5 days. Early interactions of Bd with amphibian skin were observed using light microscopy and transmission electron microscopy. To validate the observations in vitro, comparison was made with skin from experimentally infected frogs. Additional in vitro experiments were performed to elucidate the process of intracellular colonization in L. caerulea. Early interactions of Bd with amphibian skin are: attachment of zoospores to host skin, zoospore germination, germ tube development, penetration into skin cells, invasive growth in the host skin, resulting in the loss of host cell cytoplasm. Inoculation of A. muletensis and L. caerulea skin was followed within 24 h by endobiotic development, with sporangia located intracellularly in the skin. Evidence is provided of how intracellular colonization is established and how colonization by Bd proceeds to deeper skin layers. Older thalli develop rhizoid-like structures that spread to deeper skin layers, form a swelling inside the host cell to finally give rise to a new thallus. In X. laevis, interaction of Bd with skin was limited to an epibiotic state, with sporangia developing upon the skin. Only the superficial epidermis was affected. Epidermal cells seemed to be used as a nutrient source without development of intracellular thalli. The in vitro data agreed with the results obtained after experimental infection of the studied frog species. These data suggest that the colonization strategy of B. dendrobatidis is host dependent, with the extent of colonization most likely determined by inherent characteristics of the host epidermis.	[Van Rooij, Pascale; Martel, An; Brutyn, Melanie; Ducatelle, Richard; Haesebrouck, Freddy; Pasmans, Frank] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [D'Herde, Katharina] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, B-9000 Ghent, Belgium; [Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Van Rooij, P (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	pascale.vanrooij@ugent.be	Haesebrouck, Freddy/M-3857-2014; D'Herde, Katharina/AAM-4570-2020; Martel, An/D-3713-2014; Pasmans, Frank/D-3667-2014	Haesebrouck, Freddy/0000-0002-1709-933X; D'Herde, Katharina/0000-0001-6591-0476; Croubels, Siska/0000-0001-6357-3517	PVR by research grant from Ghent University [BOF08/24J/004]	PVR by research grant from Ghent University	Funding for this work was provided to PVR by research grant BOF08/24J/004 from Ghent University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr DJS, 2001, MYCOTA, V7, P93; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2009, RES VET SCI, V87, P106, DOI 10.1016/j.rvsc.2008.11.005; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Campbell CR, 2012, INT J BIOCHEM CELL B, V44, P431, DOI 10.1016/j.biocel.2011.12.002; Carver S, 2010, COPEIA, P487, DOI 10.1643/CH-09-128; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, MOL ECOL, V18, P4731, DOI 10.1111/j.1365-294X.2009.04385.x; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Green DE, 2007, HERPETOL CONSERV BIO, V2, P43; Hill WA, 2010, J AM ASSOC LAB ANIM, V49, P215; IUCN, 2011, 2011 1 IUCN RED LIST; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Lotters S, 2009, ECOHEALTH, V6, P358, DOI 10.1007/s10393-010-0281-6; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; LONGCORE JE, 1995, MYCOLOGIA, V87, P25, DOI 10.2307/3760942; Marantelli Gerry, 2004, Pacific Conservation Biology, V10, P173; Marcum RD, 2010, DIS AQUAT ORGAN, V91, P17, DOI 10.3354/dao02235; Martel A, 2011, MED MYCOL, V49, P143, DOI 10.3109/13693786.2010.508185; Moss AS, 2010, DIS AQUAT ORGAN, V92, P149, DOI 10.3354/dao02223; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; NISHIKAWA A, 1990, IN VITRO CELL DEV B, V26, P1128; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Shin W, 2001, CAN J BOT, V79, P1083, DOI 10.1139/b01-086; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Van Rooij P, 2010, ATLA-ALTERN LAB ANIM, V38, P519, DOI 10.1177/026119291003800614; Vermout S, 2008, MYCOPATHOLOGIA, V166, P267, DOI 10.1007/s11046-008-9104-5; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walker SF, 2008, CURR BIOL, V18, pR853, DOI 10.1016/j.cub.2008.07.033; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x	46	45	46	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41481	10.1371/journal.pone.0041481	http://dx.doi.org/10.1371/journal.pone.0041481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911798	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600080
J	Bhatt, SP; Nigam, P; Misra, A; Guleria, R; Luthra, K; Jain, SK; Pasha, MAQ				Bhatt, Surya Prakash; Nigam, Priyanka; Misra, Anoop; Guleria, Randeep; Luthra, Kalpana; Jain, S. K.; Pasha, M. A. Qadar			Association of the Myostatin Gene with Obesity, Abdominal Obesity and Low Lean Body Mass and in Non-Diabetic Asian Indians in North India	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; METABOLIC SYNDROME; INSULIN-RESISTANCE; FAT; SENSITIVITY; MICE; MEN; MUTATIONS; LEPTIN; MALES	Background: To determine the association of the A55T and K153R polymorphisms of the Myostatin gene with obesity, abdominal obesity and lean body mass (LBM) in Asian Indians in north India. Materials and Methods: A total of 335 subjects (238 men and 97 women) were assessed for anthropometry, % body fat (BF), LBM and biochemical parameters. Associations of Myostatin gene polymorphisms were evaluated with anthropometric, body composition and biochemical parameters. In A55T polymorphism, BMI (p = 0.04), suprailiac skinfold (p = 0.05), total skinfold (p = 0.008), % BF (p = 0.002) and total fat mass (p = 0.003) were highest and % LBM (p = 0.03) and total LBM (Kg) were lowest (p = 0.04) in subjects with Thr/Thr genotype as compared to other genotypes. Association analysis of K153R polymorphism showed that subjects with R/R genotype had significantly higher BMI (p = 0.05), waist circumference (p = 0.04), % BF (p = 0.04) and total fat mass (p = 0.03), and lower % LBM (p = 0.02) and total LBM [(Kg), (p = 0.04)] as compared to other genotypes. Using a multivariate logistic regression model after adjusting for age and sex, subjects with Thr/Thr genotype of A55T showed high risk for high % BF (OR, 3.92, 95% CI: 2.61-12.41), truncal subcutaneous adiposity (OR, 2.9, 95% CI: 1.57-6.60)] and low LBM (OR, 0.64, 95% CI: 0.33-0.89) whereas R/R genotype of K153R showed high risk of obesity (BMI; OR, 3.2, 95% CI: 1.2-12.9; % BF, OR, 3.6, 95% CI: 1.04-12.4), abdominal obesity (OR, 2.12, 95% CI: 2.71-14.23) and low LBM (OR, 0.61, 95% CI: 0.29-0.79). Conclusions/Significance: We report that variants of Myostatin gene predispose to obesity, abdominal obesity and low lean body mass in Asian Indians in north India.	[Bhatt, Surya Prakash] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Bhatt, Surya Prakash; Guleria, Randeep] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India; [Bhatt, Surya Prakash; Luthra, Kalpana] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Nigam, Priyanka; Misra, Anoop] Diabet Fdn India, New Delhi, India; [Nigam, Priyanka; Misra, Anoop] Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India; [Misra, Anoop] Fortis C DOC Ctr Excellence Diabet Metab Dis & En, New Delhi, India; [Jain, S. K.] Jamia Hamdard, Dept Biotechnol, New Delhi, India; [Pasha, M. A. Qadar] Inst Genom & Integrat Biol, Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jamia Hamdard University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Bhatt, SP (corresponding author), All India Inst Med Sci, Dept Med, New Delhi 110029, India.	anoopmisra@metabolicresearchindia.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Indian Council of Medical Research, Government of India [5/9/70/2008-RHM]	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This study was fully supported by a grant from the Indian Council of Medical Research (No. 5/9/70/2008-RHM) Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Choi SJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE1031, DOI 10.1152/ajpendo.00656.2010; Chowdhury B, 1996, METABOLISM, V45, P634, DOI 10.1016/S0026-0495(96)90036-0; Ferrell RE, 1999, GENOMICS, V62, P203, DOI 10.1006/geno.1999.5984; Ge XJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE90, DOI 10.1152/ajpendo.00113.2012; Goel K, 2010, HEART, V96, P579, DOI 10.1136/hrt.2009.183236; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Gonzalez-Freire M, 2010, AGE, V32, P405, DOI 10.1007/s11357-010-9139-7; Gu ZL, 2004, SCI CHINA SER C, V47, P25, DOI 10.1360/02yc0201; Han DS, 2011, CLIN ENDOCRINOL, V75, P857, DOI 10.1111/j.1365-2265.2011.04120.x; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; John I, 1991, NUCL ACIDS RES, V19; Jorgensen JOL, 2010, PEDIATR NEPHROL, V25, P705, DOI 10.1007/s00467-009-1334-3; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McFarlane C, 2011, AM J PHYSL CELL PHYS, V301; McPherron, 2012, J CLIN INVEST, V109, P595; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316; Nishiyama A, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-19; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Santiago C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016323; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Seibert MJ, 2001, J AM GERIATR SOC, V49, P1093, DOI 10.1046/j.1532-5415.2001.49214.x; Siriett V, 2006, J CELL PHYSIOL, V209, P866, DOI 10.1002/jcp.20778; Thomis MAI, 2004, EUR J APPL PHYSIOL, V92, P267, DOI 10.1007/s00421-004-1093-6; Unni US, 2009, EUR J CLIN NUTR, V63, P1206, DOI 10.1038/ejcn.2009.32; Vikram NK, 2006, INDIAN J MED RES, V124, P677; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4	37	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e40977	10.1371/journal.pone.0040977	http://dx.doi.org/10.1371/journal.pone.0040977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916099	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800005
J	Lahut, S; Omur, O; Uyan, O; Agim, ZS; Ozoguz, A; Parman, Y; Deymeer, F; Oflazer, P; Koc, F; Ozcelik, H; Auburger, G; Basak, AN				Lahut, Suna; Omur, Ozgur; Uyan, Ozgun; Agim, Zeynep Sena; Ozoguz, Aslihan; Parman, Yesim; Deymeer, Feza; Oflazer, Piraye; Koc, Filiz; Ozcelik, Hilmi; Auburger, Georg; Basak, A. Nazli			ATXN2 and Its Neighbouring Gene SH2B3 Are Associated with Increased ALS Risk in the Turkish Population	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LENGTH POLYGLUTAMINE EXPANSIONS; GENOME-WIDE ASSOCIATION; HEXANUCLEOTIDE REPEAT; ATAXIN-2; MUTATIONS; SCA2; SUSCEPTIBILITY; PATHOGENESIS; DISEASE	Expansions of the polyglutamine (polyQ) domain (>= 34) in Ataxin-2 (ATXN2) are the primary cause of spinocerebellar ataxia type 2 (SCA2). Recent studies reported that intermediate-length (27-33) expansions increase the risk of Amyotrophic Lateral Sclerosis (ALS) in 1-4% of cases in diverse populations. This study investigates the Turkish population with respect to ALS risk, genotyping 158 sporadic, 78 familial patients and 420 neurologically healthy controls. We re-assessed the effect of ATXN2 expansions and extended the analysis for the first time to cover the ATXN2 locus with 18 Single Nucleotide Polymorphisms (SNPs) and their haplotypes. In accordance with other studies, our results confirmed that 31-32 polyQ repeats in the ATXN2 gene are associated with risk of developing ALS in 1.7% of the Turkish ALS cohort (p = 0.0172). Additionally, a significant association of a 136 kb haplotype block across the ATXN2 and SH2B3 genes was found in 19.4% of a subset of our ALS cohort and in 10.1% of the controls (p = 0.0057, OR: 2.23). ATXN2 and SH2B3 encode proteins that both interact with growth receptor tyrosine kinases. Our novel observations suggest that genotyping of SNPs at this locus may be useful for the study of ALS risk in a high percentage of individuals and that ATXN2 and SH2B3 variants may interact in modulating the disease pathway.	[Lahut, Suna; Omur, Ozgur; Uyan, Ozgun; Agim, Zeynep Sena; Ozoguz, Aslihan; Basak, A. Nazli] Bogazici Univ, Mol Biol & Genet Dept, Neurodegenerat Res Lab, Istanbul, Turkey; [Parman, Yesim; Deymeer, Feza; Oflazer, Piraye] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Istanbul, Turkey; [Koc, Filiz] Cukurova Univ, Sch Med, Dept Neurol, Adana, Turkey; [Ozcelik, Hilmi] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada; [Auburger, Georg] Goethe Univ Frankfurt, Frankfurt, Germany	Bogazici University; Istanbul University; Cukurova University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Goethe University Frankfurt	Lahut, S (corresponding author), Bogazici Univ, Mol Biol & Genet Dept, Neurodegenerat Res Lab, Istanbul, Turkey.	basak@boun.edu.tr	Agim, Zeynep Sena/L-8142-2019; Koc, Filiz/A-9125-2017	Agim, Zeynep Sena/0000-0002-8699-9884; , Piraye/0000-0001-8202-5313	Suna and Inan Kirac Foundation; Bogazici University; Deutsche Forschungsgemeinschaft [AU96/13-1]	Suna and Inan Kirac Foundation; Bogazici University(Bogazici University); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Suna and Inan Kirac Foundation (http://en.kiraca.com.tr/Corp-Responsibility/detail_kiracfoundation.aspx?SectionID=C2%2bWE3 CIWXkxHtpw8lqgFA%3d%3d&ContentId=faQeVeZudHFv1A4ACnP5uA%3d%3d), Bogazici University Research Funds (http://www.arastirma.boun.edu.tr/arastirma.php?a_I=tr&p=130) and Deutsche Forschungsgemeinschaft(AU96/13-1) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2001, BIOCHEM SOC T, V29, P529, DOI 10.1042/BST0290529; Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Auburger Georg W J, 2012, Handb Clin Neurol, V103, P423, DOI 10.1016/B978-0-444-51892-7.00026-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chen YP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.015; Choudhry S, 2001, HUM MOL GENET, V10, P2437, DOI 10.1093/hmg/10.21.2437; Colombrita C, 2011, ARCH ITAL BIOL, V149, P83, DOI 10.4449/aib.v149i1.1261; Corrado L, 2011, HUM GENET, V130, P575, DOI 10.1007/s00439-011-1000-2; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P739, DOI 10.1001/archneurol.2011.111; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gispert S, 2012, NEUROBIOL DIS, V45, P356, DOI 10.1016/j.nbd.2011.08.021; Gwinn-Hardy KA, 2000, NEUROLOGY, V54, P504, DOI 10.1212/WNL.54.2.504; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Huynh DP, 2007, EXP NEUROL, V203, P531, DOI 10.1016/j.expneurol.2006.09.009; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Lee JK, 2010, STAT BIOINFORMATICS, P293; Lee T, 2011, NEUROLOGY, V76, P2062, DOI 10.1212/WNL.0b013e31821f4447; Lee T, 2011, HUM MOL GENET, V20, P1697, DOI 10.1093/hmg/ddr045; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Nonis D, 2008, CELL SIGNAL, V20, P1725, DOI 10.1016/j.cellsig.2008.05.018; O'Brien KB, 2002, J BIOL CHEM, V277, P8673, DOI 10.1074/jbc.M109165200; Pang JT, 2002, BRAIN, V125, P656, DOI 10.1093/brain/awf060; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Ross OA, 2011, HUM MOL GENET, V20, P3207, DOI 10.1093/hmg/ddr227; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Soraru G, 2011, NEUROLOGY, V76, P2030, DOI 10.1212/WNL.0b013e31821e557a; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b; van de Loo S, 2009, EXP NEUROL, V215, P110, DOI 10.1016/j.expneurol.2008.09.020; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Van Langenhove T, 2011, NEUROBIOL AGING; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026433; Yu ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017951	48	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42956	10.1371/journal.pone.0042956	http://dx.doi.org/10.1371/journal.pone.0042956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916186	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800038
J	Lopez, S; Buil, A; Souto, JC; Casademont, J; Blangero, J; Martinez-Perez, A; Fontcuberta, J; Lathrop, M; Almasy, L; Soria, JM				Lopez, Sonia; Buil, Alfonso; Carlos Souto, Juan; Casademont, Jordi; Blangero, John; Martinez-Perez, Angel; Fontcuberta, Jordi; Lathrop, Mark; Almasy, Laura; Manuel Soria, Jose			Sex-Specific Regulation of Mitochondrial DNA Levels: Genome-Wide Linkage Analysis to Identify Quantitative Trait Loci	PLOS ONE			English	Article							COPY NUMBER; OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; GENETIC-DETERMINANTS; DEPLETION SYNDROME; CANCER RISK; D-LOOP; DISEASE; CELLS; PHENOTYPES	Altered mitochondrial DNA (mtDNA) levels have been associated with common diseases in humans. We investigated the genetic mechanism that controls mtDNA levels using genome-wide linkage analyses in families from the Genetic Analysis of Idiopathic Thrombophilia Project (GAIT). We measure mtDNA levels by quantitative real-time PCR in 386 subjects from 21 extended Spanish families. A variance component linkage method using 485 microsatellites was conducted to evaluate linkage and to detect quantitative trait loci (QTLs) involved in the control of mtDNA levels. The heritalibility of mtDNA levels was 0.33 (p = 1.82e-05). We identified a QTL on Chromosome 2 (LOD = 2.21) using all of the subjects, independently on their sex. When females and males were analysed separately, three QTLs were identified. Females showed the same QTL on Chromosome 2 (LOD = 3.09), indicating that the QTL identified in the analysis using all of the subjects was a strong female QTL, and another one on Chromosome 3 (LOD = 2.67), whereas in males a QTL was identified on Chromosome 1 (LOD = 2.81). These QTLs were fine-mapped to find associations with mtDNA levels. The most significant SNP association was for the rs10888838 on Chromosome 1 in males. This SNP mapped to the gene MRPL37, involved in mitochondrial protein translation. The rs2140855 on Chromosome 2 showed association in the analysis using all of the subjects. It was near the gene CMPK2, which encodes a mitochondrial enzyme of the salvage pathway of deoxyribonucleotide synthesis. Our results provide evidence of a sex-specific genetic mechanism for the control of mtDNA levels and provide a framework to identify new genes that influence mtDNA levels.	[Lopez, Sonia; Buil, Alfonso; Martinez-Perez, Angel; Manuel Soria, Jose] Hosp Santa Creu & Sant Pau, Inst Biomed Res, Unit Genom Complex Dis, Barcelona, Spain; [Carlos Souto, Juan; Fontcuberta, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Haematol, Haemostasis & Thrombosis Unit, E-08193 Barcelona, Spain; [Casademont, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Internal Med, E-08193 Barcelona, Spain; [Blangero, John; Almasy, Laura] Texas Biomed Res Inst, Dept Populat Genet, San Antonio, TX USA; [Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, Evry, France	Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Texas Biomedical Research Institute; CEA; UDICE-French Research Universities; Universite Paris Saclay	Lopez, S (corresponding author), Hosp Santa Creu & Sant Pau, Inst Biomed Res, Unit Genom Complex Dis, Barcelona, Spain.	jsoria@santpau.cat	Martinez-Perez, Angel/AAC-4339-2019; Almasy, Laura/V-3156-2019; Casademont, Jordi/GPK-8669-2022; Blangero, John/ABA-7175-2021; Lopez, Sonia/AAC-8830-2019; Soria Fernández, José Manuel/AAD-6761-2019; Casademont, Jordi/A-6828-2010	Martinez-Perez, Angel/0000-0002-5934-1454; Casademont, Jordi/0000-0002-8100-1827; Lopez, Sonia/0000-0002-5023-5153; Soria Fernández, José Manuel/0000-0002-6226-4293; Casademont, Jordi/0000-0002-8100-1827; Buil, Alfonso/0000-0002-3097-1014	Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria [PI-11/00184, PI-08/0420, PI-08/0756, RECAVA-RD06/0014]; Ministerio de Ciencia e Innovacion [SAF2008/01859]; Agencia de Gestio d'ajuts Universitaris i de Recerca [SGR 2009-1240]; "Contratos Posdoctorales de Perfeccionamiento Sara Borrell" from 'Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria' (ISCIII-FIS)	Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia de Gestio d'ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); "Contratos Posdoctorales de Perfeccionamiento Sara Borrell" from 'Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria' (ISCIII-FIS)	This work was supported by the 'Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria' [PI-11/00184, PI-08/0420, PI-08/0756, RECAVA-RD06/0014]; the 'Ministerio de Ciencia e Innovacion' [SAF2008/01859]; and the 'Agencia de Gestio d'ajuts Universitaris i de Recerca' [SGR 2009-1240]. SL was supported by "Contratos Posdoctorales de Perfeccionamiento Sara Borrell" from 'Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria' (ISCIII-FIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; Carter AM, 1997, ARTERIOSCL THROM VAS, V17, P589, DOI 10.1161/01.ATV.17.3.589; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chiu YF, 2010, HUM GENET, V128, P501, DOI 10.1007/s00439-010-0877-5; Colom B, 2007, CELL PHYSIOL BIOCHEM, V19, P205, DOI 10.1159/000099208; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Cote HCF, 2011, MITOCHONDRION, V11, P520, DOI 10.1016/j.mito.2011.01.011; Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101; Czarnecka AM, 2010, ONCOL REP, V23, P531, DOI 10.3892/or_00000666; Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367; Dyke B, 1995, 2 SW FDN BIOM RES DE; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129; Gavrilova-Jordan LP, 2007, SEMIN REPROD MED, V25, P154, DOI 10.1055/s-2007-973428; Giordano C, 2011, ESTROGENS AMELIORATE; Guevara R, 2009, FREE RADICAL BIO MED, V46, P169, DOI 10.1016/j.freeradbiomed.2008.09.035; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Kushnareva Y, 2010, ANN NY ACAD SCI, V1201, P50, DOI 10.1111/j.1749-6632.2010.05633.x; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Marti R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Seda O, 2008, HYPERTENSION, V51, P1156, DOI 10.1161/HYPERTENSIONAHA.107.105247; Simpkins JW, 2008, MOL CELL ENDOCRINOL, V290, P51, DOI 10.1016/j.mce.2008.04.013; Song GJ, 2008, FERTIL STERIL, V90, P2238, DOI 10.1016/j.fertnstert.2007.10.059; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200; Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001530; Zhang RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-130	57	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42711	10.1371/journal.pone.0042711	http://dx.doi.org/10.1371/journal.pone.0042711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916149	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800024
J	Lord, A; Horn, D; Breakspear, M; Walter, M				Lord, Anton; Horn, Dorothea; Breakspear, Michael; Walter, Martin			Changes in Community Structure of Resting State Functional Connectivity in Unipolar Depression	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; CINGULATE CORTEX; SMALL-WORLD; BRAIN; ORGANIZATION; ARCHITECTURE; DISEASE; CLASSIFICATION; NONDETECTION; PARCELLATION	Major depression is a prevalent disorder that imposes a significant burden on society, yet objective laboratory-style tests to assist in diagnosis are lacking. We employed network-based analyses of "resting state" functional neuroimaging data to ascertain group differences in the endogenous cortical activity between healthy and depressed subjects. We additionally sought to use machine learning techniques to explore the ability of these network-based measures of resting state activity to provide diagnostic information for depression. Resting state fMRI data were acquired from twenty two depressed outpatients and twenty two healthy subjects matched for age and gender. These data were anatomically parcellated and functional connectivity matrices were then derived using the linear correlations between the BOLD signal fluctuations of all pairs of cortical and subcortical regions. We characterised the hierarchical organization of these matrices using network-based matrics, with an emphasis on their mid-scale "modularity" arrangement. Whilst whole brain measures of organization did not differ between groups, a significant rearrangement of their community structure was observed. Furthermore we were able to classify individuals with a high level of accuracy using a support vector machine, primarily through the use of a modularity-based metric known as the participation index. In conclusion, the application of machine learning techniques to features of resting state fMRI network activity shows promising potential to assist in the diagnosis of major depression, now suggesting the need for validation in independent data sets.	[Lord, Anton; Breakspear, Michael] Queensland Inst Med Res, Div Mental Hlth Res, Brisbane, Qld 4006, Australia; [Lord, Anton] Univ Queensland, St Lucia, Qld, Australia; [Horn, Dorothea; Walter, Martin] Leibnitz Inst Neurobiol, Clin Affect Neuroimaging Lab, Magdeburg, Germany; [Horn, Dorothea; Walter, Martin] Otto Von Guericke Univ, Dept Psychiat, Magdeburg, Germany; [Horn, Dorothea; Walter, Martin] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Breakspear, Michael] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Breakspear, Michael] Black Dog Inst, Sydney, NSW, Australia; [Breakspear, Michael] Royal Brisbane & Womans Hosp, Brisbane, Qld, Australia; [Walter, Martin] Ctr Behav & Brain Sci, Magdeburg, Germany	QIMR Berghofer Medical Research Institute; University of Queensland; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Otto von Guericke University; University of New South Wales Sydney; Black Dog Institute; Royal Brisbane & Women's Hospital	Lord, A (corresponding author), Queensland Inst Med Res, Div Mental Hlth Res, Brisbane, Qld 4006, Australia.	antonL@qimr.edu.au	Breakspear, Michael/M-5859-2014; Breakspear, Michael/ABF-6302-2020	Breakspear, Michael/0000-0003-4943-3969; Walter, Martin/0000-0001-7857-4483; Lord, Anton/0000-0003-2405-9827	German Research Foundation [SFB 779/A6]	German Research Foundation(German Research Foundation (DFG))	This study was funded by grant SFB 779/A6 from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Borowsky SJ, 2000, J GEN INTERN MED, V15, P381, DOI 10.1046/j.1525-1497.2000.12088.x; Breakspear M, 2011, NEUROIMAGE, V58, P293, DOI 10.1016/j.neuroimage.2011.03.056; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; COYNE JC, 1995, GEN HOSP PSYCHIAT, V17, P3, DOI 10.1016/0163-8343(94)00056-J; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Cullen KR, 2009, NEUROSCI LETT, V460, P227, DOI 10.1016/j.neulet.2009.05.022; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Dimitriadou E., 2010, E1071 MISC FUNCTIONS; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Ferrarini L, 2011, NEUROIMAGE, V56, P1453, DOI 10.1016/j.neuroimage.2011.02.028; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P490, DOI 10.1002/hbm.20414; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hickie I, 2007, BRIT MED J, V335, P329, DOI 10.1136/bmj.39268.497350.AD; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee BT, 2008, PROG NEURO-PSYCHOPH, V32, P778, DOI 10.1016/j.pnpbp.2007.12.009; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Mitterschiffthaler MT, 2003, NEUROREPORT, V14, P177, DOI 10.1097/00001756-200302100-00003; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palomero-Gallagher N, 2009, HUM BRAIN MAPP, V30, P2336, DOI 10.1002/hbm.20667; Parker G, 2007, BRIT MED J, V335, P328, DOI 10.1136/bmj.39268.475799.AD; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; PEREZSTABLE EJ, 1990, ARCH INTERN MED, V150, P1083, DOI 10.1001/archinte.150.5.1083; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; RUBINOV M, 2007, HUM BRAIN MAPP; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Walter H, 2007, J AFFECT DISORDERS, V101, P175, DOI 10.1016/j.jad.2006.11.017; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhou Y, 2010, J AFFECT DISORDERS, V121, P220, DOI 10.1016/j.jad.2009.05.029	72	123	133	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41282	10.1371/journal.pone.0041282	http://dx.doi.org/10.1371/journal.pone.0041282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916105	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800009
J	Zwerling, A; Cojocariu, M; McIntosh, F; Pietrangelo, F; Behr, MA; Schwartzman, K; Benedetti, A; Dendukuri, N; Menzies, D; Pai, M				Zwerling, Alice; Cojocariu, Mihaela; McIntosh, Fiona; Pietrangelo, Filomena; Behr, Marcel A.; Schwartzman, Kevin; Benedetti, Andrea; Dendukuri, Nandini; Menzies, Dick; Pai, Madhukar			TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; WITHIN-SUBJECT VARIABILITY; CELL ASSAYS; TESTS; DIAGNOSIS; RISK	Background: While many North American healthcare institutions are switching from Tuberculin Skin Test (TST) to Interferon-gamma release assays (IGRAs), there is relatively limited data on association between occupational tuberculosis (TB) risk factors and test positivity and/or patterns of test discordance. Methods: We recruited a cohort of Canadian health care workers (HCWs) in Montreal, and performed both TST and QuantiFERON-TB Gold In Tube (QFT) tests, and assessed risk factors and occupational exposure. Results: In a cross-sectional analysis of baseline results, the prevalence of TST positivity using the 10 mm cut-off was 5.7% (22/388, 95% CI: 3.6-8.5%), while QFT positivity was 6.2% (24/388, 95% CI: 4-9.1%). Overall agreement between the tests was poor (kappa = 0.26), and 8.3% of HCWs had discordant test results, most frequently TST2/QFT+ (17/388, 4.4%). TST positivity was associated with total years worked in health care, non-occupational exposure to TB and BCG vaccination received after infancy or on multiple occasions. QFT positivity was associated with having worked as a HCW in a foreign country. Conclusions: Our results suggest that LTBI prevalence as measured by either the TST or the QFT is low in this HCW population. Of concern is the high frequency of unexplainable test discordance, namely: TST-/QFT+ subjects, and the lack of any association between QFT positivity and clear-cut recent TB exposure. If these discordant results are indeed false positives, the use of QFT in lieu of TST in low TB incidence settings could result in overtreatment of uninfected individuals.	[Zwerling, Alice; Behr, Marcel A.; Benedetti, Andrea; Dendukuri, Nandini; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Zwerling, Alice; Cojocariu, Mihaela; Behr, Marcel A.; Schwartzman, Kevin; Benedetti, Andrea; Menzies, Dick; Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; [Pietrangelo, Filomena] McGill Univ, Dept Occupat Hlth & Safety, Ctr Hlth, Montreal, PQ, Canada; [Cojocariu, Mihaela; McIntosh, Fiona] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Zwerling, A (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Canadian Institutes of Health Research (CIHR) [81362]; Fonds de recherche du Quebec-Sante	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR) grant 81362. AZ received a doctoral fellowship from CIHR, and MP received a New Investigator Award from CIHR. MP also received a salary award from Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; [Anonymous], 2008, Canada Communicable Disease Report, V34, P1; Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6; Ciaschetti A, 2007, G Ital Med Lav Ergon, V29, P406; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Cummings KJ, 2009, INFECT CONT HOSP EP, V30, P1123, DOI 10.1086/644754; DORMAN S, 2009, AM J RESP CRIT CARE, pA1010; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Long R., 2007, CANADIAN TUBERCULOSI, V6th; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Reichman L.B., 2000, TUBERCULOSIS COMPREH; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; SSSQ, 2009, EP TUB QUEB 2004 200; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	30	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43014	10.1371/journal.pone.0043014	http://dx.doi.org/10.1371/journal.pone.0043014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916197	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800041
J	Neukamm, SS; Toth, R; Morrice, N; Campbell, DG; MacKintosh, C; Lehmann, R; Haering, HU; Schleicher, ED; Weigert, C				Neukamm, Sabine S.; Toth, Rachel; Morrice, Nick; Campbell, David G.; MacKintosh, Carol; Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin D.; Weigert, Cora			Identification of the Amino Acids 300-600 of IRS-2 as 14-3-3 Binding Region with the Importance of IGF-1/Insulin-Regulated Phosphorylation of Ser-573	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; IN-VIVO; PROTEIN; RESISTANCE; ISOFORM; DOMAIN; SITES; ASSOCIATION	Phosphorylation of insulin receptor substrate (IRS)-2 on tyrosine residues is a key event in IGF-1/insulin signaling and leads to activation of the PI 3-kinase and the Ras/MAPK pathway. Furthermore, phosphorylated serine/threonine residues on IRS-2 can induce 14-3-3 binding. In this study we searched IRS-2 for novel phosphorylation sites and investigated the interaction between IRS-2 and 14-3-3. Mass spectrometry identified a total of 24 serine/threonine residues on IRS-2 with 12 sites unique for IRS-2 while the other residues are conserved in IRS-1 and IRS-2. IGF-1 stimulation led to increased binding of 14-3-3 to IRS-2 in transfected HEK293 cells and this binding was prevented by inhibition of the PI 3-kinase pathway and an Akt/PKB inhibitor. Insulin-stimulated interaction between endogenous IRS-2 and 14-3-3 was observed in rat hepatoma cells and in mice liver after an acute insulin stimulus and refeeding. Using different IRS-2 fragments enabled localization of the IGF-1-dependent 14-3-3 binding region spanning amino acids 300-600. The 24 identified residues on IRS-2 included several 14-3-3 binding candidates in the region 300-600. Single alanine mutants of these candidates led to the identification of serine 573 as 14-3-3 binding site. A phospho-site specific antibody was generated to further characterize serine 573. IGF-1-dependent phosphorylation of serine 573 was reduced by inhibition of PI 3-kinase and Akt/PKB. A negative role of this phosphorylation site was implicated by the alanine mutant of serine 573 which led to enhanced phosphorylation of Akt/PKB in an IGF-1 time course experiment. To conclude, our data suggest a physiologically relevant role for IGF-1/insulin-dependent 14-3-3 binding to IRS-2 involving serine 573.	[Neukamm, Sabine S.; Lehmann, Rainer; Schleicher, Erwin D.; Weigert, Cora] Univ Tubingen Hosp, Dept Internal Med 4, Div Clin Chem & Pathobiochem, Tubingen, Germany; [Neukamm, Sabine S.; Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin D.; Weigert, Cora] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Paul Langerhans Inst Tuebingen, Tubingen, Germany; [Toth, Rachel] Univ Dundee, Coll Life Sci, Div Signal Transduct & Therapy, Dundee, Scotland; [Morrice, Nick] Univ Glasgow, Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Campbell, David G.; MacKintosh, Carol] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med 4, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Dundee; Beatson Institute; University of Glasgow; University of Dundee; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Neukamm, SS (corresponding author), Univ Tubingen Hosp, Dept Internal Med 4, Div Clin Chem & Pathobiochem, Tubingen, Germany.	Cora.Weigert@med.uni-tuebingen.de	Campbell, David G/K-1874-2015; MacKintosh, Carol/B-8210-2011; Lehmann, Rainer/AAF-4281-2019	Campbell, David G/0000-0003-2278-2149; MacKintosh, Carol/0000-0001-9166-589X; Lehmann, Rainer/0000-0003-1218-6810	Deutsche Forschungsgemeinschaft [GRK 1302/1, 1302/2]; German Federal Ministry of Education and Research; MRC [G1100713, MC_EX_G0801767, MC_U127084354] Funding Source: UKRI; Medical Research Council [MC_EX_G0801767, MC_U127084354, G1100713] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by grants from the Deutsche Forschungsgemeinschaft to HUH, ES and CW [GRK 1302/1 and 1302/2]. This study was supported in part by a grant from the German Federal Ministry of Education and Research to the German Centre for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cullere X, 1998, J VIROL, V72, P558; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Du XP, 1996, J BIOL CHEM, V271, P7362, DOI 10.1074/jbc.271.13.7362; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, pE824, DOI 10.1152/ajpendo.00409.2010; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Giraud J, 2007, MOL ENDOCRINOL, V21, P2294, DOI 10.1210/me.2007-0159; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Harlow E., 1988, ANTIBODIES LAB MANUA; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Oriente F, 2005, J BIOL CHEM, V280, P40642, DOI 10.1074/jbc.M508570200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Sharfi H, 2008, AM J PHYSIOL-ENDOC M, V294, pE307, DOI 10.1152/ajpendo.00534.2007; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Weigert C, 2005, J BIOL CHEM, V280, P37393, DOI 10.1074/jbc.M506134200; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200; Xiang XQ, 2002, MOL ENDOCRINOL, V16, P552, DOI 10.1210/me.16.3.552; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yi ZP, 2007, DIABETES, V56, P1508, DOI 10.2337/db06-1355; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	55	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43296	10.1371/journal.pone.0043296	http://dx.doi.org/10.1371/journal.pone.0043296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912850	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000308063700078
J	Wang, N; Li, QG; Zhang, L; Lin, HL; Hu, J; Li, DG; Shi, SZ; Cui, SY; Zhou, JH; Ji, JY; Wan, JJ; Cai, GY; Chen, XM				Wang, Nan; Li, Qinggang; Zhang, Li; Lin, Hongli; Hu, Jie; Li, Diangeng; Shi, Suozhu; Cui, Shaoyuan; Zhou, Jianhui; Ji, Jiayao; Wan, Jiajia; Cai, Guangyan; Chen, Xiangmei			Mesenchymal Stem Cells Attenuate Peritoneal Injury through Secretion of TSG-6	PLOS ONE			English	Article							IN-VITRO; ADHESION; HYALURONAN; PROTEIN; MEMBRANE; HEART; MODEL; TRANSPLANTATION; INTERFERENCE; PROGRESSION	Background: Mesothelial cell injury plays an important role in peritoneal fibrosis. Present clinical therapies aimed at alleviating peritoneal fibrosis have been largely inadequate. Mesenchymal stem cells (MSCs) are efficient for repairing injuries and reducing fibrosis. This study was designed to investigate the effects of MSCs on injured mesothelial cells and peritoneal fibrosis. Methodology/Principal Findings: Rat bone marrow-derived MSCs (5x10(6)) were injected into Sprague-Dawley (SD) rats via tail vein 24 h after peritoneal scraping. Distinct reductions in adhesion formation; infiltration of neutrophils, macrophage cells; number of fibroblasts; and level of transforming growth factor (TGF)-beta 1 were found in MSCs-treated rats. The proliferation and repair of peritoneal mesothelial cells in MSCs-treated rats were stimulated. Mechanically injured mesothelial cells co-cultured with MSCs in transwells showed distinct increases in migration and proliferation. In vivo imaging showed that MSCs injected intravenously mainly accumulated in the lungs which persisted for at least seven days. No apparent MSCs were observed in the injured peritoneum even when MSCs were injected intraperitoneally. The injection of serum-starved MSCs-conditioned medium (CM) intravenously reduced adhesions similar to MSCs. Antibody based protein array of MSCs-CM showed that the releasing of TNF alpha-stimulating gene (TSG)-6 increased most dramatically. Promotion of mesothelial cell repair and reduction of peritoneal adhesion were produced by the administration of recombinant mouse (rm) TSG-6, and were weakened by TSG-6-RNA interfering. Conclusions/Significance: Collectively, these results indicate that MSCs may attenuate peritoneal injury by repairing mesothelial cells, reducing inflammation and fibrosis. Rather than the engraftment, the secretion of TSG-6 by MSCs makes a major contribution to the therapeutic benefits of MSCs.	[Wang, Nan; Li, Qinggang; Zhang, Li; Hu, Jie; Li, Diangeng; Shi, Suozhu; Cui, Shaoyuan; Zhou, Jianhui; Ji, Jiayao; Wan, Jiajia; Cai, Guangyan; Chen, Xiangmei] Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Wang, Nan; Li, Qinggang; Zhang, Li; Hu, Jie; Li, Diangeng; Shi, Suozhu; Cui, Shaoyuan; Zhou, Jianhui; Ji, Jiayao; Wan, Jiajia; Cai, Guangyan; Chen, Xiangmei] Mil Med Postgrad Coll, Beijing, Peoples R China; [Wang, Nan; Ji, Jiayao; Wan, Jiajia] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Lin, Hongli] Dalian Med Univ, Affiliated Hosp 1, Dept Nephrol, Liaoning, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University; Dalian Medical University	Wang, N (corresponding author), Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	caiguangyan@sina.com; xmchen301@126.com			National High Technology Research and Development Program [2011AA020115]; National Basic Research Program of China [2011CB964904]; National key Technology RD Program [2011BA110B08]; Health Industry Scientific Research Special Project [201002010]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National key Technology RD Program(National Key Technology R&D Program); Health Industry Scientific Research Special Project	This research was supported by a grant (2011AA020115; http://www.863.gov.cn) from the National High Technology Research and Development Program and a grant (2011CB964904; http://www.973.gov.cn) from the National Basic Research Program of China, a grant (2011BA110B08; http://kjzc.jhgl.org) from the National key Technology R&D Program, and a grant (201002010; http://www.moh.gov.cn) from the Health Industry Scientific Research Special Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cahill RA, 2008, WORLD J GASTROENTERO, V14, P4861, DOI 10.3748/wjg.14.4861; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fang CC, 2010, WORLD J SURG, V34, P721, DOI 10.1007/s00268-009-0378-7; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2009, STEM CELLS, V27, P971, DOI 10.1002/stem.12; Guo H, 2009, BRIT J SURG, V96, P1323, DOI 10.1002/bjs.6722; Guo Q, 2008, BRIT J SURG, V95, P252, DOI 10.1002/bjs.5890; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Kamel RM, 2010, EUR J OBSTET GYN R B, V150, P111, DOI 10.1016/j.ejogrb.2010.02.003; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Lauder CIW, 2011, J SURG RES, V171, P877, DOI 10.1016/j.jss.2010.06.028; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Li LL, 2008, TRANSPL INT, V21, P1181, DOI 10.1111/j.1432-2277.2008.00742.x; Liu HJ, 2006, SURGERY, V140, P441, DOI 10.1016/j.surg.2005.12.014; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nie J, 2007, KIDNEY INT, V72, P1336, DOI 10.1038/sj.ki.5002533; Ninichuk V, 2006, KIDNEY INT, V70, P121, DOI 10.1038/sj.ki.5001521; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Saxena R, 2008, PEDIATR NEPHROL, V23, P695, DOI 10.1007/s00467-007-0580-5; Segura T, 2007, J SURG RES, V141, P162, DOI 10.1016/j.jss.2006.07.045; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Takahashi M, 2005, CIRCULATION, V112, pU321; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Whang SH, 2011, J SURG RES, V167, P245, DOI 10.1016/j.jss.2009.06.020; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2003, KIDNEY INT, V64, pS43, DOI 10.1046/j.1523-1755.2003.08805.x; Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Yung S, 1998, KIDNEY INT, V54, P2160, DOI 10.1046/j.1523-1755.1998.00177.x; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217	51	84	91	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43768	10.1371/journal.pone.0043768	http://dx.doi.org/10.1371/journal.pone.0043768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912904	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700132
J	Wang, XY; Keefe, KM; Jensen-Taubman, SM; Yang, DL; Yan, K; Linnoila, RI				Wang, Xiao-Yang; Keefe, Kathleen M.; Jensen-Taubman, Sandra M.; Yang, Danlei; Yan, Kai; Linnoila, R. Ilona			Novel Method for Isolation of Murine Clara Cell Secretory Protein-Expressing Cells with Traces of Stemness	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; MOUSE LUNG; BRONCHIOLAR EPITHELIUM; IDENTIFICATION; DIFFERENTIATION; PROLIFERATION; DEFICIENCY; EXPOSURE; RENEWAL; NUMBER	Clara cells are non-ciliated, secretory bronchiolar epithelial cells that serve to detoxify harmful inhaled substances. Clara cells also function as stem/progenitor cells for repair in the bronchioles. Clara cell secretory protein (CCSP) is specifically expressed in pulmonary Clara cells and is widely used as a Clara cell marker. In addition CCSP promoter is commonly used to direct gene expression into the lung in transgenic models. The discovery of CCSP immunoreactivity in plasma membranes of airway lining cells prompted us to explore the possibility of enriching Clara cells by flow cytometry. We established a novel and simple method for the isolation of CCSP-expressing cell Clara cells using a combination of mechanical and enzymatic dissociation followed by flow cytometry sorting technology. We showed that similar to 25% of dissociated cells from whole lung expressed CCSP. In the resulting preparation, up to 98% of cells expressed CCSP. Notably, we found that several common stem cell markers including CD44, CD133, Sca-1 and Sox2 were expressed in CCSP+ cells. Moreover, CCSP+ cells were able to form spheroid colonies in vitro with 0.97 parts per thousand efficiency. Parallel studies in vivo confirmed that a small population of CCSP- expressing cells in mouse airways also demonstrates stem cell-like properties such as label retention and harboring rare bronchioalveolar stem cells (BASCs) in terminal bronchioles (TBs). We conclude that CCSP+ cells exhibit a number of stem cell-like features including stem cell marker expression, bronchosphere colony formation and self-renewal ability. Clara cell isolation by flow cytometry sorting is a useful method for investigating the function of primary Clara cells in stem cell research and mouse models.	[Wang, Xiao-Yang; Keefe, Kathleen M.; Jensen-Taubman, Sandra M.; Yang, Danlei; Yan, Kai; Linnoila, R. Ilona] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, XY (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	xiaoyangwang@gmail.com; Linnoila@mail.nih.gov			National Cancer Institute at the National Institutes of Health	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the National Cancer Institute at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELINSKY SA, 1995, IN VITRO CELL DEV-AN, V31, P361; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; CHICHESTER CH, 1991, AM J RESP CELL MOL, V4, P179, DOI 10.1165/ajrcmb/4.2.179; Coppens JT, 2007, AM J PHYSIOL-LUNG C, V292, pL1155, DOI 10.1152/ajplung.00454.2006; Dai XL, 2006, EXP BIOL MED, V231, P746; Dave V, 2008, AM J RESP CELL MOL, V38, P337, DOI 10.1165/rcmb.2007-0182OC; DEVEREUX TR, 1980, IN VITRO CELL DEV B, V16, P958; EVANS MJ, 1976, LAB INVEST, V35, P246; Fernandez-Gonzalez R, 2010, METHODS MOL BIOL, V621, P1, DOI 10.1007/978-1-60761-063-2_1; Germano D, 2009, AM J RESP CRIT CARE, V179, P939, DOI 10.1164/rccm.200809-1390OC; HACKETT BP, 1992, AM J PHYSIOL, V262, pL399, DOI 10.1152/ajplung.1992.262.4.L399; Hegab AE, 2010, STEM CELLS DEV, V19, P523, DOI 10.1089/scd.2009.0287; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Jensen-Taubman S, 2010, TOXICOL SCI, V117, P238, DOI 10.1093/toxsci/kfq177; Katavolos P, 2009, VET PATHOL, V46, P604, DOI 10.1354/vp.08-VP-0255-B-FL; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Linnoila RI, 2000, ANN NY ACAD SCI, V923, P249; MARTIN J, 1990, BIOCHEM SOC T, V18, P664, DOI 10.1042/bst0180664; MASSEY TE, 1987, CAN J PHYSIOL PHARM, V65, P2368, DOI 10.1139/y87-375; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; MONTEFORT S, 1993, EUR RESPIR J, V6, P1257; OREFFO VIC, 1990, ENVIRON HEALTH PERSP, V85, P51, DOI 10.2307/3430665; Potten CS, 2002, J CELL SCI, V115, P2381; SINGH G, 1988, J HISTOCHEM CYTOCHEM, V36, P73, DOI 10.1177/36.1.3275712; Stripp BR, 2002, AM J RESP CELL MOL, V27, P170, DOI 10.1165/ajrcmb.27.2.200200270c; Stripp BR, 1996, AM J PHYSIOL-LUNG C, V271, pL656, DOI 10.1152/ajplung.1996.271.4.L656; Stripp BR, 2000, ANN NY ACAD SCI, V923, P202; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; WALKER SR, 1989, EXP LUNG RES, V15, P553, DOI 10.3109/01902148909069618; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wang XY, 2007, LAB INVEST, V87, P527, DOI 10.1038/labinvest.3700552; Wong AP, 2009, CYTOTHERAPY, V11, P676, DOI 10.3109/14653240903313974; Wong AP, 2009, J CLIN INVEST, V119, P336, DOI 10.1172/JCI36882; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	12	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43008	10.1371/journal.pone.0043008	http://dx.doi.org/10.1371/journal.pone.0043008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916196	gold, Green Submitted, Green Published			2022-12-27	WOS:000307824300024
J	van Enst, WA; Scholten, RJPM; Hooft, L				van Enst, Wynanda A.; Scholten, Rob J. P. M.; Hooft, Lotty			Identification of Additional Trials in Prospective Trial Registers for Cochrane Systematic Reviews	PLOS ONE			English	Article							PUBLICATION BIAS; REPORTING BIAS	Background: Publication and selective outcome reporting bias are a threat to the validity of systematic reviews. Extensive searching for additional trials in prospective trial registers could reduce this problem. We have evaluated how authors of Cochrane systematic reviews currently make use of trial registers as an additional source for the identification of potentially eligible trials. Methodology/Principal Findings: We included 210 systematic Cochrane reviews of interventions published between 2008 and 2010 of which the protocol was first published in 2008. When prospective trial registers were searched we recorded the names of the register(s), the authors' motive(s) and if they yielded any extra trials. In 80 reviews (38.1%) the authors had searched in one or more prospective trial register(s) of which 55% had searched in overlapping search portals and individual registers. Most frequently assessed were the MetaRegister (66.3%) and Clinicaltrials.gov (60%) which is in sharp contrast of other registers or portals like the WHO ICTRP Search Portal (20%). Reported motives to use registers were to identify ongoing trials (83.3%), to identify unpublished outcomes or trials (23.5%), to identify recently published trials (11.8%), or to identify any relevant trial (3.9%). In 28 reviews (35%) the authors had selected (ongoing) trials identified in trial registers as potentially eligible. Discussion: Trial registers as an additional source of information are gaining acknowledgement amongst Cochrane reviewers. Nevertheless, searches seem to be inefficient as overlapping databases are frequently consulted, while the WHO ICTRP Search Portal that includes the data from all approved registers worldwide is being underused. Moreover, the emphasis is now on the identification of ongoing trials, although the prospective registers offer a broader potential. Further familiarity of registers and guidance how to search and to report will help to implement this as a common method and utilize the full potential of prospective trial registers for systematic reviews.	[van Enst, Wynanda A.; Scholten, Rob J. P. M.; Hooft, Lotty] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van Enst, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Dutch Cochrane Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.a.vanenst@amc.uva.nl			ZonMw (The Netherlands Organisation for Health Research and Development)	ZonMw (The Netherlands Organisation for Health Research and Development)(Netherlands Organization for Health Research and Development)	The Dutch Cochrane Centre had received a grant of ZonMw (The Netherlands Organisation for Health Research and Development) in 2003 to establish the Netherlands Trial Register. This grant has not been used to finance the current study. Therefore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackhall K, 2007, INJURY PREV, V13, P359, DOI 10.1136/ip.2007.017020; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Duffy S, 2012, CLIN TRIAL IN PRESS; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Egger M, 2003, Health Technol Assess, V7, P1; Fleming PS, 2013, EUR J ORTHODONT, V35, P244, DOI 10.1093/ejo/cjs016; Ghersi Davina, 2009, J Evid Based Med, V2, P1, DOI 10.1111/j.1756-5391.2009.01014.x; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Higgins J., 2011, COCHRAN HDB SYSTEMAT, V5; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Lefebvre C, 2008, COCHRANE HDB SYSTEMA, P95, DOI [10.1002/9780470712184.ch6, DOI 10.1002/9780470712184.CH6]; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Trinquart L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035219; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; WHO, 2012, INT CLIN TRIALS REG; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; World Health Organization, 2011, INT CLIN TRIALS REG	25	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42812	10.1371/journal.pone.0042812	http://dx.doi.org/10.1371/journal.pone.0042812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916163	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600029
J	Li, W; Xu, YP; Zhang, ZX; Cao, WY; Li, F; Zhou, XP; Chen, GY; Cai, XZ				Li, Wen; Xu, You-Ping; Zhang, Zhi-Xin; Cao, Wen-Yuan; Li, Fei; Zhou, Xueping; Chen, Gong-You; Cai, Xin-Zhong			Identification of Genes Required for Nonhost Resistance to Xanthomonas oryzae pv. oryzae Reveals Novel Signaling Components	PLOS ONE			English	Article							HYPERSENSITIVE REACTION; PATHOGEN XANTHOMONAS; NEGATIVE REGULATOR; EFFECTOR PROTEINS; DEFENSE; DISEASE; CALRETICULIN; CALCIUM; PLANTS; INDUCTION	Background: Nonhost resistance is a generalized, durable, broad-spectrum resistance exhibited by plant species to a wide variety of microbial pathogens. Although nonhost resistance is an attractive breeding strategy, the molecular basis of this form of resistance remains unclear for many plant-microbe pathosystems, including interactions with the bacterial pathogen of rice, Xanthomonas oryzae pv. oryzae (Xoo). Methods and Findings: Virus-induced gene silencing (VIGS) and an assay to detect the hypersensitive response (HR) were used to screen for genes required for nonhost resistance to Xoo in N. benthamiana. When infiltrated with Xoo strain YN-1, N. benthamiana plants exhibited a strong necrosis within 24 h and produced a large amount of H2O2 in the infiltrated area. Expression of HR-and defense-related genes was induced, whereas bacterial numbers dramatically decreased during necrosis. VIGS of 45 ACE (Avr/Cf-elicited) genes revealed identified seven genes required for nonhost resistance to Xoo in N. benthamiana. The seven genes encoded a calreticulin protein (ACE35), an ERF transcriptional factor (ACE43), a novel Solanaceous protein (ACE80), a hydrolase (ACE117), a peroxidase (ACE175) and two proteins with unknown function (ACE95 and ACE112). The results indicate that oxidative burst and calcium-dependent signaling pathways play an important role in nonhost resistance to Xoo. VIGS analysis further revealed that ACE35, ACE80, ACE95 and ACE175, but not the other three ACE genes, interfered with the Cf-4/Avr4-dependent HR. Conclusions/Significance: N. benthamiana plants inoculated with Xoo respond by rapidly eliciting an HR and nonhost resistance. The oxidative burst and other signaling pathways are pivotal in Xoo-N. benthamiana nonhost resistance, and genes involved in this response partially overlap with those involved in Cf/Avr4-dependent HR. The seven genes required for N. benthamiana-mediated resistance to Xoo provide a basis for further dissecting the molecular mechanism of nonhost resistance.	[Li, Wen; Zhang, Zhi-Xin; Cao, Wen-Yuan; Li, Fei; Zhou, Xueping; Cai, Xin-Zhong] Zhejiang Univ, Coll Agr & Biotechnol, Inst Biotechnol, Hangzhou 310027, Peoples R China; [Xu, You-Ping] Zhejiang Univ, Ctr Anal & Measurement, Hangzhou 310027, Peoples R China; [Zhou, Xueping; Cai, Xin-Zhong] Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310027, Peoples R China; [Chen, Gong-You] Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban S, Minist Agr, Shanghai 200030, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University	Li, W (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Biotechnol, Hangzhou 310027, Peoples R China.	gyouchen@sjtu.edu.cn; xzhcai@zju.edu.cn	CHEN, Gongyou/AAA-9694-2019	CHEN, Gongyou/0000-0003-1979-2880	Program for Changjiang Scholars and Innovative Research Team in University [IRT0943]; National Basic Research Program of China [2009CB119000]; Fundamental Research Funds for the Central Universities [2011XZZX006]; Zhejiang Provincial Natural Science Foundation of China [LZ12C14002]; Program for New Century Excellent Talents in University [NCET-08-0485];  [2009ZX08009-044B]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 	This work was financially supported by grants from the Program for Changjiang Scholars and Innovative Research Team in University (no. IRT0943), the genetically modified organisms breeding major projects (no. 2009ZX08009-044B), the National Basic Research Program of China (no. 2009CB119000), the Fundamental Research Funds for the Central Universities (no. 2011XZZX006), the Zhejiang Provincial Natural Science Foundation of China (no. LZ12C14002) and the Program for New Century Excellent Talents in University (no. NCET-08-0485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chen MH, 2005, PLANT PHYSIOL, V138, P1866, DOI 10.1104/pp.105.064386; Chen XW, 2010, P NATL ACAD SCI USA, V107, P8029, DOI 10.1073/pnas.0912311107; Crofts AJ, 1998, TRENDS PLANT SCI, V3, P396, DOI 10.1016/S1360-1385(98)01312-0; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Droillard MJ, 1997, PLANTA, V202, P341, DOI 10.1007/s004250050136; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gonzalez C, 2007, MOL PLANT MICROBE IN, V20, P534, DOI 10.1094/MPMI-20-5-0534; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Han SW, 2011, CURR OPIN MICROBIOL, V14, P62, DOI 10.1016/j.mib.2010.12.006; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Holub EB, 2004, TRENDS PLANT SCI, V9, P211, DOI 10.1016/j.tplants.2004.03.002; Hong W, 2007, MOL PLANT PATHOL, V8, P515, DOI 10.1111/J.1364-3703.2007.00412.X; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kawano T, 2003, PLANT CELL REP, V21, P829, DOI 10.1007/s00299-003-0591-z; KLEMENT Z, 1967, ANNU REV PHYTOPATHOL, V5, P17, DOI 10.1146/annurev.py.05.090167.000313; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lacy G. H., 1982, PHYTOPATHOGENIC PROK, V2, P149; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Lenk A, 2009, ADV BOT RES, V51, P91, DOI 10.1016/S0065-2296(09)51003-8; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Lipka U, 2008, CURR OPIN PLANT BIOL, V11, P404, DOI 10.1016/j.pbi.2008.04.004; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Niks RE, 2009, NEW PHYTOL, V182, P817, DOI 10.1111/j.1469-8137.2009.02849.x; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Park CJ, 2010, CELL MICROBIOL, V12, P1017, DOI 10.1111/j.1462-5822.2010.01489.x; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Persson S, 2001, PLANT PHYSIOL, V126, P1092, DOI 10.1104/pp.126.3.1092; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; Romeis T, 2001, EUR MOL BIOL ORG J, V20, P556; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Schweizer P, 2007, PHYSIOL MOL PLANT P, V70, P3, DOI 10.1016/j.pmpp.2007.07.004; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang CC, 2006, FUNCT PLANT BIOL, V33, P347, DOI 10.1071/FP05096; Wang XE, 2009, MOL PLANT MICROBE IN, V22, P1227, DOI 10.1094/MPMI-22-10-1227; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Xu YP, 2007, J INTEGR PLANT BIOL, V49, P1726, DOI 10.1111/j.1744-7909.2007.00569.x; Xu YouPing, 2008, Journal of Zhejiang University (Agriculture and Life Sciences), V34, P119; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zhu JW, 2008, EUR J PLANT PATHOL, V122, P307, DOI 10.1007/s10658-008-9294-1	57	39	41	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42796	10.1371/journal.pone.0042796	http://dx.doi.org/10.1371/journal.pone.0042796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912739	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500100031
J	Eckstein, RL; Ruch, D; Otte, A; Donath, TW				Eckstein, R. Lutz; Ruch, Diana; Otte, Annette; Donath, Tobias W.			Invasibility of a Nutrient-Poor Pasture through Resident and Non-Resident Herbs Is Controlled by Litter, Gap Size and Propagule Pressure	PLOS ONE			English	Article							SEEDLING ESTABLISHMENT; PLANT LITTER; ECOLOGICAL RESISTANCE; WATER AVAILABILITY; SOIL RESOURCES; INVASION; VEGETATION; COMMUNITIES; DISTURBANCE; REMOVAL	Since inference concerning the relative effects of propagule pressure, biotic interactions, site conditions and species traits on the invasibility of plant communities is limited, we carried out a field experiment to study the role of these factors for absolute and relative seedling emergence in three resident and three non-resident confamilial herb species on a nutrient-poor temperate pasture. We set up a factorial field experiment with two levels each of the factors litter cover (0 and 400 g m(-2)), gap size (0.01 and 0.1 m(2)) and propagule pressure (5 and 50 seeds) and documented soil temperature, soil water content and relative light availability. Recruitment was recorded in spring and autumn 2010 and in spring 2011 to cover initial seedling emergence, establishment after summer drought and final establishment after the first winter. Litter alleviated temperature and moisture conditions and had positive effects on proportional and absolute seedling emergence during all phases of recruitment. Large gaps presented competition-free space with high light availability but showed higher temperature amplitudes and lower soil moisture. Proportional and absolute seedling recruitment was significantly higher in large than in small gaps. In contrast, propagule pressure facilitated absolute seedling emergence but had no effects on proportional emergence or the chance for successful colonisation. Despite significantly higher initial seedling emergence of resident than non-resident species, seed mass and other species-specific traits may be better predictors for idiosyncratic variation in seedling establishment than status. Our data support the fluctuating resource hypothesis and demonstrate that the reserve effect of seeds may facilitate seedling emergence. The direct comparison of propagule pressure with other environmental factors showed that propagule pressure affects absolute seedling abundance, which may be crucial for species that depend on other individuals for sexual reproduction. However, propagule batch size did not significantly affect the chance for successful colonisation of disturbed plots.	[Eckstein, R. Lutz; Ruch, Diana; Otte, Annette; Donath, Tobias W.] Univ Giessen, Inst Landscape Ecol & Resource Management, Res Ctr BioSyst Land Use & Nutr IFZ, Giessen, Germany	Justus Liebig University Giessen	Eckstein, RL (corresponding author), Univ Giessen, Inst Landscape Ecol & Resource Management, Res Ctr BioSyst Land Use & Nutr IFZ, Giessen, Germany.	lutz.eckstein@umwelt.uni-giessen.de	Eckstein, Lutz/A-9241-2012; Donath, Tobias W./B-2856-2012	Donath, Tobias W./0000-0003-1874-1096				AGUILERA MO, 1993, J ECOL, V81, P253, DOI 10.2307/2261495; Boeken B, 2001, J VEG SCI, V12, P825, DOI 10.2307/3236870; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bullock J. M., 2000, Seeds: the ecology of regeneration in plant communities, P375, DOI 10.1079/9780851994321.0375; BULLOCK JM, 1995, OIKOS, V72, P273, DOI 10.2307/3546229; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Davis MA, 2005, ECOGRAPHY, V28, P696, DOI 10.1111/j.2005.0906-7590.04205.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis MA, 2001, ECOL LETT, V4, P421, DOI 10.1046/j.1461-0248.2001.00246.x; Dierschke H., 2002, KULTURGRASLAND; Donath TW, 2008, J ECOL, V96, P272, DOI 10.1111/j.1365-2745.2007.01338.x; Donath TW, 2006, BIOL CONSERV, V130, P315, DOI 10.1016/j.biocon.2005.12.022; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; Donath TW, 2004, AGR ECOSYST ENVIRON, V104, P439, DOI 10.1016/j.agee.2004.01.039; Eckstein RL, 2011, ANN BOT-LONDON, V108, P177, DOI 10.1093/aob/mcr097; Eckstein RL, 2005, J ECOL, V93, P807, DOI 10.1111/j.1365-2745.2005.01015.x; Eckstein RL, 2005, NEW PHYTOL, V166, P525, DOI 10.1111/j.1469-8137.2005.01336.x; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1; Foster BL, 2004, ECOLOGY, V85, P1541, DOI 10.1890/03-3165; GOLDBERG DE, 1983, OECOLOGIA, V60, P149, DOI 10.1007/BF00379516; Grime J. P., 1979, Plant strategies and vegetation processes.; Gross KL, 2005, ECOLOGY, V86, P476, DOI 10.1890/04-0122; GROSS KL, 1984, J ECOL, V72, P369, DOI 10.2307/2260053; HLUG (Hessisches Landesamt fu r Umwelt und Geologie), 2011, UMW HESS KLIM; HOBBS RJ, 1988, AUST J ECOL, V13, P171, DOI 10.1111/j.1442-9993.1988.tb00966.x; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Jensen K, 2003, BASIC APPL ECOL, V4, P579, DOI 10.1078/1439-1791-00179; Kaligaric M, 2011, PLANT BIOSYST, V145, P688, DOI 10.1080/11263504.2011.601338; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Loydi A, 2009, PLANT ECOL, V201, P471, DOI 10.1007/s11258-008-9468-0; Milbau A, 2003, NEW PHYTOL, V159, P657, DOI 10.1046/j.1469-8137.2003.00833.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Morgan JW, 1997, J APPL ECOL, V34, P566, DOI 10.2307/2404907; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rasran L, 2007, FOLIA GEOBOT, V42, P271, DOI 10.1007/BF02806467; Renne IJ, 2006, ECOLOGY, V87, P2264, DOI 10.1890/0012-9658(2006)87[2264:SIGIEO]2.0.CO;2; Rotundo JL, 2005, J ECOL, V93, P829, DOI 10.1111/j.1365-2745.2005.01022.x; Ruprecht E, 2010, J VEG SCI, V21, P1069, DOI 10.1111/j.1654-1103.2010.01206.x; Ruprecht E, 2010, BIOL CONSERV, V143, P449, DOI 10.1016/j.biocon.2009.11.012; RYSER P, 1993, J VEG SCI, V4, P195, DOI 10.2307/3236105; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Skorka P, 2010, BIOL CONSERV, V143, P856, DOI 10.1016/j.biocon.2009.12.030; Spackova I, 2004, FOLIA GEOBOT, V39, P41, DOI 10.1007/BF02803263; StatSoft Inc, 2011, STATISTICA WIND SOFT; Thiele J, 2006, PHYTOCOENOLOGIA, V36, P281, DOI 10.1127/0340-269X/2006/0036-0281; Thompson K, 2001, J ECOL, V89, P1054, DOI 10.1111/j.1365-2745.2001.00627.x; Thomsen MA, 2006, ECOL LETT, V9, P160, DOI 10.1111/j.1461-0248.2005.00857.x; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Voss N, 2011, J VEG SCI, V22, P726, DOI 10.1111/j.1654-1103.2011.01284.x; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x	54	16	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41887	10.1371/journal.pone.0041887	http://dx.doi.org/10.1371/journal.pone.0041887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911863	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300080
J	Rocca, RA; Magoon, G; Reynolds, DF; Krahn, T; Tilroe, VO; Boots, PMO; Grierson, AJ				Rocca, Richard A.; Magoon, Gregory; Reynolds, David F.; Krahn, Thomas; Tilroe, Vincent O.; Boots, Peter M. Op den Velde; Grierson, Andrew J.			Discovery of Western European R1b1a2 Y Chromosome Variants in 1000 Genomes Project Data: An Online Community Approach	PLOS ONE			English	Article							POPULATIONS; DIVERSITY; IBERIA	The authors have used an online community approach, and tools that were readily available via the Internet, to discover genealogically and therefore phylogenetically relevant Y-chromosome polymorphisms within core haplogroup R1b1a2-L11/S127 (rs9786076). Presented here is the analysis of 135 unrelated L11 derived samples from the 1000 Genomes Project. We were able to discover new variants and build a much more complex phylogenetic relationship for L11 sub-clades. Many of the variants were further validated using PCR amplification and Sanger sequencing. The identification of these new variants will help further the understanding of population history including patrilineal migrations in Western and Central Europe where R1b1a2 is the most frequent haplogroup. The fine-grained phylogenetic tree we present here will also help to refine historical genetic dating studies. Our findings demonstrate the power of citizen science for analysis of whole genome sequence data.	[Krahn, Thomas] FamilyTreeDNA Genom Res Ctr, Houston, TX USA; [Grierson, Andrew J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	University of Sheffield		rrocca@live.com	Grierson, Andy/A-5067-2009	Grierson, Andy/0000-0001-7039-6731				Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; DeFrancesco L, 2012, NAT BIOTECHNOL, V30, P126, DOI 10.1038/nbt0212-126a; Donnelly P, 2011, SCIENCE, V331, P1024, DOI 10.1126/science.1204089; Ellis N, 2002, GENOME RES, V12, P339; He M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004684; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Koch J., 2009, PALAEOHISPANICA, V9, P339; Koch John T., 2006, CELTIC CULTURE HIST; Lacan M, 2011, P NATL ACAD SCI USA, V108, P18255, DOI 10.1073/pnas.1113061108; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Larmuseau MHD, 2011, FORENSIC SCI INT-GEN, V5, P95, DOI 10.1016/j.fsigen.2010.08.020; Lee E. J., 2012, AM J PHYS ANTHR; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Mallory Joseph P., 1997, ENCY INDOEUROPEAN CU; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Pollack Andrew, 2011, NEW YORK TIMES, pB1; Rozen S, 2000, Methods Mol Biol, V132, P365; Russo E, 2001, NATURE, V413, P4; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	29	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41634	10.1371/journal.pone.0041634	http://dx.doi.org/10.1371/journal.pone.0041634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911832	Green Published, Green Accepted, gold			2022-12-27	WOS:000306751300060
J	Van Loey, NE; van de Schoot, R; Faber, AW				Van Loey, Nancy E.; van de Schoot, Rens; Faber, Albertus W.			Posttraumatic Stress Symptoms after Exposure to Two Fire Disasters: Comparative Study	PLOS ONE			English	Article							MOTOR-VEHICLE ACCIDENTS; PERITRAUMATIC DISSOCIATION; EVENT SCALE; RISK-FACTORS; BURN INJURY; IMPACT; DISORDER; EPIDEMIOLOGY; PREDICTORS; VICTIMS	This study investigated traumatic stress symptoms in severely burned survivors of two fire disasters and two comparison groups of patients with "non-disaster" burn injuries, as well as risk factors associated with acute and chronic stress symptoms. Patients were admitted to one out of eight burn centers in the Netherlands or Belgium. The Impact of Event Scale (IES) was administered to 61 and 33 survivors respectively of two fire disasters and 54 and 57 patients with "nondisaster" burn etiologies at 2 weeks, 3, 6, 12 and 24 months after the event. We used latent growth modeling (LGM) analyses to investigate the stress trajectories and predictors in the two disaster and two comparison groups. The results showed that initial traumatic stress reactions in disaster survivors with severe burns are more intense and prolonged during several months relative to survivors of "non-disaster" burn injuries. Excluding the industrial fire group, all participants' symptoms on average decreased over the two year period. Burn severity, peritraumatic anxiety and dissociation predicted the long-term negative outcomes only in the industrial fire group. In conclusion, fire disaster survivors appear to experience higher levels of traumatic stress symptoms on the short term, but the long-term outcome appears dependent on factors different from the first response. Likely, the younger age, and several beneficial post-disaster factors such as psychosocial aftercare and social support, along with swift judicial procedures, contributed to the positive outcome in one disaster cohort.	[Van Loey, Nancy E.] Assoc Dutch Burns Ctr, Dept Psychosocial & Behav Res, Beverwijk, Netherlands; [van de Schoot, Rens] Univ Utrecht, Dept Methods & Stat, Utrecht, Netherlands; [Faber, Albertus W.] Martini Hosp, Dept Clin Psychol, Groningen, Netherlands	Utrecht University; Martini Hospital	Van Loey, NE (corresponding author), Assoc Dutch Burns Ctr, Dept Psychosocial & Behav Res, Beverwijk, Netherlands.	nvanloey@burns.nl	Van Loey, Nancy/Y-3936-2019		Dutch Burns Foundation [01.05, 03.90, 04.2012]	Dutch Burns Foundation	The study was supported by the Dutch Burns Foundation (Grant numbers: 01.05, 03.90, 04.2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RE, 2006, J NERV MENT DIS, V194, P485, DOI 10.1097/01.nmd.0000228503.95503.e9; Adler A, 1943, J AMER MED ASSOC, V123, P1098, DOI 10.1001/jama.1943.02840520014004; [Anonymous], GAS PIP EXPL GHISL; APA, 2000, DIAGN STAT MAN MENT; Barillo DJ, 2006, J BURN CARE RES, V27, P622, DOI 10.1097/01.BCR.0000236823.08124.1C; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno George A, 2010, Psychol Sci Public Interest, V11, P1, DOI 10.1177/1529100610387086; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Broberg AG, 2005, J CHILD PSYCHOL PSYC, V46, P1279, DOI 10.1111/j.1469-7610.2005.01439.x; Brom D, 1985, NEDERLANDS TIJDSCHRI, V40, P164; Bui E, 2010, J TRAUMA STRESS, V23, P759, DOI 10.1002/jts.20592; Dirkzwager AJE, 2006, BRIT J PSYCHIAT, V189, P144, DOI 10.1192/bjp.bp.105.017855; Esselman PC, 2006, AM J PHYS MED REHAB, V85, P383, DOI 10.1097/01.phm.0000202095.51037.a3; Hickling EJ, 1999, J TRAUMA STRESS, V12, P345, DOI 10.1023/A:1024784711484; Holgersen KH, 2010, J TRAUMA STRESS, V23, P413, DOI 10.1002/jts.20530; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Joseph S, 2000, J TRAUMA STRESS, V13, P101, DOI 10.1023/A:1007777032063; Kaysen D, 2010, J INTERPERS VIOLENCE, V25, P63, DOI 10.1177/0886260508329131; Lawrence JW, 2012, J BURN CARE RES, V33, P136, DOI 10.1097/BCR.0b013e3182374452; Lensvelt-Mulders G, 2008, CLIN PSYCHOL REV, V28, P1138, DOI 10.1016/j.cpr.2008.03.006; Maes M, 2000, EUR ARCH PSY CLIN N, V250, P156, DOI 10.1007/s004060070034; MARMAR CR, 1994, AM J PSYCHIAT, V151, P902; Mason ST, 2010, J BURN CARE RES, V31, P64, DOI 10.1097/BCR.0b013e3181cb8ee6; Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9; McFarlane Alexander C, 2002, World Psychiatry, V1, P153; McNally RJ, 2003, ANNU REV PSYCHOL, V54, P229, DOI 10.1146/annurev.psych.54.101601.145112; Muthen L, 2007, MUTH N MUTH N; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Preacher K.J., 2008, LATENT GROWTH CURVE; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sveen J, 2010, J ANXIETY DISORD, V24, P618, DOI 10.1016/j.janxdis.2010.03.021; Sveen J, 2010, J BURN CARE RES, V31, P310, DOI 10.1097/BCR.0b013e3181d0f523; Tang CSK, 2007, J NERV MENT DIS, V195, P54, DOI 10.1097/01.nmd.0000242971.84798.bc; ter Smitten MH, 2011, BURNS, V37, P753, DOI 10.1016/j.burns.2010.12.018; van der Hart O, 2008, J TRAUMA DISSOCIATIO, V9, P481, DOI 10.1080/15299730802223362; van Loey NE, 2012, J TRAUMA ACUTE CARE, V72, P513, DOI 10.1097/TA.0b013e3182199072; Van Loey NEE, 2003, AM J CLIN DERMATOL, V4, P245, DOI 10.2165/00128071-200304040-00004; Van Loey NEE, 2003, J TRAUMA STRESS, V16, P361, DOI 10.1023/A:1024465902416; Welling L, 2005, BURNS, V31, P548, DOI 10.1016/j.burns.2005.01.009; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371	41	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41532	10.1371/journal.pone.0041532	http://dx.doi.org/10.1371/journal.pone.0041532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22911810	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300053
J	Feng, J; Liu, B; Zhang, ZQ; Ren, Y; Li, Y; Gan, F; Huang, YP; Chen, XD; Shen, P; Wang, L; Tang, B; Tang, XF				Feng, Jie; Liu, Bin; Zhang, Ziqian; Ren, Yan; Li, Yang; Gan, Fei; Huang, Yuping; Chen, Xiangdong; Shen, Ping; Wang, Lei; Tang, Bing; Tang, Xiao-Feng			The Complete Genome Sequence of Natrinema sp J7-2, a Haloarchaeon Capable of Growth on Synthetic Media without Amino Acid Supplements	PLOS ONE			English	Article							EXTREMELY HALOPHILIC ARCHAEON; ARGININE TRANSLOCATION PATHWAY; HALOFERAX-VOLCANII; SP-NOV.; SALT-LAKE; PHYLOGENETIC NETWORKS; HALOARCULA-HISPANICA; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; GEN. NOV.	Natrinema sp. J7-2 is an extreme haloarchaeon capable of growing on synthetic media without amino acid supplements. Here we report the complete genome sequence of Natrinema sp. J7-2 which is composed of a 3,697,626-bp chromosome and a 95,989-bp plasmid pJ7-I. This is the first complete genome sequence of a member of the genus Natrinema. We demonstrate that Natrinema sp. J7-2 can use gluconate, glycerol, or acetate as the sole carbon source and that its genome encodes complete metabolic pathways for assimilating these substrates. The biosynthetic pathways for all 20 amino acids have been reconstructed, and we discuss a possible evolutionary relationship between the haloarchaeal arginine synthetic pathway and the bacterial lysine synthetic pathway. The genome harbors the genes for assimilation of ammonium and nitrite, but not nitrate, and has a denitrification pathway to reduce nitrite to N2O. Comparative genomic analysis suggests that most sequenced haloarchaea employ the TrkAH system, rather than the Kdp system, to actively uptake potassium. The genomic analysis also reveals that one of the three CRISPR loci in the Natrinema sp. J7-2 chromosome is located in an integrative genetic element and is probably propagated via horizontal gene transfer (HGT). Finally, our phylogenetic analysis of haloarchaeal genomes provides clues about evolutionary relationships of haloarchaea.	[Feng, Jie; Zhang, Ziqian; Gan, Fei; Huang, Yuping; Chen, Xiangdong; Shen, Ping; Tang, Bing; Tang, Xiao-Feng] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Liu, Bin; Ren, Yan; Li, Yang; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Wang, Lei] Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin, Peoples R China	Wuhan University; Nankai University	Feng, J (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	tangb@whu.edu.cn; tangxf@whu.edu.cn	Gan, Fei/I-8599-2017; Feng, Jie/AAZ-1723-2021; Wang, Lei/C-5176-2009	Feng, Jie/0000-0001-8358-5654; Wang, Lei/0000-0003-4427-0881	National Natural Science Foundation of China [30870063, 30970071]; Program of Introducing Talents of Discipline to Universities of China [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities of China(Ministry of Education, China - 111 Project)	This work was supported in part by the National Natural Science Foundation of China (30870063, 30970071) and the Program of Introducing Talents of Discipline to Universities of China (B06018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020237; Anderson I, 2009, STAND GENOMIC SCI, V1, P218, DOI 10.4056/sigs.31864; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; BAUM BR, 1992, TAXON, V41, P3, DOI 10.2307/1222480; Bolhuis A, 2002, MICROBIOL-SGM, V148, P3335, DOI 10.1099/00221287-148-11-3335; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Bonete Maria Jose, 2008, Saline Syst, V4, P9, DOI 10.1186/1746-1448-4-9; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cabello P, 2004, MICROBIOL-SGM, V150, P3527, DOI 10.1099/mic.0.27303-0; Castillo AM, 2006, INT J SYST EVOL MICR, V56, P2683, DOI 10.1099/ijs.0.64421-0; CHIARIOTTI L, 1986, MOL GEN GENET, V202, P42, DOI 10.1007/BF00330514; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; EISENBERG H, 1992, ADV PROTEIN CHEM, V43, P1, DOI 10.1016/S0065-3233(08)60553-7; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fitch WM, 1997, J MOL EVOL S1, pS65; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Gonzalez O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000799; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Hochuli M, 1999, J BACTERIOL, V181, P3226, DOI 10.1128/JB.181.10.3226-3237.1999; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KAMEKURA M, 1992, J BACTERIOL, V174, P736, DOI 10.1128/jb.174.3.736-742.1992; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KAURI T, 1990, SYST APPL MICROBIOL, V13, P14, DOI 10.1016/S0723-2020(11)80174-8; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Liu HL, 2011, J BACTERIOL, V193, P6086, DOI 10.1128/JB.05953-11; Lledo B, 2005, GENE, V361, P80, DOI 10.1016/j.gene.2005.07.011; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malfatti S, 2009, STAND GENOMIC SCI, V1, P150, DOI 10.4056/sigs.23264; McGenity TJ, 1998, INT J SYST BACTERIOL, V48, P1187, DOI 10.1099/00207713-48-4-1187; MEVARECH M, 1985, J BACTERIOL, V162, P461, DOI 10.1128/JB.162.1.461-462.1985; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; OREN A, 1995, FEMS MICROBIOL ECOL, V18, P75, DOI 10.1016/0168-6496(95)00044-B; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; RAGAN MA, 1992, BIOSYSTEMS, V28, P47, DOI 10.1016/0303-2647(92)90007-L; Rawls KS, 2011, J BACTERIOL, V193, P4469, DOI 10.1128/JB.00276-11; Roh SW, 2010, J BACTERIOL, V192, P4528, DOI 10.1128/JB.00663-10; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunders E, 2010, STAND GENOMIC SCI, V2, P107, DOI 10.4056/sigs.681272; Shen P, 1994, CHINESE J GENET, V21, P409; Shi WL, 2006, EXTREMOPHILES, V10, P599, DOI 10.1007/s00792-006-0003-8; Shukla Hem D., 2006, Astrobiology, V6, P249; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; SOLIMAN GSH, 1982, ZBL BAKT MIK HYG I C, V3, P318, DOI 10.1016/S0721-9571(82)80045-8; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Strahl H, 2008, EXTREMOPHILES, V12, P741, DOI 10.1007/s00792-008-0177-3; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Tapingkae W, 2008, INT J SYST EVOL MICR, V58, P2378, DOI 10.1099/ijs.0.65644-0; Thomas JR, 2006, FEMS MICROBIOL LETT, V256, P44, DOI 10.1111/j.1574-6968.2006.00107.x; Tindall BJ, 2009, STAND GENOMIC SCI, V1, P270, DOI 10.4056/sigs.42644; TOMLINSON GA, 1986, INT J SYST BACTERIOL, V36, P66, DOI 10.1099/00207713-36-1-66; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Wanner C, 1999, GENETICS, V152, P1417; White RH, 2006, BIOCHEMISTRY-US, V45, P12366, DOI 10.1021/bi061018a; Xin HW, 2000, INT J SYST EVOL MICR, V50, P1297, DOI 10.1099/00207713-50-3-1297; Xu XW, 2005, INT J SYST EVOL MICR, V55, P1311, DOI 10.1099/ijs.0.63622-0; Xu ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023562; Ye XC, 2003, FEMS MICROBIOL LETT, V221, P53, DOI 10.1016/S0378-1097(03)00175-7; Zhang Fan, 2009, Weishengwu Xuebao, V49, P1445; Zhang H, 2007, FEMS MICROBIOL LETT, V275, P168, DOI 10.1111/j.1574-6968.2007.00881.x; Zhang H, 2009, EXTREMOPHILES, V13, P669, DOI 10.1007/s00792-009-0251-5	83	21	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41621	10.1371/journal.pone.0041621	http://dx.doi.org/10.1371/journal.pone.0041621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911826	gold, Green Submitted, Green Published			2022-12-27	WOS:000306687700125
J	Mercado, N; Hakim, A; Kobayashi, Y; Meah, S; Usmani, OS; Chung, KF; Barnes, PJ; Ito, K				Mercado, Nicolas; Hakim, Amir; Kobayashi, Yoshiki; Meah, Sally; Usmani, Omar S.; Chung, Kian Fan; Barnes, Peter J.; Ito, Kazuhiro			Restoration of Corticosteroid Sensitivity by p38 Mitogen Activated Protein Kinase Inhibition in Peripheral Blood Mononuclear Cells from Severe Asthma	PLOS ONE			English	Article							FACTOR-KAPPA-B; INSENSITIVE ASTHMA; GENE-EXPRESSION; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; RESISTANT ASTHMA; MAPK INHIBITOR; T-CELLS; RECEPTOR; INFLAMMATION	Background: Severe asthma accounts for a small number of asthmatics but represents a disproportionate cost to health care systems. The underlying mechanism in severe asthma remains unknown but several mechanisms are likely to be involved because of a very heterogeneous profile. We investigated the effects of a p38MAPK inhibitor in corticosteroid sensitivity in peripheral blood mononuclear cells (PBMCs) from severe asthmatics and the profile of its responders. Methodology/Principal Findings: Corticosteroid sensitivity was determined by measuring dexamethasone inhibition of CD3/28 and TNF-alpha induced IL-8 production in PBMCs by using ELISA. PBMCs from severe asthmatics were relatively less sensitive to dexamethasone (Dex) as compared to those of non-severe asthmatics and healthy volunteers. The IC50 values of Dex negatively correlated with decreased glucocorticoid receptor (GR) nuclear translocation assessed using immunocytochemistry (r = -0.65; p<0.0005) and with decreased FEV1 (% predicted) (r = 0.6; p<0.0005). A p38 alpha/beta inhibitor (SB203580) restored Dex-sensitivity in a subpopulation of severe asthma that was characterized by a defective GR nuclear translocation, clinically by lower FEV1 and higher use of oral prednisolone. We also found that SB203580 partially inhibited GR phosphorylation at serine 226, resulting in increased GR nuclear translocation in IL-2/IL-4 treated corticosteroid insensitive U937s. Conclusions/Significance: p38MAPK alpha/beta is involved in defective GR nuclear translocation due to phosphorylation at Ser226 and this will be a useful biomarker to identify responders to p38MAPK alpha/beta inhibitor in the future.	[Mercado, Nicolas; Hakim, Amir; Kobayashi, Yoshiki; Meah, Sally; Usmani, Omar S.; Chung, Kian Fan; Barnes, Peter J.; Ito, Kazuhiro] Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London, England; [Hakim, Amir; Meah, Sally; Usmani, Omar S.; Chung, Kian Fan] Royal Brompton Hosp, Biomed Res Unit, London SW3 6LY, England	Imperial College London; Royal Brompton Hospital	Mercado, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London, England.	k.ito@imperial.ac.uk	Chung, Kian Fan/I-8456-2019; Ito, Kazuhiro/AAF-5994-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; hakim, amir/0000-0002-4884-3141; Barnes, Peter/0000-0002-5122-4018; mercado, nicolas/0000-0002-8728-0994	Asthma UK [04-56]; Medical Research Council (MRC) [G0700900]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Trust at Imperial College London; MRC [G0700900] Funding Source: UKRI; Medical Research Council [G0700900, G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10148, CDF-2011-04-053] Funding Source: researchfish	Asthma UK; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Trust at Imperial College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by grants from Asthma UK [04-56] and from the Medical Research Council (MRC) [G0700900]. The study was supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Trust at Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Barnes Peter J, 2004, Proc Am Thorac Soc, V1, P264, DOI 10.1513/pats.200402-014MS; Barnes PJ, 2006, TRENDS MOL MED, V12, P515, DOI 10.1016/j.molmed.2006.09.006; Bergmann MW, 2004, IMMUNOLOGY, V111, P430, DOI 10.1111/j.0019-2805.2004.01833.x; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; Bhavsar P, 2008, THORAX; Bhavsar PK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-71; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Chung KF, 1999, EUR RESPIR J, V13, P1198; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; Dente FL, 2006, ANN ALLERG ASTHMA IM, V97, P312, DOI 10.1016/S1081-1206(10)60795-8; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; GINA, 2011, GLOB IN ASTHM GUID; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; Goleva E, 2009, AM J RESP CELL MOL, V40, P223, DOI 10.1165/rcmb.2007-0327OC; Hamilton LM, 2003, CLIN EXP ALLERGY, V33, P233, DOI 10.1046/j.1365-2222.2003.01593.x; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; KAM JC, 1993, J IMMUNOL, V151, P3460; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; LEUNG DYM, 1995, J EXP MED, V181, P33, DOI 10.1084/jem.181.1.33; Li LB, 2007, BLOOD, V110, P1570, DOI 10.1182/blood-2007-01-070755; Little SA, 2002, AM J MED, V112, P446, DOI 10.1016/S0002-9343(02)01047-1; Livingston E, 2007, EUR RESPIR J, V29, P64, DOI 10.1183/09031936.06.00120505; Mann BS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-59; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Mercado N, 2011, MOL PHARMACOL, V80, P1128, DOI 10.1124/mol.111.071993; Polosa R, 2007, INTERN MED J; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Rossios C, 2012, BRIT J PHARMACOL, V167, P775, DOI 10.1111/j.1476-5381.2012.01864.x; Saatian B, 2006, BIOCHEM J, V393, P657, DOI 10.1042/BJ20050791; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saha SK, 2008, J ALLERGY CLIN IMMUN, V121, P685, DOI 10.1016/j.jaci.2008.01.005; Schafer PH, 1999, J IMMUNOL, V162, P7110; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Shaw DE, 2007, CHEST, V132, P1871, DOI 10.1378/chest.07-1047; Silvestri M, 2006, CLIN EXP ALLERGY, V36, P1373, DOI 10.1111/j.1365-2222.2006.02502.x; Singh D, 2010, J CLIN PHARMACOL, V50, P94, DOI 10.1177/0091270009347873; Sorkness RL, 2007, J APPL PHYSL; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200	46	83	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41582	10.1371/journal.pone.0041582	http://dx.doi.org/10.1371/journal.pone.0041582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911818	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700118
J	Henning, T; Weigend, M				Henning, Tilo; Weigend, Maximilian			Total Control - Pollen Presentation and Floral Longevity in Loasaceae (Blazing Star Family) Are Modulated by Light, Temperature and Pollinator Visitation Rates	PLOS ONE			English	Article							NECTAR; MOVEMENTS; DISPERSAL; EVOLUTION; RESPONSES; FLOWERS; PLANTS	Stamen movements can be understood as a mechanism influencing pollen presentation and increasing outbreeding success of hermaphroditic flowers via optimized male function. In this study we experimentally analyzed the factors regulating autonomous and thigmonastic (triggered by flower visitors) stamen movements in eight species of Loasaceae. Both types of stamen movements are positively influenced by light and temperature and come to a virtual standstill in the dark and at low temperatures (12 degrees C). Pollen presentation is thus discontinued during periods where pollinators are not active. Overall stamen presentation increases with increasing flower age. Contrary to expectation, no geometrical correlation between the floral scale stimulated and the stamen fascicle reacting exists, indicating that the stimulus is transmitted over the receptacle and stamen maturation dictates which and how many stamens react. Thigmonastic stamen presentation is dramatically accelerated compared to autonomous movement (3-37 times), indicating that the rate of stamen maturation can be adjusted to different visitation schedules. Flowers can react relatively uniformly down to stimulation intervals of 10-15 min., consistently presenting comparable numbers of stamens in the flower c. 5 min. after the stimulus and can thus keep the amount of pollen presented relatively constant even under very high visitation frequencies of 4-6 visits/h. Thigmonastic pollen presentation dramatically reduces the overall duration of the staminate phase (to 1/3rd in Nasa macrothyrsa). Similarly, the carpellate phase is dramatically reduced after pollination, down to 1 d from 4 d. Overall flower longevity is reduced by more than 2/3rds under high visitation rates (<3 d versus 10 d under visitor exclusion) and depleted and pollinated flowers are rapidly removed from the pool. Complex floral behaviour in Loasaceae thus permits a near-total control over pollen dispensation schedules and floral longevity of the individual flower by an extraordinary fine-tuning to both biotic and abiotic factors.	[Henning, Tilo] Free Univ Berlin, Inst Biol Morphol & Systemat Phanerogamen, Berlin, Germany; [Weigend, Maximilian] Univ Bonn, Nees Inst Biodiversitat Pflanzen, Bonn, Germany	Free University of Berlin; University of Bonn	Henning, T (corresponding author), Free Univ Berlin, Inst Biol Morphol & Systemat Phanerogamen, Berlin, Germany.	tilo.henning@fu-berlin.de	Weigend, Maximilian/F-7989-2014	Weigend, Maximilian/0000-0003-0813-6650; Henning, Tilo/0000-0003-1929-3264	NaFoG (Elsa Neumann Stipendium des Landes Berlin); botconsult GmbH	NaFoG (Elsa Neumann Stipendium des Landes Berlin); botconsult GmbH	Funds provided by NaFoG (Elsa Neumann Stipendium des Landes Berlin, http://www.fu-berlin.de/en/forschung/service/foerderung/nachwuchsfoerder/nachwuchs/nafoeg.html, PhD study of the first author), and botconsult GmbH (http://www.botconsult.de/) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2006, ANN BOT-LONDON, V98, P503, DOI 10.1093/aob/mcl136; [Anonymous], ERGEBNISSE WELTWEITE; Ashman T. L., 1996, FLORAL BIOL STUDIES, P112, DOI DOI 10.1007/978-1-4613-1165-2_5; Biernaskie JM, 2002, OIKOS, V98, P98, DOI 10.1034/j.1600-0706.2002.980110.x; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Castellanos MC, 2006, AM NAT, V167, P288, DOI 10.1086/498854; CRESSWELL JE, 1990, OECOLOGIA, V82, P450, DOI 10.1007/BF00319785; Dafni A, 2000, PLANT SYST EVOL, V222, P113, DOI 10.1007/BF00984098; Darwin C., 1875, MOVEMENTS HABITS CLI; Dostert Nicolas, 1999, Harvard Papers in Botany, V4, P439; GRANT V, 1979, PLANT SYST EVOL, V132, P313, DOI 10.1007/BF00982393; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Harter B, 1995, APIDOLOGIE, V26, P356; Henning T, 2009, BOT J LINN SOC, V161, P278, DOI 10.1111/j.1095-8339.2009.01006.x; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; JAFFE MJ, 1977, BOT GAZ, V138, P438, DOI 10.1086/336946; Jersakova J, 2006, OECOLOGIA, V147, P60, DOI 10.1007/s00442-005-0254-6; Johnson SD, 2004, P ROY SOC B-BIOL SCI, V271, P803, DOI 10.1098/rspb.2003.2659; LeBuhn G, 1998, EVOL ECOL, V12, P111, DOI 10.1023/A:1006563108498; LEBUHN G, 1994, AM MIDL NAT, V131, P257, DOI 10.2307/2426251; Linnaeus C., 1745, FLORA SUECICA, DOI 10.5962/bhl.title.714; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; MOURE J. S., 1951, DUSENIA, V2, P25; Pinheiro J., 2011, NLME LINEAR NONLINEA; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; SATTER RL, 1973, PLANT PHYSIOL, V52, P202, DOI 10.1104/pp.52.3.202; SATTER RL, 1981, ANNU REV PLANT PHYS, V32, P83, DOI 10.1146/annurev.pp.32.060181.000503; Schlindwein C, 1997, BOT ACTA, V110, P177, DOI 10.1111/j.1438-8677.1997.tb00626.x; Schlindwein C, 1997, PLANT SYST EVOL, V204, P179, DOI 10.1007/BF00989204; Schlindwein C., 1992, C LAT AM ZOOL 12 C B, P73; Scott R, 1903, ANN BOT-LONDON, V17, P761, DOI 10.1093/oxfordjournals.aob.a088942; SIBOAKA T, 1969, ANN REV PLANT PHYSIO, V20, P165; SMITH A P, 1974, Biotropica, V6, P263, DOI 10.2307/2989670; Thomson J, 2003, AM NAT, V162, pS1, DOI 10.1086/378683; URBAN I, 1886, JB BOTANISCHEN GARTE, V4, P364; Urban I., 1892, BER DEUT BOT GES, V10, P259; vanDoorn WG, 1997, J EXP BOT, V48, P1615, DOI 10.1093/jexbot/48.314.1615; WEBB CJ, 1987, ANN MO BOT GARD, V74, P51, DOI 10.2307/2399261; WEBER A., 1993, VERH ZOOL BOT GES OS, V130, P99; Weigend M, 2010, BIOL J LINN SOC, V100, P124, DOI 10.1111/j.1095-8312.2010.01419.x; Weintraub M, 1952, N PHYTOL, V3, P357, DOI [10.1111/j.1469-8137.1952.tb05196.x, DOI 10.1111/J.1469-8137.1952.TB05196.X]; WILLMER PG, 1983, ECOL ENTOMOL, V8, P455, DOI 10.1111/j.1365-2311.1983.tb00524.x; WITTMANN D., 1995, BIOCIENCIAS, V3, P19; Zuur Alain F., 2009, P1	45	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41121	10.1371/journal.pone.0041121	http://dx.doi.org/10.1371/journal.pone.0041121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916102	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800008
J	Kleinschmidt, MA; de Graaf, P; van Teeffelen, HAAM; Timmers, HTM				Kleinschmidt, Markus A.; de Graaf, Petra; van Teeffelen, Hetty A. A. M.; Timmers, H. Th Marc			Cell Cycle Regulation by the PRMT6 Arginine Methyltransferase through Repression of Cyclin-Dependent Kinase Inhibitors	PLOS ONE			English	Article							PREMATURE SENESCENCE; H3K4 TRIMETHYLATION; GENE-EXPRESSION; HISTONE H3R2; METHYLATION; PROTEIN; P21; BINDING; TARGET; PROLIFERATION	PRMT6 belongs to the family of Protein Arginine Methyltransferase (PRMT) enzymes that catalyze the methylation of guanidino nitrogens of arginine residues. PRMT6 has been shown to modify the tail of histone H3, but the in vivo function of PRMT6 is largely unknown. Here, we show that PRMT6 regulates cell cycle progression. Knockdown of PRMT6 expression in the human osteosarcoma cell line U2OS results in an accumulation of cells at the G2 checkpoint. Loss of PRMT6 coincides with upregulation of p21 and p27, two members of the CIP/KIP family of cyclin-dependent kinase (CDK) inhibitors. Gene expression and promoter analysis show that p21 and p27 are direct targets of PRMT6, which involves methylation of arginine-2 of histone H3. Our findings imply arginine methylation of histones by PRMT6 in cell cycle regulation.	[Kleinschmidt, Markus A.] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; Univ Med Ctr Utrecht, Netherlands Prote Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Kleinschmidt, MA (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands.	h.t.m.timmers@umcutrecht.nl		de Graaf, Petra/0000-0002-3183-8901	NWO-TOP [700.57.302]; Netherlands Proteomics Center	NWO-TOP(Netherlands Organization for Scientific Research (NWO)); Netherlands Proteomics Center	This work was financially supported by grants from NWO-TOP (#700.57.302) and Netherlands Proteomics Center to HTMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Gillespie David A F, 2006, Subcell Biochem, V40, P355; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Harrison MJ, 2010, NUCLEIC ACIDS RES, V38, P2201, DOI 10.1093/nar/gkp1203; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Invernizzi CF, 2007, AIDS, V21, P795, DOI 10.1097/QAD.0b013e32803277ae; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kim C, 2010, BBA-GEN SUBJECTS, V1800, P977, DOI 10.1016/j.bbagen.2010.06.004; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Kottemann MC, 2009, DNA REPAIR, V8, P944, DOI 10.1016/j.dnarep.2009.06.001; Lee YH, 2012, PROTEIN ARGININE MET, DOI [10.1089/scd.2011.0330, DOI 10.1089/SCD.2011.0330]; Lim Y, 2008, J BIOCHEM, V144, P523, DOI 10.1093/jb/mvn097; Mainprize TG, 2001, J NEURO-ONCOL, V51, P205, DOI 10.1023/A:1010671908204; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Polotskaia A, 2007, CELL CYCLE, V6, P2524, DOI 10.4161/cc.6.20.4799; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Wagner S, 2006, J BIOL CHEM, V281, P27242, DOI 10.1074/jbc.M605172200; Waldmann T, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-11; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	42	49	62	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41446	10.1371/journal.pone.0041446	http://dx.doi.org/10.1371/journal.pone.0041446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916108	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800011
J	Bhushan, V; Saha, G; Lindsen, J; Shimojo, S; Bhattacharya, J				Bhushan, Vidya; Saha, Goutam; Lindsen, Job; Shimojo, Shinsuke; Bhattacharya, Joydeep			How We Choose One over Another: Predicting Trial-by-Trial Preference Decision	PLOS ONE			English	Article							GENERALIZED SYNCHRONIZATION; STIMULI; EEG; RECOGNITION; COMPETENCE; LIKELIHOOD; TIME	Preference formation is a complex problem as it is subjective, involves emotion, is led by implicit processes, and changes depending on the context even within the same individual. Thus, scientific attempts to predict preference are challenging, yet quite important for basic understanding of human decision making mechanisms, but prediction in a group-average sense has only a limited significance. In this study, we predicted preferential decisions on a trial by trial basis based on brain responses occurring before the individuals made their decisions explicit. Participants made a binary preference decision of approachability based on faces while their electrophysiological responses were recorded. An artificial neural network based pattern-classifier was used with time-frequency resolved patterns of a functional connectivity measure as features for the classifier. We were able to predict preference decisions with a mean accuracy of 74.3 +/- 2.79% at participant-independent level and of 91.4 +/- 3.8% at participant-dependent level. Further, we revealed a causal role of the first impression on final decision and demonstrated the temporal trajectory of preference decision formation.	[Bhushan, Vidya; Saha, Goutam] Indian Inst Technol, Dept Elect & Elect Commun Engn, Kharagpur 721302, W Bengal, India; [Lindsen, Job; Bhattacharya, Joydeep] Univ London, Dept Psychol, London, England; [Shimojo, Shinsuke] CALTECH, Div Biol, Pasadena, CA 91125 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of London; California Institute of Technology	Bhushan, V (corresponding author), Indian Inst Technol, Dept Elect & Elect Commun Engn, Kharagpur 721302, W Bengal, India.	j.bhattacharya@gold.ac.uk	Saha, Goutam/AAH-6281-2020	Saha, Goutam/0000-0001-6187-1684	JST.ERATO; DST, Government of India; JST.CREST; MEXT.gCOE	JST.ERATO(Japan Science & Technology Agency (JST)); DST, Government of India(Department of Science & Technology (India)); JST.CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT.gCOE	The research has been partially supported by JST.ERATO (SS, JB) and DST, Government of India (JB, GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Rhiannon Jones for data collection. We also thank Dr. Sam Gilbert for raising the issue of motor responses. SS is supported by JST.CREST and MEXT.gCOE.	Abarbanel HDI, 1996, PHYS REV E, V53, P4528, DOI 10.1103/PhysRevE.53.4528; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; [Anonymous], 2008, 1 IMPRESSIONS; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Bhattacharya J, 2005, HUM BRAIN MAPP, V26, P1, DOI 10.1002/hbm.20104; Bishop CM, 2006, PATTERN RECOGN, Vxx; Campbell DW, 2009, DEPRESS ANXIETY, V26, P419, DOI 10.1002/da.20474; Campbell DW, 2011, J PERS, V79, P335, DOI 10.1111/j.1467-6494.2010.00687.x; Chapman KW, 2010, J SENS STUD, V25, P35, DOI 10.1111/j.1745-459X.2010.00294.x; Chau T, 2009, J NEURAL ENG, V6, P1; Clithero JA, 2011, NEUROIMAGE, V56, P699, DOI 10.1016/j.neuroimage.2010.03.057; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; DEECKE L, 1987, CIBA F SYMP, V132, P231; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dominguez LG, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/058001; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haykin SS, 1999, NEURAL NETWORKS COMP, Vxxi; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hogarth RM, 1980, JUDGMENT CHOICE PSYC, Vxi; Hopfield JJ, 2001, P NATL ACAD SCI USA, V98, P1282, DOI 10.1073/pnas.031567098; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; Leclerc D, 2004, INT J INTERCULT REL, V28, P181, DOI 10.1016/j.ijintrel.2004.06.006; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Leotti LA, 2010, TRENDS COGN SCI, V14, P457, DOI 10.1016/j.tics.2010.08.001; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; Marchisano C, 2003, J SENS STUD, V18, P487, DOI 10.1111/j.1745-459X.2003.tb00402.x; Meyer K, 2010, NAT NEUROSCI, V13, P667, DOI 10.1038/nn.2533; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Pockett S, 2009, CLIN NEUROPHYSIOL, V120, P695, DOI 10.1016/j.clinph.2008.12.044; PRUZANSKY S, 1964, J ACOUST SOC AM, V36, P2041, DOI 10.1121/1.1919320; Santos IM, 2011, Q J EXP PSYCHOL, V64, P751, DOI 10.1080/17470218.2010.519779; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589	44	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43351	10.1371/journal.pone.0043351	http://dx.doi.org/10.1371/journal.pone.0043351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912859	Green Published, Green Accepted, gold			2022-12-27	WOS:000308063700087
J	Fu, XY; Tan, DM; Hou, ZH; Hu, ZL; Liu, GZ; Ouyang, Y; Liu, F				Fu, Xiaoyu; Tan, Deming; Hou, Zhouhua; Hu, Zhiliang; Liu, Guozhen; Ouyang, Yi; Liu, Fei			The Effect of miR-338-3p on HBx Deletion-Mutant (HBx-d382) Mediated Liver-Cell Proliferation through CyclinD1 Regulation	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; X PROTEIN HBX; HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; MESSENGER-RNA; GENE; TUMOR; D1; TRANSACTIVATION; IDENTIFICATION	Objective: Hepatitis B Virus (HBV) DNA integration and HBV X (HBx) deletion mutation occurs in HBV-positive liver cancer patients, and C-terminal deletion in HBx gene mutants are highly associated with hepatocarcinogenesis. Our previous study found that the HBx-d382 deletion mutant (deleted at nt 382-400) can down-regulate miR-338-3p expression in HBx-expressing cells. The aim of the present study is to examine the role of miR-338-3p in the HBx-d382-mediated liver-cell proliferation. Methods: We established HBx-expressing LO2 cells by Lipofectamine 2000 transfection. A miR-338-3p mimics or inhibitor was transfected into LO2/HBx-d382 and LO2/HBx cells using miR-NC as a control miRNA. In silico analysis of potential miR-338-3p targets revealed that miR-338-3p could target the cell cycle regulatory protein CyclinD1. To confirm that CyclinD1 is negatively regulated by miR-338-3p, we constructed luciferase reporters with wild-type and mutated CyclinD1-39UTR target sites for miR-338-3p binding. We examined the CyclinD1 expression by real-time PCR and western blot, and proliferation activity by flow cytometric cell cycle analysis, Edu incorporation, and soft agar colony. Results: HBx-d382 exhibited enhanced proliferation and CyclinD1 expression in LO2 cells. miR-338-3p expression inhibited cell proliferation in LO2/HBx-d382 cells (and LO2/HBx cells), and also negatively regulated CyclinD1 protein expression. Of the two putative miR-338-3p binding sites in the CyclinD1-39UTR region, the effect of miR-338-3p on the second binding site (nt 2397-2403) was required for the inhibition. Conclusion: miR-338-3p can directly regulate CyclinD1 expression through binding to the CyclinD1-39UTR region, mainly at nt 2397-2403. Down-regulation of miR-338-3p expression is required for liver cell proliferation in both LO2/HBx and LO2/HBx-d382 mutant cells, although the effect is more pronounced in LO2/HBx-d382 cells. Our study elucidated a novel mechanism, from a new miRNA-regulation perspective, underlying the propensity of HBx deletion mutants to induce hepatocarcinogenesis at a faster rate than HBx.	[Fu, Xiaoyu; Tan, Deming; Hou, Zhouhua; Liu, Guozhen; Ouyang, Yi; Liu, Fei] Cent South Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Hu, Zhiliang] Second Hosp Nanjing, Nanjing, Jiangsu, Peoples R China	Central South University	Tan, DM (corresponding author), Cent South Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China.	dmtxy2012@163.com	Hu, Zhiliang/AAS-3469-2020	Hu, Zhiliang/0000-0001-8543-821X; Fu, Xiaoyu/0000-0003-4467-2418	National Natural Science Foundationof China [30872228]	National Natural Science Foundationof China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundationof China (No 30872228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; BEASLEY RP, 1981, LANCET, V2, P1129; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bouchard M, 2001, J VIROL, V75, P4247, DOI 10.1128/JVI.75.9.4247-4257.2001; BRECHOT C, 1980, NATURE, V286, P533, DOI 10.1038/286533a0; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen WN, 2000, BIOCHEM BIOPH RES CO, V276, P885, DOI 10.1006/bbrc.2000.3562; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cheng P, 2009, ONCOL REP, V22, P1101, DOI 10.3892/or_00000542; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Elmore LW, 1997, P NATL ACAD SCI USA, V94, P14707, DOI 10.1073/pnas.94.26.14707; Hou Zhouhua, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P282; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Hulit J, 2002, BIOCHEM PHARMACOL, V64, P827, DOI 10.1016/S0006-2952(02)01145-0; Iavarone M, 2003, J HEPATOL, V39, P253, DOI 10.1016/S0168-8278(03)00217-4; Ikehara M, 2003, ONCOL REP, V10, P137; Jiao J, 2007, EUR J GASTROEN HEPAT, V19, P1114, DOI 10.1097/MEG.0b013e3282748ee2; Klein A, 2003, ONCOGENE, V22, P2910, DOI 10.1038/sj.onc.1206539; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lassus P, 1996, EMBO J, V15, P4566, DOI 10.1002/j.1460-2075.1996.tb00834.x; Lastowska M, 1997, GENE CHROMOSOME CANC, V19, P143; Liu Y, 2009, CHINESE MED J-PEKING, V122, P10, DOI 10.3760/cma.j.issn.0366-6999.2009.01.003; Minami M, 2005, ONCOGENE, V24, P4340, DOI 10.1038/sj.onc.1208628; Minemura M, 2005, ONCOL REP, V14, P495; Misra KP, 2004, VIRUS RES, V105, P157, DOI 10.1016/j.virusres.2004.05.006; Montorsi M, 2007, HEPATO-GASTROENTEROL, V54, P2040; MURAKAMI S, 1994, J BIOL CHEM, V269, P15118; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murillo CA, 2004, J AM COLL SURGEONS, V199, pS11; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; Patil MA, 2006, CANCER BIOL THER, V5, P111, DOI 10.4161/cbt.5.1.2379; Plantaz D, 1997, AM J PATHOL, V150, P81; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sauter ER, 2002, CANCER GENE THER, V9, P807, DOI 10.1038/sj.cgt.7700492; Sirma H, 1999, ONCOGENE, V18, P4848, DOI 10.1038/sj.onc.1202867; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tralhao JG, 2002, P NATL ACAD SCI USA, V99, P6991, DOI 10.1073/pnas.092657699; Tu H, 2001, CANCER RES, V61, P7803; Venard V, 2000, J MED VIROL, V62, P177, DOI 10.1002/1096-9071(200010)62:2&lt;177::AID-JMV8&gt;3.0.CO;2-V; Wang JC, 2004, VIRUS RES, V102, P133, DOI 10.1016/j.virusres.2004.01.023; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Yang MC, 2005, CYTOKINE GROWTH F R, V16, P387, DOI 10.1016/j.cytogfr.2005.02.008; Yeh CT, 2000, ONCOGENE, V19, P5213, DOI 10.1038/sj.onc.1203903; Yu YM, 2009, J IMMUNOL METHODS, V350, P29, DOI 10.1016/j.jim.2009.07.008; Zhu HZ, 2004, EXP MOL PATHOL, V76, P44, DOI 10.1016/j.yexmp.2003.09.001; Zhu PA, 2007, ACTA BIOCH BIOPH SIN, V39, P265, DOI 10.1111/j.1745-7270.2007.00279.x	53	28	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43204	10.1371/journal.pone.0043204	http://dx.doi.org/10.1371/journal.pone.0043204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912826	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700060
J	Rozen, WM; Edirisinghe, Y; Crock, J				Rozen, Warren M.; Edirisinghe, Yasith; Crock, John			Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease	PLOS ONE			English	Article							CONTRACTURE	Introduction: While Dupuytren's disease can cause disabling contractures requiring open surgery, a less-invasive option using Clostridium Histolyticum collagenase (CHC) via percutaneous injection was recently reported. A recent prospective, randomized trial demonstrated few complications during 90 days follow-up, however did not assess any longer term follow-up for these patients. Long-term outcomes in this setting have not been adequately reported, and the current manuscript aims to identify late complications from the clinical use of percutaneous CHC. Methods: The current manuscript reports an extended 12-month follow-up for a cohort of twelve of patients enrolled in the original prospective, randomized trial, treated at a single institution. An analysis of complications requiring surgical intervention was undertaken. Results: Two of twelve patients reported debilitating pain and triggering requiring surgical intervention. Extensive deep-tissue scarring and adhesions were identified, providing the first visual and qualitative analysis of the pathologic effects of CHC. Conclusion: Late complications from CHC use can and have occurred, outside the follow-up period of the initial phase III trials. Longer term follow-up of such patients is thus essential, and further investigation and characterization of the late effects of CHC use is warranted.	[Rozen, Warren M.; Edirisinghe, Yasith; Crock, John] So Hlth, Dandenong Hosp, Dept Plast & Reconstruct Surg, Dandenong, Vic, Australia; [Rozen, Warren M.; Edirisinghe, Yasith; Crock, John] Monash Univ, Fac Med, Dept Surg, Clayton, Vic, Australia	Monash University	Rozen, WM (corresponding author), So Hlth, Dandenong Hosp, Dept Plast & Reconstruct Surg, Dandenong, Vic, Australia.	warrenrozen@hotmail.com	Rozen, Warren Matthew/AAE-6296-2022	Rozen, Warren Matthew/0000-0002-4092-182X				Amadio PC, 2009, J BONE JOINT SURG AM, V91A, P496, DOI 10.2106/JBJS.H.01697; Badalamente MA, 2002, J HAND SURG-AM, V27A, P788, DOI 10.1053/jhsu.2002.35299; Badalamente MA, 2007, J HAND SURG-AM, V32A, P767, DOI 10.1016/j.jhsa.2007.04.002; Bayat A, 2006, ANN ROY COLL SURG, V88, P3, DOI 10.1308/003588406X83104; Desai SS, 2010, EXPERT OPIN BIOL TH, V10, P1395, DOI 10.1517/14712598.2010.510509; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Rayan GM, 2007, J BONE JOINT SURG AM, V89A, P190, DOI 10.2106/00004623-200701000-00026; RYDEVIK B, 1989, SCAND J PLAST RECONS, V23, P17, DOI 10.3109/02844318909067503; Saar JD, 2000, PLAST RECONSTR SURG, V106, P125, DOI 10.1097/00006534-200007000-00024; SUOMALAINEN K, 1992, ANTIMICROB AGENTS CH, V36, P227, DOI 10.1128/AAC.36.1.227; Townley WA, 2006, BRIT MED J, V332, P397, DOI 10.1136/bmj.332.7538.397	12	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43406	10.1371/journal.pone.0043406	http://dx.doi.org/10.1371/journal.pone.0043406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912868	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700096
J	Tewson, P; Westenberg, M; Zhao, YX; Campbell, RE; Quinn, AM; Hughes, TE				Tewson, Paul; Westenberg, Mara; Zhao, Yongxin; Campbell, Robert E.; Quinn, Anne Marie; Hughes, Thomas E.			Simultaneous Detection of Ca2+ and Diacylglycerol Signaling in Living Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; GREEN FLUORESCENT PROTEIN; REPORTER; DOMAIN	Phospholipase C produces two second messengers - diacylglycerol (DAG), which remains in the membrane, and inositol triphosphate (IP3), which triggers the release of calcium ions (Ca2+) from intracellular stores. Genetically encoded sensors based on a single circularly permuted fluorescent protein (FP) are robust tools for studying intracellular Ca2+ dynamics. We have developed a robust sensor for DAG based on a circularly permuted green FP that can be co-imaged with the red fluorescent Ca2+ sensor R-GECO for simultaneous measurement of both second messengers.	[Tewson, Paul; Westenberg, Mara; Quinn, Anne Marie; Hughes, Thomas E.] Montana Mol, Bozeman, MT USA; [Hughes, Thomas E.] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Zhao, Yongxin; Campbell, Robert E.] Univ Alberta, Dept Chem, Edmonton, AB, Canada	Montana State University System; Montana State University Bozeman; University of Alberta	Tewson, P (corresponding author), Montana Mol, Bozeman, MT USA.	thughesgfp@mac.com	Zhao, Yongxin/AAE-3708-2020; Zhao, Yongxin/F-1874-2015	Zhao, Yongxin/0000-0003-4188-5725; Zhao, Yongxin/0000-0003-4188-5725; Campbell, Robert E./0000-0003-0604-092X; Hughes, Thomas/0000-0002-8430-070X	NIMH - National Institue of Mental Health [1R43MH096670-01A1]; Montana Board of Research and Commercialization [11-37]; Alberta Innovates; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH096670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS082222] Funding Source: NIH RePORTER	NIMH - National Institue of Mental Health; Montana Board of Research and Commercialization; Alberta Innovates; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIMH - National Institue of Mental Health (1R43MH096670-01A1), and The Montana Board of Research and Commercialization #11-37 to A. M. Q., and by Alberta Innovates (Y.Z.), Canadian Institutes of Health Research (R. E. C), and Natural Sciences and Engineering Research Council of Canada (R. E. C.). R. E. C. holds a Tier II Canada Research Chair in Bioanalytical Chemistry.	Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Zhao Y, 2011, AIDS RES HUM RETRO S, DOI [10.1126/science.1208592, DOI 10.1126/SCIENCE.1208592]	16	43	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42791	10.1371/journal.pone.0042791	http://dx.doi.org/10.1371/journal.pone.0042791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912738	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700023
J	Trainor, C; Butterworth, KT; McGarry, CK; McMahon, SJ; O'Sullivan, JM; Hounsell, AR; Prise, KM				Trainor, Colman; Butterworth, Karl T.; McGarry, Conor K.; McMahon, Stephen J.; O'Sullivan, Joe M.; Hounsell, Alan R.; Prise, Kevin M.			DNA Damage Responses following Exposure to Modulated Radiation Fields	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PRIMARY HUMAN FIBROBLASTS; IRRADIATED GLIOMA-CELLS; BYSTANDER RESPONSES; NITRIC-OXIDE; CELLULAR-RESPONSE; TUMOR-CELLS; SURVIVAL; INDUCE; 53BP1	During the delivery of advanced radiotherapy treatment techniques modulated beams are utilised to increase dose conformity across the target volume. Recent investigations have highlighted differential cellular responses to modulated radiation fields particularly in areas outside the primary treatment field that cannot be accounted for by scattered dose alone. In the present study, we determined the DNA damage response within the normal human fibroblast AG0-1522B and the prostate cancer cell line DU-145 utilising the DNA damage assay. Cells plated in slide flasks were exposed to 1 Gy uniform or modulated radiation fields. Modulated fields were delivered by shielding 25%, 50% or 75% of the flask during irradiation. The average number of 53BP1 or gamma H2AX foci was measured in 2 mm intervals across the slide area. Following 30 minutes after modulated radiation field exposure an increase in the average number of foci out-of-field was observed when compared to non-irradiated controls. In-field, a non-uniform response was observed with a significant decrease in the average number of foci compared to uniformly irradiated cells. Following 24 hrs after exposure there is evidence for two populations of responding cells to bystander signals in-and out-of-field. There was no significant difference in DNA damage response between 25%, 50% or 75% modulated fields. The response was dependent on cellular secreted intercellular signalling as physical inhibition of intercellular communication abrogated the observed response. Elevated residual DNA damage observed within out-of-field regions decreased following addition of an inducible nitric oxide synthase inhibitor (Aminoguanidine). These data show, for the first time, differential DNA damage responses in-and out-of-field following modulated radiation field delivery. This study provides further evidence for a role of intercellular communication in mediating cellular radiobiological response to modulated radiation fields and may inform the refinement of existing radiobiological models for the optimization of advanced radiotherapy treatment plans.	[Trainor, Colman; Butterworth, Karl T.; McGarry, Conor K.; McMahon, Stephen J.; O'Sullivan, Joe M.; Hounsell, Alan R.; Prise, Kevin M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [McGarry, Conor K.; O'Sullivan, Joe M.; Hounsell, Alan R.] Belfast Hlth & Social Care Trust, No Ireland Canc Ctr, Belfast, Antrim, North Ireland	Queens University Belfast	Trainor, C (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	ctrainor14@qub.ac.uk	Butterworth, Karl/I-7476-2019; Prise, Kevin/N-7872-2015	Butterworth, Karl/0000-0001-7170-6789; Prise, Kevin/0000-0001-6134-7946; McGarry, Conor/0000-0001-6396-2184; McMahon, Stephen/0000-0001-5980-6728; O'Sullivan, Joe/0000-0001-6999-2739	Cancer Research UK [C1513/A7047, C212/A11342]; Health and Social care Research and Development Office of the Northern Ireland; Northern Ireland Department of Education and Learning; Public Health Agency [EAT/3977/08] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Health and Social care Research and Development Office of the Northern Ireland; Northern Ireland Department of Education and Learning; Public Health Agency	Cancer Research UK grant C1513/A7047 to KMP. Cancer Research UK grant C212/A11342 to ARH. Health and Social care Research and Development Office of the Northern Ireland a Fellowship Award to CMcG Northern Ireland Department of Education and Learning for a studentship to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Butterworth KT, 2011, INT J RADIAT ONCOL, V79, P1516, DOI 10.1016/j.ijrobp.2010.11.034; Butterworth KT, 2010, PHYS MED BIOL, V55, P1607, DOI 10.1088/0031-9155/55/6/005; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Han W, 2007, BRIT J RADIOL, V80, pS7, DOI 10.1259/bjr/44550200; Hu BR, 2006, CARCINOGENESIS, V27, P245, DOI 10.1093/carcin/bgi224; Mackonis EC, 2007, PHYS MED BIOL, V52, P5469, DOI 10.1088/0031-9155/52/18/001; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 1998, RADIAT RES, V149, P256, DOI 10.2307/3579958; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Prise KM, 2005, LANCET ONCOL, V6, P520, DOI 10.1016/S1470-2045(05)70246-1; PRISE KM, 1994, INT J RADIAT BIOL, V66, P537, DOI 10.1080/09553009414551581; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ryan LA, 2008, RADIAT RES, V169, P188, DOI 10.1667/RR1141.1; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao C, 2003, CANCER RES, V63, P8437; Shao C, 2002, INT J RADIAT BIOL, V78, P837, DOI 10.1080/09553000210149786; Shao C, 2008, MUTAT RES-FUND MOL M, V638, P139, DOI 10.1016/j.mrfmmm.2007.09.007; Smilenov LB, 2006, RADIAT PROT DOSIM, V122, P256, DOI 10.1093/rpd/ncl461; Sokolov MV, 2005, ONCOGENE, V24, P7257, DOI 10.1038/sj.onc.1208886; Suchowerska N, 2005, PHYS MED BIOL, V50, P3041, DOI 10.1088/0031-9155/50/13/005; Syme A, 2009, PHYS MED BIOL, V54, P6623, DOI 10.1088/0031-9155/54/21/012; Tartier L, 2007, CANCER RES, V67, P5872, DOI 10.1158/0008-5472.CAN-07-0188; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; Trainor C, 2012, RADIAT RES, V177, P44, DOI 10.1667/RR2656.1; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439	29	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43326	10.1371/journal.pone.0043326	http://dx.doi.org/10.1371/journal.pone.0043326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912853	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700081
J	Yamada, T; Ohta, H; Watanabe, H; Kanai, C; Tani, M; Ohno, T; Takayama, Y; Iwanami, A; Kato, N; Hashimoto, R				Yamada, Takashi; Ohta, Haruhisa; Watanabe, Hiromi; Kanai, Chieko; Tani, Masayuki; Ohno, Taisei; Takayama, Yuko; Iwanami, Akira; Kato, Nobumasa; Hashimoto, Ryuichiro			Functional Alterations in Neural Substrates of Geometric Reasoning in Adults with High-Functioning Autism	PLOS ONE			English	Article							WORKING-MEMORY; NEUROCOGNITIVE DEVELOPMENT; FLUID INTELLIGENCE; CORPUS-CALLOSUM; VISUAL-SEARCH; FMRI; PERFORMANCE; TASK; SCHIZOPHRENIA; CONNECTIVITY	Individuals with autism spectrum condition (ASC) are known to excel in some perceptual cognitive tasks, but such developed functions have been often regarded as "islets of abilities" that do not significantly contribute to broader intellectual capacities. However, recent behavioral studies have reported that individuals with ASC have advantages for performing Raven's (Standard) Progressive Matrices (RPM/RSPM), a standard neuropsychological test for general fluid intelligence, raising the possibility that ASC's cognitive strength can be utilized for more general purposes like novel problem solving. Here, the brain activity of 25 adults with high-functioning ASC and 26 matched normal controls (NC) was measured using functional magnetic resonance imaging (fMRI) to examine neural substrates of geometric reasoning during the engagement of a modified version of the RSPM test. Among the frontal and parietal brain regions involved in fluid intelligence, ASC showed larger activation in the left lateral occipitotemporal cortex (LOTC) during an analytic condition with moderate difficulty than NC. Activation in the left LOTC and ventrolateral prefrontal cortex (VLPFC) increased with task difficulty in NC, whereas such modulation of activity was absent in ASC. Furthermore, functional connectivity analysis revealed a significant reduction of activation coupling between the left inferior parietal cortex and the right anterior prefrontal cortex during both figural and analytic conditions in ASC. These results indicate altered pattern of functional specialization and integration in the neural system for geometric reasoning in ASC, which may explain its atypical cognitive pattern, including performance on the Raven's Matrices test.	[Yamada, Takashi; Ohta, Haruhisa; Watanabe, Hiromi; Kanai, Chieko; Tani, Masayuki; Ohno, Taisei; Takayama, Yuko; Iwanami, Akira; Kato, Nobumasa; Hashimoto, Ryuichiro] Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan; [Kanai, Chieko; Kato, Nobumasa; Hashimoto, Ryuichiro] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Showa University; Japan Science & Technology Agency (JST)	Yamada, T (corresponding author), Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan.	dbridges50@gmail.com		Hashimoto, Ryu-ichiro/0000-0002-9661-3412	CREST of Japanese Science and Technology (JST); Kakenhi	CREST of Japanese Science and Technology (JST); Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST of Japanese Science and Technology (JST) to NK and Grant-in-Aid for Research Activity Start-up (Kakenhi) to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bolte S, 2009, J AUTISM DEV DISORD, V39, P678, DOI 10.1007/s10803-008-0667-2; Bracci S, 2012, J NEUROPHYSIOL, V107, P1443, DOI 10.1152/jn.00619.2011; Casanova MF, 2009, PHILOS T R SOC B, V364, P1433, DOI 10.1098/rstb.2008.0331; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P55, DOI 10.1111/j.1467-7687.2008.00743.x; Dawson M, 2007, PSYCHOL SCI, V18, P657, DOI 10.1111/j.1467-9280.2007.01954.x; Desco M, 2011, NEUROIMAGE, V57, P281, DOI 10.1016/j.neuroimage.2011.03.063; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fox MD, 2005, NEUROIMAGE, V25, P771, DOI 10.1016/j.neuroimage.2004.12.025; Geake JG, 2005, NEUROIMAGE, V26, P555, DOI 10.1016/j.neuroimage.2005.01.035; Geake JG, 2010, NEUROIMAGE, V49, P3489, DOI 10.1016/j.neuroimage.2009.09.008; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Hampshire A, 2011, CEREB CORTEX, V21, P1, DOI 10.1093/cercor/bhq085; Hayashi M, 2008, BRAIN COGNITION, V66, P306, DOI 10.1016/j.bandc.2007.09.008; Johnson MR, 2006, BIOL PSYCHIAT, V60, P11, DOI 10.1016/j.biopsych.2005.11.012; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kanai C, 2012, RES AUTISM SPECT DIS, V6, P7; Keary CJ, 2009, J AUTISM DEV DISORD, V39, P834, DOI 10.1007/s10803-009-0689-4; Koch K, 2012, NEUROPSYCHOLOGIA, V50, P958, DOI 10.1016/j.neuropsychologia.2012.02.002; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Lynn R, 2004, WESCHLER ADULT INTEL, V32; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Preusse F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00022; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Soulieres I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025372; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; van der Ven AHGS, 2000, PERSONALITY INDIVIDU, V29; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2	47	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43220	10.1371/journal.pone.0043220	http://dx.doi.org/10.1371/journal.pone.0043220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912831	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700063
J	Antonsson, A; Bialasiewicz, S; Rockett, RJ; Jacob, K; Bennett, IC; Sloots, TP				Antonsson, Annika; Bialasiewicz, Seweryn; Rockett, Rebecca J.; Jacob, Kevin; Bennett, Ian C.; Sloots, Theo P.			Exploring the Prevalence of Ten Polyomaviruses and Two Herpes Viruses in Breast Cancer	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; EPSTEIN-BARR-VIRUS; QUANTITATIVE PCR ASSAYS; PERIPHERAL-BLOOD; REAL-TIME; LYMPHOTROPIC POLYOMAVIRUS; MOLECULAR-BIOLOGY; DNA; CARCINOMA; SKIN	Several different viruses have been proposed to play a role in breast carcinogenesis. The aim of this study was to investigate the prevalence of a subset of viruses in breast cancer tissue. We investigated the prevalence of 12 DNA viruses: EBV and CMV from the Herpesviridae family and SV40, BKV, JCV, MCV, WUV, KIV, LPV, HPyV6, HPyV7, and TSV from the Polyomaviridae family in 54 fresh frozen breast tumour specimens. Relevant clinical data and basic lifestyle data were available for all patients. The tissue samples were DNA extracted and real-time PCR assays were used for viral detection. The highest prevalence, 10% (5/54), was found for EBV. MCV, HPyV6, and HPyV7 were detected in single patient samples (2% each), while WUV, KIV, JCV, BKV, LPV, SV40, TSV and CMV were not detected in the 54 breast cancer specimens analysed here. Further investigations are needed to elucidate the potential role of viruses, and particularly EBV, in breast carcinogenesis.	[Antonsson, Annika] Queensland Inst Med Res, Dept Populat Hlth, Brisbane, Qld 4006, Australia; [Bialasiewicz, Seweryn; Rockett, Rebecca J.; Jacob, Kevin; Sloots, Theo P.] Sir Albert Sakzewski Virus Res Ctr, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Queensland Childrens Hlth Serv, Brisbane, Qld, Australia; [Bennett, Ian C.] Princess Alexandra Hosp, Breast & Endocrine Unit, Dept Surg, Brisbane, Qld 4102, Australia	QIMR Berghofer Medical Research Institute	Antonsson, A (corresponding author), Queensland Inst Med Res, Dept Populat Hlth, Brisbane, Qld 4006, Australia.	annika.antonsson@qimr.edu.au	Antonsson, Annika/A-2725-2015; Bialasiewicz, Seweryn/F-1414-2010; Bennett, Ian/G-3058-2013; Sloots, Theo P/E-6118-2011	Antonsson, Annika/0000-0002-7383-8416; Bialasiewicz, Seweryn/0000-0001-9474-6943; Bennett, Ian/0000-0002-5951-9291; Bennett, Ian/0000-0002-3634-9680	QCMRI Program Grant [5006]; Garnett Passe and Rodney Williams Memorial Foundation	QCMRI Program Grant; Garnett Passe and Rodney Williams Memorial Foundation	This study was funded by the QCMRI Program Grant 5006 (Queensland Children's Medical Research Institute). http://www.qcmri.org.au/Funding/Programs.aspx. Annika Antonsson is supported by a fellowship from the Garnett Passe and Rodney Williams Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; Antonsson A, 2011, J MED VIROL, V83, P2157, DOI 10.1002/jmv.22223; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; Boldorini R, 2005, ACTA CYTOL, V49, P235, DOI 10.1159/000326143; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Cox B, 2010, BRIT J CANCER, V102, P1665, DOI 10.1038/sj.bjc.6605675; Delbue S, 2008, J CLIN MICROBIOL, V46, P2461, DOI 10.1128/JCM.00381-08; Delbue S, 2010, J CLIN VIROL, V47, P156, DOI 10.1016/j.jcv.2009.11.029; DORRIES K, 1994, VIROLOGY, V198, P59, DOI 10.1006/viro.1994.1008; Dorries K, 1998, DEV BIOLOGICALS, V94, P71; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FERRANTE P, 1995, J MED VIROL, V47, P219, DOI 10.1002/jmv.1890470306; Foulongne V, 2010, BRIT J DERMATOL, V162, P59, DOI 10.1111/j.1365-2133.2009.09381.x; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Hachana M, 2009, BREAST CANCER RES TR, V113, P43, DOI 10.1007/s10549-008-9901-z; Hachana M, 2011, BREAST CANC RES TREA; Hirsch HH, 2001, J INFECT DIS, V184, P1494, DOI 10.1086/324425; Khan G, 2011, EXP MOL PATHOL, V91, P466, DOI 10.1016/j.yexmp.2011.04.018; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Lawson James S, 2010, Cancers (Basel), V2, P752, DOI 10.3390/cancers2020752; Lawson JS, 2006, FUTURE MICROBIOL, V1, P33, DOI 10.2217/17460913.1.1.33; ONORATO IM, 1985, REV INFECT DIS, V7, P479; Pal A, 2006, J VIROL METHODS, V135, P32, DOI 10.1016/j.jviromet.2006.01.018; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Sastre-Garau X, 2009, J PATHOL, V218, P48, DOI 10.1002/path.2532; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Weigelt B, 2009, NAT REV CLIN ONCOL, V6, P718, DOI 10.1038/nrclinonc.2009.166; ZURHAUSEN H, 1979, MED MICROBIOL IMMUN, V167, P137, DOI 10.1007/BF02121180	32	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e39842	10.1371/journal.pone.0039842	http://dx.doi.org/10.1371/journal.pone.0039842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916092	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600002
J	Wasser, SK; Hayward, LS; Hartman, J; Booth, RK; Broms, K; Berg, J; Seely, E; Lewis, L; Smith, H				Wasser, Samuel K.; Hayward, Lisa S.; Hartman, Jennifer; Booth, Rebecca K.; Broms, Kristin; Berg, Jodi; Seely, Elizabeth; Lewis, Lyle; Smith, Heath			Using Detection Dogs to Conduct Simultaneous Surveys of Northern Spotted (Strix occidentalis caurina) and Barred Owls (Strix varia)	PLOS ONE			English	Article							HABITAT SELECTION; RATES; DISTURBANCE; MANAGEMENT; QUALITY; ALBERTA; RANGE; DNA	State and federal actions to conserve northern spotted owl (Strix occidentalis caurina) habitat are largely initiated by establishing habitat occupancy. Northern spotted owl occupancy is typically assessed by eliciting their response to simulated conspecific vocalizations. However, proximity of barred owls (Strix varia)-a significant threat to northern spotted owls-can suppress northern spotted owl responsiveness to vocalization surveys and hence their probability of detection. We developed a survey method to simultaneously detect both species that does not require vocalization. Detection dogs (Canis familiaris) located owl pellets accumulated under roost sites, within search areas selected using habitat association maps. We compared success of detection dog surveys to vocalization surveys slightly modified from the U.S. Fish and Wildlife Service's Draft 2010 Survey Protocol. Seventeen 2 km 62 km polygons were each surveyed multiple times in an area where northern spotted owls were known to nest prior to 1997 and barred owl density was thought to be low. Mitochondrial DNA was used to confirm species from pellets detected by dogs. Spotted owl and barred owl detection probabilities were significantly higher for dog than vocalization surveys. For spotted owls, this difference increased with number of site visits. Cumulative detection probabilities of northern spotted owls were 29% after session 1, 62% after session 2, and 87% after session 3 for dog surveys, compared to 25% after session 1, increasing to 59% by session 6 for vocalization surveys. Mean detection probability for barred owls was 20.1% for dog surveys and 7.3% for vocal surveys. Results suggest that detection dog surveys can complement vocalization surveys by providing a reliable method for establishing occupancy of both northern spotted and barred owl without requiring owl vocalization. This helps meet objectives of Recovery Actions 24 and 25 of the Revised Recovery Plan for the Northern Spotted Owl.	[Wasser, Samuel K.; Hayward, Lisa S.; Hartman, Jennifer; Booth, Rebecca K.; Berg, Jodi; Seely, Elizabeth; Smith, Heath] Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA; [Lewis, Lyle] US Fish & Wildlife Serv, Vancouver, WA USA	University of Washington; University of Washington Seattle; United States Department of the Interior; US Fish & Wildlife Service	Wasser, SK (corresponding author), Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA.	wassers@uw.edu	Wasser, Samuel K/I-5542-2015		USFWS [10100-0-J001MOD4]; Seattle Audubon; Washington Forest Law Center; Wilburforce Foundation; Endangered Species and Habitat Conservation; Red Bluff Fish and Wildlife Office	USFWS(US Fish & Wildlife Service); Seattle Audubon; Washington Forest Law Center; Wilburforce Foundation; Endangered Species and Habitat Conservation; Red Bluff Fish and Wildlife Office	This research was funded by a grant from the USF&WS grant # 10100-0-J001MOD4, Seattle Audubon (http://www.seattleaudubon.org/sas/), the Washington Forest Law Center (http://wflc.org/), and the Wilburforce Foundation (http://www.wilburforce.org/). The Assistant Project Leader, Endangered Species and Habitat Conservation, Red Bluff Fish and Wildlife Office provided partial funding and participated in the design and implementation of this study. However, as indicated by the disclaimer in the manuscript, The findings and conclusions in this article are those of the author(s) and do not necessarily represent the views of the U.S. Fish and Wildlife Service. No other funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RG, 2006, WILDLIFE MONOGR, P1; Ball MC, 2007, CONSERV GENET, V8, P577, DOI 10.1007/s10592-006-9193-y; BLAKESLEY JA, 1992, J WILDLIFE MANAGE, V56, P388, DOI 10.2307/3808840; Boulanger J, 2002, URSUS, V13, P137; Carroll C, 2008, CONSERV BIOL, V22, P1026, DOI 10.1111/j.1523-1739.2008.00931.x; Crozier ML, 2006, CONDOR, V108, P760, DOI 10.1650/0010-5422(2006)108[760:DTPOBO]2.0.CO;2; Forsman ED, 1983, PNW162 USDA FOR SERV, P8; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Franklin Alan B., 1996, Studies in Avian Biology, V17, P12; Gutierrez RJ, 2007, BIOL INVASIONS, V9, P181, DOI 10.1007/s10530-006-9025-5; Hamer TE, 2007, CONDOR, V109, P750, DOI 10.1650/0010-5422(2007)109[750:HRAAHS]2.0.CO;2; Harrison RL, 2006, WILDLIFE SOC B, V34, P548, DOI 10.2193/0091-7648(2006)34[548:ACOSMF]2.0.CO;2; Hayward LS, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00199.1; MacKay Paula, 2008, P183; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mazur KM, 2000, BIRDS N AM; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Reid JA, 1999, WILDLIFE SOC B, V27, P986; Singleton PH, 2010, J WILDLIFE MANAGE, V74, P285, DOI 10.2193/2008-548; Smith DA, 2003, ANIM CONSERV, V6, P339, DOI 10.1017/S136794300300341X; Thomas JW, 1990, CONSERVATION STRATEG; U.S. Fish and Wildlife Service, 2010, DRAFT PROT SURV PROP; United States Fish and Wildlife Service, 2011, PROT SURV PROP MAN A; *US FISH WILDL SER, 2011, REV REC PLAN NO SPOT; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x; Wasser SK, 2008, NAT HIST, V117, P48; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2005, ANN NY ACAD SCI, V1046, P109, DOI 10.1196/annals.1343.010; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wiens JD, 2011, J WILDLIFE MANAGE, V75, P531, DOI 10.1002/jwmg.82; Zabel CJ, 2003, ECOL APPL, V13, P1027, DOI 10.1890/02-5084	33	17	19	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42892	10.1371/journal.pone.0042892	http://dx.doi.org/10.1371/journal.pone.0042892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916175	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600032
J	Ebrahimi, KH; Hagedoorn, PL; Hagen, WR				Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.			A Synthetic Peptide with the Putative Iron Binding Motif of Amyloid Precursor Protein (APP) Does Not Catalytically Oxidize Iron	PLOS ONE			English	Article							HUMAN H-CHAIN; PYROCOCCUS-FURIOSUS FERRITIN; SITE-DIRECTED MUTAGENESIS; HUMAN-SERUM TRANSFERRIN; ALZHEIMERS-DISEASE; CORE FORMATION; FERROXIDASE KINETICS; OXIDASE ACTIVITY; HORSE SPLEEN; HUMAN-LIVER	The beta-amyloid precursor protein (APP), which is a key player in Alzheimer's disease, was recently reported to possess an Fe(II) binding site within its E2 domain which exhibits ferroxidase activity [Duce et al. 2010, Cell 142: 857]. The putative ligands of this site were compared to those in the ferroxidase site of ferritin. The activity was indirectly measured using transferrin, which scavenges the Fe(III) product of the reaction. A 22-residue synthetic peptide, named FD1, with the putative ferroxidase site of APP, and the E2 domain of APP were each reported to exhibit 40% of the ferroxidase activity of APP and of ceruloplasmin. It was also claimed that the ferroxidase activity of APP is inhibited by Zn(II) just as in ferritin. We measured the ferroxidase activity indirectly (i) by the incorporation of the Fe(III) product of the ferroxidase reaction into transferrin and directly (ii) by monitoring consumption of the substrate molecular oxygen. The results with the FD1 peptide were compared to the established ferroxidase activities of human H-chain ferritin and of ceruloplasmin. For FD1 we observed no activity above the background of non-enzymatic Fe(II) oxidation by molecular oxygen. Zn(II) binds to transferrin and diminishes its Fe(III) incorporation capacity and rate but it does not specifically bind to a putative ferroxidase site of FD1. Based on these results, and on comparison of the putative ligands of the ferroxidase site of APP with those of ferritin, we conclude that the previously reported results for ferroxidase activity of FD1 and - by implication - of APP should be re-evaluated.	[Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Delft University of Technology	Ebrahimi, KH (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	w.r.hagen@tudelft.nl	Ebrahimi, Kourosh Honarmand/X-4579-2019; Hagedoorn, Peter-Leon/C-8535-2014; Hagen, Wilfred R./H-8918-2017	Ebrahimi, Kourosh Honarmand/0000-0001-6628-944X; Hagedoorn, Peter-Leon/0000-0001-6342-2022; Hagen, Wilfred R./0000-0002-1609-6671	Dutch National Research School Combination - Catalysis Controlled by Chemical Design (NRSC-Catalysis)	Dutch National Research School Combination - Catalysis Controlled by Chemical Design (NRSC-Catalysis)	This work was supported by a research grant from the Dutch National Research School Combination - Catalysis Controlled by Chemical Design (NRSC-Catalysis). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BAKKER GR, 1986, J BIOL CHEM, V261, P3182; Bou-Abdallah F, 2004, BIOCHEMISTRY-US, V43, P4332, DOI 10.1021/bi0498813; Bou-Abdallah F, 2003, J BIOL INORG CHEM, V8, P489, DOI 10.1007/s00775-003-0455-6; Bou-Abdallah F, 2002, BIOCHEM J, V364, P57, DOI 10.1042/bj3640057; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Bou-Abdallah F, 2008, J AM CHEM SOC, V130, P17801, DOI 10.1021/ja8054035; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Ebrahimi KH, 2010, J BIOL INORG CHEM, V15, P1243, DOI 10.1007/s00775-010-0682-6; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; HARRIS WR, 1988, J INORG BIOCHEM, V33, P211, DOI 10.1016/0162-0134(88)80050-3; HARRIS WR, 1983, BIOCHEMISTRY-US, V22, P3920, DOI 10.1021/bi00285a030; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; LEVI S, 1988, J BIOL CHEM, V263, P18086; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; OSAKI S, 1966, J BIOL CHEM, V241, P5053; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Pouvreau LAM, 2008, METHOD ENZYMOL, V436, P97, DOI 10.1016/S0076-6879(08)36006-6; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Snow CL, 2011, J INORG BIOCHEM, V105, P972, DOI 10.1016/j.jinorgbio.2011.04.003; SUN S, 1992, J BIOL CHEM, V267, P25160; SUN SJ, 1993, BIOCHEMISTRY-US, V32, P9362, DOI 10.1021/bi00087a015; Tabner Brian J, 2010, Int J Alzheimers Dis, V2011, P546380, DOI 10.4061/2011/546380; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Tinoco AD, 2005, J AM CHEM SOC, V127, P11218, DOI 10.1021/ja052768v; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Treffry A, 1998, J BIOL INORG CHEM, V3, P682, DOI 10.1007/s007750050282; TREFFRY A, 1995, BIOCHEMISTRY-US, V34, P15204, DOI 10.1021/bi00046a028; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Wan L, 2012, J ALZHEIMERS DIS, V30, P523, DOI 10.3233/JAD-2012-111169; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Watthanawisuth N., 2011, IEEE DEFENSE SCI RES, P1, DOI DOI 10.4061/2011/971021; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	41	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e40287	10.1371/journal.pone.0040287	http://dx.doi.org/10.1371/journal.pone.0040287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916096	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800002
J	Boudou-Rouquette, P; Narjoz, C; Golmard, JL; Thomas-Schoemann, A; Mir, O; Taieb, F; Durand, JP; Coriat, R; Dauphin, A; Vidal, M; Tod, M; Loriot, MA; Goldwasser, F; Blanchet, B				Boudou-Rouquette, Pascaline; Narjoz, Celine; Golmard, Jean Louis; Thomas-Schoemann, Audrey; Mir, Olivier; Taieb, Fabrice; Durand, Jean-Philippe; Coriat, Romain; Dauphin, Alain; Vidal, Michel; Tod, Michel; Loriot, Marie-Anne; Goldwasser, Francois; Blanchet, Benoit			Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; BODY-COMPOSITION; PHARMACOKINETICS; ERLOTINIB; ABCG2; KINASE; IMPACT; QUANTIFICATION; METABOLITE; INHIBITOR	Background: Identifying predictive biomarkers of drug response is of key importance to improve therapy management and drug selection in cancer therapy. To date, the influence of drug exposure and pharmacogenetic variants on sorafenib-induced toxicity remains poorly documented. The aim of this pharmacokinetic/pharmacodynamic (PK/PD) study was to investigate the relationship between early toxicity and drug exposure or pharmacogenetic variants in unselected adult outpatients treated with single-agent sorafenib for advanced solid tumors. Methods: Toxicity was recorded in 54 patients on days 15 and 30 after treatment initiation and sorafenib exposure was assessed in 51 patients. The influence of polymorphisms in CYP3A5, UGT1A9, ABCB1 and ABCG2 was examined in relation to sorafenib exposure and toxicity. Clinical characteristics, drug exposure and pharmacogenetic variants were tested univariately for association with toxicities. Candidate variables with p<0.1 were analyzed in a multivariate analysis. Results: Gender was the sole parameter independently associated with sorafenib exposure (p = 0.0008). Multivariate analysis showed that increased cumulated sorafenib (AUC(cum)) was independently associated with any grade >= 3 toxicity (p = 0.037); UGT1A9 polymorphism (rs17868320) with grade >= 2 diarrhea (p = 0.015) and female gender with grade >= 2 hand-foot skin reaction (p = 0.018). Using ROC curve, the threshold AUCcum value of 3,161 mg/L. h was associated with the highest risk to develop any grade >= 3 toxicity (p = 0.018). Conclusion: In this preliminary study, increased cumulated drug exposure and UGT1A9 polymorphism (rs17868320) identified patients at high risk for early sorafenib-induced severe toxicity. Further PK/PD studies on larger population are warranted to confirm these preliminary results.	[Boudou-Rouquette, Pascaline; Thomas-Schoemann, Audrey; Mir, Olivier; Durand, Jean-Philippe; Coriat, Romain; Goldwasser, Francois; Blanchet, Benoit] Ctr Etud & Recours Inhibiteurs Angiogenese, Paris, France; [Boudou-Rouquette, Pascaline; Mir, Olivier; Durand, Jean-Philippe; Coriat, Romain; Goldwasser, Francois] Hop Cochin, AP HP, Unite Cancerol Med, F-75674 Paris, France; [Narjoz, Celine; Loriot, Marie-Anne] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Unite Fonct Pharmacogenet & Oncol Mol, Paris, France; [Narjoz, Celine; Loriot, Marie-Anne] Univ Paris 05, INSERM, UMR S 775, Paris, France; [Golmard, Jean Louis] Hop La Pitie Salpetriere, AP HP, Dept Biostat, Paris, France; [Thomas-Schoemann, Audrey; Taieb, Fabrice; Dauphin, Alain; Vidal, Michel; Blanchet, Benoit] Hop Cochin, AP HP, Unite Fonct Pharmacocinet & Pharmacochim, F-75674 Paris, France; [Thomas-Schoemann, Audrey; Vidal, Michel] Univ Paris 05, UFR Pharm, CNRS, UMR8638, Paris, France; [Tod, Michel] Hop Croix Rousse, Hosp Civils Lyon, F-69317 Lyon, France; [Tod, Michel] Univ Lyon, EMR3738, Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon	Boudou-Rouquette, P (corresponding author), Ctr Etud & Recours Inhibiteurs Angiogenese, Paris, France.	benoit.blanchet@cch.aphp.fr	Goldwasser, François/P-4861-2017; Vidal, Michel/ABA-3396-2020; /ABG-4006-2020; Coriat, Romain/O-7902-2017; /AFP-4402-2022; Mir, Olivier/GNP-7828-2022	/0000-0002-4860-305X; /0000-0002-4860-305X; Mir, Olivier/0000-0002-6761-4002; Vidal, Michel/0000-0002-4858-1591; Loriot, Marie-Anne/0000-0001-9102-2667; NARJOZ, Celine/0000-0001-6959-3527				Agarwal S, 2011, J PHARMACOL EXP THER, V336, P223, DOI 10.1124/jpet.110.175034; Azad NS, 2009, CLIN CANCER RES, V15, P1411, DOI 10.1158/1078-0432.CCR-08-1141; Blanchet B, 2009, J PHARMACEUT BIOMED, V49, P1109, DOI 10.1016/j.jpba.2009.02.008; Blanchet B, 2010, EXPERT OPIN DRUG SAF, V9, P275, DOI 10.1517/14740330903510608; Cusatis G, 2006, J NATL CANCER I, V98, P1739, DOI 10.1093/jnci/djj469; Delbaldo C, 2006, CLIN CANCER RES, V12, P6073, DOI 10.1158/1078-0432.CCR-05-2596; Dranitsaris G, 2012, ANN ONCOLOGY; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Gnoth MJ, 2010, DRUG METAB DISPOS, V38, P1341, DOI 10.1124/dmd.110.032052; Gomo C, 2011, INVEST NEW DRUG, V29, P1511, DOI 10.1007/s10637-010-9514-3; Hornecker M, 2011, INVEST NEW DRUGS; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Jain L, 2011, BRIT J CLIN PHARMACO, V72, P294, DOI 10.1111/j.1365-2125.2011.03963.x; Janmahasatian S, 2005, CLIN PHARMACOKINET, V44, P1051, DOI 10.2165/00003088-200544100-00004; Kuypers DRJ, 2005, CLIN PHARMACOL THER, V78, P351, DOI 10.1016/j.clpt.2005.06.007; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Lemos C, 2011, PHARMACOGENOMICS, V12, P159, DOI 10.2217/PGS.10.172; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Li J, 2007, CANCER BIOL THER, V6, P432, DOI 10.4161/cbt.6.3.3763; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Mathijssen RHJ, 2009, CLIN PHARMACOL THER, V85, P23, DOI 10.1038/sj.clpt.6100511; Morimoto M, 2011, HEPATOL RES, V41, P296, DOI 10.1111/j.1872-034X.2011.00778.x; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; National Cancer Institute, 2009, COMM TERM CRIT ADV E; National Cancer Institute, 2006, COMM TERM CRIT ADV E; Porta C, 2007, CLIN EXP MED, V7, P127, DOI 10.1007/s10238-007-0145-8; Prado CMM, 2011, CANCER CHEMOTH PHARM, V67, P93, DOI 10.1007/s00280-010-1288-y; Rudin CM, 2008, J CLIN ONCOL, V26, P1119, DOI 10.1200/JCO.2007.13.1128; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Thomas F, 2009, EUR J CANCER, V45, P2316, DOI 10.1016/j.ejca.2009.05.007; Tod M, 2011, PHARM RES-DORDR, V28, P3199, DOI 10.1007/s11095-011-0499-1; Treinen-Moslen M, 2006, PHARMACOL THERAPEUT, V112, P649, DOI 10.1016/j.pharmthera.2006.05.007; van Erp NP, 2009, CANCER TREAT REV, V35, P692, DOI 10.1016/j.ctrv.2009.08.004; van Erp NP, 2009, J CLIN ONCOL, V27, P4406, DOI 10.1200/JCO.2008.21.7679; Villeneuve L, 2003, J PHARMACOL EXP THER, V307, P117, DOI 10.1124/jpet.103.054072; White-Koning M, 2011, CLIN CANCER RES, V17, P4862, DOI 10.1158/1078-0432.CCR-10-3278; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013	39	79	80	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42875	10.1371/journal.pone.0042875	http://dx.doi.org/10.1371/journal.pone.0042875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912756	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100039
J	Fillinger, S; Ajouz, S; Nicot, PC; Leroux, P; Bardin, M				Fillinger, Sabine; Ajouz, Sakhr; Nicot, Philippe C.; Leroux, Pierre; Bardin, Marc			Functional and Structural Comparison of Pyrrolnitrin- and Iprodione-Induced Modifications in the Class III Histidine-Kinase Bos1 of Botrytis cinerea	PLOS ONE			English	Article							IN-FIELD STRAINS; DICARBOXIMIDE-RESISTANCE; PHENYLPYRROLE-RESISTANCE; FUNGICIDE RESISTANCE; SIGNAL-TRANSDUCTION; NEUROSPORA-CRASSA; GENETIC-ANALYSIS; USTILAGO-MAYDIS; HAMP DOMAINS; MECHANISMS	Dicarboximides and phenylpyrroles are commonly used fungicides against plant pathogenic ascomycetes. Although their effect on fungal osmosensing systems has been shown in many studies, their modes-of-action still remain unclear. Laboratory-or field-mutants of fungi resistant to either or both fungicide categories generally harbour point mutations in the sensor histidine kinase of the osmotic signal transduction cascade. In the present study we compared the mechanisms of resistance to the dicarboximide iprodione and to pyrrolnitrin, a structural analogue of phenylpyrrole fungicides, in Botrytis cinerea. Pyrrolnitrin-induced mutants and iprodione-induced mutants of B. cinerea were produced in vitro. For the pyrrolnitrin-induced mutants, a high level of resistance to pyrrolnitrin was associated with a high level of resistance to iprodione. For the iprodione-induced mutants, the high level of resistance to iprodione generated variable levels of resistance to pyrrolnitrin and phenylpyrroles. All selected mutants showed hypersensitivity to high osmolarity and regardless of their resistance levels to phenylpyrroles, they showed strongly reduced fitness parameters (sporulation, mycelial growth, aggressiveness on plants) compared to the parental phenotypes. Most of the mutants presented modifications in the osmosensing class III histidine kinase affecting the HAMP domains. Site directed mutagenesis of the bos1 gene was applied to validate eight of the identified mutations. Structure modelling of the HAMP domains revealed that the replacements of hydrophobic residues within the HAMP domains generally affected their helical structure, probably abolishing signal transduction. Comparing mutant phenotypes to the HAMP structures, our study suggests that mutations perturbing helical structures of HAMP2-4 abolish signal-transduction leading to loss-of-function phenotype. The mutation of residues E529, M427, and T581, without consequences on HAMP structure, highlighted their involvement in signal transduction. E529 and M427 seem to be principally involved in osmotic signal transduction.	[Fillinger, Sabine; Leroux, Pierre] BIOGER CPP, INRA UR1290, Thiverval Grignon, France; [Ajouz, Sakhr; Nicot, Philippe C.; Bardin, Marc] INRA, UR407, Plant Pathol Unit, F-84143 Montfavet, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Fillinger, S (corresponding author), BIOGER CPP, INRA UR1290, Thiverval Grignon, France.	sabine.fillinger@versailles.inra.fr; marc.bardin@avignon.inra.fr		Fillinger, Sabine/0000-0003-4683-0803; Nicot, Philippe C./0000-0002-9272-3753; BARDIN, Marc/0000-0002-2803-7695	French National Research Agency (ANR-ECOSERRE project); Institut National de la Recherche Agronomique (INRA - SPE DurLB project); Syrian government	French National Research Agency (ANR-ECOSERRE project)(French National Research Agency (ANR)); Institut National de la Recherche Agronomique (INRA - SPE DurLB project); Syrian government	This work was supported in part by the French National Research Agency (ANR-ECOSERRE project; Dr. Bardin and Dr. Nicot; http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/) and by a grant from Institut National de la Recherche Agronomique (INRA - SPE DurLB project; Dr. Bardin, Dr. Ajouz, Dr. Nicot, Dr. Leroux, and Dr. Fillinger; http://www4.inra.fr/sante-plantes-environnement/). A grant for studies was provided by the Syrian government for Dr. Ajouz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013; Ajouz S, 2011, BIOCONTROL, V56, P353, DOI 10.1007/s10526-010-9333-7; Ajouz S, 2010, PLANT PATHOL, V59, P556, DOI 10.1111/j.1365-3059.2009.02230.x; Ajouz S, 2011, EUR J PLANT PATHOL, V129, P31, DOI 10.1007/s10658-010-9638-5; Ajouz S, 2010, FUNGAL BIOL-UK, V114, P949, DOI 10.1016/j.funbio.2010.09.004; Alberoni G, 2010, EUR J PLANT PATHOL, V128, P171, DOI 10.1007/s10658-010-9642-9; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Arima K, 1964, AGR BIOL CHEM TOKYO, V28, P275; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avenot H, 2005, CURR GENET, V47, P234, DOI 10.1007/s00294-005-0568-2; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chernin L, 1996, CURR MICROBIOL, V32, P208, DOI 10.1007/s002849900037; Cui W, 2004, PHYTOPATHOLOGY, V94, P1129, DOI 10.1094/PHYTO.2004.94.10.1129; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; Decognet V, 2009, PHYTOPATHOLOGY, V99, P185, DOI 10.1094/PHYTO-99-2-0185; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dry IB, 2004, FUNGAL GENET BIOL, V41, P102, DOI 10.1016/j.fgb.2003.09.002; Duffy B, 2003, ANNU REV PHYTOPATHOL, V41, P501, DOI 10.1146/annurev.phyto.41.052002.095606; Dunin-Horkawicz S, 2010, J MOL BIOL, V397, P1156, DOI 10.1016/j.jmb.2010.02.031; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elad Y, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P223; Elmer PAG, 2006, PLANT PATHOL, V55, P155, DOI 10.1111/j.1365-3059.2006.01348.x; FARETRA F, 1993, MYCOL RES, V97, P620, DOI 10.1016/S0953-7562(09)81187-8; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Hammer PE, 1999, FEMS MICROBIOL LETT, V180, P39, DOI 10.1111/j.1574-6968.1999.tb08775.x; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; JANISIEWICZ WJ, 1988, PHYTOPATHOLOGY, V78, P1697, DOI 10.1094/Phyto-78-1697; Jarvis RW, 1977, BOTRYOTINIA BOTRYTIS; Kanetis L, 2008, PHYTOPATHOLOGY, V98, P205, DOI 10.1094/PHYTO-98-2-0205; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Leroux P, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P195; LEROUX P, 1992, PESTIC SCI, V36, P255, DOI 10.1002/ps.2780360312; Leroux P, 2002, PEST MANAG SCI, V58, P876, DOI 10.1002/ps.566; Leroux P, 1999, CROP PROT, V18, P687, DOI 10.1016/S0261-2194(99)00074-5; Levis C, 1997, CURR GENET, V32, P157, DOI 10.1007/s002940050261; Liu WW, 2008, FUNGAL GENET BIOL, V45, P1062, DOI 10.1016/j.fgb.2008.04.003; Ma ZH, 2006, PEST MANAG SCI, V62, P991, DOI 10.1002/ps.1275; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Myresiotis CK, 2007, PLANT DIS, V91, P407, DOI 10.1094/PDIS-91-4-0407; Nathues E, 2007, MOL PLANT PATHOL, V8, P653, DOI 10.1111/J.1364-3703.2007.00421.X; Okada A, 2005, J PESTIC SCI, V30, P378, DOI 10.1584/jpestics.30.378; ORTH AB, 1995, APPL ENVIRON MICROB, V61, P2341, DOI 10.1128/AEM.61.6.2341-2345.1995; Oshima M, 2002, PHYTOPATHOLOGY, V92, P75, DOI 10.1094/PHYTO.2002.92.1.75; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pillonel C, 1997, PESTIC SCI, V49, P229, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;229::AID-PS525&gt;3.0.CO;2-T; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Viaud M, 2006, MOL PLANT MICROBE IN, V19, P1042, DOI 10.1094/MPMI-19-1042; Vignutelli A, 2002, MYCOL RES, V106, P329, DOI 10.1017/S0953756202005683; Watts KJ, 2008, J BACTERIOL, V190, P2118, DOI 10.1128/JB.01858-07; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x; Ziogas BN, 2005, EUR J PLANT PATHOL, V113, P83, DOI 10.1007/s10658-005-1227-7	57	46	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42520	10.1371/journal.pone.0042520	http://dx.doi.org/10.1371/journal.pone.0042520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912706	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100015
J	Zhang, LJ; Qi, RF; Zhong, JH; Xu, Q; Zheng, G; Lu, GM				Zhang, Long Jiang; Qi, Rongfeng; Zhong, Jianhui; Xu, Qiang; Zheng, Gang; Lu, Guang Ming			The Effect of Hepatic Encephalopathy, Hepatic Failure, and Portosystemic Shunt on Brain Volume of Cirrhotic Patients: A Voxel-Based Morphometry Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; DEFAULT-MODE; ABNORMALITIES; IMPAIRMENT; MATTER	Purpose: To evaluate the effect of hepatic encephalopathy (HE), hepatic failure, and portosystemic shunt (PS) on the brain volume alteration in cirrhotic patients with MRI voxel-based morphometry (VBM). Methods: Sixty cirrhotic patients (overt HE [OHE], n = 11; minimal HE [MHE], n = 19; non HE [nHE], n = 30) including 12 with pre- and post-transjugular intrahepatic portosystemic shunt (TIPS) scanning and 40 healthy controls were recruited. Neuropsychological and laboratory tests were performed in all patients. VBM was analyzed with ANOVA test among 4 groups, and t-tests for patients with different hepatic function, PS scores, and TIPS. Multiple linear regression was performed to investigate the effect of venous blood ammonia levels, Child-Pugh scores, and PS on the brain volumes in all patients. Results: Cirrhotic patients exhibited decreased volume in many areas of gray matter (GM), increased volume in thalamus, and increased whiter matter (WM) volume, with the extent of affected brain volume greater in HE patients than nHE patients. Hepatic failure also resulted in decreased GM volume. Patients with high PS scores and TIPS displayed decreased GM and increased WM volume in some regions. Post-TIPS patients displayed increased GM volume in the thalamus. Multiple covariate regression results suggested that Child-Pugh score was a major factor to affect GM volume, while PS mainly affected WM volume. Conclusion: Brain structure abnormalities appeared bilaterally symmetrical in cirrhotic patients, and the impairment was more extensive in HE patients than those without HE. Increased thalamus volume was not associated with HE progression. Hepatic failure and PS altered cirrhotic patients' brain structure.	[Zhang, Long Jiang; Qi, Rongfeng; Zheng, Gang; Lu, Guang Ming] Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing, Jiangsu, Peoples R China; [Zhong, Jianhui] Univ Rochester, Sch Med & Dent, Dept Imaging Sci, Rochester, NY USA; [Xu, Qiang] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	Nanjing University; University of Rochester; University of Electronic Science & Technology of China	Zhang, LJ (corresponding author), Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020	Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [30700194, 81101039]; Natural Scientific Foundation of Jiangsu province, China [BK2007572]; China Postdoctoral Science Foundation of Jiangsu Province [100283C]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Jiangsu province, China; China Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation)	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 30700194 for Long Jiang Zhang; Grant No. 81101039 fro Gang Zheng], the Natural Scientific Foundation of Jiangsu province, China [Grant No. BK2007572 for Long Jiang Zhang], and China Postdoctoral Science Foundation of Jiangsu Province (Grant No. 100283C for Gang Zheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brancatelli G, 2001, RADIOLOGY, V220, P321, DOI 10.1148/radiology.220.2.r01au23321; Bryce TJ, 2003, AM J ROENTGENOL, V181, P1629, DOI 10.2214/ajr.181.6.1811629; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Chen HJ, 2011, EUR J RADIOL; Cordoba J, 2011, J HEPATOL, V54, P1030, DOI 10.1016/j.jhep.2010.11.015; DeLong M, 2009, PARKINSONISM RELAT D, V15, pS237, DOI 10.1016/S1353-8020(09)70822-3; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Gupta RK, 2010, METAB BRAIN DIS, V25, P355, DOI 10.1007/s11011-010-9206-x; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Krieger S, 1997, J HEPATOL, V27, P121, DOI 10.1016/S0168-8278(97)80290-5; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Matsusue E, 2005, AM J NEURORADIOL, V26, P347; Mechtcheriakov S, 2005, NEURORADIOLOGY, V47, P27, DOI 10.1007/s00234-004-1298-8; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; ROSS BD, 1994, RADIOLOGY, V193, P457, DOI 10.1148/radiology.193.2.7972763; Rovira A, 2008, AM J NEURORADIOL, V29, P1612, DOI 10.3174/ajnr.A1139; TARTER RE, 1986, LANCET, V2, P893; Weissenborn K, 2007, GUT, V56, P1736, DOI 10.1136/gut.2006.110569; Wu XJ, 2010, J HEPATO-BIL-PAN SCI, V17, P701, DOI 10.1007/s00534-010-0270-8; Yoshikawa T, 2011, MAGN RESON MED SCI, V10, P21, DOI 10.2463/mrms.10.21; ZENEROLI ML, 1987, J HEPATOL, V4, P283, DOI 10.1016/S0168-8278(87)80536-6; Zhang LJ, 2007, ACTA RADIOL, V48, P781, DOI 10.1080/02841850701422161; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295	31	31	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42824	10.1371/journal.pone.0042824	http://dx.doi.org/10.1371/journal.pone.0042824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912746	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100036
J	Tran, PT; Sharifi, MN; Poddar, S; Dent, RM; Niyogi, KK				Tran, Phoi T.; Sharifi, Marina N.; Poddar, Subhajit; Dent, Rachel M.; Niyogi, Krishna K.			Intragenic Enhancers and Suppressors of Phytoene Desaturase Mutations in Chlamydomonas reinhardtii	PLOS ONE			English	Article							SYNTHASE GENE FAMILY; CAROTENOID BIOSYNTHESIS; ZETA-CAROTENE; HAEMATOCOCCUS-PLUVIALIS; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; TERMINAL OXIDASE; CAPSICUM-ANNUUM; BINDING SITES; ABSCISIC-ACID	Photosynthetic organisms synthesize carotenoids for harvesting light energy, photoprotection, and maintaining the structure and function of photosynthetic membranes. A light-sensitive, phytoene-accumulating mutant, pds1-1, was isolated in Chlamydomonas reinhardtii and found to be genetically linked to the phytoene desaturase (PDS) gene. PDS catalyzes the second step in carotenoid biosynthesis-the conversion of phytoene to zeta-carotene. Decreased accumulation of downstream colored carotenoids suggested that the pds1-1 mutant is leaky for PDS activity. A screen for enhancers of the pds1-1 mutation yielded the pds1-2 allele, which completely lacks PDS activity. A second independent null mutant (pds1-3) was identified using DNA insertional mutagenesis. Both null mutants accumulate only phytoene and no other carotenoids. All three phytoene-accumulating mutants exhibited slower growth rates and reduced plating efficiency compared to wildtype cells and white phytoene synthase mutants. Insight into amino acid residues important for PDS activity was obtained through the characterization of intragenic suppressors of pds1-2. The suppressor mutants fell into three classes: revertants of the pds1-1 point mutation, mutations that changed PDS amino acid residue Pro64 to Phe, and mutations that converted PDS residue Lys90 to Met. Characterization of pds1-2 intragenic suppressors coupled with computational structure prediction of PDS suggest that amino acids at positions 90 and 143 are in close contact in the active PDS enzyme and have important roles in its structural stability and/or activity.	[Tran, Phoi T.; Sharifi, Marina N.; Poddar, Subhajit; Dent, Rachel M.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Phys Biosci Div,Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tran, PT (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Phys Biosci Div,Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	niyogi@berkeley.edu	Tran, Phoi/G-4594-2013	Poddar, Subhajit/0000-0002-9764-3242; Sharifi, Marina/0000-0003-0128-3033	National Institute of General Medical Sciences [R01GM058799]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058799] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by award number R01GM058799 from the National Institute of General Medical Sciences (to KKN). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aluru MR, 2009, PLANT PHYSIOL, V150, P904, DOI 10.1104/pp.109.135780; ARMSTRONG GA, 1989, MOL GEN GENET, V216, P254, DOI 10.1007/BF00334364; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Bohne F, 2002, BBA-GENE STRUCT EXPR, V1579, P26, DOI 10.1016/S0167-4781(02)00500-6; Breitenbach J, 2001, J AGR FOOD CHEM, V49, P5270, DOI 10.1021/jf0106751; Busch M, 2002, PLANT PHYSIOL, V128, P439, DOI [10.1104/pp.128.2.439, 10.1104/pp.010573]; Calucci L, 2004, J AGR FOOD CHEM, V52, P4274, DOI 10.1021/jf0353741; Campisi L, 2006, PLANT GROWTH REGUL, V48, P79, DOI 10.1007/s10725-005-4831-9; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Conti A, 2004, PLANT CELL PHYSIOL, V45, P445, DOI 10.1093/pcp/pch052; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; DAVIES JP, 1992, NUCLEIC ACIDS RES, V20, P2959, DOI 10.1093/nar/20.12.2959; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; FRASER PD, 1993, BIOCHEM J, V291, P687, DOI 10.1042/bj2910687; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Giovannucci E, 1999, JNCI-J NATL CANCER I, V91, P317, DOI 10.1093/jnci/91.4.317; GIULIANO G, 1993, PLANT CELL, V5, P379, DOI 10.1105/tpc.5.4.379; Gonzalez-Ballester D, 2005, ANAL BIOCHEM, V340, P330, DOI 10.1016/j.ab.2005.01.031; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Grunewald K, 2000, PLANT PHYSIOL, V122, P1261, DOI 10.1104/pp.122.4.1261; Hable WE, 1998, MOL GEN GENET, V257, P167; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; HERRIN DL, 1992, J BIOL CHEM, V267, P8260; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2009, PLANT SIGNAL BEHAV, V4, P208, DOI 10.4161/psb.4.3.7798; LINDEN H, 1993, PHYSIOL PLANTARUM, V88, P229, DOI 10.1111/j.1399-3054.1993.tb05493.x; Maluf MP, 1997, J EXP BOT, V48, P1259, DOI 10.1093/jxb/48.6.1259; MAYER MP, 1989, PESTIC BIOCHEM PHYS, V34, P111, DOI 10.1016/0048-3575(89)90148-X; McCarthy SS, 2004, GENETICS, V168, P1249, DOI 10.1534/genetics.104.030635; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Page JE, 2004, PLANT PHYSIOL, V134, P1401, DOI 10.1104/pp.103.038133; PECKER I, 1992, P NATL ACAD SCI USA, V89, P4962, DOI 10.1073/pnas.89.11.4962; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qin GJ, 2007, CELL RES, V17, P471, DOI 10.1038/cr.2007.40; ROCK CD, 1991, P NATL ACAD SCI USA, V88, P7496, DOI 10.1073/pnas.88.17.7496; Rozen S, 2000, Methods Mol Biol, V132, P365; Schafer L, 2006, PLANT CELL ENVIRON, V29, P1349, DOI 10.1111/j.1365-3040.2006.01515.x; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Simkin AJ, 2003, J PLANT PHYSIOL, V160, P439, DOI 10.1078/0176-1617-00871; Simkin AJ, 2000, J AGR FOOD CHEM, V48, P4676, DOI 10.1021/jf0006426; Steinbrenner J, 2006, APPL ENVIRON MICROB, V72, P7477, DOI 10.1128/AEM.01461-06; Stolbova A. V., 1999, Genetika, V35, P111; TAYLOR HF, 1967, NATURE, V215, P1513, DOI 10.1038/2151513a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vila M, 2008, PROCESS BIOCHEM, V43, P1147, DOI 10.1016/j.procbio.2008.06.014; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang T, 2005, NEW PHYTOL, V167, P751, DOI 10.1111/j.1469-8137.2005.01454.x; Wass MN, 2009, PROTEINS, V77, P147, DOI 10.1002/prot.22513; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Werner R, 1998, PLANT MOL BIOL REP, V16, P295, DOI 10.1023/A:1007583508766; Wetzel CM, 1998, PLANT MOL BIOL, V37, P1045, DOI 10.1023/A:1006021522259; Wurtzel ET, 2001, J EXP BOT, V52, P161, DOI 10.1093/jexbot/52.354.161; Yamamoto H.Y., 2004, OXYGENIC PHOTOSYNTHE, P539	73	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42196	10.1371/journal.pone.0042196	http://dx.doi.org/10.1371/journal.pone.0042196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22912689	Green Submitted, gold, Green Published			2022-12-27	WOS:000307380900024
J	Zalamea, PC; Heuret, P; Sarmiento, C; Rodriguez, M; Berthouly, A; Guitet, S; Nicolini, E; Delnatte, C; Barthelemy, D; Stevenson, PR				Zalamea, Paul-Camilo; Heuret, Patrick; Sarmiento, Carolina; Rodriguez, Manuel; Berthouly, Anne; Guitet, Stephane; Nicolini, Eric; Delnatte, Cesar; Barthelemy, Daniel; Stevenson, Pablo R.			The Genus Cecropia: A Biological Clock to Estimate the Age of Recently Disturbed Areas in the Neotropics	PLOS ONE			English	Article							FORESTS; TREES; PATTERNS; RATES	Forest successional processes following disturbance take decades to play out, even in tropical forests. Nonetheless, records of vegetation change in this ecosystem are scarce, increasing the importance of the chronosequence approach to study forest recovery. However, this approach requires accurate dating of secondary forests, which until now was a difficult and/or expensive task. Cecropia is a widespread and abundant pioneer tree genus of the Neotropics. Here we propose and validate a rapid and straightforward method to estimate the age of secondary forest patches based on morphological observations of Cecropia trees. We found that Cecropia-inferred ages were highly correlated with known ages of the forest. We also demonstrate that Cecropia can be used to accurately date disturbances and propose twenty-one species distributed all over the geographical range of the genus as potential secondary forest chronometer species. Our method is limited in applicability by the maximal longevity of Cecropia individuals. Although the oldest chronosequence used in this study was 20 years old, we argue that at least for the first four decades after disturbance, the method described in this study provides very accurate estimations of secondary forest ages. The age of pioneer trees provides not only information needed to calculate the recovery of carbon stocks that would help to improve forest management, but also provides information needed to characterize the initial floristic composition and the rates of species remigration into secondary forest. Our contribution shows how successional studies can be reliably and inexpensively extended without the need to obtain forest ages based on expensive or potentially inaccurate data across the Neotropics.	[Zalamea, Paul-Camilo] IRD, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Zalamea, Paul-Camilo; Sarmiento, Carolina; Rodriguez, Manuel; Stevenson, Pablo R.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Heuret, Patrick; Berthouly, Anne] INRA, UMR ECOFOG Ecol Forets Guyane, Kourou, French Guiana; [Heuret, Patrick; Delnatte, Cesar] Museum Hist Nat, Aix En Provence, France; [Sarmiento, Carolina; Nicolini, Eric] CIRAD, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Guitet, Stephane] DTRD, Off Natl Forets, Cayenne, French Guiana; [Guitet, Stephane; Barthelemy, Daniel] INRA, UMR AMAP Bot & Bioinformat Architecture Plantes, F-34060 Montpellier, France; [Barthelemy, Daniel] CIRAD, BIOS Direct, Montpellier, France	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidad de los Andes (Colombia); INRAE; Museum National d'Histoire Naturelle (MNHN); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; CIRAD	Zalamea, PC (corresponding author), Smithsonian Trop Res Inst, Ancon, Panama.	camilozalamea@gmail.com	Sarmiento, Carolina/ABF-3966-2020; HEURET, Patrick/GNH-3499-2022; Guitet, Stéphane/F-5616-2016	Sarmiento, Carolina/0000-0002-8575-7170; Guitet, Stéphane/0000-0003-2374-4240; Zalamea, Paul-Camilo/0000-0002-0987-4164; barthelemy, Daniel/0000-0003-3187-2517	Ecos-Nord-Colciencias and Paris 13 University grant [C08A01]; Institut de Recherche pour le Developpement (France)	Ecos-Nord-Colciencias and Paris 13 University grant; Institut de Recherche pour le Developpement (France)	This research was supported by an Ecos-Nord-Colciencias and Paris 13 University grant (C08A01), and the Institut de Recherche pour le Developpement (France) doctoral grant to PCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawa KS, 1997, NATURE, V386, P562, DOI 10.1038/386562a0; Berg CC, 2005, FLORA NEOTROPICA MON, V94, P1, DOI DOI 10.2307/4393938; Brienen RJW, 2009, BIOTROPICA, V41, P186, DOI 10.1111/j.1744-7429.2008.00462.x; BROKAW NVL, 1987, J ECOL, V75, P9, DOI 10.2307/2260533; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; CONDIT R, 1993, FOREST ECOL MANAG, V62, P123, DOI 10.1016/0378-1127(93)90046-P; ESRI, 2008, ARCMAP 9 3; Heuret P, 2002, AM J BOT, V89, P1180, DOI 10.3732/ajb.89.7.1180; KORNING J, 1994, J TROP ECOL, V10, P151, DOI 10.1017/S026646740000780X; Laurance WF, 2004, FOREST ECOL MANAG, V190, P131, DOI 10.1016/j.foreco.2003.09.011; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Lugo AE, 2009, BIOTROPICA, V41, P589, DOI 10.1111/j.1744-7429.2009.00550.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; Martinez-Ramos M, 1999, TRENDS PLANT SCI, V4, P386, DOI 10.1016/S1360-1385(99)01478-8; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Neeff T, 2006, ECOSYSTEMS, V9, P609, DOI 10.1007/s10021-006-0001-9; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; PINHEIRO J., 2009, NLME LINEAR NONLINEA; R Core Team, 2016, R FDN STAT COMP; Sanchez-Azofeifa GA, 2009, ECOL APPL, V19, P480, DOI 10.1890/08-1149.1; Terborgh J, 1997, J TROP ECOL, V13, P833, DOI 10.1017/S0266467400011020; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Zalamea P-C, 2010, THESIS U MONTPELLIER; Zalamea PC, 2008, AM J BOT, V95, P263, DOI 10.3732/ajb.95.3.263; Zalamea PC, 2011, P ROY SOC B-BIOL SCI, V278, P2437, DOI 10.1098/rspb.2010.2259	27	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42643	10.1371/journal.pone.0042643	http://dx.doi.org/10.1371/journal.pone.0042643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22916144	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900053
J	ten Berge, HFM; van der Meer, HG; Steenhuizen, JW; Goedhart, PW; Knops, P; Verhagen, J				ten Berge, Hein F. M.; van der Meer, Hugo G.; Steenhuizen, Johan W.; Goedhart, Paul W.; Knops, Pol; Verhagen, Jan			Olivine Weathering in Soil, and Its Effects on Growth and Nutrient Uptake in Ryegrass (Lolium perenne L.): A Pot Experiment	PLOS ONE			English	Article							PLANT; BIOAVAILABILITY; PHYTOTOXICITY; SERPENTINE; NICKEL; SEQUESTRATION; ROCK; TOOL; CO2; NI	Mineral carbonation of basic silicate minerals regulates atmospheric CO2 on geological time scales by locking up carbon. Mining and spreading onto the earth's surface of fast-weathering silicates, such as olivine, has been proposed to speed up this natural CO2 sequestration ('enhanced weathering'). While agriculture may offer an existing infrastructure, weathering rate and impacts on soil and plant are largely unknown. Our objectives were to assess weathering of olivine in soil, and its effects on plant growth and nutrient uptake. In a pot experiment with perennial ryegrass (Lolium perenne L.), weathering during 32 weeks was inferred from bioavailability of magnesium (Mg) in soil and plant. Olivine doses were equivalent to 1630 (OLIV1), 8150, 40700 and 204000 (OLIV4) kg ha(-1). Alternatively, the soluble Mg salt kieserite was applied for reference. Olivine increased plant growth (+ 15.6%) and plant K concentration (+ 16.5%) in OLIV4. At all doses, olivine increased bioavailability of Mg and Ni in soil, as well as uptake of Mg, Si and Ni in plants. Olivine suppressed Ca uptake. Weathering estimated from a Mg balance was equivalent to 240 kg ha(-1) (14.8% of dose, OLIV1) to 2240 kg ha(-1) (1.1%, OLIV4). This corresponds to gross CO2 sequestration of 290 to 2690 kg ha(-1) (29 10(3) to 269 10(3) kg km(-2).) Alternatively, weathering estimated from similarity with kieserite treatments ranged from 13% to 58% for OLIV1. The Olsen model for olivine carbonation predicted 4.0% to 9.0% weathering for our case, independent of olivine dose. Our % values observed at high doses were smaller than this, suggesting negative feedbacks in soil. Yet, weathering appears fast enough to support the 'enhanced weathering' concept. In agriculture, olivine doses must remain within limits to avoid imbalances in plant nutrition, notably at low Ca availability; and to avoid Ni accumulation in soil and crop.	[ten Berge, Hein F. M.; van der Meer, Hugo G.; Steenhuizen, Johan W.; Verhagen, Jan] WUR Plant Res Int, Wageningen, Netherlands; [Goedhart, Paul W.] WUR Biometris, Wageningen, Netherlands; [Knops, Pol] Innovat Concepts BV, Gorinchem, Netherlands		ten Berge, HFM (corresponding author), WUR Plant Res Int, Wageningen, Netherlands.	hein.tenberge@wur.nl	Goedhart, Paul/F-7836-2013	Goedhart, Paul/0000-0002-9586-9862; Verhagen, Jan/0000-0001-8408-0543	Strategic Knowledge Development Programme of Wageningen UR on Climate Change (Netherlands Ministry of Economic Affairs, Agriculture and Innovation); OCI Nitrogen	Strategic Knowledge Development Programme of Wageningen UR on Climate Change (Netherlands Ministry of Economic Affairs, Agriculture and Innovation); OCI Nitrogen	This study was financed by the Strategic Knowledge Development Programme of Wageningen UR on Climate Change (Netherlands Ministry of Economic Affairs, Agriculture and Innovation); and by OCI Nitrogen (www.ocinitrogen.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, TRACE METALS SOILS P; Asemaneh T, 2007, PLANT SOIL, V293, P49, DOI 10.1007/s11104-006-9147-7; Bearat H, 2006, ENVIRON SCI TECHNOL, V40, P4802, DOI 10.1021/es0523340; CIPEC, 2005, BENCHM EN CONS CAN O, P56; Cochran W.G., 1967, STAT METHODS; Dahlin D. C., 2005, DOEARCTR04002; Dessert C, 2001, EARTH PLANET SC LETT, V188, P459, DOI 10.1016/S0012-821X(01)00317-X; DIJKSHOORN W, 1979, NETH J AGR SCI, V27, P241; DUNSMORE HE, 1992, ENERG CONVERS MANAGE, V33, P565, DOI 10.1016/0196-8904(92)90057-4; Fernandez S, 1999, COMMUN SOIL SCI PLAN, V30, P1867, DOI 10.1080/00103629909370338; Gregg SJ, 1982, ADSORPTION SURFACE A; Hangx SJT, 2009, INT J GREENH GAS CON, V3, P757, DOI 10.1016/j.ijggc.2009.07.001; Hartmann J, 2008, NATURWISSENSCHAFTEN, V95, P1159, DOI 10.1007/s00114-008-0434-4; Hartmann J, 2009, CHEM GEOL, V265, P237, DOI 10.1016/j.chemgeo.2009.03.024; Kohler P, 2010, P NATL ACAD SCI USA, V107, P20228, DOI 10.1073/pnas.1000545107; Kwon S, 2011, J ENVIRON SCI-CHINA, V23, P1233, DOI 10.1016/S1001-0742(10)60555-4; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; LASAGA AC, 1998, PR S GEOCH, P3; Lazarus BE, 2011, PLANT SOIL, V342, P327, DOI 10.1007/s11104-010-0698-2; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; MACINTIRE WH, 1959, J AGR FOOD CHEM, V7, P566, DOI 10.1021/jf60102a007; Miranda M, 2009, J TRACE ELEM MED BIO, V23, P231, DOI 10.1016/j.jtemb.2009.03.004; Mora A, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003209; Nagy L, 1997, NEW PHYTOL, V137, P267, DOI 10.1046/j.1469-8137.1997.00799.x; Neel C, 2007, APPL GEOCHEM, V22, P724, DOI 10.1016/j.apgeochem.2006.11.008; Olsen AA, 2007, THESIS VIRGINIA POLY; Olsen AA, 2007, AM MINERAL, V92, P598, DOI 10.2138/am.2007.2462; Rooney CP, 2007, ENVIRON POLLUT, V145, P596, DOI 10.1016/j.envpol.2006.04.008; Samecka-Cymerman A, 2009, ENVIRON GEOL, V58, P509, DOI 10.1007/s00254-008-1524-5; Schuiling RD, 2006, CLIMATIC CHANGE, V74, P349, DOI 10.1007/s10584-005-3485-y; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Smolders E, 2009, ENVIRON TOXICOL CHEM, V28, P1633, DOI 10.1897/08-592.1; Suchet PA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001891; TNO, 2008, TNO U R 0776 B DESK; UNFCCC, 1992, FCCCINFORMAL84 UNFCC; Weng LP, 2004, ENVIRON SCI TECHNOL, V38, P156, DOI 10.1021/es030053r; Wilson SA, 2009, ECON GEOL, V104, P95, DOI 10.2113/gsecongeo.104.1.95	37	41	41	14	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42098	10.1371/journal.pone.0042098	http://dx.doi.org/10.1371/journal.pone.0042098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912685	Green Submitted, gold, Green Published			2022-12-27	WOS:000307378500011
J	Zhang, YR; Hu, G; Yuan, ZY; Chen, LW				Zhang, Yurong; Hu, Gang; Yuan, Zuyi; Chen, Liwei			Glycosylated Hemoglobin in Relationship to Cardiovascular Outcomes and Death in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CORONARY-HEART-DISEASE; LOWER-EXTREMITY AMPUTATIONS; CAUSE-SPECIFIC MORTALITY; KONG CHINESE PATIENTS; MIDDLE-AGED PATIENTS; GLYCEMIC CONTROL; RISK-FACTORS; MICROVASCULAR COMPLICATIONS; CHRONIC HYPERGLYCEMIA; ATHEROSCLEROSIS RISK	Background: Chronic hyperglycemia in type 2 diabetes increases the risk of microvascular events. However, there is continuing uncertainty about its effect on macrovascular outcomes and death. We conducted a meta-analysis of prospective studies to estimate the association of glycosylated hemoglobin level with the risk of all-cause mortality and cardiovascular outcomes among patients with type 2 diabetes. Methodology/Principal Findings: We systematically searched the MEDLINE database through April 2011 by using Medical Subject Heading search terms and a standardized protocol. We included prospective cohort studies that reported data of glycosylated hemoglobin level on the risk of incident cardiovascular events and all-cause mortality. Relative risk estimates (continuous and categorical variables) were derived or abstracted from each cohort study. Twenty six studies were included in this analysis with a mean follow-up rang of 2.2-16 years. The pooled relative risk associated with a 1% increase in glycosylated hemoglobin level among patients with type 2 diabetes was 1.15 (95% CI, 1.11 to 1.20) for all-cause mortality, 1.17 (95% CI, 1.12 to 1.23) for cardiovascular disease, 1.15 (95% CI, 1.10 to 1.20) for coronary heart disease, 1.11 (95% CI, 1.05 to 1.18) for heart failure, 1.11 (95% CI, 1.06 to 1.17) for stroke, and 1.29 (95% CI, 1.18 to 1.40) for peripheral arterial disease, respectively. In addition, a positive dose-response trend existed between glycosylated hemoglobin level and cardiovascular outcomes. Conclusions/Significance: Chronic hyperglycemia is associated with an increased risk for cardiovascular outcomes and all-cause mortality among patients with type 2 diabetes, likely independently from other conventional risk factors.	[Zhang, Yurong; Yuan, Zuyi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Zhang, Yurong; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA USA; [Chen, Liwei] Merck Sharp & Dohme Corp, Dept Epidemiol, Whitehouse Stn, NJ USA	Xi'an Jiaotong University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Merck & Company	Zhang, YR (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Xian 710049, Shaanxi, Peoples R China.	zhangyurong72@163.com; gang.hu@pbrc.edu	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017; Yuan, Zuyi/0000-0002-4141-0298	Guanghua Scholarship Fund from Xi'an Jiaotong University [GH 0203106]; National Natural Science Foundation of China [50976088]; Louisiana State University's Improving Clinical Outcomes Network (LSU ICON)	Guanghua Scholarship Fund from Xi'an Jiaotong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Louisiana State University's Improving Clinical Outcomes Network (LSU ICON)	This work was supported by Guanghua Scholarship Fund from Xi'an Jiaotong University (No. GH 0203106), the National Natural Science Foundation of China (No. 50976088), and Louisiana State University's Improving Clinical Outcomes Network (LSU ICON). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2002, DIABETES CARE, V25, P894, DOI 10.2337/diacare.25.5.894; Adler AI, 1999, AM HEART J, V138, pS353; Agewall S, 1997, AM J CARDIOL, V80, P164, DOI 10.1016/S0002-9149(97)00312-3; Aguilar D, 2009, J AM COLL CARDIOL, V54, P422, DOI 10.1016/j.jacc.2009.04.049; Amer Diabet Assoc, 2000, DIABETES CARE, V23, pS32; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Blaum CS, 2005, DIABETIC MED, V22, P543, DOI 10.1111/j.1464-5491.2005.01457.x; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Colayco DC, 2011, DIABETES CARE, V34, P77, DOI 10.2337/dc10-1318; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; della Rovere GR, 2003, NUTR METAB CARDIOVAS, V13, P46, DOI 10.1016/S0939-4753(03)80167-9; Donnan PT, 2006, DIABETES CARE, V29, P1231, DOI 10.2337/dc05-1911; Drechsler C, 2009, CIRCULATION, V120, P2421, DOI 10.1161/CIRCULATIONAHA.109.857268; Elley CR, 2008, DIABETIC MED, V25, P1295, DOI 10.1111/j.1464-5491.2008.02581.x; Elley CR, 2010, DIABETES CARE, V33, P1347, DOI 10.2337/dc09-1444; Florkowski CM, 2001, DIABETES RES CLIN PR, V53, P113, DOI 10.1016/S0168-8227(01)00246-7; GALL MA, 1995, DIABETES, V44, P1303, DOI 10.2337/diabetes.44.11.1303; Gaster B, 1998, ARCH INTERN MED, V158, P134, DOI 10.1001/archinte.158.2.134; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hirai FE, 2008, DIABETES CARE, V31, P493, DOI 10.2337/dc07-1161; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Iribarren C, 2001, CIRCULATION, V103, P2668; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Klein R, 1996, ANN INTERN MED, V124, P90, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00003; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; KUUSISTO J, 1994, DIABETES, V43, P960, DOI 10.2337/diabetes.43.8.960; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Landman GW, 2010, BRIT J GEN PRACT, V60, P172, DOI 10.3399/bjgp10X483517; Lehto S, 1997, DIABETES, V46, P1354, DOI 10.2337/diabetes.46.8.1354; Lehto S, 1996, STROKE, V27, P63, DOI 10.1161/01.STR.27.1.63; Lehto S, 1996, DIABETES CARE, V19, P607, DOI 10.2337/diacare.19.6.607; Mattock MB, 1998, DIABETES, V47, P1786, DOI 10.2337/diabetes.47.11.1786; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Moss SE, 1999, DIABETES CARE, V22, P951, DOI 10.2337/diacare.22.6.951; MOSS SE, 1994, ARCH INTERN MED, V154, P2473; Moss SE, 1996, ARCH FAM MED, V5, P391, DOI 10.1001/archfami.5.7.391; MOSS SE, 1991, AM J PUBLIC HEALTH, V81, P1158, DOI 10.2105/AJPH.81.9.1158; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2005, LANCET NEUROL, V4, P821, DOI 10.1016/S1474-4422(05)70227-1; Selvin E, 2005, ARCH INTERN MED, V165, P1910, DOI 10.1001/archinte.165.16.1910; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Shah S, 2009, ADV THER, V26, P325, DOI 10.1007/s12325-009-0006-9; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shichiri M, 2000, DIABETES CARE, V23, pB21; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; Stevens R, 2004, DIABETES CARE, V27, P201, DOI 10.2337/diacare.27.1.201; Stratton IM, 2006, DIABETOLOGIA, V49, P1761, DOI 10.1007/s00125-006-0297-1; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Valensi P, 2008, INT J CLIN PRACT, V62, P1809, DOI 10.1111/j.1742-1241.2008.01917.x; van Hateren KJJ, 2011, INT J CLIN PRACT, V65, P415, DOI 10.1111/j.1742-1241.2010.02596.x; Yang XL, 2008, CLIN NEUROL NEUROSUR, V110, P701, DOI 10.1016/j.clineuro.2008.04.010; Yang XL, 2007, DIABETES-METAB RES, V23, P220, DOI 10.1002/dmrr.675; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; Yang XL, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-9; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	63	112	121	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42551	10.1371/journal.pone.0042551	http://dx.doi.org/10.1371/journal.pone.0042551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912709	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500019
J	Cai, BH; Hsu, PC; Hsin, IL; Chao, CF; Lu, MH; Lin, HC; Chiou, SH; Tao, PL; Chen, JY				Cai, Bi-He; Hsu, Pei-Ching; Hsin, I-Lun; Chao, Chung-Faye; Lu, Mei-Hua; Lin, Hwang-Chi; Chiou, Shih-Hwa; Tao, Pao-Luh; Chen, Jang-Yi			p53 Acts as a Co-Repressor to Regulate Keratin 14 Expression during Epidermal Cell Differentiation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; TRANSCRIPTIONAL REPRESSION; DNA-BINDING; KERATINOCYTE DIFFERENTIATION; SP1-DEPENDENT REPRESSOR; NEGATIVE REGULATION; PIFITHRIN-ALPHA; GENE-EXPRESSION; MUTANT P53; IN-VIVO	During epidermal cell differentiation, keratin 14 (K14) expression is down-regulated, p53 expression varies, and the expression of the p53 target genes, p21 and 14-3-3s, increases. These trends suggest that the relative transcriptional activity of p53 is increased during epidermal cell differentiation. To determine the relationship between K14 and p53, we constructed K14 promoters of various sizes and found that wild-type p53 could repress the promoter activity of all of the K14 promoter constructs in H1299 cells. K14-p160 contains an SP1 binding site mutation that prevents p53 from repressing K14 expression. Using a DNA affinity precipitation assay, we confirmed that p53 forms a complex with SP1 at the SP1 binding site between nucleotides -48 and -43 on the K14 promoter. Thus, our data indicate that p53 acts as a co-repressor to down-regulate K14 expression by binding to SP1. Next, we used a 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced epidermal cell differentiation model to examine the inhibition of K14 expression caused by increased p53 activity. Human ovarian teratocarcinoma C9 cells were treated with TPA to induce differentiation. Over-expression of the dominant negative p53 mutant Delta TAp53, which inhibits p53 activity, prevented the TPA-induced K14 down-regulation in C9 cells. Furthermore, treatment of normal primary human foreskin keratinocytes (PHFK) with the p53 inhibitor pifithrin-alpha (PFT-alpha) showed that the inhibition of p53 activity relieves K14 repression during epidermal cell differentiation. Finally, we found that TPA induces the phosphorylation of p53 at residue 378, which enhances the affinity of p53 to bind to Sp1 and repress K14 expression.	[Cai, Bi-He; Hsu, Pei-Ching; Hsin, I-Lun; Chao, Chung-Faye; Lu, Mei-Hua; Chen, Jang-Yi] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Lin, Hwang-Chi] Shin Kong Wu Ho Su Mem Hosp, Div Plast Surg, Taipei, Taiwan; [Cai, Bi-He; Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Tao, Pao-Luh] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Mental Hlth & Addict Med, Miaoli, Taiwan; [Cai, Bi-He; Hsu, Pei-Ching] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hsin, I-Lun] Chung Shan Med Univ, Inst Med & Mol Toxicol, Taichung, Taiwan	National Defense Medical Center; Shin Kong Wu Ho Su Memorial Hospital; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; Chung Shan Medical University	Cai, BH (corresponding author), Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan.	jychen01@ndmctsgh.edu.tw	Cai, Bi-He/V-5756-2019; Cai, Bi-He/AAB-2965-2020; Tao, Pao-Luh/F-6085-2010	Cai, Bi-He/0000-0003-4226-6096; Hsin, I-Lun/0000-0003-4711-3582	Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-97-DR-11]; National Science Council, Republic of China [NSC97-2320-B-016-005 -MY3]	Shin Kong Wu Ho-Su Memorial Hospital; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-97-DR-11 to CFC and HCL] and the National Science Council, Republic of China [NSC97-2320-B-016-005 -MY3 to PLT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Baran W, 2005, ACTA DERMATOVEN ALP, V14, P79; Beitzinger M, 2006, ONCOGENE, V25, P813, DOI 10.1038/sj.onc.1209125; BERNERD F, 1992, J INVEST DERMATOL, V98, P902, DOI 10.1111/1523-1747.ep12460344; BOEHNCKE WH, 1994, ARCH DERMATOL RES, V287, P68, DOI 10.1007/BF00370721; Cai BH, 2012, J BIOCHEM, V152, P99, DOI 10.1093/jb/mvs053; Cai BH, 2009, NUCLEIC ACIDS RES, V37, P1984, DOI 10.1093/nar/gkp033; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Chua CC, 2006, AM J PHYSIOL-HEART C, V290, pH2606, DOI 10.1152/ajpheart.01138.2005; Codelia VA, 2010, MOL HUM REPROD, V16, P734, DOI 10.1093/molehr/gaq045; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Farmer G, 1996, NUCLEIC ACIDS RES, V24, P4281, DOI 10.1093/nar/24.21.4281; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Ichikawa T, 2008, ONCOGENE, V27, P409, DOI 10.1038/sj.onc.1210658; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Innocente SA, 2005, BIOCHEM BIOPH RES CO, V329, P713, DOI 10.1016/j.bbrc.2005.02.028; JAKEN S, 1988, CARCINOGENESIS, V9, P1033, DOI 10.1093/carcin/9.6.1033; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Lin HC, 2008, PIGM CELL MELANOMA R, V21, P559, DOI 10.1111/j.1755-148X.2008.00487.x; Lu Mei-Hua, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P169; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pal S, 2001, CANCER RES, V61, P6952; Paramio JM, 2000, MOL CARCINOGEN, V29, P251, DOI 10.1002/1098-2744(200012)29:4<251::AID-MC1007>3.0.CO;2-O; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Qin JZ, 2002, ONCOGENE, V21, P2991, DOI 10.1038/sj.onc.1205404; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Rajagopalan S, 2010, NUCLEIC ACIDS RES, V38, P893, DOI 10.1093/nar/gkp1041; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Sengupta S, 2005, ONCOGENE, V24, P1738, DOI 10.1038/sj.onc.1208380; Sherman L, 2002, VIROLOGY, V292, P309, DOI 10.1006/viro.2001.1263; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06	63	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41742	10.1371/journal.pone.0041742	http://dx.doi.org/10.1371/journal.pone.0041742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911849	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300068
J	Wang, T; Su, YJ; Li, Y				Wang, Ting; Su, Yingjuan; Li, Yuan			Population Genetic Variation in the Tree Fern Alsophila spinulosa (Cyatheaceae): Effects of Reproductive Strategy	PLOS ONE			English	Article							BREEDING SYSTEMS; DIVERSITY; VARIABILITY; EVOLUTION; BIOLOGY; MARKERS; OPHIOGLOSSACEAE; DIFFERENTIATION; RECOMBINATION; PTERIDOPHYTA	Background: Essentially all ferns can perform both sexual and asexual reproduction. Their populations represent suitable study objects to test the population genetic effects of different reproductive systems. Using the diploid homosporous fern Alsophila spinulosa as an example species, the main purpose of this study was to assess the relative impact of sexual and asexual reproduction on the level and structure of population genetic variation. Methodology/Principal Findings: Inter-simple sequence repeats analysis was conducted on 140 individuals collected from seven populations (HSG, LCH, BPC, MPG, GX, LD, and ZHG) in China. Seventy-four polymorphic bands discriminated a total of 127 multilocus genotypes. Character compatibility analysis revealed that 50.0 to 70.0% of the genotypes had to be deleted in order to obtain a tree-like structure in the data set from populations HSG, LCH, MPG, BPC, GX, and LD; and there was a gradual decrease of conflict in the data set when genotypes with the highest incompatibility counts were successively deleted. In contrast, in population ZHG, only 33.3% of genotypes had to be removed to achieve complete compatibility in the data set, which showed a sharp decline in incompatibility upon the deletion of those genotypes. All populations examined possessed similar levels of genetic variation. Population ZHG was not found to be more differentiated than the other populations. Conclusions/Significance: Sexual recombination is the predominant source of genetic variation in most of the examined populations of A. spinulosa. However, somatic mutation contributes most to the genetic variation in population ZHG. This change of the primary mode of reproduction does not cause a significant difference in the population genetic composition. Character compatibility analysis represents an effective approach to separate the role of sexual and asexual components in shaping the genetic pattern of fern populations.	[Wang, Ting] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Hubei, Peoples R China; [Su, Yingjuan; Li, Yuan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Sun Yat Sen University	Wang, T (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Hubei, Peoples R China.	suyj@mail.sysu.edu.cn			National Natural Science Foundation of China [30771763, 30970290, 31070594]; Innovative Program of Chinese Academy of Sciences [KSCX2-YW-Z-0940]; Natural Science Foundation of Hubei Province, China [O631061H01]; Opening Fund of Laboratory Sun Yat-sen University; Guangdong Key Laboratory of Plant Resources [plant01k13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province); Opening Fund of Laboratory Sun Yat-sen University; Guangdong Key Laboratory of Plant Resources	This work was supported by the National Natural Science Foundation of China (Grant No. 30771763, 30970290, and 31070594), the Innovative Program of Chinese Academy of Sciences (KSCX2-YW-Z-0940), the Outstanding Young Scientist Project" of the Natural Science Foundation of Hubei Province, China (Grant No. O631061H01), and the Opening Fund of Laboratory Sun Yat-sen University (2010), and Guangdong Key Laboratory of Plant Resources (plant01k13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, FERNS FERN ALLIES JA; Asker S. E., 1992, APOMIXIS PLANTS; Camacho FJ, 2001, AM J BOT, V88, P1065, DOI 10.2307/2657089; Ceplitis A, 2001, EVOLUTION, V55, P1581, DOI 10.1111/j.0014-3820.2001.tb00677.x; Chapman H, 2004, HEREDITY, V92, P182, DOI 10.1038/sj.hdy.6800392; Chen YY, 2010, BIOCHEM SYST ECOL, V38, P1129, DOI 10.1016/j.bse.2010.12.016; Chiou WL, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P485; Dong SY, 2009, ANN BOT FENN, V46, P381, DOI 10.5735/085.046.0502; Eicchorn S., 2003, BIOL PLANTS; Fu L.G., 1992, CHINA PLANT RED DATA, V1; Grant V., 1981, PLANT SPECIATION; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hassel K, 2005, AM J BOT, V92, P1684, DOI 10.3732/ajb.92.10.1684; HAUFLER CH, 1987, AM J BOT, V74, P953, DOI 10.2307/2443877; Haufler CH, 2002, BIOSCIENCE, V52, P1081, DOI 10.1641/0006-3568(2002)052[1081:HAOOPI]2.0.CO;2; Haufler Christopher H., 1992, P145; Hock Z, 2009, PLANT ECOL, V202, P123, DOI 10.1007/s11258-008-9541-8; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hooper EA, 1997, AM J BOT, V84, P1664, DOI 10.2307/2446464; Houliston GJ, 2004, AM J BOT, V91, P37, DOI 10.3732/ajb.91.1.37; Jimenez A, 2010, ANN BOT-LONDON, V106, P149, DOI 10.1093/aob/mcq094; Johns RJ, 1991, CURTISS BOT MAG, V8, P107; Kameyama Y, 2006, J PLANT RES, V119, P357, DOI 10.1007/s10265-006-0282-2; Kjolner S, 2006, BOT J LINN SOC, V152, P209, DOI 10.1111/j.1095-8339.2006.00545.x; Klekowski E.J., 1969, BOT J LINN SOC, V62, P361, DOI [DOI 10.1111/J.1095-8339.1969.TB01973.X, 10.1007/978-3-642-18475-8, DOI 10.1007/978-3-642-18475-8]; Klekowski EJ, 1979, EXPT BIOL FERNS, P133; Korpelainen H, 1996, AM J BOT, V83, P58, DOI 10.2307/2445954; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li ZH, 2005, COURSE STAT ANAL SPS; LLOYD RM, 1974, ANN MO BOT GARD, V61, P318, DOI 10.2307/2395060; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Maki M, 1998, HEREDITY, V80, P604; McVeigh I, 1937, BOT REV, V3, P457; Mes THM, 1998, MOL ECOL, V7, P1719, DOI 10.1046/j.1365-294x.1998.00508.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; RANKER TA, 1992, HEREDITY, V69, P175, DOI 10.1038/hdy.1992.111; Ranker TA, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P107, DOI 10.1017/CBO9780511541827.005; Richards AJ, 1996, FOLIA GEOBOT PHYTOTX, V31, P405, DOI 10.1007/BF02815385; Rumsey FJ, 1999, BIOL J LINN SOC, V66, P333, DOI 10.1111/j.1095-8312.1999.tb01894.x; Sokal RR, 2003, BIOMETRY; SOLTIS DE, 1986, AM J BOT, V73, P588, DOI 10.2307/2444264; SOLTIS DE, 1987, AM NAT, V130, P219, DOI 10.1086/284706; Su YJ, 2005, MOL PHYLOGENET EVOL, V34, P323, DOI 10.1016/j.ympev.2004.10.016; Suter M, 2000, INT J PLANT SCI, V161, P233, DOI 10.1086/314258; Tryon R. M., 1982, FERNS ALLIED PLANTS; van der Hulst RGM, 2000, MOL ECOL, V9, P1, DOI 10.1046/j.1365-294x.2000.00704.x; Van der Hulst RGM, 2003, HEREDITY, V90, P326, DOI 10.1038/sj.hdy.6800248; Wang JH, 1996, GUIHAIA, V16, P283; WHITE RA, 1969, B TORREY BOT CLUB, V96, P10, DOI 10.2307/2484004; Wilkinson M, 1995, PICA95 SOFTWARE DOCU; WILKINSON M, 2001, PICA SOFTWARE DOCUME; Willis K. J., 2002, EVOLUTION PLANTS; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zhang XC, 2004, FLORA REIPUBLICAE PO, P249; Zhou ZQ, 2004, J GUIZHOU NORMAL U N, V22, P100; [No title captured]	57	4	5	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41780	10.1371/journal.pone.0041780	http://dx.doi.org/10.1371/journal.pone.0041780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911855	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300074
J	Wang, ZH; Ma, N; Riley, J; Armstead, WM; Liu, RY				Wang, Zhenhong; Ma, Nan; Riley, John; Armstead, William M.; Liu, Renyu			Salvinorin A Administration after Global Cerebral Hypoxia/Ischemia Preserves Cerebrovascular Autoregulation via Kappa Opioid Receptor in Piglets	PLOS ONE			English	Article							SIGNAL-REGULATED-KINASE; ACUTE ISCHEMIC-STROKE; MEK1 PROTEIN-KINASE; HALLUCINOGEN SALVINORIN; NITRIC-OXIDE; RAT MODEL; IN-VIVO; NEUROPROTECTION; AGONIST; ACTIVATION	Background: Cerebral hypoxia/ischemia (HI) is not uncommon during the perinatal period. If occurring, it can result in severe neurologic disabilities that persist throughout life. Salvinorin A, a non-opioid Kappa opioid receptors (KOR) selective agonist, has the potential to address this devastating situation. We have demonstrated that salvinorin A administration before HI, preserves pial artery autoregulative function through both the KOR and extracellular signal-regulated kinases (ERK) pathways. In the present study, we tested the hypothesis that administration of salvinorin A after HI could preserve cerebral autoregulation via KOR and ERK pathway. Methodology/Principal Findings: The response of the pial artery to hypercapnia, hypotension and isoproterenol were monitored before and 1 hour after HI in piglets equipped with a cranial window. Four groups of drug administration were performed after HI. The control group had DMSO (1 mu l/kg, i.v.) administrated immediately after HI. Two salvinorin A treated groups had salvinorin A (10 mu g/kg, i.v.) administrated 0 and 30 min after HI, respectively. The 4th group had salvinorin A and the KOR antagonist norbinaltorphimine (Nor-BIN, 1 mu M topical) co-administrated 0 min after HI (n = 5). The dilation responses of the pial artery to hypercapnia and hypotension were impaired after global HI and were preserved with salvinorin A administration immediately or 30 min after HI. The preservation of autoregulation was abolished when nor-BIN was administered. Levels of phosphor-ERK(pERK)/ERK in the cerebrospinal fluid (CSF) were measured before and 1 hour after HI. After HI, the pERK/ERK levels significantly increased in both DMSO control group and salvinorin A and nor-BIN co-administration group. The elevated levels of pERK/ERK were not observed with salvinorin A only groups. Conclusions: Salvinorin A administration 0 and 30 min after HI preserves autoregulation of pial artery to hypercapnia and hypotension via kappa opioid receptor and ERK pathway.	[Wang, Zhenhong; Ma, Nan; Riley, John; Armstead, William M.; Liu, Renyu] Hosp Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Wang, Zhenhong] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University	Wang, ZH (corresponding author), Hosp Univ Penn, Dept Anesthesiol & Crit Care, 3400 Spruce St, Philadelphia, PA 19104 USA.	William.Armstead@uphs.upenn.edu; liur@uphs.upenn.edu	Ma, Nan/L-1282-2013	Ma, Nan/0000-0003-4006-1003; Riley, John/0000-0002-7932-8935	National Institutes of Health [K08-GM-093115-01, NS53410]; Department of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania; McCabe foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM093115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania; McCabe foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health grant number K08-GM-093115-01(PI, RL) and NS53410 (PI, WA). It is also supported by the Department of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania (PI, RL); McCabe foundation (PI, RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Armstead WM, 2008, BRAIN RES, V1231, P121, DOI 10.1016/j.brainres.2008.06.115; Armstead WM, 2011, BRAIN RES, V1376, P88, DOI 10.1016/j.brainres.2010.12.052; BASKIN DS, 1984, NATURE, V312, P551, DOI 10.1038/312551a0; Blom I, 2003, DEV MED CHILD NEUROL, V45, P233, DOI 10.1017/S001216220300046X; Braida D, 2009, BRIT J PHARMACOL, V157, P844, DOI 10.1111/j.1476-5381.2009.00230.x; Butelman ER, 2009, J PHARMACOL EXP THER, V328, P588, DOI 10.1124/jpet.108.145342; Chabrier S, 2011, THROMB RES, V127, P13, DOI 10.1016/j.thromres.2010.10.003; Charron C, 2008, PHYSIOL BEHAV, V93, P502, DOI 10.1016/j.physbeh.2007.10.015; Chen TY, 2004, STROKE, V35, P1180, DOI 10.1161/01.STR.0000125011.93188.c6; Choi JS, 2006, NEUROSCI LETT, V409, P187, DOI 10.1016/j.neulet.2006.09.053; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Feng Y, 2004, LIFE SCI, V75, P2615, DOI 10.1016/j.lfs.2004.07.008; Goyagi T, 2003, STROKE, V34, P1533, DOI 10.1161/01.STR.0000072512.30658.E7; HALL ED, 1988, STROKE, V19, P1008, DOI 10.1161/01.STR.19.8.1008; HAYWARD NJ, 1993, EUR J NEUROSCI, V5, P961, DOI 10.1111/j.1460-9568.1993.tb00947.x; Hooker JM, 2008, NEUROIMAGE, V41, P1044, DOI 10.1016/j.neuroimage.2008.03.003; Hurvitz Edward, 2004, Top Stroke Rehabil, V11, P51; Jeong S, 2012, J NEUROSURG ANESTH, V24, P51, DOI 10.1097/ANA.0b013e3182368d70; Liebelt B, 2010, NEUROSCIENCE, V166, P1091, DOI 10.1016/j.neuroscience.2009.12.067; Maddahi A, 2011, J CEREBR BLOOD F MET, V31, P144, DOI 10.1038/jcbfm.2010.62; MAYHAN WG, 1988, AM J PHYSIOL, V255, pH879, DOI 10.1152/ajpheart.1988.255.4.H879; Melief EJ, 2011, MOL PHARMACOL, V80, P920, DOI 10.1124/mol.111.074195; Mowry M, 2003, J PSYCHOACTIVE DRUGS, V35, P379, DOI 10.1080/02791072.2003.10400021; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Park EM, 2004, NEUROSCIENCE, V123, P147, DOI 10.1016/j.neuroscience.2003.08.023; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Su DS, 2007, NEUROSCI LETT, V423, P113, DOI 10.1016/j.neulet.2007.06.044; Su DAS, 2012, ANESTH ANALG, V114, P200, DOI 10.1213/ANE.0b013e31823a5d36; Su DS, 2011, ANESTHESIOLOGY, V114, P374, DOI 10.1097/ALN.0b013e318204e029; Teksin ZS, 2009, EUR J PHARM BIOPHARM, V72, P471, DOI 10.1016/j.ejpb.2009.01.002; Vortherms TA, 2006, MOL INTERV, V6, P257, DOI 10.1124/mi.6.5.7; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; Wu DC, 2000, J CEREBR BLOOD F MET, V20, P1320, DOI 10.1097/00004647-200009000-00007; Yang L, 2011, BRAIN RES, V1383, P307, DOI 10.1016/j.brainres.2011.01.083; Zeynalov E, 2006, J CEREBR BLOOD F MET, V26, P414, DOI 10.1038/sj.jcbfm.9600196; Zhang ZA, 2003, ANESTH ANALG, V97, P1776, DOI 10.1213/01.ANE.0000087800.56290.2E; Zhao P, 2006, J NEUROPATH EXP NEUR, V65, P945, DOI 10.1097/01.jnen.0000235123.05677.4b	41	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41724	10.1371/journal.pone.0041724	http://dx.doi.org/10.1371/journal.pone.0041724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911847	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300066
J	Zhou, AM; Lu, YY; Zeng, L; Xu, YJ; Liang, GW				Zhou, Aiming; Lu, Yongyue; Zeng, Ling; Xu, Yijuan; Liang, Guangwen			Does Mutualism Drive the Invasion of Two Alien Species? The Case of Solenopsis invicta and Phenacoccus solenopsis	PLOS ONE			English	Article							IMPORTED FIRE ANT; ARGENTINE ANTS; BIOLOGICAL INVASIONS; LABORATORY COLONIES; RAIN-FOREST; APHID; HYMENOPTERA; HONEYDEW; COTTON; FORMICIDAE	Although mutualism between ants and honeydew-producing hemipterans has been extensively recognized in ecosystem biology, however few attempts to test the hypothesis that mutualism between two alien species leads to the facilitation of the invasion process. To address this problem, we focus on the conditional mutualism between S. invicta and P. solenopsis by field investigations and indoor experiments. In the laboratory, ant colony growth increased significantly when ants had access to P. solenopsis and animal-based food. Honeydew produced by P. solenopsis also improved the survival of ant workers. In the field, colony density of P. solenopsis was significantly greater on plots with ants than on plots without ants. The number of mealybug mummies on plants without fire ants was almost three times that of plants with fire ants, indicating a strong effect of fire ants on mealybug survival. In addition, the presence of S. invicta successfully contributed to the spread of P. solenopsis. The quantity of honeydew consumption by S. invicta was significantly greater than that of a presumptive native ant, Tapinoma melanocephalum. When compared with the case without ant tending, mealybugs tended by ants matured earlier and their lifespan and reproduction increased. T. melanocephalum workers arrived at honeydew more quickly than S. invicta workers, while the number of foraging S. invicta workers on plants steadily increased, eventually exceeding that number of T. melanocephalum foragers. Overall, these results suggest that the conditional mutualism between S. invicta and P. solenopsis facilitates population growth and fitness of both species. S. invicta tends to acquire much more honeydew and drive away native ants, promoting their predominance. These results suggest that the higher foraging tempo of S. invicta may provide more effective protection of P. solenopsis than native ants. Thus mutualism between these two alien species may facilitate the invasion success of both species.	[Zhou, Aiming; Lu, Yongyue; Zeng, Ling; Xu, Yijuan; Liang, Guangwen] S China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhou, AM (corresponding author), S China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou, Guangdong, Peoples R China.	xuyijuan@yahoo.com; gwliang@scau.edu.cn			National Natural Science Foundation of China [31101498]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31101498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2007, OIKOS, V116, P1238, DOI 10.1111/j.0030-1299.2007.15629.x; Akintola A. J., 2008, Agricultural Journal, V3, P1, DOI 10.3923/ijar.2008.1.26; BANKS CJ, 1958, J EXP BIOL, V35, P703; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Brightwell RJ, 2010, BIOL INVASIONS, V12, P2051, DOI 10.1007/s10530-009-9607-0; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; BUCKLEY R, 1987, ADV ECOL RES, V16, P53; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; Carter W., 1973, INSECTS RELATION PLA; Coppler LB, 2007, FLA ENTOMOL, V90, P419, DOI 10.1653/0015-4040(2007)90[419:RIFAHF]2.0.CO;2; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2007, ECOL ENTOMOL, V32, P583, DOI 10.1111/j.1365-2311.2007.00910.x; Daane KM, 2006, CROP PROT, V25, P592, DOI 10.1016/j.cropro.2005.08.015; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; Dejean A, 2003, REV MOSAICS DOMINAT; Delabie Jacques H. C., 2001, Neotropical Entomology, V30, P501, DOI 10.1590/S1519-566X2001000400001; Diaz D, 2004, J ECON ENTOMOL, V97, P222, DOI 10.1603/0022-0493-97.2.222; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Eisner T., 1957, BULL MUS COMP ZOOL, V116, P429; Flatt T, 2000, ECOLOGY, V81, P3522, DOI 10.1890/0012-9658(2000)081[3522:TEOMAO]2.0.CO;2; FUCHS TW, 1991, SOUTHWEST ENTOMOL, V16, P215; GLANCEY BM, 1981, INSECT SOC, V28, P395, DOI 10.1007/BF02224196; Helms KR, 2008, ENVIRON ENTOMOL, V37, P487, DOI 10.1603/0046-225X(2008)37[487:PRACGI]2.0.CO;2; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Hodgson C, 2008, ZOOTAXA, P1; Holland J. Nathaniel, 2005, P17; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Kaplan I, 2002, ENVIRON ENTOMOL, V31, P1175, DOI 10.1603/0046-225X-31.6.1175; Kaplan I, 2005, ECOLOGY, V86, P1640, DOI 10.1890/04-0016; Lach L, 2003, ANN MO BOT GARD, V90, P91, DOI 10.2307/3298529; Li J, 2008, PLANT QUARANTINE, V22, P19; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Lu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001302; [陆永跃 LU Yong-Yue], 2008, [环境昆虫学报, Journal of Environmental Entomology], V30, P386; Mittler T. E., 1958, Proceedings of the Royal Entomological Society of London (A), V33, P49; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Ness JH, 2004, BIOL INVASIONS, V6, P445, DOI 10.1023/B:BINV.0000041556.88920.dd; Nixon G.E.J., 1951, ASS ANTS APHIDS COCC; Phillips P. A., 1991, California Agriculture, V45, P26; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; PORTER SD, 1989, J KANSAS ENTOMOL SOC, V62, P288; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; SORENSEN AA, 1981, INSECT SOC, V28, P129, DOI 10.1007/BF02223701; Stadler B, 2002, ECOL LETT, V5, P216, DOI 10.1046/j.1461-0248.2002.00300.x; Stradling D, 1978, FOOD FEEDING HABITS, P81; Tobin John E., 1994, P279; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Tschinkel WR, 2006, FIRE ANTS; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Vitousek PM, 1996, AM SCI, V84, P468; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wheeler W.M., 1960, ANTS THEIR STRUCTURE; Whittaker J, 1991, EFFECTS ANTS TEMPERA, P67; Williams D. J., 1992, Mealybugs of Central and South America.; WILLIAMS DF, 1987, ARCH INSECT BIOCHEM, V4, P251, DOI 10.1002/arch.940040403; WILLIAMS DF, 1980, J ECON ENTOMOL, V73, P176, DOI 10.1093/jee/73.1.176; Yao I, 2000, OIKOS, V89, P3, DOI 10.1034/j.1600-0706.2000.890101.x; [曾玲 Zeng Ling], 2005, [昆虫知识, Entomological  Knowledge], V42, P144; Zhou AM, 2012, SOCIOBIOLOGY, V59, P71	63	34	41	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41856	10.1371/journal.pone.0041856	http://dx.doi.org/10.1371/journal.pone.0041856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911859	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700159
J	Labrenz, F; Themann, M; Wascher, E; Beste, C; Pfleiderer, B				Labrenz, Franziska; Themann, Maria; Wascher, Edmund; Beste, Christian; Pfleiderer, Bettina			Neural Correlates of Individual Performance Differences in Resolving Perceptual Conflict	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SELECTIVE VISUAL-ATTENTION; ANTERIOR CINGULATE CORTEX; INFERIOR TEMPORAL CORTEX; MEDIAL PREFRONTAL CORTEX; TOP-DOWN; ORBITOFRONTAL CORTEX; BUNDESENS THEORY; COVERT SHIFTS; BOTTOM-UP	Attentional mechanisms are a crucial prerequisite to organize behavior. Most situations may be characterized by a 'competition' between salient, but irrelevant stimuli and less salient, relevant stimuli. In such situations top-down and bottom-up mechanisms interact with each other. In the present fMRI study, we examined how interindividual differences in resolving situations of perceptual conflict are reflected in brain networks mediating attentional selection. Doing so, we employed a change detection task in which subjects had to detect luminance changes in the presence and absence of competing distractors. The results show that good performers presented increased activation in the orbitofrontal cortex (BA 11), anterior cingulate (BA 25), inferior parietal lobule (BA 40) and visual areas V2 and V3 but decreased activation in BA 39. This suggests that areas mediating top-down attentional control are stronger activated in this group. Increased activity in visual areas reflects distinct neuronal enhancement relating to selective attentional mechanisms in order to solve the perceptual conflict. Opposed to good performers, brain areas activated by poor performers comprised the left inferior parietal lobule (BA 39) and fronto-parietal and visual regions were continuously deactivated, suggesting that poor performers perceive stronger conflict than good performers. Moreover, the suppression of neural activation in visual areas might indicate a strategy of poor performers to inhibit the processing of the irrelevant non-target feature. These results indicate that high sensitivity in perceptual areas and increased attentional control led to less conflict in stimulus processing and consequently to higher performance in competitive attentional selection.	[Labrenz, Franziska; Beste, Christian] Ruhr Univ Bochum, Inst Cognit Neurosci Biopsychol, Bochum, Germany; [Wascher, Edmund] IFADO Leibniz Res Ctr, Dortmund, Germany; [Themann, Maria; Pfleiderer, Bettina] Univ Munster, Dept Clin Radiol, Munster, Germany	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); University of Munster	Labrenz, F (corresponding author), Ruhr Univ Bochum, Inst Cognit Neurosci Biopsychol, Univ Str 150, Bochum, Germany.	franziska.labrenz@rub.de	Labrenz, Franziska/AAQ-7131-2020; Wascher, Edmund/N-6848-2019; Wascher, Edmund/B-8457-2019; Labrenz, Franziska/ABC-9386-2021	Wascher, Edmund/0000-0003-3616-9767; Labrenz, Franziska/0000-0001-7284-3451	Deutsche Forschungsgemeinschaft [BE 4045/6-1, PF 244/13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) BE 4045/6-1 (to C.B.) and PF 244/13 (to B.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBAS H, 1988, J COMP NEUROL, V276, P313, DOI 10.1002/cne.902760302; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Beste C, 2011, CURR BIOL, V21, P876, DOI 10.1016/j.cub.2011.03.065; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Chadick JZ, 2011, NAT NEUROSCI, V14, P830, DOI 10.1038/nn.2823; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Fishburn P. C., 1970, PUBLICATIONS OPERATI, V18; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gruska A, 2010, HDB INDIVIDUAL DIFFE; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hilimire MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012677; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hung J, 2005, J NEUROSCI, V25, P9602, DOI 10.1523/JNEUROSCI.0879-05.2005; Hung J, 2011, J NEUROSCI, V31, P15904, DOI 10.1523/JNEUROSCI.2626-11.2011; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; Poghosyan V, 2005, EUR J NEUROSCI, V22, P225, DOI 10.1111/j.1460-9568.2005.04181.x; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Proulx MJ, 2008, PSYCHOL RES-PSYCH FO, V72, P106, DOI 10.1007/s00426-006-0077-z; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Schreij D, 2008, PERCEPT PSYCHOPHYS, V70, P208, DOI 10.3758/PP.70.2.208; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Stokes M, 2009, P NATL ACAD SCI USA, V106, P19569, DOI 10.1073/pnas.0905306106; Talairach J., 1988, COPLANAR STEREOTAXIC; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; Treue S, 2007, NEURON, V55, P174, DOI 10.1016/j.neuron.2007.07.005; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; Ward B, 2002, DECONVULATION ANAL F; Wascher E, 2010, J NEUROPHYSIOL, V103, P1057, DOI 10.1152/jn.00376.2009; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Windischberger C, 2002, COGNITIVE BRAIN RES, V13, P129, DOI 10.1016/S0926-6410(01)00101-X; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Zenon A, 2010, J COGNITIVE NEUROSCI, V22, P918, DOI 10.1162/jocn.2009.21233	77	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42849	10.1371/journal.pone.0042849	http://dx.doi.org/10.1371/journal.pone.0042849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916169	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800033
J	Nelis, LC				Nelis, Lisa Castillo			Life Form and Life History Explain Variation in Population Processes in a Grassland Community Invaded by Exotic Plants and Mammals	PLOS ONE			English	Article							DYNAMICS; RECRUITMENT; INVASIONS; TRAITS	The existence of general characteristics of plant invasiveness is still debated. One reason we may not have found these characteristics is because we do not yet understand how processes underlying population dynamics contribute to community composition in invaded communities. Here I modify Ricker stock-recruitment models to parameterize processes important to community dynamics in an invaded grassland community: immigration, maximum intrinsic growth rate, self-regulation, and limitation by other species. I then used the parameterized models in a multi-species stochastic simulation to determine how processes affected long-term community dynamics. By parameterizing the models using the frequency of the 18 most common species in the grassland, I determined that life history and life form are stronger predictors of underlying processes than is native status. Immigration maintains exotic annual grasses and the dominant native perennial grass in the community. Growth rate maintains other perennial species. While the model mirrors the frequency of native species well, exotic species have lower observed than parameterized frequencies, suggesting that they are not reaching their potential frequency. These results, combined with results from past research, suggest that disturbance may be key to maintaining exotic species in the community. Here I showed that a continuous modified Ricker model fit discrete grassland frequency data well. This allowed me to model the dominant species in the community simultaneously and gain insight into the processes that determine community composition.	[Nelis, Lisa Castillo] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA	University of Chicago	Nelis, LC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	lnelis@stanford.edu			National Science Foundation (NSF) [011780, 10456110, 0452687, 0708462]; ARCS (Achievement Rewards for College Scientists) Foundation Chicago; University of Chicago Hinds Fund; Sigma Xi; Rotary One; Southeast Chicago Rotary Club	National Science Foundation (NSF)(National Science Foundation (NSF)); ARCS (Achievement Rewards for College Scientists) Foundation Chicago; University of Chicago Hinds Fund; Sigma Xi; Rotary One; Southeast Chicago Rotary Club	The majority of funding was provided by the National Science Foundation (NSF; www.nsf.gov) Minority Postdoctoral Fellowship, Doctoral Dissertation Improvement Grant, Dissertation Enhancement Grant, Graduate Research Fellowship, and grants: 011780, 10456110, 0452687, and 0708462. Additional funding was provided by the ARCS (Achievement Rewards for College Scientists) Foundation Chicago, (http://www.arcsfoundation.org/chicago/), The University of Chicago Hinds Fund (http://evbio.uchicago.edu/), Sigma Xi (http://www.sigmaxi.org/), Rotary One (http://www.rotaryone.org/), Southeast Chicago Rotary Club (http://www.rccse.org/), and personal funds. With the exception of the author who contributed personal funds to this research, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley HL, 2010, J ECOL, V98, P645, DOI 10.1111/j.1365-2745.2010.01650.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Castilla J. C., 1987, ISLAS OCEANICAS CHIL, P15; Colwell RK, 2013, ESTIMATES STAT ESTIM; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; Greimler Josef, 2002, Pacific Science, V56, P263, DOI 10.1353/psc.2002.0022; Grime J. P., 2001, PLANT STRATEGIES VEG; Haberle SG, 2003, J BIOGEOGR, V30, P239, DOI 10.1046/j.1365-2699.2003.00780.x; Hulme PE, 2011, TRENDS ECOL EVOL, V26, P318, DOI 10.1016/j.tree.2011.03.018; ILES TC, 1994, NETH J SEA RES, V32, P399, DOI 10.1016/0077-7579(94)90017-5; Lamarque LJ, 2011, BIOL INVASIONS, V13, P1969, DOI 10.1007/s10530-011-0015-x; Lande R., 2003, OXFORD SERIES ECOLOG; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.2307/176946; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGhee JD, 2008, J WILDLIFE MANAGE, V72, P196, DOI 10.2193/2006-484; Meiners SJ, 2007, ECOLOGY, V88, P1098, DOI 10.1890/06-1505; Nelis LC, 2012, OECOLOGIA, DOI [10.1007/s00442-00012-02265-00444, DOI 10.1007/S00442-00012-02265-00444]; Nelis LC, 2008, THESIS U CHICAGO CHI; Nelis LC, 2010, P R SOC B, V277, P539, DOI 10.1098/rspb.2009.1564; Poulsen JR, 2007, AM NAT, V170, P167, DOI 10.1086/518945; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Skottsberg C, 1920, NATURAL HIST J FERNA, DOI 10.5962/bhl.title.41367; Thompson K, 2011, TRENDS ECOL EVOL, V26, P319, DOI 10.1016/j.tree.2011.03.020; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; van Kleunen M, 2011, TRENDS ECOL EVOL, V26, P317, DOI 10.1016/j.tree.2011.03.019; Zunino S, 1989, MUSEO NATURAL HIST N, V316, P8	26	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42906	10.1371/journal.pone.0042906	http://dx.doi.org/10.1371/journal.pone.0042906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916178	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800035
J	Pan, QF; Wang, Q; Yuan, F; Xing, SH; Zhao, JY; Choi, YH; Verpoorte, R; Tian, YS; Wang, GF; Tang, KX				Pan, Qifang; Wang, Quan; Yuan, Fang; Xing, Shihai; Zhao, Jingya; Choi, Young Hae; Verpoorte, Robert; Tian, Yuesheng; Wang, Guofeng; Tang, Kexuan			Overexpression of ORCA3 and G10H in Catharanthus roseus Plants Regulated Alkaloid Biosynthesis and Metabolism Revealed by NMR-Metabolomics	PLOS ONE			English	Article							STRICTOSIDINE SYNTHASE; CELL-CULTURES; HAIRY ROOTS; GERANIOL 10-HYDROXYLASE; MULTIVARIATE-ANALYSIS; H-1-NMR SPECTROSCOPY; PHENOLIC-COMPOUNDS; TISSUE-CULTURES; EXPRESSION; PATHWAY	In order to improve the production of the anticancer dimeric indole alkaloids in Catharanthuse roseus, much research has been dedicated to culturing cell lines, hairy roots, and efforts to elucidate the regulation of the monoterpenoid indole alkaloid (MIA) biosynthesis. In this study, the ORCA3 (Octadecanoid-derivative Responsive Catharanthus AP2-domain) gene alone or integrated with the G10H (geraniol 10-hydroxylase) gene were first introduced into C. roseus plants. Transgenic C. roseus plants overexpressing ORCA3 alone (OR lines), or co-overexpressing G10H and ORCA3 (GO lines) were obtained by genetic modification. ORCA3 overexpression induced an increase of AS, TDC, STR and D4H transcripts but did not affect CRMYC2 and G10H transcription. G10H transcripts showed a significant increase under G10H and ORCA3 co-overexpression. ORCA3 and G10H overexpression significantly increased the accumulation of strictosidine, vindoline, catharanthine and ajmalicine but had limited effects on anhydrovinblastine and vinblastine levels. NMR-based metabolomics confirmed the higher accumulation of monomeric indole alkaloids in OR and GO lines. Multivariate data analysis of H-1 NMR spectra showed change of amino acid, organic acid, sugar and phenylpropanoid levels in both OR and GO lines compared to the controls. The result indicated that enhancement of MIA biosynthesis by ORCA3 and G10H overexpression might affect other metabolic pathways in the plant metabolism of C. roseus.	[Pan, Qifang; Wang, Quan; Yuan, Fang; Xing, Shihai; Zhao, Jingya; Tian, Yuesheng; Wang, Guofeng; Tang, Kexuan] Shanghai Jiao Tong Univ, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, SJTU Cornell Inst Sustainable Agr & Biotechnol, Plant Biotechnol Res Ctr,Sch Agr & Biol, Shanghai 200030, Peoples R China; [Pan, Qifang; Choi, Young Hae; Verpoorte, Robert] Leiden Univ, Nat Prod Lab, Inst Biol Leiden, Leiden, Netherlands	Shanghai Jiao Tong University; Leiden University; Leiden University - Excl LUMC	Pan, QF (corresponding author), Shanghai Jiao Tong Univ, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, SJTU Cornell Inst Sustainable Agr & Biotechnol, Plant Biotechnol Res Ctr,Sch Agr & Biol, Shanghai 200030, Peoples R China.	kxtang1@yahoo.com	Choi, Young Hae/O-7886-2016; Verpoorte, Robert/Y-4363-2019; Tang, Kexuan/E-3555-2013	Choi, Young Hae/0000-0003-1484-1700; Tang, Kexuan/0000-0002-8748-9624; Verpoorte, Robert/0000-0001-6180-1424	China National High-Tech "863" Program [2011AA100605]; Shanghai Science and Technology Committee [08391911800]; Shanghai Leading Academic Discipline Project [B209]	China National High-Tech "863" Program(National High Technology Research and Development Program of China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was funded by China National High-Tech "863" Program (grant number 2011AA100605), Shanghai Science and Technology Committee (grant number 08391911800), and Shanghai Leading Academic Discipline Project (project number B209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi BH, 2007, PLANT CELL REP, V26, P1367, DOI 10.1007/s00299-007-0344-5; [Anonymous], 1997, ALAKLOIDS; Burlat V, 2004, PLANT J, V38, P131, DOI 10.1111/j.1365-313X.2004.02030.x; Canel C, 1998, PLANTA, V205, P414, DOI 10.1007/s004250050338; Charlton A, 2004, PLANT BIOTECHNOL J, V2, P27, DOI 10.1046/j.1467-7652.2003.00045.x; Choi HK, 2004, PHYTOCHEMISTRY, V65, P857, DOI 10.1016/j.phytochem.2004.01.019; Choi YH, 2004, PLANT PHYSIOL, V135, P2398, DOI 10.1104/pp.104.041012; Choi YH, 2006, J NAT PROD, V69, P742, DOI 10.1021/np050535b; Chung IM, 2007, BIOTECHNOL PROGR, V23, P327, DOI 10.1021/bp060258e; Collu G, 2001, FEBS LETT, V508, P215, DOI 10.1016/S0014-5793(01)03045-9; El-Sayed Magdi, 2007, Phytochemistry Reviews, V6, P277, DOI 10.1007/s11101-006-9047-8; Guirimand G, 2009, PLANT CELL REP, V28, P1215, DOI 10.1007/s00299-009-0722-2; Hisiger Steve, 2007, Phytochemistry Reviews, V6, P207, DOI 10.1007/s11101-006-9036-y; Hoekenga Owen A, 2008, J Biomol Tech, V19, P159; Hughes EH, 2004, BIOTECHNOL BIOENG, V86, P718, DOI 10.1002/bit.20081; Jaggi M, 2011, APPL MICROBIOL BIOT, V90, P1005, DOI 10.1007/s00253-011-3131-8; Kim HK, 2010, PHYTOCHEMISTRY, V71, P773, DOI 10.1016/j.phytochem.2010.02.001; Kumar S, 2012, PROTOPLASMA, V249, P423, DOI 10.1007/s00709-011-0294-1; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Liu DH, 2011, AFR J BIOTECHNOL, V10, P3260; Magnotta M, 2007, PHYTOCHEMISTRY, V68, P1922, DOI 10.1016/j.phytochem.2007.04.037; Mahroug S, 2006, PLANTA, V223, P1191, DOI 10.1007/s00425-005-0167-y; Mattoo AK, 2006, PLANT PHYSIOL, V142, P1759, DOI 10.1104/pp.106.084400; MORENO PRH, 1995, PLANT CELL TISS ORG, V42, P1, DOI 10.1007/BF00037677; Murata J, 2005, PLANT J, V44, P581, DOI 10.1111/j.1365-313X.2005.02557.x; Murata J, 2008, PLANT CELL, V20, P524, DOI 10.1105/tpc.107.056630; Mustafa Natali Rianika, 2007, Phytochemistry Reviews, V6, P243, DOI 10.1007/s11101-006-9039-8; Noteborn HPJM, 2000, J BIOTECHNOL, V77, P103, DOI 10.1016/S0168-1656(99)00210-2; OKeefe BR, 1997, J NAT PROD, V60, P261, DOI 10.1021/np960703n; Oudin Audrey, 2007, Phytochemistry Reviews, V6, P259, DOI 10.1007/s11101-006-9054-9; Pan QF, 2010, PLANT GROWTH REGUL, V60, P133, DOI 10.1007/s10725-009-9429-1; Pauw B, 2004, J BIOL CHEM, V279, P52940, DOI 10.1074/jbc.M404391200; Pearce HL, 2005, ADV ENZYME REGUL, V45, P229, DOI 10.1016/j.advenzreg.2005.02.017; Peebles CAM, 2011, METAB ENG, V13, P234, DOI 10.1016/j.ymben.2010.11.005; Peebles CAM, 2009, METAB ENG, V11, P76, DOI 10.1016/j.ymben.2008.09.002; Pomahacova B, 2009, J PLANT PHYSIOL, V166, P1405, DOI 10.1016/j.jplph.2009.02.015; Ren YF, 2009, J GENET GENOMICS, V36, P621, DOI 10.1016/S1673-8527(08)60154-X; ROTHSTEIN SJ, 1987, P NATL ACAD SCI USA, V84, P8439, DOI 10.1073/pnas.84.23.8439; Roytrakul Sittiruk, 2007, Phytochemistry Reviews, V6, P383, DOI 10.1007/s11101-006-9022-4; Siberil Y, 2001, PLANT MOL BIOL, V45, P477, DOI 10.1023/A:1010650906695; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; Suttipanta N, 2007, BBA-GENE STRUCT EXPR, V1769, P139, DOI 10.1016/j.bbaexp.2007.01.006; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Heijden R, 2004, CURR MED CHEM, V11, P607; VANDERHEIJDEN R, 1989, PLANT CELL TISS ORG, V18, P231, DOI 10.1007/BF00043397; VANDERKROL AR, 1988, NATURE, V333, P866, DOI 10.1038/333866a0; Wang CT, 2010, PLANT CELL REP, V29, P887, DOI 10.1007/s00299-010-0874-0; Wang Q, 2010, PLANT CELL REP, V29, P185, DOI 10.1007/s00299-009-0811-2; Ward JL, 2003, PHYTOCHEMISTRY, V62, P949, DOI 10.1016/S0031-9422(02)00705-7; Whitmer S, 2002, PLANT CELL TISS ORG, V69, P85, DOI 10.1023/A:1015090224398; Xu MJ, 2007, SCI CHINA SER C, V50, P234, DOI 10.1007/s11427-007-0030-4; Yang SO, 2009, BIOSCI BIOTECH BIOCH, V73, P2032, DOI 10.1271/bbb.90240; Zarate Rafael, 2007, Phytochemistry Reviews, V6, P475, DOI 10.1007/s11101-006-9020-6; Zhang HT, 2011, PLANT J, V67, P61, DOI 10.1111/j.1365-313X.2011.04575.x; Zhao Jian, 2007, Phytochemistry Reviews, V6, P435, DOI 10.1007/s11101-006-9050-0; Zhou ML, 2011, APPL MICROBIOL BIOT, V90, P1229, DOI 10.1007/s00253-011-3228-0; Zhou ML, 2010, APPL MICROBIOL BIOT, V88, P737, DOI 10.1007/s00253-010-2822-x	57	74	86	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43038	10.1371/journal.pone.0043038	http://dx.doi.org/10.1371/journal.pone.0043038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916202	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800044
J	Aljakna, A; Choi, S; Savage, H; Blair, RH; Gu, TJ; Svenson, KL; Churchill, GA; Hibbs, M; Korstanje, R				Aljakna, Aleksandra; Choi, Seungbum; Savage, Holly; Blair, Rachael Hageman; Gu, Tongjun; Svenson, Karen L.; Churchill, Gary A.; Hibbs, Matt; Korstanje, Ron			Pla2g12b and Hpn Are Genes Identified by Mouse ENU Mutagenesis That Affect HDL Cholesterol	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TRANSMEMBRANE SERINE-PROTEASE; CARDIOVASCULAR-DISEASE; MICE DEFICIENT; HEPSIN; METABOLISM; PHYSIOLOGY; EXPRESSION; VARIANCE; LIVER	Despite considerable progress understanding genes that affect the HDL particle, its function, and cholesterol content, genes identified to date explain only a small percentage of the genetic variation. We used N-ethyl-N-nitrosourea mutagenesis in mice to discover novel genes that affect HDL cholesterol levels. Two mutant lines (Hlb218 and Hlb320) with low HDL cholesterol levels were established. Causal mutations in these lines were mapped using linkage analysis: for line Hlb218 within a 12 Mbp region on Chr 10; and for line Hlb320 within a 21 Mbp region on Chr 7. High-throughput sequencing of Hlb218 liver RNA identified a mutation in Pla2g12b. The transition of G to A leads to a cysteine to tyrosine change and most likely causes a loss of a disulfide bridge. Microarray analysis of Hlb320 liver RNA showed a 7-fold downregulation of Hpn; sequencing identified a mutation in the 3' splice site of exon 8. Northern blot confirmed lower mRNA expression level in Hlb320 and did not show a difference in splicing, suggesting that the mutation only affects the splicing rate. In addition to affecting HDL cholesterol, the mutated genes also lead to reduction in serum non-HDL cholesterol and triglyceride levels. Despite low HDL cholesterol levels, the mice from both mutant lines show similar atherosclerotic lesion sizes compared to control mice. These new mutant mouse models are valuable tools to further study the role of these genes, their affect on HDL cholesterol levels, and metabolism.	[Aljakna, Aleksandra; Choi, Seungbum; Savage, Holly; Blair, Rachael Hageman; Gu, Tongjun; Svenson, Karen L.; Churchill, Gary A.; Hibbs, Matt; Korstanje, Ron] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Aljakna, A (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	ron.korstanje@jax.org	Khan, Aleksandra Aljakna/AAJ-5913-2021; Churchill, Gary/AAY-7496-2020; Gu, Tongjun/AAE-4801-2020	Khan, Aleksandra Aljakna/0000-0002-9652-740X; Churchill, Gary/0000-0001-9190-9284; 	National Institute of General Medical Sciences [GM076468]; National Heart, Lung, and Blood Institute [HL095668]; American Recovery and Reinvestment Act (ARRA); National Research Service Award (NSRA) fellowship [1F32 HL095240]; National Cancer Institute [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095240, R01HL095668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Recovery and Reinvestment Act (ARRA); National Research Service Award (NSRA) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (grant GM076468 to AA, RK and GC); the National Heart, Lung, and Blood Institute (grant HL095668 and an American Recovery and Reinvestment Act (ARRA) supplement to RK and a National Research Service Award (NSRA) fellowship 1F32 HL095240 to RHB); and by the National Cancer Institute Cancer Core (grant CA034196 to the Jackson Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI M, 1987, CELL, V50, P237, DOI 10.1016/0092-8674(87)90219-4; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Fafalios A, 2011, NAT MED, V17, P1577, DOI 10.1038/nm.2531; Farmer JA, 2011, CURR ATHEROSCLER REP, V13, P107, DOI 10.1007/s11883-011-0166-3; Ferre F, 2005, BIOINFORMATICS, V21, P2336, DOI 10.1093/bioinformatics/bti328; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Gross DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010796; Guan M, 2011, HEPATOLOGY, V53, P458, DOI 10.1002/hep.24066; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hooper AJ, 2011, J LIPID RES, V52, P593, DOI 10.1194/jlr.R008896; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; KURACHI K, 1994, METHOD ENZYMOL, V244, P100; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1067, DOI 10.1021/bi00403a032; Liden M, 2003, MOL ASPECTS MED, V24, P403, DOI 10.1016/S0098-2997(03)00036-0; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; NISHINA PM, 1990, J LIPID RES, V31, P859; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Ragbir S, 2010, CURR ATHEROSCLER REP, V12, P343, DOI 10.1007/s11883-010-0091-x; Ralph SJ, 2010, MOL ASPECTS MED, V31, P29, DOI 10.1016/j.mam.2009.12.006; Rouault M, 2003, BIOCHEMISTRY-US, V42, P11494, DOI 10.1021/bi0349930; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Strong A, 2010, CURR CARDIOVASC RISK, V4, P461, DOI 10.1007/s12170-010-0131-7; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; TORRESROSADO A, 1993, P NATL ACAD SCI USA, V90, P7181, DOI 10.1073/pnas.90.15.7181; Toth Peter P, 2007, Curr Atheroscler Rep, V9, P81, DOI 10.1007/BF02693933; TSUJI A, 1991, J BIOL CHEM, V266, P16948; Wang Chun, 2010, Front Biosci (Schol Ed), V2, P515; Ward JR, 2009, CLIN EXP IMMUNOL, V156, P386, DOI 10.1111/j.1365-2249.2009.03886.x; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Wu QY, 1998, J CLIN INVEST, V101, P321, DOI 10.1172/JCI1617	66	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43139	10.1371/journal.pone.0043139	http://dx.doi.org/10.1371/journal.pone.0043139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912808	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700047
J	Fatouros, NE; Lucas-Barbosa, D; Weldegergis, BT; Pashalidou, FG; van Loon, JJA; Dicke, M; Harvey, JA; Gols, R; Huigens, ME				Fatouros, Nina E.; Lucas-Barbosa, Dani; Weldegergis, Berhane T.; Pashalidou, Foteini G.; van Loon, Joop J. A.; Dicke, Marcel; Harvey, Jeffrey A.; Gols, Rieta; Huigens, Martinus E.			Plant Volatiles Induced by Herbivore Egg Deposition Affect Insects of Different Trophic Levels	PLOS ONE			English	Article							ELM LEAF BEETLE; WHITEBACKED PLANTHOPPER; COTESIA-GLOMERATA; PIERIS-BRASSICAE; RICE PLANTS; OVIPOSITION; DEFENSE; RESPONSES; CUES; PARASITOIDS	Plants release volatiles induced by herbivore feeding that may affect the diversity and composition of plant-associated arthropod communities. However, the specificity and role of plant volatiles induced during the early phase of attack, i.e. egg deposition by herbivorous insects, and their consequences on insects of different trophic levels remain poorly explored. In olfactometer and wind tunnel set-ups, we investigated behavioural responses of a specialist cabbage butterfly (Pieris brassicae) and two of its parasitic wasps (Trichogramma brassicae and Cotesia glomerata) to volatiles of a wild crucifer (Brassica nigra) induced by oviposition of the specialist butterfly and an additional generalist moth (Mamestra brassicae). Gravid butterflies were repelled by volatiles from plants induced by cabbage white butterfly eggs, probably as a means of avoiding competition, whereas both parasitic wasp species were attracted. In contrast, volatiles from plants induced by eggs of the generalist moth did neither repel nor attract any of the tested community members. Analysis of the plant's volatile metabolomic profile by gas chromatography-mass spectrometry and the structure of the plant-egg interface by scanning electron microscopy confirmed that the plant responds differently to egg deposition by the two lepidopteran species. Our findings imply that prior to actual feeding damage, egg deposition can induce specific plant responses that significantly influence various members of higher trophic levels.	[Fatouros, Nina E.; Lucas-Barbosa, Dani; Weldegergis, Berhane T.; Pashalidou, Foteini G.; van Loon, Joop J. A.; Dicke, Marcel; Gols, Rieta; Huigens, Martinus E.] Wageningen Univ, Entomol Lab, Res Ctr, Wageningen, Netherlands; [Harvey, Jeffrey A.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Huigens, Martinus E.] Dutch Butterfly Conservat, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Fatouros, NE (corresponding author), Wageningen Univ, Entomol Lab, Res Ctr, Wageningen, Netherlands.	nina.fatouros@wur.nl	Pashalidou, Foteini/Y-3913-2019; gols, rieta/H-7291-2019; Weldegergis, Berhane/F-6961-2012; Lucas-Barbosa, Dani/AAD-8133-2020; Harvey, Jeffrey A/B-7439-2008; Fatouros, Nina/AAO-9698-2020; Dicke, Marcel/B-2300-2010; KNAW, NIOO-KNAW/A-4320-2012; van Loon, Joop J.A./B-3744-2009	Harvey, Jeffrey A/0000-0002-4227-7935; Fatouros, Nina/0000-0003-0841-3144; Dicke, Marcel/0000-0001-8565-8896; Weldegergis, Berhane T./0000-0001-8838-7876; Gols, Rieta/0000-0002-6839-8225; KNAW, NIOO-KNAW/0000-0002-3835-159X; Paschalidou, Foteini/0000-0001-5746-8227; van Loon, Joop J.A./0000-0002-4260-0501	Netherlands Organisation for Scientific Research (NWO/ALW VENI) [863.05.020, 863.09.002]	Netherlands Organisation for Scientific Research (NWO/ALW VENI)(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organisation for Scientific Research (NWO/ALW VENI grants 863.05.020 to Dr. Huigens and 863.09.002 to Dr. Fatouros) is acknowledged for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbyshev NF, 1997, J ECON ENTOMOL, V90, P652, DOI 10.1093/jee/90.2.652; BEAMENT J. W. L., 1957, BULL ENT RES, V48, P109, DOI 10.1017/S0007485300054134; Beyaert I., 2011, P ROY SOC LOND B BIO, V279, P101; Blenn B, 2012, J CHEM ECOL, DOI [10.1007/s10886-10012-10132-10888, DOI 10.1007/S10886-10012-10132-10888]; Bruce TJA, 2010, BIOL LETTERS, V6, P314, DOI 10.1098/rsbl.2009.0953; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; Bruessow F, 2007, PLANT SIGNAL BEHAV, V2, P165, DOI 10.4161/psb.2.3.3690; Colazza S, 2004, J CHEM ECOL, V30, P945, DOI 10.1023/B:JOEC.0000028460.70584.d1; Colazza S, 2004, J EXP BIOL, V207, P47, DOI 10.1242/jeb.00732; Colazza S, 2010, PROG BIOL CONTROL, V9, P97, DOI 10.1007/978-1-4020-9110-0_4; Conti E, 2010, J EXP BIOL, V213, P3911, DOI 10.1242/jeb.045922; Conti E, 2008, EUR J ENTOMOL, V105, P839, DOI 10.14411/eje.2008.111; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Desurmont GA, 2011, ECOL ENTOMOL, V36, P335, DOI 10.1111/j.1365-2311.2011.01277.x; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Doss RP, 2000, P NATL ACAD SCI USA, V97, P6218, DOI 10.1073/pnas.110054697; DOSS RP, 1995, J CHEM ECOL, V21, P97, DOI 10.1007/BF02033665; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Eriksson L, 2006, MULTI AND MEGAVARI 1; Fatouros NE, 2005, ENTOMOL EXP APPL, V115, P207, DOI 10.1111/j.1570-7458.2005.00245.x; Fatouros NE, 2008, P NATL ACAD SCI USA, V105, P10033, DOI 10.1073/pnas.0707809105; Fatouros NE, 2009, J CHEM ECOL, V35, P1373, DOI 10.1007/s10886-009-9714-5; Penaflor MFGV, 2011, PLANTA, V234, P207, DOI 10.1007/s00425-011-1409-9; Figueroa IA, 2010, ATTRACTION TRICHOGRA; GEERVLIET JBF, 1994, ENTOMOL EXP APPL, V73, P289, DOI 10.1007/BF02382480; Geervliet JBF, 1996, J INSECT BEHAV, V9, P525, DOI 10.1007/BF02213877; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6; Gols R, 2009, OIKOS, V118, P733, DOI 10.1111/j.1600-0706.2008.17231.x; Gorb S., 2001, ATTACHMENT DEVICES I; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Harvey JA, 2000, ECOL ENTOMOL, V25, P267, DOI 10.1046/j.1365-2311.2000.00265.x; Harvey JA, 2011, J CHEM ECOL, V37, P1081, DOI 10.1007/s10886-011-0024-3; Harvey JA, 2011, POPUL ECOL, V53, P587, DOI 10.1007/s10144-011-0267-4; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hilker M, 2002, J EXP BIOL, V205, P455; Hilker M, 2011, PHYTOCHEMISTRY, V72, P1612, DOI 10.1016/j.phytochem.2011.02.018; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Hilker M, 2006, J CHEM ECOL, V32, P1379, DOI 10.1007/s10886-006-9057-4; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2007, CURR OPIN PLANT BIOL, V10, P409, DOI 10.1016/j.pbi.2007.06.001; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037420; Little D, 2007, PLANT PHYSIOL, V143, P784, DOI 10.1104/pp.106.090837; Lucas-Barbosa D, 2012, FUNCT ECOL IN PRESS; MATTIACCI L, 1995, J INSECT BEHAV, V8, P485, DOI 10.1007/BF01995321; Meiners T, 2005, ENTOMOL EXP APPL, V115, P171, DOI 10.1111/j.1570-7458.2005.00280.x; Meiners T, 1997, OECOLOGIA, V112, P87, DOI 10.1007/s004420050287; Meiners T, 2000, J CHEM ECOL, V26, P221, DOI 10.1023/A:1005453830961; Mumm R, 2005, ENTOMOL EXP APPL, V115, P217, DOI 10.1111/j.1570-7458.2005.00262.x; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; NOLDUS LPJJ, 1991, PHYSIOL ENTOMOL, V16, P329, DOI 10.1111/j.1365-3032.1991.tb00571.x; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pashalidou FG, 2010, ECOL ENTOMOL, V35, P748, DOI 10.1111/j.1365-2311.2010.01235.x; Petzold-Maxwell J, 2011, ECOL ENTOMOL, V36, P700, DOI 10.1111/j.1365-2311.2011.01315.x; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; Poelman EH, 2008, TRENDS PLANT SCI, V13, P534, DOI 10.1016/j.tplants.2008.08.003; Poelman EH, 2008, ENTOMOL EXP APPL, V127, P218, DOI 10.1111/j.1570-7458.2008.00700.x; Polaszek A, 2010, PROG BIOL CONTROL, V9, P237, DOI 10.1007/978-1-4020-9110-0_9; Schoonhoven L. M., 2005, Insect-plant biology; Schroder R, 2005, PLANT PHYSIOL, V138, P470, DOI 10.1104/pp.105.059915; Seino Y, 1996, APPL ENTOMOL ZOOL, V31, P467, DOI 10.1303/aez.31.467; SHAPIRO AM, 1987, OECOLOGIA, V71, P631, DOI 10.1007/BF00379310; Smallegange RC, 2007, J CHEM ECOL, V33, P1831, DOI 10.1007/s10886-007-9350-x; Suzuki Y, 1996, APPL ENTOMOL ZOOL, V31, P111, DOI 10.1303/aez.31.111; Tamiru A, 2012, J CHEM ECOL, V38, P231, DOI 10.1007/s10886-012-0082-1; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Turlings TCJ, 2004, PHYSIOL ENTOMOL, V29, P45, DOI 10.1111/j.1365-3032.2004.0362.x; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Velikova V, 2010, J CHEM ECOL, V36, P629, DOI 10.1007/s10886-010-9801-7	73	110	116	0	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43607	10.1371/journal.pone.0043607	http://dx.doi.org/10.1371/journal.pone.0043607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912893	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700121
J	Franck, P; Siegwart, M; Olivares, J; Toubon, JF; Lavigne, C				Franck, Pierre; Siegwart, Myriam; Olivares, Jerome; Toubon, Jean-Francois; Lavigne, Claire			Multiple Origins of the Sodium Channel kdr Mutations in Codling Moth Populations	PLOS ONE			English	Article							INSECTICIDE RESISTANCE MECHANISMS; CYDIA-POMONELLA LEPIDOPTERA; AZINPHOS-METHYL RESISTANCE; IN-HOUSE FLIES; PYRETHROID RESISTANCE; KNOCKDOWN RESISTANCE; DELTAMETHRIN RESISTANCE; EVOLUTIONARY GENETICS; L. LEPIDOPTERA; TORTRICIDAE	Resistance to insecticides is one interesting example of a rapid current evolutionary change. DNA variability in the voltage-gated sodium channel gene (trans-membrane segments 5 and 6 in domain II) was investigated in order to estimate resistance evolution to pyrethroid in codling moth populations at the World level. DNA variation among 38 sequences revealed a unique kdr mutation (L1014F) involved in pyrethroid resistance in this gene region, which likely resulted from several convergent substitutions. The analysis of codling moth samples from 52 apple orchards in 19 countries using a simple PCR-RFLP confirmed that this kdr mutation is almost worldwide distributed. The proportions of kdr mutation were negatively correlated with the annual temperatures in the sampled regions. Homozygous kdr genotypes in the French apple orchards showed lower P450 cytochrome oxidase activities than other genotypes. The most plausible interpretation of the geographic distribution of kdr in codling moth populations is that it has both multiple independent origins and a spreading limited by low temperature and negative interaction with the presence of alternative resistance mechanisms to pyrethroid in the populations.	[Franck, Pierre; Siegwart, Myriam; Olivares, Jerome; Toubon, Jean-Francois; Lavigne, Claire] INRA, Plantes & Syst Culture Hort UR1115, Avignon, France	INRAE	Franck, P (corresponding author), INRA, Plantes & Syst Culture Hort UR1115, Avignon, France.	Pierre.Franck@avignon.inra.fr		Lavigne, Claire/0000-0003-2869-5177; Franck, Pierre/0000-0002-1904-8325	French program ECOGER "Ecco des vergers"	French program ECOGER "Ecco des vergers"	This study was partially funded by the French program ECOGER "Ecco des vergers". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alon M, 2006, INSECT BIOCHEM MOLEC, V36, P71, DOI 10.1016/j.ibmb.2005.10.007; Anstead JA, 2005, INSECT BIOCHEM MOLEC, V35, P249, DOI 10.1016/j.ibmb.2004.12.004; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Boivin T, 2001, ENTOMOL EXP APPL, V99, P381, DOI 10.1023/A:1019232611880; Bouvier JC, 1998, ARCH INSECT BIOCHEM, V39, P55, DOI 10.1002/(SICI)1520-6327(1998)39:2&lt;55::AID-ARCH2&gt;3.0.CO;2-1; Bouvier JC, 2001, HEREDITY, V87, P456, DOI 10.1046/j.1365-2540.2001.00928.x; Brooke BD, 2008, T ROY SOC TROP MED H, V102, P524, DOI 10.1016/j.trstmh.2008.01.001; Brun-Barale A, 2005, PEST MANAG SCI, V61, P549, DOI 10.1002/ps.1002; Cao XM, 2006, ENVIRON ENTOMOL, V35, P1, DOI 10.1603/0046-225X-35.1.1; Davies TGE, 2008, PEST MANAG SCI, V64, P1126, DOI 10.1002/ps.1617; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; DESOUSA G, 1995, ANAL BIOCHEM, V229, P86, DOI 10.1006/abio.1995.1382; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; Franck P, 2010, J APPL ENTOMOL, V134, P191, DOI 10.1111/j.1439-0418.2009.01426.x; Fuentes-Contreras E, 2007, J ECON ENTOMOL, V100, P551, DOI 10.1603/0022-0493(2007)100[551:EOARAA]2.0.CO;2; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guerrero FD, 2002, J MED ENTOMOL, V39, P747, DOI 10.1603/0022-2585-39.5.747; Guillemaud T, 1996, HEREDITY, V77, P535, DOI 10.1038/hdy.1996.181; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Jamroz RC, 1998, INSECT BIOCHEM MOLEC, V28, P1031, DOI 10.1016/S0965-1748(98)00094-0; Joly E, 1996, Methods Mol Biol, V58, P237; Kwon DH, 2004, PESTIC BIOCHEM PHYS, V80, P21, DOI 10.1016/j.pestbp.2004.06.001; Labbe P, 2005, J EVOLUTION BIOL, V18, P1471, DOI 10.1111/j.1420-9101.2005.00938.x; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Meraner A, 2008, MOL PHYLOGENET EVOL, V48, P825, DOI 10.1016/j.ympev.2008.05.026; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Park Y, 1997, INSECT BIOCHEM MOLEC, V27, P9, DOI 10.1016/S0965-1748(96)00077-X; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Reuveny H, 2004, ARCH INSECT BIOCHEM, V57, P92, DOI 10.1002/arch.20016; Reyes M, 2009, B ENTOMOL RES, V99, P359, DOI 10.1017/S0007485308006366; Reyes M, 2007, PEST MANAG SCI, V63, P890, DOI 10.1002/ps.1421; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; Ricci B, 2009, LANDSCAPE ECOL, V24, P337, DOI 10.1007/s10980-008-9308-6; Rinkevich FD, 2006, INSECT MOL BIOL, V15, P157, DOI 10.1111/j.1365-2583.2006.00620.x; Rinkevich FD, 2007, INSECT BIOCHEM MOLEC, V37, P550, DOI 10.1016/j.ibmb.2007.02.013; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sauphanor B, 1998, ENTOMOL EXP APPL, V88, P247, DOI 10.1023/A:1003452216629; Sauphanor B, 1998, J ECON ENTOMOL, V91, P1225, DOI 10.1093/jee/91.6.1225; Sauphanor B, 2000, PEST MANAG SCI, V56, P74, DOI 10.1002/(SICI)1526-4998(200001)56:1<74::AID-PS96>3.0.CO;2-C; ShelDeshova G. G., 1967, ENTOMOL REV, V46, P349; SMITH JM, 1992, J MOL EVOL, V34, P126; SMITH L. C., 1955, Journal of the Department of Agriculture of South Australia, V59, P12; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Soleno J, 2008, PEST MANAG SCI, V64, P964, DOI 10.1002/ps.1582; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THWAITE WG, 1993, PEST CONTROL & SUSTAINABLE AGRICULTURE, P166; Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392; VARELA LG, 1993, J ECON ENTOMOL, V86, P1, DOI 10.1093/jee/86.1.1; Voudouris CC, 2011, PESTIC BIOCHEM PHYS, V100, P229, DOI 10.1016/j.pestbp.2011.04.006; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Williamson MS, 1996, MOL GENETICS EVOLUTI, P53; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	60	14	14	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43543	10.1371/journal.pone.0043543	http://dx.doi.org/10.1371/journal.pone.0043543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912889	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700117
J	Higuchi, T; Sakamoto, S; Kakinuma, Y; Kai, S; Yagyu, K; Todaka, H; Chi, E; Okada, S; Ujihara, T; Morisawa, K; Ono, M; Sugiyama, Y; Ishida, W; Fukushima, A; Tsuda, M; Agata, Y; Taniguchi, T				Higuchi, Takuma; Sakamoto, Shuji; Kakinuma, Yoshihiko; Kai, Shoko; Yagyu, Ken-ichi; Todaka, Hiroshi; Chi, Eunsup; Okada, Shoshiro; Ujihara, Takako; Morisawa, Keiko; Ono, Masafumi; Sugiyama, Yasunori; Ishida, Waka; Fukushima, Atsuki; Tsuda, Masayuki; Agata, Yasutoshi; Taniguchi, Taketoshi			High Expression of Nuclear Factor 90 (NF90) Leads to Mitochondrial Degradation in Skeletal and Cardiac Muscles	PLOS ONE			English	Article							MESSENGER-RNA STABILIZATION; ACTIVATED T-CELLS; BINDING-PROTEIN; NEGATIVE REGULATOR; IN-VIVO; KINASE; GENE; AUTOPHAGOSOME; BIOGENESIS; NF45	While NF90 has been known to participate in transcription, translation and microRNA biogenesis, physiological functions of this protein still remain unclear. To uncover this, we generated transgenic (Tg) mice using NF90 cDNA under the control of beta-actin promoter. The NF90 Tg mice exhibited a reduction in body weight compared with wild-type mice, and a robust expression of NF90 was detected in skeletal muscle, heart and eye of the Tg mice. To evaluate the NF90 overexpression-induced physiological changes in the tissues, we performed a number of analyses including CT-analysis and hemodynamic test, revealing that the NF90 Tg mice developed skeletal muscular atrophy and heart failure. To explore causes of the abnormalities in the NF90 Tg mice, we performed histological and biochemical analyses for the skeletal and cardiac muscles of the Tg mice. Surprisingly, these analyses demonstrated that mitochondria in those muscular tissues of the Tg mice were degenerated by autophagy. To gain further insight into the cause for the mitochondrial degeneration, we identified NF90-associated factors by peptide mass fingerprinting. Of note, approximately half of the NF90-associated complexes were ribosome-related proteins. Interestingly, protein synthesis rate was significantly suppressed by high-expression of NF90. These observations suggest that NF90 would negatively regulate the function of ribosome via its interaction with the factors involved in the ribosome function. Furthermore, we found that the translations or protein stabilities of PGC-1 and NRF-1, which are critical transcription factors for expression of mitochondrial genes, were significantly depressed in the skeletal muscles of the NF90 Tg mice. Taken together, these findings suggest that the mitochondrial degeneration engaged in the skeletal muscle atrophy and the heart failure in the NF90 Tg mice may be caused by NF90-induced posttranscriptional repression of transcription factors such as PGC-1 and NRF-1 for regulating nuclear-encoded genes relevant to mitochondrial function.	[Higuchi, Takuma; Sakamoto, Shuji; Kai, Shoko; Yagyu, Ken-ichi; Todaka, Hiroshi; Chi, Eunsup; Morisawa, Keiko; Sugiyama, Yasunori; Taniguchi, Taketoshi] Kochi Med Sch, Ctr Sci Res, Mol Biol Lab, Kochi, Japan; [Kakinuma, Yoshihiko] Kochi Med Sch, Dept Cardiovasc Control, Kochi, Japan; [Okada, Shoshiro] Aichi Med Univ, Sch Med, Dept Pharmacol, Aichi, Japan; [Ujihara, Takako] Kochi Med Sch, Ctr Sci Res, Facil Radioisotope Res, Kochi, Japan; [Ono, Masafumi] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Ishida, Waka; Fukushima, Atsuki] Kochi Med Sch, Dept Ophthalmol, Kochi, Japan; [Tsuda, Masayuki] Kochi Med Sch, Ctr Sci Res, Div Lab Anim Sci, Kochi, Japan; [Agata, Yasutoshi] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Kochi University; Kochi University; Aichi Medical University; Kochi University; Kochi University; Kochi University; Kochi University; Kyoto University	Higuchi, T (corresponding author), Kochi Med Sch, Ctr Sci Res, Mol Biol Lab, Kochi, Japan.	sshuji@kochi-u.ac.jp		Kakinuma, Yoshihiko/0000-0001-5470-9128; Agata, Yasutoshi/0000-0001-9642-6994	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21790280]; Kochi University Presidenta's Discretionary Grant	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kochi University Presidenta's Discretionary Grant	This work was supported by a Grant-in-Aid for Young Scientists (B) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (grant numbers: 21790280. URL:http://kaken.nii.ac.jp/en/p/21790280) and The Kochi University Presidenta's Discretionary Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Jin Y, 2005, ELECTROPHORESIS, V26, P1019, DOI 10.1002/elps.200410187; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KAO PN, 1994, J BIOL CHEM, V269, P20691; Kiesler P, 2010, J BIOL CHEM, V285, P8256, DOI 10.1074/jbc.M109.041004; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sakamoto S, 2001, J BIOL CHEM, V276, P37237, DOI 10.1074/jbc.M105543200; Sakamoto S, 1999, BIOCHEMISTRY-US, V38, P3355, DOI 10.1021/bi982099g; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tian B, 2001, J BIOL CHEM, V276, P9936, DOI 10.1074/jbc.M007328200; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu P, 2010, J IMMUNOL, V185, P5140, DOI 10.4049/jimmunol.1000849	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43340	10.1371/journal.pone.0043340	http://dx.doi.org/10.1371/journal.pone.0043340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912857	Green Published, gold			2022-12-27	WOS:000308063700085
J	Keller, C; Kroening, S; Zuehlke, J; Kunath, F; Krueger, B; Goppelt-Struebe, M				Keller, Christof; Kroening, Sven; Zuehlke, Jonathan; Kunath, Frank; Krueger, Bettina; Goppelt-Struebe, Margarete			Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RHO-KINASE INHIBITOR; TISSUE GROWTH-FACTOR; MUSCLE ACTIN EXPRESSION; TGF-BETA; DIABETIC-NEPHROPATHY; MYOFIBROBLAST TRANSDIFFERENTIATION; TRANSCRIPTION FACTORS; FEEDBACK LOOP; CANCER-CELLS	Background: Renal tubular epithelial cells of proximal and distal origin differ markedly in their physiological functions. Therefore, we hypothesized that they also differ in their capacity to undergo epithelial to mesenchymal alterations. Results: We used cultures of freshly isolated primary human tubular cells. To distinguish cells of different tubular origin we took advantage of the fact that human proximal epithelial cells uniquely express N-cadherin instead of E-cadherin as major cell-cell adhesion molecule. To provoke mesenchymal alteration we treated these cocultures with TGF-beta for up to 6 days. Within this time period, the morphology of distal tubular cells was barely altered. In contrast to tubular cell lines, E-cadherin was not down-regulated by TGF-beta, even though TGF-beta signal transduction was initiated as demonstrated by nuclear localization of Smad2/3. Analysis of transcription factors and miRNAs possibly involved in E-cadherin regulation revealed high levels of miRNAs of the miR200-family, which may contribute to the stability of E-cadherin expression in human distal tubular epithelial cells. By contrast, proximal tubular epithelial cells altered their phenotype when treated with TGF-beta. They became elongated and formed three-dimensional structures. Rho-kinases were identified as modulators of TGF-beta-induced morphological alterations. Non-specific inhibition of Rho-kinases resulted in stabilization of the epithelial phenotype, while partial effects were observed upon downregulation of Rho-kinase isoforms ROCK1 and ROCK2. The distinct reactivity of proximal and distal cells was retained when the cells were cultured as polarized cells. Conclusions: Interference with Rho-kinase signaling provides a target to counteract TGF-beta-mediated mesenchymal alterations of epithelial cells, particularly in proximal tubular epithelial cells. Furthermore, primary distal tubular cells differed from cell lines by their high phenotypic stability which included constant expression of E-cadherin. Our cell culture system of primary epithelial cells is thus suitable to understand and modulate cellular remodeling processes of distinct tubular cells relevant for human renal disease.	[Keller, Christof; Kroening, Sven; Zuehlke, Jonathan; Goppelt-Struebe, Margarete] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Kunath, Frank] Univ Erlangen Nurnberg, Dept Urol, D-91054 Erlangen, Germany; [Krueger, Bettina] Univ Erlangen Nurnberg, Dept Cellular & Mol Physiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Keller, C (corresponding author), Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany.	margarete.goppelt-struebe@uk-erlangen.de	Kunath, Frank/AAF-9389-2019	Kunath, Frank/0000-0003-3951-6058	Marohn Stiftung of the University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft [SFB423]	Marohn Stiftung of the University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Marohn Stiftung of the University of Erlangen-Nuremberg. CK and JZ were recipients of fellowships from the Deutsche Forschungsgemeinschaft, SFB423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bonventre JV, 1998, AM J PHYSIOL-RENAL, V275, pF623, DOI 10.1152/ajprenal.1998.275.5.F623; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Das S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-94; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Forino M, 2006, INT J EXP PATHOL, V87, P197, DOI 10.1111/j.1365-2613.2006.00479.x; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Fu P, 2006, J AM SOC NEPHROL, V17, P3105, DOI 10.1681/ASN.2005121366; Fukumoto Y, 2005, HEART, V91, P391, DOI 10.1136/hrt.2003.029470; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hills CE, 2009, AM J PHYSIOL-RENAL, V296, pF614, DOI 10.1152/ajprenal.90500.2008; Hugo HJ, 2011, CELLS TISSUES ORGANS, V193, P23, DOI 10.1159/000320174; Hutchison N, 2009, CELL SIGNAL, V21, P1522, DOI 10.1016/j.cellsig.2009.05.012; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Jiang J, 2004, TOXICOL SCI, V80, P170, DOI 10.1093/toxsci/kfh143; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Komers R, 2011, CURR OPIN NEPHROL HY, V20, P77, DOI 10.1097/MNH.0b013e32834131f8; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kroening S, 2010, J CELL PHYSIOL, V223, P703, DOI 10.1002/jcp.22079; Kroening S, 2010, AM J PHYSIOL-RENAL, V298, pF796, DOI 10.1152/ajprenal.00528.2009; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P3319, DOI 10.1093/ndt/gfp305; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nishikimi T, 2006, J PHARMACOL SCI, V100, P22, DOI 10.1254/jphs.FMJ05003X5; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Park JW, 2011, J PHARMACOL EXP THER, V338, P271, DOI 10.1124/jpet.111.179457; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Ruperez M, 2005, KIDNEY INT, V68, P39; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Satoh S, 2002, EUR J PHARMACOL, V455, P169, DOI 10.1016/S0014-2999(02)02619-5; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Seidel B, 2004, ONCOGENE, V23, P5532, DOI 10.1038/sj.onc.1207718; Shimazui T, 2006, ONCOL REP, V15, P1181; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian YC, 2003, AM J PHYSIOL-RENAL, V285, pF130, DOI 10.1152/ajprenal.00408.2002; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Zhang C, 2004, LIFE SCI, V75, P367, DOI 10.1016/j.lfs.2004.02.005; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	60	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43584	10.1371/journal.pone.0043584	http://dx.doi.org/10.1371/journal.pone.0043584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912891	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700119
J	Lu, D; Davis, MPA; Abreu-Goodger, C; Wang, W; Campos, LS; Siede, J; Vigorito, E; Skarnes, WC; Dunham, I; Enright, AJ; Liu, PT				Lu, Dong; Davis, Matthew P. A.; Abreu-Goodger, Cei; Wang, Wei; Campos, Lia S.; Siede, Julia; Vigorito, Elena; Skarnes, William C.; Dunham, Ian; Enright, Anton J.; Liu, Pentao			MiR-25 Regulates Wwp2 and Fbxw7 and Promotes Reprogramming of Mouse Fibroblast Cells to iPSCs	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; TUMOR-SUPPRESSOR; SELF-RENEWAL; MICRORNA BIOGENESIS; RNA INTERFERENCE; UBIQUITIN LIGASE; GENERATION; EXPRESSION; ADULT	Background: miRNAs are a class of small non-coding RNAs that regulate gene expression and have critical functions in various biological processes. Hundreds of miRNAs have been identified in mammalian genomes but only a small number of them have been functionally characterized. Recent studies also demonstrate that some miRNAs have important roles in reprogramming somatic cells to induced pluripotent stem cells (iPSCs). Methods: We screened 52 miRNAs cloned in a piggybac (PB) vector for their roles in reprogramming of mouse embryonic fibroblast cells to iPSCs. To identify targets of miRNAs, we made Dgcr8-deficient embryonic stem (ES) cells and introduced miRNA mimics to these cells, which lack miRNA biogenesis. The direct target genes of miRNA were identified through global gene expression analysis and target validation. Results and conclusion: We found that over-expressing miR-25 or introducing miR-25 mimics enhanced production of iPSCs. We identified a number of miR-25 candidate gene targets. Of particular interest were two ubiquitin ligases, Wwp2 and Fbxw7, which have been proposed to regulate Oct4, c-Myc and Klf5, respectively. Our findings thus highlight the complex interplay between miRNAs and transcription factors involved in reprogramming, stem cell self-renewal and maintenance of pluripotency.	[Lu, Dong; Davis, Matthew P. A.; Wang, Wei; Campos, Lia S.; Skarnes, William C.; Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge, England; [Davis, Matthew P. A.; Abreu-Goodger, Cei; Dunham, Ian; Enright, Anton J.] European Bioinformat Inst, Cambridge, England; [Siede, Julia; Vigorito, Elena] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Lu, D (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	pl2@sanger.ac.uk	Enright, Anton/F-3094-2011; Abreu-Goodger, Cei/A-1268-2010	Enright, Anton/0000-0002-6090-3100; Abreu-Goodger, Cei/0000-0001-8302-9893; Dunham, Ian/0000-0003-2525-5598; Davis, Matthew/0000-0002-9909-3651	Wellcome Trust [077186/Z/05/Z]; MRC [G0700287, G1001781] Funding Source: UKRI; Medical Research Council [G1001781, G0700287] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by The Wellcome Trust (077186/Z/05/Z; www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Anton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026257; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu N, 2010, J BIOL CHEM; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang HY, 2012, ONCOL REP, V27, P594, DOI 10.3892/or.2011.1530; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	84	53	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e40938	10.1371/journal.pone.0040938	http://dx.doi.org/10.1371/journal.pone.0040938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912667	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700002
J	Scalley-Kim, ML; Hess, BW; Kelly, RL; Krostag, ARF; Lustig, KH; Marken, JS; Ovendale, PJ; Posey, AR; Smolak, PJ; Taylor, JDL; Wood, CL; Bienvenue, DL; Probst, P; Salmon, RA; Allison, DS; Foy, TM; Raport, CJ				Scalley-Kim, Michelle L.; Hess, Bruce W.; Kelly, Ryan L.; Krostag, Anne-Rachel F.; Lustig, Kurt H.; Marken, John S.; Ovendale, Pamela J.; Posey, Aaron R.; Smolak, Pamela J.; Taylor, Janelle D. L.; Wood, C. L.; Bienvenue, David L.; Probst, Peter; Salmon, Ruth A.; Allison, Daniel S.; Foy, Teresa M.; Raport, Carol J.			Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-INDUCED ARTHRITIS; CENTRAL-NERVOUS-SYSTEM; CCR5 D32 POLYMORPHISM; RHEUMATOID-ARTHRITIS; RECEPTOR CCR5; NEGATIVE ASSOCIATION; IN-VIVO; SCLEROSIS LESIONS; PERIPHERAL-BLOOD	Chemokines play a key role in leukocyte recruitment during inflammation and are implicated in the pathogenesis of a number of autoimmune diseases. As such, inhibiting chemokine signaling has been of keen interest for the development of therapeutic agents. This endeavor, however, has been hampered due to complexities in the chemokine system. Many chemokines have been shown to signal through multiple receptors and, conversely, most chemokine receptors bind to more than one chemokine. One approach to overcoming this complexity is to develop a single therapeutic agent that binds and inactivates multiple chemokines, similar to an immune evasion strategy utilized by a number of viruses. Here, we describe the development and characterization of a novel therapeutic antibody that targets a subset of human CC chemokines, specifically CCL3, CCL4, and CCL5, involved in chronic inflammatory diseases. Using a sequential immunization approach, followed by humanization and phage display affinity maturation, a therapeutic antibody was developed that displays high binding affinity towards the three targeted chemokines. In vitro, this antibody potently inhibits chemotaxis and chemokine-mediated signaling through CCR1 and CCR5, primary chemokine receptors for the targeted chemokines. Furthermore, we have demonstrated in vivo efficacy of the antibody in a SCID-hu mouse model of skin leukocyte migration, thus confirming its potential as a novel therapeutic chemokine antagonist. We anticipate that this antibody will have broad therapeutic utility in the treatment of a number of autoimmune diseases due to its ability to simultaneously neutralize multiple chemokines implicated in disease pathogenesis.	[Scalley-Kim, Michelle L.; Krostag, Anne-Rachel F.; Marken, John S.; Smolak, Pamela J.; Taylor, Janelle D. L.; Wood, C. L.; Allison, Daniel S.] VLST Corp, Dept Prot Engn, Seattle, WA USA; [Hess, Bruce W.; Lustig, Kurt H.; Ovendale, Pamela J.; Posey, Aaron R.; Probst, Peter; Salmon, Ruth A.; Foy, Teresa M.; Raport, Carol J.] VLST Corp, Dept Immunol & Preclin Pharmacol, Seattle, WA USA; [Kelly, Ryan L.; Bienvenue, David L.] VLST Corp, Dept Prot Sci, Seattle, WA USA		Scalley-Kim, ML (corresponding author), VLST Corp, Dept Prot Engn, Seattle, WA USA.	tfoy@vlstcorp.com			VLST Corporation	VLST Corporation	VLST Corporation funded the work in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Amat M, 2006, BRIT J PHARMACOL, V149, P666, DOI 10.1038/sj.bjp.0706912; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Barcellos LF, 2000, IMMUNOGENETICS, V51, P281, DOI 10.1007/s002510050621; Barnes DA, 1998, J CLIN INVEST, V101, P2910, DOI 10.1172/JCI2172; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Buatois V, 2010, J IMMUNOL, V185, P2544, DOI 10.4049/jimmunol.1000182; Burns JM, 2002, J BIOL CHEM, V277, P2785, DOI 10.1074/jbc.M109884200; Carballido JM, 2003, J IMMUNOL METHODS, V273, P125, DOI 10.1016/S0022-1759(02)00422-2; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Conklyn MJ, 1996, CYTOKINE, V8, P762, DOI 10.1006/cyto.1996.0101; Coyle PK, 2010, AM J MANAG CARE, V16, pS164; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Dahl ME, 2008, J PHARMACOL EXP THER, V327, P926, DOI 10.1124/jpet.108.142695; Deer JR, 2004, BIOTECHNOL PROGR, V20, P880, DOI 10.1021/bp034383r; Didier PJ, 1999, INFLAMMATION, V23, P75, DOI 10.1023/A:1020243701890; Dogan RNE, 2004, FRONT BIOSCI-LANDMRK, V9, P1500, DOI 10.2741/1284; Fagete S, 2009, MABS-AUSTIN, V1, P288, DOI 10.4161/mabs.1.3.8527; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fleishaker DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3685; Gade-Andavolu R, 2004, GENET MED, V6, P126, DOI 10.1097/01.GIM.0000127274.45301.54; Guan E, 2002, J BIOL CHEM, V277, P32348, DOI 10.1074/jbc.M203077200; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Jones JM, 2008, CYTOKINE, V43, P220, DOI 10.1016/j.cyto.2008.05.016; JONES ST, 1991, BIO-TECHNOL, V9, P579; Kabat EA, 1991, SEQUENCES PROTEINS I; KASAMA T, 1995, J CLIN INVEST, V95, P2868, DOI 10.1172/JCI117993; Katschke KJ, 2001, ARTHRITIS RHEUM, V44, P1022, DOI 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.3.CO;2-E; Kohem C, 2007, SCAND J RHEUMATOL, V36, P359, DOI 10.1080/03009740701393999; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Mahad DJ, 2004, J NEUROPATH EXP NEUR, V63, P262, DOI 10.1093/jnen/63.3.262; Matsui M, 2002, J NEUROIMMUNOL, V128, P16, DOI 10.1016/S0165-5728(02)00121-2; Mueller A, 2006, BIOCHEM PHARMACOL, V72, P739, DOI 10.1016/j.bcp.2006.06.001; PlaterZyberk C, 1997, IMMUNOL LETT, V57, P117, DOI 10.1016/S0165-2478(97)00075-8; Pokorny V, 2005, ANN RHEUM DIS, V64, P487, DOI 10.1136/ard.2004.023333; Prahalad S, 2006, GENES IMMUN, V7, P264, DOI 10.1038/sj.gene.6364298; Reid C, 2006, PROTEIN ENG DES SEL, V19, P317, DOI 10.1093/protein/gzl015; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rossol M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2733; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; Russo RC, 2010, CURR OPIN DRUG DISC, V13, P414; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sapir Y, 2010, J IMMUNOL, V185, P2589, DOI 10.4049/jimmunol.1000666; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schier Robert, 1996, Human Antibodies and Hybridomas, V7, P97; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Sellebjerg F, 2000, J NEUROIMMUNOL, V102, P98, DOI 10.1016/S0165-5728(99)00166-6; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Silversides JA, 2004, MULT SCLER J, V10, P149, DOI 10.1191/1352458504ms994oa; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Sorensen TL, 1998, SEMIN NEUROL, V18, P287, DOI 10.1055/s-2008-1040879; Tak P.P., 2012, ANN RHEUM DIS; Tran EH, 2000, EUR J IMMUNOL, V30, P1410, DOI 10.1002/(SICI)1521-4141(200005)30:5<1410::AID-IMMU1410>3.0.CO;2-L; Trebst C, 2001, AM J PATHOL, V159, P1701, DOI 10.1016/S0002-9440(10)63017-9; Volin MV, 1998, CLIN IMMUNOL IMMUNOP, V89, P44, DOI 10.1006/clin.1998.4590; Yang YF, 2002, EUR J IMMUNOL, V32, P2124, DOI 10.1002/1521-4141(200208)32:8<2124::AID-IMMU2124>3.0.CO;2-S; Zapico I, 2000, GENES IMMUN, V1, P288, DOI 10.1038/sj.gene.6363673	66	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43332	10.1371/journal.pone.0043332	http://dx.doi.org/10.1371/journal.pone.0043332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912856	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700084
J	Asher, E; Greenberg-Dotan, S; Halevy, J; Glick, S; Reuveni, H				Asher, Elad; Greenberg-Dotan, Sari; Halevy, Jonathan; Glick, Shimon; Reuveni, Haim			Defensive Medicine in Israel - A Nationwide Survey	PLOS ONE			English	Article							MALPRACTICE LITIGATION; GENERAL-PRACTITIONERS; RISK; GUIDELINES; PHYSICIANS; QUESTIONNAIRE; PATIENT; REFORM	Background: Defensive medicine is the practice of diagnostic or therapeutic measures conducted primarily as a safeguard against possible malpractice liability. We studied the extent, reasons, and characteristics of defensive medicine in the Israeli health care system. Methods and Findings: Cross-sectional study performed in the Israeli health care system between April and July 2008 in a sample (7%) of board certified physicians from eight medical disciplines (internal medicine, pediatrics, general surgery, family medicine, obstetrics and gynecology, orthopedic surgery, cardiology, and neurosurgery). A total of 889 physicians (7% of all Israeli board certified specialists) completed the survey. The majority [60%, (95%CI 0.57-0.63)] reported practicing defensive medicine; 40% (95%CI 0.37-0.43) consider every patient as a potential threat for a medical lawsuit; 25% (95%CI 0.22-0.28) have previously been sued at least once during their career. Independent predictors for practicing defensive medicine were surgical specialty [OR = 1.6 (95%CI 1.2-2.2), p = 0.0004], not performing a fellowship abroad [OR = 1.5 (95%CI 1.1-2), p = 0.027], and previous exposure to lawsuits [OR = 2.4 (95%CI 1.7-3.4), p<0.0001]. Independent predictors for the risk of being sued during a physician's career were male gender [OR = 1.6 (95%CI 1.1-2.2), p = 0.012] and surgery specialty [OR = 3.2 (95%CI 2.4-4.3), p<0.0001] (general surgery, obstetrics and gynecology, orthopedic surgery, and neurosurgery). Conclusions: Defensive medicine is very prevalent in daily physician practice in all medical disciplines. It exposes patients to complications due to unnecessary tests and procedures, affects quality of care and costs, and undermines doctor-patient relationships. Further studies are needed to understand how to minimize defensive medicine resulting from an increased malpractice liability market.	[Asher, Elad] Chaim Sheba Med Ctr, Ramat Gan, Israel; [Greenberg-Dotan, Sari; Glick, Shimon; Reuveni, Haim] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Halevy, Jonathan] Shaare Zedek Med Ctr, Jerusalem, Israel	Chaim Sheba Medical Center; Ben Gurion University; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Asher, E (corresponding author), Chaim Sheba Med Ctr, Ramat Gan, Israel.	El.asher@gmail.com	Asher, Elad/I-3544-2019	Asher, Elad/0000-0003-3381-605X	Israeli National Institute for Health Policy Research	Israeli National Institute for Health Policy Research	The study was supported by The Israeli National Institute for Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RE, 1999, ARCH INTERN MED, V159, P2399, DOI 10.1001/archinte.159.20.2399; Asher E, 2010, EC SOCIAL ASPECTS IS, P110; Asher E, 2007, EUR J INTERN MED, V18, P35, DOI 10.1016/j.ejim.2006.07.021; Avraham R, 2011, AM J LAW MED, V37, P7, DOI 10.1177/009885881103700101; BALDWIN LM, 1995, JAMA-J AM MED ASSOC, V274, P1606, DOI 10.1001/jama.274.20.1606; Bleich A, 2011, ISR MED ASSOC J, V13, P653; COOK WR, 1994, CAN FAM PHYSICIAN, V40, P689; Eddy DM, 1998, HEALTH AFFAIR, V17, P7, DOI 10.1377/hlthaff.17.4.7; ENNIS M, 1991, LANCET, V338, P616, DOI 10.1016/0140-6736(91)90616-W; Girgis S, 1999, MED J AUSTRALIA, V171, P362, DOI 10.5694/j.1326-5377.1999.tb123693.x; Glassman PA, 1996, J HEALTH POLIT POLIC, V21, P219, DOI 10.1215/03616878-21-2-219; GOYERT GL, 1989, NEW ENGL J MED, V320, P706, DOI 10.1056/NEJM198903163201106; Hiyama T, 2006, WORLD J GASTROENTERO, V12, P7671, DOI 10.3748/wjg.v12.i47.7671; Huda W, 2011, AM J ROENTGENOL, V196, pW159, DOI 10.2214/AJR.10.4981; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Leask K, 2005, ARCH DIS CHILD, V90, P1256, DOI 10.1136/adc.2005.083097; Mello MM, 2002, TEX LAW REV, V80, P1595; Michota Franklin A, 2009, Cleve Clin J Med, V76 Suppl 4, pS119, DOI 10.3949/ccjm.76.s4.19; Passmore K, 2002, POSTGRAD MED J, V78, P671, DOI 10.1136/pmj.78.925.671; Reed DA, 2008, TEACH LEARN MED, V20, P205, DOI 10.1080/10401330802199443; Sclar David, 2003, HARV HLTH POLY REV, V4, P75; SLOAN FA, 1995, MED CARE, V33, P700, DOI 10.1097/00005650-199507000-00006; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; SUMMERTON N, 1995, BRIT MED J, V310, P27, DOI 10.1136/bmj.310.6971.27; Tippett TM, 2010, J NEUROSURG, V113, P1127, DOI 10.3171/2010.6.JNS10930; Toker A, 2004, AM J OTOLARYNG, V25, P245, DOI 10.1016/j.amjoto.2004.02.002; US Congress Office of Technology Assessment, 1994, US C OFF TECHN ASS P; WEISMAN CS, 1988, MED CARE, V26, P298, DOI 10.1097/00005650-198803000-00006; Ziakas A, 2004, J Invasive Cardiol, V16, P129	30	32	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42613	10.1371/journal.pone.0042613	http://dx.doi.org/10.1371/journal.pone.0042613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AN	22916140	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300013
J	Stern, RF; Andersen, RA; Jameson, I; Kupper, FC; Coffroth, MA; Vaulot, D; Le Gall, F; Veron, B; Brand, JJ; Skelton, H; Kasai, F; Lilly, EL; Keeling, PJ				Stern, Rowena F.; Andersen, Robert A.; Jameson, Ian; Kuepper, Frithjof C.; Coffroth, Mary-Alice; Vaulot, Daniel; Le Gall, Florence; Veron, Benoit; Brand, Jerry J.; Skelton, Hayley; Kasai, Fumai; Lilly, Emily L.; Keeling, Patrick J.			Evaluating the Ribosomal Internal Transcribed Spacer (ITS) as a Candidate Dinoflagellate Barcode Marker	PLOS ONE			English	Article							SP-NOV; MOLECULAR PHYLOGENY; GENETIC DIVERSITY; LIFE-CYCLE; DINOPHYCEAE; DNA; SYMBIODINIUM; EVOLUTION; COMPLEX; GENUS	Background: DNA barcoding offers an efficient way to determine species identification and to measure biodiversity. For dinoflagellates, an ancient alveolate group of about 2000 described extant species, DNA barcoding studies have revealed large amounts of unrecognized species diversity, most of which is not represented in culture collections. To date, two mitochondrial gene markers, Cytochrome Oxidase I (COI) and Cytochrome b oxidase (COB), have been used to assess DNA barcoding in dinoflagellates, and both failed to amplify all taxa and suffered from low resolution. Nevertheless, both genes yielded many examples of morphospecies showing cryptic speciation and morphologically distinct named species being genetically similar, highlighting the need for a common marker. For example, a large number of cultured Symbiodinium strains have neither taxonomic identification, nor a common measure of diversity that can be used to compare this genus to other dinoflagellates. Methodology/Principal Findings: The purpose of this study was to evaluate the Internal Transcribed Spacer units 1 and 2 (ITS) of the rDNA operon, as a high resolution marker for distinguishing species dinoflagellates in culture. In our study, from 78 different species, the ITS barcode clearly differentiated species from genera and could identify 96% of strains to a known species or sub-genus grouping. 8.3% showed evidence of being cryptic species. A quarter of strains identified had no previous species identification. The greatest levels of hidden biodiversity came from Scrippsiella and the Pfiesteriaceae family, whilst Heterocapsa strains showed a high level of mismatch to their given species name. Conclusions/Significance: The ITS marker was successful in confirming species, revealing hidden diversity in culture collections. This marker, however, may have limited use for environmental barcoding due to paralogues, the potential for unidentifiable chimaeras and priming across taxa. In these cases ITS would serve well in combination with other markers or for specific taxon studies.	[Stern, Rowena F.] Sir Alister Hardy Fdn Ocean Sci, The Laboratory, Plymouth, Devon, England; [Andersen, Robert A.] Provasoli Guillard Natl Ctr Culture Marine Phytop, W Boothbay Harbor, ME USA; [Jameson, Ian] Commonwealth Sci & Ind Res Org Marine & Atmospher, Australian Natl Algae Culture Collect, Hobart, Tas, Australia; [Kuepper, Frithjof C.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Coffroth, Mary-Alice] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Veron, Benoit] Univ Caen Basse Normandie, Algobank Caen, Caen, France; [Vaulot, Daniel; Le Gall, Florence] Roscoff Culture Collect, Stn Biol Roscoff, Roscoff, France; [Brand, Jerry J.] Univ Texas Austin, Sch Biol Sci, Sect MCD Biol, Austin, TX 78712 USA; [Skelton, Hayley] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Kasai, Fumai] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Lilly, Emily L.] Virginia Mil Inst, Dept Biol, Lexington, VA 24450 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); UHI Millennium Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universite de Caen Normandie; UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Austin; University of Connecticut; National Institute for Environmental Studies - Japan; University of British Columbia	Stern, RF (corresponding author), Sir Alister Hardy Fdn Ocean Sci, The Laboratory, Plymouth, Devon, England.	rost@sahfos.ac.uk	Véron, Benoît/I-2942-2012; Vaulot, Daniel/T-6649-2019; /AAY-2080-2020; Brand, JJ/GQR-2139-2022	Véron, Benoît/0000-0002-8434-8981; Vaulot, Daniel/0000-0002-0717-5685; /0000-0002-1365-9723; Keeling, Patrick/0000-0002-7644-0745; Kuepper, Frithjof/0000-0003-1273-7109	Genome Canada; United Kingdom Natural Environment Research Council [Oceans 2025 NF3, MGF 154]; National Science Foundation [OCE 04-24994, OCE-09-26822]	Genome Canada(Genome Canada); United Kingdom Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation(National Science Foundation (NSF))	This project was funded by Genome Canada. The authors would also like to acknowledge the United Kingdom Natural Environment Research Council for funding the CCAP (Oceans 2025 NF3 and MGF 154) and National Science Foundation grants OCE 04-24994 and OCE-09-26822 for funding Symbiodinium analysis by MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, J PHYCOL, V32, P424, DOI 10.1111/j.0022-3646.1996.00424.x; Al-Kandari MA, 2011, HARMFUL ALGAE, V10, P636, DOI 10.1016/j.hal.2011.04.017; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; Dodge J.D., 1982, P1; Ferrell J, 2008, EVALUATION DNA BARCO; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; GERBI SA, 1986, BIOSYSTEMS, V19, P247, DOI 10.1016/0303-2647(86)90001-8; GHAZAROSSIAN VE, 1974, BIOCHEM BIOPH RES CO, V59, P1219, DOI 10.1016/0006-291X(74)90444-6; Giacobbe MG, 2000, PHYCOLOGIA, V39, P177, DOI 10.2216/i0031-8884-39-3-177.1; Gile GH, 2010, J PHYCOL, V46, P743, DOI 10.1111/j.1529-8817.2010.00851.x; Gottschling M, 2005, MOL PHYLOGENET EVOL, V36, P444, DOI 10.1016/j.ympev.2005.03.036; Hansen G, 2000, J PHYCOL, V36, P394, DOI 10.1046/j.1529-8817.2000.99172.x; HANSEN G, 1995, PHYCOLOGIA, V34, P166, DOI 10.2216/i0031-8884-34-2-166.1; Hansen G, 2009, J PHYCOL, V45, P251, DOI 10.1111/j.1529-8817.2008.00621.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoef-Emden Kerstin, 2007, Protist, V158, P135, DOI 10.1016/j.protis.2007.02.001; Hunter RL, 2007, J PHYCOL, V43, P120, DOI 10.1111/j.1529-8817.2006.00309.x; Iwataki M, 2004, PHYCOLOGIA, V43, P394, DOI 10.2216/i0031-8884-43-4-394.1; Jeong HJ, 2005, J EUKARYOT MICROBIOL, V52, P382, DOI 10.1111/j.1550-7408.2005.00051.x; John U, 2005, J PLANKTON RES, V27, P199, DOI 10.1093/plankt/fbh160; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029013; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li HC, 2008, J MED MICROBIOL, V57, P592, DOI 10.1099/jmm.0.47607-0; Lilly EL, 2007, J PHYCOL, V43, P1329, DOI 10.1111/j.1529-8817.2007.00420.x; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Litaker RW, 2005, J PHYCOL, V41, P643, DOI 10.1111/j.1529-8817.2005.00075.x; Lowe CD, 2010, PROTIST, V161, P212, DOI 10.1016/j.protis.2009.11.003; Maddison DR, 2005, MACCLADE; Mason PL, 2007, J PHYCOL, V43, P799, DOI 10.1111/j.1529-8817.2007.00370.x; Matsuyama Y, 1996, HARMFUL TOXIC ALGAL, P247; McLachlin J, 1997, PHYCOLOGIA, V36, P48; Montresor M, 2003, PHYCOLOGIA, V42, P56, DOI 10.2216/i0031-8884-42-1-56.1; Morado JF, 2005, SPECIES IDENTITY LIF; Morill LC, 1981, J PLANKTON RES, V3, P53; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Nguyen HDT, 2008, PERSOONIA, V21, P57, DOI 10.3767/003158508X361334; Park TG, 2007, APPL ENVIRON MICROB, V73, P2552, DOI 10.1128/AEM.02389-06; Penna A, 2005, MAR BIOL, V148, P13, DOI 10.1007/s00227-005-0067-5; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Santos SR, 2002, MOL PHYLOGENET EVOL, V23, P97, DOI 10.1016/S1055-7903(02)00010-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scholin CA, 1995, PHYCOLOGIA, V34, P472, DOI 10.2216/i0031-8884-34-6-472.1; Shankle AM, 2004, J PHYCOL, V40, P239, DOI 10.1111/j.1529-8817.2004.03021.x; Sherwood AR, 2007, J PHYCOL, V43, P605, DOI 10.1111/j.1529-8817.2007.00341.x; SILVA ES, 1995, PHYCOLOGIA, V34, P396, DOI 10.2216/i0031-8884-34-5-396.1; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Steidinger KA, 1996, J PHYCOL, V32, P157, DOI 10.1111/j.0022-3646.1996.00157.x; Steidinger Karen A., 1997, P387, DOI 10.1016/B978-012693018-4/50005-7; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor DL, 1974, SYMBIOSIS SEA, P245; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; TAYLOR FJR, 1975, ENVIRON LETT, V9, P103, DOI 10.1080/00139307509435840; Thornhill DJ, 2008, J PHYCOL, V44, P1126, DOI 10.1111/j.1529-8817.2008.00567.x; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Touzet N, 2007, APPL ENVIRON MICROB, V73, P3333, DOI 10.1128/AEM.02161-06; Trench R.K., 1997, P1275; TRENCH RK, 1987, J PHYCOL, V23, P469, DOI 10.1111/j.1529-8817.1987.tb02534.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4	81	75	81	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42780	10.1371/journal.pone.0042780	http://dx.doi.org/10.1371/journal.pone.0042780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916158	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300016
J	Zhang, L; Yin, S; Tan, WL; Xiao, D; Weng, YC; Wang, WJ; Li, TT; Shi, JW; Shuai, LF; Li, HW; Zhou, JH; Allain, JP; Li, CY				Zhang, Ling; Yin, Sen; Tan, Wanlong; Xiao, Dong; Weng, Yunceng; Wang, Wenjing; Li, Tingting; Shi, Junwen; Shuai, Lifang; Li, Hongwei; Zhou, Jianhua; Allain, Jean-Pierre; Li, Chengyao			Recombinant Interferon-gamma Lentivirus Co-Infection Inhibits Adenovirus Replication Ex Vivo	PLOS ONE			English	Article							GB-VIRUS-C; IN-VIVO; RHESUS MACAQUES; GENE DELIVERY; IFN-GAMMA; HIV-1; EXPRESSION; VECTORS; INFECTION; CELLS	Recombinant interferon-gamma (IFN gamma) production in cultured lentivirus (LV) was explored for inhibition of target virus in cells co-infected with adenovirus type 5 (Ad5). The ability of three different promoters of CMV, EF1 alpha and Ubiquitin initiating the enhanced green fluorescence protein (GFP) activities within lentiviruses was systematically assessed in various cell lines, which showed that certain cell lines selected the most favorable promoter driving a high level of transgenic expression. Recombinant IFN gamma lentivirus carrying CMV promoter (LV-CMV-IFN gamma) was generated to co-infect 293A cells with a viral surrogate of recombinant GFP Ad5 in parallel with LV-CMV-GFP control. The best morphologic conditions were observed from the two lentiviruses co-infected cells, while single adenovirus infected cells underwent clear pathologic changes. Viral load of adenoviruses from LV-CMV-IFN gamma or LV-CMV-GFP co-infected cell cultures was significantly lower than that from adenovirus alone infected cells (P = 0.005-0.041), and the reduction of adenoviral load in the co-infected cells was 86% and 61%, respectively. Ad5 viral load from LV-CMV-IFN gamma co-infected cells was significantly lower than that from LV-CMV-GFP co-infection (P = 0.032), which suggested that IFN gamma rather than GFP could further enhance the inhibition of Ad5 replication in the recombinant lentivirus co-infected cells. The results suggest that LV-CMV-IFN gamma co-infection could significantly inhibit the target virus replication and might be a potential approach for alternative therapy of severe viral diseases.	[Zhang, Ling; Yin, Sen; Weng, Yunceng; Wang, Wenjing; Li, Tingting; Li, Hongwei; Allain, Jean-Pierre; Li, Chengyao] So Med Univ, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China; [Xiao, Dong; Shi, Junwen] So Med Univ, Inst Oncol, Guangzhou, Guangdong, Peoples R China; [Tan, Wanlong] So Med Univ, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Shuai, Lifang] Guangzhou Mil Ctr Dis Control, Guangzhou, Guangdong, Peoples R China; [Zhou, Jianhua] Chinese Acad Agr Sci, Harbin Vet Res Inst, Lab Lentiviruses & Horse Dis, Harbin, Peoples R China; [Allain, Jean-Pierre] Univ Cambridge, Dept Hematol, Cambridge, England	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of Cambridge	Zhang, L (corresponding author), So Med Univ, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China.	chengyaoli@hotmail.com	Weng, Yunceng/AAV-9980-2020		S&T Grand Special Program [2012ZX10001008, 2009ZX10004-305]; National Basic Research Program of China (973 Program) [2010CB530204, 2009CB522507]; National Natural Science Foundation of China [31100657, 81071348]; Guangdong Provincial Science and Technology Foundation [8151051501000014, 2010B060500010]	S&T Grand Special Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Foundation	This work was supported by the grants from S&T Grand Special Program (No. 2012ZX10001008 and 2009ZX10004-305), National Basic Research Program of China (973 Program No. 2010CB530204 and 2009CB522507), National Natural Science Foundation of China (No. 31100657 and 81071348) and Guangdong Provincial Science and Technology Foundation (No. 8151051501000014 and 2010B060500010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 1999, J VIROL, V73, P7671, DOI 10.1128/JVI.73.9.7671-7677.1999; Brule F, 2007, BIOCHEM PHARMACOL, V74, P898, DOI 10.1016/j.bcp.2007.06.036; Bukovsky AA, 1999, J VIROL, V73, P7087, DOI 10.1128/JVI.73.8.7087-7092.1999; Cao SB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-48; Corbeau P, 1998, VIROLOGY, V243, P268, DOI 10.1006/viro.1998.9089; Dale CJ, 2000, J MED PRIMATOL, V29, P240, DOI 10.1034/j.1600-0684.2000.290317.x; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fischetti L, 2004, AIDS, V18, P1208, DOI 10.1097/00002030-200405210-00017; Frese M, 2002, HEPATOLOGY, V35, P694, DOI 10.1053/jhep.2002.31770; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Giavedoni L, 1997, J VIROL, V71, P866, DOI 10.1128/JVI.71.2.866-872.1997; Gorry PR, 2007, JAIDS-J ACQ IMM DEF, V46, P390, DOI 10.1097/QAI.0b013e31815aba08; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; Iidal T, 2004, ARCH VIROL, V149, P743, DOI 10.1007/s00705-003-0229-z; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Kim JJ, 2001, VACCINE, V19, P2496, DOI 10.1016/S0264-410X(00)00479-5; Kim SY, 2002, J BIOTECHNOL, V93, P183, DOI 10.1016/S0168-1656(01)00388-1; Klimatcheva E, 2001, MOL THER, V3, P928, DOI 10.1006/mthe.2001.0344; Li CY, 2006, AIDS, V20, P379, DOI 10.1097/01.aids.0000200536.79360.03; Li HW, 2005, BIOCHEM BIOPH RES CO, V336, P29, DOI 10.1016/j.bbrc.2005.08.035; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nattermann J, 2003, AIDS, V17, P1457, DOI 10.1097/00002030-200307040-00006; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Scherer LJ, 2011, HUM MOL GENET, V20, pR100, DOI 10.1093/hmg/ddr160; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Younes HM, 2002, J PHARM SCI-US, V91, P2, DOI 10.1002/jps.10007; Zeng LB, 2006, J GENE MED, V8, P18, DOI 10.1002/jgm.825	32	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42455	10.1371/journal.pone.0042455	http://dx.doi.org/10.1371/journal.pone.0042455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916129	Green Submitted, gold, Green Published			2022-12-27	WOS:000307824300010
J	Basappa; Sugahara, K; Thimmaiah, KN; Bid, HK; Houghton, PJ; Rangappa, KS				Basappa; Sugahara, Kazuyuki; Thimmaiah, Kuntebommanahalli N.; Bid, Hemant K.; Houghton, Peter J.; Rangappa, Kanchugarakoppal S.			Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule	PLOS ONE			English	Article							TUMOR-GROWTH; INHIBITORS; HEPARIN; TRANSFORMATION; METASTASIS; DOMAIN; AGENTS	The angiogenic process is controlled by variety of factors of which the vascular endothelial growth factor (VEGF) pathway plays a major role. A series of heparan sulfate mimetic small molecules targeting VEGF/VEGFR pathway has been synthesized. Among them, compound 8 (2-butyl-5-chloro-3-(4-nitro-benzyl)-3H-imidazole-4-carbaldehyde) was identified as a significant binding molecule for the heparin-binding domain of VEGF, determined by high-throughput-surface plasmon resonance assay. The data predicted strong binding of compound 8 with VEGF which may prevent the binding of VEGF to its receptor. We compared the structure of compound 8 with heparan sulfate (HS), which have in common the functional ionic groups such as sulfate, nitro and carbaldehyde that can be located in similar positions of the disaccharide structure of HS. Molecular docking studies predicted that compound 8 binds at the heparin binding domain of VEGF through strong hydrogen bonding with Lys-30 and Gln-20 amino acid residues, and consistent with the prediction, compound 8 inhibited binding of VEGF to immobilized heparin. In vitro studies showed that compound 8 inhibits the VEGF-induced proliferation migration and tube formation of mouse vascular endothelial cells, and finally the invasion of a murine osteosarcoma cell line (LM8G7) which secrets high levels of VEGF. In vivo, these effects produce significant decrease of tumor burden in an experimental model of liver metastasis. Collectively, these data indicate that compound 8 may prevent tumor growth through a direct effect on tumor cell proliferation and by inhibition of endothelial cell migration and angiogenesis mediated by VEGF. In conclusion, compound 8 may normalize the tumor vasculature and microenvironment in tumors probably by inhibiting the binding of VEGF to its receptor.	[Basappa; Sugahara, Kazuyuki] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Thimmaiah, Kuntebommanahalli N.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Bid, Hemant K.; Houghton, Peter J.] Nationwide Childrens Hosp, Ctr Childhood Canc, Columbus, OH USA; [Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Basappa] Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Basappa] Bangalore Univ, Dept Chem, Bangalore 560056, Karnataka, India	Hokkaido University; St Jude Children's Research Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Mysore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Bangalore University	Basappa (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan.	rangappaks@gmail.com	Houghton, Peter/E-3265-2011	Basappa, Basappa/0000-0002-8844-468X	INSA (Indian National Science Academy)-JSPS (Japan Society for the Promotion of Science) program; Future Drug Discovery and Medical Care Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); JSPS; VGST from government of Karnataka; USPHS award [CA23099]; NATIONAL CANCER INSTITUTE [P01CA023099] Funding Source: NIH RePORTER	INSA (Indian National Science Academy)-JSPS (Japan Society for the Promotion of Science) program; Future Drug Discovery and Medical Care Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); VGST from government of Karnataka; USPHS award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the INSA (Indian National Science Academy)-JSPS (Japan Society for the Promotion of Science) program between India (to K.S.R.) and Japan (to K.S.), Future Drug Discovery and Medical Care Innovation Program (K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), and a Grant-in-aid (19-07194) from JSPS, VGST from government of Karnataka (B.) and USPHS award CA23099 (P.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Basappa, 2010, CANCER LETT, V297, P231, DOI 10.1016/j.canlet.2010.05.016; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; BENEZRA M, 1992, CANCER RES, V52, P5656; CIOMEI M, 1994, BIOCHEM PHARMACOL, V47, P295, DOI 10.1016/0006-2952(94)90020-5; Compain P, 2001, BIOORGAN MED CHEM, V9, P3077, DOI 10.1016/S0968-0896(01)00176-6; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; Dawson MI, 2008, J MED CHEM, V51, P5650, DOI 10.1021/jm800456k; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1987, NATURE, V329, P671, DOI 10.1038/329671a0; Gallos JK, 2003, CURR ORG CHEM, V7, P397, DOI 10.2174/1385272033372734; Gaonkar SL, 2009, MED CHEM RES, V18, P221, DOI 10.1007/s00044-008-9121-4; Goss PE, 1995, CLIN CANCER RES, V1, P935; HORI A, 1991, CANCER RES, V51, P6180; Ishida K, 2004, CHEM BIOL, V11, P367, DOI 10.1016/j.chembiol.2004.02.015; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Kavitha BCV, 2004, BIOORG MED CHEM LETT, V14, P3279, DOI 10.1016/j.bmcl.2004.03.098; Kavitha CV, 2005, J CHEM CRYSTALLOGR, V35, P957, DOI 10.1007/s10870-005-5249-y; Lee CM, 2002, CANCER RES, V62, P4282; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Perion R, 2005, TETRAHEDRON, V61, P9118, DOI 10.1016/j.tet.2005.07.033; Priya BS, 2005, BIOORGAN MED CHEM, V13, P2623, DOI 10.1016/j.bmc.2005.01.026; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Saito A, 2008, CHEM-ASIAN J, V3, P1607, DOI 10.1002/asia.200800099; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Slee DH, 2001, J MED CHEM, V44, P2094, DOI 10.1021/jm000508c; SOLA F, 1995, CANCER CHEMOTH PHARM, V36, P217, DOI 10.1007/BF00685849; STEIN CA, 1993, CANCER RES, V53, P2239; Tiligada E., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P553; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; WELLSTEIN A, 1991, JNCI-J NATL CANCER I, V83, P716, DOI 10.1093/jnci/83.10.716; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s	36	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e39444	10.1371/journal.pone.0039444	http://dx.doi.org/10.1371/journal.pone.0039444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916091	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000307823600001
J	Sandvik, GK; Tomter, AB; Bergan, J; Zoppellaro, G; Barra, AL; Rohr, AK; Kolberg, M; Ellefsen, S; Andersson, KK; Nilsson, GE				Sandvik, Guro K.; Tomter, Ane B.; Bergan, Jonas; Zoppellaro, Giorgio; Barra, Anne-Laure; Rohr, Asmund K.; Kolberg, Matthias; Ellefsen, Stian; Andersson, K. Kristoffer; Nilsson, Goeran E.			Studies of Ribonucleotide Reductase in Crucian Carp-An Oxygen Dependent Enzyme in an Anoxia Tolerant Vertebrate	PLOS ONE			English	Article							HIGH-FIELD EPR; MAGNETIC CIRCULAR-DICHROISM; HERPES-SIMPLEX-VIRUS; HIGH-FREQUENCY EPR; CELL-CYCLE; DNA-DAMAGE; TYROSYL RADICALS; BIFERROUS SITE; IRON CENTER; PROTEIN R2	The enzyme ribonucleotide reductase (RNR) catalyzes the conversion of ribonucleotides to deoxyribonucleotides, the precursors for DNA. RNR requires a thiyl radical to activate the substrate. In RNR of eukaryotes (class Ia RNR), this radical originates from a tyrosyl radical formed in reaction with oxygen (O-2) and a ferrous di-iron center in RNR. The crucian carp (Carassius carassius) is one of very few vertebrates that can tolerate several months completely without oxygen (anoxia), a trait that enables this fish to survive under the ice in small ponds that become anoxic during the winter. Previous studies have found indications of cell division in this fish after 7 days of anoxia. This appears nearly impossible, as DNA synthesis requires the production of new deoxyribonucleotides and therefore active RNR. We have here characterized RNR in crucian carp, to search for adaptations to anoxia. We report the full-length sequences of two paralogs of each of the RNR subunits (R1i, R1ii, R2i, R2ii, p53R2i and p53R2ii), obtained by cloning and sequencing. The mRNA levels of these subunits were measured with quantitative PCR and were generally well maintained in hypoxia and anoxia in heart and brain. We also report maintained or increased mRNA levels of the cell division markers proliferating cell nuclear antigen (PCNA), brain derived neurotrophic factor (BDNF) and Ki67 in anoxic hearts and brains. Electron paramagnetic resonance (EPR) measurements on in vitro expressed crucian carp R2 and p53R2 proteins gave spectra similar to mammalian RNRs, including previously unpublished human and mouse p53R2 EPR spectra. However, the radicals in crucian carp RNR small subunits, especially in the p53R2ii subunit, were very stable at 0 degrees C. A long half-life of the tyrosyl radical during wintertime anoxia could allow for continued cell division in crucian carp.	[Sandvik, Guro K.; Tomter, Ane B.; Bergan, Jonas; Zoppellaro, Giorgio; Rohr, Asmund K.; Kolberg, Matthias; Andersson, K. Kristoffer; Nilsson, Goeran E.] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Barra, Anne-Laure] CNRS, UPR 3228, LNCMI G, Lab Natl Champs Magnet Intenses, Grenoble, France; [Ellefsen, Stian] Lillehammer Univ Coll, Lillehammer, Norway	University of Oslo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Inland Norway University of Applied Sciences	Sandvik, GK (corresponding author), Univ Oslo, Dept Mol Biosci, Oslo, Norway.	g.k.sandvik@imbv.uio.no	Kolberg, Matthias/G-2784-2011; Kolberg, Matthias/AAY-3478-2021; Nilsson, Göran Erik/Q-6129-2019; Kjendseth, Åsmund Røhr/O-2543-2016; Zoppellaro, Giorgio/F-8453-2012; Nilsson, Goran E/K-7668-2012	Kolberg, Matthias/0000-0001-8288-5364; Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Zoppellaro, Giorgio/0000-0003-2304-2564; Nilsson, Goran E/0000-0002-3195-3053; Bergan, Jonas/0000-0003-4267-8904	European Community [PIEF-GA-2009235237]; Research Council of Norway [177661/V30, 214239/F20, 186406/V40]; Norwegian Cancer Society [539012]	European Community(European Commission); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the PEOPLE Marie Curie Actions Intra-European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2009235237 to GZ), the Research Council of Norway (http://www.rcn.no) (Grants 177661/V30 and 214239/F20 to KKA; 186406/V40 to GEN), and the Norwegian Cancer Society (http://www.kreftforeningen.no) (539012 to KKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 1996, J AM CHEM SOC, V118, P895, DOI 10.1021/ja9529192; AMELLEM O, 1994, BRIT J CANCER, V70, P857, DOI 10.1038/bjc.1994.411; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Andersson K. K., 1995, ADV INORG CHEM, V43, P359; Andersson KK, 2003, J BIOL INORG CHEM, V8, P235, DOI 10.1007/s00775-002-0429-0; Andersson KK, 2002, SPECTROCHIM ACTA A, V58, P1101, DOI 10.1016/S1386-1425(01)00700-4; Andersson KK, 2008, ROBONUCLEOTIDE REDUC; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atta M, 1996, J BIOL INORG CHEM, V1, P210, DOI 10.1007/s007750050045; ATTA M, 1994, J AM CHEM SOC, V116, P6429, DOI 10.1021/ja00093a051; Bennati M, 2005, BIOL CHEM, V386, P1007, DOI 10.1515/BC.2005.117; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; BLAZKA P., 1958, PHYSIOL ZOOL, V31, P117; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brischwein K, 1997, EUR J BIOCHEM, V244, P286, DOI 10.1111/j.1432-1033.1997.00286.x; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chimploy K, 2000, J BIOL CHEM, V275, P39267, DOI 10.1074/jbc.M006233200; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Douglas RM, 2003, J APPL PHYSIOL, V94, P2068, DOI 10.1152/japplphysiol.01029.2002; Eisch AJ, 2007, CURR PHARM BIOTECHNO, V8, P147; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Ellefsen S, 2008, ANAL BIOCHEM, V376, P83, DOI 10.1016/j.ab.2008.01.028; Ellefsen S, 2008, PHYSIOL GENOMICS, V35, P5, DOI 10.1152/physiolgenomics.90221.2008; Engstrom M, 2000, J PHYS CHEM A, V104, P5149, DOI 10.1021/jp0006633; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; Evans H, 2008, PHYSIOL GENOMICS, V35, P18, DOI 10.1152/physiolgenomics.90266.2008; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; Graslund A, 2007, APPL MAGN RESON, V31, P447, DOI 10.1007/BF03166595; Graslund A, 1996, ANNU REV BIOPH BIOM, V25, P259; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hoganson CW, 1996, J AM CHEM SOC, V118, P4672, DOI 10.1021/ja953979a; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; JOHANSSON D, 1995, J EXP BIOL, V198, P853; JOHNSTON IA, 1983, J EXP BIOL, V104, P73; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kauppi B, 1996, J MOL BIOL, V262, P706, DOI 10.1006/jmbi.1996.0546; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; Lendzian F, 2005, BBA-BIOENERGETICS, V1707, P67, DOI 10.1016/j.bbabio.2004.02.011; Leung AYH, 2005, HISTOCHEM CELL BIOL, V124, P105, DOI 10.1007/s00418-005-0003-2; Lu B, 2004, NEURON GLIA BIOL, V1, P377, DOI 10.1017/S1740925X05000232; MAGNUSSON KE, 1976, BIOTECHNOL BIOENG, V18, P865, DOI 10.1002/bit.260180608; Mathews CZ, 1996, MOL MAR BIOL BIOTECH, V5, P284; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nilsson GE, 2001, NEWS PHYSIOL SCI, V16, P217; NILSSON GE, 1990, J EXP BIOL, V150, P295; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; Ohno S., 1970, EVOLUTION GENE DUPLI; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reichard P, 1997, TRENDS BIOCHEM SCI, V22, P81, DOI 10.1016/S0968-0004(97)01003-7; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; ROSS W, 1995, J CLIN PATHOL-CL MOL, V48, pM113; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmidt PP, 1996, J BIOL CHEM, V271, P23615, DOI 10.1074/jbc.271.39.23615; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; Shang HQ, 2011, GENE, V475, P30, DOI 10.1016/j.gene.2010.12.008; Sjoberg BM, 1997, STRUCT BOND, V88, P139; Smith RW, 1996, AM J PHYSIOL-REG I, V271, pR897, DOI 10.1152/ajpregu.1996.271.4.R897; Sollid J, 2005, AM J PHYSIOL-REG I, V289, pR1196, DOI 10.1152/ajpregu.00267.2005; Stecyk JAW, 2004, SCIENCE, V306, P77, DOI 10.1126/science.1100763; Strand KR, 2004, J BIOL CHEM, V279, P46794, DOI 10.1074/jbc.M407346200; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; SYMONS MCR, 1978, ANN REP PROGR CHEM A, V75, P117, DOI 10.1039/pr9787500117; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; Tomter AB, 2008, BIOCHEMISTRY-US, V47, P11300, DOI 10.1021/bi801212f; Tomter AB, 2013, COORDIN CHEM REV, V257, P3, DOI 10.1016/j.ccr.2012.05.021; Tomter AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025022; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; UN S, 1995, J AM CHEM SOC, V117, P10713, DOI 10.1021/ja00148a013; Uppsten M, 2006, J MOL BIOL, V359, P365, DOI 10.1016/j.jmb.2006.03.035; van Dam PJ, 1998, J AM CHEM SOC, V120, P5080, DOI 10.1021/ja9737127; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Vornanen M, 2011, NATURWISSENSCHAFTEN, V98, P225, DOI 10.1007/s00114-011-0764-5; Vornanen M, 2009, FISH PHYSIOL, V27, P397, DOI 10.1016/S1546-5098(08)00009-5; Wei PP, 2006, BIOCHEMISTRY-US, V45, P14043, DOI 10.1021/bi061127p; Zupanc GKH, 2009, SEMIN CELL DEV BIOL, V20, P683, DOI 10.1016/j.semcdb.2008.12.001	86	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42784	10.1371/journal.pone.0042784	http://dx.doi.org/10.1371/journal.pone.0042784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916159	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800022
J	Banerjee, S; Mujumdar, N; Dudeja, V; Mackenzie, T; Krosch, TK; Sangwan, V; Vickers, SM; Saluja, AK				Banerjee, Sulagna; Mujumdar, Nameeta; Dudeja, Vikas; Mackenzie, Tiffany; Krosch, Tara K.; Sangwan, Veena; Vickers, Selwyn M.; Saluja, Ashok K.			MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MULTIPLE-MYELOMA CELLS; HEAT-SHOCK-PROTEIN-70 FAMILY; METASTATIC PROPERTIES; ONCOPROTEIN FUNCTIONS; INDUCED APOPTOSIS; CYTOPLASMIC TAIL; MUCIN 1; HSP70; ADENOCARCINOMA	Background: MUC1 is a type I transmembrane glycoprotein aberrantly overexpressed in various cancer cells including pancreatic cancer. The cytosolic end of MUC1 (MUC1-c) is extensively involved in a number of signaling pathways. MUC1-c is reported to inhibit apoptosis in a number of cancer cells, but the mechanism of inhibition is unclear. Method: Expression of MUC1-c was studied in the pancreatic cancer cell line MIAPaCa-2 at the RNA level by using qRTPCR and at the protein level by Western blotting. MUC1-c expression was inhibited either by siRNA or by a specific peptide inhibitor, GO-201. Effect of MUC1-c inhibition on viability and proliferation and lysosomal permeabilization were studied. Association of MUC1-c with HSP70 was detected by co-immunoprecipitation of MUC1-c and HSP70. Localization of MUC1-c in cellular organelles was monitored by immunofluorescence and with immuno-blotting by MUC1-c antibody after subcellular fractionation. Results: Inhibition of MUC1-c by an inhibitor (GO-201) or siRNA resulted in reduced viability and reduced proliferation of pancreatic cancer cells. Furthermore, GO-201, the peptide inhibitor of MUC1-c, was effective in reducing tumor burden in pancreatic cancer mouse model. MUC1-c was also found to be associated with HSP70 in the cytosol, although a significant amount of MUC1 was also seen to be present in the lysosomes. Inhibition of MUC1 expression or activity showed an enhanced Cathepsin B activity in the cytosol, indicating lysosomal permeabilization. Therefore this study indicates that MUC1-c interacted with HSP70 in the cytosol of pancreatic cancer cells and localized to the lysosomes in these cells. Further, our results showed that MUC1-c protects pancreatic cancer cells from cell death by stabilizing lysosomes and preventing release of Cathepsin B in the cytosol.	[Banerjee, Sulagna; Mujumdar, Nameeta; Dudeja, Vikas; Mackenzie, Tiffany; Krosch, Tara K.; Sangwan, Veena; Vickers, Selwyn M.; Saluja, Ashok K.] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Mackenzie, Tiffany] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Vickers, Selwyn M.; Saluja, Ashok K.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Banerjee, S (corresponding author), Univ Minnesota, Dept Surg, Div Basic & Translat Res, Box 242 UMHC, Minneapolis, MN 55455 USA.	asaluja@umn.edu			National Institutes of Health [R21 5R21CA131663-02, R01 5R01CA124723-05]; Catherine and Robert Goodale foundation; NATIONAL CANCER INSTITUTE [R01CA124723, P50CA101955, R21CA131663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catherine and Robert Goodale foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the National Institutes of Health R21 5R21CA131663-02, R01 5R01CA124723-05 and Catherine and Robert Goodale foundation to AKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464; Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Baldus SE, 2004, CRIT REV CL LAB SCI, V41, P189, DOI 10.1080/10408360490452040; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Creagh EM, 2000, EXP CELL RES, V257, P58, DOI 10.1006/excr.2000.4856; Croce MV, 2003, J HISTOCHEM CYTOCHEM, V51, P781, DOI 10.1177/002215540305100609; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joshi MD, 2009, MOL CANCER THER, V8, P3056, DOI 10.1158/1535-7163.MCT-09-0646; Kawano T, 2007, CANCER RES, V67, P11576, DOI 10.1158/0008-5472.CAN-07-2756; Khodarev N, 2010, ONCOGENE, V29, P920, DOI 10.1038/onc.2009.391; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Kufe D, 2010, ONCOGENE, V29, P5663, DOI 10.1038/onc.2010.334; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; LIGTENBERG MJL, 1992, CANCER RES, V52, P2318; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; MCDONALD JK, 1975, LIFE SCI, V17, P1269; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Petersen NHT, 2010, CELL CYCLE, V9, P2305, DOI 10.4161/cc.9.12.12052; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Ren CY, 2004, J CANCER RES CLIN, V130, P245, DOI 10.1007/s00432-003-0537-4; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Saluja A, 2008, J GASTROEN HEPATOL, V23, pS42, DOI 10.1111/j.1440-1746.2007.05272.x; Satoh S, 2000, INT J CANCER, V88, P507, DOI 10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; Traven A, 2004, CANCER CELL, V5, P107, DOI 10.1016/S1535-6108(04)00029-7; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Voos W, 2003, MOL CELL, V11, P1, DOI 10.1016/S1097-2765(03)00002-9; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yin L, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12584; Yin L, 2010, MOL PHARMACOL, V78, P166, DOI 10.1124/mol.110.065011; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	62	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43020	10.1371/journal.pone.0043020	http://dx.doi.org/10.1371/journal.pone.0043020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912777	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500100050
J	Gao, MS; Coggin, A; Yagnik, K; Teplitski, M				Gao, Mengsheng; Coggin, Andrew; Yagnik, Kruti; Teplitski, Max			Role of Specific Quorum-Sensing Signals in the Regulation of Exopolysaccharide II Production within Sinorhizobium meliloti Spreading Colonies	PLOS ONE			English	Article							RHIZOBIUM-LEGUME SYMBIOSIS; ACYL HOMOSERINE LACTONES; PSEUDOMONAS-AERUGINOSA; GALACTOGLUCAN BIOSYNTHESIS; SWARMING MOTILITY; BIOFILM FORMATION; NODULE INVASION; GENE-EXPRESSION; EPS II; INFECTION	Background: Quorum sensing (QS) in Sinorhizobium meliloti involves at least half a dozen different N-acyl homoserine lactone (AHL) signals. These signals are produced by SinI, the sole AHL synthase in S. meliloti Rm8530. The sinI gene is regulated by two LuxR-type transcriptional regulators, SinR and ExpR. Mutations in sinI, sinR and expR abolish the production of exopolysaccharide II (EPS II). Methodology/Principal Findings: This study investigated a new type of coordinated surface spreading of Rm8530 that can be categorized as swarming. Motility assays on semi-solid surfaces revealed that both flagella and EPS II are required for this type of motility. The production of EPS II depends on AHLs produced by SinI. Of these AHLs, only C-16:1- and 3-oxo-C-16:1- homoserine lactones (HSLs) stimulated swarming in an ExpR-dependent manner. These two AHLs induced the strongest response in the wggR reporter fusions. WggR is a positive regulator of the EPS II biosynthesis gene expression. The levels of the wggR activation correlated with the extent of swarming. Furthermore, swarming of S. meliloti required the presence of the high molecular weight (HMW) fraction of EPS II. Within swarming colonies, a recombinase-based RIVET reporter in the wggR gene was resolved in 30% of the cells, indicating an enhanced regulation of EPS II production in the subpopulation of cells, which was sufficient to support swarming of the entire colony. Conclusions/Significance: Swarming behavior of S. meliloti Rm8530 on semi-solid surfaces is found to be dependent on the functional QS regulatory cascades. Even though multiple AHL signals are produced by the bacterium, only two AHLs species, C-16:1- and 3-oxo-C-16:1-HSLs, affected swarming by up-regulating the expression of wggR. While EPS II is produced by Rm8530 as high and low molecular weight fractions, only the HMW EPS II facilitated initial stages of swarming, thus, suggesting a function for this polymer.	[Gao, Mengsheng; Coggin, Andrew; Yagnik, Kruti; Teplitski, Max] Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Gao, MS (corresponding author), Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA.	msgao@ufl.edu		Yagnik, Kruti/0000-0001-6494-2142	United States Department of Agriculture National Research Initiative [2007-35319-18158]; CRIS project [FLA-SWS-004631]; Current Research Information System [FLA-SWS-004984]; University of Florida Research Innovation Grant program; University of Florida Institute of Food and Agricultural Sciences; University of Florida	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); CRIS project; Current Research Information System(United States Department of Agriculture (USDA)); University of Florida Research Innovation Grant program; University of Florida Institute of Food and Agricultural Sciences(University of Florida); University of Florida(University of Florida)	This work was supported by United States Department of Agriculture National Research Initiative 2007-35319-18158 (CRIS project # FLA-SWS-004631) in cooperation with The Current Research Information System # FLA-SWS-004984. Additional funding was provided by University of Florida Research Innovation Grant program. Research contribution of KY was funded by University of Florida Institute of Food and Agricultural Sciences Dean for Summer Research Internship Program. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlawane C, 2008, MOL PLANT MICROBE IN, V21, P1498, DOI 10.1094/MPMI-21-11-1498; Bahlawane C, 2008, J BACTERIOL, V190, P3456, DOI 10.1128/JB.00062-08; Baumgarth B, 2005, MICROBIOL-SGM, V151, P259, DOI 10.1099/mic.0.27442-0; Becker A, 1997, J BACTERIOL, V179, P1375, DOI 10.1128/jb.179.4.1375-1384.1997; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bittner AN, 2006, J BACTERIOL, V188, P3507, DOI 10.1128/JB.188.10.3507-3515.2006; Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Daniels R, 2006, P NATL ACAD SCI USA, V103, P14965, DOI 10.1073/pnas.0511037103; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Driscoll BT, 1997, MICROBIOL-SGM, V143, P489, DOI 10.1099/00221287-143-2-489; FINAN TM, 1995, GENE, V152, P65, DOI 10.1016/0378-1119(94)00643-7; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gao MS, 2008, MOL PLANT MICROBE IN, V21, P162, DOI 10.1094/MPMI-21-2-0162; Gao MS, 2010, MOL PLANT MICROBE IN, V23, P355, DOI 10.1094/MPMI-23-4-0355; Gao MS, 2005, J BACTERIOL, V187, P7931, DOI 10.1128/JB.187.23.7931-7944.2005; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; GLAZEBROOK J, 1989, CELL, V56, P661, DOI 10.1016/0092-8674(89)90588-6; GLAZEBROOK J, 1991, METHOD ENZYMOL, V204, P398; Gonzalez JE, 1996, P NATL ACAD SCI USA, V93, P8636, DOI 10.1073/pnas.93.16.8636; GOTZ R, 1987, J BACTERIOL, V169, P3146; Gurich N, 2009, J BACTERIOL, V191, P4372, DOI 10.1128/JB.00376-09; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; KELLER M, 1995, MOL PLANT MICROBE IN, V8, P267, DOI 10.1094/MPMI-8-0267; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lindum PW, 1998, J BACTERIOL, V180, P6384; Llamas I, 2004, APPL ENVIRON MICROB, V70, P3715, DOI [10.1128/AEM.70.6.3715-3723.2004, 10.1128/aem.70.6.3715-3723.2004]; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; Marketon MM, 2002, J BACTERIOL, V184, P5686, DOI 10.1128/JB.184.20.5686-5695.2002; Marketon MM, 2003, J BACTERIOL, V185, P325, DOI 10.1128/JB.185.1.325-331.2003; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; McIntosh M, 2009, MOL MICROBIOL, V74, P1238, DOI 10.1111/j.1365-2958.2009.06930.x; McIntosh M, 2008, J BACTERIOL, V190, P5308, DOI 10.1128/JB.00063-08; Mueller K, 2011, J BACTERIOL, V193, P485, DOI 10.1128/JB.01129-10; MULLER P, 1993, MOL PLANT MICROBE IN, V6, P55, DOI 10.1094/MPMI-6-055; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Nogales J, 2012, J BACTERIOL; OCHSNER UA, 1995, P NATL ACAD SCI USA, V92, P6424, DOI 10.1073/pnas.92.14.6424; Oke V, 1999, MOL MICROBIOL, V32, P837, DOI 10.1046/j.1365-2958.1999.01402.x; Pellock BJ, 2002, J BACTERIOL, V184, P5067, DOI 10.1128/JB.184.18.5067-5076.2002; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Sorroche FG, 2010, CURR MICROBIOL, V61, P465, DOI 10.1007/s00284-010-9639-9; Soto MJ, 2002, MOL MICROBIOL, V43, P371, DOI 10.1046/j.1365-2958.2002.02749.x; Sule S, 2009, LETT APPL MICROBIOL, V49, P596, DOI 10.1111/j.1472-765X.2009.02716.x; Tian CF, 2012, P NATL ACAD SCI USA, V109, P6751, DOI 10.1073/pnas.1120260109; Venturi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009998; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; ZHAN HJ, 1989, P NATL ACAD SCI USA, V86, P3055, DOI 10.1073/pnas.86.9.3055	58	35	36	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42611	10.1371/journal.pone.0042611	http://dx.doi.org/10.1371/journal.pone.0042611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912712	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500100017
J	Kamphuis, W; Mamber, C; Moeton, M; Kooijman, L; Sluijs, JA; Jansen, AHP; Verveer, M; de Groot, LR; Smith, VD; Rangarajan, S; Rodriguez, JJ; Orre, M; Hol, EM				Kamphuis, Willem; Mamber, Carlyn; Moeton, Martina; Kooijman, Lieneke; Sluijs, Jacqueline A.; Jansen, Anne H. P.; Verveer, Monique; de Groot, Lody R.; Smith, Vanessa D.; Rangarajan, Sindhoo; Rodriguez, Jose J.; Orre, Marie; Hol, Elly M.			GFAP Isoforms in Adult Mouse Brain with a Focus on Neurogenic Astrocytes and Reactive Astrogliosis in Mouse Models of Alzheimer Disease	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; TRIPLE-TRANSGENIC MODEL; INTERMEDIATE-FILAMENTS; SENILE PLAQUES; IMMUNOHISTOCHEMICAL CHARACTERIZATION; SUBVENTRICULAR ZONE; BETA; EXPRESSION; IDENTIFICATION; PATHOLOGY	Glial fibrillary acidic protein (GFAP) is the main astrocytic intermediate filament (IF). GFAP splice isoforms show differential expression patterns in the human brain. GFAP delta is preferentially expressed by neurogenic astrocytes in the subventricular zone (SVZ), whereas GFAP(+1) is found in a subset of astrocytes throughout the brain. In addition, the expression of these isoforms in human brain material of epilepsy, Alzheimer and glioma patients has been reported. Here, for the first time, we present a comprehensive study of GFAP isoform expression in both wild-type and Alzheimer Disease (AD) mouse models. In cortex, cerebellum, and striatum of wild-type mice, transcripts for Gfap-alpha, Gfap-beta, Gfap-gamma, Gfap-delta, Gfap-kappa, and a newly identified isoform Gfap-zeta, were detected. Their relative expression levels were similar in all regions studied. GFAP alpha showed a widespread expression whilst GFAP delta distribution was prominent in the SVZ, rostral migratory stream (RMS), neurogenic astrocytes of the subgranular zone (SGZ), and subpial astrocytes. In contrast to the human SVZ, we could not establish an unambiguous GFAP delta localization in proliferating cells of the mouse SVZ. In APPswePS1dE9 and 3xTgAD mice, plaque-associated reactive astrocytes had increased transcript levels of all detectable GFAP isoforms and low levels of a new GFAP isoform, Gfap-Delta Ex7. Reactive astrocytes in AD mice showed enhanced GFAP alpha and GFAP delta immunolabeling, less frequently increased vimentin and nestin, but no GFAP kappa or GFAP(+1) staining. In conclusion, GFAP delta protein is present in SVZ, RMS, and neurogenic astrocytes of the SGZ, but also outside neurogenic niches. Furthermore, differential GFAP isoform expression is not linked with aging or reactive gliosis. This evidence points to the conclusion that differential regulation of GFAP isoforms is not involved in the reorganization of the IF network in reactive gliosis or in neurogenesis in the mouse brain.	[Kamphuis, Willem; Mamber, Carlyn; Moeton, Martina; Kooijman, Lieneke; Sluijs, Jacqueline A.; Jansen, Anne H. P.; Verveer, Monique; de Groot, Lody R.; Smith, Vanessa D.; Rangarajan, Sindhoo; Orre, Marie; Hol, Elly M.] Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Dept Astrocyte Biol & Neurodegenerat, Amsterdam, Netherlands; [Hol, Elly M.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Smith, Vanessa D.] Mayo Clin, Coll Med, Rochester, MN USA; [Rodriguez, Jose J.] Univ Basque Country UPV EHU, Dept Neurosci, Leioa, Spain; [Rodriguez, Jose J.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Mayo Clinic; University of Basque Country; Basque Foundation for Science	Kamphuis, W (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Dept Astrocyte Biol & Neurodegenerat, Amsterdam, Netherlands.	w.kamphuis@nin.knaw.nl	Hol, Elly/J-2025-2019; Hol, Elly M/F-1891-2013	Hol, Elly/0000-0001-5604-2603; Hol, Elly M/0000-0001-5604-2603	Internationale Stichting Alzheimer Onderzoek (ISAO) [08504]; Netherlands Organization for Scientific Research (NWO) [865.09.003]	Internationale Stichting Alzheimer Onderzoek (ISAO); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Internationale Stichting Alzheimer Onderzoek (ISAO; M.O. [#08504]) and the Netherlands Organization for Scientific Research (NWO; VICI grant to E. M. H. [865.09.003]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Andreiuolo F, 2008, NEUROPATHOLOGY; Arnold SE, 1996, ACTA NEUROPATHOL, V91, P269, DOI 10.1007/s004010050425; Bandyopadhyay U, 2010, MOL CELL, V39, P535, DOI 10.1016/j.molcel.2010.08.004; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Boer K, 2010, EPILEPSY RES, V90, P99, DOI 10.1016/j.eplepsyres.2010.03.014; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Choi KC, 2009, NEUROSCI LETT, V463, P182, DOI 10.1016/j.neulet.2009.07.076; Condorelli DF, 1999, J NEUROSCI RES, V56, P219, DOI 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2; Condorelli DF, 1999, NEUROCHEM RES, V24, P709, DOI 10.1023/A:1021016828704; Dijk F, 2004, INVEST OPHTH VIS SCI, V45, P330, DOI 10.1167/iovs.03-0285; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ENG LF, 1992, PROG BRAIN RES, V94, P353; FEINSTEIN DL, 1992, J NEUROSCI RES, V32, P1, DOI 10.1002/jnr.490320102; Fuller S, 2009, EXPERT REV NEUROTHER, V9, P1585, DOI 10.1586/ERN.09.111; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hanzel DK, 1999, NAT BIOTECHNOL, V17, P53, DOI 10.1038/5225; Heo DH, 2012, J NEURO-ONCOL, V108, P45, DOI 10.1007/s11060-012-0801-z; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Hyder CL, 2011, J CELL SCI, V124, P1363, DOI 10.1242/jcs.041244; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kato S, 1998, PATHOL INT, V48, P332, DOI 10.1111/j.1440-1827.1998.tb03915.x; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; LIN RCS, 1995, NEUROBIOL DIS, V2, P79, DOI 10.1006/nbdi.1995.0008; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Mei X, 2010, NEUROSCIENCE, V171, P92, DOI 10.1016/j.neuroscience.2010.08.001; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Middeldorp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007663; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; Nawashiro H, 1998, NEUROREPORT, V9, P1691, DOI 10.1097/00001756-199806010-00004; Nawashiro H, 2000, J CEREBR BLOOD F MET, V20, P1040, DOI 10.1097/00004647-200007000-00003; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; NOPPE M, 1986, CLIN CHIM ACTA, V155, P143, DOI 10.1016/0009-8981(86)90275-5; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Peters O, 2009, J ALZHEIMERS DIS, V18, P177, DOI 10.3233/JAD-2009-1140; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Rutka JT, 1999, INT J DEV NEUROSCI, V17, P503, DOI 10.1016/S0736-5748(99)00049-0; Salmina AB, 2009, J ALZHEIMERS DIS, V16, P485, DOI 10.3233/JAD-2009-0988; SARRIA AJ, 1994, J CELL SCI, V107, P1593; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tanaka H, 2002, J NEUROSCI RES, V67, P11, DOI 10.1002/jnr.10004.abs; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Vehmas AK, 2003, NEUROBIOL AGING, V24, P321, DOI 10.1016/S0197-4580(02)00090-8; Vincent AJ, 2010, J ALZHEIMERS DIS, V22, P699, DOI 10.3233/JAD-2010-101089; WESTERMARK B, 1973, ACTA PATH MICRO IM A, VA 81, P791; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wharton SB, 2009, DEMENT GERIATR COGN, V27, P465, DOI 10.1159/000217729; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xu KX, 1999, GLIA, V25, P390, DOI 10.1002/(SICI)1098-1136(19990215)25:4<390::AID-GLIA8>3.0.CO;2-7; Xue ZG, 2004, EXP CELL RES, V298, P431, DOI 10.1016/j.yexcr.2004.04.023; YAMADA T, 1992, ACTA NEUROPATHOL, V84, P157, DOI 10.1007/BF00311389; Yoshida T, 2007, J HUM GENET, V52, P362, DOI 10.1007/s10038-007-0124-7; ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P	80	183	193	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42823	10.1371/journal.pone.0042823	http://dx.doi.org/10.1371/journal.pone.0042823			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912745	gold, Green Published			2022-12-27	WOS:000307500100035
J	Lopez-del Hoyo, N; Fazioli, L; Lopez-Begines, S; Fernandez-Sanchez, L; Cuenca, N; Llorens, J; de la Villa, P; Mendez, A				Lopez-del Hoyo, Natalia; Fazioli, Lucrezia; Lopez-Begines, Santiago; Fernandez-Sanchez, Laura; Cuenca, Nicolas; Llorens, Jordi; de la Villa, Pedro; Mendez, Ana			Overexpression of Guanylate Cyclase Activating Protein 2 in Rod Photoreceptors In Vivo Leads to Morphological Changes at the Synaptic Ribbon	PLOS ONE			English	Article							MOUSE RETINA; LOCALIZATION; EXPRESSION; SYNAPSES; CLONING; TRANSMISSION; DYNAMICS; MUTATION; REVEALS; BASSOON	Guanylate cyclase activating proteins are EF-hand containing proteins that confer calcium sensitivity to retinal guanylate cyclase at the outer segment discs of photoreceptor cells. By making the rate of cGMP synthesis dependent on the free intracellular calcium levels set by illumination, GCAPs play a fundamental role in the recovery of the light response and light adaptation. The main isoforms GCAP1 and GCAP2 also localize to the synaptic terminal, where their function is not known. Based on the reported interaction of GCAP2 with Ribeye, the major component of synaptic ribbons, it was proposed that GCAP2 could mediate the synaptic ribbon dynamic changes that happen in response to light. We here present a thorough ultrastructural analysis of rod synaptic terminals in loss-of-function (GCAP1/GCAP2 double knockout) and gain-of-function (transgenic overexpression) mouse models of GCAP2. Rod synaptic ribbons in GCAPs-/- mice did not differ from wildtype ribbons when mice were raised in constant darkness, indicating that GCAPs are not required for ribbon early assembly or maturation. Transgenic overexpression of GCAP2 in rods led to a shortening of synaptic ribbons, and to a higher than normal percentage of club-shaped and spherical ribbon morphologies. Restoration of GCAP2 expression in the GCAPs-/- background (GCAP2 expression in the absence of endogenous GCAP1) had the striking result of shortening ribbon length to a much higher degree than overexpression of GCAP2 in the wildtype background, as well as reducing the thickness of the outer plexiform layer without affecting the number of rod photoreceptor cells. These results indicate that preservation of the GCAP1 to GCAP2 relative levels is relevant for maintaining the integrity of the synaptic terminal. Our demonstration of GCAP2 immunolocalization at synaptic ribbons at the ultrastructural level would support a role of GCAPs at mediating the effect of light on morphological remodeling changes of synaptic ribbons.	[Lopez-del Hoyo, Natalia; Fazioli, Lucrezia; Lopez-Begines, Santiago; Llorens, Jordi; Mendez, Ana] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain; [Fernandez-Sanchez, Laura; Cuenca, Nicolas] Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain; [Llorens, Jordi] Univ Barcelona, Dept Physiol Sci 2, Barcelona, Spain; [de la Villa, Pedro] Univ Alcala de Henares, Dept Physiol, Madrid, Spain; [Mendez, Ana] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat d'Alacant; University of Barcelona; Universidad de Alcala; University of Barcelona	Lopez-del Hoyo, N (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain.	mendezzu@idibell.cat	Lopez del Hoyo, Natalia/K-7816-2013; Méndez, Ana/F-9729-2016; Llorens, Jordi/A-6959-2008; Cuenca, Nicolas/I-2007-2015; López, Santiago/AAZ-3824-2021; Fernandez-Sanchez, Laura/AAB-5663-2019; de la Villa, Pedro/G-2322-2016	Lopez del Hoyo, Natalia/0000-0001-9333-8235; Méndez, Ana/0000-0001-6393-1644; Llorens, Jordi/0000-0002-3894-9401; Cuenca, Nicolas/0000-0002-6767-5710; López, Santiago/0000-0001-8809-8919; Fernandez-Sanchez, Laura/0000-0002-3629-0156; de la Villa, Pedro/0000-0001-9856-6616	Spanish Ministry of Science and Innovation [BFU2008-04199/BFI, BFU2011-26519/BFI, BFU2009-06945, SAF2010-21879, RETICS RD07/0062/0008, BFU2009-07793/BFI, RETICS RD07/0062/0012]; European Community [210042/RODCELL]; Bellvitge Biomedical Research Institute (IDIBELL) [10IDB012]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Bellvitge Biomedical Research Institute (IDIBELL)	This work was supported by grants from the Spanish Ministry of Science and Innovation to A. M. (BFU2008-04199/BFI and BFU2011-26519/BFI), to J.Ll. (BFU2009-06945), to P.dlV. (SAF2010-21879 and RETICS RD07/0062/0008), to N.C. (BFU2009-07793/BFI and RETICS RD07/0062/0012); from the European Community to A. M. (Marie-Curie Reintegration grant 210042/RODCELL) and from The Bellvitge Biomedical Research Institute (IDIBELL) to A. M. (10IDB012). N.L.-H. was the recipient of an Bellvitge Biomedical Research Institute (IDIBELL) PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adly MA, 1999, INVEST OPHTH VIS SCI, V40, P2165; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Balkema GW, 2001, VISUAL NEUROSCI, V18, P789, DOI 10.1017/S0952523801185123; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Biehlmaier O, 2007, NEUROCHEM INT, V50, P189, DOI 10.1016/j.neuint.2006.08.001; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; Fuchs M, 2012, J COMP NEUR IN PRESS; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Grossman GH, 2009, INVEST OPHTH VIS SCI, V50, P3074, DOI 10.1167/iovs.08-3190; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; LoGiudice L, 2009, NEUROSCIENTIST, V15, P380, DOI 10.1177/1073858408331373; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Prescott ED, 2005, CURR OPIN NEUROBIOL, V15, P431, DOI 10.1016/j.conb.2005.07.005; Regus-Leidig H, 2010, MOL VIS, V16, P2690; Regus-Leidig H, 2009, J COMP NEUROL, V512, P814, DOI 10.1002/cne.21915; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Snellman J, 2011, NAT NEUROSCI, V14, P1135, DOI 10.1038/nn.2870; Spiwoks-Becker I, 2004, EUR J NEUROSCI, V19, P1559, DOI 10.1111/j.1460-9568.2004.03198.x; Thoreson WB, 2007, MOL NEUROBIOL, V36, P205, DOI 10.1007/s12035-007-0019-9; Van Epps HA, 2004, J NEUROSCI, V24, P8641, DOI 10.1523/JNEUROSCI.2892-04.2004; Venkatesan JK, 2010, J NEUROSCI, V30, P6559, DOI 10.1523/JNEUROSCI.3701-09.2010; Vollrath L, 1996, MICROSC RES TECHNIQ, V35, P472, DOI 10.1002/(SICI)1097-0029(19961215)35:6<472::AID-JEMT6>3.0.CO;2-K; Vollrath L, 2001, MARC MALPIG SYMP SER, V7, P499; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; Werblin FS, 2011, J PHYSIOL-LONDON, V589, P3691, DOI 10.1113/jphysiol.2011.210617; Zampighi GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016944; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	49	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42994	10.1371/journal.pone.0042994	http://dx.doi.org/10.1371/journal.pone.0042994			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912773	Green Published, gold			2022-12-27	WOS:000307500100049
J	Molenaar-de Backer, MWA; Lukashov, VV; van Binnendijk, RS; Boot, HJ; Zaaijer, HL				Molenaar-de Backer, Marijke W. A.; Lukashov, Vladimir V.; van Binnendijk, Rob S.; Boot, Hein J.; Zaaijer, Hans L.			Global Co-Existence of Two Evolutionary Lineages of Parvovirus B19 1a, Different in Genome-Wide Synonymous Positions	PLOS ONE			English	Article							DUTCH BLOOD-DONORS; NUCLEOTIDE COMPOSITION; CELLULAR CORECEPTOR; GENETIC DIVERSITY; DNA; SEQUENCE; IDENTIFICATION; INFECTION; VIREMIA; ASSAYS	Parvovirus B19 (B19V) can cause infection in humans. To date, three genotypes of B19V, with subtypes, are known, of which genotype 1a is the most prevalent genotype in the Western world. We sequenced the genome of B19V strains of 65 asymptomatic, recently infected Dutch blood donors, to investigate the spatio-temporal distribution of B19V strains, in the years 2003-2009. The sequences were compared to B19V sequences from Dutch patients with fifth disease, and to global B19V sequences as available from GenBank. All Dutch B19V strains belonged to genotype 1a. Phylogenetic analysis of the strains from Dutch blood donors showed that two groups of genotype 1a co-exist. A clear-cut division into the two groups was also found among the B19V strains from Dutch patients, and among the B19V sequences in GenBank. The two groups of genotype 1a co-exist around the world and do not appear to differ in their ability to cause disease. Strikingly, the two groups of B19V predominantly differ in synonymous mutations, distributed throughout the entire genome of B19V. We propose to call the two groups of B19V genotype 1a respectively subtype 1a1 and 1a2.	[Molenaar-de Backer, Marijke W. A.; Zaaijer, Hans L.] Sanquin Blood Supply Fdn, Dept Blood Borne Infect, Amsterdam, Netherlands; [Molenaar-de Backer, Marijke W. A.] Sanquin Blood Supply Fdn, Dept Viral Diagnost Serv, Amsterdam, Netherlands; [Lukashov, Vladimir V.] Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol, Dept Med Microbiol, Amsterdam, Netherlands; [van Binnendijk, Rob S.; Boot, Hein J.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands; [Zaaijer, Hans L.] Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, Lab Clin Virol, Amsterdam, Netherlands	University of Amsterdam; Netherlands National Institute for Public Health & the Environment; University of Amsterdam	Molenaar-de Backer, MWA (corresponding author), Sanquin Blood Supply Fdn, Dept Blood Borne Infect, Amsterdam, Netherlands.	m.molenaar@sanquin.nl						Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Barroso H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014548; Baylis SA, 2004, J VIROL METHODS, V121, P7, DOI 10.1016/j.jviromet.2004.05.011; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; BROWN KE, 1994, CRIT REV ONCOL HEMAT, V16, P1, DOI 10.1016/1040-8428(94)90040-X; Fauquet C., 2005, 8 ICTV; Gigler A, 1995, J GEN VIROL 3, V76, P519; Hokynar K, 2000, J GEN VIROL, V81, P1017, DOI 10.1099/0022-1317-81-4-1017; Kooistra K, 2011, VOX SANG, V100, P261, DOI 10.1111/j.1423-0410.2010.01423.x; Koppelman MHGM, 2007, VOX SANG, V93, P208, DOI 10.1111/j.1423-0410.2007.00957.x; Koppelman MHGM, 2011, TRANSFUSION, V51, P1346, DOI 10.1111/j.1537-2995.2010.02995.x; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; MORI J, 1987, J GEN VIROL, V68, P2797, DOI 10.1099/0022-1317-68-11-2797; MORINET F, 1986, ARCH VIROL, V90, P165, DOI 10.1007/BF01314155; Morita E, 2002, SPRINGER SEMIN IMMUN, V24, P187, DOI 10.1007/s00281-002-0099-6; Munakata Y, 2005, BLOOD, V106, P3449, DOI 10.1182/blood-2005-02-0536; NUNOUE T, 1985, J PEDIATR-US, V107, P38, DOI 10.1016/S0022-3476(85)80610-7; Parsyan A, 2007, TRANSFUSION MED, V17, P263, DOI 10.1111/j.1365-3148.2007.00765.x; SATO H, 1991, J VIROL, V65, P5485, DOI 10.1128/JVI.65.10.5485-5490.1991; Servant A, 2002, J VIROL, V76, P9124, DOI 10.1128/JVI.76.18.9124-9134.2002; Servant-Delmas A, 2010, J VIROL, V84, P9658, DOI 10.1128/JVI.00684-10; SHADE RO, 1986, J VIROL, V58, P921, DOI 10.1128/JVI.58.3.921-936.1986; Suzuki M, 2009, J VIROL, V83, P10975, DOI 10.1128/JVI.00273-09; UMENE K, 1990, J GEN VIROL, V71, P983, DOI 10.1099/0022-1317-71-4-983; UMENE K, 1991, J GEN VIROL, V72, P1997, DOI 10.1099/0022-1317-72-8-1997; van Hemert FJ, 2007, VIROLOGY, V361, P447, DOI 10.1016/j.virol.2006.11.021; Weigel-Kelley KA, 2003, BLOOD, V102, P3927, DOI 10.1182/blood-2003-05-1522; Zaaijer HL, 2004, EPIDEMIOL INFECT, V132, P1161, DOI 10.1017/S0950268804002730; Zsiros J, 1999, J MOL EVOL, V48, P102, DOI 10.1007/PL00006437	32	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43206	10.1371/journal.pone.0043206	http://dx.doi.org/10.1371/journal.pone.0043206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912828	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100072
J	Niedringhaus, M; Chen, X; Dzakpasu, R; Conant, K				Niedringhaus, Mark; Chen, Xin; Dzakpasu, Rhonda; Conant, Katherine			MMPs and Soluble ICAM-5 Increase Neuronal Excitability within In Vitro Networks of Hippocampal Neurons	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; LONG-TERM POTENTIATION; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; NMDA RECEPTOR; SPINE ENLARGEMENT; SILENT SYNAPSES; PLASTICITY; MATRIX-METALLOPROTEINASE-9; MECHANISMS	Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that are released from neurons in an activity dependent manner. Published studies suggest their activity is important to varied forms of learning and memory. At least one MMP can stimulate an increase in the size of dendritic spines, structures which represent the post synaptic component for a large number of glutamatergic synapses. This change may be associated with increased synaptic glutamate receptor incorporation, and an increased amplitude and/or frequency of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) mini excitatory post-synaptic currents (EPSCs). An associated increase in the probability of action potential occurrence would be expected. While the mechanism(s) by which MMPs may influence synaptic structure and function are not completely understood, MMP dependent shedding of specific cell adhesion molecules (CAMs) could play an important role. CAMs are ideally positioned to be cleaved by synaptically released MMPs, and shed N terminal domains could potentially interact with previously unengaged integrins to stimulate dendritic actin polymerization with spine expansion. In the present study, we have used multielectrode arrays (MEAs) to investigate MMP and soluble CAM dependent changes in neuronal activity recorded from hippocampal cultures. We have focused on intercellular adhesion molecule-5 (ICAM-5) in particular, as this CAM is expressed on glutamatergic dendrites and shed in an MMP dependent manner. We show that chemical long-term potentiation (cLTP) evoked changes in recorded activity, and the dynamics of action potential bursts in particular, are altered by MMP inhibition. A blocking antibody to beta(1) integrins has a similar effect. We also show that the ectodomain of ICAM-5 can stimulate beta(1) integrin dependent increases in spike counts and burst number. These results support a growing body of literature suggesting that MMPs have important effects on neuronal excitability. They also support the possibility that MMP dependent shedding of specific synaptic CAMs can contribute to these effects.	[Niedringhaus, Mark; Dzakpasu, Rhonda; Conant, Katherine] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Chen, Xin; Dzakpasu, Rhonda] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Conant, Katherine] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University	Niedringhaus, M (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.	dzakpasu@physics.georgetown.edu; kec84@georgetown.edu	Dzakpasu, Rhonda/F-8060-2019	Dzakpasu, Rhonda/0000-0002-7223-4602	Luce Foundation; National Institutes of Health, National Institute on Aging [029806]; Division Of Physics [1205919] Funding Source: National Science Foundation	Luce Foundation; National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Dr. Niedringhaus, Dr. Chen, and Dr. Dzakpasu were supported by the Luce Foundation. Dr. Conant was supported by a grant from the National Institutes of Health, National Institute on Aging (grant No. 029806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bernard-Trifilo JA, 2005, J NEUROCHEM, V93, P834, DOI 10.1111/j.1471-4159.2005.03062.x; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Brown TE, 2008, SYNAPSE, V62, P886, DOI 10.1002/syn.20562; Brown Travis E, 2007, Learn Mem, V14, P214, DOI 10.1101/lm.476207; Chen X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031907; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Clifford MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-21; Cohen D, 2011, J NEUROPHYSIOL, V106, P2314, DOI 10.1152/jn.00969.2010; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Conant K, 2011, J NEUROCHEM, V118, P521, DOI 10.1111/j.1471-4159.2010.07153.x; Docherty SJ, 2010, GENES BRAIN BEHAV, V9, P234, DOI 10.1111/j.1601-183X.2009.00553.x; Fragkouli A, 2012, J NEUROCHEM, V121, P239, DOI 10.1111/j.1471-4159.2011.07637.x; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hoffman KB, 1998, BRAIN RES, V811, P29, DOI 10.1016/S0006-8993(98)00906-8; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Israel JM, 2008, J NEUROSCI, V28, P385, DOI 10.1523/JNEUROSCI.5198-07.2008; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim J, 2011, J BIOL CHEM, V285, P22919; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; Leonardo CC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-34; Lim ST, 2012, J NEUROCHEM, V120, P741, DOI 10.1111/j.1471-4159.2011.07592.x; LOUGHLIN SE, 1986, NEUROSCIENCE, V18, P307, DOI 10.1016/0306-4522(86)90156-9; Madhavan R, 2007, THESIS GEORGIA I TEC; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Meighan PC, 2007, J NEUROCHEM, V102, P2085, DOI 10.1111/j.1471-4159.2007.04682.x; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Milward EA, 2007, J NEUROIMMUNOL, V187, P9, DOI 10.1016/j.jneuroim.2007.04.010; Mizoguchi H, 2007, J NEUROCHEM, V100, P1579, DOI 10.1111/j.1471-4159.2006.04288.x; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nagy V, 2007, LEARN MEMORY, V14, P655, DOI 10.1101/lm.678307; Ogita H, 2008, J MICROSC-OXFORD, V231, P455, DOI 10.1111/j.1365-2818.2008.02058.x; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Pennartz CMA, 2002, PROG BRAIN RES, V138, P143, DOI 10.1016/S0079-6123(02)38076-2; Perouansky M, 2010, ANESTHESIOLOGY, V113, P1299, DOI 10.1097/ALN.0b013e3181f90ccc; Popescu IR, 2010, J PHYSIOL-LONDON, V588, P939, DOI 10.1113/jphysiol.2009.181461; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Samochowiec A, 2010, BRAIN RES, V1327, P103, DOI 10.1016/j.brainres.2010.02.072; Savtchouk I, 2011, J NEUROSCI, V31, P501, DOI 10.1523/JNEUROSCI.2608-10.2011; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Snyder K, 2012, NEUROPSYCHOPHARMACOL, V37, P520, DOI 10.1038/npp.2011.218; Stegenga J, 2010, BIOPHYS J, V98, P2452, DOI 10.1016/j.bpj.2010.02.026; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051907; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Weinhberger O, 2009, ANN M SOC NEUR, V322, pD16; Wright John W., 2007, Neural Plasticity, V2007, DOI 10.1155/2007/73813; Yong VW, 2007, J NEUROL SCI, V259, P79, DOI 10.1016/j.jns.2006.11.021	75	38	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42631	10.1371/journal.pone.0042631	http://dx.doi.org/10.1371/journal.pone.0042631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912716	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500100019
J	Fernandez-Mercado, M; Yip, BH; Pellagatti, A; Davies, C; Larrayoz, MJ; Kondo, T; Perez, C; Killick, S; McDonald, EJ; Odero, MD; Agirre, X; Prosper, F; Calasanz, MJ; Wainscoat, JS; Boultwood, J				Fernandez-Mercado, Marta; Yip, Bon Ham; Pellagatti, Andrea; Davies, Carwyn; Jose Larrayoz, Maria; Kondo, Toshinori; Perez, Cristina; Killick, Sally; McDonald, Emma-Jane; Dolores Odero, Maria; Agirre, Xabier; Prosper, Felipe; Jose Calasanz, Maria; Wainscoat, James S.; Boultwood, Jacqueline			Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics	PLOS ONE			English	Article							DNMT3A MUTATIONS; MYELODYSPLASTIC SYNDROMES; PROGNOSTIC IMPACT; ASXL1; TET2; EVENTS; RUNX1; IDH2; NPM1; JAK2	Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cases. We aimed to study the frequency and relationship of a wide range of genes previously reported as mutated in AML (ASXL1, NPM1, FLT3, TET2, IDH1/2, RUNX1, DNMT3A, NRAS, JAK2, WT1, CBL, SF3B1, TP53, KRAS and MPL) in a series of 84 CN-AML cases. The most frequently mutated genes in primary cases were NPM1 (60.8%) and FLT3 (50.0%), and in secondary cases ASXL1 (48.5%) and TET2 (30.3%). We showed that 85% of CN-AML patients have mutations in at least one of ASXL1, NPM1, FLT3, TET2, IDH1/2 and/or RUNX1. Serial samples from 19 MDS/CMML cases that progressed to AML were analyzed for ASXL1/TET2/IDH1/2 mutations; seventeen cases presented mutations of at least one of these genes. However, there was no consistent pattern in mutation acquisition during disease progression. This report concerns the analysis of the largest number of gene mutations in CN-AML studied to date, and provides insight into the mutational profile of CN-AML.	[Fernandez-Mercado, Marta; Yip, Bon Ham; Pellagatti, Andrea; Davies, Carwyn; Wainscoat, James S.; Boultwood, Jacqueline] John Radcliffe Hosp, LLR Mol Haematol Unit, NDCLS, Oxford OX3 9DU, England; [Pellagatti, Andrea; Dolores Odero, Maria; Jose Calasanz, Maria] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Kondo, Toshinori] Kawasaki Med Sch, Div Hematol, Okayama, Japan; [Perez, Cristina] Univ Navarra, Lab Myeloproliferat Syndromes, Oncol Area, Fdn Appl Med Res,Clin Univ, E-31080 Pamplona, Spain; [Killick, Sally; McDonald, Emma-Jane] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England; [Dolores Odero, Maria] Univ Navarra, Div Oncol, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Div Canc, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Area Cell Therapy, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Hematol Serv, E-31080 Pamplona, Spain	University of Oxford; University of Navarra; Kawasaki Medical School; University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra	Fernandez-Mercado, M (corresponding author), John Radcliffe Hosp, LLR Mol Haematol Unit, NDCLS, Oxford OX3 9DU, England.	jacqueline.boultwood@ndcls.ox.ac.uk	, Bon Ham Yip/E-4925-2019; Prosper, Felipe/H-6859-2017; Calasanz, MJ/R-5813-2016; Agirre, Xabier/ABE-4110-2020; Odero/ABG-9860-2020	, Bon Ham Yip/0000-0002-2105-3254; Prosper, Felipe/0000-0001-6115-8790; Calasanz, MJ/0000-0002-0374-3008; Odero/0000-0002-8858-2054; Boultwood, Jacqueline/0000-0002-4330-2928; Pellagatti, Andrea/0000-0002-6122-0221; Fernandez-Mercado, Marta/0000-0003-3458-9231	Leukaemia and Lymphoma Research; Kay Kendall Leukaemia Fund of the United Kingdom	Leukaemia and Lymphoma Research; Kay Kendall Leukaemia Fund of the United Kingdom	This work was supported by Leukaemia and Lymphoma Research and the Kay Kendall Leukaemia Fund of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, HAEMATOL-HEMATOL J, V93, P1595, DOI 10.3324/haematol.13187; Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Beer PA, 2010, BLOOD, V115, P2891, DOI 10.1182/blood-2009-08-236596; Boultwood J, 2010, LEUKEMIA, V24, P1062, DOI 10.1038/leu.2010.20; Carbuccia N, 2010, LEUKEMIA, V24, P469, DOI 10.1038/leu.2009.218; Chou WC, 2010, BLOOD, V116, P4086, DOI 10.1182/blood-2010-05-283291; Couronne L, 2010, LEUKEMIA, V24, P201, DOI 10.1038/leu.2009.169; Dicker F, 2010, LEUKEMIA, V24, P1528, DOI 10.1038/leu.2010.124; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Flach J, 2011, LEUKEMIA, V25, P713, DOI 10.1038/leu.2010.304; Ishikawa Y, 2009, EUR J HAEMATOL, V83, P90, DOI 10.1111/j.1600-0609.2009.01261.x; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Pratcorona M, 2011, HAEMATOLOGICA; Renneville A, 2012, LEUKEMIA; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894	23	50	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42334	10.1371/journal.pone.0042334	http://dx.doi.org/10.1371/journal.pone.0042334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912701	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500016
J	Wu, J; Shekhar, N; Lele, PP; Lele, TP				Wu, Jun; Shekhar, Nandini; Lele, Pushkar P.; Lele, Tanmay P.			FRAP Analysis: Accounting for Bleaching during Image Capture	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; FLUORESCENCE RECOVERY; IN-VIVO; DIFFUSION MEASUREMENTS; RATE CONSTANTS; BINDING; DYNAMICS; REVEALS; PARAMETERS; TRANSPORT	The analysis of Fluorescence Recovery After Photobleaching (FRAP) experiments involves mathematical modeling of the fluorescence recovery process. An important feature of FRAP experiments that tends to be ignored in the modeling is that there can be a significant loss of fluorescence due to bleaching during image capture. In this paper, we explicitly include the effects of bleaching during image capture in the model for the recovery process, instead of correcting for the effects of bleaching using reference measurements. Using experimental examples, we demonstrate the usefulness of such an approach in FRAP analysis.	[Wu, Jun; Shekhar, Nandini; Lele, Tanmay P.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA; [Lele, Pushkar P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	State University System of Florida; University of Florida; Harvard University	Wu, J (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	tlele@che.ufl.edu	Wu, Jun/Q-7143-2018	Wu, Jun/0000-0002-4457-5485; Lele, Pushkar/0000-0002-2894-3487	National Science Foundation [CMMI 0954302, CMMI 0927945]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation under awards CMMI 0954302 (TPL) and CMMI 0927945 (TPL). http://www.nsf.gov/awards/award_visualization_noscript.jsp?org = CMMI (R) ion = US-FL&instId = 0015354000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON DM, 1985, J CELL BIOL, V100, P1309, DOI 10.1083/jcb.100.4.1309; Braeckmans K, 2007, BIOPHYS J, V92, P2172, DOI 10.1529/biophysj.106.099838; Bulinski JC, 2001, J CELL SCI, V114, P3885; Deschout H, 2010, OPT EXPRESS, V18, P22886, DOI 10.1364/OE.18.022886; Dragestein KA, 2008, J CELL BIOL, V180, P729, DOI 10.1083/jcb.200707203; Kang M, 2008, BIOPHYS J, V95, pL13, DOI 10.1529/biophysj.108.135913; Kang MC, 2010, BIOPHYS J, V99, P2737, DOI 10.1016/j.bpj.2010.09.013; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; KAUFMAN EN, 1990, BIOPHYS J, V58, P873, DOI 10.1016/S0006-3495(90)82432-2; KAUFMAN EN, 1991, BIOPHYS J, V60, P596, DOI 10.1016/S0006-3495(91)82089-6; Lele TP, 2008, BIOCHEM BIOPH RES CO, V369, P929, DOI 10.1016/j.bbrc.2008.02.137; Lele TP, 2006, BIOPHYS CHEM, V120, P32, DOI 10.1016/j.bpc.2005.10.007; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Mueller F, 2012, METHODS MOL BIOL, V833, P153, DOI 10.1007/978-1-61779-477-3_11; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Smisdom N, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3569620; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stasevich TJ, 2010, BIOPHYS J, V99, P3093, DOI 10.1016/j.bpj.2010.08.059; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; van Royen Martin E., 2008, V464, P363, DOI 10.1007/978-1-60327-461-6_20; Wagner S, 2004, J CELL BIOL, V164, P843, DOI 10.1083/jcb.200307002	25	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42854	10.1371/journal.pone.0042854	http://dx.doi.org/10.1371/journal.pone.0042854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912750	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500030
J	Pozo-Rodriguez, F; Lopez-Campos, JL; Alvarez-Martinez, CJ; Castro-Acosta, A; Aguero, R; Hueto, J; Hernandez-Hernandez, J; Barron, M; Abraira, V; Forte, A; Nieto, JMS; Lopez-Gabaldon, E; Cosio, BG; Agusti, A				Pozo-Rodriguez, Francisco; Luis Lopez-Campos, Jose; Alvarez-Martinez, Carlos J.; Castro-Acosta, Ady; Agueero, Ramon; Hueto, Javier; Hernandez-Hernandez, Jesus; Barron, Manuel; Abraira, Victor; Forte, Anabel; Sanchez Nieto, Juan Miguel; Lopez-Gabaldon, Encarnacion; Cosio, Borja G.; Agusti, Alvar		AUDIPOC Study Grp	Clinical Audit of COPD Patients Requiring Hospital Admissions in Spain: AUDIPOC Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-CARE; ACUTE EXACERBATIONS; IMPACT	Backgrounds: AUDIPOC is a nationwide clinical audit that describes the characteristics, interventions and outcomes of patients admitted to Spanish hospitals because of an exacerbation of chronic obstructive pulmonary disease (ECOPD), assessing the compliance of these parameters with current international guidelines. The present study describes hospital resources, hospital factors related to case recruitment variability, patients' characteristics, and adherence to guidelines. Methodology/Principal Findings: An organisational database was completed by all participant hospitals recording resources and organisation. Over an 8-week period 11,564 consecutive ECOPD admissions to 129 Spanish hospitals covering 70% of the Spanish population were prospectively identified. At hospital discharge, 5,178 patients (45% of eligible) were finally included, and thus constituted the audited population. Audited patients were reassessed 90 days after admission for survival and readmission rates. A wide variability was observed in relation to most variables, hospital adherence to guidelines, and readmissions and death. Median inpatient mortality was 5% (across-hospital range 0-35%). Among discharged patients, 37% required readmission (0-62%) and 6.5% died (0-35%). The overall mortality rate was 11.6% (0-50%). Hospital size and complexity and aspects related to hospital COPD awareness were significantly associated with case recruitment. Clinical management most often complied with diagnosis and treatment recommendations but rarely (<50%) addressed guidance on healthy life-styles. Conclusions/Significance: The AUDIPOC study highlights the large across-hospital variability in resources and organization of hospitals, patient characteristics, process of care, and outcomes. The study also identifies resources and organizational characteristics associated with the admission of COPD cases, as well as aspects of daily clinical care amenable to improvement.	[Pozo-Rodriguez, Francisco; Alvarez-Martinez, Carlos J.; Castro-Acosta, Ady] Hosp 12 Octubre, Inst Invest, E-28041 Madrid, Spain; [Pozo-Rodriguez, Francisco; Luis Lopez-Campos, Jose; Castro-Acosta, Ady; Cosio, Borja G.; Agusti, Alvar] Inst Salud Carlos III, Ctr Biomed Res Resp Dis CIBERES, Madrid, Spain; [Luis Lopez-Campos, Jose] Hosp Univ Virgen del Rocio, IBiS, Seville, Spain; [Agueero, Ramon] Hosp Univ Marques de Valdecilla, Santander, Spain; [Hueto, Javier] Complejo Hosp Navarra, Pamplona, Spain; [Hernandez-Hernandez, Jesus] Hosp Nuestra Sra Sonsoles, Avila, Spain; [Barron, Manuel] Complejo Hosp San Millan, Logrono, Spain; [Abraira, Victor] Hosp Univ Ramon y Cajal, IRYCIS, Madrid, Spain; [Abraira, Victor] Inst Salud Carlos III, Ctr Biomed Res Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Forte, Anabel] Univ Castellon, Dept Stat & Operat Res, Castellon de La Plana, Spain; [Sanchez Nieto, Juan Miguel] Hosp Univ Morales Meseguer, Murcia, Spain; [Lopez-Gabaldon, Encarnacion] Hosp Virgen Salud, Toledo, Spain; [Cosio, Borja G.] Hosp Univ Son Espases, Balearic Isl, Spain; [Agusti, Alvar] Hosp Clin Barcelona, Inst Torax, Barcelona, Spain	Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario Marques de Valdecilla (HUMV); Servicio Navarro de Salud - Osasunbidea; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Universitat Jaume I; Meseguer General University Hospital Morales; Complejo Hospitalario de Toledo; Hospital Universitari Son Espases; University of Barcelona; Hospital Clinic de Barcelona	Pozo-Rodriguez, F (corresponding author), Hosp 12 Octubre, Inst Invest, E-28041 Madrid, Spain.	fpozo@h12o.es	Alfageme, Inmaculada/K-2092-2014; Barbé, Ferran/A-5988-2010; Alcázar-Navarrete, Bernardino/X-8947-2018; Forte, Anabel/Q-1512-2015; Valle-Falcones, Manuel/AAB-5557-2019; Represas-Represas, Cristina/AAA-7143-2019; Forte, Anabel/GLT-9488-2022; Andújar-Espinosa, Rubén/ABD-6716-2020; López-Quílez, Antonio/H-5945-2011; Ussetti, Piedad/B-3853-2014; Marcos, Pedro J/K-9965-2015; Garcia-Navarro, Alvar Agusti/F-4474-2015; Clemente, Marta Garcia/P-6628-2016; Castro-Acosta, Ady Angelica/H-4163-2011; Perez, Nicolas/A-7850-2015; G.Cosio, Borja/P-4963-2017; Fernandez, Virginia Leiro/B-9679-2018; FERNANDEZ, DANIEL LOPEZ/H-8651-2015; Guardia, Sergi Pascual/L-7652-2014; Lopez-Campos Bodineau, Jose Luis/Q-1637-2018	Alfageme, Inmaculada/0000-0002-5106-1669; Barbé, Ferran/0000-0002-2340-8928; Alcázar-Navarrete, Bernardino/0000-0003-2356-9366; Forte, Anabel/0000-0001-9534-1817; Valle-Falcones, Manuel/0000-0002-0900-146X; Represas-Represas, Cristina/0000-0002-5908-6684; Forte, Anabel/0000-0001-9534-1817; Andújar-Espinosa, Rubén/0000-0002-6714-9438; López-Quílez, Antonio/0000-0002-7022-9260; Ussetti, Piedad/0000-0002-3439-5536; Marcos, Pedro J/0000-0001-9600-3537; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Clemente, Marta Garcia/0000-0003-0463-5946; Castro-Acosta, Ady Angelica/0000-0001-7591-6011; Perez, Nicolas/0000-0002-1192-5901; G.Cosio, Borja/0000-0002-6388-8209; Fernandez, Virginia Leiro/0000-0001-9613-430X; FERNANDEZ, DANIEL LOPEZ/0000-0003-2131-9515; Guardia, Sergi Pascual/0000-0002-6567-0916; Canon-Barroso, Lourdes/0000-0002-9164-8915; AYERBE GARCIA, RUTH/0000-0001-8459-5037; ESTEBAN, CRISTOBAL/0000-0001-9878-7806; Ordonez Gomez, Paola Lisseth/0000-0001-8463-7057; Hernandez Hernandez, Jesus R./0000-0002-7526-1120; Abraira, Victor/0000-0002-4615-8503; Lopez-Campos Bodineau, Jose Luis/0000-0003-1703-1367; Pajares, Virginia/0000-0002-0916-527X; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249; Ruiz Albi, Tomas/0000-0003-4785-7151; Abascal-Bolado, Beatriz/0000-0001-6712-9923; Domenech del Rio, Adolfo/0000-0002-3127-9150; Villanueva, Manuel Angel/0000-0003-3256-9579; Boukichou Abdelkader, Nisa/0000-0002-7427-531X; Gullon, Jose Antonio/0000-0002-3007-0873; CORBACHO, DOLORES/0000-0003-1239-5276; Cascante, Jose Antonio/0000-0003-2830-9272; Borderias, Luis/0000-0003-3296-9644; Rio, Maria Teresa/0000-0003-2958-1067	Fondo de Investigacion Sanitaria (FIS); Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion [PI 08/90129, PI 90486, PI08/90578, PI 07/90503, PI 08/90251, PI 07/90516, PI 08/90529, PI 07/90309, PI 08/90457, PI 07/90721, PI 08/90550, PI08/90447, PI07/90403, PI 08/90486]; Spanish Respiratory Society (SEPAR); CIBER de Enfermedades Respiratorias (CIBERES)	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Respiratory Society (SEPAR); CIBER de Enfermedades Respiratorias (CIBERES)	This work was supported by Fondo de Investigacion Sanitaria (FIS), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (PI 08/90129, PI 90486, PI08/90578, PI 07/90503, PI 08/90251, PI 07/90516, PI 08/90529, PI 07/90309, PI 08/90457, PI 08/90129, PI 07/90721, PI 08/90550, PI08/90447, PI07/90403, PI 08/90486), Spanish Respiratory Society (SEPAR) and CIBER de Enfermedades Respiratorias (CIBERES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2010, EUR RESPIR J, V35, P1031, DOI 10.1183/09031936.00056209; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; [Anonymous], 2011, NICE CLIN GUIDELINE; [Anonymous], 2010, GUIA PRACT CLIN DIAG; Barba R, 2012, EUR RESPIR J, V39, P46, DOI 10.1183/09031936.00013211; Berger Z, 2010, J EVAL CLIN PRACT, V16, P1045, DOI 10.1111/j.1365-2753.2009.01247.x; Calderon-Larranaga A, 2011, THORAX, V66, P191, DOI 10.1136/thx.2010.147058; Cody Ron, 2005, CODYS DATA CLEANING; Gutierrez PC, 2010, MED CLIN-BARCELONA, V134, P505, DOI 10.1016/j.medcli.2009.12.002; Davidoff F, 1999, ANN INTERN MED, V130, P1019, DOI 10.7326/0003-4819-130-12-199906150-00022; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Eddy D M, 1984, Health Aff (Millwood), V3, P74, DOI 10.1377/hlthaff.3.2.74; Flottorp SA, 2010, USING AUDIT FEEDBACK; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Hernandez-Garcia I, 2011, REV CLIN ESP, V211, P219, DOI 10.1016/j.rce.2010.10.009; Holt JB, 2011, INT J CHRONIC OBSTR, V6, P321, DOI 10.2147/COPD.S19945; Hurst JR, 2009, AM J RESP CRIT CARE, V179, P369, DOI 10.1164/rccm.200807-1067OC; Instituto Nacional de Estadistica, 2011, INEBASE; Liaaen ED, 2010, RESP MED, V104, P1304, DOI 10.1016/j.rmed.2010.03.007; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Lynch SM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-71265-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; NICE and the Healthcare Commission, 2002, PRINC BEST PRACT CLI; Pozo-Rodriguez F, 2010, ARCH BRONCONEUMOL, V46, P349, DOI 10.1016/j.arbres.2010.04.004; Pretto JJ, INTERN MED IN PRESS; Price LC, 2006, THORAX, V61, P837, DOI 10.1136/thx.2005.049940; [Royal College of Physicians of London British Thoracic Society British Lung Foundation], 2011, REP NAT CHRON OBSTR; Soriano JB, 2010, EUR RESPIR J, V36, P758, DOI 10.1183/09031936.00138409; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586	29	66	66	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42156	10.1371/journal.pone.0042156	http://dx.doi.org/10.1371/journal.pone.0042156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22911875	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600061
J	Farmer, C; Cox, JJ; Fletcher, EV; Woods, CG; Wood, JN; Schorge, S				Farmer, Clare; Cox, James J.; Fletcher, E. V.; Woods, C. Geoffrey; Wood, John N.; Schorge, Stephanie			Splice Variants of Na(V)1.7 Sodium Channels Have Distinct beta Subunit-Dependent Biophysical Properties	PLOS ONE			English	Article							ALPHA-SUBUNIT; MESSENGER-RNAS; DIFFERENTIAL EXPRESSION; RAT-BRAIN; PAIN; TARGETS; SCN9A; ERYTHROMELALGIA; ERYTHERMALGIA; INACTIVATION	Genes encoding the alpha subunits of neuronal sodium channels have evolutionarily conserved sites of alternative splicing but no functional differences have been attributed to the splice variants. Here, using Na(V)1.7 as an exemplar, we show that the sodium channel isoforms are functionally distinct when co-expressed with beta subunits. The gene, SCN9A, encodes the alpha subunit of the Na(V)1.7 channel, and contains both sites of alternative splicing that are highly conserved. In conditions where the intrinsic properties of the Na(V)1.7 splice variants were similar when expressed alone, co-expression of beta 1 subunits had different effects on channel availability that were determined by splicing at either site in the alpha subunit. While the identity of exon 5 determined the degree to which beta 1 subunits altered voltage-dependence of activation (P = 0.027), the length of exon 11 regulated how far beta 1 subunits depolarised voltage-dependence of inactivation (P = 0.00012). The results could have a significant impact on channel availability, for example with the long version of exon 11, the co-expression of beta 1 subunits could lead to nearly twice as large an increase in channel availability compared to channels containing the short version. Our data suggest that splicing can change the way that Na-V channels interact with beta subunits. Because splicing is conserved, its unexpected role in regulating the functional impact of beta subunits may apply to multiple voltage-gated sodium channels, and the full repertoire of beta subunit function may depend on splicing in alpha subunits.	[Farmer, Clare; Fletcher, E. V.; Schorge, Stephanie] UCL Inst Neurol, London, England; [Cox, James J.; Wood, John N.] UCL Wolfson Inst Biomed Res, London, England; [Woods, C. Geoffrey] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England	University of London; University College London; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Farmer, C (corresponding author), UCL Inst Neurol, Queen Sq, London, England.	s.schorge@ucl.ac.uk	Schorge, Stephanie/C-8515-2009; Fletcher, Emily V/AAN-9916-2020; Cox, James/R-1910-2016	Schorge, Stephanie/0000-0003-1541-5148; Fletcher, Emily V/0000-0002-9786-4221; 	Royal Society; MRC; BBSRC; Wellcome Trust; World University Program [R31-2008-000-10103-0]; Pfizer; Medical Research Council [G0601440, G1100340, G0901905] Funding Source: researchfish; MRC [MR/J012742/1, G0601440, G0901905, G1100340] Funding Source: UKRI	Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); World University Program; Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SS holds a University Research Fellowship from the Royal Society. This work was funded by the MRC (CF, JJC, JNW, SS), BBSRC (JJC, JNW), and Wellcome Trust (JJC, CGW, JNW, SS), and World University Program grant R31-2008-000-10103-0 (JNW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Funding was received from Pfizer (JJC, CGW). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Blackburn-Munro G, 1999, NEUROSCIENCE, V90, P153, DOI 10.1016/S0306-4522(98)00415-1; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Chatelier A, 2008, J NEUROPHYSIOL, V99, P2241, DOI 10.1152/jn.01350.2007; Choi JS, 2006, NEUROLOGY, V67, P1563, DOI 10.1212/01.wnl.0000231514.33603.1e; Choi JS, 2010, BRAIN, V133, P1823, DOI 10.1093/brain/awq114; Copley RR, 2004, TRENDS GENET, V20, P171, DOI 10.1016/j.tig.2004.02.001; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dib-Hajj SD, 2008, ADV GENET, V63, P85, DOI 10.1016/S0065-2660(08)01004-3; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Fischer TZ, 2009, ANN NEUROL, V65, P733, DOI 10.1002/ana.21678; Fletcher EV, 2011, J BIOL CHEM, V286, P36700, DOI 10.1074/jbc.M111.250225; Gazina EV, 2010, NEUROSCIENCE, V166, P195, DOI 10.1016/j.neuroscience.2009.12.011; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; GUSTAFSON TA, 1993, J BIOL CHEM, V268, P18648; Jarecki BW, 2009, CHANNELS, V3, P259; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017; Patino GA, 2010, NEUROSCI LETT; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; SARAO R, 1991, NUCLEIC ACIDS RES, V19, P5673, DOI 10.1093/nar/19.20.5673; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; Thun J, 2009, BRAIN RES, V1269, P11, DOI 10.1016/j.brainres.2009.02.044; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	27	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41750	10.1371/journal.pone.0041750	http://dx.doi.org/10.1371/journal.pone.0041750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911851	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300069
J	Jumpertz, R; Guijarro, A; Pratley, RE; Mason, CC; Piomelli, D; Krakoff, J				Jumpertz, Reiner; Guijarro, Ana; Pratley, Richard E.; Mason, Clinton C.; Piomelli, Daniele; Krakoff, Jonathan			Associations of Fatty Acids in Cerebrospinal Fluid with Peripheral Glucose Concentrations and Energy Metabolism	PLOS ONE			English	Article							ESTIMATED DESATURASE ACTIVITIES; DIET-INDUCED OBESITY; SKELETAL-MUSCLE; INSULIN SENSITIVITY; ALZHEIMERS-DISEASE; PALMITOLEIC ACID; RISK-FACTORS; FOOD-INTAKE; BRAIN; MICE	Rodent experiments have emphasized a role of central fatty acid (FA) species, such as oleic acid, in regulating peripheral glucose and energy metabolism. Thus, we hypothesized that central FAs are related to peripheral glucose regulation and energy expenditure in humans. To test this we measured FA species profiles in cerebrospinal fluid (CSF) and plasma of 32 individuals who stayed in our clinical inpatient unit for 6 days. Body composition was measured by dual energy X-ray absorptiometry and glucose regulation by an oral glucose test (OGTT) followed by measurements of 24 hour (24EE) and sleep energy expenditure (SLEEP) as well as respiratory quotient (RQ) in a respiratory chamber. CSF was obtained via lumbar punctures; FA concentrations were measured by liquid chromatography/mass spectrometry. As expected, FA concentrations were higher in plasma compared to CSF. Individuals with high concentrations of CSF very-long-chain saturated FAs had lower rates of SLEEP. In the plasma moderate associations of these FAs with higher 24EE were observed. Moreover, CSF monounsaturated long-chain FA (palmitoleic and oleic acid) concentrations were associated with lower RQs and lower glucose area under the curve during the OGTT. Thus, FAs in the CSF strongly correlated with peripheral metabolic traits. These physiological parameters were most specific to long-chain monounsaturated (C16:1, C18:1) and very-long-chain saturated (C24:0, C26:0) FAs. Conclusions: Together with previous animal experiments these initial cross-sectional human data indicate that central FA species are linked to peripheral glucose and energy homeostasis.	[Jumpertz, Reiner] Charite, Klin Endokrinol Diabet & Ernahrungsmed, D-13353 Berlin, Germany; [Jumpertz, Reiner; Pratley, Richard E.; Mason, Clinton C.; Krakoff, Jonathan] NIDDK, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ USA; [Guijarro, Ana; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Pratley, Richard E.] Sanford Burnham Med Res Inst, Orlando, FL USA; [Piomelli, Daniele] Italian Inst Technol, Genoa, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California Irvine; Sanford Burnham Prebys Medical Discovery Institute; Istituto Italiano di Tecnologia - IIT	Jumpertz, R (corresponding author), Charite, Klin Endokrinol Diabet & Ernahrungsmed, D-13353 Berlin, Germany.	reiner.jumpertz@charite.de		GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173; Jumpertz von Schwartzenberg, Reiner/0000-0002-5544-099X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health [DK-073955]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069015, R01DK073955] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institutes of Health grant DK-073955 to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Cadas H, 1997, J NEUROSCI, V17, P1226; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Cha SH, 2006, P NATL ACAD SCI USA, V103, P15410, DOI 10.1073/pnas.0607334103; Cha SH, 2005, P NATL ACAD SCI USA, V102, P14557, DOI 10.1073/pnas.0507300102; Chen CT, 2008, PROSTAG LEUKOTR ESS, V79, P85, DOI 10.1016/j.plefa.2008.09.003; Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; DHOPESHWARKAR G A, 1972, Biochimica et Biophysica Acta, V255, P572, DOI 10.1016/0005-2736(72)90161-7; Edmond J, 2001, J MOL NEUROSCI, V16, P181, DOI 10.1385/JMN:16:2-3:181; Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Haywood SC, 2009, AM J PHYSIOL-ENDOC M, V297, pE50, DOI 10.1152/ajpendo.90673.2008; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jumpertz R, 2011, J CLIN ENDOCR METAB, V96, P787, DOI 10.1210/jc.2010-2028; Kawashima A, 2009, J NUTR SCI VITAMINOL, V55, P400, DOI 10.3177/jnsv.55.400; Kien CL, 2007, OBESITY, V15, P1640, DOI 10.1038/oby.2007.195; Kien CL, 2005, AM J CLIN NUTR, V82, P320, DOI 10.1093/ajcn/82.2.320; Kitazawa H, 2009, LIPIDS, V44, P765, DOI 10.1007/s11745-009-3320-8; Krakoff J, 2008, DIABETES, V57, P3267, DOI 10.2337/db08-0577; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kumar MV, 2002, P NATL ACAD SCI USA, V99, P1921, DOI 10.1073/pnas.042683699; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Mitchell RW, 2011, PROSTAG LEUKOTR ESS, V85, P293, DOI 10.1016/j.plefa.2011.04.007; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Ohrvall M, 1996, J INTERN MED, V239, P111, DOI 10.1046/j.1365-2796.1996.410753000.x; Pan DA, 1995, J CLIN INVEST, V96, P2802, DOI 10.1172/JCI118350; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Ross RA, 2010, AM J PHYSIOL-ENDOC M, V299, pE633, DOI 10.1152/ajpendo.00190.2010; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Schwinkendorf DR, 2011, INT J OBESITY, V35, P336, DOI 10.1038/ijo.2010.159; Smedman AEM, 1999, AM J CLIN NUTR, V69, P22; STE ML, 2000, P NATL ACAD SCI USA, V97, P12339; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc10-0002, 10.2337/dc09-0544]; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; van den Berg SAA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-24; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Warensjo E, 2008, NUTR METAB CARDIOVAS, V18, P683, DOI 10.1016/j.numecd.2007.11.002; Weyer C, 1999, INT J OBESITY, V23, P715, DOI 10.1038/sj.ijo.0800910; Yang ZH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-120; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; Zhou YE, 2009, METABOLISM, V58, P158, DOI 10.1016/j.metabol.2008.09.008	47	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41503	10.1371/journal.pone.0041503	http://dx.doi.org/10.1371/journal.pone.0041503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911803	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300050
J	Sorochkina, AI; Plotnikov, EY; Rokitskaya, TI; Kovalchuk, SI; Kotova, EA; Sychev, SV; Zorov, DB; Antonenko, YN				Sorochkina, Alexandra I.; Plotnikov, Egor Y.; Rokitskaya, Tatyana I.; Kovalchuk, Sergei I.; Kotova, Elena A.; Sychev, Sergei V.; Zorov, Dmitry B.; Antonenko, Yuri N.			N-Terminally Glutamate-Substituted Analogue of Gramicidin A as Protonophore and Selective Mitochondrial Uncoupler	PLOS ONE			English	Article							BIOMEMBRANE-PRODUCED ENERGY; OXIDATIVE-PHOSPHORYLATION; LIPID-BILAYERS; ELECTROCHEMICAL GRADIENT; TRANSMEMBRANE CHANNEL; PHOSPHOLIPID-VESICLES; ACETYL GRAMICIDIN; FLUORESCENT-PROBE; ELECTRIC FORM; MEMBRANE	Limited uncoupling of oxidative phosphorylation could be beneficial for cells by preventing excessive generation of reactive oxygen species. Typical uncouplers are weak organic acids capable of permeating across membranes with a narrow gap between efficacy and toxicity. Aimed at designing a nontoxic uncoupler, the protonatable amino acid residue Glu was substituted for Val at the N-terminus of the pentadecapeptide gramicidin A (gA). The modified peptide [Glu1]gA exhibited high uncoupling activity in isolated mitochondria, in particular, abolishing membrane potential at the inner mitochondrial membrane with the same or even larger efficacy as gA. With mitochondria in cell culture, the depolarizing activity of [Glu1]gA was observed at concentrations by an order of magnitude lower than those of gA. On the contrary, [Glu1]gA was much less potent in forming proton channels in planar lipid bilayers than gA. Remarkably, at uncoupling concentrations, [Glu1]gA did not alter cell morphology and was nontoxic in MTT test, in contrast to gA showing high toxicity. The difference in the behavior of [Glu1]gA and gA in natural and artificial membranes could be ascribed to increased capability of [Glu1]gA to permeate through membranes and/or redistribute between different membranes. Based on the protective role of mild uncoupling, [Glu1]gA and some other proton-conducting gA analogues may be considered as prototypes of prospective therapeutic agents.	[Sorochkina, Alexandra I.; Plotnikov, Egor Y.; Rokitskaya, Tatyana I.; Kotova, Elena A.; Zorov, Dmitry B.; Antonenko, Yuri N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Kovalchuk, Sergei I.; Sychev, Sergei V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Sorochkina, AI (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	yuriantonenko@yahoo.com	Kovalchuk, Sergey I/J-3247-2014; Plotnikov, Egor Y/F-8592-2019; Antonenko, Yuri N/K-1323-2013; Kotova, Elena/A-6214-2012; Zorov, Dmitry B./AAB-1738-2019; Rokitskaya, Tatyana/J-3541-2013	Kovalchuk, Sergey I/0000-0001-5273-3431; Plotnikov, Egor Y/0000-0003-2838-3704; Zorov, Dmitry B./0000-0003-0863-8490; Rokitskaya, Tatyana/0000-0002-7719-1875	Russian Foundation for Basic Research [12-04-00199, 11-04-00771, 11-04-01307]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported in part by the Russian Foundation for Basic Research grants 12-04-00199, 11-04-00771 and 11-04-01307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Andersen O S, 1999, Methods Enzymol, V294, P208; Antonenko YN, 2011, J BIOL CHEM, V286, P17831, DOI 10.1074/jbc.M110.212837; AZZONE GF, 1978, BIOCHIM BIOPHYS ACTA, V501, P296, DOI 10.1016/0005-2728(78)90035-X; BAKEEVA LE, 1970, BIOCHIM BIOPHYS ACTA, V216, P13, DOI 10.1016/0005-2728(70)90154-4; BAMBERG E, 1979, J MEMBRANE BIOL, V50, P257, DOI 10.1007/BF01868892; BAMBERG E, 1977, P NATL ACAD SCI USA, V74, P2402, DOI 10.1073/pnas.74.6.2402; BEZRUKOV SM, 1984, BIOL MEMBRANY, V1, P659; Chen Y, 1999, J BIOL CHEM, V274, P18364, DOI 10.1074/jbc.274.26.18364; Chernyshev A, 2003, BIOPHYS J, V84, P238, DOI 10.1016/S0006-3495(03)74845-0; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1544, DOI 10.1021/bi00509a021; Cukierman S, 1997, BIOPHYS J, V73, P2489, DOI 10.1016/S0006-3495(97)78277-8; Cunha FM, 2011, CURR DRUG TARGETS, V12, P783; DEAMER DW, 1987, J BIOENERG BIOMEMBR, V19, P457; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Doebler JA, 1999, CELL BIOL TOXICOL, V15, P279, DOI 10.1023/A:1007651417519; GOODALL MC, 1971, ARCH BIOCHEM BIOPHYS, V147, P129, DOI 10.1016/0003-9861(71)90318-3; Gowen JA, 2002, BIOPHYS J, V83, P880, DOI 10.1016/S0006-3495(02)75215-6; Greathouse D V, 1999, Methods Enzymol, V294, P525; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Heytler P G, 1979, Methods Enzymol, V55, P462; HLADKY SB, 1984, CURR TOP MEMBR TRANS, V21, P327; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Koeppe RE, 1996, ANNU REV BIOPH BIOM, V25, P231; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KRISHNAMOORTHY G, 1986, BIOCHEMISTRY-US, V25, P6666, DOI 10.1021/bi00369a051; LARIS PC, 1975, BIOCHIM BIOPHYS ACTA, V376, P415, DOI 10.1016/0005-2728(75)90163-2; LEUNG J, 1973, BIOCHIM BIOPHYS ACTA, V298, P718, DOI 10.1016/0005-2736(73)90088-6; LIBERMAN EA, 1969, NATURE, V222, P1076, DOI 10.1038/2221076a0; MATTICE GL, 1995, BIOCHEMISTRY-US, V34, P6827, DOI 10.1021/bi00020a029; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147; Mobashery N, 1997, FEBS LETT, V412, P15, DOI 10.1016/S0014-5793(97)00709-6; MORROW JS, 1979, J MOL BIOL, V132, P733, DOI 10.1016/0022-2836(79)90386-3; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; NICOLAY K, 1994, J BIOENERG BIOMEMBR, V26, P327, DOI 10.1007/BF00763104; PADAN E, 1973, EUR J BIOCHEM, V40, P431, DOI 10.1111/j.1432-1033.1973.tb03212.x; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Perevoshchikova IV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P663, DOI 10.1134/S000629790906011X; PODLESKI T, 1969, NATURE, V221, P541, DOI 10.1038/221541a0; Robinson HJ, 1942, J PHARMACOL EXP THER, V74, P75; Rokitskaya TI, 2012, EUR BIOPHYS J BIOPHY, V41, P129, DOI 10.1007/s00249-011-0764-6; Rokitskaya TI, 2002, BIOPHYS J, V82, P865, DOI 10.1016/S0006-3495(02)75448-9; Rostovtseva TK, 1998, BIOPHYS J, V75, P1783, DOI 10.1016/S0006-3495(98)77620-9; ROTTENBERG H, 1989, BIOCHEMISTRY-US, V28, P4355, DOI 10.1021/bi00436a035; Saparov SM, 2000, BIOPHYS J, V79, P2526, DOI 10.1016/S0006-3495(00)76493-9; SEOH SA, 1993, BIOPHYS J, V65, P1817, DOI 10.1016/S0006-3495(93)81239-6; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Stuart JA, 1999, J BIOENERG BIOMEMBR, V31, P517, DOI 10.1023/A:1005456725549; Sychev SV, 1996, J PEPT SCI, V2, P141, DOI 10.1002/psc.59; SZABO G, 1979, SCIENCE, V203, P55, DOI 10.1126/science.83000; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; URRY DW, 1971, P NATL ACAD SCI USA, V68, P672, DOI 10.1073/pnas.68.3.672; VANDERMEULEN DL, 1976, BIOCHIM BIOPHYS ACTA, V449, P340, DOI 10.1016/0005-2728(76)90146-8; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353	64	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41919	10.1371/journal.pone.0041919	http://dx.doi.org/10.1371/journal.pone.0041919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911866	gold, Green Submitted, Green Published			2022-12-27	WOS:000306751300083
J	Choy, HA				Choy, Henry A.			Multiple Activities of LigB Potentiate Virulence of Leptospira interrogans: Inhibition of Alternative and Classical Pathways of Complement	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEINS; FACTOR-H; IMMUNE EVASION; STAPHYLOCOCCUS-AUREUS; BORRELIA-BURGDORFERI; SURFACE PROTEIN; ANTILEPTOSPIRAL ACTIVITY; HUMAN PLASMINOGEN; BINDING PROTEIN; CLUMPING FACTOR	Microbial pathogens acquire the immediate imperative to avoid or counteract the formidable defense of innate immunity as soon as they overcome the initial physical barriers of the host. Many have adopted the strategy of directly disrupting the complement system through the capture of its components, using proteins on the pathogen's surface. In leptospirosis, pathogenic Leptospira spp. are resistant to complement-mediated killing, in contrast to the highly vulnerable non-pathogenic strains. Pathogenic L. interrogans uses LenA/LfhA and LcpA to respectively sequester and commandeer the function of two regulators, factor H and C4BP, which in turn bind C3b or C4b to interrupt the alternative or classical pathways of complement activation. LigB, another surface-proximal protein originally characterized as an adhesin binding multiple host proteins, has other activities suggesting its importance early in infection, including binding extracellular matrix, plasma, and cutaneous repair proteins and inhibiting hemostasis. In this study, we used a recent model of ectopic expression of LigB in the saprophyte, L. biflexa, to test the hypothesis that LigB also interacts with complement proteins C3b and C4b to promote the virulence of L. interrogans. The surface expression of LigB partially rescued the non-pathogen from killing by 5% normal human serum, showing 1.3- to 48-fold greater survival 4 to 6 d following exposure to complement than cultures of the non-expressing parental strain. Recombinant LigB7'-12 comprising the LigB-specific immunoglobulin repeats binds directly to human complement proteins, C3b and C4b, with respective K(d)s of 43 +/- 26 nM and 69 +/- 18 nM. Repeats 9 to 11, previously shown to contain the binding domain for fibronectin and fibrinogen, are also important in LigB-complement interactions, which interfere with the alternative and classical pathways measured by complement-mediated hemolysis of erythrocytes. Thus, LigB is an adaptable interface for L. interrogans to efficiently counteract the multiple homeostatic processes of the host.	[Choy, Henry A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Choy, Henry A.] HACme Lab Serv, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Choy, HA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	hachoy@ucla.edu			National Institutes of Health [AI-034431]; VA Medical Research Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034431, R29AI034431, R21AI034431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Medical Research Funds(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the National Institutes of Health (AI-034431) and VA Medical Research Funds to David A. Haake. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; BANFI E, 1982, J GEN MICROBIOL, V128, P813; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10; Barbosa AS, 2009, INFECT IMMUN, V77, P1137, DOI 10.1128/IAI.01310-08; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Choy HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016879; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; Cinco M, 2010, NEW MICROBIOL, V33, P283; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; JOHNSON RC, 1966, J BACTERIOL, V91, P1403, DOI 10.1128/JB.91.4.1403-1409.1966; JOHNSON RC, 1967, J BACTERIOL, V93, P513, DOI 10.1128/JB.93.2.513-519.1967; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Kenedy MR, 2009, INFECT IMMUN, V77, P2773, DOI 10.1128/IAI.00318-09; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2011, MOL MICROBIOL, V79, P1063, DOI 10.1111/j.1365-2958.2010.07510.x; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Luo SS, 2011, J BIOL CHEM, V286, P8021, DOI 10.1074/jbc.M110.130138; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x; Narita M, 2005, AM J TROP MED HYG, V73, P652, DOI 10.4269/ajtmh.2005.73.652; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2011, MICROB PATHOGENESIS, V51, P360, DOI 10.1016/j.micpath.2011.06.008; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259	62	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41566	10.1371/journal.pone.0041566	http://dx.doi.org/10.1371/journal.pone.0041566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911815	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700112
J	Jung, K; Wang, QH; Kim, Y; Scheuer, K; Zhang, ZW; Shen, Q; Chang, KO; Saif, LJ				Jung, Kwonil; Wang, Qiuhong; Kim, Yunjeong; Scheuer, Kelly; Zhang, Zhenwen; Shen, Quan; Chang, Kyeong-Ok; Saif, Linda J.			The Effects of Simvastatin or Interferon-alpha on Infectivity of Human Norovirus Using a Gnotobiotic Pig Model for the Study of Antivirals	PLOS ONE			English	Article							PORCINE RESPIRATORY CORONAVIRUS; GENE-EXPRESSION; UNITED-STATES; DISEASE; STATINS; GASTROENTERITIS; MODULATION; ROTAVIRUS; PARTICLES; RESPONSES	The lack of an animal model for human norovirus (HuNoV) has hindered the development of therapeutic strategies. This study demonstrated that a commonly used cholesterol-lowering statin medication, simvastatin, which increases HuNoV replication in an in vitro replicon system, also enhances HuNoV infectivity in the gnotobiotic (Gn) pig model. In contrast, oral treatment with interferon (IFN)-alpha reduces HuNoV infectivity. Young piglets, all with A or H1 histo-blood group antigens on enterocytes, were treated orally with 8 mg/kg/day of simvastatin; 5 days later, the pigs were inoculated orally with a GII.4 HuNoV (HS194/2009/US strain) and then treated with simvastatin for 5 more days. Simvastatin induced significantly earlier onset and longer duration of HuNoV fecal shedding in treated pigs, frequently with higher fecal viral titers. Simvastatin impaired poly (I:C)-induced IFN-alpha expression in macrophages or dendritic cells, possibly due to lowered toll-like receptor (TLR) 3 expression; however, the mechanisms were not related to interferon regulatory factor 3 or nuclear factor kappa B signaling pathway. Thus, the enhanced, earlier infectivity of HuNoV in simvastatin-treated pigs coincided with the inhibitory effect of simvastatin on innate immunity. In contrast to the increased HuNoV shedding that simvastatin induced, viral shedding during the treatment period was reduced or curtailed in the HuNoV-inoculated pigs pre-treated/treated with human IFN-alpha. Our findings are the first to indicate that IFN-alpha has potential as antiviral therapy against HuNoV. Based on these intriguing and novel findings using the Gn pig model, we confirmed that HuNoV infectivity is altered by treatment with simvastatin or IFN-alpha. Collectively, these findings indicate that Gn pigs are a useful model to test immunomodulators or efficacy of antivirals against HuNoV.	[Jung, Kwonil; Wang, Qiuhong; Scheuer, Kelly; Zhang, Zhenwen; Shen, Quan; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Vet Prevent Med, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Kim, Yunjeong; Chang, Kyeong-Ok] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA	University System of Ohio; Ohio State University; Kansas State University	Jung, K (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Vet Prevent Med, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	saif.2@osu.edu	Saif, Linda/E-4005-2011	Kim, Yunjeong/0000-0002-2977-4400	National Institute of Allergy and Infectious Diseases, National Institutes of Health [U01 AI08001, R01 AI056351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056351] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by two grants (co-PI, Dr. Linda Saif) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Grant U01 AI08001 (Dr. K.O. Chang, PI) and Grant R01 AI056351 (Dr. R. Baric, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Chang KO, 2009, J VIROL, V83, P8587, DOI 10.1128/JVI.00005-09; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Cheetham S, 2007, J VIROL, V81, P3535, DOI 10.1128/JVI.01306-06; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; Cummins JM, 2005, AM J VET RES, V66, P164, DOI 10.2460/ajvr.2005.66.164; CUMMINS JM, 1995, VET IMMUNOL IMMUNOP, V45, P355, DOI 10.1016/0165-2427(94)05351-R; Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/eri.11.56, 10.1586/ERI.11.56]; Delang L, 2009, HEPATOLOGY, V50, P6, DOI 10.1002/hep.22916; Esseili MA, 2012, APPL ENVIRON MICROB, V78, P786, DOI 10.1128/AEM.07081-11; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; FORTI RL, 1985, J CLIN MICROBIOL, V21, P689, DOI 10.1128/JCM.21.5.689-693.1985; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Gonzalez AM, 2010, IMMUNOLOGY, V131, P242, DOI 10.1111/j.1365-2567.2010.03298.x; HaslerRapacz J, 1996, ARTERIOSCL THROM VAS, V16, P137, DOI 10.1161/01.ATV.16.1.137; Hodgkinson CP, 2008, PHARMACOGENET GENOM, V18, P803, DOI 10.1097/FPC.0b013e3283050aff; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Jung K, 2006, RES VET SCI, V81, P310, DOI 10.1016/j.rvsc.2006.03.005; Jung K, 2010, VET IMMUNOL IMMUNOP, V136, P335, DOI 10.1016/j.vetimm.2010.03.022; Jung K, 2009, J GEN VIROL, V90, P2713, DOI 10.1099/vir.0.014001-0; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kim YC, 2010, IMMUNOLOGY, V130, P484, DOI 10.1111/j.1365-2567.2010.03269.x; LECCE J G, 1990, Molecular Biotherapy, V2, P211; Li GM, 2007, MICROBES INFECT, V9, P96, DOI 10.1016/j.micinf.2006.10.015; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Miller LC, 2009, CLIN VACCINE IMMUNOL, V16, P360, DOI 10.1128/CVI.00269-08; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Morillo SG, 2011, REV ASSOC MED BRAS, V57, P462, DOI 10.1590/S0104-42302011000400023; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Namangala B, 2006, J INTERF CYTOK RES, V26, P675, DOI 10.1089/jir.2006.26.675; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Perry JW, 2010, J VIROL, V84, P6163, DOI 10.1128/JVI.00331-10; Rondy M, 2011, EPIDEMIOL INFECT, V139, P453, DOI 10.1017/S0950268810000993; Roos-Weil D, 2011, TRANSPLANTATION; Ross JW, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-39; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schwartz S, 2011, BLOOD; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Somasekharan S, 2008, J MEMBRANE BIOL, V222, P17, DOI 10.1007/s00232-008-9099-3; Souza M, 2007, J VIROL, V81, P9183, DOI 10.1128/JVI.00558-07; Takanashi S, 2011, 30 AM SOC VIR, P298; Takanashi S, 2011, J CLIN MICROBIOL, V49, P3234, DOI 10.1128/JCM.00305-11; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Troeger H, 2009, GUT, V58, P1070, DOI 10.1136/gut.2008.160150; Watanuki H, 2009, VET IMMUNOL IMMUNOP, V131, P273, DOI 10.1016/j.vetimm.2009.04.005; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zhang SW, 2011, J MED VIROL, V83, P1476, DOI 10.1002/jmv.22108	54	58	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41619	10.1371/journal.pone.0041619	http://dx.doi.org/10.1371/journal.pone.0041619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911825	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700124
J	Magnusson, LU; Lundqvist, A; Karlsson, MN; Skalen, K; Levin, M; Wiklund, O; Boren, J; Hulten, LM				Magnusson, Lisa U.; Lundqvist, Annika; Karlsson, Merja Nurkkala; Skalen, Kristina; Levin, Max; Wiklund, Olov; Boren, Jan; Hulten, Lillemor Mattsson			Arachidonate 15-Lipoxygenase Type B Knockdown Leads to Reduced Lipid Accumulation and Inflammation in Atherosclerosis	PLOS ONE			English	Article							OXIDATIVE MODIFICATION; EXPRESSION; LDL; 8S-LIPOXYGENASE; IDENTIFICATION; INTERLEUKIN-2; ANGIOGENESIS; MACROPHAGES; PRODUCTS; INCREASE	Inflammation in the vascular wall is important for development of atherosclerosis. We have shown previously that arachidonate 15-lipoxygenase type B (ALOX15B) is more highly expressed in human atherosclerotic lesions than in healthy arteries. This enzyme oxidizes fatty acids to substances that promote local inflammation and is expressed in lipid-loaded macrophages (foam cells) present in the atherosclerotic lesions. Here, we investigated the role of ALOX15B in foam cell formation in human primary macrophages and found that silencing of human ALOX15B decreased cellular lipid accumulation as well as proinflammatory cytokine secretion from macrophages. To investigate the role of ALOX15B in promoting the development of atherosclerosis in vivo, we used lentiviral shRNA silencing and bone marrow transplantation to knockdown mouse Alox15b gene expression in LDL-receptor-deficient (Ldlr(-/-)) mice. Knockdown of mouse Alox15b in vivo decreased plaque lipid content and markers of inflammation. In summary, we have shown that ALOX15B influences progression of atherosclerosis, indicating that this enzyme has an active proatherogenic role.	[Magnusson, Lisa U.; Lundqvist, Annika; Karlsson, Merja Nurkkala; Skalen, Kristina; Levin, Max; Wiklund, Olov; Boren, Jan; Hulten, Lillemor Mattsson] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Wallenberg Lab,Inst Med,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Magnusson, LU (corresponding author), Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Wallenberg Lab,Inst Med,Sahlgrenska Acad, Gothenburg, Sweden.	lisa.magnusson@gu.se			Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Foundation for Strategic Research; Sahlgrenska University Hospital ALF; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Sahlgrenska University Hospital ALF; Novo Nordisk Fonden(Novo Nordisk Foundation)	Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Foundation for Strategic Research and the Sahlgrenska University Hospital ALF research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bae J, 2008, J MICROBIOL BIOTECHN, V18, P377; Danielsson KN, 2008, ATHEROSCLEROSIS, V199, P34, DOI 10.1016/j.atherosclerosis.2007.10.027; Eefting D, 2009, J VASC SURG, V50, P152, DOI 10.1016/j.jvs.2009.03.027; EZAKI M, 1995, J LIPID RES, V36, P1996; FROST SC, 1985, J BIOL CHEM, V260, P2646; Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116; Furstenberger G, 2002, PROSTAG OTH LIPID M, V68-9, P235, DOI 10.1016/S0090-6980(02)00033-3; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Hedrick CC, 1999, ADV EXP MED BIOL, V469, P455; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Jisaka M, 1997, J BIOL CHEM, V272, P24410, DOI 10.1074/jbc.272.39.24410; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; KUHN H, 1994, J LIPID RES, V35, P1749; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e; Ribatti D, 2008, ANN MED, V40, P606, DOI 10.1080/07853890802186913; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schweiger D, 2007, J LIPID RES, V48, P553, DOI 10.1194/jlr.M600311-JLR200; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Upadhya S, 2004, ANGIOLOGY, V55, P289, DOI 10.1177/000331970405500308; Waddington E, 2001, ANAL BIOCHEM, V292, P234, DOI 10.1006/abio.2001.5075; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003	29	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43142	10.1371/journal.pone.0043142	http://dx.doi.org/10.1371/journal.pone.0043142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912809	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700048
J	Qiu, XH; Yan, X; Liu, MX; Han, RC				Qiu, Xuehong; Yan, Xun; Liu, Mingxing; Han, Richou			Genetic and Proteomic Characterization of rpoB Mutations and Their Effect on Nematicidal Activity in Photorhabdus luminescens LN2	PLOS ONE			English	Article							INSECT PATHOGENIC NEMATODES; III SECRETION SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; ENTOMOPATHOGENIC NEMATODES; XENORHABDUS-NEMATOPHILA; RIFAMPIN RESISTANCE; MOLECULAR ANALYSIS; BACILLUS-SUBTILIS; OXIDATIVE STRESS; DRUG-RESISTANCE	Rifampin resistant (Rif(R)) mutants of the insect pathogenic bacterium Photorhabdus luminescens LN2 from entomopathogenic nematode Heterorhabditis indica LN2 were genetically and proteomically characterized. The Rif(R) mutants showed typical phase one characters of Photorhabdus bacteria, and insecticidal activity against Galleria mellonella larvae, but surprisingly influenced their nematicidal activity against axenic infective juveniles (IJs) of H. bacteriophora H06, an incompatible nematode host. 13 out of 34 Rif(R) mutants lost their nematicidal activity against H06 IJs but supported the reproduction of H06 nematodes. 7 nematicidal-producing and 7 non-nematicidal-producing Rif(R) mutants were respectively selected for rpoB sequence analysis. rpoB mutations were found in all 14 Rif(R) mutants. The rpoB (P564L) mutation was found in all 7 mutants which produced nematicidal activity against H06 nematodes, but not in the mutants which supported H06 nematode production. Allelic exchange assays confirmed that the Rif-resistance and the impact on nematicidal activity of LN2 bacteria were conferred by rpoB mutation(s). The non-nematicidal-producing Rif(R) mutant was unable to colonize in the intestines of H06 IJs, but able to colonize in the intestines of its indigenous LN2 IJs. Proteomic analysis revealed different protein expression between wild-type strain and Rif(R) mutants, or between nematicidal-producing and non nematicidal-producing mutants. At least 7 putative proteins including DsbA, HlpA, RhlE, RplC, NamB (a protein from T3SS), and 2 hypothetical proteins (similar to unknown protein YgdH and YggE of Escherichia coli respectively) were probably involved in the nematicidal activity of LN2 bacteria against H06 nematodes. This hypothesis was further confirmed by creating insertion-deletion mutants of three selected corresponding genes (the downregulated rhlE and namB, and upregualted dsbA). These results indicate that the rpoB mutations greatly influence the symbiotic association between the symbionts and their entomopathogenic nematode hosts.	[Qiu, Xuehong; Yan, Xun; Liu, Mingxing; Han, Richou] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Qiu, XH (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	richou-han@163.net			National Natural Science Foundation of China [31010103912, 31000879, 31101494]; Natural Science Foundation of Guangdong Province, China [10151026001000010]; Guangzhou Science & Technology Project [2011J2200032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Guangzhou Science & Technology Project	This work was supported by National Natural Science Foundation of China (No: 31010103912, No: 31000879 and No: 31101494), Natural Science Foundation of Guangdong Province, China (No: 10151026001000010) and Guangzhou Science & Technology Project (No: 2011J2200032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst R. J., 1990, Entomopathogenic nematodes in biological control., P75; AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; AKHURST RJ, 1983, EXP PARASITOL, V55, P258, DOI 10.1016/0014-4894(83)90020-6; An RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013154; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Bowen DJ, 1998, APPL ENVIRON MICROB, V64, P3029; Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Carata E, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-18; Cartier G, 2010, BIOCHEMISTRY-US, V49, P2636, DOI 10.1021/bi902082d; Castaneda-Garcia A, 2011, J ANTIMICROB CHEMOTH, V66, P1489, DOI 10.1093/jac/dkr165; Chalabaev S, 2007, PROTEOMICS, V7, P4499, DOI 10.1002/pmic.200700609; Ciche TA, 2006, BIOL CONTROL, V38, P22, DOI 10.1016/j.biocontrol.2005.11.016; Cowles CE, 2004, MOL MICROBIOL, V54, P464, DOI 10.1111/j.1365-2958.2004.04271.x; Cui LZ, 2010, ANTIMICROB AGENTS CH, V54, P5222, DOI 10.1128/AAC.00437-10; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; EHLERS R-U, 1990, Revue de Nematologie, V13, P417; Ensign JC, 2002, PCT Patent, Patent No. [US6379946 B1, 6379946]; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Gentry DR, 2007, ANTIMICROB AGENTS CH, V51, P2048, DOI 10.1128/AAC.01066-06; Georgis R, 2006, BIOL CONTROL, V38, P103, DOI 10.1016/j.biocontrol.2005.11.005; GERRITSEN LJM, 1993, FUND APPL NEMATOL, V16, P367; Gerritsen LJM, 1997, FUND APPL NEMATOL, V20, P317; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; HAN R, 1990, Revue de Nematologie, V13, P411; Han RC, 2001, FEMS MICROBIOL ECOL, V35, P239, DOI 10.1111/j.1574-6941.2001.tb00809.x; Han RC, 1998, NEMATOLOGICA, V44, P425, DOI 10.1163/005525998X00089; Han RC, 1999, NEMATOLOGY, V1, P687, DOI 10.1163/156854199508711; HAN RH, 1991, J INVERTEBR PATHOL, V58, P27, DOI 10.1016/0022-2011(91)90158-M; Herrera L, 2003, INT J ANTIMICROB AG, V21, P403, DOI 10.1016/S0924-8579(03)00036-0; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Heungens K, 2002, MOL MICROBIOL, V45, P1337, DOI 10.1046/j.1365-2958.2002.03100.x; Hu K., 1995, Journal of Nematology, V27, P502; HUBNER P, 1993, MOL MICROBIOL, V10, P123, DOI 10.1111/j.1365-2958.1993.tb00909.x; Jain C, 2008, RNA, V14, P381, DOI 10.1261/rna.800308; Jiang QY, 1990, CHINESE SCI BULL, V35, P302; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kim S, 2005, APPL ENVIRON MICROB, V71, P2762, DOI 10.1128/AEM.71.5.2762-2765.2005; Lai CX, 2002, MICROBIOL-SGM, V148, P3365, DOI 10.1099/00221287-148-11-3365; Martens EC, 2005, CELL MICROBIOL, V7, P1723, DOI 10.1111/j.1462-5822.2005.00585.x; Maughan H, 2004, J BACTERIOL, V186, P2481, DOI 10.1128/JB.186.8.2481-2486.2004; MILLER N, 1994, J CLIN MICROBIOL, V32, P393, DOI 10.1128/JCM.32.2.393-397.1994; Mitchinson G.A., 1985, B INT UNION TUBERC, V65, P30; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Perkins AE, 2008, J BACTERIOL, V190, P807, DOI 10.1128/JB.00901-07; POINER GO, 1966, PARASITOLOGY, V56, P385, DOI 10.1017/S0031182000070980; Qiu XH, 2009, APPL ENVIRON MICROB, V75, P4221, DOI 10.1128/AEM.02967-08; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt MA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-98; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Sicard M, 2004, J EVOLUTION BIOL, V17, P985, DOI 10.1111/j.1420-9101.2004.00748.x; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stinson MW, 1998, INFECT IMMUN, V66, P259, DOI 10.1128/IAI.66.1.259-265.1998; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Wang QZ, 2007, J PROTEOME RES, V6, P4564, DOI 10.1021/pr070242z; Watanabe Y, 2011, J CLIN MICROBIOL, V49, P2680, DOI 10.1128/JCM.02144-10; WOODLEY CL, 1972, ANTIMICROB AGENTS CH, V2, P245, DOI 10.1128/AAC.2.4.245; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006; Yuen LKW, 1999, J CLIN MICROBIOL, V37, P3844, DOI 10.1128/JCM.37.12.3844-3850.1999; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zhang Y, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P235; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	71	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43114	10.1371/journal.pone.0043114	http://dx.doi.org/10.1371/journal.pone.0043114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912803	Green Published, Green Submitted, gold			2022-12-27	WOS:000308063700045
J	Tajiri, N; Acosta, S; Glover, LE; Bickford, PC; Simancas, AJ; Yasuhara, T; Date, I; Solomita, MA; Antonucci, I; Stuppia, L; Kaneko, Y; Borlongan, CV				Tajiri, Naoki; Acosta, Sandra; Glover, Loren E.; Bickford, Paula C.; Jacotte Simancas, Alejandra; Yasuhara, Takao; Date, Isao; Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio; Kaneko, Yuji; Borlongan, Cesar V.			Intravenous Grafts Of Amniotic Fluid-Derived Stem Cells Induce Endogenous Cell Proliferation and Attenuate Behavioral Deficits in Ischemic Stroke Rats	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; SPATIAL MEMORY PERFORMANCE; FOCAL CEREBRAL-ISCHEMIA; LONG-TERM POTENTIATION; MORRIS WATER MAZE; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; DORSAL HIPPOCAMPUS; BRAIN-INJURY; NEUROGENESIS	We recently reported isolation of viable rat amniotic fluid-derived stem (AFS) cells [1]. Here, we tested the therapeutic benefits of AFS cells in a rodent model of ischemic stroke. Adult male Sprague-Dawley rats received a 60-minute middle cerebral artery occlusion (MCAo). Thirty-five days later, animals exhibiting significant motor deficits received intravenous transplants of rat AFS cells or vehicle. At days 60-63 post-MCAo, significant recovery of motor and cognitive function was seen in stroke animals transplanted with AFS cells compared to vehicle-infused stroke animals. Infarct volume, as revealed by hematoxylin and eosin (H&E) staining, was significantly reduced, coupled with significant increments in the cell proliferation marker, Ki67, and the neuronal marker, MAP2, in the dentate gyrus (DG) [2] and the subventricular zone (SVZ) of AFS cell-transplanted stroke animals compared to vehicle-infused stroke animals. A significantly higher number of double-labeled Ki67/MAP2-positive cells and a similar trend towards increased Ki67/MAP2 double-labeling were observed in the DG and SVZ of AFS cell-transplanted stroke animals, respectively, compared to vehicle-infused stroke animals. This study reports the therapeutic potential of AFS cell transplantation in stroke animals, possibly via enhancement of endogenous repair mechanisms.	[Tajiri, Naoki; Acosta, Sandra; Glover, Loren E.; Bickford, Paula C.; Solomita, Marianna A.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Jacotte Simancas, Alejandra] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencias Salud, E-08193 Barcelona, Spain; [Yasuhara, Takao; Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio] Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy; [Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio] Univ G dAnnunzio, Sch Adv Studies G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio] Aging Res Ctr, Stem TeCh Grp, Chieti, Italy	State University System of Florida; University of South Florida; Autonomous University of Barcelona; Okayama University; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Tajiri, N (corresponding author), Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Bickford, Paula C/J-5970-2012; Yasuhara, Takao/AEU-1075-2022; Kaneko, Yuji/J-6447-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Bickford, Paula C/0000-0001-9657-7725; Borlongan, Cesar/0000-0002-2966-9782; Stuppia, Liborio/0000-0002-6232-0996	SanBio Inc.; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.	SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.	CVB is supported in part by SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2010, REJUV RES, V13, P581, DOI 10.1089/rej.2009.1011; Anisman H, 2002, J NEUROSCI, V22, P7809; Antonucci I, 2011, CELL TRANSPLANT, V20, P789, DOI 10.3727/096368910X539074; Bergado JA, 2011, NEUROSCIENCE, V172, P256, DOI 10.1016/j.neuroscience.2010.10.064; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Borlongan CV, 2005, BRAIN RES, V1048, P116, DOI 10.1016/j.brainres.2005.04.087; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chopp M, 2009, CELL TRANSPLANT, V18, P691, DOI 10.3727/096368909X470883; Clark RE, 2007, J NEUROSCI, V27, P6647, DOI 10.1523/JNEUROSCI.0913-07.2007; Clarke MSF, 1999, LEARN MEMORY, V6, P634, DOI 10.1101/lm.6.6.634; Clavel C, 2008, CURR OPIN ORGAN TRAN, V13, P36, DOI 10.1097/MOT.0b013e3282f428d1; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Duva CA, 1997, BEHAV NEUROSCI, V111, P1184, DOI 10.1037/0735-7044.111.6.1184; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Fukunaga A, 2003, ACTA NEUROCHIR, V145, P473, DOI 10.1007/s00701-003-0038-x; Fukunaga A, 1999, CELL TRANSPLANT, V8, P435, DOI 10.1177/096368979900800415; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Ghionzoli M, 2010, PEDIATR SURG INT, V26, P79, DOI 10.1007/s00383-009-2504-x; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; Graham GD, 2003, STROKE, V34, P2847, DOI 10.1161/01.STR.0000101752.23813.C3; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Gusev PA, 2001, J NEUROPHYSIOL, V86, P881, DOI 10.1152/jn.2001.86.2.881; Health USNIo, 2012, CLIN TRIALS; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kalogiannidis I, 2011, CLIN EXP OBSTET GYN, V38, P239; Kaneko Y, 2011, J PINEAL RES, V50, P272, DOI 10.1111/j.1600-079X.2010.00837.x; Lin MS, 2011, STROKE, V42, P2850, DOI 10.1161/STROKEAHA.111.613133; Liu TJ, 2008, SHOCK, V29, P603, DOI 10.1097/SHK.0b013e318157e845; Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010; Mauro A, 2010, VET RES COMMUN, V34, pS25, DOI 10.1007/s11259-010-9393-2; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; McLaughlin D, 2006, J NEUROSCI RES, V83, P1190, DOI 10.1002/jnr.20828; Mimura T, 2005, J NEUROPATH EXP NEUR, V64, P1108, DOI 10.1097/01.jnen.0000190068.03009.b5; Miyoshi E, 2012, BEHAV BRAIN RES, V226, P171, DOI 10.1016/j.bbr.2011.09.011; NISHINO H, 1993, BRAIN RES BULL, V32, P517, DOI 10.1016/0361-9230(93)90300-Z; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; Ou YL, 2010, BRAIN RES, V1366, P217, DOI 10.1016/j.brainres.2010.09.098; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pisani A, 2005, MOVEMENT DISORD, V20, P395, DOI 10.1002/mds.20394; Pisu MG, 2011, BEHAV BRAIN RES, V222, P73, DOI 10.1016/j.bbr.2011.03.021; Prasongchean W, 2012, STEM CELLS DEV, V21, P675, DOI 10.1089/scd.2011.0281; Prusa Andrea-Romana, 2002, Med Sci Monit, V8, pRA253; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rehni AK, 2007, BEHAV BRAIN RES, V183, P95, DOI 10.1016/j.bbr.2007.05.028; Richardson DP, 2002, EUR J NEUROSCI, V16, P1593, DOI 10.1046/j.1460-9568.2002.02214.x; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Rush BK, 2010, J STROKE CEREBROVASC, V19, P326, DOI 10.1016/j.jstrokecerebrovasdis.2009.09.009; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Tabuse M, 2010, J CLIN NEUROSCI, V17, P1412, DOI 10.1016/j.jocn.2010.01.056; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wattanathorn J, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/429505; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Xu J, 2012, NEUROPHARMACOLOGY, V62, P2424, DOI 10.1016/j.neuropharm.2012.02.014; Yasuhara T, 2006, FRONT BIOSCI-LANDMRK, V11, P760, DOI 10.2741/1834; Yip TR, 2007, STROKE, V38, P1952, DOI 10.1161/STROKEAHA.106.479477; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zvejniece L, 2012, J NEUROSCI METH, V208, P197, DOI 10.1016/j.jneumeth.2012.05.018	78	64	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43779	10.1371/journal.pone.0043779	http://dx.doi.org/10.1371/journal.pone.0043779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912905	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700133
J	Tokarska-Schlattner, M; Epand, RF; Meiler, F; Zandomeneghi, G; Neumann, D; Widmer, HR; Meier, BH; Epand, RM; Saks, V; Wallimann, T; Schlattner, U				Tokarska-Schlattner, Malgorzata; Epand, Raquel F.; Meiler, Flurina; Zandomeneghi, Giorgia; Neumann, Dietbert; Widmer, Hans R.; Meier, Beat H.; Epand, Richard M.; Saks, Valdur; Wallimann, Theo; Schlattner, Uwe			Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects	PLOS ONE			English	Article							MITOCHONDRIAL CREATINE-KINASE; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; OXIDATIVE STRESS; EXOGENOUS PHOSPHOCREATINE; CYCLOCREATINE PHOSPHATE; PERMEABILITY TRANSITION; ISCHEMIC MYOCARDIUM; MAGNETIC-RESONANCE; MOLECULAR-DYNAMICS	A broad spectrum of beneficial effects has been ascribed to creatine (Cr), phosphocreatine (PCr) and their cyclic analogues cyclo-(cCr) and phospho-cyclocreatine (PcCr). Cr is widely used as nutritional supplement in sports and increasingly also as adjuvant treatment for pathologies such as myopathies and a plethora of neurodegenerative diseases. Additionally, Cr and its cyclic analogues have been proposed for anti-cancer treatment. The mechanisms involved in these pleiotropic effects are still controversial and far from being understood. The reversible conversion of Cr and ATP into PCr and ADP by creatine kinase, generating highly diffusible PCr energy reserves, is certainly an important element. However, some protective effects of Cr and analogues cannot be satisfactorily explained solely by effects on the cellular energy state. Here we used mainly liposome model systems to provide evidence for interaction of PCr and PcCr with different zwitterionic phospholipids by applying four independent, complementary biochemical and biophysical assays: (i) chemical binding assay, (ii) surface plasmon resonance spectroscopy (SPR), (iii) solid-state P-31-NMR, and (iv) differential scanning calorimetry (DSC). SPR revealed low affinity PCr/phospholipid interaction that additionally induced changes in liposome shape as indicated by NMR and SPR. Additionally, DSC revealed evidence for membrane packing effects by PCr, as seen by altered lipid phase transition. Finally, PCr efficiently protected against membrane permeabilization in two different model systems: liposome-permeabilization by the membrane-active peptide melittin, and erythrocyte hemolysis by the oxidative drug doxorubicin, hypoosmotic stress or the mild detergent saponin. These findings suggest a new molecular basis for non-energy related functions of PCr and its cyclic analogue. PCr/phospholipid interaction and alteration of membrane structure may not only protect cellular membranes against various insults, but could have more general implications for many physiological membrane-related functions that are relevant for health and disease.	[Tokarska-Schlattner, Malgorzata; Saks, Valdur; Schlattner, Uwe] Univ Grenoble 1, LBFA, Grenoble, France; [Tokarska-Schlattner, Malgorzata; Saks, Valdur; Schlattner, Uwe] INSERM, U1055, Grenoble, France; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Meiler, Flurina; Neumann, Dietbert; Wallimann, Theo] Swiss Fed Inst Technol, Inst Cell Biol, Zurich, Switzerland; [Zandomeneghi, Giorgia; Meier, Beat H.] Swiss Fed Inst Technol, Inst Phys Chem, Zurich, Switzerland; [Widmer, Hans R.] Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); McMaster University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; University Hospital of Bern	Tokarska-Schlattner, M (corresponding author), Univ Grenoble 1, LBFA, Grenoble, France.	malgorzata.tokarska-schlattner@ujf-grenoble.fr	Widmer, Hans Rudolf/O-5172-2017; Widmer, Hans R./AAC-8948-2022; , Richard/R-2316-2019; Schlattner, Uwe/D-1267-2009; Wallimann, Theo/C-6047-2008; Zandomeneghi, Giorgia/J-8124-2016	Widmer, Hans Rudolf/0000-0003-3378-8765; , Richard/0000-0002-9602-9558; Schlattner, Uwe/0000-0003-1159-5911; Wallimann, Theo/0000-0003-4957-5836; Zandomeneghi, Giorgia/0000-0001-9452-8751; Tokarska-Schlattner, Malgorzata/0000-0003-4401-7050; Neumann, Dietbert/0000-0002-4316-684X	European Community [EIF ANTHRAWES 41870, ERG ANTHRAPLUS 249202]; Agence Nationale de la Recherche; Swiss Heart Foundation; Wolfermann-Nageli-Stiftung; Heart and Stroke Foundation of Ontario [T6915]	European Community(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Swiss Heart Foundation; Wolfermann-Nageli-Stiftung; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a Marie Curie Intraeuropean Fellowship (EIF ANTHRAWES 41870) and a European Reintegration Grant (ERG ANTHRAPLUS 249202) of the European Community (to M.T.S.), the Agence Nationale de la Recherche (chaire d'excellence to U.S.), as well as the Swiss Heart Foundation, the Wolfermann-Nageli-Stiftung (to U.S.) and the Heart and Stroke Foundation of Ontario Grant T6915 (to R.M.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; ANNESLEY TM, 1977, BIOCHEM BIOPH RES CO, V74, P185, DOI 10.1016/0006-291X(77)91392-4; ANYUKHOVSKY EP, 1986, BIOCHEM MED METAB B, V35, P327, DOI 10.1016/0885-4505(86)90090-3; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Braegger Christian P, 2003, J Cyst Fibros, V2, P177, DOI 10.1016/S1569-1993(03)00089-4; Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621; BRUMM T, 1992, BIOPHYS J, V61, P1018, DOI 10.1016/S0006-3495(92)81909-4; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Ceddia RB, 2004, J PHYSIOL-LONDON, V555, P409, DOI 10.1113/jphysiol.2003.056291; Chen JCH, 2008, INT J TECHNOL MANAGE, V43, P1; Deldicque L, 2008, J APPL PHYSIOL, V104, P371, DOI 10.1152/japplphysiol.00873.2007; Deldicque L, 2007, AM J PHYSIOL-CELL PH, V293, pC1263, DOI 10.1152/ajpcell.00162.2007; Dolder M, 2003, J BIOL CHEM, V278, P17760, DOI 10.1074/jbc.M208705200; Dubinnyi MA, 2006, SOLID STATE NUCL MAG, V29, P305, DOI 10.1016/j.ssnmr.2005.10.009; Fimognari C, 2009, MUTAT RES-FUND MOL M, V670, P59, DOI 10.1016/j.mrfmmm.2009.07.005; GREENHAFF PL, 1993, CLIN SCI, V84, P565, DOI 10.1042/cs0840565; Guidi C, 2008, BBA-GEN SUBJECTS, V1780, P16, DOI 10.1016/j.bbagen.2007.09.018; HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367; Hass CJ, 2007, NEUROREHAB NEURAL RE, V21, P107, DOI 10.1177/1545968306293449; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; HESPEL P, 1990, J PHYSIOL-LONDON, V427, P347, DOI 10.1113/jphysiol.1990.sp018175; Hespel P, 2001, CAN J APPL PHYSIOL, V26, pS79, DOI 10.1139/h2001-045; Hespel Peter, 2007, V46, P245; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Ingwall JS, 2002, J MOL CELL CARDIOL, V34, P1111, DOI 10.1006/jmcc.2002.2062; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Klivenyi P, 2004, NEUROBIOL DIS, V15, P610, DOI 10.1016/j.nbd.2003.12.014; KONOREV E A, 1991, Biokhimiya, V56, P1701; Kornacker M, 2001, INT J CANCER, V94, P513, DOI 10.1002/ijc.1502; Kristensen CA, 1999, BRIT J CANCER, V79, P278, DOI 10.1038/sj.bjc.6690045; Kurosawa Y, 2012, J CLIN INVE IN PRESS; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Lee SK, 1997, J TOXICOL ENV HEALTH, V51, P557, DOI 10.1080/009841097159836; Lenz H, 2007, MOL CELL BIOCHEM, V306, P153, DOI 10.1007/s11010-007-9565-8; LI PK, 1982, CLIN CHEM, V28, P92; LILLIE JW, 1993, CANCER RES, V53, P3172; LOMBARDINI JB, 1983, EXP EYE RES, V37, P239, DOI 10.1016/0014-4835(83)90158-6; MARTIN KJ, 1994, CANCER RES, V54, P5160; Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; MILLER EE, 1993, P NATL ACAD SCI USA, V90, P3304, DOI 10.1073/pnas.90.8.3304; MILLER K, 1993, AM J PHYSIOL, V265, pC1544, DOI 10.1152/ajpcell.1993.265.6.C1544; Nabuurs C, 2010, J BIOL CHEM, V285, P39588, DOI 10.1074/jbc.M110.164665; OGorman E, 1997, FEBS LETT, V414, P253, DOI 10.1016/S0014-5793(97)01045-4; Pacher P, 2005, TRENDS PHARMACOL SCI, V26, P302, DOI 10.1016/j.tips.2005.04.003; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; QIU XX, 1993, BIOCHIM BIOPHYS ACTA, V1147, P59, DOI 10.1016/0005-2736(93)90316-R; Ravina B, 2006, NEUROLOGY, V66, P664; Rayburn JR, 1995, FOOD CHEM TOXICOL, V33, P1021, DOI 10.1016/0278-6915(95)00080-1; Rodriguez M, 2005, J MOL CELL CARDIOL, V38, P723, DOI 10.1016/j.yjmcc.2005.02.019; Ronca G, 1989, CARDIOPROTECTION PHO, P61; RUDA MY, 1988, AM HEART J, V116, P393, DOI 10.1016/0002-8703(88)90611-4; SAKS VA, 1993, CURR THER RES CLIN E, V53, P565, DOI 10.1016/S0011-393X(05)80663-0; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; SANDERS CR, 1994, PROG NUCL MAG RES SP, V26, P421, DOI 10.1016/0079-6565(94)80012-X; Schimmel L, 1996, ANTICANCER RES, V16, P375; Schlattner U, 2000, J BIOENERG BIOMEMBR, V32, P123, DOI 10.1023/A:1005576831968; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2000, J BIOL CHEM, V275, P17314, DOI 10.1074/jbc.M001919200; Schlattner U, 2004, J BIOL CHEM, V279, P24334, DOI 10.1074/jbc.M314158200; Schlattner U, 2003, RECENT RES DEV BIOL, V1, P93; Schroder L, 2004, J MAGN RESON, V171, P213, DOI 10.1016/j.jmr.2004.08.015; SEBRING LA, 1986, BIOCHIM BIOPHYS ACTA, V884, P559, DOI 10.1016/0304-4165(86)90208-4; Sestili P, 2006, FREE RADICAL BIO MED, V40, P837, DOI 10.1016/j.freeradbiomed.2005.10.035; SHAROV VG, 1986, BIOCHEM MED METAB B, V35, P101, DOI 10.1016/0885-4505(86)90064-2; SHAROV VG, 1987, J THORAC CARDIOV SUR, V94, P749; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Speer O, 2004, MOL CELL BIOCHEM, V256, P407, DOI 10.1023/B:MCBI.0000009886.98508.e7; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; Tokarska-Schlattner M, 2007, BBA-BIOENERGETICS, V1767, P1276, DOI 10.1016/j.bbabio.2007.08.006; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; WALLIMAN.T, 1973, EUR J BIOCHEM, V38, P180, DOI 10.1111/j.1432-1033.1973.tb03048.x; Wallimann T, 2007, MOL SYSTEM BIOENERGE, P195, DOI [10.1002/9783527621095.ch7, DOI 10.1002/9783527621095.CH7, DOI 10.1002/9783527621095]; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wallimann Theo, 2007, V46, P1; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Wyss Markus, 2007, V46, P309; Young JF, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-9; ZUCCHI R, 1989, J MOL CELL CARDIOL, V21, P67, DOI 10.1016/0022-2828(89)91494-6	82	50	51	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43178	10.1371/journal.pone.0043178	http://dx.doi.org/10.1371/journal.pone.0043178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912820	Green Published, gold			2022-12-27	WOS:000308063700056
J	Zhu, H; Urban, DJ; Blashka, J; McPheeters, MT; Kroeze, WK; Mieczkowski, P; Overholser, JC; Jurjus, GJ; Dieter, L; Mahajan, GJ; Rajkowska, G; Wang, ZF; Sullivan, PF; Stockmeier, CA; Roth, BL				Zhu, Hu; Urban, Daniel J.; Blashka, Jared; McPheeters, Matthew T.; Kroeze, Wesley K.; Mieczkowski, Piotr; Overholser, James C.; Jurjus, George J.; Dieter, Lesa; Mahajan, Gouri J.; Rajkowska, Grazyna; Wang, Zefeng; Sullivan, Patrick F.; Stockmeier, Craig A.; Roth, Bryan L.			Quantitative Analysis of Focused A-To-I RNA Editing Sites by Ultra-High-Throughput Sequencing in Psychiatric Disorders	PLOS ONE			English	Article							SEROTONIN 2C RECEPTOR; PRE-MESSENGER-RNA; HUMAN TRANSCRIPTOME; HUMAN BRAIN; KAINATE RECEPTORS; PREFRONTAL CORTEX; GENE-EXPRESSION; SUBUNIT; CHANNELS; SUICIDE	A-to-I RNA editing is a post-transcriptional modification of single nucleotides in RNA by adenosine deamination, which thereby diversifies the gene products encoded in the genome. Thousands of potential RNA editing sites have been identified by recent studies (e. g. see Li et al, Science 2009); however, only a handful of these sites have been independently confirmed. Here, we systematically and quantitatively examined 109 putative coding region A-to-I RNA editing sites in three sets of normal human brain samples by ultra-high-throughput sequencing (uHTS). Forty of 109 putative sites, including 25 previously confirmed sites, were validated as truly edited in our brain samples, suggesting an overestimation of A-to-I RNA editing in these putative sites by Li et al (2009). To evaluate RNA editing in human disease, we analyzed 29 of the confirmed sites in subjects with major depressive disorder and schizophrenia using uHTS. In striking contrast to many prior studies, we did not find significant alterations in the frequency of RNA editing at any of the editing sites in samples from these patients, including within the 5HT(2C) serotonin receptor (HTR2C). Our results indicate that uHTS is a fast, quantitative and high-throughput method to assess RNA editing in human physiology and disease and that many prior studies of RNA editing may overestimate both the extent and disease-related variability of RNA editing at the sites we examined in the human brain.	[Zhu, Hu; Urban, Daniel J.; Blashka, Jared; McPheeters, Matthew T.; Kroeze, Wesley K.; Wang, Zefeng; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Mieczkowski, Piotr; Sullivan, Patrick F.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Overholser, James C.; Dieter, Lesa] Case Western Reserve Univ, Dept Psychol, Cleveland, OH 44106 USA; [Jurjus, George J.; Stockmeier, Craig A.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Jurjus, George J.] Louis Stokes Cleveland VA Med Ctr, Dept Psychiat, Cleveland, OH USA; [Mahajan, Gouri J.; Rajkowska, Grazyna; Stockmeier, Craig A.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Ctr Psychiat Neurosci, Jackson, MS 39216 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Mississippi; University of Mississippi Medical Center	Zhu, H (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	bryan_roth@med.unc.edu	zhu, hu/GQQ-8365-2022; Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010; Overholser, James/AAF-7017-2020	Roth, Bryan/0000-0002-0561-6520; Overholser, James/0000-0002-4242-2215; Wang, Zefeng/0000-0002-6605-3637; Mieczkowski, Piotr/0000-0003-2418-0096	National Institutes of Health the National Institute of Mental Health [MH61887, MH82441, MH67996, RR17701]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061887, U19MH082441, R01MH067996] Funding Source: NIH RePORTER	National Institutes of Health the National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this study came from The National Institutes of Health (MH61887, MH82441, MH67996, RR17701) the National Institute of Mental Health Psychoactive Drug Screening Program Contract. BLR was supported by the Michael Hooker Distinguished Chair of Pharmacology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AI, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq107; AKBARIAN S, 1995, BRAIN RES, V699, P297, DOI 10.1016/0006-8993(95)00922-D; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2012, GENOME RES; Bernard A, 1999, EUR J NEUROSCI, V11, P604, DOI 10.1046/j.1460-9568.1999.00479.x; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Dracheva S, 2008, MOL PSYCHIATR, V13, P1001, DOI 10.1038/sj.mp.4002081; Dracheva S, 2008, NEUROREPORT, V19, P379, DOI 10.1097/WNR.0b013e3282f556d2; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Gardiner Katheleen, 2006, Briefings in Functional Genomics & Proteomics, V5, P37, DOI 10.1093/bfgp/ell006; Gonzalez C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1446; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harrison PJ, 1995, NEUROSCI LETT, V200, P151, DOI 10.1016/0304-3940(95)12102-A; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Iwamoto K, 2003, NEUROSCI LETT, V346, P169, DOI 10.1016/S0304-3940(03)00608-6; Kawahara Y, 2008, J NEUROSCI, V28, P12834, DOI 10.1523/JNEUROSCI.3896-08.2008; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Nimmich ML, 2009, NEUROSCI RES, V63, P288, DOI 10.1016/j.neures.2009.01.003; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; NUTT SL, 1994, NEUROREPORT, V5, P1679, DOI 10.1097/00001756-199408150-00034; O'Neil RT, 2011, NEUROBIOL DIS; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; PASCHEN W, 1994, CELL MOL NEUROBIOL, V14, P259, DOI 10.1007/BF02088324; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Ramaswami G, 2012, NAT METHODS; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI 10.1038/nchembio.434; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Silberberg G, 2011, HUM MOL GENET; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; Sodhi MSK, 2005, MOL PHARMACOL, V68, P711, DOI 10.1124/mol.105.014134; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Vissel B, 2001, NEURON, V29, P217, DOI 10.1016/S0896-6273(01)00192-1; Vollmar W, 2004, NEUROBIOL DIS, V15, P371, DOI 10.1016/j.nbd.2003.11.006; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765	52	29	30	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43227	10.1371/journal.pone.0043227	http://dx.doi.org/10.1371/journal.pone.0043227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912834	Green Submitted, gold, Green Published			2022-12-27	WOS:000308063700064
J	Hamasaki, T; Suzuki, H; Shirohzu, H; Matsumoto, T; D'Alessandro-Gabazza, CN; Gil-Bernabe, P; Boveda-Ruiz, D; Naito, M; Kobayashi, T; Toda, M; Mizutani, T; Taguchi, O; Morser, J; Eguchi, Y; Kuroda, M; Ochiya, T; Hayashi, H; Gabazza, EC; Ohgi, T				Hamasaki, Tomohiro; Suzuki, Hiroshi; Shirohzu, Hisao; Matsumoto, Takahiro; D'Alessandro-Gabazza, Corina N.; Gil-Bernabe, Paloma; Boveda-Ruiz, Daniel; Naito, Masahiro; Kobayashi, Tetsu; Toda, Masaaki; Mizutani, Takayuki; Taguchi, Osamu; Morser, John; Eguchi, Yutaka; Kuroda, Masahiko; Ochiya, Takahiro; Hayashi, Hirotake; Gabazza, Esteban C.; Ohgi, Tadaaki			Efficacy of a Novel Class of RNA Interference Therapeutic Agents	PLOS ONE			English	Article							ACUTE LUNG INJURY; PULMONARY-FIBROSIS; DISEASE; SIRNA; BETA	RNA interference (RNAi) is being widely used in functional gene research and is an important tool for drug discovery. However, canonical double-stranded short interfering RNAs are unstable and induce undesirable adverse effects, and thus there is no currently RNAi-based therapy in the clinic. We have developed a novel class of RNAi agents, and evaluated their effectiveness in vitro and in mouse models of acute lung injury (ALI) and pulmonary fibrosis. The novel class of RNAi agents (nkRNA (R), PnkRNA (TM)) were synthesized on solid phase as single-stranded RNAs that, following synthesis, self-anneal into a unique helical structure containing a central stem and two loops. They are resistant to degradation and suppress their target genes. nkRNA and PnkRNA directed against TGF-beta 1mRNA ameliorate outcomes and induce no off-target effects in three animal models of lung disease. The results of this study support the pathological relevance of TGF-beta 1 in lung diseases, and suggest the potential usefulness of these novel RNAi agents for therapeutic application.	[Hamasaki, Tomohiro; Suzuki, Hiroshi; Shirohzu, Hisao; Matsumoto, Takahiro; Mizutani, Takayuki; Hayashi, Hirotake; Gabazza, Esteban C.; Ohgi, Tadaaki] BONAC Corp, BIO Factory 4F, Kurume, Fukuoka, Japan; [Matsumoto, Takahiro; D'Alessandro-Gabazza, Corina N.; Gil-Bernabe, Paloma; Boveda-Ruiz, Daniel; Toda, Masaaki; Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie, Japan; [D'Alessandro-Gabazza, Corina N.; Naito, Masahiro; Kobayashi, Tetsu; Taguchi, Osamu] Mie Univ, Grad Sch Med, Dept Pulm & Crit Care Med, Tsu, Mie, Japan; [Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Tokyo 104, Japan; [Mizutani, Takayuki; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan; [Eguchi, Yutaka] Osaka Univ, Grad Sch Med, Mol Genet Lab, Dept Med Genet, Osaka, Japan; [Morser, John] Stanford Univ, Div Hematol, Sch Med, Stanford, CA 94305 USA	Mie University; Mie University; National Cancer Center - Japan; Tokyo Medical University; Osaka University; Stanford University	Hamasaki, T (corresponding author), BONAC Corp, BIO Factory 4F, Kurume, Fukuoka, Japan.	gabazza@doc.medic.mie-u.ac.jp; ohgi@bonac.co.jp	Ochiya, Takahiro/AAH-7585-2019	Gabazza, Esteban/0000-0001-5748-1499	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Center of Excellence Grant from Mie University; Grants-in-Aid for Scientific Research [23659626] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Excellence Grant from Mie University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Center of Excellence Grant from Mie University. No additional external funding received for this study. The funders were not involved in study design, data analysis, decision to publish, or preparation of the manuscript.	Abe Hiroshi, 2009, Nucleic Acids Symp Ser (Oxf), P65, DOI 10.1093/nass/nrp033; Abe N, 2007, J AM CHEM SOC, V129, P15108, DOI 10.1021/ja0754453; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Chernolovskaya EL, CURR OPIN MOL THER, V12, P158; D'Alessandro-Gabazza CN, 2012, AM J RESP CELL MOL, V46, P397, DOI 10.1165/rcmb.2011-0158OC; De Fougerolles AR, 2008, HUM GENE THER, V19, P125, DOI 10.1089/hum.2008.928; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kedmi R, 2009, NANOMEDICINE-UK, V4, P853, DOI 10.2217/NNM.09.74; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Lares MR, TRENDS BIOTECHNOL, V28, P570; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Madtes DK, 1998, AM J RESP CRIT CARE, V158, P424, DOI 10.1164/ajrccm.158.2.9711112; Matthay MA, ANN REV PATHOL, V6, P147; Pecot CV, NAT REV CANC, V11, P59; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Sledz CA, 2005, BLOOD, V106, P787, DOI 10.1182/blood-2004-12-4643; Takagi T, 2009, J THROMB HAEMOST, V7, P2053, DOI 10.1111/j.1538-7836.2009.03642.x; Watts JK, J PATHOL, V226, P365; Willis BC, 2003, AM J PHYSIOL-LUNG C, V285, pL1192, DOI 10.1152/ajplung.00379.2002; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	25	29	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42655	10.1371/journal.pone.0042655	http://dx.doi.org/10.1371/journal.pone.0042655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916145	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600021
J	Renner, M; Schweizer, C; Bannai, H; Triller, A; Levi, S				Renner, Marianne; Schweizer, Claude; Bannai, Hiroko; Triller, Antoine; Levi, Sabine			Diffusion Barriers Constrain Receptors at Synapses	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; GABA(A) RECEPTORS; GLYCINE RECEPTORS; EXTRASYNAPTIC MEMBRANES; INHIBITORY SYNAPSES; LATERAL MOBILITY; GEPHYRIN; SUBUNIT; MOLECULE; TRANSMISSION	The flux of neurotransmitter receptors in and out of synapses depends on receptor interaction with scaffolding molecules. However, the crowd of transmembrane proteins and the rich cytoskeletal environment may constitute obstacles to the diffusion of receptors within the synapse. To address this question, we studied the membrane diffusion of the gamma-aminobutyric acid type A receptor (GABA(A)R) subunits clustered (gamma 2) or not (alpha 5) at inhibitory synapses in rat hippocampal dissociated neurons. Relative to the extrasynaptic region, gamma 2 and alpha 5 showed reduced diffusion and increased confinement at both inhibitory and excitatory synapses but they dwelled for a short time at excitatory synapses. In contrast, gamma 2 was similar to 3-fold more confined and dwelled similar to 3-fold longer in inhibitory synapses than alpha 5, indicating faster synaptic escape of alpha 5. Furthermore, using a gephyrin dominant-negative approach, we showed that the increased residency time of gamma 2 at inhibitory synapses was due to receptor-scaffold interactions. As shown for GABA(A)R, the excitatory glutamate receptor 2 subunit ( GluA2) of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) had lower mobility in both excitatory and inhibitory synapses but a higher residency time at excitatory synapses. Therefore barriers impose significant diffusion constraints onto receptors at synapses where they accumulate or not. Our data further reveal that the confinement and the dwell time but not the diffusion coefficient report on the synapse specific sorting, trapping and accumulation of receptors.	[Renner, Marianne; Schweizer, Claude; Bannai, Hiroko; Triller, Antoine; Levi, Sabine] CNRS, UMR8197, INSERM, U1024,IBENS, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Renner, M (corresponding author), CNRS, UMR8197, INSERM, U1024,IBENS, Paris, France.	antoine.triller@ens.fr; sabine.levi@inserm.fr	Bannai, Hiroko/I-7130-2014; LEVI, SABINE/AAX-5607-2020; Renner, Marianne/H-5315-2011	Bannai, Hiroko/0000-0002-0951-488X; Levi, Sabine/0000-0002-9927-0945; TRILLER, Antoine/0000-0002-7530-1233; Renner, Marianne/0000-0002-8727-6581	INSERM; Association Francaise contre les Myopathies (AFM); Agence Nationale de la Recherche (ANR) [Neur-043-02]; Toyobo Biotechnology Foundation; Japan Society for the Promotion of Science [06J06775]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Toyobo Biotechnology Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by INSERM and Association Francaise contre les Myopathies (AFM). CS was supported by INSERM, MR by Agence Nationale de la Recherche (ANR) grant Neur-043-02 and HB by the Toyobo Biotechnology Foundation and the Japan Society for the Promotion of Science (06J06775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bonneau S, 2005, IEEE T IMAGE PROCESS, V14, P1384, DOI 10.1109/TIP.2005.852794; Bouthour W, 2011, CEREB CORTEX; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; BUSSELL SJ, 1995, BIOPHYS J, V68, P1836, DOI 10.1016/S0006-3495(95)80360-7; Calamai M, 2009, J NEUROSCI, V29, P7639, DOI 10.1523/JNEUROSCI.5711-08.2009; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christie SB, 2002, PROG BRAIN RES, V136, P157; Crestani F, 2002, NEUROPHARMACOLOGY, V43, P679, DOI 10.1016/S0028-3908(02)00159-4; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Danglot L, 2003, MOL CELL NEUROSCI, V23, P264, DOI 10.1016/S1044-7431(03)00069-1; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Goslin K., 1998, RAT HIPPOCAMPAL NEUR, P339; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, J NEUROSCI, V16, P103; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Renner ML, 2009, NEUROPHARMACOLOGY, V56, P30, DOI 10.1016/j.neuropharm.2008.07.022; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Swanwick CC, 2006, J COMP NEUROL, V495, P497, DOI 10.1002/cne.20897; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	59	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43032	10.1371/journal.pone.0043032	http://dx.doi.org/10.1371/journal.pone.0043032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912780	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500100054
J	Shi, LH; Ko, ML; Abbott, LC; Ko, GYP				Shi, Liheng; Ko, Michael L.; Abbott, Louise C.; Ko, Gladys Y. -P.			Identification of Peptide Lv, a Novel Putative Neuropeptide That Regulates the Expression of L-Type Voltage-Gated Calcium Channels in Photoreceptors	PLOS ONE			English	Article							CA2+ CHANNELS; SYNAPTIC PLASTICITY; TERMINAL MITOSIS; MEMORY; PROTEINS; CELLS; PROTEOME; HORMONES; CA(V)1.2; GENOME	Neuropeptides are small protein-like signaling molecules with diverse roles in regulating neural functions such as sleep/wake cycles, pain modulation, synaptic plasticity, and learning and memory. Numerous drugs designed to target neuropeptides, their receptors, or relevant pathways have been developed in the past few decades. Hence, the discovery and characterization of new neuropeptides and their functions have received considerable attention from scientific research. Computational bioinformatics coupled with functional assays are powerful tools to address the difficulties in discovering new bioactive peptides. In this study, a new bioinformatic strategy was designed to screen full length human and mouse cDNA databases to search for novel peptides. One was discovered and named peptide Lv because of its ability to enhance L-type voltage-gated calcium channel (L-VGCC) currents in retinal photoreceptors. Using matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS), peptide Lv was detected in the culture media, which indicated that it was secreted from 661W cells transfected with the gene. In vitro treatments with either glutathione S-transferase (GST) fusion peptide Lv or synthesized peptide Lv enhanced L-VGCC channel activities in cone photoreceptors. At the molecular level, peptide Lv stimulated cAMP production, enhanced phosphorylation of extracellular signal-regulated kinase (ERK), and increased the protein expression of L-VGCC alpha 1 subunits in cone photoreceptors. Therefore, the biological activities of peptide Lv may be very important in the modulation of L-VGCC dependent neural plasticity.	[Shi, Liheng; Ko, Michael L.; Abbott, Louise C.; Ko, Gladys Y. -P.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Shi, LH (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	gko@cvm.tamu.edu	Abbott, Louise C/AAC-4392-2022		National Institutes of Health [RO1 EY017452]; College of Veterinary Medicine and Biomedical Sciences at Texas AM University; NATIONAL EYE INSTITUTE [R01EY017452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Medicine and Biomedical Sciences at Texas AM University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health RO1 EY017452 to GK and a postdoctoral research award from the College of Veterinary Medicine and Biomedical Sciences at Texas A&M University to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; ADLER R, 1984, J CELL BIOL, V99, P1173, DOI 10.1083/jcb.99.3.1173; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; BeleckyAdams T, 1996, DEV BIOL, V178, P304, DOI 10.1006/dbio.1996.0220; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carpio Y, 2006, PEPTIDES, V27, P710, DOI 10.1016/j.peptides.2005.08.013; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chiu PCN, 2008, HUM REPROD, V23, P1385, DOI 10.1093/humrep/den047; Choo KH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-249; Couceyro PR, 2003, PROTEIN EXPRES PURIF, V32, P185, DOI 10.1016/j.pep.2003.08.015; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Eisenhaber B, 2010, METHODS MOL BIOL, V609, P365, DOI 10.1007/978-1-60327-241-4_21; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GLEASON E, 1992, VISUAL NEUROSCI, V8, P315, DOI 10.1017/S0952523800005058; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Lovejoy DA, 2009, ANN NY ACAD SCI, V1163, P215, DOI 10.1111/j.1749-6632.2008.03629.x; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Rosenberg D, 2002, ANN NY ACAD SCI, V968, P65, DOI 10.1111/j.1749-6632.2002.tb04327.x; Rotzinger S, 2010, PEPTIDES, V31, P736, DOI 10.1016/j.peptides.2009.12.015; Sakurai T, 2010, ANN NY ACAD SCI, V1200, P149, DOI 10.1111/j.1749-6632.2010.05513.x; Schiller MR, 1996, FEBS LETT, V382, P6, DOI 10.1016/0014-5793(96)00083-X; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilding John P. H., 2001, Current Opinion in Pharmacology, V1, P656, DOI 10.1016/S1471-4892(01)00111-4; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	44	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43091	10.1371/journal.pone.0043091	http://dx.doi.org/10.1371/journal.pone.0043091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912796	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100061
J	Shimizu, K; Takahama, S; Endo, Y; Sawasaki, T				Shimizu, Kouhei; Takahama, Shoukichi; Endo, Yaeta; Sawasaki, Tatsuya			Stress-Inducible Caspase Substrate TRB3 Promotes Nuclear Translocation of Procaspase-3	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTIONAL ACTIVITY; CELL-DEATH; ER STRESS; ADIPOCYTE DIFFERENTIATION; INDUCED APOPTOSIS; ACTIVATION; PATHWAY; TRIBBLES; ATF4	Pseudokinase TRB3 is a stress-inducible nuclear protein, which has recently been shown to be involved in ER stress-induced apoptosis. However, it remains unclear how TRB3 contributes to the process. We recently demonstrated that TRB3 was cleaved by caspase-3 (CASP3) in vitro and also in apoptosis-induced cells. Thus, we investigate the role of TRB3 cleavage in the apoptotic process to address the above question. Overexpression studies revealed that the cleavage of TRB3 promoted CASP3/7 activation and apoptosis. In contrast, the anti-apoptotic effects were found under TRB3 non-cleavable conditions, such as ER stress, and also when the CASP3/7 activation was enhanced by knockdown of endogenous TRB3 expression. Interestingly, nuclear translocation of procaspase-3 (proCASP3) was observed in cells either overexpressing TRB3 or under tunicamycin-induced ER stress. Although forced cytoplasmic expression of proCASP3 enhanced apoptosis significantly, its nuclear expression did not produce any pro-apoptotic effect, suggesting that nuclear distribution of proCASP3 is not critical for the execution of apoptosis. Thus, TRB3 might prevent cytoplasmic activation of CASP3 by promoting proCASP3 entry into the nucleus, and thereby inhibit apoptosis. Taken together, our results suggest that TRB3, through its own cleavage, functions as a molecular switch between the cell survival and apoptotic pathways under stressful conditions.	[Shimizu, Kouhei; Endo, Yaeta; Sawasaki, Tatsuya] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Takahama, Shoukichi; Endo, Yaeta; Sawasaki, Tatsuya] Ehime Univ, Venture Business Lab, Matsuyama, Ehime, Japan; [Endo, Yaeta; Sawasaki, Tatsuya] Ehime Univ, Proteomed Res Ctr, Toon, Japan; [Endo, Yaeta; Sawasaki, Tatsuya] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan	Ehime University; Ehime University; Ehime University; RIKEN	Shimizu, K (corresponding author), Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan.	sawasaki@ehime-u.ac.jp		Sawasaki, Tatsuya/0000-0002-7952-0556; Shimizu, Kouhei/0000-0001-9523-4296	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology in Japan; Grants-in-Aid for Scientific Research [22310127] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a Grant-in-Aid for Scientific Research (B) (Dr. Sawasaki) and a Grant-in-Aid for JSPS Fellows (Dr. Shimizu) from Japan Society for the Promotion of Science, and a Grant-in-Aid for Scientific Research on Innovative Areas (Dr. Sawasaki) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Corcoran CA, 2005, CANCER BIOL THER, V4, P1063, DOI 10.4161/cbt.4.10.2205; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Giri K, 2003, FEBS LETT, V555, P380, DOI 10.1016/S0014-5793(03)01294-8; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Manns J, 2011, FASEB J, V25, P3250, DOI 10.1096/fj.10-177527; Misiti F, 2005, NEUROCHEM INT, V46, P575, DOI 10.1016/j.neuint.2005.01.001; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohoka N, 2010, BIOCHEM BIOPH RES CO, V392, P289, DOI 10.1016/j.bbrc.2009.12.175; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Shikama Y, 2001, EXP CELL RES, V264, P315, DOI 10.1006/excr.2000.5153; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tadokoro D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.65; Takahashi Y, 2008, J LIPID RES, V49, P880, DOI 10.1194/jlr.M700545-JLR200; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Wali VB, 2009, APOPTOSIS, V14, P1366, DOI 10.1007/s10495-009-0406-y; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Wurstle ML, 2010, J BIOL CHEM, V285, P33209, DOI 10.1074/jbc.M110.113860; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	41	19	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42721	10.1371/journal.pone.0042721	http://dx.doi.org/10.1371/journal.pone.0042721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912727	Green Submitted, Green Published, gold			2022-12-27	WOS:000307378500025
J	Mitin, N; Rossman, KL; Der, CJ				Mitin, Natalia; Rossman, Kent L.; Der, Channing J.			Identification of a Novel Actin-Binding Domain within the Rho Guanine Nucleotide Exchange Factor TEM4	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ARP2/3 COMPLEX; CRYSTAL-STRUCTURE; F-ACTIN; CELL-MIGRATION; PDZ-RHOGEF; ATP-ACTIN; ADP-ACTIN; PROTEIN; GTPASES	Spatio-temporal activation of Rho GTPases is essential for their function in a variety of biological processes and is achieved in part by regulating the localization of their activators, the Rho guanine nucleotide exchange factors (RhoGEFs). In this study, we provide the first characterization of the full-length protein encoded by RhoGEF TEM4 and delineate its domain structure, catalytic activity, and subcellular localization. First, we determined that TEM4 can stimulate guanine nucleotide exchange on RhoA and the related RhoB and RhoC isoforms. Second, we determined that TEM4, like other Dbl RhoGEFs, contains a functional pleckstrin homology (PH) domain immediately C-terminal to the catalytic Dbl homology (DH) domain. Third, using immunofluorescence analysis, we showed that TEM4 localizes to the actin cytoskeleton through sequences in the N-terminus of TEM4 independently of the DH/PH domains. Using site-directed mutagenesis and deletion analysis, we identified a minimal region between residues 81 and 135 that binds directly to F-actin and has an similar to 90-fold higher affinity for ATP-loaded F-actin. Finally, we demonstrated that a single point mutation (R130D) within full-length TEM4 abolishes actin binding and localization of TEM4 to the actin cytoskeleton, as well as dampens the in vivo activity of TEM4 towards RhoC. Taken together, our data demonstrate that TEM4 contains a novel actin binding domain and binding to actin is essential for TEM4 subcellular localization and activity. The unique subcellular localization of TEM4 suggests a spatially-restricted activity and expands the diversity of mechanisms by which RhoGEF function can be regulated.	[Mitin, Natalia] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mitin, N (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	nmitin@med.unc.edu		Der, Channing/0000-0002-7751-2747	NIH GI SPORE Developmental Research [CA106991]; NIH grant [CA129610]; NATIONAL CANCER INSTITUTE [R01CA129610, P50CA106991] Funding Source: NIH RePORTER	NIH GI SPORE Developmental Research; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH GI SPORE Developmental Research grant to N.M. and K.L.R. (CA106991) and NIH grant CA129610 to C.J.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Banerjee J, 2009, BIOCHEMISTRY-US, V48, P8032, DOI 10.1021/bi9010013; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; De Toledo M, 2000, FEBS LETT, V480, P287, DOI 10.1016/S0014-5793(00)01953-0; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; Fuentes EJ, 2003, J BIOL CHEM, V278, P21188, DOI 10.1074/jbc.M211792200; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Mohl M, 2006, N-S ARCH PHARMACOL, V373, P333, DOI 10.1007/s00210-006-0083-0; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rumenapp U, 2002, BIOCHEM J, V366, P721, DOI 10.1042/BJ20020654; Ruskamo S, 2009, ACTA CRYSTALLOGR D, V65, P1217, DOI 10.1107/S0907444909037330; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; St Croix B, 2000, SCIENCE, V289, P1197; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Winkler S, 2005, BIOCHEM BIOPH RES CO, V335, P1280, DOI 10.1016/j.bbrc.2005.08.025; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zheng J, 1997, J BIOL CHEM, V272, P30340, DOI 10.1074/jbc.272.48.30340	66	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41876	10.1371/journal.pone.0041876	http://dx.doi.org/10.1371/journal.pone.0041876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911862	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300079
J	Behura, SK; Severson, DW				Behura, Susanta K.; Severson, David W.			Comparative Analysis of Codon Usage Bias and Codon Context Patterns between Dipteran and Hymenopteran Sequenced Genomes	PLOS ONE			English	Article							TRANSFER-RNA GENES; DROSOPHILA-MELANOGASTER; EVOLUTION; SELECTION; LENGTH	Background: Codon bias is a phenomenon of non-uniform usage of codons whereas codon context generally refers to sequential pair of codons in a gene. Although genome sequencing of multiple species of dipteran and hymenopteran insects have been completed only a few of these species have been analyzed for codon usage bias. Methods and Principal Findings: Here, we use bioinformatics approaches to analyze codon usage bias and codon context patterns in a genome-wide manner among 15 dipteran and 7 hymenopteran insect species. Results show that GAA is the most frequent codon in the dipteran species whereas GAG is the most frequent codon in the hymenopteran species. Data reveals that codons ending with C or G are frequently used in the dipteran genomes whereas codons ending with A or T are frequently used in the hymenopteran genomes. Synonymous codon usage orders (SCUO) vary within genomes in a pattern that seems to be distinct for each species. Based on comparison of 30 one-to-one orthologous genes among 17 species, the fruit fly Drosophila willistoni shows the least codon usage bias whereas the honey bee (Apis mellifera) shows the highest bias. Analysis of codon context patterns of these insects shows that specific codons are frequently used as the 3'- and 5'-context of start and stop codons, respectively. Conclusions: Codon bias pattern is distinct between dipteran and hymenopteran insects. While codon bias is favored by high GC content of dipteran genomes, high AT content of genes favors biased usage of synonymous codons in the hymenopteran insects. Also, codon context patterns vary among these species largely according to their phylogeny.	[Behura, Susanta K.; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	University of Notre Dame	Behura, SK (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	sbehura@nd.edu		behura, Susanta/0000-0003-1057-2435; BEHURA, SUSANTA/0000-0002-0654-6288	National Institute for Allergy and Infectious Diseases, National Institutes of Health [RO1-AI059342, RO1-AI079125-A1, R21-AI088335]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088335, R01AI079125, R01AI059342] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants RO1-AI059342, RO1-AI079125-A1, and R21-AI088335 from the National Institute for Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 1997, GENE, V205, P269, DOI 10.1016/S0378-1119(97)00400-9; Angellotti MC, 2007, NUCLEIC ACIDS RES, V35, pW132, DOI 10.1093/nar/gkm392; Aoi MC, 2011, J MOL EVOL, V73, P74, DOI 10.1007/s00239-011-9457-0; Behura SK, 2011, INSECT MOL BIOL, V20, P177, DOI 10.1111/j.1365-2583.2010.01055.x; Behura SK, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00933.x; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; BULMER M, 1988, J EVOLUTION BIOL, V1, P15, DOI 10.1046/j.1420-9101.1988.1010015.x; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Das S, 2009, GENE, V443, P121, DOI 10.1016/j.gene.2009.04.022; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Fullen G., 1994, COMPLEX INT, V1; Heger A, 2007, GENETICS, V177, P1337, DOI 10.1534/genetics.107.070466; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Jorgensen FG, 2007, MOL BIOL EVOL, V24, P611, DOI 10.1093/molbev/msl190; Kliman RM, 2003, GENET RES, V81, P89, DOI 10.1017/S0016672302006067; KOPELOWITZ J, 1992, J MOL BIOL, V225, P261, DOI 10.1016/0022-2836(92)90920-F; Moriyama EN, 1998, NUCLEIC ACIDS RES, V26, P3188, DOI 10.1093/nar/26.13.3188; Moura G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000847; Moura GR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026817; Pesole G, 2000, GENE, V261, P85, DOI 10.1016/S0378-1119(00)00471-6; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Powell JR, 2003, J MOL EVOL, V57, pS214, DOI 10.1007/s00239-003-0030-3; Powell JR, 1997, P NATL ACAD SCI USA, V94, P7784, DOI 10.1073/pnas.94.15.7784; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Tats A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-463; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Vinogradov AE, 2001, J MOL EVOL, V52, P2, DOI 10.1007/s002390010128; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	41	97	101	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43111	10.1371/journal.pone.0043111	http://dx.doi.org/10.1371/journal.pone.0043111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912801	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700044
J	Chatterjee, N; Banerjee, T; Datta, S				Chatterjee, Nilanjana; Banerjee, Tanmay; Datta, Santanu			Accurate Estimation of Nucleic Acids by Amplification Efficiency Dependent PCR	PLOS ONE			English	Article							REAL-TIME PCR; ISOCITRATE DEHYDROGENASE; BRANCH POINT; ACETATE METABOLISM; MATHEMATICAL-MODEL; QUANTITATIVE PCR; RT-PCR; PHOSPHORYLATION; QUANTIFICATION; EXPRESSION	Accurate estimation of template - DNA or RNA by real time PCR is dependent on the amplification efficiency (F) of the reaction. The analytical equation describing the kinetics of PCR that is influenced by template re-annealing is formulated. It predicts the gradual reduction of F - from its initial value of 2, leading to template saturation. From an experimental standpoint, due to the exponential nature of the reaction a minute change in F can lead to a large error in the estimation of the initial template concentration. On the basis of individual variation in the amplification efficiency we have formulated a simple mathematical model and an MS Excel based data analysis software that allows accurate and automated quantification of initial template concentration. This method which does not require any normalisation with housekeeping genes was validated by transcript profiling of the genes in the TCA/glyoxylate cycle of E. coli. Consistent with published reports, we observed a precise and specific induction of the glyoxylate shunt genes when the bacteria was shifted from a six carbon glucose media to a two carbon source like acetate.	[Chatterjee, Nilanjana; Banerjee, Tanmay; Datta, Santanu] AstraZeneca India Private Ltd, Mol Biol Sect, Bangalore, Karnataka, India	AstraZeneca	Chatterjee, N (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	santanu.datta@gmail.com						Batsch A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-95; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Foster Russell G, 2007, Methods Mol Biol, V362, P3; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gevertz JL, 2005, BIOTECHNOL BIOENG, V92, P346, DOI 10.1002/bit.20617; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Holms H, 1996, FEMS MICROBIOL REV, V19, P85, DOI 10.1111/j.1574-6976.1996.tb00255.x; Kainz P, 2000, BBA-GENE STRUCT EXPR, V1494, P23, DOI 10.1016/S0167-4781(00)00200-1; LAKSHMI TM, 1978, CAN J MICROBIOL, V24, P149, DOI 10.1139/m78-027; Lalam N, 2004, ADV APPL PROBAB, V36, P602, DOI 10.1239/aap/1086957587; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; Lievens A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr775; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1971, J BIOL CHEM, V246, P6511; Mhlanga MM, 2001, METHODS, V25, P463, DOI 10.1006/meth.2001.1269; Niesters HGM, 2001, METHODS, V25, P419, DOI 10.1006/meth.2001.1264; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platts AE, 2008, ANAL BIOCHEM, V380, P315, DOI 10.1016/j.ab.2008.05.048; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Sevall JS, 2001, METHODS, V25, P452, DOI 10.1006/meth.2001.1267; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; STUELAND CS, 1988, J BIOL CHEM, V263, P19475; Swillens S, 2008, ANAL BIOCHEM, V373, P370, DOI 10.1016/j.ab.2007.10.019; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; WALSH K, 1984, J BIOL CHEM, V259, P9646; WALSH K, 1985, J BIOL CHEM, V260, P8430; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x; Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	43	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42063	10.1371/journal.pone.0042063	http://dx.doi.org/10.1371/journal.pone.0042063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912684	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700010
J	Gerecke, KM; Jiao, Y; Pagala, V; Smeyne, RJ				Gerecke, Kim M.; Jiao, Yun; Pagala, Viswajeeth; Smeyne, Richard J.			Exercise Does Not Protect against MPTP-Induced Neurotoxicity in BDNF Happloinsufficent Mice	PLOS ONE			English	Article							NIGRA PARS COMPACTA; DOPAMINERGIC NIGROSTRIATAL NEURONS; FAMILIAL PARKINSONS-DISEASE; MITOCHONDRIAL COMPLEX I; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; PHYSICAL-ACTIVITY; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; ANTIDEPRESSANT TREATMENT	Exercise has been demonstrated to potently protect substantia nigra pars compacta (SN) dopaminergic neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. One mechanism proposed to account for this neuroprotection is the upregulation of neurotrophic factors. Several neurotrophic factors, including Brain Derived Neurotrophic Factor (BDNF), have been shown to upregulate in response to exercise. In order to determine if exercise-induced neuroprotection is dependent upon BDNF, we compared the neuroprotective effects of voluntary exercise in mice heterozygous for the BDNF gene (BDNF+/-) with strain-matched wild-type (WT) mice. Stereological estimates of SNpc DA neurons from WT mice allowed 90 days exercise via unrestricted running demonstrated complete protection against the MPTP-induced neurotoxicity. However, BDNF+/- mice allowed 90 days of unrestricted exercise were not protected from MPTP-induced SNpc DA neuron loss. Proteomic analysis comparing SN and striatum from 90 day exercised WT and BDNF+/- mice showed differential expression of proteins related to energy regulation, intracellular signaling and trafficking. These results suggest that a full genetic complement of BDNF is critical for the exercise-induced neuroprotection of SNpc DA neurons.	[Gerecke, Kim M.] Rhodes Coll, Dept Psychol, Memphis, TN 38112 USA; [Gerecke, Kim M.] Rhodes Coll, Neurosci Program, Memphis, TN 38112 USA; [Jiao, Yun; Smeyne, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Pagala, Viswajeeth] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gerecke, KM (corresponding author), Rhodes Coll, Dept Psychol, Memphis, TN 38112 USA.	gereckek@rhodes.edu		Smeyne, Richard/0000-0002-8459-5472	American Lebanese Syrian Associated Charities (ALSAC); NIH [RO1 NS070825, NS039006]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825, R01NS039006] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the American Lebanese Syrian Associated Charities (ALSAC) and NIH grants RO1 NS070825 and NS039006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck DS, 2006, BEHAV BRAIN RES, V168, P345, DOI 10.1016/j.bbr.2005.11.008; Annepu J, 2000, NEUROSCI LETT, V289, P209, DOI 10.1016/S0304-3940(00)01300-8; Baker SA, 2005, BRAIN RES, V1039, P177, DOI 10.1016/j.brainres.2005.01.052; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BERKMAN LF, 1993, J CLIN EPIDEMIOL, V46, P1129, DOI 10.1016/0895-4356(93)90112-E; BLOMQUIST KB, 1987, PERCEPT MOTOR SKILL, V65, P175, DOI 10.2466/pms.1987.65.1.175; Bloomer RJ, 2008, MED SCI SPORT EXER, V40, P1385, DOI 10.1249/MSS.0b013e31816f1550; Boger HA, 2011, GENES BRAIN BEHAV, V10, P186, DOI 10.1111/j.1601-183X.2010.00654.x; Boyd JD, 2007, BRAIN RES, V1175, P107, DOI 10.1016/j.brainres.2007.07.067; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Castro-Caldas M, 2009, J MOL NEUROSCI, V38, P114, DOI 10.1007/s12031-008-9141-z; Cechetti F, 2008, BRAIN RES, V1188, P182, DOI 10.1016/j.brainres.2007.10.012; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Chen S, 2008, FEBS LETT, V582, P603, DOI 10.1016/j.febslet.2008.01.028; Chou JL, 2011, J PROTEOMICS, V74, P466, DOI 10.1016/j.jprot.2010.12.012; Chourbaji S, 2004, MOL BRAIN RES, V121, P28, DOI 10.1016/j.molbrainres.2003.11.002; Chung YC, 2011, NEUROPHARMACOLOGY, V60, P963, DOI 10.1016/j.neuropharm.2011.01.043; Coban A, 2007, J NEUROCHEM, V100, P1177, DOI 10.1111/j.1471-4159.2006.04294.x; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Collier TJ, 2002, J COMP NEUROL, V442, P320, DOI 10.1002/cne.10108; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Cook R, 2003, MOL BRAIN RES, V110, P279, DOI 10.1016/S0169-328X(02)00659-9; Deters N, 2009, BIOCHEM BIOPH RES CO, V379, P400, DOI 10.1016/j.bbrc.2008.12.140; DEUTCH AY, 1986, NEUROSCI LETT, V68, P51, DOI 10.1016/0304-3940(86)90228-4; Ding QX, 2006, EUR J NEUROSCI, V24, P1265, DOI 10.1111/j.1460-9568.2006.05026.x; Ding YX, 2011, NEUROCHEM RES, V36, P1759, DOI 10.1007/s11064-011-0491-5; Dluzen DE, 2001, EXP NEUROL, V170, P121, DOI 10.1006/exnr.2001.7698; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Evans D A, 1993, Ann Epidemiol, V3, P71; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Fisher BE, 2004, J NEUROSCI RES, V77, P378, DOI 10.1002/jnr.20162; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; FRIM DM, 1994, EXP NEUROL, V128, P172, DOI 10.1006/exnr.1994.1125; Garza AA, 2004, PHARMACOL BIOCHEM BE, V77, P209, DOI 10.1016/j.pbb.2003.10.020; Gerecke KM, 2010, BRAIN RES, V1341, P72, DOI 10.1016/j.brainres.2010.01.053; GERLACH M, 1991, EUR J PHARM-MOLEC PH, V208, P273, DOI 10.1016/0922-4106(91)90073-Q; GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Grosse G, 2005, DEV BRAIN RES, V156, P111, DOI 10.1016/j.devbraines.2004.12.012; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; HATTORI T, 1995, NEUROSCI RES, V21, P191, DOI 10.1016/0168-0102(94)00849-B; Hill RA, 2011, BRAIN RES, V1384, P51, DOI 10.1016/j.brainres.2011.01.060; Hutter-Saunders JAL, 2011, NEUROSCIENCE, V180, P293, DOI 10.1016/j.neuroscience.2011.02.015; Ito T, 2013, EXP TOXICOL PATHOL, V65, P121, DOI 10.1016/j.etp.2011.06.009; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Jiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029447; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; KNUSEL B, 1991, ADV EXP MED BIOL, V293, P351; Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8; KOPIN IJ, 1992, ANN NY ACAD SCI, V648, P96, DOI 10.1111/j.1749-6632.1992.tb24527.x; Kurz A, 2012, J NEURAL TRANSM, V119, P297, DOI 10.1007/s00702-011-0717-3; LANGSTON JW, 1984, BRAIN RES, V292, P390; Lau YS, 2011, EUR J NEUROSCI, V33, P1264, DOI 10.1111/j.1460-9568.2011.07626.x; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Liberatore GT, 1999, NAT MED, V5, P1403; Mabandla MV, 2010, BEHAV BRAIN RES, V211, P16, DOI 10.1016/j.bbr.2010.02.045; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; McCormack AL, 2006, NEUROSCIENCE, V141, P929, DOI 10.1016/j.neuroscience.2006.03.069; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meissner W, 2003, MOL NEUROBIOL, V28, P209, DOI 10.1385/MN:28:3:209; Mejias R, 2006, J NEUROSCI, V26, P4500, DOI 10.1523/JNEUROSCI.0122-06.2006; Michael GJ, 2011, NEUROGENETICS, V12, P295, DOI 10.1007/s10048-011-0294-5; Monaco R, 1999, J PROTEIN CHEM, V18, P859, DOI 10.1023/A:1020679229110; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Moy LY, 1998, BRAIN RES, V790, P264, DOI 10.1016/S0006-8993(98)00069-9; MUTHANE U, 1994, EXP NEUROL, V126, P195, DOI 10.1006/exnr.1994.1058; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nagatsu T, 2006, J NEURAL TRANSM-SUPP, P53; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; NICKLAS WJ, 1987, LIFE SCI, V40, P721, DOI 10.1016/0024-3205(87)90299-2; Pacelli C, 2011, BBA-MOL BASIS DIS, V1812, P1041, DOI 10.1016/j.bbadis.2010.12.022; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; PEREZOTANO I, 1994, NEUROSCI LETT, V175, P121, DOI 10.1016/0304-3940(94)91094-4; Petersen A, 2001, BRAIN RES BULL, V56, P331, DOI 10.1016/S0361-9230(01)00580-9; Poon HF, 2005, NEUROBIOL DIS, V18, P492, DOI 10.1016/j.nbd.2004.12.009; Radak Z, 2007, APPL PHYSIOL NUTR ME, V32, P942, DOI 10.1139/H07-081; RANSOM BR, 1987, NEUROSCI LETT, V75, P323, DOI 10.1016/0304-3940(87)90543-X; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Rieker C, 2012, EUR J NEUROSCI, V35, P735, DOI 10.1111/j.1460-9568.2012.08003.x; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Russo-Neustadt A, 2001, BEHAV BRAIN RES, V120, P87, DOI 10.1016/S0166-4328(00)00364-8; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; Schaaf M J, 2000, Stress, V3, P201, DOI 10.3109/10253890009001124; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Shi M, 2009, AM J PATHOL, V175, P54, DOI 10.2353/ajpath.2009.081019; Smeyne M, 2001, GLIA, V34, P73, DOI 10.1002/glia.1042; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Smith BA, 2011, BRAIN RES, V1386, P70, DOI 10.1016/j.brainres.2011.02.003; SPINA MB, 1992, J NEUROCHEM, V59, P99, DOI 10.1111/j.1471-4159.1992.tb08880.x; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Sterky FH, 2012, HUM MOL GENET, V21, P1078, DOI 10.1093/hmg/ddr537; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Sun LJ, 2010, BRAIN RES, V1335, P74, DOI 10.1016/j.brainres.2010.03.079; SUNDSTROM E, 1988, BRAIN RES BULL, V21, P257, DOI 10.1016/0361-9230(88)90240-7; Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605; TAKEI N, 1991, J NEUROCHEM, V57, P1178, DOI 10.1111/j.1471-4159.1991.tb08277.x; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; TSUKAHARA T, 1995, NEUROSURGERY, V37, P733, DOI 10.1227/00006123-199510000-00018; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; VANHOOF C, 1994, EUR J BIOCHEM, V226, P899; Vega SR, 2006, MED SCI SPORT EXER, V38, P675, DOI 10.1249/01.mss.0000210195.94952.50; Verhave PS, 2012, NEUROPHARMACOLOGY, V62, P1700, DOI 10.1016/j.neuropharm.2011.11.016; Walters TL, 1999, EXP NEUROL, V156, P62, DOI 10.1006/exnr.1998.6997; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Watabe M, 2004, J PHARMACOL EXP THER, V311, P948, DOI 10.1124/jpet.104.071381; Wu SY, 2011, BRAIN BEHAV IMMUN, V25, P135, DOI 10.1016/j.bbi.2010.09.006; Yanagita S, 2007, LIFE SCI, V80, P356, DOI 10.1016/j.lfs.2006.09.027; ZANG LY, 1993, J BIOL CHEM, V268, P16504; Zeevalk GD, 2001, J PHARMACOL EXP THER, V298, P925; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510; Zigmond Michael J, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS147, DOI 10.1016/S1353-8020(11)70046-3; Zigmond MJ, 2009, PARKINSONISM RELAT D, V15, pS42, DOI 10.1016/S1353-8020(09)70778-3; Zou LL, 2000, NEUROSCI LETT, V281, P167, DOI 10.1016/S0304-3940(00)00853-3	133	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43250	10.1371/journal.pone.0043250	http://dx.doi.org/10.1371/journal.pone.0043250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912838	Green Submitted, Green Published, gold			2022-12-27	WOS:000308063700068
J	Tagliamonte, M; Marasco, D; Ruggiero, A; De Stradis, A; Tornesello, ML; Totrov, M; Buonaguro, FM; Buonaguro, L				Tagliamonte, Maria; Marasco, Daniela; Ruggiero, Alessia; De Stradis, Angelo; Tornesello, Maria Lina; Totrov, Maxim; Buonaguro, Franco Maria; Buonaguro, Luigi			HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; HUMAN MONOCLONAL-ANTIBODY; NEUTRALIZING ACTIVITY; ASSEMBLY PROPERTIES; DENDRITIC CELLS; V3 LOOP; EPITOPE; PROTEINS; DESIGN; ENVELOPE	Heterologous protein scaffolds engrafted with structurally defined HIV Env epitopes recognized by broadly neutralizing monoclonal antibodies (MAbs) represent a promising strategy to elicit broad neutralizing antibodies. In such regards, a protein scaffold based on the HIV p24 CA protein is a highly attractive approach, providing also Gag epitopes for eliciting HIV non-neutralizing protective antibodies and specific CD4(+) and CD8(+) T cell responses. In the present study, computational techniques were employed to verify the presence of acceptor sites for conformational HIV Env epitopes and, as proof of concept, the analysis of HIV p24 CA-based scaffolds using a complete V3 loop in a MAb-bound conformation is presented. The V3-p24 epitope-scaffold proteins show the formation of capsomers made of hexamers similarly to the p24 wild type protein. Moreover, the conformational V3 loop presented on p24 scaffold is recognized by a panel of anti-V3 MAbs. The results suggest that HIV p24 CA protein has suitable acceptor sites for engrafting foreign epitopes, without disrupting the formation of capsomer hexamer structures, and that the V3 epitope does retain its antibody-bound conformation. This strongly support the feasibility of developing a scaffolding strategy based on p24 CA proteins displaying conformational minimal structural, antigenic HIV Env epitopes.	[Tagliamonte, Maria; Tornesello, Maria Lina; Buonaguro, Franco Maria; Buonaguro, Luigi] Ist Nazl Tumori Fond G Pascale, AIDS Reference Ctr, Lab Mol Biol & Viral Oncogenesis, Naples, Italy; [Marasco, Daniela] Univ Naples Federico II, Sch Biotechnol Sci, Dept Biol Sci, Naples, Italy; [Marasco, Daniela; Ruggiero, Alessia] Natl Resource Council, Inst Biostruct & Bioimaging, Naples, Italy; [De Stradis, Angelo] Natl Resource Council, Inst Plant Virol, Bari, Italy; [Totrov, Maxim] Molsoft LLC, La Jolla, CA USA	IRCCS Fondazione Pascale; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Tagliamonte, M (corresponding author), Ist Nazl Tumori Fond G Pascale, AIDS Reference Ctr, Lab Mol Biol & Viral Oncogenesis, Naples, Italy.	irccsvir@unina.it	DE STRADIS, ANGELO/B-2969-2013; Maria, Buonaguro Franco/AAF-4888-2019; Tagliamonte, Maria/I-2423-2016; Ruggiero, Alessia/GRJ-9538-2022; Marasco, Daniela/H-4848-2015; Buonaguro, Luigi/AAV-5655-2020; Buonaguro, Franco M./T-6028-2019; Tornesello, Maria Lina/A-1964-2008	DE STRADIS, ANGELO/0000-0003-1624-2365; Ruggiero, Alessia/0000-0002-3508-385X; Marasco, Daniela/0000-0002-6618-2949; Buonaguro, Franco M./0000-0002-7491-7220; Tornesello, Maria Lina/0000-0002-3523-3264; Buonaguro, Luigi/0000-0002-6380-7114; totrov, maxim/0000-0001-8594-274X; Tagliamonte, Maria/0000-0002-7167-4817	European Community [201433]; NGIN Programme	European Community(European Commission); NGIN Programme	The study was supported by the European Community's Seventh Framework Programme "Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies - NGIN" (FP7/2007-2013) under grant agreement no 201433. Dr. Tagliamonte is funded by the NGIN Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Bachmann MF, 1996, EUR J IMMUNOL, V26, P2595, DOI 10.1002/eji.1830261109; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Buonaguro L, 2001, ANTIVIR RES, V49, P35, DOI 10.1016/S0166-3542(00)00136-4; Buonaguro L, 2011, CLIN VACCINE IMMUNOL, V18, P2003, DOI 10.1128/CVI.05326-11; Buonaguro L, 2010, CURR HIV RES, V8, P299, DOI 10.2174/157016210791208659; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chakraborty K, 2006, BIOCHEM J, V399, P483, DOI 10.1042/BJ20060588; CHENGMAYER C, 1988, P NATL ACAD SCI USA, V85, P2815, DOI 10.1073/pnas.85.8.2815; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Hinton HJ, 2008, CURR TOP MICROBIOL, V319, P1; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Martelli G.P., 1984, METHOD VIROL, V8, P143, DOI DOI 10.1016/B978-0-12-470208-0.50011-6; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nardin EH, 2004, INFECT IMMUN, V72, P6519, DOI 10.1128/IAI.72.11.6519-6527.2004; Netter HJ, 2001, J VIROL, V75, P2130, DOI 10.1128/JVI.75.5.2130-2141.2001; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pantophlet R, 2008, VIROLOGY, V381, P251, DOI 10.1016/j.virol.2008.08.032; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Ross AL, 2010, LANCET INFECT DIS, V10, P305, DOI 10.1016/S1473-3099(10)70069-4; Ruedl C, 2002, EUR J IMMUNOL, V32, P818, DOI 10.1002/1521-4141(200203)32:3<818::AID-IMMU818>3.0.CO;2-U; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vietheer PT, 2007, ANTIVIR THER, V12, P477; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Vos Q, 2000, IMMUNOL REV, V176, P154; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang BZ, 2007, J VIROL, V81, P10869, DOI 10.1128/JVI.00542-07; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zinkernagel RM, 2001, ADV IMMUNOL, V79, P1, DOI 10.1016/S0065-2776(01)79001-3	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43318	10.1371/journal.pone.0043318	http://dx.doi.org/10.1371/journal.pone.0043318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912852	Green Published, gold, Green Submitted			2022-12-27	WOS:000308063700080
J	Kim, TH; Song, J; Llaguno, SRA; Murnan, E; Liyanarachchi, S; Palanichamy, K; Yi, JY; Viapiano, MS; Nakano, I; Yoon, SO; Wu, H; Parada, LF; Kwon, CH				Kim, Tae Hyong; Song, Jieun; Llaguno, Sheila R. Alcantara; Murnan, Eric; Liyanarachchi, Sandya; Palanichamy, Kamalakannan; Yi, Ji-Yeun; Viapiano, Mariano Sebastian; Nakano, Ichiro; Yoon, Sung Ok; Wu, Hong; Parada, Luis F.; Kwon, Chang-Hyuk			Suppression of Peroxiredoxin 4 in Glioblastoma Cells Increases Apoptosis and Reduces Tumor Growth	PLOS ONE			English	Article							OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; PROTECTS CELLS; GLIOMA-CELLS; P53; EXPRESSION; RADIATION; CANCER; DIFFERENTIATION; PROLIFERATION	Glioblastoma multiforme (GBM), the most common and aggressive primary brain malignancy, is incurable despite the best combination of current cancer therapies. For the development of more effective therapies, discovery of novel candidate tumor drivers is urgently needed. Here, we report that peroxiredoxin 4 (PRDX4) is a putative tumor driver. PRDX4 levels were highly increased in a majority of human GBMs as well as in a mouse model of GBM. Reducing PRDX4 expression significantly decreased GBM cell growth and radiation resistance in vitro with increased levels of ROS, DNA damage, and apoptosis. In a syngenic orthotopic transplantation model, Prdx4 knockdown limited GBM infiltration and significantly prolonged mouse survival. These data suggest that PRDX4 can be a novel target for GBM therapies in the future.	[Kim, Tae Hyong; Song, Jieun; Murnan, Eric; Yi, Ji-Yeun; Viapiano, Mariano Sebastian; Nakano, Ichiro; Kwon, Chang-Hyuk] Ohio State Univ, Dardinger Ctr Neurooncol & Neurosci, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Kim, Tae Hyong; Song, Jieun; Murnan, Eric; Yi, Ji-Yeun; Kwon, Chang-Hyuk] Ohio State Univ, Solid Tumor Program, James Comprehens Canc Ctr, Wexner Med Ctr, Columbus, OH 43210 USA; [Llaguno, Sheila R. Alcantara; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Liyanarachchi, Sandya] Ohio State Univ, Human Canc Genet Program, Wexner Med Ctr, Columbus, OH 43210 USA; [Palanichamy, Kamalakannan] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA; [Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Wexner Med Ctr, Columbus, OH 43210 USA; [Wu, Hong] Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Wu, Hong] Univ Calif Los Angeles, Sch Med, Inst Mol Med, Los Angeles, CA USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kim, TH (corresponding author), Ohio State Univ, Dardinger Ctr Neurooncol & Neurosci, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA.	Chang-Hyuk.Kwon@osumc.edu	Nakano, Ichiro/AAR-9562-2020; Palanichamy, Kamalakannan/E-3807-2011; Nakano, Ichiro/F-2076-2014; Kwon, Chang-hyuk/E-3450-2011; Song, Jieun/A-3567-2013; Yoon, Sung Ok/C-5992-2012; Palanichamy, Kamalakannan/Z-1376-2019; Parada, luis F/B-9400-2014; Viapiano, Mariano/AAE-5787-2019	Nakano, Ichiro/0000-0002-0916-3207; Nakano, Ichiro/0000-0002-6734-3468; Song, Jieun/0000-0001-7886-1765; Viapiano, Mariano/0000-0002-8756-388X; Alcantara, Sheila/0000-0002-1586-4384	OSU CCC Start-up Fund; American Cancer Society Institutional Research Seed Grant; NATIONAL CANCER INSTITUTE [R01CA152065] Funding Source: NIH RePORTER	OSU CCC Start-up Fund; American Cancer Society Institutional Research Seed Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by OSU CCC Start-up Fund and American Cancer Society Institutional Research Seed Grant (to C.-H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Dal-Pizzol F, 2003, J NEURO-ONCOL, V61, P89, DOI 10.1023/A:1022168805198; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao Z, 2008, FREE RADICAL BIO MED, V45, P1501, DOI 10.1016/j.freeradbiomed.2008.08.009; Gridley DS, 2011, INT J RADIAT BIOL, V87, P1173, DOI 10.3109/09553002.2011.624393; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang DH, 2011, MOL CELL, V44, P545, DOI 10.1016/j.molcel.2011.08.040; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim HS, 2003, AM J PHYSIOL-LUNG C, V285, pL363, DOI 10.1152/ajplung.00078.2003; Kwon C-H, 2009, CNS CANC MODELS MARK, P77; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Lee HC, 2004, INT J MOL MED, V13, P883; Li MH, 2004, INT J ONCOL, V24, P305; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu XD, 2009, CANCER INVEST, V27, P345, DOI 10.1080/07357900802438577; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Martin V, 2007, FREE RADICAL BIO MED, V42, P1715, DOI 10.1016/j.freeradbiomed.2007.02.028; Morgan C, 2003, BRIT J CANCER, V89, P1314, DOI 10.1038/sj.bjc.6601302; Park HJ, 2008, J PROTEOME RES, V7, P1138, DOI 10.1021/pr7007237; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polytarchou C, 2008, MOL CELL BIOL, V28, P7451, DOI 10.1128/MCB.00688-08; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schulte Janin, 2011, BMC Med, V9, P137, DOI 10.1186/1741-7015-9-137; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Smith PS, 2007, FREE RADICAL BIO MED, V42, P787, DOI 10.1016/j.freeradbiomed.2006.11.032; Smith-Pearson PS, 2008, FREE RADICAL BIO MED, V45, P1178, DOI 10.1016/j.freeradbiomed.2008.07.015; Stresing V, 2012, ONCOGENE; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Verhaak RG, 2009, REPRODUCIBLE GENE EX; Wang HQ, 2009, FEBS LETT, V583, P1511, DOI 10.1016/j.febslet.2009.04.009; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; Won H, 2012, ANTIOXID REDOX SIGN, V16, P245, DOI 10.1089/ars.2011.3952; Wurdak H, 2010, CELL STEM CELL, V6, P37, DOI 10.1016/j.stem.2009.11.002; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	54	30	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42818	10.1371/journal.pone.0042818	http://dx.doi.org/10.1371/journal.pone.0042818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916164	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600030
J	Morzaria-Luna, HN; Ainsworth, CH; Kaplan, IC; Levin, PS; Fulton, EA				Morzaria-Luna, Hem Nalini; Ainsworth, Cameron H.; Kaplan, Isaac C.; Levin, Phillip S.; Fulton, Elizabeth A.			Exploring Trade-Offs between Fisheries and Conservation of the Vaquita Porpoise (Phocoena sinus) Using an Atlantis Ecosystem Model	PLOS ONE			English	Article							MARINE ECOSYSTEMS; MANAGEMENT; CALIFORNIA; LONG; BIODIVERSITY; OBJECTIVES; MAMMALS	Background: Minimizing fishery bycatch threats might involve trade-offs between maintaining viable populations and economic benefits. Understanding these trade-offs can help managers reconcile conflicting goals. An example is a set of bycatch reduction measures for the Critically Endangered vaquita porpoise (Phocoena sinus), in the Northern Gulf of California, Mexico. The vaquita is an endemic species threatened with extinction by artisanal net bycatch within its limited range; in this area fisheries are the chief source of economic productivity. Methodology/Principal Findings: We analyze trade-offs between conservation of the vaquita and fisheries, using an end-to-end Atlantis ecosystem model for the Northern Gulf of California. Atlantis is a spatially-explicit model intended as a strategic tool to test alternative management strategies. We simulated increasingly restrictive fisheries regulations contained in the vaquita conservation plan: implementing progressively larger spatial management areas that exclude gillnets, shrimp driftnets and introduce a fishing gear that has no vaquita bycatch. We found that only the most extensive spatial management scenarios recovered the vaquita population above the threshold necessary to downlist the species from Critically Endangered. The scenario that excludes existing net gear from the 2008 area of vaquita distribution led to moderate decrease in net present value (US$ 42 million) relative to the best-performing scenario and a two-fold increase in the abundance of adult vaquita over the course of 30 years. Conclusions/Significance: Extended spatial management resulted in the highest recovery of the vaquita population. The economic cost of proposed management actions was unequally divided between fishing fleets; the loss of value from finfish gillnet fisheries was never recovered. Our analysis shows that managers will have to confront difficult trade-offs between management scenarios for vaquita conservation.	[Morzaria-Luna, Hem Nalini; Ainsworth, Cameron H.] Marine Resources Assessment Grp Amer Inc, Seattle, WA USA; [Kaplan, Isaac C.; Levin, Phillip S.] NOAA, Conservat Biol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Fulton, Elizabeth A.] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Div Marine & Atmospher Res, Hobart, Tas, Australia	National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Morzaria-Luna, HN (corresponding author), Marine Resources Assessment Grp Amer Inc, Seattle, WA USA.	HemNalini.MorzariaLuna@noaa.gov	Fulton, Beth/AAJ-1398-2021; Fulton, Beth/A-2871-2008	Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917	David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This project was funded by The David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuacorp de Hidalgo, 2009, PESCA RIBERENA MULTI; Ainsworth CH, 2008, ECOL MODEL, V214, P361, DOI 10.1016/j.ecolmodel.2008.02.039; Ainsworth C. H., 2011, NMFSNWFSC110 NOAA; Ainsworth CH, 2012, J APPL ECOL, V49, P63, DOI 10.1111/j.1365-2664.2011.02064.x; Ainsworth CH, 2005, CAN J FISH AQUAT SCI, V62, P1104, DOI 10.1139/F05-010; Aragon-Noriega EA, 2010, INT J SUST DEV WORLD, V17, P410, DOI 10.1080/13504509.2010.500823; Avila-Forcada S, 2012, MAR POLICY, V36, P613, DOI 10.1016/j.marpol.2011.10.012; Barlow J, 1997, MAR MAMMAL SCI, V13, P44, DOI 10.1111/j.1748-7692.1997.tb00611.x; Bobadilla M, 2011, ENVIRON SCI POLICY, V14, P998, DOI 10.1016/j.envsci.2011.06.003; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Boyd IL, 2010, BIOL CONSERV, V143, P1664, DOI 10.1016/j.biocon.2010.04.006; Chan KMA, 2007, CONSERV BIOL, V21, P59, DOI 10.1111/j.1523-1739.2006.00570.x; Cheung WWL, 2008, ECOL ECON, V66, P193, DOI 10.1016/j.ecolecon.2007.09.001; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CIRVA, 2012, 4 M INT COMM REC VAQ; D'Agrosa C, 1995, R INT WHAL COM; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Fulton EA, 2007, ALTERNATIVE MANAGEME; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Diaz-Uribe JG, 2012, ECOL MODEL, V230, P73, DOI 10.1016/j.ecolmodel.2012.01.009; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE101, DOI 10.1111/j.1748-7692.2010.00449.x; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE79, DOI 10.1111/j.1748-7692.2010.00438.x; Gerrodette Tim, 1995, V16, P273; Hohn AA, 1996, J ZOOL, V239, P235, DOI 10.1111/j.1469-7998.1996.tb05450.x; Homewood K., 2010, TRADE OFFS CONSERVAT; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hutton T., 2010, USE EC INCENTIVES MA; INAPESCA, 2011, EV BIOT RED ARR PROT; INAPESCA NMFS, 2012, FISH TECHN RES COLL; INE WWF, 2006, CONS VAQ HAB ALT GOL; IUCN, 2010, IUCN RED LIS; Jaramillo-Legorreta AM, 1999, MAR MAMMAL SCI, V15, P957, DOI 10.1111/j.1748-7692.1999.tb00872.x; Jaramillo-Legorreta A, 2007, CONSERV BIOL, V21, P1653, DOI 10.1111/j.1523-1739.2007.00825.x; Levin PS, 2009, J APPL ECOL, V46, P735, DOI 10.1111/j.1365-2664.2009.01667.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Lluch-Cota SE, 2010, PROG OCEANOGR, V87, P114, DOI 10.1016/j.pocean.2010.09.007; LOZANO H, 2006, THESIS U BRIT COLUMB; Mardle S, 2002, J ENVIRON MANAGE, V65, P49, DOI 10.1006/jema.2001.0518; Marquez-Farias J. F., 2006, SUSTENTABILIDAD PESC, P303; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Morales-Zarate MV, 2004, ECOL MODEL, V174, P331, DOI 10.1016/j.ecolmodel.2003.09.028; Munguia-Vega A, 2007, MOL ECOL, V16, P4051, DOI 10.1111/j.1365-294X.2007.03319.x; ORTIZ I, 2002, THESIS U WASHINGTON; Perez-Valencia S, 2011, MANIFESTACION IMPACT; PRONATURA, 2010, PESC EXP CAM RED ARR; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Rojas-Bracho L, 2008, PHOCOENA SINUS; Rojas-Bracho L, 2006, MAMMAL REV, V36, P179, DOI 10.1111/j.1365-2907.2006.00088.x; Rose KA, 2010, MAR COAST FISH, V2, P115, DOI 10.1577/C09-059.1; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Sanchirico JN, 2006, ECOL APPL, V16, P1643, DOI 10.1890/1051-0761(2006)016[1643:WANZAE]2.0.CO;2; SEMARNAT, 2008, PROGR ACC CONS EXP V; [SEMARNAT CONANP], 2010, LIN OT AP PROGR ACC; SGPA, 2010, RES MAN IMP MOD REG; SGPA, 2009, RES MAN IMP MOD REG; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Vidal Omar, 1995, Reports of the International Whaling Commission Special Issue, V16, P247	60	18	18	1	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42917	10.1371/journal.pone.0042917	http://dx.doi.org/10.1371/journal.pone.0042917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916180	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600033
J	Naseeb, S; Delneri, D				Naseeb, Samina; Delneri, Daniela			Impact of Chromosomal Inversions on the Yeast DAL Cluster	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE ORDER; HUMAN GENOME; EVOLUTION; PROTEIN; TRANSCRIPTION; INDUCTION; DROSOPHILA; CASSETTES; SELECTION	Chromosomal rearrangements occur readily in nature and are a major reshaping force during genome evolution. Such large scale modifications are usually deleterious causing several fitness defects, but sometimes can confer an advantage and become adaptive. For example the DAL metabolic cluster in yeast was assembled in recent evolutionary times in the Hemiascomycetes lineage, through a set of rearrangements that brought together the genes involved in the allantoin degradation pathway. In eukaryotes, the existence of physical clustering of genes with related functions supports the notion that neighbouring ORFs tend to be co-expressed and that the order of genes along the chromosomes may have biological significance, rather than being random as previously believed. In this study, we investigate the phenotypic effect that inversions have on the DAL gene cluster, expressed during nitrogen starvation. In all Saccharomyces "sensu stricto" species the order of the DAL cluster is conserved, while in the "sensu lato" species Naumovia castellii, which grows significantly worse than S. cerevisiae on allantoin, the cluster includes two nested inversions encompassing three DAL genes. We constructed several inverted and non-inverted S. cerevisiae strains possessing different inversions including those to mimic the configuration of the N. castellii DAL cluster. We showed that the inversion of DAL2 lower its own expression and reduces yeast fitness during nitrogen starvation. This rearrangement also altered the expression of the neighbouring genes DAL1 and DAL4. Moreover, we showed that the expression of the DAL4 anti-sense transcript (SUT614) does not change upon inversions of DAL2 and therefore is unlikely to be involved in its regulation. These results show that the order of the DAL cluster has an impact on the phenotype and gene expression, suggesting that these rearrangements may have been adaptive in the "sensu stricto" group in relation to the low availability of nitrogen in the environment.	[Naseeb, Samina; Delneri, Daniela] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Naseeb, S (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	d.delneri@manchester.ac.uk		Delneri, Daniela/0000-0001-8070-411X; Naseeb, Samina/0000-0003-3599-5813	Higher Education Commission Pakistan; Faculty of Life Sciences, University of Manchester; Natural Environment Research Council (NERC); Natural Environment Research Council [NE/B500190/1] Funding Source: researchfish	Higher Education Commission Pakistan(Higher Education Commission of Pakistan); Faculty of Life Sciences, University of Manchester; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	S. Naseeb was funded by Higher Education Commission Pakistan and a bursary from the Faculty of Life Sciences, University of Manchester. Work on chromosomal inversions in D. Delneri's laboratory was supported by Natural Environment Research Council (NERC) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; BONIERBALE MW, 1988, GENETICS, V120, P1095; Carter Z, 2010, YEAST, V27, P765, DOI 10.1002/yea.1774; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Coffman JA, 1996, MOL CELL BIOL, V16, P847; COOPER TG, 1987, J BACTERIOL, V169, P4660, DOI 10.1128/jb.169.10.4660-4667.1987; Cooper TG, 1996, MYCOTA, V3, P139; CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; DORRINGTON RA, 1993, NUCLEIC ACIDS RES, V21, P3777, DOI 10.1093/nar/21.16.3777; Du T, 2004, CURRENT PROTOCOLS MO; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Feder JL, 2003, GENETICS, V163, P939; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kahm M, 2010, J STAT SOFTWARE, V33; Kensche PR, 2008, TRENDS GENET, V24, P207, DOI 10.1016/j.tig.2008.02.003; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Lang GI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025290; LARUE TA, 1968, A VAN LEEUW J MICROB, V34, P153, DOI 10.1007/BF02046425; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Meadows LA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000552; Mezey JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-2; NEI M, 1967, GENETICS, V57, P625; Oliver Brian, 2002, J Biol, V1, P4; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; SHAW DD, 1983, SCIENCE, V220, P1165, DOI 10.1126/science.6407107; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sturtevant AH, 1921, P NATL ACAD SCI USA, V7, P235, DOI 10.1073/pnas.7.8.235; SUMRADA R, 1978, J BACTERIOL, V135, P498, DOI 10.1128/JB.135.2.498-510.1978; van Driel R, 2003, J CELL SCI, V116, P4067, DOI 10.1242/jcs.00779; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WARNER JW, 1976, J MAMMAL, V57, P10, DOI 10.2307/1379509; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yerushalmi U, 2007, B MATH BIOL, V69, P2261, DOI 10.1007/s11538-007-9219-8	45	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42022	10.1371/journal.pone.0042022	http://dx.doi.org/10.1371/journal.pone.0042022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916115	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800007
J	Thun, GA; Ferrarotti, I; Imboden, M; Rochat, T; Gerbase, M; Kronenberg, F; Bridevaux, PO; Zemp, E; Zorzetto, M; Ottaviani, S; Russi, EW; Luisetti, M; Probst-Hensch, NM				Thun, Gian-Andri; Ferrarotti, Ilaria; Imboden, Medea; Rochat, Thierry; Gerbase, Margaret; Kronenberg, Florian; Bridevaux, Pierre-Olivier; Zemp, Elisabeth; Zorzetto, Michele; Ottaviani, Stefania; Russi, Erich W.; Luisetti, Maurizio; Probst-Hensch, Nicole M.			SERPINA1 PiZ and PiS Heterozygotes and Lung Function Decline in the SAPALDIA Cohort	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; SYSTEMIC INFLAMMATION; ALPHA(1)-ANTITRYPSIN DEFICIENCY; GENERAL-POPULATION; FOLLOW-UP; ALPHA-1-ANTITRYPSIN DEFICIENCY; MZ HETEROZYGOTES; AIR-POLLUTION; BODY-WEIGHT	Background: Severe alpha1-antitrypsin (AAT) deficiency is a strong risk factor for COPD. But the impact of gene variants resulting in mild or intermediate AAT deficiency on the longitudinal course of respiratory health remains controversial. There is indication from experimental studies that pro-inflammatory agents like cigarette smoke can interact with these variants and thus increase the risk of adverse respiratory health effects. Therefore, we tested the effect of the presence of a protease inhibitor (Pi) S or Z allele (PiMS and PiMZ) on the change in lung function in different inflammation-exposed subgroups of a large, population-based cohort study. Methodology and Principal Findings: The SAPALDIA population includes over 4600 subjects from whom SERPINA1 genotypes for S and Z alleles, spirometry and respiratory symptoms at baseline and after 11 years follow-up, as well as proxies for inflammatory conditions, such as detailed smoking history, obesity and high sensitivity C-reactive protein (hs-CRP), were available. All analyses were performed by applying multivariate regression models. There was no overall unfavourable effect of PiMS or PiMZ genotype on lung function change. We found indication that PiZ heterozygosity interacted with inflammatory stimuli leading to an accelerated decline in measures in use as indices for assessing mild airway obstruction. Obese individuals with genotype PiMM had an average annual decline in the forced mid expiratory flow (Delta FEF25-75%) of 58.4 ml whereas in obese individuals with PiMZ it amounted to 92.2 ml (p = 0.03). Corresponding numbers for persistent smokers differed even more strongly (66.8 ml (PiMM) vs. 108.2 ml (PiMZ), p = 0.005). Equivalent, but less strong associations were observed for the change in the FEV1/FVC ratio. Conclusions: We suggest that, in addition to the well established impact of the rare PiZZ genotype, one Z allele may be sufficient to accelerate lung function decline in population subgroups characterized by elevated levels of low grade inflammation.	[Thun, Gian-Andri; Imboden, Medea; Zemp, Elisabeth; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Thun, Gian-Andri; Imboden, Medea; Zemp, Elisabeth; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Ferrarotti, Ilaria; Zorzetto, Michele; Ottaviani, Stefania; Luisetti, Maurizio] Univ Pavia, Ctr Diag Inherited Antitrypsin Deficiency Alpha1, Inst Resp Dis, IRCCS San Matteo Hosp Fdn, I-27100 Pavia, Italy; [Rochat, Thierry; Gerbase, Margaret; Bridevaux, Pierre-Olivier] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria; [Russi, Erich W.] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; IRCCS Fondazione San Matteo; University of Pavia; University of Geneva; Medical University of Innsbruck; University of Zurich; University Zurich Hospital	Thun, GA (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	Nicole.Probst@unibas.ch	Kronenberg, Florian/B-1736-2008; Ottaviani, Stefania/AAD-4644-2022; Ferrarotti, Ilaria/AEX-4579-2022; Zorzetto, Michele/K-2281-2015; Russi, Erich/AGN-8387-2022; Bridevaux, Pierre-Olivier/AAN-8046-2021; Ottaviani, Stefania/K-6356-2016	Kronenberg, Florian/0000-0003-2229-1120; Ottaviani, Stefania/0000-0002-2039-230X; Zorzetto, Michele/0000-0002-7826-3666; Ottaviani, Stefania/0000-0002-2039-230X; Thun, Gian Andri/0000-0003-4436-3455; ferrarotti, ilaria/0000-0003-4892-4192	Swiss National Science Foundation [33CS30_134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, 3233-054996, PDFMP3-123171]; Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/ Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Zurich; Schweizerische Unfallversicherungsanstalt (SUVA); Freiwillige Akademische Gesellschaft; UBS Wealth Foundation; Talecris Biotherapeutics GmbH; Abbott Diagnostics; Kedrion S.p.A.; IRCCS (Istituto di ricovero e cura a carattere scientific) Foundation San Matteo Hospital; Cariplo Foundation; Talecris GmbH; eALTA Award; Grifols International S.A.	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/ Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Zurich; Schweizerische Unfallversicherungsanstalt (SUVA); Freiwillige Akademische Gesellschaft; UBS Wealth Foundation; Talecris Biotherapeutics GmbH; Abbott Diagnostics(Abbott Laboratories); Kedrion S.p.A.; IRCCS (Istituto di ricovero e cura a carattere scientific) Foundation San Matteo Hospital; Cariplo Foundation(Fondazione Cariplo); Talecris GmbH; eALTA Award; Grifols International S.A.	The Swiss Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) was supported by the Swiss National Science Foundation (grants no 33CS30_134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, 3233-054996, PDFMP3-123171), the Federal Office for Forest, Environment and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/ Basel Landschaft, Geneva, Ticino, Valais and Zurich, Schweizerische Unfallversicherungsanstalt (SUVA), Freiwillige Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH and Abbott Diagnostics. The Center for Diagnosis of Inherited Alpha1-antitrypsin Deficiency in Pavia is supported by grants from Talecris Biotherapeutics GmbH, Kedrion S.p.A., IRCCS (Istituto di ricovero e cura a carattere scientific) Foundation San Matteo Hospital, and Cariplo Foundation 2006 projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by SUVA, Talecris Biotherapeutics GmbH, Abbott Diagnostics and Kedrion S.p.A. The Center for Diagnosis of Inherited Alpha1-antitrypsin Deficiency in Pavia is supported by grants from Talecris Biotherapeutics GmbH and Kedrion S.p.A. NPH has received an unrestricted research grant from Talecris GmbH. The grant money was applied to covering part of the salary costs for GAT. IF has received educational and consultancy fees, research grant (eALTA Award), and travel support from Talecris Biotherapeutics GmbH and Kedrion S.p.A. TR has received fees for consulting once in 2011 by Talecris Biotherapeutics GmbH. SO has received travel support from Grifols International S.A. and consultancy fees by Kedrion S.p.A. ML travels to European Respiratory Society and American Thoracic Society congresses have been funded by Talecris Biotherapeutics GmbH, has performed paid lectures for Kedrion S.p.A., has obtained research funds by Talecris Biotherapeutics GmbH, as well as funds for staff members. None of the companies was involved in defining specific aims, conduct of data analysis, data interpretation or decision to publish. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Alam S, 2011, AM J RESP CELL MOL, V45, P261, DOI 10.1165/rcmb.2010-0328OC; Banauch GI, 2010, CHEST, V138, P1116, DOI 10.1378/chest.10-0187; Bridevaux PO, 2009, EUR RESPIR J, V34, P332, DOI 10.1183/09031936.00162608; Bullo M, 2003, OBES RES, V11, P525, DOI 10.1038/oby.2003.74; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; COCHRANE GM, 1974, THORAX, V29, P389, DOI 10.1136/thx.29.4.389; Curjuric I, 2010, EUR RESPIR J, V35, P505, DOI 10.1183/09031936.00044309; Dahl M, 2005, EUR RESPIR J, V26, P67, DOI 10.1183/09031936.05.00135704; Dahl M, 2002, ANN INTERN MED, V136, P270, DOI 10.7326/0003-4819-136-4-200202190-00006; Dahl M, 2011, THORAX, V66, P197, DOI 10.1136/thx.2009.131193; DeMeo DL, 2004, THORAX, V59, P396, DOI 10.1136/thx.2003.012856; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; ERIKSSON S, 1985, EUR J RESPIR DIS, V67, P279; Ferrarotti I., 2012, THORAX; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Hall IP, 2010, THORAX, V65, P760, DOI 10.1136/thx.2010.147173; Hersh CP, 2004, THORAX, V59, P843, DOI 10.1136/thx.2004.022541; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Imboden M, 2009, ENVIRON HEALTH PERSP, V117, P1420, DOI 10.1289/ehp.0800430; JANUS ED, 1985, LANCET, V1, P152; JOHNSON D, 1979, J BIOL CHEM, V254, P4022; Kabesch M, 2004, THORAX, V59, P569, DOI 10.1136/thx.2003.016667; Kunzli N, 2005, SWISS MED WKLY, V135, P503; Luisetti M, 2004, THORAX, V59, P164, DOI 10.1136/thorax.2003.006494; Malerba M, 2006, THORAX, V61, P129, DOI 10.1136/thx.2005.043471; Margretardottir OB, 2009, COPD, V6, P250, DOI 10.1080/15412550903049157; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; McKeever T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021593; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mulgrew AT, 2004, CHEST, V125, P1952, DOI 10.1378/chest.125.5.1952; Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382; Probst-Hensch NM, 2010, THORAX, V65, P150, DOI 10.1136/thx.2009.115063; Roytblat L, 2000, OBES RES, V8, P673, DOI 10.1038/oby.2000.86; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Sandford AJ, 2001, AM J RESP CRIT CARE, V163, P469, DOI 10.1164/ajrccm.163.2.2006158; Senn O, 2005, EUR RESPIR J, V26, P909, DOI 10.1183/09031936.05.00021605; Senn O, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-35; Silva GE, 2003, CHEST, V123, P1435, DOI 10.1378/chest.123.5.1435; Simon MR, 2010, J ALLERGY CLIN IMMUN, V126, P527, DOI 10.1016/j.jaci.2010.05.016; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Sorheim IC, 2010, CHEST, V138, P1125, DOI 10.1378/chest.10-0746; Sunyer J, 2008, EUR RESPIR J, V32, P92, DOI 10.1183/09031936.00052507; Thomason MJ, 2000, THORAX, V55, P785, DOI 10.1136/thorax.55.9.785; von Ehrenstein OS, 2002, EUR RESPIR J, V19, P1099, DOI 10.1183/09031936.02.00104302; Vonk JM, 2003, THORAX, V58, P322, DOI 10.1136/thorax.58.4.322; Wadsworth MEJ, 2004, AM J RESP CELL MOL, V31, P559, DOI 10.1165/rcmb.2004-0027OC; Zorzetto M, 2008, CLIN CHEM, V54, P1331, DOI 10.1373/clinchem.2007.102798	48	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42728	10.1371/journal.pone.0042728	http://dx.doi.org/10.1371/journal.pone.0042728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912729	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307500100025
J	Iraola, G; Vazquez, G; Spangenberg, L; Naya, H				Iraola, Gregorio; Vazquez, Gustavo; Spangenberg, Lucia; Naya, Hugo			Reduced Set of Virulence Genes Allows High Accuracy Prediction of Bacterial Pathogenicity in Humans	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; IV SECRETION SYSTEM; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; GENOME SEQUENCE; STAPHYLOCOCCUS-AUREUS; SIGNAL-TRANSDUCTION; BORDETELLA-PETRII; HELICOBACTER-PYLORI; BIOFILM FORMATION	Although there have been great advances in understanding bacterial pathogenesis, there is still a lack of integrative information about what makes a bacterium a human pathogen. The advent of high-throughput sequencing technologies has dramatically increased the amount of completed bacterial genomes, for both known human pathogenic and non-pathogenic strains; this information is now available to investigate genetic features that determine pathogenic phenotypes in bacteria. In this work we determined presence/absence patterns of 814 different virulence-related genes among more than 600 finished bacterial genomes from both human pathogenic and non-pathogenic strains, belonging to different taxonomic groups (i.e: Actinobacteria, Gammaproteobacteria, Firmicutes, etc.). An accuracy of 95% using a cross-fold validation scheme with in-fold feature selection is obtained when classifying human pathogens and non-pathogens. A reduced subset of highly informative genes (120) is presented and applied to an external validation set. The statistical model was implemented in the BacFier v1.0 software (freely available at http://bacfier.googlecode.com/files/Bacfier_v1_0.zip), that displays not only the prediction (pathogen/non-pathogen) and an associated probability for pathogenicity, but also the presence/absence vector for the analyzed genes, so it is possible to decipher the subset of virulence genes responsible for the classification on the analyzed genome. Furthermore, we discuss the biological relevance for bacterial pathogenesis of the core set of genes, corresponding to eight functional categories, all with evident and documented association with the phenotypes of interest. Also, we analyze which functional categories of virulence genes were more distinctive for pathogenicity in each taxonomic group, which seems to be a completely new kind of information and could lead to important evolutionary conclusions.	[Iraola, Gregorio; Spangenberg, Lucia; Naya, Hugo] Inst Pasteur, Unidad Bioinformat, Montevideo, Uruguay; [Iraola, Gregorio] Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay; [Vazquez, Gustavo] Univ Nacl Sur, Dept Ciencias & Ingn Computac, Blanca, Argentina; [Naya, Hugo] Univ Republica, Fac Agron, Dept Prod Anim & Pasturas, Montevideo, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Iraola, G (corresponding author), Inst Pasteur, Unidad Bioinformat, Montevideo, Uruguay.	naya@pasteur.edu.uy	Iraola, Gregorio/L-6539-2019	Iraola, Gregorio/0000-0002-6516-3404; Naya, Hugo/0000-0001-6982-4399; Vazquez, Gustavo/0000-0002-5549-7929	Agencia Nacional de Investigacion e Innovacion - Uruguay; Comision Sectorial de Investigacion Cientifica - Uruguay; Consejo Nacional de Investigacion Cientifica y Tecnica - Argentina	Agencia Nacional de Investigacion e Innovacion - Uruguay; Comision Sectorial de Investigacion Cientifica - Uruguay; Consejo Nacional de Investigacion Cientifica y Tecnica - Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors acknowledge the financial support provided by Agencia Nacional de Investigacion e Innovacion - Uruguay (PhD. grant to LS), Comision Sectorial de Investigacion Cientifica - Uruguay (MSc grant to GI) and Consejo Nacional de Investigacion Cientifica y Tecnica - Argentina (research grant to GV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dabbagh B, 2008, J BACTERIOL, V190, P7141, DOI 10.1128/JB.00676-08; ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreatta M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013680; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Backert Steffen, 2002, Keio J Med, V51 Suppl 2, P6; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; BUDARINA ZI, 1994, ARCH MICROBIOL, V161, P252, DOI 10.1007/s002030050050; Celli J, 2000, CELL MICROBIOL, V2, P1, DOI 10.1046/j.1462-5822.2000.00033.x; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Dearden JC, 2009, SAR QSAR ENVIRON RES, V20, P241, DOI 10.1080/10629360902949567; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Farizo KM, 2000, INFECT IMMUN, V68, P4049, DOI 10.1128/IAI.68.7.4049-4054.2000; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fry NK, 2005, EMERG INFECT DIS, V11, P1131, DOI 10.3201/eid1107.050046; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Gross R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-449; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Ja_e AB, 2005, ANNU REV CELL DEV BI, V21, P247; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kehl-Fie TE, 2009, J BACTERIOL, V191, P4976, DOI 10.1128/JB.00123-09; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marjuki H, 2010, ARCH VIROL, V155, P925, DOI 10.1007/s00705-010-0666-4; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Muller M, 2005, RES MICROBIOL, V156, P131, DOI 10.1016/j.resmic.2004.09.016; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Poon KKH, 2008, J BACTERIOL, V190, P1857, DOI 10.1128/JB.01546-07; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Robinson C, 2001, NAT REV MOL CELL BIO, V2, P350, DOI 10.1038/35073038; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; Schoenhals GJ, 1999, MICROBIOL-UK, V145, P1769, DOI 10.1099/13500872-145-7-1769; Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shikuma NJ, 2009, J BACTERIOL, V191, P4082, DOI 10.1128/JB.01540-08; Sinev M. A., 1993, Molekulyarnaya Biologiya (Moscow), V27, P1218; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Spangenberg L, 2011, BIOINFORMATICS, V27, P2782, DOI 10.1093/bioinformatics/btr476; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Stark D, 2007, J MED MICROBIOL, V56, P435, DOI 10.1099/jmm.0.46976-0; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Titz B, 2006, J BACTERIOL, V188, P7700, DOI 10.1128/JB.00820-06; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Valenski ML, 2003, J BACTERIOL, V185, P5007, DOI 10.1128/JB.185.16.5007-5011.2003; Waters RC, 2007, PROTEIN SCI, V16, P769, DOI 10.1110/ps.072785407; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yim L, 2011, APPL ENV MICROBIOL; Zhang XH, 2005, J APPL MICROBIOL, V98, P1011, DOI 10.1111/j.1365-2672.2005.02583.x; Zink SD, 2002, INFECT IMMUN, V70, P1657, DOI 10.1128/IAI.70.3.1657-1663.2002	81	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42144	10.1371/journal.pone.0042144	http://dx.doi.org/10.1371/journal.pone.0042144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22916122	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000017
J	Downey, RV; Griffiths, HJ; Linse, K; Janussen, D				Downey, Rachel V.; Griffiths, Huw J.; Linse, Katrin; Janussen, Dorte			Diversity and Distribution Patterns in High Southern Latitude Sponges	PLOS ONE			English	Article							WEDDELL SEA; SHETLAND ISLANDS; MARINE SPONGES; BIODIVERSITY; BIOGEOGRAPHY; PORIFERA; OCEAN; DEMOSPONGIAE; ECOLOGY; FAUNA	Sponges play a key role in Antarctic marine benthic community structure and dynamics and are often a dominant component of many Southern Ocean benthic communities. Understanding the drivers of sponge distribution in Antarctica enables us to understand many of general benthic biodiversity patterns in the region. The sponges of the Antarctic and neighbouring oceanographic regions were assessed for species richness and biogeographic patterns using over 8,800 distribution records. Species-rich regions include the Antarctic Peninsula, South Shetland Islands, South Georgia, Eastern Weddell Sea, Kerguelen Plateau, Falkland Islands and north New Zealand. Sampling intensity varied greatly within the study area, with sampling hotspots found at the Antarctic Peninsula, South Georgia, north New Zealand and Tierra del Fuego, with limited sampling in the Bellingshausen and Amundsen seas in the Southern Ocean. In contrast to previous studies we found that eurybathy and circumpolar distributions are important but not dominant characteristics in Antarctic sponges. Overall Antarctic sponge species endemism is similar to 43%, with a higher level for the class Hexactinellida (68%). Endemism levels are lower than previous estimates, but still indicate the importance of the Polar Front in isolating the Southern Ocean fauna. Nineteen distinct sponge distribution patterns were found, ranging from regional endemics to cosmopolitan species. A single, distinct Antarctic demosponge fauna is found to encompass all areas within the Polar Front, and the sub-Antarctic regions of the Kerguelen Plateau and Macquarie Island. Biogeographical analyses indicate stronger faunal links between Antarctica and South America, with little evidence of links between Antarctica and South Africa, Southern Australia or New Zealand. We conclude that the biogeographic and species distribution patterns observed are largely driven by the Antarctic Circumpolar Current and the timing of past continent connectivity.	[Downey, Rachel V.; Griffiths, Huw J.; Linse, Katrin] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Janussen, Dorte] Forschungsinst & Nat Museum Senckenberg, Sekt Marine Evertebraten 1, Frankfurt, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Senckenberg Gesellschaft fur Naturforschung (SGN)	Downey, RV (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England.	hjg@bas.ac.uk	Downey, Rachel/Q-4156-2019; Griffiths, Huw J/D-4234-2009	Griffiths, Huw J/0000-0003-1764-223X; Linse, Katrin/0000-0003-3477-3047; Downey, Rachel/0000-0001-9275-8879	Scientific Committee on Antarctic Research Marine Biodiversity Information Network (SCAR-MarBIN); TOTAL Foundation; German Research Foundation [JA 1063/14-1, JA 1063/14-2]; NERC [bas0100026] Funding Source: UKRI; Natural Environment Research Council [bas0100026] Funding Source: researchfish	Scientific Committee on Antarctic Research Marine Biodiversity Information Network (SCAR-MarBIN); TOTAL Foundation(Total SA); German Research Foundation(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank the Scientific Committee on Antarctic Research Marine Biodiversity Information Network (SCAR-MarBIN) and the TOTAL Foundation for providing the funding to create the database. This paper is a contribution to the British Antarctic Survey core project, Environmental Change and Evolution. DJ would like to thank the German Research Foundation which finances projects JA 1063/14-1, 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2011, DEEP-SEA RES PT II, V58, P242, DOI 10.1016/j.dsr2.2010.05.016; Amsler MO, 2009, ANTARCT SCI, V21, P579, DOI 10.1017/S0954102009990356; Arntz Wolf E., 1997, P3; Avila C, 2000, J EXP MAR BIOL ECOL, V252, P27, DOI 10.1016/S0022-0981(00)00227-6; AYLING AL, 1980, BIOL BULL, V158, P271, DOI 10.2307/1540854; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2008, GLOBAL ECOL BIOGEOGR, V17, P84, DOI 10.1111/j.1466-8238.2007.00342.x; Barnes DKA, 2009, MAR ECOL PROG SER, V393, P13, DOI 10.3354/meps08246; Barnes DKA, 2000, VIE MILIEU, V50, P261; Barthel D, 1997, POLAR BIOL, V17, P91, DOI 10.1007/s003000050110; BARTHEL D, 1992, ANTARCT SCI, V4, P137, DOI 10.1017/S0954102092000221; Barthel D, 1994, ANTARCTIC HEXACTINEL, V6; Barthel D, 1989, DEEP SEA NEWSLETTER, V16, P8; BELIAEV GM, 1957, AM I BIOL SCI, V112, P116; BERGQUIST P R, 1978, P268; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Burton M., 1934, Great Barrier Reef Expedition 1928-9, V4, P513; Campos M, 2007, REV BRAS ZOOL, V24, P742, DOI 10.1590/S0101-81752007000300027; Campos M, 2007, REV BRAS ZOOL, V24, P687, DOI 10.1590/S0101-81752007000300021; Cattaneo-Vietti R., 2000, P539; Cerrano C, 2000, POLAR BIOL, V23, P441, DOI 10.1007/s003000050466; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Clarke A, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000886; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Convey P, BIOGEOGRAPH IN PRESS, P471; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; De Broyer C., 1996, B MUS CIV ST NAT VER, V20, P547; De Broyer C, 2011, SCAR MARBIN REGISTER; De Broyer C, 2011, DEEP-SEA RES PT II, V58, P5, DOI 10.1016/j.dsr2.2010.10.007; DELL RK, 1972, ADV MAR BIOL, V10, P1, DOI 10.1016/S0065-2881(08)60416-2; Eastman JT, 1999, ANTARCT SCI, V11, P293, DOI 10.1017/S0954102099000383; GendronBadou A, 1997, CR ACAD SCI II A, V325, P343, DOI 10.1016/S1251-8050(97)81382-1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griffiths HJ, 2011, DEEP-SEA RES PT II, V58, P18, DOI 10.1016/j.dsr2.2010.10.008; Griffiths HJ, 2011, ECOGRAPHY, V34, P616, DOI 10.1111/j.1600-0587.2010.06612.x; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Gutt J, 1998, ANTARCT SCI, V10, P398, DOI 10.1017/S0954102098000480; Gutt J, 2003, MAR ECOL PROG SER, V253, P77, DOI 10.3354/meps253077; GUTT J, 1995, ANTARCT SCI, V7, P227, DOI 10.1017/S0954102095000320; Hedgpeth J.W., 1969, Antarctic Map fo Ser, V11, P1; Held C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P135; HELMUTH B, 1994, MAR BIOL, V120, P421, DOI 10.1007/BF00680216; Hillenbrand CD, 2003, MAR GEOL, V193, P253, DOI 10.1016/S0025-3227(02)00659-X; Hogg MM, 2010, DEEP SEA SPONGE GROU; Hogg OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019795; Hommersand MH, 2009, BOT MAR, V52, P509, DOI 10.1515/BOT.2009.081; HOOPER JNA, 1994, SPONGES IN TIME AND SPACE, P191; Hooper JNA, 2002, SYSTEMA PORIFERA GUI; Janussen D, 2007, DEEP-SEA RES PT II, V54, P1864, DOI 10.1016/j.dsr2.2007.07.012; Janussen D, 2009, ZOOTAXA, P1; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Koltun V. M., 1970, Symp. zool. Soc. Lond., VNo. 25, P285; Koltun VM, 1969, ANTARCTIC MAP FOLIO, V11, P13; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; Linse K, 2004, DEEP-SEA RES PT II, V51, P1827, DOI 10.1016/j.dsr2.2004.07.016; Linse K, 2007, POLAR BIOL, V30, P1059, DOI 10.1007/s00300-007-0265-3; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Lockhart S.J., 2009, WGEMM0932 CCAMLR; Lorz AN, 2009, ZOOKEYS, P91, DOI 10.3897/zookeys.18.103; Maldonado Manuel, 2002, P21; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; MCCLINTOCK JB, 1994, J CHEM ECOL, V20, P859, DOI 10.1007/BF02059583; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Munilla T, 2009, ANTARCT SCI, V21, P99, DOI 10.1017/S095410200800151X; NELSON DM, 1982, GEOCHIM COSMOCHIM AC, V46, P491, DOI 10.1016/0016-7037(82)90153-3; Pansini M, 1999, SCI MAR, V63, P203, DOI 10.3989/scimar.1999.63s1203; PEARSE JS, 1991, AM ZOOL, V31, P65; Primo C, 2007, ANTARCT SCI, V19, P321, DOI 10.1017/S0954102007000521; Rapp HT, 2011, DEEP-SEA RES PT II, V58, P58, DOI 10.1016/j.dsr2.2010.05.022; Rex MA, 1997, MARINE BIODIVERSITY-BOOK, P94, DOI 10.1017/CBO9780511752360.006; Rogers AD, 2007, PHILOS T R SOC B, V362, P2191, DOI 10.1098/rstb.2006.1948; SARA M, 1992, POLAR BIOL, V12, P559; Simpson T., 1984, CELL BIOL SPONGES; TABACHNICK KR, 1994, SPONGES IN TIME AND SPACE, P225; Teixido N, 2006, DEEP-SEA RES PT II, V53, P972, DOI 10.1016/j.dsr2.2006.02.008; THORPE JP, 1994, ZOOL SCR, V23, P3, DOI 10.1111/j.1463-6409.1994.tb00368.x; Thrush S, 2006, DEEP-SEA RES PT II, V53, P959, DOI 10.1016/j.dsr2.2006.02.006; Usher KM, 2004, MAR ECOL PROG SER, V270, P117, DOI 10.3354/meps270117; Van Soest RWM, 2011, WORLD PORIFERA DATAB; VANSOEST RWM, 1994, SPONGES IN TIME AND SPACE, P213; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z	86	69	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41672	10.1371/journal.pone.0041672	http://dx.doi.org/10.1371/journal.pone.0041672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911840	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000306751300063
J	Li, ZM; Huang, JJ; Xia, Y; Sun, J; Huang, Y; Wang, Y; Zhu, YJ; Li, YJ; Zhao, W; Wei, WX; Lin, TY; Huang, HQ; Jiang, WQ				Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Sun, Jian; Huang, Ying; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi			Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; ABSOLUTE MONOCYTE; RESPONSE CRITERIA; PROGNOSTIC-FACTOR; SURVIVAL; LYMPHOPENIA; EXPRESSION; COUNT; TUMOR; CHEMOTHERAPY	Background: Recent research has shown a correlation between immune microenvironment and lymphoma biology. This study aims to investigate the prognostic significance of the immunologically relevant lymphocyte-to-monocyte ratio (LMR), in diffuse large B-cell lymphoma (DLBCL) in the rituximab era. Methodology/Principal Findings: We analyzed retrospective data from 438 newly diagnosed DLBCL patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy. We randomly selected 200 patients (training set) to generate a cutoff value for LMR by receiver operating characteristic (ROC) curve analysis. LMR was then analyzed in a testing set (n = 238) and in all patients (n = 438) for validation. The LMR cutoff value for survival analysis determined by ROC curve in the training set was 2.6. Patients with low LMR tended to have more adverse clinical characteristics. Low LMR at diagnosis was associated with worse survival in DLBCL, and could also identify high-risk patients in the low-risk IPI category. Multivariate analysis identified LMR as an independent prognostic factor of survival in the testing set and in all patients. Conclusions/Significance: Baseline LMR, a surrogate biomarker of the immune microenvironment, is an effective prognostic factor in DLBCL patients treated with R-CHOP therapy. Future prospective studies are required to confirm our findings.	[Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Sun, Jian; Huang, Ying; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Ctr Canc, Dept Clin Trial Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, ZM (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	lzmlzmlzm@yahoo.com	jiang, wen/GYI-9662-2022; Wu, William K.K./A-3277-2009	Wu, William K.K./0000-0002-5662-5240; Qiu, Guixing/0000-0002-4597-9350	National Natural Science Foundation of China [81071950]; Fundamental Research Funds for the Central Universities [10ykpy36]; National-Eleventh Five Technology Major Project [2008ZX09312-002, 2012ZX09301]; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National-Eleventh Five Technology Major Project; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	This work was supported by National Natural Science Foundation of China (NO. 81071950), Fundamental Research Funds for the Central Universities (NO. 10ykpy36), National-Eleventh Five Technology Major Project (NO. 2008ZX09312-002, 2012ZX09301), and Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid Muhammad Bilal, 2005, Asian Pac J Cancer Prev, V6, P531; Alizadeh AA, 2011, BLOOD, V118, P1350, DOI 10.1182/blood-2011-03-345272; Ansell SM, 2001, J CLIN ONCOL, V19, P720, DOI 10.1200/JCO.2001.19.3.720; Bari A, 2010, ANN ONCOL, V21, P1486, DOI 10.1093/annonc/mdp531; Bhaskaran K, 2004, AIDS, V18, P673, DOI [10.1097/01.aids.0000111464.61782.64, 10.1097/00002030-200403050-00012]; Borg C, 2004, CANCER-AM CANCER SOC, V101, P2675, DOI 10.1002/cncr.20688; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Coiffier B, 2007, ONCOGENE, V26, P3603, DOI 10.1038/sj.onc.1210376; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Dworacki G, 2001, CLIN CANCER RES, V7, p947S; Huang JJ, 2011, ANN ONCOL, V22, P149, DOI 10.1093/annonc/mdq314; Huang JJ, 2011, HUM PATHOL, V42, P1459, DOI 10.1016/j.humpath.2010.12.014; Ishii H, 2012, INT J CANCER, V130, P48, DOI 10.1002/ijc.25969; Kim DH, 2007, LEUKEMIA, V21, P2227, DOI 10.1038/sj.leu.2404780; Kim YR, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-34; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lin Y, 2011, BLOOD, V117, P872, DOI 10.1182/blood-2010-05-283820; Morton LM, 2008, BLOOD, V112, P5150, DOI 10.1182/blood-2008-01-133587; Moskowitz C, 2012, BEST PRACT RES CL HA, V25, P41, DOI 10.1016/j.beha.2012.01.008; Pileri SA, 2011, SEMIN DIAGN PATHOL, V28, P113, DOI 10.1053/j.semdp.2011.02.001; Porrata LF, 2007, LEUKEMIA, V21, P2554, DOI 10.1038/sj.leu.2404819; Porrata LF, 2004, CLIN EXP MED, V4, P78, DOI 10.1007/s10238-004-0041-4; Porrata LF, 2012, BRIT J HAEMATOL, V157, P321, DOI 10.1111/j.1365-2141.2012.09067.x; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Vegso G, 2011, PATHOL ONCOL RES, V17, P443, DOI 10.1007/s12253-010-9329-8; Wada N, 2012, HISTOPATHOLOGY, V60, P924, DOI 10.1111/j.1365-2559.2011.04161.x; Wada N, 2012, HISTOPATHOLOGY, V60, P313, DOI 10.1111/j.1365-2559.2011.04096.x; Wilcox RA, 2011, LEUKEMIA, V25, P1502, DOI 10.1038/leu.2011.112; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Wilcox RA, 2009, BLOOD, V114, P2936, DOI 10.1182/blood-2009-05-220111	35	221	232	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41658	10.1371/journal.pone.0041658	http://dx.doi.org/10.1371/journal.pone.0041658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	23300886	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700134
J	Ma, JM; Xu, JQ; Anderson, RN; Jemal, A				Ma, Jiemin; Xu, Jiaquan; Anderson, Robert N.; Jemal, Ahmedin			Widening Educational Disparities in Premature Death Rates in Twenty Six States in the United States, 1993-2007	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SOCIOECONOMIC-STATUS; ALL-CAUSE; INEQUALITIES; ADULTS; TRENDS; NORWAY; GAP	Background: Eliminating socioeconomic disparities in health is an overarching goal of the U.S. Healthy People decennial initiatives. We present recent trends in mortality by education among working-aged populations. Methods and Findings: Age-standardized death rates and their average annual percent change for all-cause and five major causes (cancer, heart disease, stroke, diabetes, and accidents) were calculated from 1993 through 2007 for individuals aged 25-64 years by educational attainment as a marker of socioeconomic status, using national vital registration data for 26 states with consistent educational information on the death certificates. Rate ratios and rate differences were used to assess disparities (<= 12 versus >= 16 years of education) for 1993 through 2007. From 1993 through 2007, relative educational disparities in all-cause mortality continued to increase among working-aged men and women in the U. S., due to larger decreases of mortality rates among the most educated coupled with smaller decreases or even worsening trends in the less educated. For example, the rate ratios of all-cause mortality increased from 2.5 (95% confidence interval (CI), 2.4-2.6) in 1993 to 3.6 (95% CI, 3.5-3.7) in 2007 in men and from 1.9 (95% CI, 1.8-2.0) to 3.0 (95% CI, 2.9-3.1) in women. Generally, the rate differences (per 100,000 persons) of all-cause mortality increased from 415.5 (95% CI, 399.1-431.9) in 1993 to 472.7 (95% CI, 460.2-485.2) in 2007 in men and from 165.4 (95% CI, 154.5-176.2) to 256.2 (95% CI, 248.3-264.2) in women. Disparity patterns varied largely across the five specific causes considered in this study, with the largest increases of relative disparities for accidents, especially in women. Conclusions: Relative educational differentials in mortality continued to widen among men and women despite emphasis on reducing disparities in the U. S. Healthy People decennial initiatives.	[Ma, Jiemin; Jemal, Ahmedin] Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30329 USA; [Xu, Jiaquan; Anderson, Robert N.] Ctr Dis Control & Prevent, Mortal Stat Branch, Natl Ctr Hlth Stat, Hyattsville, MD USA	American Cancer Society; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Ma, JM (corresponding author), Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30329 USA.	jiemin.ma@cancer.org	shen, Guanxin/F-7441-2011	Liu, Hongbo/0000-0002-7187-8115	American Cancer Society and the Centers for Disease Control and Prevention	American Cancer Society and the Centers for Disease Control and Prevention	The American Cancer Society and the Centers for Disease Control and Prevention funded the analysis, interpretation, and compilation of surveillance data. No staff at either agency, other than the authors, was involved in the conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2010, 2010 NAT HEALTHC DIS; Ahluwalia IB, 2008, J COMMUN HEALTH, V33, P293, DOI 10.1007/s10900-008-9106-8; Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Berkman L F, 1997, IARC Sci Publ, P51; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225; Hadden WC, 2008, INT J HEALTH SERV, V38, P47, DOI 10.2190/HS.38.1.c; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kominski R., 1994, ED ATTAINMENT US MAR, P20; Korhonen N, 2011, INJURY, V42, P885, DOI 10.1016/j.injury.2010.08.033; Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046; Mackenbach JP, 2010, SOC SCI MED, V71, P1249, DOI 10.1016/j.socscimed.2010.07.014; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Minino A., 2007, NATL VITAL STAT REP, V55, P1; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Rim Sun Hee, 2011, Morbidity and Mortality Weekly Report, V60, P42; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Rostron BL, 2010, ED REP CLASS DEATH C, Viii; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schalick LM, 2000, INT J HEALTH SERV, V30, P13, DOI 10.2190/8QMH-4FAB-XAWP-VU95; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786; Sorlie PD, 1996, EPIDEMIOLOGY, V7, P437, DOI 10.1097/00001648-199607000-00017; Steenland K, 2004, AM J PUBLIC HEALTH, V94, P1037, DOI 10.2105/AJPH.94.6.1037; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; U.S. Department of Health and Human Services, 2010, HLTH PEOPL 2020; U.S. Department of Health and Human Services, 2007, HLTH PEOPL 2010 MIDC; WHO, 2018, INT STAT CLASS DIS R; World Health Organization, 1977, INT STAT CLASS DIS R	37	76	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41560	10.1371/journal.pone.0041560	http://dx.doi.org/10.1371/journal.pone.0041560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977GL	23094023	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600087
J	Wang, Y; Guo, LH; Cai, SP; Dai, MZ; Yang, QN; Yu, WH; Yan, NH; Zhou, XM; Fu, J; Guo, XW; Han, PF; Wang, J; Liu, XY				Wang, Yun; Guo, Liheng; Cai, Su-Ping; Dai, Meizhi; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin; Fu, Jin; Guo, Xinwu; Han, Pengfei; Wang, Jun; Liu, Xuyang			Exome Sequencing Identifies Compound Heterozygous Mutations in CYP4V2 in a Pedigree with Retinitis Pigmentosa	PLOS ONE			English	Article							CORNEO-RETINAL DYSTROPHY; FATTY-ACID; CRYSTALLINE DYSTROPHY; DOCOSAHEXAENOIC ACID; CLINICAL-TRIAL; METABOLISM; GENE; DEFICIENCY; CAPTURE	Retinitis pigmentosa (RP) is a heterogeneous group of progressive retinal degenerations characterized by pigmentation and atrophy in the mid-periphery of the retina. Twenty two subjects from a four-generation Chinese family with RP and thin cornea, congenital cataract and high myopia is reported in this study. All family members underwent complete ophthalmologic examinations. Patients of the family presented with bone spicule-shaped pigment deposits in retina, retinal vascular attenuation, retinal and choroidal dystrophy, as well as punctate opacity of the lens, reduced cornea thickness and high myopia. Peripheral venous blood was obtained from all patients and their family members for genetic analysis. After mutation analysis in a few known RP candidate genes, exome sequencing was used to analyze the exomes of 3 patients III2, III4, III6 and the unaffected mother II2. A total of 34,693 variations shared by 3 patients were subjected to several filtering steps against existing variation databases. Identified variations were verified in the rest family members by PCR and Sanger sequencing. Compound heterozygous c. 802-8_810del17insGC and c. 1091-2A>G mutations of the CYP4V2 gene, known as genetic defects for Bietti crystalline corneoretinal dystrophy, were identified as causative mutations for RP of this family.	[Wang, Yun; Guo, Liheng; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin] W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Ophthalm Labs, Chengdu, Sichuan Provinc, Peoples R China; [Wang, Yun; Guo, Liheng; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin] W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Dept Ophthalmol, Chengdu, Sichuan Provinc, Peoples R China; [Cai, Su-Ping; Liu, Xuyang] Jinan Univ, Shenzhen Eye Hosp, Shenzhen, Peoples R China; [Dai, Meizhi; Fu, Jin; Guo, Xinwu; Han, Pengfei; Wang, Jun] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Sichuan University; Sichuan University; Jinan University; Beijing Genomics Institute (BGI)	Wang, Y (corresponding author), W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Ophthalm Labs, Chengdu, Sichuan Provinc, Peoples R China.	wangj@genomics.org.cn; xliu1213@yahoo.com.cn	Wang, Jun/A-7261-2013; Cai, Shanqing/F-6880-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Beal, Deryk S./0000-0001-9488-4326; Yu, Wenhan/0000-0002-0125-4358; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Ghosh, Satrajit/0000-0002-5312-6729	National Natural Science Foundation of China (NSFC) [81000370]; National Basic Research Program of China (973 Program) [2011CB510201]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81000370) and the National Basic Research Program of China (973 Program, 2011CB510201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1987, EXP EYE RES, V44, P155, DOI 10.1016/S0014-4835(87)80034-9; Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1297, DOI 10.1001/archopht.122.9.1297; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CONVERSE CA, 1983, T OPHTHAL SOC UK, V103, P508; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; GONG JX, 1992, INVEST OPHTH VIS SCI, V33, P2596; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hoffman DR, 2004, AM J OPHTHALMOL, V137, P704, DOI 10.1016/j.ajo.2003.10.045; HOFFMAN DR, 1995, EXP EYE RES, V60, P279, DOI 10.1016/S0014-4835(05)80110-1; HOFFMAN DR, 1993, EXP EYE RES, V57, P359, DOI 10.1006/exer.1993.1135; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jin ZB, 2006, JPN J OPHTHALMOL, V50, P426, DOI 10.1007/s10384-006-0350-0; KAISERKUPFER MI, 1994, AM J OPHTHALMOL, V118, P569, DOI 10.1016/S0002-9394(14)76572-9; Kelly EJ, 2011, MOL INTERV, V11, P124, DOI 10.1124/mi.11.2.10; Lai TYY, 2007, INVEST OPHTH VIS SCI, V48, P5212, DOI 10.1167/iovs.07-0660; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Lee J, 1998, MOL GENET METAB, V65, P143, DOI 10.1006/mgme.1998.2723; Lee J, 2001, INVEST OPHTH VIS SCI, V42, P1707; Lee KYC, 2005, INVEST OPHTH VIS SCI, V46, P3812, DOI 10.1167/iovs.05-0378; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; Li GQ, 2009, NUCLEIC ACIDS RES, V37, pD1025, DOI 10.1093/nar/gkn966; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029066; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Shan MG, 2005, MOL VIS, V11, P738	29	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e33673	10.1371/journal.pone.0033673	http://dx.doi.org/10.1371/journal.pone.0033673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22911857	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500004
J	Jin, XM; Ishii, H; Bai, ZB; Itokazu, T; Yamashita, T				Jin, Xuemei; Ishii, Hiroshi; Bai, Zhongbin; Itokazu, Takahide; Yamashita, Toshihide			Temporal Changes in Cell Marker Expression and Cellular Infiltration in a Controlled Cortical Impact Model in Adult Male C57BL/6 Mice	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CERVICAL LYMPH-NODES; FUNCTIONAL RECOVERY; IMMUNE-RESPONSE; T-CELLS; INFLAMMATION; MICROGLIA; SYSTEM; CNS	Background: Traumatic injury to the central nervous system (CNS) triggers a robust inflammatory response that leads to axonal damage and secondary degeneration of spared tissue. In contrast, some immune responses have neuroprotective effects. However, detailed information regarding the dynamics of immune responses after traumatic CNS injury is still unavailable. Methods: In the present study, changes in the immune cells present in the injured brain, spleen, and cervical lymph nodes (CLNs), which are draining lymphatic organs from the CNS, were analyzed after controlled cortical impact (CCI) by flow cytometry and immunohistochemistry. Results: The number of neutrophils and macrophages that infiltrated the injured brain immediately increased 1 d post-injury and declined rapidly thereafter. In the injured brain, resident microglia showed a bimodal increase during the first week and in the chronic phase (>= 3 weeks) after injury. Increase in the Iba-1(+) microglia/macrophages was observed around the injured site. Morphologic analysis showed that Iba-1(+) cells were round at 1 week, whereas those at 3 weeks were more ramified. Furthermore, CD86(+)/CD11b(+) M1-like microglia increased at 4 weeks after CCI, whereas CD206(+)/CD11b(+) M2-like microglia increased at 1 week. These results suggest that different subsets of microglia increased in the acute and chronic phases after CCI. Dendritic cells and T cells increased transiently within 1 week in the injured brain. In the CLNs and the spleen, T cells showed dynamic changes after CCI. In particular, the alteration in the number of T cells in the CLNs showed a similar pattern, with a 1-week delay, to that of microglia in the injured brain. Conclusion: The data from this study provide useful information on the dynamics of immune cells in CNS injuries.	[Jin, Xuemei; Ishii, Hiroshi; Itokazu, Takahide; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Jin, Xuemei; Ishii, Hiroshi; Itokazu, Takahide; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan; [Bai, Zhongbin] Yunnan Agr Univ, Key Lab Puer Tea Sci, Minist Educ, Kunming, Peoples R China	Osaka University; Japan Science & Technology Agency (JST); Yunnan Agricultural University	Jin, XM (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	; Schierup, Mikkel Heide/F-1675-2010; Zhang, Guojie/J-7273-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; FANG, Xiaodong/K-6743-2018	Meng, Yuhuan/0000-0001-7464-3103; Schierup, Mikkel Heide/0000-0002-5028-1790; Zhang, Guojie/0000-0001-6860-1521; Wang, Jun/0000-0002-2113-5874; Yamashita, Toshihide/0000-0003-4559-7018; Wang, Jun/0000-0002-8540-8931; He, Mingze/0000-0002-8164-2480; Mailund, Thomas/0000-0001-6206-9239; Jin, Xin/0000-0001-7554-4975; Hvilsom, Christina/0000-0001-7870-6888; FANG, Xiaodong/0000-0001-7061-3337; Itokazu, Takahide/0000-0003-2977-7190	Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arneth BM, 2010, J NEUROIMMUNOL, V219, P123, DOI 10.1016/j.jneuroim.2009.12.011; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; Dardiotis E, 2012, BRAIN INJURY PATHOGE; De Haas AH, 2007, GLIA, V55, P1374, DOI 10.1002/glia.20554; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; FORD AL, 1995, J IMMUNOL, V154, P4309; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hatterer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003321; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Herz J, 2010, EXP NEUROL, V225, P9, DOI 10.1016/j.expneurol.2009.11.019; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nguyen HX, 2011, JOVE-J VIS EXP, DOI 10.3791/2698; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Sagar D, 2012, J NEUROIMMUNE PHARM, V7, P74, DOI 10.1007/s11481-011-9302-7; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Schwartz M, 2005, ACTA NEUROCHIR SUPPL, V93, P147; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Soares HD, 1995, J NEUROSCI, V15, P8223; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; WIDNER H, 1988, SCAND J IMMUNOL, V28, P563, DOI 10.1111/j.1365-3083.1988.tb01488.x; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; YAMADA S, 1991, AM J PHYSIOL, V261, pH1197, DOI 10.1152/ajpheart.1991.261.4.H1197; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	48	135	140	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41892	10.1371/journal.pone.0041892	http://dx.doi.org/10.1371/journal.pone.0041892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911864	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300081
J	Ma, JW; Huang, CM; Yao, XX; Shi, C; Sun, LF; Yuan, L; Lei, P; Zhu, HF; Liu, HB; Wu, XW; Ning, Q; Zhou, C; Shen, GX				Ma, Jingwei; Huang, Chunmei; Yao, Xinxin; Shi, Chuan; Sun, Lifang; Yuan, Lu; Lei, Ping; Zhu, Huifen; Liu, Hongbo; Wu, Xiongwen; Ning, Qin; Zhou, Chun; Shen, Guanxin			Inhibition of Hepatitis B Virus and Induction of Hepatoma Cell Apoptosis by ASGPR-Directed Delivery of shRNAs	PLOS ONE			English	Article							SMALL INTERFERING RNAS; ASIALOGLYCOPROTEIN RECEPTOR; INCREASES MIGRATION; NATURAL-HISTORY; PROTEIN-X; SURVIVIN; GENE; EXPRESSION; LIVER; SIRNA	Hepatitis B virus (HBV) infection is a worldwide liver disease and nearly 25% of chronic HBV infections terminate in hepatocellular carcinoma (HCC). Currently, there is no effective therapy to inhibit HBV replication and to eliminate hepatoma cells, making it highly desired to develop novel therapies for these two stages of the HBV-caused detrimental disease. Recently, short hairpin RNA (shRNA) has emerged as a potential therapy for virus-infected disease and cancer. Here, we have generated a shRNA, pGenesil-siHBV4, which effectively inhibits HBV replication in the human hepatoma cell line HepG2.2.15. The inhibitory effects of pGenesil-siHBV4 are manifested by the decrease of both the HBV mRNA level and the protein levels of the secreted HBV surface antigen (HBsAg) and HBV e antigen (HBeAg), and by the reduction of secreted HBV DNA. Using mouse hydrodynamic tail vein injection, we demonstrate that pGenesil-siHBV4 is effective in inhibiting HBV replication in vivo. Because survivin plays a key role in cancer cell escape from apoptosis, we further generated pGenesil-siSurvivin, a survivin-silencing shRNA, and showed its effect of triggering apoptosis of HBV-containing hepatoma cells. To develop targeted shRNA therapy, we have identified that as a specific binder of the asialoglycoprotein receptor (ASGPR), jetPEI-Hepatocyte delivers pGenesil-siHBV4 and pGenesil-siSurvivin specifically to hepatocytes, not other types of cells. Finally, co-transfection of pGenesil-siHBV4 and pGenesil-siSurvivin exerts synergistic effects in inducing hepatoma cell apoptosis, a novel approach to eliminate hepatoma by downregulating survivin via multiple mechanisms. The application of these novel shRNAs with the jetPEI-Hepatocyte targeting strategy demonstrates the proof-of-principle for a promising approach to inhibit HBV replication and eliminate hepatoma cells with high specificity.	[Zhou, Chun] Columbia Univ, Dept Environm Hlth Sci, New York, NY 10027 USA; [Ma, Jingwei; Huang, Chunmei; Yao, Xinxin; Shi, Chuan; Sun, Lifang; Yuan, Lu; Lei, Ping; Zhu, Huifen; Liu, Hongbo; Wu, Xiongwen; Shen, Guanxin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	Columbia University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhou, C (corresponding author), Columbia Univ, Dept Environm Hlth Sci, New York, NY 10027 USA.	cz2132@columbia.edu; guanxin_shen@yahoo.com.cn	shen, Guanxin/F-7441-2011	Liu, Hongbo/0000-0002-7187-8115	Program for Changjiang Scholars and Innovative Research Team in University [IRT1131]; State Project on Major Infectious Diseases Prevention [2012ZX10002006-003]; International Science & Technology Cooperation Program of China [2011DFA31030]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State Project on Major Infectious Diseases Prevention; International Science & Technology Cooperation Program of China	This research work was supported by Program for Changjiang Scholars and Innovative Research Team in University (Grant, No: IRT1131), State Project on Major Infectious Diseases Prevention (Grant 2012ZX10002006-003), and the International Science & Technology Cooperation Program of China (2011DFA31030). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Budker VG, 2006, J GENE MED, V8, P874, DOI 10.1002/jgm.920; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Chen Y, 2004, WORLD J GASTROENTERO, V10, P82; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; Gong Q, 2011, DNA CELL BIOL, V30, P347, DOI 10.1089/dna.2010.1172; Guan SH, 2007, WORLD J GASTROENTERO, V13, P228, DOI 10.3748/wjg.v13.i2.228; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ikeguchi M, 2002, DIAGN MOL PATHOL, V11, P33, DOI 10.1097/00019606-200203000-00007; KANEKO S, 1988, J VIROL, V62, P3979, DOI 10.1128/JVI.62.11.3979-3984.1988; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim EM, 2005, J CONTROL RELEASE, V108, P557, DOI 10.1016/j.jconrel.2005.09.001; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Li Donghua, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P383; Li L, 2009, MOL BIOSYST, V5, P1361, DOI 10.1039/b903428e; Liu FJ, 2007, WORLD J GASTROENTERO, V13, P5324, DOI 10.3748/wjg.v13.i40.5324; Liu HY, 2007, CANCER BIOL THER, V6, P697; Liu YQ, 2009, MOL THER, V17, P269, DOI 10.1038/mt.2008.266; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Masiero M, 2007, MOL ASPECTS MED, V28, P143, DOI 10.1016/j.mam.2006.12.004; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Nguyen DH, 2008, J CELL PHYSIOL, V216, P289, DOI 10.1002/jcp.21416; NISHIKAWA M, 1995, AM J PHYSIOL-GASTR L, V268, pG849, DOI 10.1152/ajpgi.1995.268.5.G849; O'Driscoll L, 2003, CURR CANCER DRUG TAR, V3, P131, DOI 10.2174/1568009033482038; Pan XF, 2011, MOL IMMUNOL, V48, P1573, DOI 10.1016/j.molimm.2011.03.012; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shu Y, 2011, MOL THER, V19, P1304, DOI 10.1038/mt.2011.23; Shu Y, 2011, METHODS, V54, P204, DOI 10.1016/j.ymeth.2011.01.008; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; Zhang R, 2010, CANCER GENE THER, V17, P275, DOI 10.1038/cgt.2009.68; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031458; Zhou Y, 2010, J BIOL CHEM, V285, P12159, DOI 10.1074/jbc.M109.067629	50	76	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46096	10.1371/journal.pone.0046096	http://dx.doi.org/10.1371/journal.pone.0046096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094023	gold, Green Published, Green Submitted			2022-12-27	WOS:000310050200007
J	Yueh, MF; Li, T; Evans, RM; Hammock, B; Tukey, RH				Yueh, Mei-Fei; Li, Tao; Evans, Ronald M.; Hammock, Bruce; Tukey, Robert H.			Triclocarban Mediates Induction of Xenobiotic Metabolism through Activation of the Constitutive Androstane Receptor and the Estrogen Receptor Alpha	PLOS ONE			English	Article							WASTE-WATER TREATMENT; UDP-GLUCURONOSYLTRANSFERASE-1 UGT1 LOCUS; INHIBITORY CROSS-TALK; NUCLEAR RECEPTOR; IN-VITRO; ANTIMICROBIAL TRICLOCARBAN; SIGNALING PATHWAY; GENE-EXPRESSION; TRANSGENIC MICE; HUMAN LIVER	Triclocarban (3,4,4'-trichlorocarbanilide, TCC) is used as a broad-based antimicrobial agent that is commonly added to personal hygiene products. Because of its extensive use in the health care industry and resistance to degradation in sewage treatment processes, TCC has become a significant waste product that is found in numerous environmental compartments where humans and wildlife can be exposed. While TCC has been linked to a range of health and environmental effects, few studies have been conducted linking exposure to TCC and induction of xenobiotic metabolism through regulation by environmental sensors such as the nuclear xenobiotic receptors (XenoRs). To identify the ability of TCC to activate xenobiotic sensors, we monitored XenoR activities in response to TCC treatment using luciferase-based reporter assays. Among the XenoRs in the reporter screening assay, TCC promotes both constitutive androstane receptor (CAR) and estrogen receptor alpha (ER alpha) activities. TCC treatment to hUGT1 mice resulted in induction of the UGT1A genes in liver. This induction was dependent upon the constitutive active/androstane receptor (CAR) because no induction occurred in hUGT1Car(-/-) mice. Induction of the UGT1A genes by TCC corresponded with induction of Cyp2b10, another CAR target gene. TCC was demonstrated to be a phenobarbital-like activator of CAR in receptor-based assays. While it has been suggested that TCC be classified as an endocrine disruptor, it activates ER alpha leading to induction of Cyp1b1 in female ovaries as well as in promoter activity. Activation of ER alpha by TCC in receptor-based assays also promotes induction of human CYP2B6. These observations demonstrate that TCC activates nuclear xenobiotic receptors CAR and ER alpha both in vivo and in vitro and might have the potential to alter normal physiological homeostasis. Activation of these xenobiotic-sensing receptors amplifies gene expression profiles that might represent a mechanistic base for potential human health effects from exposure to TCC.	[Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Chem, Lab Environm Toxicol, La Jolla, CA 92037 USA; [Li, Tao; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hammock, Bruce] Univ Calif Davis, Ctr Canc, Dept Entomol, Davis, CA 95616 USA; [Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Biochem, Lab Environm Toxicol, La Jolla, CA 92037 USA; [Yueh, Mei-Fei; Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California Davis; Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Yueh, MF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Pharmacol, Lab Environm Toxicol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rtukey@ucsd.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Evans, Richard/0000-0002-8651-6889	United States Public Health Service [P42ES010337]; ARRA Supplement [P42ES010337, P42ES004699, GM086713]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100481, R01GM086713] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); ARRA Supplement; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by United States Public Health Service Grants P42ES010337 (RE and RHT), a 2009 ARRA Supplement to Superfund grant P42ES010337 (RHT and MFY) and P42ES004699 (BDH), and GM086713 (RHT). BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Cai HL, 2010, DRUG METAB DISPOS, V38, P879, DOI 10.1124/dmd.109.030130; Carthew P, 1998, TOXICOL SCI, V44, P46, DOI 10.1093/toxsci/44.1.46; Chen F, 2011, ENVIRON POLLUT, V159, P1490, DOI 10.1016/j.envpol.2011.03.016; Chen JG, 2008, ENDOCRINOLOGY, V149, P1173, DOI 10.1210/en.2007-1057; Chen SJ, 2005, J BIOL CHEM, V280, P37547, DOI 10.1074/jbc.M506683200; Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68; Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Giudice BD, 2010, ENVIRON TOXICOL CHEM, V29, P966, DOI 10.1002/etc.105; Halden RU, 2005, ENVIRON SCI TECHNOL, V39, P1420, DOI 10.1021/es049071e; Heidler J, 2008, ENVIRON SCI TECHNOL, V42, P6324, DOI 10.1021/es703008y; Heidler J, 2006, ENVIRON SCI TECHNOL, V40, P3634, DOI 10.1021/es052245n; Higgins CP, 2009, ENVIRON TOXICOL CHEM, V28, P2580, DOI 10.1897/09-013.1; HILES RA, 1978, DRUG METAB DISPOS, V6, P177; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Kumar KS, 2010, ARCH ENVIRON CON TOX, V58, P275, DOI 10.1007/s00244-009-9383-y; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Liu JY, 2011, TOXICOL APPL PHARM, V255, P200, DOI 10.1016/j.taap.2011.06.017; Lo R, 2010, BBA-GENE REGUL MECH, V1799, P469, DOI 10.1016/j.bbagrm.2010.01.005; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Min GS, 2002, J BIOL CHEM, V277, P34626, DOI 10.1074/jbc.M205239200; Nguyen N, 2008, J BIOL CHEM, V283, P7901, DOI 10.1074/jbc.M709244200; Perencevich EN, 2001, AM J INFECT CONTROL, V29, P281, DOI 10.1067/mic.2001.115469; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Schebb NH, 2011, ENVIRON SCI TECHNOL, V45, P3109, DOI 10.1021/es103650m; Scientific Commitee on Consumer Products (2005) SCCP, 2005, SCCP085104; Senekeo-Effenberger K, 2007, DRUG METAB DISPOS, V35, P419, DOI 10.1124/dmd.106.013243d; Strassburg CP, 1997, MOL PHARMACOL, V52, P212, DOI 10.1124/mol.52.2.212; Strassburg CP, 1998, MOL PHARMACOL, V54, P647; Strassburg CP, 1997, CANCER RES, V57, P2979; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Tukey RH, 2001, MOL PHARMACOL, V59, P405, DOI 10.1124/mol.59.3.405; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yueh MF, 2011, MOL PHARMACOL, V79, P1053, DOI 10.1124/mol.110.070649; Yueh MF, 2007, J BIOL CHEM, V282, P8749, DOI 10.1074/jbc.M610790200	51	59	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37705	10.1371/journal.pone.0037705	http://dx.doi.org/10.1371/journal.pone.0037705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22912892	Green Published, gold			2022-12-27	WOS:000305350000007
